10027919	0	(ROOT (S (NP (NNP Doc_10027919_0_16_Chemical)) (VP (VBZ suppresses) (NP (NNS Doc_10027919_28_57_Disease)) (PP (IN without) (S (VP (VBG inducing) (NP (NNS Doc_10027919_75_92_Disease)) (PP (IN in) (NP (NP (NNS dogs)) (PP (IN with) (NP (NNS Doc_10027919_106_119_Disease))))))))) (. .)))
10027919	1	(ROOT (S (NP (JJ Doc_10027919_133_143_Chemical) (NN therapy)) (VP (VP (VBZ suppresses) (NP (NP (NN serum) (NNS levels)) (PP (IN of) (NP (NP (JJ parathyroid) (NN hormone)) (PRN (-LRB- -LRB-) (NP (NNP PTH)) (-RRB- -RRB-))))) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NNS Doc_10027919_222_235_Disease)))))) (CC but) (VP (VBZ has) (NP (JJ several) (NNS drawbacks)) (, ,) (PP (VBG including) (NP (NP (JJ Doc_10027919_273_286_Disease) (JJ and/or) (JJ marked) (NNS Doc_10027919_301_329_Disease)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (MD may) (VP (VB lead) (PP (TO to) (NP (NNS Doc_10027919_349_370_Disease))))))))))) (. .)))
10027919	2	(ROOT (S (NP (NP (DT A) (JJ new) (JJ Doc_10027919_378_387_Chemical) (NN analogue)) (, ,) (NP (NP (NNS Doc_10027919_398_414_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_10027919_416_419_Chemical)) (-RRB- -RRB-))) (, ,)) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB have) (NP (JJ promising) (NNS characteristics)))))))) (. .)))
10027919	3	(ROOT (S (NP (DT This) (NN study)) (VP (VBD was) (VP (VBN undertaken) (S (VP (TO to) (VP (VB determine) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NNP OCT)))) (PP (IN on) (NP (NP (NNP serum) (NNP PTH) (NNS levels)) (CC and) (NP (NN bone) (NN turnover)))) (PP (IN in) (NP (NP (NNS states)) (PP (IN of) (NP (NP (JJ normal)) (CC or) (NP (NNS Doc_10027919_591_614_Disease))))))))))) (. .)))
10027919	4	(ROOT (S (NP (CD Sixty) (NNS dogs)) (VP (VBD were) (ADJP (ADJP (ADJP (RB either) (JJ nephrectomized)) (PRN (-LRB- -LRB-) (NP (NNP Nx)) (, ,) (NP (NNP N) (NNP =) (NNP 38)) (-RRB- -RRB-))) (CC or) (ADJP (ADJP (JJ sham-operated)) (PRN (-LRB- -LRB-) (NP (NP (NNP Sham)) (, ,) (NP (NNP N) (NNP =) (CD 22))) (-RRB- -RRB-))))) (. .)))
10027919	5	(ROOT (S (NP (DT The) (NNS animals)) (VP (VBD received) (NP (JJ supplemental) (NNS Doc_10027919_743_752_Chemical)) (S (VP (TO to) (VP (VB enhance) (NP (NNP PTH) (NN secretion)))))) (. .)))
10027919	6	(ROOT (S (S (PP (NP (CD Fourteen) (NNS weeks)) (IN after) (NP (NP (DT the) (NN start)) (PP (IN of) (NP (JJ Doc_10027919_813_822_Chemical) (NN supplementation))))) (, ,) (NP (NP (NN half)) (PP (IN of) (NP (DT the) (NNP Nx) (CC and) (NNP Sham) (NNS dogs)))) (VP (VBD received) (NP (NP (NNS doses)) (PP (IN of) (NP (NP (NNS Doc_10027919_887_890_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (QP (CD three) (NNS times))) (PP (IN per) (NP (NN week)))) (-RRB- -RRB-))))))) (: ;) (S (NP (DT the) (JJ other) (NN half)) (VP (VBD were) (VP (VBN given) (NP (NP (NN vehicle)) (PP (IN for) (NP (CD 60) (NNS weeks))))))) (. .)))
10027919	7	(ROOT (S (ADVP (RB Thereafter)) (, ,) (NP (NP (DT the) (NN treatment) (NNS modalities)) (PP (IN for) (NP (NP (DT a) (NN subset)) (PP (IN of) (NP (NNS animals)))))) (VP (VBD were) (VP (VBN crossed) (PRT (RP over)) (PP (IN for) (NP (DT an) (JJ additional) (CD eight) (NNS months))))) (. .)))
10027919	8	(ROOT (S (S (NP (NP (JJ Biochemical) (CC and) (JJ hormonal) (NNS indices)) (PP (IN of) (NP (NNS Doc_10027919_1110_1117_Chemical) (CC and) (NN bone) (NN metabolism)))) (VP (VBD were) (VP (VBN measured) (PP (IN throughout) (NP (DT the) (NN study)))))) (, ,) (CC and) (S (NP (NN bone) (NNS biopsies)) (VP (VBD were) (VP (VBN done) (PP (PP (IN at) (NP (NN baseline))) (, ,) (PP (NP (CD 60) (NNS weeks)) (IN after) (NP (NNS Doc_10027919_1230_1233_Chemical) (CC or) (NN vehicle) (NN treatment))) (, ,) (CC and) (PP (IN at) (NP (NP (DT the) (NN end)) (PP (IN of) (NP (DT the) (NN crossover) (NN period))))))))) (. .)))
10027919	9	(ROOT (S (PP (IN In) (NP (NNP Nx) (NNS dogs))) (, ,) (NP (NNS Doc_10027919_1317_1320_Chemical)) (ADVP (RB significantly)) (VP (VBD decreased) (NP (NNP serum) (NNP PTH) (NNS levels)) (ADVP (RB soon)) (PP (IN after) (NP (NP (DT the) (NN induction)) (PP (IN of) (NP (NNS Doc_10027919_1390_1409_Disease)))))) (. .)))
10027919	10	(ROOT (S (PP (IN In) (NP (JJ long-standing) (NNS Doc_10027919_1428_1457_Disease))) (, ,) (NP (NP (NNP OCT)) (PRN (-LRB- -LRB-) (NP (CD 0.03) (NN microg/kg)) (-RRB- -RRB-))) (VP (VBD stabilized) (NP (NNP serum) (NNP PTH) (NNS levels)) (PP (IN during) (NP (DT the) (JJ first) (NNS months)))) (. .)))
10027919	11	(ROOT (S (S (NP (NNP Serum) (NNP PTH) (NNS levels)) (VP (VBD rose) (ADVP (RB thereafter)))) (, ,) (CC but) (S (NP (DT the) (NN rise)) (VP (VBD was) (ADJP (RBR less) (JJ pronounced)) (PP (VBN compared) (PP (IN with) (NP (NP (NN baseline)) (PP (IN than) (NP (NP (DT the) (NN rise)) (VP (VBN seen) (PP (IN in) (NP (NNP Nx) (NN control))))))))))) (. .)))
10027919	12	(ROOT (S (NP (DT These) (NNS effects)) (VP (VBD were) (VP (VBN accompanied) (PP (IN by) (NP (NP (NNS episodes)) (PP (IN of) (NP (NNS Doc_10027919_1703_1716_Disease) (CC and) (NNS Doc_10027919_1721_1738_Disease))))))) (. .)))
10027919	13	(ROOT (S (PP (IN In) (NP (NP (NNS animals)) (PP (IN with) (NP (JJ normal) (JJ renal) (NN function))))) (, ,) (NP (NNP OCT)) (VP (VBN induced) (NP (NP (DT a) (JJ transient) (NN decrease)) (PP (IN in) (NP (NNP serum) (NNP PTH) (NNS levels)))) (PP (IN at) (NP (NP (DT a) (NN dose)) (PP (IN of) (NP (NP (CD 0.1) (NN microg/kg)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD was) (RB not) (VP (VBN sustained) (PP (IN with) (S (VP (VBG lowering) (PP (IN of) (NP (DT the) (NNS doses))))))))))))))) (. .)))
10027919	14	(ROOT (S (PP (IN In) (NP (NNP Nx) (NNS dogs))) (, ,) (NP (NNS Doc_10027919_1924_1927_Chemical)) (VP (VP (VBD reversed) (NP (NP (JJ abnormal) (NN bone) (NN formation)) (, ,) (PP (JJ such) (IN as) (NP (NNS Doc_10027919_1970_1983_Disease) (CC and) (NNS Doc_10027919_1988_1996_Disease))))) (, ,) (CC but) (VP (VBD did) (RB not) (VP (ADVP (RB significantly)) (VB alter) (NP (NP (DT the) (NN level)) (PP (IN of) (NP (NN bone) (NN turnover))))))) (. .)))
10027919	15	(ROOT (S (PP (IN In) (NP (NN addition))) (, ,) (NP (NNS Doc_10027919_2071_2074_Chemical)) (VP (VBD improved) (NP (NP (NP (JJ mineralization) (NN lag) (NN time) (, ,)) (-LRB- -LRB-) (SBAR (WHNP (WDT that)) (S (VP (VBZ is)))) (, ,) (SBAR (WHNP (NP (DT the) (NN rate)) (WHPP (IN at) (WHNP (WDT which)))) (S (VP (VBD osteoid) (NP (NNS mineralizes))))) (-RRB- -RRB-)) (PP (IN in) (NP (DT both) (NNP Nx) (CC and) (NNP Sham) (NNS dogs))))) (. .)))
10027919	16	(ROOT (S (S (NP (DT These) (NNS results)) (VP (VBP indicate) (SBAR (IN that) (S (SBAR (RB even) (IN though) (S (NP (NNS Doc_10027919_2237_2240_Chemical)) (VP (VBZ does) (RB not) (ADVP (RB completely)) (VP (VB prevent) (NP (NP (DT the) (NN occurrence)) (PP (IN of) (NP (NP (NNS Doc_10027919_2287_2300_Disease)) (PP (IN in) (NP (JJ experimental) (NNS dogs)))))) (PP (IN with) (NP (NNS Doc_10027919_2327_2346_Disease))))))) (, ,) (NP (PRP it)) (VP (MD may) (VP (VB be) (PP (IN of) (NP (NP (NN use)) (PP (IN in) (NP (NP (DT the) (NN management)) (PP (IN of) (NP (NNS Doc_10027919_2386_2415_Disease))))))) (SBAR (IN because) (S (NP (PRP it)) (VP (VBZ does) (RB not) (VP (VB induce) (NP (NNS Doc_10027919_2443_2460_Disease)))))))))))) (CC and) (, ,) (S (ADVP (RB therefore)) (, ,) (VP (VBZ does) (RB not) (VP (VB increase) (NP (NP (DT the) (NN risk)) (PP (IN of) (NP (NNS Doc_10027919_2507_2528_Disease))))))) (. .)))
10074612	0	(ROOT (NP (NP (NNP Doc_10074612_0_11_Disease)) (, ,) (NP (NNS Doc_10074612_13_24_Disease)) (, ,) (CC and) (NP (NP (NNS Doc_10074612_30_38_Disease)) (PP (IN after) (NP (NP (JJ high-dose) (JJ intravenous) (NNS Doc_10074612_67_85_Chemical)) (PP (IN in) (NP (DT a) (JJ monitored) (NN patient)))))) (. .)))
10074612	1	(ROOT (S (NP (PRP We)) (VP (VBP report) (NP (NP (DT a) (NN case)) (PP (IN of) (NP (NNS Doc_10074612_130_141_Disease) (, ,) (NNS Doc_10074612_143_154_Disease) (, ,) (CC and) (NNS Doc_10074612_160_168_Disease)))) (PP (IN after) (NP (NP (JJ intravenous) (NN administration)) (PP (IN of) (NP (NP (JJ high-dose) (NNS Doc_10074612_215_233_Chemical)) (PP (IN in) (NP (NP (DT a) (JJ 73-year-old) (NN patient)) (SBAR (WHNP (WP who)) (S (VP (VBD underwent) (NP (NP (JJ electrocardiographic) (PRN (-LRB- -LRB-) (NP (NNP ECG)) (-RRB- -RRB-)) (NN monitoring)) (PP (IN throughout) (NP (DT the) (NN episode)))))))))))))) (. .)))
10074612	2	(ROOT (S (NP (EX There)) (VP (VBD was) (NP (NP (DT a) (NN history)) (PP (IN of) (NP (NP (JJ Doc_10074612_358_366_Disease) (NNS Doc_10074612_367_382_Disease)) (ADVP (NP (CD 9) (NNS years)) (RBR earlier)))))) (. .)))
10074612	3	(ROOT (S (NP (DT The) (NN patient)) (VP (VBD was) (VP (VBN admitted) (PP (IN with) (NP (NP (NP (DT a) (NNS Doc_10074612_432_456_Disease)) (PP (IN with) (NP (NNS Doc_10074612_462_472_Disease)))) (, ,) (NP (ADJP (RB rapidly) (VBN progressive)) (NNS Doc_10074612_494_507_Disease)) (, ,) (CC and) (NP (NP (NNS Doc_10074612_513_522_Disease)) (SBAR (WHNP (WDT that)) (S (VP (VBD required) (NP (JJ mechanical) (NN ventilation)) (PP (IN in) (NP (DT the) (JJ intensive) (NN care) (NN unit))))))))))) (. .)))
10074612	4	(ROOT (S (PP (IN After) (S (VP (VBG receiving) (NP (JJ advanced) (NN cardiopulmonary) (NN resuscitation))))) (, ,) (NP (DT the) (NN patient)) (VP (VBD recovered) (NP (JJ cardiac) (NN rhythm))) (. .)))
10074612	5	(ROOT (S (NP (DT The) (NNP ECG)) (VP (VBD showed) (NP (DT a) (JJ junctional) (NN rhythm)) (PP (IN without) (NP (NNS Doc_10074612_725_747_Disease)))) (. .)))
10074612	6	(ROOT (S (NP (DT This) (NN study)) (VP (VBZ reviews) (NP (NP (DT the) (JJ current) (VBN proposed) (NNS mechanisms)) (PP (IN of) (NP (NP (NNS Doc_10074612_803_815_Disease)) (PP (IN after) (NP (NP (DT a) (JJ high) (NN dose)) (PP (IN of) (NP (NP (JJ intravenous) (NNS Doc_10074612_849_867_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_10074612_869_873_Chemical)) (-RRB- -RRB-)))))))))) (. .)))
10074612	7	(ROOT (S (NP (DT These) (NNS mechanisms)) (VP (VBP are) (RB not) (VP (ADVP (RB well)) (VBN understood) (SBAR (IN because) (S (, ,) (PP (IN in) (NP (JJS most) (NNS cases))) (, ,) (NP (DT the) (NNS patients)) (VP (VBD were) (RB not) (VP (VBN monitored) (PP (IN at) (NP (NP (DT the) (NN moment)) (PP (IN of) (NP (DT the) (NN event))))))))))) (. .)))
10074612	8	(ROOT (S (S (NP (NNP Rapid) (NN infusion) (CC and) (JJ underlying) (NNS Doc_10074612_1031_1046_Disease)) (VP (VBD were) (NP (NP (JJ important) (NN risk) (NNS factors)) (PP (IN in) (NP (NP (DT the) (NN case)) (VP (VBN reported) (ADVP (RB here)))))))) (, ,) (CC and) (S (NP (DT the) (NNS authors)) (NP (NP (NN discount) (NNS Doc_10074612_1127_1149_Disease)) (PP (IN as) (NP (DT the) (JJ main) (NN mechanism))))) (. .)))
10091616	0	(ROOT (NP (NP (NN Worsening)) (PP (IN of) (NP (NN Doc_10091616_13_21_Chemical-induced) (NNS Doc_10091616_30_41_Disease))) (PP (IN by) (NP (NN motor) (CC and) (JJ mental) (NNS tasks))) (. .)))
10091616	1	(ROOT (S (NP (NP (CD Ten) (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBD had) (NP (NP (NNS Doc_10091616_90_109_Disease)) (PP (IN with) (NP (VBG disabling) (NNS Doc_10091616_125_135_Disease)))))))) (VP (VBD were) (VP (VBN included) (PP (IN in) (NP (DT this) (NN study))) (S (VP (TO to) (VP (VB evaluate) (NP (NP (NP (DT the) (NN role)) (PP (IN of) (NP (NP (JJ mental)) (PRN (-LRB- -LRB-) (NP (JJ mental) (NN calculation)) (-RRB- -RRB-)) (CC and) (NP (NN motor)) (PRN (-LRB- -LRB-) (NP (NP (NP (NN flexion/extension)) (PP (IN of) (NP (JJ right) (NNS fingers)))) (, ,) (NP (NP (NN flexion/extension)) (PP (IN of) (NP (JJ left) (NNS fingers)))) (, ,) (NP (NP (NN flexion/extension)) (PP (IN of) (NP (NP (DT the) (NN neck)) (, ,) (NP (NN speaking) (NNS aloud)))))) (-RRB- -RRB-))))) (NNS tasks)) (PP (IN on) (NP (NP (DT the) (VBG worsening)) (PP (IN of) (NP (NP (JJ peak-dose) (NNS Doc_10091616_381_391_Disease)) (PP (VBG following) (NP (NP (NN administration)) (PP (IN of) (NP (NP (DT an) (JJ effective) (JJ single) (NN dose)) (PP (IN of) (NP (NNS Doc_10091616_448_459_Chemical)))))))))))))))) (. .)))
10091616	2	(ROOT (S (PP (VBN Compared) (PP (IN with) (NP (NP (DT the) (NN score)) (PP (IN at) (NP (NP (NN rest)) (PRN (-LRB- -LRB-) (NP (QP (CD 1.3) (CD +)) (NN /) (NN -0.3)) (-RRB- -RRB-))))))) (, ,) (NP (NP (DT a) (JJ significant) (NN aggravation)) (PP (IN of) (NP (DT the) (JJ Doc_10091616_539_549_Disease) (NN score)))) (VP (VBD was) (VP (VP (VBN observed) (PP (IN during) (NP (NP (NP (VBG speaking) (NNS aloud)) (PRN (-LRB- -LRB-) (NP (CD 5.2) (NNS +)) (: /) (NP (NP (CD -1.1)) (, ,) (NP (NNP p) (NNP <) (NNP 0.05))) (-RRB- -RRB-))) (, ,) (NP (NP (NNS movements)) (PP (IN of) (NP (NP (NN right)) (PRN (-LRB- -LRB-) (NP (CD 4.5) (NNS +)) (: /) (NP (NP (CD -1.0)) (, ,) (NP (NNP p) (NNP <) (NNP 0.05))) (-RRB- -RRB-)))))))) (CC and) (VP (VBN left) (NP (PRN (-LRB- -LRB-) (NP (CD 3.7) (NNS +)) (: /) (NP (NP (CD -0.8)) (, ,) (NP (NNP p) (NNP <) (NNP 0.05))) (-RRB- -RRB-)) (NNS fingers))) (, ,) (NP (NP (NP (NNS movements)) (PP (IN of) (NP (NP (DT the) (NN neck)) (PRN (-LRB- -LRB-) (NP (CD 5.1) (NNS +)) (: /) (NP (NP (CD -1.0)) (, ,) (NP (NNP p) (NNP <) (NNP 0.05))) (-RRB- -RRB-))))) (, ,) (CC and) (NP (NP (JJ mental) (NN calculation)) (PRN (-LRB- -LRB-) (NP (CD 3.1) (NNS +)) (: /) (NP (NP (CD -1.0)) (, ,) (NP (NNP p) (NNP <) (NNP 0.05))) (-RRB- -RRB-)))))) (. .)))
10091616	3	(ROOT (S (NP (DT These) (NNS results)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NP (NN activation) (NNS tasks)) (PP (JJ such) (IN as) (`` ``) (NP (NN speaking)))) (VP (ADVP (RB aloud)) ('' '') (MD could) (VP (VB be) (VP (VBN used) (PP (IN for) (NP (NP (JJ objective) (NN assessment)) (PP (IN of) (NP (JJ Doc_10091616_887_897_Disease) (NN severity))))))))))) (. .)))
10193809	0	(ROOT (NP (NP (NNP Urine) (NNP N-acetyl-beta-D-glucosaminidase)) (: --) (NP (NP (DT a) (NN marker)) (PP (IN of) (NP (JJ tubular) (NN damage)))) (. ?)))
10193809	1	(ROOT (S (SBAR (IN Although) (S (NP (NP (DT an) (NN indicator)) (PP (IN of) (NP (NP (NNS Doc_10193809_104_129_Disease)) (, ,) (NP (DT an) (VBN increased) (ADJP (ADJP (RB urinary) (JJ Doc_10193809_152_160_Chemical-beta-D-glucosaminidase)) (PRN (-LRB- -LRB-) (NP (NNP NAG)) (-RRB- -RRB-))) (NN activity))))) (VP (MD might) (VP (VB reflect))))) (VP (VBD increased) (NP (JJ lysosomal) (NN activity)) (PP (IN in) (NP (JJ renal) (JJ tubular) (NNS cells)))) (. .)))
10193809	2	(ROOT (S (NP (NP (NNP Doc_10193809_275_300_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_10193809_302_305_Chemical)) (-RRB- -RRB-))) (VP (VBD was) (VP (VBN administered) (PP (TO to) (NP (NNP Sprague) (NNP Dawley) (NNS rats))) (S (VP (TO to) (VP (VB induce) (NP (NNS Doc_10193809_357_368_Disease))))))) (. .)))
10193809	3	(ROOT (S (NP (NP (JJ Total) (NN protein) (, ,) (NN albumin) (, ,) (NNP NAG) (NN activity) (CC and) (NN protein)) (NP (JJ electrophoretic) (NN pattern))) (VP (VBD were) (VP (VBN assessed) (PP (IN in) (NP (NP (JJ daily) (NN urine) (NNS samples)) (PP (IN for) (NP (CD 33) (NNS days))))))) (. .)))
10193809	4	(ROOT (S (S (NP (NP (DT The) (JJ morphological) (NN appearance)) (PP (IN of) (NP (DT the) (NNS kidneys)))) (VP (VBD was) (ADJP (JJ examined) (PP (IN on) (NP (NNS days))) (NP (CD three) (, ,) (CD four) (, ,) (CD six) (, ,) (CD eight) (CC and) (CD thirty))) (NP (CD three)))) (CC and) (S (NP (DT the) (NNP NAG)) (VP (VBP isoenzyme) (ADJP (JJ patterns) (PP (IN on) (NP (NNS days))) (NP (CD zero) (, ,) (CD four) (, ,) (CD eight) (CC and) (CD thirty))) (NP (CD three)))) (. .)))
10193809	5	(ROOT (S (PP (VBG Following) (NP (NP (JJ intravenous) (JJ Doc_10193809_705_708_Chemical) (NN urine) (NN volume)) (CC and) (NP (NNP urine) (NNP NAG)))) (NP (NN activity)) (VP (VP (VBD increased) (ADVP (RB significantly)) (PP (IN by) (NP (NN day) (CD two)))) (, ,) (CC but) (VP (VBD returned) (S (VP (TO to) (VP (ADJP (JJ normal)) (PP (IN by) (NP (NN day) (CD four)))))))) (. .)))
10193809	6	(ROOT (S (PP (IN After) (NP (NN day) (CD four))) (NP (DT all)) (VP (VBD treated) (SBAR (S (NP (NNS animals)) (VP (VBD exhibited) (NP (DT a) (JJ marked) (NN rise)) (PP (IN in) (NP (NP (NN urine) (NN albumin)) (, ,) (NP (JJ total) (NN protein) (NN excretion)) (CC and) (NP (NNP NAG) (NN activity)))))))) (. .)))
10193809	7	(ROOT (S (NP (NNS Electrophoresis)) (VP (VBD showed) (NP (DT a) (JJ generalised) (NN increase)) (PP (IN in) (NP (NP (NN middle)) (CC and) (NP (JJ high) (JJ molecular) (NN weight) (NN urine) (NNS proteins)))) (PP (IN from) (NP (NN day) (CD four) (NNS onwards)))) (. .)))
10193809	8	(ROOT (S (NP (NN Protein) (NNS droplets)) (ADVP (RB first)) (VP (VBD appeared) (ADJP (JJ prominent) (PP (IN in) (NP (JJ tubular) (NNS cells)))) (PP (IN on) (NP (NN day) (CD four)))) (. .)))
10193809	9	(ROOT (S (NP (NP (NNP Peak) (NNP urine) (NNP NAG) (NN activity)) (CC and) (NP (DT a) (NAC (NN change) (PP (IN in) (NP (NNP NAG)))) (NN isoenzyme) (NN pattern))) (VP (VBD coincided) (PP (IN with) (NP (NP (PDT both) (DT the) (JJ peak) (NNS Doc_10193809_1219_1230_Disease)) (CC and) (NP (DT the) (NN reduction)))) (PP (IN in) (NP (NN intracellular) (NN protein) (CC and) (NN NAG) (NNS droplets))) (PRN (-LRB- -LRB-) (NP (NP (NN day)) (NP (CD six) (NNS onwards))) (-RRB- -RRB-))) (. .)))
10193809	10	(ROOT (S (NP (DT This) (NN animal) (NN model)) (VP (VBZ demonstrates) (SBAR (IN that) (S (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (NP (JJ lysosomal) (NN turnover)) (CC and) (NP (RB hence) (NN urine) (NN NAG) (NN activity))))) (, ,) (VP (VBZ occurs) (SBAR (WHADVP (WRB when)) (S (NP (VBN increased) (NN protein)) (VP (VBZ is) (VP (VBN presented) (PP (TO to) (NP (DT the) (JJ tubular) (NNS cells))))))))))) (. .)))
10193809	11	(ROOT (S (NP (NNP Urine) (NNP NAG) (NN activity)) (VP (VBZ is) (ADVP (RB thus)) (NP (NP (NP (DT a) (NN measure)) (PP (IN of) (NP (NP (VBN altered) (NN function)) (PP (IN in) (NP (DT the) (JJ renal) (NNS tubules)))))) (CC and) (ADVP (RB not) (JJ simply)) (NP (NP (DT an) (NN indicator)) (PP (IN of) (NP (NN damage)))))) (. .)))
10225068	0	(ROOT (NP (NP (NP (NNP Doc_10225068_0_21_Disease)) (PP (IN after) (NP (NP (JJ spinal) (NN anaesthesia)) (PP (IN with) (NP (JJ hyperbaric) (ADJP (CD 5) (NN %)) (NNS Doc_10225068_66_76_Chemical)))))) (: :) (NP (NP (DT a) (NN review)) (PP (IN of) (NP (NP (CD six) (NNS cases)) (PP (IN of) (NP (NP (NNS Doc_10225068_103_124_Disease)) (VP (VBN reported) (PP (TO to) (NP (DT the) (NNP Swedish) (NNP Pharmaceutical) (NNP Insurance) (NNP 1993-1997))))))))) (. .)))
10225068	1	(ROOT (S (NP (NP (CD Six) (NNS cases)) (PP (IN of) (NP (NP (NNS Doc_10225068_198_219_Disease)) (PP (IN with) (NP (VBG varying) (NN severity)))))) (VP (VBD were) (VP (VBN reported) (PP (TO to) (NP (DT the) (NNP Swedish) (NNP Pharmaceutical) (NNP Insurance))) (PP (IN during) (NP (DT the) (NN period) (CD 1993-1997))))) (. .)))
10225068	2	(ROOT (S (NP (DT All)) (VP (VBD were) (VP (VBN associated) (PP (IN with) (NP (JJ spinal) (NN anaesthesia))) (S (VP (VBG using) (NP (JJ hyperbaric) (ADJP (CD 5) (NN %)) (NNS Doc_10225068_389_399_Chemical)))))) (. .)))
10225068	3	(ROOT (S (S (NP (CD Five) (NNS cases)) (VP (VBD had) (NP (JJ single-shot) (JJ spinal) (NN anaesthesia)))) (CC and) (S (NP (PRP one)) (VP (VBD had) (NP (NP (DT a) (NN repeat) (NN spinal)) (ADJP (JJ anaesthetic) (JJ due))) (PP (TO to) (NP (JJ inadequate) (NN block))))) (. .)))
10225068	4	(ROOT (S (NP (NP (DT The) (NN dose)) (PP (IN of) (NP (NP (JJ hyperbaric) (ADJP (CD 5) (NN %)) (NNS Doc_10225068_538_548_Chemical)) (VP (VBN administered))))) (VP (VBD ranged) (PP (IN from) (NP (QP (CD 60) (TO to) (CD 120)) (NN mg)))) (. .)))
10225068	5	(ROOT (S (NP (NP (CD Three)) (PP (IN of) (NP (DT the) (NNS cases)))) (VP (VBD were) (ADVP (RBS most) (RB likely)) (VP (VBN caused) (PP (IN by) (NP (NP (JJ direct) (NNS Doc_10225068_641_654_Disease)) (PP (IN of) (NP (JJ hyperbaric) (ADJP (CD 5) (NN %)) (NNS Doc_10225068_672_682_Chemical))))))) (. .)))
10225068	6	(ROOT (S (S (PP (IN In) (NP (DT the) (JJ other) (CD 3) (NNS cases))) (, ,) (NP (JJ direct) (NNS Doc_10225068_713_726_Disease)) (VP (VBD was) (ADVP (RB also)) (ADJP (JJ probable)))) (, ,) (CC but) (S (ADVP (RB unfortunately)) (NP (JJ radiological) (NNS investigations)) (VP (VBD were) (RB not) (VP (VBN done) (S (VP (TO to) (VP (ADVP (RB definitely)) (VB exclude) (NP (DT a) (JJ compressive) (NN aetiology)))))))) (. .)))
10225068	7	(ROOT (S (NP (DT All) (NNS cases)) (VP (VBD sustained) (NP (JJ permanent) (NNS Doc_10225068_883_904_Disease))) (. .)))
10225068	8	(ROOT (S (NP (PRP We)) (VP (VBP recommend) (SBAR (IN that) (S (NP (JJ hyperbaric) (NNS Doc_10225068_935_945_Chemical)) (VP (MD should) (VP (VB be) (VP (VBN administered) (PP (IN in) (S (NP (NP (NNS concentrations)) (UCP (RB not) (ADJP (QP (JJR greater) (IN than) (CD 2)) (NN %)) (CC and) (PP (IN at) (NP (DT a) (JJ total) (NN dose) (RB preferably))))) (RB not) (VP (VBG exceeding) (NP (CD 60) (NN mg))))))))))) (. .)))
10328196	0	(ROOT (NP (NP (NP (JJ Systemic) (NNS Doc_10328196_9_17_Disease)) (PP (VBG following) (NP (NP (NN administration)) (PP (IN of) (NP (NP (NP (NNS Doc_10328196_46_55_Chemical)) (PRN (-LRB- -LRB-) (NP (RB formerly) (NN Doc_10328196_66_75_Chemical)) (-RRB- -RRB-))) (PP (IN for) (NP (NNS Doc_10328196_81_90_Disease)))))))) (: :) (NP (NP (NN association)) (PP (IN of) (NP (NP (NNS Doc_10328196_107_130_Disease)) (PP (IN with) (NP (NP (NNS apoptosis)) (PP (IN of) (NP (JJ lesional) (NNS lymphocytes)))))))) (. .)))
10328196	1	(ROOT (S (NP (NP (NNP Doc_10328196_183_192_Chemical)) (PRN (-LRB- -LRB-) (NP (RB formerly) (NN Doc_10328196_203_212_Chemical)) (-RRB- -RRB-))) (VP (VBZ is) (NP (NP (DT an) (JJ immunosuppressive) (NN agent)) (SBAR (WHNP (WDT that)) (S (VP (VBZ interferes) (PP (IN with) (NP (JJ T-cell) (NN activation)))))))) (. .)))
10328196	2	(ROOT (S (PP (IN After) (NP (NP (CD 2) (NNS individuals)) (PP (IN with) (NP (NP (NNS Doc_10328196_309_318_Disease)) (VP (VBN developed) (NP (DT a) (JJ Doc_10328196_331_354_Disease) (JJ following) (NN treatment)) (PP (IN with) (NP (JJ oral) (NNS Doc_10328196_385_394_Chemical)))))))) (NP (NP (JJ lesional) (NN skin) (NNS cells)) (CC and) (NP (VBN activated) (JJ peripheral) (NN blood) (NNS cells))) (VP (VBD were) (VP (VBN analyzed) (PP (IN for) (NP (NP (NN induction)) (PP (IN of) (NP (NNS apoptosis))))))) (. .)))
10328196	3	(ROOT (S (NP (NP (DT A) (JJ keratome) (NN skin) (NN specimen)) (PP (IN from) (NP (NP (CD 1) (NN patient)) (PP (IN with) (NP (NN Doc_10328196_553_562_Chemical-induced) (NNS Doc_10328196_571_594_Disease)))))) (VP (VBD had) (NP (NP (DT a) (JJ 2.3-fold) (NN increase)) (PP (IN in) (NP (NP (NN percentage)) (PP (IN of) (NP (NP (JJ apoptotic) (NNS cells)) (PRN (-LRB- -LRB-) (PP (TO to) (NP (CD 48) (NN %))) (-RRB- -RRB-))))))) (PP (VBN compared) (PP (IN with) (NP (NP (DT an) (ADJP (JJ unaffected) (JJ Doc_10328196_689_698_Chemical-treated)) (NN patient)) (PP (IN with) (NP (NP (NNS Doc_10328196_720_729_Disease)) (PRN (-LRB- -LRB-) (NP (CD 21) (NN %)) (-RRB- -RRB-)))))))) (. .)))
10328196	4	(ROOT (S (NP (NP (JJ Activated) (JJ peripheral) (NN blood) (NN T) (NNS cells)) (PP (IN from) (NP (NP (NNS patients)) (PP (IN with) (NP (NNS Doc_10328196_791_800_Disease)))))) (VP (VBD tended) (S (VP (TO to) (VP (VB exhibit) (NP (NP (JJR greater) (NN spontaneous) (CC or) (NN Doc_10328196_842_855_Chemical-induced) (NNS apoptosis)) (SBAR (IN than) (SINV (VBD did) (NP (JJ normal) (NNP T) (NNS cells)))))))) (, ,) (PP (ADVP (RB particularly)) (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NNS Doc_10328196_931_940_Chemical)))))) (. .)))
10328196	5	(ROOT (S (NP (NP (JJ Severe) (JJ adverse) (NNS effects)) (PP (IN of) (NP (NNS Doc_10328196_981_990_Chemical)))) (VP (VBP include) (NP (NP (NNS Doc_10328196_999_1004_Disease)) (, ,) (NP (NNS Doc_10328196_1006_1012_Disease)) (, ,) (CC and) (NP (NNS Doc_10328196_1018_1041_Disease)))) (. .)))
10328196	6	(ROOT (S (NP (DT These) (NNS symptoms)) (VP (MD may) (VP (VP (VB be) (NP (NP (DT the) (NN result)) (PP (IN of) (NP (NP (JJ drug-induced) (NNS apoptosis)) (PP (IN of) (NP (NP (JJ lesional) (NNS leukocytes)) (, ,) (NP (RB especially) (VBN activated) (NN T) (NNS lymphocytes)))))))) (, ,) (CC and) (ADVP (RB possibly)) (VP (VB release) (PP (IN of) (NP (JJ inflammatory) (NNS mediators)))))) (. .)))
10328196	7	(ROOT (S (SBAR (IN Because) (S (NP (NP (NNS patients)) (PP (IN with) (NP (JJ severe) (NNS Doc_10328196_1239_1248_Disease)))) (VP (MD may) (VP (VB develop) (NP (NNS Doc_10328196_1261_1275_Disease)) (PP (IN from) (NP (JJ various) (JJ systemic) (NNS therapies))))))) (, ,) (NP (JJ clinical) (NN monitoring)) (VP (VBZ is) (ADJP (JJ advisable) (PP (IN for) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (NNS Doc_10328196_1360_1381_Disease)) (SBAR (WHNP (WP who)) (S (VP (VBP are) (VP (VBN treated) (PP (IN with) (NP (JJ immune) (NNS modulators))))))))))))) (. .)))
10354657	0	(ROOT (S (NP (NP (NN Effect)) (PP (IN of) (NP (NP (JJ Doc_10354657_10_17_Chemical) (NN maintenance) (NN therapy)) (PP (IN on) (NP (NN thyroid) (CC and) (NN parathyroid)))))) (VP (VBP function)) (. .)))
10354657	1	(ROOT (S (S (VP (TO To) (VP (VB assess) (NP (NNS changes))))) (VP (VBN induced) (PP (IN by) (NP (NP (JJ Doc_10354657_116_123_Chemical) (NN maintenance) (NN therapy)) (PP (IN on) (NP (NP (DT the) (NN incidence)) (PP (IN of) (NP (NN thyroid) (, ,) (NN parathyroid) (CC and) (NN ion) (NNS alterations)))))))) (. .)))
10354657	2	(ROOT (S (NP (DT These)) (VP (VBD were) (VP (VBN evaluated) (PP (IN with) (S (VP (VP (VBG respect) (PP (TO to) (NP (NP (DT the) (NN duration)) (PP (IN of) (NP (JJ Doc_10354657_259_266_Chemical) (NN therapy) (, ,) (NN age) (, ,) (NN sex) (, ,) (CC and) (NN family) (NN history)))))) (-LRB- -LRB-) (SBAR (IN whether) (CC or) (RB not) (S (NP (DT the) (NN patient)) (VP (VBD had) (NP (NP (DT a) (JJ first-degree) (NN relative)) (PP (IN with) (NP (NNS Doc_10354657_366_381_Disease))))))) (-RRB- -RRB-)))))) (. .)))
10354657	3	(ROOT (NP (JJ Prospective) (NN study) (. .)))
10354657	4	(ROOT (NP (NP (NNP Affective) (NNPS Disorders) (NNP Clinic)) (PP (IN at) (NP (NP (NP (NNP St.) (NNP Mary) (POS 's)) (NN Hospital)) (, ,) (NP (NNP Montreal)))) (. .)))
10354657	5	(ROOT (S (NP (NP (NP (CD One) (CD hundred) (CC and) (CD one) (NNS patients)) (PRN (-LRB- -LRB-) (NP (NP (CD 28) (NNS men)) (CC and) (NP (CD 73) (NNS women))) (-RRB- -RRB-))) (PP (IN with) (NP (NP (NNS Doc_10354657_547_563_Disease)) (VP (VBG receiving) (NP (NP (JJ Doc_10354657_574_581_Chemical) (NN maintenance) (NN therapy)) (VP (VBG ranging) (PP (IN from) (NP (CD 1))) (NP (NN year)))))))) (VP (VBZ 's) (PP (TO to) (NP (NP (CD 32) (NNS years) (POS ')) (NN duration)))) (. .)))
10354657	6	(ROOT (S (NP (DT The) (NN control) (NN group)) (VP (VBD consisted) (PP (IN of) (NP (NP (CD 82) (NNS patients)) (PP (IN with) (NP (DT no) (NNS Doc_10354657_698_709_Disease) (CC or) (NN endocrinological) (NNS diagnoses))))) (PP (IN from) (NP (NP (DT the) (NN hospital) (POS 's)) (JJ out-patient) (NNS clinics)))) (. .)))
10354657	7	(ROOT (NP (NP (NNP OUTCOME) (NNP MEASURES)) (: :) (NP (NP (NNP Laboratory) (NNS analyses)) (PP (IN of) (NP (JJ Doc_10354657_822_829_Chemical) (, ,) (JJ Doc_10354657_831_840_Chemical) (CC and) (JJ thyroid-stimulating) (NN hormone) (NNS levels))) (UCP (VP (VBN performed) (PP (IN before) (S (VP (VBG beginning) (NP (JJ Doc_10354657_907_914_Chemical) (NN therapy)))))) (CC and) (PP (IN at) (NP (JJ biannual) (NN follow-up))))) (. .)))
10354657	8	(ROOT (S (NP (NNP Doc_10354657_959_973_Disease)) (VP (VBD developed) (PP (IN in) (NP (CD 40) (NNS patients))) (, ,) (PP (VBG excluding) (NP (NP (CD 8) (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBD were) (NP (NP (NNS Doc_10354657_1030_1041_Disease)) (PP (IN at) (NP (NN baseline)))))))))) (. .)))
10354657	9	(ROOT (S (NP (NP (DT All) (NNS patients)) (VP (VBG having) (NP (NP (JJ first-degree) (NNS relatives)) (VP (VBN affected) (PP (IN by) (NP (NNS Doc_10354657_1110_1125_Disease))))))) (VP (VBD had) (VP (VBN accelerated) (NP (NP (NN onset)) (PP (IN of) (NP (NP (NP (NNS Doc_10354657_1151_1165_Disease)) (PRN (-LRB- -LRB-) (NP (NP (CD 3.7) (NNS years)) (PP (IN after) (NP (NN onset))) (PP (IN of) (NP (JJ Doc_10354657_1192_1199_Chemical) (NN therapy)))) (-RRB- -RRB-))) (PP (VBN compared) (PP (IN with) (NP (NP (NNS patients)) (PP (IN without) (NP (DT a) (NN family) (NN history)))))) (PRN (-LRB- -LRB-) (NP (NP (CD 8.6) (NNS years)) (PP (IN after) (NP (NN onset))) (PP (IN of) (NP (JJ Doc_10354657_1283_1290_Chemical) (NN therapy)))) (-RRB- -RRB-))))))) (. .)))
10354657	10	(ROOT (S (NP (NP (NNP Women)) (PP (IN over) (NP (NP (CD 60) (NNS years)) (PP (IN of) (NP (NN age)))))) (VP (VBD were) (ADVP (RBR more) (RB often)) (VP (VBN affected) (PP (IN by) (NP (NP (NNS Doc_10354657_1356_1370_Disease)) (PP (IN than) (NP (NNS women))))) (PP (IN under) (NP (NP (CD 60) (NNS years)) (PP (IN of) (NP (NP (NN age)) (PRN (-LRB- -LRB-) (NP (NP (CD 34.6) (NN %)) (CC versus) (NP (CD 31.9) (NN %))) (-RRB- -RRB-)))))))) (. .)))
10354657	11	(ROOT (S (NP (NP (JJ Doc_10354657_1426_1435_Chemical) (NNS levels)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN on) (NP (JJ Doc_10354657_1458_1465_Chemical) (NN treatment)))))) (VP (VBD were) (ADJP (JJ unchanged) (PP (IN from) (NP (NN baseline) (NNS levels))))) (. .)))
10354657	12	(ROOT (S (PP (IN After) (NP (JJ Doc_10354657_1519_1526_Chemical) (NN treatment))) (, ,) (NP (JJ Doc_10354657_1538_1545_Chemical) (NNS levels)) (VP (VBD were) (ADJP (JJR higher)) (PP (IN than) (NP (DT either) (NN baseline) (NNS levels) (CC or) (NN control) (NNS levels)))) (. .)))
10354657	13	(ROOT (S (ADVP (RB Thus)) (, ,) (NP (JJ Doc_10354657_1618_1625_Chemical) (NN treatment)) (VP (VBN counteracted) (NP (NP (DT the) (NN decrease)) (PP (IN in) (NP (NP (JJ plasma) (JJ Doc_10354657_1672_1679_Chemical) (NNS levels)) (VP (VBN associated) (PP (IN with) (NP (VBG aging)))))))) (. .)))
10354657	14	(ROOT (S (NP (JJ Familial) (NNS Doc_10354657_1732_1747_Disease)) (VP (VBZ is) (NP (NP (DT a) (NN risk) (NN factor)) (PP (IN for) (NP (NP (NNS Doc_10354657_1769_1783_Disease) (CC and) (NNS Doc_10354657_1788_1801_Disease)) (PP (IN during) (NP (JJ Doc_10354657_1809_1816_Chemical) (NN therapy))))))) (. .)))
10411803	0	(ROOT (S (NP (JJ Severe) (JJ immune) (NNS Doc_10411803_14_30_Disease)) (VP (VBN associated) (PP (IN with) (NP (NP (JJ prophylactic) (NN use)) (PP (IN of) (NP (NP (NNS Doc_10411803_67_76_Chemical)) (PP (IN in) (NP (ADJP (JJ obstetric) (CC and) (JJ gynecologic)) (NNS procedures)))))))) (. .)))
10411803	1	(ROOT (S (NP (NP (ADJP (JJ Second) (: -) (CC and) (JJ third-generation)) (NNS Doc_10411803_147_161_Chemical)) (, ,) (NP (RB especially) (NNS Doc_10411803_174_183_Chemical)) (, ,)) (VP (VBP are) (ADVP (RB increasingly)) (VP (VBN associated) (PP (IN with) (NP (JJ severe) (, ,) (ADJP (RB sometimes) (JJ fatal)) (JJ immune) (NNS Doc_10411803_249_265_Disease))))) (. .)))
10411803	2	(ROOT (S (NP (PRP We)) (VP (VBD noticed) (SBAR (IN that) (S (NP (NP (CD 10)) (PP (IN of) (NP (NP (PRP$ our) (CD 35) (NNS cases)) (PP (IN of) (NP (NN Doc_10411803_305_314_Chemical-induced) (NNS Doc_10411803_323_340_Disease)))))) (VP (VBD were) (PP (IN in) (NP (NP (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBD had) (VP (VBN received) (NP (NP (JJ Doc_10411803_375_384_Chemical) (NN prophylactically)) (PP (IN for) (NP (ADJP (JJ obstetric) (CC and) (JJ gynecologic)) (NNS procedures)))))))))))))) (. .)))
10411803	3	(ROOT (S (NP (NP (CD Eight)) (PP (IN of) (NP (NP (DT these) (NNS cases)) (PP (IN of) (NP (JJ severe) (JJ immune) (NNS Doc_10411803_482_498_Disease)))))) (VP (VBP are) (VP (VBN described))) (. .)))
10414674	0	(ROOT (NP (NP (NNPS Effects)) (PP (IN of) (NP (JJ nonsteroidal) (JJ anti-inflammatory) (NNS drugs))) (PP (IN on) (NP (NP (NNS hemostasis)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NNS Doc_10414674_79_113_Disease))))))) (. .)))
10414674	1	(ROOT (S (NP (JJ Platelet) (NN function)) (VP (VBZ is) (VP (VBN impaired) (PP (IN by) (NP (NP (JJ nonsteroidal) (JJ anti-inflammatory) (NNS drugs)) (PRN (-LRB- -LRB-) (NP (NNP NSAIDs)) (-RRB- -RRB-)))) (PP (IN with) (NP (JJ prominent) (JJ anti-inflammatory) (NNS properties))))) (. .)))
10414674	2	(ROOT (S (NP (NP (PRP$ Their) (NN safety)) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG undergoing) (NP (JJ intracranial) (NN surgery)))))) (VP (VBZ is) (PP (IN under) (NP (NN debate)))) (. .)))
10414674	3	(ROOT (S (NP (NP (NNS Patients)) (PP (IN with) (NP (NP (NNS Doc_10414674_327_361_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_10414674_363_366_Disease)) (-RRB- -RRB-))))) (VP (VBD were) (VP (VBN randomized) (S (VP (TO to) (VP (VB receive) (S (NP (CC either) (NP (NNS Doc_10414674_402_412_Chemical)) (, ,) (NP (CD 100) (NN mg)) (, ,) (NP (NP (NP (CD three) (NNS times)) (NP (DT a) (NN day))) (PRN (-LRB- -LRB-) (NP (NP (JJ Doc_10414674_441_451_Chemical) (NN group)) (, ,) (NP (NP (NN n)) (SBAR (S (VP (SYM =) (NP (CD 9))))))) (-RRB- -RRB-))) (CC or) (NP (DT a) (JJ weak) (NN NSAID)) (, ,) (NP (NNS Doc_10414674_483_496_Chemical)) (, ,) (NP (CD 1) (NN g)) (, ,) (NP (NP (NP (CD three) (NNS times)) (NP (DT a) (NN day))) (PRN (-LRB- -LRB-) (NP (NP (JJ Doc_10414674_522_535_Chemical) (NN group)) (, ,) (NP (NP (NN n)) (SBAR (S (VP (SYM =) (NP (CD 9))))))) (-RRB- -RRB-)))) (VP (VBG starting) (ADVP (RB immediately)) (PP (IN after) (NP (NP (DT the) (NN diagnosis)) (PP (IN of) (NP (JJ Doc_10414674_594_604_Disease) (NNS Doc_10414674_605_608_Disease)))))))))))) (. .)))
10414674	4	(ROOT (S (NP (NNP Treatment)) (VP (VBD was) (VP (VBN continued) (PP (IN for) (NP (CD 3) (NNS days))) (ADVP (RB postoperatively)))) (. .)))
10414674	5	(ROOT (S (NP (JJ Test) (NN blood) (NNS samples)) (VP (VBD were) (VP (VBN taken) (PP (PP (IN before) (NP (NN treatment) (CC and) (NN surgery))) (CONJP (RB as) (RB well) (IN as)) (PP (IN on) (NP (DT the) (ADJP (JJS first) (, ,) (ADJP (JJ third)) (, ,) (CC and) (ADJP (RB fifth) (JJ postoperative))) (NNS mornings)))))) (. .)))
10414674	6	(ROOT (S (NP (NP (JJ Maximal) (NNS Doc_10414674_795_815_Disease)) (VP (VBN induced) (PP (IN by) (NP (NP (CD 6) (NN microM)) (PP (IN of) (NP (NNS Doc_10414674_839_860_Chemical))))))) (VP (VBD decreased) (PP (IN after) (NP (NP (NN administration)) (PP (IN of) (NP (NNS Doc_10414674_895_905_Chemical)))))) (. .)))
10414674	7	(ROOT (S (NP (NNP Aggregation)) (VP (VBD was) (ADJP (ADJP (ADJP (JJR lower)) (PRN (-LRB- -LRB-) (NP (NNP P) (QP (CD <) (CD .05))) (-RRB- -RRB-))) (PP (IN in) (NP (DT the) (JJ Doc_10414674_946_956_Chemical) (NN group)))) (PP (IN than) (IN in) (NP (NP (DT the) (JJ Doc_10414674_975_988_Chemical) (NN group)) (PP (PP (ADVP (RB just)) (IN before) (NP (NN surgery))) (CC and) (PP (IN on) (NP (DT the) (JJ third) (NN postoperative) (NN day))))))) (. .)))
10414674	8	(ROOT (S (PP (IN In) (NP (NN contrast))) (, ,) (NP (JJ maximal) (NNS Doc_10414674_1072_1092_Disease)) (VP (VBD increased) (PP (IN in) (NP (NP (DT the) (JJ Doc_10414674_1110_1123_Chemical) (NN group)) (PP (IN on) (NP (DT the) (JJ third) (NN postoperative) (NN day))))) (PP (IN as)) (PP (VBN compared) (PP (IN with) (NP (NP (DT the) (JJ pretreatment) (JJ Doc_10414674_1195_1215_Disease) (NNS results)) (PRN (-LRB- -LRB-) (NP (NNP P) (QP (CD <) (CD .05))) (-RRB- -RRB-)))))) (. .)))
10414674	9	(ROOT (S (NP (NP (CD One) (NN patient)) (PP (IN in) (NP (DT the) (JJ Doc_10414674_1254_1264_Chemical) (NN group)))) (VP (VBD developed) (NP (DT a) (JJ postoperative) (JJ intracranial) (NNS Doc_10414674_1310_1318_Disease))) (. .)))
10414674	10	(ROOT (S (NP (NP (NNP Coagulation)) (PRN (-LRB- -LRB-) (NP (NP (NN prothrombin) (NN time) (NNP -LSB-) (NNP PT) (NNP -RSB-)) (, ,) (NP (JJ activated) (JJ partial) (NN thromboplastin) (NN time) (NNP -LSB-) (NNP APPT) (NNP -RSB-)) (, ,) (NP (NN fibrinogen) (NN concentration)) (, ,) (CC and) (NP (NNP antithrombin) (NNP III) (NNP -LSB-) (NNP AT) (NNP III) (NNP -RSB-))) (-RRB- -RRB-))) (VP (VBD was) (ADJP (JJ comparable) (PP (IN between) (NP (DT the) (CD two) (NNS groups))))) (. .)))
10414674	11	(ROOT (S (NP (NNS Doc_10414674_1498_1508_Chemical) (CONJP (CC but) (RB not)) (NNS Doc_10414674_1517_1530_Chemical)) (VP (VBN impaired) (NP (JJ platelet) (NN function)) (PP (IN in) (NP (NNS patients))) (PP (IN with) (NP (NNS Doc_10414674_1575_1578_Disease)))) (. .)))
10414674	12	(ROOT (S (SBAR (IN If) (S (NP (NNS Doc_10414674_1583_1593_Chemical)) (VP (VBZ is) (VP (VBN used) (PP (IN before) (NP (NP (NN surgery)) (PP (IN on) (NP (JJ cerebral) (NNS Doc_10414674_1629_1645_Disease))))))))) (, ,) (NP (PRP it)) (VP (MD may) (VP (VB pose) (NP (DT an) (JJ additional) (NN risk) (NN factor)) (PP (IN for) (NP (NNS Doc_10414674_1689_1699_Disease))))) (. .)))
10523326	0	(ROOT (S (NP (NNP Doc_10523326_0_12_Chemical)) (VP (VBP synthase) (NP (NN expression)) (PP (IN in) (NP (NP (DT the) (NN course)) (PP (IN of) (NP (JJ lead-induced) (NNS Doc_10523326_63_75_Disease)))))) (. .)))
10523326	1	(ROOT (S (NP (PRP We)) (ADVP (RB recently)) (VP (VBD showed) (NP (NP (NP (JJ elevated) (JJ reactive) (NN Doc_10523326_114_120_Chemical) (NNS species)) (PRN (-LRB- -LRB-) (NP (NNP ROS)) (-RRB- -RRB-))) (, ,) (NP (NP (VBN reduced) (JJ urinary) (NN excretion)) (PP (IN of) (NP (NP (JJ Doc_10523326_165_167_Chemical) (NNS metabolites)) (PRN (-LRB- -LRB-) (NP (NNP NOx)) (-RRB- -RRB-))))) (, ,) (CC and) (NP (NP (VBN increased) (JJ Doc_10523326_201_203_Chemical) (NN sequestration)) (PP (IN as) (NP (NNS Doc_10523326_221_234_Chemical))) (PP (IN in) (NP (JJ various) (NNS tissues))) (PP (IN in) (NP (NP (NNS rats)) (PP (IN with) (NP (NN Doc_10523326_267_271_Chemical-induced) (NNS Doc_10523326_280_292_Disease)))))))) (. .)))
10523326	2	(ROOT (S (NP (DT This) (NN study)) (VP (VBD was) (VP (VBN designed) (S (VP (TO to) (VP (VB discern) (SBAR (IN whether) (S (NP (NP (DT the) (NN reduction)) (PP (IN in) (NP (NP (JJ urinary) (NN NOx)) (PP (IN in) (NP (JJ lead-induced) (NNS Doc_10523326_382_394_Disease)))))) (VP (VBZ is) (, ,) (PP (IN in) (NP (NN part))) (, ,) (ADJP (JJ due)) (PP (TO to) (NP (JJ depressed) (NNS Doc_10523326_425_427_Chemical) (NN synthase) (PRN (-LRB- -LRB-) (NP (NNP NOS)) (-RRB- -RRB-)) (NN expression))))))))))) (. .)))
10523326	3	(ROOT (S (NP (NNP Male) (NNP Sprague-Dawley) (NNS rats)) (VP (VBD were) (ADVP (RB randomly)) (VP (VBN assigned) (PP (TO to) (NP (NP (NP (DT a) (JJ lead-treated) (NN group)) (PRN (-LRB- -LRB-) (NP (NP (NP (JJ given) (NNS Doc_10523326_534_546_Chemical)) (, ,) (NP (CD 100) (NN ppm)) (, ,)) (PP (IN in) (NP (NP (NN drinking) (NN water)) (CC and) (NP (JJ regular) (NN rat) (NN chow))))) (-RRB- -RRB-))) (, ,) (NP (DT a) (NN group) (VBN given) (NN lead)) (CC and) (NP (NN Doc_10523326_621_630_Chemical-fortified) (NN chow)) (, ,) (CC or) (NP (NP (DT a) (JJ normal) (NN control) (NN group)) (VP (VBN given) (NP (DT either) (JJ regular) (NN food) (CC and) (NN water) (CC or) (NNS Doc_10523326_712_721_Chemical-fortified) (NN food)) (PP (IN for) (NP (CD 12) (NNS weeks))))))))) (. .)))
10523326	4	(ROOT (S (NP (NP (JJ Tail) (NN blood) (NN pressure)) (, ,) (NP (NP (ADJP (RB urinary) (JJ NOx)) (NN excretion)) (, ,) (NP (NP (NN plasma) (NNS Doc_10523326_802_817_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_10523326_819_822_Chemical)) (-RRB- -RRB-))) (, ,) (CC and) (NP (NP (ADJP (JJ endothelial) (CC and) (JJ inducible)) (NNP NOS) (PRN (-LRB- -LRB-) (NP (NP (NNS eNOS)) (CC and) (NP (NNS iNOS))) (-RRB- -RRB-)) (NNS isotypes)) (PP (IN in) (NP (DT the) (NN aorta) (CC and) (NN kidney)))))) (VP (VBD were) (VP (VBN measured))) (. .)))
10523326	5	(ROOT (S (NP (DT The) (JJ lead-treated) (NN group)) (VP (VP (VBD exhibited) (NP (DT a) (NN rise)) (PP (IN in) (NP (NP (NN blood) (NN pressure) (CC and) (NN plasma) (NNS Doc_10523326_992_995_Chemical) (NN concentration)) (, ,) (NP (DT a) (NN fall)))) (PP (IN in) (NP (NP (ADJP (RB urinary) (JJ NOx)) (NN excretion)) (, ,) (CC and) (NP (NP (DT a) (JJ paradoxical) (NN rise)) (PP (IN in) (NP (NN vascular) (CC and) (JJ renal) (NN tissue) (NNS eNOS))))))) (CC and) (VP (VBZ iNOS) (NP (NN expression)))) (. .)))
10523326	6	(ROOT (S (NP (JJ Doc_10523326_1122_1131_Chemical) (NN supplementation)) (VP (VP (VBD ameliorated) (NP (NNS Doc_10523326_1160_1172_Disease))) (, ,) (VP (VBD lowered) (NP (NN plasma) (NNS Doc_10523326_1189_1192_Chemical) (NN concentration))) (, ,) (CC and) (VP (VBD raised) (NP (ADJP (RB urinary) (JJ NOx)) (NN excretion) (NN while)) (S (ADVP (RB significantly)) (VP (VBG lowering) (NP (NP (NN vascular)) (, ,) (CONJP (CC but) (RB not)) (NP (JJ renal) (, ,) (NN tissue) (NNS eNOS) (CC and) (NNS iNOS) (NN expression))))))) (. .)))
10523326	7	(ROOT (S (NP (JJ Doc_10523326_1328_1337_Chemical) (NN supplementation)) (VP (VBD had) (NP (NP (DT no) (NN effect)) (PP (IN on) (NP (NP (DT either) (NN blood) (NN pressure)) (, ,) (NP (NN plasma) (NNS Doc_10523326_1401_1404_Chemical)) (, ,) (CC or) (NP (NNP NOS) (NN expression))))) (PP (IN in) (NP (DT the) (NN control) (NN group)))) (. .)))
10523326	8	(ROOT (S (NP (DT The) (NN study)) (ADVP (RB also)) (VP (VBD revealed) (NP (NP (JJ significant) (NN inhibition)) (PP (IN of) (NP (NNP NOS) (JJ enzymatic) (NN activity)))) (PP (IN by) (NP (NP (NN lead)) (PP (IN in) (NP (JJ cell-free) (NNS preparations)))))) (. .)))
10523326	9	(ROOT (S (PP (IN In) (NP (NN conclusion))) (, ,) (NP (NP (JJ lead-induced) (NNS Doc_10523326_1582_1594_Disease)) (PP (IN in) (NP (DT this) (NN model)))) (VP (VBD was) (VP (VBN associated) (PP (IN with) (NP (NP (DT a) (ADJP (JJ compensatory)) (NN upregulation)) (PP (IN of) (NP (NN renal) (CC and) (NN vascular) (NNS eNOS) (CC and) (NNS iNOS) (NN expression))))))) (. .)))
10523326	10	(ROOT (S (NP (DT This)) (VP (VBZ is) (, ,) (PP (IN in) (NP (NN part))) (, ,) (ADJP (JJ due) (PP (TO to) (NP (NP (JJ ROS-mediated) (JJ Doc_10523326_1743_1745_Chemical) (NN inactivation)) (, ,) (NP (NP (JJ lead-associated) (NN inhibition)) (PP (IN of) (NP (NNP NOS) (NN activity)))) (, ,) (CC and) (NP (NP (RB perhaps) (JJ stimulatory) (NNS actions)) (PP (IN of) (NP (NP (VBN increased) (NN shear) (NN stress)) (VP (VBN associated) (PP (IN with) (NP (NNS Doc_10523326_1878_1890_Disease))))))))))) (. .)))
10524660	0	(ROOT (S (NP (NNP Doc_10524660_0_19_Chemical)) (VP (VBZ induces) (NP (NP (NNS attacks)) (PP (IN of) (NP (NP (NNS Doc_10524660_39_60_Disease)) (PP (IN in) (NP (NP (NNS sufferers)) (PP (IN of) (NP (NNS Doc_10524660_77_95_Disease))))))))) (. .)))
10524660	1	(ROOT (S (NP (NNS Doc_10524660_97_115_Disease) (CC and) (NNS Doc_10524660_120_141_Disease)) (VP (VBP have) (NP (DT the) (JJ same) (JJ Doc_10524660_156_160_Disease) (NN phase)) (, ,) (S (VP (ADVP (RB thus)) (VBG indicating) (SBAR (IN that) (S (NP (NNS Doc_10524660_189_207_Disease) (CC and) (NNS Doc_10524660_212_233_Disease)) (VP (VBP share) (NP (NP (DT a) (JJ common) (NN pathway)) (PP (IN of) (NP (NN nociception)))))))))) (. .)))
10524660	2	(ROOT (S (PP (IN In) (NP (JJ recent) (NNS years))) (, ,) (NP (VBG increasing) (NN evidence)) (VP (VBZ has) (VP (VBN suggested) (SBAR (IN that) (S (NP (NP (DT the) (NN messenger) (NN molecule) (NN Doc_10524660_352_364_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_10524660_366_368_Chemical)) (-RRB- -RRB-))) (VP (VBZ is) (VP (VBN involved) (PP (IN in) (NP (NP (JJ Doc_10524660_385_389_Disease) (NNS mechanisms)) (PP (IN of) (NP (NNS Doc_10524660_404_425_Disease))))))))))) (. .)))
10524660	3	(ROOT (S (SBAR (IN In) (NN order) (S (VP (TO to) (VP (VB clarify) (SBAR (IN whether) (S (NP (DT the) (JJ same)) (VP (VBZ is) (ADJP (JJ true) (PP (IN for) (NP (NNS Doc_10524660_476_494_Disease))))))))))) (, ,) (PP (IN in) (NP (DT the) (JJ present) (NN study))) (NP (PRP we)) (VP (VBD examined) (NP (DT the) (JJ Doc_10524660_533_541_Disease) (NN response)) (PP (TO to) (NP (NP (JJ intravenous) (NN infusion)) (PP (IN of) (NP (NP (NP (NNS Doc_10524660_578_597_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_10524660_599_602_Chemical)) (-RRB- -RRB-))) (PRN (-LRB- -LRB-) (NP (NP (CD 0.5) (NN microg/kg/min)) (PP (IN for) (NP (CD 20) (NN min)))) (-RRB- -RRB-)))))) (PP (IN in) (NP (NP (CD 12) (NNS sufferers)) (PP (IN of) (NP (NNS Doc_10524660_654_672_Disease)))))) (. .)))
10524660	4	(ROOT (S (NP (DT The) (JJ specific) (NN aim)) (VP (VBD was) (S (VP (TO to) (VP (VB elucidate) (SBAR (IN whether) (S (NP (DT an) (NN aura)) (VP (VBD and/or) (SBAR (S (NP (NP (DT an) (NN attack)) (PP (IN of) (NP (NNS Doc_10524660_744_765_Disease)))) (VP (MD could) (VP (VB be) (VP (VBN induced))))))))))))) (. .)))
10524660	5	(ROOT (S (NP (CD Fourteen) (JJ healthy) (NNS subjects)) (VP (VBD served) (PP (IN as) (NP (NNS controls)))) (. .)))
10524660	6	(ROOT (S (NP (NNP Aura) (NNS symptoms)) (VP (VBD were) (RB not) (VP (VBN elicited) (PP (IN in) (NP (DT any) (NN subject))))) (. .)))
10524660	7	(ROOT (S (NP (NNP Doc_10524660_878_886_Disease)) (VP (VBD was) (ADJP (RBR more) (JJ severe) (PP (IN in) (NP (NNS migraineurs)))) (PP (IN than) (IN in) (NP (NP (DT the) (NNS controls)) (PP (PP (IN during) (FRAG (CC and) (ADVP (RB immediately) (PP (IN after) (NP (JJ Doc_10524660_968_971_Chemical) (NN infusion) (PRN (-LRB- -LRB-) (VP (VBN p) (S (VP (SYM =) (NP (CD 0.037))))) (-RRB- -RRB-))))))) (CONJP (RB as) (RB well) (IN as)) (PP (IN during) (NP (NP (DT the) (JJ following) (CD 11) (NN h)) (PRN (-LRB- -LRB-) (VP (VBN p) (S (VP (SYM =) (NP (CD 0.008))))) (-RRB- -RRB-)))))))) (. .)))
10524660	8	(ROOT (S (PP (IN In) (NP (DT the) (NNS controls))) (, ,) (NP (DT the) (NN Doc_10524660_1062_1065_Chemical-induced) (NNS Doc_10524660_1074_1082_Disease)) (ADVP (RB gradually)) (VP (VBD disappeared) (, ,) (SBAR (IN whereas) (S (PP (IN in) (NP (JJ migraineurs) (NN peak) (NNS Doc_10524660_1134_1142_Disease))) (NP (NN intensity)) (VP (VBD occurred) (PP (IN at) (NP (NP (DT a) (JJ mean) (NN time)) (PP (IN of) (NP (CD 240) (NN min) (NN post-infusion))))))))) (. .)))
10524660	9	(ROOT (S (PP (IN At) (NP (DT this) (NN time))) (NP (NP (DT the) (JJ induced) (NNS Doc_10524660_1228_1236_Disease)) (PP (IN in) (NP (NP (CD 6)) (PP (IN of) (NP (CD 12) (NNS migraineurs)))))) (VP (VBD fulfilled) (NP (DT the) (JJ diagnostic) (NNS criteria)) (PP (IN for) (NP (NP (NNS Doc_10524660_1298_1319_Disease)) (PP (IN of) (NP (DT the) (NNP International) (NNP Doc_10524660_1341_1349_Disease) (NNP Society)))))) (. .)))
10524660	10	(ROOT (S (NP (DT The) (NNS results)) (ADVP (RB therefore)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NNS Doc_10524660_1394_1396_Chemical)) (VP (VBZ is) (VP (VBN involved) (PP (IN in) (NP (NP (DT the) (JJ Doc_10524660_1416_1420_Disease) (NNS mechanisms)) (PP (IN of) (NP (NNS Doc_10524660_1435_1453_Disease)))))))))) (. .)))
10524660	11	(ROOT (S (SBAR (IN Since) (S (NP (JJ cortical) (NN spreading) (NNS Doc_10524660_1480_1490_Disease)) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB liberate) (NP (NNS Doc_10524660_1518_1520_Chemical)) (PP (IN in) (NP (NNS animals))))))))))) (, ,) (NP (DT this) (NN finding)) (VP (MD may) (VP (VB help) (NP (NP (PRP$ our) (NN understanding)) (PP (IN of) (NP (NP (DT the) (NN coupling)) (PP (IN between) (NP (NN cortical)))))) (S (VP (VBG spreading) (NP (NNS Doc_10524660_1616_1626_Disease) (CC and) (NNS Doc_10524660_1631_1639_Disease)) (PP (IN in) (NP (NNS Doc_10524660_1643_1661_Disease))))))) (. .)))
10533019	0	(ROOT (NP (NP (NNP Rapid) (NN reversal)) (PP (IN of) (NP (ADJP (JJ life-threatening) (JJ Doc_10533019_35_44_Chemical-induced)) (NNS Doc_10533019_53_59_Disease))) (PP (IN with) (NP (NNS Doc_10533019_65_81_Chemical))) (. .)))
10533019	1	(ROOT (S (NP (PRP We)) (VP (VBP describe) (NP (NP (DT a) (NN patient)) (SBAR (WHNP (WP who)) (S (VP (VBD developed) (NP (NNS Doc_10533019_119_125_Disease)) (PP (IN with) (NP (JJ sudden) (NNS Doc_10533019_138_156_Disease))) (PP (IN after) (NP (NP (DT the) (NN infusion)) (PP (IN of) (NP (JJ intravenous) (NNS Doc_10533019_191_200_Chemical)))))))))) (. .)))
10533019	2	(ROOT (S (NP (NP (DT The) (NN administration)) (PP (IN of) (NP (NNS Doc_10533019_224_240_Chemical)))) (ADVP (RB rapidly)) (VP (VBD resolved) (NP (NP (DT the) (NN patient) (POS 's)) (NNS Doc_10533019_272_278_Disease)) (PP (IN with) (NP (NP (JJ prompt) (NN recovery)) (PP (IN of) (NP (JJ respiratory) (NN function))))) (, ,) (S (VP (VBG averting) (NP (NP (DT the) (NN need)) (PP (IN for) (NP (ADJP (RBR more) (JJ aggressive)) (NN airway) (NN management) (CC and) (NN ventilatory) (NN support))))))) (. .)))
10533019	3	(ROOT (S (NP (DT The) (NN emergency) (NN physician)) (VP (MD should) (VP (VB be) (ADJP (JJ aware)) (SBAR (SBAR (IN that) (S (NP (JJ life-threatening) (NNS Doc_10533019_468_474_Disease)) (VP (MD may) (VP (VB accompany) (NP (NP (DT the) (NN administration)) (PP (IN of) (NP (JJ intravenous) (NNS Doc_10533019_523_532_Chemical)))))))) (CC and) (SBAR (IN that) (S (NP (NNS Doc_10533019_542_558_Chemical)) (VP (MD may) (VP (VB be) (NP (DT a) (ADJP (JJ rapid) (CC and) (JJ effective)) (NN remedy))))))))) (. .)))
10539815	0	(ROOT (NP (NP (NP (NNS Predictors)) (PP (IN of) (NP (NP (NNS Doc_10539815_14_38_Disease)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (NNS Doc_10539815_56_69_Disease)) (PP (IN during) (NP (ADJP (JJ Doc_10539815_77_88_Chemical-converting) (JJ enzyme)) (NN inhibitor) (NN therapy)))))))))) (: :) (NP (NP (NNS results)) (PP (IN from) (NP (NP (DT the) (NNS studies)) (PP (IN of) (NP (NP (NNS Doc_10539815_154_182_Disease)) (PRN (-LRB- -LRB-) (NP (NNP SOLVD)) (-RRB- -RRB-)))))))))
10539815	1	(ROOT (S (SBAR (IN Although) (S (NP (CD Doc_10539815_212_223_Chemical-converting) (JJ enzyme) (NN inhibitor) (NN therapy)) (VP (VBZ reduces) (NP (NN mortality) (NNS rates)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (NNS Doc_10539815_301_325_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_10539815_327_330_Disease)) (-RRB- -RRB-))))))))) (, ,) (NP (PRP it)) (VP (MD may) (ADVP (RB also)) (VP (VB cause) (NP (NNS Doc_10539815_351_375_Disease)))) (. .)))
10539815	2	(ROOT (S (NP (JJ Little) (NN information)) (VP (VBZ is) (ADJP (JJ available) (S (VP (TO to) (VP (VB predict) (SBAR (WHNP (WDT which)) (S (NP (NNS patients)) (VP (VBP are) (PP (IN at) (NP (JJS highest) (NN risk))) (PP (IN for) (NP (DT this) (NN complication))))))))))) (. .)))
10539815	3	(ROOT (S (S (VP (TO To) (VP (VB quantify) (NP (NP (JJ specific) (JJ clinical) (NNS predictors)) (PP (IN of) (NP (NP (NNS Doc_10539815_533_560_Disease)) (PP (IN in) (NP (NNS patients)))))) (PP (IN with) (NP (NP (NNS Doc_10539815_578_581_Disease)) (SBAR (WHNP (WP who)) (S (VP (VBP are) (VP (VBN prescribed) (S (ADJP (JJ Doc_10539815_601_612_Chemical-converting)))))))))))) (VP (VBP enzyme) (NP (NN inhibitor) (NN therapy))) (. .)))
10539815	4	(ROOT (S (NP (PRP We)) (VP (VBD analyzed) (NP (NNS data)) (PP (IN from) (NP (NP (DT the) (NNPS Studies)) (PP (IN of) (NP (NP (NP (NNS Doc_10539815_695_723_Disease)) (PRN (-LRB- -LRB-) (NP (NNP SOLVD)) (-RRB- -RRB-))) (, ,) (NP (NP (DT a) (JJ randomized) (, ,) (JJ double-blind) (, ,) (JJ placebo-controlled) (NN trial)) (PP (IN of) (NP (NNS Doc_10539815_789_798_Chemical)))))))) (PP (IN for) (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (NNS Doc_10539815_820_823_Disease)))))) (. .)))
10539815	5	(ROOT (S (NP (EX There)) (VP (VBD were) (NP (NP (CD 3379) (NNS patients)) (VP (ADVP (RB randomly)) (VBN assigned) (PP (TO to) (NP (NNS Doc_10539815_871_880_Chemical))) (PP (IN with) (NP (NP (NP (DT a) (JJ median) (NN follow-up)) (PP (IN of) (NP (CD 974) (NNS days)))) (CC and) (NP (NP (CD 3379) (NNS patients)) (VP (ADVP (RB randomly)) (VBN assigned) (PP (TO to) (NP (NN placebo))) (PP (IN with) (NP (NP (DT a) (JJ mean) (NN follow-up)) (PP (IN of) (NP (CD 967) (NNS days)))))))))))) (. .)))
10539815	6	(ROOT (S (NP (NNP Doc_10539815_999_1023_Disease)) (VP (VBD was) (VP (VBN defined) (PP (IN as) (NP (NP (DT a) (NN rise)) (PP (IN in) (NP (NP (NN serum) (NNS Doc_10539815_1055_1065_Chemical)) (JJ >) (NN /) (S (VP (SYM =) (NP (CD 0.5) (NN mg/dL)))))) (PRN (-LRB- -LRB-) (NP (CD 44) (NN micromol/L)) (-RRB- -RRB-)))) (PP (IN from) (NP (NN baseline))))) (. .)))
10539815	7	(ROOT (S (NP (PRP We)) (VP (VBD used) (NP (JJ time-to-event) (NN analysis)) (S (VP (TO to) (VP (VB identify) (NP (NP (JJ potential) (NNS predictors)) (PP (IN of) (NP (NN decrease)))) (PP (IN in) (NP (NP (JJ renal) (NN function)) (PP (VBG including) (NP (NP (NN age)) (, ,) (NP (JJ baseline) (NN ejection) (NN fraction)) (, ,) (NP (NN baseline) (NNS Doc_10539815_1256_1266_Chemical)) (, ,) (NP (NP (JJ low) (JJ systolic) (NN blood) (NN pressure)) (PRN (-LRB- -LRB-) (NP (QP (CD <) (CD 100)) (NN mm) (NN Hg)) (-RRB- -RRB-)) (, ,) (NP (NP (NN history)) (PP (IN of) (NP (NNS Doc_10539815_1321_1333_Disease) (, ,) (NNS Doc_10539815_1335_1343_Disease) (, ,) (CC and) (NN use))) (PP (IN of) (NP (NN antiplatelet) (, ,) (NN diuretic) (, ,) (CC and) (NN beta-blocker) (NN therapy))))))))))))) (. .)))
10539815	8	(ROOT (S (NP (NP (NNS Patients)) (VP (ADVP (RB randomly)) (VBN assigned) (PP (TO to) (NP (NNS Doc_10539815_1445_1454_Chemical))))) (VP (VBD had) (NP (NP (DT a) (ADJP (NP (CD 33) (NN %)) (JJR greater)) (NN likelihood)) (PP (IN of) (NP (NNS Doc_10539815_1487_1511_Disease)))) (PP (IN than) (NP (NP (NNS controls)) (PRN (-LRB- -LRB-) (NP (NNP P) (QP (CD =) (CD .003))) (-RRB- -RRB-))))) (. .)))
10539815	9	(ROOT (S (PP (IN By) (NP (JJ multivariate) (NN analysis))) (, ,) (PP (IN in) (NP (NP (PDT both) (DT the) (NN placebo)) (CC and) (NP (JJ Doc_10539815_1587_1596_Chemical) (NNS groups)))) (NP (NP (JJR older) (NN age)) (, ,) (NP (JJ diuretic) (NN therapy)) (, ,) (CC and) (NP (NNS Doc_10539815_1637_1645_Disease))) (VP (VBD were) (VP (VBN associated) (PP (IN with) (NP (NNS Doc_10539815_1667_1691_Disease))) (, ,) (SBAR (IN whereas) (S (NP (NP (NN beta-blocker) (NN therapy)) (CC and) (NP (JJR higher) (NN ejection) (NN fraction))) (VP (VBD were) (ADJP (JJ renoprotective))))))) (. .)))
10539815	10	(ROOT (S (NP (JJR Older) (NN age)) (VP (VBD was) (VP (VP (VBN associated) (PP (IN with) (NP (NP (DT a) (JJR greater) (NN risk)) (PP (IN of) (NP (NP (VBG developing) (NNS Doc_10539815_1831_1855_Disease)) (PP (IN in) (NP (DT both) (NNS groups)))))))) (, ,) (CC but) (VP (ADVP (ADVP (RB significantly) (RBR more) (RB so)) (PP (IN in) (NP (NP (DT the) (JJ Doc_10539815_1905_1914_Chemical) (NN group)) (PRN (-LRB- -LRB-) (SBAR (UCP (ADJP (JJ Doc_10539815_1922_1931_Chemical)) (: :) (NP (NP (NN risk) (NN ratio) (NNP -LSB-) (NNP RR)) (NP (NP (QP (CD -RSB-) (CD 1.42))) (PP (IN per) (NP (CD 10) (NNS years))) (, ,) (ADJP (CD 95) (NN %))))) (S (NP (NP (NN confidence) (NN interval) (NNP -LSB-) (NNP CI)) (VP (VBG -RSB-) (NP (CD 1.32-1) (CD .52)) (PP (IN with) (NP (NP (NNS Doc_10539815_2012_2021_Chemical)) (: ;) (NP (NN placebo)) (: :) (NP (NNP RR) (CD 1.18)) (, ,) (ADJP (CD 95) (NN %)))))) (VP (VBP CI) (NP (CD 1.12-1) (CD .25))))) (-RRB- -RRB-)))))))) (. .)))
10539815	11	(ROOT (S (NP (JJ Doc_10539815_2060_2068_Chemical) (NN therapy)) (VP (VBD was) (ADVP (RB likewise)) (VP (VBN associated) (PP (IN with) (NP (NP (DT a) (JJR greater) (NN risk)) (PP (IN of) (NP (NNS Doc_10539815_2124_2148_Disease))))) (PP (IN in) (NP (DT the) (JJ Doc_10539815_2156_2165_Chemical) (NN group))) (PRN (-LRB- -LRB-) (S (NP (NP (NNP RR) (CD 1.89)) (, ,) (ADJP (CD 95) (NN %))) (VP (VBP CI) (NP (CD 1.70-2) (CD .08)))) (-RRB- -RRB-)) (PP (IN than) (IN in) (NP (NP (DT the) (NN placebo) (NN group)) (PRN (-LRB- -LRB-) (NP (NP (NNP RR) (CD 1.35)) (, ,) (NP (NP (CD 95) (NN %)) (SBAR (S (VP (VBP CI) (NP (CD 1.09-1) (CD .66))))))) (-RRB- -RRB-)))))) (. .)))
10539815	12	(ROOT (S (ADVP (RB Conversely)) (, ,) (NP (NNS Doc_10539815_2267_2276_Chemical)) (VP (VBD had) (NP (NP (DT a) (ADJP (JJ relative) (JJ renoprotective)) (NN effect)) (PRN (-LRB- -LRB-) (NP (NP (NP (NNP RR) (CD 1.33)) (, ,) (NP (ADJP (CD 95) (NN %)) (NNP CI))) (NP (CD 1.13-1) (CD .53))) (-RRB- -RRB-))) (PP (VBN compared) (PP (IN with) (NP (NP (NP (NN placebo)) (PRN (-LRB- -LRB-) (NP (NP (NP (NNP RR) (NNP 1.96)) (, ,) (NP (ADJP (CD 95) (NN %)) (NNP CI))) (NP (CD 1.57-2) (CD .44))) (-RRB- -RRB-))) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NNS Doc_10539815_2409_2417_Disease))))))))) (. .)))
10539815	13	(ROOT (S (NP (NP (DT A) (JJR lower) (NN risk)) (PP (IN of) (NP (NNS Doc_10539815_2435_2451_Disease)))) (VP (VBD was) (VP (VBN seen) (PP (IN in) (NP (NP (DT both) (NNS groups)) (PP (IN with) (NP (NP (NN beta-blocker) (NN therapy)) (PRN (-LRB- -LRB-) (NP (NP (NP (NNP RR) (CD 0.70)) (, ,) (NP (ADJP (CD 95) (NN %)) (NNP CI))) (NP (CD 0.57-0) (CD .85))) (-RRB- -RRB-)) (CC and) (NP (JJR higher) (NN baseline) (NN ejection) (NN fraction)) (PRN (-LRB- -LRB-) (NP (NP (NNP RR) (CD 0.93)) (PP (IN per) (NP (NP (ADJP (CD 5) (NN %)) (NN increment)) (, ,) (NP (ADJP (CD 95) (NN %)) (NNP CI) (NNP 0.91-0) (. .) (NNP 96))))) (-RRB- -RRB-)))))))) (. .)))
10539815	14	(ROOT (S (NP (JJ Doc_10539815_2628_2637_Chemical) (NN use)) (VP (VBD caused) (NP (DT a) (ADJP (CD 33) (NN %)) (NN increase)) (PP (IN in) (NP (NP (DT the) (NN risk)) (PP (IN of) (NP (NP (NNS Doc_10539815_2679_2703_Disease)) (PP (IN in) (NP (NNS patients))))))) (PP (IN with) (NP (NNS Doc_10539815_2721_2724_Disease)))) (. .)))
10539815	15	(ROOT (S (NP (NP (JJ Doc_10539815_2726_2734_Chemical) (NN use)) (CC and) (NP (JJ advanced) (NN age))) (VP (VBD increased) (NP (DT this) (NN risk))) (. .)))
10539815	16	(ROOT (S (S (NP (NNP Doc_10539815_2777_2785_Disease)) (VP (VBD was) (VP (VBN associated) (PP (IN with) (NP (NP (DT an) (VBN increased) (NN risk)) (PP (IN of) (NP (NP (NNS Doc_10539815_2827_2843_Disease)) (PP (IN in) (NP (NP (DT all) (NNS patients)) (PP (IN with) (NP (NNS Doc_10539815_2865_2868_Disease)))))))))))) (, ,) (CC but) (S (NP (DT this) (NN risk)) (VP (VBD was) (VP (VBN reduced) (PP (IN in) (NP (NP (NP (NP (DT the) (JJ Doc_10539815_2903_2912_Chemical) (NN group)) (PP (VBN compared) (PP (IN with) (NP (DT the) (NN placebo) (NN group))))) (. .) (NP (NP (JJ beta-Blocker) (NN therapy)) (CC and) (NP (JJR higher) (NN ejection) (NN fraction)))) (VP (VBD were) (ADJP (JJ renoprotective)) (PP (IN in) (NP (NP (DT all) (NNS patients)) (ADVP (RB regardless) (PP (IN of) (NP (NN therapy)))))))))))) (. .)))
10565806	0	(ROOT (S (NP (JJ Hypomania-like) (NN syndrome)) (VP (VBN induced) (PP (IN by) (NP (NNS Doc_10565806_35_45_Chemical)))) (. .)))
10565806	1	(ROOT (S (NP (PRP We)) (VP (VBP report) (NP (DT a) (JJ female) (NN patient)) (PP (IN with) (NP (NP (DT a) (NN diagnosis)) (PP (IN of) (NP (NP (DT a) (ADJP (RB not) (RB otherwise)) (JJ specified) (NNS Doc_10565806_120_138_Disease)) (PRN (-LRB- -LRB-) (NP (NNP DSM-IV)) (-RRB- -RRB-)))) (SBAR (WHNP (WP who)) (S (VP (VBD developed) (NP (NN hypomania)) (PP (RB shortly) (IN after) (NP (NP (DT the) (NN introduction)) (PP (IN of) (NP (JJ Doc_10565806_206_216_Chemical) (NN treatment))))))))))) (. .)))
10692744	0	(ROOT (NP (CD Doc_10692744_0_13_Chemical-induced) (NNS Doc_10692744_22_40_Disease) (. .)))
10692744	1	(ROOT (S (NP (NP (JJ Acute) (NNS Doc_10692744_48_57_Disease)) (VP (VBN induced) (PP (IN by) (NP (NNS Doc_10692744_69_82_Chemical))))) (VP (VBZ is) (NP (NP (DT a) (ADJP (RB well) (JJ known)) (JJ adverse) (NN drug) (NN reaction)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NNS Doc_10692744_138_154_Disease))))))) (. .)))
10692744	2	(ROOT (S (NP (PRP We)) (VP (VBP report) (NP (NP (DT a) (NN case)) (PP (IN of) (NP (NN Doc_10692744_176_189_Chemical-induced) (NNS Doc_10692744_198_216_Disease)))) (PP (IN in) (NP (NP (DT a) (NN patient)) (PP (IN with) (NP (JJ normal) (JJ renal) (NN function))))) (, ,) (S (VP (TO to) (VP (VB highlight) (NP (NP (VBG predisposing) (NNS factors)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (ADVP (RB frequently)) (VP (VBN overlooked)))))))))) (. .)))
10728962	0	(ROOT (NP (NP (NNP Doc_10728962_0_11_Chemical)) (PP (IN in) (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (NN Doc_10728962_32_41_Chemical-induced) (NNS Doc_10728962_50_61_Disease))))) (PP (IN in) (NP (JJ severe) (NNS Doc_10728962_72_85_Disease))) (. .)))
10728962	1	(ROOT (S (NP (NP (DT The) (NN use)) (PP (IN of) (NP (NP (JJ phosphodiesterase) (NNS inhibitors)) (PP (JJ such) (IN as) (NP (NP (NNS Doc_10728962_135_144_Chemical)) (PP (IN in) (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (JJ severe) (NNS Doc_10728962_172_185_Disease)))))))))) (VP (VBZ is) (ADVP (RB frequently)) (VP (VBN restricted) (SBAR (IN because) (S (NP (PRP they)) (VP (VBP cause) (NP (NN vasodilation) (CC and) (NNS Doc_10728962_247_258_Disease))))))) (. .)))
10728962	2	(ROOT (S (PP (IN In) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (JJ decompensated) (NNS Doc_10728962_291_304_Disease)) (PP (IN with) (NP (NP (NNS Doc_10728962_310_321_Disease)) (PP (IN after) (NP (NP (NN treatment)) (PP (IN with) (NP (NNS Doc_10728962_343_352_Chemical))))))))))) (, ,) (NP (NP (JJ low) (NNS doses)) (PP (IN of) (NP (NNS Doc_10728962_367_378_Chemical)))) (VP (VBD restored) (NP (NN blood) (NN pressure)) (PP (IN without) (S (VP (VBG inhibiting) (NP (NP (DT the) (JJ inotropic) (NN effect)) (PP (IN of) (NP (NNS Doc_10728962_446_455_Chemical)))))))) (. .)))
10743694	0	(ROOT (NP (NP (NNP Treatment)) (PP (IN of) (S (VP (VBG Doc_10743694_13_23_Chemical-related) (NP (JJ adverse) (NNS effects)) (PP (IN by) (NP (NN conversion))) (PP (TO to) (NP (NP (NNS Doc_10743694_65_77_Chemical)) (PP (IN in) (NP (NN liver) (NN transplant) (NNS recipients)))))))) (. .)))
10743694	1	(ROOT (S (SBAR (WHADVP (WRB When)) (S (NP (JJ Doc_10743694_115_125_Chemical) (NN side) (NNS effects)) (VP (VBP persist) (PP (IN despite) (NP (NN dose) (NN reduction)))))) (, ,) (NP (NP (NP (NN conversion)) (PP (TO to) (NP (NN Doc_10743694_185_197_Chemical-based) (NN immunosuppression)))) (PRN (-LRB- -LRB-) (NP (NNP CyA)) (-RRB- -RRB-))) (VP (VBZ is) (ADJP (JJ necessary))) (. .)))
10743694	2	(ROOT (S (NP (PRP We)) (VP (VBD characterized) (NP (NP (JJ Doc_10743694_259_269_Chemical) (NN side) (NNS effects)) (SBAR (WHNP (WDT that)) (S (VP (VBD warranted) (NP (NP (NP (NN discontinuation)) (PP (IN of) (NP (DT the) (NN drug)))) (, ,) (CC and) (NP (NP (NNS outcomes)) (PP (IN after) (NP (NN conversion)))))))))) (. .)))
10743694	3	(ROOT (S (PP (IN Of) (NP (NP (CD 388) (NN liver) (NNS recipients)) (SBAR (WHNP (WP who)) (S (VP (VBD received) (NP (NNS Doc_10743694_395_405_Chemical)) (PP (IN as) (NP (JJ primary) (NN immunosuppression)))))))) (, ,) (NP (CD 70)) (VP (VBD required) (NP (NN conversion)) (PP (TO to) (NP (NNS Doc_10743694_462_465_Chemical)))) (. .)))
10743694	4	(ROOT (S (NP (PRP We)) (VP (VBD recorded) (NP (NN indication)) (PP (IN for) (NP (NN conversion))) (, ,) (SBAR (IN whether) (S (NP (NN conversion)) (VP (VBD was) (ADVP (RB early) (CC or) (RB late)) (PP (IN after) (NP (NP (NP (NN transplantation) (, ,) (NNS Doc_10743694_566_576_Chemical) (NN dose) (CC and) (NN trough) (NN blood) (NN level)) (PP (IN at) (NP (NN conversion)))) (, ,) (CC and) (NP (NP (NN incidence)) (PP (IN of) (NP (NN rejection)))))) (PP (IN after) (NP (NN conversion))))))) (. .)))
10743694	5	(ROOT (S (NP (NNP Conversion)) (VP (VBD was) (ADVP (RB early)) (PP (IN in) (NP (NP (NP (CD 29) (NNS patients)) (PRN (-LRB- -LRB-) (NP (CD 41.4) (NN %)) (-RRB- -RRB-))) (CC and) (NP (NP (JJ late)) (PP (IN in) (NP (CD 41))) (PRN (-LRB- -LRB-) (NP (CD 58.6) (NN %)) (-RRB- -RRB-)))))) (. .)))
10743694	6	(ROOT (S (S (NP (NP (NNS Indications)) (PP (IN for) (NP (JJ early) (NN conversion)))) (VP (VBD were) (NP (NP (NP (NP (NNS Doc_10743694_771_784_Disease)) (PRN (-LRB- -LRB-) (NP (CD 20)) (-RRB- -RRB-))) (, ,) (PRN (-LRB- -LRB-) (NP (NN insulin-dependent)) (-RRB- -RRB-))) (NP (NP (NP (NP (NN diabetes) (NNS mellitus)) (PRN (-LRB- -LRB-) (NP (NNP Doc_10743694_830_834_Disease)) (-RRB- -RRB-))) (PRN (-LRB- -LRB-) (NP (CD 5)) (-RRB- -RRB-))) (, ,) (NP (NP (NN nephrotoxicity)) (PRN (-LRB- -LRB-) (NP (CD 3)) (-RRB- -RRB-))) (, ,) (NP (NP (NNS Doc_10743694_861_891_Disease)) (PRN (-LRB- -LRB-) (NP (CD 6)) (-RRB- -RRB-))) (, ,) (CC and) (NP (NP (NNS Doc_10743694_901_915_Disease)) (PRN (-LRB- -LRB-) (NP (CD 1)) (-RRB- -RRB-))))))) (, ,) (CC and) (SINV (PP (IN for) (NP (JJ late) (NN conversion))) (VP (VBD were)) (NP (NP (NNS Doc_10743694_950_963_Disease)) (PRN (-LRB- -LRB-) (NP (CD 15)) (-RRB- -RRB-)) (, ,) (NP (NP (NP (NNS Doc_10743694_970_974_Disease)) (PRN (-LRB- -LRB-) (NP (CD 12)) (-RRB- -RRB-))) (, ,) (NP (NP (NN nephrotoxicity)) (PRN (-LRB- -LRB-) (NP (CD 3)) (-RRB- -RRB-))) (, ,) (NP (NP (NNS Doc_10743694_1001_1012_Disease)) (PRN (-LRB- -LRB-) (NP (CD 5)) (-RRB- -RRB-))) (, ,) (NP (NP (NN hepatotoxicity)) (PRN (-LRB- -LRB-) (NP (CD 6)) (-RRB- -RRB-))) (, ,) (NP (NP (NP (NNS Doc_10743694_1038_1078_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_10743694_1080_1084_Disease)) (-RRB- -RRB-))) (PRN (-LRB- -LRB-) (NP (CD 2)) (-RRB- -RRB-))) (, ,) (NP (NP (NNS Doc_10743694_1091_1105_Disease)) (PRN (-LRB- -LRB-) (NP (CD 1)) (-RRB- -RRB-))) (, ,) (NP (NP (NNS Doc_10743694_1111_1127_Disease)) (PRN (-LRB- -LRB-) (NP (CD 1)) (-RRB- -RRB-))) (, ,) (CC and) (NP (NP (NNS Doc_10743694_1137_1145_Disease)) (PRN (-LRB- -LRB-) (NP (CD 1)) (-RRB- -RRB-)))))) (. .)))
10743694	7	(ROOT (S (NP (DT All) (JJ early-conversion) (NNS patients)) (VP (VBD showed) (NP (NP (NN improvement/resolution)) (PP (IN of) (NP (NNS symptoms))))) (. .)))
10743694	8	(ROOT (S (S (PP (IN Among) (NP (JJ late-conversion) (NNS patients))) (, ,) (NP (NP (CD 37)) (PRN (-LRB- -LRB-) (NP (CD 90.2) (NN %)) (-RRB- -RRB-))) (VP (VBD had) (VP (VBN improvement/resolution)))) (: ;) (S (PP (IN in) (NP (NP (CD 4)) (PRN (-LRB- -LRB-) (NP (CD 9.8) (NN %)) (-RRB- -RRB-)))) (, ,) (NP (JJ adverse) (NNS effects)) (VP (VBD persisted))) (. .)))
10743694	9	(ROOT (S (NP (DT The) (JJ overall) (NN rejection) (NN rate)) (VP (VBD was) (NP (CD 30) (NN %))) (. .)))
10743694	10	(ROOT (S (NP (NP (JJ Sixty-two) (NNS patients)) (PRN (-LRB- -LRB-) (NP (CD 88.6) (NN %)) (-RRB- -RRB-))) (VP (VBP are) (ADJP (JJ alive) (PP (IN with) (NP (NP (VBG functioning) (NNS grafts)) (UCP (ADJP (NP (CD 686) (NNS +)) (JJ /)) (: -) (NP (NP (CD 362) (NNS days) (PRN (-LRB- -LRB-) (NP (NP (NN range)) (, ,) (NP (CD 154-1433) (NNS days))) (-RRB- -RRB-))) (PP (IN after) (NP (NN conversion))))))))) (. .)))
10743694	11	(ROOT (S (SBAR (WHADVP (WRB When)) (S (NP (JJ Doc_10743694_1495_1505_Chemical) (NN side) (NNS effects)) (VP (VBP are) (ADJP (JJ unresponsive) (PP (TO to) (NP (NN dose) (NN reduction))))))) (, ,) (NP (NP (NN conversion)) (PP (TO to) (NP (NNS Doc_10743694_1569_1572_Chemical)))) (VP (MD can) (VP (VB be) (VP (VBN accomplished) (ADVP (RB safely)) (, ,) (PP (IN with) (NP (NP (DT no) (VBN increased) (NN risk)) (PP (IN of) (NP (NP (NN rejection)) (CC and) (NP (JJ excellent) (JJ long-term) (NN outcome))))))))) (. .)))
1079693	0	(ROOT (NP (NP (JJ Ocular) (NNS manifestations)) (PP (IN of) (NP (NNS Doc_1079693_25_54_Disease))) (. .)))
1079693	1	(ROOT (S (NP (PRP We)) (VP (VBD followed) (NP (NP (CD 210) (NNS cases)) (PP (IN of) (NP (JJ Doc_1079693_81_110_Disease) (ADJP (RB closely) (PP (IN for) (NP (NNS eleven)))) (NNS years))))) (. .)))
1079693	2	(ROOT (S (NP (NP (NP (NNP Thirty-six)) (PP (IN of) (NP (DT the) (CD 210) (NNS patients)))) (PRN (-LRB- -LRB-) (NP (CD 17.2) (NN %)) (-RRB- -RRB-))) (VP (VBD developed) (NP (NNS Doc_1079693_186_199_Disease))) (. .)))
1079693	3	(ROOT (S (NP (NNP Doc_1079693_201_214_Disease)) (VP (VBD was) (VP (VBN seen) (ADVP (RBS most) (RB frequently)) (PP (IN in) (NP (NP (JJ young) (JJ female) (NNS patients)) (PRN (-LRB- -LRB-) (NP (QP (CD 0) (TO to) (CD 4) (NNS years))) (-RRB- -RRB-)))) (PP (IN with) (NP (NP (DT the) (NN monoarticular) (CC or) (NN pauciatricular) (NN form)) (PP (IN of) (NP (DT the) (NNS Doc_1079693_333_342_Disease))))))) (. .)))
1079693	4	(ROOT (S (ADVP (RB However)) (, ,) (NP (NP (CD 30) (NN %)) (PP (IN of) (NP (DT the) (NNS patients)))) (VP (VBD developed) (NP (NNS Doc_1079693_383_390_Disease)) (PP (IN after) (NP (NP (CD 16) (NNS years)) (PP (IN of) (NP (NN age)))))) (. .)))
1079693	5	(ROOT (S (SBAR (IN Although) (S (NP (NP (CD 61) (NN %)) (PP (IN of) (NP (NNS patients)))) (VP (VBD had) (NP (NP (DT a) (JJ noncontributory) (NN ocular) (NN history)) (PP (IN on) (NP (NN entry))))))) (, ,) (NP (CD 42) (NN %)) (VP (VBD had) (NP (NP (JJ active) (NNS Doc_1079693_501_508_Disease)) (PP (IN on) (NP (NN entry))))) (. .)))
1079693	6	(ROOT (S (NP (PRP$ Our) (NN approach)) (VP (VBD was) (ADJP (JJ effective) (PP (IN in) (S (VP (VBG detecting) (NP (NNS Doc_1079693_559_566_Disease)) (PP (IN in) (NP (NP (JJ new) (NNS cases) (CC and) (NNS exacerbations)) (PP (IN of) (NP (NP (NNS Doc_1079693_601_608_Disease)) (PP (IN in) (NP (JJ established) (NNS cases)))))))))))) (. .)))
1079693	7	(ROOT (S (NP (NP (JJ Forty-four) (NN percent)) (PP (IN of) (NP (NP (NNS patients)) (PP (IN with) (NP (NNS Doc_1079693_667_674_Disease)))))) (VP (VBD had) (NP (NP (CD one)) (CC or) (NP (ADJP (RBR more) (JJ identifiable)) (NNS signs) (CC or) (NNS symptoms)) (, ,) (PP (JJ such) (IN as) (NP (NP (JJ red) (NN eye)) (, ,) (NP (NNS Doc_1079693_740_751_Disease)) (, ,) (NP (NNS Doc_1079693_753_776_Disease)) (, ,) (CC or) (NP (NNS Doc_1079693_781_792_Disease))))) (, ,) (PP (IN in) (NP (NP (NN order)) (PP (IN of) (NP (VBG decreasing) (NN frequency)))))) (. .)))
1079693	8	(ROOT (S (PP (RB Even) (IN after) (NP (RB early) (JJ detection) (CC and) (JJ prompt) (NN treatment))) (, ,) (NP (NP (CD 41) (NN %)) (PP (IN of) (NP (NP (NNS cases)) (PP (IN of) (NP (NNS Doc_1079693_893_900_Disease)))))) (VP (VBD did) (RB not) (VP (VB respond) (PP (TO to) (NP (NP (QP (JJR more) (IN than) (CD six)) (NNS months)) (PP (IN of) (NP (JJ intensive) (JJ topical) (NN treatment))))) (PP (IN with) (NP (NNS Doc_1079693_977_992_Chemical) (CC and) (NNS mydriatics))))) (. .)))
1079693	9	(ROOT (S (PP (IN Despite) (NP (DT this))) (, ,) (NP (EX there)) (VP (VBD was) (NP (NP (DT a) (JJ dramatic) (NN decrease)) (PP (IN in) (NP (NP (DT the) (ADJP (CD 50) (NN %)) (NN incidence)) (PP (IN of) (S (VP (VBG blinding) (NP (NP (NNS complications)) (PP (IN of) (NP (NP (NNS Doc_1079693_1103_1110_Disease)) (VP (VBN cited) (PP (IN in) (NP (JJR earlier) (NNS studies)))))))))))))) (. .)))
1079693	10	(ROOT (S (NP (NNS Doc_1079693_1137_1145_Disease) (CC and) (NNS Doc_1079693_1150_1166_Disease)) (VP (VBD occurred) (PP (IN in) (NP (NP (QP (RB only) (CD 22))) (CC and) (NP (NP (CD 13) (NN %)) (PP (IN of) (NP (PRP$ our) (NN group)))))) (, ,) (ADVP (RB respectively))) (. .)))
1079693	11	(ROOT (S (NP (PRP We)) (VP (VP (VBD used) (NP (NNS Doc_1079693_1231_1242_Chemical) (CC or) (NNS Doc_1079693_1246_1264_Chemical)) (PP (IN in) (NP (NP (CD 173)) (PP (IN of) (NP (CD 210) (NNS cases)))))) (CC and) (VP (VBD found) (S (NP (NP (RB only) (CD one) (NN case)) (PP (IN of) (NP (NNS Doc_1079693_1312_1329_Disease)))) (ADJP (JJ attributable) (PP (TO to) (NP (DT these) (NNS drugs))))))) (. .)))
1079693	12	(ROOT (S (S (NP (ADJP (RB Systemically) (VBN administered)) (NNS Doc_1079693_1385_1400_Chemical)) (VP (VBD were) (VP (VBN used) (PP (IN in) (NP (NP (CD 75)) (PP (IN of) (NP (CD 210) (NNS cases)))))))) (: ;) (S (NP (NP (DT a) (JJ significant) (NN number)) (PP (IN of) (NP (NN posterior) (NN subcapsular) (NNS Doc_1079693_1477_1486_Disease)))) (VP (VBD was) (VP (VBN found)))) (. .)))
1079693	13	(ROOT (S (NP (JJ Typical) (JJ Doc_1079693_1506_1526_Disease) (NN sicca)) (VP (VBD developed) (PP (IN in) (NP (NP (CD three)) (PP (IN of) (NP (DT the) (JJ Doc_1079693_1559_1566_Disease) (NNS cases)))))) (. .)))
1079693	14	(ROOT (S (NP (NP (DT This) (NN association)) (PP (IN with) (NP (NNP Doc_1079693_1596_1603_Disease) (CC and) (NNP JRA)))) (VP (VBD was) (RB not) (VP (VBN noted) (ADVP (RB previously)))) (. .)))
1079693	15	(ROOT (S (NP (NP (NNP Surgical) (NN treatment)) (PP (IN of) (NP (NNS Doc_1079693_1660_1669_Disease) (, ,) (NNS Doc_1079693_1671_1687_Disease) (, ,) (CC and) (NNS Doc_1079693_1693_1701_Disease)))) (VP (VBD achieved) (ADVP (RB uniformly) (S (VP (VBG discouraging) (NP (NNS results)))))) (. .)))
10840460	0	(ROOT (NP (NP (NP (JJ Doc_10840460_0_16_Chemical-induced) (NNS Doc_10840460_25_33_Disease)) (PP (IN in) (NP (JJ freely-moving) (JJ conscious) (NNS rats)))) (: :) (NP (NP (JJ behavioral) (NN approach)) (PP (TO to) (NP (NP (DT a) (JJ new) (NN model)) (PP (IN of) (NP (NNS Doc_10840460_105_118_Disease)))))) (. .)))
10840460	1	(ROOT (S (VP (TO To) (VP (VB develop) (NP (NP (DT a) (NN model)) (PP (IN of) (NP (NNS Doc_10840460_151_164_Disease)))) (PP (IN in) (NP (NP (NNS rats)) (VP (VBG using) (NP (DT a) (JJ behavioral) (NN approach))))))) (. .)))
10840460	2	(ROOT (S (NP (NP (NNP Doc_10840460_202_218_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_10840460_220_222_Chemical)) (-RRB- -RRB-)) (, ,) (NP (NP (DT an) (JJ antitumoral) (NN agent)) (VP (VBN known) (S (VP (TO to) (VP (VB produce) (NP (JJ toxic) (NNS effects)) (PP (IN on) (NP (DT the) (NN bladder) (NN wall))) (PP (IN through) (NP (PRP$ its) (JJ main) (JJ toxic) (NN metabolite) (NNS Doc_10840460_331_339_Chemical)))))))) (, ,)) (VP (VBD was) (VP (VBN used) (S (VP (TO to) (VP (VB induce) (NP (NNS Doc_10840460_360_368_Disease))))))) (. .)))
10840460	3	(ROOT (NP (NP (NNP MATERIALS) (CC AND) (NNP METHODS)) (: :) (S (S (NP (NNP CP)) (VP (VBD was) (VP (VBN administered) (PP (IN at) (NP (ADJP (JJ doses) (PP (IN of) (NP (CD 50) (, ,) (CD 100) (CC and) (CD 200)))) (NNP mg) (. .) (PRN (: /) (NP (NNP kg) (. .))) (NNP i.p.))) (PP (TO to) (NP (JJ male) (NNS rats)))))) (, ,) (CC and) (S (NP (PRP$ their) (NN behavior)) (VP (VP (VBD observed)) (CC and) (VP (VBD scored))))) (. .)))
10840460	4	(ROOT (S (NP (NP (DT The) (NNS effects)) (PP (IN of) (NP (NP (NP (NNS Doc_10840460_523_531_Chemical)) (-LRB- -LRB-) (NP (NP (QP (CD 0.5) (TO to) (CD 4))) (NP (NNP mg) (. .) (NNP /) (NNP kg) (. .) (NNP i.v.))) (-RRB- -RRB-)) (PP (IN on) (NP (JJ Doc_10840460_559_561_Chemical-induced) (JJ behavioral) (NNS modifications)))))) (VP (VBD were) (VP (VBN tested) (UCP (VP (VBN administered) (ADVP (RB alone))) (CC and) (PP (IN after) (NP (NP (NNS Doc_10840460_636_644_Chemical)) (PRN (-LRB- -LRB-) (FRAG (FRAG (NP (CD 1) (NN mg)) (. .)) (: /) (FRAG (ADJP (JJ kg) (. .)) (ADJP (JJ s.c.)))) (-RRB- -RRB-))))))) (. .)))
10840460	5	(ROOT (S (PP (IN In) (NP (NN addition))) (, ,) (SBAR (NP (CD 90) (NNS minutes)) (IN after) (S (NP (NNP CP)) (VP (VBZ injection) (, ,) (INTJ (DT that) (VBZ is)) (, ,) (PP (IN at) (NP (NP (DT the) (NN time)) (PP (IN of) (NP (NP (NN administration)) (PP (IN of) (NP (NNS Doc_10840460_749_757_Chemical)))))))))) (, ,) (NP (DT the) (NN bladder)) (VP (VBD was) (VP (VBN removed) (PP (IN in) (NP (NP (DT some) (NNS rats)) (PP (IN for) (NP (JJ histological) (NN examination))))))) (. .)))
10840460	6	(ROOT (S (ADVP (RB Finally)) (, ,) (S (VP (TO to) (VP (VB show) (SBAR (IN that) (S (NP (DT the) (NN bladder)) (VP (VBZ is) (ADJP (JJ essential) (PP (IN for) (NP (DT the) (JJ CP-induced) (JJ behavioral) (NNS modifications)))))))))) (, ,) (NP (JJ female) (NNS rats)) (ADVP (RB also)) (VP (VBD received) (SBAR (FRAG (FRAG (FRAG (NP (NP (NNP CP)) (PP (IN at) (NP (NP (NNS doses)) (PP (IN of) (NP (CD 200) (NN mg)))))) (. .)) (: /) (FRAG (X (NP (NP (NNP kg) (. .) (NNP i.p.) (NNP and)) (PP (IN of) (NP (CD 20)))) (NP (NP (NNP mg) (. .)) (PP (IN by) (NP (NP (DT the) (JJ intravesical) (NN route)) (, ,) (CC and) (NP (NP (NNS Doc_10840460_1021_1029_Chemical)) (PP (IN at) (NP (NP (NNS doses)) (PP (IN of) (NP (CD 0.5) (NN mg))))))))) (. .)) (PP (PP (IN by) (NP (DT the) (JJ intravesical) (NN route))) (CC and) (PP (IN of) (NP (CD 5) (NN mg))))) (. .)) (: /) (FRAG (NP (NP (NNP kg) (. .)) (NP (NNP i.v.) (NNP RESULTS))) (: :) (NP (NP (NP (JJ CP) (JJ dose-relatedly) (JJ induced) (JJ marked) (JJ behavioral) (NNS modifications)) (PP (IN in) (NP (JJ male) (NNS rats)))) (: :) (NP (NP (NN breathing) (NN rate) (NN decrease)) (, ,) (NP (NP (NN closing)) (PP (IN of) (NP (NP (DT the) (NNS eyes) (CC and) (NN occurrence)) (PP (IN of) (NP (JJ specific) (NNS postures)))))))))))) (. .)))
10840460	7	(ROOT (S (NP (JJ Doc_10840460_1261_1269_Chemical) (NN dose-dependently)) (VP (VBD reversed) (NP (DT these) (NNS Doc_10840460_1302_1322_Disease))) (. .)))
10840460	8	(ROOT (S (NP (NP (DT A) (NN dose)) (PP (IN of) (FRAG (NP (JJ 0.5) (NN mg) (. .)) (: /) (NP (NN kg)) (. .)))) (VP (VBD produced) (NP (NP (DT a) (NN reduction)) (PP (IN of) (NP (NP (QP (RB almost) (CD 50)) (NN %)) (PP (IN of) (NP (NP (DT the) (JJ behavioral) (NN score)) (VP (VBN induced) (PP (IN by) (FRAG (X (ADVP (RB Doc_10840460_1416_1418_Chemical)) (NP (CD 200) (NN mg)) (. .)) (: /) (NP (NN kg))))))))))) (. .)))
10840460	9	(ROOT (S (NP (DT This) (NN effect)) (VP (VBD was) (ADVP (RB completely)) (VP (VBN prevented) (PP (IN by) (NP (NN pretreatment))) (PP (IN with) (NP (NNS Doc_10840460_1489_1497_Chemical))))) (. .)))
10840460	10	(ROOT (S (PP (IN At) (NP (NP (DT the) (NN time)) (PP (IN of) (NP (NP (NN administration)) (PP (IN of) (NP (NNS Doc_10840460_1532_1540_Chemical))))))) (, ,) (NP (NP (JJ histological) (NNS modifications)) (PP (IN of) (NP (DT the) (NN bladder) (NN wall))) (, ,) (PP (JJ such) (IN as) (NP (JJ chorionic) (CC and) (NN muscle) (NN layer) (NNS Doc_10840460_1625_1630_Disease))) (, ,)) (VP (VBD were) (ADJP (JJ observed))) (. .)))
10840460	11	(ROOT (S (PP (IN In) (NP (JJ female) (NNS rats))) (, ,) (S (FRAG (FRAG (NP (NNS Doc_10840460_1663_1665_Chemical)) (NP (CD 200) (NN mg)) (. .)) (: /) (FRAG (NP (NN kg)) (. .))) (NP (NNP i.p.)) (VP (VBD produced) (NP (DT the) (JJ same) (JJ marked) (JJ behavioral) (NNS modifications)) (SBAR (IN as) (S (NP (DT those)) (VP (VBD observed) (PP (IN in) (NP (JJ male) (NNS rats)))))))) (. .)))
10840460	12	(ROOT (S (S (VP (VBN Administered) (PP (IN at) (NP (NP (DT the) (NN dose)) (PP (IN of) (NP (CD 20) (NN mg))))))) (. .) (ADVP (RB intravesically)) (, ,) (NP (NNP CP)) (VP (VBD did) (RB not) (VP (VB produce) (NP (DT any) (JJ behavioral) (NNS effects)) (, ,) (SBAR (IN whereas) (S (NP (NP (NNS Doc_10840460_1867_1875_Chemical)) (PP (IN at) (NP (CD 0.5) (NNP mg) (. .) (JJ intravesically) (NNS induced)))) (VP (NNP behavioral) (S (NP (NNS modifications)) (ADJP (JJ identical) (PP (TO to) (NP (NP (DT those)) (PP (IN under) (NP (ADJP (JJ Doc_10840460_1960_1962_Chemical) (NP (CD 200))) (NNP mg) (. .) (PRN (: /) (NP (NNP kg) (. .))) (NNP i.p.)))))))))) (, ,) (PP (IN with) (NP (DT the) (JJ same) (JJ maximal) (NNS levels))))) (. .)))
10840460	13	(ROOT (FRAG (X (ADVP (RB Conversely)) (, ,) (NP (NP (NNS Doc_10840460_2023_2031_Chemical)) (NP (CD 5) (NN mg))) (. .)) (: /) (NP (NP (NNP kg) (. .)) (SBAR (S (NP (NNP i.v.)) (VP (VBD did) (RB not) (VP (VB produce) (NP (DT any) (JJ behavioral) (NNS effects)) (ADVP (IN at) (DT all))))))) (. .)))
10840460	14	(ROOT (S (ADVP (RB Overall)) (, ,) (NP (DT these) (NNS results)) (VP (VBP indicate) (SBAR (IN that) (S (NP (NP (DT this) (JJ experimental) (NN model)) (PP (IN of) (NP (JJ CP-induced) (NNS Doc_10840460_2182_2190_Disease)))) (VP (MD may) (VP (VP (VB be) (NP (NP (DT an) (JJ interesting) (JJ new) (JJ behavioral) (NN model)) (PP (IN of) (NP (JJ inflammatory) (NNS Doc_10840460_2250_2263_Disease)))) (, ,) (S (VP (VBG allowing) (NP (NP (DT a) (JJR better) (NN understanding)) (PP (IN of) (NP (DT these) (NNS Doc_10840460_2306_2323_Disease))))))) (CC and) (VP (ADVP (RB thus)) (NP (DT a) (JJR better) (JJ therapeutic) (NN approach)) (PP (TO to) (NP (PRP them))))))))) (. .)))
10910842	0	(ROOT (S (NP (JJ Doc_10910842_0_12_Chemical-induced) (NNS Doc_10910842_21_39_Disease)) (VP (VBZ is) (VP (VBN caused) (ADVP (RBR more) (PP (IN by) (NP (NNS Doc_10910842_58_65_Disease)))) (PP (IN than) (IN by) (NP (VBN altered) (JJ Doc_10910842_82_95_Chemical) (NN receptor) (NN expression))))) (. .)))
10910842	1	(ROOT (S (NP (NP (JJ Large) (NNS doses)) (PP (IN of) (NP (NNS glucocorticoids)))) (VP (MD can) (VP (VP (VB alter) (NP (NN muscle)) (ADVP (RB physiology))) (CC and) (VP (VB susceptibility) (S (VP (TO to) (VP (VB neuromuscular) (S (VP (VBG blocking) (NP (NNS drugs)) (PP (IN by) (NP (NP (NNS mechanisms)) (VP (RB not) (ADVP (RB clearly)) (VBN understood)))))))))))) (. .)))
10910842	2	(ROOT (S (NP (PRP We)) (VP (VBD investigated) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (JJ moderate) (CC and) (JJ large) (NNS doses))) (PP (IN of) (NP (NP (NNS Doc_10910842_324_336_Chemical)) (PP (IN on) (NP (NN muscle) (NN function) (CC and) (NN pharmacology))))) (, ,) (CC and) (NP (PRP$ their) (NN relationship))) (PP (TO to) (NP (NP (NP (NNS changes)) (PP (IN in) (NP (NN muscle) (NN size)))) (CC and) (NP (NP (JJ Doc_10910842_427_440_Chemical) (NN receptor)) (PRN (-LRB- -LRB-) (NP (NNP AChR)) (-RRB- -RRB-)) (NP (NN expression)))))) (. .)))
10910842	3	(ROOT (S (PP (IN With) (NP (JJ institutional) (NN approval))) (, ,) (NP (CD 35) (JJ Sprague-Dawley) (NNS rats)) (VP (VBD were) (ADVP (RB randomly)) (VP (VBN allocated) (S (VP (TO to) (VP (VB receive) (NP (NP (JJ daily) (NNS subcutaneous) (NNS doses)) (PP (IN of) (NP (NP (NP (NP (NP (CD 10) (VBG mg/kg) (NNS Doc_10910842_593_605_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP P10) (NN group)) (-RRB- -RRB-))) (, ,) (NP (NP (CD 100) (JJ mg/kg) (NNS Doc_10910842_629_641_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP P100) (NN group)) (-RRB- -RRB-))) (, ,) (CC or) (NP (NP (DT an) (JJ equal) (NN volume)) (PP (IN of) (NP (NN saline))))) (PRN (-LRB- -LRB-) (NP (NNP S) (NN group)) (-RRB- -RRB-))) (PP (IN for) (NP (CD 7) (NNS days))))))))))) (. .)))
10910842	4	(ROOT (S (NP (NP (DT A) (JJ fourth) (NN group)) (PP (IN of) (NP (NNS rats)))) (VP (VBD was) (NP (NP (NN pair) (NN fed)) (PRN (-LRB- -LRB-) (NP (NP (NN food)) (VP (VBN restricted))) (-RRB- -RRB-)) (PP (IN with) (NP (NP (DT the) (CD P100) (NNS rats)) (PP (IN for) (NP (NP (CD 7) (NNS days)) (PRN (-LRB- -LRB-) (NP (NNP FR) (NN group)) (-RRB- -RRB-)))))))) (. .)))
10910842	5	(ROOT (S (PP (IN On) (NP (NNP Day) (CD 8))) (, ,) (S (NP (DT the) (JJ nerve-evoked) (NN peak)) (VP (VB twitch) (NP (NP (NNS tensions)) (, ,) (NP (JJ tetanic) (NNS tensions)) (, ,) (CC and) (NP (NN fatigability))))) (, ,) (CC and) (S (NP (NP (DT the) (JJ dose-response) (NNS curves)) (PP (IN of) (NP (NP (NNS Doc_10910842_920_934_Chemical)) (PP (IN in) (NP (DT the) (JJ tibialis) (NNS cranialis) (NN muscle)))))) (VP (VBD were) (VP (VP (VBN measured) (PP (IN in) (NP (NN vivo)))) (CC and) (VP (VBN related) (PP (TO to) (NP (NP (NN muscle) (NN mass) (CC or) (NN expression)) (PP (IN of) (NP (NNP AChRs))))))))) (. .)))
10910842	6	(ROOT (S (NP (NP (NNP Rate)) (PP (IN of) (NP (NN body) (NN weight) (NN gain)))) (VP (VBD was) (VP (VBN depressed) (PP (IN in) (NP (DT the) (CD P100) (, ,) (NNP FR) (, ,) (CC and) (NNP P10) (NNS groups))) (PP (VBN compared) (PP (IN with) (NP (DT the) (NNP S) (NN group)))))) (. .)))
10910842	7	(ROOT (S (NP (JJ Tibialis) (NN muscle) (NN mass)) (VP (VBD was) (ADJP (ADJP (JJR smaller)) (PP (IN in) (NP (DT the) (NNP P100) (NN group)))) (PP (IN than) (PP (IN in) (NP (DT the) (NNP P10) (CC or) (NNP S) (NNS groups))))) (. .)))
10910842	8	(ROOT (S (S (NP (NP (DT The) (JJ evoked) (NN peak) (NN twitch)) (CC and) (NP (JJ tetanic) (NNS tensions))) (VP (VBD were) (ADJP (ADJP (JJR less)) (PP (IN in) (NP (DT the) (NNP P100) (NN group)))) (PP (IN than) (PP (IN in) (NP (DT the) (NNP P10) (CC or) (NNP S) (NNS groups)))) (, ,) (ADVP (RB however)))) (, ,) (NP (NP (NN tension)) (PP (IN per) (NP (NP (NN milligram)) (PP (IN of) (NP (NN muscle) (NN mass)))))) (VP (VBD was) (ADJP (ADJP (JJR greater)) (PP (IN in) (NP (DT the) (NNP P100) (NN group)))) (PP (IN than) (PP (IN in) (NP (DT the) (NNP S) (NN group))))) (. .)))
10910842	9	(ROOT (S (NP (NP (DT The) (ADJP (CD 50) (NN %)) (JJ effective) (NN dose)) (PP (IN of) (NP (NP (NP (NNS Doc_10910842_1443_1457_Chemical)) (PRN (-LRB- -LRB-) (NP (NN microg/kg)) (-RRB- -RRB-))) (PP (IN in) (NP (DT the) (JJ tibialis) (NN muscle)))))) (VP (VBD was) (ADJP (ADJP (JJR smaller)) (PP (IN in) (NP (NP (DT the) (NN P10)) (PRN (-LRB- -LRB-) (NP (NP (NNP 33.6) (NNP +) (NNP /)) (: -) (NP (CD 5.4))) (-RRB- -RRB-))))) (PP (IN than) (IN in) (NP (NP (NP (DT the) (NNP S)) (PRN (-LRB- -LRB-) (NP (CD 61.9) (NNP +) (NNS /)) (, -) (NP (CD 5.0)) (-RRB- -RRB-))) (CC or) (NP (DT the) (NN P100) (PRN (-LRB- -LRB-) (NP (CD 71.3) (NNP +) (NNS /)) (, -) (NP (CD 9.6)) (-RRB- -RRB-)) (NNS groups))))) (. .)))
10910842	10	(ROOT (S (NP (JJ AChR) (NN expression)) (VP (VBD was) (ADJP (ADJP (JJR less)) (PP (IN in) (NP (DT the) (NNP P10) (NN group)))) (PP (IN than) (PP (IN in) (NP (DT the) (NNP S) (NN group))))) (. .)))
10910842	11	(ROOT (S (NP (DT The) (JJ evoked) (NNS tensions)) (VP (VBD correlated) (PP (IN with) (NP (NP (NN muscle) (NN mass)) (PRN (-LRB- -LRB-) (NP (NP (NP (NP (SYM r)) (PRN (-LRB- -LRB-) (NP (CD 2)) (-RRB- -RRB-))) (ADJP (JJ =) (NP (CD 0.32)))) (, ,) (NP (NNP P) (NNP <) (NNP 0.001))) (-RRB- -RRB-)))) (, ,) (ADVP (RB however)) (, ,) (PP (RB not) (IN with) (NP (NP (NN expression)) (PP (IN of) (NP (NNP AChR)))))) (. .)))
10910842	12	(ROOT (S (NP (NP (DT The) (ADJP (CD 50) (NN %)) (JJ effective) (NN dose)) (PP (IN of) (NP (NNS Doc_10910842_1796_1810_Chemical)))) (VP (VBD did) (RB not) (VP (VB correlate) (PP (IN with) (NP (NP (NN muscle) (NN mass)) (CC or) (NP (NNP AChR) (NN expression)))))) (. .)))
10910842	13	(ROOT (S (NP (PRP$ Our) (NNS results)) (VP (VP (VBP suggest) (SBAR (IN that) (S (NP (NP (DT the) (NNS Doc_10910842_1895_1920_Disease)) (PP (IN after) (NP (NNS Doc_10910842_1927_1939_Chemical)))) (VP (VP (VBZ is) (ADJP (JJ dose-dependent))) (, ,) (CC and) (VP (VBZ derives) (ADVP (RB primarily)) (PP (IN from) (NP (NNS Doc_10910842_1986_2000_Disease)))))))) (CC and) (VP (VBZ derives) (ADVP (RBR less) (RB so)) (PP (IN from) (NP (NP (NNS changes)) (PP (IN in) (NP (NNP AChR) (NN expression))))))) (. .)))
10910842	14	(ROOT (S (NP (NP (DT The) (NNS mechanisms)) (SBAR (WHPP (IN by) (WHNP (WDT which))) (S (NP (JJ chronic) (JJ glucocorticoid) (NN therapy) (NNS alters)) (VP (VBP neuromuscular) (ADJP (JJ physiology) (CC and) (JJ pharmacology)))))) (VP (VBP are) (ADJP (JJ unclear))) (. .)))
10910842	15	(ROOT (S (NP (PRP We)) (VP (VBP suggest) (SBAR (IN that) (S (NP (DT the) (JJ observed) (NNS effects)) (VP (VBP are) (ADJP (JJ dose-dependent) (CC and) (JJ derive)) (PP (RB primarily) (PP (IN from) (NP (NNS Doc_10910842_2267_2281_Disease) (CC and) (NN derive))) (CC less) (PP (IN from) (NP (NP (NNS changes)) (PP (IN in) (NP (JJ Doc_10910842_2314_2327_Chemical) (NN receptor) (NN expression)))))))))) (. .)))
11009181	0	(ROOT (NP (NP (NNP Doc_11009181_0_11_Chemical)) (: :) (NP (NP (DT an) (VBN underutilized) (NN therapy)) (PP (IN for) (NP (NNS Doc_11009181_42_61_Disease)))) (. .)))
11009181	1	(ROOT (S (NP (NNP Doc_11009181_63_74_Chemical)) (VP (VBD was) (NP (DT the) (JJ first) (JJ dopaminergic) (NN drug)) (ADVP (RB ever)) (VP (VBN used) (S (VP (TO to) (VP (VB treat) (NP (NP (NNS symptoms)) (PP (IN of) (NP (NNS Doc_11009181_138_157_Disease))))))))) (. .)))
11009181	2	(ROOT (S (SBAR (IN While) (S (NP (JJ powerful) (NN antiparkinsonian) (NNS effects)) (VP (VBD had) (VP (VBN been) (VP (VBN observed) (ADVP (RB as) (RB early)) (PP (IN as) (NP (CD 1951)))))))) (, ,) (NP (NP (DT the) (NN potential)) (PP (IN of) (S (VP (VBG treating) (NP (VBG fluctuating) (NNS Doc_11009181_273_292_Disease)) (PP (IN by) (NP (NP (JJ subcutaneous) (NN administration)) (PP (IN of) (NP (NNS Doc_11009181_327_338_Chemical))))))))) (VP (VBZ has) (ADVP (RB only) (RB recently)) (VP (VBN become) (NP (NP (DT the) (NN subject)) (PP (IN of) (NP (JJ systematic) (NN study)))))) (. .)))
11009181	3	(ROOT (S (NP (NP (DT A) (NN number)) (PP (IN of) (NP (NP (JJ small) (NN scale)) (NP (JJ clinical) (NNS trials))))) (VP (VBP have) (ADVP (RB unequivocally)) (VP (VBN shown) (SBAR (SBAR (IN that) (S (NP (JJ intermittent) (JJ subcutaneous) (JJ Doc_11009181_493_504_Chemical) (NNS injections)) (VP (VBP produce) (NP (NP (NN antiparkinsonian) (NN benefit)) (ADJP (JJ close) (CONJP (IN if) (RB not)) (JJ identical))) (PP (TO to) (NP (NP (DT that)) (VP (VBN seen) (PP (IN with) (NP (NNS Doc_11009181_590_598_Chemical))))))))) (CC and) (SBAR (IN that) (S (NP (JJ Doc_11009181_608_619_Chemical) (NN rescue) (NNS injections)) (VP (MD can) (ADVP (RB reliably)) (VP (VB revert) (NP (NNS off-periods)) (ADVP (RB even)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ complex) (JJ on-off) (NN motor) (NNS swings)))))))))))) (. .)))
11009181	4	(ROOT (S (NP (NNS Continuous)) (VP (VBZ subcutaneous) (SBAR (S (NP (JJ Doc_11009181_745_756_Chemical) (NNS infusions)) (VP (MD can) (VP (VB reduce) (NP (JJ daily) (NN off-time)) (PP (IN by) (NP (NP (QP (JJR more) (IN than) (CD 50)) (NN %)) (PP (IN in) (NP (NP (DT this) (NN group)) (PP (IN of) (NP (NP (NNS patients)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ appears) (S (VP (TO to) (VP (VB be) (NP (NP (DT a) (JJR stronger) (NN effect)) (PP (IN than) (NP (NP (DT that)) (VP (ADVP (RB generally)) (VBN seen) (PP (IN with) (NP (JJ add-on) (NN therapy))) (PP (IN with) (NP (NP (JJ oral) (JJ Doc_11009181_930_938_Chemical) (NNS agonists)) (CC or) (NP (JJ COMT) (NNS inhibitors))))))))))))))))))))))))) (. .)))
11009181	5	(ROOT (S (NP (NP (JJ Extended) (NN follow-up) (NNS studies)) (PP (IN of) (NP (QP (IN up) (TO to) (CD 8)) (NNS years)))) (VP (VBP have) (VP (VBN demonstrated) (NP (NP (JJ long-term) (NN persistence)) (PP (IN of) (NP (JJ Doc_11009181_1055_1066_Chemical) (NN efficacy)))))) (. .)))
11009181	6	(ROOT (S (PP (IN In) (NP (NN addition))) (, ,) (NP (EX there)) (VP (VBZ is) (VP (VBG convincing) (NP (JJ clinical) (NN evidence)) (SBAR (IN that) (S (NP (ADJP (JJ monotherapy) (PP (IN with) (NP (JJ continuous) (NNS subcutaneous)))) (JJ Doc_11009181_1174_1185_Chemical) (NNS infusions)) (VP (VBZ is) (VP (VBN associated) (PP (IN with) (NP (NP (JJ marked) (NNS reductions)) (PP (IN of) (NP (VBG preexisting) (NN Doc_11009181_1248_1256_Chemical-induced) (NNS Doc_11009181_1265_1276_Disease))))))))))) (. .)))
11009181	7	(ROOT (S (NP (NP (DT The) (JJ main) (NN side) (NNS effects)) (PP (IN of) (NP (JJ subcutaneous) (JJ Doc_11009181_1316_1327_Chemical) (NN treatment)))) (VP (VBP are) (VP (VBN related) (PP (TO to) (NP (JJ cutaneous) (NN tolerability) (NNS problems))) (, ,) (SBAR (IN whereas) (S (NP (NN sedation) (CC and) (NNS Doc_11009181_1407_1418_Disease) (NNS complications)) (VP (VBP play) (NP (DT a) (JJR lesser) (NN role))))))) (. .)))
11009181	8	(ROOT (S (PP (VBN Given) (NP (NP (DT the) (JJ marked) (NN degree)) (PP (IN of) (NP (NP (NN efficacy)) (PP (IN of) (NP (NP (JJ subcutaneous) (JJ Doc_11009181_1505_1516_Chemical) (NN treatment)) (PP (IN in) (NP (JJ fluctuating) (NNS Doc_11009181_1542_1561_Disease))))))))) (, ,) (NP (DT this) (NN approach)) (VP (VBZ seems) (S (VP (TO to) (VP (VB deserve) (NP (ADJP (RBR more) (JJ widespread)) (JJ clinical) (NN use)))))) (. .)))
11022397	0	(ROOT (S (VP (VBG Probing) (NP (NP (JJ peripheral)) (CC and) (NP (JJ central) (JJ cholinergic) (NN system) (NNS responses)))) (. .)))
11022397	1	(ROOT (S (S (NP (NP (DT The) (JJ pharmacological) (NN response)) (PP (TO to) (NP (NP (NNS drugs)) (SBAR (WHNP (WDT that)) (S (VP (VBP act) (PP (IN on) (NP (NP (DT the) (JJ cholinergic) (NN system)) (PP (IN of) (NP (DT the) (NNS iris))))))))))) (VP (VBZ has) (VP (VBN been) (VP (VBN used) (S (VP (TO to) (VP (VB predict) (NP (NP (NNS deficits)) (PP (IN in) (NP (JJ central) (JJ cholinergic) (NN functioning)))) (PP (JJ due) (TO to) (NP (NP (NNS diseases)) (PP (JJ such) (IN as) (NP (NNS Doc_11022397_250_269_Disease)))))))))))) (, ,) (CC yet) (S (NP (NP (NNS correlations)) (PP (IN between) (NP (JJ central) (CC and) (JJ peripheral) (NNS responses)))) (VP (VBP have) (RB not) (VP (VBN been) (VP (ADVP (RB properly)) (VBN studied))))) (. .)))
11022397	2	(ROOT (S (NP (DT This) (NN study)) (VP (VBD assessed) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (NP (JJ normal) (VBG aging)) (PP (IN on) (NP (NP (LST (-LRB- -LRB-) (LS 1) (-RRB- -RRB-)) (NP (DT the) (NN Doc_11022397_419_430_Chemical-induced) (NN increase)) (PP (IN in) (NP (NN pupil) (NN diameter)))) (, ,) (CC and) (NP (LST (-LRB- -LRB-) (LS 2) (-RRB- -RRB-)) (NP (DT the) (NN reversal)) (PP (IN of) (NP (NP (DT this) (NN effect)) (PP (IN with) (NP (NNS Doc_11022397_508_519_Chemical)))))))))))) (. .)))
11022397	3	(ROOT (S (NP (NNP Doc_11022397_521_532_Chemical)) (VP (VBD was) (VP (VBN used) (PP (IN as) (NP (DT a) (JJ positive) (NN control))) (S (VP (TO to) (VP (VB detect) (NP (JJ age-dependent) (NNS changes)) (PP (IN in) (NP (NP (JJ central) (JJ cholinergic) (NN functioning)) (PP (IN in) (NP (DT the) (JJ elderly)))))))))) (. .)))
11022397	4	(ROOT (S (VP (VB Randomized) (NP (JJ double-blind) (JJ controlled) (NN trial))) (. .)))
11022397	5	(ROOT (S (S (VP (VBG Ten) (ADJP (ADJP (JJ healthy) (JJ elderly)) (PRN (-LRB- -LRB-) (S (VP (VB mean) (NP (NN age) (CD 70)))) (-RRB- -RRB-)) (CC and) (ADJP (CD 9) (JJ young)) (PRN (-LRB- -LRB-) (S (VP (VB mean) (NP (NN age) (CD 33)))) (-RRB- -RRB-))))) (VP (VBZ volunteers)) (. .)))
11022397	6	(ROOT (S (NP (JJ Pupil) (NN diameter)) (VP (VBD was) (VP (VBN monitored) (S (VP (VBG using) (NP (DT a) (JJ computerized) (JJ infrared) (NN pupillometer)) (PP (IN over) (NP (CD 4) (NNS hours))))))) (. .)))
11022397	7	(ROOT (S (NP (DT The) (NN study)) (VP (VBD involved) (NP (CD 4) (NNS sessions))) (. .)))
11022397	8	(ROOT (S (PP (IN In) (NP (CD 1) (NN session))) (, ,) (NP (NP (NNS Doc_11022397_929_940_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (CD 20) (NN microL)) (, ,) (NP (CD 0.01) (NN %))) (-RRB- -RRB-))) (VP (VBD was) (VP (VBN administered) (PP (TO to) (NP (NP (CD one) (NN eye)) (CC and) (NP (NN placebo)))) (PP (TO to) (NP (DT the) (JJ other))))) (. .)))
11022397	9	(ROOT (S (PP (IN In) (NP (DT another) (NN session))) (, ,) (NP (NP (NNS Doc_11022397_1034_1045_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (CD 20) (NN microL)) (, ,) (NP (CD 0.01) (NN %))) (-RRB- -RRB-))) (VP (VBD was) (VP (VP (VBN administered) (PP (TO to) (NP (DT both) (NNS eyes)))) (, ,) (VP (VBN followed) (PP (ADVP (NP (CD 23) (NNS minutes)) (RBR later)) (IN by) (NP (NP (DT the) (NN application)) (PP (IN of) (NP (NP (NNS Doc_11022397_1144_1155_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (CD 20) (NN microL)) (, ,) (NP (CD 0.1) (NN %))) (-RRB- -RRB-)))))) (PP (TO to) (NP (CD one) (NN eye)))) (CC and) (VP (VBN placebo) (PP (TO to) (NP (DT the) (JJ other)))))) (. .)))
11022397	10	(ROOT (S (NP (DT All) (NN eye) (NNS drops)) (VP (VBD were) (VP (VBN given) (PP (IN in) (NP (DT a) (JJ randomized) (NN order))))) (. .)))
11022397	11	(ROOT (S (PP (IN In) (NP (CD 2) (JJ separate) (NNS sessions))) (, ,) (S (NP (NP (DT a) (JJ single) (NN dose)) (PP (IN of) (NP (NP (NP (NNS Doc_11022397_1300_1311_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (CD 0.5) (NN mg)) (, ,) (NP (NN intravenously))) (-RRB- -RRB-))) (CC or) (NP (NN placebo))))) (VP (VBD was) (VP (VBN administered)))) (, ,) (CC and) (S (NP (NP (DT the) (NNS effects)) (PP (IN on) (NP (NN word) (NN recall)))) (VP (VBD were) (VP (VBN measured) (S (VP (VBG using) (NP (DT the) (NNP Buschke) (NNP Selective) (NNP Reminding) (NNP Test)) (PP (IN over) (NP (CD 2) (NNS hours)))))))) (. .)))
11022397	12	(ROOT (NP (NP (NNP OUTCOME) (NNP MEASURES)) (: :) (NP (NP (JJ Pupil) (NN size)) (PP (IN at) (NP (NP (NN time) (NNS points)) (PP (IN after) (NP (NP (NN administration)) (PP (IN of) (NP (NNS Doc_11022397_1535_1546_Chemical) (CC and) (NNS Doc_11022397_1551_1562_Chemical)))))))) (: ;) (NP (NP (NNS Doc_11022397_1564_1575_Chemical-induced)) (NP (NNS Doc_11022397_1584_1609_Disease))) (. .)))
11022397	13	(ROOT (S (NP (EX There)) (VP (VBD was) (NP (NP (DT no) (JJ significant) (NN difference)) (PP (IN between) (NP (JJ elderly) (CC and) (JJ young) (NNS volunteers)))) (PP (IN in) (NP (JJ pupillary) (NN response))) (PP (TO to) (NP (NP (NNS Doc_11022397_1718_1729_Chemical)) (PP (IN at) (NP (DT any) (NN time) (NN point))) (PRN (-LRB- -LRB-) (VP (VBN p) (NP (CD >) (CD 0.05))) (-RRB- -RRB-))))) (. .)))
11022397	14	(ROOT (S (NP (DT The) (JJ elderly) (NN group)) (VP (VBD had) (NP (NP (DT a) (ADJP (RB significantly) (JJR greater)) (NN Doc_11022397_1806_1817_Chemical-induced) (NN net)) (ADJP (JJ decrease) (PP (IN in) (NP (NN pupil) (NN size))) (NP (CD 85) (, ,) (CD 125) (, ,) (CD 165) (CC and) (CD 215))) (NP (NNS minutes))) (PP (IN after) (NP (NN administration))) (, ,) (PP (VBN compared) (PP (IN with) (NP (NP (DT the) (JJ young) (NN group)) (PRN (-LRB- -LRB-) (VP (VBN p) (NP (CD <) (CD 0.05))) (-RRB- -RRB-)))))) (. .)))
11022397	15	(ROOT (S (PP (VBN Compared) (PP (IN with) (NP (DT the) (JJ young) (NN group)))) (, ,) (NP (DT the) (JJ elderly) (NN group)) (VP (VBD had) (NP (JJR greater) (NN Doc_11022397_2007_2018_Chemical-induced) (NNS Doc_11022397_2027_2052_Disease)) (NP (CD 60) (, ,) (CD 90) (CC and) (CD 120)) (PP (NP (NNS minutes)) (PP (IN after) (NP (NN administration))) (PRN (-LRB- -LRB-) (ADVP (RB p)) (ADJP (JJ <) (NP (CD 0.05))) (-RRB- -RRB-)))) (. .)))
11022397	16	(ROOT (S (NP (EX There)) (VP (VBZ is) (NP (NP (DT an) (JJ age-related) (NN pupillary) (NN response)) (PP (TO to) (NP (NP (NNS Doc_11022397_2167_2178_Chemical)) (SBAR (WHNP (WDT that)) (S (VP (VBZ is) (RB not) (VP (VBN found) (PP (IN with) (NP (NNS Doc_11022397_2202_2213_Chemical))))))))))) (. .)))
11022397	17	(ROOT (S (ADVP (RB Thus)) (, ,) (NP (NNS Doc_11022397_2221_2232_Chemical)) (VP (MD may) (VP (VB be) (ADJP (JJ useful) (S (VP (TO to) (VP (VB assess) (NP (NNS variations)) (PP (IN in) (NP (NP (JJ central) (JJ cholinergic) (NN function)) (PP (IN in) (NP (JJ elderly) (NNS patients))))))))))) (. .)))
11027904	0	(ROOT (S (NP (NP (JJ Doc_11027904_0_4_Disease) (NNS responses)) (PP (IN in) (NP (NNS Doc_11027904_18_27_Chemical-maintained)))) (VP (VBD opioid) (NP (NNS abusers))) (. .)))
11027904	1	(ROOT (S (NP (NP (VBG Providing) (JJ Doc_11027904_65_69_Disease) (NN management)) (PP (IN for) (NP (JJ known) (JJ opioid) (NNS abusers)))) (VP (VBZ is) (NP (DT a) (ADJP (JJ challenging)) (JJ clinical) (NN task)) (, ,) (PP (IN in) (NP (NN part))) (SBAR (IN because) (S (NP (RB little)) (VP (VBZ is) (VP (VBN known) (PP (IN about) (NP (NP (PRP$ their) (JJ Doc_11027904_182_186_Disease) (NN experience)) (CC and) (NP (JJ analgesic) (NNS requirements))))))))) (. .)))
11027904	2	(ROOT (S (NP (DT This) (NN study)) (VP (VBD was) (VP (VBN designed) (S (VP (TO to) (VP (VB describe) (NP (NP (NP (JJ Doc_11027904_262_266_Disease) (NN tolerance) (CC and) (JJ analgesic) (NN response)) (PP (IN in) (NP (NP (DT a) (NN sample)) (PP (IN of) (NP (NNS Doc_11027904_315_329_Disease)))))) (VP (VBN stabilized) (PP (IN in) (NP (NNP Doc_11027904_344_353_Chemical-maintenance) (PRN (-LRB- -LRB-) (NP (NNP MM)) (-RRB- -RRB-)) (NN treatment)))) (PRN (-LRB- -LRB-) (VP (VBN n) (S (VP (SYM =) (NP (CD 60))))) (-RRB- -RRB-))) (PP (IN in) (NP (NN comparison))) (PP (TO to) (NP (NP (VBN matched) (JJ nondependent) (NN control) (NNS subjects)) (PRN (-LRB- -LRB-) (VP (VBN n) (S (VP (SYM =) (NP (CD 60))))) (-RRB- -RRB-))))))))) (. .)))
11027904	3	(ROOT (S (PP (IN By) (S (VP (VBG using) (NP (DT a) (JJ placebo-controlled) (, ,) (JJ two-way) (JJ factorial) (NN design))))) (, ,) (NP (NP (NN tolerance)) (PP (TO to) (NP (JJ cold-pressor) (PRN (-LRB- -LRB-) (NP (NNP CP)) (-RRB- -RRB-)) (NNS Doc_11027904_543_547_Disease)))) (VP (VBD was) (VP (VBN examined) (, ,) (PP (DT both) (PP (IN before)) (CC and) (PP (IN after) (NP (NP (JJ oral) (NN administration)) (PP (IN of) (NP (NP (JJ therapeutic) (NNS doses)) (PP (IN of) (NP (ADJP (ADJP (ADJP (JJ common) (JJ opioid)) (PRN (-LRB- -LRB-) (NP (NNP Doc_11027904_643_656_Chemical) (QP (CD 2) (CD mg))) (-RRB- -RRB-))) (CC and) (ADJP (ADJP (JJ nonsteroidal) (JJ anti-inflammatory)) (PRN (-LRB- -LRB-) (NP (NNP Doc_11027904_699_708_Chemical) (QP (CD 10) (CD mg))) (-RRB- -RRB-)))) (JJ analgesic) (NNS agents)))))))))) (. .)))
11027904	4	(ROOT (S (NP (NNS Results)) (VP (VBD showed) (SBAR (IN that) (S (NP (NNP MM) (NNS individuals)) (VP (VBD were) (ADJP (RB significantly) (RBR less) (JJ tolerant)) (PP (IN of) (NP (NP (NNP CP) (NNP Doc_11027904_808_812_Disease)) (PP (IN than) (NP (NN control) (NNS subjects))))) (, ,) (VP (VBG replicating) (NP (JJ previous) (NN work))))))) (. .)))
11027904	5	(ROOT (S (NP (JJ Analgesic) (NNS effects)) (VP (VBD were) (ADJP (JJ significant)) (PP (ADVP (DT neither)) (IN for) (NP (NP (NN medication)) (CC nor) (NP (NN group))))) (. .)))
11027904	6	(ROOT (S (NP (DT These) (NNS data)) (VP (VBP indicate) (SBAR (IN that) (S (NP (NNP MM)) (VP (VBD opioid) (SBAR (S (NP (NNS abusers)) (VP (VBP represent) (NP (NP (DT a) (JJ Doc_11027904_987_1002_Disease) (NN subset)) (PP (IN of) (NP (JJ clinical) (NNS patients))))))))))) (. .)))
11027904	7	(ROOT (S (NP (NP (PRP$ Their) (NNS complaints)) (PP (IN of) (NP (NNS Doc_11027904_1052_1056_Disease)))) (VP (MD should) (VP (VB be) (VP (VP (VBN evaluated) (ADVP (RB seriously))) (CC and) (VP (VBN managed) (ADVP (RB aggressively)))))) (. .)))
11058428	0	(ROOT (S (NP (JJ High-dose) (NNS Doc_11058428_10_28_Chemical)) (VP (MD may) (VP (VB do) (NP (JJR more) (NN harm)) (PP (IN for) (NP (NNS Doc_11058428_50_68_Disease))))) (. .)))
11058428	1	(ROOT (S (PP (IN Because) (PP (IN of) (NP (NP (DT the) (NNP National) (NNP Acute) (NNP Doc_11058428_100_118_Disease) (NNP Studies)) (PRN (-LRB- -LRB-) (NP (NNP NASCIS)) (-RRB- -RRB-))))) (, ,) (NP (JJ high-dose) (NNS Doc_11058428_147_165_Chemical)) (VP (VBD became) (NP (NP (DT the) (NN standard)) (PP (IN of) (NP (NN care)))) (PP (IN for) (NP (DT the) (JJ acute) (NNS Doc_11058428_208_226_Disease)))) (. .)))
11058428	2	(ROOT (S (PP (IN In) (NP (DT the) (NNS NASCIS))) (, ,) (NP (EX there)) (VP (VBD was) (NP (NP (DT no) (NN mention)) (PP (VBG regarding) (NP (NP (DT the) (NN possibility)) (PP (IN of) (NP (JJ acute) (JJ Doc_11058428_299_313_Chemical) (NNS Doc_11058428_314_322_Disease)))))) (SBAR (IN that) (S (NP (JJ high-dose) (NNS Doc_11058428_338_356_Chemical)) (VP (MD may) (VP (VB cause)))))) (. .)))
11058428	3	(ROOT (S (NP (NP (DT The) (NN dosage)) (PP (IN of) (NP (NP (NNS Doc_11058428_382_400_Chemical)) (VP (VBN recommended) (PP (IN by) (NP (DT the) (NNP NASCIS) (CD 3))))))) (VP (VBZ is) (NP (NP (DT the) (JJS highest) (NN dose)) (PP (IN of) (NP (NP (NNS Doc_11058428_452_460_Chemical)) (VP (ADVP (RB ever)) (VBG being) (VP (VBN used) (PP (IN during) (NP (NP (DT a) (JJ 2-day) (NN period)) (PP (IN for) (NP (DT any) (JJ clinical) (NN condition))))))))))) (. .)))
11058428	4	(ROOT (S (NP (PRP We)) (VP (VBP hypothesize) (SBAR (IN that) (S (NP (PRP it)) (VP (MD may) (VP (VB cause) (NP (NP (DT some) (NNS Doc_11058428_565_585_Disease)) (PP (IN of) (NP (JJ Doc_11058428_589_607_Disease) (NNS patients))))))))) (. .)))
11058428	5	(ROOT (S (ADVP (RB Further)) (, ,) (S (NP (JJ Doc_11058428_627_634_Chemical) (NNS Doc_11058428_635_643_Disease)) (VP (VBZ recovers) (ADVP (RB naturally)))) (CC and) (S (NP (NP (DT the) (JJ neurological) (NN improvement)) (VP (VBN shown) (PP (IN in) (NP (DT the) (NNS NASCIS))))) (VP (MD may) (VP (VB be) (NP (NP (NP (RB just) (DT a) (NN recording)) (PP (IN of) (NP (NP (DT this) (JJ natural) (NN motor) (NN recovery)) (PP (IN from) (NP (DT the) (JJ Doc_11058428_780_787_Chemical) (NNS Doc_11058428_788_796_Disease)))))) (, ,) (CONJP (RB instead) (IN of)) (NP (NP (DT any) (NN protection)) (SBAR (IN that) (S (NP (NNS Doc_11058428_829_847_Chemical)) (VP (VBZ offers) (PP (TO to) (NP (DT the) (NNS Doc_11058428_862_880_Disease))))))))))) (. .)))
11058428	6	(ROOT (S (PP (TO To) (NP (PRP$ our) (NN knowledge))) (, ,) (NP (DT this)) (VP (VBZ is) (NP (NP (DT the) (JJ first) (NN discussion)) (VP (VBG considering) (NP (DT the) (NN possibility)) (SBAR (IN that) (S (NP (NP (DT the) (NNS Doc_11058428_966_984_Chemical)) (VP (VBN recommended) (PP (IN by) (NP (NNP NASCIS))))) (VP (MD may) (VP (VB cause) (NP (JJ acute) (JJ Doc_11058428_1023_1037_Chemical) (NNS Doc_11058428_1038_1046_Disease))))))))) (. .)))
11063349	0	(ROOT (NP (NP (NP (NNP Conversion)) (PP (TO to) (NP (NP (JJ Doc_11063349_14_23_Chemical) (NN immunosuppression)) (PP (IN in) (NP (JJ renal) (NN transplant) (NNS recipients)))))) (: :) (NP (NP (NN report)) (PP (IN of) (NP (DT an) (JJ initial) (NN experience)))) (. .)))
11063349	1	(ROOT (S (NP (NP (DT The) (NN aim)) (PP (IN of) (NP (DT this) (NN study)))) (VP (VBZ is) (S (VP (TO to) (VP (VB evaluate) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (JJ Doc_11063349_171_175_Chemical) (NN conversion)))) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG undergoing) (NP (NP (NP (NNS Doc_11063349_210_222_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_11063349_224_227_Chemical)) (-RRB- -RRB-))) (CC or) (NP (NP (NNS Doc_11063349_232_242_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_11063349_244_247_Chemical)) (-RRB- -RRB-))) (NP (NNS Doc_11063349_249_257_Disease)))))))))) (. .)))
11063349	2	(ROOT (S (NP (CD Twenty) (JJ renal) (NN transplant) (NNS recipients)) (VP (VBD were) (VP (VBN switched) (PP (TO to) (NP (NP (NP (JJ fixed) (NN dose) (NNS Doc_11063349_331_340_Chemical)) (-LRB- -LRB-) (NP (NNS Doc_11063349_342_346_Chemical)) (-RRB- -RRB-) (-LRB- -LRB-) (ADJP (CD 5) (JJ mg/day)) (-RRB- -RRB-)) (ADJP (NP (QP (CD 0) (TO to) (CD 204)) (NNS months)) (JJ posttransplant)))))) (. .)))
11063349	3	(ROOT (S (NP (NNP Drug) (NN monitoring)) (VP (VBD was) (RB not) (ADVP (RB initially)) (VP (VBN used) (S (VP (TO to) (VP (VB adjust) (NP (NNS doses))))))) (. .)))
11063349	4	(ROOT (S (NP (NP (DT The) (NNS indications)) (PP (IN for) (NP (NN switch)))) (VP (VBD were) (NP (NP (NP (NP (JJ chronic) (NNS Doc_11063349_487_490_Chemical)) (CC or) (NP (JJ Doc_11063349_494_497_Chemical) (NN nephrotoxicity))) (PRN (-LRB- -LRB-) (NP (CD 12)) (-RRB- -RRB-)) (, ,) (NP (JJ acute) (NNS Doc_11063349_525_528_Chemical)) (CC or) (NP (NP (JJ Doc_11063349_532_535_Chemical) (NNS Doc_11063349_536_544_Disease)) (PRN (-LRB- -LRB-) (NP (CD 3)) (-RRB- -RRB-)) (, ,) (NP (NP (JJ severe) (NNS Doc_11063349_557_575_Disease)) (PRN (-LRB- -LRB-) (NP (CD 2)) (-RRB- -RRB-))))) (, ,) (NP (NP (NP (NNS Doc_11063349_581_624_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_11063349_626_630_Disease)) (-RRB- -RRB-))) (PP (IN in) (NP (NP (NN remission)) (PRN (-LRB- -LRB-) (NP (CD 2)) (-RRB- -RRB-))))) (, ,) (CC and) (NP (NP (NN hepatotoxicity)) (PP (IN in) (NP (CD 1)))))) (. .)))
11063349	5	(ROOT (S (NP (NNP Follow-up)) (VP (VBZ is) (NP (QP (CD 7) (TO to) (CD 24)) (NNS months))) (. .)))
11063349	6	(ROOT (SINV (PP (IN In) (NP (DT the) (CD 12) (NNS patients))) (VP (VBD switched) (SBAR (IN because) (S (PP (IN of) (NP (JJ chronic) (NN nephrotoxicity))) (NP (EX there)) (VP (VBD was) (NP (NP (DT a) (JJ significant) (NN decrease)) (PP (IN in) (NP (NN serum) (NNS Doc_11063349_817_827_Chemical)))))))) (NP (NP (NNP -LSB-) (NNP 233) (NNP +)) (PRN (: /) (NP (QP (CD -34) (TO to) (CD 210)) (NNS +)) (: /)) (NP (NP (CD -56) (NN micromol/liter) (PRN (-LRB- -LRB-) (NP (NNP P) (NNP <) (NNP 0.05)) (-RRB- -RRB-))) (PP (IN at) (NP (NP (CD 6) (NNS months)) (VP (VBN -RSB-)))))) (. .)))
11063349	7	(ROOT (S (NP (NNP Doc_11063349_888_906_Disease)) (VP (VBD improved) (PP (IN in) (NP (CD two) (NNS patients)))) (. .)))
11063349	8	(ROOT (S (NP (NP (DT No) (NN relapse)) (PP (IN of) (NP (NNS Doc_11063349_947_951_Disease)))) (VP (VBD was) (ADJP (JJ observed))) (. .)))
11063349	9	(ROOT (S (NP (NP (NP (ADJP (NP (CD Five) (NNS patients)) (JJ developed)) (NNS Doc_11063349_990_999_Disease)) (PRN (-LRB- -LRB-) (NP (NP (CD two) (NNS Doc_11063349_1005_1035_Disease)) (, ,) (NP (NP (CD one) (NNS Doc_11063349_1041_1065_Disease)) (PP (IN with) (NP (JJ polyclonal) (JJ Doc_11063349_1082_1086_Disease) (NN lung) (NNS infiltrate))))) (-RRB- -RRB-))) (CC and) (NP (CD two))) (VP (VBD had) (NP (NNS Doc_11063349_1116_1140_Disease))) (. .)))
11063349	10	(ROOT (S (NP (EX There)) (VP (VBD were) (NP (DT no) (NNS deaths))) (. .)))
11063349	11	(ROOT (S (NP (NNP Doc_11063349_1164_1168_Chemical)) (VP (VBD was) (VP (VBN discontinued) (PP (PP (IN in) (NP (CD four) (NNS patients))) (, ,) (RB because) (PP (IN of) (NP (NP (NP (NNS Doc_11063349_1215_1224_Disease)) (PP (IN in) (NP (CD two)))) (, ,) (NP (NP (NNS Doc_11063349_1233_1237_Disease)) (PP (IN in) (NP (CD one)))) (, ,) (CC and) (NP (NP (JJ oral) (NNS Doc_11063349_1255_1269_Disease)) (PP (IN in) (NP (CD one))))))))) (. .)))
11063349	12	(ROOT (S (NP (JJ Doc_11063349_1278_1282_Chemical) (NNS levels)) (VP (VBD were) (NP (ADJP (ADJP (ADJP (ADJP (JJ high)) (PRN (-LRB- -LRB-) (ADVP (RB >)) (ADJP (NP (CD 15)) (JJ ng/ml)) (-RRB- -RRB-))) (PP (IN in) (NP (NP (CD 7)) (PP (IN of) (NP (CD 13)))))) (PRN (-LRB- -LRB-) (NP (CD 54) (NN %)) (-RRB- -RRB-))) (NNS patients))) (. .)))
11063349	13	(ROOT (S (NP (JJ Doc_11063349_1352_1356_Chemical) (NN conversion)) (VP (VBZ provides) (NP (JJ adequate) (NN immunosuppression) (S (VP (TO to) (VP (VB enable) (NP (JJ Doc_11063349_1414_1417_Chemical) (NN withdrawal))))))) (. .)))
11063349	14	(ROOT (S (ADVP (RB However)) (, ,) (SBAR (WHADVP (WRB when)) (S (S (VP (VBG converting) (NP (NNS patients)) (PP (TO to) (NP (JJ Doc_11063349_1467_1471_Chemical) (NN drug) (NNS levels))))) (VP (MD should) (VP (VB be) (VP (VBN monitored) (S (VP (TO to) (VP (VB avoid) (NP (ADJP (JJ over-immunosuppression) (CC and) (JJ adequate)) (JJ antiviral) (CC and) (NNS Doc_11063349_1563_1593_Disease) (NNS prophylaxis)))))))))) (VP (MD should) (VP (VB be) (VP (VBN given)))) (. .)))
11077455	0	(ROOT (S (NP (NN Electro-oculography)) (, ,) (ADVP (RB electroretinography)) (, ,) (NP (JJ visual) (NN evoked)) (VP (VP (VBZ potentials)) (, ,) (CC and) (VP (VBP multifocal) (ADVP (RB electroretinography)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NN Doc_11077455_120_130_Chemical-attributed) (NNS Doc_11077455_142_167_Disease))))))) (. .)))
11077455	1	(ROOT (S (NP (NP (JJ Symptomatic) (NNS Doc_11077455_190_215_Disease)) (VP (VBN thought) (S (VP (TO to) (VP (VB be) (VP (VBN associated) (PP (IN with) (NP (NNS Doc_11077455_246_256_Chemical))))))))) (VP (VBZ has) (VP (VBN been) (VP (VBN reported)))) (. .)))
11077455	2	(ROOT (S (NP (DT The) (JJ current) (NN study)) (VP (VBD investigated) (NP (NP (DT the) (JJ visual) (NNS fields) (CC and) (JJ visual) (NN electrophysiology)) (PP (IN of) (NP (CD eight) (NNS patients)))) (PP (IN with) (NP (NP (VBN known) (NN Doc_11077455_383_393_Chemical-attributed) (NNS Doc_11077455_405_422_Disease)) (, ,) (SBAR (WHNP (CD three) (WHPP (IN of) (WHNP (WP whom)))) (S (VP (VBD were) (VP (VBN reported) (ADVP (RB previously))))))))) (. .)))
11077455	3	(ROOT (S (NP (NP (CD Six)) (PP (IN of) (NP (DT the) (NNS patients)))) (VP (VBD were) (ADVP (RB no) (RB longer)) (VP (VBG receiving) (NP (NNS Doc_11077455_509_519_Chemical)))) (. .)))
11077455	4	(ROOT (S (NP (DT The) (JJ central) (CC and) (JJ peripheral) (NNS fields)) (VP (VBD were) (VP (VBN examined) (PP (IN with) (NP (DT the) (NNP Humphrey) (NNP Visual) (NNP Field) (NNP Analyzer))))) (. .)))
11077455	5	(ROOT (S (NP (JJ Full) (JJ visual) (NN electrophysiology)) (, ,) (PP (VBG including) (NP (NP (NN flash) (NN electroretinography)) (PRN (-LRB- -LRB-) (NP (NNP ERG)) (-RRB- -RRB-)))) (, ,) (NP (NP (NN pattern) (NN electroretinography)) (, ,) (NP (NP (NNP multifocal) (NNP ERG)) (VP (VBG using) (NP (NP (DT the) (NNP VERIS) (NN system)) (, ,) (NP (NN electro-oculography)) (, ,) (CC and) (NP (NP (NN flash) (CC and) (NN pattern)) (NP (JJ visual) (JJ evoked) (NNS potentials)))))) (, ,)) (VP (VBD was) (VP (VBN undertaken))) (. .)))
11077455	6	(ROOT (S (NP (CD Seven) (NNS patients)) (VP (VBD showed) (NP (JJ marked) (NNS Doc_11077455_884_909_Disease)) (PP (IN with) (NP (NP (DT some) (NN sparing)) (PP (IN of) (NP (DT the) (JJ temporal) (JJ visual) (NN field)))))) (. .)))
11077455	7	(ROOT (NP (DT The) (JJ eighth) (JJ exhibited) (JJ concentric) (NN constriction) (. .)))
11077455	8	(ROOT (S (S (NP (JJS Most) (JJ electrophysiological) (NNS responses)) (VP (VBD were) (ADVP (RB usually)) (PP (ADVP (RB just)) (IN within) (NP (JJ normal) (NNS limits))))) (: ;) (S (NP (CD two) (NNS patients)) (VP (VBD had) (NP (JJ subnormal) (NNP Arden) (JJ electro-oculography) (NNS indices)))) (: ;) (CC and) (S (NP (CD one) (NN patient)) (VP (VBD showed) (NP (DT an) (ADJP (RB abnormally) (VBN delayed)) (NN photopic) (VBG b) (NN wave)))) (. .)))
11077455	9	(ROOT (S (ADVP (RB However)) (, ,) (S (NP (CD five) (NNS patients)) (VP (VBD showed) (NP (JJ delayed) (JJ 30-Hz) (NN flicker) (NNS b) (NNS waves)))) (, ,) (CC and) (S (NP (CD seven) (NNS patients)) (VP (VBD showed) (NP (JJ delayed) (NN oscillatory) (NNS potentials)))) (. .)))
11077455	10	(ROOT (S (NP (NNP Multifocal) (NNP ERG)) (VP (VP (VBD showed) (NP (NP (NNS abnormalities)) (SBAR (WHNP (WDT that)) (S (ADVP (RB sometimes)) (VP (VBN correlated) (PP (IN with) (NP (DT the) (JJ visual) (NN field) (NN appearance)))))))) (CC and) (VP (VBD confirmed) (SBAR (IN that) (S (NP (DT the) (NN deficit)) (VP (VBZ occurs) (PP (IN at) (NP (DT the) (JJ retinal) (NN level)))))))) (. .)))
11077455	11	(ROOT (S (NP (JJ Marked) (NNS Doc_11077455_1497_1522_Disease)) (VP (VBZ appears) (S (VP (TO to) (VP (VB be) (VP (VBN associated) (PP (IN with) (NP (JJ Doc_11077455_1553_1563_Chemical) (NN therapy)))))))) (. .)))
11077455	12	(ROOT (S (NP (NP (DT The) (NN field) (NNS defects)) (CC and) (NP (DT some) (JJ electrophysiological) (NNS abnormalities))) (VP (VBP persist) (SBAR (WHADVP (WRB when)) (S (NP (JJ Doc_11077455_1648_1658_Chemical) (NN therapy)) (VP (VBZ is) (VP (VBN withdrawn)))))) (. .)))
11078231	0	(ROOT (FRAG (NP (NNP Doc_11078231_0_19_Disease)) (ADJP (JJ due) (PP (TO to) (NP (NP (NNS Doc_11078231_27_48_Disease)) (PP (IN during) (NP (JJ Doc_11078231_56_66_Chemical) (NN stress)))))) (ADVP (RB echocardiography)) (. .)))
11078231	1	(ROOT (S (NP (NP (JJ Doc_11078231_92_102_Chemical) (NN stress) (NN echocardiography)) (PRN (-LRB- -LRB-) (NP (NNP DSE)) (-RRB- -RRB-))) (VP (VBZ is) (NP (NP (DT a) (ADJP (JJ useful) (CC and) (JJ safe)) (NN provocation) (NN test)) (PP (IN for) (NP (NNS Doc_11078231_175_194_Disease))))) (. .)))
11078231	2	(ROOT (S (PP (IN Until) (NP (RB now))) (, ,) (S (NP (DT the) (NN test)) (VP (VBZ has) (VP (VBN been) (VP (VBN focused) (ADVP (RB only)) (PP (IN on) (NP (NP (DT the) (JJ organic) (NN lesion)) (PP (IN in) (NP (DT the) (JJ coronary) (NN artery))))))))) (, ,) (CC and) (S (NP (JJ positive) (NNP DSE)) (VP (VBZ has) (VP (VBN indicated) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (JJ significant) (VBN fixed) (NNS Doc_11078231_349_373_Disease))))))) (. .)))
11078231	3	(ROOT (S (NP (NP (DT The) (NN aim)) (PP (IN of) (NP (DT the) (JJ present) (NN study)))) (VP (VBZ is) (S (VP (TO to) (VP (VB examine) (SBAR (IN whether) (S (NP (NP (NNS Doc_11078231_426_445_Disease)) (ADJP (JJ due) (PP (TO to) (NP (NNS Doc_11078231_453_467_Disease))))) (VP (VBZ is) (VP (VBN induced) (PP (IN by) (NP (NNS Doc_11078231_482_492_Chemical))))))))))) (. .)))
11078231	4	(ROOT (S (NP (PRP We)) (VP (VBD performed) (NP (NNP DSE)) (PP (IN on) (NP (CD 51) (NNS patients))) (PP (PP (IN with) (NP (NNS Doc_11078231_531_554_Disease))) (CC but) (PP (IN without) (NP (JJ significant) (JJ fixed) (NNS Doc_11078231_585_609_Disease))))) (. .)))
11078231	5	(ROOT (S (NP (DT All) (NNS patients)) (VP (VBD had) (NP (NP (JJ anginal) (NNS attacks)) (PP (IN at) (NP (NN rest)))) (PP (IN with) (NP (NP (NNP ST) (NNP elevation)) (PP (IN on) (NP (NP (DT the) (NN electrocardiogram)) (PRN (-LRB- -LRB-) (NP (NNP Doc_11078231_696_710_Disease)) (-RRB- -RRB-))))))) (. .)))
11078231	6	(ROOT (S (S (NP (NNP Doc_11078231_713_727_Disease)) (VP (VBD was) (VP (VBN induced) (PP (IN by) (NP (NP (JJ intracoronary) (NN injection)) (PP (IN of) (NP (NNS Doc_11078231_770_783_Chemical)))))))) (, ,) (CC and) (S (NP (DT no) (VBN fixed) (NNS Doc_11078231_798_822_Disease)) (VP (VBD was) (VP (VBN documented) (PP (IN on) (NP (NP (NNS angiograms)) (PP (IN in) (NP (DT all) (NNS patients)))))))) (. .)))
11078231	7	(ROOT (S (NP (NNP DSE)) (VP (VBD was) (VP (VBN performed) (PP (IN with) (NP (NP (JJ intravenous) (JJ Doc_11078231_904_914_Chemical) (NN infusion)) (PP (IN with) (NP (NP (DT an) (JJ incremental) (NNS doses)) (PP (IN of) (NP (NP (CD 5)) (, ,) (NP (CD 10)) (, ,) (NP (CD 20)) (, ,) (NP (CD 30)) (, ,) (CC and) (NP (CD 40) (NN microg/kg/min)))))))) (NP (DT every) (CD 5) (NNS minutes)))) (. .)))
11078231	8	(ROOT (S (PP (IN Of) (NP (DT the) (CD 51) (NNS patients))) (, ,) (NP (CD 7) (NNS patients)) (VP (VBD showed) (ADVP (RB asynergy)) (PP (IN with) (NP (NNP ST) (NNP elevation)))) (. .)))
11078231	9	(ROOT (S (S (NP (NP (DT All) (CD 7) (NNS patients)) (PRN (-LRB- -LRB-) (NP (CD 13.7) (NN %)) (-RRB- -RRB-))) (VP (VBD had) (VP (VBN Doc_11078231_1099_1109_Disease) (PP (IN during) (NP (NN asynergy)))))) (, ,) (CC and) (S (NP (DT both) (JJ Doc_11078231_1136_1146_Disease) (CC and) (JJ electrocardiographic) (NNS changes)) (VP (VBD were) (VP (VBN preceded) (PP (IN by) (NP (NN asynergy)))))) (. .)))
11078231	10	(ROOT (S (NP (DT These) (NNS findings)) (VP (VBP indicate) (SBAR (IN that) (S (NP (NNS Doc_11078231_1236_1246_Chemical)) (VP (MD can) (VP (VB provoke) (NP (NP (NNS Doc_11078231_1259_1273_Disease)) (PP (IN in) (NP (DT some) (NNS patients)))) (PP (IN with) (NP (NNS Doc_11078231_1296_1319_Disease)))))))) (. .)))
11078231	11	(ROOT (S (SBAR (WHADVP (WRB When)) (S (NP (NNP DSE)) (VP (VBZ is) (VP (VBN performed) (S (VP (TO to) (VP (VB evaluate) (NP (NP (NNS Doc_11078231_1355_1378_Disease)) (, ,) (CONJP (RB not) (JJ only)) (NP (NP (JJ fixed) (NNS Doc_11078231_1395_1412_Disease)) (, ,) (CONJP (CC but) (RB also)) (NP (NNS Doc_11078231_1423_1437_Disease))))))))))) (VP (MD should) (VP (VB be) (VP (VBN considered) (PP (IN as) (NP (NP (DT a) (NN genesis)) (PP (IN of) (NP (NN asynergy)))))))) (. .)))
11079278	0	(ROOT (S (NP (NP (NN Effect)) (PP (IN of) (NP (JJ intravenous) (JJ Doc_11079278_22_32_Chemical) (CC or) (JJ intravenous) (NNS Doc_11079278_48_58_Chemical) (IN plus)))) (VP (VBN glucagon) (PP (IN on) (NP (NN Doc_11079278_76_86_Chemical-induced) (NNS Doc_11079278_95_114_Disease)))) (. .)))
11079278	1	(ROOT (NP (NP (NNP STUDY) (NNP OBJECTIVE)) (: :) (S (VP (VP (TO To) (VP (VB determine) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (NP (NNS Doc_11079278_160_170_Chemical)) (PP (IN on) (NP (JJ Doc_11079278_174_184_Chemical) (NN stress) (NN testing)))))) (PP (IN with) (NP (NP (JJ Doc_11079278_205_229_Chemical) (JJ single-photon) (NN emission)) (VP (VBN computed) (NP (NP (JJ tomography) (NN imaging)) (CC and) (NP (JJ ST-segment) (NN monitoring)))))))) (, ,) (CC and) (VP (TO to) (VP (VB assess) (NP (NP (DT the) (NN impact)) (PP (IN of) (NP (JJ intravenous) (NN glucagon)))) (PP (IN on) (NP (NP (NNP Doc_11079278_360_370_Chemical) (POS 's)) (NNS effects))))))) (. .)))
11079278	2	(ROOT (NP (NP (NNP Randomized)) (, ,) (NP (JJ double-blind) (, ,) (JJ placebo-controlled) (NN trial)) (. .)))
11079278	3	(ROOT (NP (NP (NNP Community)) (NP (NN hospital)) (. .)))
11079278	4	(ROOT (NP (NP (JJ Twenty-two) (NNS patients)) (PP (IN with) (NP (ADJP (JJ known) (JJ reversible)) (NN perfusion) (NNS defects))) (. .)))
11079278	5	(ROOT (S (NP (NNS Patients)) (VP (VBD underwent) (NP (NP (JJ Doc_11079278_575_585_Chemical) (NN stress) (NNS tests)) (PP (IN per) (NP (JJ standard) (NN protocol))))) (. .)))
11079278	6	(ROOT (S (S (SBAR (IN Before) (S (NP (NNS Doc_11079278_629_639_Chemical)) (VP (VBD was) (VP (VBN begun))))) (, ,) (NP (DT no) (NN therapy)) (VP (VBD was) (VP (VBN given) (PP (IN during) (NP (DT the) (JJ first) (NN visit)))))) (, ,) (CC and) (S (NP (NNS patients)) (VP (VBD were) (VP (VBN randomized) (PP (IN on) (NP (JJ subsequent) (NNS visits))) (S (VP (TO to) (VP (VB receive) (NP (NP (NNS Doc_11079278_757_767_Chemical) (CC or) (NNS Doc_11079278_771_781_Chemical)) (PP (CC plus) (NP (NN glucagon) (CD 1) (NN mg)))))))))) (. .)))
11079278	7	(ROOT (S (NP (NNP Doc_11079278_802_812_Chemical)) (VP (VBD was) (VP (VBN dosed) (S (VP (TO to) (VP (VB achieve) (NP (DT a) (JJ resting) (JJ Doc_11079278_844_857_Chemical) (NN heart) (NN rate)) (PP (IN below) (NP (NP (CD 65) (NN beats/minute)) (CC or) (NP (NP (DT a) (JJ total) (JJ intravenous) (NN dose)) (PP (IN of) (NP (CD 20) (NN mg))))))))))) (. .)))
11079278	8	(ROOT (S (S (NP (NNP MEASUREMENTS) (CC AND) (NNP MAIN)) (VP (VBZ RESULTS))) (: :) (S (NP (NNS Doc_11079278_960_970_Chemical)) (VP (VP (VBD reduced) (NP (JJ maximum) (NN heart) (NN rate)) (NP (CD 31) (NN %))) (, ,) (VP (VBD summed) (NP (NP (NN stress) (NNS scores)) (ADJP (CD 29) (NN %)))) (, ,) (CC and) (VP (VBD summed) (S (NP (NN difference) (NNS scores)) (NP (NP (CD 43) (NN %)) (PP (IN versus) (NP (NN control)))))))) (. .)))
11079278	9	(ROOT (S (NP (NNP Doc_11079278_1078_1088_Chemical) (CC plus) (NNP glucagon)) (ADVP (RB also)) (VP (VBD reduced) (NP (DT the) (JJ maximum) (NN heart) (NN rate)) (NP (NP (CD 29) (NN %)) (PP (IN versus) (NP (NN control))))) (. .)))
11079278	10	(ROOT (S (NP (JJ Summed) (NN stress) (CC and) (JJ summed) (NN difference) (NNS scores)) (VP (VBD were) (RB not) (ADJP (RB significantly) (JJ reduced)) (, ,) (SBAR (IN although) (S (NP (PRP they)) (VP (VBD were) (ADJP (ADJP (NP (CD 18) (NN %) (CC and) (CD 30) (NN %)) (JJR lower)) (PRN (, ,) (ADVP (RB respectively)) (, ,))) (PP (IN than) (NP (NN control))))))) (. .)))
11079278	11	(ROOT (S (NP (DT No) (JJ significant) (NNS differences)) (VP (VBD were) (VP (VBN found) (PP (IN in) (NP (NP (DT any) (NN parameter)) (PP (IN between) (NP (NNS Doc_11079278_1363_1373_Chemical) (CC and) (NNS Doc_11079278_1378_1388_Chemical-glucagon))))))) (. .)))
11079278	12	(ROOT (S (PP (IN During) (NP (JJ Doc_11079278_1418_1428_Chemical) (NN stress) (NN testing))) (, ,) (NP (NNS Doc_11079278_1445_1455_Chemical)) (VP (VBZ attenuates) (CC or) (VBZ eliminates) (NP (NP (NN evidence)) (PP (IN of) (NP (NNS Doc_11079278_1493_1512_Disease))))) (. .)))
11079278	13	(ROOT (S (NP (NP (NNP Glucagon) (CD 1) (NN mg)) (PRN (, ,) (SBAR (IN although) (FRAG (ADJP (RB somewhat) (JJ effective)))) (, ,))) (VP (VBZ does) (RB not) (VP (VB correct) (NP (DT this) (NN effect)) (PP (TO to) (NP (DT the) (NN extent))) (SBAR (IN that) (S (NP (PRP it)) (VP (MD can) (VP (VB be) (VP (VBN administered) (S (ADJP (JJ clinically)))))))))) (. .)))
11099450	0	(ROOT (S (NP (NP (NN Evidence)) (PP (IN of) (ADJP (JJ functional)))) (VP (VBP somatotopy) (PP (IN in) (NP (NNP GPi))) (PP (IN from) (NP (NP (NNS results)) (PP (IN of) (NP (NN pallidotomy)))))) (. .)))
11099450	1	(ROOT (S (NP (NP (DT The) (NN objective)) (PP (IN of) (NP (DT this) (NN study)))) (VP (VBD was) (S (VP (TO to) (VP (VB explore) (NP (NP (DT the) (ADJP (JJ functional)) (NN anatomy)) (PP (IN of) (NP (NP (DT the) (ADJP (JJ globus) (JJ pallidus)) (NNS internus)) (PRN (-LRB- -LRB-) (NP (NNP GPi)) (-RRB- -RRB-))))) (PP (IN by) (S (VP (VBG studying) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NP (JJ unilateral) (ADJP (ADJP (JJ pallidotomy) (PP (IN on) (NP (JJ Doc_11099450_227_239_Disease) (`` `) (JJ off) ('' ') (NNS signs)))) (CC and) (ADJP (JJ Doc_11099450_256_264_Chemical-induced))) (NNS dyskinesias)) (PRN (-LRB- -LRB-) (NP (NNP Doc_11099450_286_289_Disease)) (-RRB- -RRB-)))))))))))) (. .)))
11099450	2	(ROOT (S (NP (PRP We)) (VP (VBD found) (NP (JJ significant) (JJ positive) (NNS correlations)) (PP (IN between) (NP (NP (NP (DT the) (JJ preoperative) (JJ Doc_11099450_360_368_Chemical) (NNS responsiveness)) (PP (IN of) (NP (NN motor) (NNS signs)))) (CC and) (NP (NP (DT the) (JJ Doc_11099450_407_415_Chemical) (NNS responsiveness)) (PP (IN of) (NP (NP (NNS scores)) (PP (IN in) (NP (NP (NP (NP (JJ timed) (NNS tests)) (PRN (-LRB- -LRB-) (NP (NP (NNP Core) (NNP Assessment) (NNP Program)) (PP (IN for) (NP (NNP Intracerebral) (NNPS Transplantations)))) (-RRB- -RRB-))) (PP (IN in) (NP (DT the) (JJ contralateral) (NNS limbs)))) (CC and) (NP (NP (DT the) (NN improvement)) (PP (IN in) (NP (DT these) (NNS scores))))))))))) (PP (IN after) (NP (NN surgery))) (, ,) (SBAR (IN whereas) (S (NP (EX there)) (VP (VBD was) (NP (NP (DT no) (NN correlation)) (PP (IN with) (NP (NP (DT the) (NN improvement)) (PP (IN in) (NP (NNS Doc_11099450_652_655_Disease)))))))))) (. .)))
11099450	3	(ROOT (S (NP (PRP We)) (ADVP (RB also)) (VP (VBD found) (NP (NP (DT a) (ADJP (RB highly) (JJ significant)) (NN correlation)) (PRN (-LRB- -LRB-) (NP (NP (NNP P)) (: :) (NP (NP (NNP <) (CD 0.0001) (, ,) (CD r)) (SBAR (S (VP (SYM =) (NP (CD 0.8))))))) (-RRB- -RRB-))) (PP (IN between) (NP (NP (DT the) (NN volume)) (PP (IN of) (NP (NP (DT the) (JJ ventral) (NN lesion)) (PP (IN in) (NP (NP (DT the) (NN GPi)) (CC and) (NP (DT the) (NN improvement)))))))) (PP (IN in) (NP (NP (NNS Doc_11099450_802_805_Disease)) (PP (IN in) (NP (DT the) (JJ contralateral) (NNS limbs))))) (, ,) (SBAR (IN whereas) (S (NP (EX there)) (VP (VBD was) (NP (NP (NP (DT no) (NN correlation)) (PP (IN between) (NP (DT the) (JJ ventral) (NN volume)))) (CC and) (NP (NP (DT the) (NN improvement)) (PP (IN in) (NP (JJ Doc_11099450_917_929_Disease) (`` `) (JJ off) ('' ') (NNS signs))))))))) (. .)))
11099450	4	(ROOT (S (NP (NP (DT The) (NNS volumes)) (PP (IN of) (NP (NP (DT the) (JJ total) (NN lesion) (NN cylinder)) (CC and) (NP (DT the) (JJ dorsal) (NN lesion))))) (VP (VBD did) (RB not) (VP (VB correlate) (PP (IN with) (NP (NP (DT the) (NN outcome)) (PP (IN of) (NP (DT either) (JJ Doc_11099450_1051_1062_Disease) (CC or) (JJ Doc_11099450_1066_1078_Disease) (`` `) (JJ off) ('' ') (NNS signs))))))) (. .)))
11099450	5	(ROOT (S (NP (NP (DT The) (NN differential) (JJ predictive) (NN value)) (PP (IN of) (NP (NP (JJ Doc_11099450_1129_1137_Chemical) (NNS responsiveness)) (PP (IN for) (NP (NP (DT the) (NN outcome)) (PP (IN of) (NP (NP (JJ Doc_11099450_1172_1184_Disease) (`` `) (JJ off) ('' ') (NNS signs) (CC and) (NNS Doc_11099450_1201_1204_Disease)) (CC and) (NP (NP (DT the) (JJ different) (NNS correlations)) (PP (IN of) (NP (NP (JJ ventral) (NN lesion) (NN volume)) (PP (IN with) (NP (NP (NNS Doc_11099450_1266_1277_Disease)) (CC and) (NP (JJ Doc_11099450_1282_1294_Disease) (`` `) (JJ off) ('' ') (NNS signs)))))))))))))) (VP (VBP indicate) (SBAR (IN that) (S (NP (JJ different) (JJ anatomical) (CC or) (JJ pathophysiological) (NNS substrates)) (VP (MD may) (VP (VB be) (ADJP (JJ responsible) (PP (IN for) (NP (NP (DT the) (NN generation)) (PP (IN of) (NP (NP (JJ Doc_11099450_1416_1428_Disease) (`` `) (JJ off) ('' ') (NNS signs)) (CC and) (NP (NNS Doc_11099450_1445_1456_Disease)))))))))))) (. .)))
11099450	6	(ROOT (S (SBAR (IN Whereas) (S (NP (NP (NNS cells)) (PP (IN in) (NP (NP (DT a) (JJR wider) (NN area)) (PP (IN of) (NP (DT the) (NNP GPi)))))) (VP (MD may) (VP (VB be) (VP (VBN implicated) (PP (IN in) (NP (NNS Doc_11099450_1520_1532_Disease)))))))) (, ,) (NP (DT the) (JJ ventral) (NN GPi)) (VP (VBZ seems) (S (VP (TO to) (VP (VB be) (ADJP (JJ crucial) (PP (IN for) (NP (NP (DT the) (NN manifestation)) (PP (IN of) (NP (NNS Doc_11099450_1595_1598_Disease)))))))))) (. .)))
11099450	7	(ROOT (S (NP (PRP We)) (VP (VBP suggest) (SBAR (IN that) (S (NP (PRP$ our) (NNS observations)) (VP (VBP are) (NP (NP (JJ additional) (NN proof)) (PP (IN of) (NP (NP (DT the) (ADJP (JJ functional)) (NN somatotopy)) (PP (IN of) (NP (NP (DT the) (NNS systems)) (PP (IN within) (NP (DT the) (NNP GPi))))))) (SBAR (WHNP (WDT that)) (S (VP (VB mediate) (NP (NNS Doc_11099450_1726_1738_Disease) (CC and) (NNS Doc_11099450_1743_1754_Disease)) (, ,) (ADVP (RB especially)) (PP (IN along) (NP (NP (DT the) (JJ dorsoventral) (NN trajectory)) (VP (VBN used) (PP (IN in) (NP (NN pallidotomy)))))))))))))) (. .)))
11099450	8	(ROOT (S (NP (NP (DT The) (NN outcome)) (PP (IN of) (NP (NP (NN pallidotomy)) (SBAR (WHPP (IN in) (WHNP (WDT which))) (S (NP (DT the) (NN lesion)) (VP (VBZ involves) (NP (DT the) (ADJP (JJ ventral) (CC and) (JJ dorsal)) (NN GPi)))))))) (VP (VP (MD could) (VP (VB be) (NP (NP (DT the) (JJ net) (NN effect)) (PP (IN of) (NP (NP (NN alteration)) (PP (IN in) (NP (NP (DT the) (NN activity)) (PP (IN of) (NP (NP (NNS pathways)) (SBAR (WHNP (WDT which)) (S (VP (VB mediate) (NP (JJ different) (NNS symptoms)))))))))))))) (, ,) (CC and) (VP (ADVP (RB hence)) (MD could) (VP (VB be) (NP (NN variable))))) (. .)))
11185967	0	(ROOT (S (S (VP (VBG Screening) (PP (IN for) (NP (NN stimulant))))) (VP (VBP use) (PP (IN in) (NP (JJ adult) (NN emergency) (NN department) (JJ Doc_11185967_58_65_Disease) (NNS patients)))) (. .)))
11185967	1	(ROOT (S (NP (NP (DT The) (NN objective)) (PP (IN of) (NP (DT this) (NN study)))) (VP (VBD was) (S (VP (TO to) (VP (VB determine) (NP (NP (DT the) (NN prevalence)) (PP (IN of) (NP (NP (JJ positive) (NN plasma) (NN drug) (NN screening)) (PP (IN for) (NP (NNS Doc_11185967_185_192_Chemical) (CC or) (NNS Doc_11185967_196_207_Chemical)))))) (PP (IN in) (NP (JJ adult) (NN emergency) (NN department) (JJ Doc_11185967_238_245_Disease) (NNS patients))))))) (. .)))
11185967	2	(ROOT (S (NP (NP (DT This) (JJ prospective) (NN study)) (VP (VBN evaluated) (NP (NP (JJ consecutive) (JJ eligible) (JJ Doc_11185967_319_326_Disease) (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBD had) (NP (DT a) (NN plasma) (NN sample)))))))) (VP (VBN collected) (PP (IN as) (NP (NP (NN part)) (PP (IN of) (NP (PRP$ their) (JJ clinical) (NN evaluation)))))) (. .)))
11185967	3	(ROOT (S (NP (NNP Plasma)) (VP (VBD was) (VP (VBN tested) (PP (IN for) (NP (NP (NNS Doc_11185967_430_441_Chemical)) (CC and) (NP (DT the) (JJ Doc_11185967_450_457_Chemical) (JJ metabolite) (NNS Doc_11185967_469_484_Chemical)))) (S (VP (VBG using) (NP (JJ enzyme-mediated) (NN immunoassay) (NN methodology)))))) (. .)))
11185967	4	(ROOT (S (NP (NP (NNP Plasma) (NNS samples)) (PP (IN with) (NP (NP (NP (NNS Doc_11185967_552_567_Chemical)) (NP (QP (JJR greater) (IN than) (CD 150)) (NN ng/mL))) (CC or) (NP (DT an) (JJ Doc_11185967_597_608_Chemical) (ADJP (QP (JJR greater) (IN than) (CD 500))) (NN ng/mL))))) (VP (VBD were) (VP (VBN defined) (S (ADJP (RB as) (JJ positive))))) (. .)))
11185967	5	(ROOT (S (S (NP (NP (JJ Patient) (NNS demographics)) (, ,) (NP (NP (NN history)) (PP (IN of) (NP (JJ underlying) (NN drug) (CC or) (NN Doc_11185967_710_717_Chemical-related) (NNS Doc_11185967_726_733_Disease) (NN disorder)))) (, ,)) (VP (VBD estimated) (NP (NN time)) (PP (IN from) (NP (NP (NP (NNS Doc_11185967_764_771_Disease)) (PP (TO to) (NP (NN sample) (NN collection)))) (, ,) (NP (NP (NN history) (CC or) (NN suspicion)) (PP (IN of) (NP (NNS Doc_11185967_818_825_Chemical)))) (CC or) (NP (NP (JJ Doc_11185967_829_840_Chemical) (NN abuse)) (, ,) (NP (NP (NNS results)) (PP (IN of) (NP (JJ clinical) (NN urine) (NN testing))))))) (PP (IN for) (NP (NP (NNS drugs)) (PP (IN of) (NP (NN abuse))))))) (, ,) (CC and) (S (NP (JJ assay) (NNS results)) (VP (VBD were) (VP (VBN recorded) (PP (IN without) (NP (JJ patient) (NNS identifiers)))))) (. .)))
11185967	6	(ROOT (S (S (NP (CD Fourteen) (ADJP (ADJP (QP (IN of) (CD 248))) (PRN (-LRB- -LRB-) (NP (NP (NP (CD 5.6) (NN %)) (, ,) (NP (NP (ADJP (CD 95) (NN %)) (NNP CI)) (NP (CD 2.7) (NN %)))) (NP (CD -8.5) (NN %))) (-RRB- -RRB-))) (NN plasma) (NNS samples)) (VP (VBD were) (ADJP (JJ positive) (PP (IN by) (S (ADVP (RB immunoassay)) (VP (VBG testing) (PP (IN for) (NP (NNS Doc_11185967_1069_1084_Chemical))))))))) (CC and) (S (NP (NP (DT no) (NNS samples)) (PRN (-LRB- -LRB-) (NP (NP (NP (CD 0) (NN %)) (, ,) (NP (ADJP (CD 95) (NN %)) (NNP CI))) (NP (CD 0-1) (CD .2) (NN %))) (-RRB- -RRB-))) (VP (VBD were) (ADJP (JJ positive) (PP (IN for) (NP (NNS Doc_11185967_1138_1149_Chemical)))))) (. .)))
11185967	7	(ROOT (S (NP (JJ Positive) (NN test) (NNS results)) (VP (VBD were) (ADJP (RBR more) (JJ common) (PP (IN in) (NP (NP (JJ patient) (NNS visits)) (SBAR (WHADVP (WRB where)) (S (NP (EX there)) (VP (VBD was) (NP (NP (DT a) (NN history) (CC or) (NN suspicion)) (PP (IN of) (NP (NNS Doc_11185967_1250_1257_Chemical) (CC or) (NNS Doc_11185967_1261_1272_Chemical) (NN abuse))))))) (PRN (-LRB- -LRB-) (NP (NNP p) (QP (CD <) (CD 0.0005))) (-RRB- -RRB-)))))) (. .)))
11185967	8	(ROOT (S (PP (IN During) (NP (DT this) (NN study) (NN period))) (, ,) (NP (NP (JJ routine) (NN plasma) (NN screening)) (PP (IN for) (NP (NP (NNS Doc_11185967_1361_1368_Chemical) (CC and) (NNS Doc_11185967_1373_1385_Chemical)) (PP (IN in) (NP (JJ adult) (JJ Doc_11185967_1395_1402_Disease) (NNS patients)))))) (VP (VBD had) (NP (DT a) (JJ low) (NN yield))) (. .)))
11185967	9	(ROOT (S (PP (IN As) (NP (DT a) (NN result))) (, ,) (NP (JJ routine) (NN plasma) (NN screening)) (VP (MD would) (VP (VB yield) (NP (NP (JJ few) (NNS cases)) (PP (IN of) (NP (NN stimulant) (NN drug))) (SBAR (WHPP (IN in) (WHNP (WDT which))) (S (NP (EX there)) (VP (VBD was) (RB neither) (NP (NP (DT a) (NN history)) (CC nor) (NP (NP (NN suspicion)) (PP (IN of) (NP (NP (NNS Doc_11185967_1561_1571_Disease)) (PP (IN in) (NP (DT this) (NN population))))))))))))) (. .)))
11195262	0	(ROOT (NP (NP (NNP Contribution)) (PP (IN of) (NP (NNS Doc_11195262_16_32_Chemical))) (PP (TO to) (NP (DT the) (NNS Doc_11195262_40_99_Disease))) (. .)))
11195262	1	(ROOT (S (NP (PRP We)) (VP (VBP report) (NP (NP (DT the) (NN case)) (PP (IN of) (NP (DT a) (JJ 62-year-old) (NN man)))) (SBAR (SBAR (WHNP (WP who)) (S (VP (VBD was) (VP (VBN administered) (NP (NP (NNS Doc_11195262_162_178_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_11195262_180_183_Chemical)) (-RRB- -RRB-))))))) (CC and) (SBAR (WHNP (WP who)) (S (ADVP (RB subsequently)) (VP (VBD developed) (NP (NP (DT the) (NNS Doc_11195262_220_279_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_11195262_281_286_Disease)) (-RRB- -RRB-)))))))) (. .)))
11195262	2	(ROOT (S (NP (PRP He)) (VP (VBD had) (VP (VBN been) (VP (VBG taking) (NP (NP (NNS Doc_11195262_308_311_Chemical)) (PP (IN for) (NP (NP (NN treatment)) (PP (IN of) (NP (JJ idiopathic) (JJ generalized) (NNS Doc_11195262_352_376_Disease)))))) (SBAR (IN since) (S (NP (PRP he)) (VP (VBD was) (ADJP (NP (CD 56) (NNS years)) (JJ old)))))))) (. .)))
11195262	3	(ROOT (S (PP (IN After) (S (VP (VBG substituting) (NP (NNS Doc_11195262_423_426_Chemical)) (PP (IN with) (NP (NNS Doc_11195262_432_442_Chemical)))))) (, ,) (NP (DT the) (NN serum) (NNS Doc_11195262_454_460_Chemical) (NN level)) (VP (VBD returned) (PP (TO to) (ADJP (JJ normal)))) (. .)))
11195262	4	(ROOT (S (NP (PRP We)) (VP (VBP consider) (S (NP (NP (DT this) (NN episode)) (PP (IN of) (NP (NNS Doc_11195262_515_520_Disease)))) (VP (TO to) (VP (VB be) (NP (NP (DT the) (NN result)) (PP (IN of) (NP (NP (DT a) (NN combination)) (PP (IN of) (NP (NP (NNS factors)) (PP (VBG including) (NP (NP (DT a) (NNS Doc_11195262_578_616_Disease)) (CC and) (NP (NP (DT the) (JJ long-term) (NN administration)) (PP (IN of) (NP (NNS Doc_11195262_653_656_Chemical))))))))))))))) (. .)))
11208990	0	(ROOT (NP (NP (NNP Association)) (PP (IN of) (NP (JJ Doc_11208990_15_27_Chemical) (NN production) (CC and) (NNS apoptosis))) (PP (IN in) (NP (NP (DT a) (NN model)) (PP (IN of) (NP (JJ experimental) (NNS Doc_11208990_80_91_Disease))))) (. .)))
11208990	1	(ROOT (S (PP (IN In) (NP (JJ recent) (NNS studies))) (NP (NP (VBN increased) (NNS amounts)) (PP (IN of) (NP (NP (NP (NNS Doc_11208990_144_156_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_11208990_158_160_Chemical)) (-RRB- -RRB-))) (CC and) (NP (NNS apoptosis))))) (VP (VBP have) (VP (VBN been) (VP (VBN implicated) (PP (IN in) (NP (NP (JJ various) (JJ pathological) (NNS conditions)) (PP (IN in) (NP (DT the) (NN kidney)))))))) (. .)))
11208990	2	(ROOT (S (NP (PRP We)) (VP (VBP have) (VP (VBN studied) (NP (NP (DT the) (NN role)) (PP (IN of) (NP (NP (NNS Doc_11208990_275_277_Chemical)) (CC and) (NP (PRP$ its) (NN association))))) (PP (IN with) (NP (NP (NNS apoptosis)) (PP (IN in) (NP (NP (DT an) (JJ experimental) (NN model)) (PP (IN of) (NP (NP (NNS Doc_11208990_341_359_Disease)) (VP (VBN induced) (PP (IN by) (NP (NP (DT a) (JJ single) (NN injection)) (PP (IN of) (NP (NP (NNS Doc_11208990_393_403_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_11208990_405_408_Chemical)) (-RRB- -RRB-))))))))))))))) (. .)))
11208990	3	(ROOT (S (NP (NP (DT The) (NN alteration)) (PP (IN in) (NP (DT the) (JJ Doc_11208990_442_444_Chemical) (NN pathway)))) (VP (VBD was) (VP (VBN assessed) (PP (PP (IN by) (S (VP (VBG measuring) (NP (JJ Doc_11208990_479_486_Chemical) (NNS levels)) (PP (IN in) (NP (NN serum/urine)))))) (CC and) (PP (IN by) (S (VP (VBG evaluating) (NP (DT the) (NNS changes)) (PP (IN in) (NP (NP (NN vascular) (NN reactivity)) (PP (IN of) (NP (DT the) (ADJP (JJ isolated) (JJ perfused)) (NN rat) (NN kidney) (PRN (-LRB- -LRB-) (NP (NNP IPRK)) (-RRB- -RRB-)) (NN system))))))))))) (. .)))
11208990	4	(ROOT (S (NP (NNS Rats)) (VP (VBD were) (ADJP (JJ stratified) (PP (IN into) (NP (NN control) (NNS groups) (CC and) (NN Doc_11208990_658_661_Chemical-induced) (NNS Doc_11208990_670_681_Disease) (NNS groups))))) (. .)))
11208990	5	(ROOT (S (NP (DT These) (CD two) (NNS groups)) (VP (VBD were) (ADVP (RB then)) (VP (VBN divided) (PP (IN into) (: :) (NP (NP (NN group) (CD 1)) (, ,) (NP (NP (NP (NNS animals)) (VP (VBG receiving) (NP (NN saline)))) (: ;) (CC and) (NP (NP (NN group) (CD 2)) (, ,) (NP (NP (NNS animals)) (VP (VBG receiving) (NP (NP (NNS Doc_11208990_797_811_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP AG)) (-RRB- -RRB-)) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (NP (NP (DT a) (JJ specific) (NN inhibitor)) (PP (IN of) (NP (JJ inducible-Doc_11208990_860_862_Chemical) (NN synthase)))))))))))))))) (. .)))
11208990	6	(ROOT (S (PP (IN On) (NP (NN day) (CD 21))) (, ,) (NP (NNS rats)) (VP (VBD were) (VP (VBN sacrificed) (PP (IN after) (S (VP (VBG obtaining) (NP (NN material)) (PP (IN for) (NP (JJ biochemical) (NN analysis)))))))) (. .)))
11208990	7	(ROOT (S (NP (NP (JJ Histopathological) (NN examination)) (PP (IN of) (NP (NP (DT the) (NNS kidneys)) (PP (IN of) (NP (NP (NNS rats)) (VP (VBN treated) (PP (IN with) (NP (NNS Doc_11208990_1031_1034_Chemical))))))))) (VP (VBD revealed) (NP (NP (JJ focal) (NNS areas)) (PP (IN of) (NP (JJ Doc_11208990_1059_1082_Disease) (CC and) (JJ mild) (NNS Doc_11208990_1092_1123_Disease))))) (. .)))
11208990	8	(ROOT (S (NP (PRP They)) (ADVP (RB also)) (VP (VBD had) (NP (NP (ADJP (RB significantly) (JJR higher)) (NNS levels)) (PP (IN of) (NP (NNS Doc_11208990_1170_1181_Disease)))) (PP (VBN compared) (PP (IN with) (NP (NP (NN control) (CC and) (NN treatment) (NNS groups)) (PRN (-LRB- -LRB-) (NP (NNP P) (NNP <) (NNP 0.05)) (-RRB- -RRB-)))))) (. .)))
11208990	9	(ROOT (S (NP (JJ Urine) (JJ Doc_11208990_1243_1250_Chemical) (NNS levels)) (VP (VBD were) (ADVP (RB significantly)) (VP (VBN increased) (PP (IN in) (NP (NP (DT the) (NN Doc_11208990_1294_1297_Chemical-Doc_11208990_1298_1309_Disease) (NN group)) (PRN (-LRB- -LRB-) (NP (NNP P) (NNP <) (NNP 0.05)) (-RRB- -RRB-)))))) (. .)))
11208990	10	(ROOT (S (PP (IN In) (NP (DT the) (NNP IPRK) (NNS Doc_11208990_1340_1353_Chemical) (CC and) (NNS Doc_11208990_1358_1371_Chemical))) (NP (JJ related) (NNS responses)) (VP (VBD were) (ADJP (RB significantly) (JJ impaired)) (PP (IN in) (NP (DT the) (NN Doc_11208990_1425_1428_Chemical-Doc_11208990_1429_1440_Disease) (NN group)))) (. .)))
11208990	11	(ROOT (S (NP (NNS Apoptosis)) (VP (VBD was) (RB not) (VP (VBN detected) (PP (IN in) (NP (NNS controls))))) (. .)))
11208990	12	(ROOT (S (ADVP (RB However)) (, ,) (PP (IN in) (NP (DT the) (NN Doc_11208990_1504_1507_Chemical-Doc_11208990_1508_1519_Disease) (NN group))) (, ,) (NP (JJ numerous) (JJ apoptotic) (NNS cells)) (VP (VBD were) (VP (VBN identified) (PP (IN in) (NP (DT the) (JJ tubulointerstitial) (NNS areas))))) (. .)))
11208990	13	(ROOT (S (NP (RB Double) (NN staining)) (VP (VBD revealed) (NP (JJ numerous) (JJ interstitial) (JJ apoptotic) (NNS cells)) (S (VP (TO to) (VP (VB stain) (PP (IN for) (NP (NP (NNP ED1)) (, ,) (NP (NP (DT a) (NN marker)) (PP (IN for) (NP (NNS monocytes/macrophages)))))))))) (. .)))
11208990	14	(ROOT (S (NP (NP (NNP Treatment)) (PP (IN with) (NP (NNP AG)))) (VP (VP (VBD prevented) (NP (NP (DT the) (NN impairment)) (PP (IN of) (NP (JJ renal) (NN vascular) (NN bed) (NNS responses))))) (CC and) (VP (VBD reduced) (NP (DT both) (NN urine)) (NP (JJ Doc_11208990_1816_1823_Chemical) (NNS levels) (CC and) (NNS apoptosis)) (S (VP (TO to) (VP (VB control) (NP (NNS levels))))))) (. .)))
11208990	15	(ROOT (S (NP (PRP We)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NP (NNS interactions)) (PP (IN between) (NP (NNS Doc_11208990_1913_1915_Chemical) (CC and) (NNS apoptosis)))) (VP (VBP are) (ADJP (JJ important) (PP (IN in) (NP (NP (DT the) (NNS pathogenesis)) (PP (IN of) (NP (DT the) (NN Doc_11208990_1971_1974_Chemical-induced) (NNS Doc_11208990_1983_1992_Disease)))))))))) (. .)))
11226639	0	(ROOT (NP (NP (JJ Dual) (NNS effects)) (PP (IN of) (NP (NP (NNS Doc_11226639_16_25_Chemical)) (PP (IN on) (NP (NN Doc_11226639_29_40_Chemical-induced) (NNS Doc_11226639_49_57_Disease))))) (PP (IN in) (NP (NNS rats))) (. .)))
11226639	1	(ROOT (S (S (NP (NNP Doc_11226639_67_76_Chemical)) (VP (VBZ affects) (NP (DT the) (JJ circadian) (NN sleep/wake) (NN cycle)))) (, ,) (CC but) (S (NP (PRP it)) (VP (VBZ is) (RB not) (ADJP (JJ clear)) (SBAR (IN whether) (S (NP (PRP it)) (VP (MD may) (VP (VB influence) (NP (JJ drug-induced) (NNS Doc_11226639_175_183_Disease)))))))) (. .)))
11226639	2	(ROOT (S (NP (NNP Doc_11226639_185_203_Chemical)) (VP (VBD was) (VP (VBN administered) (ADVP (RB intraperitoneally)) (PP (IN into) (NP (NP (JJ male) (NNS rats)) (VP (VBN pre-treated) (PP (IN with) (NP (NP (NNS Doc_11226639_271_280_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (CD 0.05)) (, ,) (NP (CD 0.5)) (, ,) (NP (CD 5)) (CC and) (NP (CD 50) (NN mg/kg))) (-RRB- -RRB-))))))))) (. .)))
11226639	3	(ROOT (S (NP (NP (JJ Doc_11226639_310_319_Chemical) (NN pre-treatment)) (VP (VBN affected) (PP (IN in) (NP (DT a) (JJ dual) (NN manner) (NNS Doc_11226639_360_371_Chemical) (NN Doc_11226639_372_380_Disease))))) (, ,) (ADVP (RB however)) (, ,) (NP (DT no) (JJ dose-effect) (NN correlation)) (VP (VBD was) (VP (VBN found))) (. .)))
11226639	4	(ROOT (S (PP (IN In) (ADJP (JJ particular))) (, ,) (NP (JJ low) (NNS doses)) (VP (VP (VBD reduced) (NP (DT the) (NN latency)) (PP (TO to))) (CC and) (VP (VBZ prolonged) (NP (NP (DT the) (NN duration)) (PP (IN of) (NP (JJ Doc_11226639_507_518_Chemical) (NNS Doc_11226639_519_527_Disease)))))) (. .)))
11226639	5	(ROOT (S (PP (IN In) (NP (NN contrast))) (, ,) (NP (NP (DT the) (JJS highest) (NN dose)) (PP (IN of) (NP (NP (NNS Doc_11226639_562_571_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 50) (NN mg/kg)) (-RRB- -RRB-))))) (VP (VP (VBD caused) (NP (DT a) (JJ paradoxical) (NN increase)) (PP (IN in) (NP (DT the) (NN latency)))) (CC and) (VP (VBD produced) (NP (NP (NP (DT a) (JJ sustained) (NN reduction)) (PP (IN of) (NP (NP (DT the) (NN duration)) (PP (IN of) (NP (NNS Doc_11226639_682_690_Disease)))))) (, ,) (CC and) (NP (NP (DT a) (NN reduction)) (PP (IN in) (NP (NN mortality) (NN rate))))))) (. .)))
11226639	6	(ROOT (S (NP (ADJP (JJ Doc_11226639_727_736_Chemical) (NP (CD 0.5) (CC and) (CD 5))) (NN mg/kg)) (VP (VBD influenced) (NP (NP (DT the) (NN duration)) (CONJP (CC but) (RB not)) (NP (NP (DT the) (NN latency)) (PP (IN of) (NP (NNS Doc_11226639_800_808_Chemical)))) (: -) (CC or) (NP (NN Doc_11226639_813_821_Chemical-induced) (NNS Doc_11226639_830_838_Disease)))) (. .)))
11226639	7	(ROOT (S (ADVP (RB Thus)) (, ,) (NP (NP (DT the) (JJ dual) (NN action)) (PP (IN of) (NP (NP (NNS Doc_11226639_865_874_Chemical)) (PP (IN on) (NP (JJ pharmacological) (NNS Doc_11226639_894_902_Disease)))))) (VP (VBZ seems) (S (VP (TO to) (VP (VB be) (ADJP (JJ specific) (PP (IN for) (NP (NP (DT the) (JJ Doc_11226639_932_943_Chemical) (NN mechanism)) (PP (IN of) (NP (NN action)))))))))) (. .)))
11230490	0	(ROOT (S (VP (VP (NNP Reduced) (NP (NNS Doc_11230490_8_22_Disease))) (CC and) (VP (VBD preserved) (NP (NP (NN antitumor) (NN efficacy)) (PP (IN of) (NP (JJ liposome-encapsulated) (NNS Doc_11230490_81_92_Chemical) (CC and) (NNS Doc_11230490_97_113_Chemical)))) (PP (VBN compared) (PP (IN with) (NP (NP (JJ conventional) (NNS Doc_11230490_141_152_Chemical) (CC and) (NNS Doc_11230490_157_173_Chemical)) (PP (IN in) (NP (NP (DT a) (JJ randomized) (, ,) (JJ multicenter) (NN trial)) (PP (IN of) (NP (NNS Doc_11230490_212_236_Disease)))))))))) (. .)))
11230490	1	(ROOT (S (VP (TO To) (VP (VB determine) (SBAR (IN whether) (S (NP (NP (NP (NNS Doc_11230490_268_274_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (NP (JJ liposome-encapsulated) (NNS Doc_11230490_298_309_Chemical)) (: ;) (NP (DT The) (JJ Liposome) (NN Company))) (, ,) (NP (NNP Elan) (NNP Corporation)) (, ,) (NP (NNP Princeton)) (, ,) (FW NJ)) (-RRB- -RRB-))) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (NNS Doc_11230490_386_402_Chemical)))))) (ADVP (RB significantly)) (VP (VBZ reduces) (NP (JJ Doc_11230490_425_436_Chemical) (NNS Doc_11230490_437_451_Disease)) (PP (IN while) (S (VP (VBG providing) (NP (JJ comparable) (NN antitumor) (NN efficacy)) (PP (IN in) (NP (NP (JJ first-line) (NN treatment)) (PP (IN of) (NP (NP (NNS Doc_11230490_525_549_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_11230490_551_554_Disease)) (-RRB- -RRB-)))))))))))))) (. .)))
11230490	2	(ROOT (FRAG (NP (NNS PATIENTS) (CC AND) (NNS METHODS)) (: :) (S (NP (NP (CD Two) (CD hundred) (JJ ninety-seven) (NNS patients)) (PP (IN with) (NP (NP (NNS Doc_11230490_618_621_Disease)) (CC and) (NP (NP (DT no) (JJ prior) (NN chemotherapy)) (PP (IN for) (NP (JJ metastatic) (NN disease))))))) (VP (VBD were) (VP (VBN randomized) (S (VP (TO to) (VP (VB receive) (NP (NP (NP (DT either) (CD 60) (NN mg/m)) (PRN (-LRB- -LRB-) (NP (CD 2)) (-RRB- -RRB-))) (PP (IN of) (NP (NP (NNP Myocet)) (PRN (-LRB- -LRB-) (NP (NNP M)) (-RRB- -RRB-)) (CC or) (NP (JJ conventional) (NNS Doc_11230490_746_757_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP A)) (-RRB- -RRB-)))) (, ,) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (NP (CD 600) (NN mg/m) (PRN (-LRB- -LRB-) (NP (CD 2)) (-RRB- -RRB-))) (PP (IN of) (NP (NP (NNS Doc_11230490_798_814_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_11230490_816_817_Chemical)) (-RRB- -RRB-)))))) (, ,) (NP (QP (DT every) (CD 3)) (NNS weeks))))) (PP (IN until) (NP (UCP (NP (NN disease) (NN progression)) (CC or) (ADJP (JJ unacceptable))) (NNS Doc_11230490_876_884_Disease))))))))) (. .)))
11230490	3	(ROOT (S (NP (NNP Doc_11230490_886_900_Disease)) (VP (VBD was) (VP (VBN defined) (PP (IN by) (NP (NP (NNS reductions)) (PP (IN in) (NP (NP (JJ left-ventricular) (NN ejection) (NN fraction)) (, ,) (VP (VBN assessed) (PP (IN by) (NP (NP (JJ serial) (JJ multigated) (JJ radionuclide) (NN angiography) (NNS scans)) (, ,) (CC or) (NP (NNS Doc_11230490_1031_1055_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_11230490_1057_1060_Disease)) (-RRB- -RRB-))))))))))) (. .)))
11230490	4	(ROOT (S (NP (NNP Antitumor)) (ADVP (RB efficacy)) (VP (VBD was) (VP (VBN assessed) (PP (IN by) (NP (NP (JJ objective) (JJ Doc_11230490_1108_1113_Disease) (NN response) (NNS rates)) (PRN (-LRB- -LRB-) (NP (NNP World) (NNP Health) (NNP Organization) (NNPS criteria)) (-RRB- -RRB-)) (, ,) (NP (NP (NN time)) (PP (TO to) (NP (NN progression)))) (, ,) (CC and) (NP (NN survival)))))) (. .)))
11230490	5	(ROOT (S (NP (NP (CD Six) (NN percent)) (PP (IN of) (NP (NP (NP (NNP MC) (NNS patients)) (PRN (PP (FW versus) (NP (CD 21) (NN %)))) (PRN (-LRB- -LRB-) (PP (VBG including) (NP (NP (CD five) (NNS cases)) (PP (IN of) (NP (NNS Doc_11230490_1274_1277_Disease))))) (-RRB- -RRB-))) (PP (IN of) (NP (NNP AC) (NNS patients)))))) (VP (VBD developed) (NP (NP (NNS Doc_11230490_1304_1318_Disease)) (PRN (-LRB- -LRB-) (NP (NNP P) (QP (CD =) (CD .0002))) (-RRB- -RRB-)))) (. .)))
11230490	6	(ROOT (S (NP (NP (JJ Median) (JJ cumulative) (JJ Doc_11230490_1349_1360_Chemical) (NN dose)) (PP (IN at) (NP (NN onset)))) (VP (VBD was) (NP (NP (QP (JJR more) (IN than) (CD 2,220)) (NN mg/m)) (PRN (-LRB- -LRB-) (NP (CD 2)) (-RRB- -RRB-))) (PP (IN for) (NP (NP (NNP MC)) (PP (IN versus) (NP (NP (CD 480) (NN mg/m) (PRN (-LRB- -LRB-) (NP (CD 2)) (-RRB- -RRB-))) (PP (IN for) (NP (NP (NNP AC)) (PRN (-LRB- -LRB-) (NP (NP (NP (NNP P)) (SBAR (S (VP (SYM =) (NP (CD .0001)))))) (, ,) (NP (NN hazard) (NN ratio)) (, ,) (FW 5.04)) (-RRB- -RRB-))))))))) (. .)))
11230490	7	(ROOT (S (NP (NNP MC) (NNS patients)) (ADVP (RB also)) (VP (VBD experienced) (NP (QP (JJR less) (IN grade) (CD 4)) (NNS Doc_11230490_1510_1521_Disease))) (. .)))
11230490	8	(ROOT (S (NP (NP (JJ Antitumor) (NN efficacy)) (PP (IN of) (NP (NNP MC) (CC versus) (NNP AC)))) (VP (VP (VBD was) (ADJP (JJ comparable))) (: :) (NP (NP (NP (JJ objective) (NN response) (NNS rates)) (, ,) (NP (NP (CD 43) (NN %)) (PP (IN versus) (NP (CD 43) (NN %))))) (: ;) (NP (NP (JJ median) (NN time)) (PP (TO to) (NP (NN progression)))) (, ,) (NP (NP (CD 5.1) (NN %)) (PP (IN versus) (NP (CD 5.5) (NNS months)))) (: ;) (NP (NP (JJ median) (NN time)) (PP (TO to) (NP (NN treatment) (NN failure)))) (, ,) (NP (NP (CD 4.6)) (PP (IN versus) (NP (CD 4.4) (NNS months)))) (: ;) (CC and) (NP (NP (JJ median) (NN survival)) (, ,) (NP (NP (CD 19)) (PP (IN versus) (NP (CD 16) (NNS months))))))) (. .)))
11230490	9	(ROOT (S (NP (NNP Doc_11230490_1779_1785_Chemical)) (VP (VP (VBZ improves) (NP (NP (DT the) (JJ therapeutic) (NN index)) (PP (IN of) (NP (NP (NNS Doc_11230490_1820_1831_Chemical)) (PP (IN by) (S (VP (ADVP (RB significantly)) (VBG reducing) (NP (NNS Doc_11230490_1858_1872_Disease) (CC and) (NN grade) (CD 4) (NNS Doc_11230490_1885_1896_Disease))))))))) (CC and) (VP (VBZ provides) (NP (JJ comparable) (NN antitumor)) (ADVP (RB efficacy)) (, ,) (SBAR (WHADVP (WRB when)) (S (VP (VBN used) (PP (IN in) (NP (NN combination))) (PP (IN with) (NP (NP (NNS Doc_11230490_1971_1987_Chemical)) (PP (IN as) (NP (JJ first-line) (NN therapy))))) (PP (IN for) (NP (NNS Doc_11230490_2014_2017_Disease)))))))) (. .)))
11243580	0	(ROOT (NP (NP (DT The) (NN role)) (PP (IN of) (NP (JJ nitrergic) (NN system))) (PP (IN in) (NP (NN Doc_11243580_32_41_Chemical-induced) (NNS Doc_11243580_50_60_Disease))) (PP (IN in) (NP (DT the) (NN mouse))) (. .)))
11243580	1	(ROOT (S (NP (NP (NP (DT The) (NNS effects)) (PP (IN of) (NP (NP (NP (NNS Doc_11243580_90_121_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_11243580_123_129_Chemical)) (-RRB- -RRB-))) (NP (DT a) (JJ Doc_11243580_133_145_Chemical) (PRN (-LRB- -LRB-) (NP (NNP Doc_11243580_147_149_Chemical)) (-RRB- -RRB-)) (NN synthase) (NNS inhibitor) (CC and) (NNS Doc_11243580_174_184_Chemical))))) (, ,) (NP (DT a) (JJ Doc_11243580_188_190_Chemical) (NN precursor)) (, ,)) (VP (VBD were) (VP (VBN investigated) (PP (IN on) (NP (NN Doc_11243580_223_232_Chemical-induced) (NNS Doc_11243580_241_252_Disease))))) (. .)))
11243580	2	(ROOT (S (PP (IN In) (NP (DT the) (JJ first) (NN experiment))) (, ,) (NP (NP (CD four) (NNS groups)) (PP (IN of) (NP (NNS mice)))) (VP (VBD received) (S (NP (NP (JJ physiological) (NN saline)) (PRN (-LRB- -LRB-) (NP (CD 0.9) (NN %)) (-RRB- -RRB-)) (, ,) (NP (NP (NP (NNS Doc_11243580_337_347_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 300) (NN mg/kg)) (, ,) (NP (NNP i.p.)) (-RRB- -RRB-))) (, ,) (NP (NP (NNS Doc_11243580_367_373_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 100) (NN mg/kg)) (, ,) (NP (NNP i.p.)) (-RRB- -RRB-))) (CC and) (NP (NP (NNS Doc_11243580_396_404_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 2) (NN mg/kg)) (-RRB- -RRB-)))) (, ,)) (ADJP (RB respectively)))) (. .)))
11243580	3	(ROOT (S (PP (NP (CD Thirty) (NNS minutes)) (IN after) (NP (DT these) (NNS injections))) (, ,) (NP (DT all) (NNS mice)) (VP (VBD received) (NP (NP (NNS Doc_11243580_487_496_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 50) (NN mg/kg)) (, ,) (NP (NNP i.p.)) (-RRB- -RRB-)))) (. .)))
11243580	4	(ROOT (S (S (PP (IN In) (NP (DT the) (JJ second) (NN experiment))) (, ,) (NP (NP (CD four) (NNS groups)) (PP (IN of) (NP (NNS mice)))) (VP (VBD received) (NP (JJ similar) (NN treatment)) (PP (IN in) (NP (NP (DT the) (JJ first) (NN experiment)) (, ,) (CC and) (NP (CD 30) (NN min)))) (PP (IN after) (NP (DT these) (NNS injections))))) (, ,) (NP (DT all) (NNS mice)) (VP (VBD received) (NP (NP (DT a) (JJR higher) (NN dose)) (PP (IN of) (NP (NP (NNS Doc_11243580_683_692_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 80) (NN mg/kg)) (-RRB- -RRB-)))))) (. .)))
11243580	5	(ROOT (S (NP (NP (NP (NNP Doc_11243580_705_711_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 100) (NN mg/kg)) (, ,) (NP (NNP i.p.)) (-RRB- -RRB-))) (CC and) (NP (NP (NNS Doc_11243580_734_742_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 2) (NN mg/kg)) (-RRB- -RRB-)))) (ADVP (RB significantly)) (VP (VBD decreased) (NP (NP (DT the) (NN incidence)) (PP (IN of) (NP (NP (NNS Doc_11243580_794_803_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 50) (NN mg/kg)) (-RRB- -RRB-)) (: -) (NP (JJ induced) (NNS Doc_11243580_823_834_Disease)))))) (. .)))
11243580	6	(ROOT (S (PP (IN In) (NP (NN contrast))) (, ,) (NP (DT the) (JJ Doc_11243580_853_863_Chemical) (NN treatment)) (VP (VBD increased) (NP (NP (DT the) (NN incidence)) (PP (IN of) (NP (NP (NP (NNS Doc_11243580_901_910_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 80) (NN mg/kg)) (, ,) (NP (NNP i.p.)) (-RRB- -RRB-))) (: -) (NP (JJ induced) (NNS Doc_11243580_936_947_Disease))))) (ADVP (RB significantly))) (. .)))
11243580	7	(ROOT (S (NP (DT These) (NNS results)) (VP (MD may) (VP (VB suggest) (SBAR (IN that) (S (NP (NNS Doc_11243580_994_996_Chemical)) (VP (VBZ is) (NP (NP (DT a) (JJ proconvulsant) (NN mediator)) (PP (IN in) (NP (NN Doc_11243580_1028_1037_Chemical-induced) (NNS Doc_11243580_1046_1057_Disease))))))))) (. .)))
11245434	0	(ROOT (S (NP (NNP Erythropoietin)) (VP (VBZ restores) (NP (DT the) (NN Doc_11245434_28_34_Disease-induced) (NN reduction)) (PP (IN in) (NP (NP (JJ Doc_11245434_56_72_Chemical) (NNS Doc_11245434_73_85_Disease)) (PP (IN in) (NP (NN rat) (NNS Doc_11245434_93_99_Disease)))))) (. .)))
11245434	1	(ROOT (S (NP (NP (DT The) (NN aim)) (PP (IN of) (NP (DT this) (NN study)))) (VP (VBD was) (S (VP (TO to) (VP (VB examine) (NP (NP (DT the) (NN impact)) (PP (IN of) (NP (JJ Doc_11245434_152_158_Disease) (NN prevention)))) (PP (IN by) (NP (NP (NP (NP (JJ recombinant) (JJ human) (NN erythropoietin)) (PRN (-LRB- -LRB-) (NP (NNP rHuEPO)) (-RRB- -RRB-))) (NN treatment)) (PP (IN on) (NP (NP (DT the) (NNS Doc_11245434_232_244_Disease)) (PP (IN of) (NP (NP (NNS Doc_11245434_248_264_Chemical)) (PP (IN in) (NP (JJ solid) (JJ experimental) (NNS Doc_11245434_287_293_Disease))))))))))))) (. .)))
11245434	2	(ROOT (S (NP (NNP Doc_11245434_295_301_Disease)) (VP (VBD was) (VP (VBN induced) (S (VP (VBG using) (NP (NP (DT a) (JJ single) (NN dose)) (PP (IN of) (NP (NNS Doc_11245434_337_348_Chemical)))) (PRN (-LRB- -LRB-) (NP (CD 50) (NN mg/kg) (NN i.v.)) (-RRB- -RRB-)) (S (VP (VBG resulting) (PP (IN in) (NP (NP (NP (DT a) (JJ long-lasting) (NN reduction)) (PRN (-LRB- -LRB-) (NP (CD 30) (NN %)) (-RRB- -RRB-))) (PP (IN of) (NP (DT the) (NN hemoglobin) (NN concentration))))))))))) (. .)))
11245434	3	(ROOT (S (PP (IN In) (NP (DT a) (JJ second) (NN group))) (, ,) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (NNS Doc_11245434_480_486_Disease)))) (VP (VBD was) (VP (VBN prevented) (PP (IN by) (NP (NP (JJ rHuEPO) (PRN (-LRB- -LRB-) (NP (NNP 1000) (NNP IU/kg)) (-RRB- -RRB-)) (ADJP (VBN administered) (NP (QP (CD s.c.) (CD three)))) (NN times/week)) (PP (VBG starting) (NP (NP (CD 7) (NNS days)) (PP (IN before) (NP (JJ Doc_11245434_582_593_Chemical) (NN application))))))))) (. .)))
11245434	4	(ROOT (S (PP (NP (CD Four) (NNS days)) (IN after) (NP (JJ Doc_11245434_623_634_Chemical) (NN treatment))) (, ,) (NP (NP (NNS Doc_11245434_646_652_Disease)) (PRN (-LRB- -LRB-) (NP (NP (NNS DS-Doc_11245434_657_664_Disease)) (PP (IN of) (NP (DT the) (NN rat)))) (-RRB- -RRB-))) (VP (VBD were) (VP (VBN implanted) (NP (NN s.c.)) (PP (IN onto) (NP (DT the) (JJ hind) (NN food) (NN dorsum))))) (. .)))
11245434	5	(ROOT (S (NP (CC Neither) (NP (NNS Doc_11245434_732_743_Chemical)) (CC nor) (NP (NN rHuEPO) (NN treatment))) (VP (VBD influenced) (NP (JJ Doc_11245434_776_781_Disease) (NN growth) (NN rate)) (ADVP (FW per) (FW se))) (. .)))
11245434	6	(ROOT (S (SBAR (WHADVP (WRB When)) (S (NP (NNS Doc_11245434_807_813_Disease)) (VP (VBD were) (VP (VBN treated) (PP (IN with) (NP (NP (DT a) (JJ single) (NN dose)) (PP (IN of) (NP (NP (NNS Doc_11245434_849_865_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 60) (NN mg/kg) (NN i.p.)) (-RRB- -RRB-)))) (NP (CD 5) (NNS days)))) (PP (IN after) (NP (NN implantation))))))) (, ,) (NP (NP (DT a) (NN growth) (NN delay)) (PP (IN with) (NP (NP (DT a) (JJ subsequent) (NN regrowth)) (PP (IN of) (NP (DT the) (NNS Doc_11245434_958_964_Disease)))))) (VP (VBD was) (ADJP (JJ observed))) (. .)))
11245434	7	(ROOT (S (PP (IN In) (NP (DT the) (JJ Doc_11245434_986_992_Disease) (NN group))) (, ,) (NP (DT the) (NN growth) (NN delay)) (VP (VBD was) (ADJP (RB significantly) (JJR shorter)) (PP (VBN compared) (PP (IN with) (NP (NP (JJ nonanemic) (NNS controls)) (PRN (-LRB- -LRB-) (NP (NP (JJ 13.3) (NNS days)) (CC versus) (NP (CD 8.6) (NNS days))) (-RRB- -RRB-)))))) (. .)))
11245434	8	(ROOT (S (PP (IN In) (NP (NP (DT the) (NN group)) (SBAR (WHADVP (WRB where)) (S (NP (NNS Doc_11245434_1124_1130_Disease)) (VP (VBD was) (VP (VBN prevented) (PP (IN by) (NP (NN rHuEPO) (NN treatment))))))))) (, ,) (NP (NN growth) (NN delay)) (VP (VBD was) (ADJP (JJ comparable) (PP (IN with) (NP (NP (DT that)) (PP (IN of) (NP (JJ nonanemic) (NNS controls)))))) (PRN (-LRB- -LRB-) (ADJP (QP (CD 13.3) (NNS days))) (-RRB- -RRB-))) (. .)))
11245434	9	(ROOT (S (NP (DT These) (NNS results)) (VP (VBP suggest) (SBAR (IN that) (S (NP (JJ chemotherapy-induced) (NNS Doc_11245434_1287_1293_Disease)) (VP (VBZ reduces) (NP (NP (NNS Doc_11245434_1302_1314_Disease)) (PP (IN of) (NP (NP (NNS Doc_11245434_1318_1334_Chemical)) (PP (IN in) (NP (NNS Doc_11245434_1338_1344_Disease)))))) (, ,) (SBAR (IN whereas) (S (NP (NP (NN correction)) (PP (IN of) (NP (NP (NNS Doc_11245434_1368_1374_Disease)) (PP (IN by) (NP (NP (NN rHuEPO) (NN treatment)) (PRN (-LRB- -LRB-) (ADJP (JJ epoetin) (NN alpha)) (-RRB- -RRB-))))))) (VP (VBZ increases) (NP (DT the) (NN sensitivity)) (, ,) (ADVP (RB probably)) (PP (IN as) (NP (NP (DT a) (NN result)) (PP (IN of) (NP (NP (DT an) (VBN improved) (JJ Doc_11245434_1474_1480_Chemical) (NN supply)) (PP (TO to) (NP (JJ Doc_11245434_1491_1496_Disease) (NN tissue)))))))))))))) (. .)))
11271907	0	(ROOT (S (NP (JJ Fatal) (NNS Doc_11271907_6_30_Disease)) (VP (VBZ secondary) (PP (TO to) (NP (JJ Doc_11271907_44_60_Chemical) (NN therapy)))) (. .)))
11271907	1	(ROOT (S (NP (NNP Doc_11271907_70_94_Disease)) (VP (VBZ is) (NP (NP (DT a) (ADJP (JJ rare) (CC but) (JJ important)) (NN complication)) (PP (IN of) (NP (JJ Doc_11271907_135_151_Chemical) (NN therapy))))) (. .)))
11271907	2	(ROOT (S (NP (NP (JJ Echocardiographic) (NN identification)) (PP (IN of) (NP (DT the) (NN disorder)))) (VP (MD can) (VP (VB be) (VP (VBN made)))) (. .)))
11271907	3	(ROOT (S (NP (PRP We)) (VP (VBP believe) (SBAR (IN that) (S (NP (NP (DT the) (NN ultrasound) (NNS features)) (PP (IN of) (NP (DT this) (NN disorder)))) (VP (VBP have) (RB not) (VP (VBN been) (VP (ADVP (RB previously)) (VBN reported))))))) (. .)))
11282081	0	(ROOT (S (NP (NP (NNPS Effects)) (PP (IN of) (NP (NP (NNS Doc_11282081_11_20_Chemical)) (PP (IN on) (NP (NP (NNS Doc_11282081_24_43_Disease)) (CC and) (NP (PRP$ its) (NN electrophysiological))))))) (VP (VBZ determinants) (PP (IN in) (NP (NNS dogs)))) (. .)))
11282081	1	(ROOT (S (NP (JJ Doc_11282081_107_125_Disease-induced) (NN remodeling)) (VP (VP (VBZ promotes) (NP (NP (DT the) (NN occurrence) (CC and) (NN maintenance)) (PP (IN of) (NP (NP (NNS Doc_11282081_188_207_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_11282081_209_211_Disease)) (-RRB- -RRB-)))))) (CC and) (VP (VBZ decreases) (S (NP (JJ L-type) (NNS Doc_11282081_234_240_Chemical)) (ADJP (JJ current))))) (. .)))
11282081	2	(ROOT (S (NP (EX There)) (VP (VBZ is) (ADVP (RB also)) (NP (DT a) (JJ clinical) (NN suggestion)) (SBAR (IN that) (S (NP (NP (JJ acute) (JJ L-type) (NNS Doc_11282081_304_306_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 2)) (-RRB- -RRB-))) (VP (VB channel) (SBAR (S (NP (NN blockade)) (VP (MD can) (VP (VB promote) (NP (NP (NNS Doc_11282081_339_341_Disease)) (, ,) (ADJP (JJ consistent) (PP (IN with) (NP (NP (DT an) (NNS Doc_11282081_362_364_Disease)) (VP (VBG promoting) (NP (NP (NN effect)) (PP (IN of) (NP (JJ Doc_11282081_385_391_Chemical) (NN channel) (NN inhibition))))))))))))))))) (. .)))
11282081	3	(ROOT (S (S (VP (TO To) (VP (VB evaluate) (NP (NP (DT the) (JJ potential) (NNS mechanisms)) (PP (IN of) (NP (JJ Doc_11282081_461_463_Disease) (NN promotion)))) (PP (IN by) (NP (JJ Doc_11282081_477_483_Chemical) (NN channel) (NNS blockers)))))) (, ,) (NP (PRP we)) (VP (VBN administered) (S (NP (NNS Doc_11282081_518_527_Chemical)) (VP (TO to) (VP (VB Doc_11282081_531_539_Chemical-Doc_11282081_540_550_Chemical) (NP (JJ anesthetized) (NNS dogs)))))) (. .)))
11282081	4	(ROOT (S (S (NP (NNP Doc_11282081_570_579_Chemical)) (VP (VBD was) (VP (VBN used) (PP (IN as) (NP (DT a) (NN comparison) (NN drug)))))) (CC and) (S (NP (NP (JJ autonomic) (NN blockade)) (PP (IN with) (NP (NNS Doc_11282081_638_646_Chemical) (CC and) (NNS Doc_11282081_651_658_Chemical)))) (VP (VBD was) (VP (VBN applied) (PP (IN in) (NP (DT some) (NNS experiments)))))) (. .)))
11282081	5	(ROOT (S (NP (NP (JJ Epicardial) (NN mapping)) (PP (IN with) (NP (CD 240) (JJ epicardial) (NNS electrodes)))) (VP (VBD was) (VP (VBN used) (S (VP (TO to) (VP (VB evaluate) (NP (NN activation)) (PP (IN during) (NP (NNS Doc_11282081_781_783_Disease)))))))) (. .)))
11282081	6	(ROOT (SINV (ADJP (JJ Doc_11282081_794_803_Chemical)) (VP (VBD caused) (NP (JJ Doc_11282081_811_813_Disease) (NN promotion)) (PP (IN in) (NP (NP (CD six) (NNS dogs)) (, ,) (NP (NP (VBG increasing) (JJ mean) (NN duration)) (PP (IN of) (NP (NP (NNS Doc_11282081_865_867_Disease)) (VP (VBN induced) (PP (IN by) (NP (NN burst) (NN pacing)))))) (, ,) (PP (IN from) (NP (NP (QP (CD 8) (CD +))) (PRN (: /) (NP (NP (NP (CD -4) (NNS s)) (PRN (-LRB- -LRB-) (NP (JJ mean) (JJ +) (NNS /)) (, -) (NP (NNP S.E.)) (-RRB- -RRB-))) (PP (TO to) (NP (CD 95) (NNS +)))) (: /)))))))) (NP (NP (CD -39) (NNS s)) (PRN (-LRB- -LRB-) (NP (NP (NNP P) (NNP <) (NNP 0.01)) (PP (IN vs.) (NP (NN control)))) (-RRB- -RRB-)) (PP (IN at) (NP (NP (DT a) (NN loading) (NN dose)) (PP (IN of) (NP (NP (CD 0.1) (NN mg/kg)) (CC and) (NP (NNP 228) (NNP +)))))) (PRN (: /) (NP (NP (NP (CD -101) (NNS s)) (PRN (-LRB- -LRB-) (NP (NNP P)) (NP (NP (QP (CD <) (CD 0.0005))) (PP (IN vs.) (NP (NN control)))) (-RRB- -RRB-))) (PP (IN at) (NP (NP (DT a) (NN dose)) (PP (IN of) (NP (CD 0.2))))))) (VP (VBG mg/kg))) (. .)))
11282081	7	(ROOT (S (NP (VBG Underlying) (JJ electrophysiological) (NNS mechanisms)) (VP (VBD were) (VP (VBN studied) (PP (IN in) (NP (NP (NN detail)) (PP (IN in) (NP (CD five) (JJ additional) (NNS dogs))))) (PP (PP (IN under) (NP (NN control) (NNS conditions))) (CC and) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NP (DT the) (JJR higher) (NN dose)) (PP (IN of) (NP (NNS Doc_11282081_1205_1214_Chemical)))))))))) (. .)))
11282081	8	(ROOT (S (PP (IN In) (NP (DT these) (NNS experiments))) (, ,) (NP (NNP Doc_11282081_1238_1247_Chemical) (NNP shortened)) (VP (VP (VBP mean) (NP (NP (JJ effective) (JJ refractory) (NN period)) (PRN (-LRB- -LRB-) (NP (NNP ERP)) (-RRB- -RRB-))) (PP (IN from) (NP (NP (CD 122) (NNS +)) (PRN (: /) (VP (VBN -5) (PP (TO to) (NP (QP (CD 114) (CD +))))) (: /)) (NP (NP (CD -4) (NN ms) (PRN (-LRB- -LRB-) (NP (NNP P) (NNP <) (NNP 0.02)) (-RRB- -RRB-))) (PP (IN at) (NP (DT a) (NN cycle) (NN length))) (PP (IN of) (NP (CD 300) (NN ms))) (, ,) (NP (NP (VBN decreased) (NN ERP) (NN heterogeneity)) (PRN (-LRB- -LRB-) (NP (PP (IN from) (NP (NP (QP (CD 15) (CD +))) (PRN (: /) (NP (QP (CD -1) (TO to) (CD 10)) (NNS +)) (: /)))) (NP (NP (CD -1) (NN %)) (, ,) (NP (NNP P) (NNP <) (NNP 0.05)))) (-RRB- -RRB-))))))) (, ,) (VP (ADVP (RB heterogeneously)) (VBD accelerated) (NP (JJ atrial) (NN conduction))) (CC and) (VP (VBD decreased) (NP (NP (DT the) (NN cycle) (NN length)) (PP (IN of) (NP (NP (NNS Doc_11282081_1504_1506_Disease)) (PRN (-LRB- -LRB-) (NP (CD 94) (NNS +)) (: /) (NP (NP (CD -4)) (PP (TO to) (NP (NP (QP (CD 84) (CD +))) (PRN (: /) (NP (NP (CD -3) (NN ms)) (, ,) (NP (NNP P) (NNP <) (NNP 0.005))))))) (-RRB- -RRB-))))))) (. .)))
11282081	9	(ROOT (S (NP (NNP Doc_11282081_1539_1548_Chemical)) (VP (VP (VBD did) (RB not) (VP (VB affect) (NP (NP (NNP ERP)) (, ,) (NP (JJ Doc_11282081_1569_1571_Disease) (NN cycle) (NN length)) (CC or) (NP (JJ Doc_11282081_1588_1590_Disease) (NN duration))))) (, ,) (CC but) (VP (VBD produced) (S (NP (NN conduction) (NN acceleration)) (ADJP (JJ similar) (PP (TO to) (NP (NP (DT that)) (VP (VBN caused) (PP (IN by) (NP (NP (NNS Doc_11282081_1664_1673_Chemical)) (PRN (-LRB- -LRB-) (VP (VBN n) (S (VP (SYM =) (NP (CD 5))))) (-RRB- -RRB-))))))))))) (. .)))
11282081	10	(ROOT (S (PP (IN In) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (JJ autonomic) (NN blockade))))) (, ,) (NP (NNS Doc_11282081_1720_1729_Chemical)) (VP (VBD failed) (S (VP (TO to) (VP (VB promote) (NP (NP (NP (NNS Doc_11282081_1748_1750_Disease)) (CC and) (NP (VBN increased))) (, ,) (CONJP (RB rather) (IN than)) (NP (NP (VBG decreasing)) (, ,) (NP (NNS refractoriness)))))))) (. .)))
11282081	11	(ROOT (S (NP (CC Neither) (NP (NNS Doc_11282081_1814_1823_Chemical)) (CC nor) (NP (NNS Doc_11282081_1828_1837_Chemical))) (VP (VBD affected) (NP (JJ atrial) (NN conduction)) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (JJ autonomic) (NN blockade)))))) (. .)))
11282081	12	(ROOT (S (NP (JJ Epicardial) (NN mapping)) (VP (VBD suggested) (SBAR (IN that) (S (NP (NNS Doc_11282081_1938_1947_Chemical)) (VP (VBD promoted) (NP (NNS Doc_11282081_1957_1959_Disease)) (PP (IN by) (S (VP (VBG increasing) (NP (NP (DT the) (NN number)) (PP (IN of) (NP (NP (JJ simultaneous) (NNS wavefronts)) (VP (VBN reflected) (PP (IN by) (NP (NP (JJ separate) (NNS zones)) (PP (IN of) (NP (NN reactivation))))) (PP (IN in) (NP (DT each) (NN cycle)))))))))))))) (. .)))
11282081	13	(ROOT (S (NP (NNP Doc_11282081_2084_2093_Chemical)) (VP (VBZ promotes) (NP (NP (NNS Doc_11282081_2103_2105_Disease)) (PP (IN in) (NP (JJ normal) (NNS dogs)))) (PP (IN by) (S (VP (VBG promoting) (NP (JJ multiple) (NN circuit)) (ADVP (RB reentry)) (, ,) (S (NP (DT an) (NN effect)) (ADJP (JJ dependent) (PP (IN on) (NP (JJ intact) (JJ autonomic) (NN tone) (CC and) (RB not)))) (S (VP (VBN shared) (PP (IN by) (NP (NNS Doc_11282081_2223_2232_Chemical)))))))))) (. .)))
11284996	0	(ROOT (S (NP (NNP Calcitonin)) (VP (VBD gene-related) (NP (JJ peptide) (NNS levels)) (PP (IN during) (NP (NN Doc_11284996_46_58_Chemical-induced) (NNS Doc_11284996_67_75_Disease))) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ chronic) (NNS Doc_11284996_101_122_Disease)))))) (. .)))
11284996	1	(ROOT (S (NP (PRP It)) (VP (VBZ has) (VP (VBN been) (VP (VBN proposed) (SBAR (IN that) (S (NP (NP (NP (NNS Doc_11284996_150_162_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_11284996_164_166_Chemical)) (-RRB- -RRB-))) (VP (VBN induced) (NP (NP (NNS Doc_11284996_176_184_Disease)) (PP (IN in) (NP (NNS Doc_11284996_188_205_Disease)))))) (VP (MD may) (VP (VB be) (VP (VBN associated) (PP (IN with) (NP (NP (NN release)) (PP (IN of) (NP (NP (JJ calcitonin) (JJ gene-related) (NN peptide)) (PRN (-LRB- -LRB-) (NP (NNP CGRP)) (-RRB- -RRB-)))))))))))))) (. .)))
11284996	2	(ROOT (S (PP (IN In) (NP (DT the) (JJ present) (NN study))) (NP (PRP we)) (VP (VBD aimed) (S (VP (TO to) (VP (VB investigate) (NP (NP (NN plasma) (NNS levels)) (PP (IN of) (NP (NNP CGRP)))) (PP (IN during) (NP (NP (NNS Doc_11284996_354_362_Disease)) (VP (VBN induced) (PP (IN by) (NP (NP (NP (DT the) (JJ Doc_11284996_378_380_Chemical) (NN donor) (NNS Doc_11284996_387_406_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_11284996_408_411_Chemical)) (-RRB- -RRB-))) (PP (IN in) (NP (CD 16) (NNS patients))))) (PP (IN with) (NP (NP (JJ chronic) (NNS Doc_11284996_441_462_Disease)) (CC and) (NP (CD 16) (JJ healthy) (NNS controls))))))))))) (. .)))
11284996	3	(ROOT (S (NP (DT The) (NNS subjects)) (VP (VBD were) (ADVP (RB randomly)) (VP (VBN allocated) (S (VP (TO to) (VP (VB receive) (NP (CD 0.5) (JJ microg/kg/min) (NNS Doc_11284996_554_557_Chemical) (CC or) (NN placebo)) (PP (IN over) (NP (NP (CD 20) (NN min)) (PP (IN on) (NP (CD two) (NN Doc_11284996_588_596_Disease-free) (NNS days)))))))))) (. .)))
11284996	4	(ROOT (S (NP (NNP Blood) (NNS samples)) (VP (VBD were) (VP (VBN collected) (PP (IN at) (NP (NP (NN baseline)) (, ,) (NP (CD 10)) (, ,) (NP (CD 20)) (CC and) (NP (CD 60) (NN min)))) (PP (IN after) (NP (NP (NN start)) (PP (IN of) (NP (NN infusion))))))) (. .)))
11284996	5	(ROOT (S (S (NP (DT Both) (NNS patients) (CC and) (NNS controls)) (VP (VBD developed) (NP (ADJP (RB significantly) (JJR stronger)) (JJ immediate) (NNS Doc_11284996_763_771_Disease)) (PP (IN on) (NP (DT the) (NNP GTN) (NN day))) (PP (IN than) (PP (IN on) (NP (DT the) (NN placebo) (NN day)))))) (CC and) (S (NP (DT the) (NNS Doc_11284996_819_827_Disease)) (VP (VBD was) (ADJP (ADJP (RB significantly) (RBR more) (JJ pronounced) (PP (IN in) (NP (NNS patients)))) (PP (IN than) (PP (IN in) (NP (NNS controls))))))) (. .)))
11284996	6	(ROOT (S (NP (EX There)) (VP (VBD was) (NP (NP (DT no) (NN difference)) (PP (IN between) (NP (NP (DT the) (NN area)) (PP (IN under) (NP (DT the) (NNP CGRP) (NN curve))))) (PRN (-LRB- -LRB-) (NP (NNP AUCCGRP)) (-RRB- -RRB-))) (PP (IN on) (NP (NP (NNS Doc_11284996_967_970_Chemical)) (PP (IN vs.) (NP (NP (NN placebo) (NN day)) (PP (IN in) (NP (NP (DT either) (NNS patients)) (PRN (-LRB- -LRB-) (NP (NNP P) (QP (CD =) (CD 0.65))) (-RRB- -RRB-)) (CC or) (NP (NNS controls)) (PRN (-LRB- -LRB-) (NP (NNP P) (QP (CD =) (CD 0.48))) (-RRB- -RRB-))))))))) (. .)))
11284996	7	(ROOT (S (NP (NP (DT The) (NNP AUCCGRP)) (VP (VBN recorded) (PP (IN on) (NP (DT the) (JJ Doc_11284996_1065_1068_Chemical) (NN day))))) (VP (VBD did) (RB not) (VP (VB differ) (PP (IN between) (NP (NP (NNS patients) (CC and) (NNS controls)) (PRN (-LRB- -LRB-) (NP (NNP P) (NNP =) (NNP 0.36)) (-RRB- -RRB-)))))) (. .)))
11284996	8	(ROOT (S (PP (DT Both) (IN in) (NP (NNS patients) (CC and) (NNS controls))) (, ,) (NP (NNP CGRP) (NNS levels)) (VP (VBD changed) (ADVP (RB significantly)) (PP (IN over) (NP (NN time))) (, ,) (PP (IN on) (NP (NP (PDT both) (DT the) (NNS Doc_11284996_1216_1219_Chemical)) (CC and) (NP (CD placebo) (NNS days) (PRN (-LRB- -LRB-) (NP (NNP P) (NNP <) (NNP 0.05)) (-RRB- -RRB-)))))) (. .)))
11284996	9	(ROOT (S (NP (DT The) (JJ present) (NN study)) (VP (VBZ indicates) (SBAR (IN that) (S (NP (JJ Doc_11284996_1282_1284_Chemical-induced) (JJ immediate) (NNS Doc_11284996_1303_1311_Disease)) (VP (VBZ is) (RB not) (VP (VBN associated) (PP (IN with) (NP (NP (NN release)) (PP (IN of) (NP (NNP CGRP)))))))))) (. .)))
11302406	0	(ROOT (NP (CD Doc_11302406_0_11_Chemical-induced) (NNS Doc_11302406_20_38_Disease) (. .)))
11302406	1	(ROOT (S (VP (TO To) (VP (VP (VB present) (NP (NP (DT a) (NN case)) (PP (IN of) (NP (NP (NN Doc_11302406_72_83_Chemical-associated) (NNS Doc_11302406_95_113_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_11302406_115_118_Disease)) (-RRB- -RRB-)))))) (CC and) (VP (VB discuss) (NP (NP (NNP Doc_11302406_132_143_Chemical) (POS 's)) (NN role)) (PP (IN in) (S (VP (VBG causing) (NP (NNS Doc_11302406_162_165_Disease)))))))) (. .)))
11302406	2	(ROOT (NP (NP (NNP CASE) (NNP SUMMARY)) (: :) (NP (NP (DT A) (JJ 68-year-old) (JJ white) (NN woman)) (PP (IN with) (NP (NP (NNP Candida) (NNP glabrata)) (VP (VBN isolated) (PP (IN from) (NP (NP (DT a) (JJ presacral) (NNS abscess)) (VP (VBN developed) (NP (NP (NNS Doc_11302406_273_276_Disease)) (SBAR (S (PP (NP (CD eight) (NNS days)) (IN after) (S (VP (VBG commencing) (NP (NP (JJ oral) (NNS Doc_11302406_310_321_Chemical)) (SBAR (S (NP (DT The) (NN patient)) (VP (VBD had) (NP (NP (DT no) (JJ other) (NN risk) (NNS factors)) (PP (IN for) (NP (NNS Doc_11302406_364_367_Disease)))) (, ,) (PP (VBG including) (NP (NNS Doc_11302406_379_402_Disease) (, ,) (NNS Doc_11302406_404_418_Disease) (, ,) (NNS Doc_11302406_420_444_Disease) (, ,) (CC and) (NN electrolyte) (NNS abnormalities)))))))))) (NP (EX There)) (VP (VBD was) (NP (NP (DT a) (JJ temporal) (NN association)) (PP (IN between) (NP (NP (DT the) (NN initiation)) (PP (IN of) (NP (NNS Doc_11302406_535_546_Chemical) (CC and) (NNS Doc_11302406_551_554_Disease))))))))))))))))) (. .)))
11302406	3	(ROOT (S (S (NP (DT The) (NNS Doc_11302406_560_563_Disease)) (VP (VBD resolved) (SBAR (WHADVP (WRB when)) (S (NP (NNS Doc_11302406_578_589_Chemical)) (VP (VBD was) (VP (VBN discontinued))))))) (: ;) (S (ADVP (RB however)) (, ,) (NP (DT the) (NN patient)) (VP (VBD continued) (S (VP (TO to) (VP (VB have) (NP (NP (NNS Doc_11302406_647_681_Disease) (CC and) (NNS Doc_11302406_686_722_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_11302406_724_728_Disease)) (-RRB- -RRB-))) (PP (IN until) (NP (CD six) (NNS days))) (PP (IN after) (NP (NN drug) (NN cessation) (NNS DISCUSSION)))))))) (: :) (S (NP (NP (NN Use)) (PP (IN of) (NP (DT the) (NNP Naranjo) (NN probability) (NN scale)))) (VP (VBZ indicates) (NP (NP (DT a) (JJ probable) (NN relationship)) (PP (IN between) (NP (NP (NP (DT the) (NN use)) (PP (IN of) (NP (NNS Doc_11302406_868_879_Chemical)))) (CC and) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (NNS Doc_11302406_903_906_Disease))))))))) (. .)))
11302406	4	(ROOT (S (NP (DT The) (JJ possible) (NN mechanism)) (VP (VBZ is) (NP (NP (NNS Doc_11302406_934_944_Disease)) (PP (IN of) (S (VP (ADVP (RB rapidly)) (VBG activating) (NP (VBN delayed) (NN rectifier) (NNS Doc_11302406_985_994_Chemical) (NNS currents))))))) (. .)))
11302406	5	(ROOT (S (PP (IN In) (NP (PRP$ our) (NN patient))) (, ,) (NP (EX there)) (VP (VBD was) (NP (NP (DT no) (JJ other) (NN etiology)) (VP (VBN identified)) (SBAR (WHNP (WDT that)) (S (VP (MD could) (VP (VB explain) (NP (NP (NNS Doc_11302406_1079_1094_Disease) (CC or) (NNS Doc_11302406_1098_1101_Disease)) (SBAR (S (NP (NP (DT The) (JJ complete) (NN disappearance)) (PP (IN of) (NP (NP (NNS Doc_11302406_1132_1136_Disease) (CC and) (NNS Doc_11302406_1141_1175_Disease)) (VP (VBN followed) (PP (IN by) (NP (NP (NN normalization)) (PP (IN of) (NP (NNP QT) (NNP interval))))) (SBAR (IN after) (S (NP (DT the) (NN drug)) (VP (VBD was) (VP (VBN stopped) (ADVP (RB strongly)))))))))) (VP (VBZ suggests) (NP (NNS Doc_11302406_1262_1273_Chemical)) (PP (IN as) (NP (DT the) (NN etiology))))))))))))) (. .)))
11302406	6	(ROOT (S (NP (NNS Clinicians)) (VP (MD should) (VP (VB be) (ADJP (JJ aware)) (SBAR (IN that) (S (NP (NP (NNS Doc_11302406_1336_1347_Chemical)) (, ,) (ADJP (RB even) (PP (IN at) (NP (JJ low) (NNS doses)))) (, ,)) (VP (MD may) (VP (VB cause) (NP (NNS Doc_11302406_1378_1409_Disease)))))) (, ,) (S (VP (VBG leading) (PP (TO to) (NP (NNS Doc_11302406_1422_1425_Disease))))))) (. .)))
11302406	7	(ROOT (S (NP (JJ Serial) (JJ electrocardiographic) (NN monitoring)) (VP (MD may) (VP (VB be) (VP (VBN considered) (SBAR (WHADVP (WRB when)) (S (NP (NNS Doc_11302406_1489_1500_Chemical)) (VP (VBZ is) (VP (VBN administered) (PP (IN in) (NP (NP (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBP are) (PP (IN at) (NP (NP (NN risk)) (PP (IN for) (NP (NNS Doc_11302406_1549_1572_Disease))))))))))))))))) (. .)))
11337188	0	(ROOT (S (NP (NNP Doc_11337188_0_37_Disease)) (VP (VBN associated) (PP (IN with) (NP (NNS Doc_11337188_54_63_Chemical)))) (. .)))
11337188	1	(ROOT (SINV (NP (NP (DT A) (JJ 67-year-old) (NN man)) (SBAR (WHNP (WP who)) (S (VP (VBD was) (VP (VBN treated) (PP (IN with) (NP (NP (NNS Doc_11337188_104_113_Chemical)) (PP (IN for) (NP (NP (CD one) (NN week)) (PP (RB because) (IN of) (NP (NNS Doc_11337188_138_170_Disease)))))))))))) (, ,) (VP (VBD developed)) (NP (NP (NNS Doc_11337188_182_195_Disease) (CC and) (NN diffuse)) (, ,) (NP (NP (JJ symmetric) (, ,) (JJ palpable) (NNS Doc_11337188_229_245_Disease)) (PP (IN on) (NP (PRP$ his) (NNS feet))))) (. .)))
11337188	2	(ROOT (S (NP (NNP Doc_11337188_259_276_Disease)) (VP (VBD were) (VP (VBN noted) (PP (IN on) (NP (PRP$ his) (NNS fingers))))) (. .)))
11337188	3	(ROOT (S (NP (NN Skin) (NNS biopsies)) (VP (VBD showed) (NP (NNS findings)) (NP (NP (JJ diagnostic)) (PP (IN of) (NP (NNS Doc_11337188_348_375_Disease))))) (. .)))
11337188	4	(ROOT (S (S (NP (NNP Doc_11337188_377_386_Chemical)) (VP (VBD was) (VP (VBN discontinued)))) (CC and) (S (NP (NN patient)) (VP (VBD was) (VP (VBN treated) (PP (IN with) (NP (NNS Doc_11337188_433_448_Chemical)))))) (. .)))
11337188	5	(ROOT (S (NP (DT The) (NNS Doc_11337188_454_458_Disease)) (VP (VBD disappeared) (SBAR (IN after) (S (NP (NP (CD three) (NNS weeks)) (CC and) (NP (JJ renal) (NN function))) (VP (VBD returned) (PP (TO to) (ADJP (JJ normal))))))) (. .)))
11337188	6	(ROOT (S (NP (NNP Doc_11337188_528_555_Disease)) (VP (VBZ presents) (SBAR (IN as) (S (NP (NP (JJ palpable) (NNS Doc_11337188_577_584_Disease)) (PP (IN of) (NP (DT the) (JJR lower) (NNS extremities)))) (ADVP (RB often)) (VP (VBN accompanied) (PP (IN by) (NP (NNS Doc_11337188_631_645_Disease) (, ,) (NNS Doc_11337188_647_657_Disease) (, ,) (CC and) (NNS Doc_11337188_663_680_Disease))))))) (. .)))
11337188	7	(ROOT (S (NP (NP (JJ Etiologic) (NNS factors)) (CC or) (NP (JJ associated) (NNS disorders))) (VP (VBP include) (NP (NNS Doc_11337188_732_742_Disease) (, ,) (NNS medications) (, ,) (NNS Doc_11337188_757_782_Disease) (CC and) (NNS Doc_11337188_787_796_Disease))) (. .)))
11337188	8	(ROOT (S (ADVP (RB However)) (, ,) (PP (IN in) (NP (NP (NN half)) (PP (IN of) (NP (DT the) (NNS cases))))) (NP (DT no) (JJ etiologic) (NN factor)) (VP (VBZ is) (VP (VBN identified))) (. .)))
11337188	9	(ROOT (S (S (ADVP (RB Usually)) (NP (PRP it)) (VP (VBZ is) (NP (DT a) (JJ self-limited) (NN disorder)))) (, ,) (CC but) (S (NP (JJ Doc_11337188_906_920_Chemical) (NN therapy)) (VP (MD may) (VP (VB be) (VP (VBN needed) (PP (IN in) (NP (JJ life-threatening) (NNS cases))) (SBAR (IN since) (S (NP (NP (JJ early) (NN treatment)) (PP (IN with) (NP (NP (NNS Doc_11337188_996_1011_Chemical)) (PP (IN in) (NP (JJ severe) (NNS cases)))))) (VP (MD can) (VP (VB prevent) (NP (NNS complications)))))))))) (. .)))
11337188	10	(ROOT (S (NP (NNP Doc_11337188_1055_1064_Chemical)) (VP (MD should) (VP (VB be) (VP (VBN included) (PP (IN among) (NP (NP (DT the) (NNS drugs)) (SBAR (WHNP (WDT that)) (S (VP (MD can) (VP (VB cause) (NP (NNS Doc_11337188_1115_1142_Disease))))))))))) (. .)))
1141447	0	(ROOT (NP (NP (DT The) (JJ renal) (NN pathology)) (PP (IN in) (NP (DT a) (NN case))) (PP (IN of) (NP (NN Doc_1141447_33_40_Chemical-induced) (NNS Doc_1141447_49_67_Disease))) (. .)))
1141447	1	(ROOT (S (NP (NP (DT A) (NN case)) (PP (IN of) (NP (NN Doc_1141447_79_86_Chemical-induced) (NNS Doc_1141447_95_113_Disease)))) (VP (VBZ is) (VP (VBN reported))) (. .)))
1141447	2	(ROOT (S (PP (IN At) (NP (NN necropsy))) (NP (NN microscopy)) (VP (VBD shoed) (NP (ADJP (JJ unique) (CC and) (JJ extensive)) (NN damage)) (PP (TO to) (NP (NP (NNS cells)) (VP (VBG lining) (NP (DT the) (JJ distal) (NN nephron)))))) (. .)))
1141447	3	(ROOT (S (NP (PRP It)) (VP (VBZ is) (VP (VBN suggested) (SBAR (IN that) (S (NP (DT these) (NNS changes)) (VP (VBP represent) (NP (NP (DT a) (JJ specific) (JJ toxic) (NN effect)) (PP (IN of) (NP (NP (NNS Doc_1141447_292_299_Chemical)) (, ,) (VP (VBN reported) (ADVP (RB here)) (PP (IN for) (NP (NP (DT the) (JJ first) (NN time)) (PP (IN in) (NP (NN man)))))))))))))) (. .)))
11467664	0	(ROOT (S (NP (NNP Doc_11467664_0_20_Disease)) (VP (VBN associated) (PP (IN with) (NP (NP (DT the) (NN use)) (PP (IN of) (NP (NNS Doc_11467664_48_57_Chemical)))))) (. .)))
11467664	1	(ROOT (S (NP (PRP We)) (VP (VBP report) (NP (NP (DT a) (NN patient)) (SBAR (WHNP (WP who)) (S (VP (VBD developed) (NP (NNS Doc_11467664_93_113_Disease)) (PP (RB shortly) (IN after) (NP (NP (NN initiation)) (PP (IN of) (NP (NN treatment))))) (PP (IN with) (NP (NNS Doc_11467664_157_180_Chemical)))))))) (. .)))
11467664	2	(ROOT (S (NP (NP (NNP Ultrasound)) (PP (IN of) (NP (NP (DT the) (NN liver)) (CC and) (NP (NNP abdominal) (NNP CT))))) (VP (VBD were) (ADJP (JJ normal))) (. .)))
11467664	3	(ROOT (S (NP (DT An) (NNP ERCP)) (VP (VBD showed) (NP (JJ normal) (NN biliary)) (ADVP (RB anatomy))) (. .)))
11467664	4	(ROOT (S (NP (DT A) (NNS percutaneous) (NN liver)) (ADVP (RB biopsy)) (VP (VBD was) (VP (VBN obtained) (S (VP (VBG showing) (NP (JJ marked) (NNS Doc_11467664_331_342_Disease)))) (, ,) (PP (IN with) (NP (NP (JJ portal) (NNS Doc_11467664_356_361_Disease)) (, ,) (NP (NN ductular) (NN proliferation)) (, ,) (CC and) (NP (JJ acute) (NNS Doc_11467664_397_409_Disease)))))) (. .)))
11467664	5	(ROOT (S (S (NP (NNP Doc_11467664_411_434_Chemical)) (VP (VBD was) (VP (VBN discontinued)))) (, ,) (CC and) (S (NP (NP (DT the) (NN patient) (POS 's)) (NNS Doc_11467664_471_479_Disease)) (VP (VBN resolved) (ADVP (RB slowly)) (PP (IN over) (NP (NP (DT a) (NN period)) (PP (IN of) (NP (JJ several) (NNS months))))))) (. .)))
11467664	6	(ROOT (S (S (PP (VBN Given) (NP (NP (DT the) (NN onset)) (PP (IN of) (NP (NP (PRP$ his) (NNP Doc_11467664_552_560_Disease) (CD 2) (NN wk)) (PP (IN after) (NP (NP (DT the) (NN initiation)) (PP (IN of) (NP (NNS Doc_11467664_590_599_Chemical))))))))) (, ,) (NP (PRP we)) (VP (VBP believe) (SBAR (IN that) (S (NP (DT this) (NN case)) (VP (VBZ represents) (NP (NP (DT an) (NN example)) (PP (IN of) (NP (NN Doc_11467664_652_661_Chemical-associated) (NN hepatotoxicity))))))))) (, ,) (NP (DT the) (JJ first) (JJ such) (NN case)) (VP (VBD reported)) (. .)))
11524350	0	(ROOT (NP (NP (NP (JJ Systemic) (NNS Doc_11524350_9_17_Disease) (CC and) (NNS resuscitation)) (PP (IN in) (NP (NNS Doc_11524350_39_50_Chemical)))) (: -) (NP (NP (, ,) (JJ Doc_11524350_53_68_Chemical) (NN -)) (, ,) (CC or) (NP (NN Doc_11524350_74_85_Chemical-infused) (NNS rats))) (. .)))
11524350	1	(ROOT (S (NP (PRP We)) (VP (VBD compared) (NP (NP (DT the) (JJ systemic) (NNS Doc_11524350_125_133_Disease)) (PP (IN of) (NP (NNS Doc_11524350_137_148_Chemical) (, ,) (NNS Doc_11524350_150_165_Chemical) (, ,) (CC and) (NNS Doc_11524350_171_182_Chemical)))) (PP (IN in) (NP (JJ anesthetized) (NNS rats)))) (. .)))
11524350	2	(ROOT (S (NP (PRP We)) (ADVP (RB also)) (VP (VBD compared) (NP (DT the) (NN ability)) (PP (TO to) (NP (JJ resuscitate) (NNS rats))) (PP (IN after) (NP (NP (JJ lethal) (NNS doses)) (PP (IN of) (NP (DT these) (JJ local) (NNS anesthetics)))))) (. .)))
11524350	3	(ROOT (S (NP (NNP Doc_11524350_301_312_Chemical) (, ,) (NNP Doc_11524350_314_329_Chemical) (, ,) (CC or) (NNP Doc_11524350_334_345_Chemical)) (VP (VBD was) (VP (VBN infused) (PP (IN at) (NP (NP (DT a) (NP (NP (NN rate)) (PP (IN of) (NP (CD 2) (NN mg))) (. .) (NP (JJ kg) (-LRB- -LRB-) (NN -1) (-RRB- -RRB-)) (. .)) (NN min)) (PRN (-LRB- -LRB-) (NP (CD -1)) (-RRB- -RRB-)))) (SBAR (IN while) (S (NP (NP (NN electrocardiogram)) (, ,) (NP (NN electroencephalogram)) (, ,) (CC and) (NP (JJ arterial) (NN pressure))) (VP (VBD were) (ADJP (RB continuously) (VBN monitored))))))) (. .)))
11524350	4	(ROOT (S (S (SBAR (WHADVP (WRB When)) (S (NP (NNS Doc_11524350_496_504_Disease)) (VP (VBD was) (VP (VBN recorded))))) (, ,) (NP (NN drug) (NN infusion)) (VP (VBD was) (VP (VBN stopped)))) (CC and) (S (NP (DT a) (NN resuscitation) (NN sequence)) (VP (VBD was) (VP (VBN begun)))) (. .)))
11524350	5	(ROOT (S (NP (JJ Doc_11524350_585_596_Chemical) (CD 0.01) (NN mg/kg)) (VP (VBD was) (VP (VBN administered) (PP (IN at) (NP (JJ 1-min) (NNS intervals))) (SBAR (IN while) (S (NP (JJ external) (JJ cardiac) (NNS compressions)) (VP (VBD were) (VP (VBN applied))))))) (. .)))
11524350	6	(ROOT (S (NP (NNP Resuscitation)) (VP (VBD was) (VP (VBN considered) (ADJP (JJ successful)) (SBAR (WHADVP (WRB when)) (S (NP (DT a) (JJ systolic) (JJ arterial) (NN pressure) (NN >) (CC or) (NN =) (CD 100) (NN mm) (NN Hg)) (VP (VBD was) (VP (VBN achieved) (PP (IN within) (NP (CD 5) (NN min))))))))) (. .)))
11524350	7	(ROOT (S (NP (NP (DT The) (JJ cumulative) (NNS doses)) (PP (IN of) (NP (NNS Doc_11524350_835_850_Chemical) (CC and) (NNS Doc_11524350_855_866_Chemical))) (SBAR (WHNP (WDT that)) (S (VP (VBD produced) (NP (NNS Doc_11524350_881_889_Disease)))))) (VP (VP (VBD were) (ADJP (JJ similar))) (CC and) (VP (VBD were) (ADJP (JJR larger)) (PP (IN than) (NP (NP (DT those)) (PP (IN of) (NP (NNS Doc_11524350_933_944_Chemical))))))) (. .)))
11524350	8	(ROOT (S (S (NP (NP (DT The) (JJ cumulative) (NNS doses)) (PP (IN of) (NP (NP (NNS Doc_11524350_970_985_Chemical)) (SBAR (WHNP (WDT that)) (S (VP (VBD produced) (NP (NNS Doc_11524350_1000_1012_Disease) (CC and) (NNS Doc_11524350_1017_1025_Disease)))))))) (VP (VBD were) (ADJP (JJR smaller)) (PP (IN than) (NP (NP (DT the) (JJ corresponding) (NNS doses)) (PP (IN of) (NP (NNS Doc_11524350_1071_1082_Chemical))))))) (, ,) (CC but) (S (NP (PRP they)) (VP (VBD were) (ADJP (JJR larger)) (PP (IN than) (NP (NP (DT those)) (PP (IN of) (NP (NNS Doc_11524350_1119_1130_Chemical))))))) (. .)))
11524350	9	(ROOT (S (NP (NP (DT The) (NN number)) (PP (IN of) (NP (JJ successful) (NNS resuscitations)))) (VP (VBD did) (RB not) (VP (VB differ) (PP (IN among) (NP (NNS groups))))) (. .)))
11524350	10	(ROOT (S (ADVP (RB However)) (, ,) (NP (NP (DT a) (JJR smaller) (NN dose)) (PP (IN of) (NP (NNS Doc_11524350_1228_1239_Chemical)))) (VP (VBD was) (VP (VBN required) (PP (IN in) (NP (DT the) (JJ Doc_11524350_1260_1271_Chemical) (NN group))) (PP (IN than) (PP (IN in) (NP (DT the) (JJ other) (NNS groups)))))) (. .)))
11524350	11	(ROOT (S (NP (PRP We)) (VP (VBP conclude) (SBAR (SBAR (IN that) (S (NP (NP (DT the) (JJ systemic) (NNS Doc_11524350_1334_1342_Disease)) (PP (IN of) (NP (NNS Doc_11524350_1346_1361_Chemical)))) (VP (VBZ is) (ADJP (JJ intermediate) (PP (IN between) (NP (NP (DT that)) (PP (IN of) (NP (NNS Doc_11524350_1394_1405_Chemical) (CC and) (NNS Doc_11524350_1410_1421_Chemical)))))) (SBAR (WHADVP (WRB when)) (S (VP (VBN administered) (PP (IN at) (NP (DT the) (JJ same) (NN rate))))))))) (CC and) (SBAR (IN that) (S (NP (NN Doc_11524350_1466_1477_Chemical-induced) (NNS Doc_11524350_1486_1500_Disease)) (VP (VBZ appears) (S (VP (TO to) (VP (VB be) (ADJP (RBR more) (JJ susceptible) (PP (TO to) (NP (NP (NN treatment)) (PP (IN than) (NP (NP (DT that)) (VP (VBN induced) (PP (IN by) (NP (NNS Doc_11524350_1566_1577_Chemical) (CC or) (NNS Doc_11524350_1581_1596_Chemical))))))))))))))))) (. .)))
11573852	0	(ROOT (NP (NP (JJ Doc_11573852_0_14_Chemical-induced) (NNS Doc_11573852_23_31_Disease)) (PP (IN in) (NP (DT a) (NN patient))) (PP (IN with) (NP (NNS Doc_11573852_50_54_Disease))) (. .)))
11573852	1	(ROOT (S (VP (TO To) (VP (VB report) (NP (NP (DT a) (NN case)) (PP (IN of) (NP (NP (JJ multiple) (NNS episodes)) (PP (IN of) (NP (JJ Doc_11573852_108_115_Disease) (NN activity)))))) (PP (IN in) (NP (NP (DT an) (JJ Doc_11573852_131_135_Disease) (NN patent)) (PP (VBG following) (NP (JJ Doc_11573852_153_167_Chemical) (NN infusion))))))) (. .)))
11573852	2	(ROOT (NP (NP (NNP CASE) (NNP SUMMARY)) (: :) (S (S (S (NP (DT A) (JJ 46-year-old) (JJ African-American) (NN man)) (VP (VBD experienced) (NP (JJ recurrent) (NNS Doc_11573852_249_267_Disease)) (PP (IN during) (NP (NP (JJ intravenous) (NN infusion)) (PP (IN of) (NP (NNS Doc_11573852_299_313_Chemical))))))) (, ,) (RB then) (S (NP (NP (JJ petit) (NN mal) (NNS Doc_11573852_330_338_Disease)) (PP (IN as) (NP (DT the) (NN infusion)))) (VP (VBD was) (VP (VBN stopped))))) (CC and) (S (NP (DT the) (NN drug) (NNS concentrations)) (VP (VBD decreased) (PP (IN with) (NP (NN time)))))) (. .)))
11573852	3	(ROOT (S (NP (NP (DT The) (NNS patients)) (NP (JJ concurrent) (NNS medications))) (VP (VBD included) (NP (NP (NNS Doc_11573852_461_471_Chemical)) (, ,) (NP (NNS Doc_11573852_473_484_Chemical)) (, ,) (NP (NNS Doc_11573852_486_498_Chemical)) (, ,) (NP (NNS Doc_11573852_500_514_Chemical)) (, ,) (CC and) (NP (NNS Doc_11573852_520_536_Chemical)))) (. .)))
11573852	4	(ROOT (S (PP (IN Despite) (NP (NP (NN administration)) (PP (IN of) (NP (NNS Doc_11573852_564_573_Chemical) (CC and) (NNS Doc_11573852_578_587_Chemical))))) (, ,) (NP (DT the) (NNS Doc_11573852_593_601_Disease)) (VP (VP (VBD persisted)) (CC and) (VP (VBD occurred) (ADVP (RB only)) (PP (IN during) (NP (JJ Doc_11573852_637_650_Chemical) (NN administration))))) (. .)))
11573852	5	(ROOT (S (NP (NP (NNS Doc_11573852_679_683_Disease) (CC and) (NNS Doc_11573852_688_711_Disease)) (, ,) (SBAR (WHNP (DT both) (WHPP (IN of) (WHNP (WDT which)))) (S (NP (DT the) (NN patient)) (VP (VBD had)))) (, ,)) (VP (MD can) (ADVP (RB potentially)) (VP (VB cause) (NP (NNS Doc_11573852_766_774_Disease)))) (. .)))
11573852	6	(ROOT (S (S (NP (DT The) (NN patient)) (VP (VBD had) (NP (NP (DT a) (NN history)) (PP (IN of) (NP (JJ Doc_11573852_805_812_Chemical) (NN abuse)))))) (: ;) (S (NP (NP (NP (NNS Doc_11573852_820_827_Chemical)) (NP (NN intake))) (CONJP (RB as) (RB well) (IN as)) (NP (NN withdrawal))) (VP (MD can) (ADVP (RB also)) (VP (VB cause) (NP (NNS Doc_11573852_872_880_Disease))))) (. .)))
11573852	7	(ROOT (S (NP (NNP Doc_11573852_882_892_Chemical)) (ADVP (RB also)) (VP (VBZ has) (NP (NP (DT a) (NN potential)) (PP (IN for) (S (VP (VBG inducing) (NP (NNS Doc_11573852_927_935_Disease))))))) (. .)))
11573852	8	(ROOT (S (ADVP (RB However)) (, ,) (NP (NP (DT these) (JJ other) (JJ potential) (NNS causes)) (PP (IN of) (NP (NNS Doc_11573852_978_985_Disease)))) (VP (VBD were) (VP (VBN ruled) (PRT (RP out)))) (. .)))
11573852	9	(ROOT (S (NP (NP (DT The) (NN time) (NN course)) (PP (IN of) (NP (NNS events)))) (VP (VBD suggested) (SBAR (IN that) (S (NP (NNS Doc_11573852_1043_1057_Chemical)) (VP (VBD was) (NP (NP (DT the) (NN cause)) (PP (IN of) (NP (NP (DT the) (NNS Doc_11573852_1079_1087_Disease)) (PP (IN in) (NP (DT this) (JJ Doc_11573852_1096_1100_Disease) (NN patient)))))))))) (. .)))
11573852	10	(ROOT (S (NP (NNP Doc_11573852_1123_1137_Chemical)) (VP (VBZ seems) (S (VP (TO to) (VP (VB be) (NP (NP (DT the) (JJ probable) (NN cause)) (PP (IN of) (NP (DT the) (NNS Doc_11573852_1176_1184_Disease)))))))) (. .)))
11573852	11	(ROOT (S (S (PP (TO To) (NP (NN date))) (, ,) (NP (NP (QP (RB only) (CD three)) (NNS cases)) (PP (IN of) (NP (NP (NNS Doc_11573852_1215_1223_Disease)) (VP (VBN associated) (PP (IN with) (NP (NNS Doc_11573852_1240_1254_Chemical))))))) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (PP (IN in) (NP (DT the) (NN literature))))))) (, ,) (CC but) (S (NP (NN healthcare) (NNS providers)) (VP (MD should) (VP (VB be) (ADJP (JJ aware) (PP (IN of) (NP (NP (DT the) (NN potential)) (PP (IN for) (NP (DT this) (JJ rare) (JJ adverse) (NN effect))))))))) (. .)))
11583940	0	(ROOT (NP (NP (NNS Doc_11583940_0_9_Chemical) (CC and) (NNS Doc_11583940_14_35_Chemical)) (PP (IN for) (NP (JJ calcineurin-free) (NN immunosuppression))) (PP (IN in) (NP (JJ renal) (NN transplant) (NNS recipients))) (. .)))
11583940	1	(ROOT (S (NP (NP (NN Calcineurin) (NNS inhibitors)) (, ,) (PP (JJ such) (IN as) (NP (NNS Doc_11583940_139_151_Chemical) (CC and) (NNS Doc_11583940_156_166_Chemical))) (, ,)) (VP (VBP have) (VP (VBN been) (ADJP (JJ available)) (PP (IN for) (NP (QP (RB almost) (CD 20)) (NNS years))))) (. .)))
11583940	2	(ROOT (S (SBAR (IN Although) (S (NP (DT these) (NNS drugs)) (VP (VP (VBP are) (ADJP (RB highly) (JJ effective))) (CC and) (VP (VBP represent) (NP (NP (DT the) (NN mainstay)) (PP (IN of) (NP (NN transplant) (NN immunosuppression)))))))) (, ,) (NP (PRP they)) (VP (VBP are) (VP (VBN associated) (PP (IN with) (NP (JJ acute) (CC and) (JJ chronic) (NN nephrotoxicity))))) (. .)))
11583940	3	(ROOT (S (S (NP (NP (JJ Acute) (NN nephrotoxicity)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ occurs) (PP (IN in) (NP (DT the) (JJ early) (NN period))) (PP (IN after) (NP (NN transplantation)))))) (, ,)) (VP (VBZ leads) (PP (TO to) (NP (NP (DT a) (JJR higher) (NN rate)) (PP (IN of) (NP (NN dialysis))))))) (, ,) (CC and) (S (NP (JJ chronic) (NN nephrotoxicity)) (VP (MD may) (ADVP (RB eventually)) (VP (VB result) (PP (IN in) (NP (NN graft) (NN loss)))))) (. .)))
11583940	4	(ROOT (S (NP (NP (NNP Acute)) (CC and) (NP (JJ chronic) (NN nephrotoxicity))) (VP (VBZ is) (VP (VBG becoming) (ADJP (RBR more) (JJ common) (PP (IN as) (NP (NP (DT the) (NN use)) (PP (IN of) (NP (NP (JJ marginal) (NNS kidneys)) (PP (IN for) (NP (NN transplantation) (NNS increases)))))))))) (. .)))
11583940	5	(ROOT (S (NP (NP (NP (CD Two)) (NP (ADJP (RB recently) (JJ available)) (NN immunosuppressive) (NNS agents))) (, ,) (NP (NP (NNS Doc_11583940_716_737_Chemical) (CC and) (NNS Doc_11583940_742_751_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_11583940_753_762_Chemical)) (-RRB- -RRB-))) (, ,)) (VP (VBP have) (NP (DT no) (NN nephrotoxicity))) (. .)))
11583940	6	(ROOT (S (NP (NP (DT The) (NN use)) (PP (IN of) (NP (NP (DT these) (NNS drugs)) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (JJ other) (NNS agents)))))))) (VP (VBZ has) (VP (VBN led) (PP (TO to) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (NP (JJ new) (NNS paradigms)) (PP (IN of) (NP (JJ immunosuppressive) (NN therapy))))))))) (. .)))
11583940	7	(ROOT (S (NP (DT This) (NN paper)) (VP (VBZ reviews) (NP (NP (DT the) (NNS results)) (PP (IN of) (NP (JJ clinical) (NNS trials))) (SBAR (WHNP (WDT that)) (S (VP (VBP have) (VP (VBN investigated) (NP (DT these) (JJ new) (NNS approaches)) (S (VP (TO to) (VP (VB immunosuppression) (PP (IN in) (NP (JJ renal) (NN transplant) (NNS recipients)))))))))))) (. .)))
11694026	0	(ROOT (FRAG (PP (ADVP (RB Tolerability)) (IN of) (NP (NP (NNS Doc_11694026_16_26_Chemical) (CC and) (NNS Doc_11694026_31_42_Chemical)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ NSAID-induced) (NNS Doc_11694026_74_83_Disease))))))) (: /) (NP (NNS Doc_11694026_84_94_Disease)) (. .)))
11694026	1	(ROOT (S (NP (NP (JJ Previous) (NNS studies)) (VP (VBN evaluated) (NP (NP (DT the) (NN tolerance)) (PP (IN of) (NP (NNS Doc_11694026_140_150_Chemical) (CC and) (NNS Doc_11694026_155_166_Chemical)))) (PP (IN in) (NP (NP (NNS subjects)) (PP (IN with) (NP (NNS cutaneous))))))) (, ,) (NP (ADJP (JJ respiratory) (CC and) (JJ anaphylactoid)) (NNS reactions)) (VP (VBN induced) (PP (IN by) (NP (NP (JJ nonsteroidal) (JJ anti-inflammatory) (NNS drugs)) (PRN (-LRB- -LRB-) (NP (NNP NSAIDs)) (-RRB- -RRB-))))) (. .)))
11694026	2	(ROOT (S (PP (IN In) (NP (DT this) (NN study))) (NP (PRP we)) (VP (VBD investigated) (NP (NP (NN tolerability) (CC and) (NN reliability)) (PP (IN of) (NP (NNS Doc_11694026_355_365_Chemical) (CC and) (NNS Doc_11694026_370_381_Chemical)))) (PP (IN in) (NP (NP (DT a) (ADJP (RB very) (JJ large)) (NN number)) (PP (IN of) (NP (NNS patients))))) (PP (IN with) (NP (NP (DT an) (JJ exclusive) (JJ well-documented) (NN history)) (PP (IN of) (NP (NNP Doc_11694026_462_467_Chemical-induced) (NNP Doc_11694026_476_485_Disease) (NNP /) (NNP Doc_11694026_486_496_Disease)))))) (. .)))
11694026	3	(ROOT (S (ADVP (RB Furthermore)) (, ,) (NP (PRP we)) (VP (VBN evaluated) (SBAR (IN whether) (S (NP (DT some) (NNS factors)) (VP (VBP have) (NP (DT the) (NN potential) (S (VP (TO to) (VP (VB increase) (NP (NP (DT the) (NN risk)) (PP (IN of) (NP (NN reaction)))) (PP (TO to) (NP (NNS Doc_11694026_600_611_Chemical) (CC and) (NNS Doc_11694026_616_626_Chemical))))))))))) (. .)))
11694026	4	(ROOT (S (NP (NP (DT A) (JJ single-placebo-controlled) (JJ oral) (NN challenge) (NN procedure)) (PP (IN with) (NP (NNS Doc_11694026_686_696_Chemical) (CC or) (NNS Doc_11694026_700_711_Chemical)))) (VP (VBD was) (VP (VBN applied) (PP (TO to) (NP (NP (CD 829) (NNS patients)) (PP (IN with) (NP (NP (DT a) (NN history)) (PP (IN of) (NP (NNP Doc_11694026_758_763_Chemical-induced) (NNP Doc_11694026_772_781_Disease) (NNP /) (NNP Doc_11694026_782_792_Disease))))))))) (. .)))
11694026	5	(ROOT (S (NP (NP (NP (DT A) (NN total)) (PP (IN of) (NP (CD 75/829))) (PRN (-LRB- -LRB-) (NP (CD 9.4) (NN %)) (-RRB- -RRB-))) (NNS patients)) (VP (VBD experienced) (NP (NNS reactions)) (PP (TO to) (NP (NNS Doc_11694026_853_863_Chemical) (CC or) (NNS Doc_11694026_867_878_Chemical)))) (. .)))
11694026	6	(ROOT (S (PP (IN Of) (NP (NP (DT the) (CD 715) (NNS patients)) (VP (VBN tested) (PP (IN with) (NP (NNP Doc_11694026_912_922_Chemical) (CD 62)))))) (PRN (-LRB- -LRB-) (NP (CD 8.6) (NN %)) (-RRB- -RRB-)) (VP (VBD showed) (NP (DT a) (JJ positive) (NN test)) (, ,) (SBAR (IN while) (S (PP (IN of) (NP (NP (CD 114) (NNS subjects)) (VP (VBN submitted) (PP (TO to) (NP (NP (DT the) (NN challenge)) (PP (IN with) (NP (NNS Doc_11694026_1011_1022_Chemical)))))))) (, ,) (NP (NP (CD 13)) (PRN (-LRB- -LRB-) (NP (CD 9.6) (NN %)) (-RRB- -RRB-))) (VP (VBD did) (RB not) (VP (VB tolerate) (NP (DT this) (NN drug))))))) (. .)))
11694026	7	(ROOT (S (ADVP (RB Furthermore)) (, ,) (NP (NP (CD 18.28) (NN %)) (PP (IN of) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (NP (DT a) (NN history)) (PP (IN of) (NP (JJ chronic) (NNS Doc_11694026_1120_1129_Disease)))) (CC and) (NP (NP (CD 11.8) (NN %)) (PP (IN of) (NP (NP (NNS subjects)) (PP (IN with) (NP (NP (DT an) (NN history)) (PP (IN of) (NP (NP (NP (NN Doc_11694026_1171_1176_Chemical-induced) (NNS Doc_11694026_1185_1194_Disease)) (PRN (: /) (S (NP (NNS Doc_11694026_1195_1205_Disease) (CC or) (NNS Doc_11694026_1209_1219_Disease)) (ADJP (RB alone))))) (PRN (-LRB- -LRB-) (PP (PP (IN with)) (CC or) (PP (IN without) (NP (JJ chronic) (NNS Doc_11694026_1251_1260_Disease)))) (-RRB- -RRB-)))))))))))))) (VP (VBD resulted) (S (VP (TO to) (VP (VB be) (ADJP (JJ intolerant) (PP (TO to) (NP (JJ alternative) (NNS drugs)))))))) (. .)))
11694026	8	(ROOT (S (S (VP (VBN Taken) (ADVP (RB together)))) (, ,) (NP (PRP$ our) (NNS results)) (VP (VBP confirm) (NP (NP (DT the) (JJ good) (NN tolerability)) (PP (IN of) (NP (NNS Doc_11694026_1371_1381_Chemical) (CC and) (NNS Doc_11694026_1386_1397_Chemical)))) (PP (IN in) (NP (NP (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBD experienced) (NP (NP (JJ Doc_11694026_1426_1435_Disease) (JJ /) (NNS Doc_11694026_1436_1446_Disease)) (VP (VBN caused) (PP (IN by) (NP (NNP NSAIDs))))))))))) (. .)))
11694026	9	(ROOT (S (ADVP (RB However)) (, ,) (NP (NP (DT the) (NN risk)) (PP (IN of) (NP (NP (NN reaction)) (PP (TO to) (NP (DT these) (JJ alternative) (NN study) (NNS drugs)))))) (VP (VBZ is) (ADJP (RB statistically) (JJ increased)) (PP (PP (IN by) (NP (NP (DT a) (NN history)) (PP (IN of) (NP (JJ chronic) (NNS Doc_11694026_1579_1588_Disease))))) (CC and) (PRN (, ,) (ADVP (IN above) (DT all)) (, ,)) (PP (IN by) (NP (NP (DT a) (NN history)) (PP (IN of) (NP (JJ NSAID-induced) (NNS Doc_11694026_1635_1645_Disease))))))) (. .)))
11704023	0	(ROOT (NP (NP (NNP Comparison)) (PP (IN of) (NP (NP (NNS aqueous)) (CC and) (NP (JJ gellan) (JJ ophthalmic) (NNS Doc_11704023_44_51_Chemical)))) (PP (IN with) (NP (NN placebo))) (PP (IN on) (NP (NP (DT the) (JJ 24-hour) (NN heart) (NN rate) (NN response)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN on) (NP (NP (NN treatment)) (PP (IN for) (NP (NNS Doc_11704023_129_137_Disease))))))))) (. .)))
11704023	1	(ROOT (S (NP (JJ Topical) (NN beta-blocker) (NN treatment)) (VP (VBZ is) (NP (NP (JJ routine) (NN therapy)) (PP (IN in) (NP (NP (DT the) (NN management)) (PP (IN of) (NP (NP (NNS patients)) (PP (IN with) (NP (NNS Doc_11704023_233_241_Disease))))))))) (. .)))
11704023	2	(ROOT (S (NP (NP (JJ Therapy) (NNS results)) (PP (IN in) (NP (JJ systemic) (NN absorption)))) (, ,) (ADVP (RB however)) (, ,) (NP (NP (DT the) (NN degree)) (PP (IN of) (NP (NP (NN reduction)) (PP (IN of) (NP (NN resting) (CC and) (NN peak) (NN heart) (NN rate)))))) (VP (VBZ has) (RB not) (VP (VBN been) (VP (VBN quantified)))) (. .)))
11704023	3	(ROOT (S (NP (DT This) (NN trial)) (VP (VBN evaluated) (NP (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (NN placebo)))) (, ,) (NP (NP (ADJP (CD 0.5) (NN %)) (NN aqueous) (NNS Doc_11704023_437_444_Chemical)) (PRN (-LRB- -LRB-) (NP (JJ Doc_11704023_446_453_Chemical) (NN solution)) (-RRB- -RRB-))) (CC and) (NP (NP (DT a) (ADJP (CD 0.5) (NN %)) (JJ Doc_11704023_475_482_Chemical) (NN suspension)) (SBAR (WHNP (WDT that)) (S (VP (VBZ forms) (NP (NP (DT a) (NN gel)) (PP (IN on) (NP (NN application)))) (PP (TO to) (NP (NP (NP (DT the) (NN conjunctiva)) (PRN (-LRB- -LRB-) (NP (JJ Doc_11704023_546_553_Chemical) (NN gellan)) (-RRB- -RRB-))) (PP (IN on) (NP (NP (DT the) (JJ 24-hour) (NN heart) (NN rate)) (PP (IN in) (NP (NP (NNS patients)) (VP (ADVP (RB currently)) (VBG being) (VP (VBN treated) (PP (IN for) (NP (NNS Doc_11704023_628_636_Disease)))))))))))))))) (S (VP (TO to) (VP (VB quantify) (NP (NP (DT the) (NN reduction)) (PP (IN in) (NP (JJ mean) (NN heart) (NN rate)))))))) (. .)))
11704023	4	(ROOT (S (NP (NP (NP (JJ Forty-three) (JJ Caucasian) (NNS patients)) (PP (IN with) (NP (NP (JJ primary) (NNS Doc_11704023_736_755_Disease) (CC or) (NNS Doc_11704023_759_778_Disease)) (PP (IN with) (NP (DT a) (JJ mean) (PRN (-LRB- -LRB-) (NP (NNP +) (NNP /)) (, -) (NP (NNP SD)) (-RRB- -RRB-)) (NN age))))) (PP (IN of) (NP (CD 63)))) (PRN (-LRB- -LRB-) (VP (VBN +) (NP (NNP /) (CD -8))) (-RRB- -RRB-)) (NP (NNS years))) (VP (VBD were) (VP (VP (VBN randomized)) (CC and) (VP (VBN crossed) (PRT (RP over)) (PP (IN in) (NP (NP (DT a) (JJ double-masked) (NN manner)) (PP (TO to) (NP (NP (CD 14) (NNS days)) (PP (IN of) (NP (NN treatment))))))) (PP (IN with) (NP (NP (NP (NN placebo)) (PRN (-LRB- -LRB-) (NP (NP (NN morning) (CC and) (NN evening)) (PP (IN in) (NP (DT both) (NNS eyes)))) (-RRB- -RRB-))) (, ,) (NP (NP (JJ Doc_11704023_954_961_Chemical) (NN solution)) (PRN (-LRB- -LRB-) (NP (NP (NN morning) (CC and) (NN evening)) (PP (IN in) (NP (DT both) (NNS eyes)))) (-RRB- -RRB-))) (, ,) (CC or) (NP (NP (JJ Doc_11704023_1010_1017_Chemical) (NN gellan)) (PRN (-LRB- -LRB-) (NP (NP (NN morning)) (PP (IN in) (NP (NP (DT both) (NNS eyes)) (PP (IN with) (NP (NN placebo))))) (PP (IN in) (NP (DT the) (NN evening)))) (-RRB- -RRB-)))))))) (. .)))
11704023	5	(ROOT (S (PP (IN On) (NP (NP (DT the) (JJ 13th) (NN day)) (PP (IN of) (NP (DT each) (NN period))))) (, ,) (NP (NN heart) (NN rate)) (VP (VBD was) (VP (VBN recorded) (ADVP (RB continuously)) (PP (IN during) (NP (DT a) (JJ typical) (, ,) (JJ ambulant) (JJ 24-hour) (NN period))))) (. .)))
11704023	6	(ROOT (S (S (NP (NP (DT Both) (JJ Doc_11704023_1203_1210_Chemical) (NN solution)) (CC and) (NP (JJ Doc_11704023_1224_1231_Chemical) (NN gellan))) (VP (VBD reduced) (NP (DT the) (JJ mean) (JJ 24-hour) (NN heart) (NN rate)) (PP (VBN compared) (PP (IN with) (NP (NP (NN placebo)) (PRN (-LRB- -LRB-) (NP (NP (NNP P) (NNP <)) (CC or) (NP (NNP =) (CD .001))) (-RRB- -RRB-))))))) (, ,) (CC and) (S (NP (DT this) (NN reduction)) (VP (VBD was) (ADJP (ADJP (RBS most) (JJ pronounced)) (PP (IN during) (NP (DT the) (JJ daytime)))) (PRN (-LRB- -LRB-) (NP (NP (CD -7.5) (NN %) (NN change)) (PP (IN in) (NP (NP (JJ mean) (NN heart) (NN rate)) (, ,) (NP (CD -5.7) (NN beats/min))))) (-RRB- -RRB-)))) (. .)))
11704023	7	(ROOT (S (NP (JJ Doc_11704023_1423_1430_Chemical) (NN gellan)) (VP (VBD showed) (NP (DT a) (ADJP (ADJP (JJ numerically)) (CC but) (RB not) (ADJP (RB significantly) (JJR smaller))) (NN reduction)) (PP (IN in) (NP (JJ 24-hour) (NN heart) (NN rate))) (, ,) (PP (VBN compared) (PP (IN with) (NP (JJ Doc_11704023_1536_1543_Chemical) (NN solution))))) (. .)))
11704023	8	(ROOT (S (S (PP (IN During) (NP (DT the) (NN night))) (, ,) (NP (NP (DT the) (JJ mean) (JJ 12-hour) (NN heart) (NN rate)) (PP (IN on) (NP (NN placebo) (CC and) (NN Doc_11704023_1615_1622_Chemical) (NN gellan)))) (VP (VBD were) (ADJP (ADJP (DT both) (RB significantly) (JJR less)) (PP (IN than) (PP (IN on) (NP (JJ Doc_11704023_1667_1674_Chemical) (NN solution))))))) (: ;) (S (NP (NP (DT the) (NN difference)) (PP (IN between) (NP (NN solution) (CC and) (NN gellan) (NNS treatments)))) (VP (VBD was) (ADJP (RB statistically) (JJ significant)) (PRN (-LRB- -LRB-) (NP (NNP P) (QP (CD =) (CD .01))) (-RRB- -RRB-)))) (. .)))
11704023	9	(ROOT (S (NP (NP (DT Both) (JJ Doc_11704023_1798_1805_Chemical) (NN solution)) (CC and) (NP (JJ Doc_11704023_1819_1826_Chemical) (NN gellan))) (VP (VB decrease) (NP (NP (DT the) (JJ mean) (JJ 24-hour) (NN heart) (NN rate)) (PP (VBN compared) (PP (IN with) (NP (NN placebo)))))) (. .)))
11704023	10	(ROOT (S (NP (DT This) (NN response)) (VP (VBD was) (ADJP (ADJP (RBS most) (JJ pronounced)) (PP (IN during) (NP (DT the) (JJ active) (JJ daytime) (NN period))))) (. .)))
11704023	11	(ROOT (S (NP (DT These) (NNS data)) (VP (VB quantify) (NP (NP (DT the) (JJ modest) (NNS Doc_11704023_1993_2004_Disease)) (VP (VBN associated) (PP (IN with) (NP (NP (JJ ophthalmic) (NN beta-blocker) (NN therapy)) (PP (IN in) (NP (DT a) (JJ typical) (NN patient) (NN population))))) (PP (IN on) (NP (NP (NN therapy)) (PP (IN for) (NP (NNS Doc_11704023_2100_2108_Disease)))))))) (. .)))
11704023	12	(ROOT (S (SBAR (IN Although) (S (NP (NN exercise) (NN performance)) (VP (VBD was) (RB not) (VP (VBN assessed) (PP (IN in) (NP (DT this) (NN trial))))))) (, ,) (NP (NP (NNS reductions)) (PP (IN of) (NP (DT this) (NN magnitude)))) (VP (MD should) (RB not) (VP (VB have) (NP (JJ substantial) (JJ clinical) (NNS consequences)))) (. .)))
11705128	0	(ROOT (NP (NP (NP (NNP Management) (NNS strategies)) (PP (IN for) (NP (NP (NN Doc_11705128_26_35_Chemical-induced) (JJ hemolytic) (NN anemia)) (PP (IN in) (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (NNS Doc_11705128_81_92_Disease)))))))) (: :) (NP (NP (JJ clinical)) (CC and) (NP (JJ economic) (NNS implications))) (. .)))
11705128	1	(ROOT (FRAG (S (VP (ADVP (RB Recently)) (VBN published) (S (NP (NNS studies)) (VP (VB have) (VP (VBN demonstrated) (NP (NP (VBN increased) (NN efficacy) (CC and) (NN cost-effectiveness)) (PP (IN of) (NP (NN combination) (NN therapy))))))) (PP (IN with) (NP (NN interferon) (CC and) (NNS Doc_11705128_272_280_Chemical))))) (: /) (NP (NP (NNS Doc_11705128_281_290_Chemical)) (PP (VBN compared) (PP (IN with) (NP (NP (JJ Doc_11705128_305_321_Chemical) (NN monotherapy)) (PP (IN in) (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (NP (NNS Doc_11705128_354_373_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_11705128_375_378_Disease)) (-RRB- -RRB-)))))))))) (. .)))
11705128	2	(ROOT (S (NP (NN Combination) (NN therapy)) (VP (VBZ is) (VP (VBN associated) (PP (IN with) (NP (DT a) (ADJP (RB clinically) (JJ important)) (JJ adverse) (NN effect))) (: :) (NP (NP (ADJP (JJ Doc_11705128_459_468_Chemical-induced) (JJ hemolytic)) (NN anemia)) (PRN (-LRB- -LRB-) (NP (NNP Doc_11705128_495_499_Disease)) (-RRB- -RRB-))))) (. .)))
11705128	3	(ROOT (S (NP (NP (DT The) (NN objective)) (PP (IN of) (NP (DT this) (NN study)))) (VP (VBD was) (S (VP (TO to) (VP (VB evaluate) (NP (NP (DT the) (JJ direct) (NN health-care) (NNS costs) (CC and) (NN management)) (PP (IN of) (NP (NNS Doc_11705128_593_597_Disease)))) (PP (IN during) (NP (NP (NN treatment)) (PP (IN of) (NP (NP (NNS Doc_11705128_618_621_Disease)) (PP (IN in) (NP (DT a) (JJ clinical) (NN trial) (NN setting))))))))))) (. .)))
11705128	4	(ROOT (S (NP (DT A) (JJ systematic) (NN literature) (NN review)) (VP (VBD was) (VP (VBN conducted) (S (VP (TO to) (VP (VB synthesize) (NP (NN information)) (PP (IN on) (NP (NP (DT the) (NN incidence) (CC and) (NN management)) (PP (IN of) (NP (NNS Doc_11705128_766_770_Disease)))))))))) (. .)))
11705128	5	(ROOT (S (NP (NNP Decision-analytic) (NNS techniques)) (VP (VBD were) (VP (VBN used) (S (VP (TO to) (VP (VB estimate) (NP (NP (DT the) (NN cost)) (PP (IN of) (S (VP (VBG treating) (NP (NNS Doc_11705128_844_848_Disease))))))))))) (. .)))
11705128	6	(ROOT (S (NP (NN Uncertainty)) (VP (VBD was) (VP (VBN evaluated) (S (VP (VBG using) (NP (NN sensitivity) (NNS analyses)))))) (. .)))
11705128	7	(ROOT (S (NP (NP (NNP Doc_11705128_913_917_Disease)) (, ,) (VP (VBN defined) (PP (IN as) (NP (NP (DT a) (NN reduction)) (PP (IN in) (NP (NN hemoglobin))))) (PP (TO to) (NP (QP (JJR less) (IN than) (CD 100) (CD g/L))))) (, ,)) (VP (VBZ occurs) (PP (IN in) (NP (NP (QP (RB approximately) (CD 7) (NN %) (TO to) (CD 9) (NN %))) (PP (IN of) (NP (NP (NNS patients)) (VP (VBN treated) (PP (IN with) (NP (NN combination) (NN therapy))))))))) (. .)))
11705128	8	(ROOT (S (NP (NP (DT The) (NN standard)) (PP (IN of) (NP (NP (NN care)) (PP (IN for) (NP (NP (NN management)) (PP (IN of) (NP (NNS Doc_11705128_1096_1100_Disease)))))))) (VP (VBZ is) (NP (NP (NN reduction) (CC or) (NN discontinuation)) (PP (IN of) (NP (DT the) (JJ Doc_11705128_1140_1149_Chemical) (NN dosage))))) (. .)))
11705128	9	(ROOT (S (NP (PRP We)) (VP (VBD estimated) (NP (NP (DT the) (JJ direct) (NN cost)) (PP (IN of) (S (VP (VBG treating) (NP (ADJP (RB clinically) (JJ significant)) (NNS Doc_11705128_1222_1226_Disease)) (S (VP (TO to) (VP (VB be) (NP (NP (CD 170)) (PP (IN per) (NP (NP (NN patient)) (VP (VBG receiving) (NP (NP (NN combination) (NN therapy)) (PP (IN per) (NP (NP (JJ 48-week) (NN treatment) (NN course)) (PRN (-LRB- -LRB-) (NP (NN range) (CD 68)) (, -) (NP (CD 692)) (-RRB- -RRB-))))))))))))))))) (. .)))
11705128	10	(ROOT (S (NP (NP (DT The) (NNS results)) (PP (IN of) (NP (DT the) (JJ one-way) (NN sensitivity) (NNS analyses)))) (VP (VBD ranged) (PP (IN from) (NP (QP (CD 57) (TO to) (CD 317))))) (. .)))
11705128	11	(ROOT (S (PP (IN In) (NP (NN comparison))) (, ,) (NP (NP (DT the) (NN cost)) (PP (IN of) (NP (NP (CD 48) (NNS weeks)) (PP (IN of) (NP (NN combination) (NN therapy)))))) (VP (VBZ is) (NP (CD 16,459))) (. .)))
11705128	12	(ROOT (S (NP (NP (DT The) (JJ direct) (NN cost)) (PP (IN of) (S (VP (VBG treating) (NP (ADJP (RB clinically) (JJ significant)) (NNS Doc_11705128_1535_1539_Disease)))))) (VP (VBZ is) (NP (NP (NP (CD 1) (NN %)) (PRN (-LRB- -LRB-) (NP (QP (CD 170) (IN /) (CD 16,459))) (-RRB- -RRB-))) (PP (IN of) (NP (NN drug) (NN treatment) (NNS costs))))) (. .)))
11705128	13	(ROOT (S (NP (NNS Questions)) (VP (VBP remain) (PP (IN about) (NP (NP (NP (DT the) (JJ optimal) (NN dose)) (PP (IN of) (NP (NNS Doc_11705128_1629_1638_Chemical)))) (CC and) (NP (NP (DT the) (NN incidence)) (PP (IN of) (NP (NP (NNS Doc_11705128_1660_1664_Disease)) (PP (IN in) (NP (DT a) (JJ real-world) (NN population))))))))) (. .)))
11705128	14	(ROOT (S (PP (IN Despite) (NP (DT these) (NNS uncertainties))) (, ,) (NP (NP (DT this) (JJ initial) (NN evaluation)) (PP (IN of) (NP (NP (DT the) (JJ direct) (NN cost)) (PP (IN of) (S (VP (VBG treating) (NP (NNS Doc_11705128_1777_1781_Disease)))))))) (VP (VBZ provides) (NP (NP (DT an) (NN estimate)) (PP (IN of) (NP (NP (DT the) (NX (NX (NN cost)) (CC and) (NX (NN management) (NNS implications)))) (PP (IN of) (NP (DT this) (ADJP (RB clinically) (JJ important)) (JJ adverse) (NN effect))))))) (. .)))
11752998	0	(ROOT (NP (NP (JJ Preliminary) (NN efficacy) (NN assessment)) (PP (IN of) (NP (JJ intrathecal) (NN injection))) (PP (IN of) (NP (NP (DT an) (JJ American) (NN formulation)) (PP (IN of) (NP (NP (NNS Doc_11752998_87_96_Chemical)) (PP (IN in) (NP (NNS humans))))))) (. .)))
11752998	1	(ROOT (S (S (NP (NP (JJ Preclinical) (NNS studies)) (PP (IN of) (NP (JJ intrathecal) (NNS Doc_11752998_155_164_Chemical)))) (VP (VBP suggest) (SBAR (S (NP (PRP it)) (VP (MD may) (VP (VB be) (ADJP (JJ effective) (PP (IN in) (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (NP (NNS Doc_11752998_213_235_Disease)) (PP (IN in) (NP (NNS humans)))))))))))))) (, ,) (CC and) (S (NP (NP (JJ preliminary) (NNS studies)) (PP (IN in) (NP (NP (NNS volunteers) (CC and) (NNS patients)) (PP (IN with) (NP (NP (DT a) (JJ Swedish) (NN formulation)) (PP (IN of) (NP (NNS Doc_11752998_328_337_Chemical)))))))) (VP (VBZ suggests) (SBAR (S (NP (PRP it)) (VP (MD may) (VP (VB be) (ADJP (JJ effective)) (PP (PP (IN in) (NP (JJ Doc_11752998_370_386_Disease) (NNS states))) (CONJP (CC but) (RB not)) (PP (IN with) (NP (JJ acute) (NNS noxious) (NN stimulation)))))))))) (. .)))
11752998	2	(ROOT (S (NP (NP (DT The) (NN purpose)) (PP (IN of) (NP (DT this) (NN study)))) (VP (VBD was) (S (VP (TO to) (VP (VB screen) (PP (IN for) (NP (NP (NN efficacy)) (PP (IN of) (NP (NP (DT a) (JJ different) (NN formulation)) (PP (IN of) (NP (NP (NNS Doc_11752998_517_526_Chemical)) (VP (VBN marketed) (PP (IN in) (NP (DT the) (NNP US)))))))))) (, ,) (S (VP (VP (VBG using) (NP (DT both) (ADJP (JJ acute) (JJ noxious)) (NN stimulation))) (CC and) (VP (VBG Doc_11752998_588_597_Chemical-evoked) (NP (JJ mechanical) (NNS Doc_11752998_616_632_Disease))))))))) (. .)))
11752998	3	(ROOT (S (PP (VBG Following) (NP (NP (NNP Food) (CC and) (NNP Drug) (NNP Administration)) (CC and) (NP (NP (JJ institutional) (NN review) (NN board) (NN approval)) (CC and) (NP (VBN written) (JJ informed) (NN consent))))) (, ,) (NP (CD 65) (NNS volunteers)) (VP (VBD were) (VP (VBN studied) (PP (IN in) (NP (NP (NP (CD two) (NNS trials)) (: :) (NP (NP (DT an) (JJ open-label) (, ,) (JJ dose-escalating) (NN trial)) (PP (IN with) (NP (NP (JJ intrathecal) (JJ Doc_11752998_848_857_Chemical) (NNS doses)) (PP (IN of) (NP (CD 0.25-2) (CD .0) (NNS mg))))))) (CC and) (NP (NP (DT a) (JJ double-blind) (, ,) (JJ placebo-controlled) (NN trial)) (PP (IN of) (NP (NP (NNS Doc_11752998_927_936_Chemical)) (, ,) (NP (CD 2) (NN mg))))))))) (. .)))
11752998	4	(ROOT (S (S (NP (JJ Cerebrospinal) (NN fluid)) (VP (VBD was) (VP (VBN obtained) (PP (IN for) (NP (JJ pharmacokinetic) (NN analysis)))))) (, ,) (CC and) (S (NP (NP (JJ Doc_11752998_1011_1015_Disease) (NNS ratings)) (PP (IN in) (NP (NP (NN response)) (PP (PP (TO to) (NP (NP (JJ acute) (NN heat) (NNS stimuli) (CC and) (NNS areas)) (PP (IN of) (NP (NNS Doc_11752998_1071_1094_Disease) (CC and) (NNS Doc_11752998_1099_1108_Disease))))) (PP (IN after) (NP (JJ intradermal) (JJ Doc_11752998_1127_1136_Chemical) (NN injection))))))) (VP (VBD were) (VP (VBN determined)))) (. .)))
11752998	5	(ROOT (S (NP (NNP Doc_11752998_1173_1182_Chemical)) (VP (VP (VBD produced) (NP (DT no) (NN effect)) (PP (IN on) (NP (JJ Doc_11752998_1205_1209_Disease) (NN report))) (PP (TO to) (NP (ADJP (JJ acute) (JJ noxious)) (JJ thermal) (CC or) (NN chemical) (NN stimulation)))) (CC but) (VP (VBD reduced) (NP (NNS Doc_11752998_1278_1301_Disease) (CC and) (NNS Doc_11752998_1306_1315_Disease)) (PP (IN from) (NP (NP (JJ intradermal) (JJ Doc_11752998_1333_1342_Chemical) (NN injection)) (PP (IN for) (NP (QP (IN at) (JJS least) (CD 24)) (NN h.)))))))))
11752998	6	(ROOT (S (PP (IN In) (NP (NN contrast))) (, ,) (NP (NP (NN residence) (NN time)) (PP (IN of) (NP (NP (NNS Doc_11752998_1403_1412_Chemical)) (PP (IN in) (NP (JJ cerebrospinal) (NN fluid)))))) (VP (VBD was) (ADJP (JJ short)) (PRN (-LRB- -LRB-) (NP (QP (CD <) (CD 4)) (NNS h)) (-RRB- -RRB-))) (. .)))
11752998	7	(ROOT (S (NP (DT These) (NNS results)) (VP (VBP show) (NP (JJ selective) (NN inhibition)) (PP (IN by) (NP (NP (JJ intrathecal) (NNS Doc_11752998_1523_1532_Chemical)) (PP (IN of) (NP (NP (NNS Doc_11752998_1536_1552_Disease)) (, ,) (VP (VBN presumed) (S (VP (TO to) (VP (VB reflect) (NP (NP (JJ central) (NN sensitization)) (PP (IN in) (NP (NNS humans)))) (PP (IN after) (NP (JJ peripheral) (JJ Doc_11752998_1623_1632_Chemical) (NN injection)))))))))))) (. .)))
11752998	8	(ROOT (S (NP (DT The) (JJ long-lasting) (NN effect)) (VP (VBZ is) (ADJP (JJ consistent) (PP (IN with) (SBAR (WHNP (WDT that)) (S (VP (VP (VBD observed) (PP (IN in) (NP (NP (JJ preliminary) (NNS reports)) (PP (IN of) (NP (NNS patients))))) (PP (IN with) (NP (JJ chronic) (NNS Doc_11752998_1749_1765_Disease)))) (CC and) (VP (VBZ is) (RB not) (ADJP (JJ due) (PP (TO to) (NP (NP (VBN prolonged) (NN residence)) (PP (IN of) (NP (NP (NNS Doc_11752998_1807_1816_Chemical)) (PP (IN in) (NP (JJ cerebrospinal) (NN fluid))))))))))))))) (. .)))
11827497	0	(ROOT (S (NP (JJ Delayed-onset) (NNS Doc_11827497_14_21_Chemical-induced)) (VP (VBZ Doc_11827497_30_46_Disease)) (. .)))
11827497	1	(ROOT (S (NP (JJ Doc_11827497_60_67_Chemical-induced) (NNS Doc_11827497_76_92_Disease)) (VP (VBZ presents) (NP (QP (CD 5) (TO to) (CD 12)) (NNS days)) (PP (IN after) (NP (JJ Doc_11827497_121_128_Chemical) (NN exposure))) (, ,) (PP (IN with) (CC or) (IN without) (NP (NNS Doc_11827497_155_187_Disease)))) (. .)))
11827497	2	(ROOT (S (NP (NP (JJ Delayed) (NN recognition) (CC and) (NN treatment)) (PP (IN of) (NP (NN Doc_11827497_226_233_Chemical-induced) (NNS Doc_11827497_242_258_Disease)))) (VP (VBP contribute) (PP (TO to) (NP (JJ poor) (NN patient) (NNS outcomes)))) (. .)))
11827497	3	(ROOT (S (VP (TO To) (VP (VB describe) (CC and) (VB increase) (NP (NP (NN awareness)) (PP (IN of) (NP (NP (DT a) (JJ clinical) (NN scenario)) (SBAR (WHPP (IN in) (WHNP (WDT which))) (S (NP (NP (DT the) (NN onset) (CC or) (NNS manifestations)) (PP (IN of) (NP (NN Doc_11827497_405_412_Chemical-induced) (NNS Doc_11827497_421_437_Disease)))) (VP (VBP are) (VP (VBN delayed)))))))))) (. .)))
11827497	4	(ROOT (S (VP (VB Retrospective) (NP (NN case) (NN series))) (. .)))
11827497	5	(ROOT (NP (NP (CD Three) (JJ large) (JJ urban) (NNS hospitals)) (PRN (-LRB- -LRB-) (PP (IN with) (NP (JJ active) (JJ cardiovascular) (NN surgery) (NNS programs))) (-RRB- -RRB-)) (. .)))
11827497	6	(ROOT (S (NP (CD 14) (NNS patients)) (VP (VBN seen) (PP (IN over) (NP (NP (DT a) (JJ 3-year) (NN period)) (SBAR (WHPP (IN in) (WHNP (WP whom))) (S (NP (NN Doc_11827497_626_633_Chemical-induced) (NNS Doc_11827497_642_658_Disease)) (VP (VBD became) (ADJP (JJ apparent) (PP (IN on) (NP (JJ delayed) (NN presentation)))) (PP (IN with) (NP (JJ Doc_11827497_704_718_Disease) (NNS complications))))))))) (. .)))
11827497	7	(ROOT (S (NP (NP (JJ Platelet) (NNS counts)) (, ,) (NP (NP (NN onset)) (PP (IN of) (NP (NNP objectively))))) (VP (VBD determined) (NP (NP (NNS Doc_11827497_797_812_Disease)) (, ,) (NP (NP (NNS results)) (PP (IN of) (NP (JJ Doc_11827497_825_832_Chemical-induced) (JJ platelet) (NN factor) (CD 4) (NN antibody) (NNS tests)))) (, ,) (CC and) (NP (NNS outcomes)))) (. .)))
11827497	8	(ROOT (S (NP (NNS Patients)) (VP (VBD went) (NP (NN home)) (PP (IN after) (NP (NP (NNS hospitalizations)) (SBAR (WHNP (WDT that)) (S (VP (VBD had) (VP (VBN included) (NP (NN heparin) (NN exposure)))))))) (PRN (: --) (PP (IN in) (NP (JJS most) (NNS cases))) (, ,) (SBAR (IN with) (S (NP (DT no) (NNS Doc_11827497_999_1015_Disease)) (VP (VBD recognized)))) (: --)) (SBAR (RB only) (S (VP (TO to) (VP (VB return) (PP (TO to) (NP (NP (DT the) (NN hospital)) (PRN (-LRB- -LRB-) (NP (NN median)) (, ,) (NP (NN day) (CD 14)) (-RRB- -RRB-)))) (PP (IN with) (NP (JJ Doc_11827497_1081_1095_Disease) (NNS complications)))))))) (. .)))
11827497	9	(ROOT (S (NP (NNP Thromboemboli)) (VP (VBD were) (NP (NP (NNS venous)) (PRN (-LRB- -LRB-) (NP (NP (CD 12) (NNS patients)) (, ,) (NP (NP (CD 7)) (PP (IN with) (NP (NNS Doc_11827497_1158_1174_Disease))))) (-RRB- -RRB-)) (CC or) (NP (NP (NP (NN arterial)) (PRN (-LRB- -LRB-) (NP (CD 4) (NNS patients)) (-RRB- -RRB-))) (CC or) (NP (DT both))))) (. .)))
11827497	10	(ROOT (S (NP (JJ Platelet) (NNS counts)) (VP (VBD were) (ADVP (RB mildly)) (VP (VBN decreased) (PP (IN in) (NP (NP (QP (DT all) (CC but) (CD 2)) (NNS patients)) (PP (IN on) (NP (JJ second) (NN presentation))))))) (. .)))
11827497	11	(ROOT (S (PP (IN On) (NP (NN readmission))) (, ,) (NP (CD 11) (NNS patients)) (VP (VBD received) (SBAR (S (NP (NP (JJ therapeutic) (NN heparin)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD worsened) (NP (NP (NP (DT the) (NNS patients) (POS ')) (JJ clinical) (NN condition)) (CC and) (, ,) (PP (IN in) (NP (DT all) (CD 11) (NNS cases))))))) (, ,)) (VP (VBD decreased) (NP (NP (DT the) (JJ platelet) (NN count)) (PRN (-LRB- -LRB-) (S (VP (VB mean) (PP (IN at) (NP (NN readmission))) (, ,) (S (VP (VBG 143) (NP (NP (SYM x)) (SBAR (S (NP (NP (CD 10)) (PRN (-LRB- -LRB-) (NP (CD 9)) (-RRB- -RRB-)) (NP (NN cells/L)) (: ;)) (VP (VBP mean) (NP (NN nadir)) (PP (IN after) (NP (NP (JJ Doc_11827497_1511_1518_Chemical) (NN re-exposure)) (, ,) (NP (CD 39) (ADJP (ADJP (QP (CD x) (CD 10))) (PRN (-LRB- -LRB-) (NP (CD 9)) (-RRB- -RRB-))) (NN cells/L)))))))))))) (-RRB- -RRB-))))))) (. .)))
11827497	12	(ROOT (S (NP (NP (NNS Results)) (PP (IN of) (NP (NP (JJ serologic) (NNS tests)) (PP (IN for) (NP (NN Doc_11827497_1584_1591_Chemical-induced) (NNS antibodies)))))) (VP (VBD were) (ADJP (JJ positive) (PP (IN in) (NP (DT all) (NNS patients))))) (. .)))
11827497	13	(ROOT (S (NP (JJ Subsequent) (NNS treatments)) (VP (VBD included) (NP (NP (NP (NP (JJ alternative) (NNS anticoagulants)) (PRN (-LRB- -LRB-) (NP (CD 11) (NNS patients)) (-RRB- -RRB-))) (, ,) (NP (NP (JJ thrombolytic) (NNS drugs)) (PRN (-LRB- -LRB-) (NP (CD 3) (NNS patients)) (-RRB- -RRB-))) (, ,) (NP (NP (JJ inferior) (NN vena) (NN cava) (NNS filters)) (PRN (-LRB- -LRB-) (NP (CD 3) (NNS patients)) (-RRB- -RRB-))) (CC and) (NP (PRN (, ,) (ADVP (RB eventually)) (, ,)) (NNS Doc_11827497_1805_1813_Chemical))) (PRN (-LRB- -LRB-) (NP (CD 11) (NNS patients)) (-RRB- -RRB-)))) (. .)))
11827497	14	(ROOT (S (NP (CD Three) (NNS patients)) (VP (VBD died)) (. .)))
11827497	15	(ROOT (S (NP (JJ Delayed-onset) (NN Doc_11827497_1877_1884_Chemical-induced) (NNS Doc_11827497_1893_1909_Disease)) (VP (VBZ is) (ADVP (RB increasingly)) (VP (VBG being) (VP (VBN recognized)))) (. .)))
11827497	16	(ROOT (S (S (VP (TO To) (VP (VB avoid) (NP (JJ disastrous) (NNS outcomes))))) (, ,) (NP (NNS physicians)) (VP (MD must) (VP (VB consider) (NP (NN Doc_11827497_1999_2006_Chemical-induced) (NNS Doc_11827497_2015_2031_Disease)) (SBAR (WHADVP (WRB whenever)) (S (NP (NP (NP (NP (DT a) (ADJP (RB recently) (JJ hospitalized)) (NN patient) (NNS returns)) (PP (IN with) (NP (NNS Doc_11827497_2086_2101_Disease)))) (: ;) (NP (NP (NN therapy)) (PP (IN with) (NP (JJ alternative) (NNS anticoagulants))))) (, ,) (NP (RB not) (NNS Doc_11827497_2148_2155_Chemical)) (, ,)) (VP (MD should) (VP (VB be) (VP (VBN initiated)))))))) (. .)))
11838826	0	(ROOT (NP (NP (NNP Treatment)) (PP (IN of) (NP (NN Doc_11838826_13_24_Chemical-induced) (NNS Doc_11838826_33_51_Disease))) (PP (IN with) (NP (NP (DT a) (JJ Doc_11838826_59_67_Chemical) (NN agonist)) (PP (IN in) (NP (NNS children))))) (. .)))
11838826	1	(ROOT (S (ADVP (RB Doc_11838826_101_112_Chemical)) (, ,) (NP (NP (DT a) (JJ potent) (NN antagonist)) (PP (IN of) (NP (NP (NP (DT both) (NN serotonergic)) (PRN (-LRB- -LRB-) (NP (CD 5HT2A)) (-RRB- -RRB-))) (CC and) (NP (JJ dopaminergic) (NN D2) (NNS receptors))))) (VP (VBZ is) (VP (VBN associated) (PP (IN with) (NP (NP (NNS Doc_11838826_212_230_Disease)) (PP (IN in) (NP (NNS adults) (CC and) (NNS children))))))) (. .)))
11838826	2	(ROOT (S (ADVP (RB Chronically)) (NP (NP (JJ elevated) (NN prolactin) (NNS levels)) (PP (IN in) (NP (NP (NNS children)) (PP (IN with) (NP (NNS Doc_11838826_310_323_Disease)))))) (VP (MD may) (VP (VB be) (VP (VBN associated) (PP (IN with) (NP (NP (VBN arrested) (NN growth) (CC and) (NN development)) (VP (VBG resulting) (PP (IN in) (NP (DT either) (JJ Doc_11838826_399_414_Disease) (CC or) (JJ short) (NN stature))))))))) (. .)))
11838826	3	(ROOT (S (NP (DT These) (NNS possibilities)) (VP (VBP stress) (NP (NP (DT the) (NN importance)) (PP (IN of) (S (VP (VBG developing) (NP (DT a) (ADJP (JJ safe) (CC and) (JJ effective)) (NN approach)) (PP (TO to) (NP (NP (JJ drug-induced) (NNS Doc_11838826_535_553_Disease)) (PP (IN in) (NP (NN youth)))))))))) (. .)))
11838826	4	(ROOT (S (NP (PRP We)) (VP (VBP report) (NP (NP (DT the) (JJ successful) (NN treatment)) (PP (IN of) (NP (NN Doc_11838826_602_613_Chemical-induced) (NNS Doc_11838826_622_640_Disease)))) (PP (IN with) (NP (NP (NNS Doc_11838826_646_657_Chemical)) (PP (IN in) (NP (NN youth)))))) (. .)))
11838826	5	(ROOT (S (NP (PRP We)) (VP (VBD undertook) (NP (NP (DT a) (NN retrospective) (NN case) (NN review)) (PP (IN of) (NP (CD four) (NNS children)))) (PP (IN with) (NP (NP (NN Doc_11838826_740_751_Chemical-induced) (NNS Doc_11838826_760_778_Disease)) (VP (VBN treated) (PP (IN with) (NP (NNS Doc_11838826_792_803_Chemical))))))) (. .)))
11838826	6	(ROOT (S (NP (NP (CD Four) (NNS males)) (PRN (-LRB- -LRB-) (NP (NP (NN age)) (NP (CD 6-11) (NNS years))) (-RRB- -RRB-))) (VP (VP (PP (IN with) (NP (NP (NP (NNP Diagnostic) (CC and) (NNP Statistical) (NNP Manual)) (PP (IN of) (NP (JJ Doc_11838826_884_900_Disease) (PRN (-LRB- -LRB-) (NP (JJ fourth) (NN edition)) (-RRB- -RRB-)) (NNS Doc_11838826_918_934_Disease)))) (CC or) (NP (NNS Doc_11838826_938_947_Disease)))) (, ,) (PP (IN with) (NP (NP (NN Doc_11838826_954_965_Chemical-induced) (NNS elevations)) (PP (IN in) (NP (NP (NN serum) (NN prolactin) (NNS levels)) (PRN (-LRB- -LRB-) (NP (NP (CD 57.5-129) (NN ng/mL)) (, ,) (NP (JJ normal) (JJ 5-15) (NN ng/mL))) (-RRB- -RRB-)))))) (, ,) (VBD were) (VP (VBN treated) (PP (IN with) (NP (NNS Doc_11838826_1066_1077_Chemical))))) (PRN (-LRB- -LRB-) (S (VP (VB mean) (NP (NP (NN dose) (CD 2.13) (NNP +) (NNP /)) (: -) (NP (CD 0.09) (NN mg/week))))) (-RRB- -RRB-))) (. .)))
11838826	7	(ROOT (S (SBAR (WHADVP (WRB When)) (S (NP (NN serum) (NN prolactin) (NNS levels)) (VP (VBD normalized) (PP (IN in) (NP (DT all) (CD four) (NNS subjects)))))) (PRN (-LRB- -LRB-) (S (VP (VB mean) (ADJP (ADJP (NP (CD 11.2) (NNS +)) (JJ /)) (: -) (ADJP (RB 10.9) (JJ ng/mL))))) (-RRB- -RRB-)) (, ,) (NP (DT the) (JJ Doc_11838826_1205_1216_Chemical) (NN dose)) (VP (VBD was) (VP (VBN reduced) (PP (TO to) (NP (NP (CD 1) (NN mg/week)) (PP (IN in) (NP (NP (CD three)) (PP (IN of) (NP (CD four) (NNS subjects))))))))) (. .)))
11838826	8	(ROOT (S (S (NP (NP (DT The) (JJ mean) (NN duration)) (PP (IN of) (NP (NP (NN therapy)) (PP (IN with) (NP (NNS Doc_11838826_1308_1319_Chemical)))))) (VP (VBD was) (NP (NP (CD 523.5) (JJ +) (NNS /)) (: -) (NP (CD 129.7) (NNS days))))) (, ,) (CC and) (S (NP (NP (DT the) (JJ mean) (NN duration)) (PP (IN of) (NP (NP (NN therapy)) (PP (IN with) (NP (NNS Doc_11838826_1384_1395_Chemical)))))) (VP (VBD was) (NP (NP (CD 788.5) (JJ +) (NNS /)) (: -) (NP (CD 162.5) (NNS days))))) (. .)))
11838826	9	(ROOT (S (NP (NNP Doc_11838826_1422_1433_Chemical)) (VP (VBD was) (ADVP (RB well)) (VP (VBN tolerated) (PP (IN without) (NP (JJ adverse) (NNS effects))))) (. .)))
11838826	10	(ROOT (S (S (NP (NNP Doc_11838826_1491_1502_Chemical)) (VP (MD may) (VP (VB be) (ADJP (JJ useful) (PP (IN for) (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (NN Doc_11838826_1538_1549_Chemical-induced) (NNS Doc_11838826_1558_1576_Disease)))))) (PP (IN in) (NP (NN youth)))))) (: ;) (S (ADVP (RB however)) (, ,) (NP (JJ further) (NN research)) (VP (VBZ is) (VP (VBN needed)))) (. .)))
11847945	0	(ROOT (S (VP (VB Acute) (NP (NNS Doc_11847945_6_27_Disease)) (PP (IN after) (NP (NP (NN exposure)) (PP (TO to) (NP (NNS Doc_11847945_46_56_Chemical)))))) (. .)))
11847945	1	(ROOT (S (VP (TO To) (VP (VB report) (NP (NP (DT a) (NN case)) (PP (IN of) (NP (NP (JJ acute) (NNS Doc_11847945_95_116_Disease)) (PP (VBG following) (NP (NP (NN exposure)) (PP (TO to) (NP (DT the) (JJ inhalational) (JJ anesthetic) (NNS Doc_11847945_167_177_Chemical)))))))))) (. .)))
11847945	2	(ROOT (FRAG (NP (NNP CASE) (NNP SUMMARY)) (: :) (S (NP (NP (DT A) (JJ 70-year-old) (JJ healthy) (NN woman)) (PP (IN from) (NP (NNP Iraq)))) (VP (VBD developed) (NP (JJ acute) (NNS Doc_11847945_247_268_Disease)) (NP (CD 3) (NNS weeks)) (PP (VBG following) (NP (NP (NN repair)) (PP (IN of) (NP (NP (DT the) (JJ right) (NN rotator) (NN cuff)) (PP (IN under) (NP (JJ general) (NN anesthesia))))))))) (. .)))
11847945	3	(ROOT (S (NP (EX There)) (VP (VBD was) (NP (NP (NP (DT no) (NN evidence)) (PP (IN for) (NP (JJ viral) (, ,) (NNP autoimmune) (, ,)))) (CC or) (NP (NP (JJ metabolic) (NNS causes)) (PP (IN of) (NP (NNS Doc_11847945_414_423_Disease)))))) (. .)))
11847945	4	(ROOT (S (NP (DT No) (JJ other) (NNS medications)) (VP (VBD were) (VP (VBN involved) (PP (IN except) (IN for) (NP (NP (NNS Doc_11847945_471_479_Chemical)) (PP (IN for) (NP (NNS Doc_11847945_484_493_Disease))))))) (. .)))
11847945	5	(ROOT (S (S (NP (DT The) (JJ Doc_11847945_499_506_Chemical) (NN aminotransferase)) (VP (VBD was) (VP (VBN elevated) (PP (TO to) (NP (NP (DT a) (JJ peak) (NN concentration)) (PP (IN of) (NP (NNP 1533) (NNP U/L)))))))) (CC and) (S (NP (DT the) (NN serum) (NNS Doc_11847945_587_596_Chemical)) (VP (VBD reached) (NP (NP (DT a) (NN peak)) (PP (IN of) (NP (CD 17.0) (NN mg/dL)))))) (. .)))
11847945	6	(ROOT (S (NP (EX There)) (VP (VBD was) (NP (NP (JJ slow) (NN improvement)) (PP (IN over) (NP (CD 4) (NNS months))))) (. .)))
11847945	7	(ROOT (S (NP (NP (JJ Accidental) (NN reexposure)) (PP (IN by) (NP (NP (DT the) (NN patient)) (PP (TO to) (NP (NNS Doc_11847945_709_717_Chemical)))))) (VP (VBD was) (ADJP (JJ uneventful))) (. .)))
11847945	8	(ROOT (S (NP (NP (DT The) (JJ clinical) (CC and) (JJ histologic) (NN picture)) (PP (IN of) (NP (DT this) (NN case)))) (VP (VBZ resembles) (NP (NP (JJ Doc_11847945_805_814_Chemical) (NN hepatitis)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ has) (NP (DT a) (JJ significant) (NN mortality) (NN rate))))))) (. .)))
11847945	9	(ROOT (S (NP (NP (NNP Doc_11847945_879_889_Chemical)) (, ,) (NP (DT a) (JJ common) (JJ anesthetic) (NN agent)) (, ,)) (VP (MD can) (VP (VB cause) (NP (JJ severe) (NNS Doc_11847945_935_956_Disease)))) (. .)))
11858397	0	(ROOT (S (NP (NNP Doc_11858397_0_18_Disease)) (VP (VBN induced) (PP (IN by) (NP (NP (NNS Doc_11858397_30_44_Chemical)) (PP (IN in) (NP (DT an) (JJ elderly) (NN woman))))) (PP (IN with) (S (VP (VBG preexisting) (NP (JJ complete) (NNS Doc_11858397_91_115_Disease)))))) (. .)))
11858397	1	(ROOT (S (NP (EX There)) (VP (VBZ is) (NP (NP (DT a) (VBG growing) (NN list)) (PP (IN of) (NP (NP (NNS drugs)) (VP (VBN implicated) (PP (IN in) (NP (VBN acquired) (NNS Doc_11858397_173_189_Disease) (CC and) (NNS Doc_11858397_194_212_Disease)))))))) (. .)))
11858397	2	(ROOT (S (ADVP (RB However)) (, ,) (NP (NP (DT the) (JJ torsadogenic) (NN potential)) (PP (IN of) (NP (NP (NNS Doc_11858397_253_267_Chemical)) (, ,) (NP (DT a) (ADJP (RB commonly) (VBN used)) (ADJP (JJ antiemetic) (CC and) (JJ prokinetic)) (NN drug)) (, ,)))) (VP (VBZ has) (RB not) (VP (VBN been) (VP (VBN reported) (PP (IN in) (NP (DT the) (NN literature))) (, ,) (PP (IN despite) (NP (NP (PRP$ its) (JJ chemical) (NN similarity)) (PP (TO to) (NP (NNS Doc_11858397_393_405_Chemical)))))))) (. .)))
11858397	3	(ROOT (S (NP (PRP We)) (VP (VBP report) (PP (IN on) (NP (DT a) (JJ 92-year-old) (NN woman))) (PP (IN with) (S (VP (VBG preexisting) (NP (NP (JJ complete) (NNS Doc_11858397_466_490_Disease)) (SBAR (WHNP (WP who)) (S (VP (VBD developed) (NP (NNS Doc_11858397_505_523_Disease)) (PP (IN after) (NP (NP (JJ intravenous) (CC and) (JJ oral) (NN administration)) (PP (IN of) (NP (NNS Doc_11858397_569_583_Chemical))))))))))))) (. .)))
11858397	4	(ROOT (S (NP (DT This) (NN patient)) (ADVP (RB also)) (VP (VBD developed) (NP (NNS Doc_11858397_613_631_Disease)) (SBAR (WHADVP (WRB when)) (S (NP (NNS Doc_11858397_637_646_Chemical) (CC and) (NNS Doc_11858397_651_663_Chemical)) (VP (VBD were) (VP (VBN given) (ADVP (RB simultaneously))))))) (. .)))
11858397	5	(ROOT (S (NP (DT These) (CD two) (NNS episodes)) (VP (VBD were) (VP (VBN suppressed) (ADVP (RB successfully)) (PP (IN after) (S (VP (VP (VBG discontinuing) (NP (DT the) (JJ offending) (NNS drugs))) (CC and) (VP (VBG administering) (NP (NN class) (NN IB) (NNS drugs)))))))) (. .)))
11858397	6	(ROOT (S (NP (DT This)) (VP (VBZ is) (NP (DT the) (JJ first) (NN documentation)) (SBAR (IN that) (S (NP (NNS Doc_11858397_850_864_Chemical)) (VP (VBZ provokes) (NP (JJ Doc_11858397_874_892_Disease) (NNS clinically)))))) (. .)))
11858397	7	(ROOT (S (NP (NNP Doc_11858397_905_919_Chemical)) (VP (MD should) (VP (VB be) (VP (VBN used) (ADVP (RB cautiously)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (DT a) (NN risk)) (PP (IN of) (NP (NNS Doc_11858397_973_991_Disease)))))))))) (. .)))
11860278	0	(ROOT (S (NP (NNP Doc_11860278_0_8_Chemical) (NNP D2) (NN receptor) (NNS signaling)) (VP (VBZ controls) (NP (NP (JJ neuronal) (NN cell) (NN death)) (VP (VBN induced) (PP (IN by) (NP (ADJP (JJ muscarinic) (CC and) (JJ glutamatergic)) (NNS drugs)))))) (. .)))
11860278	1	(ROOT (S (NP (NP (NNP Doc_11860278_107_115_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP DA)) (-RRB- -RRB-)) (, ,) (PP (IN through) (NP (CD D1/D2) (JJ receptor-mediated) (NNS signaling))) (, ,)) (VP (VBZ plays) (NP (NP (DT a) (JJ major) (NN role)) (PP (IN in) (NP (NP (DT the) (NN control)) (PP (IN of) (NP (NP (NNS Doc_11860278_202_220_Disease)) (VP (VBG arising) (PP (IN in) (NP (DT the) (JJ limbic) (NN system)))))))))) (. .)))
11860278	2	(ROOT (SINV (ADVP (RB Excitotoxicity)) (VP (VBG leading) (S (VP (TO to) (VP (VB neuronal) (NP (NP (NN cell) (NN death)) (PP (IN in) (NP (DT the) (VBN affected) (NNS areas)))))))) (VP (VBZ is)) (NP (NP (DT a) (JJ major) (NN consequence)) (PP (IN of) (NP (NP (NNS Doc_11860278_345_353_Disease)) (PP (IN at) (NP (DT the) (JJ cellular) (NN level)))))) (. .)))
11860278	3	(ROOT (S (PP (IN In) (NP (DT this) (NN respect))) (, ,) (NP (RB little)) (VP (VBZ is) (VP (VBN known) (PP (IN about) (NP (NP (DT the) (NN role)) (PP (IN of) (NP (NNP DA) (NNS receptors))))) (PP (IN in) (NP (NP (DT the) (NN occurrence)) (PP (IN of) (NP (ADJP (JJ Doc_11860278_462_470_Disease-induced) (JJ neuronal)) (NN cell) (NN death))))))) (. .)))
11860278	4	(ROOT (S (ADVP (RB Here)) (NP (PRP we)) (VP (VBP analyze) (NP (NP (NP (DT the) (NN occurrence)) (PP (IN of) (NP (NP (NNS Doc_11860278_534_542_Disease) (CC and) (NNS Doc_11860278_547_560_Disease)) (PP (IN in) (NP (NNP D2R)))))) (: -) (UCP (ADJP (JJ /)) (: -) (NP (NP (NNS mice)) (VP (VBN treated) (PP (IN with) (NP (DT the) (JJ cholinergic) (JJ agonist) (NNS Doc_11860278_614_625_Chemical)))))))) (. .)))
11860278	5	(ROOT (S (NP (PRP We)) (VP (VBD compared) (NP (DT these) (NNS results)) (PP (IN with) (NP (NP (DT those)) (VP (ADVP (RB previously)) (VBN obtained) (PP (IN with) (NP (NP (NP (NNS Doc_11860278_689_700_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP KA)) (-RRB- -RRB-))) (, ,) (NP (DT a) (JJ potent) (JJ Doc_11860278_716_725_Chemical) (NN agonist)))))))) (. .)))
11860278	6	(ROOT (S (ADVP (RB Importantly)) (, ,) (NP (NP (NNP D2R)) (PRN (: -) (NP (NNP /)) (: -)) (NNS mice)) (VP (VP (VBP develop) (NP (NNS Doc_11860278_769_777_Disease)) (PP (IN at) (NP (NP (NNS doses)) (PP (IN of) (NP (NP (DT both) (NNS drugs)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (RB not) (ADJP (JJ epileptogenic) (PP (IN for) (NP (NNP WT) (NNS littermates)))))))))))) (CC and) (VP (VBP show) (NP (JJR greater) (NNS Doc_11860278_864_877_Disease)))) (. .)))
11860278	7	(ROOT (S (ADVP (RB However)) (, ,) (NP (NN Doc_11860278_888_899_Chemical-induced) (NNS Doc_11860278_908_916_Disease)) (VP (VBP result) (PRT (RP in)) (NP (DT a) (ADJP (RBR more) (JJ widespread)) (JJ neuronal) (NN death)) (PP (IN in) (NP (DT both) (NNP WT) (CC and) (NNP D2R))) (: -) (UCP (ADJP (JJ /)) (: -) (NP (NP (NNS brains)) (PP (IN in) (NP (NP (NN comparison)) (PP (TO to) (NP (NNP KA)))))))) (. .)))
11860278	8	(ROOT (S (ADVP (RB Thus)) (, ,) (NP (NP (DT the) (NN absence)) (PP (IN of) (NP (NNP D2R)))) (VP (VBZ lowers) (NP (NP (DT the) (NN threshold)) (PP (IN for) (NP (NP (NNS Doc_11860278_1061_1069_Disease)) (VP (VBN induced) (PP (IN by) (NP (DT both) (NNS Doc_11860278_1086_1095_Chemical) (CC and) (NNS Doc_11860278_1100_1113_Chemical)))))))) (. .)))
11860278	9	(ROOT (S (ADVP (RB Moreover)) (, ,) (NP (NP (DT the) (JJ dopaminergic) (NN control)) (PP (IN of) (NP (NN Doc_11860278_1153_1161_Disease-induced) (NNS Doc_11860278_1170_1187_Disease)))) (VP (VBZ seems) (S (VP (TO to) (VP (VB be) (VP (VBN mediated) (PP (IN by) (NP (NP (JJ distinct) (NNS interactions)) (PP (IN of) (NP (NNP D2R))))) (S (VP (VBG signaling) (PP (IN with) (NP (DT these) (CD two) (NNS neurotransmitters)))))))))) (. .)))
11860495	0	(ROOT (S (NP (JJ Doc_11860495_0_7_Chemical) (NN structure) (CC and) (NN pharmacological) (NNS properties)) (VP (VBP determine) (NP (NP (DT the) (JJ anti-Doc_11860495_68_75_Disease) (NNS effects)) (PP (IN of) (NP (NP (NNS Doc_11860495_87_108_Chemical)) (PP (IN in) (NP (NP (DT the) (JJ passive) (NN avoidance) (NN task)) (PP (IN in) (NP (NNS rats))))))))) (. .)))
11860495	1	(ROOT (S (NP (NP (NNP Doc_11860495_148_169_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_11860495_171_176_Chemical)) (-RRB- -RRB-))) (VP (VBZ has) (VP (VBN generated) (NP (NN interest)) (PP (IN as) (NP (NP (CD one)) (PP (IN of) (NP (DT the) (ADJP (RBS most) (JJ potent)) (JJ memory-enhancing) (NNS neurosteroids))))) (S (VP (TO to) (VP (VB be) (VP (VBN examined) (PP (IN in) (NP (JJ rodent) (NN learning) (NNS studies))))))) (, ,) (PP (IN with) (NP (NP (JJ particular) (NN importance)) (PP (IN in) (NP (DT the) (VBG ageing) (NN process))))))) (. .)))
11860495	2	(ROOT (S (NP (NP (DT The) (NN mechanism)) (SBAR (WHPP (IN by) (WHNP (WDT which))) (S (NP (DT this) (JJ endogenous) (NNS Doc_11860495_390_397_Chemical)) (VP (VBZ enhances) (NP (NN memory) (NN formation)))))) (VP (VBZ is) (VP (VBN hypothesized) (S (VP (TO to) (VP (VB involve) (NP (NNS actions)) (PP (IN on) (NP (JJ glutamatergic) (CC and) (JJ GABAergic) (NNS systems)))))))) (. .)))
11860495	3	(ROOT (S (NP (DT This) (NNS hypothesis)) (VP (VBZ stems) (PP (IN from) (NP (NNS findings))) (SBAR (IN that) (S (NP (NNS Doc_11860495_540_545_Chemical)) (VP (VBZ is) (NP (NP (NP (DT a) (JJ potent) (JJ positive) (NN modulator)) (PP (IN of) (NP (NP (JJ Doc_11860495_580_600_Chemical) (NNS receptors)) (PRN (-LRB- -LRB-) (NP (NNP NMDARs)) (-RRB- -RRB-))))) (CC and) (NP (NP (DT a) (JJ negative) (NN modulator)) (PP (IN of) (NP (JJ Doc_11860495_648_671_Chemical) (PRN (-LRB- -LRB-) (NP (NNP A)) (-RRB- -RRB-)) (NNS receptors)))) (PRN (-LRB- -LRB-) (NP (NP (NNS Doc_11860495_686_690_Chemical)) (VP (PRN (-LRB- -LRB-) (NP (NNP A)) (-RRB- -RRB-)) (VBN Rs))) (-RRB- -RRB-))))))) (. .)))
11860495	4	(ROOT (S (ADVP (RB Moreover)) (, ,) (NP (NNS Doc_11860495_708_713_Chemical)) (VP (VBZ is) (ADJP (JJ able) (S (VP (TO to) (VP (VB reverse) (NP (NP (NP (DT the) (NN Doc_11860495_737_744_Disease-like) (NNS effects)) (PP (IN of) (NP (NNP NMDAR)))) (CC and) (NP (NP (NNS Doc_11860495_771_775_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP A)) (-RRB- -RRB-)) (NP (NN R) (NNS ligands))))))))) (. .)))
11860495	5	(ROOT (S (S (VP (TO To) (VP (VB investigate) (NP (DT this) (NNS hypothesis))))) (, ,) (NP (NP (DT the) (JJ present) (NN study)) (PP (IN in) (NP (NNS rats)))) (VP (VBD examined) (NP (NP (DT the) (JJ memory-altering) (NNS abilities)) (PP (IN of) (NP (NP (JJ structural) (NNS analogs)) (PP (IN of) (NP (NP (NNS Doc_11860495_911_916_Chemical)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP differ) (PP (IN in) (NP (PRP$ their) (ADJP (JJ modulation) (PP (IN of) (NP (NP (NNP NMDAR) (NNP and/or) (NNP Doc_11860495_967_971_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP A)) (-RRB- -RRB-))))) (NN R) (NN function)))))))))))) (. .)))
11860495	6	(ROOT (S (NP (NP (DT The) (NNS analogs)) (VP (VBN tested))) (VP (VP (VBD were)) (: :) (NP (NP (NP (NNS Doc_11860495_1011_1039_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (DT an) (NN agent)) (SBAR (WHNP (WDT that)) (S (VP (VP (VBZ is) (ADJP (JJ inactive) (PP (IN at) (NP (NNP Doc_11860495_1070_1074_Chemical) (PRN (-LRB- -LRB-) (NP (NNP A)) (-RRB- -RRB-)) (NNP Rs))))) (CC and) (VP (VBZ NMDARs)))))) (-RRB- -RRB-))) (, ,) (NP (NP (NNS Doc_11860495_1093_1108_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (NNS Doc_11860495_1110_1155_Chemical)) (, ,) (NP (NP (DT an) (NN inhibitor)) (PP (IN of) (NP (DT both) (NNP Doc_11860495_1178_1182_Chemical) (PRN (-LRB- -LRB-) (NP (NNP A)) (-RRB- -RRB-)) (NNP Rs)))) (CC and) (NP (NNP NMDARs))) (-RRB- -RRB-))) (, ,) (CC and) (NP (NP (DT a) (ADJP (ADJP (RB newly) (JJ synthesized)) (PRN (-LRB- -LRB-) (NP (NNP -)) (-RRB- -RRB-))) (JJ Doc_11860495_1229_1234_Chemical) (NN enantiomer)) (PRN (-LRB- -LRB-) (SBAR (WHNP (WDT which)) (S (VP (VP (VBZ is) (ADJP (JJ identical) (PP (TO to) (NP (NP (NNS Doc_11860495_1269_1274_Chemical)) (PP (IN in) (NP (NP (NNS effects)) (PP (IN on) (NP (NNP Doc_11860495_1289_1293_Chemical) (PRN (-LRB- -LRB-) (NP (NNP A)) (-RRB- -RRB-)) (NNP Rs))))))))) (CC and) (VP (VBZ NMDARs))))) (-RRB- -RRB-))))) (. .)))
11860495	7	(ROOT (S (NP (NP (DT The) (JJ memory-enhancing) (NNS effects)) (PP (IN of) (NP (NP (NNS Doc_11860495_1344_1349_Chemical)) (CC and) (NP (PRP$ its) (NNS analogs))))) (VP (VBD were) (VP (VBN tested) (PP (IN in) (NP (NP (DT the) (JJ passive) (NN avoidance) (NN task)) (VP (VBG using) (NP (NP (DT the) (NN model)) (PP (IN of) (NP (NN Doc_11860495_1427_1438_Chemical-induced) (NNS Doc_11860495_1447_1454_Disease))))))))) (. .)))
11860495	8	(ROOT (S (NP (NP (DT Both) (NNS Doc_11860495_1461_1466_Chemical)) (CC and) (NP (PRP$ its) (PRN (-LRB- -LRB-) (NP (NNP -)) (-RRB- -RRB-)) (NN enantiomer))) (VP (VBD blocked) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NNS Doc_11860495_1513_1524_Chemical))))) (. .)))
11860495	9	(ROOT (S (NP (DT The) (NNS results)) (VP (VBP show) (SBAR (IN that) (S (, ,) (PP (IN unlike) (NP (NNS Doc_11860495_1556_1561_Chemical))) (, ,) (NP (NNS Doc_11860495_1563_1591_Chemical) (CC and) (NNS Doc_11860495_1596_1620_Chemical)) (VP (VBD failed) (S (VP (TO to) (VP (VB block) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (NNS Doc_11860495_1651_1662_Chemical))))))) (, ,) (S (VP (VBG suggesting) (SBAR (IN that) (S (S (VP (VBG altering) (NP (NP (DT the) (NN modulation)) (PP (IN of) (NP (JJ Doc_11860495_1707_1711_Chemical) (NNS receptors)))))) (VP (VBZ diminishes) (NP (NP (DT the) (JJ memory-enhancing) (NNS effects)) (PP (IN of) (NP (NNS Doc_11860495_1765_1770_Chemical))))))))))))) (. .)))
11860495	10	(ROOT (S (ADVP (RB Moreover)) (, ,) (NP (NN enantioselectivity)) (VP (VBD was) (VP (VBN demonstrated) (PP (IN by) (NP (NP (DT the) (NN ability)) (PP (IN of) (NP (JJ natural) (NNS Doc_11860495_1844_1849_Chemical))))) (S (VP (TO to) (VP (VB be) (NP (NP (DT an) (NN order)) (PP (IN of) (NP (NP (NN magnitude)) (ADJP (ADJP (RBR more) (JJ effective) (PP (IN than) (NP (PRP$ its) (JJ synthetic) (NN enantiomer)))) (PP (IN in) (S (VP (VBG reversing) (NP (NN Doc_11860495_1936_1947_Chemical-induced) (NNS Doc_11860495_1956_1963_Disease)))))))))))))) (. .)))
11860495	11	(ROOT (S (NP (DT These) (NNS results)) (VP (VBP identify) (NP (NP (DT a) (JJ novel) (JJ neuropharmacological) (NN site)) (PP (IN for) (NP (NP (DT the) (NN modulation)) (PP (IN of) (NP (NN memory) (NNS processes)))))) (PP (IN by) (NP (JJ neuroactive) (NNS Doc_11860495_2076_2084_Chemical)))) (. .)))
11861791	0	(ROOT (S (NP (NP (NNP Activation)) (PP (IN of) (NP (JJ Doc_11861791_14_30_Chemical) (NN polymerase)))) (VP (VBZ contributes) (PP (TO to) (NP (NP (NN development)) (PP (IN of) (NP (NN Doc_11861791_72_83_Chemical-induced) (NNS Doc_11861791_92_105_Disease)))))) (. .)))
11861791	1	(ROOT (S (NP (NP (NNP Activation)) (PP (IN of) (NP (NP (NP (DT the) (JJ nuclear) (JJ enzyme) (JJ Doc_11861791_140_156_Chemical) (NN polymerase)) (PRN (-LRB- -LRB-) (NP (NNP PARP)) (-RRB- -RRB-))) (PP (IN by) (NP (JJ oxidant-mediated) (NN DNA) (NN damage)))))) (VP (VBZ is) (NP (NP (DT an) (JJ important) (NN pathway)) (PP (IN of) (NP (NP (NN cell) (NN dysfunction) (CC and) (NN tissue) (NN injury)) (PP (IN in) (NP (NP (NNS conditions)) (VP (VBN associated) (PP (IN with) (NP (JJ oxidative) (NN stress)))))))))) (. .)))
11861791	2	(ROOT (S (NP (VBN Increased) (NN oxidative) (NN stress)) (VP (VBZ is) (NP (NP (NP (DT a) (JJ major) (NN factor)) (VP (VBN implicated) (PP (IN in) (NP (NP (DT the) (NNS Doc_11861791_379_393_Disease)) (PP (IN of) (NP (NP (NNS Doc_11861791_397_408_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_11861791_410_413_Chemical)) (-RRB- -RRB-)))))))) (, ,) (NP (DT a) (ADJP (RB widely) (VBN used)) (NN antitumor) (NN Doc_11861791_440_453_Chemical) (NN antibiotic)))) (. .)))
11861791	3	(ROOT (S (ADVP (RB Thus)) (, ,) (NP (PRP we)) (VP (VBN hypothesized) (SBAR (IN that) (S (NP (NP (DT the) (NN activation)) (PP (IN of) (NP (NNP PARP)))) (VP (MD may) (VP (VB contribute) (PP (TO to) (NP (DT the) (NN Doc_11861791_538_541_Chemical-induced) (NNS Doc_11861791_550_564_Disease)))))))) (. .)))
11861791	4	(ROOT (S (S (VP (VBG Using) (NP (UCP (NP (NP (DT a) (JJ dual) (NN approach)) (PP (IN of) (NP (NN PARP-1) (NN suppression)))) (, ,) (PP (IN by) (NP (JJ genetic) (NN deletion))) (CC or) (NP (NP (JJ pharmacological) (NN inhibition)) (PP (IN with) (NP (DT the) (NNP Doc_11861791_670_686_Chemical) (NNP PARP) (NN inhibitor))))) (NNS Doc_11861791_702_706_Chemical)))) (, ,) (NP (PRP we)) (ADVP (RB now)) (VP (VBP demonstrate) (NP (NP (DT the) (NN role)) (PP (IN of) (NP (NNP PARP)))) (PP (IN in) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (NP (NNS Doc_11861791_766_785_Disease)) (VP (VBN induced) (PP (IN by) (NP (NNS Doc_11861791_797_800_Chemical))))))))) (. .)))
11861791	5	(ROOT (NP (NP (NNP PARP-1) (NNP +) (PRN (: /) (ADJP (JJ +) (CC and) (JJ PARP-1)) (: -)) (NNP /)) (: -) (NP (NP (NNS mice)) (VP (VBN received) (NP (NP (DT a) (JJ single) (NN injection)) (PP (IN of) (NP (NP (NNS Doc_11861791_862_865_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 25) (NN mg/kg) (NN i.p)) (-RRB- -RRB-))))))) (. .)))
11861791	6	(ROOT (S (PP (NP (CD Five) (NNS days)) (IN after) (NP (JJ Doc_11861791_898_901_Chemical) (NN administration))) (, ,) (NP (JJ left) (NN ventricular) (NN performance)) (VP (VBD was) (ADJP (RB significantly) (JJ depressed) (PP (IN in) (NP (NP (NNP PARP-1) (NNP +)) (PRN (: /) (UCP (NP (CD +) (NNS mice)) (, ,) (CC but) (ADVP (RB only) (PP (TO to) (NP (DT a) (JJR smaller) (NN extent)))) (PP (IN in) (NP (NN PARP-1)) (: -))) (: /)) (: -) (NP (NNS ones)))))) (. .)))
11861791	7	(ROOT (S (NP (JJ Similar) (NNS experiments)) (VP (VBD were) (VP (VBN conducted) (PP (IN in) (NP (NP (JJ BALB/c) (NNS mice)) (VP (VBN treated) (PP (IN with) (NP (NNS Doc_11861791_1105_1109_Chemical) (CC or) (NN vehicle)))))))) (. .)))
11861791	8	(ROOT (S (NP (NP (NNP Treatment)) (PP (IN with) (NP (DT a) (NNS Doc_11861791_1139_1143_Chemical)))) (VP (VP (ADVP (RB significantly)) (VBD improved) (NP (NNS Doc_11861791_1167_1186_Disease))) (CC and) (VP (VBD increased) (NP (NP (DT the) (NN survival)) (PP (IN of) (NP (DT the) (NNS animals)))))) (. .)))
11861791	9	(ROOT (S (PP (IN In) (NP (NN addition))) (NP (NNS Doc_11861791_1242_1246_Chemical)) (ADVP (RB significantly)) (VP (VBD reduced) (NP (NP (NP (DT the) (NN Doc_11861791_1273_1276_Chemical-induced) (NN increase)) (PP (IN in) (NP (NP (DT the) (JJ serum) (JJ Doc_11861791_1307_1314_Chemical) (NN dehydrogenase)) (CC and) (NP (JJ Doc_11861791_1333_1341_Chemical) (NN kinase) (NNS activities))))) (CONJP (CC but) (RB not)) (NP (NP (JJ metalloproteinase) (NN activation)) (PP (IN in) (NP (DT the) (NN heart)))))) (. .)))
11861791	10	(ROOT (S (ADVP (RB Thus)) (, ,) (NP (NNP PARP) (NNP activation)) (VP (VBZ contributes) (PP (TO to) (NP (NP (DT the) (NNS Doc_11861791_1452_1466_Disease)) (PP (IN of) (NP (NNS Doc_11861791_1470_1473_Chemical)))))) (. .)))
11861791	11	(ROOT (S (NP (NNP PARP) (NNS inhibitors)) (VP (MD may) (VP (VB exert) (NP (JJ protective) (NNS effects)) (PP (IN against) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (NP (JJ severe) (NNS Doc_11861791_1554_1575_Disease)) (VP (VBN associated) (PP (IN with) (NP (DT the) (JJ Doc_11861791_1596_1599_Chemical) (NN treatment)))))))))) (. .)))
11868798	0	(ROOT (NP (NP (NNP Doc_11868798_0_14_Chemical)) (: :) (SQ (VBZ is) (NP (PRP it)) (NP (NP (DT a) (NN novel) (NN drug)) (PP (IN for) (NP (NP (DT the) (NN prevention)) (PP (IN of) (NP (NN Doc_11868798_57_71_Chemical-related) (NNS Doc_11868798_80_91_Disease)))))) (PP (IN in) (NP (JJ Doc_11868798_95_101_Disease) (NNS patients)) (. ?)))))
11868798	1	(ROOT (S (NP (NNP Nephrotoxicity)) (VP (VBZ is) (NP (NP (DT the) (JJ major) (JJ adverse) (NN effect)) (PP (IN of) (NP (NP (NNS Doc_11868798_169_183_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_11868798_185_188_Chemical)) (-RRB- -RRB-))))) (, ,) (S (ADVP (RB often)) (VP (VBG limiting) (NP (NP (NN administration)) (PP (IN of) (NP (JJ full) (NN dosage))))))) (. .)))
11868798	2	(ROOT (S (NP (JJ Selective) (JJ distal) (JJ tubular) (NN epithelial) (NNS Doc_11868798_273_281_Disease)) (VP (VBZ seems) (S (VP (TO to) (VP (VB be) (ADJP (JJ responsible) (PP (IN for) (NP (NP (DT the) (JJ profound) (JJ Doc_11868798_323_332_Chemical) (NN wasting)) (SBAR (WHNP (WDT that)) (S (VP (VBZ is) (NP (NP (DT a) (JJ major) (JJ clinical) (NN side) (NN effect)) (PP (IN of) (NP (NP (NN treatment)) (PP (IN with) (NP (NNS Doc_11868798_396_399_Chemical)))))))))))))))) (. .)))
11868798	3	(ROOT (S (NP (JJ Doc_11868798_401_410_Chemical) (NN depletion)) (ADVP (RB also)) (VP (VBZ potentiates) (NP (NP (DT the) (JJ tubular) (NNS Doc_11868798_450_458_Disease)) (PP (IN of) (NP (NNS Doc_11868798_462_465_Chemical))))) (. .)))
11868798	4	(ROOT (S (NP (DT This) (NN study)) (VP (VBD was) (VP (VBN designed) (S (VP (TO to) (VP (VB assess) (NP (NP (DT the) (NN ability)) (PP (IN of) (NP (NNS Doc_11868798_516_530_Chemical)))) (S (VP (VP (TO to) (VP (VB reduce) (NP (JJ Doc_11868798_541_550_Chemical) (NNS requirements)))) (CC and) (VP (TO to) (VP (VB prevent) (NP (NP (NNS Doc_11868798_579_590_Disease)) (PP (IN in) (NP (JJ Doc_11868798_594_605_Disease) (NNS patients)))) (PP (IN on) (NP (JJ Doc_11868798_618_621_Chemical) (NN treatment)))))))))))) (. .)))
11868798	5	(ROOT (S (PP (IN In) (NP (DT this) (NN study))) (NP (NP (CD 26) (NNS patients)) (PP (IN with) (NP (JJ various) (NNS Doc_11868798_681_704_Disease)))) (VP (VBD were) (VP (VBN randomized) (S (VP (TO to) (VP (VB receive) (NP (CC either) (NP (NP (JJ intravenous) (NNS Doc_11868798_751_754_Chemical)) (ADVP (RB alone))) (CC or) (NP (NP (JJ Doc_11868798_764_767_Chemical) (CC and) (JJ oral) (NNS Doc_11868798_777_791_Chemical)) (NP (CD 100) (NN mg)))) (ADVP (ADVP (RB twice) (JJ daily)) (SBAR (WHADVP (WRB when)) (S (VP (VBG developing) (NP (NP (DT a) (JJ proven)) (CC or) (NP (VBN suspected) (NNS Doc_11868798_849_865_Disease)))))))))))) (. .)))
11868798	6	(ROOT (S (NP (NP (NNS Patients)) (VP (VBG receiving) (NP (JJ concomitant) (NNS Doc_11868798_907_910_Chemical) (CC and) (NNS Doc_11868798_915_929_Chemical)))) (VP (VBD had) (NP (ADJP (RB significantly) (JJR higher)) (NN plasma) (NN Doc_11868798_962_971_Chemical) (NNS levels)) (PP (IN than) (S (NP (DT those)) (VP (VBG receiving) (NP (NNS Doc_11868798_1000_1003_Chemical)) (ADVP (RB alone)) (PRN (-LRB- -LRB-) (NP (NNP P) (QP (CD =) (CD 0.0027))) (-RRB- -RRB-)))))) (. .)))
11868798	7	(ROOT (S (NP (NP (DT Those) (NNS patients)) (VP (VBG receiving) (NP (NNS Doc_11868798_1049_1052_Chemical) (CC and) (NNS Doc_11868798_1057_1071_Chemical)))) (VP (VBD required) (NP (ADJP (RB significantly) (JJR less)) (JJ Doc_11868798_1100_1109_Chemical) (NN supplementation)) (S (VP (TO to) (VP (VB maintain) (NP (PRP$ their) (NN plasma) (NNS Doc_11868798_1151_1160_Chemical)) (PP (IN within) (NP (NP (DT the) (JJ normal) (NN range)) (PRN (-LRB- -LRB-) (NP (NNP P) (QP (CD =) (CD 0.022))) (-RRB- -RRB-)))))))) (. .)))
11868798	8	(ROOT (S (ADVP (RB Moreover)) (, ,) (NP (JJ urinary) (JJ Doc_11868798_1216_1225_Chemical) (NNS losses)) (VP (VBD were) (ADJP (RB significantly) (JJR less)) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NNS Doc_11868798_1279_1282_Chemical) (CC and) (NNS Doc_11868798_1287_1301_Chemical)) (PP (IN than) (S (NP (DT those)) (VP (VBG receiving) (NP (NNS Doc_11868798_1323_1326_Chemical)) (ADVP (RB alone)) (PRN (-LRB- -LRB-) (NP (NNP P) (QP (CD =) (CD 0.040))) (-RRB- -RRB-))))))))) (. .)))
11868798	9	(ROOT (S (NP (DT This) (NN study)) (VP (VBD showed) (SBAR (IN that) (S (NP (NNS Doc_11868798_1381_1395_Chemical)) (VP (MD can) (VP (VP (VB reduce) (NP (JJ Doc_11868798_1407_1416_Chemical) (NNS requirements))) (CC and) (VP (VB prevent) (NP (NNS Doc_11868798_1442_1453_Disease)) (PP (IN by) (S (VP (VBG reducing) (NP (JJ urinary) (JJ Doc_11868798_1474_1483_Chemical) (NN loss)) (PP (IN in) (NP (NP (JJ Doc_11868798_1492_1503_Disease) (NNS patients)) (PP (IN on) (NP (JJ Doc_11868798_1516_1519_Chemical) (NN treatment)))))))))))))) (. .)))
11890511	0	(ROOT (S (NP (NNP Doc_11890511_0_20_Disease)) (VP (VBZ occurs) (PP (VBG following) (NP (NP (NN substantia) (NN nigra) (NNS lesions)) (PP (IN in) (NP (DT the) (NN rat)))))) (. .)))
11890511	1	(ROOT (S (NP (JJ Erectile) (NN function)) (VP (VBD was) (VP (VBN assessed) (NP (NP (NP (CD 6) (NNS weeks)) (PP (VBG following) (NP (NN uni)))) (: -) (CC and) (NP (NP (JJ bilateral) (NNS injections)) (PP (IN of) (NP (NP (NNS Doc_11890511_157_174_Chemical)) (PP (IN in) (NP (NP (DT the) (NN substantia) (NN nigra) (NN nucleus)) (PP (IN of) (NP (DT the) (NN brain))))))))))) (. .)))
11890511	2	(ROOT (S (NP (JJ Behavioral) (NN Doc_11890511_232_243_Chemical-induced) (NN penile) (NNS erections)) (VP (VBD were) (VP (VP (VBN reduced) (PRN (-LRB- -LRB-) (NP (CD 5/8)) (-RRB- -RRB-))) (CC and) (VP (VBN increased) (PRN (-LRB- -LRB-) (NP (CD 3/8)) (-RRB- -RRB-))) (PP (IN in) (NP (ADJP (JJ uni) (: -) (CC and) (JJ bilateral)) (JJ lesioned) (NNS animals))))) (. .)))
11890511	3	(ROOT (S (NP (NP (JJ Intracavernous) (NNS pressures)) (, ,) (PP (VBG following) (NP (NP (JJ electrical) (NN stimulation)) (PP (IN of) (NP (DT the) (JJ cavernous) (NN nerve))))) (, ,)) (VP (VBD decreased) (PP (IN in) (NP (JJ lesioned) (NNS animals)))) (. .)))
11890511	4	(ROOT (S (NP (NP (NNS Lesions)) (PP (IN of) (NP (DT the) (NN substantia) (NN nigra)))) (VP (VBD were) (VP (VBN confirmed) (PP (IN by) (NP (NN histology))))) (. .)))
11890511	5	(ROOT (S (NP (NP (NNP Concentration)) (PP (IN of) (NP (NP (NNS Doc_11890511_540_548_Chemical)) (CC and) (NP (PRP$ its) (NNS metabolites))))) (VP (VBD were) (VP (VBN decreased) (PP (IN in) (NP (NP (DT the) (NN striatum)) (PP (IN of) (NP (NN substantia) (NN nigra) (JJ lesioned) (NNS rats))))))) (. .)))
11890511	6	(ROOT (S (NP (NP (NNS Lesions)) (PP (IN of) (NP (DT the) (NN substantia) (NN nigra)))) (VP (VP (VBP are) (ADVP (RB therefore)) (VP (VBN associated) (PP (IN with) (NP (NP (NNS Doc_11890511_697_717_Disease)) (PP (IN in) (NP (NNS rats))))))) (CC and) (VP (MD may) (VP (VB serve) (PP (IN as) (NP (DT a) (NN model) (S (VP (TO to) (VP (VB study) (NP (NNS Doc_11890511_760_780_Disease)) (PP (IN in) (NP (NNS Doc_11890511_784_803_Disease))))))))))) (. .)))
11900788	0	(ROOT (NP (NP (JJ Doc_11900788_0_8_Chemical) (NN potentiation)) (PP (IN of) (NP (NN Doc_11900788_25_33_Chemical-induced) (NNS Doc_11900788_42_51_Disease))) (PP (IN in) (NP (NNS mice))) (. .)))
11900788	1	(ROOT (S (PP (IN In) (NP (DT the) (JJ present) (NN study))) (, ,) (NP (NP (NNS effects)) (PP (IN of) (NP (NP (NNS Doc_11900788_94_102_Chemical)) (PP (IN on) (NP (NP (NNS Doc_11900788_106_115_Disease)) (VP (VBN induced) (PP (IN by) (NP (NP (NNS Doc_11900788_127_135_Chemical)) (PP (IN in) (NP (NNS mice))))))))))) (VP (VBP have) (VP (VBN been) (VP (VBN investigated)))) (. .)))
11900788	2	(ROOT (S (NP (NNS Doc_11900788_168_176_Chemical) (CONJP (CC but) (RB not)) (NNS Doc_11900788_185_193_Chemical)) (VP (VBN induced) (NP (DT a) (JJ dose-dependent) (NNS Doc_11900788_219_228_Disease))) (. .)))
11900788	3	(ROOT (S (NP (NP (DT The) (NN response)) (PP (IN of) (NP (NNS Doc_11900788_246_254_Chemical)))) (VP (VBD was) (VP (VBN potentiated) (PP (IN by) (NP (NNS Doc_11900788_274_282_Chemical))))) (. .)))
11900788	4	(ROOT (S (NP (NP (JJ Intraperitoneal) (NN administration)) (PP (IN of) (NP (NNS Doc_11900788_318_326_Chemical) (, ,) (NNS Doc_11900788_328_336_Chemical) (, ,) (NNS Doc_11900788_338_350_Chemical) (, ,) (CC and) (NNS Doc_11900788_356_369_Chemical))) (PP (TO to) (NP (NNS mice)))) (VP (VBD reduced) (NP (NP (NNS Doc_11900788_386_395_Disease)) (VP (VBN induced) (PP (IN by) (NP (NP (DT a) (NN combination)) (PP (IN of) (NP (NP (NNS Doc_11900788_424_432_Chemical)) (PP (IN with) (NP (NNS Doc_11900788_438_446_Chemical)))))))))) (. .)))
11900788	5	(ROOT (S (NP (NP (JJ Intracerebroventricular) (NN injection)) (PP (IN of) (NP (NNS Doc_11900788_485_493_Chemical) (, ,) (NNS Doc_11900788_495_508_Chemical) (, ,) (CC and) (NNS Doc_11900788_514_522_Chemical)))) (ADVP (RB also)) (VP (VBD decreased) (NP (NP (NNS Doc_11900788_538_547_Disease)) (VP (VBN induced) (PP (IN by) (NP (NNP Doc_11900788_559_567_Chemical) (CC plus) (NNP Doc_11900788_573_581_Chemical)))))) (. .)))
11900788	6	(ROOT (S (NP (NP (JJ Intraperitoneal) (NN administration)) (PP (IN of) (NP (NP (NNS Doc_11900788_617_625_Chemical)) (, ,) (CONJP (CC but) (RB not)) (NP (NP (NN intraperitoneal) (CC or) (NN intracerebroventricular) (NN injection)) (PP (IN of) (NP (NNS Doc_11900788_691_704_Chemical))))))) (, ,) (VP (VBD decreased) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (NP (DT a) (JJ single) (NN dose)) (PP (IN of) (NP (NNS Doc_11900788_747_755_Chemical))))))) (. .)))
11900788	7	(ROOT (S (S (NP (PRP It)) (VP (VBD was) (VP (VBN concluded) (SBAR (IN that) (S (NP (JJ Doc_11900788_779_787_Chemical) (NNS Doc_11900788_788_797_Disease)) (VP (MD can) (VP (VB be) (VP (VBN elicited) (PP (IN by) (NP (ADJP (JJ opioid) (CC and) (JJ cholinergic)) (NNS receptors))))))))))) (, ,) (CC and) (S (NP (NP (DT the) (NN potentiation)) (PP (IN of) (NP (NP (NNS Doc_11900788_875_883_Chemical)) (VP (VBN induced) (PP (IN by) (NP (NNS Doc_11900788_895_903_Chemical))))))) (VP (MD may) (ADVP (RB also)) (VP (VB be) (VP (VBN mediated) (PP (IN through) (NP (JJ cholinergic) (NN receptor) (NNS mechanisms))))))) (. .)))
11912119	0	(ROOT (S (NP (NNP Force) (NN overflow) (CC and) (NN Doc_11912119_19_27_Chemical-induced)) (VP (VBZ dyskinesias) (PP (IN in) (NP (NNS Doc_11912119_51_70_Disease)))) (. .)))
11912119	1	(ROOT (S (NP (PRP We)) (VP (VBD assessed) (NP (NP (NN force) (NN coordination)) (PP (IN of) (NP (NP (DT the) (NN hand)) (PP (IN in) (NP (NP (NNS Doc_11912119_118_137_Disease)) (CC and) (NP (PRP$ its) (NN relationship))))))) (PP (PP (TO to) (NP (NP (NN motor) (NNS complications)) (PP (IN of) (NP (JJ Doc_11912119_185_193_Chemical) (NN therapy))))) (, ,) (RB particularly) (PP (TO to) (NP (NP (NN Doc_11912119_219_227_Chemical-induced) (NNS dyskinesias)) (PRN (-LRB- -LRB-) (NP (NNP Doc_11912119_249_252_Disease)) (-RRB- -RRB-)))))) (. .)))
11912119	2	(ROOT (S (NP (PRP We)) (VP (VBD studied) (NP (NP (CD two) (NNS groups)) (PP (IN of) (NP (JJ Doc_11912119_280_299_Disease) (NNS patients)))) (PP (PP (IN with)) (PRN (-LRB- -LRB-) (S (NP (NNS Doc_11912119_315_334_Disease)) (VP (VBZ +) (NP (NP (NNS Doc_11912119_337_340_Disease)) (, ,) (VP (VBN n) (S (VP (SYM =) (NP (CD 23)))))))) (-RRB- -RRB-)) (CC and) (PP (IN without) (NP (NP (NN Doc_11912119_362_370_Chemical-induced) (NNS dyskinesias)) (PRN (-LRB- -LRB-) (NP (NP (NNS Doc_11912119_392_411_Disease)) (: -) (NP (NP (NNS Doc_11912119_414_417_Disease)) (, ,) (NP (NP (NN n)) (SBAR (S (VP (SYM =) (NP (CD 10)))))))) (-RRB- -RRB-)) (, ,) (CC and) (NP (JJ age-matched) (JJ healthy) (NNS controls)))))) (. .)))
11912119	3	(ROOT (S (NP (NP (DT The) (NN motor) (NN score)) (PP (IN of) (NP (NP (DT the) (NNP Unified) (NNP Doc_11912119_493_512_Disease) (NNP Rating) (NNP Scale)) (, ,) (NP (DT a) (JJ Doc_11912119_529_539_Disease) (NN score)) (CC and) (NP (NP (NN force)) (PP (IN in) (NP (DT a) (JJ grip-lift) (NN paradigm))))))) (VP (VBD were) (VP (VBN assessed) (NP (NNP ON) (CC and) (NNP OFF) (NNS Doc_11912119_605_613_Chemical)))) (. .)))
11912119	4	(ROOT (S (NP (NP (DT A) (JJ pathological) (NN increase)) (PP (IN of) (NP (NNS forces)))) (VP (VBD was) (VP (VBN seen) (PP (IN in) (NP (NP (NNP ON-state)) (PP (IN in) (NP (JJ Doc_11912119_673_692_Disease) (JJ +) (NNS Doc_11912119_695_698_Disease))))) (ADVP (RB only)))) (. .)))
11912119	5	(ROOT (S (PP (IN In) (NP (JJ Doc_11912119_708_727_Disease) (JJ +) (NNS Doc_11912119_730_733_Disease))) (, ,) (NP (NP (DT the) (NN force)) (VP (VBN involved) (PP (IN in) (S (VP (VBG pressing) (PRT (RP down)) (NP (DT the) (NN object)) (PP (IN before) (NP (NN lifting)))))))) (VP (VBD was) (ADVP (RB significantly)) (VP (VBN increased) (PP (IN by) (NP (NP (NNS Doc_11912119_828_836_Chemical)) (PRN (-LRB- -LRB-) (PP (IN by) (NP (NP (CD 61) (NN %)) (, ,) (NP (NNP P) (NNP <) (NNP 0.05)))) (-RRB- -RRB-)))))) (. .)))
11912119	6	(ROOT (S (NP (NP (DT An) (NN overshooting)) (PP (IN of) (NP (NP (JJ peak) (NN grip) (NN force)) (PP (PP (IN by) (NP (NP (CD 51) (NN %)) (PRN (-LRB- -LRB-) (NP (NNP P) (NNP <) (NNP 0.05)) (-RRB- -RRB-)))) (CC and) (PP (IN of) (NP (NP (JJ static) (NN grip) (NN force)) (PP (IN by) (NP (NP (CD 45) (NN %)) (PRN (-LRB- -LRB-) (NP (NNP P) (NNP <) (NNP 0.01)) (-RRB- -RRB-)))))))))) (VP (VBD was) (VP (VBN observed) (PP (IN in) (NP (DT the) (NN ON))) (: -) (PP (VBN compared) (PP (IN with) (NP (DT the) (JJ OFF-drug) (NN condition)))))) (. .)))
11912119	7	(ROOT (S (PP (IN In) (NP (NN contrast))) (, ,) (NP (DT no) (JJ excessive) (NN force)) (VP (VBD was) (VP (VBN found) (PP (IN in) (NP (NP (NNS Doc_11912119_1060_1079_Disease)) (: -) (NP (NNS Doc_11912119_1082_1085_Disease)))))) (. .)))
11912119	8	(ROOT (S (NP (NP (NNP Peak) (NN grip) (NN force)) (PP (IN in) (NP (NNP ON-state)))) (VP (VBD was) (ADVP (ADVP (NP (NP (CD 140) (NN %)) (PRN (-LRB- -LRB-) (NP (NNP P) (NNP <) (NNP 0.05)) (-RRB- -RRB-))) (JJR higher)) (PP (IN in) (NP (NNS Doc_11912119_1145_1164_Disease)) (ADVP (NP (CD +) (NNS Doc_11912119_1167_1170_Disease)) (IN than)))) (PP (IN in) (NP (NP (NNS Doc_11912119_1179_1198_Disease)) (: -) (NP (NNS Doc_11912119_1201_1204_Disease)))) (, ,) (SBAR (IN while) (S (NP (JJ static) (NN grip) (NN force)) (VP (VBD was) (VP (VBN increased) (PP (IN by) (NP (NP (NP (CD 138) (NN %)) (PRN (-LRB- -LRB-) (NP (NNP P) (NNP <) (NNP 0.01)) (-RRB- -RRB-))) (PP (IN between) (NP (NNS groups)))))))))) (. .)))
11912119	9	(ROOT (S (NP (NP (NNP Severity)) (PP (IN of) (NP (JJ peak-dose) (NNS Doc_11912119_1301_1312_Disease)))) (VP (VBD was) (ADVP (RB strongly)) (VP (VBN correlated) (PP (IN with) (NP (NP (NN grip) (NN force)) (PP (IN in) (NP (NNP ON-state))) (PRN (-LRB- -LRB-) (VP (VBN r) (S (VP (SYM =) (NP (CD 0.79)))) (PP (IN with) (NP (NP (JJ peak) (NN force)) (, ,) (NP (NNP P) (NNP <) (NNP 0.01))))) (-RRB- -RRB-)))))) (. .)))
11912119	10	(ROOT (S (NP (DT No) (NN correlation)) (VP (VBD was) (VP (VBN observed) (PP (PP (IN between) (NP (NP (NNS forces)) (CC and) (NP (DT the) (NN motor) (NN score)))) (CONJP (RB as) (RB well) (IN as)) (PP (IN with) (NP (NP (DT the) (JJ daily) (NN dose)) (PP (IN of) (NP (JJ dopaminergic) (NN medication)))))))) (. .)))
11912119	11	(ROOT (S (NP (NNP Force) (NN excess)) (VP (VBD was) (ADVP (RB only)) (VP (VBN observed) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NNS Doc_11912119_1573_1576_Disease) (CC and) (NN motor) (NNS fluctuations))))))) (. .)))
11912119	12	(ROOT (S (NP (DT A) (JJ close) (NN relationship)) (VP (VBD was) (VP (VBN seen) (PP (IN between) (NP (NP (DT the) (NN overshooting)) (PP (IN of) (NP (NNS forces) (CC and) (NNS Doc_11912119_1670_1681_Disease))))) (PP (IN in) (NP (DT the) (JJ ON-drug) (NN condition))))) (. .)))
11912119	13	(ROOT (S (NP (PRP We)) (VP (VBP postulate) (SBAR (IN that) (S (NP (DT both) (NNS Doc_11912119_1731_1734_Disease) (CC and) (NN grip) (NN force) (NN excess)) (VP (VBP share) (NP (NP (JJ common) (JJ pathophysiological) (NNS mechanisms)) (VP (VBN related) (PP (TO to) (NP (NN motor) (NNS fluctuations))))))))) (. .)))
11999899	0	(ROOT (NP (NP (JJ Behavioral) (NNS effects)) (PP (IN of) (NP (NNS Doc_11999899_22_28_Chemical))) (PP (IN on) (NP (NN Doc_11999899_32_41_Chemical-treated) (NNS mice))) (. .)))
11999899	1	(ROOT (S (NP (NP (NP (DT The) (NNS effects)) (PP (IN of) (NP (NP (NNS Doc_11999899_71_82_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_11999899_84_90_Chemical)) (-RRB- -RRB-))))) (, ,) (NP (DT a) (NP (NP (JJ noncompetitive) (NNS Doc_11999899_110_130_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_11999899_132_136_Chemical)) (-RRB- -RRB-))) (NN receptor) (NN antagonist)) (, ,)) (VP (VBD were) (VP (VBN studied) (PP (IN on) (NP (NP (NN Doc_11999899_175_183_Chemical-related) (NNS behaviors)) (VP (VBN induced) (PP (IN by) (NP (JJ Doc_11999899_213_222_Chemical) (NNS treatments)))))))) (. .)))
11999899	2	(ROOT (S (NP (DT This) (NN study)) (VP (VBZ focuses) (PP (IN on) (NP (NP (JJ behavioral) (NNS syndromes)) (SBAR (WHNP (WDT that)) (S (VP (MD may) (VP (VBN used) (PP (IN as) (NP (NP (NP (NNS models)) (PP (IN for) (NP (NP (NNS Doc_11999899_306_325_Disease)) (, ,) (CC or) (NP (NNS Doc_11999899_330_348_Disease)) (, ,)))) (CC and) (NP (NP (PRP$ its) (NN response)) (PP (IN after) (NP (JJ glutamatergic) (NN blockage))))))))))))) (. .)))
11999899	3	(ROOT (S (NP (NP (NP (NNP Doc_11999899_397_406_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 1) (NN mg/kg)) (-RRB- -RRB-))) (, ,) (VP (VBN administered) (ADVP (RB once) (NP (DT every) (JJ other) (NN day))) (PP (IN for) (NP (CD 4) (NNS days)))) (, ,)) (VP (VBD produced) (NP (NNS increases)) (PP (IN in) (NP (NP (NNS Doc_11999899_486_506_Disease)) (, ,) (NP (NN tongue) (NN protrusion)) (CC and) (NP (NNS vacuous)))) (S (VP (VBG chewing) (PP (IN in) (NP (NP (NNS mice)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP are) (NP (NP (NNS signs)) (ADJP (JJ indicative)) (PP (IN of) (NP (NNS Doc_11999899_585_603_Disease)))))))))))) (. .)))
11999899	4	(ROOT (S (NP (NNP Doc_11999899_605_614_Chemical)) (ADVP (RB also)) (VP (VBD produced) (NP (NP (NNS Doc_11999899_629_635_Disease) (CC and) (NNS Doc_11999899_640_649_Disease)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP are) (NP (NP (NNS signs) (NN suggestive)) (PP (IN of) (NP (NNS Doc_11999899_681_700_Disease))))))))) (. .)))
11999899	5	(ROOT (S (NP (NP (NP (NNP Doc_11999899_702_708_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 0.1) (NN mg/kg)) (-RRB- -RRB-))) (, ,) (VP (VBN administered) (NP (CD 30) (NN min)) (PP (IN before) (NP (DT the) (NN observation) (NN test)))) (, ,)) (VP (VBD prevented) (NP (NP (DT the) (JJ vacuous) (VBG chewing) (NNS movements)) (, ,) (NP (NN tongue) (NNS protrusions)) (CC and) (NP (NP (NNS Doc_11999899_835_844_Disease)) (VP (VBN induced) (PP (IN by) (NP (NNS Doc_11999899_856_865_Chemical))))))) (. .)))
11999899	6	(ROOT (S (ADVP (RB However)) (, ,) (NP (JJ Doc_11999899_876_882_Chemical) (NN injection)) (VP (VBD produced) (NP (NP (DT a) (JJ significant) (NN increase)) (PP (IN of) (NP (NNS Doc_11999899_928_934_Disease)))) (PP (IN in) (NP (NN Doc_11999899_938_947_Chemical-treated) (NNS mice)))) (. .)))
11999899	7	(ROOT (S (NP (NP (NP (NNP Doc_11999899_962_971_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 1) (NN mg/kg)) (-RRB- -RRB-))) (, ,) (VP (VP (VBN administered) (NP (CD 90) (NN min)) (PP (IN before) (NP (DT the) (NN test)))) (CC and) (VP (VBN followed) (PP (IN by) (NP (NP (JJ Doc_11999899_1035_1045_Chemical) (NN injection)) (PRN (-LRB- -LRB-) (NP (CD 0.1) (NN mg/kg)) (-RRB- -RRB-))))) (NP (CD 5) (NN min)) (PP (IN before) (NP (DT the) (NN test)))) (, ,)) (VP (VBD did) (RB not) (VP (VB produce) (NP (NNS Doc_11999899_1107_1122_Disease)) (PP (IN in) (NP (NNS mice))))) (. .)))
11999899	8	(ROOT (S (PP (IN On) (NP (DT the) (JJ other) (NN hand))) (, ,) (NP (NNS Doc_11999899_1151_1160_Chemical)) (VP (VBN induced) (NP (NP (NNS increases)) (PP (IN in) (NP (NNS Doc_11999899_1182_1188_Disease) (CC and) (NNS Doc_11999899_1193_1202_Disease)))) (PP (VBN compared) (PP (TO to) (NP (NN control) (NNS mice))))) (. .)))
11999899	9	(ROOT (S (NP (ADJP (ADJP (JJ Doc_11999899_1229_1235_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 0.1) (NN mg/kg)) (-RRB- -RRB-))) (NN administration)) (VP (VBD attenuated) (NP (NP (DT the) (NNS Doc_11999899_1278_1287_Disease) (CC and) (NNS Doc_11999899_1292_1298_Disease)) (VP (VBN induced) (PP (IN by) (NP (NNS Doc_11999899_1310_1319_Chemical)))))) (. .)))
11999899	10	(ROOT (S (NP (NP (NNP Pretreatment)) (PP (IN with) (NP (NP (JJ Doc_11999899_1339_1348_Chemical) (PRN (-LRB- -LRB-) (NP (CD 1) (NN mg/kg)) (-RRB- -RRB-)) (ADJP (ADJP (CD 24) (JJ h)) (SBAR (IN before) (S (NP (DT the) (NN observation) (NN test)) (VP (VBD produced) (NP (NNS increases)) (PP (IN in) (NP (NP (NNS vacuous) (VBG chewing) (NNS movements)) (CC and) (NP (NN tongue)))))))) (NN protrusion)) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (NP (NNS increases)) (PP (IN in) (NP (NP (NNS Doc_11999899_1487_1493_Disease) (CC and) (NNS Doc_11999899_1498_1507_Disease)) (, ,) (SBAR (IN whereas) (S (NP (NP (NNS Doc_11999899_1517_1523_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 0.1) (NN mg/kg)) (-RRB- -RRB-))) (VP (VBD injection) (NP (CD 90) (NN min)) (PP (IN before) (NP (DT the) (NN test)))))))))))) (VP (VBD reversed) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NNS Doc_11999899_1593_1602_Chemical))))) (. .)))
11999899	11	(ROOT (S (NP (DT These) (NNS results)) (VP (VBP show) (SBAR (IN that) (S (NP (NNS Doc_11999899_1628_1637_Chemical)) (VP (VBZ produces) (ADJP (JJ different) (CC and) (JJ Doc_11999899_1661_1679_Disease)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VP (VBP are) (ADJP (VBN related) (PP (TO to) (NP (NP (NN dose) (CC and) (NN schedule)) (VP (VBN employed)))))) (CC and) (VP (MD can) (VP (VB be) (VP (VBN considered) (PP (IN as) (NP (NP (NNS Doc_11999899_1754_1766_Disease-like)) (CC and) (NP (JJ Doc_11999899_1776_1794_Disease) (NNS signs)))))))))))))) (. .)))
11999899	12	(ROOT (S (NP (NP (DT The) (JJ glutamatergic) (NN blockage)) (VP (VBN produced) (PP (IN by) (NP (NNS Doc_11999899_1841_1845_Chemical))))) (VP (MD can) (VP (VB restore) (NP (NP (DT these) (NNS signs)) (, ,) (PP (JJ such) (IN as) (NP (NP (NNS vacuous)) (VP (VBG chewing) (NP (NP (NNS movements)) (, ,) (NP (NN tongue) (NNS protrusions)) (, ,) (NP (NNS Doc_11999899_1926_1935_Disease)) (CC and) (NP (NNS Doc_11999899_1940_1946_Disease))) (PP (VBG according) (PP (TO to) (NP (DT the) (JJ employed) (NN model)))))))))) (. .)))
12013711	0	(ROOT (NP (NP (JJ Doc_12013711_0_11_Chemical-associated) (, ,) (JJ benign) (JJ transient) (NNS Doc_12013711_41_60_Disease)) (PP (IN in) (NP (JJ Doc_12013711_64_77_Disease) (NNS patients))) (PP (IN with) (NP (NP (DT a) (JJ past) (NN history)) (PP (IN of) (NP (NNP LSD) (NN abuse))))) (. .)))
12013711	1	(ROOT (S (NP (NP (CD Two) (JJ Doc_12013711_125_138_Disease) (NNS patients)) (, ,) (SBAR (SBAR (WHNP (WP who)) (S (VP (VBD had) (NP (NP (DT a) (JJ prior) (NN history)) (PP (IN of) (NP (NNP LSD) (NN abuse))))))) (CC and) (SBAR (WHNP (WP who)) (S (VP (VBD had) (ADVP (RB previously)) (VP (VBN developed) (NP (NNS Doc_12013711_219_222_Disease)) (PP (IN with) (NP (JJ classic) (NNS antipsychotics)))))))) (, ,)) (VP (VBD were) (ADVP (RB successfully)) (VP (VBN treated) (PP (IN with) (NP (NNS Doc_12013711_283_294_Chemical))))) (. .)))
12013711	2	(ROOT (S (NP (PRP They)) (DT both) (VP (VBD reported) (NP (NP (JJ short) (NNS episodes)) (PP (IN of) (NP (NP (JJ transient) (NNS Doc_12013711_343_362_Disease)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD appeared) (ADVP (RB immediately)) (PP (IN after) (S (VP (VBG starting) (NP (NN treatment)) (PP (IN with) (NP (NNS Doc_12013711_421_432_Chemical))))))))))))) (. .)))
12013711	3	(ROOT (S (NP (DT This) (NN imagery)) (VP (VBD resembled) (S (NP (NNS Doc_12013711_457_476_Disease)) (ADJP (RB previously) (JJ experienced) (PP (IN as) (NP (NP (`` ``) (NNS flashbacks) ('' '')) (VP (VBN related) (PP (TO to) (NP (JJ prior) (NNP LSD) (NN consumption))))))))) (. .)))
12013711	4	(ROOT (S (S (NP (JJ Doc_12013711_550_561_Chemical) (NN administration)) (VP (VBD was) (VP (VBN continued)))) (CC and) (S (NP (DT the) (NNS Doc_12013711_599_618_Disease)) (ADVP (RB gradually)) (VP (VBD wore) (PRT (RP off)))) (. .)))
12013711	5	(ROOT (S (PP (IN During) (NP (DT a) (JJ six-month) (NN follow-up) (NN period))) (, ,) (NP (EX there)) (VP (VBD was) (NP (NP (DT no) (NN recurrence)) (PP (IN of) (NP (NNS Doc_12013711_703_722_Disease))))) (. .)))
12013711	6	(ROOT (S (NP (DT This) (NN phenomenon)) (VP (MD may) (VP (VB be) (VP (VBN interpreted) (PP (IN as) (NP (NP (DT a) (ADJP (JJ benign) (, ,) (JJ short-term) (CC and) (JJ self-limiting)) (NN side) (NN effect)) (SBAR (WHNP (WDT which)) (S (VP (VBZ does) (RB not) (VP (VP (VB contraindicate) (NP (NP (DT the) (NN use)) (PP (IN of) (NP (NNS Doc_12013711_854_865_Chemical))))) (CC or) (VP (VB interfere) (PP (IN with) (NP (NN treatment))))))))))))) (. .)))
12013711	7	(ROOT (S (NP (NP (NNS Conclusions)) (PP (VBN based) (PP (IN on) (NP (CD two) (NN case) (NNS reports))))) (VP (MD should) (VP (VB be) (VP (VBN taken) (PP (IN with) (NP (JJ appropriate) (NN caution)))))) (. .)))
12042105	0	(ROOT (NP (CD Doc_12042105_0_10_Chemical-induced) (NNS Doc_12042105_19_34_Disease) (. .)))
12042105	1	(ROOT (S (NP (NNP Doc_12042105_36_46_Chemical)) (VP (VBZ is) (NP (NP (DT a) (ADJP (RB recently) (VBN developed)) (JJ antiepileptic) (NN medication)) (SBAR (WHNP (WDT that)) (S (VP (VBZ is) (VP (VBG becoming) (NP (NP (JJR more)) (VP (ADVP (RB widely)) (VBN prescribed) (PP (RB because) (IN of) (NP (NP (PRP$ its) (NN efficacy)) (PP (IN in) (S (VP (VBG treating) (NP (NNS Doc_12042105_172_191_Disease))))))))))))))) (. .)))
12042105	2	(ROOT (S (NP (NNS Urologists)) (VP (MD should) (VP (VB be) (ADJP (JJ aware)) (SBAR (IN that) (S (NP (DT this) (NN medication)) (VP (MD can) (VP (VB cause) (NP (NNS Doc_12042105_251_269_Disease)) (PP (IN in) (NP (NP (NNS patients)) (ADJP (JJ secondary) (PP (TO to) (NP (NP (NN inhibition)) (PP (IN of) (NP (JJ carbonic) (NN anhydrase)))))))))))))) (. .)))
12042105	3	(ROOT (S (PP (IN In) (NP (NN addition))) (PRN (, ,) (S (S (NP (DT a) (JJ distal) (JJ tubular) (NN acidification) (NN defect)) (VP (MD may) (VP (VB result)))) (, ,) (ADVP (RB thus)) (S (VP (VBG impairing) (NP (NP (DT the) (ADJP (JJ normal) (JJ compensatory)) (NN drop)) (PP (IN in) (NP (NN urine) (NN pH.)))))))) (NP (DT These) (NNS factors)) (VP (MD can) (VP (VB lead) (PP (TO to) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (JJ Doc_12042105_494_511_Chemical) (NNS Doc_12042105_512_527_Disease))))))) (. .)))
12042105	4	(ROOT (S (NP (PRP We)) (VP (VBP report) (NP (NP (DT the) (JJ first) (CD two) (NNS cases)) (PP (IN of) (NP (NP (NN Doc_12042105_562_572_Chemical-induced) (NNS Doc_12042105_581_596_Disease)) (PP (IN in) (NP (DT the) (JJ urologic) (NN literature))))))) (. .)))
12091028	0	(ROOT (S (VP (VB Doc_12091028_0_8_Chemical) (PP (IN in) (NP (NP (JJ war/tropical) (NN surgery)) (PRN (-LRB- -LRB-) (NP (NP (DT a) (JJ final) (NN tribute)) (PP (TO to) (NP (DT the) (JJ racemic) (NN mixture)))) (-RRB- -RRB-))))) (. .)))
12091028	1	(ROOT (S (NP (NP (DT A) (NN technique)) (PP (IN of) (NP (NP (JJ continuous) (JJ intravenous) (NN anaesthesia)) (PP (IN with) (NP (NNS Doc_12091028_130_138_Chemical)))))) (VP (VBD was) (VP (VBN used) (ADVP (RB successfully)) (PP (PP (IN during) (NP (NP (DT the) (NNP Somalia) (JJ civil) (NN war)) (PP (IN in) (NP (CD 1994))))) (CC and) (PP (IN in) (NP (NP (NNP north) (NNP Uganda)) (PP (IN in) (NP (CD 1999)))))) (PP (IN for) (NP (NP (CD 64) (NNS operations)) (PP (IN in) (NP (CD 62) (NNS patients))))) (, ,) (VP (VBN aged) (PP (IN from) (NP (CD 6) (NNS weeks))) (PP (TO to) (NP (CD 70) (NNS years)))) (, ,) (S (VP (VBG undergoing) (NP (NP (NN limb) (CC and) (NN abdominal) (NN surgery)) (PP (VBG including) (NP (NP (NN caesarian) (NNS sections) (CC and) (NNS interventions)) (PP (IN in) (NP (NNS neonates)))))))))) (. .)))
12091028	2	(ROOT (S (NP (NP (NNP Operations)) (VP (VBG lasting) (PRT (RP up)) (PP (TO to) (NP (CD 2h))))) (VP (MD could) (VP (VB be) (VP (VBN performed) (PP (IN in) (NP (NP (DT the) (NN absence)) (PP (IN of) (NP (NP (JJ sophisticated) (NN equipment)) (PP (JJ such) (IN as) (NP (NN pulse) (NNS oximeters) (CC or) (NNS ventilators))))))) (PP (IN in) (S (NP (NP (NNS patients)) (PP (IN on) (NP (JJ spontaneous) (NN ventilation)))) (VP (VBG breathing) (NP (JJ air/Doc) (JJ _) (NNS 12091028_570_576_Chemical)) (ADVP (RB only)))))))) (. .)))
12091028	3	(ROOT (S (PP (IN After) (NP (NP (NP (NN premedication)) (PP (IN with) (NP (NP (NNS Doc_12091028_608_616_Chemical)) (, ,) (NP (NNS Doc_12091028_618_632_Chemical)) (CC and) (NP (JJ local) (NN anaesthesia))))) (, ,) (CC and) (NP (NP (NN induction)) (PP (IN with) (NP (NP (JJ standard) (NNS doses)) (PP (IN of) (NP (NNS Doc_12091028_693_701_Chemical)))))))) (, ,) (NP (NP (DT a) (NN maintenance) (NN dose)) (PP (IN of) (NP (NP (CD 10-20) (NN microg/kg/min)) (PP (IN of) (NP (NNS Doc_12091028_748_756_Chemical)))))) (VP (VBD proved) (ADJP (JJ safe) (CC and) (JJ effective))) (. .)))
12091028	4	(ROOT (S (NP (NNS Emphasis)) (VP (VBD was) (VP (VBN placed) (PP (IN on) (NP (JJ bedside) (JJ clinical) (NN monitoring))) (, ,) (S (VP (VBG relying) (ADVP (RB heavily)) (PP (IN on) (NP (DT the) (NN heart) (NN rate))))))) (. .)))
12091028	5	(ROOT (S (NP (NNP Doc_12091028_871_879_Chemical)) (VP (VP (PRN (, ,) (SBAR (IN unless) (FRAG (ADJP (JJ contraindicated) (CC or) (JJ risky)))) (, ,)) (VBZ remains) (NP (NP (DT the) (ADJP (RB only) (JJ necessary)) (JJ complementary) (NN drug)) (PP (TO to) (NP (NP (NNS Doc_12091028_963_971_Chemical)) (SBAR (IN as) (S (NP (PRP it)) (VP (VBZ buffers) (NP (PRP$ its) (JJ cardiovascular) (NN response))))))))) (CC and) (VP (VBZ decreases) (NP (NP (DT the) (NN duration) (CC and) (NN intensity)) (PP (IN of) (NP (JJ operative) (CC and) (JJ postoperative) (NNS Doc_12091028_1086_1100_Disease)))))) (. .)))
12091028	6	(ROOT (S (NP (JJ Local) (JJ anaesthetic) (NNS blocks)) (VP (VBD were) (ADJP (JJ useful) (PP (IN in) (S (VP (VBG decreasing) (NP (NP (DT the) (NN requirement)) (PP (IN for) (NP (JJ postoperative) (NNS Doc_12091028_1187_1196_Disease))))))))) (. .)))
12091028	7	(ROOT (S (NP (DT An) (NN antisialogue)) (VP (VBD was) (ADVP (RB usually)) (ADJP (JJ unnecessary)) (PP (IN in) (NP (NP (NNS operations)) (VP (VBG lasting) (PRT (RP up)) (PP (TO to) (NP (QP (CD 2) (CD h)))) (, ,) (S (NP (NNS Doc_12091028_1271_1285_Chemical)) (VP (VBG being) (NP (NP (DT the) (JJS best) (NN choice)) (PP (PP (IN for) (NP (NP (PRP$ its) (JJS lowest) (NN psychotropic)) (CC and) (NP (JJ chronotropic) (NNS effects)))) (, ,) (RB especially) (PP (IN in) (NP (DT a) (JJ hot) (NN climate))))))))))) (. .)))
12091028	8	(ROOT (S (NP (NP (NN Experience)) (PP (IN in) (NP (JJ war/tropical) (NNS settings)))) (VP (VBZ suggests) (SBAR (S (NP (DT this) (NN technique)) (VP (MD could) (VP (VB be) (ADJP (JJ useful)) (PP (PP (IN in) (NP (NP (JJ civilian) (NNS contexts)) (PP (JJ such) (IN as) (NP (JJ outdoor) (JJ life-saving) (NN emergency) (NN surgery))))) (CC or) (PP (IN in) (NP (JJ mass) (NNS casualties)))) (SBAR (WHADVP (WRB where)) (, ,) (S (NP (NP (NNP e.g.) (NNP amputation)) (CC and) (NP (JJ rapid) (NN extrication))) (VP (VBD were) (VP (VBN required)))))))))) (. .)))
12093990	0	(ROOT (S (NP (NNS Intravenous)) (VP (VBD Doc_12093990_12_21_Chemical) (NP (NN treatment)) (PP (IN for) (NP (JJ severe) (NNS Doc_12093990_43_61_Disease))) (PP (IN in) (NP (JJ immunocompromised) (NNS children)))) (. .)))
12093990	1	(ROOT (S (NP (NNS Adenovirus)) (VP (VBZ is) (NP (NP (DT an) (JJ important) (NN cause)) (PP (IN of) (NP (NN morbidity) (CC and) (NN mortality))) (PP (IN in) (NP (DT the) (JJ immunocompromised) (NN host))))) (. .)))
12093990	2	(ROOT (S (NP (NP (DT The) (NN incidence)) (PP (IN of) (NP (NP (JJ severe) (NNS Doc_12093990_220_238_Disease)) (PP (IN in) (NP (NNS pediatrics)))))) (VP (VBZ is) (VP (VBG increasing) (PP (IN in) (NP (NN association))) (PP (IN with) (NP (NP (VBG growing) (NNS numbers)) (PP (IN of) (NP (NP (JJ immunocompromised) (NNS children)) (, ,) (SBAR (WHADVP (WRB where)) (S (NP (NN case) (NN fatality) (NNS rates)) (ADVP (ADVP (RB as) (JJ high)) (PP (IN as) (NP (QP (CD 50) (NN %) (TO to) (CD 80) (NN %))))) (VP (VBP have) (VP (VBN been) (VP (VBN reported)))))))))))) (. .)))
12093990	3	(ROOT (SINV (S (NP (EX There)) (VP (VP (VBP are) (NP (NP (DT no) (JJ approved) (JJ antiviral) (NNS agents)) (PP (IN with) (NP (NP (JJ proven) (NN efficacy)) (PP (IN for) (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (JJ severe) (NNS Doc_12093990_490_508_Disease))))))))) (, ,) (CC nor) (VP (VBP are) (ADVP (RB there)) (NP (DT any) (JJ prospective) (NN randomized))))) (, ,) (VP (VBD controlled)) (NP (NP (NNS trials)) (PP (IN of) (NP (ADJP (RB potentially) (JJ useful)) (JJ anti-adenovirus) (NNS therapies)))) (. .)))
12093990	4	(ROOT (S (NP (NP (JJ Apparent) (JJ clinical) (NN success)) (PP (IN in) (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (JJ severe) (NNS Doc_12093990_672_690_Disease)))))) (VP (VBZ is) (VP (VBN limited) (PP (TO to) (NP (NP (DT a) (JJ few) (NN case) (NNS reports)) (CC and) (NP (JJ small) (NN series)))))) (. .)))
12093990	5	(ROOT (S (NP (NN Experience)) (VP (VBZ is) (NP (NP (JJS greatest)) (PP (IN with) (NP (JJ intravenous) (NNS Doc_12093990_782_791_Chemical) (CC and) (NNS Doc_12093990_796_805_Chemical))))) (. .)))
12093990	6	(ROOT (S (NP (NP (NNP Doc_12093990_807_816_Chemical)) (, ,) (NP (DT a) (JJ Doc_12093990_820_829_Chemical) (NN analogue)) (, ,)) (VP (VBZ has) (NP (NP (JJ broad) (JJ antiviral) (NN activity)) (PP (IN against) (NP (DT both) (NNP RNA) (CC and) (NNP DNA) (NNS viruses))) (, ,) (PP (VBG including) (NP (NP (VBN documented) (NN activity)) (PP (IN against) (NP (NP (NNS adenovirus)) (PP (IN in) (NP (NNP vitro))))))))) (. .)))
12093990	7	(ROOT (S (NP (NNP Doc_12093990_962_971_Chemical)) (VP (VBZ is) (VP (VBN licensed) (PP (PP (IN in) (NP (NP (JJ aerosol) (NN form)) (PP (IN for) (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (NNS Doc_12093990_1021_1058_Disease))))))) (, ,) (CC and) (ADVP (RB orally)) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (NN interferon)))))) (S (VP (TO to) (VP (VB treat) (SBAR (S (NP (NNP Doc_12093990_1111_1122_Disease) (. .) (NNPS Intravenous) (NNP Doc_12093990_1136_1145_Chemical)) (VP (VBZ is) (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (NP (NN choice)) (PP (IN for) (NP (NNS Doc_12093990_1177_1217_Disease)))))))))))))) (. .)))
12093990	8	(ROOT (S (NP (NP (DT The) (ADJP (RBS most) (JJ common)) (JJ adverse) (NN effect)) (PP (IN of) (NP (JJ intravenous) (NNS Doc_12093990_1265_1274_Chemical)))) (VP (VBZ is) (NP (JJ reversible) (JJ mild) (NNS Doc_12093990_1294_1300_Disease))) (. .)))
12093990	9	(ROOT (S (NP (NP (DT The) (NN use)) (PP (IN of) (NP (NP (NNS Doc_12093990_1313_1322_Chemical)) (PP (IN in) (NP (JJ severe) (NNS Doc_12093990_1333_1353_Disease)))))) (VP (VBZ has) (VP (VBN been) (VP (VBN limited) (PP (IN by) (NP (NP (JJ adverse) (NNS effects)) (, ,) (SBAR (WHNP (NP (DT the) (RBS most) (JJ significant)) (WHPP (IN of) (WHNP (WDT which)))) (S (VP (VBZ is) (ADJP (JJ nephrotoxicity)))))))))) (. .)))
12093990	10	(ROOT (S (NP (PRP We)) (VP (VP (VB report) (NP (PRP$ our) (NN experience)) (PP (IN with) (NP (NP (JJ intravenous) (JJ Doc_12093990_1493_1502_Chemical) (NN therapy)) (PP (IN for) (NP (JJ severe) (NNS Doc_12093990_1522_1540_Disease))))) (PP (IN in) (NP (NP (DT a) (NN series)) (PP (IN of) (NP (JJ immunocompromised) (NNS children)))))) (CC and) (VP (VB review) (NP (DT the) (NN literature)))) (. .)))
12093990	11	(ROOT (FRAG (NP (NNP DESIGN/METHODS)) (: :) (S (NP (PRP We)) (VP (ADVP (RB retrospectively)) (VBN reviewed) (NP (NP (DT the) (JJ medical) (NNS records)) (PP (IN of) (NP (NP (CD 5) (NNS children)) (VP (VBN treated) (PP (IN with) (NP (NP (JJ intravenous) (NNS Doc_12093990_1713_1722_Chemical)) (PP (IN for) (NP (VBN documented) (JJ severe) (NNS Doc_12093990_1745_1763_Disease))))))))))) (. .)))
12093990	12	(ROOT (S (NP (CD Two) (NNS patients)) (VP (VBD developed) (NP (JJ adenovirus) (NNS Doc_12093990_1799_1819_Disease)) (PP (IN after) (NP (JJ cardiac) (CC and) (NN bone) (NN marrow) (NNS transplants))) (, ,) (ADVP (RB respectively))) (. .)))
12093990	13	(ROOT (S (NP (DT The) (NN bone) (NN marrow) (NN transplant) (NN patient)) (ADVP (RB also)) (VP (VBD received) (NP (JJ intravenous) (NNS Doc_12093990_1938_1947_Chemical)) (PP (IN for) (NP (JJ progressive) (JJ disseminated) (NN disease)))) (. .)))
12093990	14	(ROOT (S (S (NP (DT An) (JJ additional) (CD 3) (NNS children)) (VP (VBD developed) (NP (NNS Doc_12093990_2021_2041_Disease)))) (: ;) (S (NP (CD 2)) (VP (VBD were) (NP (NP (NNS neonates)) (, ,) (SBAR (WHNP (NP (CD 1)) (WHPP (IN of) (WHNP (WP whom)))) (S (VP (VBD had) (NP (JJ partial) (NNS Doc_12093990_2082_2099_Disease)))))))) (. .)))
12093990	15	(ROOT (S (NP (DT The) (VBG remaining) (NN infant)) (VP (VBD had) (ADVP (RB recently)) (VP (VBN undergone) (NP (DT a) (JJ cardiac) (NN transplant)))) (. .)))
12093990	16	(ROOT (S (NP (JJ Intravenous) (NNS Doc_12093990_2179_2188_Chemical)) (VP (VBD was) (VP (VBN administered) (PP (IN on) (NP (DT a) (JJ compassionate-use) (NN protocol))))) (. .)))
12093990	17	(ROOT (S (S (NP (NP (JJ Complete) (JJ clinical) (NN recovery)) (VP (VBN followed) (ADVP (RB later)) (PP (IN by) (NP (JJ viral) (NN clearance))))) (VP (VBD was) (VP (VBN observed) (PP (IN in) (NP (CD 2) (NNS children)))))) (: :) (S (NP (DT the) (JJ cardiac) (NN transplant)) (VP (VBD recipient) (PP (IN with) (NP (NP (JJ adenovirus) (NNS Doc_12093990_2386_2406_Disease)) (CC and) (NP (DT the) (JJ immunocompetent) (NN neonate)))) (PP (IN with) (NP (NNS Doc_12093990_2444_2464_Disease))))) (. .)))
12093990	18	(ROOT (S (NP (DT The) (VBG remaining) (CD 3) (NNS children)) (VP (VBD died) (PP (IN of) (NP (NNS Doc_12093990_2499_2517_Disease)))) (. .)))
12093990	19	(ROOT (S (NP (JJ Intravenous) (JJ Doc_12093990_2531_2540_Chemical) (NN therapy)) (VP (VBD was) (ADJP (RB well) (JJ tolerated))) (. .)))
12093990	20	(ROOT (S (NP (NP (NN Use)) (PP (IN of) (NP (NP (NNS Doc_12093990_2576_2585_Chemical)) (PP (IN in) (NP (CD 1) (NN child)))))) (VP (VBD was) (VP (VBN associated) (PP (IN with) (NP (NNS Doc_12093990_2617_2642_Disease) (CC and) (NNS Doc_12093990_2647_2658_Disease))))) (. .)))
12093990	21	(ROOT (S (NP (NP (PRP$ Our) (NN series)) (PP (IN of) (NP (NNS patients)))) (VP (VBZ is) (NP (NP (NN representative)) (PP (IN of) (NP (NP (DT the) (NN spectrum)) (PP (IN of) (NP (NP (JJ immunocompromised) (NNS children)) (PP (IN at) (NP (JJS greatest) (NN risk))))))) (PP (IN for) (NP (JJ severe) (NNS Doc_12093990_2787_2805_Disease))) (, ,) (NP (RB namely) (JJ solid-organ) (CC and) (NN bone) (NN marrow) (NN transplant) (NNS recipients)) (, ,) (NP (NNS neonates)) (, ,) (CC and) (NP (NP (NNS children)) (PP (IN with) (NP (NNS Doc_12093990_2893_2909_Disease)))))) (. .)))
12093990	22	(ROOT (S (SBAR (IN Although) (S (NP (JJ intravenous) (NNS Doc_12093990_2932_2941_Chemical)) (VP (VBD was) (RB not) (ADJP (JJ effective) (PP (IN for) (NP (DT all) (NNS children)))) (PP (PP (IN with) (NP (NP (JJ severe) (NNS Doc_12093990_2989_3007_Disease)) (PP (IN in) (NP (DT this) (NN series))))) (CC or) (PP (IN in) (NP (DT the) (NN literature))))))) (, ,) (NP (NN therapy)) (VP (VBZ is) (ADJP (JJ unlikely) (S (VP (TO to) (VP (VB be) (PP (IN of) (NP (NN benefit))) (SBAR (IN if) (S (VP (VBN begun) (ADVP (RB late)) (PP (IN in) (NP (NP (DT the) (NN course)) (PP (IN of) (NP (DT the) (NNS Doc_12093990_3117_3126_Disease))))))))))))) (. .)))
12093990	23	(ROOT (S (NP (NP (RB Early) (NN identification)) (, ,) (VP (VBN eg) (PP (IN by) (NP (NP (NN polymerase) (NN chain) (NN reaction)) (PP (IN of) (NP (DT those) (NNS patients))))) (PP (IN at) (NP (NP (NN risk)) (PP (IN of) (NP (JJ disseminated) (NNS Doc_12093990_3224_3242_Disease))))))) (VP (MD may) (VP (VB permit) (NP (RBR earlier) (JJ antiviral) (NN treatment)) (CC and) (NP (NP (JJR better) (NN evaluation)) (PP (IN of) (NP (JJ therapeutic) (NN response)))))) (. .)))
12093990	24	(ROOT (S (NP (NP (CD Two)) (PP (IN of) (NP (NP (CD 5) (NNS children)) (PP (IN with) (NP (NP (JJ severe) (NNS Doc_12093990_3372_3390_Disease)) (VP (VBN treated) (PP (IN with) (NP (JJ intravenous) (NNS Doc_12093990_3416_3425_Chemical))))))))) (VP (VBD recovered)) (. .)))
12093990	25	(ROOT (S (NP (NP (DT The) (NN availability)) (PP (IN of) (NP (ADJP (JJR newer) (JJ rapid)) (JJ diagnostic) (NNS techniques))) (, ,) (PP (JJ such) (IN as) (NP (NN polymerase) (NN chain) (NN reaction))) (, ,)) (VP (MD may) (VP (VB make) (S (NP (NP (JJR earlier)) (, ,) (NP (NP (ADJP (RBR more) (JJ effective)) (NN treatment)) (PP (IN of) (NP (NNS Doc_12093990_3573_3593_Disease))))) (ADJP (JJ possible))))) (. .)))
12093990	26	(ROOT (S (PP (VBN Given) (NP (NP (DT the) (NN seriousness) (CC and) (VBG increasing) (NN prevalence)) (PP (IN of) (NP (NP (NNS Doc_12093990_3655_3673_Disease)) (PP (IN in) (NP (JJ certain) (NNS hosts))))))) (, ,) (NP (NP (RB especially) (NNS children)) (, ,) (NP (NP (DT a) (JJ large) (, ,) (JJ multicenter) (JJ clinical) (NN trial)) (PP (IN of) (NP (ADJP (RB potentially) (JJ useful)) (JJ anti-adenoviral) (NNS therapies))) (, ,) (PP (JJ such) (IN as) (NP (JJ intravenous) (NNS Doc_12093990_3818_3827_Chemical)))) (, ,)) (VP (VBZ is) (ADVP (RB clearly)) (VP (VBN required) (S (VP (TO to) (VP (VB demonstrate) (NP (DT the) (ADJP (ADJP (RBS most) (JJ effective)) (CC and) (ADJP (RBS least) (JJ toxic))) (NN therapy))))))) (. .)))
12101159	0	(ROOT (NP (NP (NP (JJ Delayed) (JJ Doc_12101159_8_17_Disease) (NNS Doc_12101159_18_32_Disease)) (PP (IN after) (NP (JJ Doc_12101159_39_48_Chemical) (NNS Doc_12101159_49_57_Disease)))) (: ;) (NP (NP (NN resuscitation)) (PP (IN with) (NP (JJ high) (NN dose) (NN intravenous) (NNS Doc_12101159_100_107_Chemical)))) (. .)))
12101159	1	(ROOT (S (NP (DT A) (ADJP (CD 51) (NN year) (JJ old)) (NN man)) (VP (VBD took) (NP (NP (DT a) (JJ mixed) (NNS Doc_12101159_140_148_Disease)) (PP (VBG including) (NP (NP (CD 1.8-3) (CD .6) (NN g)) (PP (IN of) (NP (NNS Doc_12101159_172_181_Chemical) (, ,) (NNS Doc_12101159_183_194_Chemical) (, ,) (NNS Doc_12101159_196_203_Chemical) (, ,) (NNS Doc_12101159_205_223_Chemical) (, ,) (CC and) (NNS Doc_12101159_229_236_Chemical))))))) (. .)))
12101159	2	(ROOT (S (NP (PRP He)) (ADVP (RB initially)) (VP (VP (VBD presented) (PP (TO to) (NP (NN hospital))) (PP (IN after) (NP (NP (CD six) (NNS hours)) (PP (IN with) (NP (JJ mild) (NNS Doc_12101159_299_310_Disease)))))) (CC and) (VP (VBD was) (VP (VBN treated) (PP (IN with) (NP (NP (VBN activated) (NN charcoal)) (CC and) (NP (JJ intravenous) (NNS fluids))))))) (. .)))
12101159	3	(ROOT (S (PP (NP (CD Eighteen) (NNS hours)) (IN after) (NP (DT the) (NNS Doc_12101159_400_408_Disease))) (NP (PRP he)) (VP (VBD had) (NP (CD two) (JJ generalised) (NNS Doc_12101159_432_453_Disease))) (. .)))
12101159	4	(ROOT (S (NP (DT The) (NN patient)) (VP (VP (VBD remained) (ADJP (JJ unresponsive)) (PP (IN with) (NP (NP (JJ junctional) (NNS Doc_12101159_505_516_Disease)) (, ,) (NP (JJ unrecordable) (NN blood) (NN pressure)) (, ,)))) (CC and) (VP (ADVP (RB then)) (VBD became) (NP (NNS Doc_12101159_563_572_Disease)))) (. .)))
12101159	5	(ROOT (S (NP (PRP He)) (VP (VBD was) (VP (VBN resuscitated) (PP (IN with) (NP (NP (NP (JJ high) (NN dose)) (PRN (-LRB- -LRB-) (NP (QP (CD 13.5) (CD g))) (-RRB- -RRB-))) (NP (NP (JJ intravenous) (NNS Doc_12101159_630_637_Chemical) (CC and) (NNS Doc_12101159_642_652_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_12101159_654_665_Chemical)) (-RRB- -RRB-))))))) (. .)))
12101159	6	(ROOT (S (NP (PRP He)) (VP (VBD required) (NP (NP (JJ inotropic) (NN support) (CC and) (JJ temporary) (NN pacing)) (PP (IN over) (NP (DT the) (JJ next) (CD 48) (NNS hours))))) (. .)))
12101159	7	(ROOT (S (NP (DT This) (NN case)) (VP (VBZ suggests) (SBAR (S (NP (EX there)) (VP (VBZ is) (NP (NP (DT a) (NN role)) (PP (IN for) (NP (NP (JJ aggressive) (JJ high) (NN dose)) (VP (VBG intravenous) (NP (JJ Doc_12101159_815_822_Chemical) (NN therapy)) (PP (PP (IN in) (NP (JJ severe) (JJ Doc_12101159_841_850_Chemical) (NNS Doc_12101159_851_859_Disease))) (, ,) (RB particularly) (PP (IN with) (NP (NP (DT the) (NN onset)) (PP (IN of) (NP (NNS Doc_12101159_892_900_Disease)))))))))))))) (. .)))
12101159	8	(ROOT (S (NP (PRP It)) (VP (MD should) (VP (VB be) (VP (VBN considered) (ADVP (RB early) (PP (IN in) (NP (NP (NNS cases)) (PP (IN of) (NP (NNS Doc_12101159_944_958_Disease)))))) (PP (IN after) (NP (JJ Doc_12101159_965_974_Chemical) (NNS Doc_12101159_975_983_Disease)))))) (. .)))
12101159	9	(ROOT (S (NP (DT The) (NN case)) (ADVP (RB also)) (VP (VBZ highlights) (NP (DT the) (NNS problems)) (PP (IN with) (NP (JJ delayed) (NNS Doc_12101159_1036_1044_Disease))) (SBAR (WHADVP (WRB when)) (S (NP (JJ whole) (NN bowel) (NN irrigation)) (VP (VBZ is) (RB not) (ADJP (VBN administered)))))) (. .)))
12109865	0	(ROOT (NP (NP (JJ Low-molecular-weight) (NN heparin)) (PP (IN for) (NP (DT the) (NN treatment))) (PP (IN of) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ mechanical) (NN heart) (NNS valves))))) (. .)))
12109865	1	(ROOT (S (NP (NP (DT The) (NN interruption)) (PP (IN of) (NP (JJ oral) (JJ anticoagulant) (-LRB- -LRB-) (NNP OAC) (-RRB- -RRB-) (NN administration)))) (VP (VBZ is) (ADVP (RB sometimes)) (VP (VBN indicated) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ mechanical) (NN heart) (NNS valves)))) (, ,) (ADVP (RB mainly))) (PP (IN before) (NP (NP (JJ noncardiac) (NN surgery)) (, ,) (NP (JJ non-surgical) (NNS interventions)) (, ,) (CC and) (NP (NN pregnancy)))))) (. .)))
12109865	2	(ROOT (S (NP (NP (JJ Unfractionated) (NN heparin)) (PRN (-LRB- -LRB-) (NP (NNP UH)) (-RRB- -RRB-))) (VP (VBZ is) (ADVP (RB currently)) (NP (NP (DT the) (NN substitute)) (PP (IN for) (NP (VBN selected) (NNS patients))))) (. .)))
12109865	3	(ROOT (S (NP (NP (NNP Doc_12109865_382_410_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP LMWH)) (-RRB- -RRB-))) (VP (VP (VBZ offers) (NP (JJ theoretical) (NNS advantages)) (PP (IN over) (NP (NNP UH)))) (, ,) (CC but) (VP (VBZ is) (RB not) (VP (ADVP (RB currently)) (VBN considered) (PP (IN in) (NP (JJ clinical) (NNS guidelines))) (PP (IN as) (NP (DT an) (NN alternative))) (S (VP (TO to) (VP (VB UH) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ prosthetic) (NNS valves))))))))))) (. .)))
12109865	4	(ROOT (S (NP (NP (DT The) (NN aim)) (PP (IN of) (NP (DT the) (JJ present) (NN study)))) (VP (VBD was) (S (VP (VP (TO to) (VP (VB review) (NP (NP (DT the) (NNS data)) (VP (VBN accumulated) (ADVP (RB so) (RB far)) (PP (IN on) (NP (NP (DT the) (NN use)) (PP (IN of) (NP (NP (NNS Doc_12109865_669_673_Chemical)) (PP (IN in) (NP (DT this) (JJ patient) (NN population))))))))))) (CC and) (VP (TO to) (VP (VB discuss) (NP (PRP$ its) (NN applicability)) (PP (IN in) (NP (JJ common) (NN practice)))))))) (. .)))
12109865	5	(ROOT (S (PP (IN For) (NP (DT this) (NN paper))) (, ,) (NP (NP (DT the) (JJ current) (JJ medical) (NN literature)) (PP (IN on) (NP (NP (NNP LMWH)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ mechanical) (NN heart) (NNS valves)))))))) (VP (VBD was) (VP (ADVP (RB extensively)) (VBN reviewed))) (. .)))
12109865	6	(ROOT (S (NP (EX There)) (VP (VBD were) (NP (NP (CD eight) (NN series)) (CC and) (NP (CD six) (NN case) (NNS reports)))) (. .)))
12109865	7	(ROOT (S (S (NP (NP (NN None)) (PP (IN of) (NP (DT the) (NNS studies)))) (VP (VBD was) (VP (VBN randomized)))) (, ,) (CC and) (S (NP (RB only) (CD one)) (VP (VBD was) (NP (JJ prospective)))) (. .)))
12109865	8	(ROOT (S (NP (NP (NNP Data)) (SBAR (S (VP (TO to) (VP (VB establish) (NP (DT the) (JJ Doc_12109865_1028_1042_Disease) (NN risk))))))) (VP (VBD were) (ADJP (JJ incomplete))) (. .)))
12109865	9	(ROOT (S (S (PP (IN After) (S (VP (VBG excluding) (NP (NN case) (NNS reports))))) (, ,) (NP (DT the) (JJ following) (NNS groups)) (VP (VBD were) (VP (VBN constructed) (: :) (NP (NP (PRN (-LRB- -LRB-) (X (SYM a)) (-RRB- -RRB-)) (JJ short-term) (NN administration)) (, ,) (PP (IN after) (NP (NP (NN valve) (NN insertion)) (PRN (-LRB- -LRB-) (VP (VBN n) (S (VP (SYM =) (NP (NNS 212))))) (-RRB- -RRB-)))))))) (: ;) (S (LST (-LRB- -LRB-) (NN b) (-RRB- -RRB-)) (NP (JJ short-term) (, ,) (JJ perioperative) (-LRB- -LRB-) (NN noncardiac) (-RRB- -RRB-)) (VP (VBZ /) (NP (NP (NP (NP (NN periprocedural)) (PRN (-LRB- -LRB-) (NP (NNP n) (QP (CD =) (CD 114))) (-RRB- -RRB-))) (, ;) (PRN (-LRB- -LRB-) (X (SYM c)) (-RRB- -RRB-))) (ADJP (JJ long-term) (, ,) (JJ due))) (S (VP (TO to) (VP (VB intolerance) (PP (TO to) (NP (NP (NNP OAC)) (PRN (-LRB- -LRB-) (VP (VBN n) (S (VP (SYM =) (NP (CD 16))))) (-RRB- -RRB-))))))) (: ;) (S (-LRB- -LRB-) (NP (SYM d)) (-RRB- -RRB-) (NP (NP (JJ long-term)) (, ,) (PP (IN in) (NP (NP (NN pregnancy)) (PRN (-LRB- -LRB-) (VP (VBN n) (S (VP (SYM =) (NP (CD 10))))) (-RRB- -RRB-)))))))) (. .)))
12109865	10	(ROOT (S (S (NP (NP (DT The) (NN incidence) (NN rate)) (PP (IN of) (NP (NNS Doc_12109865_1378_1393_Disease)))) (VP (VBD was) (NP (NP (CD 0.9) (NN %)) (PP (IN for) (NP (NP (PDT all) (DT the) (NNS studies)) (CC and) (NP (CD 0.5)) (, ,) (NP (CD 0)) (, ,) (NP (CD 20)) (, ,) (CC and) (NP (NP (CD 0) (NN %)) (PP (IN in) (NP (NP (NNS groups)) (UCP (NP (SYM a)) (, ,) (NP (SYM b)) (, ,) (NP (SYM c)) (, ,) (CC and) (NP (SYM d)) (, ,) (PP (IN respectively))))))))))) (: ;) (S (PP (IN for) (NP (NNS Doc_12109865_1490_1500_Disease))) (, ,) (NP (DT the) (JJ overall) (NN rate)) (VP (VBD was) (NP (NP (CD 3.4) (NN %)) (PRN (-LRB- -LRB-) (NP (NP (CD 3.8)) (, ,) (NP (CD 2.6)) (, ,) (NP (CD 10)) (, ,) (CC and) (NP (NP (CD 0) (NN %)) (PP (IN for) (NP (DT the) (JJ respective) (NNS groups))))) (-RRB- -RRB-))))) (. .)))
12109865	11	(ROOT (S (PP (IN In) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ mechanical) (NN heart) (NNS valves))))) (, ,) (NP (JJ short-term) (JJ Doc_12109865_1644_1648_Chemical) (NN therapy)) (VP (VBZ compares) (ADVP (RB favorably)) (PP (IN with) (NP (NNP UH)))) (. .)))
12109865	12	(ROOT (S (NP (NP (NNP Data)) (PP (IN on) (NP (NP (ADJP (JJ mid) (: -) (CC and) (JJ long-term)) (JJ Doc_12109865_1712_1716_Chemical) (NN administration)) (PP (IN in) (NP (DT these) (NNS patients)))))) (VP (VBP are) (ADJP (JJ sparse))) (. .)))
12109865	13	(ROOT (S (NP (JJ Further) (JJ randomized) (NNS studies)) (VP (VBP are) (VP (VBN needed) (S (VP (TO to) (VP (VB confirm) (NP (NP (DT the) (NN safety)) (CC and) (NP (JJ precise) (NNS indications))) (PP (IN for) (NP (NP (DT the) (NN use)) (PP (IN of) (NP (NNP LMWH))))) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ mechanical) (NN heart) (NNS valves)))))))))) (. .)))
12139551	0	(ROOT (X (S (VP (VBG Doc_12139551_0_14_Disease) (PP (IN after) (NP (JJ intravenous) (NNS Doc_12139551_33_47_Chemical))))) (: -) (NP (NP (DT a) (NN case)) (PP (IN of) (NP (NP (CD five) (VBN repeated) (NNS injections)) (PP (IN of) (NP (NP (NNS Doc_12139551_88_102_Chemical)) (VP (VBG causing) (NP (NP (CD five) (NNS episodes)) (PP (IN of) (NP (NNS Doc_12139551_128_142_Disease)))))))))) (. .)))
12139551	1	(ROOT (S (NP (PRP We)) (VP (VBP describe) (NP (NP (DT a) (NN patient)) (SBAR (WHADVP (WRB where)) (S (NP (NP (JJ intravenous) (NN injection)) (PP (IN of) (NP (NNS Doc_12139551_197_211_Chemical)))) (VP (VBD was) (ADVP (RB immediately)) (VP (VBN followed) (PP (IN by) (NP (NNS Doc_12139551_240_248_Disease))) (ADVP (RB repeatedly)))))))) (. .)))
12139551	2	(ROOT (S (NP (DT The) (NN patient)) (VP (VBD received) (NP (QP (CD Doc_12139551_282_296_Chemical) (CD 10)) (NN mg) (NN i.v.)) (PP (NP (CD five) (NNS times)) (IN during) (NP (CD 48) (NN h.))))))
12139551	3	(ROOT (S (PP (IN After) (S (VP (VP (VBG interviewing) (NP (DT the) (VBG attending) (NNS nurses))) (CC and) (VP (VBG reviewing) (NP (DT the) (VBN written) (NN documentation)))))) (, ,) (NP (PRP it)) (VP (VBZ is) (ADJP (JJ clear)) (SBAR (IN that) (S (NP (NP (DT every) (NN administration)) (PP (IN of) (NP (NNS Doc_12139551_454_468_Chemical)))) (VP (VBD was) (ADVP (ADVP (RB immediately)) (PRN (-LRB- -LRB-) (PP (IN within) (NP (PRP s))) (-RRB- -RRB-))) (VP (VBN followed) (PP (IN by) (NP (NNS Doc_12139551_508_516_Disease)))))))) (. .)))
12139551	4	(ROOT (S (NP (DT The) (NNS Doc_12139551_522_530_Disease)) (VP (VBD lasted) (NP (CD 15-30) (NNS s)) (PP (IN on) (NP (CD four) (NNS occasions))) (, ,) (PP (IN on) (NP (NP (CD one) (NN occasion)) (SBAR (S (NP (PRP it)) (VP (VBD lasted) (NP (CD 2) (NN min)))))))) (. .)))
12139551	5	(ROOT (S (NP (DT The) (NN patient)) (VP (VBD received) (NP (JJ Doc_12139551_619_627_Chemical) (JJ 0.5-1) (NN mg) (CC and) (NN chest) (NNS compressions)) (, ,) (SBAR (IN before) (S (NP (JJ sinus) (NN rhythm)) (ADVP (RB again)) (VP (VBD took) (PRT (RP over)))))) (. .)))
12139551	6	(ROOT (S (NP (PRP We)) (VP (VB interpret) (NP (NP (DT this)) (PP (IN as) (NP (NP (NNS episodes)) (PP (IN of) (NP (NP (NNS Doc_12139551_731_745_Disease)) (VP (VBN caused) (PP (IN by) (NP (NNS Doc_12139551_756_770_Chemical)))))))))) (. .)))
12139551	7	(ROOT (S (NP (NP (DT The) (JJ rapid) (NN injection)) (PP (IN via) (NP (NP (DT the) (JJ central) (NNS venous) (NN route)) (CC and) (NP (NP (DT the) (JJ concomitant) (NN tapering)) (PP (IN of) (NP (JJ Doc_12139551_853_861_Chemical) (NN infusion))))))) (VP (MD might) (VP (VB have) (VP (VBN contributed) (PP (IN in) (S (VP (VBG precipitating) (NP (DT the) (JJ adverse) (NN drug) (NN reaction)))))))) (. .)))
12180796	0	(ROOT (S (NP (NP (NP (JJ Immunohistochemical) (NN study)) (PP (IN on) (NP (NP (JJ inducible) (NN type)) (PP (IN of) (NP (NP (NNS Doc_12180796_47_59_Chemical)) (PRN (-LRB- -LRB-) (NP (NNS iNOS)) (-RRB- -RRB-))))))) (, ,) (NP (NP (JJ basic) (JJ fibroblast) (NN growth) (NN factor)) (PRN (-LRB- -LRB-) (NP (NN bFGF)) (-RRB- -RRB-))) (CC and) (NP (NP (NP (JJ Doc_12180796_110_115_Disease) (NN growth) (NN factor-beta1)) (PRN (-LRB- -LRB-) (NP (NNP TGF-beta1)) (-RRB- -RRB-))) (PP (IN in) (NP (NP (NNS Doc_12180796_151_160_Disease)) (VP (VBN induced) (PP (IN in) (NP (NNS rats))) (PP (IN by) (NP (NNS Doc_12180796_180_190_Chemical) (CC and) (NNS Doc_12180796_195_207_Chemical)))))))) (, ,) (VP (VBZ vasodilators)) (. .)))
12180796	1	(ROOT (S (NP (NP (NNP Doc_12180796_223_232_Disease)) (VP (VBN induced) (PP (IN in) (NP (NNS rats))) (PP (IN by) (NP (NNS vasodilators) (, ,) (NNS Doc_12180796_266_276_Chemical) (CC and) (NNS Doc_12180796_281_293_Chemical))))) (, ,) (VP (VBD was) (VP (VBN examined) (ADVP (RB immunohistochemically)) (PP (IN for) (NP (NP (NNS expressions)) (PP (IN of) (NP (NP (JJ inducible) (NN type)) (PP (IN of) (NP (NP (NP (JJ Doc_12180796_367_379_Chemical) (NN synthase)) (PRN (-LRB- -LRB-) (NP (NNS iNOS)) (-RRB- -RRB-))) (, ,) (NP (NP (JJ basic) (JJ fibroblast) (NN growth) (NN factor)) (PRN (-LRB- -LRB-) (NP (NN bFGF)) (-RRB- -RRB-))) (CC and) (NP (NP (JJ Doc_12180796_439_444_Disease) (NN growth) (NN factor-beta1)) (PRN (-LRB- -LRB-) (NP (NNP TGF-beta1)) (-RRB- -RRB-))))))))))) (. .)))
12180796	2	(ROOT (S (NP (NNS Rats)) (VP (VBD were) (VP (VBN administered) (NP (NP (NNS Doc_12180796_501_511_Chemical)) (PP (IN for) (NP (CD 24) (NNS hours)))) (PP (IN by) (NP (JJ intravenous) (NN infusion))) (PP (IN with) (CC or) (IN without) (S (VP (VBG following) (NP (NP (JJ repeated) (JJ daily) (JJ oral) (NNS administrations)) (PP (IN of) (NP (NNS Doc_12180796_614_626_Chemical))))))))) (. .)))
12180796	3	(ROOT (S (S (NP (NP (NNP Irrespective)) (PP (IN of) (NP (NP (JJ Doc_12180796_644_656_Chemical) (NN administration)) (, ,) (NP (JJ iNOS) (NNS antigens))))) (VP (VBD were) (ADJP (ADJP (RB remarkably) (JJ abundant) (PP (IN in) (NP (NP (NN ED-1-positive) (NNS cells)) (PP (IN on) (NP (NN day) (CD 5)))))) (CC and) (ADJP (ADJP (CD 8) (JJ post-Doc_12180796_755_765_Chemical-infusion)) (PRN (-LRB- -LRB-) (NP (NNP DPI)) (-RRB- -RRB-)))))) (: ;) (S (NP (NN bFGF) (NNS antigens)) (VP (VBD were) (ADJP (RB remarkably) (JJ abundant) (PP (IN in) (NP (NN ED-1-positive) (NNS cells)))) (PP (IN on) (NP (QP (CD 1) (CC and) (CD 3))) (ADVP (RB DPI))))) (: ;) (S (NP (NN TGF-beta1) (NNS antigens)) (VP (VBD were) (VP (VBN observed) (PP (IN in) (NP (NN ED-1-positive) (NNS cells))) (PP (IN on) (CC and) (IN after) (NP (CD 5) (NN DPI)))))) (. .)))
12180796	4	(ROOT (S (S (NP (DT These) (NNS results)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NP (DT the) (JJ peak) (NN expression)) (PP (IN of) (NP (JJ iNOS) (NN antigen)))) (VP (VBD was) (VP (VBN followed) (PP (IN by) (NP (NP (DT that)) (PP (IN of) (NP (NN bFGF) (NN antigen))))))))))) (, ,) (CC and) (S (NP (NN bFGF)) (VP (MD may) (VP (VB have) (NP (NP (DT a) (JJ suppressive) (NN effect)) (PP (IN on) (NP (NP (JJ iNOS) (NN expression)) (PP (IN in) (NP (DT these) (NN rat) (NNS Doc_12180796_1108_1117_Disease) (NNS models))))))))) (. .)))
12180796	5	(ROOT (S (PP (IN On) (NP (DT the) (JJ other) (NN hand))) (, ,) (NP (NNS TGF-beta1)) (VP (VBD was) (RB not) (VP (VBN considered) (S (VP (TO to) (VP (VB have) (NP (NP (DT a) (JJ suppressive) (NN effect)) (PP (IN on) (NP (NP (JJ iNOS) (NN expression)) (PP (IN in) (NP (DT these) (NNS models))))))))))) (. .)))
12231232	0	(ROOT (NP (NP (DT The) (NN striatum)) (PP (IN as) (NP (NP (DT a) (NN target)) (PP (IN for) (NP (JJ anti-rigor) (NNS effects))))) (PP (IN of) (NP (NP (NP (DT an) (NN antagonist)) (PP (IN of) (NP (CD mGluR1)))) (, ,) (CONJP (CC but) (RB not)) (NP (NP (DT an) (NN agonist)) (PP (IN of) (NP (NN group) (ADJP (NNP II) (JJ metabotropic)) (NN Doc_12231232_120_129_Chemical) (NNS receptors)))))) (. .)))
12231232	1	(ROOT (S (NP (NP (DT The) (NN aim)) (PP (IN of) (NP (DT the) (JJ present) (NN study)))) (VP (VBD was) (S (VP (TO to) (VP (VB find) (PRT (RP out)) (SBAR (IN whether) (S (NP (NP (NP (DT the) (JJ metabotropic) (NN receptor) (CD 1) (-LRB- -LRB-) (NN mGluR1) (-RRB- -RRB-)) (CC and) (NP (NN group) (NNP II) (NNS mGluRs))) (, ,) (ADJP (JJ localized) (PP (IN in) (NP (DT the) (NN striatum)))) (, ,)) (VP (VBP are) (VP (VBN involved) (PP (IN in) (NP (NP (JJ antiparkinsonian-like) (NNS effects)) (PP (IN in) (NP (NNS rats))))))))))))) (. .)))
12231232	2	(ROOT (S (NP (NP (NP (NNP Doc_12231232_334_345_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 1) (NN mg/kg) (NN ip)) (-RRB- -RRB-))) (VP (VBN induced) (NP (NN Doc_12231232_367_379_Disease-like) (NNS Doc_12231232_385_400_Disease))) (, ,) (VP (VBN measured) (PP (IN as) (NP (NP (NP (NP (DT an) (VBN increased) (NN resistance)) (PP (IN of) (NP (NP (DT a) (NN rat) (POS 's)) (JJ hind) (NN foot))) (PP (TO to) (NP (JJ passive) (NN flexion) (CC and) (NN extension))) (PP (IN at) (NP (DT the) (JJ ankle) (NN joint)))) (. .) (NP (NP (NP (NNS Doc_12231232_512_551_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (NNP AIDA)) (: ;) (NP (CD 0.5-15) (JJ microg/0) (CD .5) (NNS microl))) (-RRB- -RRB-))) (, ,) (NP (DT a) (ADJP (JJ potent) (CC and) (JJ selective)) (JJ mGluR1) (NN antagonist)) (, ,) (CC or) (NP (NP (NNS Doc_12231232_631_675_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (NNS Doc_12231232_677_687_Chemical)) (: ;) (NP (CD 7.5-15) (JJ microg/0) (CD .5) (NNS microl))) (-RRB- -RRB-))))) (, ,) (NP (NP (DT a) (JJ selective) (NN group)) (ADJP (NNP II) (JJ agonist))) (, ,))))) (VP (VBD was) (VP (VBN injected) (ADVP (RB bilaterally)) (PP (IN into) (NP (NP (DT the) (NN striatum)) (PP (IN of) (NP (NN Doc_12231232_792_803_Chemical-treated) (NNS animals))))))) (. .)))
12231232	3	(ROOT (S (NP (NP (NNP AIDA)) (PP (IN in) (NP (NP (NNS doses)) (PP (IN of) (NP (JJ 7.5-15) (JJ microg/0) (CD .5) (NN microl)))))) (VP (VBD diminished) (NP (DT the) (NN Doc_12231232_878_889_Chemical-induced) (NNS Doc_12231232_898_913_Disease))) (. .)))
12231232	4	(ROOT (S (PP (IN In) (NP (NN contrast))) (, ,) (NP (JJ Doc_12231232_928_938_Chemical) (NNS injections)) (VP (VBD were) (ADJP (JJ ineffective))) (. .)))
12231232	5	(ROOT (S (NP (DT The) (JJ present) (NNS results)) (VP (MD may) (VP (VB suggest) (SBAR (IN that) (S (NP (NP (NP (DT the) (NN blockade)) (PP (IN of) (NP (JJ striatal) (NNS mGluR1)))) (, ,) (CC but) (NP (NP (RB not) (DT the) (NN stimulation)) (PP (IN of) (NP (NN group) (NNP II) (NNS mGluRs)))) (, ,)) (VP (MD may) (VP (VB ameliorate) (NP (JJ Doc_12231232_1097_1109_Disease) (NNS Doc_12231232_1110_1125_Disease)))))))) (. .)))
12448656	0	(ROOT (NP (NP (DT A) (NN phase) (NNP II) (NN study)) (PP (IN of) (NP (NNS Doc_12448656_20_31_Chemical))) (PP (IN in) (NP (JJ advanced) (JJ metastatic) (NNS Doc_12448656_55_75_Disease))) (. .)))
12448656	1	(ROOT (SINV (S (S (VP (TO To) (VP (VB evaluate) (NP (NP (DT the) (NN Doc_12448656_105_113_Disease) (CC and) (NN activity)) (PP (IN of) (NP (NP (NNS Doc_12448656_130_141_Chemical)) (PP (IN in) (NP (NNS patients)))))) (PP (IN with) (NP (JJ advanced) (JJ metastatic) (NNS Doc_12448656_179_196_Disease)))))) (CC and) (S (VP (TO to) (VP (VB measure) (NP (NP (NNS changes)) (PP (IN of) (NP (CD one) (JJ angiogenic) (NN factor)))))))) (, ,) (VP (VBP vascular) (NP (NP (JJ endothelial) (NN growth) (NN factor)) (PRN (-LRB- -LRB-) (NP (NNP VEGF)) (-RRB- -RRB-)))) (NP (NP (CD 165)) (, ,) (PP (IN with) (NP (NN therapy)))) (. .)))
12448656	2	(ROOT (FRAG (NP (NNS PATIENTS) (CC AND) (NNS METHODS)) (: :) (S (NP (CD 29) (NNS patients)) (VP (VBD were) (VP (VBN enrolled) (PP (IN on) (NP (NP (DT a) (NN study)) (PP (IN of) (NP (NP (NNS Doc_12448656_368_379_Chemical)) (VP (VBG using) (NP (DT an) (JJ intra-patient) (NN dose) (NN escalation) (NN schedule)))))))))) (. .)))
12448656	3	(ROOT (S (NP (NNS Patients)) (VP (VBD began) (SBAR (S (NP (NP (NNS Doc_12448656_444_455_Chemical)) (PP (IN at) (NP (CD 400)))) (VP (VP (VBD mg/d)) (CC and) (VP (VBD escalated) (ADJP (RB as) (JJ tolerated) (PP (TO to) (NP (NP (CD 1200)) (VP (VBN mg/d) (PP (IN by) (NP (NN day) (CD 54)))))))))))) (. .)))
12448656	4	(ROOT (S (S (NP (NP (NNP Fifty-nine)) (PP (IN per) (NP (NP (NN cent)) (PP (IN of) (NP (NNS patients)))))) (VP (VBD had) (VP (VBN had) (NP (JJ previous) (NN therapy)) (PP (IN with) (NP (NN IL-2)))))) (CC and) (S (NP (CD 52) (NN %)) (VP (VBD were) (NP (NP (NN performance) (NN status)) (NP (CD 2) (CC or) (CD 3))))) (. .)))
12448656	5	(ROOT (S (NP (JJ Systemic) (NN plasma) (NN VEGF165) (NNS levels)) (VP (VBD were) (VP (VBN measured) (PP (IN by) (NP (NP (JJ dual) (JJ monoclonal) (NN ELISA)) (PP (IN in) (NP (CD 8) (NNS patients))))))) (. .)))
12448656	6	(ROOT (S (NP (CD 24) (NNS patients)) (VP (VBD were) (ADJP (JJ evaluable) (PP (IN for) (NP (NN response)))) (PP (IN with) (NP (NP (CD one) (JJ partial) (NN response)) (PP (IN of) (NP (NP (CD 11) (NNS months)) (UCP (NP (NP (NN duration)) (PP (IN of) (NP (NP (NP (DT a) (NN patient)) (PP (IN with) (NP (JJ hepatic) (CC and) (JJ pulmonary) (NNS Doc_12448656_848_858_Disease)))) (PRN (-LRB- -LRB-) (NP (CD 4) (NN %)) (-RRB- -RRB-)) (, ,) (NP (CD one) (JJ minor) (NN response)) (, ,)))) (CC and) (ADJP (NP (CD 2) (NNS patients)) (JJ stable) (PP (IN for) (NP (IN over) (CD 6) (NNS months)))))))))) (. .)))
12448656	7	(ROOT (S (S (NP (NNS Doc_12448656_926_936_Disease) (CC and) (NNS Doc_12448656_941_953_Disease)) (VP (VBD were) (NP (JJ prominent) (NNS Doc_12448656_969_979_Disease)))) (CC and) (S (NP (JJS most) (NNS patients)) (VP (MD could) (RB not) (VP (VB tolerate) (NP (DT the) (CD 1200) (NN mg/day) (NN dose) (NN level))))) (. .)))
12448656	8	(ROOT (S (NP (JJ Systemic) (NN plasma) (NN VEGF165) (NNS levels)) (VP (VBD did) (RB not) (VP (VB change) (PP (IN with) (NP (NN therapy))))) (. .)))
12448656	9	(ROOT (S (NP (DT These) (NNS results)) (VP (VBP are) (ADJP (JJ consistent) (PP (IN with) (NP (NP (DT a) (JJ low) (NN level)) (PP (IN of) (NP (NP (NN activity)) (PP (IN of) (NP (NP (NNS Doc_12448656_1178_1189_Chemical)) (PP (IN in) (NP (NNS Doc_12448656_1193_1213_Disease))))))))))) (. .)))
12448656	10	(ROOT (S (S (NP (NP (NNP Administration)) (PP (IN of) (NP (NP (NNS doses)) (PP (IN over) (NP (CD 800)))))) (ADVP (RB mg/day)) (VP (VBD was) (ADJP (JJ difficult) (S (VP (TO to) (VP (VB achieve) (PP (IN in) (NP (DT this) (JJ patient) (NN population))))))))) (, ,) (ADVP (RB however)) (S (NP (JJR lower) (NNS doses)) (VP (VBD were) (ADJP (JJ practical)))) (. .)))
12448656	11	(ROOT (S (NP (NP (NP (DT The) (JJ dose-response) (NN relationship)) (PRN (, ,) (IN if) (DT any) (, ,))) (PP (IN of) (NP (NP (NNS Doc_12448656_1387_1398_Chemical)) (PP (IN for) (NP (NNS Doc_12448656_1403_1423_Disease)))))) (VP (VBZ is) (ADJP (JJ unclear))) (. .)))
12452237	0	(ROOT (SQ (MD Can) (NP (NNS Doc_12452237_4_13_Chemical)) (VP (VB reduce) (NP (JJ Doc_12452237_21_36_Chemical) (JJ induced) (NNS Doc_12452237_45_66_Disease))) (. ?)))
12452237	1	(ROOT (S (NP (DT This) (NN study)) (VP (VBD was) (VP (VBN undertaken) (S (VP (TO to) (VP (VB determine) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (JJ Doc_12452237_121_130_Chemical) (NN pretreatment)))) (PP (IN on) (NP (NP (NN reduction)) (PP (IN of) (NP (NN Doc_12452237_160_175_Chemical-induced) (NNS Doc_12452237_184_191_Disease))))) (PP (IN in) (NP (NNS patients))) (S (VP (VBG undergoing) (NP (JJ general) (NN anesthesia)) (PP (IN for) (NP (JJ gynecological) (NN surgery)))))))))) (. .)))
12452237	2	(ROOT (S (NP (NP (CD One) (CD hundred)) (CC and) (NP (JJ thirty-five) (NNS patients))) (VP (VBD were) (VP (VBN assigned) (PP (TO to) (NP (NP (CD one)) (PP (IN of) (NP (NP (CD three) (NNS groups)) (PP (IN in) (NP (DT a) (JJ prospective) (, ,) (JJ double) (JJ blind) (, ,) (JJ randomized) (NN manner))))))))) (. .)))
12452237	3	(ROOT (S (NP (NP (NNP Group) (NNP PS)) (, ,) (NP (DT the) (NN control) (NN group)) (, ,)) (VP (VBD received) (SBAR (S (NP (NP (JJ normal) (NN saline)) (CC and) (NP (NNS Doc_12452237_442_457_Chemical))) (VP (NP (NP (NP (CD 1.5) (NN mg) (NN x) (NN kg)) (PRN (-LRB- -LRB-) (NP (CD -1)) (-RRB- -RRB-))) (: ;) (S (NP (NNP Group) (NNP LS)) (, ,) (X (X (X (NP (NP (NNS Doc_12452237_485_494_Chemical)) (NP (CD 1.5) (NN mg))) (NP (SYM x)) (NP (NP (NP (NN kg)) (PRN (-LRB- -LRB-) (NP (CD -1)) (-RRB- -RRB-))) (CC and) (NP (QP (CD Doc_12452237_515_530_Chemical) (CD 1.5)) (NN mg)))) (NP (SYM x))) (NP (NP (NP (NP (NN kg)) (PRN (-LRB- -LRB-) (NP (CD -1)) (-RRB- -RRB-))) (: ;) (NP (NP (NNP Group) (NNP PR)) (, ,) (NP (JJ normal) (NN saline)))) (CC and) (NP (NP (NNS Doc_12452237_576_586_Chemical)) (NP (CD 0.6) (NN mg))))) (NP (SYM x)) (VP (VBP kg)))) (PRN (-LRB- -LRB-) (NP (CD -1)) (-RRB- -RRB-)))))) (. .)))
12452237	4	(ROOT (S (S (NP (ADJP (JJ Doc_12452237_604_612_Chemical) (NP (CD 0.1))) (JJ mg) (NNS x) (NN kg) (PRN (-LRB- -LRB-) (NP (CD -1)) (-RRB- -RRB-)) (NN iv)) (VP (VBD was) (VP (VBN given) (PP (IN for) (NP (NN premedication)))))) (CC and) (S (NP (DT all) (NNS patients)) (VP (VBD were) (VP (VBN monitored) (PP (IN with) (NP (NP (DT a) (JJ noninvasive) (NN blood) (NN pressure) (NN monitor)) (, ,) (NP (NNP ECG)) (CC and) (NP (NN pulse) (NN oximetry))))))) (. .)))
12452237	5	(ROOT (S (NP (NNP Anesthesia)) (VP (VBD was) (VP (VBN induced) (PP (IN with) (NP (CD 5))) (S (VP (VBG mg.kg) (S (-LRB- -LRB-) (NP (CD -1)) (-RRB- -RRB-) (NP (NP (NNP Doc_12452237_799_809_Chemical) (NNP iv) (. .)) (VP (VBN followed) (PP (IN by) (NP (NP (NNS Doc_12452237_826_841_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Group) (NNP PS)) (, ,) (NP (NNP LS)) (-RRB- -RRB-)) (CC or) (NP (NNS Doc_12452237_860_870_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Group) (NNP PR)) (-RRB- -RRB-)))) (PP (IN for) (NP (JJ tracheal) (NN intubation)))))))))) (. .)))
12452237	6	(ROOT (S (PP (VBG Following) (NP (NP (NN administration)) (PP (IN of) (NP (DT these) (NNS agents))))) (, ,) (NP (NP (DT the) (NN presence) (, ,) (CC and) (NN degree)) (PP (IN of) (NP (NNS Doc_12452237_977_990_Disease)))) (VP (VBD were) (VP (VBN assessed) (ADVP (RB visually)) (PP (IN on) (NP (DT a) (CD four) (NN point) (NN scale))) (PP (IN by) (NP (NP (CD one) (NN investigator)) (SBAR (WHNP (WP who)) (S (VP (VBD was) (VP (VBN blinded) (PP (TO to) (NP (NP (DT the) (NN drug)) (VP (VBN administered)))))))))))) (. .)))
12452237	7	(ROOT (S (NP (NP (DT The) (NN blood) (NN pressure) (CC and) (NN heart) (NN rate)) (PP (IN of) (NP (DT each) (NN patient)))) (VP (VBD were) (VP (VBN monitored) (PP (IN on) (NP (CD nine) (NNS occasions))))) (. .)))
12452237	8	(ROOT (S (NP (CD Twenty-four) (NNS hours) (RB later)) (, ,) (NP (DT any) (NNS Doc_12452237_1211_1218_Disease)) (VP (VBD experienced) (SBAR (S (VP (VBD was) (VP (VP (VBN assessed) (PP (VBG according) (PP (TO to) (NP (DT a) (JJ structured) (NN questionaire))))) (CC and) (VP (VBN graded) (PP (IN by) (NP (DT a) (CD four) (NN point) (NN scale)))) (PP (IN by) (NP (NP (CD one) (NN investigator)) (VP (VBN blinded) (PP (TO to) (NP (DT the) (JJ intraoperative) (NN management))))))))))) (. .)))
12452237	9	(ROOT (S (NP (DT The) (NNS results)) (VP (VBP indicate) (SBAR (IN that) (S (NP (NNS Doc_12452237_1404_1424_Disease)) (VP (VBD was) (RB not) (VP (VBN found) (PP (IN in) (NP (NNP Group) (NNP PR))) (SBAR (IN while) (S (NP (NP (DT the) (NNS patients)) (PP (IN in) (NP (NNP Group) (NNP LS)))) (VP (VBD had) (NP (NP (DT a) (JJR lower) (NN incidence)) (PP (IN of) (NP (NNS Doc_12452237_1507_1527_Disease)))) (PP (IN than) (NP (NP (DT those)) (PP (IN in) (NP (NP (NNP Group) (NNP PS)) (PRN (-LRB- -LRB-) (NP (NNP p) (QP (CD <) (CD 0.001))) (-RRB- -RRB-)))))))))))))) (. .)))
12452237	10	(ROOT (S (PP (IN At) (NP (CD 24) (NN h))) (, ,) (NP (NP (DT the) (NN incidence)) (PP (IN of) (NP (NNS Doc_12452237_1590_1597_Disease)))) (VP (VBD was) (ADJP (ADJP (JJR higher) (PP (IN in) (NP (NNP Group) (NNP PS)))) (PP (IN than) (PP (IN in) (NP (NNP Group) (NNP LS) (CC and) (NNP PR))))) (PRN (-LRB- -LRB-) (ADVP (RB p)) (ADJP (JJ <) (NP (CD 0.05))) (-RRB- -RRB-))) (. .)))
12452237	11	(ROOT (S (NP (DT A) (NN correlation)) (VP (VBD was) (RB not) (VP (VBN found) (PP (IN between) (NP (NP (NP (DT the) (NN incidence)) (PP (IN of) (NP (NNS Doc_12452237_1710_1717_Disease)))) (CC and) (NP (NP (DT the) (NN occurrence)) (PP (IN of) (NP (NNS Doc_12452237_1740_1760_Disease)))))))) (. .)))
12452237	12	(ROOT (S (NP (NP (DT The) (NNS changes)) (PP (IN in) (NP (ADJP (JJ systolic) (CC and) (JJ diastolic)) (NN blood) (NN pressure) (CC and) (NN heart) (NN rate)))) (VP (VBD were) (RB not) (ADJP (JJ significant) (PP (IN among) (NP (DT the) (CD three) (NNS groups))))) (. .)))
12452237	13	(ROOT (S (PP (IN In) (NP (NN conclusion))) (, ,) (SBAR (WHADVP (WRB where)) (S (NP (NNS Doc_12452237_1896_1911_Chemical)) (VP (VBZ is) (VP (VBN used))))) (, ,) (NP (NNS Doc_12452237_1921_1930_Chemical)) (VP (VBZ is) (VP (VBN proven) (S (VP (TO to) (VP (VB be) (NP (NP (DT the) (ADJP (JJ useful) (JJ pretreatment)) (NN agent)) (PP (IN for) (NP (NP (DT the) (NN reduction)) (PP (IN of) (NP (NNS Doc_12452237_1998_2019_Disease))))))))))) (. .)))
12481039	0	(ROOT (S (S (VP (NNP Reduced) (NP (JJ Doc_12481039_8_14_Chemical) (NN channel) (NN density)))) (, ,) (NP (JJ altered)) (VP (VP (VBP voltage) (NP (NP (NN dependence)) (PP (IN of) (NP (NN inactivation))))) (, ,) (CC and) (VP (VBD increased) (ADVP (RB susceptibility)) (PP (TO to) (NP (NP (NNS Doc_12481039_108_116_Disease)) (PP (IN in) (NP (NNS mice))))) (S (VP (VBG lacking) (S (NP (JJ Doc_12481039_133_139_Chemical) (NN channel) (NN beta)) (ADJP (JJ 2-subunits))))))) (. .)))
12481039	1	(ROOT (S (NP (JJ Doc_12481039_165_171_Chemical) (NN channel) (NNS beta-subunits)) (VP (VBP modulate) (NP (NP (NN channel) (NN gating)) (, ,) (NP (NN assembly)) (, ,) (CC and) (NP (NP (NN cell) (NN surface) (NN expression)) (PP (IN in) (NP (JJ heterologous) (NN cell) (NNS systems)))))) (. .)))
12481039	2	(ROOT (S (NP (PRP We)) (VP (VBD generated) (NP (JJ beta2) (PRN (-LRB- -LRB-) (FRAG (ADJP (RB -) (JJ /)) (: -)) (-RRB- -RRB-)) (NNS mice)) (S (VP (TO to) (VP (VB investigate) (NP (NP (DT the) (NN role)) (PP (IN of) (NP (CD beta2)))) (PP (IN in) (NP (NP (NN control)) (PP (IN of) (NP (NP (JJ Doc_12481039_363_369_Chemical) (NN channel) (NN density)) (, ,) (NP (NN localization)) (, ,) (CC and) (NP (NN function)))))) (PP (IN in) (NP (NP (NNS neurons)) (PP (IN in) (NP (NN vivo))))))))) (. .)))
12481039	3	(ROOT (S (NP (NP (NNS Measurements)) (PP (IN of) (NP (NP (NP (NNS Doc_12481039_450_465_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_12481039_467_470_Chemical)) (-RRB- -RRB-))) (ADJP (JJ binding))))) (VP (VBD showed) (NP (DT a) (JJ significant) (NN reduction)) (PP (IN in) (NP (NP (DT the) (NN level)) (PP (IN of) (NP (NN plasma) (NN membrane) (JJ Doc_12481039_543_549_Chemical) (NNS channels))))) (PP (IN in) (NP (JJ beta2) (PRN (-LRB- -LRB-) (FRAG (ADJP (RB -) (JJ /)) (: -)) (-RRB- -RRB-)) (NNS neurons)))) (. .)))
12481039	4	(ROOT (S (NP (NP (DT The) (NN loss)) (PP (IN of) (NP (CD beta2)))) (VP (VBD resulted) (PP (IN in) (NP (JJ negative) (NNS shifts))) (PP (PP (IN in) (NP (NP (DT the) (JJ voltage) (NN dependence)) (PP (IN of) (NP (NN inactivation))))) (CONJP (RB as) (RB well) (IN as)) (PP (NP (NP (JJ significant) (NNS decreases)) (PP (IN in) (NP (JJ Doc_12481039_706_712_Chemical) (JJ current) (NN density)))) (IN in) (NP (ADJP (RB acutely) (JJ dissociated)) (NN hippocampal) (NNS neurons))))) (. .)))
12481039	5	(ROOT (S (S (NP (NP (DT The) (JJ integral)) (PP (IN of) (NP (NP (DT the) (JJ compound) (NN action) (NN potential)) (PP (IN in) (NP (JJ optic) (NN nerve)))))) (VP (VBD was) (VP (ADVP (RB significantly)) (VBN reduced)))) (, ,) (CC and) (S (NP (NP (DT the) (NN threshold)) (PP (IN for) (NP (NN action) (JJ potential) (NN generation)))) (VP (VBD was) (VP (VBN increased) (, ,) (S (VP (VBG indicating) (NP (DT a) (NN reduction)) (PP (IN in) (NP (NP (DT the) (NN level)) (PP (IN of) (NP (JJ functional) (NN plasma) (NN membrane) (JJ Doc_12481039_992_998_Chemical) (NNS channels)))))))))) (. .)))
12481039	6	(ROOT (S (PP (IN In) (NP (NP (NN contrast)) (, ,) (NP (DT the) (NN conduction) (NN velocity)) (, ,) (NP (NP (DT the) (NN number) (CC and) (NN size)) (PP (IN of) (NP (NP (NNS axons)) (PP (IN in) (NP (DT the) (JJ optic) (NN nerve)))))) (, ,) (CC and) (NP (NP (DT the) (JJ specific) (NN localization)) (PP (IN of) (NP (NP (NP (NNS Doc_12481039_1129_1131_Chemical)) (PRN (-LRB- -LRB-) (NP (NN v)) (-RRB- -RRB-))) (SBAR (S (NP (NP (CD 1.6) (NNS channels)) (PP (IN in) (NP (NP (DT the) (NNS nodes)) (PP (IN of) (NP (NNP Ranvier)))))) (VP (VBD were) (ADJP (JJ unchanged))) (. .)))))))) (NP (JJ beta2) (PRN (-LRB- -LRB-) (FRAG (ADJP (RB -) (JJ /)) (: -)) (-RRB- -RRB-)) (NNS mice)) (VP (VBD displayed) (NP (JJ increased) (NN susceptibility)) (PP (TO to) (NP (NNS Doc_12481039_1241_1249_Disease))) (, ,) (SBAR (IN as) (S (VP (VP (VBD indicated) (PP (IN by) (NP (NP (VBN reduced) (NN latency) (CC and) (NN threshold)) (PP (IN for) (NP (NN Doc_12481039_1301_1312_Chemical-induced) (NNS Doc_12481039_1321_1329_Disease)))))) (, ,) (CC but) (VP (VBD seemed) (ADJP (JJ normal)) (PP (IN in) (NP (JJ other) (JJ neurological) (NNS tests)))))))) (. .)))
12481039	7	(ROOT (S (NP (PRP$ Our) (NNS observations)) (VP (VBP show) (SBAR (IN that) (S (NP (JJ beta2-subunits)) (VP (VP (VBP play) (NP (DT an) (JJ important) (NN role)) (PP (IN in) (NP (NP (NP (DT the) (NN regulation)) (PP (IN of) (NP (JJ Doc_12481039_1464_1470_Chemical) (NN channel) (NN density)))) (CC and) (NP (NP (NN function)) (PP (IN in) (NP (NP (NNS neurons)) (PP (IN in) (NP (NN vivo))))))))) (CC and) (VP (VBP are) (VP (VBN required) (PP (IN for) (NP (NP (JJ normal) (NN action) (NN potential) (NN generation) (CC and) (NN control)) (PP (IN of) (NP (NN excitability))))))))))) (. .)))
12549952	0	(ROOT (S (VP (VB Doc_12549952_0_19_Disease) (PP (IN with) (NP (NP (JJ concurrent) (NNS Doc_12549952_36_45_Chemical)) (CC and) (NP (JJ Doc_12549952_50_61_Chemical) (NN therapy))))) (. .)))
12549952	1	(ROOT (S (S (VP (TO To) (VP (VB report) (NP (NP (DT a) (NN case)) (PP (IN of) (NP (JJ fatal) (NNS Doc_12549952_108_121_Disease))))))) (VP (ADVP (RB possibly)) (VBN associated) (PP (IN with) (NP (NP (JJ concurrent) (NN use)) (PP (IN of) (NP (NNS Doc_12549952_165_174_Chemical) (CC and) (NNS Doc_12549952_179_190_Chemical)))))) (. .)))
12549952	2	(ROOT (FRAG (NP (NNP CASE) (NNP SUMMARY)) (: :) (S (NP (NP (DT A) (JJ 41-year-old) (JJ Chinese) (NN man)) (PP (IN with) (NP (NP (DT a) (NN history)) (PP (IN of) (NP (NNS Doc_12549952_250_265_Disease)))))) (VP (VBD had) (VP (VBN been) (VP (VBN treated) (PP (IN with) (NP (NNS Doc_12549952_288_299_Chemical) (CC and) (NNS Doc_12549952_304_315_Chemical))) (PP (IN for) (NP (DT the) (JJ past) (CD 5) (NNS years))))))) (. .)))
12549952	3	(ROOT (S (NP (PRP He)) (VP (VBD received) (NP (NP (DT a) (JJ 10-day) (NN course)) (PP (IN of) (NP (NNS Doc_12549952_369_378_Chemical)))) (PP (IN as) (NP (NP (DT an) (NN aid)) (PP (IN for) (NP (NN smoking) (NN cessation))))) (PP (ADVP (NP (CD 10) (NNS weeks)) (RB prior)) (TO to) (NP (NN presentation)))) (. .)))
12549952	4	(ROOT (S (NP (PRP He)) (VP (VBD developed) (NP (NNS Doc_12549952_456_475_Disease)) (PP (IN with) (NP (NP (JJ rapid) (NN deterioration)) (PP (IN of) (NP (JJ renal) (NN function)))))) (. .)))
12549952	5	(ROOT (S (NP (NNP Liver)) (ADVP (RB biopsy)) (VP (VBD showed) (NP (NP (NN evidence)) (PP (IN of) (NP (JJ nonspecific) (NNS Doc_12549952_564_595_Disease))))) (. .)))
12549952	6	(ROOT (S (NP (JJ Doc_12549952_597_600_Chemical) (NN condition)) (VP (VBD was) (ADVP (RBR further)) (VP (VBN complicated) (PP (IN by) (NP (NNS Doc_12549952_638_644_Disease) (CC and) (NNS Doc_12549952_649_661_Disease))))) (. .)))
12549952	7	(ROOT (S (NP (NNP Death)) (VP (VBD resulted) (NP (CD 19) (NNS days)) (PP (IN after) (NP (NP (DT the) (NN onset)) (PP (IN of) (NP (NNS symptoms)))))) (. .)))
12549952	8	(ROOT (S (NP (NP (DT The) (NN likelihood)) (SBAR (IN that) (S (NP (NNS Doc_12549952_735_744_Chemical)) (VP (VBN induced) (ADVP (RB hepatotoxicity)) (PP (IN in) (NP (PRP$ our) (NN patient))))))) (VP (VBD was) (ADJP (JJ possible)) (, ,) (PP (VBN based) (PP (IN on) (NP (DT the) (NNP Naranjo) (NN probability) (NN scale))))) (. .)))
12549952	9	(ROOT (S (SBAR (IN Although) (S (NP (EX there)) (VP (VBZ is) (VP (VBG increasing) (NP (NP (NN evidence)) (PP (IN of) (NP (NP (NN hepatotoxicity)) (VP (VBN induced) (PP (IN by) (NP (NNS Doc_12549952_916_925_Chemical))))))))))) (, ,) (NP (DT this)) (VP (VBZ is) (NP (NP (DT the) (JJ first) (NN case)) (PP (IN of) (NP (NN fatality))) (SBAR (WHNP (WDT that)) (S (VP (MD could) (VP (VB have) (VP (VBN resulted) (PP (IN from) (NP (NP (NNS Doc_12549952_992_1011_Disease)) (PP (IN in) (NP (DT a) (NN patient))))) (S (VP (VBG receiving) (NP (JJ Doc_12549952_1035_1044_Chemical) (NN while)) (PP (IN on) (NP (NP (JJ concomitant) (NN treatment)) (PP (IN with) (NP (NNS Doc_12549952_1081_1092_Chemical)))))))))))))) (. .)))
12549952	10	(ROOT (S (NP (NNS Clinicians)) (VP (MD should) (VP (VB be) (ADJP (JJ aware) (PP (IN of) (NP (NP (DT the) (NN possibility)) (PP (IN of) (NP (NP (NNS Doc_12549952_1156_1174_Disease)) (VP (VBN induced) (PP (IN by) (NP (NP (NNS Doc_12549952_1186_1195_Chemical)) (VP (VBN given) (ADVP (RB concurrently)) (PP (IN with) (NP (JJ other) (JJ hepatotoxic) (NNS drugs)))))))))))))) (. .)))
1255900	0	(ROOT (S (S (NP (JJ Pyeloureteral) (NN filling) (NNS defects)) (VP (VBN associated) (PP (IN with) (NP (JJ systemic) (NN anticoagulation))))) (: :) (S (NP (DT a) (NN case)) (VP (VBP report))) (. .)))
1255900	1	(ROOT (S (NP (NP (DT The) (NN etiology)) (PP (IN of) (NP (NNS Doc_1255900_103_126_Disease)))) (VP (VBZ has) (ADVP (RB long)) (VP (VBN been) (VP (VBN attributed) (PP (TO to) (NP (JJ chronic) (NNS Doc_1255900_163_172_Disease) (CC and) (NNS Doc_1255900_177_189_Disease)))))) (. .)))
1255900	2	(ROOT (S (NP (DT A) (NN case)) (VP (VBZ is) (VP (VBN presented) (SBAR (IN that) (S (VP (VBZ is) (ADJP (JJ unique) (PP (IN in) (SBAR (IN that) (S (NP (NP (DT the) (JJ acute) (NN onset)) (CC and) (NP (NP (DT the) (JJ rapid) (NN resolution)) (PP (IN of) (NP (NP (JJ pyeloureteral) (NN filling) (NNS defects)) (PP (IN in) (NP (DT this) (NN patient))))))) (VP (VBD were) (VP (VBN documented) (PP (IN by) (NP (NN radiography)))))))))))))) (. .)))
1255900	3	(ROOT (S (NP (EX There)) (VP (VBZ is) (NP (NP (DT no) (NN evidence)) (PP (IN of) (NP (NP (ADJP (JJ antecedent) (CC or) (JJ concurrent)) (NNS Doc_1255900_405_414_Disease)) (PP (IN in) (NP (DT this) (NN patient))))))) (. .)))
1255900	4	(ROOT (S (NP (DT The) (NN disease)) (VP (VP (VBD occurred) (ADJP (JJ subsequent) (PP (TO to) (NP (NP (DT the) (NN initiation)) (PP (IN of) (NP (NP (JJ Doc_1255900_485_492_Chemical) (NN therapy)) (PP (IN for) (NP (VBN suspected) (JJ pelvic) (NNS Doc_1255900_522_538_Disease))))))))) (CC and) (VP (VBD cleared) (ADJP (RB rapidly) (JJ subsequent)) (PP (TO to) (NP (PRP$ its) (NN discontinuation))))) (. .)))
1255900	5	(ROOT (S (NP (NP (DT The) (NN rate)) (PP (IN of) (NP (NP (NN resolution)) (PP (IN of) (NP (DT the) (JJ radiographic) (NNS findings)))))) (VP (MD may) (VP (VB be) (ADJP (JJ helpful) (PP (IN in) (NP (NP (JJ distinguishing)) (PP (IN between) (NP (JJ true) (NNS Doc_1255900_692_715_Disease) (CC and) (NNS Doc_1255900_720_741_Disease)))))))) (. .)))
12571256	0	(ROOT (NP (NP (NP (JJ Nephrotoxic) (NNS effects)) (PP (IN in) (NP (JJ high-risk) (NNS patients)))) (VP (VBG undergoing) (ADVP (RB angiography))) (. .)))
12571256	1	(ROOT (S (NP (NP (DT The) (NN use)) (PP (IN of) (NP (JJ iodinated) (NN contrast) (NN medium)))) (VP (MD can) (VP (VB result) (PP (IN in) (NP (NNS Doc_12571256_129_140_Disease))))) (. .)))
12571256	2	(ROOT (S (SBAR (IN Whether) (S (NP (JJ iso-osmolar) (NN contrast) (NN medium)) (VP (VBZ is) (ADJP (RBR less) (JJ nephrotoxic) (PP (IN than) (NP (NP (JJ low-osmolar) (NN contrast) (NN medium)) (PP (IN in) (NP (JJ high-risk) (NNS patients))))))))) (VP (VBZ is) (ADJP (JJ uncertain))) (. .)))
12571256	3	(ROOT (S (NP (PRP We)) (VP (VBD conducted) (NP (DT a) (JJ randomized) (, ,) (JJ double-blind) (, ,) (JJ prospective) (, ,) (JJ multicenter) (NN study)) (S (VP (VBG comparing) (NP (NP (DT the) (JJ nephrotoxic) (NNS effects)) (PP (IN of) (NP (NP (DT an) (JJ iso-osmolar) (, ,) (JJ dimeric) (, ,) (JJ nonionic) (NN Doc_12571256_419_434_Chemical)) (, ,) (NP (NNS Doc_12571256_436_445_Chemical)) (, ,)))) (PP (IN with) (NP (NP (DT those)) (PP (IN of) (NP (NP (DT a) (JJ low-osmolar) (, ,) (JJ nonionic) (, ,) (JJ monomeric) (NN contrast) (NN medium)) (, ,) (NP (NNS Doc_12571256_513_520_Chemical))))))))) (. .)))
12571256	4	(ROOT (S (NP (DT The) (NN study)) (VP (VBD involved) (NP (CD 129) (NNS patients)) (PP (IN with) (NP (NNS Doc_12571256_559_567_Disease))) (PP (IN with) (NP (NP (JJ serum) (JJ Doc_12571256_579_589_Chemical) (NNS concentrations)) (PP (IN of) (NP (NP (QP (CD 1.5) (TO to) (CD 3.5)) (NN mg)) (PP (IN per) (NP (NN deciliter))))) (SBAR (WHNP (WP who)) (S (VP (VBD underwent) (NP (JJ coronary) (CC or) (JJ aortofemoral) (NN angiography)))))))) (. .)))
12571256	5	(ROOT (S (NP (DT The) (JJ primary) (NN end) (NN point)) (VP (VBD was) (NP (NP (DT the) (JJ peak) (NN increase)) (PP (IN from) (NP (NP (NN base) (NN line)) (PP (IN in) (NP (NP (DT the) (JJ Doc_12571256_754_764_Chemical) (NN concentration)) (PP (IN during) (NP (DT the) (CD three) (NNS days)))))))) (PP (IN after) (NP (NN angiography)))) (. .)))
12571256	6	(ROOT (S (NP (JJ Other) (NN end) (NNS points)) (VP (VBD were) (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (NP (DT the) (JJ Doc_12571256_861_871_Chemical) (NN concentration)) (PP (IN of) (NP (NP (NP (CD 0.5) (NN mg)) (PP (IN per) (NP (NN deciliter)))) (CC or) (NP (NP (JJR more)) (, ,) (NP (NP (DT an) (NN increase)) (PP (IN of) (NP (NP (CD 1.0) (NN mg)) (PP (IN per) (NP (NP (QP (CD deciliter) (CC or) (JJR more))) (, ,) (CC and) (NP (NP (DT a) (NN change)) (PP (IN in) (NP (NP (DT the) (JJ Doc_12571256_984_994_Chemical) (NN concentration)) (PP (IN from) (NP (NN day) (CD 0))))))))))))))))) (PP (TO to) (NP (NN day) (CD 7)))) (. .)))
12571256	7	(ROOT (S (NP (DT The) (JJ Doc_12571256_1043_1053_Chemical) (NN concentration)) (VP (VBD increased) (ADJP (RB significantly) (JJR less)) (PP (IN in) (NP (NP (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBD received) (NP (NNS Doc_12571256_1122_1131_Chemical)))))))) (. .)))
12571256	8	(ROOT (S (PP (IN From) (NP (NP (NN day) (CD 0)) (PP (TO to) (NP (NN day) (CD 3))))) (, ,) (NP (NP (DT the) (JJ mean) (NN peak) (NN increase)) (PP (IN in) (NP (NNS Doc_12571256_1180_1190_Chemical)))) (VP (VBD was) (NP (NP (CD 0.13) (NN mg)) (PP (IN per) (NP (NP (NP (NN deciliter)) (PP (IN in) (NP (DT the) (JJ Doc_12571256_1224_1233_Chemical) (NN group)))) (CC and) (NP (NP (QP (CD 0.55) (CD mg))) (PP (IN per) (NP (NP (NN deciliter)) (PP (IN in) (NP (NP (DT the) (JJ Doc_12571256_1273_1280_Chemical) (NN group)) (PRN (-LRB- -LRB-) (NP (NP (NP (NP (NNP P)) (SBAR (S (VP (SYM =) (NP (CD 0.001)))))) (: ;) (NP (NP (DT the) (NN increase)) (PP (IN with) (NP (NP (NNS Doc_12571256_1315_1324_Chemical)) (PP (CC minus) (NP (NP (DT the) (NN increase)) (PP (IN with) (NP (NNS Doc_12571256_1349_1356_Chemical))))))))) (, ,) (NP (NP (CD -0.42) (NN mg)) (PP (IN per) (NP (JJ deciliter) (JJ -LSB-) (CD 95) (NN percent) (NN confidence) (NN interval)))) (, ,) (NP (NP (CD -0.73)) (PP (TO to) (NP (CD -0.22) (NNS -RSB-))))) (-RRB- -RRB-))))))))))) (. .)))
12571256	9	(ROOT (S (NP (NP (CD Two)) (PP (IN of) (NP (NP (DT the) (CD 64) (NNS patients)) (PP (IN in) (NP (NP (DT the) (JJ Doc_12571256_1462_1471_Chemical) (NN group)) (PRN (-LRB- -LRB-) (NP (CD 3) (NN percent)) (-RRB- -RRB-))))))) (VP (VBD had) (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (NP (DT the) (JJ Doc_12571256_1513_1523_Chemical) (NN concentration)) (PP (IN of) (NP (NP (CD 0.5) (NN mg)) (PP (IN per) (NP (NP (NN deciliter)) (CC or) (NP (JJR more))))))))) (, ,) (PP (IN as) (PP (VBN compared) (PP (IN with) (NP (NP (CD 17)) (PP (IN of) (NP (NP (DT the) (CD 65) (NNS patients)) (PP (IN in) (NP (NP (NP (DT the) (JJ Doc_12571256_1617_1624_Chemical) (NN group)) (PRN (-LRB- -LRB-) (NP (CD 26) (NN percent)) (-RRB- -RRB-))) (PRN (-LRB- -LRB-) (NP (NP (NP (NP (NNP P)) (SBAR (S (VP (SYM =) (NP (CD 0.002)))))) (: ;) (NP (NP (NNS odds) (NN ratio)) (PP (IN for) (NP (NP (PDT such) (DT an) (NN increase)) (PP (IN in) (NP (DT the) (JJ Doc_12571256_1693_1702_Chemical) (NN group))))))) (, ,) (NP (NP (QP (CD 0.09) (CD -LSB-))) (NP (CD 95) (NN percent) (NN confidence) (NN interval))) (, ,) (NP (NP (CD 0.02)) (PP (TO to) (NP (CD 0.41) (NNS -RSB-))))) (-RRB- -RRB-))))))))))) (. .)))
12571256	10	(ROOT (S (S (NP (NP (DT No) (NN patient)) (VP (VBG receiving) (NP (NNS Doc_12571256_1785_1794_Chemical)))) (VP (VBD had) (NP (NP (DT an) (NN increase)) (PP (IN of) (NP (NP (CD 1.0) (NN mg)) (PP (IN per) (NP (NP (NN deciliter)) (CC or) (NP (JJR more))))))))) (, ,) (CC but) (S (NP (NP (CD 10) (NNS patients)) (PP (IN in) (NP (NP (DT the) (JJ Doc_12571256_1867_1874_Chemical) (NN group)) (PRN (-LRB- -LRB-) (NP (CD 15) (NN percent)) (-RRB- -RRB-))))) (VP (VBD did))) (. .)))
12571256	11	(ROOT (S (NP (NP (DT The) (JJ mean) (NN change)) (PP (IN in) (NP (NP (DT the) (JJ Doc_12571256_1922_1932_Chemical) (NN concentration)) (PP (IN from) (NP (NP (NN day) (CD 0)) (PP (TO to) (NP (NN day) (CD 7)))))))) (VP (VBD was) (NP (NP (CD 0.07) (NN mg)) (PP (IN per) (NP (NP (NP (NN deciliter)) (PP (IN in) (NP (DT the) (JJ Doc_12571256_2000_2009_Chemical) (NN group)))) (CC and) (NP (NP (CD 0.24) (NN mg)) (PP (IN per) (NP (NP (NN deciliter)) (PP (IN in) (NP (NP (DT the) (JJ Doc_12571256_2049_2056_Chemical) (NN group)) (PRN (-LRB- -LRB-) (NP (NP (NP (NP (NNP P)) (SBAR (S (VP (SYM =) (NP (CD 0.003)))))) (: ;) (NP (NP (NN value)) (PP (IN in) (NP (NP (DT the) (JJ Doc_12571256_2086_2095_Chemical) (NN group)) (PP (CC minus) (NP (NP (DT the) (NN value)) (PP (IN in) (NP (DT the) (JJ Doc_12571256_2125_2132_Chemical) (NN group))))))))) (, ,) (NP (NP (CD -0.17) (NN mg)) (PP (IN per) (NP (JJ deciliter) (JJ -LSB-) (CD 95) (NN percent) (NN confidence) (NN interval)))) (, ,) (NP (NP (CD -0.34)) (PP (TO to) (NP (CD -0.07) (NNS -RSB-))))) (-RRB- -RRB-))))))))))) (. .)))
12571256	12	(ROOT (S (NP (NP (NNP Doc_12571256_2227_2238_Disease)) (VP (VBN induced) (PP (IN by) (NP (NN contrast) (NN medium))))) (VP (MD may) (VP (VB be) (ADJP (RBR less) (JJ likely) (S (VP (TO to) (VP (VB develop) (PP (IN in) (NP (JJ high-risk) (NNS patients))))))) (SBAR (WHADVP (WRB when)) (S (NP (NNS Doc_12571256_2323_2332_Chemical)) (VP (VBZ is) (VP (VBN used) (PP (RB rather) (IN than) (NP (DT a) (JJ low-osmolar) (, ,) (JJ nonionic) (NN contrast) (NN medium))))))))) (. .)))
12600698	0	(ROOT (NP (NP (JJ Protective) (NN effect)) (PP (IN of) (NP (NP (NNS Doc_12600698_21_30_Chemical)) (PP (IN against) (NP (NN Doc_12600698_39_51_Chemical-induced) (NN vestibulotoxicity))))) (PP (IN in) (NP (DT the) (NN guinea) (NN pig))) (. .)))
12600698	1	(ROOT (S (NP (DT This) (NN study)) (VP (VBD investigated) (NP (NP (NN alleviation)) (PP (IN of) (NP (NN Doc_12600698_136_148_Chemical-induced) (NN vestibulotoxicity)))) (PP (IN by) (NP (NP (NNS Doc_12600698_178_187_Chemical)) (PP (IN in) (NP (NN guinea) (NNS pigs)))))) (. .)))
12600698	2	(ROOT (S (NP (NP (NNP Doc_12600698_204_213_Chemical)) (, ,) (NP (DT a) (ADJP (JJ free) (JJ radical)) (NN scavenger)) (, ,)) (VP (VP (VBZ has) (NP (ADJP (JJ potent) (JJ free)) (JJ radical) (NN quenching) (NN action))) (CC and) (VP (VBZ is) (VP (VBN used) (PP (IN in) (NP (JJ clinical) (NN practice))) (S (VP (TO to) (VP (VB treat) (NP (NNS Doc_12600698_324_343_Disease)))))))) (. .)))
12600698	3	(ROOT (S (S (NP (NNP Doc_12600698_345_357_Chemical)) (VP (VBD was) (VP (VBN administered) (PP (TO to) (NP (DT the) (JJ inner) (NN ear))) (PP (IN by) (NP (NP (JJ osmotic) (NN pump)) (PP (IN for) (NP (CD 24) (NN h)))))))) (, ,) (CC and) (S (NP (NP (NP (NNS Doc_12600698_422_431_Chemical)) (PRN (-LRB- -LRB-) (VP (VBN n) (S (VP (SYM =) (NP (CD 8))))) (-RRB- -RRB-))) (CC or) (NP (NP (NN saline)) (PRN (-LRB- -LRB-) (VP (VBN n) (S (VP (SYM =) (NP (CD 6))))) (-RRB- -RRB-)))) (VP (VBD was) (ADVP (RB intraperitoneally)) (VP (VBN injected) (NP (RB once) (DT a) (NN day)) (PP (IN for) (NP (CD 7) (NNS days)))))) (. .)))
12600698	4	(ROOT (S (NP (PRP We)) (VP (VBD observed) (NP (JJ horizontal) (JJ vestibulo-ocular) (NNS reflex)) (PP (IN as) (NP (NP (DT a) (NN marker)) (PP (IN of) (NP (JJ postoperative) (NN vestibular) (NN function)))))) (. .)))
12600698	5	(ROOT (S (NP (NP (NNS Animals)) (VP (VBN injected) (PP (IN with) (NP (NN saline))))) (VP (VBD showed) (NP (ADJP (RB statistically) (JJR smaller)) (NNS gains)) (PP (IN than) (NP (NP (DT those)) (VP (VBN injected) (PP (IN with) (NP (NNS Doc_12600698_694_703_Chemical))))))) (. .)))
12600698	6	(ROOT (S (NP (DT These) (NNS results)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NNS Doc_12600698_732_741_Chemical)) (VP (VBZ suppresses) (NP (NNS Doc_12600698_753_765_Chemical-induced)) (ADVP (RB vestibulotoxicity)))))) (. .)))
12691807	0	(ROOT (NP (NP (JJ Doc_12691807_0_8_Chemical-induced) (NN oromandibular) (NNS Doc_12691807_31_39_Disease)) (PP (IN in) (NP (NNS Doc_12691807_43_73_Disease))) (. .)))
12691807	1	(ROOT (S (NP (JJ Doc_12691807_75_83_Chemical-induced) (NNS Doc_12691807_92_103_Disease)) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (PP (IN in) (NP (NNS Doc_12691807_126_145_Disease) (CC and) (NNS Doc_12691807_150_173_Disease)))))) (. .)))
12691807	2	(ROOT (S (NP (JJ Cranial) (NNS Doc_12691807_183_192_Disease)) (VP (VBP are) (ADJP (JJ rare) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (NNS Doc_12691807_219_249_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_12691807_251_254_Disease)) (-RRB- -RRB-)))))))) (. .)))
12691807	3	(ROOT (S (PP (IN In) (NP (DT this) (NN report))) (NP (PRP we)) (VP (VBP describe) (NP (NP (DT an) (JJ unusual) (NN case)) (PP (IN of) (NP (NP (ADJP (JJ reversible) (JJ Doc_12691807_314_322_Chemical-induced)) (NNS Doc_12691807_331_353_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_12691807_355_358_Disease)) (-RRB- -RRB-))))) (PP (IN in) (NP (DT a) (JJ Doc_12691807_365_368_Disease) (NN patient) (S (VP (TO to) (VP (VP (VB highlight) (NP (NP (DT the) (NN importance)) (PP (IN of) (S (VP (VBG recognizing) (NP (NP (DT this) (NN drug) (JJ related) (NN complication)) (PP (IN in) (NP (NP (DT the) (NN management)) (PP (IN of) (NP (NNS Doc_12691807_472_475_Disease))))))))))) (, ,) (CC and) (VP (VB discuss) (NP (DT the) (JJ possible) (VBG underlying) (NN pathophysiology))))))))) (. .)))
12734532	0	(ROOT (NP (NP (NN Case) (NN report)) (: :) (NP (NP (NP (NNS Doc_12734532_13_21_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_12734532_23_42_Chemical)) (-RRB- -RRB-))) (PP (IN as) (NP (NP (DT a) (NN cause)) (PP (IN of) (NP (NNS Doc_12734532_58_79_Disease)))))) (. .)))
12734532	1	(ROOT (S (NP (NP (NNP Doc_12734532_81_100_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_12734532_102_105_Chemical)) (-RRB- -RRB-))) (VP (VBZ is) (NP (NP (DT a) (JJ sympathetic) (NNS Doc_12734532_124_129_Chemical)) (VP (VBN used) (PP (IN in) (NP (NP (JJ over-the-counter) (JJ cold) (NNS remedies)) (CC and) (NP (JJ weight-control) (NNS preparations)))) (ADVP (RB worldwide))))) (. .)))
12734532	2	(ROOT (S (NP (PRP$ Its) (NN use)) (VP (VBZ has) (VP (VBN been) (VP (VBN associated) (PP (IN with) (NP (JJ Doc_12734532_245_257_Disease) (NNS episodes) (CC and) (NNS Doc_12734532_271_290_Disease))) (PP (IN in) (NP (JJR younger) (NNS women)))))) (. .)))
12734532	3	(ROOT (S (NP (JJ Several) (NNS reports)) (VP (VBP have) (VP (VBN linked) (NP (NP (DT the) (NN abuse)) (PP (IN of) (NP (NNS Doc_12734532_350_353_Chemical)))) (PP (IN with) (NP (NP (NNS Doc_12734532_359_376_Disease)) (, ,) (SBAR (WHADVP (RB especially) (WRB when)) (S (NP (NNS Doc_12734532_394_402_Disease)) (VP (VBZ is) (ADJP (VBN involved))))))))) (. .)))
12734532	4	(ROOT (S (NP (PRP We)) (VP (VBP report) (NP (ADVP (RB here)) (NP (NP (DT the) (JJ first) (NN case)) (PP (IN of) (NP (NP (NNS Doc_12734532_449_457_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_12734532_459_462_Chemical)) (-RRB- -RRB-))))) (: -) (NP (NP (JJ induced) (NNS Doc_12734532_472_489_Disease)) (PP (IN in) (NP (DT a) (JJ young) (NN woman))) (SBAR (WHNP (WP who)) (S (VP (VBD was) (VP (VBG using) (NP (PRP it)) (PP (IN at) (NP (NP (VBN recommended) (NNS doses)) (PP (IN for) (NP (NN weight) (NN control)))))))))))) (. .)))
12734532	5	(ROOT (S (PP (IN In) (NP (NN addition))) (, ,) (NP (PRP we)) (VP (VBP review) (NP (NP (DT the) (CD 7) (JJ other) (NNS cases)) (PP (IN of) (NP (JJ Doc_12734532_609_612_Chemical) (JJ related) (NNS Doc_12734532_621_638_Disease))) (SBAR (WHNP (WDT that)) (S (VP (VBP have) (VP (VBN been) (VP (VBN reported) (ADVP (RB so) (RB far))))))))) (. .)))
12734532	6	(ROOT (S (NP (NP (NNP Physicians)) (CC and) (NP (NNS patients))) (VP (MD should) (VP (VB be) (ADJP (JJ alert) (PP (TO to) (NP (NP (DT the) (JJ potential) (JJ cardiac) (NN risk)) (VP (VBN associated) (PP (PP (IN with) (NP (NP (DT the) (NN use)) (PP (IN of) (NP (NNS Doc_12734532_768_771_Chemical))))) (, ,) (RB even) (PP (IN at) (NP (NP (NNS doses)) (VP (ADVP (RB generally)) (VBN considered) (S (VP (TO to) (VP (VB be) (ADJP (JJ safe))))))))))))))) (. .)))
12739036	0	(ROOT (S (NP (NP (JJ Differential) (NN diagnosis)) (PP (IN of) (NP (JJ high) (NN serum) (NNS Doc_12739036_37_45_Chemical)))) (VP (VBP kinase) (NP (NP (NNS levels)) (PP (IN in) (NP (NNS Doc_12739036_63_91_Disease))))) (. .)))
12739036	1	(ROOT (S (NP (PRP We)) (VP (VBP report) (NP (DT the) (JJ clinical) (CC and) (JJ bioptic) (NNS findings)) (PP (IN for) (NP (NP (DT a) (JJ 57-year-old) (NN woman)) (PP (IN with) (NP (JJ severe) (NN Doc_12739036_173_184_Chemical-induced) (NNS Doc_12739036_193_201_Disease)))))) (. .)))
12739036	2	(ROOT (S (PP (IN Since) (NP (CD 1989))) (, ,) (NP (PRP she)) (VP (VBD had) (VP (VP (VBN been) (VP (VBG suffering) (PP (IN from) (NP (NP (NP (NNS Doc_12739036_243_271_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_12739036_273_276_Disease)) (-RRB- -RRB-))) (PP (IN with) (NP (NNS Doc_12739036_283_300_Disease))))))) (CC and) (VP (VBN undergone) (NP (NP (NNS periods)) (PP (IN of) (NP (NN treatment)))) (PP (IN with) (NP (NNS Doc_12739036_341_353_Chemical) (CC and) (NNS Doc_12739036_358_374_Chemical)))))) (. .)))
12739036	3	(ROOT (S (NP (NP (JJ Additional) (NN therapy)) (PP (IN with) (NP (NP (NNS Doc_12739036_400_411_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP CQ)) (-RRB- -RRB-))))) (VP (VBD was) (VP (VBN started) (PP (RB because) (IN of) (NP (NNS Doc_12739036_440_450_Disease))))) (. .)))
12739036	4	(ROOT (S (PP (IN At) (NP (NP (DT the) (JJ same) (NN time)) (, ,) (NP (NP (RB slightly) (VBN increased) (JJ Doc_12739036_489_497_Chemical) (NN kinase)) (PRN (-LRB- -LRB-) (NP (NNP CK)) (-RRB- -RRB-))))) (NP (NNS levels)) (VP (VBD were) (VP (VBN noted))) (. .)))
12739036	5	(ROOT (S (S (NP (NNP Doc_12739036_529_537_Disease)) (VP (VBD was) (VP (VBN suspected)))) (, ,) (CC and) (S (NP (DT the) (NN patient)) (VP (VBD was) (VP (VBN treated) (PP (IN with) (NP (NNS Doc_12739036_586_594_Chemical)))))) (. .)))
12739036	6	(ROOT (S (S (NP (DT The) (NNP CK) (NN increase)) (VP (VBD persisted) (, ,) (ADVP (RB however)))) (, ,) (CC and) (S (NP (PRP she)) (VP (VBD developed) (NP (JJ progressive) (NNS Doc_12739036_662_679_Disease) (CC and) (NNS Doc_12739036_684_700_Disease)))) (. .)))
12739036	7	(ROOT (S (NP (JJ Routine) (NNS controls)) (VP (VBD revealed) (NP (NP (ADJP (RB markedly) (JJ elevated)) (NN CK) (NNS levels)) (PP (IN of) (NP (CD 1,700) (NNS U/l))))) (. .)))
12739036	8	(ROOT (S (NP (DT The) (JJ neurological) (CC and) (JJ electrophysiological) (NNS findings)) (VP (VBD were) (RB not) (ADJP (JJ typical) (PP (IN of) (NP (NNS Doc_12739036_841_849_Disease))))) (. .)))
12739036	9	(ROOT (S (ADVP (RB Thus)) (, ,) (NP (NP (NN muscle) (NN biopsy)) (PP (IN of) (NP (DT the) (JJ deltoid) (NN muscle)))) (VP (VBD was) (VP (VBN performed) (PP (IN in) (NP (NN order))) (S (VP (TO to) (VP (VB exclude) (NP (JJ Doc_12739036_927_939_Disease) (CC or) (JJ toxic) (NNS Doc_12739036_949_957_Disease))))))) (. .)))
12739036	10	(ROOT (S (SBAR (IN As) (S (NP (PRP it)) (VP (VBD revealed) (NP (NN Doc_12739036_974_985_Chemical-induced) (NNS Doc_12739036_994_1002_Disease))))) (, ,) (NP (NN medication)) (VP (VBD was) (VP (VBN stopped))) (. .)))
12739036	11	(ROOT (S (S (VP (VBG Discriminating) (PP (IN between) (NP (JJ primary) (NN Doc_12739036_1059_1062_Disease-induced) (NNS Doc_12739036_1071_1110_Disease))))) (CC and) (S (NP (JJ drug-induced) (NN side) (NNS effects)) (VP (VBZ is) (ADJP (JJ important) (PP (IN for) (NP (NP (JJ appropriate) (NN treatment)) (PP (IN of) (NP (JJ Doc_12739036_1183_1186_Disease) (NNS patients)))))))) (. .)))
12745515	0	(ROOT (S (NP (NNP Doc_12745515_0_7_Disease)) (VP (VBN associated) (PP (IN with) (NP (JJ Doc_12745515_24_41_Disease) (CC and) (JJ sustained-release) (NNS Doc_12745515_64_73_Chemical)))) (. .)))
12745515	1	(ROOT (S (NP (DT This) (NN case) (NN report)) (VP (VBZ describes) (NP (NP (DT a) (JJ generalized) (NNS Doc_12745515_116_123_Disease)) (VP (VBN associated) (PP (IN with) (NP (NP (JJ sustained-release) (JJ Doc_12745515_158_167_Chemical) (NN use)) (CC and) (NP (NNS Doc_12745515_176_193_Disease))))))) (. .)))
12745515	2	(ROOT (S (NP (NP (DT The) (NN subject)) (, ,) (NP (DT a) (JJ 31-year-old) (JJ female) (NN smoker)) (, ,)) (VP (VBD was) (VP (VBG participating) (PP (IN in) (NP (NP (DT a) (JJ clinical) (NN trial)) (VP (VBG evaluating) (NP (NP (DT an) (JJ investigational) (NN medication)) (PP (IN for) (NP (NN smoking) (NN cessation))) (SBAR (WHNP (WDT that)) (S (VP (VBD used) (NP (JJ sustained-release) (NNS Doc_12745515_366_375_Chemical)) (PP (IN as) (NP (DT an) (JJ active) (NN control)))))))))))) (. .)))
12745515	3	(ROOT (S (PP (IN After) (NP (NP (CD 5) (NNS weeks)) (PP (IN of) (NP (JJ Doc_12745515_415_424_Chemical) (NN use))))) (, ,) (NP (DT the) (NN subject)) (VP (VBD experienced) (NP (DT a) (JJ generalized) (JJ tonic) (JJ clonic) (NNS Doc_12745515_481_488_Disease)) (PP (IN after) (S (VP (VP (VBG staying) (PRT (RP up)) (NP (RB nearly) (DT all) (NN night) (NN packing))) (CC and) (VP (VBG moving) (PP (TO to) (NP (DT a) (JJ new) (NN residence)))))))) (. .)))
12745515	4	(ROOT (S (NP (DT The) (NN patient)) (VP (VBD had) (NP (NP (DT no) (JJ other) (NN risk) (NNS factors)) (PP (IN for) (NP (NNS Doc_12745515_604_612_Disease))))) (. .)))
12745515	5	(ROOT (S (NP (PRP We)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NNS Doc_12745515_630_647_Disease)) (VP (MD may) (VP (VB add) (PP (TO to) (NP (NP (DT the) (NN risk)) (PP (IN of) (NP (NN Doc_12745515_671_680_Chemical-associated) (NNS Doc_12745515_692_700_Disease)))))))))) (. .)))
12760988	0	(ROOT (NP (NP (NP (NNP Doc_12760988_0_21_Disease)) (PP (IN after) (NP (NNS Doc_12760988_28_43_Chemical)))) (: :) (NP (NP (DT no) (NN evidence)) (PP (IN for) (NP (DT an) (JJ inflammatory) (NN origin)))) (. .)))
12760988	1	(ROOT (S (NP (NP (DT A) (JJ common) (NN side) (NN effect)) (VP (VBN associated) (PP (IN with) (NP (NNS Doc_12760988_122_137_Chemical))))) (VP (VBZ is) (NP (NNS Doc_12760988_141_162_Disease))) (. .)))
12760988	2	(ROOT (S (S (NP (NP (DT The) (NNS pathogenesis)) (PP (IN of) (NP (DT this) (NNS Doc_12760988_189_196_Disease)))) (VP (VBZ is) (ADVP (RB still)) (ADJP (JJ unclear)))) (: ;) (S (NP (NNS Doc_12760988_215_227_Disease)) (VP (VBZ has) (VP (VBN been) (VP (VBN suggested) (PP (CC but) (PP (IN without) (S (VP (VBG convincing) (NP (NN evidence)))))))))) (. .)))
12760988	3	(ROOT (S (NP (PRP We)) (VP (VBD designed) (NP (DT the) (JJ present) (NN study)) (S (VP (TO to) (VP (VB investigate) (SBAR (IN whether) (S (NP (DT an) (JJ inflammatory) (NN reaction)) (VP (VBZ contributes) (PP (TO to) (NP (DT this) (NNS Doc_12760988_378_385_Disease)))))))))) (. .)))
12760988	4	(ROOT (S (NP (NP (DT The) (NN incidence) (CC and) (NN severity)) (PP (IN of) (NP (NN Doc_12760988_417_432_Chemical-associated) (NNS Doc_12760988_444_451_Disease)))) (VP (VBD was) (VP (VBN determined) (PP (IN in) (NP (NP (CD 64) (NNS patients)) (VP (VBN pretreated) (PP (IN with) (NP (NN saline) (CC or) (NNS Doc_12760988_508_521_Chemical))) (PP (IN before) (NP (NP (NNS Doc_12760988_529_544_Chemical)) (PRN (-LRB- -LRB-) (VP (VBN n) (S (VP (SYM =) (NP (CD 32)))) (PP (IN for) (NP (DT each)))) (-RRB- -RRB-))))))))) (. .)))
12760988	5	(ROOT (S (S (NP (NP (NN Incidence) (CC and) (NN severity)) (PP (IN of) (NP (NNS Doc_12760988_590_597_Disease)))) (VP (VBD did) (RB not) (VP (VB differ) (ADVP (RB significantly)) (PP (IN between) (NP (DT the) (CD two) (NNS groups)))))) (: :) (S (S (NP (NP (CD 15) (NNS patients)) (PP (IN in) (NP (DT the) (JJ Doc_12760988_670_683_Chemical) (NN group)))) (VP (VBD complained) (PP (IN of) (NP (NNS Doc_12760988_704_711_Disease))) (PP (VBN compared) (PP (IN with) (NP (NP (CD 18) (NNS patients)) (PP (IN in) (NP (DT the) (JJ saline) (NN group)))))))) (, ,) (CC and) (S (NP (JJ severe) (NNS Doc_12760988_770_777_Disease)) (VP (VBD was) (VP (VBN reported) (PP (IN by) (NP (NP (CD five) (NNS patients)) (CC and) (NP (CD three) (NNS patients))) (, ,) (ADVP (RB respectively))) (PRN (-LRB- -LRB-) (FRAG (RB not) (ADJP (JJ significant))) (-RRB- -RRB-)))))) (. .)))
12760988	6	(ROOT (S (PP (IN At) (NP (CD 48) (NN h))) (PP (IN after) (NP (NN surgery))) (, ,) (NP (NP (CD 12) (NNS patients)) (PP (IN in) (NP (DT both) (NNS groups)))) (ADVP (RB still)) (VP (VBN suffered) (PP (IN from) (NP (NNS Doc_12760988_930_937_Disease))) (PRN (-LRB- -LRB-) (FRAG (RB not) (ADJP (JJ significant))) (-RRB- -RRB-))) (. .)))
12760988	7	(ROOT (S (PP (IN In) (NP (NN addition))) (, ,) (NP (NP (JJ interleukin-6) (-LRB- -LRB-) (NN IL-6) (-RRB- -RRB-)) (PP (IN as) (NP (NP (DT an) (JJ early) (NN marker)) (PP (IN of) (NP (NNS Doc_12760988_1013_1025_Disease)))))) (VP (VBD was) (VP (VBN assessed) (PP (IN in) (NP (NP (DT a) (NN subgroup)) (PP (IN of) (NP (NP (CD 10) (NNS patients)) (VP (VBN pretreated) (PP (IN with) (NP (NN saline)))))))))) (. .)))
12760988	8	(ROOT (S (S (S (NP (PRP We)) (VP (VBD found) (NP (NP (DT an) (NN increase)) (PP (IN of) (NP (NN IL-6)))) (PP (IN for) (NP (RB only) (CD three) (NNS patients))))) (, ,) (CC but) (S (NP (RB only) (CD one) (NN patient)) (VP (VBD reported) (NP (NNS Doc_12760988_1176_1183_Disease))))) (: ;) (S (NP (NP (DT no) (NN relationship)) (PP (IN between) (NP (NP (NNS Doc_12760988_1209_1216_Disease)) (CC and) (NP (NP (DT the) (NN increase)) (PP (IN of) (NP (NN IL-6))))))) (VP (VBD was) (VP (VBN found)))) (. .)))
12760988	9	(ROOT (S (PP (IN In) (NP (NN conclusion))) (, ,) (NP (EX there)) (VP (VBZ is) (NP (NP (DT no) (NN evidence)) (PP (IN for) (NP (NP (DT an) (JJ inflammatory) (NN origin)) (PP (IN of) (NP (NN Doc_12760988_1319_1334_Chemical-associated) (NNS Doc_12760988_1346_1353_Disease))))))) (. .)))
12760988	10	(ROOT (S (NP (NP (NNP Administration)) (PP (IN of) (NP (NP (NNS Doc_12760988_1387_1400_Chemical)) (PP (IN before) (NP (NNS Doc_12760988_1408_1423_Chemical)))))) (VP (VBD was) (RB not) (ADJP (JJ effective) (PP (IN in) (S (VP (VBG decreasing) (NP (NP (DT the) (NN incidence)) (CC or) (NP (NP (DT the) (NN severity)) (PP (IN of) (NP (NN Doc_12760988_1489_1504_Chemical-induced) (NNS Doc_12760988_1513_1534_Disease)))))))))) (. .)))
12760988	11	(ROOT (S (ADVP (RB Furthermore)) (, ,) (NP (EX there)) (VP (VBD was) (NP (NP (DT no) (JJ significant) (NN relationship)) (PP (IN between) (NP (NNS Doc_12760988_1595_1616_Disease) (CC and) (NN time) (NN course))) (PP (IN of) (NP (NP (JJ interleukin-6) (NNS concentrations)) (, ,) (NP (NP (DT a) (NN marker)) (PP (IN of) (NP (NNS Doc_12760988_1678_1690_Disease)))))))) (. .)))
12760988	12	(ROOT (S (NP (NP (NNP Pretreatment)) (PP (IN with) (NP (NNS Doc_12760988_1710_1723_Chemical)))) (VP (VBZ is) (RB not) (ADJP (JJ justified) (S (VP (TO to) (VP (VB prevent) (NP (NNS Doc_12760988_1752_1773_Disease)) (PP (IN after) (NP (NNS Doc_12760988_1780_1795_Chemical)))))))) (. .)))
12842176	0	(ROOT (S (NP (NP (NN Effect)) (PP (IN of) (NP (NP (NP (NNS Doc_12842176_10_17_Chemical)) (PP (IN on) (NP (JJ hepatic) (CC and) (NN brain) (NN cytochrome) (NNS P450s)))) (CC and) (NP (NP (NN influence)) (PP (IN of) (NP (NNP P450))))))) (VP (VBN modulation) (PP (IN in) (NP (JJ Doc_12842176_92_99_Chemical) (JJ induced) (NNS Doc_12842176_108_121_Disease)))) (. .)))
12842176	1	(ROOT (S (NP (NP (JJ Oral) (NN administration)) (PP (IN of) (NP (NP (NP (NNS Doc_12842176_146_153_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (CD 2.5)) (, ,) (NP (NP (CD 5)) (, ,) (NP (CD 10)) (CC and) (NP (CD 15) (NN mg/kg))) (, ,) (NP (NN body) (NN weight))) (-RRB- -RRB-))) (PP (IN for) (NP (CD 5) (NNS days)))))) (VP (VBD was) (VP (VBN found) (S (VP (TO to) (VP (VB produce) (NP (NP (DT a) (JJ dose-dependent) (NN increase)) (PP (IN in) (NP (NP (DT the) (NN activity)) (PP (IN of) (NP (NP (NP (CD P450) (JJ dependent) (NNS Doc_12842176_285_302_Chemical-Doc_12842176_303_304_Chemical-deethylase)) (PRN (-LRB- -LRB-) (NP (NNP EROD)) (-RRB- -RRB-))) (, ,) (NP (NP (NNS Doc_12842176_324_342_Chemical-Doc_12842176_343_344_Chemical-dealkylase)) (PRN (-LRB- -LRB-) (NP (NNP PROD)) (-RRB- -RRB-))) (CC and) (NP (NP (JJ Doc_12842176_367_389_Chemical) (NN demethylase)) (PRN (-LRB- -LRB-) (NP (NNP Doc_12842176_403_407_Chemical-d)) (-RRB- -RRB-)))))))) (PP (IN in) (NP (NN rat) (NN brain) (CC and) (NN liver)))))))) (. .)))
12842176	2	(ROOT (S (NP (NP (DT A) (JJ significant) (NN increase)) (PP (IN in) (NP (DT the) (NN hepatic) (CC and) (NN brain) (NN P450) (NNS monooxygenases)))) (VP (VBD was) (ADVP (RB also)) (VP (VBN observed) (SBAR (WHADVP (WRB when)) (S (NP (NP (DT the) (NN duration)) (PP (IN of) (NP (NP (NN exposure)) (PP (IN of) (NP (NP (NP (JJ low) (NN dose)) (PRN (-LRB- -LRB-) (NP (CD 2.5) (NN mg/kg)) (-RRB- -RRB-))) (PP (IN of) (NP (NNS Doc_12842176_578_585_Chemical)))))))) (VP (VBD was) (VP (VBN increased) (PP (IN from) (NP (CD 5) (NNS days))) (PP (TO to) (NP (QP (CD 15) (CC or) (CD 21)) (NNS days))))))))) (. .)))
12842176	3	(ROOT (S (S (NP (NNP Doc_12842176_630_632_Chemical)) (VP (VBD observed) (PP (IN with) (NP (JJ different) (NNS doses))))) (, ,) (NP (NP (DT the) (NN magnitude)) (PP (IN of) (NP (NP (NN induction)) (PP (IN in) (NP (NP (DT the) (NN activity)) (PP (IN of) (NP (CD P450) (NNS monooxygenases)))))))) (VP (VBD was) (ADJP (ADJP (NP (QP (JJ several) (CD fold))) (JJR higher) (PP (IN in) (NP (NN liver) (NNS microsomes)))) (SBAR (WHADVP (WRB when)) (S (VP (VBN compared) (PP (IN with) (NP (DT the) (NN brain)))))))) (. .)))
12842176	4	(ROOT (S (NP (JJ Western) (VBG blotting) (NNS studies)) (VP (VBP have) (VP (VBN indicated) (SBAR (IN that) (S (NP (NP (DT the) (NN increase)) (PP (IN in) (NP (DT the) (CD P450) (NNS enzymes)))) (VP (MD could) (VP (VB be) (ADJP (JJ due) (PP (TO to) (NP (NP (DT the) (NN increase)) (PP (IN in) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (NP (NNP P450) (CD 1A1/1A2) (, ,) (CD 2B1/2B2)) (CC and) (NP (CD 2E1) (NNS isoenzymes))))))))))))))) (. .)))
12842176	5	(ROOT (S (PP (IN In) (S (NP (JJ vitro) (NNS studies)) (VP (VBG using) (NP (JJ organic) (NNS inhibitors))))) (NP (NP (JJ specific)) (PP (IN for) (NP (JJ individual) (NN P450) (NNS isoenzymes) (CC and) (NN antibody) (NN inhibition) (NNS experiments)))) (VP (VBP have) (ADVP (RBR further)) (VP (VBN demonstrated) (SBAR (IN that) (S (NP (NP (DT the) (NN increase)) (PP (IN in) (NP (NP (DT the) (NN activity)) (PP (IN of) (NP (NN PROD) (, ,) (NNS Doc_12842176_1161_1165_Chemical) (CC and) (NNS Doc_12842176_1170_1174_Chemical-d)))))) (VP (VBP are) (ADJP (JJ due) (PP (TO to) (NP (NP (DT the) (NN increase)) (PP (IN in) (NP (NP (DT the) (NNS levels)) (PP (IN of) (NP (NP (NNP P450) (CD 2B1/2B2) (, ,) (CD 1A1/1A2)) (CC and) (NP (CD 2E1) (NNS isoenzymes))))))))) (, ,) (ADVP (RB respectively))))))) (. .)))
12842176	6	(ROOT (S (NP (NN Induction) (NNS studies)) (VP (VBP have) (ADVP (RBR further)) (VP (VBN shown) (SBAR (IN that) (S (SBAR (IN while) (S (NP (NP (NP (NN pretreatment)) (PP (IN of) (NP (NP (NNS Doc_12842176_1338_1358_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP MC)) (-RRB- -RRB-))))) (, ,) (NP (NP (DT an) (NN inducer)) (PP (IN of) (NP (NNP P4501A1/1A2)))) (, ,)) (VP (VBD did) (RB not) (VP (VB produce) (NP (DT any) (JJ significant) (NN effect)) (PP (IN in) (NP (NP (NP (DT the) (NN incidence)) (PP (IN of) (NP (JJ Doc_12842176_1451_1458_Chemical) (JJ induced) (NNS Doc_12842176_1467_1478_Disease)))) (, ,) (NP (NP (NN pretreatment)) (PP (IN with) (NP (NP (NNS Doc_12842176_1498_1511_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP PB)) (-RRB- -RRB-))))) (, ,) (NP (NP (DT an) (NN inducer)) (PP (IN of) (NP (NNP P450) (CD 2B1/2B2)))) (CC or) (NP (NP (NNS Doc_12842176_1548_1555_Chemical)) (, ,) (NP (NP (DT an) (NN inducer)) (PP (IN of) (NP (QP (CD P450) (CD 2E1)) (JJ catalysed) (NNS reactions))))))))))) (, ,) (ADVP (RB significantly)) (VP (VBD increased) (NP (NP (DT the) (NN incidence)) (PP (IN of) (NP (JJ Doc_12842176_1642_1649_Chemical) (JJ induced) (NNS Doc_12842176_1658_1669_Disease))))))))) (. .)))
12842176	7	(ROOT (S (ADVP (RB Similarly)) (, ,) (S (SBAR (WHADVP (WRB when)) (S (NP (NP (DT the) (NN P450-mediated) (NN metabolism)) (PP (IN of) (NP (NNS Doc_12842176_1719_1726_Chemical)))) (VP (VBD was) (VP (VBN blocked) (PP (IN by) (NP (NP (JJ Doc_12842176_1742_1757_Chemical) (NN incidence)) (PP (IN of) (NP (NNS Doc_12842176_1771_1782_Disease))))))))) (VP (VBD was) (VP (VBN increased) (PP (IN in) (NP (NP (NNS animals)) (VP (VBN treated) (PP (IN with) (NP (NP (NP (NNS Doc_12842176_1821_1828_Chemical)) (VP (VBG indicating) (NP (DT that) (NNS Doc_12842176_1845_1852_Chemical)) (ADVP (FW per) (FW se)))) (CC or) (NP (NP (PRP$ its) (NNS metabolites)) (VP (VBN formed) (PP (IN by) (NP (NNP PB))))))))))))) (CC or) (S (NP (JJ Doc_12842176_1895_1902_Chemical) (JJ inducible) (NN P450) (NNS isoenzymes)) (VP (VBP are) (VP (VBN involved) (PP (IN in) (NP (PRP$ its) (JJ neurobehavioral) (NNS Doc_12842176_1965_1973_Disease)))))) (. .)))
12851669	0	(ROOT (NP (NP (JJ Absolute) (CC and) (JJ attributable) (NN risk)) (PP (IN of) (NP (NP (NNS Doc_12851669_34_56_Disease)) (PP (IN in) (NP (NP (NNS women)) (PP (IN on) (NP (VBN combined) (NNS Doc_12851669_78_97_Chemical) (CC and) (NNS Doc_12851669_102_118_Chemical))))))) (. .)))
12851669	1	(ROOT (S (VP (TO To) (VP (VB achieve) (NP (NP (JJ absolute) (NN risk) (NNS estimates)) (PP (IN of) (NP (NP (NP (NNS Doc_12851669_169_191_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_12851669_193_196_Disease)) (-RRB- -RRB-))) (PP (PP (IN among) (NP (NP (NNS women)) (PP (IN on) (NP (NP (NNP Doc_12851669_213_232_Chemical) (CC plus) (NNP Doc_12851669_238_254_Chemical)) (PRN (-LRB- -LRB-) (NP (JJ Doc_12851669_256_259_Chemical) (JJ /) (NNS Doc_12851669_260_262_Chemical)) (-RRB- -RRB-)))))) (, ,) (CC and) (PP (IN among) (NP (NP (NNS women)) (PP (IN on) (NP (VBN combined) (NNS Doc_12851669_293_312_Chemical)))))) (PRN (-LRB- -LRB-) (NP (NNP Doc_12851669_314_318_Chemical)) (-RRB- -RRB-))))))) (. .)))
12851669	2	(ROOT (S (PP (IN From) (NP (NP (DT the) (JJ Danish) (NNP National) (NNP Register)) (PP (IN of) (NP (NP (NNS Patients)) (PRN (-LRB- -LRB-) (NP (NNP NRP)) (-RRB- -RRB-)))))) (, ,) (NP (NP (CD 1996) (TO to) (CD 1998)) (, ,) (NP (NP (DT the) (NNS records)) (PP (IN of) (NP (NP (QP (CD 1.1) (CD million)) (JJ Danish) (NNS women)) (, ,) (NP (NP (NNS ages)) (NP (QP (CD 15) (TO to) (CD 44)) (NNS years)))))) (, ,)) (VP (VBD were) (VP (VBN searched) (PP (IN for) (NP (NP (NN evidence)) (PP (IN of) (NP (NNS Doc_12851669_489_492_Disease))))))) (. .)))
12851669	3	(ROOT (S (NP (JJ Doc_12851669_494_497_Chemical) (NN use)) (VP (VBD was) (VP (VBN ascertained) (PP (IN through) (NP (JJ mailed) (NNS questionnaires))))) (. .)))
12851669	4	(ROOT (FRAG (NP (NP (NNS Sales) (NNS statistics)) (PP (IN of) (NP (NNS Doc_12851669_569_573_Chemical) (CC and) (NNS Doc_12851669_578_581_Chemical)))) (: /) (S (NP (NNS Doc_12851669_582_584_Chemical)) (VP (VBD were) (VP (VBN provided) (PP (IN through) (NP (JJ Danish) (NNP Drug) (NNPS Statistics)))))) (. .)))
12851669	5	(ROOT (S (PP (IN During) (NP (NP (DT the) (NN time) (NN frame)) (PP (IN of) (NP (DT the) (NN study))))) (, ,) (NP (CD 330) (NNS women)) (VP (VBD were) (VP (VBN found) (S (VP (TO to) (VP (VB have) (VP (VBN had) (NP (JJ Doc_12851669_709_712_Disease) (NN while)) (PP (IN on) (NP (NNS Doc_12851669_722_726_Chemical))))))))) (. .)))
12851669	6	(ROOT (S (PP (IN Of) (NP (DT these) (NNS women))) (, ,) (NP (CD 67)) (VP (VBD were) (PP (IN on) (NP (NN Doc_12851669_755_769_Chemical-containing) (NNS Doc_12851669_781_785_Chemical)))) (. .)))
12851669	7	(ROOT (S (NP (CD Eleven)) (VP (VBD were) (PP (IN on) (NP (JJ Doc_12851669_802_805_Chemical) (JJ /) (NNS Doc_12851669_806_808_Chemical)))) (. .)))
12851669	8	(ROOT (S (NP (NP (DT The) (JJ corresponding) (JJ absolute) (NN risk)) (PP (IN of) (NP (NNS Doc_12851669_845_848_Disease)))) (VP (VBD was) (NP (NP (NP (NP (CD 3.4)) (PRN (-LRB- -LRB-) (NP (NP (NN range)) (, ,) (NP (CD 3.1-3) (CD .8))) (-RRB- -RRB-))) (PP (IN per) (NP (NP (QP (CD 10) (CD 000)) (NNS women) (NNS years)) (PP (IN among) (NP (NP (DT the) (NNS women)) (PP (IN on) (NP (NNS Doc_12851669_916_920_Chemical)))))))) (, ,) (NP (NP (NP (CD 4.2)) (PRN (-LRB- -LRB-) (NP (NP (NN range)) (, ,) (NP (CD 3.2-5) (CD .2))) (-RRB- -RRB-))) (PP (IN per) (NP (NP (QP (CD 10) (CD 000)) (NNS women) (NNS years)) (PP (IN among) (NP (NP (NNS women)) (PP (IN on) (NP (NN Doc_12851669_981_995_Chemical-containing) (NNS Doc_12851669_1007_1011_Chemical)))))))) (, ,) (CC and) (NP (NP (NP (CD 3.1)) (PRN (-LRB- -LRB-) (NP (NP (NN range)) (, ,) (NP (CD 1.3-4) (CD .9))) (-RRB- -RRB-))) (PP (IN per) (NP (NP (QP (CD 10) (CD 000)) (NNS women) (NNS years)) (PP (IN among) (NP (NP (DT the) (NNS women)) (PP (IN on) (NP (JJ Doc_12851669_1080_1083_Chemical) (JJ /) (NNS Doc_12851669_1084_1086_Chemical)))))))))) (. .)))
12851669	9	(ROOT (S (NP (PRP$ Our) (NNS results)) (VP (VBP suggest) (SBAR (S (NP (NP (DT the) (JJ absolute) (NN risk)) (PP (IN of) (NP (NP (NNS Doc_12851669_1141_1144_Disease)) (PP (IN among) (NP (NP (JJ Danish) (NNS women)) (PP (IN on) (NP (NNS Doc_12851669_1167_1171_Chemical)))))))) (VP (VBZ is) (ADJP (JJ similar) (PP (TO to) (NP (NP (DT that)) (PP (IN among) (NP (NNS women)))))) (S (VP (VBG taking) (NP (JJ Doc_12851669_1210_1213_Chemical) (JJ /) (NNS Doc_12851669_1214_1216_Chemical)))))))) (. .)))
12852481	0	(ROOT (S (NP (NP (NNP Comparison)) (PP (IN of) (NP (NP (JJ developmental) (NN toxicology)) (PP (IN of) (NP (NNS Doc_12852481_42_49_Chemical))))) (PRN (-LRB- -LRB-) (NP (NNP Doc_12852481_51_71_Chemical)) (-RRB- -RRB-)) (PP (IN in) (NP (NP (NNS rats)) (VP (VBG using))))) (VP (VBD selected) (S (VP (VBG dosing) (NP (NNS paradigms))))) (. .)))
12852481	1	(ROOT (S (NP (NP (NP (NNP Analysis)) (PP (IN of) (NP (NP (DT the) (NN literature)) (PP (IN for) (NP (JJ nonsteroidal) (JJ anti-inflammatory) (NNS drugs)))))) (PRN (-LRB- -LRB-) (NP (NNP NSAIDs)) (-RRB- -RRB-))) (VP (VBZ suggests) (SBAR (IN that) (S (NP (NP (DT a) (JJ low) (NN incidence)) (PP (IN of) (NP (NNS Doc_12852481_236_259_Disease)))) (VP (VBZ occurs) (PP (IN in) (NP (NP (NNS rats)) (VP (VBN given) (NP (NP (NNP NSAIDs)) (PP (IN on) (NP (JJ specific) (NNS days)))) (PP (IN during) (NP (NNS organogenesis)))))))))) (. .)))
12852481	2	(ROOT (S (NP (NP (NP (NNP Doc_12852481_327_334_Chemical)) (PRN (-LRB- -LRB-) (NP (JJ Doc_12852481_336_356_Chemical) (NNP -LSB-) (NNP Doc_12852481_358_361_Chemical) (NNP -RSB-)) (-RRB- -RRB-))) (, ,) (NP (DT an) (JJ irreversible) (ADJP (JJ cyclooxygenase) (NP (CD 1) (CC and) (CD 2))) (NN inhibitor)) (, ,)) (VP (VBZ induces) (NP (NNS Doc_12852481_423_446_Disease)) (SBAR (WHADVP (WRB when)) (S (VP (VBN administered) (S (VP (TO to) (VP (VB Wistar) (NP (NP (NNS rats)) (PP (IN on) (NP (JJ gestational) (NN day))) (PRN (-LRB- -LRB-) (NP (NNP GD)) (-RRB- -RRB-)) (NP (NP (CD 9) (, ,) (CD 10) (, ,) (CC or) (CD 11)) (PRN (-LRB- -LRB-) (NP (NNP Kimmel) (NNP CA)) (, ,) (NP (NNP Wilson) (NNP JG))) (, ,) (NP (NNP Schumacher) (NNP HJ))))))))))) (. .)))
12852481	3	(ROOT (S (VP (ADVP (ADVP (RB Teratology)) (PRN (NP (NP (CD 4:15) (CD -24)) (, ,) (NP (CD 1971))) (-RRB- -RRB-)))) (. .)))
12852481	4	(ROOT (S (NP (EX There)) (VP (VBP are) (NP (NP (DT no) (VBN published) (JJ Doc_12852481_605_608_Chemical) (NNS studies)) (VP (VBG using) (NP (NP (DT the) (JJ multiple) (NN dosing) (NN paradigm)) (PP (IN of) (NP (NNP GDs) (CD 6)))) (PP (TO to) (NP (CD 17)))))) (. .)))
12852481	5	(ROOT (S (NP (NP (NNS Objectives)) (PP (IN of) (NP (DT the) (JJ current) (NN study)))) (VP (VBD were) (S (VP (TO to) (VP (VB compare) (NP (NP (NP (NNS results)) (PP (IN between) (NP (NP (NNP Sprague-Dawley)) (PRN (-LRB- -LRB-) (NP (NNP SD)) (-RRB- -RRB-))))) (CC and) (NP (NP (NNP Wistar) (NNS strains)) (SBAR (WHADVP (WRB when)) (S (NP (NNS Doc_12852481_776_779_Chemical)) (VP (VBZ is) (VP (VBN administered) (PP (IN on) (NP (NP (NNP GD) (CD 9) (, ,) (CD 10)) (, ,) (CC or) (NP (CD 11)) (: ;))) (S (VP (VP (TO to) (VP (VB compare) (NP (NP (DT the) (NN malformation) (NNS patterns)) (PP (VBG following) (NP (NP (JJ single) (CC and) (JJ multiple) (NNS dosings)) (PP (IN during) (NP (NP (NNS organogenesis)) (PP (IN in) (NP (NNP SD) (NNS rats)))))))))) (: ;) (CC and) (VP (TO to) (VP (VB test) (NP (DT the) (NNS hypothesis)) (SBAR (IN that) (S (NP (JJ maternal) (NNS Doc_12852481_965_990_Disease)) (VP (VBZ confounds) (NP (NP (DT the) (NN detection)) (PP (IN of) (NP (JJ low) (NN incidence) (NNS Doc_12852481_1032_1045_Disease)))) (PP (IN with) (NP (NP (NNS Doc_12852481_1051_1054_Chemical)) (SBAR (WHADVP (WRB when)) (S (NP (DT a) (JJ multiple) (NN dosing) (NN paradigm)) (VP (VBZ is) (VP (VBN used)))))))))))))))))))))))) (. .)))
12852481	6	(ROOT (S (NP (NNP Doc_12852481_1105_1108_Chemical)) (VP (VBD was) (VP (VBN administered) (PP (PP (IN as) (NP (NP (NP (DT a) (JJ single) (NN dose)) (PP (IN on) (NP (NNP GD) (CD 9))) (PRN (-LRB- -LRB-) (NP (NP (CD 0)) (, ,) (NP (CD 250)) (, ,) (NP (CD 500)) (, ,) (CC or) (NP (CD 625) (NN mg/kg))) (-RRB- -RRB-))) (, ,) (NP (NP (CD 10)) (PRN (-LRB- -LRB-) (NP (NP (CD 0)) (, ,) (NP (CD 500)) (, ,) (NP (CD 625)) (, ,) (CC or) (NP (CD 750) (NN mg/kg))) (-RRB- -RRB-))) (, ,) (CC or) (NP (NP (CD 11)) (PRN (-LRB- -LRB-) (NP (NP (CD 0)) (, ,) (NP (CD 500)) (, ,) (NP (CD 750)) (, ,) (CC or) (NP (CD 1000) (NN mg/kg))) (-RRB- -RRB-))))) (CC and) (PP (IN from) (NP (NNP GD) (CD 6)))) (PP (TO to) (NP (NP (NP (NNP GD) (CD 17)) (PRN (-LRB- -LRB-) (NP (NP (CD 0)) (, ,) (NP (CD 50)) (, ,) (NP (CD 125)) (, ,) (CC or) (NP (NP (CD 250) (NN mg/kg)) (NP (DT a) (NN day)))) (-RRB- -RRB-))) (PP (IN in) (NP (DT the) (JJ multiple) (NN dose) (NN study))))) (PP (TO to) (NP (NNP SD) (NNS rats))))) (. .)))
12852481	7	(ROOT (S (S (NP (NNS Animals)) (VP (VBD were) (VP (VBN killed) (PP (IN on) (NP (NNP GD) (CD 21)))))) (, ,) (CC and) (S (NP (NNS fetuses)) (VP (VBD were) (VP (VBN examined) (ADVP (RB viscerally))))) (. .)))
12852481	8	(ROOT (S (S (NP (DT The) (NN literature) (NN evaluation)) (VP (VBD suggested) (SBAR (IN that) (S (NP (NNP NSAIDs)) (VP (VB induce) (NP (NP (NNS Doc_12852481_1474_1500_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_12852481_1502_1506_Disease)) (-RRB- -RRB-)) (CC and) (NP (NP (NP (NNS Doc_12852481_1512_1527_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_12852481_1529_1532_Disease)) (-RRB- -RRB-))) (PP (IN in) (NP (NP (NNS rats) (CC and) (NNS Doc_12852481_1546_1566_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_12852481_1568_1570_Disease)) (-RRB- -RRB-)) (, ,) (NP (NNS Doc_12852481_1573_1576_Disease)) (, ,) (CC and) (NP (NP (NNS Doc_12852481_1582_1586_Disease)) (PP (IN in) (NP (NP (NNS rabbits)) (PRN (-LRB- -LRB-) (NP (NP (NNP Cook) (NNP JC) (CC et) (NNP al.)) (, ,) (NP (CD 2003))) (-RRB- -RRB-)))))))))))))) (: ;) (S (ADVP (RB hence)) (, ,) (NP (DT the) (JJ present) (NN study)) (VP (VBD focused) (PP (IN on) (NP (DT these) (NNS Doc_12852481_1664_1677_Disease))) (, ,) (SBAR (RB even) (IN though) (S (NP (NNS Doc_12852481_1691_1694_Chemical)) (VP (VBZ induces) (NP (JJ several) (JJ other) (JJ low-incidence) (NNS Doc_12852481_1731_1744_Disease))))))) (. .)))
12852481	9	(ROOT (S (PP (IN In) (NP (JJ single) (NN dose) (NNS studies))) (, ,) (NP (NNP Doc_12852481_1770_1772_Disease) (, ,) (NNP Doc_12852481_1774_1776_Disease) (, ,) (CC and) (NNP Doc_12852481_1782_1785_Disease)) (VP (VBD were) (VP (VBN induced) (PP (IN on) (NP (NNP GDs) (CD 9) (CC and) (CD 10))))) (. .)))
12852481	10	(ROOT (S (NP (NNP Doc_12852481_1816_1819_Disease)) (ADVP (RB also)) (VP (VBD was) (VP (VBN noted) (PP (VBG following) (NP (NP (NN treatment)) (PP (IN on) (NP (NNP GD) (CD 11))))))) (. .)))
12852481	11	(ROOT (S (PP (IN In) (NP (NN contrast))) (, ,) (S (NP (NNS Doc_12852481_1878_1880_Disease) (CC and) (NNS Doc_12852481_1885_1887_Disease)) (VP (VBD were) (VP (VBN noted) (PP (IN in) (NP (NP (DT the) (JJ multiple) (NN dose) (NN study) (NN design)) (PP (RB only) (IN in) (NP (DT the) (JJ high-dose) (NN group)))))))) (, ,) (CC and) (S (NP (NNS Doc_12852481_1966_1969_Disease)) (VP (VBD was) (VP (VBN noted) (PP (IN across) (NP (DT all) (NN dose) (NNS groups)))))) (. .)))
12852481	12	(ROOT (S (NP (NP (JJ High) (NN concordance)) (PP (IN in) (NP (NP (JJ major) (NNS Doc_12852481_2043_2066_Disease)) (PP (IN between) (NP (NNP Wistar) (CC and) (NNP SD) (NNS rats)))))) (VP (VBD were) (VP (VBN noted) (PP (IN with) (NP (NP (DT the) (NN exception)) (PP (IN of) (NP (NP (NNS Doc_12852481_2127_2130_Disease)) (PP (IN in) (NP (DT the) (NNP SD) (NNS rats) (CC and) (NNS Doc_12852481_2150_2163_Disease))))))) (PP (IN in) (NP (DT the) (NNP Wistar) (NNS rats))))) (. .)))
12852481	13	(ROOT (S (NP (NNS Variations) (CC and) (NNS Doc_12852481_2199_2212_Disease)) (VP (VBD were) (ADJP (JJ similar)) (SBAR (WHADVP (WRB when)) (S (NP (NNS Doc_12852481_2231_2234_Chemical)) (VP (VBD was) (VP (VBN administered) (PP (PP (IN as) (NP (DT a) (JJ single) (NN dose))) (CC or) (PP (IN during) (NP (NP (DT the) (NN period)) (PP (IN of) (NP (NP (NNS organogenesis)) (PRN (-LRB- -LRB-) (NP (NNP GDs) (QP (CD 6) (TO to) (CD 17))) (-RRB- -RRB-)))))))))))) (. .)))
12852481	14	(ROOT (S (NP (PRP It)) (VP (VBD was) (ADVP (RB also)) (ADJP (JJ evident) (SBAR (WHNP (WDT that)) (S (, ,) (PP (IN by) (S (VP (VBG titrating) (NP (DT the) (NN dose) (S (VP (TO to) (VP (VB achieve) (NP (NP (DT a) (JJ maximum) (JJ tolerated) (NN dose)) (, ,) (NP (NP (NNS Doc_12852481_2407_2420_Disease)) (SBAR (WHNP (WDT that)) (S (ADVP (RB normally)) (VP (VBP occur) (PP (IN at) (NP (JJ low) (NN incidence))) (, ,) (SBAR (IN as) (S (VP (VBD reported) (PP (IN from) (NP (JJ previous) (JJ single) (NN dose) (NNS studies)))))))))))))))))) (, ,) (VP (MD could) (ADVP (RB also)) (VP (VB be) (VP (VBN induced) (PP (IN with) (NP (NNS Doc_12852481_2533_2536_Chemical))) (PP (VBN given) (PP (IN at) (NP (JJ multiple) (NNS doses))))))))))) (. .)))
1286498	0	(ROOT (NP (NP (NP (NNP Reversal)) (PP (IN of) (NP (NP (JJ central) (JJ Doc_1286498_20_34_Chemical) (NNS effects)) (PP (IN by) (NP (NP (NNS Doc_1286498_46_56_Chemical)) (PP (IN after) (NP (NP (JJ intravenous) (JJ conscious) (NN sedation)) (PP (IN with) (NP (NNS Doc_1286498_99_107_Chemical) (CC and) (NNS opioids)))))))))) (: :) (NP (NP (NN report)) (PP (IN of) (NP (DT a) (JJ double-blind) (NN multicenter) (NN study)))) (. .)))
1286498	1	(ROOT (NP (NP (DT The) (NNS Doc_1286498_169_179_Chemical)) (PP (IN in) (NP (NNP Intravenous) (NNPS Conscious) (NNP Sedation))) (PP (IN with) (NP (NNP Doc_1286498_219_227_Chemical) (NNP Multicenter) (NNP Study) (NNP Group) (NNP II))) (. .)))
1286498	2	(ROOT (S (NP (NP (DT The) (NN efficacy) (CC and) (NN safety)) (PP (IN of) (NP (NP (DT a) (JJ new) (JJ Doc_1286498_289_303_Chemical) (NN antagonist)) (, ,) (NP (NNS Doc_1286498_316_326_Chemical)) (, ,)))) (VP (VBD were) (VP (VBN assessed) (PP (IN in) (NP (DT a) (JJ double-blind) (NN multicenter) (NN study))))) (. .)))
1286498	3	(ROOT (S (NP (NP (NP (NNP Doc_1286498_379_389_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (JJ mean) (NN dose)) (, ,) (NP (CD 0.76) (NN mg))) (-RRB- -RRB-))) (CC or) (NP (NP (NN placebo)) (PRN (-LRB- -LRB-) (NP (NP (JJ mean) (NN dose)) (, ,) (NP (CD 8.9) (NN ml))) (-RRB- -RRB-)))) (VP (VBD was) (VP (VBN administered) (ADVP (RB intravenously)) (PP (TO to) (NP (QP (CD 130) (CC and) (CD 67)) (NNS patients))) (, ,) (ADVP (RB respectively)) (, ,) (SBAR (WHNP (WP who)) (S (VP (VBD had) (VP (VBN been) (VP (VBN given) (NP (NP (NNS Doc_1286498_530_538_Chemical)) (PP (IN in) (NP (NN conjunction)))) (PP (IN with) (NP (NP (DT an) (NN opioid)) (PRN (-LRB- -LRB-) (NP (NP (NNS Doc_1286498_570_578_Chemical)) (, ,) (NP (NNS Doc_1286498_580_590_Chemical)) (, ,) (CC or) (NP (NNS Doc_1286498_595_603_Chemical))) (-RRB- -RRB-)))) (PP (IN for) (NP (NP (DT the) (NN induction) (CC and) (NN maintenance)) (PP (IN of) (NP (NP (JJ intravenous) (JJ conscious) (NN sedation)) (PP (IN for) (NP (JJ diagnostic) (CC or) (JJ therapeutic) (JJ surgical) (NNS procedures)))))))))))))) (. .)))
1286498	4	(ROOT (S (NP (DT The) (NN group)) (VP (VBP assessable) (PP (IN for) (NP (NP (NN efficacy)) (VP (VBN comprised) (NP (NP (CD 122) (NNS patients)) (VP (VBN treated) (PP (IN with) (NP (NP (NNS Doc_1286498_794_804_Chemical)) (CC and) (NP (NP (CD 64) (NNS patients)) (VP (VBN given) (NP (NN placebo)))))))))))) (. .)))
1286498	5	(ROOT (S (PP (IN After) (NP (NP (CD 5) (NNS minutes)) (, ,) (NP (CD 80/115)) (PRN (-LRB- -LRB-) (NP (CD 70) (NN %)) (-RRB- -RRB-)) (NP (NN Doc_1286498_866_876_Chemical-treated) (NNS patients)))) (, ,) (PP (VBN compared) (PP (IN with) (NP (NP (NP (CD 21/63)) (PRN (-LRB- -LRB-) (NP (CD 33) (NN %)) (-RRB- -RRB-))) (NP (JJ placebo-treated) (NNS patients))))) (, ,) (VP (VBD were) (ADJP (RB completely) (JJ awake) (CC and) (JJ alert)) (, ,) (SBAR (IN as) (S (VP (VBD indicated) (PP (IN by) (NP (NP (DT a) (NN score)) (PP (IN of) (NP (CD 5))))) (PP (IN on) (NP (NP (NP (DT the) (NNP Observer) (POS 's)) (NNP Assessment)) (PP (IN of) (NP (NNP Alertness/Sedation) (NNP Scale))))))))) (. .)))
1286498	6	(ROOT (S (NP (NP (JJ Ninety-five) (NN percent)) (PP (IN of) (NP (NP (NNS patients)) (PP (IN in) (NP (NP (DT each) (NN group)) (SBAR (WHNP (WP who)) (S (VP (VBN attained) (NP (NP (DT a) (NN score)) (PP (IN of) (NP (CD 5)))) (PP (IN at) (NP (DT the) (JJ 5-minute) (NN assessment))))))))))) (VP (VBD showed) (NP (NP (DT no) (NN loss)) (PP (IN of) (NP (NNS alertness)))) (PP (IN throughout) (NP (DT the) (JJ 180-minute) (NN assessment) (NN period)))) (. .)))
1286498	7	(ROOT (S (NP (JJ Doc_1286498_1239_1249_Chemical-treated) (NNS patients)) (ADVP (RB also)) (VP (VBD performed) (ADJP (RB significantly) (JJR better)) (PP (IN on) (NP (NP (DT the) (JJ Finger-to-Nose) (NN Test)) (CC and) (NP (NP (DT the) (NN recall)) (PP (IN of) (NP (NP (NNS pictures)) (VP (VBN shown) (PP (IN at) (NP (DT the) (JJ 5-minute) (NN assessment)))))))))) (. .)))
1286498	8	(ROOT (S (NP (NNP Doc_1286498_1391_1401_Chemical)) (VP (VBD was) (ADJP (RB well) (JJ tolerated)) (, ,) (PP (IN with) (NP (NP (DT no) (JJ serious) (JJ adverse) (NNS effects)) (VP (VBN reported))))) (. .)))
1286498	9	(ROOT (S (NP (NP (NP (NNP Thirty-nine)) (PRN (-LRB- -LRB-) (NP (CD 30) (NN %)) (-RRB- -RRB-))) (PP (IN of) (NP (NP (NN Doc_1286498_1485_1495_Chemical-treated) (NNS patients)) (, ,) (PP (VBN compared) (PP (IN with) (NP (NP (NP (CD 17)) (PRN (-LRB- -LRB-) (NP (CD 25) (NN %)) (-RRB- -RRB-))) (PP (IN of) (NP (JJ placebo-treated) (NNS patients))))))))) (VP (VBD had) (NP (QP (CD one) (CC or) (JJR more)) (JJ drug-related) (JJ adverse) (NNS experiences))) (. .)))
1286498	10	(ROOT (S (NP (DT The) (ADJP (RBS most) (JJ common)) (JJ adverse) (NNS effects)) (VP (VBD were) (NP (NP (NP (NNS Doc_1286498_1652_1658_Disease) (CC and) (NNS Doc_1286498_1663_1671_Disease)) (PP (IN in) (NP (NP (DT the) (JJ Doc_1286498_1679_1689_Chemical) (NN group)) (CC and) (NP (NNS Doc_1286498_1700_1706_Disease))))) (CC and) (NP (NP (JJ injection-site) (NNS Doc_1286498_1726_1730_Disease)) (PP (IN in) (NP (DT the) (NN placebo) (NN group)))))) (. .)))
1286498	11	(ROOT (S (NP (NNP Doc_1286498_1753_1763_Chemical)) (VP (VBD was) (VP (VBN found) (S (VP (TO to) (VP (ADVP (RB promptly)) (VB reverse) (NP (NP (NN sedation)) (VP (VBN induced) (PP (IN by) (NP (NP (NNS Doc_1286498_1814_1822_Chemical)) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NNS opioids)))))))))))))) (. .)))
12907924	0	(ROOT (NP (NP (JJ Doc_12907924_0_15_Chemical-induced) (NNS Doc_12907924_24_53_Disease)) (PP (IN in) (NP (DT an) (JJ elderly) (NN man))) (. .)))
12907924	1	(ROOT (S (NP (NP (DT An) (JJ 82-year-old) (NN man)) (PP (IN with) (NP (JJ Doc_12907924_97_127_Disease) (CC and) (JJ early) (NNS Doc_12907924_138_157_Disease)))) (VP (VBD was) (VP (VBN started) (PP (IN on) (NP (NNS Doc_12907924_173_188_Chemical))))) (. .)))
12907924	2	(ROOT (S (NP (JJ Significant) (NNS Doc_12907924_202_231_Disease)) (VP (VP (VBD ensued)) (CC but) (VP (VBN diminished) (PP (IN over) (NP (JJ several) (NNS weeks))) (SBAR (WHADVP (WRB when)) (S (NP (NNS Doc_12907924_278_293_Chemical)) (VP (VBD was) (VP (VBN replaced) (PP (IN by) (NP (NNS Doc_12907924_310_321_Chemical))))))))) (. .)))
12907924	3	(ROOT (S (S (NP (DT The) (NN patient)) (VP (VBD had) (NP (DT no) (JJ prior) (JJ Doc_12907924_348_359_Disease) (NN history)))) (, ,) (CC but) (S (NP (PRP he)) (VP (VBD had) (NP (NP (DT a) (NN sister)) (PP (IN with) (NP (NNS Doc_12907924_394_423_Disease)))))) (. .)))
12907924	4	(ROOT (S (NP (PRP It)) (VP (VBZ appears) (SBAR (IN that) (S (NP (NNS Doc_12907924_441_456_Chemical)) (VP (VBD precipitated) (NP (NP (DT the) (NN patient) (POS 's)) (JJ pathological) (NN behavior)))))) (. .)))
12911170	0	(ROOT (S (VP (VB Doc_12911170_0_13_Chemical-induced) (NP (JJ acute) (NNS Doc_12911170_28_50_Disease) (CC and) (NNS Doc_12911170_55_82_Disease))) (. .)))
12911170	1	(ROOT (S (NP (NNP Doc_12911170_84_97_Chemical)) (VP (VBZ has) (VP (VBN been) (VP (VBN associated) (PP (IN with) (NP (NP (JJ several) (NN side) (NNS effects)) (PP (VBG including) (NP (NNS Doc_12911170_154_176_Disease) (CC and) (NNS Doc_12911170_181_197_Disease)))))))) (. .)))
12911170	2	(ROOT (S (NP (NP (DT The) (NN combination)) (PP (IN of) (NP (DT both) (NN side) (NNS effects)))) (VP (VBZ is) (ADJP (RB extremely) (JJ rare))) (. .)))
12911170	3	(ROOT (S (PP (IN In) (NP (DT this) (NN report))) (, ,) (NP (PRP we)) (VP (VBP describe) (NP (NP (DT a) (NN case)) (PP (IN of) (NP (NN Doc_12911170_293_306_Chemical-induced) (NNS Doc_12911170_315_337_Disease) (CC and) (NNS Doc_12911170_342_369_Disease))))) (. .)))
12911170	4	(ROOT (S (NP (NNP Doc_12911170_371_387_Disease)) (VP (VBD improved) (PP (IN after) (S (VP (VBG stopping) (NP (NP (DT the) (NN drug) (CC and) (NN initiation)) (PP (IN of) (NP (JJ Doc_12911170_439_446_Chemical) (NN therapy)))))))) (. .)))
12911170	5	(ROOT (S (ADVP (RB Unfortunately)) (, ,) (S (NP (JJ acute) (NNS Doc_12911170_477_499_Disease)) (VP (VBD was) (ADJP (JJ irreversible)))) (CC and) (S (NP (DT the) (NN patient)) (VP (VBD developed) (NP (NNS Doc_12911170_543_566_Disease)))) (. .)))
1300436	0	(ROOT (NP (NP (JJ Potential) (JJ deleterious) (NN effect)) (PP (IN of) (NP (NNS Doc_1300436_32_42_Chemical))) (PP (IN in) (NP (JJ radiocontrast) (NNS Doc_1300436_60_71_Disease))) (. .)))
1300436	1	(ROOT (S (NP (NP (DT The) (NN purpose)) (PP (IN of) (NP (NP (DT the) (NN study)) (SBAR (S (VP (VBD was) (S (VP (TO to) (VP (VB determine) (NP (NP (DT the) (NN efficacy)) (PP (IN of) (NP (NP (NNS Doc_1300436_131_141_Chemical)) (PP (IN in) (NP (NN addition)))))) (PP (TO to) (NP (NP (NP (JJ intravenous) (NNS fluids)) (PP (IN in) (NP (NP (DT the) (NN prevention)) (PP (IN of) (NP (JJ radiocontrast) (NNS Doc_1300436_211_222_Disease))))) (. .) (NP (CD 18) (NNS patients)) (, ,)) (VP (VBN referred) (PP (TO to) (NP (DT a) (JJ radiocontrast) (NN study)))))))))))))) (, ,) (VP (VBN considered) (PP (IN at) (NP (NP (NN risk)) (PP (RB because) (IN of) (NP (JJ preexisting) (NNS Doc_1300436_314_333_Disease)))))) (, ,)) (VP (VBD were) (VP (VBN enrolled) (PP (IN in) (NP (NP (DT a) (JJ prospective) (, ,) (JJ randomized) (, ,) (JJ controlled) (NN trial)) (, ,) (VP (VBN performed) (PP (IN at) (NP (NP (DT the) (JJ secondary) (NN care) (NN center)) (PP (IN of) (NP (DT a) (JJ 1,100-bed) (JJ private) (NN university) (NN hospital)))))))))) (. .)))
1300436	2	(ROOT (S (PP (IN In) (NP (NP (NN addition)) (PP (TO to) (NP (NNS fluids))))) (, ,) (NP (DT the) (NN treatment) (NN group)) (VP (VBD received) (NP (NP (NNS Doc_1300436_532_542_Chemical)) (PRN (-LRB- -LRB-) (NP (JJ mean) (NN dose) (NN 110) (NN mg)) (-RRB- -RRB-))) (ADVP (RB intravenously)) (PP (ADVP (NP (CD 30) (NN min)) (RB prior)) (TO to) (NP (NP (DT the) (NN injection)) (PP (IN of) (NP (NN contrast) (NN material)))))) (. .)))
1300436	3	(ROOT (S (NP (DT The) (NN control) (NN group)) (VP (VBD received) (NP (NP (NNS fluids)) (PRN (-LRB- -LRB-) (S (VP (VB mean) (NP (CD 3) (NNS liters)))) (-RRB- -RRB-)))) (. .)))
1300436	4	(ROOT (S (NP (JJ Radiological) (NNS studies)) (VP (VBD were) (ADVP (RB mostly)) (NP (NP (NNS angiographies)) (VP (VBN performed) (PP (IN with) (NP (DT both) (ADJP (JJ ionic) (CC and) (JJ non-ionic)) (NN contrast) (NN material))))) (, ,) (PP (IN at) (NP (NP (DT an) (JJ average) (NN dose)) (PP (IN of) (NP (CD 245) (NN ml)))))) (. .)))
1300436	5	(ROOT (S (NP (NP (NNP Doc_1300436_815_856_Disease)) (PP (IN in) (NP (DT the) (NN group)))) (VP (VBD pretreated) (PP (IN with) (NP (NP (NNS Doc_1300436_886_896_Chemical)) (PRN (-LRB- -LRB-) (VP (VBN p) (NP (QP (CD <) (CD 0.005))) (PP (IN by) (NP (NNP ANOVA)))) (-RRB- -RRB-)))) (, ,) (PP (IN with) (NP (NP (DT a) (NN rise)) (PP (IN in) (NP (NP (NP (NP (NN serum) (NNS Doc_1300436_940_950_Chemical)) (PP (IN from) (NP (NP (QP (CD 145) (CD +)) (NNS /)) (PRN (: -) (NP (QP (CD 13) (TO to) (CD 182)) (NNS +)) (: /))))) (: -) (NP (NP (CD 16) (NN mumol/l)) (PP (IN at) (NP (NP (CD 24) (NN h)) (, ,) (SBAR (IN while) (S (NP (DT no) (NN change)) (VP (VBD occurred) (PP (IN in) (NP (DT the) (NN control) (NN group)))))))))) (PRN (-LRB- -LRB-) (PP (IN from) (NP (NP (CD 141) (JJ +) (NNS /)) (PRN (: -) (NP (QP (CD 6) (TO to) (CD 142)) (NNS +)) (: /)) (: -) (NP (CD 7) (NN mumol/l)))) (-RRB- -RRB-))))))) (. .)))
1300436	6	(ROOT (S (NP (NNP Doc_1300436_1083_1096_Disease)) (VP (VBD was) (VP (VBN associated) (PP (IN with) (NP (NP (NNS Doc_1300436_1117_1128_Disease)) (PP (IN in) (NP (DT the) (NN Doc_1300436_1136_1146_Chemical-treated) (NN group))))))) (. .)))
1300436	7	(ROOT (S (NP (NNP Doc_1300436_1162_1172_Chemical)) (VP (MD may) (VP (VB be) (VP (VBN deleterious) (PP (IN in) (NP (NP (DT the) (NN prevention)) (PP (IN of) (NP (JJ radiocontrast) (NNS Doc_1300436_1227_1238_Disease)))))))) (. .)))
133615	0	(ROOT (S (VP (VB Progestational) (NP (NNS agents) (CC and) (NNS Doc_133615_26_43_Disease))) (. .)))
133615	1	(ROOT (NP (FW VII) (. .)))
133615	2	(ROOT (NP (NP (NP (JJ Doc_133615_50_64_Disease) (CC and) (JJ other) (NNS complications)) (PP (IN of) (NP (NP (JJ Doc_133615_92_110_Chemical) (NN therapy)) (PP (IN in) (NP (NN relationship))))) (S (VP (TO to) (VP (VB pretreatment) (NP (NP (NNS levels)) (PP (IN of) (NP (JJ Doc_133615_161_178_Disease) (NNS factors)))))))) (: :) (NP (NP (NN summary) (NN report)) (PP (IN of) (NP (DT a) (JJ ten-year) (NN study)))) (. .)))
133615	3	(ROOT (S (PP (IN During) (NP (DT a) (JJ ten-year) (NN period))) (, ,) (NP (CD 348) (NNS women)) (VP (VBD were) (VP (VBN studied) (PP (IN for) (NP (NP (DT a) (NN total)) (PP (IN of) (NP (NP (CD 5,877) (JJ patient) (NNS months)) (PP (IN in) (NP (CD four) (JJ separate) (NNS studies))))))) (S (VP (VBG relating) (NP (NNS Doc_133615_343_362_Chemical)) (PP (TO to) (NP (NP (NNS changes)) (PP (IN in) (NP (JJ hematologic) (NNS parameters))))))))) (. .)))
133615	4	(ROOT (S (NP (NP (NP (JJ Significant) (NNS increases)) (PP (IN in) (NP (NP (JJ certain) (NNS factors)) (PP (IN of) (NP (DT the) (NNS Doc_133615_449_466_Disease) (CC and) (NN fibrinolysin) (NNS systems)))))) (PRN (-LRB- -LRB-) (NP (NP (NP (NNS factors)) (NP (PRP I))) (, ,) (NP (NP (NNP II) (, ,) (NNP VII) (, ,) (NNP VIII) (, ,) (NNP IX) (, ,)) (CC and) (NP (NNP X))) (CC and) (NP (NN plasminogen))) (-RRB- -RRB-))) (VP (VBD were) (VP (VBN observed) (PP (IN in) (NP (DT the) (JJ treated) (NNS groups))))) (. .)))
133615	5	(ROOT (S (NP (JJ Severe) (NNS complications)) (VP (VBD developed) (PP (IN in) (NP (CD four) (NNS patients)))) (. .)))
133615	6	(ROOT (S (NP (DT All) (CD four)) (VP (VBD had) (NP (DT an) (JJ abnormal) (JJ Doc_133615_653_670_Disease) (NN profile)) (, ,) (S (VP (VBG suggesting) (`` ``) (NP (NNS Doc_133615_692_710_Disease)) ('' '') (PP (IN before) (NP (NP (NN initiation)) (PP (IN of) (NP (NN therapy)))))))) (. .)))
133615	7	(ROOT (S (S (NP (NP (DT Some)) (PP (IN of) (NP (DT these) (NNS findings)))) (VP (VBD represented) (NP (NP (DT the) (ADJP (RBS most) (JJ extreme)) (NNS abnormalities)) (VP (VBN seen) (PP (IN in) (NP (NP (DT the) (JJ entire) (NN group)) (PP (IN of) (NP (NNS patients))))))))) (: ;) (S (NP (DT some)) (VP (VBD increased) (ADVP (RBR further)) (PP (IN during) (NP (NN therapy))))) (. .)))
133615	8	(ROOT (S (NP (NP (CD One)) (PP (IN of) (NP (DT these) (NNS patients)))) (VP (VBD developed) (NP (DT a) (NNS Doc_133615_919_940_Disease)) (PP (IN before) (S (VP (VBG receiving) (NP (DT any) (NN medication))))) (, ,) (SBAR (ADVP (RB shortly)) (IN after) (S (NP (DT the) (JJ base-line) (NNS values)) (VP (VBD were) (VP (VBN obtained)))))) (. .)))
133615	9	(ROOT (S (S (NP (CD One) (NN patient)) (VP (VBD developed) (NP (NNS Doc_133615_1046_1057_Disease)) (NP (CD 19) (NNS months)) (SBAR (IN after) (S (NP (PRP she)) (VP (VBD began) (NP (NN therapy))))))) (, ,) (CC and) (S (NP (DT another)) (VP (VBD developed) (NP (NNS Doc_133615_1115_1131_Disease)) (PP (IN after) (NP (NP (CD 27) (NNS months)) (PP (IN of) (NP (NN therapy))))))) (. .)))
133615	10	(ROOT (S (NP (DT The) (JJ fourth) (NN patient)) (VP (VBD developed) (NP (NNS Doc_133615_1189_1205_Disease)) (NP (CD 14) (NNS days)) (PP (IN after) (NP (NP (NN initiation)) (PP (IN of) (NP (JJ contraceptive) (NN therapy)))))) (. .)))
133615	11	(ROOT (S (NP (DT All) (CD four) (NNS patients)) (VP (VBD were) (PP (IN of) (NP (DT the) (NNP A) (CC or) (NNP AB) (NNP blood) (NN group)))) (. .)))
133615	12	(ROOT (S (NP (JJ Previous) (NNS studies)) (VP (VBD suggested) (NP (NP (DT the) (NN possiblility)) (PP (IN of) (NP (NP (VBN increased) (NN propensity)) (PP (IN for) (NP (NP (JJ Doc_133615_1380_1394_Disease) (NNS episodes)) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG possessing) (NP (DT the) (NNP A) (NN antigen))))))))))) (. .)))
133615	13	(ROOT (S (NP (PRP It)) (VP (VBZ appears) (PP (IN from) (NP (DT these) (NNS data))) (SBAR (IN that) (S (NP (JJ hematologic) (NNS work-ups)) (VP (MD may) (VP (VB be) (ADJP (JJ useful) (PP (IN in) (NP (NP (NNS women)) (SBAR (WHNP (WP who)) (S (VP (VBP are) (VP (IN about) (S (VP (TO to) (VP (VB start) (NP (JJ long-term) (JJ Doc_133615_1551_1569_Chemical) (NN therapy))))))))))))))))) (. .)))
1355091	0	(ROOT (S (NP (NNP Doc_1355091_0_23_Disease)) (VP (VBZ occurs) (S (VP (VBG following) (NP (NP (ADJP (NN alpha) (JJ 2-adrenoceptor)) (NN blockade)) (PP (IN in) (NP (JJ chronic) (NN Doc_1355091_82_90_Chemical-pretreated) (NNS conscious))) (X (X (ADVP (RB spontaneously)) (NP (JJ Doc_1355091_126_138_Disease) (NNS rats)) (. .)) (NP (CD 1))))))) (. .)))
1355091	1	(ROOT (S (NP (NNPS Studies)) (VP (VBD were) (VP (VBN performed) (S (VP (TO to) (VP (VB evaluate) (SBAR (IN whether) (X (X (NP (NP (JJ chronic) (NNS Doc_1355091_199_207_Chemical)) (NP (NN treatment) (NNS alters))) (NP (NP (DT the) (ADJP (NN alpha) (JJ 2-adrenoceptor)) (NN function)) (PP (IN for) (NP (NP (JJ orthostatic) (NN control)) (PP (IN of) (NP (NP (JJ arterial) (NN blood) (NN pressure)) (PP (IN in) (NP (NP (JJ conscious) (JJ spontaneously) (JJ Doc_1355091_337_349_Disease) (NNS rats)) (PRN (-LRB- -LRB-) (NP (NNP SHR)) (-RRB- -RRB-))))))))) (. .)) (NP (CD 2))))))))) (. .)))
1355091	2	(ROOT (S (NP (NP (NNP Conscious) (NNP SHR)) (PRN (-LRB- -LRB-) (NP (JJ male) (JJ 300-350) (NN g)) (-RRB- -RRB-))) (VP (VBD were) (VP (VBN subjected) (PP (TO to) (NP (NP (CD 90) (NNS degrees)) (SBAR (S (NP (NP (JJ head-up) (NNS tilts)) (PP (IN for) (NP (CD 60)))) (VP (VBZ s) (VP (VBG following) (NP (NP (JJ acute) (NN administration)) (PP (IN of) (NP (NP (NNS Doc_1355091_482_490_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (CD 0.1) (NN mg)) (NP (JJ kg-1) (NN i.p.))) (-RRB- -RRB-)) (CC or) (NP (NNS Doc_1355091_513_524_Chemical)) (PRN (-LRB- -LRB-) (NP (QP (CD 3) (CD mg)) (NN kg-1) (NN i.v.)) (-RRB- -RRB-))))))))))))) (. .)))
1355091	3	(ROOT (S (NP (NNP Doc_1355091_543_566_Disease)) (VP (VBD was) (VP (VBN determined) (PP (IN by) (NP (NP (NP (DT the) (JJ average) (NN decrease)) (PRN (-LRB- -LRB-) (NP (NNP %)) (-RRB- -RRB-))) (PP (IN in) (NP (NP (JJ mean) (JJ arterial) (NN pressure)) (PRN (-LRB- -LRB-) (NP (NNP MAP) (NNP femoral)) (-RRB- -RRB-)))))) (PP (IN over) (NP (DT the) (JJ 60-s) (NN tilt) (NN period))))) (. .)))
1355091	4	(ROOT (S (NP (NP (DT The) (JJ basal) (NN MAP)) (PP (IN of) (NP (JJ conscious) (NNP SHR)))) (VP (VBD was) (VP (VBN reduced) (PP (TO to) (NP (DT a) (JJ similar) (NN extent))) (PP (IN by) (NP (NP (NNS Doc_1355091_743_751_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (NP (CD -23) (NN %)) (PRN (-LRB- -LRB-) (NP (NNP -)) (-RRB- -RRB-)) (NP (CD -26) (NN %))) (NP (NNP MAP))) (-RRB- -RRB-)) (CC and) (NP (NNS Doc_1355091_774_785_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (NP (CD -16) (NN %)) (PRN (-LRB- -LRB-) (NP (NNP -)) (-RRB- -RRB-)) (NP (CD -33) (NN %))) (NP (NNP MAP))) (-RRB- -RRB-)))))) (. .)))
1355091	5	(ROOT (S (ADVP (RB However)) (, ,) (NP (DT the) (JJ head-up) (NN tilt)) (VP (VBN induced) (NP (NP (NNS Doc_1355091_839_862_Disease)) (PP (IN in) (NP (NP (DT the) (NNP SHR)) (VP (VBN treated) (PP (PP (IN with) (NP (NP (NNS Doc_1355091_887_895_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (CD -16) (NN %)) (SBAR (S (VP (VBP MAP) (, ,) (S (NP (NN n)) (VP (SYM =) (NP (CD 6)))))))) (-RRB- -RRB-)))) (, ,) (CONJP (CC but) (RB not)) (PP (IN in) (FRAG (NP (NP (DT the) (NNP SHR)) (VP (VBN treated) (PP (IN with) (NP (NP (NNS Doc_1355091_947_958_Chemical)) (PRN (-LRB- -LRB-) (S (NP (QP (JJR less) (IN than) (CD +2)) (NN %)) (VP (VBP MAP) (, ,) (S (NP (NN n)) (VP (SYM =) (NP (CD 6)))))) (-RRB- -RRB-)))))) (. .))))))) (NP (CD 3)))) (. .)))
1355091	6	(ROOT (S (NP (NNP Conscious) (NNP SHR)) (VP (VBD were) (VP (VBN treated) (PP (IN for) (NP (NP (CD 4) (NNS days)) (PP (IN with) (NP (NNS Doc_1355091_1033_1041_Chemical))))) (PP (IN at) (NP (NP (CD 2) (JJ mg) (JJ kg-1) (JJ day-1) (NN i.p.)) (PP (IN for) (NP (JJ chronic) (ADJP (NN alpha) (JJ 1-adrenoceptor)) (NN blockade))))))) (. .)))
1355091	7	(ROOT (S (NP (NP (NNP MAP)) (PP (IN in) (NP (NP (NNP conscious) (NNP SHR)) (PP (IN after) (NP (JJ chronic) (JJ Doc_1355091_1144_1152_Chemical) (NN treatment)))))) (VP (VBD was) (ADJP (NP (CD 14) (NN %)) (JJR lower) (PP (IN than) (PP (IN in) (NP (DT the) (NNP untreated) (NNP SHR))))) (PRN (-LRB- -LRB-) (VP (VBN n) (S (VP (SYM =) (NP (CD 8))))) (-RRB- -RRB-))) (. .)))
1355091	8	(ROOT (S (NP (NP (NNP Head-up) (NNP tilts)) (PP (IN in) (NP (DT these) (NNS rats)))) (VP (VBD did) (RB not) (VP (VB produce) (NP (NNS Doc_1355091_1256_1279_Disease)) (SBAR (WHADVP (WRB when)) (S (VP (VBD performed) (ADVP (DT either) (RB prior)) (PP (TO to) (CC or) (IN after) (NP (NP (JJ acute) (NN dosing)) (PP (IN of) (NP (NNS Doc_1355091_1336_1344_Chemical))))) (PRN (-LRB- -LRB-) (NP (NP (CD 0.1) (NN mg)) (NP (JJ kg-1) (NN i.p.))) (-RRB- -RRB-))))))) (. .)))
1355091	9	(ROOT (S (ADVP (RB Conversely)) (, ,) (NP (NP (NN administration)) (PP (IN of) (NP (NP (NP (NNS Doc_1355091_1395_1406_Chemical)) (PRN (-LRB- -LRB-) (NP (QP (CD 3) (CD mg)) (NN kg-1) (NN i.v.)) (-RRB- -RRB-))) (PP (IN in) (NP (JJ chronic) (NNS Doc_1355091_1435_1443_Chemical)))))) (VP (VBD treated) (SBAR (S (NP (NNP SHR)) (VP (VBD decreased) (NP (NP (NP (DT the) (JJ basal) (NN MAP)) (PP (IN by) (NP (CD 12-31) (NN %)))) (PRN (-LRB- -LRB-) (VP (VBN n) (S (VP (SYM =) (NP (CD 4))))) (-RRB- -RRB-)) (, ,) (CC and) (NP (NP (JJ subsequent) (NNS tilts)) (VP (VBN induced) (NP (NP (JJ further) (NNS drops)) (PP (IN of) (NP (NP (NNP MAP)) (RRC (PP (IN by) (NP (NP (CD 19-23) (NN %)) (PP (IN in) (NP (DT these) (NNS rats)))) (. .)) (NP (CD 4))))))))))))) (. .)))
1355091	10	(ROOT (S (NP (NP (DT The) (NN pressor) (NNS responses) (CC and) (NNS Doc_1355091_1603_1614_Disease)) (PP (TO to) (NP (NP (NP (DT the) (ADJP (NN alpha) (JJ 1-agonist)) (NNS Doc_1355091_1638_1648_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (CD 0.6)) (CC and) (NP (CD 2) (JJ micrograms) (JJ kg-1) (NN i.v.))) (-RRB- -RRB-))) (, ,) (NP (NP (DT the) (ADJP (NN alpha) (JJ 2-agonist)) (NNS Doc_1355091_1703_1715_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (CD 1)) (CC and) (NP (CD 3) (JJ micrograms) (JJ kg-1) (NN i.v.))) (-RRB- -RRB-))) (, ,) (CC and) (NP (NP (NNS Doc_1355091_1752_1765_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (CD 0.1)) (CC and) (NP (CD 1.0) (JJ micrograms) (JJ kg-1) (NN i.v.))) (-RRB- -RRB-)))))) (VP (VBD were) (VP (VBN determined) (PP (IN in) (NP (JJ conscious) (NNP SHR))) (PP (IN with) (CC and) (IN without) (NP (JJ chronic) (JJ Doc_1355091_1859_1867_Chemical) (NN pretreatment))))) (. .)))
1355091	11	(ROOT (S (NP (CC Both) (NP (DT the) (NN pressor)) (CC and) (NP (NP (JJ Doc_1355091_1903_1914_Disease) (NNS effects)) (PP (IN of) (NP (NNS Doc_1355091_1926_1936_Chemical))))) (VP (VBD were) (VP (VBN abolished) (PP (IN in) (NP (NP (NP (JJ chronic) (NNS Doc_1355091_1963_1971_Chemical)) (VP (VBN treated) (NP (NP (NNP SHR)) (PRN (-LRB- -LRB-) (VP (VBN n) (S (VP (SYM =) (NP (CD 4))))) (-RRB- -RRB-)) (ADJP (IN as) (PP (VBN compared) (PP (TO to) (NP (DT the) (NNP untreated) (NNP SHR)))))))) (PRN (-LRB- -LRB-) (VP (VBN n) (S (VP (SYM =) (NP (CD 4))))) (-RRB- -RRB-)))))) (. .)))
1355091	12	(ROOT (S (S (PP (IN On) (NP (DT the) (JJ other) (NN hand))) (, ,) (NP (NP (DT the) (NN pressor) (NNS effects)) (PP (IN of) (NP (NNS Doc_1355091_2076_2088_Chemical)))) (VP (VBD were) (ADJP (JJ similar) (PP (IN in) (NP (NP (DT both) (NNS groups)) (PP (IN of) (NP (NNP SHR)))))))) (, ,) (CC but) (S (NP (DT the) (VBG accompanying) (NNS Doc_1355091_2146_2157_Disease)) (VP (VBD was) (ADJP (ADJP (JJR greater)) (PP (IN in) (NP (NNP SHR)))) (PP (IN with) (NP (JJ chronic) (JJ Doc_1355091_2190_2198_Chemical) (NN treatment))) (PP (IN than) (PP (IN without) (NP (JJ such) (NN treatment)))))) (. .)))
1355091	13	(ROOT (S (ADVP (RB Furthermore)) (, ,) (NP (NP (DT the) (NNS Doc_1355091_2255_2266_Disease)) (SBAR (WHNP (WDT that)) (S (VP (VBD accompanied) (SBAR (S (NP (NP (DT the) (NN Doc_1355091_2288_2301_Chemical-induced) (NN pressor) (NN effect)) (PP (IN in) (NP (NNP SHR)))) (VP (VBD was) (ADJP (JJ similar)) (PP (IN with) (CC and) (IN without) (NP (JJ chronic) (JJ Doc_1355091_2369_2377_Chemical) (NN treatment))) (PP (IN despite) (NP (NP (DT a) (CD 47-71) (NN %) (NN reduction)) (PP (IN of) (NP (NP (DT the) (NN pressor) (NN effect)) (PP (IN in) (NP (NP (NN chronic)) (ADJP (NN alpha) (JJ 1-receptor))))))))))))))) (VP (VBD blocked) (NP (NP (NNP SHR) (. .)) (PRN (-LRB- -LRB-) (NP (NP (NNP ABSTRACT) (NNP TRUNCATED) (NNP AT)) (NP (CD 400) (NNS WORDS))) (-RRB- -RRB-))))))
1415380	0	(ROOT (S (NP (NNP Doc_1415380_0_25_Disease)) (VP (VBN associated) (PP (IN with) (NP (NP (NN ingestion)) (PP (IN of) (NP (NNS Doc_1415380_55_62_Chemical)))))) (. .)))
1415380	1	(ROOT (S (NP (NP (NNP Doc_1415380_64_89_Disease)) (PP (VBG following) (NP (JJ Doc_1415380_100_107_Chemical) (NN ingestion)))) (VP (VBZ is) (NP (DT a) (ADJP (RB newly) (JJ described)) (NN phenomenon)) (, ,) (PP (IN with) (NP (NP (RB just) (CD two) (JJ previous) (NNS descriptions)) (PP (IN of) (NP (NP (CD 4) (NNS cases)) (PP (IN in) (NP (DT the) (NN literature)))))))) (. .)))
1415380	2	(ROOT (S (NP (PRP We)) (VP (VBP describe) (NP (DT a) (JJ 5th) (NN case))) (. .)))
1415380	3	(ROOT (S (NP (DT The) (NN reaction)) (VP (MD may) (VP (VB be) (VP (VBN mediated) (PP (IN by) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NNS antibodies) (NN reactive))))) (PP (IN against) (NP (NP (NNS platelets)) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NNS Doc_1415380_346_353_Chemical)))))))))) (. .)))
1415380	4	(ROOT (S (NP (NNP Treatment)) (VP (VBZ has) (VP (VBN included) (NP (NP (NN use)) (PP (IN of) (NP (NP (NN plasma) (NN exchange)) (, ,) (NP (NNS Doc_1415380_402_412_Chemical)) (, ,) (NP (NNS Doc_1415380_414_421_Chemical)) (, ,) (CC and) (NP (NNS Doc_1415380_427_439_Chemical))))))) (. .)))
1415380	5	(ROOT (S (NP (DT The) (NNS patients)) (VP (VBP have) (RB all) (VP (VBN regained) (NP (NP (DT some) (NN degree)) (PP (IN of) (NP (JJ renal) (NN function)))))) (. .)))
1415380	6	(ROOT (S (ADVP (RB However)) (, ,) (NP (PRP it)) (VP (VBZ is) (ADJP (JJ unclear)) (SBAR (IN whether) (S (NP (NP (JJ pharmacological) (NN treatment)) (CC or) (NP (JJ spontaneous) (NN resolution))) (VP (VBZ is) (ADJP (JJ responsible) (PP (IN for) (NP (DT the) (NN improvement)))))))) (. .)))
1415380	7	(ROOT (S (NP (JJ Doc_1415380_622_629_Chemical-associated) (NNS Doc_1415380_641_666_Disease)) (ADVP (RB probably)) (VP (VBZ occurs) (ADVP (ADVP (RBR more) (RB often)) (SBAR (IN than) (S (VP (VBZ is) (VP (VBN recognized))))))) (. .)))
1415380	8	(ROOT (S (NP (PRP It)) (VP (VBZ is) (ADJP (JJ important) (S (VP (VP (TO to) (VP (VB recognize) (NP (DT this) (NN reaction)) (SBAR (WHADVP (WRB when)) (S (NP (PRP it)) (VP (VBZ occurs)))))) (CC and) (VP (TO to) (VP (VB avoid) (NP (JJ further) (JJ Doc_1415380_793_800_Chemical) (NN exposure))))))) (, ,) (SBAR (IN since) (S (NP (DT the) (NN reaction)) (VP (VBZ seems) (S (VP (TO to) (VP (VB be) (ADJP (JJ recurrent))))))))) (. .)))
1423339	0	(ROOT (S (S (NP (NNP Doc_1423339_0_17_Disease)) (VP (VBN associated) (PP (IN with) (NP (JJ Doc_1423339_34_45_Chemical) (NNS Doc_1423339_46_54_Disease))))) (: :) (S (NP (DT a) (NN case)) (VP (VBP report))) (. .)))
1423339	1	(ROOT (S (NP (DT An) (JJ elderly) (NN woman)) (VP (VBD developed) (NP (DT an) (ADJP (JJ Doc_1423339_101_110_Disease-like) (JJ subacute)) (NNS Doc_1423339_125_133_Disease)) (PP (IN as) (NP (NP (DT a) (NN result)) (PP (IN of) (NP (JJ Doc_1423339_149_160_Chemical) (NNS Doc_1423339_161_169_Disease)))))) (. .)))
1423339	2	(ROOT (S (NP (NP (NNP Analysis)) (PP (IN of) (NP (DT the) (NNS manifestations)))) (VP (VBD showed) (SBAR (IN that) (S (NP (NP (JJ severe) (NN impairment)) (PP (IN of) (NP (NN memory)))) (VP (VBD accounted) (PP (IN for) (NP (NP (RB virtually) (DT all)) (PP (IN of) (NP (DT the) (NNS abnormalities))))))))) (. .)))
1423339	3	(ROOT (S (NP (EX There)) (VP (VBZ is) (NP (NN evidence)) (SBAR (IN that) (S (NP (NP (JJ cerebral) (NNS reactions)) (PP (TO to) (NP (NN drug) (NNS Doc_1423339_342_350_Disease)))) (VP (MD can) (VP (VB exhibit) (NP (NP (NNS patterns)) (SBAR (WHNP (WDT that)) (S (VP (VBP suggest) (NP (NP (ADJP (RB highly) (JJ selective)) (NN involvement)) (PP (IN of) (NP (NP (JJ functional) (NNS subdivisions)) (PP (IN of) (NP (DT the) (NN brain))))))))))))))) (. .)))
1445986	0	(ROOT (S (VP (VB Doc_1445986_0_9_Chemical-induced) (NP (JJ immune) (NNS Doc_1445986_25_41_Disease))) (. .)))
1445986	1	(ROOT (S (NP (NP (NNP Immune) (NNP Doc_1445986_50_66_Disease)) (ADJP (JJ due) (PP (TO to) (NP (DT a) (JJ drug-adsorption) (NN mechanism))))) (VP (VBZ has) (VP (VBN been) (VP (VBN described) (ADVP (RB primarily)) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (JJ Doc_1445986_153_164_Chemical) (CC and) (JJ first-generation) (NNS Doc_1445986_186_200_Chemical)))))))) (. .)))
1445986	2	(ROOT (S (NP (PRP We)) (VP (VBP describe) (NP (NP (DT a) (NN patient)) (SBAR (WHNP (WP who)) (S (VP (VBD developed) (NP (NNS Doc_1445986_238_244_Disease)) (PP (IN while) (S (VP (VBG receiving) (NP (JJ intravenous) (NNS Doc_1445986_273_282_Chemical)))))))))) (. .)))
1445986	3	(ROOT (S (NP (JJ Doc_1445986_284_293_Chemical-dependent) (NNS antibodies)) (VP (VBD were) (VP (VBN detected) (PP (PP (IN in) (NP (NP (DT the) (NN patient) (POS 's)) (NN serum))) (CC and) (PP (IN in) (NP (NP (DT an) (NN eluate)) (VP (VBN prepared) (PP (IN from) (NP (PRP$ his) (JJ red) (NN blood) (NNS cells))))))))) (. .)))
1445986	4	(ROOT (S (NP (DT The) (NN eluate)) (ADVP (RB also)) (VP (VBD reacted) (ADVP (RB weakly)) (PP (IN with) (NP (NP (JJ red) (NN blood) (NNS cells)) (PP (IN in) (NP (NP (DT the) (NN absence)) (PP (IN of) (NP (NNS Doc_1445986_474_483_Chemical))))))) (, ,) (S (VP (VBG suggesting) (NP (NP (DT the) (JJ concomitant) (NN formation)) (PP (IN of) (NP (JJ warm-reactive) (NNS autoantibodies))))))) (. .)))
1445986	5	(ROOT (S (NP (NP (DT These) (NNS observations)) (, ,) (PP (IN in) (NP (NP (NN conjunction)) (PP (IN with) (NP (NP (JJ clinical) (CC and) (NN laboratory) (NN evidence)) (PP (IN of) (NP (NN extravascular) (NNS Doc_1445986_645_654_Disease))))))) (, ,)) (VP (VBP are) (ADJP (JJ consistent) (PP (IN with) (NP (JJ drug-induced) (NNS Doc_1445986_689_705_Disease)))) (, ,) (S (ADVP (RB possibly)) (VP (VBG involving) (NP (ADJP (DT both) (JJ drug-adsorption) (CC and) (JJ autoantibody)) (NN formation) (NNS mechanisms))))) (. .)))
1445986	6	(ROOT (S (NP (DT This) (NN case)) (VP (VBZ emphasizes) (NP (NP (DT the) (NN need)) (PP (IN for) (NP (NP (VBN increased) (NN awareness)) (PP (IN of) (NP (NP (JJ hemolytic) (NNS reactions)) (PP (TO to) (NP (DT all) (NNS Doc_1445986_870_884_Chemical))))))))) (. .)))
14633084	0	(ROOT (S (VP (VB Use) (PP (IN of) (NP (NP (NNS Doc_14633084_7_20_Chemical)) (PP (IN with) (NP (NP (NNS Doc_14633084_26_31_Chemical)) (PP (IN for) (NP (NP (DT the) (NN prevention)) (PP (IN of) (NP (NN Doc_14633084_54_64_Chemical-induced) (NNS Doc_14633084_73_93_Disease)))))))))) (. .)))
14633084	1	(ROOT (S (NP (NP (NNP Doc_14633084_100_120_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_14633084_122_124_Disease)) (-RRB- -RRB-))) (VP (VBZ is) (NP (NP (DT a) (JJ limiting) (NN side-effect)) (PP (IN of) (NP (NP (NN chemotherapy)) (PP (IN with) (NP (NP (NNS Doc_14633084_173_183_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_14633084_185_188_Chemical)) (-RRB- -RRB-)))))))) (. .)))
14633084	2	(ROOT (S (PP (IN In) (NP (NP (DT the) (NN study)) (VP (VBN presented) (ADVP (RB here))))) (, ,) (NP (PRP we)) (VP (VBD investigated) (NP (NP (DT the) (NN use)) (PP (IN of) (NP (NP (NNS Doc_14633084_247_260_Chemical)) (PP (IN in) (NP (NN combination)))))) (PP (IN with) (NP (NP (NNS Doc_14633084_281_286_Chemical)) (PP (IN for) (NP (NP (DT the) (NN prevention)) (PP (IN of) (NP (NN Doc_14633084_309_312_Chemical-induced) (NNS Doc_14633084_321_323_Disease)))))))) (. .)))
14633084	3	(ROOT (S (NP (NP (NNP Male) (NNP Wistar) (NNS rats)) (PRN (-LRB- -LRB-) (NP (NP (CD 150-200) (NN g)) (: ;) (NP (NP (CD 6) (NNS rats)) (PP (IN per) (NP (NN group))))) (-RRB- -RRB-))) (VP (VBD were) (VP (VBN treated) (PP (IN with) (NP (NP (NP (NN saline) (CC or) (NNS Doc_14633084_409_414_Chemical)) (ADVP (NP (NP (CD 5) (NN min)) (PRN (-LRB- -LRB-) (NP (NNP i.p.)) (-RRB- -RRB-))) (IN before))) (CC and) (NP (QP (CD 2) (CC and) (CD 6)) (NN h)))) (PP (IN after) (PRN (-LRB- -LRB-) (NP (NNP v.o.)) (-RRB- -RRB-)) (NP (NP (NN administration)) (PP (IN of) (NP (NNS Doc_14633084_480_483_Chemical))))))) (. .)))
14633084	4	(ROOT (S (NP (NP (CD One) (, ,) (CD two) (CC or) (CD three) (NNS doses)) (PP (IN of) (NP (NNS Doc_14633084_512_517_Chemical)))) (VP (VBD were) (VP (VBN replaced) (PP (IN with) (NP (JJ Doc_14633084_537_550_Chemical) (UCP (ADVP (RB alone)) (CC or) (PP (IN with) (NP (JJ Doc_14633084_565_578_Chemical) (NN plus)))) (NNS Doc_14633084_584_589_Chemical))))) (. .)))
14633084	5	(ROOT (S (NP (NNP Doc_14633084_591_599_Disease)) (VP (VBD was) (VP (VBN evaluated) (NP (NP (CD 24) (NN h)) (PP (IN after) (NP (PRP$ its) (NN induction)))) (PP (PP (IN by) (NP (NP (DT the) (NNS changes)) (PP (IN in) (NP (NN bladder) (JJ wet) (NN weight))))) (CC and) (PP (IN by) (NP (JJ macroscopic) (CC and) (JJ microscopic) (NN analysis)))))) (. .)))
14633084	6	(ROOT (S (NP (NP (DT The) (NN replacement)) (PP (IN of) (NP (NP (DT the) (JJ last) (NN dose)) (CC or) (NP (NP (DT the) (JJ last) (CD two) (NNS doses)) (PP (IN of) (NP (NP (NNS Doc_14633084_788_793_Chemical)) (PP (IN with) (NP (NNS Doc_14633084_799_812_Chemical))))))))) (VP (VBD reduced) (NP (DT the) (NN increase)) (PP (IN in) (NP (NP (NN bladder) (JJ wet) (NN weight)) (VP (VBN induced) (PP (IN by) (NP (NNS Doc_14633084_867_870_Chemical))) (PP (IN by) (NP (NP (CD 84.79) (NN %)) (CC and) (NP (CD 89.13) (NN %))))))) (, ,) (ADVP (RB respectively))) (. .)))
14633084	7	(ROOT (S (PP (IN In) (NP (NN addition))) (, ,) (NP (PRP it)) (ADVP (RB almost)) (VP (VBD abolished) (NP (NP (DT the) (JJ macroscopic) (CC and) (JJ microscopic) (NNS alterations)) (VP (VBN induced) (PP (IN by) (NP (NNS Doc_14633084_995_998_Chemical)))))) (. .)))
14633084	8	(ROOT (S (ADVP (RB Moreover)) (, ,) (NP (NP (DT the) (NN addition)) (PP (IN of) (NP (NP (NNS Doc_14633084_1026_1039_Chemical)) (PP (TO to) (NP (DT the) (JJ last) (CD two) (NNS doses))) (PP (IN of) (NP (NNS Doc_14633084_1065_1070_Chemical)))))) (VP (VBD was) (ADJP (RBR more) (JJ efficient) (PP (IN than) (NP (NP (CD three) (NNS doses)) (PP (IN of) (NP (NNS Doc_14633084_1110_1115_Chemical)))))) (ADVP (RB alone)) (SBAR (WHADVP (WRB when)) (S (VP (VBN evaluated) (ADVP (RB microscopically)))))) (. .)))
14633084	9	(ROOT (S (NP (NP (NNP Doc_14633084_1166_1179_Chemical)) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (NNS Doc_14633084_1200_1205_Chemical)))))) (VP (VBD was) (ADJP (JJ efficient) (PP (IN in) (S (VP (VBG blocking) (NP (NN Doc_14633084_1232_1235_Chemical-induced) (NNS Doc_14633084_1244_1246_Disease))))))) (. .)))
14633084	10	(ROOT (S (ADVP (RB However)) (, ,) (NP (NP (DT the) (NN replacement)) (PP (IN of) (NP (JJ last) (CD two) (NNS doses))) (PP (IN of) (NP (NP (NP (NNS Doc_14633084_1294_1299_Chemical)) (PP (IN with) (NP (NN saline)))) (CC or) (NP (NP (DT all)) (PP (IN of) (NP (NP (DT the) (JJ Doc_14633084_1326_1331_Chemical) (NNS doses)) (PP (IN with) (NP (NNS Doc_14633084_1343_1356_Chemical))))))))) (VP (VBD did) (RB not) (VP (VB prevent) (NP (NNS Doc_14633084_1373_1375_Disease)))) (. .)))
14648024	0	(ROOT (NP (NP (JJ Doc_14648024_0_24_Chemical-induced) (NNS Doc_14648024_33_49_Disease)) (PP (IN in) (NP (NNS patients))) (PP (IN with) (NP (NNS Doc_14648024_67_95_Disease))) (. .)))
14648024	1	(ROOT (S (NP (NP (NNP Doc_14648024_97_113_Disease)) (VP (VBN associated) (PP (IN with) (NP (NP (NP (NNS Doc_14648024_130_154_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_14648024_156_160_Chemical)) (-RRB- -RRB-))) (PP (IN for) (NP (NNS Doc_14648024_166_194_Disease)))))) (PRN (-LRB- -LRB-) (NP (NNP Doc_14648024_196_199_Disease)) (-RRB- -RRB-))) (VP (VBZ is) (ADJP (RB very) (JJ rare))) (. .)))
14648024	2	(ROOT (S (NP (PRP We)) (VP (VBP describe) (NP (NP (CD four) (NNS patients)) (PP (IN with) (NP (JJ classic) (NNS Doc_14648024_254_257_Disease))) (SBAR (WHNP (WP who)) (S (VP (VBD developed) (NP (NNS Doc_14648024_272_288_Disease)) (PP (IN during) (NP (JJ Doc_14648024_296_300_Chemical) (NN therapy)))))))) (. .)))
14648024	3	(ROOT (S (NP (NP (ADJP (JJ Doc_14648024_310_315_Disease) (CC and) (JJ subsequent)) (JJ multiple) (JJ Doc_14648024_340_347_Disease) (NNS Doc_14648024_348_368_Disease)) (PP (IN over) (NP (NNS extremities)))) (VP (VBD developed) (PP (IN on) (NP (NNP D11) (, ,) (NNS D16) (, ,) (NNP D17) (, ,) (CC and) (NNP D19))) (, ,) (ADVP (RB respectively)) (, ,) (PP (IN after) (NP (JJ Doc_14648024_443_447_Chemical) (NN therapy)))) (. .)))
14648024	4	(ROOT (S (NP (NP (DT The) (NN skin)) (VP (ADVP (RB biopsy)) (VBN taken) (PP (IN from) (NP (DT each) (NN patient))))) (VP (VBD was) (ADJP (JJ consistent) (PP (IN with) (NP (NNS Doc_14648024_517_533_Disease))))) (. .)))
14648024	5	(ROOT (S (NP (DT All) (NNS patients)) (VP (VBD received) (NP (NP (JJ short) (NN course)) (PP (IN of) (NP (NNS Doc_14648024_573_581_Chemical))))) (. .)))
14648024	6	(ROOT (S (S (NP (NNP Doc_14648024_583_588_Disease)) (VP (VBD subsided) (ADVP (RB rapidly)))) (CC and) (S (NP (DT the) (NN skin) (NNS lesions)) (VP (VBD regressed) (ADVP (RB completely)))) (. .)))
14648024	7	(ROOT (S (NP (DT All) (NNS patients)) (VP (VBD achieved) (NP (JJ complete) (NN remission)) (PP (IN without) (NP (NP (NN withdrawal)) (PP (IN of) (NP (NNS Doc_14648024_712_716_Chemical)))))) (. .)))
14648024	8	(ROOT (S (NP (NNP Doc_14648024_718_722_Chemical)) (VP (VBD seemed) (S (VP (TO to) (VP (VB be) (NP (NP (DT the) (ADJP (RBS most) (JJ possible)) (NN etiology)) (PP (IN of) (NP (NP (NNS Doc_14648024_766_782_Disease)) (PP (IN in) (NP (PRP$ our) (NNS patients)))))))))) (. .)))
14648024	9	(ROOT (S (NP (NP (JJ Short-term) (NN use)) (PP (IN of) (NP (NNS Doc_14648024_818_825_Chemical)))) (VP (VBZ is) (ADJP (RB very) (JJ effective) (PP (IN in) (NP (NN Doc_14648024_847_851_Chemical-induced) (NNS Doc_14648024_860_876_Disease))))) (. .)))
14704468	0	(ROOT (S (NP (NP (NN Effect)) (PP (IN of) (NP (DT some)))) (VP (VBZ convulsants) (PP (IN on) (NP (NP (DT the) (JJ protective) (NN activity)) (PP (IN of) (NP (NP (NNS Doc_14704468_57_68_Chemical)) (CC and) (NP (PRP$ its) (NNS combinations)))))) (PP (IN with) (NP (NP (NNS Doc_14704468_95_104_Chemical) (CC or) (NNS Doc_14704468_108_118_Chemical)) (PP (IN in) (NP (JJ amygdala-kindled) (NNS rats)))))) (. .)))
14704468	1	(ROOT (S (NP (NP (NNP Doc_14704468_145_156_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 5) (NN mg/kg)) (-RRB- -RRB-))) (VP (VBN exerted) (NP (NP (DT a) (JJ significant) (JJ protective) (NN action)) (PP (IN in) (NP (JJ amygdala-kindled) (NNS rats)))) (, ,) (S (VP (VBG reducing) (NP (DT both) (NNS Doc_14704468_247_254_Disease) (CC and) (NN afterdischarge) (NNS durations))))) (. .)))
14704468	2	(ROOT (S (NP (NP (NP (DT The) (NNS combinations)) (PP (IN of) (NP (NP (NP (NNS Doc_14704468_305_316_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 2.5) (NN mg/kg)) (-RRB- -RRB-))) (PP (IN with) (NP (NNS Doc_14704468_334_343_Chemical) (, ,) (NNS Doc_14704468_345_355_Chemical) (, ,) (CC or) (NNS Doc_14704468_360_373_Chemical)))))) (PRN (-LRB- -LRB-) (VP (VBN applied) (PP (IN at) (NP (PRP$ their) (JJ subprotective) (NNS doses)))) (-RRB- -RRB-))) (ADVP (RB also)) (VP (VBD exhibited) (NP (JJ antiseizure) (NN effect)) (PP (IN in) (NP (DT this) (NN test)))) (. .)))
14704468	3	(ROOT (S (ADVP (RB However)) (, ,) (NP (QP (RB only) (CD two)) (JJ first) (NNS combinations)) (VP (VBD occurred) (S (VP (TO to) (VP (VB be) (PP (IN of) (NP (JJ pharmacodynamic) (NN nature))))))) (. .)))
14704468	4	(ROOT (S (PP (IN Among) (NP (JJ several) (NNS chemoconvulsants))) (, ,) (NP (NP (NNS Doc_14704468_572_583_Chemical) (, ,) (NNS Doc_14704468_585_609_Chemical) (CC and) (NNS Doc_14704468_614_624_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (DT the) (NN opener)) (PP (IN of) (NP (JJ L-type) (JJ Doc_14704468_647_654_Chemical) (NNS channels)))) (-RRB- -RRB-))) (VP (VBD reversed) (NP (NP (NP (DT the) (JJ protective) (NN activity)) (PP (IN of) (NP (NP (NNS Doc_14704468_701_712_Chemical)) (ADVP (RB alone))))) (CC and) (NP (NP (PRP$ its) (NN combination)) (PP (IN with) (NP (NNS Doc_14704468_744_753_Chemical)))))) (. .)))
14704468	5	(ROOT (S (PP (IN On) (NP (DT the) (JJ other) (NN hand))) (, ,) (NP (NNS Doc_14704468_774_785_Chemical) (, ,) (NNS Doc_14704468_787_800_Chemical) (CC and) (NNS Doc_14704468_805_815_Chemical)) (VP (VBD inhibited) (NP (NP (DT the) (JJ anticonvulsive) (NN action)) (PP (IN of) (NP (NNS Doc_14704468_855_866_Chemical)))) (PP (VBN combined) (PP (IN with) (NP (NNS Doc_14704468_881_891_Chemical))))) (. .)))
14704468	6	(ROOT (S (NP (DT The) (NNS results)) (VP (VBP support) (NP (DT the) (NNS hypothesis)) (SBAR (IN that) (S (NP (NP (DT the) (JJ protective) (NN activity)) (PP (IN of) (NP (NP (NNS Doc_14704468_960_971_Chemical)) (CC and) (NP (NP (PRP$ its) (NNS combinations)) (PP (IN with) (NP (JJ other) (NNS antiepileptics))))))) (VP (MD may) (VP (VB involve) (NP (NP (NN potentiation)) (PP (IN of) (NP (JJ GABAergic) (NN neurotransmission) (CC and) (NN blockade))) (PP (IN of) (NP (NP (NNP L-type)) (PP (IN of) (NP (JJ Doc_14704468_1101_1108_Chemical) (NNS channels))))))))))) (. .)))
14736955	0	(ROOT (S (NP (NP (NNP Mitochondrial) (NNP DNA)) (CC and) (NP (PRP$ its) (JJ respiratory) (NN chain) (NNS products))) (VP (VBP are) (ADJP (JJ defective) (PP (IN in) (NP (JJ Doc_14736955_70_81_Chemical) (NNS Doc_14736955_82_91_Disease))))) (. .)))
14736955	1	(ROOT (S (NP (NNP Doc_14736955_105_116_Chemical)) (VP (VBZ induces) (NP (NP (DT a) (JJ self-perpetuating) (NNS Doc_14736955_145_156_Disease)) (VP (VBN characterized) (PP (IN by) (NP (NP (JJ early) (NNS Doc_14736955_180_221_Disease)) (PP (IN in) (NP (NNS rats)))))))) (. .)))
14736955	2	(ROOT (S (NP (PRP We)) (VP (VBD investigated) (NP (NP (DT the) (JJ potential) (NN role)) (PP (IN of) (NP (NNS Doc_14736955_269_289_Disease)))) (PP (IN in) (NP (NP (DT the) (NN onset)) (PP (IN of) (NP (DT these) (NNS lesions)))))) (. .)))
14736955	3	(ROOT (S (NP (NNS Rats)) (VP (VP (VBD were) (VP (VBN treated) (PP (IN with) (NP (NP (NP (JJ intravenous) (NNS Doc_14736955_365_376_Chemical)) (-LRB- -LRB-) (NP (NP (NP (QP (CD 1) (CD mg)) (NN kg)) (PRN (-LRB- -LRB-) (NP (CD -1)) (-RRB- -RRB-)) (NP (NN week))) (PRN (-LRB- -LRB-) (NP (CD -1)) (-RRB- -RRB-))) (-RRB- -RRB-)) (PP (IN for) (NP (CD 7) (NNS weeks))))))) (CC and) (VP (VBD were) (VP (VBN sacrificed) (PP (CC either) (NP (NP (NP (CD 1) (NN week)) (PRN (-LRB- -LRB-) (ADJP (`` `) (JJ short-term) ('' ')) (-RRB- -RRB-))) (CC or) (NP (NP (CD 30) (NNS weeks) (PRN (-LRB- -LRB-) (ADJP (`` `) (JJ long-term) ('' ')) (-RRB- -RRB-))) (PP (VBG following) (NP (DT the) (JJ last) (NN dose))))))))) (. .)))
14736955	4	(ROOT (S (NP (JJ Additional) (NNS rats)) (VP (VBD received) (NP (NP (DT a) (JJ single) (NN dose)) (PP (CC either) (NP (NP (CD 6) (NNS days)) (CC or) (NP (CD 2) (NN h))))) (PP (RB prior) (PP (TO to) (NP (NN euthanasia))))) (. .)))
14736955	5	(ROOT (S (NP (DT All) (NNS rats)) (VP (VBD were) (VP (VBN killed) (PP (IN at) (NP (NP (CD 48) (NNS weeks)) (PP (IN of) (NP (NN age))))))) (. .)))
14736955	6	(ROOT (S (NP (NNP Doc_14736955_634_663_Disease)) (VP (VBD was) (VP (VBN monitored) (CC and) (VBN correlated) (PP (TO to) (NP (NP (DT the) (NN activity) (CC or) (NN expression)) (PP (IN of) (NP (JJ respiratory) (NN chain) (NNS components))))))) (. .)))
14736955	7	(ROOT (S (ADVP (RB Finally)) (, ,) (NP (PRP we)) (VP (VBN quantified) (NP (NP (NP (DT both) (JJ nuclear) (CC and) (JJ mitochondrial) (NN DNA)) (PRN (-LRB- -LRB-) (NP (NNP mtDNA)) (-RRB- -RRB-))) (CONJP (RB as) (RB well) (IN as)) (NP (NP (JJ Doc_14736955_833_843_Chemical) (NN production)) (CC and) (NP (NP (DT the) (CD 4834) (NN base) (NN pair)) (NP (`` `) (JJ common) ('' ') (NN mtDNA) (NNS deletion)))))) (. .)))
14736955	8	(ROOT (S (NP (DT The) (`` `) (JJ long-term) ('' ') (NN group)) (VP (VP (VBD had) (NP (NP (JJ significant) (NNS Doc_14736955_950_980_Disease)) (, ,) (NP (NP (JJ depressed) (NNS activities)) (PP (IN of) (NP (JJ mtDNA-encoded) (JJ Doc_14736955_1020_1024_Chemical) (NN dehydrogenase)))) (CC and) (NP (NP (JJ cytochrome-c) (NN oxidase)) (PRN (-LRB- -LRB-) (NP (NNP COX)) (-RRB- -RRB-))))) (CC and) (VP (VBD increased) (NP (JJ Doc_14736955_1084_1091_Chemical) (NN synthase) (NN activity)))) (. .)))
14736955	9	(ROOT (S (PP (IN In) (NP (NN addition))) (, ,) (NP (NP (NN expression)) (PP (IN of) (NP (DT the) (JJ mtDNA-encoded) (NN COX)))) (VP (VBP subunit) (SBAR (S (S (NP (PRP I)) (VP (VBD was) (VP (VBN reduced)))) (CC and) (S (NP (NN mtDNA) (NNS levels)) (VP (VBD were) (VP (VBN decreased))))))) (. .)))
14736955	10	(ROOT (S (PP (IN In) (NP (`` `) (JJ short-term) ('' ') (NNS rats))) (, ,) (NP (EX there)) (VP (VBD were) (NP (NP (ADJP (ADJP (RBR fewer) (JJ Doc_14736955_1254_1269_Disease)) (, ,) (CC but) (ADJP (JJ similar))) (NNS numbers)) (PP (IN of) (NP (JJ Doc_14736955_1294_1312_Disease) (NN activity))))) (. .)))
14736955	11	(ROOT (S (PP (IN Among) (NP (DT all) (NNS animals))) (, ,) (NP (NNS Doc_14736955_1342_1371_Disease)) (VP (VBD were) (ADVP (RB inversely)) (VP (VBN correlated) (PP (PP (IN with) (NP (NP (NN mtDNA) (NNS levels)) (, ,) (NP (JJ mtDNA-encoded) (JJ respiratory) (NN chain) (NNS activities)))) (CC and) (PP (IN with) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (DT the) (JJ mtDNA-encoded) (JJ respiratory) (NN chain) (NN subunit) (NN COX-I)))))))) (. .)))
14736955	12	(ROOT (S (NP (NNP Injury)) (VP (VBD was) (ADVP (RB positively)) (VP (VBN correlated) (PP (IN with) (NP (NP (JJ Doc_14736955_1576_1586_Chemical) (NN production)) (CC and) (NP (NP (DT the) (NNS activities)) (PP (IN of) (NP (JJ nucleus-encoded) (ADJP (JJ mitochondrial) (CC or) (JJ cytoplasmic)) (NNS enzymes)))))))) (. .)))
14736955	13	(ROOT (S (S (NP (NP (NNS Kidneys)) (PP (IN from) (NP (DT the) (`` `) (JJ long-term) ('' ') (NN group)))) (VP (VBD showed) (NP (JJR more) (NN mtDNA) (NNS deletions)) (PP (IN than) (PP (IN in) (NP (`` `) (JJ short-term) ('' ') (NNS animals)))))) (CC and) (S (NP (DT these)) (VP (VBD were) (RB not) (VP (VBN observed) (PP (IN in) (NP (DT the) (JJ other) (NNS groups)))))) (. .)))
14736955	14	(ROOT (S (NP (DT These) (NNS results)) (VP (VBP suggest) (NP (NP (DT an) (JJ important) (NN role)) (PP (IN for) (NP (JJ quantitative) (CC and) (JJ qualitative) (NN mtDNA) (NNS alterations)))) (PP (IN through) (NP (NP (NP (DT the) (NN reduction)) (PP (IN of) (NP (JJ mtDNA-encoded) (NN respiratory) (NN chain) (NN function)))) (CC and) (NP (NP (NN induction)) (PP (IN of) (NP (NP (NNS Doc_14736955_2002_2012_Chemical)) (PP (IN in) (NP (NN Doc_14736955_2016_2027_Chemical-induced) (NNS Doc_14736955_2036_2049_Disease))))))))) (. .)))
14742097	0	(ROOT (NP (NP (DT A) (JJ randomized) (, ,) (JJ placebo-controlled) (, ,) (JJ crossover) (NN study)) (PP (IN of) (NP (NNS Doc_14742097_53_62_Chemical))) (PP (IN for) (NP (JJ Doc_14742097_67_71_Chemical-induced) (JJ female) (NNS Doc_14742097_87_105_Disease))) (. .)))
14742097	1	(ROOT (S (NP (NP (DT The) (NN objective)) (PP (IN of) (NP (DT this) (NN study)))) (VP (VBD was) (S (VP (TO to) (VP (VB determine) (SBAR (IN whether) (S (NP (NP (NNS Doc_14742097_160_169_Chemical)) (, ,) (NP (NP (DT an) (ADJP (NN alpha) (: -) (CC and) (JJ beta-adrenergic)) (NN agonist)) (VP (ADVP (RB previously)) (VBN shown) (S (VP (TO to) (VP (VB enhance) (NP (NP (JJ genital) (NN blood) (NN flow)) (PP (IN in) (NP (NNS women))))))))) (, ,)) (VP (VBZ has) (NP (NP (JJ beneficial) (NNS effects)) (PP (IN in) (S (VP (VBG reversing) (NP (JJ antidepressant-induced) (NNS Doc_14742097_325_343_Disease))))))))))))) (. .)))
14742097	2	(ROOT (S (NP (NP (JJ Nineteen) (JJ Doc_14742097_354_376_Disease) (NNS women)) (VP (VBG receiving) (PP (CC either) (NP (NNS Doc_14742097_400_410_Chemical) (, ,) (NNS Doc_14742097_412_422_Chemical) (, ,) (CC or) (NNS Doc_14742097_427_437_Chemical))))) (VP (VBD participated) (PP (IN in) (NP (NP (DT an) (JJ eight-week) (, ,) (JJ double-blind) (, ,) (JJ placebo-controlled) (, ,) (JJ cross-over) (NN study)) (PP (IN of) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NP (NNS Doc_14742097_538_547_Chemical)) (PRN (-LRB- -LRB-) (NP (QP (CD 50) (CD mg))) (-RRB- -RRB-)))))))) (PP (IN on) (NP (NP (JJ self-report) (NNS measures)) (PP (IN of) (NP (NP (JJ sexual) (NN desire)) (, ,) (NP (NN arousal)) (, ,) (NP (NN orgasm)) (, ,) (CC and) (NP (JJ sexual) (NN satisfaction))))))) (. .)))
14742097	3	(ROOT (S (SBAR (IN Although) (S (NP (EX there)) (VP (VBD were) (NP (NP (JJ significant) (NNS improvements)) (ADVP (JJ relative) (PP (TO to) (NP (NP (NN baseline)) (PP (IN in) (NP (NP (JJ sexual) (NN desire) (CC and) (NN orgasm) (NN intensity/pleasure)) (PP (IN on) (NP (CD 50) (NN mg) (NNS Doc_14742097_762_771_Chemical)))))))) (SBAR (S (ADJP (JJ 1-hr))))) (ADVP (RB prior) (PP (TO to) (NP (JJ sexual) (NN activity))))))) (, ,) (NP (NP (JJ significant) (NNS improvements)) (PP (PP (IN in) (NP (DT these) (NNS measures))) (, ,) (CONJP (RB as) (RB well) (IN as)) (PP (IN in) (NP (NP (JJ sexual) (NN arousal)) (CC and) (NP (JJ orgasmic) (NN ability)))))) (ADVP (RB also)) (VP (VBD were) (VP (VBN noted) (PP (IN with) (NP (NN placebo))))) (. .)))
14742097	4	(ROOT (S (NP (DT These) (NNS findings)) (VP (VB highlight) (NP (NP (DT the) (NN importance)) (PP (IN of) (S (VP (VBG conducting) (NP (JJ placebo-controlled) (NNS trials)) (PP (IN for) (NP (DT this) (NN condition)))))))) (. .)))
14745746	0	(ROOT (SQ (NNP Does) (NP (NN hormone)) (VP (VB therapy) (SBAR (IN for) (S (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (NNS Doc_14745746_42_55_Disease)))) (VP (VBP have) (NP (DT a) (NNS Doc_14745746_63_105_Disease)))))) (. ?)))
14745746	1	(ROOT (S (NP (DT A) (NN pilot)) (VP (VBP study)) (. .)))
14745746	2	(ROOT (S (NP (DT This) (NN pilot) (NN study)) (VP (VBZ examines) (SBAR (IN whether) (S (NP (NP (NN hormone) (NN therapy)) (PP (IN for) (NP (NNS Doc_14745746_176_189_Disease)))) (VP (VBZ affects) (NP (NN cognition)))))) (. .)))
14745746	3	(ROOT (S (NP (NP (NP (NP (NP (NNS Patients)) (VP (VBG participating) (PP (IN in) (NP (NP (DT a) (JJ randomised) (NN trial)) (PP (IN of) (NP (NP (NNS Doc_14745746_257_268_Chemical)) (, ,) (NP (NNS Doc_14745746_270_279_Chemical)))))) (ADVP (RB alone)))) (CC or) (NP (NP (VBN combined)) (PRN (-LRB- -LRB-) (NP (NNP ATAC)) (-RRB- -RRB-)))) (PRN (-LRB- -LRB-) (VP (VBN n) (S (VP (SYM =) (NP (CD 94))))) (-RRB- -RRB-))) (CC and) (NP (NP (NP (DT a) (NN group)) (PP (IN of) (NP (NP (NNS women)) (PP (IN without) (NP (NNS Doc_14745746_341_354_Disease)))))) (PRN (-LRB- -LRB-) (VP (VBN n) (S (VP (SYM =) (NP (CD 35))))) (-RRB- -RRB-)))) (VP (VBD completed) (NP (NP (DT a) (NN battery)) (PP (IN of) (NP (JJ neuropsychological) (NNS measures))))) (. .)))
14745746	4	(ROOT (S (PP (VBN Compared) (PP (IN with) (NP (DT the) (NN control) (NN group)))) (, ,) (NP (DT the) (NNS patients)) (VP (VBD were) (VP (VBN impaired) (PP (PP (IN on) (NP (NP (DT a) (VBG processing) (NN speed) (NN task)) (PRN (-LRB- -LRB-) (VP (VBN p) (S (VP (SYM =) (NP (CD 0.032))))) (-RRB- -RRB-)))) (CC and) (PP (IN on) (NP (NP (DT a) (NN measure)) (PP (IN of) (NP (JJ immediate) (JJ verbal) (NN memory))) (PRN (-LRB- -LRB-) (VP (VBN p) (S (VP (SYM =) (NP (CD 0.026))))) (-RRB- -RRB-))))) (PP (IN after) (S (VP (VBG controlling) (PP (IN for) (NP (NP (DT the) (NN use)) (PP (IN of) (NP (NP (NN hormone) (NN replacement) (NN therapy)) (PP (IN in) (NP (DT both) (NNS groups)))))))))))) (. .)))
14745746	5	(ROOT (S (NP (JJ Patient) (NN group) (NN performance)) (VP (VBD was) (RB not) (ADJP (RB significantly) (VBN related) (PP (TO to) (NP (NP (NP (NN length)) (PP (IN of) (NP (NN treatment)))) (CC or) (NP (NP (NNS measures)) (PP (IN of) (NP (JJ psychological) (NN morbidity)))))))) (. .)))
14745746	6	(ROOT (S (NP (DT The) (NNS results)) (VP (VBD showed) (NP (JJ specific) (NNS impairments)) (PP (IN in) (NP (NP (NN processing) (NN speed)) (CC and) (NP (JJ verbal) (NN memory)))) (PP (IN in) (NP (NP (NNS women)) (VP (VBG receiving) (NP (JJ hormonal) (NN therapy)) (PP (IN for) (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (NNS Doc_14745746_896_909_Disease))))))))) (. .)))
14745746	7	(ROOT (S (S (NP (JJ Verbal) (NN memory)) (VP (MD may) (VP (VB be) (ADJP (RB especially) (JJ sensitive) (PP (TO to) (NP (NP (NNS changes)) (PP (IN in) (NP (JJ Doc_14745746_967_976_Chemical) (NNS levels))))))))) (, ,) (NP (DT a) (NN finding)) (ADVP (RB commonly)) (VP (VBD reported) (PP (IN in) (NP (NP (NNS studies)) (PP (IN of) (NP (NN hormone) (NN replacement) (NN therapy))))) (PP (IN in) (NP (JJ healthy) (NNS women)))) (. .)))
14745746	8	(ROOT (S (PP (IN In) (NP (NP (NN view)) (PP (IN of) (NP (NP (DT the) (VBN increased) (NN use)) (PP (IN of) (NP (NP (NN hormone) (NNS therapies)) (PP (IN in) (NP (NP (DT an) (NN adjuvant)) (CC and) (NP (JJ preventative) (NN setting)))))))))) (NP (NP (PRP$ their) (NN impact)) (PP (IN on) (NP (JJ cognitive) (NN functioning)))) (VP (MD should) (VP (VB be) (VP (VBN investigated) (S (ADJP (RBR more) (RB thoroughly)))))) (. .)))
14975762	0	(ROOT (S (NP (NP (NNP Expression)) (PP (IN of) (NP (CD p300)))) (VP (VBZ protects) (NP (JJ cardiac) (NNS myocytes)) (PP (IN from) (NP (NP (NNS apoptosis)) (PP (IN in) (NP (NN vivo)))))) (. .)))
14975762	1	(ROOT (S (NP (NNP Doc_14975762_69_80_Chemical)) (VP (VBZ is) (NP (NP (DT an) (JJ anti-Doc_14975762_92_97_Disease) (NN agent)) (SBAR (WHNP (WDT that)) (S (VP (VP (VBZ represses) (NP (JJ cardiac-specific) (NN gene) (NN expression))) (CC and) (VP (VBZ induces) (NP (JJ myocardial) (NN cell) (NNS apoptosis)))))))) (. .)))
14975762	2	(ROOT (SINV (ADJP (JJ Doc_14975762_191_202_Chemical)) (VP (VBZ depletes)) (NP (NP (JJ cardiac) (NNS p300)) (, ,) (NP (NP (DT a) (JJ transcriptional) (NN coactivator)) (SBAR (WHNP (WDT that)) (S (VP (VBZ is) (VP (VBN required) (PP (IN for) (NP (NP (DT the) (NN maintenance)) (PP (IN of) (NP (NP (DT the) (JJ differentiated) (NN phenotype)) (PP (IN of) (NP (JJ cardiac) (NNS myocytes))))))))))))) (. .)))
14975762	3	(ROOT (S (ADVP (RB However)) (, ,) (NP (NP (DT the) (NN role)) (PP (IN of) (NP (NP (NNS p300)) (PP (IN in) (NP (NP (NN protection)) (PP (IN against) (NP (NN Doc_14975762_394_405_Chemical-induced) (NNS apoptosis)))))))) (VP (VBZ is) (ADJP (JJ unknown))) (. .)))
14975762	4	(ROOT (S (NP (NP (NNP Transgenic) (NNS mice)) (VP (VBG overexpressing) (NP (NNS p300)) (PP (IN in) (NP (NP (DT the) (NN heart)) (CC and) (NP (JJ wild-type) (NNS mice)))))) (VP (VBD were) (VP (VBN subjected) (PP (TO to) (NP (JJ Doc_14975762_522_533_Chemical) (NN treatment))))) (. .)))
14975762	5	(ROOT (S (PP (VBN Compared) (PP (IN with) (NP (JJ wild-type) (NNS mice)))) (, ,) (NP (JJ transgenic) (NNS mice)) (VP (VBD exhibited) (NP (NP (JJR higher) (NN survival) (NN rate)) (CONJP (RB as) (RB well) (IN as)) (NP (NP (JJR more)) (VP (VBN preserved) (NP (NP (JJ left) (NN ventricular) (NN function) (CC and) (JJ cardiac) (NN expression)) (PP (IN of) (NP (JJ alpha-sarcomeric) (NN actin)))))))) (. .)))
14975762	6	(ROOT (S (NP (NNP Doc_14975762_724_735_Chemical)) (VP (VBN induced) (NP (JJ myocardial) (NN cell) (NNS apoptosis)) (PP (PP (IN in) (NP (JJ wild-type) (NNS mice))) (CONJP (CC but) (RB not)) (PP (IN in) (NP (JJ transgenic) (NNS mice))))) (. .)))
14975762	7	(ROOT (S (NP (NP (NNP Expression)) (PP (IN of) (NP (CD p300)))) (VP (VBD increased) (NP (NP (NP (DT the) (JJ cardiac) (NN level)) (PP (IN of) (ADJP (JJ bcl-2) (CC and) (JJ mdm-2)))) (, ,) (CONJP (CC but) (RB not)) (NP (NP (DT that)) (PP (IN of) (NP (NP (NN p53) (CC or) (JJ other) (NNS members)) (PP (IN of) (NP (DT the) (JJ bcl-2) (NN family)))))))) (. .)))
14975762	8	(ROOT (S (NP (DT These) (NNS findings)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP (NP (NN overexpression)) (PP (IN of) (NP (CD p300)))) (VP (VP (VBZ protects) (NP (JJ cardiac) (NNS myocytes)) (PP (IN from) (NP (NN Doc_14975762_1027_1038_Chemical-induced) (NNS apoptosis)))) (CC and) (VP (VBZ reduces) (NP (NP (DT the) (NN extent)) (PP (IN of) (NP (JJ acute) (NNS Doc_14975762_1089_1102_Disease)))) (PP (IN in) (NP (NP (JJ adult) (NNS mice)) (PP (IN in) (NP (NN vivo)))))))))) (. .)))
14982270	0	(ROOT (NP (CD Doc_14982270_0_11_Chemical-induced) (NNS Doc_14982270_20_40_Disease) (. .)))
14982270	1	(ROOT (S (NP (NNP Doc_14982270_42_53_Chemical)) (VP (VBZ is) (NP (DT a) (ADJP (ADJP (RB widely) (VBN used)) (CC and) (ADJP (RB generally) (JJ well-tolerated))) (JJ antithyroid) (NN agent))) (. .)))
14982270	2	(ROOT (S (NP (DT A) (JJ 43-year-old) (NN woman)) (VP (VBD had) (NP (JJ severe) (NNS Doc_14982270_150_158_Disease) (CC and) (NNS Doc_14982270_163_170_Disease)) (NP (CD 1) (NN month)) (PP (IN after) (NP (NP (NN receiving) (NNS Doc_14982270_195_206_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 10) (NN mg) (NN tid)) (-RRB- -RRB-)) (CC and) (NP (NNS Doc_14982270_223_234_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 20) (NN mg) (NN tid)) (-RRB- -RRB-)))) (PP (IN for) (NP (NP (NN treatment)) (PP (IN of) (NP (NNS Doc_14982270_264_279_Disease)))))) (. .)))
14982270	3	(ROOT (S (NP (DT The) (NN patient)) (VP (VBD continued) (NP (NN treatment)) (PP (IN for) (NP (DT another) (CD 4) (NNS days))) (PP (IN after) (NP (NP (DT the) (NN appearance)) (PP (IN of) (NP (NNS Doc_14982270_356_364_Disease))))) (SBAR (IN until) (S (NP (PRP she)) (VP (VBD finished) (NP (DT both) (NNS medications)))))) (. .)))
14982270	4	(ROOT (S (SBAR (WHADVP (WRB When)) (S (VP (VBN seen) (PP (IN at) (NP (DT the) (NN emergency) (NN department))) (NP (CD 2) (NNS weeks) (RB later))))) (, ,) (NP (PRP she)) (ADVP (RB still)) (VP (VBD had) (NP (NP (JJ severe) (NNS Doc_14982270_476_483_Disease)) (, ,) (NP (NNS Doc_14982270_485_493_Disease)) (, ,) (CC and) (NP (NP (NNS Doc_14982270_499_517_Disease)) (, ,) (VP (VBN formed) (ADVP (RB mainly)) (PP (IN of) (NP (DT the) (JJ conjugated) (NN fraction))))))) (. .)))
14982270	5	(ROOT (S (S (NP (JJ Doc_14982270_561_572_Chemical-induced) (NNS Doc_14982270_581_592_Disease)) (VP (VBD was) (VP (VBN diagnosed)))) (, ,) (CC and) (S (NP (JJ Doc_14982270_612_623_Chemical) (NN therapy)) (VP (VBD was) (VP (VBN resumed)))) (. .)))
14982270	6	(ROOT (S (PP (IN Over) (NP (DT the) (JJ following) (CD 9) (NNS days))) (, ,) (S (NP (DT the) (NNS symptoms)) (VP (VBD improved))) (CC and) (S (NP (NN plasma) (NNS Doc_14982270_705_714_Chemical) (NNS levels)) (VP (VBD were) (ADJP (JJ normal) (PP (IN after) (NP (CD 12) (NNS weeks)))) (PP (IN without) (NP (NNS Doc_14982270_757_768_Chemical))))) (. .)))
14982270	7	(ROOT (S (PP (IN In) (NP (NP (JJ rare) (NNS cases)) (PP (IN within) (NP (NP (DT the) (JJ first) (JJ few) (NNS weeks)) (PP (IN of) (NP (NN therapy))))))) (, ,) (NP (DT this) (NN drug)) (VP (MD can) (VP (VB cause) (NP (ADJP (JJ severe) (CC and) (JJ reversible)) (NNS Doc_14982270_865_885_Disease)))) (. .)))
14982270	8	(ROOT (S (NP (NP (NNP Physicians)) (CC and) (NP (NNS patients))) (VP (MD should) (VP (VB be) (ADJP (JJ aware) (PP (IN of) (NP (DT this) (JJ adverse) (NN effect)))) (SBAR (RB so) (IN that) (S (PRN (, ,) (PP (IN upon) (NP (NN occurrence))) (, ,)) (NP (PRP they)) (VP (MD can) (VP (VP (VB discontinue) (NP (JJ Doc_14982270_997_1008_Chemical) (NN therapy))) (CC and) (VP (VB avoid) (NP (JJ unnecessary) (NN invasive) (NNS procedures))))))))) (. .)))
15042318	0	(ROOT (S (NP (NP (JJ Doc_15042318_0_19_Disease) (VBG following) (NN chemotherapy)) (PP (IN for) (NP (NN stage)))) (VP (VBP IIIE) (NP (NP (JJ diffuse) (JJ large) (JJ B-cell) (NNS Doc_15042318_79_95_Disease)) (PP (IN in) (NP (NP (DT a) (NN patient)) (PP (IN with) (NP (NP (NNS Doc_15042318_114_132_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_15042318_134_152_Disease)) (-RRB- -RRB-)))))))) (. .)))
15042318	1	(ROOT (S (NP (DT The) (NNS authors)) (VP (VBP describe) (NP (NP (NP (DT the) (JJ unusual) (NN association)) (PP (IN between) (NP (JJ diffuse) (NNP B-cell) (NNS Doc_15042318_223_239_Disease) (CC and) (NNS Doc_15042318_244_262_Disease)))) (, ,) (NP (NP (DT the) (ADJP (RBS most) (JJ common)) (NN form)) (PP (IN of) (NP (JJ adult) (NNS Doc_15042318_294_312_Disease)))) (, ,) (CC and) (NP (NP (JJ sudden) (NNS Doc_15042318_325_344_Disease)) (PP (VBG following) (NP (NP (CD one) (NN cycle)) (PP (IN of) (NP (NP (NN Doc_15042318_368_379_Chemical-based) (NN chemotherapy)) (PP (IN in) (NP (DT the) (JJ same) (NN patient)))))))))) (. .)))
15042318	2	(ROOT (S (NP (JJ Doc_15042318_420_439_Disease) (CC or) (JJ other) (NNS Doc_15042318_449_468_Disease)) (VP (VBP are) (NP (NP (JJ unusual) (NNS complications)) (PP (IN in) (NP (NP (NNS patients)) (VP (VBN treated) (PP (IN with) (NP (NN chemotherapy)))))))) (. .)))
15042318	3	(ROOT (S (NP (NP (DT The) (JJ Doc_15042318_538_554_Disease) (NN intrinsically)) (VP (VBN associated) (PP (IN with) (NP (NP (DT the) (JJ aggressive) (NN chemotherapy)) (VP (VBN employed)))))) (VP (MD could) (VP (VB function) (PP (IN as) (NP (NP (DT a) (VBG triggering) (NN factor)) (PP (IN for) (NP (NP (DT the) (NNS Doc_15042318_668_678_Disease)) (PP (IN in) (NP (NP (DT the) (JJ predisposed) (NN myocardium)) (PP (IN of) (NP (DT this) (NN patient))))))))))) (. .)))
1504402	0	(ROOT (S (VP (VB Doc_1504402_0_16_Disease) (NP (JJ immune) (NN reaction)) (PP (IN as) (NP (NP (DT a) (NN mechanism)) (PP (IN for) (NP (NN Doc_1504402_52_61_Chemical-associated) (NNS Doc_1504402_73_82_Disease)))))) (. .)))
1504402	1	(ROOT (S (S (VP (VP (TO To) (VP (VB assess) (NP (JJ lymphocyte) (NN reactivity)) (PP (TO to) (NP (NNS Doc_1504402_130_139_Chemical))))) (CC and) (VP (TO to) (VP (VB serum) (S (VP (VBG containing) (NP (JJ putative) (JJ ex) (NN vivo) (NNS Doc_1504402_181_190_Chemical)))))))) (VP (VBZ antigens) (CC or) (VBZ metabolites) (PP (IN in) (NP (NP (DT a) (NN case)) (PP (IN of) (NP (NN Doc_1504402_228_237_Chemical-induced) (NNS Doc_1504402_246_258_Disease)))))) (. .)))
1504402	2	(ROOT (NP (NP (DT A) (JJ 58-year-old) (NN woman)) (PP (IN with) (NP (DT a) (JJ clinical) (NN diagnosis))) (PP (IN of) (NP (NN Doc_1504402_318_327_Chemical-induced) (NNS Doc_1504402_336_348_Disease))) (. .)))
1504402	3	(ROOT (S (NP (NP (JJ Peripheral) (NN blood) (NN mononuclear) (NNS cells)) (VP (VBN collected) (PP (IN from) (NP (DT the) (NN patient))))) (VP (VBD were) (VP (VP (VBN cultured) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NP (DT a) (NN solution)) (PP (IN of) (NP (NNS Doc_1504402_468_477_Chemical)))))))) (CC and) (VP (ADVP (ADVP (RB also)) (PP (IN with) (NP (NN sera)))) (VBN collected) (PP (IN from) (NP (DT a) (NN volunteer))) (PP (IN before) (CC and) (IN after) (NP (JJ Doc_1504402_541_550_Chemical) (NN intake)))))) (. .)))
1504402	4	(ROOT (S (NP (DT A) (JJ similar) (NN protocol)) (VP (VBD was) (VP (VBN performed) (PP (IN with) (NP (NP (NNS lymphocytes)) (PP (IN from) (NP (DT a) (JJ healthy) (NN subject))))))) (. .)))
1504402	5	(ROOT (S (NP (DT No) (JJ lymphocyte) (NN proliferation)) (VP (VBD was) (VP (VBN observed) (PP (CC either) (PP (IN in) (NP (DT the) (NN patient))) (CC or) (PP (IN in) (NP (NP (DT the) (JJ healthy) (NN volunteer)) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (JJ Doc_1504402_752_761_Chemical) (NNS solutions)))))))))) (. .)))
1504402	6	(ROOT (S (NP (NP (DT A) (JJ significant) (NN proliferative) (NN response)) (PP (TO to) (NP (NN serum)))) (VP (VBD collected) (SBAR (IN after) (S (NP (JJ Doc_1504402_835_844_Chemical) (NN intake)) (VP (VBD was) (VP (VBN observed) (PP (IN in) (NP (NP (DT the) (NN case)) (PP (IN of) (NP (DT the) (NN patient))))) (PP (VBN compared) (PP (IN with) (NP (NP (DT the) (JJ proliferative) (NN response)) (PP (TO to) (NP (NP (DT the) (NN serum)) (VP (VBN collected) (PP (IN before) (NP (DT the) (NN drug) (NN intake)))))))))))))) (. .)))
1504402	7	(ROOT (S (NP (DT No) (NN reactivity)) (VP (VBD was) (VP (VBN found) (SBAR (WHADVP (WRB when)) (S (NP (NP (NNS lymphocytes)) (PP (IN from) (NP (DT the) (JJ healthy) (NN subject)))) (VP (VBD were) (VP (VBN tested) (PP (IN under) (NP (JJ similar) (NNS conditions))))))))) (. .)))
1504402	8	(ROOT (S (NP (NP (DT The) (NN methodology)) (VP (VBN used))) (VP (VBD allowed) (NP (NP (DT the) (NN detection)) (PP (IN of) (NP (NP (JJ lymphocyte) (NN sensitization)) (PP (TO to) (NP (NN sera)))))) (S (VP (VBG containing) (NP (CD ex) (JJ vivo-prepared) (JJ Doc_1504402_1204_1213_Chemical) (NNS antigens)))) (, ,) (S (VP (VBG suggesting) (NP (NP (DT the) (NN involvement)) (PP (IN of) (NP (NP (DT an) (JJ immunologic) (NN mechanism)) (PP (IN in) (NP (NN Doc_1504402_1282_1291_Chemical-induced) (NNS Doc_1504402_1300_1312_Disease))))))))) (. .)))
15075188	0	(ROOT (S (NP (NP (VBN Increased) (NN expression) (CC and) (NN apical)) (VP (VBG targeting) (PP (IN of) (NP (JJ renal) (NNP ENaC))))) (VP (VBZ subunits) (PP (IN in) (NP (NP (NN Doc_15075188_68_93_Chemical-induced) (NNS Doc_15075188_102_120_Disease)) (PP (IN in) (NP (NNS rats)))))) (. .)))
15075188	1	(ROOT (S (NP (NNP Doc_15075188_130_148_Disease)) (VP (VBZ is) (ADVP (RB often)) (VP (VBN accompanied) (PP (IN by) (NP (JJ Doc_15075188_173_179_Chemical) (NN retention) (CC and) (NN generalized) (NNS Doc_15075188_206_211_Disease))))) (. .)))
15075188	2	(ROOT (S (ADVP (RB However)) (, ,) (NP (NP (DT the) (JJ molecular) (NN basis)) (PP (IN for) (NP (DT the) (JJ decreased) (JJ renal) (NNS Doc_15075188_266_272_Chemical) (NN excretion)))) (VP (VBZ remains) (ADJP (JJ undefined))) (. .)))
15075188	3	(ROOT (S (NP (PRP We)) (VP (VBN hypothesized) (SBAR (IN that) (S (NP (NP (NP (JJ epithelial) (NN Na) (NN channel)) (PRN (-LRB- -LRB-) (NP (NNP ENaC)) (-RRB- -RRB-))) (ADJP (JJ subunit) (JJ dysregulation))) (VP (MD may) (VP (VB be) (ADJP (JJ responsible) (PP (IN for) (NP (DT the) (VBN increased) (NNS Doc_15075188_411_417_Chemical) (NN retention))))))))) (. .)))
15075188	4	(ROOT (S (NP (NP (DT An) (JJ experimental) (NN group)) (PP (IN of) (NP (NNS rats)))) (VP (VBD was) (VP (VBN treated) (PP (IN with) (NP (NP (NNS Doc_15075188_476_501_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (NNS Doc_15075188_503_506_Chemical)) (: ;) (NP (CD 180) (JJ mg/kg) (NN iv))) (-RRB- -RRB-)))) (, ,) (SBAR (IN whereas) (S (NP (DT the) (NN control) (NN group)) (VP (VBD received) (NP (JJ only) (NN vehicle))))))) (. .)))
15075188	5	(ROOT (S (PP (IN After) (NP (CD 7) (NNS days))) (, ,) (NP (JJ Doc_15075188_586_589_Chemical) (NN treatment)) (VP (VBN induced) (NP (NP (JJ significant) (NNS Doc_15075188_620_631_Disease)) (, ,) (NP (NNS Doc_15075188_633_648_Disease)) (, ,) (NP (JJ decreased) (JJ urinary) (JJ Doc_15075188_668_674_Chemical) (NN excretion)) (, ,) (CC and) (NP (JJ extensive) (NNS Doc_15075188_700_707_Disease)))) (. .)))
15075188	6	(ROOT (S (S (NP (NP (DT The) (NN protein) (NN abundance)) (PP (IN of) (ADJP (JJ alpha-ENaC) (CC and) (JJ beta-ENaC)))) (VP (VP (VBD was) (VP (VBN increased) (PP (PP (IN in) (NP (NP (DT the) (JJ inner) (NN stripe)) (PP (IN of) (NP (NP (DT the) (JJ outer) (NN medulla)) (PRN (-LRB- -LRB-) (NP (NNP ISOM)) (-RRB- -RRB-)))))) (CC and) (PP (IN in) (NP (NP (DT the) (JJ inner) (NN medulla)) (PRN (-LRB- -LRB-) (NP (NNP IM)) (-RRB- -RRB-))))))) (CC but) (VP (VBD was) (RB not) (VP (VBN altered) (PP (IN in) (NP (DT the) (NN cortex))) (. .))))) (NP (JJ gamma-ENaC) (NN abundance)) (VP (VBD was) (VP (VBN increased) (PP (IN in) (NP (NP (DT the) (NN cortex)) (, ,) (NP (NNP ISOM)) (, ,) (CC and) (NP (NNP IM)))))) (. .)))
15075188	7	(ROOT (S (NP (NP (JJ Immunoperoxidase) (ADJP (JJ brightfield) (: -) (CC and) (JJ laser-scanning)) (NN confocal) (NN fluorescence) (NN microscopy)) (VP (VBN demonstrated))) (VP (VBD increased) (S (VP (VP (VBG targeting) (PP (IN of) (NP (JJ alpha-ENaC) (, ,) (ADJP (JJ beta-ENaC) (, ,) (CC and) (JJ gamma-ENaC)) (NNS subunits))) (PP (TO to) (NP (NP (DT the) (JJ apical) (NN plasma) (NN membrane)) (PP (IN in) (NP (NP (DT the) (ADJP (JJ distal) (JJ convoluted)) (NN tubule)) (PRN (-LRB- -LRB-) (NP (NNP DCT2)) (-RRB- -RRB-))))))) (, ,) (VP (VBG connecting) (ADJP (ADJP (JJ tubule)) (, ,) (CC and) (ADJP (JJ cortical)))) (CC and) (VP (ADVP (RB medullary)) (VBG collecting) (NP (JJ duct) (NNS segments)))))) (. .)))
15075188	8	(ROOT (S (NP (NNP Immunoelectron)) (ADVP (RB microscopy)) (VP (ADVP (RBR further)) (VBD revealed) (NP (NP (DT an) (VBN increased) (NN labeling)) (PP (IN of) (NP (NP (ADJP (JJ alpha-ENaC) (PP (IN in) (NP (NP (DT the) (JJ apical) (NN plasma) (NN membrane)) (PP (IN of) (NP (JJ cortical) (NN collecting)))))) (JJ duct) (JJ principal) (NNS cells)) (PP (IN of) (NP (NN Doc_15075188_1413_1416_Chemical-treated) (NNS rats)))))) (, ,) (S (VP (VBG indicating) (NP (NP (VBN enhanced) (NN apical) (VBG targeting)) (PP (IN of) (NP (JJ alpha-ENaC) (NNS subunits))))))) (. .)))
15075188	9	(ROOT (S (PP (IN In) (NP (NN contrast))) (, ,) (NP (NP (NP (DT the) (NN protein) (NNS abundances)) (PP (IN of) (NP (NP (NP (NNS Doc_15075188_1531_1536_Chemical)) (PRN (: /) (NP (NP (JJ Doc_15075188_1537_1541_Chemical) (NN exchanger) (NN type) (CD 3) (-LRB- -LRB-) (NN NHE3) (-RRB- -RRB-)) (, ,) (NP (JJ Doc_15075188_1567_1584_Chemical) (NN cotransporter))))) (PRN (-LRB- -LRB-) (NP (NNP BSC-1)) (-RRB- -RRB-))))) (, ,) (CC and) (NP (NP (NN Doc_15075188_1612_1620_Chemical-sensitive) (JJ Doc_15075188_1631_1642_Chemical) (NN cotransporter)) (PRN (-LRB- -LRB-) (NP (NNP TSC)) (-RRB- -RRB-)))) (VP (VBD were) (VP (VBN decreased))) (. .)))
15075188	10	(ROOT (S (ADVP (RB Moreover)) (, ,) (S (NP (NP (DT the) (NN abundance)) (PP (IN of) (NP (NP (NP (DT the) (NN alpha)) (PRN (-LRB- -LRB-) (NP (CD 1)) (-RRB- -RRB-))) (: -) (NP (NP (NN subunit)) (PP (IN of) (NP (DT the) (NN Doc_15075188_1734_1736_Chemical-Doc_15075188_1737_1738_Chemical-ATPase))))))) (VP (VBD was) (VP (VBN decreased) (PP (IN in) (NP (NP (DT the) (NN cortex)) (CC and) (NP (NNP ISOM))))))) (, ,) (CC but) (S (NP (PRP it)) (VP (VBD remained) (ADJP (JJ unchanged)) (PP (IN in) (NP (DT the) (NNP IM))))) (. .)))
15075188	11	(ROOT (S (PP (IN In) (NP (NN conclusion))) (, ,) (NP (NP (DT the) (JJ increased) (CC or) (JJ sustained) (NN expression)) (PP (IN of) (NP (NP (JJ ENaC) (NNS subunits)) (VP (VBN combined) (PP (IN with) (S (NP (VBN increased) (NN apical)) (VP (VP (VBG targeting) (PP (IN in) (NP (DT the) (NN DCT2)))) (, ,) (VP (VBG connecting) (NP (NN tubule))) (, ,) (CC and) (VP (VBG collecting) (NP (NN duct)))))))))) (VP (VBP are) (ADJP (JJ likely) (S (VP (TO to) (VP (VB play) (NP (DT a) (NN role)) (PP (IN in) (NP (NP (DT the) (JJ Doc_15075188_2017_2023_Chemical) (NN retention)) (VP (VBN associated) (PP (IN with) (NP (NN Doc_15075188_2050_2053_Chemical-induced) (NNS Doc_15075188_2062_2080_Disease))))))))))) (. .)))
15075188	12	(ROOT (S (NP (NP (DT The) (VBN decreased) (NN abundance)) (PP (IN of) (NP (NNP NHE3) (, ,) (NNS BSC-1) (, ,) (NNP TSC) (, ,) (CC and) (NNP Doc_15075188_2131_2133_Chemical-Doc_15075188_2134_2135_Chemical-ATPase)))) (VP (MD may) (VP (VB play) (NP (DT a) (JJ compensatory) (NN role)) (S (VP (TO to) (VP (VB promote) (NP (JJ Doc_15075188_2183_2189_Chemical) (NN excretion))))))) (. .)))
15096016	0	(ROOT (NP (NP (JJ Pallidal) (NN stimulation)) (: :) (NP (NP (DT an) (NN alternative)) (PP (TO to) (NP (NN pallidotomy)))) (. ?)))
15096016	1	(ROOT (S (NP (NP (DT A) (NN resurgence)) (PP (IN of) (NP (NP (NN interest)) (PP (IN in) (NP (NP (DT the) (JJ surgical) (NN treatment)) (PP (IN of) (NP (NP (NNS Doc_15096016_107_126_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_15096016_128_130_Disease)) (-RRB- -RRB-))))))))) (VP (VBD came) (PP (IN with) (NP (NP (DT the) (NN rediscovery)) (PP (IN of) (NP (JJ posteroventral) (NN pallidotomy))))) (PP (IN by) (NP (NP (NNP Laitinen)) (PP (IN in) (NP (CD 1985)))))) (. .)))
15096016	2	(ROOT (S (NP (NP (NNP Laitinen) (POS 's)) (NN procedure)) (VP (VBD improved) (NP (NP (JJS most) (NNS symptoms)) (PP (IN in) (NP (NP (JJ drug-resistant) (NNS Doc_15096016_271_273_Disease)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD engendered) (NP (JJ wide) (NN interest)) (PP (IN in) (NP (DT the) (JJ neurosurgical) (NN community)))))))))) (. .)))
15096016	3	(ROOT (S (NP (NP (DT Another) (JJ lesioning) (NN procedure)) (, ,) (NP (JJ ventrolateral) (NN thalamotomy)) (, ,)) (VP (VBZ has) (VP (VBN become) (NP (DT a) (JJ powerful) (NN alternative) (S (VP (TO to) (VP (VB stimulate) (NP (DT the) (NN nucleus) (NNS ventralis) (NNS intermedius)))))) (, ,) (S (VP (VBG producing) (NP (JJ high) (JJ long-term) (NN success) (NNS rates) (CC and) (JJ low) (NN morbidity) (NNS rates)))))) (. .)))
15096016	4	(ROOT (S (NP (JJ Pallidal) (NN stimulation)) (VP (VBZ has) (RB not) (VP (VBN met) (PP (IN with) (NP (DT the) (JJ same) (NN success))))) (. .)))
15096016	5	(ROOT (S (PP (VBG According) (PP (TO to) (NP (DT the) (NN literature)))) (NP (NN pallidotomy)) (VP (VBZ improves) (NP (NP (DT the) (`` ``) (ADJP (IN on)) ('' '') (NNS symptoms)) (PP (IN of) (NP (NNS Doc_15096016_666_668_Disease))) (, ,) (PP (JJ such) (IN as) (NP (NP (NP (NNS Doc_15096016_678_689_Disease)) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (DT the) (`` ``) (JJ off) ('' '') (NNS symptoms)) (, ,)) (PP (JJ such) (IN as) (NP (NP (NNS Doc_15096016_730_738_Disease)) (, ,) (NP (NNS Doc_15096016_740_752_Disease)) (, ,) (CC and) (NP (JJ on-off) (NNS fluctuations)))))))) (. .)))
15096016	6	(ROOT (S (S (NP (JJ Pallidal) (NN stimulation)) (VP (VBZ improves) (NP (NNS Doc_15096016_809_821_Disease) (CC and) (NNS Doc_15096016_826_834_Disease)) (PP (TO to) (NP (DT a) (JJ minor) (NN extent))))) (: ;) (S (ADVP (RB however)) (, ,) (NP (PRP$ its) (NN strength)) (VP (VBZ seems) (S (VP (TO to) (VP (VB be) (PP (IN in) (S (VP (VBG improving) (NP (NN Doc_15096016_901_909_Chemical-induced) (NNS Doc_15096016_918_929_Disease)))))))))) (. .)))
15096016	7	(ROOT (S (NP (NNP Stimulation)) (ADVP (RB often)) (VP (VP (VBZ produces) (NP (NP (DT an) (NN improvement)) (PP (IN in) (NP (DT the) (JJ Doc_15096016_980_1000_Disease) (JJ upper) (NNS limbs))))) (, ,) (CC but) (VP (VBZ increases) (NP (NP (DT the) (`` ``) (JJ freezing) ('' '') (NN phenomenon)) (PP (IN in) (NP (DT the) (JJR lower) (NNS limbs)))) (PP (IN at) (NP (DT the) (JJ same) (NN time))))) (. .)))
15096016	8	(ROOT (S (PP (VBG Considering) (NP (NP (NP (DT the) (JJ small) (NN increase)) (PP (IN in) (NP (NP (DT the) (NN patient) (POS 's)) (NN independence)))) (, ,) (NP (NP (DT the) (JJ high) (NNS costs)) (PP (IN of) (NP (JJ bilateral) (NNS implants)))) (, ,) (CC and) (NP (NP (DT the) (NN difficulty)) (SBAR (S (NP (JJS most) (NNS patients)) (VP (VBP experience) (PP (IN in) (S (VP (VBG handling) (NP (DT the) (NNS devices))))))))))) (, ,) (NP (DT the) (NN question)) (VP (VBZ arises) (ADVP (RB as) (PP (TO to) (SBAR (IN whether) (S (NP (JJ bilateral) (JJ pallidal) (NN stimulation)) (VP (VBZ is) (NP (DT a) (JJ real) (NN alternative) (S (VP (TO to) (VP (VB pallidotomy))))))))))) (. .)))
15266215	0	(ROOT (NP (NP (NNPS Effects)) (PP (IN of) (NP (NP (NP (DT the) (JJ cyclooxygenase-2) (JJ specific) (NN inhibitor) (NNS Doc_15266215_51_61_Chemical)) (PP (IN versus) (NP (JJ nonsteroidal) (NN antiinflammatory) (NNS agents)))) (CC and) (NP (NP (NN placebo)) (PP (IN on) (NP (JJ cardiovascular) (JJ Doc_15266215_136_146_Disease) (NNS events)))))) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NNS Doc_15266215_171_180_Disease))))) (. .)))
15266215	1	(ROOT (S (NP (EX There)) (VP (VBP have) (VP (VBN been) (NP (NNS concerns)) (SBAR (IN that) (S (NP (NP (DT the) (NN risk)) (PP (IN of) (NP (JJ cardiovascular) (JJ Doc_15266215_239_249_Disease) (NNS events)))) (VP (MD may) (VP (VB be) (ADJP (JJR higher)) (PP (IN with) (NP (NP (JJ cyclooxygenase) (PRN (-LRB- -LRB-) (NP (NNP COX)) (-RRB- -RRB-)) (NN -2)) (: -) (NP (NP (JJ specific) (NNS inhibitors)) (PP (IN than) (NP (NP (ADJP (JJ nonselective) (JJ nonsteroidal)) (NN antiinflammatory) (NNS drugs)) (PRN (-LRB- -LRB-) (NP (NNP NSAIDs)) (-RRB- -RRB-))))))))))))) (. .)))
15266215	2	(ROOT (S (NP (PRP We)) (VP (VBN evaluated) (NP (NP (JJ cardiovascular) (NN event) (NNS data)) (PP (IN for) (NP (NP (NNS Doc_15266215_426_436_Chemical)) (, ,) (NP (NP (DT a) (JJ new) (NN COX-2-specific) (NN inhibitor)) (PP (IN in) (NP (QP (RB approximately) (CD 8000)) (NNS patients))))))) (PP (IN with) (NP (NP (NNS Doc_15266215_505_519_Disease) (CC and) (NNS Doc_15266215_524_544_Disease)) (VP (VBN treated) (PP (IN with) (NP (NP (DT this) (NN agent)) (PP (IN in) (NP (JJ randomized) (JJ clinical) (NNS trials))))))))) (. .)))
15266215	3	(ROOT (S (NP (NP (NP (DT The) (NN incidence)) (PP (IN of) (NP (JJ cardiovascular) (JJ Doc_15266215_632_642_Disease) (NNS events)))) (PRN (-LRB- -LRB-) (NP (NP (JJ cardiac)) (, ,) (NP (NP (NN cerebrovascular)) (CC and) (NP (JJ peripheral) (NN vascular))) (, ,) (CC or) (NP (JJ arterial) (NNS Doc_15266215_713_723_Disease))) (-RRB- -RRB-))) (VP (VBD was) (VP (VBN determined) (PP (IN by) (S (VP (VBG analyzing) (NP (NP (NP (NP (JJ pooled) (NNS Doc_15266215_760_770_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 10-80) (NN mg) (NN daily)) (-RRB- -RRB-))) (, ,) (NP (NP (NNP nonselective) (NNP NSAID)) (PRN (-LRB- -LRB-) (NP (NP (NN Doc_15266215_809_819_Chemical) (CD 75) (NN mg) (NN bid)) (, ,) (NP (NN Doc_15266215_831_840_Chemical) (CD 800) (NN mg) (NN tid)) (, ,) (CC or) (NP (NN Doc_15266215_856_864_Chemical) (CD 500) (NN mg) (NN bid))) (-RRB- -RRB-))) (CC and) (NP (NP (NN placebo) (NNS data)) (PP (IN from) (NP (CD 10) (JJ randomized) (NNS Doc_15266215_913_927_Disease))))) (CC and) (NP (NP (JJ Doc_15266215_932_952_Disease) (NNS trials)) (SBAR (WHNP (WDT that)) (S (VP (VBD were) (NP (NP (CD 6-52) (NNS weeks)) (PP (IN in) (NP (NN duration)))))))))))))) (. .)))
15266215	4	(ROOT (S (NP (NP (DT The) (NN incidence) (NNS rates)) (PP (IN of) (NP (NNS events)))) (VP (VBD were) (VP (VBN determined) (PP (PP (IN in) (NP (NP (DT all) (NNS patients)) (PRN (-LRB- -LRB-) (VP (VBN n) (S (VP (SYM =) (NP (CD 7934))))) (-RRB- -RRB-)))) (CC and) (PP (IN in) (NP (NP (NP (NNS users)) (PP (IN of) (NP (JJ low-dose) (PRN (-LRB- -LRB-) (NP (QP (CD <) (CC or) (CD =) (CD 325)) (NN mg) (NN daily)) (-RRB- -RRB-)) (NNS Doc_15266215_1113_1120_Chemical)))) (PRN (-LRB- -LRB-) (VP (VBN n) (S (VP (SYM =) (NP (CD 1051))))) (-RRB- -RRB-)) (CC and) (NP (NP (NNS nonusers)) (PP (IN of) (NP (NP (NNS Doc_15266215_1148_1155_Chemical)) (PRN (-LRB- -LRB-) (VP (VBN n) (S (VP (SYM =) (NP (CD 6883))))) (-RRB- -RRB-)))))))))) (. .)))
15266215	5	(ROOT (S (NP (NP (JJ Crude) (CC and) (JJ exposure-adjusted) (NNS incidences)) (PP (IN of) (NP (JJ Doc_15266215_1210_1220_Disease) (NNS events)))) (VP (VBD were) (ADJP (JJ similar) (PP (IN for) (NP (NNS Doc_15266215_1245_1255_Chemical) (, ,) (NNP NSAIDs) (, ,) (CC and) (NNP placebo))))) (. .)))
15266215	6	(ROOT (S (NP (NP (DT The) (NN risk)) (PP (IN of) (NP (JJ serious) (JJ Doc_15266215_1298_1308_Disease) (NNS events)))) (VP (VBD was) (ADVP (RB also)) (ADJP (JJ similar) (PP (IN for) (NP (DT each) (JJ Doc_15266215_1342_1352_Chemical) (NN dose))))) (. .)))
15266215	7	(ROOT (S (NP (JJ Doc_15266215_1359_1369_Disease) (NN risk)) (VP (VBD was) (ADJP (ADJP (RB consistently) (JJR higher)) (PP (IN for) (NP (NP (NNS users)) (PP (IN of) (NP (JJ Doc_15266215_1412_1419_Chemical) (NNS users)))))) (PP (IN than) (NP (NP (NNS nonusers)) (PP (IN of) (NP (NP (NNS Doc_15266215_1443_1450_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (NN placebo)) (, ,) (NP (NP (NP (CD 1.4) (NN %)) (PP (IN vs.) (NP (CD 0) (NN %)))) (: ;) (NP (NP (NNS Doc_15266215_1474_1484_Chemical)) (, ,) (NP (NP (CD 1.7) (NN %)) (PP (IN vs.) (NP (CD 0.2) (NN %))))) (: ;) (NP (NP (NNP NSAIDs)) (, ,) (NP (NP (CD 1.9) (NN %)) (PP (IN vs.) (NP (CD 0.5) (NN %))))))) (-RRB- -RRB-))))))) (. .)))
15266215	8	(ROOT (S (NP (NP (DT The) (NNS rates)) (PP (IN of) (NP (NP (NNS events)) (PP (IN in) (NP (NP (NNS users)) (PP (IN of) (NP (NNS Doc_15266215_1557_1564_Chemical)))))))) (VP (VBD were) (ADJP (JJ similar)) (PP (PP (IN for) (NP (DT all) (CD 3) (NN treatment) (NNS groups))) (CC and) (PP (IN across) (NP (JJ Doc_15266215_1616_1626_Chemical) (NNS doses))))) (. .)))
15266215	9	(ROOT (S (NP (NP (ADJP (JJ Short) (: -) (CC and) (JJ intermediate-term)) (NN treatment)) (PP (IN with) (NP (NP (NP (JJ therapeutic)) (PRN (-LRB- -LRB-) (NP (QP (CD 10) (CC or) (CD 20)) (NN mg) (NN daily)) (-RRB- -RRB-))) (CC and) (NP (ADJP (ADJP (JJ supratherapeutic)) (PRN (-LRB- -LRB-) (NP (QP (CD 40) (CC or) (CD 80)) (NN mg) (NN daily)) (-RRB- -RRB-))) (JJ Doc_15266215_1751_1761_Chemical) (NNS doses))))) (VP (VBD was) (RB not) (VP (VBN associated) (PP (IN with) (NP (NP (DT an) (VBN increased) (NN incidence)) (PP (IN of) (NP (NP (JJ Doc_15266215_1818_1828_Disease) (NNS events)) (ADVP (JJ relative) (PP (TO to) (NP (JJ nonselective) (NNS NSAIDs) (CC or) (NN placebo)))) (PP (IN in) (NP (JJ Doc_15266215_1882_1896_Disease) (CC and) (JJ Doc_15266215_1901_1921_Disease) (NNS patients))) (PP (IN in) (NP (JJ controlled) (JJ clinical) (NNS trials))))))))) (. .)))
15266362	0	(ROOT (NP (NP (JJ Doc_15266362_0_16_Disease) (NNS Doc_15266362_17_28_Disease)) (VP (VBG complicating) (NP (JJ Doc_15266362_42_69_Disease) (NN heart))) (. .)))
15266362	1	(ROOT (S (NP (DT The) (JJ present) (NN report)) (VP (VBZ describes) (NP (NP (DT a) (NN case)) (PP (IN of) (NP (JJ Doc_15266362_116_140_Disease) (VBG complicating) (NNS Doc_15266362_154_181_Disease))))) (. .)))
15266362	2	(ROOT (S (NP (NP (DT The) (JJ 47-year-old) (JJ female) (NN patient)) (, ,) (VP (VBN known) (S (VP (TO to) (VP (VB have) (NP (NNS Doc_15266362_229_256_Disease)))))) (, ,)) (VP (VBD was) (VP (VP (VBN admitted) (PP (IN with) (NP (NNS Doc_15266362_276_297_Disease)))) (CC and) (VP (VBN managed) (ADVP (RB aggressively)) (PP (IN with) (NP (NP (JJ Doc_15266362_328_338_Chemical) (NN infusion)) (CC and) (NP (JJ other) (NNS drugs))))) (PP (IN while) (S (VP (VBG being) (VP (VBN assessed) (PP (IN for) (NP (NN heart) (NN transplantation))))))))) (. .)))
15266362	3	(ROOT (S (PP (IN On) (NP (JJ transthoracic) (NN echocardiogram))) (, ,) (NP (PRP she)) (VP (VBD had) (NP (NP (JJ moderate) (NNS Doc_15266362_462_490_Disease)) (PP (IN with) (NP (JJ regional) (ADJP (JJ variability) (CC and) (JJ moderate)) (NNS Doc_15266362_530_550_Disease))))) (. .)))
15266362	4	(ROOT (S (NP (NP (DT The) (NN recipient) (POS 's)) (NN heart)) (VP (VBD showed) (NP (NP (DT the) (NNS features)) (PP (IN of) (NP (JJ apical) (NNS Doc_15266362_604_631_Disease) (CC and) (NNS Doc_15266362_636_647_Disease)))) (PP (IN with) (NP (JJ abundant) (NNS eosinophils)))) (. .)))
15266362	5	(ROOT (S (S (NP (NNP Doc_15266362_675_686_Disease)) (VP (VBZ is) (ADJP (JJ rare)))) (CC and) (S (NP (NNS Doc_15266362_699_723_Disease)) (VP (VBZ is) (ADJP (JJ rarer)))) (. .)))
15266362	6	(ROOT (S (NP (PRP It)) (VP (VBZ is) (ADJP (JJ likely)) (SBAR (IN that) (S (NP (NP (DT the) (NNS Doc_15266362_756_772_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_15266362_774_786_Disease)) (-RRB- -RRB-)) (NNS Doc_15266362_788_799_Disease)) (VP (VBD was) (VP (VBN related) (PP (TO to) (NP (JJ Doc_15266362_815_825_Chemical) (NN infusion) (NN therapy)))))))) (. .)))
15266362	7	(ROOT (S (NP (NNP Doc_15266362_844_868_Disease)) (VP (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (PP (IN with) (NP (NP (DT an) (NN incidence)) (PP (IN of) (NP (NP (QP (CD 2.4) (NN %) (TO to) (CD 7.2) (NN %))) (PP (IN in) (NP (JJ explanted) (NNS hearts)))))))))) (CC and) (VP (MD may) (VP (VB be) (ADJP (VBN related) (PP (TO to) (S (VP (VBG multidrug) (NP (NN therapy))))))))) (. .)))
15276120	0	(ROOT (NP (NP (NN Time) (NNS trends)) (PP (IN in) (NP (NN Doc_15276120_15_23_Chemical-associated) (NNS Doc_15276120_35_45_Disease))) (. .)))
15276120	1	(ROOT (S (NP (NP (DT The) (JJ annual) (NN incidence)) (PP (IN of) (NP (NP (NP (NN Doc_15276120_71_79_Chemical-related) (NNS Doc_15276120_88_96_Disease)) (PP (IN at) (NP (NNP Brigham)))) (CC and) (NP (NP (NNP Women) (POS 's)) (NN Hospital))))) (VP (VBD increased) (PP (IN from) (NP (NP (CD 0.97)) (PRN (: /) (NP (NP (CD 1,000) (JJ patient) (NNS admissions)) (PP (IN in) (NP (NP (NP (DT the) (JJ first) (NN time) (NN period)) (PRN (-LRB- -LRB-) (NP (NP (NNP January) (CD 1995)) (PP (TO to) (NP (NNP October) (CD 1998)))) (-RRB- -RRB-))) (PP (TO to) (NP (CD 1.19)))))) (: /)))) (NP (NP (CD 1,000) (JJ patient) (NNS admissions)) (PP (IN in) (NP (NP (NP (DT the) (JJ second) (NN time) (NN period)) (PRN (-LRB- -LRB-) (NP (NP (NNP November) (CD 1998)) (PP (TO to) (NP (NNP August) (CD 2002)))) (-RRB- -RRB-))) (PP (IN of) (NP (DT this) (NN study))))))) (. .)))
15276120	2	(ROOT (S (NP (NP (DT The) (NN proportion)) (PP (IN of) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (JJ major)) (CC and) (NP (NNS Doc_15276120_377_398_Disease))))))) (VP (VBD increased) (PP (IN from) (NP (QP (CD 20.2) (NN %) (CC and) (CD 1.9) (NN %)))) (, ,) (ADVP (RB respectively)) (, ,) (PP (IN in) (NP (DT the) (JJ first) (NN time) (NN period))) (, ,) (PP (TO to) (NP (QP (CD 33.3) (NN %) (CC and) (CD 7.8) (NN %)))) (, ,) (ADVP (RB respectively)) (, ,) (PP (IN in) (NP (DT the) (NN second)))) (. .)))
1535072	0	(ROOT (S (NP (NP (JJ Doc_1535072_0_9_Chemical) (NN treatment)) (PP (IN of) (NP (NNS Doc_1535072_23_42_Disease)))) (VP (VBN induced) (PP (IN by) (NP (JJ Doc_1535072_54_63_Chemical) (NN reuptake) (NNS blockers)))) (. .)))
1535072	1	(ROOT (S (NP (JJ Preclinical) (CC and) (JJ clinical) (NNS studies)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NNS Doc_1535072_141_150_Chemical)) (VP (VP (VBZ facilitates) (NP (JJ sexual) (NN behavior))) (CC and) (VP (MD may) (VP (VB be) (ADJP (JJ helpful) (PP (IN in) (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (NNS Doc_1535072_218_232_Disease)))))))))))) (. .)))
1535072	2	(ROOT (S (NP (DT A) (JJ single) (NN case) (NN report)) (VP (VBZ suggests) (SBAR (IN that) (S (NP (NNS Doc_1535072_269_278_Chemical)) (VP (MD may) (VP (VB be) (VP (VBN used) (S (VP (TO to) (VP (VB treat) (NP (NP (DT the) (NNS Doc_1535072_304_323_Disease)) (PP (IN of) (NP (NNS Doc_1535072_327_339_Chemical))))))))))))) (. .)))
1535072	3	(ROOT (S (NP (NP (DT This) (NN study)) (VP (VBN evaluated) (NP (NNS Doc_1535072_362_371_Chemical)) (PP (IN as) (NP (NP (DT a) (NN treatment)) (PP (IN for) (NP (DT the) (NNS Doc_1535072_395_414_Disease))))))) (VP (VBD caused) (PP (IN by) (NP (JJ Doc_1535072_425_434_Chemical) (NN reuptake) (NNS blockers)))) (. .)))
1535072	4	(ROOT (S (NP (NP (CD Six) (NNS patients)) (PP (IN with) (NP (NP (DT either) (NNS Doc_1535072_487_516_Disease)) (, ,) (NP (NNS Doc_1535072_518_534_Disease)) (, ,) (NP (NNS Doc_1535072_536_543_Disease)) (, ,) (CC or) (NP (NNS Doc_1535072_548_567_Disease)))) (SBAR (WHNP (WP who)) (S (VP (VBD suffered) (NP (NNS Doc_1535072_581_600_Disease)) (PP (IN after) (NP (NN treatment))) (PP (IN with) (NP (JJ Doc_1535072_622_631_Chemical) (NN reuptake) (NNS blockers))))))) (VP (VBD were) (VP (VBN given) (NP (NNS Doc_1535072_661_670_Chemical)) (PP (IN on) (NP (NP (DT a) (NN p.r.n.) (NN basis)) (PP (IN in) (NP (DT an) (JJ open) (JJ clinical) (NN trial))))))) (. .)))
1535072	5	(ROOT (S (NP (NP (JJ Various) (NNS doses)) (PP (IN of) (NP (NNS Doc_1535072_733_742_Chemical)))) (VP (VBD were) (VP (VBN used) (S (VP (TO to) (VP (VB determine) (NP (NP (DT the) (JJ ideal) (NN dose)) (PP (IN for) (NP (DT each) (NN patient))))))))) (. .)))
1535072	6	(ROOT (S (NP (NP (CD Five)) (PP (IN of) (NP (DT the) (CD six) (NNS patients)))) (VP (VBD experienced) (NP (JJ improved) (JJ sexual) (NN functioning)) (PP (IN after) (S (VP (VBG taking) (NP (NNS Doc_1535072_886_895_Chemical)))))) (. .)))
1535072	7	(ROOT (S (NP (CD One) (NN patient) (SBAR (WHNP (WP who)) (S (VP (VBD failed) (S (VP (TO to) (VP (VB comply) (PP (IN with) (NP (JJ Doc_1535072_935_944_Chemical) (NN treatment)))))))))) (VP (VBD had) (NP (DT no) (JJ therapeutic) (NNS effects))) (. .)))
1535072	8	(ROOT (S (NP (NP (NN Side) (NNS effects)) (PP (IN of) (NP (NNS Doc_1535072_999_1008_Chemical)))) (VP (VBD included) (NP (NP (NP (JJ excessive) (NN sweating)) (, ,) (NP (VBN increased) (NNS Doc_1535072_1048_1055_Disease))) (, ,) (CC and) (NP (NP (DT a) (JJ wound-up) (NN feeling)) (PP (IN in) (NP (DT some) (NNS patients)))))) (. .)))
1535072	9	(ROOT (S (NP (NP (DT The) (NNS results)) (PP (IN of) (NP (DT this) (NN study)))) (VP (VBP indicate) (SBAR (IN that) (S (NP (NNS Doc_1535072_1150_1159_Chemical)) (VP (MD may) (VP (VB be) (NP (NP (DT an) (JJ effective) (NN treatment)) (PP (IN for) (NP (NP (DT the) (NNS Doc_1535072_1198_1217_Disease)) (VP (VBN caused) (PP (IN by) (NP (JJ Doc_1535072_1228_1237_Chemical) (NN reuptake) (NNS blockers)))))))))))) (. .)))
1535072	10	(ROOT (S (NP (JJ Future) (JJ controlled) (NNS studies)) (VP (VBP are) (VP (VBN needed) (S (VP (TO to) (VP (ADVP (RBR further)) (VB investigate) (NP (NP (DT the) (NN effectiveness) (CC and) (NN safety)) (PP (IN of) (NP (NP (NNS Doc_1535072_1349_1358_Chemical)) (PP (IN for) (NP (DT this) (NN indication))))))))))) (. .)))
1545575	0	(ROOT (NP (NP (JJ Doc_1545575_0_20_Disease) (VBG complicating) (NN bone)) (NP (NN marrow) (NN transplantation)) (. .)))
1545575	1	(ROOT (S (NP (NNP Doc_1545575_63_83_Disease)) (VP (VBZ is) (NP (NP (DT a) (ADJP (RB potentially) (JJ serious)) (NN complication)) (PP (IN of) (NP (NP (JJ high-dose) (JJ Doc_1545575_135_151_Chemical) (NN therapy)) (VP (VBN administered) (PP (IN before) (NP (NN bone) (NN marrow) (NN transplantation)))))))) (. .)))
1545575	2	(ROOT (S (PP (IN As) (NP (NP (JJ standard) (NN practice)) (PP (IN at) (NP (PRP$ our) (NN institution))))) (, ,) (NP (NP (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBP are) (VP (VBN scheduled) (S (VP (TO to) (VP (VB receive) (NP (DT a) (NN bone) (NN marrow) (NN transplant)))))))))) (VP (VBP are) (VP (VBN treated) (ADVP (RB prophylactically)) (PP (IN with) (NP (JJ forced) (NN hydration) (CC and) (NN bladder) (NN irrigation))))) (. .)))
1545575	3	(ROOT (S (PP (IN In) (NP (DT an) (NN attempt) (S (VP (TO to) (VP (VB obviate) (NP (NP (DT the) (NN inconvenience)) (PP (IN of) (NP (NN bladder) (NN irrigation))))))))) (, ,) (NP (PRP we)) (VP (VBD conducted) (NP (NP (DT a) (NN feasibility) (NN trial)) (PP (IN of) (NP (NNS uroprophylaxis)))) (PP (IN with) (NP (NP (NNS Doc_1545575_510_515_Chemical)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ neutralizes) (NP (NP (DT the) (JJ hepatic) (NN metabolite)) (PP (IN of) (NP (NP (NNS Doc_1545575_561_577_Chemical)) (SBAR (WHNP (WDT that)) (S (VP (VBZ causes) (NP (NNS Doc_1545575_590_610_Disease)))))))))))))) (. .)))
1545575	4	(ROOT (S (PP (IN Of) (NP (NP (CD 97) (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBD received) (NP (JJ standard) (NNS prophylaxis))))))) (, ,) (NP (CD 4)) (VP (VBD had) (NP (JJ symptomatic) (NNS Doc_1545575_680_700_Disease))) (. .)))
1545575	5	(ROOT (S (PP (IN In) (NP (NN contrast))) (, ,) (NP (NP (CD two)) (PP (IN of) (NP (NP (CD four) (JJ consecutive) (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBD received) (NP (JJ Doc_1545575_761_766_Chemical) (NNS uroprophylaxis)) (PP (IN before) (NP (JJ allogeneic) (NN bone) (NN marrow) (NN transplantation))))))))) (VP (VBD had) (NP (NP (JJ severe) (NNS Doc_1545575_839_859_Disease)) (PP (IN for) (NP (QP (IN at) (JJS least) (CD 2)) (NNS weeks))))) (. .)))
1545575	6	(ROOT (S (PP (IN Because) (PP (IN of) (NP (DT this) (JJ suboptimal) (NN result)))) (, ,) (NP (PRP we)) (VP (VP (VBD resumed) (NP (NP (DT the) (NN use)) (PP (IN of) (NP (NN bladder) (NN irrigation))))) (CC and) (VP (VBD forced) (NP (NN hydration)) (S (VP (TO to) (VP (VB minimize) (NP (NP (DT the) (NN risk)) (PP (IN of) (NP (NNS Doc_1545575_1003_1023_Disease))))))))) (. .)))
15517007	0	(ROOT (S (NP (NP (NNP Consensus) (NN statement)) (PP (VBG concerning) (NP (NP (NNS Doc_15517007_31_45_Disease)) (VP (VBG occurring) (PP (IN during) (NP (NN haematopoietic))))))) (VP (VBP stem) (NP (NN cell) (NN transplantation)) (PP (IN in) (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (NNS Doc_15517007_124_143_Disease))))) (, ,) (PP (IN with) (NP (NP (JJ special) (NN reference)) (PP (TO to) (NP (NNS Doc_15517007_171_189_Disease) (CC and) (NNS Doc_15517007_194_212_Disease)))))) (. .)))
15517007	1	(ROOT (S (NP (JJ Autologous) (NN haematopoietic)) (VP (VBP stem) (SBAR (S (NP (NN cell) (NN transplantation)) (VP (VBZ is) (ADVP (RB now)) (NP (NP (DT a) (ADJP (JJ feasible) (CC and) (JJ effective)) (NN treatment)) (PP (IN for) (NP (NP (VBN selected) (NNS patients)) (PP (IN with) (NP (JJ severe) (NNS Doc_15517007_342_361_Disease)))))))))) (. .)))
15517007	2	(ROOT (S (NP (NP (NNP Worldwide)) (, ,) (NP (QP (IN over) (CD 650)) (NNS patients))) (VP (VBP have) (VP (VBN been) (VP (VBN transplanted) (PP (IN in) (NP (NP (DT the) (NN context)) (PP (IN of) (NP (NN phase) (NN I) (CC and) (NNP II) (JJ clinical) (NNS trials)))))))) (. .)))
15517007	3	(ROOT (S (NP (DT The) (NNS results)) (VP (VBP are) (ADJP (VBG encouraging) (RB enough) (S (VP (TO to) (VP (VB begin) (NP (JJ randomised) (NN phase) (NNP III) (NNP trials))))))) (. .)))
15517007	4	(ROOT (S (ADVP (RB However)) (, ,) (SBAR (IN as) (S (VP (VBD predicted)))) (, ,) (NP (NP (JJ significant) (JJ transplant-related) (NN morbidity)) (CC and) (NP (NN mortality))) (VP (VBP have) (VP (VBN been) (VP (VBN observed)))) (. .)))
15517007	5	(ROOT (S (NP (DT This)) (VP (VBZ is) (ADVP (RB primarily)) (ADJP (ADJP (JJ due) (PP (TO to) (NP (NP (NNS complications)) (VP (VBN related) (PP (TO to) (NP (NP (RB either) (DT the) (NN stage)) (PP (IN of) (NP (NP (DT the) (NN disease)) (PP (IN at) (NP (NN transplant))))))))))) (CC or) (ADJP (JJ due) (PP (TO to) (NP (NNS Doc_15517007_742_752_Disease)))))) (. .)))
15517007	6	(ROOT (S (NP (NP (DT The) (NN number)) (PP (IN of) (NP (NP (NNS deaths)) (VP (VBN related) (PP (TO to) (NP (NNS Doc_15517007_786_802_Disease))))))) (VP (VBZ is) (ADJP (JJ low))) (. .)))
15517007	7	(ROOT (S (ADVP (RB However)) (, ,) (NP (NN caution)) (VP (VBZ is) (VP (VBN required) (SBAR (WHADVP (WRB when)) (S (NP (NP (NNS Doc_15517007_845_861_Chemical) (CC or) (NNS Doc_15517007_865_879_Chemical)) (PP (JJ such) (IN as) (NP (NNS Doc_15517007_888_900_Chemical)))) (VP (VBP are) (VP (VBN used) (PP (IN in) (NP (NNS patients))) (PP (IN with) (NP (DT a) (JJ possible) (JJ underlying) (NNS Doc_15517007_949_961_Disease))) (, ,) (PP (IN for) (NP (NP (NN example)) (, ,) (NP (JJ Doc_15517007_976_994_Disease) (NNS patients)))))))))) (. .)))
15517007	8	(ROOT (S (PP (IN In) (NP (NNP November) (CD 2002))) (, ,) (NP (DT a) (NN meeting)) (VP (VBD was) (VP (VBN held) (PP (IN in) (NP (NNP Florence))) (, ,) (S (VP (VBG bringing) (PRT (RP together)) (NP (NP (DT a) (NN number)) (PP (IN of) (NP (NP (NNS experts)) (PP (IN in) (NP (JJ various) (NNS fields)))))))) (, ,) (PP (VBG including) (NP (NP (NN rheumatology)) (, ,) (NP (NN cardiology) (, ,) (NN neurology) (, ,) (NN pharmacology) (CC and) (NN transplantation) (NN medicine)))))) (. .)))
15517007	9	(ROOT (S (NP (NP (DT The) (NN object)) (PP (IN of) (NP (DT the) (NN meeting)))) (VP (VBD was) (S (VP (VP (TO to) (VP (VB analyse) (NP (NP (JJ existing) (NNS data)) (, ,) (ADJP (DT both) (JJ published) (CC or) (JJ available)) (, ,)) (PP (IN in) (NP (DT the) (NNP European) (NNP Group))) (PP (IN for) (NP (NP (NNP Blood)) (CC and) (NP (NNP Marrow) (NNP Transplantation) (NNS Doc_15517007_1346_1364_Disease) (NN database)))))) (, ,) (CC and) (VP (TO to) (VP (VB propose) (NP (DT a) (JJ safe) (NN approach)) (PP (TO to) (NP (JJ such) (NNS patients)))))))) (. .)))
15517007	10	(ROOT (S (NP (NP (DT A) (JJ full) (JJ cardiological) (NN assessment)) (PP (IN before) (CC and) (IN during) (NP (DT the) (NN transplant)))) (VP (VBD emerged) (PP (IN as) (NP (DT the) (JJ major) (NN recommendation)))) (. .)))
15531665	0	(ROOT (SQ (NNP Does) (NP (JJ supplemental) (NNS Doc_15531665_18_27_Chemical)) (VP (VB increase) (NP (JJ Doc_15531665_37_59_Disease) (NN risk)) (PP (IN in) (NP (NP (NNS women)) (PP (IN with) (NP (NNS Doc_15531665_79_87_Disease)))))) (. ?)))
15531665	1	(ROOT (S (S (NP (NNP Doc_15531665_101_110_Chemical)) (VP (VBZ acts) (PP (IN as) (NP (DT a) (JJ potent) (NN antioxidant))))) (: ;) (S (ADVP (RB however)) (, ,) (NP (PRP it)) (VP (MD can) (ADVP (RB also)) (VP (VB be) (NP (NP (DT a) (ADJP (JJ prooxidant) (CC and) (JJ glycate)) (NN protein)) (PP (IN under) (NP (NP (JJ certain) (NNS circumstances)) (PP (IN in) (NP (NNP vitro))))))))) (. .)))
15531665	2	(ROOT (S (NP (DT These) (NNS observations)) (VP (VBD led) (S (NP (PRP us)) (VP (TO to) (VP (VB hypothesize) (SBAR (IN that) (S (NP (NP (DT a) (JJ high) (NN intake)) (PP (IN of) (NP (NP (NNS Doc_15531665_299_308_Chemical)) (PP (IN in) (NP (JJ Doc_15531665_312_320_Disease) (NNS persons)))))) (VP (MD might) (VP (VB promote) (NP (NNS Doc_15531665_343_358_Disease)))))))))) (. .)))
15531665	3	(ROOT (S (NP (DT The) (NN objective)) (VP (VBD was) (S (VP (TO to) (VP (VB examine) (NP (NP (DT the) (NN relation)) (PP (IN between) (NP (JJ Doc_15531665_421_430_Chemical) (NN intake) (CC and) (NN mortality)))) (PP (IN from) (NP (NNS Doc_15531665_457_479_Disease))))))) (. .)))
15531665	4	(ROOT (S (NP (PRP We)) (VP (VBD studied) (NP (NP (DT the) (NN relation)) (PP (IN between) (NP (JJ Doc_15531665_521_530_Chemical) (NN intake) (CC and) (NN mortality)))) (PP (IN from) (NP (NP (NP (JJ total) (NNS Doc_15531665_563_585_Disease)) (PRN (-LRB- -LRB-) (VP (VBN n) (S (VP (SYM =) (NP (NNS 281))))) (-RRB- -RRB-))) (, ,) (NP (NP (NNS Doc_15531665_597_620_Disease)) (PRN (-LRB- -LRB-) (VP (VBN n) (S (VP (SYM =) (NP (CD 175))))) (-RRB- -RRB-))) (, ,) (CC and) (NP (NP (NNS Doc_15531665_636_642_Disease)) (PRN (-LRB- -LRB-) (VP (VBN n) (S (VP (SYM =) (NP (CD 57))))) (-RRB- -RRB-))))) (PP (IN in) (NP (NP (CD 1923) (JJ postmenopausal) (NNS women)) (SBAR (WHNP (WP who)) (S (VP (VBD reported) (S (VP (VBG being) (NP (NP (NNS Doc_15531665_700_708_Disease)) (PP (IN at) (NP (NN baseline)))))))))))) (. .)))
15531665	5	(ROOT (S (S (S (NP (NNP Diet)) (VP (VBD was) (VP (VBN assessed) (PP (IN with) (NP (NP (DT a) (JJ food-frequency) (NN questionnaire)) (PP (IN at) (NP (NN baseline)))))))) (, ,) (CC and) (S (NP (NP (NNS subjects)) (PP (ADVP (RB initially) (JJ free)) (IN of) (NP (NNS Doc_15531665_820_843_Disease)))) (VP (VBD were) (ADVP (RB prospectively)) (VP (VBN followed) (PP (IN for) (NP (CD 15) (NN y.) (NNS RESULTS))))))) (: :) (S (PP (IN After) (NP (NP (NN adjustment)) (PP (IN for) (NP (JJ Doc_15531665_912_934_Disease) (NN risk) (NNS factors))))) (, ,) (NP (NP (NN type)) (PP (IN of) (NP (NP (NP (JJ Doc_15531665_957_965_Disease) (NN medication)) (VP (VBN used))) (, ,) (NP (NP (NN duration)) (PP (IN of) (NP (NNS Doc_15531665_995_1003_Disease)))) (, ,) (CC and) (NP (NP (NP (NNS intakes)) (PP (IN of) (NP (NNS Doc_15531665_1020_1026_Chemical) (, ,) (NNS Doc_15531665_1028_1037_Chemical) (, ,) (CC and) (NNS Doc_15531665_1043_1056_Chemical)))) (, ,) (NP (DT the) (ADJP (VBN adjusted) (NP (NP (JJ relative) (NNS risks)) (PP (IN of) (NP (JJ total) (NNS Doc_15531665_1095_1117_Disease))))) (NN mortality)))))) (VP (VBD were) (NP (NP (CD 1.0)) (, ,) (NP (CD 0.97) (, ,) (NN 1.11) (, ,) (CD 1.47) (, ,) (CC and) (CD 1.84)) (PRN (-LRB- -LRB-) (NP (NP (NNP P)) (PP (IN for) (NP (NN trend))) (ADJP (JJ <) (NP (CD 0.01)))) (-RRB- -RRB-))) (PP (IN across) (NP (NP (NNS quintiles)) (PP (IN of) (NP (NP (JJ total) (JJ Doc_15531665_1212_1221_Chemical) (NN intake)) (PP (IN from) (NP (NN food) (CC and) (NNS supplements))))))))) (. .)))
15531665	6	(ROOT (S (NP (NP (JJ Adjusted) (JJ relative) (NNS risks)) (PP (IN of) (NP (NNS Doc_15531665_1283_1306_Disease)))) (VP (VP (VBD were) (NP (NP (CD 1.0)) (, ,) (NP (CD 0.81)) (, ,) (NP (NP (CD 0.99) (, ,) (CD 1.26) (, ,) (CC and) (CD 1.91)) (PRN (-LRB- -LRB-) (NP (NP (NNP P)) (PP (IN for) (NP (NP (NN trend)) (SBAR (S (VP (SYM =) (NP (CD 0.01)))))))) (-RRB- -RRB-))))) (CC and) (VP (PP (IN of) (NP (NNS Doc_15531665_1372_1378_Disease))) (VBD were) (NP (NP (CD 1.0)) (, ,) (NP (CD 0.52)) (, ,) (NP (NP (CD 1.23) (, ,) (CD 2.22) (, ,) (CC and) (CD 2.57)) (PRN (-LRB- -LRB-) (NP (NP (NNP P)) (PP (IN for) (NP (NN trend))) (ADJP (JJ <) (NP (CD 0.01)))) (-RRB- -RRB-)))))) (. .)))
15531665	7	(ROOT (S (SBAR (WHADVP (WRB When)) (S (NP (JJ dietary) (CC and) (JJ supplemental) (NNS Doc_15531665_1468_1477_Chemical)) (VP (VBD were) (VP (VBN analyzed) (ADVP (RB separately)))))) (, ,) (NP (RB only) (JJ supplemental) (NNS Doc_15531665_1522_1531_Chemical)) (VP (VBD showed) (NP (DT a) (JJ positive) (NN association)) (PP (IN with) (NP (NN mortality) (NNS endpoints)))) (. .)))
15531665	8	(ROOT (S (NP (JJ Doc_15531665_1588_1597_Chemical) (NN intake)) (VP (VBD was) (ADJP (JJ unrelated) (PP (TO to) (NP (NN mortality)))) (PP (IN from) (NP (NP (NNS Doc_15531665_1637_1659_Disease)) (PP (IN in) (NP (NP (DT the) (JJ nondiabetic) (NNS subjects)) (PP (IN at) (NP (NN baseline)))))))) (. .)))
15531665	9	(ROOT (S (NP (NP (DT A) (JJ high) (JJ Doc_15531665_1720_1729_Chemical) (NN intake)) (PP (IN from) (NP (NNS supplements)))) (VP (VBZ is) (VP (VBN associated) (PP (IN with) (NP (NP (DT an) (VBN increased) (NN risk)) (PP (IN of) (NP (NP (JJ Doc_15531665_1794_1816_Disease) (NN mortality)) (PP (IN in) (NP (NP (JJ postmenopausal) (NNS women)) (PP (IN with) (NP (NNS Doc_15531665_1856_1864_Disease))))))))))) (. .)))
15565293	0	(ROOT (S (NP (JJ Optical) (NN coherence)) (ADVP (RB tomography)) (VP (MD can) (VP (VB measure) (NP (JJ axonal) (NN loss)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NN Doc_15565293_70_80_Chemical-induced) (NNS Doc_15565293_89_105_Disease))))))) (. .)))
15565293	1	(ROOT (S (NP (TO To)) (VP (VBP map) (CC and) (VBP identify) (NP (NP (NP (DT the) (NN pattern)) (, ,) (PP (IN in) (NP (NN vivo))) (, ,)) (PP (IN of) (NP (NP (NNS Doc_15565293_161_180_Disease)) (PP (IN in) (NP (NN Doc_15565293_184_194_Chemical-induced) (NNS Doc_15565293_203_219_Disease)))))) (S (VP (VBG using) (NP (JJ optical) (NN coherence)) (ADVP (RB tomography)) (PRN (-LRB- -LRB-) (NP (NNP OCT)) (-RRB- -RRB-))))) (. .)))
15565293	2	(ROOT (S (NP (NNP Doc_15565293_262_272_Chemical)) (VP (VBZ is) (NP (NP (DT an) (JJ antimycobacterial) (NN agent)) (VP (ADVP (RB often)) (VBN used) (S (VP (TO to) (VP (VB treat) (NP (NNS Doc_15565293_323_335_Disease)))))))) (. .)))
15565293	3	(ROOT (S (NP (NP (DT A) (JJ serious) (NN complication)) (PP (IN of) (NP (NNS Doc_15565293_363_373_Chemical)))) (VP (VBZ is) (NP (NP (DT an) (NNS Doc_15565293_380_396_Disease)) (SBAR (WHNP (WDT that)) (S (VP (VBZ impairs) (NP (NP (JJ visual) (NN acuity)) (, ,) (NP (NN contrast) (NN sensitivity)) (, ,) (CC and) (NP (NN color) (NN vision)))))))) (. .)))
15565293	4	(ROOT (S (ADVP (RB However)) (, ,) (ADVP (RB early) (RB on)) (, ,) (SBAR (WHADVP (WRB when)) (S (NP (DT the) (JJ toxic) (NNS Doc_15565293_499_515_Disease)) (VP (VBZ is) (ADJP (ADJP (JJ mild)) (CC and) (ADJP (RB partly) (JJ reversible)))))) (, ,) (NP (DT the) (JJ funduscopic) (NNS findings)) (VP (VBP are) (ADVP (RB often)) (ADJP (JJ subtle) (CC and) (JJ easy) (S (VP (TO to) (VP (VB miss)))))) (. .)))
15565293	5	(ROOT (S (NP (NP (CD Three) (NNS subjects)) (PP (IN with) (NP (NP (NP (DT a) (NN history)) (PP (IN of) (NP (NP (NP (NP (NNS Doc_15565293_649_659_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_15565293_661_664_Chemical)) (-RRB- -RRB-))) (PRN (: -) (NP (NP (JJ induced) (NNS Doc_15565293_674_690_Disease)) (PP (IN of) (NP (JJ short)))) (: -))) (PRN (, ,) (FRAG (ADJP (JJ intermediate)) (: -)) (, ,))))) (CC and) (NP (JJ long-term) (NNS Doc_15565293_731_746_Disease))))) (VP (VBD were) (VP (VBN administered) (NP (NP (DT a) (JJ full) (JJ neuro-ophthalmologic) (NN examination)) (PP (VBG including) (NP (NP (JJ visual) (NN acuity)) (, ,) (NP (NN color) (NN vision)) (, ,) (NP (NN contrast) (NN sensitivity)) (, ,) (CC and) (NP (JJ fundus) (NN examination))))))) (. .)))
15565293	6	(ROOT (S (PP (IN In) (NP (NN addition))) (, ,) (NP (NP (NNP OCT)) (PRN (-LRB- -LRB-) (NP (NNP OCT) (CD 3000)) (, ,) (NP (NNP Humphrey-Zeiss)) (, ,) (NP (NNP Dublin) (, ,) (NNP CA)) (-RRB- -RRB-))) (VP (VBD was) (VP (VBN performed) (PP (IN on) (NP (NP (DT both) (NNS eyes)) (PP (IN of) (NP (DT each) (ADJP (JJ subject) (S (VP (VBG using) (NP (NP (DT the) (JJ retinal) (NN nerve) (NN fiber) (NN layer)) (PRN (-LRB- -LRB-) (NP (NNP RNFL)) (-RRB- -RRB-)))))) (NN analysis) (NN protocol))))))) (. .)))
15565293	7	(ROOT (S (NP (NNP OCT)) (VP (VBZ interpolates) (NP (NNS data)) (PP (IN from) (NP (NP (CD 100) (NNS points)) (PP (IN around) (NP (DT the) (JJ optic) (NN nerve))))) (S (VP (TO to) (VP (ADVP (RB effectively)) (VB map) (PRT (RP out)) (NP (DT the) (NNP RNFL)))))) (. .)))
15565293	8	(ROOT (S (NP (DT The) (NNS results)) (VP (VBD were) (PP (VBN compared) (PP (TO to) (NP (NP (DT the) (JJ calculated) (JJ average) (NN RNFL)) (PP (IN of) (NP (NP (JJ normal) (NNS eyes)) (VP (VBN accumulated) (PP (IN from) (NP (CD four) (JJ prior) (NNS studies))) (S (VP (VBG using) (S (NP (NNP OCT) (, ,) (NNP n)) (VP (SYM =) (NP (CD 661))))))))))))) (. .)))
15565293	9	(ROOT (S (PP (IN In) (NP (NP (DT all) (NNS subjects)) (PP (IN with) (NP (NP (NN history)) (PP (IN of) (NP (NN Doc_15565293_1312_1315_Chemical-induced) (NNS Doc_15565293_1324_1340_Disease))))))) (, ,) (NP (EX there)) (VP (VBD was) (NP (NP (DT a) (JJ mean) (NN loss)) (PP (IN of) (NP (ADJP (CD 72) (NN %)) (NN nerve) (NN fiber) (NN layer) (NN thickness)))) (PP (IN in) (NP (NP (DT the) (JJ temporal) (NN quadrant)) (PRN (-LRB- -LRB-) (NP (NP (JJ patient) (NN A)) (, ,) (PP (IN with) (NP (NP (NP (JJ eventual) (NN recovery)) (PP (IN of) (NP (NP (JJ visual) (NN acuity) (CC and) (NNS fields)) (, ,) (NP (ADJP (CD 58) (NN %)) (NN loss))))) (: ;) (ADJP (JJ patient) (NP (NP (NNP B)) (, ,) (PP (IN with) (NP (NP (JJ intermediate) (NNS Doc_15565293_1527_1542_Disease)) (, ,) (NP (ADJP (CD 68) (NN %)) (NN loss)))))) (: ;) (NP (NNP patient) (NNP C)) (, ,) (PP (IN with) (NP (JJ chronic) (NNS Doc_15565293_1578_1593_Disease))) (, ,) (NP (ADJP (CD 90) (NN %)) (NN loss))))) (-RRB- -RRB-)))) (, ,) (PP (IN with) (NP (NP (DT an) (JJ average) (JJ mean) (JJ optic) (NN nerve) (NN thickness)) (PP (IN of) (NP (NP (CD 26) (NNS +)) (VP (VBG /) (NP (CD -16) (NN microm)))))))) (. .)))
15565293	10	(ROOT (S (NP (EX There)) (VP (VBD was) (NP (NP (NP (DT a) (VBN combined) (JJ mean) (NN loss)) (PP (IN of) (NP (NP (CD 46) (NN %)) (PP (IN of) (NP (NP (NNS fibers)) (PP (IN from) (NP (DT the) (ADJP (JJ superior) (, ,) (JJ inferior))))))))) (, ,) (CC and) (NP (NP (JJ nasal) (NNS quadrants)) (PP (IN in) (NP (NP (DT the) (-LRB- -LRB-) (NP (CD six)) (-RRB- -RRB-) (NNS eyes)) (PP (IN of) (NP (DT all) (CD three) (NNS subjects))) (PRN (-LRB- -LRB-) (NP (NP (JJ mean) (JJ average) (NN thickness)) (PP (IN of) (NP (CD 55) (NNS +)))) (: /) (S (NP (CD -29)) (VP (VBP microm))) (-RRB- -RRB-))))))) (. .)))
15565293	11	(ROOT (S (PP (IN In) (NP (NP (NP (DT both) (NNS sets)) (PRN (-LRB- -LRB-) (NP (CD four)) (-RRB- -RRB-))) (PP (IN of) (NP (NP (NNS eyes)) (PP (IN of) (NP (NP (DT the) (NNS subjects)) (PP (IN with) (NP (NP (JJ persistent) (NNS Doc_15565293_1909_1924_Disease)) (PRN (-LRB- -LRB-) (NP (NNS patients) (NN B) (CC and) (NN C)) (-RRB- -RRB-)))))))))) (, ,) (NP (EX there)) (VP (VBD was) (NP (NP (DT an) (JJ average) (NN loss)) (PP (IN of) (NP (NP (CD 79) (NN %)) (PP (IN of) (NP (NP (NN nerve) (NN fiber) (NN thickness)) (PP (IN in) (NP (DT the) (JJ temporal) (NN quadrant))))))))) (. .)))
15565293	12	(ROOT (S (NP (NP (DT The) (NNP OCT) (NNS results)) (PP (IN in) (NP (NP (DT these) (NNS patients)) (PP (IN with) (NP (NN Doc_15565293_2081_2084_Chemical-induced) (NNS Doc_15565293_2093_2109_Disease)))))) (VP (VBP show) (NP (NP (JJ considerable) (NN loss)) (PP (RB especially) (IN of) (NP (DT the) (JJ temporal) (NNS fibers))))) (. .)))
15565293	13	(ROOT (S (NP (DT This)) (VP (VBZ is) (ADJP (JJ consistent) (PP (IN with) (NP (NP (JJ prior) (JJ histopathological) (NNS studies)) (SBAR (WHNP (WDT that)) (S (VP (VBP show) (NP (NP (JJ predominant) (NN loss)) (PP (IN of) (NP (NP (JJ parvo-cellular) (NNS axons)) (PRN (-LRB- -LRB-) (CC or) (ADJP (JJ small-caliber) (JJ axons)) (-RRB- -RRB-))))) (PP (IN within) (NP (NP (DT the) (JJ papillo-macular) (NN bundle)) (PP (IN in) (NP (JJ toxic) (CC or) (JJ hereditary) (NNS Doc_15565293_2357_2375_Disease)))))))))))) (. .)))
15565293	14	(ROOT (S (NP (NNP Doc_15565293_2377_2380_Chemical)) (VP (MD can) (VP (VB be) (NP (NP (DT a) (JJ valuable) (NN tool)) (PP (IN in) (NP (NP (DT the) (JJ quantitative) (NN analysis)) (PP (IN of) (NP (NNS Doc_15565293_2436_2454_Disease)))))))) (. .)))
15565293	15	(ROOT (S (ADVP (RB Additionally)) (, ,) (PP (IN in) (NP (NP (NNS terms)) (PP (IN of) (NP (NP (NN management)) (PP (IN of) (NP (NN Doc_15565293_2496_2499_Chemical-induced) (NNS Doc_15565293_2508_2524_Disease))))))) (, ,) (NP (PRP it)) (VP (VBZ is) (ADJP (JJ important) (S (VP (VP (TO to) (VP (ADVP (RB properly)) (VB manage) (NP (NP (NNS Doc_15565293_2561_2571_Chemical)) (VP (VBG dosing) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NNS Doc_15565293_2596_2612_Disease))))))))) (CC and) (VP (TO to) (VP (VB achieve) (NP (JJ proper) (NN transition)) (PP (TO to) (NP (DT a) (NN maintenance) (NN dose))) (SBAR (IN once) (S (NP (DT an) (JJ appropriate) (NN loading) (NN dose)) (VP (VBZ has) (VP (VBN been) (VP (VBN reached)))))))))))) (. .)))
15579441	0	(ROOT (S (VP (VP (VB Doc_15579441_0_7_Disease) (PP (IN in) (NP (NP (NNS Doc_15579441_11_24_Disease)) (PP (IN with) (NP (NNS Doc_15579441_30_41_Disease)))))) (CC and/or) (VP (VB glomerular) (NP (NNS Doc_15579441_60_72_Disease)))) (. .)))
15579441	1	(ROOT (S (PP (IN Despite) (NP (DT the) (VBG increasing) (NN need) (S (VP (TO to) (VP (VB identify) (CC and) (VB quantify) (NP (NN tissue) (NN oxygenation)) (PP (IN at) (NP (DT the) (JJ cellular) (NN level)))))))) (, ,) (NP (ADJP (RB relatively) (JJ few)) (NNS methods)) (VP (VBP have) (VP (VBN been) (ADJP (JJ available)))) (. .)))
15579441	2	(ROOT (S (PP (IN In) (NP (DT this) (NN study))) (, ,) (NP (PRP we)) (VP (VBD developed) (SBAR (S (NP (NP (DT a) (JJ new) (NN Doc_15579441_247_254_Disease-responsive) (NN reporter) (NN vector)) (VP (VBG using) (NP (NP (DT a) (NN Doc_15579441_290_297_Disease-responsive) (NN element)) (PP (IN of) (NP (NP (DT the) (CD 5) (POS ')) (NN vascular) (NN endothelial) (NN growth) (NN factor)))))) (VP (VP (VBD untranslated) (NP (NN region))) (CC and) (VP (VBD generated) (NP (DT a) (NN novel) (NN Doc_15579441_404_411_Disease-sensing)) (NP (JJ transgenic) (NN rat))))))) (. .)))
15579441	3	(ROOT (S (NP (PRP We)) (ADVP (RB then)) (VP (VBD applied) (NP (DT this) (NN animal) (NN model)) (PP (TO to) (NP (NP (DT the) (NN detection)) (PP (IN of) (NP (JJ tubulointerstitial) (NNS Doc_15579441_509_516_Disease))))) (PP (IN in) (NP (DT the) (JJ diseased) (NN kidney)))) (. .)))
15579441	4	(ROOT (S (PP (IN With) (NP (DT this) (NN model))) (, ,) (NP (PRP we)) (VP (VBD were) (ADJP (JJ able) (S (VP (TO to) (VP (VB identify) (NP (NP (NP (JJ diffuse) (JJ cortical) (NNS Doc_15579441_600_607_Disease)) (PP (IN in) (NP (DT the) (NN Doc_15579441_615_640_Chemical-induced) (NNS Doc_15579441_649_667_Disease)))) (CC and) (NP (NP (JJ focal) (CC and) (JJ segmental) (NNS Doc_15579441_692_699_Disease)) (PP (IN in) (NP (DT the) (JJ remnant) (NN kidney) (NN model)))))))))) (. .)))
15579441	5	(ROOT (S (NP (NP (NNP Expression)) (PP (IN of) (NP (DT the) (NN Doc_15579441_747_754_Disease-responsive) (NN transgene)))) (VP (VBD increased) (PP (IN throughout) (NP (DT the) (NN observation) (NN period))) (, ,) (S (VP (VBG reaching) (NP (ADJP (ADJP (JJ 2.2-fold) (PP (IN at) (NP (NP (CD 2) (NNS weeks)) (PP (IN in) (NP (DT the) (JJ Doc_15579441_857_882_Chemical) (NN model)))))) (CC and) (ADJP (JJ 2.6-fold) (PP (IN at) (NP (NP (CD 4) (NNS weeks)) (PP (IN in) (NP (DT the) (JJ remnant) (NN kidney))))))) (NN model)))) (, ,) (SBAR (IN whereas) (S (NP (NP (DT that)) (PP (IN of) (NP (JJ vascular) (JJ endothelial) (NN growth) (NN factor)))) (VP (VBD showed) (NP (DT a) (JJ mild) (NN decrease)) (, ,) (S (VP (VBG reflecting) (NP (NP (JJ distinct) (NNS behaviors)) (PP (IN of) (NP (DT the) (CD two) (NNS genes)))))))))) (. .)))
15579441	6	(ROOT (S (NP (NP (DT The) (NN degree)) (PP (IN of) (NP (NNS Doc_15579441_1079_1086_Disease)))) (VP (VBD showed) (NP (DT a) (JJ positive) (NN correlation)) (PP (IN with) (NP (JJ microscopic) (NNS Doc_15579441_1134_1159_Disease))) (PP (IN in) (NP (DT both) (NNS models)))) (. .)))
15579441	7	(ROOT (S (ADVP (RB Finally)) (, ,) (NP (PRP we)) (VP (VBD identified) (NP (NP (DT the) (NN localization)) (PP (IN of) (S (VP (VBG proliferating) (NP (NP (NN cell) (JJ nuclear) (NN antigen-positive)) (, ,) (NP (NNS ED-1-positive)) (, ,) (CC and) (NP (NP (NN terminal) (NNS Doc_15579441_1292_1296_Chemical)) (NP (JJ nick-end) (JJ labeled-positive) (NNS cells)))) (PP (IN in) (NP (NP (DT the) (JJ Doc_15579441_1336_1343_Disease) (JJ cortical) (NN area)) (PP (IN in) (NP (DT the) (JJ remnant) (NN kidney) (NN model)))))))))) (. .)))
15579441	8	(ROOT (S (NP (PRP We)) (VP (VBP propose) (NP (NP (RB here) (DT a) (ADJP (JJ possible) (JJ pathological)) (NN tie)) (PP (IN between) (NP (NP (JJ chronic) (JJ tubulointerstitial) (NNS Doc_15579441_1466_1473_Disease)) (CC and) (NP (JJ progressive) (NNS Doc_15579441_1490_1509_Disease)))))) (. .)))
15580403	0	(ROOT (NP (NP (JJ Adequate) (NN timing)) (PP (IN of) (NP (NP (JJ Doc_15580403_19_28_Chemical) (NN reduction)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (NNS Doc_15580403_56_65_Disease)) (PP (IN during) (NP (NN combination) (NN therapy))))))))) (PP (IN of) (NP (NNS Doc_15580403_96_106_Chemical) (CC and) (NNS Doc_15580403_111_120_Chemical))) (PP (IN for) (NP (NNS Doc_15580403_125_144_Disease))) (. .)))
15580403	1	(ROOT (S (NP (NNP Doc_15580403_158_174_Disease)) (VP (VBZ is) (NP (NP (CD one)) (PP (IN of) (NP (NP (DT the) (JJ major) (JJ adverse) (NNS events)) (PP (IN of) (NP (NP (DT the) (NN combination) (NN therapy)) (PP (IN of) (NP (NNS Doc_15580403_240_250_Chemical) (CC and) (NNS Doc_15580403_255_264_Chemical))))))))) (. .)))
15580403	2	(ROOT (S (PP (IN Because) (PP (IN of) (NP (NN Doc_15580403_277_286_Chemical-related) (NNS Doc_15580403_295_311_Disease)))) (, ,) (NP (NN dose) (NN reduction)) (VP (VBZ is) (NP (NP (DT a) (JJ common) (NN event)) (PP (IN in) (NP (DT this) (NN therapy))))) (. .)))
15580403	3	(ROOT (S (PP (IN In) (NP (DT this) (JJ clinical) (NN retrospective) (NN cohort) (NN study))) (NP (PRP we)) (VP (VBP have) (VP (VBN examined) (NP (NP (DT the) (JJ suitable) (NN timing)) (PP (IN of) (NP (JJ Doc_15580403_447_456_Chemical) (NN reduction)))) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NNS Doc_15580403_484_493_Disease))))) (PP (IN during) (NP (NN combination) (NN therapy))))) (. .)))
15580403	4	(ROOT (S (NP (NP (NNP Thirty-seven)) (PP (IN of) (NP (NP (CD 160) (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VP (VBD had) (NP (JJ HCV-genotype) (NNS 1b))) (, ,) (VP (VBD had) (NP (JJ high) (NN virus) (NN load))) (, ,) (CC and) (VP (VBD received) (NP (JJ 24-week) (NN combination) (NN therapy))))))))) (VP (VBD developed) (NP (NNS Doc_15580403_657_663_Disease)) (PP (IN with) (NP (NN hemoglobin) (NN level))) (S (VP (VBG <) (NP (CD 10) (JJ g/dl) (CC or) (NN Doc_15580403_698_704_Disease-related) (NNS signs)) (PP (IN during) (NP (NN therapy)))))) (. .)))
15580403	5	(ROOT (S (PP (IN After) (NP (DT that))) (, ,) (NP (DT these) (CD 37) (NNS patients)) (VP (VBD were) (VP (VBN reduced) (NP (NP (CD one) (NN tablet)) (PP (IN of) (NP (NP (NP (NNS Doc_15580403_792_801_Chemical)) (PRN (-LRB- -LRB-) (NP (QP (CD 200) (CD mg))) (-RRB- -RRB-))) (PP (IN per) (NP (NN day)))))))) (. .)))
15580403	6	(ROOT (S (PP (IN After) (NP (NP (NN reduction)) (PP (IN of) (NP (NNS Doc_15580403_839_848_Chemical))))) (, ,) (NP (NP (CD 27)) (PP (IN of) (NP (CD 37) (NNS patients)))) (VP (MD could) (VP (VB continue) (NP (NN combination) (NN therapy)) (PP (IN for) (NP (NP (DT a) (NN total)) (PP (IN of) (NP (NP (CD 24) (NNS weeks)) (PRN (-LRB- -LRB-) (NP (NN group) (NN A)) (-RRB- -RRB-)))))))) (. .)))
15580403	7	(ROOT (S (ADVP (RB However)) (, ,) (NP (NP (CD 10)) (PP (IN of) (NP (NP (CD 37) (NNS patients)) (PP (IN with) (NP (NP (NN reduction)) (PP (IN of) (NP (NNS Doc_15580403_983_992_Chemical)))))))) (VP (MD could) (RB not) (VP (VB continue) (NP (NN combination) (NN therapy)) (SBAR (IN because) (S (NP (PRP$ their) (JJ <) (CD 8.5) (JJ g/dl) (NN hemoglobin) (NNS values)) (VP (VBD decreased) (PP (TO to) (NP (QP (CC or) (CD Doc_15580403_1090_1096_Disease-related)))) (NP (NP (NP (JJ severe) (NN side) (NNS effects)) (VP (VBN occurred))) (PRN (-LRB- -LRB-) (NP (NN group) (NN B)) (-RRB- -RRB-)))))))) (. .)))
15580403	8	(ROOT (S (NP (PRP We)) (VP (VBD assessed) (NP (DT the) (JJ final) (NN efficacy) (CC and) (NN safety)) (SBAR (IN after) (S (S (NP (NP (NN reduction)) (PP (IN of) (NP (NP (NNS Doc_15580403_1206_1215_Chemical)) (PP (IN in) (NP (NP (NNS groups) (NNP A) (CC and) (NNP B.) (NNP RESULTS)) (: :) (NP (NP (DT A) (VBN sustained) (JJ virological) (NN response)) (PRN (-LRB- -LRB-) (NP (NNP SVR)) (-RRB- -RRB-)))))))) (VP (VBD was) (NP (NP (NP (CD 29.6) (NN %)) (PRN (-LRB- -LRB-) (NP (CD 8/27)) (-RRB- -RRB-))) (PP (IN in) (NP (NN group) (NN A)))))) (CC and) (S (NP (NP (CD 10) (NN %)) (PRN (-LRB- -LRB-) (NP (CD 1/10)) (-RRB- -RRB-))) (PP (IN in) (NP (NN group) (NN B))) (, ,) (ADVP (RB respectively)))))) (. .)))
15580403	9	(ROOT (S (NP (NP (NP (DT A) (CD 34.4) (NN %)) (PRN (-LRB- -LRB-) (NP (CD 12/27)) (-RRB- -RRB-))) (PP (IN of) (NP (NP (NNP SVR) (NNP +) (JJ biological) (NN response)) (PP (IN in) (NP (NN group) (NN A)))))) (VP (VBD was) (ADJP (ADJP (JJR higher) (PP (IN than) (NP (NP (NP (CD 10) (NN %)) (PRN (-LRB- -LRB-) (NP (CD 1/10)) (-RRB- -RRB-))) (PP (IN in) (NP (NN group) (NN B)))))) (PRN (-LRB- -LRB-) (NP (NNP P) (QP (CD =) (CD 0.051))) (-RRB- -RRB-))) (, ,) (PP (IN with) (NP (JJ slight) (NN significance)))) (. .)))
15580403	10	(ROOT (S (PP (IN With) (NP (NP (NN respect)) (PP (TO to) (NP (NP (NN hemoglobin) (NN level)) (PP (IN at) (NP (NP (DT the) (NN time)) (PP (IN of) (NP (JJ Doc_15580403_1534_1543_Chemical) (NN reduction))))))))) (, ,) (NP (NP (DT a) (NN rate)) (PP (IN of) (NP (NP (NN continuation)) (PP (IN of) (NP (NP (NN therapy)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (ADJP (JJ >) (CC or) (JJ =)) (ADJP (CD 10) (JJ g/dl)) (NN hemoglobin)))))))))) (VP (VBD was) (ADJP (ADVP (JJR higher) (IN than)) (SBAR (IN that) (FRAG (PP (IN in) (NP (NNS patients)))))) (PP (IN with) (NP (NP (QP (CD <) (CD 10)) (NN g/dl)) (PRN (-LRB- -LRB-) (NP (NNP P) (QP (CD =) (CD 0.036))) (-RRB- -RRB-))))) (. .)))
15580403	11	(ROOT (S (NP (NP (NN Reduction)) (PP (IN of) (NP (NP (NP (NNS Doc_15580403_1718_1727_Chemical)) (PP (IN at) (NP (NN hemoglobin) (NN level) (NNS >)))) (CC or) (NP (QP (CD =) (CD 10)) (NN g/dl))))) (VP (VBZ is) (ADJP (JJ suitable) (PP (IN in) (NP (NP (NNS terms)) (PP (IN of) (NP (NN efficacy) (CC and) (NN side) (NNS effects))))))) (. .)))
15638391	0	(ROOT (S (NP (NP (VBG Aging) (NN process)) (PP (IN of) (NP (NP (JJ epithelial) (NNS cells)) (PP (IN of) (NP (DT the) (NN rat) (NN prostate) (NN lateral)))))) (VP (VBP lobe) (PP (IN in) (NP (NP (JJ experimental) (NNS Doc_15638391_83_101_Disease)) (VP (VBN induced) (PP (IN by) (NP (NNS Doc_15638391_113_124_Chemical))))))) (. .)))
15638391	1	(ROOT (S (NP (NP (DT The) (NN aim)) (PP (IN of) (NP (DT the) (NN study)))) (VP (VBD was) (S (VP (TO to) (VP (VB examine) (NP (NP (DT the) (NN influence)) (PP (IN of) (NP (NP (NNS Doc_15638391_179_197_Disease)) (, ,) (VP (VBN induced) (PP (IN by) (NP (NP (NNS Doc_15638391_210_221_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP HAL)) (-RRB- -RRB-)))) (PP (IN on) (NP (NP (NN age)) (VP (VBN related) (NP (NP (NN morphology) (CC and) (NN function) (NNS changes)) (PP (IN of) (NP (JJ epithelial) (NNS cells)))) (PP (IN in) (NP (NN rat) (NN prostate))))))) (ADJP (JJ lateral) (JJ lobe))))))))) (. .)))
15638391	2	(ROOT (S (NP (DT The) (NN study)) (VP (VBD was) (VP (VBN performed) (PP (IN on) (NP (RB sexually) (JJ mature) (NN male) (NNS rats))))) (. .)))
15638391	3	(ROOT (S (NP (NP (JJ Serum) (NNS concentrations)) (PP (IN of) (NP (NP (NN prolactin)) (PRN (-LRB- -LRB-) (NP (NNP PRL)) (-RRB- -RRB-)) (CC and) (NP (NNS Doc_15638391_423_435_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP T)) (-RRB- -RRB-))))) (VP (VBD were) (VP (VBN measured))) (. .)))
15638391	4	(ROOT (S (NP (JJ Tissue) (NNS sections)) (VP (VBD were) (VP (VBN evaluated) (PP (IN with) (NP (NN light) (CC and) (NN electron) (NN microscopy))))) (. .)))
15638391	5	(ROOT (S (NP (NP (JJ Immunohistochemical) (NNS reactions)) (PP (IN for) (NP (NP (NNP Anti-Proliferating) (NNP Cell) (NNP Nuclear) (NNP Antigen)) (PRN (-LRB- -LRB-) (NP (NNP PCNA)) (-RRB- -RRB-))))) (VP (VBD were) (VP (VBN performed))) (. .)))
15638391	6	(ROOT (S (PP (IN In) (NP (NP (NNS rats)) (PP (IN of) (NP (NP (DT the) (JJ experimental) (NN group)) (, ,) (NP (NP (DT the) (JJ mean) (NN concentration)) (PP (IN of))))))) (: :) (NP (NNP PRL)) (VP (VBD was) (ADJP (NP (QP (JJR more) (IN than) (RB twice))) (JJR higher)) (, ,) (SBAR (IN whereas) (S (NP (NNP T) (NN concentration)) (VP (VBD was) (ADJP (RB almost) (RB twice) (JJR lower)) (PP (IN than) (NP (NP (DT that)) (PP (IN in) (NP (DT the) (NN control) (NN group))))))))) (. .)))
15638391	7	(ROOT (S (NP (NNP Light)) (ADVP (RB microscopy)) (VP (VBD visualized) (NP (NP (DT the) (NN following)) (: :) (NP (NP (NNS Doc_15638391_835_846_Disease) (CC and) (NN epithelium) (NNS Doc_15638391_862_873_Disease)) (PP (IN of) (NP (DT the) (NN glandular) (NNS ducts))) (, ,) (VP (VBN associated) (PP (IN with) (NP (VBN increased) (NNP PCNA) (NN expression))))))) (. .)))
15638391	8	(ROOT (S (NP (NNP Electron)) (ADVP (RB microscopy)) (VP (VBD revealed) (NP (NNS changes)) (PP (IN in) (NP (NN columnar) (NN epithelial) (NNS cells))) (, ,) (PP (VBG concerning) (NP (NP (NNS organelles)) (, ,) (VP (VBN engaged) (PP (IN in) (NP (NN protein) (NN synthesis) (CC and) (NN secretion))))))) (. .)))
1564236	0	(ROOT (S (NP (NP (NNP Relation)) (PP (IN of) (NP (NN perfusion) (NNS defects)))) (VP (VBD observed) (PP (IN with) (NP (JJ myocardial) (NN contrast) (NN echocardiography))) (PP (TO to) (NP (NP (NP (DT the) (NN severity)) (PP (IN of) (NP (NNS Doc_1564236_100_117_Disease)))) (: :) (NP (NP (NN correlation)) (PP (IN with) (NP (JJ Doc_1564236_136_144_Chemical-201) (JJ single-photon) (NN emission) (NN tomography))))))) (. .)))
1564236	1	(ROOT (S (NP (PRP It)) (VP (VBZ has) (VP (VBN been) (VP (ADVP (RB previously)) (VBN shown) (SBAR (IN that) (S (NP (JJ myocardial) (NN contrast) (NN echocardiography)) (VP (VBZ is) (NP (NP (DT a) (JJ valuable) (NN technique)) (PP (IN for) (S (VP (VBG delineating) (NP (NP (NNS regions)) (PP (IN of) (NP (JJ myocardial) (NN underperfusion) (JJ secondary)))) (PP (PP (TO to) (NP (NNS Doc_1564236_345_363_Disease))) (CC and) (PP (TO to) (NP (NP (JJ critical) (NNS Doc_1564236_380_397_Disease)) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (JJ hyperemic) (NN stimulation)))))))))))))))))) (. .)))
1564236	2	(ROOT (S (NP (NP (DT The) (NN aim)) (PP (IN of) (NP (DT this) (NN study)))) (VP (VBD was) (S (VP (TO to) (VP (VB determine) (SBAR (IN whether) (S (NP (NP (JJ myocardial) (NN contrast)) (VP (ADVP (RB echocardiography)) (VBN performed) (PP (IN with) (NP (NP (DT a) (JJ stable) (NN solution)) (PP (IN of) (NP (JJ sonicated) (NN albumin))))))) (VP (MD could) (VP (VB detect) (NP (NP (NNS regions)) (PP (IN of) (NP (NP (JJ myocardial) (NN underperfusion)) (VP (VBG resulting) (PP (IN from) (NP (NP (JJ various) (NNS degrees)) (PP (IN of) (NP (NNS Doc_1564236_662_679_Disease))))))))))))))))) (. .)))
1564236	3	(ROOT (S (NP (NP (DT The) (NN perfusion) (NN defect)) (VP (VBN produced) (PP (IN in) (NP (CD 16) (JJ open) (NN chest) (NNS dogs))))) (VP (VBD was) (VP (VBN compared) (PP (IN with) (NP (DT the) (JJ anatomic) (NN area))) (PP (IN at) (NP (NP (NN risk)) (VP (VBN measured) (PP (PP (IN by) (NP (DT the) (JJ postmortem) (JJ dual-perfusion) (NN technique))) (CC and) (PP (IN with) (NP (NP (ADJP (JJ Doc_1564236_838_846_Chemical-201) (JJ single-photon)) (NN emission) (NN tomography)) (PRN (-LRB- -LRB-) (NP (NNP SPECT)) (-RRB- -RRB-)))))))))) (. .)))
1564236	4	(ROOT (S (PP (IN During) (NP (DT a) (JJ transient) (PRN (-LRB- -LRB-) (ADJP (JJ 20-s)) (-RRB- -RRB-)) (JJ Doc_1564236_920_938_Disease))) (, ,) (NP (DT a) (NN perfusion) (NN defect)) (VP (VBD was) (VP (VBN observed) (PP (IN with) (NP (NN contrast) (NN echocardiography))) (PP (IN in) (NP (NP (CD 14)) (PP (IN of) (NP (DT the) (CD 15) (NNS dogs))) (SBAR (WHPP (IN in) (WHNP (WDT which))) (S (NP (DT the) (NN occlusion)) (VP (VBD was) (VP (VBN produced))))))))) (. .)))
1564236	5	(ROOT (S (NP (DT The) (NN perfusion) (NN defect)) (VP (VBD correlated) (ADVP (RB significantly)) (PP (IN with) (NP (NP (DT the) (JJ anatomic) (NN area)) (PP (IN at) (NP (NN risk))))) (PRN (-LRB- -LRB-) (NP (NP (SYM r)) (NP (NP (QP (CD =) (CD 0.74))) (: ;) (NP (NP (NN p)) (NP (QP (JJR less) (IN than) (CD 0.002)))))) (-RRB- -RRB-))) (. .)))
1564236	6	(ROOT (S (PP (IN During) (NP (NN Doc_1564236_1176_1188_Chemical-induced) (NNS Doc_1564236_1197_1206_Disease))) (, ,) (NP (NP (CD 12)) (PP (IN of) (NP (NP (DT the) (CD 16) (NNS dogs)) (PP (IN with) (NP (DT a) (JJ partial) (NNS Doc_1564236_1241_1258_Disease)))))) (VP (VBD had) (NP (NP (DT a) (JJ visible) (NN area)) (PP (IN of) (NP (NN hypoperfusion)))) (PP (IN by) (NP (NN contrast) (NN echocardiography)))) (. .)))
1564236	7	(ROOT (S (NP (NP (DT The) (CD four) (NNS dogs)) (PP (IN without) (NP (DT a) (NN perfusion) (NN defect)))) (VP (VBD had) (NP (NP (DT a) (NNS stenosis)) (SBAR (WHNP (WDT that)) (S (VP (VBD resulted) (PP (IN in) (NP (DT a) (JJ mild) (PRN (-LRB- -LRB-) (NP (QP (CD 0) (NN %) (TO to) (CD 50) (NN %))) (-RRB- -RRB-)) (NN reduction))) (PP (IN in) (NP (NN Doc_1564236_1430_1442_Chemical-induced) (NNS Doc_1564236_1451_1460_Disease)))))))) (. .)))
1564236	8	(ROOT (S (NP (NP (DT The) (NN size)) (PP (IN of) (NP (NP (DT the) (NN perfusion) (NN defect)) (PP (IN during) (NP (NNS stenosis)))))) (VP (VBD correlated) (ADVP (RB significantly)) (PP (IN with) (NP (NP (DT the) (JJ anatomic) (NN area)) (PP (IN at) (NP (NN risk))))) (PRN (-LRB- -LRB-) (NP (NP (SYM r)) (NP (NP (QP (CD =) (CD 0.61))) (: ;) (NP (NP (NN p)) (SBAR (S (VP (SYM =) (NP (CD 0.02)))))))) (-RRB- -RRB-))) (. .)))
1564236	9	(ROOT (S (S (NP (NNP Doc_1564236_1589_1597_Chemical-201) (NNP SPECT)) (VP (VBD demonstrated) (SBAR (S (NP (NP (DT a) (NN perfusion) (NN defect)) (PP (IN in) (NP (DT all) (CD 14) (NNS dogs)))) (VP (VBD analyzed) (PP (IN during) (NP (NN Doc_1564236_1671_1683_Chemical-induced) (NNS Doc_1564236_1692_1701_Disease)))))))) (: ;) (S (NP (NP (DT the) (NN size)) (PP (IN of) (NP (DT the) (NN perfusion) (NN defect)))) (VP (VBD correlated) (PP (PP (IN with) (NP (NP (DT the) (JJ anatomic) (NN area)) (PP (IN at) (NP (NP (NN risk)) (PRN (-LRB- -LRB-) (NP (NP (NP (NP (SYM r)) (SBAR (S (VP (SYM =) (NP (CD 0.58)))))) (: ;) (NP (NP (NN p)) (NP (JJR less)))) (PP (IN than) (NP (CD 0.03)))) (-RRB- -RRB-)))))) (CC and) (PP (IN with) (NP (DT the) (NN perfusion) (NN defect)))) (PP (IN by) (NP (NN contrast) (NN echocardiography))) (PRN (-LRB- -LRB-) (NP (NP (NP (NP (SYM r)) (SBAR (S (VP (SYM =) (NP (CD 0.58)))))) (: ;) (NP (NP (NN p)) (NP (JJR less)))) (PP (IN than) (NP (CD 0.03)))) (-RRB- -RRB-)))) (. .)))
1564236	10	(ROOT (S (ADVP (RB Thus)) (, ,) (NP (JJ myocardial) (NN contrast)) (ADVP (RB echocardiography)) (VP (MD can) (VP (VB be) (VP (VBN used) (S (VP (TO to) (VP (VB visualize) (CC and) (VB quantitate) (NP (NP (DT the) (NN amount)) (PP (IN of) (NP (JJ jeopardized) (NN myocardium)))) (PP (IN during) (NP (NP (ADJP (JJ moderate) (TO to) (JJ severe)) (NNS degrees)) (PP (IN of) (NP (NNS Doc_1564236_2053_2070_Disease))))))))))) (. .)))
1564236	11	(ROOT (S (NP (DT The) (NNS results)) (VP (VBD obtained) (VP (VB show) (NP (NP (DT a) (NN correlation)) (PP (IN with) (NP (DT the) (JJ anatomic) (NN area)))) (PP (IN at) (NP (NP (NN risk)) (ADJP (JJ similar) (PP (TO to) (NP (NP (DT that)) (VP (VBN obtained) (PP (IN with) (NP (NNP Doc_1564236_2173_2181_Chemical-201) (NNP SPECT))))))))))) (. .)))
15673851	0	(ROOT (S (NP (NP (DT The) (NN activation)) (PP (IN of) (NP (JJ spinal) (JJ Doc_15673851_25_45_Chemical) (NNS receptors)))) (VP (MD may) (VP (VB contribute) (PP (TO to) (NP (NP (NN degeneration)) (PP (IN of) (NP (NP (JJ spinal) (NN motor) (NNS neurons)) (VP (VBN induced) (PP (IN by) (NP (JJ neuraxial) (NNS Doc_15673851_132_140_Chemical))) (PP (IN after) (NP (NP (DT a) (JJ noninjurious) (NN interval)) (PP (IN of) (NP (NNS Doc_15673851_174_194_Disease)))))))))))) (. .)))
15673851	1	(ROOT (S (NP (PRP We)) (VP (VBD investigated) (NP (NP (DT the) (NN relationship)) (PP (IN between) (NP (NP (NP (DT the) (NN degeneration)) (PP (IN of) (NP (JJ spinal) (NN motor) (NNS neurons)))) (CC and) (NP (NP (NN activation)) (PP (IN of) (NP (JJ Doc_15673851_296_316_Chemical) (PRN (-LRB- -LRB-) (NP (NNP Doc_15673851_318_322_Chemical)) (-RRB- -RRB-)) (NNS receptors))))))) (PP (IN after) (NP (NP (JJ neuraxial) (NNS Doc_15673851_350_358_Chemical)) (PP (VBG following) (NP (NP (DT a) (JJ noninjurious) (NN interval)) (PP (IN of) (NP (NP (NNS Doc_15673851_396_412_Disease)) (PP (IN in) (NP (NNS rats)))))))))) (. .)))
15673851	2	(ROOT (S (NP (NNP Doc_15673851_422_442_Disease)) (VP (VBD was) (VP (VBN induced) (PP (IN by) (NP (NP (NNS Doc_15673851_458_474_Disease)) (PP (IN for) (NP (CD 6) (NN min))))) (PP (IN with) (NP (DT a) (NN balloon) (NN catheter))))) (. .)))
15673851	3	(ROOT (S (PP (IN In) (NP (DT a) (JJ microdialysis) (NN study))) (, ,) (S (NP (NP (CD 10) (NN muL)) (PP (IN of) (NP (NP (NP (NN saline)) (PRN (-LRB- -LRB-) (NP (NP (NN group) (NNP C)) (: ;) (NP (NP (NN n)) (SBAR (S (VP (SYM =) (NP (CD 8))))))) (-RRB- -RRB-))) (CC or) (NP (NP (CD 30) (NN mug)) (PP (IN of) (NP (NP (NNS Doc_15673851_583_591_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (NN group) (NNS M)) (: ;) (NP (NP (NN n)) (SBAR (S (VP (SYM =) (NP (CD 8))))))) (-RRB- -RRB-)))))))) (VP (VBD was) (VP (VBN injected) (NP (NP (NN intrathecally)) (PRN (-LRB- -LRB-) (NP (PRP IT)) (-RRB- -RRB-)) (ADJP (CD 0.5) (JJ h))) (PP (IN after) (NP (NN reflow)))))) (, ,) (CC and) (S (NP (NP (CD 30) (NN mug)) (PP (IN of) (NP (NP (NP (NNS Doc_15673851_675_683_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (NN group) (NN SM)) (: ;) (NP (NP (NN n)) (SBAR (S (VP (SYM =) (NP (CD 8))))))) (-RRB- -RRB-))) (CC or) (NP (NP (CD 10) (NN muL)) (PP (IN of) (NP (NP (NN saline)) (PRN (-LRB- -LRB-) (NP (NP (NN group) (NN SC)) (: ;) (NP (NP (NN n)) (SBAR (S (VP (SYM =) (NP (CD 8))))))) (-RRB- -RRB-)))))))) (VP (VBD was) (VP (VBN injected) (S (NP (PRP IT)) (ADJP (CD 0.5) (JJ h)) (PP (IN after) (NP (NN sham) (NN operation))))))) (. .)))
15673851	4	(ROOT (S (NP (JJ Microdialysis) (NNS samples)) (VP (VBD were) (VP (VBN collected) (NP (NN preischemia)) (, ,) (PP (IN before) (NP (NP (JJ IT) (NN injection)) (, ,) (CC and) (PRN (PP (IN at) (NP (CD 2)))) (, ,) (NP (CD 4)) (, ,) (NP (CD 8)) (, ,) (NP (CD 24)) (, ,) (CC and) (NP (NP (CD 48) (NN h)) (PP (IN of) (NP (NP (NN reperfusion)) (PRN (-LRB- -LRB-) (PP (IN after) (NP (NNP IT) (NN injection))) (-RRB- -RRB-))))))))) (. .)))
15673851	5	(ROOT (S (ADVP (LS Second)) (, ,) (NP (PRP we)) (VP (VBD investigated) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (NP (NNP IT) (NNP Doc_15673851_962_968_Chemical)) (PRN (-LRB- -LRB-) (NP (QP (CD 30) (CD mug))) (-RRB- -RRB-))))) (PP (IN on) (NP (NP (DT the) (JJ histopathologic) (NNS changes)) (PP (IN in) (NP (DT the) (JJ spinal) (NN cord))))) (PP (IN after) (NP (NN Doc_15673851_1034_1042_Chemical-induced) (NNS Doc_15673851_1051_1070_Disease)))) (. .)))
15673851	6	(ROOT (S (PP (IN After) (NP (NNP IT) (NNP Doc_15673851_1081_1089_Chemical))) (, ,) (NP (DT the) (ADJP (ADJP (JJ cerebrospinal) (JJ fluid)) (PRN (-LRB- -LRB-) (NP (NNP CSF)) (-RRB- -RRB-))) (JJ Doc_15673851_1121_1130_Chemical) (NN concentration)) (VP (VBD was) (VP (VBN increased) (PP (IN in) (NP (NP (NP (NN group) (NNS M)) (ADVP (JJ relative) (PP (TO to) (NP (DT both) (NN baseline) (CC and) (NN group) (NN C))))) (PRN (-LRB- -LRB-) (NP (NNP P) (NNP <) (NNP 0.05)) (-RRB- -RRB-)))))) (. .)))
15673851	7	(ROOT (S (NP (DT This) (NN increase)) (VP (VBD persisted) (PP (IN for) (NP (CD 8) (NN hrs)))) (. .)))
15673851	8	(ROOT (S (NP (NNP IT) (NNP Doc_15673851_1258_1264_Chemical)) (ADVP (RB significantly)) (VP (VBD reduced) (NP (NP (DT the) (NN number)) (PP (IN of) (NP (JJ dark-stained) (NNS alpha-motoneurons)))) (PP (IN after) (NP (NP (NN Doc_15673851_1338_1346_Chemical-induced) (NNS Doc_15673851_1355_1374_Disease)) (PP (VBN compared) (PP (IN with) (NP (DT the) (JJ saline) (NN group))))))) (. .)))
15673851	9	(ROOT (S (NP (DT These) (NNS data)) (VP (VBP indicate) (SBAR (IN that) (S (NP (NNP IT) (NNP Doc_15673851_1435_1443_Chemical)) (VP (VBZ induces) (NP (NNS Doc_15673851_1452_1471_Disease)) (PP (IN with) (NP (NP (DT a) (JJ concomitant) (NN increase)) (PP (IN in) (NP (NP (NNP CSF) (NNP Doc_15673851_1507_1516_Chemical)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (VP (VBN involved) (PP (IN in) (NP (JJ Doc_15673851_1539_1543_Chemical) (NN receptor) (NN activation))))))))))))))) (. .)))
15673851	10	(ROOT (S (NP (PRP We)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NNS opioids)) (VP (MD may) (VP (VB be) (NP (NP (NNS Doc_15673851_1596_1606_Disease)) (PP (IN in) (NP (NP (DT the) (NN setting)) (PP (IN of) (NP (NP (NNS Doc_15673851_1625_1645_Disease)) (PP (IN via) (NP (JJ Doc_15673851_1650_1654_Chemical) (NN receptor) (NN activation))))))))))))) (. .)))
15686794	0	(ROOT (NP (NP (NP (JJ Acute) (NNS Doc_15686794_6_19_Disease)) (PP (IN during) (NP (NP (JJ intravenous) (NN administration)) (PP (IN of) (NP (NNS Doc_15686794_57_67_Chemical)))))) (: :) (NP (NP (DT a) (NN report)) (PP (IN of) (NP (CD two) (NNS cases)))) (. .)))
15686794	1	(ROOT (S (NP (NNP Doc_15686794_92_102_Chemical)) (VP (VBZ represents) (NP (NP (DT an) (ADJP (JJ effective) (JJ antiarrhythmic)) (NN drug)) (PP (IN for) (NP (NP (NP (NN cardioversion)) (PP (IN of) (NP (NP (JJ recent-onset) (NNS Doc_15686794_181_200_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_15686794_202_204_Disease)) (-RRB- -RRB-))))) (CC and) (NP (NP (NN maintenance)) (PP (IN of) (NP (JJ sinus) (NN rhythm)))))))) (. .)))
15686794	2	(ROOT (S (NP (PRP We)) (ADVP (RB briefly)) (VP (VBP describe) (NP (NP (CD two) (NNS patients)) (VP (VBG suffering) (PP (IN from) (NP (NP (JJ recent-onset) (NNS Doc_15686794_300_319_Disease)) (, ,) (SBAR (WHNP (WP who)) (S (VP (VBD experienced) (NP (DT an) (JJ acute) (JJ devastating) (NNS Doc_15686794_358_371_Disease)) (NP (DT a) (JJ few) (NNS minutes)) (PP (IN after) (NP (NP (NN initiation)) (PP (IN of) (NP (JJ intravenous) (JJ Doc_15686794_418_428_Chemical) (NN loading))))))))))))) (. .)))
15686794	3	(ROOT (S (ADVP (RB Notably)) (, ,) (NP (DT this) (NN side) (NN effect)) (VP (VBZ has) (RB not) (VP (VBN been) (VP (ADVP (RB ever)) (VBN reported) (PP (IN in) (NP (DT the) (JJ medical) (NN literature)))))) (. .)))
15686794	4	(ROOT (S (NP (NNS Clinicians)) (VP (MD should) (VP (VB be) (ADJP (JJ aware) (PP (IN of) (NP (DT this) (NN reaction)))) (SBAR (IN since) (S (NP (NP (JJ prompt) (NN termination)) (PP (IN of) (NP (JJ parenteral) (NN administration)))) (VP (VBZ leads) (S (VP (TO to) (VP (VB complete) (NP (NN resolution)))))))))) (. .)))
15764424	0	(ROOT (NP (NP (NP (JJ Quantitative) (NN drug) (NNS levels)) (PP (IN in) (NP (NN stimulant) (NNS Doc_15764424_38_47_Disease)))) (: :) (NP (NP (NN relationship)) (PP (TO to) (NP (NN symptom) (NN severity) (, ,) (NNS Doc_15764424_83_97_Chemical) (CC and) (NNS Doc_15764424_102_114_Disease)))) (. .)))
15764424	1	(ROOT (S (S (S (VP (TO To) (VP (VB examine) (NP (NP (DT the) (NN relationship)) (PP (IN between) (NP (NP (JJ quantitative) (NN stimulant) (NN drug) (NNS levels)) (, ,) (NP (NNS Doc_15764424_188_202_Chemical)) (, ,) (CC and) (NP (NNS Doc_15764424_208_226_Disease)))))))) (, ,) (NP (NP (NN nineteen) (NNS patients)) (PP (IN in) (NP (NP (DT a) (JJ Doc_15764424_251_262_Disease) (NN emergency) (NN service)) (PP (IN with) (NP (NP (DT a) (NN diagnosis)) (PP (IN of) (NP (JJ Doc_15764424_301_312_Chemical) (: -) (CC or) (NN Doc_15764424_317_324_Chemical-induced) (NNS Doc_15764424_333_342_Disease)))))))) (VP (VBD were) (VP (VBN interviewed)))) (, ,) (CC and) (S (NP (NN plasma) (CC and) (NN urine)) (VP (VBD were) (VP (VBN collected) (PP (IN for) (NP (NP (JJ quantitative) (NNS assays)) (PP (IN of) (NP (NN stimulant) (NN drug) (CC and) (JJ Doc_15764424_443_456_Chemical) (NN metabolite) (NNS levels)))))))) (. .)))
15764424	2	(ROOT (S (NP (JJ Doc_15764424_476_491_Chemical) (CC or) (JJ Doc_15764424_495_506_Chemical) (NNS levels)) (VP (VBD were) (VP (VBN related) (PP (TO to) (NP (NP (JJ several) (NN psychopathology) (NNS scores)) (CC and) (NP (DT the) (JJ global) (JJ Doc_15764424_576_588_Disease) (NN rating)))))) (. .)))
15764424	3	(ROOT (S (NP (JJ Doc_15764424_597_600_Chemical) (NNS levels)) (VP (VBD were) (VP (VBN related) (PP (PP (TO to) (NP (JJ global) (NNS Doc_15764424_631_643_Disease))) (CONJP (CC but) (RB not)) (PP (TO to) (NP (JJ psychopathology) (NNS ratings)))))) (. .)))
15764424	4	(ROOT (S (SBAR (IN Although) (S (NP (NP (JJ many) (JJ other) (NNS factors)) (PP (JJ such) (IN as) (NP (NN sensitization)))) (VP (MD may) (VP (VB play) (NP (DT a) (NN role)))))) (, ,) (NP (NP (NN intensity)) (PP (IN of) (NP (JJ stimulant-induced) (NNS Doc_15764424_778_796_Disease) (CC and) (NNS stereotypies)))) (VP (VBZ appears) (S (VP (TO to) (VP (VB be) (VP (ADVP (ADVP (IN at) (JJS least)) (PP (IN in) (NP (NN part)))) (VBN dose-related)))))) (. .)))
15811908	0	(ROOT (S (NP (NNP Doc_15811908_0_16_Disease)) (VP (VBD unmasked) (PP (IN by) (NP (NNS Doc_15811908_29_40_Chemical) (CC and) (NNS Doc_15811908_45_53_Chemical)))) (. .)))
15811908	1	(ROOT (S (S (VP (TO To) (VP (VB describe) (NP (NP (DT the) (NN unmasking)) (PP (IN of) (NP (NP (NNS Doc_15811908_95_111_Disease)) (PP (IN in) (NP (DT a) (NN patient))))))))) (VP (VBN treated) (PP (IN with) (NP (NNS Doc_15811908_138_149_Chemical) (CC and) (NNS Doc_15811908_154_162_Chemical)))) (. .)))
15811908	2	(ROOT (NP (NP (NNP CASE) (NNP SUMMARY)) (: :) (NP (NP (DT A) (JJ 42-year-old) (JJ white) (NN man)) (VP (VBN developed) (NP (NP (JJ acute) (NNS Doc_15811908_218_230_Disease)) (PP (IN with) (NP (JJ severe) (NNS Doc_15811908_243_251_Disease) (CC and) (NNS Doc_15811908_256_264_Disease)))) (NP (CD 2) (NNS hours)) (PP (IN after) (NP (NP (DT the) (JJ first) (NNS doses)) (PP (IN of) (NP (NN Doc_15811908_298_309_Chemical) (CD 100) (NN mg) (CC and) (JJ Doc_15811908_321_329_Chemical) (CD 100) (NN mg))))))) (. .)))
15811908	3	(ROOT (S (S (NP (DT Both) (NNS drugs)) (VP (VBD were) (VP (ADVP (RB immediately)) (VBN discontinued)))) (, ,) (CC and) (S (NP (DT the) (NN patient)) (VP (VBD recovered) (PP (IN after) (NP (NP (JJ subsequent) (NNS Doc_15811908_423_434_Chemical)) (CC and) (NP (JJ Doc_15811908_439_448_Chemical) (NN treatment)))))) (. .)))
15811908	4	(ROOT (S (S (NP (JJ Abdominal) (NN ultrasound)) (VP (VBD showed) (NP (DT an) (JJ adrenal) (NN mass)))) (, ,) (CC and) (S (NP (JJ postoperative) (JJ histologic) (NN examination)) (VP (VBD confirmed) (NP (NP (DT the) (NN diagnosis)) (PP (IN of) (NP (NNS Doc_15811908_573_589_Disease)))))) (. .)))
15811908	5	(ROOT (S (S (NP (NP (JJ Drug-induced) (NNS symptoms)) (PP (IN of) (NP (NNS Doc_15811908_628_644_Disease)))) (VP (VBP are) (ADVP (RB often)) (VP (VBN associated) (PP (IN with) (NP (NP (DT the) (NN use)) (PP (IN of) (NP (JJ substituted) (JJ Doc_15811908_694_703_Chemical) (NNS drugs)))))))) (, ,) (CC but) (S (NP (DT the) (VBG underlying) (NN mechanism)) (VP (VBZ is) (ADJP (JJ unknown)))) (. .)))
15811908	6	(ROOT (S (PP (IN In) (NP (PRP$ our) (NN case))) (, ,) (NP (NP (NN use)) (PP (IN of) (NP (DT the) (NNP Naranjo) (NN probability) (NN scale)))) (VP (VBD indicated) (NP (NP (NP (DT a) (JJ possible) (NN relationship)) (PP (IN between) (NP (DT the) (JJ Doc_15811908_848_860_Disease) (NN crisis)))) (CC and) (NP (NP (NNS Doc_15811908_872_883_Chemical)) (CC and) (NP (JJ Doc_15811908_888_896_Chemical) (NN therapy))))) (. .)))
15811908	7	(ROOT (S (PP (IN As) (PP (IN of) (NP (NNP March) (CD 24) (, ,) (CD 2005)))) (, ,) (NP (DT this)) (VP (VBZ is) (NP (NP (DT the) (JJ first) (VBN reported) (NN case)) (PP (IN of) (NP (NP (ADJP (JJ Doc_15811908_976_987_Chemical) (: -) (CC and) (JJ Doc_15811908_993_1001_Chemical-induced)) (JJ Doc_15811908_1010_1022_Disease) (NN crisis)) (PP (IN in) (NP (NP (DT a) (NN patient)) (PP (IN with) (NP (NNS Doc_15811908_1048_1064_Disease))))))))) (. .)))
15811908	8	(ROOT (S (NP (NP (NNP Physicians)) (CC and) (NP (JJ other) (NN healthcare) (NNS professionals))) (VP (MD should) (VP (VB be) (ADJP (JJ aware) (PP (IN of) (NP (NP (DT this) (JJ potential) (JJ adverse) (NN effect)) (PP (IN of) (NP (NNS Doc_15811908_1164_1172_Chemical) (CC and) (NNS Doc_15811908_1177_1188_Chemical)))))))) (. .)))
15814210	0	(ROOT (NP (NP (JJ Minor) (NNS Doc_15814210_6_30_Disease)) (, ,) (NP (JJ cognitive) (NN development)) (, ,) (CC and) (NP (NP (JJ somatic) (NN development)) (PP (IN at) (NP (NP (DT the) (NN age)) (PP (IN of) (NP (NP (QP (CD 3) (TO to) (CD 7)) (NNS years)) (PP (IN after) (NP (NP (JJ Doc_15814210_112_125_Chemical) (NN treatment)) (PP (IN in) (NP (JJ very-low) (JJ birth-weight) (NNS infants)))))))))) (. .)))
15814210	1	(ROOT (S (NP (NP (DT The) (NN objective)) (PP (IN of) (NP (DT this) (NN study)))) (VP (VBD was) (S (VP (TO to) (VP (VB assess) (NP (NP (JJ minor) (NNS Doc_15814210_218_242_Disease)) (, ,) (NP (JJ cognitive) (NN development)) (, ,) (CC and) (NP (JJ somatic) (NN development))) (PP (IN after) (NP (NP (JJ Doc_15814210_297_310_Chemical) (NN therapy)) (PP (IN in) (NP (JJ very-low-birthweight) (NNS infants))))))))) (. .)))
15814210	2	(ROOT (S (NP (NP (JJ Thirty-three) (NNS children)) (PP (IN after) (NP (JJ Doc_15814210_380_393_Chemical) (NN treatment)))) (VP (VBD were) (VP (VBN matched) (PP (TO to) (NP (CD 33) (NNS children))) (PP (IN without) (NP (JJ Doc_15814210_440_453_Chemical) (NN treatment))))) (. .)))
15814210	3	(ROOT (S (NP (NNP Data)) (VP (VBD were) (VP (VBN assessed) (PP (IN at) (NP (NP (DT the) (NN age)) (PP (IN of) (NP (CD 3-7) (NNS years))))))) (. .)))
15814210	4	(ROOT (S (NP (NNP Doc_15814210_509_522_Chemical)) (VP (VBD was) (VP (VBN started) (PP (IN between) (NP (NP (DT the) (NN 7th)) (CC and) (NP (NP (DT the) (JJ 28th) (NN day)) (PP (IN of) (NP (NN life)))))) (PP (IN over) (NP (NP (CD 7) (NNS days)) (PP (IN with) (NP (NP (DT a) (JJ total) (NN dose)) (PP (IN of) (NP (CD 2.35) (NN mg/kg/day))))))))) (. .)))
15814210	5	(ROOT (S (NP (NN Exclusion) (NNS criteria)) (VP (VBD were) (NP (NP (NNS Doc_15814210_649_657_Disease)) (, ,) (NP (NNS Doc_15814210_659_672_Disease)) (, ,) (NP (JJ major) (JJ surgical) (NNS interventions)) (, ,) (NP (ADJP (JJ small) (PP (IN for) (NP (NP (JJ gestational) (NN age)) (, ,) (NP (NP (NN intraventricular) (NNS Doc_15814210_748_759_Disease) (NNS grades) (NNP III)) (CC and) (NP (NNP IV))) (, ,)))) (NNS Doc_15814210_779_807_Disease)) (, ,) (CC and) (NP (JJ severe) (NNS Doc_15814210_820_843_Disease)))) (. .)))
15814210	6	(ROOT (S (NP (DT Each) (NN child)) (VP (VBD was) (VP (VP (VBN examined) (PP (IN by) (NP (NP (DT a) (NN neuropediatrician)) (PP (IN for) (NP (JJ minor) (NNS Doc_15814210_902_927_Disease)))))) (CC and) (VP (VBN tested) (PP (IN by) (NP (NP (DT a) (NN psychologist)) (PP (IN for) (NP (JJ cognitive) (NN development))))) (PP (IN with) (NP (DT a) (NNP Kaufman) (NNP Assessment) (NNP Battery))) (PP (IN for) (NP (NP (NNP Children)) (CC and) (NP (DT a) (JJ Draw-a-Man) (NN Test))))))) (. .)))
15814210	7	(ROOT (S (NP (EX There)) (VP (VBD were) (NP (NP (DT no) (NNS differences)) (PP (IN in) (NP (NP (JJ demographic) (NNS data)) (, ,) (NP (NN growth)) (, ,) (CC and) (NP (NP (JJ socio-economic) (NN status)) (PP (IN between) (NP (DT the) (CD two) (NNS groups)))))))) (. .)))
15814210	8	(ROOT (S (NP (NP (JJ Fine) (NN motor) (NNS skills)) (CC and) (NP (JJ gross) (NN motor) (NN function))) (VP (VBD were) (ADJP (ADJP (RB significantly) (JJR better)) (PP (IN in) (NP (DT the) (NN control) (NN group)))) (PRN (-LRB- -LRB-) (ADVP (RB p)) (ADJP (JJ <) (NP (CD 0.01))) (-RRB- -RRB-))) (. .)))
15814210	9	(ROOT (S (PP (IN In) (NP (DT the) (JJ Draw-a-Man) (NN Test))) (, ,) (NP (DT the) (NN control) (NN group)) (VP (VBD showed) (NP (JJR better) (NNS results)) (PRN (-LRB- -LRB-) (NP (NNP p) (QP (CD <) (CD 0.001))) (-RRB- -RRB-))) (. .)))
15814210	10	(ROOT (S (NP (EX There)) (VP (VBD were) (NP (NP (DT no) (NNS differences)) (PP (IN in) (NP (NP (NN development)) (PP (IN of) (NP (NP (NN speech)) (, ,) (NP (JJ social) (NN development)) (, ,) (CC and) (NP (NP (DT the) (NNP Kaufman) (NNP Assessment) (NNP Battery)) (PP (IN for) (NP (NNP Children)))))))))) (. .)))
15814210	11	(ROOT (S (PP (IN After) (NP (JJ Doc_15814210_1460_1473_Chemical) (NN treatment))) (, ,) (NP (NNS children)) (VP (VBD showed) (NP (NP (DT a) (JJR higher) (NN rate)) (PP (IN of) (NP (JJ minor) (NNS Doc_15814210_1524_1549_Disease))))) (. .)))
15814210	12	(ROOT (S (NP (JJ Neurological) (NN development)) (VP (VBD was) (VP (VBN affected) (ADVP (RB even)) (PP (IN without) (NP (JJ neurological) (NN diagnosis))))) (. .)))
15814210	13	(ROOT (S (NP (JJ Further) (JJ long-term) (NN follow-up) (NNS studies)) (VP (MD will) (VP (VB be) (ADJP (JJ necessary) (S (VP (TO to) (VP (ADVP (RB fully)) (VB evaluate) (NP (NP (DT the) (NN impact)) (PP (IN of) (NP (NP (NNS Doc_15814210_1712_1725_Chemical)) (PP (IN on) (NP (JJ neurological) (CC and) (JJ cognitive) (NN development)))))))))))) (. .)))
15858223	0	(ROOT (NP (NP (NNP Doc_15858223_0_13_Chemical) (NNP I)) (: :) (NP (NP (NN time) (NN course)) (PP (IN of) (NP (NP (NN lipid) (NN peroxidation) (NNS biomarkers)) (, ,) (NP (NNS Doc_15858223_63_77_Disease)) (, ,) (CC and) (NP (NP (JJ Doc_15858223_83_96_Chemical) (NN metabolite) (NNS levels)) (PP (IN in) (NP (NNS rats))))))) (. .)))
15858223	1	(ROOT (S (NP (NP (DT A) (JJ single) (NN dose)) (PP (IN of) (NP (NP (NNS Doc_15858223_141_154_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_15858223_156_159_Chemical)) (-RRB- -RRB-)))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (NP (DT a) (ADJP (RB widely) (VBN used)) (JJ antiepileptic) (NN drug))))) (, ,)) (VP (VBZ is) (VP (VBN associated) (PP (IN with) (NP (JJ oxidative) (NN stress))) (PP (IN in) (NP (NP (NNS rats)) (, ,) (VP (ADVP (RB as) (RB recently)) (VBN demonstrated) (PP (IN by) (NP (NP (JJ elevated) (NNS levels)) (PP (IN of) (NP (NP (NNS Doc_15858223_297_317_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_15858223_319_332_Chemical)) (-RRB- -RRB-))))))))))) (. .)))
15858223	2	(ROOT (S (S (VP (TO To) (VP (VB determine) (SBAR (IN whether) (S (NP (EX there)) (VP (VBD was) (NP (NP (DT a) (JJ temporal) (NN relationship)) (PP (IN between) (NP (ADJP (JJ Doc_15858223_398_401_Chemical-associated) (JJ oxidative)) (NN stress) (CC and) (NN hepatotoxicity)))))))))) (, ,) (NP (JJ adult) (JJ male) (NN Sprague-Dawley) (NNS rats)) (VP (VBD were) (VP (VBN treated) (NP (NP (NN ip)) (PP (IN with) (NP (NP (NP (NNS Doc_15858223_502_505_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 500) (NN mg/kg)) (-RRB- -RRB-))) (CC or) (NP (NP (ADJP (CD 0.9) (NN %)) (NN saline)) (PRN (-LRB- -LRB-) (NP (NN vehicle)) (-RRB- -RRB-))) (ADVP (RB once) (JJ daily))))) (PP (IN for) (NP (NP (CD 2)) (, ,) (NP (CD 4)) (, ,) (NP (CD 7)) (, ,) (NP (CD 10)) (, ,) (CC or) (NP (CD 14) (NNS days)))))) (. .)))
15858223	3	(ROOT (S (NP (JJ Oxidative) (NN stress)) (VP (VBD was) (VP (VBN assessed) (PP (IN by) (S (VP (VBG determining) (NP (NP (NN plasma) (CC and) (NN liver) (NNS levels)) (PP (IN of) (NP (NP (NNS Doc_15858223_655_668_Chemical)) (, ,) (NP (NN lipid) (NNS Doc_15858223_676_690_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP LPO)) (-RRB- -RRB-)) (, ,) (CC and) (NP (NP (JJ Doc_15858223_702_721_Chemical) (NN reactive) (NNS substances)) (PRN (-LRB- -LRB-) (NP (NNP TBARs)) (-RRB- -RRB-))))))))))) (. .)))
15858223	4	(ROOT (S (NP (NNP Plasma) (CC and) (NN liver) (NNS Doc_15858223_768_781_Chemical)) (VP (VBD were) (VP (VBN elevated) (CC and) (VBN reached) (NP (DT a) (NN plateau)) (PP (IN after) (NP (NP (NN day) (CD 2)) (PP (IN of) (NP (JJ Doc_15858223_833_836_Chemical) (NN treatment))))) (PP (VBN compared) (PP (TO to) (NP (NN control)))))) (. .)))
15858223	5	(ROOT (S (NP (NNP Liver) (NNP LPO) (NNS levels)) (VP (VBD were) (RB not) (VP (VBD elevated) (PP (IN until) (NP (NN day) (CD 7))) (PP (IN of) (NP (NN treatment))) (PRN (-LRB- -LRB-) (NP (NP (JJ 1.8-fold) (JJ versus) (NN control)) (, ,) (NP (NNP p) (NNP <) (NNP 0.05))) (-RRB- -RRB-)))) (. .)))
15858223	6	(ROOT (S (NP (NN Liver) (CC and) (NN plasma) (NNS TBARs)) (VP (VBD were) (RB not) (VP (VBN increased) (PP (IN until) (NP (NP (CD 14) (NNS days)) (PRN (-LRB- -LRB-) (NP (NNS 2-fold) (IN vs.) (NN control)) (, ,) (NP (NNP p) (NNP <) (NNP 0.05)) (-RRB- -RRB-)))))) (. .)))
15858223	7	(ROOT (S (NP (NNP Doc_15858223_1053_1067_Disease)) (VP (VBD was) (VP (VBN evaluated) (PP (VBN based) (PP (PP (IN on) (NP (NP (NN serum) (NNS levels)) (PP (IN of) (NP (NP (JJ alpha-Doc_15858223_1113_1124_Chemical) (NNS Doc_15858223_1125_1126_Chemical-transferase)) (PRN (-LRB- -LRB-) (NP (NN alpha-GST)) (-RRB- -RRB-)))))) (CC and) (PP (IN by) (NP (NN histology))))))) (. .)))
15858223	8	(ROOT (S (NP (JJ Serum) (JJ alpha-GST) (NNS levels)) (VP (VBD were) (ADJP (RB significantly) (JJ elevated) (PP (IN by) (NP (NP (NN day) (CD 4)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD corresponded) (S (VP (TO to) (VP (VB hepatotoxicity) (SBAR (IN as) (S (VP (VBN shown) (PP (IN by) (NP (NP (DT the) (VBG increasing) (NN incidence)) (PP (IN of) (NP (NP (NNS Doc_15858223_1307_1319_Disease)) (PP (IN of) (NP (NP (DT the) (NN liver) (NN capsule)) (, ,) (NP (NNS Doc_15858223_1342_1350_Disease)) (, ,) (CC and) (NP (NNS Doc_15858223_1356_1365_Disease)))))))))))))))))))) (PP (IN throughout) (NP (DT the) (NN study)))) (. .)))
15858223	9	(ROOT (S (NP (NP (DT The) (NN liver) (NNS levels)) (PP (IN of) (NP (NP (JJ beta-oxidation) (NNS metabolites)) (PP (IN of) (NP (NNS Doc_15858223_1438_1441_Chemical)))))) (VP (VBD were) (VP (VBN decreased) (PP (IN by) (NP (NN day) (CD 14))) (, ,) (SBAR (IN while) (S (NP (NP (DT the) (NNS levels)) (PP (IN of) (NP (NNS Doc_15858223_1488_1497_Chemical) (CC and) (NNS Doc_15858223_1502_1515_Chemical-Doc_15858223_1516_1519_Chemical)))) (VP (VBD were) (RB not) (VP (VBD elevated) (PP (IN throughout) (NP (DT the) (NN study))))))))) (. .)))
15858223	10	(ROOT (S (ADVP (RB Overall)) (, ,) (NP (DT these) (NNS findings)) (VP (VBP indicate) (SBAR (IN that) (S (NP (JJ Doc_15858223_1598_1601_Chemical) (NN treatment)) (VP (VBZ results) (PP (IN in) (NP (JJ oxidative) (NN stress))) (, ,) (SBAR (IN as) (S (VP (VBN measured) (PP (IN by) (NP (NP (NNS levels)) (PP (IN of) (NP (NP (NNS Doc_15858223_1666_1679_Chemical)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ precedes) (NP (NP (DT the) (NN onset)) (PP (IN of) (NP (NP (NNS Doc_15858223_1709_1717_Disease)) (, ,) (NP (NNS Doc_15858223_1719_1728_Disease)) (, ,) (CC and) (NP (NP (JJ elevated) (NNS levels)) (PP (IN of) (NP (NN serum) (NN alpha-GST))))))))))))))))))))) (. .)))
15867025	0	(ROOT (NP (NP (NNP Assessment)) (PP (IN of) (NP (NP (JJ perinatal) (NNS Doc_15867025_24_35_Disease)) (CC and) (NP (JJ Doc_15867025_40_47_Disease) (NN prevention)))) (PP (IN in) (NP (NNP New) (NNP Hampshire) (NN delivery) (NNS hospitals))) (. .)))
15867025	1	(ROOT (S (VP (TO To) (VP (VB evaluate) (NP (JJ current) (NN performance)) (PP (IN on) (NP (NP (VBN recommended) (JJ perinatal) (NNS Doc_15867025_164_175_Disease)) (CC and) (NP (NP (JJ Doc_15867025_180_187_Disease) (NN prevention) (NNS practices)) (PP (IN in) (NP (NNP New) (NNP Hampshire)))))))) (. .)))
15867025	2	(ROOT (S (NP (NNP Data)) (VP (VBD were) (VP (VBN extracted) (PP (IN from) (NP (NP (CD 2021)) (VP (VBN paired) (NP (JJ mother-infant) (NNS records)) (PP (IN for) (NP (NP (DT the) (NN year) (CD 2000) (NN birth) (NN cohort)) (PP (IN in) (NP (NP (NNP New) (NNP Hampshire) (POS 's)) (CD 25) (NN delivery) (NNS hospitals)))))))))) (. .)))
15867025	3	(ROOT (S (NP (NNP Assessment)) (VP (VBD was) (VP (VBN done) (PP (IN on) (NP (NP (NP (DT the) (NN following)) (: :) (NP (NP (JJ prenatal) (NN screening)) (PP (IN for) (NP (NNS Doc_15867025_429_440_Disease) (CC and) (NNS Doc_15867025_445_452_Disease))))) (, ,) (NP (NP (NN administration)) (PP (IN of) (NP (NP (DT the) (JJ Doc_15867025_476_487_Disease) (NN vaccine) (NN birth) (NN dose)) (PP (TO to) (NP (DT all) (NNS infants)))))) (, ,) (NP (NP (NN administration)) (PP (IN of) (NP (JJ Doc_15867025_541_552_Disease) (JJ immune) (NN globulin)))))) (PP (TO to) (NP (NP (NNS infants)) (SBAR (WHNP (WP who)) (S (VP (VBD were) (VP (VBN born) (PP (TO to) (NP (NP (NN Doc_15867025_597_624_Chemical-positive) (NNS mothers)) (, ,) (NP (JJ Doc_15867025_643_650_Disease) (NN immunity)) (, ,) (CC and) (NP (NP (NN administration)) (PP (IN of) (NP (JJ in-hospital) (NN postpartum) (NNS Doc_15867025_706_713_Disease) (NN vaccine)))))) (PP (TO to) (NP (JJ Doc_15867025_725_732_Disease) (NN nonimmune) (NNS women))))))))))) (. .)))
15867025	4	(ROOT (S (NP (NP (JJ Prenatal) (NN screening) (NNS rates)) (PP (IN for) (NP (NP (NNS Doc_15867025_788_799_Disease)) (PRN (-LRB- -LRB-) (NP (CD 98.8) (NN %)) (-RRB- -RRB-)) (CC and) (NP (NNS Doc_15867025_812_819_Disease)) (PRN (-LRB- -LRB-) (NP (CD 99.4) (NN %)) (-RRB- -RRB-))))) (VP (VBD were) (ADJP (JJ high))) (. .)))
15867025	5	(ROOT (S (NP (JJ Doc_15867025_839_850_Disease) (NN vaccine) (NN birth) (NN dose)) (VP (VBD was) (VP (VBN administered) (PP (TO to) (NP (NP (CD 76.2) (NN %)) (PP (IN of) (NP (DT all) (NNS infants))))))) (. .)))
15867025	6	(ROOT (S (NP (NP (DT All) (NNS infants)) (SBAR (WHNP (WP who)) (S (VP (VBD were) (VP (VBN born) (PP (TO to) (NP (NN Doc_15867025_941_968_Chemical-positive) (NNS mothers)))))))) (ADVP (RB also)) (VP (VBD received) (NP (JJ Doc_15867025_1000_1011_Disease) (JJ immune) (NN globulin))) (. .)))
15867025	7	(ROOT (S (NP (JJ Multivariate) (JJ logistic) (NN regression)) (VP (VBD showed) (SBAR (IN that) (S (NP (NP (DT the) (NN month)) (PP (IN of) (NP (NN delivery) (CC and) (NN infant) (NN birth) (NN weight)))) (VP (VBD were) (NP (NP (JJ independent) (NNS predictors)) (PP (IN of) (NP (JJ Doc_15867025_1151_1162_Disease) (NN vaccination)))))))) (. .)))
15867025	8	(ROOT (S (NP (NP (DT The) (NN proportion)) (PP (IN of) (NP (NP (NNS infants)) (SBAR (WHNP (WP who)) (S (VP (VBD were) (VP (VBN vaccinated) (PP (IN in) (NP (NP (NNP January)) (CC and) (NP (NNP February) (CD 2000)))))))) (PRN (-LRB- -LRB-) (NP (NP (NP (CD 48.5) (NN %)) (CC and) (NP (CD 67.5) (NN %))) (, ,) (ADVP (RB respectively))) (-RRB- -RRB-))))) (VP (VBD was) (ADJP (JJR less)) (PP (IN than) (NP (DT any) (JJ other) (NNS months))) (, ,) (SBAR (IN whereas) (S (NP (NP (NP (DT the) (NN proportion)) (SBAR (WHNP (WP who)) (S (VP (VBD were) (VP (VBN vaccinated) (PP (IN in) (NP (NNP December) (CD 2000)))))))) (PRN (-LRB- -LRB-) (NP (CD 88.2) (NN %)) (-RRB- -RRB-))) (VP (VBD was) (NP (DT the) (JJS highest)))))) (. .)))
15867025	9	(ROOT (S (NP (NP (NNP Women)) (SBAR (WHNP (WP who)) (S (VP (VBD were) (VP (VBN born) (PP (IN between) (NP (CD 1971) (CC and) (CD 1975)))))))) (VP (VBD had) (NP (NP (DT the) (JJS highest) (NN rate)) (PP (IN of) (NP (NP (JJ Doc_15867025_1466_1473_Disease) (NN nonimmunity)) (PRN (-LRB- -LRB-) (NP (CD 9.5) (NN %)) (-RRB- -RRB-)))))) (. .)))
15867025	10	(ROOT (S (NP (NNP In-hospital) (NNP postpartum) (NNP Doc_15867025_1517_1524_Disease) (NN vaccine) (NN administration)) (VP (VBD was) (VP (VBN documented) (PP (IN for) (NP (NP (CD 75.6) (NN %)) (PP (IN of) (NP (JJ nonimmune) (NNS women))))))) (. .)))
15867025	11	(ROOT (S (NP (DT This) (NN study)) (VP (VP (VBZ documents) (NP (NP (JJ good) (NN compliance)) (PP (IN in) (NP (NP (NNP New) (NNP Hampshire) (POS 's)) (JJ birthing) (NNS hospitals)))) (PP (IN with) (NP (NP (JJ national) (NNS guidelines)) (PP (IN for) (NP (NP (JJ perinatal) (NNS Doc_15867025_1719_1730_Disease)) (CC and) (NP (JJ Doc_15867025_1735_1742_Disease) (NN prevention))))))) (CC and) (VP (VBZ highlights) (NP (JJ potential) (NNS areas)) (PP (IN for) (NP (NN improvement))))) (. .)))
15893386	0	(ROOT (NP (NP (JJ Doc_15893386_0_15_Chemical-induced) (NNS Doc_15893386_24_48_Disease)) (PP (IN during) (NP (JJ bronchoscopic) (NN removal))) (PP (IN of) (NP (DT a) (JJ tracheal) (JJ foreign) (NN body))) (. .)))
15893386	1	(ROOT (S (NP (NP (NNP Doc_15893386_106_130_Disease)) (PP (IN during) (NP (JJ general) (NN anesthesia)))) (VP (VBZ is) (VP (VBN considered) (NP (NP (DT an) (JJ early) (NN warning) (NN sign)) (PP (IN of) (NP (NP (DT a) (JJ possible) (NN episode)) (PP (IN of) (NP (NNS Doc_15893386_218_240_Disease)))))))) (. .)))
15893386	2	(ROOT (S (NP (NP (DT The) (NN decision)) (SBAR (IN whether) (S (VP (TO to) (VP (VB continue) (CC or) (VB discontinue) (NP (DT the) (NN procedure))))))) (VP (VBZ depends) (PP (IN on) (NP (NP (DT the) (NN urgency)) (PP (IN of) (NP (NP (DT the) (NN surgery) (CC and) (NN severity)) (PP (IN of) (NP (NNS Doc_15893386_358_382_Disease)))))))) (. .)))
15893386	3	(ROOT (S (ADVP (RB Here)) (, ,) (NP (PRP we)) (VP (VBP describe) (NP (NP (DT a) (NN case)) (PP (IN of) (NP (NP (JJ severe) (NNS Doc_15893386_419_443_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_15893386_445_457_Disease)) (-RRB- -RRB-))))) (PP (IN after) (NP (NP (JJ Doc_15893386_465_480_Chemical) (PRN (-LRB- -LRB-) (NP (NNP Doc_15893386_482_485_Chemical)) (-RRB- -RRB-)) (NN administration)) (PP (IN during) (NP (NP (JJ general) (JJ anesthetic) (NN management)) (PP (IN for) (NP (NP (JJ rigid) (JJ bronchoscopic) (NN removal)) (PP (IN of) (NP (DT a) (JJ tracheal) (JJ foreign) (NN body)))))))))) (. .)))
15893386	4	(ROOT (S (NP (NNP Anesthesia)) (VP (VBD was) (VP (VBN continued) (ADVP (RB uneventfully)) (PP (IN with) (NP (JJ Doc_15893386_642_650_Chemical) (NN infusion))) (SBAR (IN while) (S (NP (DT all) (NNS facilities)) (VP (VBD were) (ADJP (JJ available) (S (VP (TO to) (VP (VB detect) (CC and) (VB treat) (NP (NNS Doc_15893386_716_738_Disease))))))))))) (. .)))
15897593	0	(ROOT (S (NP (NNP Doc_15897593_0_11_Chemical)) (VP (VBZ protects) (PP (IN against) (NP (NN myelosuppression))) (PP (IN from) (NP (NP (DT the) (NNP DNA) (JJ cleavage-enhancing) (NNS drugs) (NN Doc_15897593_84_93_Chemical)) (CC and) (NP (NNS Doc_15897593_98_110_Chemical) (CONJP (CC but) (RB not)) (NNS Doc_15897593_119_130_Chemical))))) (. .)))
15897593	1	(ROOT (S (S (NP (NP (DT The) (JJ Doc_15897593_145_159_Chemical) (NNS Doc_15897593_160_172_Chemical) (CC and) (NNS Doc_15897593_177_188_Chemical)) (CC and) (NP (DT the) (JJ Doc_15897593_197_215_Chemical) (NNS Doc_15897593_216_225_Chemical))) (VP (VBP are) (NP (NP (JJ potent) (NNP DNA) (NN cleavage-enhancing) (NNS drugs)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (ADVP (RB widely)) (VP (VBN used) (PP (IN in) (NP (JJ clinical) (NN oncology)))))))))) (: ;) (S (ADVP (RB however)) (, ,) (NP (NNS myelosuppression) (CC and) (NNS Doc_15897593_339_355_Disease)) (VP (VBP limit) (NP (PRP$ their) (NN use)))) (. .)))
15897593	2	(ROOT (S (NP (NP (NNP Doc_15897593_373_384_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_15897593_386_394_Chemical)) (-RRB- -RRB-))) (VP (VBZ is) (VP (VBN recommended) (PP (IN for) (NP (NP (NN protection)) (PP (IN against) (NP (NN Doc_15897593_434_447_Chemical-induced) (NNS Doc_15897593_456_470_Disease))))))) (. .)))
15897593	3	(ROOT (NP (NP (NNP EXPERIMENTAL) (NNP DESIGN)) (: :) (S (S (SBAR (IN Because) (FRAG (PP (IN of) (NP (PRP$ their) (JJ widespread) (NN use))))) (, ,) (NP (NP (DT the) (JJ Doc_15897593_530_550_Disease) (VBG following) (NN coadministration)) (PP (IN of) (NP (NP (NNS Doc_15897593_581_592_Chemical)) (CC and) (NP (DT these) (CD three) (NN structurally) (JJ different) (NN DNA) (NN cleavage) (NNS enhancers))))) (VP (VBD was) (VP (VBN investigated) (PRN (: :) (S (NP (NP (NNP Sensitivity)) (PP (IN of) (NP (NP (ADJP (JJ human) (CC and) (JJ murine)) (NN blood) (NN progenitor) (NNS cells)) (PP (TO to) (NP (NNS Doc_15897593_731_740_Chemical) (, ,) (NNS Doc_15897593_742_754_Chemical) (, ,) (CC and) (NNS Doc_15897593_760_771_Chemical)))))) (ADJP (JJ +))) (: /))))) (: -) (S (NP (NNS Doc_15897593_776_787_Chemical)) (VP (VBD was) (VP (VBN determined) (PP (IN in) (NP (JJ granulocyte-macrophage) (NN colony))) (S (VP (VBG forming) (NP (NNS assays)))))))) (. .)))
15897593	4	(ROOT (S (ADVP (RB Likewise)) (, ,) (S (PP (IN in) (NP (NN vivo))) (, ,) (NP (NNP B6D2F1) (NNS mice)) (VP (VBD were) (VP (VBN treated) (PP (IN with) (NP (NNS Doc_15897593_901_910_Chemical) (, ,) (NNS Doc_15897593_912_924_Chemical) (, ,) (CC and) (NNS Doc_15897593_930_941_Chemical))) (, ,) (PP (IN with) (CC or) (IN without) (NP (NP (NNS Doc_15897593_959_970_Chemical)) (PP (IN over) (NP (NP (DT a) (JJ wide) (NN range)) (PP (IN of) (NP (NNS doses)))))))))) (: :) (S (S (ADJP (JJ posttreatment))) (, ,) (NP (DT a) (JJ full) (JJ hematologic) (NN evaluation)) (VP (VBD was) (VP (VBN done)))) (. .)))
15897593	5	(ROOT (S (S (NP (NP (JJ Nontoxic) (NNS doses)) (PP (IN of) (NP (NNS Doc_15897593_1081_1092_Chemical)))) (VP (VP (VBD reduced) (NP (NN myelosuppression) (CC and) (NNS Doc_15897593_1122_1133_Disease)) (PP (IN from) (NP (NNS Doc_15897593_1139_1151_Chemical) (CC and) (NNS Doc_15897593_1156_1165_Chemical))) (PP (IN in) (NP (NNS mice)))) (CC and) (VP (VBD antagonized) (NP (PRP$ their) (JJ antiproliferative) (NNS effects)) (PP (IN in) (NP (DT the) (NN colony) (NN assay)))))) (: ;) (S (ADVP (RB however)) (, ,) (NP (NNS Doc_15897593_1252_1263_Chemical)) (ADVP (RB neither)) (VP (VBD reduced) (NP (NP (NP (NN myelosuppression)) (, ,) (NP (NNS Doc_15897593_1298_1309_Disease))) (, ,) (CC nor) (NP (NP (DT the) (ADJP (IN in) (NN vitro)) (NNS Doc_15897593_1328_1340_Disease)) (PP (IN from) (NP (NNS Doc_15897593_1346_1357_Chemical))))))) (. .)))
15897593	6	(ROOT (S (S (SBAR (IN Although) (S (NP (PRP$ our) (NNS findings)) (VP (VBP support) (NP (DT the) (NN observation)) (SBAR (IN that) (S (NP (NNS Doc_15897593_1422_1433_Chemical)) (VP (VBZ reduces) (NP (NP (DT neither) (JJ hematologic) (NN activity)) (CC nor) (NP (NP (NN antitumor) (NN activity)) (PP (IN from) (NP (JJ Doc_15897593_1499_1510_Chemical) (NNS clinically))))))))))) (, ,) (NP (NP (DT the) (JJ potent) (NN antagonism)) (PP (IN of) (NP (JJ Doc_15897593_1548_1560_Chemical) (NN activity)))) (VP (VBZ raises) (NP (NN concern)))) (: ;) (S (NP (NP (DT a) (JJ possible) (NN interference)) (PP (IN with) (NP (JJ anticancer) (NN efficacy)))) (ADVP (RB certainly)) (VP (MD would) (VP (VB call) (PP (IN for) (NP (VBN renewed) (NN attention)))))) (. .)))
15897593	7	(ROOT (S (NP (PRP$ Our) (NNS data)) (ADVP (RB also)) (VP (VBP suggest) (SBAR (IN that) (S (NP (JJ significant) (JJ Doc_15897593_1718_1727_Chemical) (NN dose) (NNS escalation)) (VP (VBZ is) (ADVP (RB perhaps)) (ADJP (JJ possible) (PP (IN by) (NP (NP (DT the) (NN use)) (PP (IN of) (NP (NNS Doc_15897593_1778_1789_Chemical)))))))))) (. .)))
15897593	8	(ROOT (S (NP (NP (JJ Clinical) (NNS trials)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (NN brain) (NNS Doc_15897593_1830_1840_Disease)) (VP (VBG combining) (NP (NP (JJ Doc_15897593_1851_1862_Chemical) (CC and) (JJ high) (NNS doses)) (PP (IN of) (NP (NNS Doc_15897593_1881_1890_Chemical)))))))))) (VP (VBZ is) (NP (NP (JJ ongoing)) (PP (IN with) (NP (NP (DT the) (NN aim)) (PP (IN of) (S (VP (VBG improving) (ADVP (RB efficacy)) (PP (IN without) (NP (VBG aggravating) (NNS Doc_15897593_1957_1977_Disease)))))))))) (. .)))
15897593	9	(ROOT (S (SBAR (IN If) (FRAG (ADJP (JJ successful)))) (, ,) (NP (DT this)) (VP (VBZ represents) (NP (NP (DT an) (JJ exciting) (NN mechanism)) (PP (IN for) (NP (NP (JJ pharmacologic) (NN regulation)) (PP (IN of) (NP (NN side) (NNS effects)))))) (PP (IN from) (NP (JJ cytotoxic) (NN chemotherapy)))) (. .)))
15930398	0	(ROOT (NP (NP (NNP Assessment)) (PP (IN of) (NP (NP (DT the) (NN onset) (CC and) (NN persistence)) (PP (IN of) (NP (NP (NNS Doc_15930398_43_50_Disease)) (PP (IN during) (NP (JJ procedural) (NN sedation))))))) (PP (IN with) (NP (NNS Doc_15930398_83_91_Chemical))) (. .)))
15930398	1	(ROOT (S (S (VP (TO To) (VP (VB assess) (NP (NP (NNS patients) (POS ')) (NN ability) (S (VP (TO to) (VP (VB repeat) (CC and) (VB recall) (NP (NNS words))))))))) (VP (VBD presented) (PP (TO to) (NP (PRP them))) (SBAR (IN while) (S (S (VP (VBG undergoing) (NP (JJ procedural) (NN sedation)) (PP (IN with) (NP (NNS Doc_15930398_220_228_Chemical))))) (, ,) (CC and) (S (VP (VB correlate) (NP (PRP$ their) (NN recall)) (PP (IN with) (NP (NP (PRP$ their) (NN level)) (PP (IN of) (NP (NP (NN awareness) (RB as)) (VP (VBN measured) (PP (IN by) (NP (NP (NP (JJ bispectral) (NN index)) (PRN (-LRB- -LRB-) (NP (NNP BIS)) (-RRB- -RRB-))) (VP (VBG monitoring)))))))))))))) (. .)))
15930398	2	(ROOT (S (NP (DT This)) (VP (VBD was) (NP (NP (DT a) (JJ prospective) (, ,) (JJ single-intervention) (NN study)) (PP (IN of) (S (VP (VBG consenting) (NP (JJ adult) (NNS patients)) (S (VP (VBG undergoing) (NP (JJ procedural) (NN sedation)) (PP (IN with) (NP (NP (NP (NNS Doc_15930398_461_469_Chemical)) (PP (IN between) (NP (NNP December) (CD 28) (, ,) (CD 2002) (, ,)))) (CC and) (NP (NNP October) (CD 31) (, ,) (CD 2003))))))))))) (. .)))
15930398	3	(ROOT (S (NP (NNP BIS) (NN monitoring)) (VP (VBD was) (VP (VBN initiated) (S (VP (VP (VBG starting) (NP (CD 3) (NNS minutes)) (PP (IN before) (NP (DT the) (NN procedure)))) (CC and) (VP (VBG continuing) (SBAR (IN until) (S (NP (DT the) (NN patient)) (VP (VBD had) (VP (VBN regained) (NP (JJ baseline) (JJ mental) (NN status))))))))))) (. .)))
15930398	4	(ROOT (S (PP (IN At) (NP (NP (JJ 1-minute) (NNS intervals)) (PP (IN during) (NP (NP (DT the) (JJ procedural) (NN sedation)) (, ,) (SBAR (IN until) (S (NP (DT the) (NN patient)) (VP (VBD regained) (NP (JJ baseline) (JJ mental) (NN status)) (PP (IN at) (NP (NP (DT the) (NN end)) (PP (IN of) (NP (DT the) (NN procedure)))))))))))) (, ,) (S (NP (NP (DT a) (NN word)) (PP (IN from) (NP (DT a) (JJ standardized) (NN list)))) (VP (VBD was) (VP (VBN read) (ADVP (RB aloud))))) (, ,) (CC and) (S (NP (DT the) (NN patient)) (VP (VBD was) (VP (VBN asked) (S (VP (TO to) (VP (ADVP (RB immediately)) (VB repeat) (NP (DT the) (NN word)) (PP (TO to) (NP (DT the) (NN investigator))))))))) (. .)))
15930398	5	(ROOT (S (NP (DT The) (NNP BIS)) (VP (VBP score) (SBAR (S (S (PP (IN at) (NP (DT the) (NN time))) (NP (DT the) (NN word)) (VP (VBD was) (VP (VBN read)))) (CC and) (S (NP (NP (DT the) (NN patient) (POS 's)) (NN ability) (S (VP (TO to) (VP (VB repeat) (NP (DT the) (NN word)))))) (VP (VBD were) (VP (VBN recorded))))))) (. .)))
15930398	6	(ROOT (S (PP (IN After) (NP (DT the) (NN procedure))) (, ,) (NP (DT the) (NN patient)) (VP (VBD was) (VP (VBN asked) (S (VP (VP (TO to) (VP (VB state) (NP (NP (DT all)) (PP (IN of) (NP (DT the) (NNS words)))) (PP (IN from) (NP (DT the) (NN list))) (SBAR (IN that) (S (NP (PRP he) (CC or) (PRP she)) (VP (MD could) (VP (VB recall))))))) (, ,) (CC and) (VP (TO to) (VP (VB identify) (S (S (NP (DT the) (JJ last) (NN word)) (VP (VBD recalled) (PP (IN from) (RB prior)) (PP (TO to) (NP (NP (DT the) (NN start)) (PP (IN of) (NP (DT the) (NN procedure))))))) (CC and) (S (NP (DT the) (JJ first) (NN word)) (VP (VBD recalled) (PP (IN from) (SBAR (IN after) (S (NP (DT the) (NN procedure)) (VP (VBD was) (VP (VBN completed))))))))))))))) (. .)))
15930398	7	(ROOT (S (S (NP (JJ Seventy-five) (NN consenting) (NNS patients)) (VP (VBD were) (VP (VBN enrolled)))) (: ;) (S (NP (CD one) (NN patient)) (VP (VBD was) (VP (VBN excluded) (PP (IN from) (NP (NP (NN data) (NN analysis)) (PP (IN for) (NP (DT a) (NN protocol) (NN violation)))))))) (. .)))
15930398	8	(ROOT (S (NP (DT No) (JJ serious) (JJ adverse) (NNS events)) (VP (VBD were) (VP (VBN noted) (PP (IN during) (NP (DT the) (JJ procedural) (NNS sedations))))) (. .)))
15930398	9	(ROOT (S (NP (NP (DT The) (NN mean) (PRN (-LRB- -LRB-) (NP (NNP +) (NNP /)) (, -) (NP (JJ standard) (NN deviation)) (-RRB- -RRB-)) (NN time)) (PP (IN of) (NP (NN data) (NN collection)))) (VP (VBD was) (NP (NP (JJ 16.4) (NNS minutes)) (PRN (-LRB- -LRB-) (NP (NNP +)) (: /) (NP (NP (CD -7.1)) (: ;) (NP (NP (NN range)) (NP (QP (CD 5) (TO to) (CD 34)) (NNS minutes)))) (-RRB- -RRB-)))) (. .)))
15930398	10	(ROOT (S (NP (NP (DT The) (JJ mean) (NN initial)) (PRN (-LRB- -LRB-) (NP (NN preprocedure)) (-RRB- -RRB-))) (VP (VBP BIS) (SBAR (S (NP (NN score)) (VP (VBD was) (NP (NP (CD 97.1)) (PRN (-LRB- -LRB-) (NP (NNP +)) (: /) (NP (NP (CD -2.3)) (: ;) (NP (NP (NN range)) (NP (QP (CD 92) (TO to) (CD 99))))) (-RRB- -RRB-))))))) (. .)))
15930398	11	(ROOT (S (NP (NP (DT The) (JJ mean) (JJS lowest) (NN BIS) (NN score)) (VP (VBG occurring) (PP (IN during) (NP (DT these) (JJ procedural) (NNS sedations))))) (VP (VBD was) (NP (NP (NNP 66.9)) (PRN (-LRB- -LRB-) (NP (NNP +)) (: /) (NP (NP (CD -14.4)) (: ;) (NP (NP (NN range) (CD 33)) (PP (TO to) (NP (CD 91))))) (-RRB- -RRB-)))) (. .)))
15930398	12	(ROOT (S (NP (NP (DT The) (CD mean) (JJS lowest) (NNP BIS) (NN score) (NNS corresponding)) (PP (TO to) (NP (NP (DT the) (NN ability)) (PP (IN of) (NP (DT the) (NN patient) (S (VP (TO to) (VP (ADVP (RB immediately)) (VB repeat) (NP (NP (NNS words)) (VP (VBN read) (PP (IN from) (NP (DT the) (NN list))))))))))))) (VP (VBD was) (NP (NP (CD 77.1)) (PRN (-LRB- -LRB-) (NP (NP (CD 95) (NN %)) (NP (NP (NNP CI) (NNP =)) (NP (QP (CD 74.3) (TO to) (CD 80.0))))) (-RRB- -RRB-)))) (. .)))
15930398	13	(ROOT (S (NP (NP (DT The) (CD mean) (JJS highest) (NNP BIS) (NN score) (NNS corresponding)) (PP (TO to) (NP (DT the) (NNS Doc_15930398_1967_1992_Disease)))) (VP (VBD was) (NP (NP (CD 81.5)) (PRN (-LRB- -LRB-) (NP (NP (CD 95) (NN %)) (NP (NP (NNP CI) (NNP =)) (NP (QP (CD 78.1) (TO to) (CD 84.8))))) (-RRB- -RRB-)))) (. .)))
15930398	14	(ROOT (S (NP (NP (DT The) (JJ mean) (NNP BIS) (NN score) (NN corresponding)) (PP (TO to) (NP (NP (DT the) (JJ last) (NN word)) (VP (VBN recalled) (PP (IN from) (RB prior)) (PP (TO to) (NP (NP (DT the) (NN initiation)) (PP (IN of) (NP (DT the) (NN sedation))))))))) (VP (VBD was) (NP (NP (CD 96.7)) (PRN (-LRB- -LRB-) (NP (NNP +)) (: /) (NP (NP (CD -2.4)) (: ;) (NP (NP (NN range)) (NP (QP (CD 84) (TO to) (CD 98))))) (-RRB- -RRB-)))) (. .)))
15930398	15	(ROOT (SINV (S (NP (NP (DT The) (JJ mean) (NNP BIS) (NN score) (NN corresponding)) (PP (TO to) (NP (DT the) (JJ first) (NN word)))) (VP (VBD recalled) (SBAR (IN after) (S (NP (DT the) (NN procedure)) (VP (VBD was) (VP (VBN completed))))))) (VP (VBD was)) (NP (NP (CD 91.2)) (PRN (-LRB- -LRB-) (NP (NP (CD 95) (NN %)) (NP (NP (NNP CI) (NNP =)) (NP (QP (CD 88.1) (TO to) (CD 94.3))))) (-RRB- -RRB-))) (. .)))
15930398	16	(ROOT (S (NP (DT All) (NNS patients)) (VP (VBD recalled) (NP (NP (QP (IN at) (JJS least) (CD one)) (NN word)) (SBAR (WHNP (WDT that)) (S (VP (VBD had) (VP (VBN been) (VP (VBN read) (PP (TO to) (NP (PRP them))) (PP (IN during) (NP (DT the) (NN protocol)))))))))) (. .)))
15930398	17	(ROOT (S (S (NP (NP (DT The) (JJ mean) (JJS lowest) (NN BIS) (NN score)) (PP (IN for) (NP (DT any) (JJ recalled) (NN word)))) (VP (VBD was) (NP (NP (CD 91.5)) (PRN (-LRB- -LRB-) (NP (NNP +)) (: /) (NP (NP (CD -11.1)) (: ;) (NP (NP (NN range) (CD 79)) (PP (TO to) (NP (CD 98))))) (-RRB- -RRB-))))) (, ,) (CC and) (S (NP (DT no) (NNS words)) (VP (VBD were) (VP (VBN recalled) (SBAR (WHADVP (WRB when)) (S (NP (DT the) (JJ corresponding) (NNP BIS) (NN score)) (VP (VBD was) (NP (QP (JJR less) (IN than) (CD 90))))))))) (. .)))
15930398	18	(ROOT (S (NP (EX There)) (VP (VBZ is) (NP (NP (DT a) (NN range)) (PP (IN of) (NP (NNP BIS) (NNS scores))) (SBAR (WHPP (IN during) (WHNP (WDT which))) (S (NP (JJ sedated) (NNS patients)) (VP (VP (VBP are) (ADJP (JJ able) (S (VP (TO to) (VP (VB repeat) (NP (NP (NNS words)) (VP (VBN read) (PP (TO to) (NP (PRP them)))))))))) (CC but) (VP (VBP are) (RB not) (ADJP (JJ able) (S (VP (TO to) (VP (ADVP (RB subsequently)) (VB recall) (NP (DT these) (NNS words)))))))))))) (. .)))
15930398	19	(ROOT (S (ADVP (RB Furthermore)) (, ,) (NP (NNS patients)) (VP (VBD had) (NP (NP (DT no) (NN recall)) (PP (IN of) (NP (NP (NNS words)) (VP (VBN repeated) (ADVP (RB prior) (PP (TO to) (NP (JJ procedural) (NN sedation)))) (PP (IN in) (NP (NP (NNP BIS) (NNS ranges)) (VP (VBN associated) (PP (IN with) (NP (NN recall))) (PP (IN after) (NP (NP (JJ procedural) (NN sedation)) (, ,) (NP (NP (NN suggestive)) (PP (IN of) (NP (NNS Doc_15930398_2870_2888_Disease)))))))))))))) (. .)))
1595783	0	(ROOT (NP (CD Doc_1595783_0_10_Chemical) (NNS Doc_1595783_11_29_Disease) (. .)))
1595783	1	(ROOT (S (NP (NNP Doc_1595783_31_41_Chemical)) (VP (VBZ is) (NP (NP (DT an) (ADJP (JJ effective) (JJ antiarrhythmic)) (NN agent)) (SBAR (WHNP (WP$ whose) (NNS utility)) (S (VP (VBZ is) (VP (VBN limited) (PP (IN by) (NP (NP (JJ many) (NNS side-effects)) (, ,) (NP (DT the) (ADJP (RBS most) (JJ problematic)) (JJ being) (NNS Doc_1595783_153_164_Disease)))))))))) (. .)))
1595783	2	(ROOT (S (NP (NP (DT The) (NNS Doc_1595783_170_188_Disease)) (PP (IN of) (NP (NNS Doc_1595783_192_202_Chemical)))) (VP (VBZ is) (VP (VBN thought) (S (VP (TO to) (VP (VB result) (PP (IN from) (NP (NP (JJ direct) (NN injury)) (VP (VBN related) (PP (TO to) (NP (NP (DT the) (NN intracellular) (NN accumulation)) (PP (IN of) (NP (NN phospholipid) (CC and) (NNP T) (JJ cell-mediated) (NNS Doc_1595783_321_349_Disease))))))))))))) (. .)))
1595783	3	(ROOT (S (NP (NP (DT The) (JJ clinical) (CC and) (JJ radiographic) (NNS features)) (PP (IN of) (NP (NN Doc_1595783_393_403_Chemical-induced) (NNS Doc_1595783_412_430_Disease)))) (VP (VBP are) (ADJP (JJ characteristic) (CC but) (JJ nonspecific))) (. .)))
1595783	4	(ROOT (S (NP (DT The) (NN diagnosis)) (VP (VBZ depends) (PP (IN on) (NP (NP (NN exclusion)) (PP (IN of) (NP (JJ other) (NNS entities))) (, ,) (PP (JJ such) (IN as) (NP (NNS Doc_1595783_529_542_Disease) (, ,) (NNS Doc_1595783_544_553_Disease) (, ,) (CC and) (NNS Doc_1595783_559_569_Disease)))))) (. .)))
1595783	5	(ROOT (S (SBAR (IN While) (S (NP (NP (NN withdrawal)) (PP (IN of) (NP (NNS Doc_1595783_591_601_Chemical)))) (VP (VBZ leads) (PP (TO to) (NP (JJ clinical) (NN improvement))) (PP (IN in) (NP (NP (NN majority)) (PP (IN of) (NP (NNS cases)))))))) (, ,) (NP (DT this)) (VP (VBZ is) (RB not) (ADJP (RB always) (JJ possible) (CC or) (JJ advisable))) (. .)))
1595783	6	(ROOT (S (NP (NP (JJ Dose) (NN reduction)) (CC or) (NP (JJ concomitant) (JJ Doc_1595783_726_733_Chemical) (NN therapy))) (VP (MD may) (VP (VB have) (NP (NP (DT a) (NN role)) (PP (IN in) (NP (VBN selected) (NNS patients)))))) (. .)))
15974569	0	(ROOT (S (NP (NP (CD Two) (NNS prodrugs)) (PP (IN of) (NP (ADJP (JJ potent) (CC and) (JJ selective)) (JJ GluR5) (JJ Doc_15974569_43_50_Chemical) (NN receptor) (NNS antagonists)))) (VP (VBZ actives) (PP (IN in) (NP (NP (CD three) (NN animal) (NNS models)) (PP (IN of) (NP (NNS Doc_15974569_106_110_Disease)))))) (. .)))
15974569	1	(ROOT (S (NP (NP (NNP Doc_15974569_112_123_Chemical) (CD 5) (CC and) (CD 7)) (, ,) (NP (NP (CD two)) (NP (ADJP (JJ potent) (CC and) (JJ selective)) (JJ competitive) (NNP GluR5) (NNP KA) (NN receptor) (NNS antagonists))) (, ,)) (VP (VBD exhibited) (NP (JJ high) (JJ GluR5) (NN receptor)) (ADVP (RB affinity)) (PP (IN over) (NP (JJ other) (JJ Doc_15974569_251_260_Chemical) (NNS receptors)))) (. .)))
15974569	2	(ROOT (S (NP (NP (PRP$ Their) (NNS Doc_15974569_278_283_Chemical)) (ADJP (JJ prodrugs) (NP (CD 6) (CC and) (CD 8)))) (VP (VBD were) (ADJP (RB orally) (JJ active)) (PP (IN in) (NP (NP (NP (CD three) (NNS models)) (PP (IN of) (NP (NNS Doc_15974569_339_343_Disease)))) (: :) (NP (NP (NN reversal)) (PP (IN of) (NP (NP (NN Doc_15974569_357_365_Chemical-induced) (NN paw) (NNS licking)) (, ,) (NP (JJ carrageenan-induced) (NNS Doc_15974569_407_427_Disease)) (, ,) (CC and) (NP (NN Doc_15974569_433_442_Chemical-induced) (NNS Doc_15974569_451_474_Disease)))))))) (. .)))
15985056	0	(ROOT (S (NP (JJ Possible) (NNS Doc_15985056_9_21_Chemical-associated)) (VP (VBZ Doc_15985056_33_40_Disease)) (. .)))
15985056	1	(ROOT (S (S (VP (TO To) (VP (VB report) (NP (NP (DT a) (NN case)) (PP (IN of) (NP (JJ persistent) (NNS Doc_15985056_84_91_Disease))))))) (VP (VBN associated) (PP (IN by) (NP (JJ Doc_15985056_106_118_Chemical) (NN therapy)))) (. .)))
15985056	2	(ROOT (NP (NP (NNP CASE) (NNP SUMMARY)) (: :) (NP (NP (DT A) (JJ 76-year-old) (NN man)) (VP (VBN presented) (PP (IN with) (NP (JJ persistent) (NNS Doc_15985056_186_193_Disease))) (PP (IN after) (S (VP (VBG beginning) (NP (NNS Doc_15985056_210_222_Chemical)) (PP (IN for) (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (NNS Doc_15985056_244_255_Disease)))))))))) (. .)))
15985056	3	(ROOT (S (NP (NNP Doc_15985056_257_264_Disease)) (VP (VBD were) (ADJP (JJ persistent) (CC and) (JJ exhausting))) (. .)))
15985056	4	(ROOT (S (NP (NP (NNP Discontinuation)) (PP (IN of) (NP (NNS Doc_15985056_316_328_Chemical) (CC and) (NN therapy))) (PP (IN with) (NP (NNS Doc_15985056_346_354_Chemical)))) (ADVP (RB finally)) (VP (VBD resolved) (NP (NNS Doc_15985056_372_379_Disease))) (. .)))
15985056	5	(ROOT (S (NP (NP (DT No) (JJ organic) (NN cause)) (PP (IN of) (NP (NNS Doc_15985056_401_408_Disease)))) (VP (VBD was) (VP (VBN identified) (PP (IN despite) (NP (JJ extensive) (NN investigation))))) (. .)))
15985056	6	(ROOT (S (NP (JJ Pharmacotherapeutic) (NNS agents)) (VP (VBP have) (VP (VBN been) (VP (ADVP (RB uncommonly)) (VBN associated) (PP (IN with) (NP (NNS Doc_15985056_533_540_Disease)))))) (. .)))
15985056	7	(ROOT (S (NP (NP (NP (NNP Doc_15985056_542_557_Chemical)) (PRN (-LRB- -LRB-) (NP (JJ Doc_15985056_559_572_Chemical) (CC and) (JJ Doc_15985056_577_595_Chemical)) (-RRB- -RRB-))) (, ,) (NP (JJ Doc_15985056_598_613_Chemical) (-LRB- -LRB-) (NNS Doc_15985056_615_624_Chemical) (-RRB- -RRB-)) (CC and) (NP (JJ general) (NN anaesthesia))) (VP (VBP have) (VP (VBN been) (NP (NP (DT the) (JJ specific) (NNS agents)) (VP (VBN mentioned) (ADVP (RBS most) (RB frequently)) (PP (IN in) (NP (DT the) (NN literature))) (PP (IN as) (S (VP (VBG being) (VP (VBN associated) (PP (IN with) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (NNS Doc_15985056_768_775_Disease))))))))))))) (. .)))
15985056	8	(ROOT (S (NP (NP (JJ Few) (NNS cases)) (PP (IN of) (NP (JJ drug-induced) (NNS Doc_15985056_803_810_Disease)))) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (ADVP (VBN related) (PP (TO to) (NP (JJ Doc_15985056_841_850_Chemical) (NNS antimicrobials))))))) (. .)))
15985056	9	(ROOT (S (S (VP (VBG Using) (NP (DT the) (NNP Naranjo) (JJ adverse) (NN effect) (NN reaction) (NN probability) (NN scale)))) (NP (DT this) (NN event)) (VP (MD could) (VP (VB be) (VP (VBN classified) (PP (IN as) (NP (NP (NP (JJ possible)) (PRN (-LRB- -LRB-) (NP (NP (NN score)) (NP (CD 5) (NNS points))) (-RRB- -RRB-)) (, ,) (PP (RB mostly) (RB because) (IN of) (NP (DT the) (JJ close) (JJ temporal) (NN sequence)))) (, ,) (NP (NP (JJ previous) (NNS reports)) (PP (IN on) (NP (NP (DT this) (NN reaction)) (PP (IN with) (NP (JJ other) (NNS Doc_15985056_1080_1090_Chemical)))))) (CC and) (NP (NP (DT the) (NN absence)) (PP (IN of) (NP (NP (DT any) (JJ alternative) (NN explanation)) (PP (IN for) (NP (NNS Doc_15985056_1142_1149_Disease))))))))))) (. .)))
15985056	10	(ROOT (S (NP (PRP$ Our) (NNS hypothesis)) (VP (VBZ is) (SBAR (IN that) (S (NP (NP (DT a) (JJ vagal) (NN mechanism)) (VP (VBN mediated) (PP (IN by) (NP (NNS Doc_15985056_1204_1216_Chemical))))) (VP (MD could) (VP (VB be) (NP (NP (DT the) (NNS pathogenesis)) (PP (IN of) (NP (NP (NNS Doc_15985056_1246_1253_Disease)) (PP (IN in) (NP (PRP$ our) (NN patient))))))))))) (. .)))
15985056	11	(ROOT (S (NP (NP (NN Diagnosis)) (PP (IN of) (NP (JJ drug-induced) (NNS Doc_15985056_1309_1316_Disease)))) (VP (VP (VBZ is) (ADJP (JJ difficult))) (CC and) (ADVP (RB often)) (VP (VBD achieved) (ADVP (RB only)) (PP (IN by) (NP (NP (DT a) (NN process)) (PP (IN of) (NP (NN elimination))))))) (. .)))
15985056	12	(ROOT (S (ADVP (RB However)) (, ,) (S (NP (JJ Doc_15985056_1392_1401_Chemical) (NNS antimicrobials)) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (S (VP (TO to) (VP (VB be) (VP (VBN associated) (PP (IN with) (NP (NNS Doc_15985056_1458_1465_Disease))))))))))) (CC and) (S (NP (JJ vagal) (NN mechanism)) (VP (MD could) (VP (VB explain) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (DT this) (NN side-effect))))))) (. .)))
16006300	0	(ROOT (S (NP (NP (JJ Doc_16006300_0_17_Chemical) (NNS Doc_16006300_18_26_Disease)) (: :) (NP (DT the) (VBN updated) (NNS Doc_16006300_40_60_Disease)) (: ;)) (VP (VBP report) (PP (IN of) (NP (NP (CD 3) (NNS cases)) (CC and) (NP (NP (NN review)) (PP (IN of) (NP (DT the) (NN literature))))))) (. .)))
16006300	1	(ROOT (S (VP (TO To) (VP (VB describe) (NP (NP (CD 3) (NNS patients)) (PP (IN with) (NP (NN Doc_16006300_149_166_Chemical-induced) (NNS Doc_16006300_175_188_Disease) (CC and) (NN gain) (NNS insights)))) (PP (IN into) (NP (NP (DT the) (NN cause) (CC and) (NN management)) (PP (IN of) (NP (DT the) (NNS Doc_16006300_244_264_Disease))))))) (. .)))
16006300	2	(ROOT (S (NP (PRP We)) (VP (VP (VB report) (NP (DT the) (JJ clinical) (CC and) (NN laboratory) (NNS data)) (PP (IN in) (NP (NP (CD 3) (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBN presented) (PP (IN with) (NP (NP (JJ severe) (NNS Doc_16006300_358_371_Disease)) (PRN (-LRB- -LRB-) (VP (VBN corrected) (NP (NP (NP (NN serum) (NNS Doc_16006300_389_396_Chemical)) (VP (VBN >))) (CC or) (SBAR (S (VP (SYM =) (NP (CD 14) (NN mg/dL))))))) (-RRB- -RRB-)))))))))) (CC and) (VP (VB review) (NP (DT the) (JJ pertinent) (NN literature)) (PP (IN on) (NP (NNS Doc_16006300_453_473_Disease))))) (. .)))
16006300	3	(ROOT (S (NP (DT The) (CD 3) (NNS patients)) (VP (VBD had) (NP (NP (NNS Doc_16006300_503_528_Disease)) (, ,) (NP (JJ relative) (NNS Doc_16006300_539_558_Disease)) (, ,) (CC and) (NP (NP (NP (JJ low) (JJ parathyroid) (NN hormone)) (PRN (-LRB- -LRB-) (NP (NNP PTH)) (-RRB- -RRB-))) (, ,) (ADJP (JJ PTH-related) (JJ peptide)) (, ,) (CC and) (NP (JJ Doc_16006300_620_643_Chemical) (NNS concentrations))))) (. .)))
16006300	4	(ROOT (S (NP (DT No) (JJ malignant) (NN lesion)) (VP (VBD was) (VP (VBN found))) (. .)))
16006300	5	(ROOT (S (NP (NNP Treatment)) (VP (VBD included) (NP (NP (JJ aggressive) (NN hydration) (CC and) (JJ varied) (NNS amounts)) (PP (IN of) (NP (NNS Doc_16006300_753_763_Chemical))))) (. .)))
16006300	6	(ROOT (S (NP (NP (DT The) (CD 2) (NNS patients)) (PP (IN with) (NP (DT the) (JJR higher) (NNP serum) (NNP Doc_16006300_802_809_Chemical) (NNS concentrations)))) (VP (VBD received) (NP (NP (NP (JJ Doc_16006300_834_845_Chemical) (NN intravenously)) (PRN (-LRB- -LRB-) (NP (NP (NP (CD 60)) (CC and) (NP (CD 30) (NN mg))) (, ,) (ADVP (RB respectively))) (-RRB- -RRB-))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD caused) (NP (JJ severe) (NNS Doc_16006300_910_922_Disease))))))) (. .)))
16006300	7	(ROOT (S (PP (IN Of) (NP (DT the) (CD 3) (NNS patients))) (, ,) (NP (CD 2)) (VP (VBD were) (VP (VBG ingesting) (NP (NP (JJ acceptable) (NNS doses)) (PP (IN of) (NP (NP (JJ elemental) (NNS Doc_16006300_990_997_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (NP (CD 1) (NN g)) (CC and) (NP (CD 2) (NN g) (RB daily))) (, ,) (ADVP (RB respectively))) (-RRB- -RRB-))))) (PP (IN in) (NP (NP (DT the) (NN form)) (PP (IN of) (NP (NNS Doc_16006300_1047_1064_Chemical))))))) (. .)))
16006300	8	(ROOT (S (PP (IN In) (NP (NP (NN addition)) (PP (TO to) (NP (PRP$ our) (JJ highlighted) (NNS cases))))) (, ,) (NP (PRP we)) (VP (VP (VB review) (NP (NP (DT the) (NN history)) (, ,) (NP (NN classification)) (, ,) (NP (JJ pathophysiologic) (NNS features)) (, ,) (CC and) (NP (NP (NN treatment)) (PP (IN of) (NP (NNS Doc_16006300_1187_1207_Disease)))))) (CC and) (VP (VB summarize) (SBAR (S (NP (DT the) (NNS cases)) (VP (VBD reported) (PP (IN from) (NP (JJ early) (CD 1995))) (PP (TO to) (NP (NNP November) (CD 2003)))))))) (. .)))
16006300	9	(ROOT (S (NP (NNP Doc_16006300_1287_1307_Disease)) (VP (VP (MD may) (VP (VB be) (NP (NP (DT a) (JJ common) (NN cause)) (PP (IN of) (NP (JJ unexplained) (NNS Doc_16006300_1345_1358_Disease)))))) (CC and) (VP (MD can) (VP (VB be) (VP (VBN precipitated) (PP (IN by) (NP (NP (JJ small) (NNS amounts)) (PP (IN of) (NP (NP (ADJP (RB orally) (JJ ingested)) (NNS Doc_16006300_1419_1436_Chemical)) (PP (IN in) (NP (ADJP (JJ susceptible)) (NNS persons))))))))))) (. .)))
16006300	10	(ROOT (S (NP (NP (NNP Treatment)) (PP (IN with) (NP (NP (NN hydration) (, ,) (NN Doc_16006300_1487_1497_Chemical) (, ,) (CC and) (NN discontinuation)) (PP (IN of) (NP (DT the) (NNS Doc_16006300_1526_1533_Chemical) (CC and) (NNS Doc_16006300_1538_1547_Chemical) (NN source)))))) (VP (VBZ is) (ADJP (JJ adequate))) (. .)))
16006300	11	(ROOT (S (NP (JJ Doc_16006300_1568_1579_Chemical) (NN treatment)) (VP (VBZ is) (VP (VBN associated) (PP (IN with) (NP (NP (JJ considerable) (NN risk)) (PP (IN for) (NP (NNS Doc_16006300_1631_1643_Disease)))) (, ,) (ADVP (RB even))) (PP (IN in) (NP (NP (NNS cases)) (PP (IN of) (NP (ADVP (RB initially)) (JJ severe) (NNS Doc_16006300_1679_1692_Disease))))))) (. .)))
16047871	0	(ROOT (NP (CD Doc_16047871_0_8_Chemical-induced) (NNS Doc_16047871_17_44_Disease) (. .)))
16047871	1	(ROOT (S (NP (NP (NN Skin) (NNS reactions)) (VP (VBN associated) (PP (IN with) (NP (JJ oral) (NN Doc_16047871_82_90_Chemical-derived) (NNS anticoagulants))))) (VP (VBP are) (NP (DT an) (JJ uncommon) (NN occurrence))) (. .)))
16047871	2	(ROOT (S (NP (NP (NNP Doc_16047871_142_169_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_16047871_171_173_Disease)) (-RRB- -RRB-))) (VP (VBZ is) (ADVP (RB primarily)) (NP (DT a) (NNS Doc_16047871_190_223_Disease)) (, ,) (SBAR (IN though) (S (NP (JJ systemic) (NN involvement)) (VP (MD may) (VP (VB be) (VP (VBN encountered))))))) (. .)))
16047871	3	(ROOT (S (NP (PRP We)) (VP (VBP report) (NP (NP (CD 4) (NNS patients)) (PP (IN with) (NP (JJ late-onset) (NNS Doc_16047871_310_312_Disease)))) (PP (ADVP (RB probably)) (JJ due) (PP (TO to) (NP (NNS Doc_16047871_329_337_Chemical))))) (. .)))
16047871	4	(ROOT (S (NP (DT All) (CD 4) (NNS patients)) (VP (VBD presented) (PP (IN with) (NP (NP (NNS Doc_16047871_369_383_Disease)) (SBAR (WHNP (WDT that)) (S (VP (VBN developed) (PP (IN after) (S (VP (VBG receiving) (NP (NNS Doc_16047871_415_423_Chemical)) (PP (IN for) (NP (JJ several) (NNS years)))))))))))) (. .)))
16047871	5	(ROOT (S (NP (NP (DT The) (NNS results)) (PP (IN of) (NP (JJ Doc_16047871_458_469_Disease) (NNS biopsies)))) (VP (VBD were) (ADJP (JJ available) (PP (IN in) (NP (NP (CD 3) (NNS patients)) (, ,) (NP (NP (VBG confirming) (NNS Doc_16047871_520_540_Disease)) (VP (VBN resolved) (PP (IN in) (NP (DT all) (NNS patients)))))))) (SBAR (IN after) (S (NP (NNS Doc_16047871_572_580_Chemical)) (VP (VBD was) (VP (VBN discontinued)))))) (. .)))
16047871	6	(ROOT (S (PP (IN In) (NP (NP (CD 2)) (PP (IN of) (NP (DT the) (CD 4) (NNS patients))))) (, ,) (NP (NP (NN rechallenge)) (PP (IN with) (NP (NNS Doc_16047871_640_648_Chemical)))) (VP (VBD led) (PP (TO to) (NP (NP (NN recurrence)) (PP (IN of) (NP (DT the) (NNS lesions)))))) (. .)))
16047871	7	(ROOT (S (NP (NNP Doc_16047871_683_685_Disease)) (VP (MD may) (VP (VB be) (NP (NP (DT a) (JJ late-onset) (JJ adverse) (NN reaction)) (VP (VBN associated) (PP (IN with) (NP (JJ Doc_16047871_739_747_Chemical) (NN therapy))))))) (. .)))
1610717	0	(ROOT (S (NP (NNP Doc_1610717_0_7_Chemical-induced)) (VP (VBP brainstem) (NP (NNS Doc_1610717_26_34_Disease) (CC and) (NN behavior))) (. .)))
1610717	1	(ROOT (S (NP (NP (DT A) (NN variety)) (PP (IN of) (NP (NP (JJ abnormal) (NN sensory/motor) (NNS behaviors)) (VP (VBN associated) (PP (IN with) (NP (NP (JJ electrical) (NNS discharges)) (VP (VBN recorded) (PP (IN from) (NP (DT the) (JJ bilateral) (NN brainstem)))))))))) (VP (VBD were) (VP (VBN induced) (PP (IN in) (NP (JJ adult) (NNP WKY) (NNS rats))) (PP (PP (IN by) (NP (NP (JJ mechanical) (-LRB- -LRB-) (JJ electrode) (NNS implants) (-RRB- -RRB-)) (CC and) (NP (JJ DC) (JJ electrical) (JJ current) (NNS stimulations)))) (CC and) (PP (IN by) (NP (NP (JJ acute) (CC and) (JJ chronic) (NN administration)) (PP (IN of) (NP (NNS Doc_1610717_319_326_Chemical)))))))) (. .)))
1610717	2	(ROOT (S (NP (NP (DT The) (JJ electrode) (NN implant)) (VP (VP (VBN implicated) (NP (NP (CD one) (NN side)) (CC or) (NP (NP (DT the) (JJ other)) (PP (IN of) (NP (NP (DT the) (NN reticular) (NN system)) (PP (IN of) (NP (DT the) (NN brainstem)))))))) (CC but) (VP (VBZ subjects)))) (VP (VBD were) (RB not) (VP (VBN incapacitated) (PP (IN by) (NP (DT the) (NNS stimulations))))) (. .)))
1610717	3	(ROOT (S (NP (NP (NNP Doc_1610717_481_488_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 40) (NN mg/kg)) (-RRB- -RRB-))) (VP (VBD was) (VP (VBN injected) (ADVP (RB subcutaneously)) (PP (IN for) (NP (DT an) (JJ acute) (NN experiment) (CC and) (JJ subsequent) (CD 20) (NN mg/kg) (NNS doses) (RB twice) (RB daily) (IN for) (CD 3) (NNS days))) (PP (IN in) (NP (DT a) (JJ chronic) (NN study))))) (. .)))
1610717	4	(ROOT (S (NP (NNP Doc_1610717_625_632_Chemical)) (VP (VBD generated) (NP (JJR more) (JJ abnormal) (NNS behaviors)) (PP (IN in) (NP (NP (DT the) (NN brainstem) (NN perturbation) (NN group)) (, ,) (NP (RB especially) (DT the) (JJ electrically) (JJ perturbated) (NNS subjects))))) (. .)))
1610717	5	(ROOT (S (NP (DT The) (JJ abnormal) (NNS behaviors)) (VP (VBD were) (UCP (ADJP (JJ yawning)) (, ,) (NP (NP (NNS retrocollis)) (, ,) (NP (NNS Doc_1610717_804_817_Disease)) (, ,) (NP (NNS Doc_1610717_819_835_Disease)) (, ,) (NP (`` ``) (RB beating) (JJ drum) ('' '') (NN behavior)) (, ,) (NP (NN squealing)) (, ,) (NP (NN head) (NN bobbing)) (, ,) (NP (NN circling)) (, ,) (NP (NNP sniffing)) (, ,) (NP (JJ abnormal) (NN posturing)) (, ,) (CC and) (NP (JJ facial) (NN twitching))))) (. .)))
1610717	6	(ROOT (S (NP (NP (NNS Shifts)) (PP (IN in) (NP (NP (DT the) (NN power) (NN frequency) (NN spectra)) (PP (IN of) (NP (DT the) (NN discharge) (NNS patterns)))))) (VP (VBD were) (VP (VBN noted) (PP (IN between) (NP (ADJP (JJ quiet) (CC and) (JJ pacing)) (JJ behavioral) (NNS states))))) (. .)))
1610717	7	(ROOT (S (S (NP (NP (NNP Doc_1610717_1068_1084_Disease)) (PP (TO to) (NP (NP (JJ various) (NN auditory)) (, ,) (NP (NN tactile)) (, ,) (CC and) (NP (JJ visual) (NN stimulation))))) (VP (VBD was) (ADJP (JJ present)))) (CC and) (S (NP (NP (NNS shifts)) (PP (IN in) (NP (DT the) (NN brainstem) (NN ambient) (NN power) (NN spectral) (NN frequency)))) (VP (VBD occurred) (PP (IN in) (NP (NN response))) (S (VP (TO to) (VP (VB tactile) (NP (NN stimulation))))))) (. .)))
1610717	8	(ROOT (S (NP (DT These) (NNS findings)) (VP (VBP suggest) (SBAR (IN that) (S (NP (DT the) (NN brainstem)) (VP (VBZ generates) (CC and) (VBZ propagates) (NP (NP (JJ pathological) (NNS discharges)) (SBAR (WHNP (WDT that)) (S (VP (MD can) (VP (VB be) (VP (VBN elicited) (PP (IN by) (NP (NP (JJ mechanical)) (CC and) (NP (NNP DC) (JJ electrical) (NN perturbation)))))))))))))) (. .)))
1610717	9	(ROOT (S (NP (NNP Doc_1610717_1414_1421_Chemical)) (VP (VBD was) (VP (VBN found) (S (VP (TO to) (VP (VP (VB activate) (NP (DT the) (NN discharge) (NN system))) (CC and) (VP (ADVP (RB thus)) (VB induce) (NP (NP (JJ abnormal) (NNS behaviors)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (VP (VBN generated) (PP (PP (IN at) (NP (DT the) (NN discharge) (NN site))) (CC and) (PP (IN at) (NP (NP (JJ distant) (NNS sites)) (SBAR (WHPP (TO to) (WHNP (WDT which))) (S (NP (DT the) (NN discharge)) (VP (VBZ propagates)))))))))))))))))) (. .)))
1610717	10	(ROOT (S (NP (JJ Cognitive) (NNS functions)) (VP (MD may) (ADVP (RB also)) (VP (VB be) (VP (VBN involved) (SBAR (IN since) (S (NP (NP (ADJP (JJ dopaminergic) (CC and) (JJ serotonergic)) (JJ cellular) (NNS elements)) (PP (IN at) (NP (DT the) (NN brainstem) (NN level)))) (VP (VBP are) (ADVP (RB also)) (VP (VBN implicated)))))))) (. .)))
16116131	0	(ROOT (S (NP (NP (NNS rTMS)) (PP (IN of) (NP (JJ supplementary) (NN motor) (NN area)))) (VP (VBZ modulates) (NP (NP (JJ therapy-induced) (NNS Doc_16116131_59_70_Disease)) (PP (IN in) (NP (NNS Doc_16116131_74_91_Disease))))) (. .)))
16116131	1	(ROOT (S (NP (UCP (NP (DT The) (JJ neural) (NNS mechanisms)) (CC and) (ADJP (RB circuitry) (JJ involved) (PP (IN in) (NP (NNS Doc_16116131_141_149_Chemical-induced))))) (NNS Doc_16116131_158_168_Disease)) (VP (VBP are) (ADJP (JJ unclear))) (. .)))
16116131	2	(ROOT (S (S (VP (VBG Using) (NP (NP (ADJP (JJ repetitive) (JJ transcranial)) (JJ magnetic) (NN stimulation)) (PRN (-LRB- -LRB-) (NP (NNS rTMS)) (-RRB- -RRB-))) (PP (IN over) (NP (NP (NP (DT the) (JJ supplementary) (NN motor) (NN area)) (PRN (-LRB- -LRB-) (NP (NNP SMA)) (-RRB- -RRB-))) (PP (IN in) (NP (NP (DT a) (NN group)) (PP (IN of) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ advanced) (NNS Doc_16116131_317_334_Disease))))))))))) (, ,) (NP (DT the) (NNS authors)) (VP (VBD investigated) (SBAR (IN whether) (S (NP (NP (NN modulation)) (PP (IN of) (NP (NNP SMA)))) (ADVP (RB excitability)) (VP (MD may) (VP (VB result) (PP (IN in) (NP (NP (DT a) (NN modification)) (PP (IN of) (NP (NP (DT a) (JJ Doc_16116131_434_444_Disease) (NN state)) (VP (VBN induced) (PP (IN by) (NP (JJ continuous) (JJ Doc_16116131_473_484_Chemical) (NN infusion))))))))))))) (. .)))
16116131	3	(ROOT (S (NP (NP (NNS rTMS)) (PP (IN at) (NP (CD 1) (NNS Hz)))) (VP (VBD was) (VP (VBN observed) (S (VP (TO to) (VP (ADVP (RB markedly)) (VB reduce) (NP (NNS Doc_16116131_540_564_Disease))))) (, ,) (SBAR (IN whereas) (S (NP (JJ 5-Hz) (NNS rTMS)) (VP (VBN induced) (NP (DT a) (ADJP (JJ slight) (CONJP (CC but) (RB not)) (JJ significant)) (NN increase))))))) (. .)))
16132524	0	(ROOT (NP (NP (NP (NP (JJ Intracavitary) (NN chemotherapy)) (PRN (-LRB- -LRB-) (NP (NNP Doc_16132524_28_38_Chemical)) (: /) (NP (NP (NNS Doc_16132524_39_50_Chemical)) (NP (JJ liquid) (JJ crystalline) (JJ cubic) (NNS phases))) (-RRB- -RRB-))) (PP (IN for) (NP (JJ recurrent) (NNS Doc_16132524_98_110_Disease)))) (: --) (NP (JJ clinical) (NNS observations)) (. .)))
16132524	1	(ROOT (S (NP (JJ Human) (JJ malignant) (NNS Doc_16132524_153_165_Disease)) (VP (VBP have) (NP (NP (DT a) (JJ poor) (NN prognosis)) (PP (IN in) (NP (NP (NN spite)) (PP (IN of) (NP (NN surgery) (CC and) (NN radiation) (NN therapy))))))) (. .)))
16132524	2	(ROOT (S (NP (JJ Cubic) (NNS phases)) (VP (VBP consist) (PP (IN of) (NP (JJ curved) (JJ biocontinuous) (NN lipid) (NNS bilayers))) (, ,) (S (VP (VBG separating) (NP (NP (CD two) (JJ congruent) (NNS networks)) (PP (IN of) (NP (NN water) (NNS channels))))))) (. .)))
16132524	3	(ROOT (S (S (VP (VBN Used) (PP (IN as) (NP (NP (DT a) (NN host)) (PP (IN for) (NP (JJ cytotoxic) (NNS drugs))))))) (, ,) (NP (DT the) (JJ gel-like) (NN matrix)) (VP (MD can) (ADVP (RB easily)) (VP (VB be) (VP (VBN applied) (PP (TO to) (NP (NP (DT the) (NNS walls)) (PP (IN of) (NP (DT a) (JJ surgical) (NN resection) (NN cavity)))))))) (. .)))
16132524	4	(ROOT (S (PP (IN For) (NP (JJ human) (JJ Doc_16132524_478_490_Disease) (NNS recurrences))) (, ,) (NP (NP (DT the) (NN feasibility)) (, ,) (NP (NN safety)) (, ,) (CC and) (NP (NP (JJ short-term) (NNS effects)) (PP (IN of) (NP (NP (DT a) (JJ surgical) (NN intracavitary) (NN application)) (PP (IN of) (NP (NNS Doc_16132524_595_605_Chemical) (CC and) (NNS Doc_16132524_610_621_Chemical))))) (VP (VBN encapsulated) (PP (IN by) (NP (JJ liquid) (JJ crystalline) (JJ cubic) (NNS phases)))))) (VP (VBP are) (VP (VBN examined) (PP (IN in) (NP (DT a) (NN pilot) (NN study))))) (. .)))
16132524	5	(ROOT (S (NP (NP (DT A) (NN total)) (PP (IN of) (NP (NP (CD 12) (NNS patients)) (PP (IN with) (NP (NP (DT a) (NN recurrence)) (PP (IN of) (NP (DT a) (JJ Doc_16132524_747_759_Disease) (NN multiforme)))))))) (VP (VP (VBD underwent) (NP (NN re-resection))) (CC and) (VP (VBD received) (NP (NP (DT an) (JJ intracavitary) (NN application)) (PP (IN of) (NP (NNS Doc_16132524_839_849_Chemical) (CC and) (NNS Doc_16132524_854_865_Chemical)))) (NP (NP (JJ cubic) (NNS phases)) (PP (IN in) (NP (JJ different) (NNS dosages)))))) (. .)))
16132524	6	(ROOT (S (NP (NP (CD Six)) (PP (IN of) (NP (DT the) (NNS patients)))) (VP (VP (VBD received) (NP (QP (JJR more) (IN than) (CD 15)) (NN mg) (NNS Doc_16132524_946_956_Chemical))) (CC and) (VP (VBD suffered) (PP (IN from) (NP (ADJP (JJ moderate) (TO to) (JJ severe)) (NNS Doc_16132524_994_1005_Disease))) (, ,) (SBAR (IN while) (S (NP (DT the) (VBG remaining) (NNS patients)) (VP (VBD received) (NP (NP (QP (RB only) (DT a) (NN total))) (PP (IN of) (NP (CD 15) (NN mg) (NNS Doc_16132524_1067_1077_Chemical))))))))) (. .)))
16132524	7	(ROOT (S (PP (IN In) (NP (DT the) (JJ latter) (NN group))) (, ,) (NP (NNS Doc_16132524_1100_1111_Disease)) (VP (VBD was) (ADJP (ADJP (RB markedly) (JJ reduced)) (CC and) (ADJP (RB dealt) (RB medically)))) (. .)))
16132524	8	(ROOT (S (S (NP (NP (JJ Intracavitary) (NN chemotherapy)) (PP (IN in) (NP (NP (JJ recurrent) (NNS Doc_16132524_1194_1206_Disease)) (VP (VBG using) (NP (JJ cubic) (NNS phases)))))) (VP (VBZ is) (ADJP (JJ feasible) (CC and) (JJ safe)))) (, ,) (CC yet) (S (NP (DT the) (JJ clinical) (NN benefit)) (VP (VBZ remains) (S (VP (TO to) (VP (VB be) (VP (VBN examined) (PP (IN in) (NP (DT a) (JJ clinical) (NNP phase) (NNP II) (NN study))))))))) (. .)))
16157917	0	(ROOT (S (NP (NNP Doc_16157917_0_11_Chemical)) (VP (VP (VBN associated) (PP (IN with) (NP (NN exacerbation)))) (CC or) (VP (NP (IN de) (NN novo) (NNS Doc_16157917_52_61_Disease)) (PP (IN in) (NP (NNS Doc_16157917_65_98_Disease))))) (. .)))
16157917	1	(ROOT (S (NP (NP (CD Five) (NNS patients)) (PP (IN with) (NP (NP (NNS Doc_16157917_119_152_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_16157917_154_157_Disease)) (-RRB- -RRB-))))) (VP (VBN treated) (PP (IN with) (NP (NP (JJ Doc_16157917_172_183_Chemical) (PRN (-LRB- -LRB-) (NP (NNP Doc_16157917_185_188_Chemical)) (-RRB- -RRB-)) (ADJP (VBN experienced)) (NN exacerbation)) (CC or) (NP (NP (IN de) (JJ novo) (NN appearance)) (PP (IN of) (NP (NP (NNS Doc_16157917_240_255_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_16157917_257_259_Disease)) (-RRB- -RRB-)))))))) (. .)))
16157917	2	(ROOT (S (PP (IN In) (NP (CD three) (NNS patients))) (, ,) (NP (NNS Doc_16157917_281_284_Chemical)) (VP (VBD exacerbated) (NP (NNS Doc_16157917_297_299_Disease)) (PP (IN in) (NP (NP (DT a) (JJ dose-dependent) (NN manner)) (PP (IN with) (NP (JJ early) (NN aggravation))))) (PP (IN during) (NP (NN titration)))) (. .)))
16157917	3	(ROOT (S (NP (NNP Doc_16157917_368_370_Disease)) (VP (VBD disappeared) (SBAR (WHADVP (WRB when)) (S (NP (JJ Doc_16157917_388_391_Chemical) (NN dose)) (VP (VBD was) (VP (VBN decreased) (PP (IN by) (NP (QP (CD 25) (TO to) (CD 50)) (NN %)))))))) (. .)))
16157917	4	(ROOT (S (PP (IN In) (NP (CD two) (NNS patients))) (, ,) (NP (NNS Doc_16157917_442_445_Chemical)) (VP (VBD exacerbated) (NP (NP (NNS Doc_16157917_458_460_Disease)) (PP (IN in) (NP (DT a) (ADJP (ADJP (JJ delayed)) (CC but) (ADJP (RBR more) (JJ severe))) (NN manner)))) (, ,) (PP (IN with) (NP (NP (NNS Doc_16157917_503_519_Disease)) (SBAR (WHNP (WDT that)) (S (ADVP (RB only)) (VP (VBD ceased) (PP (IN after) (NP (NNP LTG) (NN withdrawal))))))))) (. .)))
16174948	0	(ROOT (NP (NP (NNP Absence)) (PP (IN of) (NP (JJ acute) (JJ cerebral) (NN vasoconstriction))) (PP (IN after) (NP (NN Doc_16174948_49_56_Chemical-associated) (NNS Doc_16174948_68_91_Disease))) (. .)))
16174948	1	(ROOT (S (NP (JJ Doc_16174948_107_114_Chemical) (NN use)) (VP (VBZ has) (VP (VBN been) (VP (VBN associated) (PP (IN with) (NP (NP (NNS Doc_16174948_144_171_Disease)) (, ,) (PP (VBG including) (NP (NP (JJ arterial) (NN vasoconstriction)) (CC and) (NP (NNS Doc_16174948_213_223_Disease))))))))) (. .)))
16174948	2	(ROOT (S (ADVP (RB However)) (, ,) (NP (EX there)) (VP (VBP are) (NP (NP (JJ few) (NNS studies)) (PP (IN of) (NP (NP (JJ angiographic) (NNS effects)) (PP (IN of) (NP (NP (NNS Doc_16174948_283_290_Chemical)) (PP (IN on) (NP (JJ human) (JJ cerebral) (NNS arteries))))))))) (. .)))
16174948	3	(ROOT (S (NP (NP (NNP Information)) (PP (IN on) (NP (DT these) (NNS effects)))) (VP (MD could) (VP (VB be) (VP (VBN obtained) (PP (IN from) (NP (NP (NNS angiograms)) (PP (IN of) (NP (NNS patients))))) (PP (IN with) (NP (NP (NN Doc_16174948_399_406_Chemical-associated) (NNS Doc_16174948_418_441_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_16174948_443_446_Disease)) (-RRB- -RRB-)) (SBAR (WHNP (WP who)) (S (VP (VBD underwent) (ADVP (RB angiography)) (ADVP (RB shortly)) (PP (IN after) (NP (JJ Doc_16174948_488_495_Chemical) (NN use))))))))))) (. .)))
16174948	4	(ROOT (S (NP (PRP We)) (VP (VP (VBD screened) (NP (NNS patients)) (PP (IN with) (NP (JJ Doc_16174948_536_539_Disease) (NN retrospectively)))) (CC and) (VP (VBD identified) (NP (DT those)) (PP (IN with) (NP (NP (JJ positive) (NN urine) (NN toxicology)) (PP (IN for) (NP (NP (NNS Doc_16174948_612_619_Chemical)) (CC or) (NP (PRP$ its) (NNS metabolites)))))))) (. .)))
16174948	5	(ROOT (S (NP (NP (JJ Quantitative) (JJ arterial) (NN diameter) (NNS measurements)) (PP (IN from) (NP (NP (NNS angiograms)) (PP (IN of) (NP (DT these) (NNS patients)))))) (VP (VBD were) (PP (VBN compared) (PP (TO to) (NP (NP (NNS measurements)) (PP (IN from) (NP (NN control) (NNS patients)))))) (PP (IN with) (NP (NP (NNS Doc_16174948_775_778_Disease)) (SBAR (WHNP (WP who)) (S (VP (VBD were) (VP (VBN matched) (PP (IN for) (NP (NP (NNS factors)) (VP (VBN known) (S (VP (TO to) (VP (VB influence) (NP (JJ arterial) (NN diameter))))))))))))))) (. .)))
16174948	6	(ROOT (S (NP (NP (JJ Qualitative) (NNS comparisons)) (PP (IN of) (NP (JJ small) (NN artery) (NNS changes)))) (ADVP (RB also)) (VP (VBD were) (VP (VBN made))) (. .)))
16174948	7	(ROOT (S (NP (NP (NN Thirteen) (NNS patients)) (PP (IN with) (NP (JJ positive) (JJ Doc_16174948_951_958_Chemical) (NN toxicology)))) (VP (VBD were) (PP (VBN compared) (PP (TO to) (NP (CD 26) (NNS controls))))) (. .)))
16174948	8	(ROOT (S (NP (EX There)) (VP (VBD were) (NP (NP (NP (DT no) (JJ significant) (NNS differences)) (PP (IN between) (NP (NP (NNS groups)) (PP (IN in) (NP (NP (DT the) (JJ mean) (NNS diameters)) (PP (IN of) (NP (DT the) (JJ intradural) (JJ internal) (NN carotid)))))))) (, ,) (NP (NP (JJ sphenoidal) (NN segment)) (PP (IN of) (NP (NP (DT the) (JJ middle) (JJ cerebral) (, ,) (JJ precommunicating) (NN segment)) (PP (IN of) (NP (DT the) (NN anterior) (NN cerebral)))))) (, ,) (CC or) (NP (NP (NN basilar) (NNS arteries)) (PRN (-LRB- -LRB-) (VP (VBN p) (ADJP (ADJP (JJR greater)) (PP (IN than) (NP (CD 0.05)))) (PP (IN for) (NP (NP (DT all) (NNS comparisons)) (, ,) (NP (JJ unpaired) (NNS t-tests))))) (-RRB- -RRB-))))) (. .)))
16174948	9	(ROOT (S (NP (EX There)) (ADVP (RB also)) (VP (VBD were) (NP (NP (DT no) (JJ significant) (NNS differences)) (PP (IN between) (NP (NP (NNS groups)) (SBAR (WHADVP (WRB when)) (S (NP (NP (JJ expressing) (NNS diameters)) (PP (IN as) (NP (NP (DT the) (NN sum)) (PP (IN of) (NP (NP (DT the) (VBG precommunicating) (NN segment)) (PP (IN of) (NP (NP (DT the) (JJ anterior) (JJ cerebral) (JJ +) (NN sphenoidal) (NN segment)) (PP (IN of) (NP (DT the) (JJ middle) (JJ cerebral) (JJ +) (JJ Doc_16174948_1484_1496_Chemical) (JJ internal) (JJ carotid) (NN artery) (VBG +) (NN basilar) (NN artery)))))))))) (VP (VBN divided) (PP (IN by) (NP (NP (DT the) (NN diameter)) (PP (IN of) (NP (DT the) (JJ petrous) (JJ internal) (JJ carotid) (NN artery))))) (PRN (-LRB- -LRB-) (ADVP (RB p)) (ADJP (JJR greater) (PP (IN than) (NP (NP (CD 0.05)) (, ,) (NP (JJ unpaired) (NNS t-tests))))) (-RRB- -RRB-))))))))) (. .)))
16174948	10	(ROOT (S (NP (JJ Qualitative) (NNS assessments)) (VP (VBD showed) (NP (CD two) (JJ arterial) (NNS irregularities)) (PP (IN in) (NP (DT the) (JJ distal) (NN vasculature))) (PP (IN in) (NP (DT each) (NN group)))) (. .)))
16174948	11	(ROOT (S (NP (NP (DT No) (JJ quantitative) (NN evidence)) (PP (IN for) (NP (NP (NP (NN narrowing)) (PP (IN of) (NP (JJ large) (JJ cerebral) (NNS arteries)))) (CC or) (NP (NP (JJ qualitative) (JJ angiographic) (NN evidence)) (PP (IN for) (NP (JJ distal) (NN narrowing) (CC or) (NNS Doc_16174948_1881_1891_Disease))))))) (VP (MD could) (VP (VB be) (VP (VBN found) (PP (IN in) (NP (NP (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBD underwent) (ADVP (RB angiography)) (PP (IN after) (NP (NP (JJ Doc_16174948_1951_1961_Disease) (NNS Doc_16174948_1962_1965_Disease)) (VP (VBN associated) (PP (IN with) (NP (JJ Doc_16174948_1982_1989_Chemical) (NN use)))))))))))))) (. .)))
16192988	0	(ROOT (S (NP (JJ Doc_16192988_0_15_Chemical) (NNS causes)) (VP (VBZ alterations) (PP (IN in) (NP (NP (DT the) (NNP MAP) (JJ kinase-related) (NNS pathways)) (PP (IN in) (NP (NP (DT the) (NNS brains)) (PP (IN of) (NP (NP (NNS mice)) (SBAR (WHNP (WDT that)) (S (VP (VBP display) (NP (VBN increased) (NNS Doc_16192988_115_129_Disease)))))))))))) (. .)))
16192988	1	(ROOT (S (NP (NNP Doc_16192988_131_151_Disease)) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (PP (IN in) (NP (NP (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VP (VBP suffer) (PP (IN from) (NP (DT some) (NNS Doc_16192988_204_225_Disease)))) (, ,) (CC and) (VP (VBP are) (ADJP (JJ common) (PP (IN in) (NP (JJ Doc_16192988_245_260_Chemical) (PRN (-LRB- -LRB-) (NP (NNP Doc_16192988_262_266_Chemical)) (-RRB- -RRB-)) (NNS abusers))))))))))))) (. .)))
16192988	2	(ROOT (S (S (VP (VBN Herein))) (, ,) (NP (PRP we)) (VP (VBP report) (SBAR (IN that) (S (NP (NP (ADJP (ADJP (JJ multiple)) (PRN (-LRB- -LRB-) (FRAG (CC but) (NP (RB not) (JJ single))) (-RRB- -RRB-))) (NNS injections)) (PP (IN of) (NP (NNS Doc_16192988_340_344_Chemical)))) (ADVP (RB significantly)) (VP (VBD increased) (NP (NNS Doc_16192988_369_383_Disease)) (PP (IN in) (NP (JJ male) (NN CD-1) (NNS mice))))))) (. .)))
16192988	3	(ROOT (S (NP (NP (DT This) (NN increase)) (PP (IN in) (NP (NNS Doc_16192988_420_434_Disease)))) (VP (VBD was) (RB not) (ADJP (JJ secondary) (PP (TO to) (NP (NN Doc_16192988_456_460_Chemical-induced) (NNS Doc_16192988_469_482_Disease))))) (. .)))
16192988	4	(ROOT (S (NP (NP (NP (NNP Analysis)) (PP (IN of) (NP (NP (NN protein) (NN expression)) (VP (VBG using) (NP (NN antibody) (NNS microarrays)))))) (CC and) (NP (JJ Western) (VBG blotting))) (VP (VBD revealed) (NP (NN differential) (NNS changes)) (PP (IN in) (NP (NNP MAP) (JJ kinase-related) (NNS pathways))) (PP (IN after) (NP (NN multiple) (CC and) (JJ single) (NN Doc_16192988_650_654_Chemical) (NNS injections)))) (. .)))
16192988	5	(ROOT (S (NP (EX There)) (VP (VBD were) (ADJP (RB statistically) (JJ significant) (PRN (-LRB- -LRB-) (S (VP (VB p) (NP (CD <) (CD 0.05)))) (-RRB- -RRB-)) (SBAR (S (VP (VBZ decreases) (PP (IN in) (NP (NNP MEK1) (, ,) (NNS Erk2p) (, ,) (NNS GSK3alpha) (, ,) (NNP 14-3-3e) (, ,) (CC and) (NNP MEK7))) (PP (IN in) (NP (NP (DT the) (NN striata)) (PP (IN of) (NP (NNS mice))))))))) (PP (IN after) (NP (NP (JJ multiple) (NNS injections)) (PP (IN of) (NP (NNS Doc_16192988_820_824_Chemical)))))) (. .)))
16192988	6	(ROOT (S (NP (NNP MEK1)) (VP (VBD was) (ADVP (RB significantly)) (VP (VBN decreased) (PP (ADVP (RB also)) (PP (IN after) (NP (NP (DT a) (JJ single) (NN injection)) (PP (IN of) (NP (NNS Doc_16192988_892_896_Chemical))))) (, ,) (CC but) (PP (TO to) (NP (DT a) (ADJP (RB much) (JJR lesser)) (NN degree)))) (PP (IN than) (IN after) (NP (NP (JJ multiple) (NNS injections)) (PP (IN of) (NP (NNS Doc_16192988_960_964_Chemical))))))) (. .)))
16192988	7	(ROOT (S (PP (IN In) (NP (DT the) (JJ frontal) (NN cortex))) (, ,) (NP (EX there)) (VP (VBD was) (NP (NP (DT a) (ADJP (RB statistically) (JJ significant)) (NN decrease)) (PP (IN in) (NP (NP (NNS GSK3alpha)) (PP (IN after) (NP (JJ multiple) (PRN (-LRB- -LRB-) (FRAG (CC but) (NP (RB not) (JJ single))) (-RRB- -RRB-)) (NNS injections))))) (PP (IN of) (NP (NNS Doc_16192988_1095_1099_Chemical))))) (. .)))
16192988	8	(ROOT (S (NP (DT These) (NNS findings)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NP (NNS alterations)) (PP (IN in) (NP (NP (NNP MAP) (JJ kinase-related) (NNS pathways)) (PP (IN in) (NP (DT the) (JJ prefronto-striatal) (NNS circuitries)))))) (VP (MD might) (VP (VB be) (VP (VBN involved) (PP (IN in) (NP (NP (DT the) (NN manifestation)) (PP (IN of) (NP (NP (NNS Doc_16192988_1252_1272_Disease)) (PP (IN in) (NP (NNS mice))))))))))))) (. .)))
16225977	0	(ROOT (NP (NP (CD Doc_16225977_0_11_Chemical) (VBN related) (NNS Doc_16225977_20_37_Disease)) (PP (IN in) (NP (DT an) (JJ adolescent) (NNS Doc_16225977_55_68_Disease))) (. .)))
16225977	1	(ROOT (S (NP (NNP Doc_16225977_70_83_Disease)) (VP (MD can) (VP (VB be) (VP (ADVP (RB effectively)) (VBN treated) (PP (IN by) (NP (NP (JJ atypical) (NNS antipsychotics)) (PP (JJ such) (IN as) (NP (NNS Doc_16225977_146_157_Chemical) (, ,) (NNS Doc_16225977_159_169_Chemical) (CC and) (NNS Doc_16225977_174_185_Chemical)))))))) (. .)))
16225977	2	(ROOT (S (ADVP (RB However)) (, ,) (NP (EX there)) (VP (VBP are) (NP (NP (CD two) (NN case) (NNS reports)) (SBAR (WHNP (WDT that)) (S (VP (VBP show) (NP (NNS Doc_16225977_233_250_Disease)) (, ,) (PP (VBG including) (NP (NP (NN motor)) (CC and) (NP (JJ phonic) (NNS variants)))) (, ,) (S (VP (VBG occurring) (PP (IN during) (NP (NN treatment))) (PP (IN with) (NP (NNS Doc_16225977_321_331_Chemical) (CC or) (NNS Doc_16225977_335_344_Chemical)))))))))) (. .)))
16225977	3	(ROOT (S (NP (PRP We)) (VP (VBP present) (NP (NP (DT a) (JJ 15-year-old) (NN girl) (NNS Doc_16225977_376_389_Disease)) (SBAR (WHNP (WP who)) (S (VP (VBD developed) (NP (JJ frequent) (NNS Doc_16225977_413_447_Disease)) (PP (IN after) (NP (NP (CD 5) (NNS months)) (PP (IN of) (NP (NP (JJ Doc_16225977_466_477_Chemical) (NN treatment)) (PRN (-LRB- -LRB-) (NP (NP (CD 1000) (NN mg)) (PP (IN per) (NP (NN day)))) (-RRB- -RRB-))))))))))) (. .)))
16225977	4	(ROOT (S (NP (DT The) (NNS Doc_16225977_511_528_Disease)) (VP (VBD resolved) (ADVP (RB completely)) (SBAR (IN after) (S (NP (PRP we)) (VP (VBD reduced) (NP (NP (DT the) (NN dose)) (PP (IN of) (NP (NP (NNS Doc_16225977_578_589_Chemical)) (ADVP (RB down) (PP (TO to) (NP (NP (CD 800) (NN mg)) (PP (IN per) (NP (NN day))))))))))))) (. .)))
16225977	5	(ROOT (S (ADVP (RB However)) (, ,) (NP (PRP$ her) (NNS Doc_16225977_627_636_Disease)) (VP (VBD recurred) (PP (IN after) (NP (DT the) (NN dose) (NN reduction)))) (. .)))
16225977	6	(ROOT (S (NP (PRP We)) (ADVP (RB then)) (VP (VBD placed) (NP (PRP her)) (PP (IN on) (NP (DT an) (JJ additional) (CD 100) (NNS mg))) (PP (IN per) (NP (NP (NN day)) (PP (IN of) (NP (NNS Doc_16225977_726_736_Chemical)))))) (. .)))
16225977	7	(ROOT (S (NP (PRP She)) (VP (VP (VBZ has) (VP (VBN been) (PP (IN in) (NP (JJ complete) (NN remission))) (PP (IN under) (NP (NP (DT the) (VBN combined) (NNS medications)) (PP (IN for) (NP (QP (JJR more) (IN than) (CD one)) (NN year))))))) (CC and) (VP (VBZ maintains) (NP (DT a) (JJ fair) (NN role) (NN function)))) (. .)))
16225977	8	(ROOT (S (NP (NP (DT No) (JJR more) (NNS Doc_16225977_871_888_Disease)) (CC or) (NP (JJ other) (NN side) (NNS effects))) (VP (VBP have) (VP (VBN been) (VP (VBN reported)))) (. .)))
16225977	9	(ROOT (S (ADVP (RB Together) (PP (IN with) (NP (ADJP (RB previously) (VBN reported)) (NNS cases)))) (, ,) (NP (PRP$ our) (NN patient)) (VP (VBZ suggests) (SBAR (IN that) (S (NP (NNS Doc_16225977_998_1015_Disease)) (VP (MD might) (VP (VB occur) (PP (IN in) (NP (JJ certain) (JJ vulnerable) (NNS individuals))) (PP (IN during) (NP (NN treatment))) (PP (IN with) (NP (NP (JJ atypical) (NNS antipsychotics)) (PP (JJ such) (IN as) (NP (NNS Doc_16225977_1116_1126_Chemical) (, ,) (NNS Doc_16225977_1128_1137_Chemical) (, ,) (CC or) (NNS Doc_16225977_1142_1153_Chemical)))))))))) (. .)))
1628552	0	(ROOT (NP (NP (NP (JJ Doc_1628552_0_11_Chemical) (JJ related) (JJ complete) (NNS Doc_1628552_29_40_Disease)) (PP (IN with) (NP (NNS Doc_1628552_46_55_Disease)))) (: :) (NP (NN case) (NN report)) (. .)))
1628552	1	(ROOT (S (NP (NP (DT A) (JJ 27-year) (ADJP (JJ old) (JJ African)) (NN woman)) (PP (IN with) (NP (NP (NN history)) (PP (IN of) (NP (JJ regular) (JJ Doc_1628552_122_133_Chemical) (NN ingestion)))))) (VP (VBD presented) (PP (IN with) (NP (NP (JJ progressive) (NNS Doc_1628552_171_194_Disease)) (, ,) (NP (NP (JJ easy) (NNS Doc_1628552_201_214_Disease)) (, ,) (NP (NN dyspnoea)) (, ,) (NP (NP (NNS Doc_1628552_226_235_Disease)) (VP (VBG progressing) (PP (TO to) (NP (NNS Doc_1628552_251_267_Disease))))))))) (. .)))
1628552	2	(ROOT (S (S (NP (JJ Ophthalmological) (NN assessment)) (VP (VBD revealed) (NP (NP (NNS features)) (PP (IN of) (NP (JJ Doc_1628552_318_329_Chemical) (NNS Doc_1628552_330_341_Disease)))))) (, ,) (NP (JJ cardiac) (NN assessment)) (VP (VBD revealed) (NP (NP (NNS features)) (PP (IN of) (NP (NP (NNS Doc_1628552_383_396_Disease)) (CC and) (NP (DT a) (JJ complete) (NNS Doc_1628552_412_423_Disease))))) (PP (IN with) (NP (JJ Doc_1628552_429_454_Disease) (NN pattern)))) (. .)))
1628552	3	(ROOT (S (NP (DT The) (NNS Doc_1628552_468_479_Disease)) (VP (VBD was) (VP (VBN treated) (PP (IN by) (NP (NP (NN pacemaker) (NN insertion)) (CC and) (NP (NP (DT the) (NNS Doc_1628552_523_536_Disease)) (VP (VBN resolved) (ADVP (RB spontaneously)) (PP (VBG following) (NP (JJ Doc_1628552_570_581_Chemical) (NN discontinuation))))))))) (. .)))
1628552	4	(ROOT (S (NP (PRP She)) (ADVP (RB however)) (VP (VBZ remains) (NP (NNS Doc_1628552_619_624_Disease))) (. .)))
1636026	0	(ROOT (NP (NP (NNPS Effects)) (PP (IN of) (NP (NNS Doc_1636026_11_19_Chemical))) (PP (IN on) (NP (DT the) (JJ isolated) (JJ perfused) (NN rat) (NN kidney))) (. .)))
1636026	1	(ROOT (S (SBAR (IN Although) (S (NP (NNS Doc_1636026_66_74_Chemical)) (VP (VBZ has) (VP (VBN been) (VP (VBN associated) (PP (IN with) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (NP (NNS Doc_1636026_119_138_Disease)) (PP (IN in) (NP (QP (JJR greater) (IN than) (CD 100)) (NNS subjects)))))))))))) (, ,) (NP (NP (DT the) (NN mechanism)) (PP (IN of) (NP (NN damage)))) (VP (VBZ remains) (ADJP (JJ unclear))) (. .)))
1636026	2	(ROOT (S (NP (NP (DT The) (JJ direct) (JJ nephrotoxic) (NNS effects)) (PP (IN of) (NP (NP (DT a) (JJ single) (NN dose)) (PP (IN of) (NP (NP (CD 15) (NN mg)) (PP (IN of) (NP (NNS Doc_1636026_270_278_Chemical)))))))) (VP (VBD were) (VP (VBN compared) (PP (IN in) (NP (NP (DT the) (VBG recirculating) (JJ isolated) (NN rat) (NN kidney)) (VP (VBN perfused) (PP (IN with) (NP (JJ cell-free) (NN buffer))) (PP (IN with) (CC or) (IN without) (NP (NP (DT the) (NN addition)) (PP (IN of) (NP (NP (CD 5) (NN mg/dL)) (PP (IN of) (NP (NNS Doc_1636026_408_417_Chemical)))))))))))) (. .)))
1636026	3	(ROOT (S (NP (EX There)) (VP (VBD were) (NP (NP (NP (DT no) (JJ significant) (NNS differences)) (PP (IN in) (NP (JJ renal) (JJ Doc_1636026_466_472_Chemical) (NN excretion)))) (, ,) (NP (JJ Doc_1636026_484_490_Chemical) (NN consumption)) (, ,) (CC or) (NP (NP (JJ urinary) (NN flow) (NNS rates)) (PP (IN in) (NP (NP (NNS kidneys)) (VP (VBN perfused) (PP (IN with) (NP (NNS Doc_1636026_551_559_Chemical))) (PP (VBN compared) (PP (IN with) (NP (DT the) (JJ drug-free) (NN control) (NNS groups)))))))))) (. .)))
1636026	4	(ROOT (S (S (PP (IN In) (NP (NN contrast))) (, ,) (NP (NP (DT a) (JJ significant) (NN decline)) (PP (IN in) (NP (NN glomerular) (NN filtration) (NN rate)))) (VP (VBD was) (VP (VBN found) (PP (IN after) (NP (NP (DT the) (NN introduction)) (PP (IN of) (NP (NNS Doc_1636026_705_713_Chemical))))) (PP (TO to) (NP (NP (DT the) (NN kidney)) (VP (VBN perfused) (PP (IN with) (NP (NNS Doc_1636026_742_751_Chemical))))))))) (: ;) (S (NP (DT no) (NNS changes)) (VP (VBD were) (VP (VBN found) (PP (IN with) (NP (NP (NNS Doc_1636026_780_788_Chemical)) (PP (IN in) (NP (NP (DT the) (NN absence)) (PP (IN of) (NP (NNS Doc_1636026_807_816_Chemical)))))))))) (. .)))
1636026	5	(ROOT (S (NP (NP (DT A) (JJ significant) (NN decrease)) (PP (IN in) (NP (NP (DT the) (JJ baseline) (NN excretion) (NN rate)) (PP (IN of) (NP (NNS Doc_1636026_875_884_Chemical)))))) (VP (VBD was) (VP (VBN found) (PP (IN in) (NP (NP (NNS rats)) (VP (VBN given) (NP (NNS Doc_1636026_909_917_Chemical)) (, ,) (PP (VBN compared) (PP (IN with) (NP (JJ drug-free) (NNS controls))))))))) (. .)))
1636026	6	(ROOT (S (ADVP (RB However)) (, ,) (NP (NP (DT the) (JJ fractional) (NN excretion)) (PP (IN of) (NP (NNS Doc_1636026_990_999_Chemical)))) (VP (VBD was) (ADJP (JJ unchanged) (PP (IN between) (NP (NP (DT the) (NNS groups)) (PP (IN over) (NP (DT the) (JJ experimental) (NN period))))))) (. .)))
1636026	7	(ROOT (S (PP (IN In) (NP (NN summary))) (, ,) (NP (NNS Doc_1636026_1075_1083_Chemical)) (VP (VBZ causes) (NP (NP (NNS Doc_1636026_1091_1123_Disease)) (, ,) (ADJP (RBS most) (JJ likely))) (PP (IN by) (S (ADVP (RB directly)) (VP (VBG altering) (NP (NP (DT the) (JJ intrarenal) (NN distribution)) (PP (IN of) (NP (NNS Doc_1636026_1189_1198_Chemical)))))))) (. .)))
16364460	0	(ROOT (S (NP (NP (NNP Microinjection)) (PP (IN of) (NP (NP (NNS Doc_16364460_18_28_Chemical)) (PP (IN into) (NP (NP (DT the) (NN CA1) (NN region)) (PP (IN of) (NP (NNS hippocampus)))))))) (VP (VBZ improves) (NP (NP (NN Doc_16364460_73_84_Chemical-induced) (NNS Doc_16364460_93_100_Disease)) (PP (IN in) (NP (JJ adult) (JJ male) (NNS rats))))) (. .)))
16364460	1	(ROOT (S (NP (NP (NP (NP (DT The) (NN effect)) (PP (IN of) (NP (NP (NP (NNS Doc_16364460_135_145_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 5-HT2) (NN antagonist)) (-RRB- -RRB-))) (PP (IN on) (NP (NP (NNS Doc_16364460_168_179_Chemical)) (PRN (-LRB- -LRB-) (NP (JJ muscarinic) (JJ cholinergic) (NN antagonist)) (-RRB- -RRB-))))))) (: -) (NP (NP (JJ induced) (NNS Doc_16364460_224_231_Disease)) (PP (IN in) (NP (NNP Morris) (NN water) (NN maze))))) (PRN (-LRB- -LRB-) (NP (NNP MWM)) (-RRB- -RRB-))) (VP (VBD was) (VP (VBN investigated))) (. .)))
16364460	2	(ROOT (S (NP (NNS Rats)) (VP (VBD were) (VP (VP (VBN divided) (PP (IN into) (NP (CD eight) (NNS groups)))) (CC and) (VP (ADVP (RB bilaterally)) (VBN cannulated) (PP (IN into) (NP (NP (CD CA1) (NN region)) (PP (IN of) (NP (DT the) (NNS hippocampus)))))))) (. .)))
16364460	3	(ROOT (S (ADVP (NP (CD One) (NN week)) (RB later)) (, ,) (NP (PRP they)) (VP (VBD received) (ADVP (RB repeatedly)) (NP (NP (NP (NP (NNS vehicles)) (PRN (-LRB- -LRB-) (NP (NP (NN saline)) (, ,) (NP (NNS Doc_16364460_435_439_Chemical)) (, ,) (NP (JJ saline) (JJ +) (NNS Doc_16364460_448_452_Chemical))) (-RRB- -RRB-))) (, ,) (NP (NP (NNS Doc_16364460_455_466_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 2) (NNS microg/0)) (NP (NP (CD .5) (JJ microl) (NN saline/side)) (: ;) (NP (NP (CD 30) (NN min)) (PP (IN before) (NP (NN training))))) (-RRB- -RRB-))) (, ,) (NP (NP (NNS Doc_16364460_526_536_Chemical)) (PRN (-LRB- -LRB-) (FRAG (NP (NP (CD 2) (, ,) (CD 4) (CC and) (CD 8) (NNS microg/0)) (NP (CD .5) (JJ microl) (NNS Doc_16364460_567_571_Chemical))) (: /) (NP (NP (NN side)) (: ;) (NP (NP (CD 20) (NN min)) (PP (IN before) (NP (NN training)))))) (-RRB- -RRB-))) (CC and) (NP (NNS Doc_16364460_606_617_Chemical))) (PRN (-LRB- -LRB-) (NP (CD 2) (NNS microg/0)) (NP (NP (CD .5) (NN microl)) (: ;) (NP (NP (CD 30) (NN min)) (PP (IN before) (NP (JJ Doc_16364460_654_664_Chemical) (NN injection))))) (-RRB- -RRB-))) (NP (NP (JJ +) (NNS Doc_16364460_676_686_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (CD 4) (NNS microg/0)) (NP (CD .5) (JJ microl) (NNS Doc_16364460_708_712_Chemical))) (-RRB- -RRB-))) (PP (IN through) (NP (NN cannulae))) (NP (DT each) (NN day))) (. .)))
16364460	4	(ROOT (S (NP (NNS Animals)) (VP (VBD were) (VP (VBN tested) (PP (IN for) (NP (NP (CD four) (JJ consecutive) (NNS days)) (PRN (-LRB- -LRB-) (NP (CD 4) (NN trial/day)) (-RRB- -RRB-)))) (PP (IN in) (NP (NP (NNP MWM)) (SBAR (WHPP (IN during) (WHNP (WDT which))) (S (NP (NP (DT the) (NN position)) (PP (IN of) (NP (JJ hidden) (NN platform)))) (VP (VBD was) (ADJP (JJ unchanged))))))))) (. .)))
16364460	5	(ROOT (S (PP (IN In) (NP (DT the) (JJ fifth) (NN day))) (, ,) (NP (DT the) (NN platform)) (VP (VBD was) (VP (VBN elevated) (PP (IN above) (NP (NP (DT the) (NN water) (NN surface)) (PP (IN in) (NP (DT another) (NN position))))) (S (VP (TO to) (VP (VB evaluate) (NP (NP (DT the) (NN function)) (PP (IN of) (NP (NN motor) (, ,) (NN motivational) (CC and) (JJ visual) (NNS systems))))))))) (. .)))
16364460	6	(ROOT (S (NP (DT The) (NNS results)) (VP (VP (VBD showed) (NP (DT a) (JJ significant) (NN increase)) (PP (IN in) (NP (NN escape) (NNS latencies)))) (CC and) (VP (VBD traveled) (NP (NNS distances)) (S (VP (TO to) (VP (VB find) (NP (NP (NN platform)) (PP (IN in) (NP (NN Doc_16364460_1129_1140_Chemical-treated) (NN group)))) (PP (IN as) (PP (VBN compared) (PP (TO to) (NP (JJ saline) (NN group)))))))))) (. .)))
16364460	7	(ROOT (S (NP (NP (JJ Doc_16364460_1184_1194_Chemical-treated) (NNS rats)) (PRN (-LRB- -LRB-) (NP (NP (CD 4) (NNS microg/0)) (NP (CD .5) (NN microl/side))) (-RRB- -RRB-))) (VP (VBD showed) (NP (DT a) (JJ significant) (NN decrease)) (PP (IN in) (NP (DT the) (JJ mentioned) (NNS parameters) (IN as))) (PP (VBN compared) (PP (TO to) (NP (NN Doc_16364460_1308_1312_Chemical-treated) (NN group))))) (. .)))
16364460	8	(ROOT (S (ADVP (RB However)) (, ,) (NP (NP (NNS Doc_16364460_1337_1348_Chemical)) (CC and) (NP (JJ Doc_16364460_1353_1363_Chemical) (NN co-administration))) (VP (VP (VBD resulted) (PP (IN in) (NP (DT a) (JJ significant) (NN decrease))) (PP (IN in) (NP (NN escape) (NNS latencies)))) (CC and) (VP (VBD traveled) (NP (NNS distances)) (PP (IN as)) (PP (VBN compared) (PP (TO to) (NP (DT the) (NN Doc_16364460_1479_1490_Chemical-treated) (NNS rats)))))) (. .)))
16364460	9	(ROOT (S (NP (PRP$ Our) (NNS findings)) (VP (VBP show) (SBAR (IN that) (S (NP (NP (NN microinjection)) (PP (IN of) (NP (NP (NNS Doc_16364460_1546_1556_Chemical)) (PP (IN into) (NP (NP (DT the) (NN CA1) (NN region)) (PP (IN of) (NP (DT the) (NNS hippocampus)))))))) (VP (VBZ improves) (NP (DT the) (NN Doc_16364460_1609_1620_Chemical-induced) (NNS Doc_16364460_1629_1636_Disease)))))) (. .)))
16418614	0	(ROOT (NP (NP (JJ Doc_16418614_0_3_Chemical-associated) (NNS Doc_16418614_15_25_Disease)) (PP (IN in) (NP (DT a) (NN girl))) (PP (IN with) (NP (NNS Doc_16418614_41_56_Disease) (CC and) (NNS Doc_16418614_61_76_Disease))) (. .)))
16418614	1	(ROOT (S (NP (JJ Palpable) (NNS Doc_16418614_87_94_Disease)) (VP (VP (VBZ is) (NP (NP (DT a) (VBG concerning) (JJ clinical) (NN finding)) (PP (IN in) (NP (JJ pediatric) (NNS patients))))) (CC and) (VP (MD can) (VP (VB have) (NP (NP (JJ many) (NNS causes)) (, ,) (PP (VBG including) (NP (JJ infectious) (CC and) (JJ autoimmune) (NNS processes))))))) (. .)))
16418614	2	(ROOT (S (NP (NP (DT A) (JJ rare) (NN cause)) (, ,) (NP (JJ drug-induced) (NNS Doc_16418614_250_260_Disease)) (, ,)) (VP (MD may) (VP (VB result) (PP (IN from) (NP (NP (DT the) (NN production)) (PP (IN of) (NP (NP (NP (JJ antineutrophil) (JJ cytoplasmic) (NNS antibodies)) (PRN (-LRB- -LRB-) (NP (NNP ANCAs)) (-RRB- -RRB-))) (PP (IN in) (NP (NN response))))))) (PP (TO to) (NP (DT a) (NN medication))))) (. .)))
16418614	3	(ROOT (S (NP (PRP We)) (VP (VBP report) (NP (NP (DT a) (NN girl)) (PP (IN with) (NP (NNS Doc_16418614_393_408_Disease) (CC and) (NNS Doc_16418614_413_428_Disease))) (SBAR (WHNP (WP who)) (S (VP (VBN presented) (PP (IN with) (NP (JJ palpable) (NNS Doc_16418614_457_473_Disease)))))))) (. .)))
16418614	4	(ROOT (S (NP (NP (DT The) (NN diagnosis)) (PP (IN of) (NP (NP (NNS Doc_16418614_492_508_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_16418614_510_513_Chemical)) (-RRB- -RRB-)) (: -) (NP (JJ associated) (NNS Doc_16418614_526_536_Disease))))) (VP (VBD was) (VP (VBN made) (PP (IN by) (NP (NP (NP (NN observation)) (PP (IN of) (NP (JJ consistent) (JJ clinical) (NNS features)))) (, ,) (NP (NP (DT the) (NN detection)) (PP (IN of) (NP (JJ elevated) (NNP ANA) (CC and) (NNP ANCA))) (PP (IN in) (NP (DT the) (NN blood)))) (, ,) (CC and) (NP (NP (DT the) (ADJP (JJ observed)) (JJ clinical) (NN resolution)) (PP (IN of) (NP (NP (NNS symptoms)) (PP (VBG following) (NP (NP (NN withdrawal)) (PP (IN of) (NP (NNS Doc_16418614_720_723_Chemical)))))))))))) (. .)))
16418614	5	(ROOT (S (S (NP (NP (JJ Subsequent) (NN treatment)) (PP (IN of) (NP (NP (JJ persistent) (NNS Doc_16418614_760_775_Disease)) (PP (IN with) (NP (NN radioablation)))))) (VP (VBD did) (RB not) (VP (VB result) (PP (IN in) (NP (NP (DT an) (NN exacerbation)) (PP (IN of) (NP (DT the) (NNS Doc_16418614_836_846_Disease)))))))) (, ,) (NP (DT a) (NN complication)) (VP (VBD described) (PP (IN in) (NP (JJ prior) (NN case) (NNS reports)))) (. .)))
16428827	0	(ROOT (S (NP (NNP Doc_16428827_0_8_Chemical)) (VP (VP (VBZ activates) (NP (JJ Doc_16428827_19_26_Chemical) (NN acetyltransferase)) (PP (IN from) (NP (JJ MC-IXC) (NNS cells)))) (CC and) (VP (VBZ improves) (NP (JJ drug-induced) (NNS Doc_16428827_89_96_Disease)))) (. .)))
16428827	1	(ROOT (S (NP (NP (DT The) (JJ Doc_16428827_102_109_Chemical) (ADJP (JJ acetyltransferase)) (PRN (-LRB- -LRB-) (NP (NNP ChAT)) (-RRB- -RRB-)) (NN activator)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ enhances) (NP (NP (JJ cholinergic) (NN transmission)) (PP (IN via) (NP (NP (DT an) (NN augmentation)) (PP (IN of) (NP (NP (DT the) (JJ enzymatic) (NN production)) (PP (IN of) (NP (NP (NNS Doc_16428827_237_250_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_16428827_252_255_Chemical)) (-RRB- -RRB-)))))))))))) (, ,)) (VP (VBZ is) (NP (NP (DT an) (JJ important) (NN factor)) (PP (IN in) (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (NP (NNS Doc_16428827_301_320_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_16428827_322_324_Disease)) (-RRB- -RRB-)))))))) (. .)))
16428827	2	(ROOT (S (NP (NP (JJ Methanolic) (NNS extracts)) (PP (IN from) (NP (NNP Pueraria) (NNP thunbergiana)))) (VP (VBD exhibited) (NP (NP (DT an) (NN activation) (NN effect)) (PRN (-LRB- -LRB-) (NP (CD 46) (NN %)) (-RRB- -RRB-))) (PP (IN on) (NP (NNP ChAT))) (PP (IN in) (ADJP (NN vitro)))) (. .)))
16428827	3	(ROOT (S (S (VP (VBG Via) (NP (NP (DT the) (JJ sequential) (NN isolation)) (PP (IN of) (NP (NNP Pueraria) (NNP thunbergiana)))))) (, ,) (NP (DT the) (JJ active) (NN component)) (VP (VBD was) (ADVP (RB ultimately)) (VP (VBN identified) (PP (IN as) (NP (NP (NNS Doc_16428827_534_542_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_16428827_544_569_Chemical)) (-RRB- -RRB-)))))) (. .)))
16428827	4	(ROOT (S (SBAR (IN In) (NN order) (S (VP (TO to) (VP (VB investigate) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NNS Doc_16428827_611_619_Chemical)))) (PP (IN from) (NP (NP (NNP Pueraria) (NNP thunbergiana)) (PP (IN on) (NP (NN Doc_16428827_650_661_Chemical-induced) (NNS Doc_16428827_670_704_Disease))))))))) (, ,) (NP (PRP we)) (VP (VBD conducted) (NP (NP (DT a) (NN series)) (PP (IN of) (PP (IN in) (NP (NN vivo) (NNS tests)))))) (. .)))
16428827	5	(ROOT (S (NP (NP (NNP Administration)) (PP (IN of) (NP (NP (NP (NNS Doc_16428827_764_772_Chemical)) (-LRB- -LRB-) (NP (CD 4.5) (JJ mg/kg) (NN body) (NN weight)) (-RRB- -RRB-)) (PP (TO to) (NP (NNS mice)))))) (VP (VBD was) (VP (VBN shown) (ADVP (RB significantly)) (S (VP (TO to) (VP (VB reverse) (NP (NN Doc_16428827_840_851_Chemical-induced) (NNS Doc_16428827_860_867_Disease))))) (, ,) (PP (VBG according) (PP (TO to) (NP (NP (DT the) (NNS results)) (PP (IN of) (NP (DT a) (JJ Y-maze) (NN test)))))))) (. .)))
16428827	6	(ROOT (S (NP (NP (NNS Injections)) (PP (IN of) (NP (NP (NNS Doc_16428827_926_937_Chemical)) (PP (IN into) (NP (NNS mice)))))) (VP (VBD resulted) (PP (IN in) (NP (NP (VBN impaired) (NN performance)) (PP (IN on) (NP (NP (JJ Y-maze) (NNS tests)) (PRN (-LRB- -LRB-) (NP (NP (DT a) (CD 37) (NN %) (NN decreases)) (PP (IN in) (NP (NN alternation) (NN behavior)))) (-RRB- -RRB-))))))) (. .)))
16428827	7	(ROOT (S (PP (IN By) (NP (NP (NN way)) (PP (IN of) (NP (NN contrast))))) (, ,) (NP (NP (NNS mice)) (VP (VBN treated) (PP (IN with) (NP (NP (NNS Doc_16428827_1078_1086_Chemical)) (ADVP (RB prior) (PP (TO to) (NP (DT the) (JJ Doc_16428827_1100_1111_Chemical) (NNS injections)))))))) (VP (VBD were) (ADVP (RB noticeably)) (VP (VBN protected) (PP (IN from) (NP (NP (DT this) (NN performance) (NN impairment)) (PRN (-LRB- -LRB-) (NP (NP (DT an) (NP (ADVP (RB approximately) (NP (CD 12) (NN %))) (CD -21) (NN %)) (NN decrease)) (PP (IN in) (NP (NN alternation) (NN behavior)))) (-RRB- -RRB-)))))) (. .)))
16428827	8	(ROOT (S (NP (DT These) (NNS results)) (VP (VBP indicate) (SBAR (SBAR (IN that) (S (NP (NNS Doc_16428827_1271_1279_Chemical)) (VP (MD might) (VP (VB play) (NP (NP (DT a) (NN role)) (PP (IN in) (NP (JJ Doc_16428827_1301_1314_Chemical) (NNS biosynthesis)))) (PP (IN as) (NP (DT a) (NNP ChAT) (NN activator))))))) (, ,) (CC and) (SBAR (IN that) (S (NP (PRP it)) (ADVP (RB also)) (VP (VBZ ameliorates) (NP (NN Doc_16428827_1378_1389_Chemical-induced) (NNS Doc_16428827_1398_1405_Disease))))))) (. .)))
16471092	0	(ROOT (S (NP (NP (JJ Urinary) (NNS symptoms)) (CC and) (NP (NP (NN quality)) (PP (IN of) (NP (NN life))))) (VP (VBZ changes) (PP (IN in) (NP (NNP Thai) (NNS women))) (PP (IN with) (NP (NP (NNS Doc_16471092_64_82_Disease)) (PP (IN after) (NP (JJ Doc_16471092_89_100_Chemical) (NN treatment)))))) (. .)))
16471092	1	(ROOT (S (VP (TO To) (VP (VB study) (NP (NP (DT the) (JJ urinary) (NNS symptoms)) (CC and) (NP (NP (NN quality)) (PP (IN of) (NP (NP (NN life) (NNS changes)) (PP (IN in) (NP (NNP Thai) (NNS women))))))) (PP (IN with) (NP (NP (NNS Doc_16471092_201_219_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_16471092_221_224_Disease)) (-RRB- -RRB-)))) (PP (IN after) (NP (JJ Doc_16471092_232_243_Chemical) (NN treatment))))) (. .)))
16471092	2	(ROOT (NP (NP (NNP MATERIAL) (CC AND) (NNP METHOD)) (: :) (S (NP (NP (NNP Thirty) (NNS women)) (PRN (-LRB- -LRB-) (VP (VBN aged) (NP (CD 30-77) (NNS years))) (-RRB- -RRB-))) (VP (VBD diagnosed) (SBAR (IN as) (S (S (VP (VBG having) (NP (NP (NNS Doc_16471092_328_331_Disease)) (PP (IN at) (NP (NP (DT the) (NNP Gynecology) (NNP Clinic)) (, ,) (NP (NP (NNP King) (NNP Chulalongkorn) (NNP Memorial) (NNP Hospital)) (PP (IN from) (NP (NNP January))))))) (PP (TO to) (NP (NNP April) (CD 2004))))) (VP (VBD were) (VP (VBN included) (PP (IN in) (NP (DT the) (JJ present) (NN study))))))))) (. .)))
16471092	3	(ROOT (S (S (VP (VBG Doc_16471092_458_469_Chemical) (NP (CD 2) (NN mg)))) (, ,) (NP (RB twice) (JJ daily)) (VP (VBD was) (VP (VBN given))) (. .)))
16471092	4	(ROOT (S (PP (IN After) (NP (CD 8) (NNS weeks) (NN treatment))) (, ,) (NP (NP (NNS changes)) (PP (IN in) (NP (NP (JJ micturition) (NN diary) (NNS variables)) (CC and) (NP (NN tolerability))))) (VP (VBD were) (VP (VBN determined))) (. .)))
16471092	5	(ROOT (S (NP (NP (JJ Short) (NN form) (CD 36)) (PRN (-LRB- -LRB-) (NP (NNP SF36)) (-RRB- -RRB-))) (VP (VBZ questionaires) (SBAR (S (-LRB- -LRB-) (NP (NNP Thai) (NN version)) (-RRB- -RRB-) (VP (VBD were) (VP (VBN given) (PP (IN before) (CC and) (IN after) (NP (NP (CD 8) (NNS weeks)) (PP (IN of) (NP (NN treatment)))))))))) (. .)))
16471092	6	(ROOT (S (PP (IN At) (NP (CD 8) (NNS weeks))) (, ,) (NP (NP (DT all) (NN micturition)) (PP (IN per) (NP (NN day)))) (VP (VBD decreased) (SBAR (FRAG (PP (IN from) (NP (CD 16)) (. .)) (NP (NP (CD 7) (JJ +) (NNS /)) (: -) (NP (NP (NP (NP (CD 5)) (. .) (NP (CD 3) (TO to) (CD 6)) (. .)) (ADJP (CD 7) (JJ +) (NN /))) (: -) (NP (NP (QP (CD 2.4) (NNS times))) (PP (IN per) (NP (NN day))))))))) (. .)))
16471092	7	(ROOT (NP (NP (NP (DT The) (NN number)) (PP (IN of) (NP (NP (JJ Doc_16471092_817_825_Disease) (NNS episodes)) (VP (VBN decreased) (PP (IN from) (NP (NP (QP (CD 5.4) (CD +)) (NNS /)) (PRN (: -) (NP (QP (CD 4.2) (TO to) (CD 1.1)) (NNS +)) (: /)))))))) (: -) (NP (NP (CD 1.0) (NNS times)) (PP (IN per) (NP (NN night)))) (. .)))
16471092	8	(ROOT (S (NP (DT The) (ADJP (RBS most) (JJ common)) (NN side) (NN effect)) (VP (VBD was) (NP (NP (NNS Doc_16471092_926_935_Disease)) (PP (IN in) (NP (NP (NP (CD 5) (NNS cases)) (PRN (-LRB- -LRB-) (NP (CD 16.7) (NN %)) (-RRB- -RRB-))) (PP (IN with) (NP (NP (CD 2) (NNS cases)) (VP (VBG reporting) (NP (NP (DT a) (JJ moderate) (NN degree)) (CC and) (NP (CD 1) (NN case))) (PP (IN with) (NP (JJ severe) (NN degree)))))))))) (. .)))
16471092	9	(ROOT (S (NP (NP (RB Only) (CD one) (NN case)) (PRN (-LRB- -LRB-) (NP (CD 3.3) (NN %)) (-RRB- -RRB-))) (VP (VBD withdrew) (PP (IN from) (NP (NP (DT the) (JJ present) (NN study)) (ADJP (JJ due) (PP (TO to) (NP (DT a) (JJ severe) (NNS Doc_16471092_1096_1105_Disease))))))) (. .)))
16471092	10	(ROOT (S (S (NP (DT The) (NN SF-36) (NNS scores)) (VP (VBD changed) (ADVP (RB significantly)) (PP (IN in) (NP (NP (DT the) (NNS domains)) (PP (IN of) (NP (JJ physical) (NN functioning))))))) (, ,) (NP (NN role)) (VP (VBP function) (NP (JJ emotional) (, ,) (JJ social) (NN function) (CC and) (JJ mental) (NN heath))) (. .)))
16471092	11	(ROOT (S (S (NP (NNP Doc_16471092_1257_1268_Chemical)) (VP (VBD was) (ADJP (RB well) (JJ tolerated)))) (CC and) (S (NP (PRP$ its) (NNS effects)) (VP (VBD improved) (NP (NP (DT the) (NN quality)) (PP (IN of) (NP (NN life)))) (PP (IN in) (NP (NNP Thai) (NNS women))) (PP (IN with) (NP (NNS Doc_16471092_1352_1355_Disease))))) (. .)))
16563323	0	(ROOT (S (NP (JJ Doc_16563323_0_12_Chemical) (NN pretreatment)) (VP (VBZ reduces) (NP (NNS Doc_16563323_34_43_Disease)) (PP (IN after) (NP (NNS Doc_16563323_50_59_Chemical)))) (. .)))
16563323	1	(ROOT (FRAG (NP (NNP STUDY) (NNP OBJECTIVE)) (: :) (S (NP (NP (DT The) (NN aim)) (PP (IN of) (NP (DT the) (NN study)))) (VP (VBD was) (S (VP (TO to) (VP (VB compare) (NP (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (ADJP (JJ pretreatment) (PP (IN with) (NP (NNP Doc_16563323_146_158_Chemical) (CD 1)))) (NN microg/kg)))) (CC and) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (NN gender))))) (PP (IN on) (NP (NP (DT the) (NN incidence)) (PP (IN of) (NP (NNS Doc_16563323_216_225_Disease))))) (PP (IN after) (NP (NP (NN anesthesia) (NN induction)) (PP (IN with) (NP (NNS Doc_16563323_258_267_Chemical)))))))))) (. .)))
16563323	2	(ROOT (S (NP (DT This)) (VP (VBD was) (NP (DT a) (JJ randomized) (, ,) (JJ double-blind) (NN study))) (. .)))
16563323	3	(ROOT (S (NP (DT The) (NN study)) (VP (VBD was) (VP (VBN conducted) (PP (IN at) (NP (DT a) (NN university) (NN hospital))))) (. .)))
16563323	4	(ROOT (S (NP (CD Sixty) (NNS patients)) (VP (VBD were) (VP (VBN pretreated) (PP (IN in) (NP (NP (DT a) (JJ randomized) (JJ double-blinded) (NN fashion)) (PP (IN with) (NP (QP (CD Doc_16563323_464_476_Chemical) (CD 1)) (NN microg/kg) (CC or) (NN placebo))))))) (. .)))
16563323	5	(ROOT (S (PP (NP (CD Two) (NNS minutes)) (IN after) (NP (NP (NNS Doc_16563323_519_531_Chemical)) (CC or) (NP (NN placebo) (NN injection)))) (, ,) (NP (JJ Doc_16563323_554_563_Chemical) (CD 0.3) (NN mg/kg)) (VP (VBD was) (VP (VBN given))) (. .)))
16563323	6	(ROOT (S (NP (NNP Doc_16563323_599_608_Disease)) (VP (VBD was) (VP (VBN recorded) (PP (IN with) (NP (NP (DT a) (NN scale)) (PP (IN of) (NP (CD 0) (TO to) (CD 3))))))) (. .)))
16563323	7	(ROOT (S (NP (NP (DT The) (NN grade)) (PP (IN of) (NP (NP (NP (NN sedation)) (-LRB- -LRB-) (NP (NN none)) (, ,) (ADJP (JJ mild) (, ,) (JJ moderate) (, ,) (JJ severe)) (-RRB- -RRB-)) (, ,) (NP (NP (NNS Doc_16563323_700_706_Disease)) (, ,) (NP (NNS Doc_16563323_708_716_Disease)) (, ,)) (CC and) (NP (NNS Doc_16563323_722_727_Disease))))) (VP (VBD were) (VP (VBN recorded) (PP (IN after) (NP (NP (NN injection)) (PP (IN of) (NP (DT both) (NNS drugs))))))) (. .)))
16563323	8	(ROOT (FRAG (NP (NNP MAIN) (NNP RESULTS)) (: :) (S (NP (NP (DT The) (NN incidence)) (PP (IN of) (NP (NNS Doc_16563323_804_813_Disease)))) (VP (VBD was) (ADJP (ADJP (RB significantly) (JJR lower) (PP (IN in) (NP (NP (DT the) (JJ Doc_16563323_845_857_Chemical) (NN group)) (PRN (-LRB- -LRB-) (NP (CD 6.7) (NN %)) (-RRB- -RRB-))))) (PP (IN than) (PP (IN in) (NP (NP (NP (DT the) (NN placebo) (NN group)) (PRN (-LRB- -LRB-) (NP (CD 70) (NN %)) (-RRB- -RRB-))) (PRN (-LRB- -LRB-) (NP (NNP P) (QP (CD <) (CD 0.001))) (-RRB- -RRB-)))))))) (. .)))
16563323	9	(ROOT (S (NP (NP (NN None)) (PP (IN of) (NP (DT the) (NNS patients)))) (VP (VBD experienced) (NP (NP (NN sedation)) (, ,) (NP (NNS Doc_16563323_959_964_Disease)) (, ,) (NP (NNS Doc_16563323_966_972_Disease)) (, ,) (CC or) (NP (NNS Doc_16563323_977_985_Disease))) (PP (IN after) (NP (NP (NN injection)) (PP (IN of) (NP (DT both) (NNS drugs)))))) (. .)))
16563323	10	(ROOT (S (PP (IN In) (NP (DT the) (NN placebo) (NN group))) (, ,) (NP (JJ male) (NNS patients)) (VP (VBD were) (VP (VBN associated) (PP (IN with) (NP (NP (ADJP (RB significantly) (JJ increased)) (NN incidence)) (PP (IN of) (NP (NNS Doc_16563323_1111_1120_Disease))))) (PP (IN after) (NP (JJ Doc_16563323_1127_1136_Chemical) (NN administration))))) (. .)))
16563323	11	(ROOT (S (VP (VB Pretreatment) (PP (IN with) (NP (NNP Doc_16563323_1183_1195_Chemical) (CD 1))) (S (VP (VBG microg/kg) (NP (VBN reduced) (NNS Doc_16563323_1216_1225_Disease)) (PP (IN after) (NP (JJ Doc_16563323_1232_1241_Chemical) (NN induction))) (PP (IN without) (NP (NP (NN side) (NNS effects)) (PP (JJ such) (IN as) (NP (NNS sedation) (, ,) (NNS Doc_16563323_1291_1296_Disease) (, ,) (NNS Doc_16563323_1298_1304_Disease) (, ,) (CC or) (NNS Doc_16563323_1309_1317_Disease)))))))) (. .)))
16563323	12	(ROOT (S (NP (NN Men) (NN experience)) (VP (VBD increased) (NP (NP (NN incidence)) (PP (IN of) (NP (NP (NNS Doc_16563323_1357_1366_Disease)) (PP (IN than) (NP (NNS women)))))) (PP (IN after) (NP (JJ Doc_16563323_1384_1393_Chemical) (NN administration)))) (. .)))
16574713	0	(ROOT (S (NP (NP (NN Memory) (NN function)) (CC and) (NP (JJ Doc_16574713_20_29_Chemical) (NN transporter) (NN promoter) (NN gene))) (VP (VBP polymorphism) (PP (IN in) (NP (JJ Doc_16574713_72_79_Chemical) (PRN (-LRB- -LRB-) (NP (NNP Doc_16574713_81_85_Chemical)) (-RRB- -RRB-)) (NNS users)))) (. .)))
16574713	1	(ROOT (S (SBAR (IN Although) (S (NP (NP (NNS Doc_16574713_103_136_Chemical)) (PRN (-LRB- -LRB-) (NP (JJ Doc_16574713_138_142_Chemical) (CC or) (JJ Doc_16574713_146_153_Chemical)) (-RRB- -RRB-))) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB damage) (NP (NN brain) (NN Doc_16574713_186_195_Chemical) (PRN (-LRB- -LRB-) (NP (NNP Doc_16574713_197_201_Chemical)) (-RRB- -RRB-)) (NNS neurons)) (PP (IN in) (NP (NP (NNS animals)) (CC and) (NP (RB possibly) (NNS humans)))))))))))) (, ,) (NP (RB little)) (VP (VBZ is) (VP (VBN known) (PP (IN about) (NP (NP (DT the) (JJ long-term) (NNS consequences)) (PP (IN of) (NP (JJ Doc_16574713_295_299_Chemical-induced) (JJ Doc_16574713_308_312_Chemical) (NNS Doc_16574713_313_331_Disease))))) (PP (IN on) (NP (NP (NNS functions)) (SBAR (WHPP (IN in) (WHNP (WDT which))) (S (NP (NNS Doc_16574713_354_358_Chemical)) (VP (VBZ is) (ADJP (VBN involved))))) (, ,) (PP (JJ such) (IN as) (NP (JJ cognitive) (NN function))))))) (. .)))
16574713	2	(ROOT (S (SBAR (IN Because) (S (NP (JJ Doc_16574713_408_412_Chemical) (NNS transporters)) (VP (VBP play) (NP (NP (DT a) (JJ key) (NN element)) (PP (IN in) (NP (NP (DT the) (NN regulation)) (PP (IN of) (NP (JJ synaptic) (JJ Doc_16574713_475_479_Chemical) (NN transmission))))))))) (NP (PRP it)) (VP (MD may) (VP (VB be) (ADJP (JJ important) (S (VP (TO to) (VP (VB control) (PP (IN for) (NP (NP (DT the) (JJ potential) (NN covariance) (NN effect)) (PP (IN of) (NP (NP (DT a) (NN polymorphism)) (PP (IN in) (NP (NP (DT the) (JJ Doc_16574713_585_589_Chemical) (NN transporter) (NN promoter) (NN gene) (NN region)) (PRN (-LRB- -LRB-) (NP (CD 5-HTTLPR)) (-RRB- -RRB-)))))))))))) (SBAR (WHADVP (WRB when)) (S (VP (VP (VBG studying) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NNS Doc_16574713_663_667_Chemical))))) (CONJP (RB as) (RB well) (IN as)) (VP (ADVP (RB cognitive)) (VBG functioning))))))) (. .)))
16574713	3	(ROOT (S (NP (NP (DT The) (NN aim)) (PP (IN of) (NP (DT the) (NN study)))) (VP (VBD was) (S (VP (TO to) (VP (VB investigate) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NP (NP (ADJP (JJ moderate) (CC and) (JJ heavy)) (JJ Doc_16574713_776_780_Chemical) (NN use)) (PP (IN on) (NP (JJ cognitive) (NN function)))) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (JJ long-term) (NN abstention))))))) (PP (IN from) (NP (NNS Doc_16574713_860_864_Chemical))) (, ,) (PP (IN in) (NP (NP (NNS subjects)) (VP (VBN genotyped) (PP (IN for) (NP (CD 5-HTTLPR)))))))))) (. .)))
16574713	4	(ROOT (S (NP (NP (DT A) (JJ second) (NN aim)) (PP (IN of) (NP (DT the) (NN study)))) (VP (VBD was) (S (VP (TO to) (VP (VB determine) (SBAR (IN whether) (S (NP (DT these) (NNS effects)) (VP (VBP differ) (PP (IN for) (NP (NNS females) (CC and) (NNS males)))))))))) (. .)))
16574713	5	(ROOT (S (NP (NP (NP (NP (NNP Fifteen) (JJ moderate) (NNS Doc_16574713_1014_1018_Chemical) (NNS users)) (PRN (-LRB- -LRB-) (NP (CD <) (NNP 55) (NN lifetime) (NNS tablets)) (-RRB- -RRB-))) (, ,) (NP (NP (CD 22) (JJ heavy) (JJ Doc_16574713_1058_1062_Chemical) (NN +) (NNS users)) (PRN (-LRB- -LRB-) (NP (CD >) (NNP 55) (NN lifetime) (NNS tablets)) (-RRB- -RRB-))) (, ,) (NP (NP (CD 16) (JJ ex-Doc_16574713_1100_1104_Chemical) (JJ +) (NNS users)) (PRN (-LRB- -LRB-) (NP (NP (JJ last) (NN tablet)) (VP (VBN >) (ADVP (NP (CD 1) (NN year)) (RB ago)))) (-RRB- -RRB-)))) (CC and) (NP (CD 13) (NNS controls))) (VP (VBD were) (VP (VBN compared) (PP (IN on) (NP (NP (DT a) (NN battery)) (PP (IN of) (NP (JJ neuropsychological) (NNS tests))))))) (. .)))
16574713	6	(ROOT (S (NP (NP (NNP DNA)) (PP (IN from) (NP (JJ peripheral) (JJ nuclear) (NN blood) (NNS cells)))) (VP (VBD was) (VP (VBN genotyped) (PP (IN for) (NP (CD 5-HTTLPR))) (S (VP (VBG using) (NP (NP (JJ standard) (NN polymerase) (NN chain) (NN reaction) (NN methods.A)) (SBAR (S (NP (JJ significant) (NN group) (NN effect)) (VP (VBD was) (VP (VBN observed) (PP (RB only) (PP (IN on) (NP (NN memory) (NN function) (NNS tasks))) (PRN (-LRB- -LRB-) (VP (VBN p) (S (VP (SYM =) (NP (CD 0.04))))) (-RRB- -RRB-)) (CC but) (RB not) (PP (IN on) (NP (NP (NP (NN reaction) (NNS times)) (PRN (-LRB- -LRB-) (VP (VBN p) (S (VP (SYM =) (NP (CD 0.61))))) (-RRB- -RRB-))) (CC or) (NP (NP (JJ attention/executive) (VBG functioning)) (PRN (-LRB- -LRB-) (VP (VBN p) (S (VP (SYM =) (NP (CD 0.59))))) (-RRB- -RRB-))))))))))))))) (. .)))
16574713	7	(ROOT (S (NP (NP (NNP Heavy)) (CC and) (NP (JJ ex-Doc_16574713_1505_1509_Chemical) (JJ +) (NNS users))) (VP (VBD performed) (ADJP (ADJP (RB significantly) (JJR poorer)) (PP (IN on) (NP (NN memory) (NNS tasks)))) (PP (IN than) (NP (NNS controls)))) (. .)))
16574713	8	(ROOT (S (PP (IN In) (NP (NN contrast))) (, ,) (NP (NP (DT no) (NN evidence)) (PP (IN of) (NP (NNS Doc_16574713_1607_1624_Disease)))) (VP (VBD was) (VP (VBN observed) (PP (IN in) (NP (JJ moderate) (JJ Doc_16574713_1650_1654_Chemical) (NNS users))))) (. .)))
16574713	9	(ROOT (S (NP (NP (DT No) (JJ significant) (NN effect)) (PP (IN of) (NP (NN 5-HTTLPR) (CC or) (NN gender)))) (VP (VBD was) (ADJP (JJ observed))) (. .)))
16574713	10	(ROOT (S (SBAR (IN While) (S (NP (NP (DT the) (NN use)) (PP (IN of) (NP (NP (NNS Doc_16574713_1737_1741_Chemical)) (PP (IN in) (NP (NP (NNS quantities)) (SBAR (WHNP (WDT that)) (S (VP (MD may) (VP (VB be) (VP (VBN considered) (S (ADJP (`` ``) (JJ moderate) ('' ''))))))))))))) (VP (VBZ is) (RB not) (VP (VBN associated) (PP (IN with) (NP (NNS Doc_16574713_1813_1840_Disease))))))) (, ,) (NP (NP (JJ heavy) (NN use)) (PP (IN of) (NP (JJ Doc_16574713_1855_1859_Chemical) (NN use)))) (VP (MD may) (VP (VB lead) (PP (TO to) (NP (JJ long) (JJ lasting) (NNS Doc_16574713_1889_1907_Disease))))) (. .)))
16574713	11	(ROOT (S (NP (NP (NP (DT No) (NN effect)) (PP (IN of) (NP (CD 5-HTTLPR)))) (CC or) (NP (NP (NN gender)) (PP (IN on) (NP (NP (NN memory) (NN function)) (CC or) (NP (JJ Doc_16574713_1963_1967_Chemical) (NN use)))))) (VP (VBD was) (ADJP (JJ observed))) (. .)))
16584858	0	(ROOT (NP (NP (NNP Role)) (PP (IN of) (NP (NP (NP (NNS Doc_16584858_8_18_Chemical)) (PP (IN on) (NP (JJ biochemical) (NNS alterations)))) (CC and) (NP (NP (JJ antioxidant) (NN status)) (PP (IN in) (NP (NN Doc_16584858_72_85_Chemical-induced) (NNS Doc_16584858_94_115_Disease)))))) (PP (IN in) (NP (NNS rats))) (. .)))
16584858	1	(ROOT (NP (NP (NP (DT The) (JJ current) (NN study)) (VP (VBN dealt) (PP (IN with) (NP (NP (DT the) (JJ protective) (NN role)) (PP (IN of) (NP (NP (NNS Doc_16584858_177_187_Chemical)) (, ,) (NP (NP (DT a) (NNS Doc_16584858_191_201_Chemical)) (PP (IN from) (NP (NP (NNP Mangifera) (NNP indica) (NNP Linn) (. .)) (PRN (-LRB- -LRB-) (NP (NNP Anacardiaceae)) (-RRB- -RRB-))))) (, ,))))) (PP (IN on) (NP (NP (NNS Doc_16584858_250_263_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_16584858_265_269_Chemical)) (-RRB- -RRB-)))))) (: -) (NP (NP (NP (JJ induced) (NNS Doc_16584858_279_300_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_16584858_302_304_Disease)) (-RRB- -RRB-))) (PP (IN in) (NP (NP (NNS rats)) (PP (IN through) (NP (PRP$ its) (JJ antioxidative) (NN mechanism)))))) (. .)))
16584858	2	(ROOT (S (NP (NP (JJ Subcutaneous) (NN injection)) (PP (IN of) (NP (NP (NP (NNS Doc_16584858_377_381_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (CD 200) (JJ mg/kg) (NN body) (NN weight)) (PP (IN in) (NP (CD 1) (NN ml) (NN saline)))) (-RRB- -RRB-))) (PP (TO to) (NP (NP (NNS rats)) (PP (IN for) (NP (CD 2) (JJ consecutive) (NNS days)))))))) (VP (VBD caused) (NP (NNS Doc_16584858_459_476_Disease)) (PP (IN in) (NP (NP (NN rat) (NN heart)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD was) (VP (VBN determined) (PP (IN by) (NP (NP (DT the) (VBN increased) (NN activity)) (PP (IN of) (NP (NP (NP (NN serum) (JJ Doc_16584858_547_554_Chemical) (NN dehydrogenase)) (PRN (-LRB- -LRB-) (NP (NNP LDH)) (-RRB- -RRB-))) (CC and) (NP (JJ Doc_16584858_579_587_Chemical) (NN phosphokinase) (NNS isoenzymes)))) (PRN (-LRB- -LRB-) (NP (NNP CK-MB)) (-RRB- -RRB-)) (, ,) (NP (JJ increased) (JJ Doc_16584858_632_641_Chemical) (NN level)) (CC and) (NP (VBN reduced) (NN plasma) (JJ Doc_16584858_667_671_Chemical) (VBG binding) (NN capacity))))))))))) (. .)))
16584858	3	(ROOT (S (NP (NP (DT The) (JJ protective) (NN role)) (PP (IN of) (NP (NNS Doc_16584858_713_723_Chemical)))) (VP (VBD was) (VP (VBN analyzed) (PP (IN by) (NP (NP (JJ Doc_16584858_740_770_Chemical) (PRN (-LRB- -LRB-) (NP (NNP Doc_16584858_772_775_Chemical)) (-RRB- -RRB-)) (NN test)) (VP (VBN used) (PP (IN for) (NP (NP (JJ macroscopic) (JJ enzyme) (NN mapping) (NN assay)) (PP (IN of) (NP (DT the) (NNS Doc_16584858_831_850_Disease)))))))))) (. .)))
16584858	4	(ROOT (S (S (NP (DT The) (NN heart) (NN tissue)) (VP (VBP antioxidant) (NP (NP (NNS enzymes)) (PP (JJ such) (IN as) (NP (NP (JJ Doc_16584858_897_907_Chemical) (NN dismutase)) (, ,) (NP (NN catalase)) (, ,) (NP (JJ Doc_16584858_929_940_Chemical) (NN peroxidase)) (, ,) (NP (JJ Doc_16584858_953_964_Chemical) (NN transferase)) (CC and) (NP (JJ Doc_16584858_981_992_Chemical) (NN reductase) (NNS activities))))))) (, ,) (NP (NP (JJ non-enzymic) (NNS antioxidants)) (PP (JJ such) (IN as) (NP (NNS cerruloplasmin) (, ,) (NNS Doc_16584858_1064_1073_Chemical) (, ,) (NNS Doc_16584858_1075_1084_Chemical) (CC and) (NNS Doc_16584858_1089_1100_Chemical) (NNS levels)))) (VP (VBD were) (VP (VBN altered) (PP (IN in) (NP (JJ Doc_16584858_1124_1126_Disease) (NNS rats))))) (. .)))
16584858	5	(ROOT (S (PP (IN Upon) (NP (NP (NN pretreatment)) (PP (IN with) (NP (NNS Doc_16584858_1156_1166_Chemical))))) (PRN (-LRB- -LRB-) (S (NP (CD 100) (JJ mg/kg) (NN body) (NN weight)) (VP (VBD suspended) (PP (IN in) (NP (NP (CD 2) (NN ml)) (PP (IN of) (NP (NNS Doc_16584858_1211_1230_Chemical))))))) (-RRB- -RRB-)) (NP (NP (VBN given) (NN intraperitoneally)) (PP (IN for) (NP (NP (CD 28) (NNS days)) (PP (TO to) (NP (JJ Doc_16584858_1271_1273_Disease) (NNS rats)))))) (VP (VBD protected) (NP (DT the) (JJ above-mentioned) (NNS parameters)) (S (VP (TO to) (VP (VB fall) (PP (IN from) (NP (DT the) (JJ normal) (NNS levels))))))) (. .)))
16584858	6	(ROOT (S (NP (NP (NNPS Activities)) (PP (IN of) (NP (NN heart) (NN tissue) (JJ enzymic) (NNS antioxidants) (CC and) (NN serum) (JJ non-enzymic) (NN antioxidants) (NNS levels)))) (VP (VBD rose) (ADVP (RB significantly)) (PP (IN upon) (NP (NP (JJ Doc_16584858_1466_1476_Chemical) (NN administration) (IN as)) (PP (VBN compared) (PP (TO to) (NP (JJ Doc_16584858_1507_1511_Chemical-induced) (JJ Doc_16584858_1520_1522_Disease) (NNS rats))))))) (. .)))
16584858	7	(ROOT (S (PP (IN From) (NP (DT the) (JJ present) (NN study))) (NP (PRP it)) (VP (VBZ is) (VP (VBN concluded) (SBAR (IN that) (S (NP (NNS Doc_16584858_1573_1583_Chemical)) (VP (VBZ exerts) (S (NP (NP (DT a) (JJ beneficial) (NN effect)) (PP (IN against) (NP (NN Doc_16584858_1619_1623_Chemical-induced) (NNS Doc_16584858_1632_1634_Disease)))) (ADJP (JJ due) (PP (TO to) (NP (NP (PRP$ its) (JJ antioxidant) (NN potential)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBN regulated) (NP (NP (DT the) (NNS tissues) (NN defense) (NN system)) (PP (IN against) (NP (NNS Doc_16584858_1720_1734_Disease)))))))))))))))) (. .)))
16586083	0	(ROOT (NP (NP (NP (NNP Cardiovascular) (NN risk)) (PP (IN with) (NP (JJ cyclooxygenase) (NNS inhibitors)))) (: :) (NP (NP (JJ general) (NN problem)) (PP (IN with) (NP (NN substance) (JJ specific) (NNS differences)))) (. ?)))
16586083	1	(ROOT (S (NP (NP (JJ Randomised) (JJ clinical) (NNS trials)) (CC and) (NP (JJ observational) (NNS studies))) (VP (VBP have) (VP (VBN shown) (NP (NP (DT an) (JJ increased) (NN risk)) (PP (IN of) (NP (NNS Doc_16586083_190_211_Disease) (, ,) (NNS Doc_16586083_213_219_Disease) (, ,) (NNS Doc_16586083_221_233_Disease) (CC and) (NNS Doc_16586083_238_251_Disease)))) (PP (IN during) (NP (NN treatment))) (PP (IN with) (NP (JJ cyclooxygenase) (NNS inhibitors))))) (. .)))
16586083	2	(ROOT (S (NP (JJ Adverse) (JJ cardiovascular) (NNS effects)) (VP (VBD occurred) (ADVP (ADVP (RB mainly)) (, ,) (CC but) (ADVP (RB not) (RB exclusively))) (, ,) (PP (IN in) (NP (NNS patients))) (PP (IN with) (NP (JJ concomitant) (NN risk) (NNS factors)))) (. .)))
16586083	3	(ROOT (S (NP (JJ Cyclooxygenase) (NNS inhibitors)) (VP (VBP cause) (NP (JJ complex) (NNS changes)) (PP (IN in) (S (NP (JJ renal) (, ,) (NN vascular) (CC and) (JJ cardiac) (NN prostanoid) (NNS profiles)) (ADVP (RB thereby)) (VP (VBG increasing) (NP (NP (NN vascular) (NN resistance)) (CC and) (NP (JJ fluid) (NN retention))))))) (. .)))
16586083	4	(ROOT (S (NP (NP (DT The) (NN incidence)) (PP (IN of) (NP (JJ cardiovascular) (JJ adverse) (NNS events)))) (VP (VBZ tends) (S (VP (TO to) (VP (VB increase) (PP (IN with) (NP (NP (DT the) (JJ daily) (NN dose)) (CC and) (NP (JJ total) (NN exposure) (NN time)))))))) (. .)))
16586083	5	(ROOT (S (NP (NP (DT A) (NN comparison)) (PP (IN of) (NP (JJ individual) (JJ selective) (CC and) (JJ unselective) (NN cyclooxygenase) (NNS inhibitors)))) (VP (VP (VBZ suggests) (NP (NP (JJ substance-specific) (NNS differences)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (MD may) (VP (VB depend) (PP (IN on) (NP (NP (NNS differences)) (PP (IN in) (NP (NP (JJ pharmacokinetic) (NNS parameters)) (CC or) (NP (JJ inhibitory) (NN potency)))))))))))) (CC and) (VP (MD may) (VP (VB be) (VP (VBN contributed) (PP (IN by) (NP (NN Doc_16586083_912_925_Chemical-independent) (NNS effects))))))) (. .)))
16586083	6	(ROOT (S (NP (NP (NNP Diagnostic) (NNS markers)) (PP (JJ such) (IN as) (NP (NP (NP (NN Doc_16586083_974_975_Chemical-terminal) (JJ pro) (NN brain)) (NP (NP (JJ natriuretic) (NN peptide)) (PRN (-LRB- -LRB-) (NP (NNP NT-proBNP)) (-RRB- -RRB-)))) (CC or) (NP (JJ high-sensitive) (JJ C-reactive) (NN protein))))) (VP (MD might) (VP (VB help) (PP (IN in) (NP (NP (DT the) (JJ early) (NN identification)) (PP (IN of) (NP (NNS patients))))) (PP (IN at) (NP (NN risk))) (, ,) (S (ADVP (RB thus)) (VP (VBG avoiding) (NP (NP (DT the) (NN occurrence)) (PP (IN of) (NP (JJ serious) (NNS Doc_16586083_1164_1187_Disease)))))))) (. .)))
16596970	0	(ROOT (S (NP (JJ Doc_16596970_0_11_Chemical) (NNS Doc_16596970_12_20_Disease)) (VP (VBP cause) (NP (JJ age-dependent) (NNS Doc_16596970_41_87_Disease))) (. .)))
16596970	1	(ROOT (S (NP (NP (NNP Children)) (SBAR (WHNP (WP who)) (S (VP (VBP have) (NP (NNS Doc_16596970_107_125_Disease)))))) (VP (VP (VBP have) (NP (NP (ADJP (ADJP (JJ continuous)) (CC or) (ADJP (RB rapidly) (JJ repeating))) (NNS Doc_16596970_163_171_Disease)) (SBAR (WHNP (WDT that)) (S (VP (MD may) (VP (VB be) (ADJP (JJ life-threatening)))))))) (CC and) (VP (MD may) (VP (VB cause) (NP (JJ life-long) (NNS changes)) (PP (IN in) (NP (NN brain) (CC and) (NN behavior)))))) (. .)))
16596970	2	(ROOT (S (NP (NP (DT The) (NN extent)) (SBAR (WHPP (TO to) (WHNP (WDT which))) (S (NP (NNS Doc_16596970_276_294_Disease)) (VP (VBZ causes) (NP (NNS Doc_16596970_302_337_Disease)))))) (VP (VBZ is) (ADJP (JJ unknown))) (. .)))
16596970	3	(ROOT (S (NP (DT A) (JJ naturalistic) (JJ auditory) (NN location) (NN discrimination) (NN method)) (VP (VBD was) (VP (VBN used) (S (VP (TO to) (VP (VB evaluate) (NP (NP (DT this) (NN question)) (VP (VBG using) (NP (NP (DT an) (NN animal) (NN model)) (PP (IN of) (NP (NNS Doc_16596970_465_483_Disease))))))))))) (. .)))
16596970	4	(ROOT (S (NP (NNP Male) (NNP Sprague-Dawley) (NNS rats)) (VP (VBD were) (VP (VBN injected) (PP (IN with) (NP (NN saline))) (PP (IN on) (NP (NP (NP (JJ postnatal) (NN day)) (PRN (-LRB- -LRB-) (NP (NNP P)) (-RRB- -RRB-)) (NP (CD 20))) (, ,) (CC or) (NP (NP (DT a) (JJ convulsant) (NN dose)) (PP (IN of) (NP (NP (NNS Doc_16596970_585_596_Chemical)) (PP (IN on) (NP (NNP P20) (CC or) (NNP P45)))))))))) (. .)))
16596970	5	(ROOT (S (NP (NP (NNP Doc_16596970_612_623_Chemical)) (PP (IN on) (NP (NP (DT either) (NN day)) (VP (VBN induced) (NP (NP (NNS Doc_16596970_646_664_Disease)) (: ;) (NP (NP (NNS Doc_16596970_666_684_Disease)) (PP (IN at) (NP (NNP P45))))))))) (VP (VBD resulted) (PP (IN in) (NP (NP (NN CA3) (NN cell) (NN loss)) (CC and) (NP (JJ spontaneous) (NNS Doc_16596970_734_742_Disease)))) (, ,) (SBAR (IN whereas) (S (NP (NNP P20) (NNS rats)) (VP (VBD had) (NP (NP (DT no) (NN cell) (NN loss)) (CC or) (NP (JJ spontaneous) (NNS Doc_16596970_793_801_Disease))))))) (. .)))
16596970	6	(ROOT (S (NP (JJ Mature) (NNS rats)) (VP (VBD were) (VP (VBN trained) (PP (IN with) (NP (JJ sound-source) (NN location) (CC and) (NN sound-silence) (NNS discriminations))))) (. .)))
16596970	7	(ROOT (S (NP (NP (NNP Control)) (PRN (-LRB- -LRB-) (NP (JJ saline) (NN P20)) (-RRB- -RRB-)) (NNS rats)) (VP (VBD acquired) (NP (DT both) (NNS discriminations)) (ADVP (RB immediately))) (. .)))
16596970	8	(ROOT (S (PP (IN In) (NP (JJ Doc_16596970_962_980_Disease) (PRN (-LRB- -LRB-) (NP (NNP P20)) (-RRB- -RRB-)) (NNS rats))) (, ,) (NP (NP (NN acquisition)) (PP (IN of) (NP (DT the) (JJ sound-source) (NN location) (NN discrimination)))) (VP (VBD was) (ADJP (RB moderately) (JJ impaired))) (. .)))
16596970	9	(ROOT (S (NP (JJ Doc_16596970_1074_1092_Disease) (PRN (-LRB- -LRB-) (NP (NNP P45)) (-RRB- -RRB-)) (NNS rats)) (VP (VBD failed) (S (VP (TO to) (VP (VB acquire) (NP (NP (DT either) (JJ sound-source) (NN location)) (CC or) (NP (JJ sound-silence) (NNS discriminations))))))) (. .)))
16596970	10	(ROOT (S (NP (NP (NNP Doc_16596970_1185_1203_Disease)) (PP (IN in) (NP (NN rat)))) (VP (VBZ causes) (NP (DT an) (JJ age-dependent) (, ,) (JJ long-term) (NN Doc_16596970_1246_1283_Disease))) (. .)))
16596970	11	(ROOT (S (NP (DT This) (NN impairment)) (VP (MD may) (VP (VB explain) (NP (NP (CD one) (NN cause)) (PP (IN of) (NP (NP (NNS Doc_16596970_1326_1367_Disease)) (PP (IN in) (NP (NNS humans)))))))) (. .)))
16600756	0	(ROOT (S (VP (VB Nerve) (NP (NP (NN growth) (NN factor) (CC and) (NNS Doc_16600756_24_38_Chemical)) (PP (IN in) (NP (NP (DT the) (NN urine)) (PP (IN of) (NP (NP (JJ female) (NNS patients)) (PP (IN with) (NP (NNS Doc_16600756_76_94_Disease))))))))) (. .)))
16600756	1	(ROOT (S (S (NP (NP (NNP NGF) (CC and) (NNP Doc_16600756_113_116_Chemical)) (PP (IN in) (NP (DT the) (NN bladder)))) (VP (MD can) (VP (VB be) (VP (VBN affected) (PP (IN by) (NP (NP (JJ pathological) (NNS changes)) (PP (IN in) (NP (DT the) (NN bladder))))))))) (CC and) (S (NP (DT these) (NNS changes)) (VP (MD can) (VP (VB be) (VP (VBN detected) (PP (IN in) (NP (NN urine))))))) (. .)))
16600756	2	(ROOT (S (NP (PRP We)) (VP (VBD investigated) (NP (NNS changes)) (PP (IN in) (NP (JJ urinary) (NN NGF) (CC and) (NNS Doc_16600756_274_277_Chemical))) (PP (IN in) (NP (NP (NNS women)) (PP (IN with) (NP (NNP OAB)))))) (. .)))
16600756	3	(ROOT (NP (NP (NNP MATERIALS) (CC AND) (NNP METHODS)) (: :) (S (NP (DT The) (NN study) (NNS groups)) (VP (VBD included) (NP (CD 65) (NNS women)) (PP (IN with) (NP (NP (NNP OAB)) (CC and) (NP (CD 20)))) (PP (IN without) (NP (NP (NN bladder) (NNS symptoms)) (SBAR (WHNP (WP who)) (S (VP (VBN served) (PP (IN as) (NP (NNS controls)))))))))) (. .)))
16600756	4	(ROOT (S (NP (NNP Evaluation)) (VP (VBD included) (NP (NP (JJ patient) (NN history)) (, ,) (NP (NNS urinalysis)) (, ,) (NP (DT a) (JJ voiding) (NN diary)) (CC and) (NP (JJ urodynamic) (NNS studies)))) (. .)))
16600756	5	(ROOT (S (NP (JJ Urine) (NNS samples)) (VP (VBD were) (VP (VBN collected))) (. .)))
16600756	6	(ROOT (S (ADVP (RB NGF)) (, ,) (NP (NNS Doc_16600756_544_548_Chemical) (, ,) (NNS Doc_16600756_550_559_Chemical) (CC and) (NNS Doc_16600756_564_568_Chemical)) (VP (VBD were) (VP (VP (VBN measured) (S (VP (VBG using) (NP (JJ enzyme-linked) (NN immunosorbent)) (ADVP (RB assay))))) (CC and) (VP (VBN compared) (PP (IN between) (NP (DT the) (NNS groups)))))) (. .)))
16600756	7	(ROOT (S (PP (IN In) (NP (NN addition))) (, ,) (NP (NP (NNS correlations)) (PP (IN between) (NP (NP (ADVP (RB urinary)) (NNP NGF) (CC and) (NNS Doc_16600756_706_708_Chemical) (, ,) (CC and) (JJ urodynamic) (NNS parameters)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NNP OAB)))))))) (VP (VBD were) (VP (VBN examined))) (. .)))
16600756	8	(ROOT (S (NP (NNP Urinary) (NNP NGF) (, ,) (NNS Doc_16600756_794_798_Chemical) (CC and) (NNS Doc_16600756_803_812_Chemical)) (VP (VBD were) (ADVP (RB significantly)) (VP (VBN increased) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NNP OAB))))) (PP (VBN compared) (PP (IN with) (NP (NP (NNS controls)) (PRN (-LRB- -LRB-) (VP (VBN p) (NP (CD <) (CD 0.05))) (-RRB- -RRB-))))))) (. .)))
16600756	9	(ROOT (S (ADVP (RB However)) (, ,) (NP (JJ urinary) (NNS Doc_16600756_914_918_Chemical)) (VP (VBD was) (RB not) (ADJP (JJ different) (PP (IN between) (NP (NNS controls) (CC and) (NNS patients)))) (PP (IN with) (NP (NNP OAB)))) (. .)))
16600756	10	(ROOT (S (PP (IN In) (NP (NP (NNS patients)) (PP (IN with) (NP (NNP OAB))))) (NP (JJ urinary) (NNS Doc_16600756_1006_1010_Chemical)) (ADVP (RB positively)) (VP (VBD correlated) (PP (IN with) (NP (NP (NN volume)) (PP (IN at) (NP (JJ first) (NN desire))))) (PP (TO to) (NP (NP (NN void)) (CC and) (NP (JJ maximum) (JJ cystometric) (NN capacity)))) (PRN (-LRB- -LRB-) (ADVP (RB p)) (ADJP (JJ <) (NP (CD 0.05))) (-RRB- -RRB-))) (. .)))
16600756	11	(ROOT (S (NP (NNP Urinary) (NNP NGF) (, ,) (NNS Doc_16600756_1126_1135_Chemical) (CC and) (NNS Doc_16600756_1140_1144_Chemical)) (VP (VBD did) (RB not) (VP (VB correlate) (PP (IN with) (NP (NP (JJ urodynamic) (NNS parameters)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NNP OAB))))))))) (. .)))
16600756	12	(ROOT (S (NP (NNP NGF) (CC and) (NNP Doc_16600756_1233_1236_Chemical)) (VP (VBP have) (NP (NP (JJ important) (NNS roles)) (PP (IN in) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (NP (NNP OAB) (NNS symptoms)) (PP (IN in) (NP (JJ female) (NNS patients))))))))) (. .)))
16600756	13	(ROOT (S (NP (NP (JJ Urinary) (NNS levels)) (PP (IN of) (NP (DT these) (NNS factors)))) (VP (MD may) (VP (VB be) (VP (VBN used) (PP (IN as) (NP (NNS markers))) (S (VP (TO to) (VP (VB evaluate) (NP (NNP OAB) (NNS symptoms)))))))) (. .)))
16629641	0	(ROOT (NP (NP (NN Definition) (CC and) (NN management)) (PP (IN of) (NP (NNS Doc_16629641_29_35_Disease))) (PP (IN in) (NP (NNS patients) (NNS Doc_16629641_48_79_Disease))) (. .)))
16629641	1	(ROOT (S (NP (NP (NNP Doc_16629641_81_121_Disease)) (PRN (-LRB- -LRB-) (NP (NNP HCV)) (-RRB- -RRB-))) (VP (MD can) (VP (VB progress) (PP (TO to) (NP (NNS Doc_16629641_144_153_Disease) (, ,) (NNS Doc_16629641_155_179_Disease) (, ,) (CC and) (NNS Doc_16629641_185_208_Disease))))) (. .)))
16629641	2	(ROOT (S (NP (NP (DT The) (JJ current) (JJS best) (NN treatment)) (PP (IN for) (NP (NNS Doc_16629641_241_254_Disease)))) (VP (VBZ is) (NP (NP (NN combination) (NN therapy)) (PP (IN with) (NP (NNS Doc_16629641_283_303_Chemical) (CC and) (NNS Doc_16629641_308_317_Chemical))))) (. .)))
16629641	3	(ROOT (S (SBAR (IN Although) (S (NP (DT this) (NN regimen)) (VP (VBZ produces) (NP (NP (VBN sustained) (JJ virologic) (NNS responses)) (PRN (-LRB- -LRB-) (NP (NNP SVRs)) (-RRB- -RRB-)) (PP (IN in) (NP (NP (QP (RB approximately) (CD 50)) (NN %)) (PP (IN of) (NP (NNS patients))))))))) (, ,) (NP (PRP it)) (VP (MD can) (VP (VB be) (VP (VBN associated) (PP (IN with) (NP (DT a) (ADJP (RB potentially) (JJ dose-limiting)) (NNS Doc_16629641_475_491_Disease)))))) (. .)))
16629641	4	(ROOT (S (S (NP (NN Hemoglobin) (NNS concentrations)) (VP (VB decrease) (ADVP (RB mainly)) (PP (IN as) (NP (NP (DT a) (NN result)) (PP (IN of) (NP (NN Doc_16629641_550_559_Chemical-induced) (NNS Doc_16629641_568_577_Disease))))))) (, ,) (CC and) (S (NP (DT this) (NNS Doc_16629641_588_594_Disease)) (VP (MD can) (VP (VB be) (ADJP (JJ problematic) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (NNS Doc_16629641_631_644_Disease)) (, ,) (RB especially) (NP (NP (DT those)) (SBAR (WHNP (WP who)) (S (VP (VBP have) (VP (VBN comorbid) (NP (NNS Doc_16629641_681_714_Disease))))))))))))))) (. .)))
16629641	5	(ROOT (S (PP (IN In) (NP (NN general))) (, ,) (NP (NNS Doc_16629641_728_734_Disease)) (VP (VP (MD can) (VP (VB increase) (NP (NP (DT the) (NN risk)) (PP (IN of) (NP (NN morbidity) (CC and) (NN mortality)))))) (, ,) (CC and) (VP (MD may) (VP (VB have) (NP (NP (JJ negative) (NNS effects)) (PP (IN on) (NP (JJ cerebral) (NN function) (CC and) (NN quality))) (PP (IN of) (NP (NN life))))))) (. .)))
16629641	6	(ROOT (S (SBAR (IN Although) (S (NP (NN Doc_16629641_866_875_Chemical-associated) (NNS Doc_16629641_887_893_Disease)) (VP (MD can) (VP (VB be) (VP (VBN reversed) (PP (IN by) (NP (NN dose) (NN reduction) (CC or) (NN discontinuation)))))))) (, ,) (NP (DT this) (NN approach)) (VP (VBZ compromises) (NP (NNS outcomes)) (PP (IN by) (S (ADVP (RB significantly)) (VP (VBG decreasing) (NP (NNP SVR) (NNS rates)))))) (. .)))
16629641	7	(ROOT (S (NP (JJ Recombinant) (JJ human) (NN erythropoietin)) (VP (VP (VBZ has) (VP (VBN been) (VP (VBN used) (S (VP (TO to) (VP (VB manage) (NP (NN Doc_16629641_1079_1088_Chemical-associated) (NNS Doc_16629641_1100_1106_Disease)))))))) (CC but) (VP (VBZ has) (NP (JJ other) (JJ potential) (NNS disadvantages)))) (. .)))
16629641	8	(ROOT (S (NP (NP (NNP Doc_16629641_1146_1156_Chemical)) (, ,) (NP (NP (DT a) (JJ liver-targeting) (NN prodrug)) (PP (IN of) (NP (NNS Doc_16629641_1187_1196_Chemical)))) (, ,)) (VP (VBZ has) (NP (DT the) (NN potential) (S (VP (TO to) (VP (VB maintain) (NP (NP (DT the) (JJ virologic) (NN efficacy)) (PP (IN of) (NP (NNS Doc_16629641_1254_1263_Chemical)))) (PP (IN while) (S (VP (VBG decreasing) (NP (NP (DT the) (NN risk)) (PP (IN of) (NP (NP (NNS Doc_16629641_1293_1309_Disease)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NNS Doc_16629641_1327_1346_Disease)))))))))))))))) (. .)))
16634859	0	(ROOT (NP (NP (NNP Impact)) (PP (IN of) (NP (JJ Doc_16634859_10_17_Chemical) (NN exposure))) (PP (IN after) (NP (NN pregnancy) (NN recognition))) (PP (IN on) (NP (JJ ultrasonographic) (JJ fetal) (NN growth) (NNS measures))) (. .)))
16634859	1	(ROOT (S (SBAR (NP (QP (JJR More) (IN than) (CD 3)) (NNS decades)) (IN after) (S (NP (NP (NNP Jones) (CC and) (NNP Smith)) (PRN (-LRB- -LRB-) (NP (CD 1973)) (-RRB- -RRB-))) (VP (VBD reported) (PP (IN on) (NP (NP (DT the) (NN devastation)) (VP (VBN caused) (PP (IN by) (NP (NP (JJ Doc_16634859_197_204_Chemical) (NN exposure)) (PP (IN on) (NP (JJ fetal) (NN development))))))))))) (, ,) (NP (NP (DT the) (NNS rates)) (PP (IN of) (NP (NP (JJ heavy) (NN drinking)) (PP (IN during) (NP (NN pregnancy)))))) (VP (VBP remain) (ADJP (RB relatively) (JJ unchanged))) (. .)))
16634859	2	(ROOT (S (NP (NP (RB Early) (NN identification)) (PP (IN of) (NP (JJ fetal) (NNS Doc_16634859_340_347_Chemical) (NN exposure) (CC and) (NN maternal) (NN abstinence)))) (VP (VBD led) (PP (TO to) (NP (JJR better) (NN infant) (NNS outcomes)))) (. .)))
16634859	3	(ROOT (S (NP (DT This) (NN study)) (VP (VBD examined) (NP (NP (DT the) (NN utility)) (PP (IN of) (NP (ADJP (JJ biometry) (PP (IN for) (S (VP (VBG detecting) (NP (NNS Doc_16634859_470_477_Chemical-related)))))) (JJ fetal) (NNS Doc_16634859_492_509_Disease))))) (. .)))
16634859	4	(ROOT (S (NP (PRP We)) (VP (VBD obtained) (NP (JJ fetal) (NN ultrasound) (NNS measures)) (PP (IN from) (NP (JJ routine) (NN ultrasound) (NNS examinations))) (PP (IN for) (NP (NP (CD 167) (JJ pregnant) (JJ hazardous) (NNS drinkers)) (SBAR (WHNP (WP who)) (S (VP (VBD were) (VP (VBN enrolled) (PP (IN in) (NP (DT a) (JJ brief) (JJ Doc_16634859_660_667_Chemical) (NN intervention) (NN study)))))))))) (. .)))
16634859	5	(ROOT (S (NP (NP (DT The) (JJ fetal) (NNS measures)) (PP (IN for) (NP (NP (NNS women)) (SBAR (WHNP (WP who)) (S (VP (VBD quit) (PP (IN after) (S (VP (VBG learning) (PP (IN of) (NP (PRP$ their) (NNS pregnancies)))))))))))) (VP (VBD were) (VP (VBN compared) (PP (IN with) (NP (NP (NNS measures)) (PP (IN for) (NP (NP (NNS women)) (SBAR (WHNP (WP who)) (S (VP (VBD continued) (NP (DT some) (NN drinking)) (PP (IN throughout) (NP (NP (DT the) (NN course)) (PP (IN of) (NP (PRP$ their) (NNS pregnancies)))))))))))))) (. .)))
16634859	6	(ROOT (S (SBAR (IN Because) (S (NP (NP (NN intensity)) (PP (IN of) (NP (JJ Doc_16634859_893_900_Chemical) (NN consumption)))) (VP (VBZ is) (VP (VBN associated) (PP (IN with) (NP (JJR poorer) (JJ fetal) (NNS outcomes))))))) (, ,) (NP (JJ separate) (NNS analyses)) (VP (VBD were) (VP (VBN conducted) (PP (IN for) (NP (DT the) (ADJP (ADJP (JJ heavy)) (PRN (-LRB- -LRB-) (NP (NP (NP (NN average)) (PP (IN of) (NP (NNP >)))) (CC or) (NP (NP (QP (CD =) (CD 5)) (NNS drinks)) (PP (IN per) (NP (NN drinking) (NN day))))) (-RRB- -RRB-))) (NNS Doc_16634859_1045_1052_Chemical) (NNS consumers))))) (. .)))
16634859	7	(ROOT (S (NP (NP (JJ Fetal) (NNS measures)) (PP (IN from) (NP (DT the) (JJ heavy-exposed) (NNS fetuses)))) (VP (VBD were) (ADVP (RB also)) (VP (VBN compared) (PP (IN with) (NP (NNS measures))) (PP (IN from) (NP (NP (DT a) (VBG nondrinking) (NN group)) (SBAR (WHNP (WDT that)) (S (VP (VBD was) (NP (NP (NN representative)) (PP (IN of) (NP (JJ normal) (, ,) (JJ uncomplicated) (NNS pregnancies)))) (PP (IN from) (NP (PRP$ our) (NNS clinics)))))))))) (. .)))
16634859	8	(ROOT (S (NP (NP (NNS Analyses)) (PP (IN of) (NP (NN covariance)))) (VP (VBD were) (VP (VBN used) (S (VP (TO to) (VP (VB determine) (SBAR (IN whether) (S (NP (EX there)) (VP (VBD were) (NP (NP (NNS differences)) (PP (IN between) (NP (NNS groups)))) (PP (IN after) (S (VP (VBG controlling) (PP (IN for) (NP (NP (NNS influences)) (PP (IN of) (NP (JJ gestational) (NN age) (CC and) (NNS Doc_16634859_1395_1405_Disease)))))))))))))))) (. .)))
16634859	9	(ROOT (S (NP (NP (QP (RB Nearly) (PDT half))) (PP (IN of) (NP (DT the) (JJ pregnant) (NNS drinkers)))) (VP (VBD abstained) (PP (IN after) (S (VP (VBG learning) (PP (IN of) (NP (PRP$ their) (NNS pregnancies))))))) (. .)))
16634859	10	(ROOT (S (SBAR (WHADVP (WRB When)) (S (NP (NNS women)) (ADVP (RB reportedly)) (VP (VBD quit) (S (VP (VBG drinking) (ADVP (RB early)) (PP (IN in) (NP (PRP$ their) (NNS pregnancies)))))))) (, ,) (NP (JJ fetal) (NN growth) (NNS measures)) (VP (VBD were) (RB not) (ADJP (RB significantly) (JJ different)) (PP (IN from) (NP (DT a) (JJ non-Doc_16634859_1630_1637_Chemical-exposed) (NN group))) (, ,) (ADVP (RB regardless) (PP (IN of) (NP (JJ prior) (NN drinking) (NNS patterns))))) (. .)))
16634859	11	(ROOT (S (NP (NP (DT Any) (JJ Doc_16634859_1696_1703_Chemical) (NN consumption) (NN postpregnancy) (NN recognition)) (PP (IN among) (NP (DT the) (JJ heavy) (NNS drinkers)))) (VP (VBD resulted) (PP (IN in) (NP (NP (NNS Doc_16634859_1779_1804_Disease) (CONJP (RB as) (RB well) (IN as)) (NNS Doc_16634859_1816_1848_Disease)) (PP (IN in) (NP (NN comparison))))) (PP (IN with) (NP (NNS women))) (SBAR (SBAR (WHNP (WP who)) (S (ADVP (RB either)) (VP (VBD quit) (NP (NN drinking))))) (CC or) (SBAR (WHNP (WP who)) (S (VP (VBD were) (ADJP (JJ nondrinkers))))))) (. .)))
16634859	12	(ROOT (S (NP (JJ Doc_16634859_1924_1935_Chemical) (NN abuse)) (VP (VBD was) (NP (NP (JJ predictive)) (PP (IN of) (NP (NP (JJR larger) (NN cranial)) (PP (TO to) (NP (NN body) (NN growth) (NNS ratios))))))) (. .)))
16634859	13	(ROOT (S (NP (NP (NNS Alterations)) (PP (IN in) (NP (JJ fetal) (JJ biometric) (NNS measurements)))) (VP (VBD were) (VP (VBN observed) (PP (IN among) (NP (NP (DT the) (JJ heavy) (NNS drinkers)) (SBAR (WHADVP (RB only) (WRB when)) (S (NP (PRP they)) (VP (VBD continued) (S (VP (VBG drinking) (PP (IN after) (S (VP (VBG becoming) (ADJP (JJ aware)) (PP (IN of) (NP (PRP$ their) (NNS pregnancies))))))))))))))) (. .)))
16634859	14	(ROOT (S (SBAR (IN Although) (S (NP (NP (DT the) (NN reliance)) (PP (IN on) (NP (JJ self-reported) (NN drinking)))) (VP (VBZ is) (NP (NP (DT a) (NN limitation)) (PP (IN in) (NP (DT this) (NN study))))))) (, ,) (NP (DT these) (NNS findings)) (VP (VBP support) (NP (NP (NP (DT the) (NNS benefits)) (PP (IN of) (NP (JJ early) (NN abstinence)))) (CC and) (NP (NP (DT the) (NN potential)) (PP (IN for) (NP (NP (NN ultrasound) (NNS examinations)) (PP (IN in) (NP (NP (DT the) (NN detection)) (PP (IN of) (NP (JJ fetal) (JJ Doc_16634859_2378_2385_Chemical) (NNS effects)))))))))) (. .)))
16710500	0	(ROOT (NP (CD Doc_16710500_0_10_Chemical-associated) (NNS Doc_16710500_22_38_Disease) (. .)))
16710500	1	(ROOT (S (NP (NNP Doc_16710500_54_64_Chemical)) (VP (VBZ is) (VP (VBN used) (PP (IN in) (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (NP (NNS Doc_16710500_93_105_Disease)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VP (VBZ is) (ADVP (RB still)) (ADJP (JJ prevalent) (PP (IN in) (NP (NNP Southeast) (NNP Asia))))) (, ,) (CC and) (VP (MD can) (VP (VB be) (VP (VBN associated) (PP (IN with) (NP (JJ permanent) (NNS Doc_16710500_188_199_Disease))))))))))))))) (. .)))
16710500	2	(ROOT (S (NP (PRP We)) (VP (VBP report) (NP (NP (CD 3) (NNS cases)) (SBAR (WHNP (WDT which)) (S (VP (VBN presented) (PP (IN with) (NP (NNS Doc_16710500_240_261_Disease)))))))) (. .)))
16710500	3	(ROOT (FRAG (NP (NNP CLINICAL) (NNP PICTURE)) (: :) (S (NP (NP (CD Three) (NNS patients)) (PP (IN with) (NP (ADJP (JJ Doc_16710500_301_311_Chemical-associated) (NN toxic)) (NNS Doc_16710500_329_345_Disease)))) (VP (VBP are) (VP (VBN described)))) (. .)))
16710500	4	(ROOT (S (NP (DT All) (CD 3) (NNS patients)) (VP (VBD had) (NP (NNS Doc_16710500_380_452_Disease))) (. .)))
16710500	5	(ROOT (S (NP (DT The) (NNS Doc_16710500_458_475_Disease)) (VP (VBD had) (NP (DT a) (JJ bitemporal) (NN flavour)) (, ,) (S (VP (VBG suggesting) (NP (NP (NN involvement)) (PP (IN of) (NP (DT the) (JJ optic) (NN chiasm))))))) (. .)))
16710500	6	(ROOT (S (PP (IN Despite) (S (VP (VBG stopping) (NP (NNS Doc_16710500_574_584_Chemical)) (PP (IN on) (NP (NN diagnosis)))))) (, ,) (NP (JJ visual) (NN function)) (VP (VBD continued) (S (VP (TO to) (VP (VB deteriorate) (PP (IN for) (NP (DT a) (JJ few) (NNS months))))))) (. .)))
16710500	7	(ROOT (S (NP (JJ Subsequent) (NN improvement)) (VP (VBD was) (ADJP (JJ mild) (PP (IN in) (NP (CD 2) (NNS cases))))) (. .)))
16710500	8	(ROOT (S (PP (IN In) (NP (DT the) (JJ third) (NN case))) (, ,) (NP (NP (JJ visual) (NN acuity)) (CC and) (NP (NN colour) (NN vision))) (VP (VBD normalised) (SBAR (CC but) (S (NP (DT the) (JJ optic) (NNS discs)) (VP (VBD were) (ADJP (JJ pale)))))) (. .)))
16710500	9	(ROOT (S (NP (DT All) (CD 3) (NNS patients)) (VP (VBD had) (NP (DT some) (JJ permanent) (NNS Doc_16710500_838_861_Disease))) (. .)))
16710500	10	(ROOT (S (NP (JJ Doc_16710500_876_886_Chemical) (NN usage)) (VP (VP (VBZ is) (VP (VBN associated) (PP (IN with) (NP (JJ permanent) (NNS Doc_16710500_922_933_Disease))))) (CC and) (VP (MD should) (VP (VB be) (VP (VP (VBN avoided) (SBAR (IN if) (FRAG (ADJP (JJ possible))))) (CC or) (VP (VBN used) (PP (IN with) (NP (NP (NN caution)) (CC and) (NP (JJ proper) (JJ ophthalmological) (NN follow-up))))))))) (. .)))
16710500	11	(ROOT (S (NP (DT The) (NN author)) (VP (VBZ postulates) (SBAR (IN that) (S (PP (IN in) (NP (NP (NNS cases)) (PP (IN of) (NP (NP (NNS Doc_16710500_1067_1077_Chemical)) (VP (VBN associated) (ADVP (RB chiasmopathy))))))) (, ,) (NP (NNS Doc_16710500_1103_1113_Chemical)) (VP (MD may) (ADVP (RB initially)) (VP (VP (VB affect) (NP (DT the) (JJ optic) (NNS nerves))) (CC and) (ADVP (RB subsequently)) (VP (VB progress) (S (VP (TO to) (VP (VB involve) (NP (DT the) (JJ optic) (NN chiasm))))))))))) (. .)))
16720068	0	(ROOT (S (NP (JJ Possible) (NNS Doc_16720068_9_39_Disease)) (VP (VBD related) (PP (TO to) (NP (JJ concomitant) (NN treatment))) (PP (IN with) (NP (NNS Doc_16720068_78_88_Chemical) (CC and) (NNS Doc_16720068_93_103_Chemical)))) (. .)))
16720068	1	(ROOT (S (NP (NP (DT A) (JJ 74-year-old) (NN man)) (PP (IN with) (NP (NNS Doc_16720068_128_147_Disease)))) (VP (VBD was) (VP (VBN admitted) (PP (TO to) (NP (NP (DT a) (JJ Doc_16720068_166_177_Disease) (NN hospital)) (ADJP (JJ due) (PP (TO to) (NP (NNS Doc_16720068_194_202_Disease) (, ,) (NNS Doc_16720068_204_220_Disease) (, ,) (NNP exhaustion) (, ,) (CC and) (NNP Doc_16720068_238_247_Disease)))))))) (. .)))
16720068	2	(ROOT (S (NP (NNP Medical) (NN treatment)) (VP (VBD was) (VP (VBN initiated) (PP (IN at) (NP (NP (DT a) (JJ daily) (NN dose)) (PP (IN of) (NP (NP (CD 20) (NN mg) (NNS Doc_16720068_306_316_Chemical)) (CC and) (NP (CD 1.2) (NN mg) (NNS Doc_16720068_328_338_Chemical)))))))) (. .)))
16720068	3	(ROOT (S (PP (IN On) (NP (NP (DT the) (JJ 10th) (NN day)) (PP (IN of) (NP (NNS Doc_16720068_359_369_Chemical) (CC and) (NNS Doc_16720068_374_384_Chemical) (NN treatment))))) (, ,) (NP (DT the) (NN patient)) (VP (VBD exhibited) (NP (NP (JJ marked) (NNS Doc_16720068_425_448_Disease)) (, ,) (NP (NN disorientation)) (, ,) (CC and) (NP (JJ severe) (NNS Doc_16720068_477_492_Disease))) (PP (IN with) (NP (NNS Doc_16720068_498_505_Disease)))) (. .)))
16720068	4	(ROOT (S (NP (DT The) (NN patient)) (VP (VBD had) (NP (NP (NP (DT a) (NNS Doc_16720068_525_530_Disease)) (PRN (-LRB- -LRB-) (NP (NNP 38.2) (NNP degrees) (NNP C)) (-RRB- -RRB-))) (, ,) (NP (NP (VBG fluctuating) (NN blood) (NN pressure)) (PRN (-LRB- -LRB-) (NP (QP (IN between) (CD 165/90) (CC and) (CD 130/70) (CD mg)) (NN mm) (NN Hg)) (-RRB- -RRB-))) (, ,) (CC and) (NP (JJ severe) (NNS Doc_16720068_625_648_Disease)))) (. .)))
16720068	5	(ROOT (S (NP (NNP Laboratory) (NNS tests)) (VP (VBD showed) (NP (NP (DT an) (NN elevation)) (PP (IN of) (NP (NP (NP (JJ Doc_16720068_690_698_Chemical) (NN phosphokinase)) (PRN (-LRB- -LRB-) (NP (QP (CD 2218) (CD IU/L))) (-RRB- -RRB-))) (, ,) (NP (NP (JJ Doc_16720068_726_735_Chemical) (NN aminotransferase)) (PRN (-LRB- -LRB-) (NP (QP (CD 134) (CD IU/L))) (-RRB- -RRB-))) (, ,) (NP (NP (JJ Doc_16720068_765_772_Chemical) (NN aminotransferase)) (PRN (-LRB- -LRB-) (NP (QP (CD 78) (CD IU/L))) (-RRB- -RRB-))) (, ,) (CC and) (NP (NP (NNP BUN)) (PRN (-LRB- -LRB-) (NP (CD 27.9) (NN mg/ml)) (-RRB- -RRB-)) (NP (NNS levels))))))) (. .)))
16720068	6	(ROOT (S (S (NP (DT The) (NN patient)) (VP (VBD received) (NP (NP (NNS Doc_16720068_851_864_Chemical)) (FRAG (CC and) (NP (NP (NNS Doc_16720068_869_877_Chemical)) (SBAR (S (VP (TO to) (VP (VB treat) (NP (PRP$ his) (NNS symptoms)))))) (. .)))) (NP (CD 7) (NNS days) (RB later)))) (, ,) (S (NP (DT the) (NNS Doc_16720068_919_924_Disease)) (VP (VBD disappeared))) (CC and) (S (NP (NP (DT the) (NN patient) (POS 's)) (JJ serum) (NNP CPK) (NNS levels)) (VP (VBD were) (VP (VBN normalized) (PRN (-LRB- -LRB-) (ADJP (QP (CD 175) (CD IU/L))) (-RRB- -RRB-))))) (. .)))
16720068	7	(ROOT (S (NP (DT This) (NN patient)) (VP (VBN presented) (PP (IN with) (NP (NP (NNS symptoms)) (PP (IN of) (NP (NP (NNS Doc_16720068_1040_1070_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_16720068_1072_1075_Disease)) (-RRB- -RRB-)))))) (, ,) (S (ADVP (RB thus)) (VP (VBG demonstrating) (SBAR (IN that) (S (NP (NN Doc_16720068_1102_1105_Disease-like) (NNS symptoms)) (VP (MD can) (VP (VB occur) (PP (IN after) (NP (NP (VBN combined) (NNS Doc_16720068_1145_1155_Chemical)) (CC and) (NP (JJ Doc_16720068_1160_1170_Chemical) (NN treatment))))))))))) (. .)))
16720068	8	(ROOT (S (NP (NP (DT The) (JJ adverse) (NN drug) (NN reaction) (NN score)) (VP (VBN obtained) (PP (IN by) (NP (DT the) (NNP Naranjo) (NN algorithm))))) (VP (VBD was) (NP (NP (CD 6)) (PP (IN in) (NP (PRP$ our) (NN case))) (, ,) (VP (VBG indicating) (NP (NP (NP (DT a) (JJ probable) (NN relationship)) (PP (IN between) (NP (NP (DT the) (NN patient) (POS 's)) (JJ Doc_16720068_1324_1327_Disease-like) (JJ adverse) (NNS symptoms)))) (CC and) (NP (NP (DT the) (VBN combined) (NN treatment)) (VP (VBN used) (PP (IN in) (NP (DT this) (NN case))))))))) (. .)))
16720068	9	(ROOT (S (NP (NP (DT The) (NN involvement)) (PP (IN of) (NP (NP (ADJP (JJ physiologic) (CC and) (JJ environmental)) (NNS aspects)) (ADJP (JJ specific) (PP (TO to) (NP (DT this) (NN patient))))))) (VP (VBD was) (VP (VBN suspected))) (. .)))
16720068	10	(ROOT (S (NP (NP (JJ Several) (NN risk) (NNS factors)) (PP (IN for) (NP (NNS Doc_16720068_1518_1521_Disease)))) (VP (MD should) (VP (VB be) (VP (VBN noted) (PP (IN in) (NP (NP (JJ elderly) (JJ Doc_16720068_1549_1559_Disease) (NNS patients)) (SBAR (WHNP (WP$ whose) (NNS symptoms)) (S (ADVP (RB often)) (VP (VBP include) (NP (NP (NNS Doc_16720068_1598_1609_Disease)) (, ,) (NP (NNS Doc_16720068_1611_1620_Disease)) (, ,) (NP (NNS Doc_16720068_1622_1634_Disease)) (, ,) (CC and) (NP (NN exhaustion))))))))))) (. .)))
16720068	11	(ROOT (S (NP (JJ Careful) (JJ therapeutic) (NN intervention)) (VP (VBZ is) (ADJP (JJ necessary) (PP (IN in) (NP (NP (NNS cases)) (PP (VBG involving) (NP (NP (JJ elderly) (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBP suffer) (PP (IN from) (NP (NNS Doc_16720068_1750_1760_Disease)))))))))))) (. .)))
16725121	0	(ROOT (S (NP (NP (NNP Down-regulation)) (PP (IN of) (NP (JJ Doc_16725121_19_33_Chemical) (NN transporter) (NN function)))) (VP (VBN induced) (PP (IN by) (NP (NP (JJ chronic) (NN administration)) (PP (IN of) (NP (NP (NNS Doc_16725121_92_103_Chemical)) (VP (VBG linking) (PP (TO to) (NP (NP (DT the) (NN alteration)) (PP (IN of) (NP (NP (NN sensitivity)) (PP (IN of) (NP (NP (JJ local-anesthetics-induced) (NNS Doc_16725121_174_185_Disease)) (CC and) (NP (DT the) (NN counteraction)))))))) (PP (IN by) (NP (NP (NN co-administration)) (PP (IN with) (NP (JJ local) (NNS anesthetics))))))))))) (. .)))
16725121	1	(ROOT (S (S (NP (NP (NNS Alterations)) (PP (IN of) (NP (NP (JJ Doc_16725121_268_282_Chemical) (NN transporter)) (PRN (-LRB- -LRB-) (NP (NNP NET)) (-RRB- -RRB-))))) (VP (VBP function) (PP (IN by) (NP (NP (JJ chronic) (NN inhibition)) (PP (IN of) (NP (NP (NNP NET)) (PP (IN in) (NP (NN relation))))))) (S (VP (TO to) (VP (VB sensitization) (S (VP (TO to) (VP (ADVP (RB Doc_16725121_371_379_Disease)) (VB induce) (PP (IN by) (NP (NNS Doc_16725121_390_397_Chemical))))))))))) (CC and) (S (NP (JJ local) (NNS anesthetics)) (VP (VBD were) (VP (VBN studied) (PP (IN in) (NP (NNS mice)))))) (. .)))
16725121	2	(ROOT (S (NP (NP (JJ Daily) (NN administration)) (PP (IN of) (NP (NP (NP (NNS Doc_16725121_466_477_Chemical)) (, ,) (NP (NP (DT an) (NN inhibitor)) (PP (IN of) (NP (DT the) (NNP NET)))) (, ,)) (PP (IN for) (NP (CD 5) (NNS days)))))) (VP (VBD decreased) (S (VP (VBG -LSB-) (NP (NP (LST (-LRB- -LRB-) (LS 3) (-RRB- -RRB-)) (NP (NNP H) (NNP -RSB-) (NNS Doc_16725121_531_545_Chemical) (NN uptake)) (PP (IN in) (NP (NP (DT the) (CD P2) (NNS fractions)) (PP (IN of) (NP (NNS hippocampus)))))) (CONJP (CC but) (RB not)) (NP (NN cortex) (, ,) (NN striatum) (CC or) (NN amygdalae)))))) (. .)))
16725121	3	(ROOT (S (NP (NP (NNP Co-administration)) (PP (IN of) (NP (NNS Doc_16725121_648_657_Chemical) (, ,) (NNS Doc_16725121_659_670_Chemical) (CC or) (NNS Doc_16725121_674_682_Chemical))) (PP (IN with) (NP (NNS Doc_16725121_688_699_Chemical)))) (VP (VBD reversed) (NP (DT this) (NN effect))) (. .)))
16725121	4	(ROOT (S (NP (NP (JJ Daily) (NN treatment)) (PP (IN of) (NP (NNS Doc_16725121_741_748_Chemical)))) (VP (VBD increased) (NP (NP (NNP -LSB-) (PRN (-LRB- -LRB-) (NP (CD 3)) (-RRB- -RRB-)) (NNP H)) (ADJP (NP (CD -RSB-) (NNS Doc_16725121_765_779_Chemical)) (JJ uptake))) (PP (IN into) (NP (DT the) (NNS hippocampus)))) (. .)))
16725121	5	(ROOT (S (NP (NP (JJ Daily) (NN administration)) (PP (IN of) (NP (NNS Doc_16725121_833_844_Chemical)))) (VP (VP (VBD increased) (NP (NP (DT the) (NN incidence)) (PP (IN of) (NP (NP (NN appearance)) (PP (IN of) (NP (NN Doc_16725121_886_895_Chemical-induced) (NNS Doc_16725121_904_915_Disease))))))) (CC and) (VP (VBD decreased) (NP (NP (DT that)) (PP (IN of) (NP (NN Doc_16725121_938_945_Chemical-induced) (NNS Doc_16725121_954_965_Disease)))))) (. .)))
16725121	6	(ROOT (S (NP (NP (NNP Co-administration)) (PP (IN of) (NP (NP (NNS Doc_16725121_988_997_Chemical)) (PP (IN with) (NP (NNS Doc_16725121_1003_1014_Chemical)))))) (VP (VBD reversed) (NP (NP (DT the) (NNS changes)) (PP (IN of) (NP (NP (JJ Doc_16725121_1039_1049_Disease) (NN activity)) (PP (IN of) (NP (NP (NNS Doc_16725121_1062_1071_Chemical) (CC and) (NNS Doc_16725121_1076_1083_Chemical)) (VP (VBN induced) (PP (IN by) (NP (NP (VBN repeated) (NN administration)) (PP (IN of) (NP (NNS Doc_16725121_1122_1133_Chemical)))))))))))) (. .)))
16725121	7	(ROOT (S (NP (DT These) (NNS results)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NP (NN down-regulation)) (PP (IN of) (NP (NP (NNP hippocampal) (NNP NET)) (VP (VBN induced) (PP (IN by) (NP (NP (JJ chronic) (NN administration)) (PP (IN of) (NP (NNS Doc_16725121_1234_1245_Chemical))))))))) (VP (MD may) (VP (VB be) (ADJP (JJ relevant) (PP (TO to) (NP (NP (NN Doc_16725121_1265_1276_Chemical-induced) (NN sensitization)) (PP (IN of) (NP (JJ Doc_16725121_1302_1311_Chemical) (NNS Doc_16725121_1312_1323_Disease))))))))))) (. .)))
16725121	8	(ROOT (S (NP (NP (NNP Inhibition)) (PP (IN of) (NP (NP (JJ Doc_16725121_1339_1344_Chemical) (NNS channels)) (PP (IN by) (NP (JJ local) (NNS anesthetics)))))) (VP (MD may) (VP (VB regulate) (NP (NP (NN Doc_16725121_1388_1399_Chemical-induced) (NN down-regulation)) (PP (IN of) (NP (NNP NET) (NN function)))))) (. .)))
16725121	9	(ROOT (S (NP (NP (JJ Repeated) (NN administration)) (PP (IN of) (NP (NNS Doc_16725121_1468_1475_Chemical)))) (VP (VBZ induces) (NP (NP (NN up-regulation)) (PP (IN of) (NP (JJ hippocampal) (NNP NET) (NN function))))) (. .)))
16725121	10	(ROOT (S (NP (NP (JJ Doc_16725121_1527_1538_Chemical-induced) (NN sensitization)) (PP (IN of) (NP (JJ Doc_16725121_1564_1573_Chemical) (NNS Doc_16725121_1574_1582_Disease)))) (VP (MD may) (VP (VB have) (S (NP (DT a) (NN mechanism)) (ADJP (JJ distinct) (PP (IN from) (S (VP (VBG kindling) (S (VP (VBG resulting) (PP (IN from) (NP (NP (VBN repeated) (NN administration)) (PP (IN of) (NP (NNS Doc_16725121_1669_1676_Chemical)))))))))))))) (. .)))
16820346	0	(ROOT (S (NP (NNP Doc_16820346_0_12_Chemical)) (VP (VP (VBD prevented)) (CC and) (VP (VBD reversed) (NP (NN Doc_16820346_36_49_Chemical-induced) (NNS Doc_16820346_58_70_Disease)) (PP (IN in) (NP (DT the) (NN rat))))) (. .)))
16820346	1	(ROOT (S (S (VP (TO To) (VP (VB assess) (NP (NP (DT the) (JJ antioxidant) (NNS effects)) (PP (IN of) (NP (NP (NNS Doc_16820346_120_132_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_16820346_134_140_Chemical)) (-RRB- -RRB-))))) (PP (IN on) (NP (NP (NNS Doc_16820346_145_158_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_16820346_160_163_Chemical)) (-RRB- -RRB-)) (: -) (NP (JJ induced) (NNS Doc_16820346_173_185_Disease))))))) (, ,) (NP (CD 60) (JJ male) (JJ Sprague-Dawley) (NNS rats)) (VP (VBD were) (VP (VBN treated) (PP (IN with) (NP (NN Doc_16820346_233_239_Chemical) (CD 30) (NN mg/kg/day) (CC or) (NN tap) (NN water))) (PP (IN for) (NP (CD 15) (NNS days))))) (. .)))
16820346	2	(ROOT (S (NP (NNP Doc_16820346_279_282_Chemical)) (VP (VBD increased) (NP (NP (NP (NP (JJ systolic) (NN blood) (NN pressure)) (PRN (-LRB- -LRB-) (NP (NNP SBP)) (-RRB- -RRB-))) (PP (IN from) (NP (NP (QP (CD 109) (CD +)) (NNS /)) (PRN (: -) (NP (QP (CD 1.8) (TO to) (CD 135)) (NNS +)) (: /))))) (: -) (NP (NP (CD 0.6) (VBG mmHg) (CC and) (NN plasma) (NNS Doc_16820346_371_381_Chemical)) (PRN (-LRB- -LRB-) (FRAG (FRAG (ADJP (NP (CD 5711)) (JJ +)) (: /)) (: -) (FRAG (FRAG (ADJP (NP (CD 284.9)) (JJ saline)) (, ,) (NP (CD 7931) (CD +)) (: /)) (: -) (FRAG (ADJP (NP (CD 392.8) (NN U/ml)) (JJ dex)) (, ,) (NP (NP (NNP P)) (ADJP (JJ <) (NP (CD 0.001))))))) (-RRB- -RRB-))))) (. .)))
16820346	3	(ROOT (S (S (PP (IN In) (NP (DT this) (NN prevention) (NN study))) (, ,) (NP (NP (NNP SBP)) (PP (IN in) (NP (DT the) (NNP Doc_16820346_480_486_Chemical) (NNP +) (JJ Doc_16820346_489_492_Chemical) (NN group)))) (VP (VBD was) (VP (VBN increased) (PP (IN from) (NP (NP (CD 115) (JJ +) (NNS /)) (PRN (: -) (NP (NP (CD 0.4)) (PP (TO to) (NP (CD 124) (NNS +)))) (: /)) (: -) (NP (CD 1.5) (NN mmHg))))))) (, ,) (CC but) (S (NP (DT this)) (VP (VBD was) (ADJP (ADJP (RB significantly) (JJR lower)) (PP (IN than) (PP (IN in) (NP (DT the) (NN Doc_16820346_596_599_Chemical-only) (NN group))))) (PRN (-LRB- -LRB-) (NP (NP (NNP P) (POS ')) (JJ <) (NN 0.05)) (-RRB- -RRB-)))) (. .)))
16820346	4	(ROOT (S (NP (NNP Doc_16820346_624_630_Chemical)) (VP (VBD reversed) (NP (NP (NP (NN Doc_16820346_640_643_Chemical-induced) (NNS Doc_16820346_652_664_Disease)) (PRN (-LRB- -LRB-) (FRAG (FRAG (ADJP (NP (CD 129)) (JJ +)) (: /)) (: -) (FRAG (FRAG (NP (CD 0.6) (NN mmHg)) (, ,) (PP (FW vs.) (NP (CD 135) (NNS +))) (: /)) (: -) (FRAG (NP (CD 0.6)) (NP (NP (NN mmHg)) (NP (NP (NNP P) (POS ')) (NNP <) (CD 0.05)))))) (-RRB- -RRB-))) (CC and) (NP (NP (VBN decreased) (NN plasma) (NNS Doc_16820346_737_747_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (NP (NP (QP (CD 7931) (CD +)) (NNS /)) (PRN (: -) (NP (NP (CD 392.8) (NNS Doc_16820346_764_767_Chemical)) (, ,) (NP (CD 1187) (NNS +))) (: /))) (: -) (NP (NP (CD 441.2) (JJ Doc_16820346_784_790_Chemical) (JJ +) (NNS Doc_16820346_793_796_Chemical)) (, ,) (NP (NNP P) (NNP <)))) (NP (CD 0.0001))) (-RRB- -RRB-))))) (. .)))
16820346	5	(ROOT (FRAG (NP (NNP Plasma) (NNP Doc_16820346_818_825_Chemical)) (: /) (S (NP (NP (NNS Doc_16820346_826_833_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP NOx)) (-RRB- -RRB-))) (VP (VBD was) (VP (VBN decreased) (PP (IN in) (NP (NN Doc_16820346_857_860_Chemical-treated) (NNS rats))) (PP (VBN compared) (PP (TO to) (NP (NP (JJ saline-treated) (NNS rats)) (PRN (-LRB- -LRB-) (NP (NP (NP (NP (QP (CD 11.2) (CD +)) (NNS /)) (PRN (: -) (NP (NP (CD 1.08) (NN microm)) (, ,) (NP (CD 15.3) (NNS +))) (: /))) (: -) (NP (NP (CD 1.17) (NN microm)) (, ,) (ADVP (RB respectively)) (, ,))) (NP (NNP P) (NNP <) (NNP 0.05))) (-RRB- -RRB-)))))))) (. .)))
16820346	6	(ROOT (S (NP (NNP Doc_16820346_976_982_Chemical)) (VP (VP (VBD affected) (NP (DT neither) (NN plasma) (NN NOx))) (CC nor) (VP (VBZ thymus) (NP (NN weight)))) (. .)))
16820346	7	(ROOT (S (ADVP (RB Thus)) (, ,) (NP (NNS Doc_16820346_1036_1048_Chemical)) (VP (VP (VBD prevented)) (CC and) (VP (VBD reversed) (NP (NN Doc_16820346_1072_1085_Chemical-induced) (NNS Doc_16820346_1094_1106_Disease)) (PP (IN in) (NP (DT the) (NN rat))))) (. .)))
16826348	0	(ROOT (S (NP (NNP Doc_16826348_0_21_Disease)) (VP (VBD caused) (PP (IN by) (NP (NP (JJ high-dose) (JJ Doc_16826348_42_62_Chemical) (NN treatment)) (PP (IN in) (NP (DT a) (NN patient))))) (PP (IN with) (NP (NNS Doc_16826348_91_113_Disease)))) (. .)))
16826348	1	(ROOT (S (S (NP (NP (DT The) (JJ central) (JJ nervous) (NN system) (NNS Doc_16826348_142_150_Disease)) (PP (IN of) (NP (JJ high-dose) (NNS Doc_16826348_164_184_Chemical)))) (VP (VBZ is) (ADJP (RB well) (VBN recognized)))) (, ,) (CC but) (S (NP (NP (DT the) (NNS Doc_16826348_213_221_Disease)) (PP (IN of) (NP (NP (NNS Doc_16826348_225_245_Chemical)) (PP (IN in) (NP (DT the) (JJ peripheral) (JJ nervous) (NN system)))))) (VP (VBZ has) (VP (VBN been) (ADJP (RB infrequently) (VBN reported))))) (. .)))
16826348	2	(ROOT (S (NP (DT A) (JJ 49-year-old) (JJ Japanese) (NN man)) (VP (VBD was) (VP (VBN diagnosed) (PP (IN with) (NP (NNS Doc_16826348_357_379_Disease))))) (. .)))
16826348	3	(ROOT (S (SBAR (IN After) (S (NP (PRP he)) (VP (VBD achieved) (NP (JJ complete) (NN remission))))) (, ,) (NP (PRP he)) (VP (VBD received) (NP (NP (JJ high-dose) (JJ Doc_16826348_441_461_Chemical) (NN treatment)) (PRN (-LRB- -LRB-) (NP (NP (CD 2) (NNS g/m2)) (NP (NP (NP (RB twice) (DT a) (NN day)) (PP (IN for) (NP (CD 5) (NNS days)))) (: ;) (NP (NP (NN total)) (, ,) (NP (CD 20) (NNS g/m2))))) (-RRB- -RRB-))) (PP (IN as) (NP (NN consolidation) (NN therapy)))) (. .)))
16826348	4	(ROOT (S (S (NP (NP (DT The) (JJ first) (NN course)) (PP (IN of) (NP (JJ high-dose) (NNS Doc_16826348_576_596_Chemical)))) (VP (VBD resulted) (PP (IN in) (NP (DT no) (JJ unusual) (NNS symptoms))))) (, ,) (CC but) (S (PP (IN on) (NP (NP (NN day) (CD 21)) (PP (IN of) (NP (NP (DT the) (JJ second) (NN course)) (PP (IN of) (NP (NN treatment))))))) (, ,) (NP (DT the) (NN patient)) (VP (VBD complained) (PP (IN of) (NP (NNS Doc_16826348_705_713_Disease))) (PP (IN in) (NP (PRP$ his) (JJ right) (NN foot))))) (. .)))
16826348	5	(ROOT (S (NP (NN Electromyogram) (CC and) (NN nerve-conduction) (NNS studies)) (VP (VBD showed) (NP (NNS Doc_16826348_784_805_Disease)) (PP (IN in) (NP (DT both) (JJ peroneal) (NNS nerves)))) (. .)))
16826348	6	(ROOT (S (S (NP (DT This) (NNS Doc_16826348_836_846_Disease)) (VP (VBD was) (ADVP (RB gradually)) (VP (VBG resolving)))) (: ;) (S (S (ADVP (RB however)) (, ,) (SBAR (IN after) (S (NP (DT the) (NN patient)) (VP (VBD received) (NP (JJ allogeneic) (NN bone) (NN marrow) (NN transplantation))))) (, ,) (NP (DT the) (NNS symptoms)) (VP (VBD worsened) (, ,) (PP (IN with) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (NNS Doc_16826348_995_1020_Disease))))))) (, ,) (CC and) (S (NP (DT the) (NNS symptoms)) (ADVP (RB subsequently)) (VP (VBD responded) (PP (TO to) (NP (NNS Doc_16826348_1065_1083_Chemical)))))) (. .)))
16826348	7	(ROOT (S (S (SBAR (IN Although) (S (NP (NP (DT the) (NNS mechanisms)) (PP (IN of) (NP (NNS Doc_16826348_1112_1133_Disease)))) (VP (VBP are) (ADVP (RB still)) (ADJP (JJ unclear))))) (, ,) (NP (JJ high-dose) (NNS Doc_16826348_1163_1183_Chemical)) (VP (VBZ is) (NP (NP (DT a) (NN therapy)) (SBAR (WHNP (WDT that)) (S (VP (VBZ is) (ADJP (RB potentially) (JJ toxic) (PP (TO to) (NP (DT the) (JJ peripheral) (JJ nervous) (NN system)))))))))) (, ,) (CC and) (S (NP (NN auto/alloimmunity)) (VP (MD may) (VP (VB play) (NP (DT an) (JJ important) (NN role)) (PP (IN in) (NP (DT these) (NNS mechanisms)))))) (. .)))
16844102	0	(ROOT (NP (NP (NN Effect)) (PP (IN of) (NP (NNS Doc_16844102_10_26_Chemical) (CC and) (NNS Doc_16844102_31_43_Chemical))) (PP (IN on) (NP (NN Doc_16844102_47_62_Chemical-induced) (NNS Doc_16844102_71_84_Disease))) (. .)))
16844102	1	(ROOT (NP (NP (NNP Doc_16844102_86_101_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_16844102_103_105_Chemical)) (-RRB- -RRB-)) (: -) (NP (NP (JJ induced) (JJ dopaminergic) (NNS Doc_16844102_128_141_Disease)) (SBAR (S (VP (VBZ is) (VP (VBN believed) (S (VP (TO to) (VP (VB be) (VP (VBN associated) (PP (IN with) (NP (NP (DT the) (VBN increased) (NN formation)) (PP (IN of) (NP (JJ free) (NNS radicals)))))))))))))) (. .)))
16844102	2	(ROOT (S (NP (DT This) (NN study)) (VP (VBD examined) (NP (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (NP (NNS Doc_16844102_252_268_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_16844102_270_278_Chemical)) (-RRB- -RRB-))))) (, ,) (NP (NP (DT a) (NN scavenger)) (PP (IN of) (NP (JJ reactive) (JJ Doc_16844102_305_311_Chemical) (NNS species)))) (, ,) (CC and) (NP (NP (NP (NNS Doc_16844102_325_337_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_16844102_339_342_Chemical)) (-RRB- -RRB-))) (, ,) (NP (DT an) (JJ Doc_16844102_348_352_Chemical) (NN chelator)) (, ,))) (PP (IN on) (NP (DT the) (JJ MA-induced) (NNS Doc_16844102_381_394_Disease)))) (. .)))
16844102	3	(ROOT (S (NP (JJ Male) (NNS rats)) (VP (VBD were) (VP (VBN treated) (PP (IN with) (NP (NNS Doc_16844102_424_426_Chemical))) (PRN (-LRB- -LRB-) (NP (NP (CD 10) (NN mg/kg)) (, ,) (NP (DT every) (CD 2) (NN h))) (PP (IN for) (NP (CD four) (NNS injections))) (-RRB- -RRB-)))) (. .)))
16844102	4	(ROOT (S (NP (DT The) (NN rat)) (VP (VBD received) (NP (NP (NP (DT either) (NNS Doc_16844102_494_502_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 20) (NN mg/kg)) (-RRB- -RRB-))) (PP (PP (ADVP (RB intraperitoneally)) (IN for) (NP (CD 3) (NNS days))) (CC and) (ADVP (NP (CD 30) (NN min)) (RB prior)) (PP (TO to) (NP (NNP MA) (NN administration))) (CC or) (PP (NP (JJ Doc_16844102_584_587_Chemical) (PRN (-LRB- -LRB-) (NP (CD 50) (NN mg/kg)) (-RRB- -RRB-)) (JJ subcutaneously) (CD 30) (NNS min)) (PP (IN before) (NP (NNP MA) (NN administration))))))) (. .)))
16844102	5	(ROOT (S (NP (NP (DT The) (NNS concentrations)) (PP (IN of) (NP (NP (NNS Doc_16844102_669_677_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP DA)) (-RRB- -RRB-)) (, ,) (NP (NNS Doc_16844102_684_693_Chemical)) (CC and) (NP (NP (NP (PRP$ their) (NNS metabolites)) (VP (VBN decreased) (ADVP (RB significantly)) (PP (IN after) (NP (NP (NNP MA) (NN administration)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD was) (VP (VBN inhibited) (PP (IN by) (NP (DT the) (NNS Doc_16844102_792_800_Chemical) (CC and) (NNS Doc_16844102_805_808_Chemical) (NN pretreatment))))))))))) (. .) (NP (NP (NNS Doc_16844102_823_831_Chemical)) (CC and) (NP (NNS Doc_16844102_836_839_Chemical))))))) (VP (VBD attenuated) (NP (NP (DT the) (NN Doc_16844102_855_857_Chemical-induced) (NNS Doc_16844102_866_878_Disease)) (CONJP (RB as) (RB well) (IN as)) (NP (DT the) (NNS alterations))) (PP (IN in) (NP (DT the) (NN locomotor) (NN activity)))) (. .)))
16844102	6	(ROOT (S (S (NP (NP (DT The) (NN level)) (PP (IN of) (NP (NN lipid) (NN peroxidation)))) (VP (VBD was) (ADJP (JJR higher)))) (CC and) (S (NP (DT the) (VBN reduced) (JJ Doc_16844102_992_1003_Chemical) (NN concentration)) (VP (VBD was) (ADJP (JJR lower)) (PP (IN in) (NP (DT the) (JJ MA-treated) (NNS rats))))) (. .)))
16844102	7	(ROOT (S (NP (DT These) (NNS changes)) (VP (VBD were) (ADVP (RB significantly)) (VP (VBN attenuated) (PP (IN by) (NP (NNS Doc_16844102_1099_1107_Chemical) (CC and) (NNS Doc_16844102_1112_1115_Chemical))))) (. .)))
16844102	8	(ROOT (S (NP (DT This)) (VP (VBZ suggests) (SBAR (IN that) (S (NP (NNS Doc_16844102_1136_1144_Chemical) (CC and) (NNS Doc_16844102_1149_1152_Chemical)) (VP (VBP ameliorate) (NP (DT the) (JJ MA-induced) (NNS Doc_16844102_1179_1194_Disease)) (PP (IN by) (S (VP (VBG decreasing) (NP (NP (DT the) (NN level)) (PP (IN of) (NP (JJ oxidative) (NN stress))))))))))) (. .)))
1687392	0	(ROOT (S (NP (NP (NNP Blockade)) (PP (IN of) (NP (ADJP (DT both) (JJ D-1) (CC and) (JJ D-2)) (JJ Doc_1687392_29_37_Chemical) (NNS receptors)))) (VP (MD may) (VP (VB induce) (NP (NNS Doc_1687392_59_68_Disease)) (PP (IN in) (NP (NP (NNP mice) (. .)) (NP (CD 1)))))) (. .)))
1687392	1	(ROOT (S (NP (NP (DT The) (NNS Doc_1687392_85_94_Disease)) (VP (VBN induced) (PP (IN by) (NP (JJ Doc_1687392_106_114_Chemical) (NNS antagonists))))) (VP (VBZ has) (VP (VBN been) (VP (VP (VBN tested)) (CC and) (VP (NP (DT the) (JJ possible) (JJ Doc_1687392_160_168_Chemical) (NNS subtypes)) (ADJP (VBN involved) (PP (IN in) (FRAG (NP (NP (NNS Doc_1687392_190_199_Disease)) (SBAR (S (VP (VBD was) (VP (VBN determined))))) (. .)))))) (NP (CD 2))))) (. .)))
1687392	2	(ROOT (S (NP (NP (JJ Doc_1687392_219_227_Chemical) (NN antagonist) (NNS Doc_1687392_239_251_Chemical)) (, ,) (NP (NN D-1) (NN antagonist) (NNS Doc_1687392_268_277_Chemical)) (CC or) (NP (NN D-2) (NN antagonist) (NNS Doc_1687392_296_305_Chemical))) (VP (VBN induced) (NP (NNS Doc_1687392_314_323_Disease))) (. .)))
1687392	3	(ROOT (S (NP (NP (DT The) (NN effect)) (PP (IN of) (NP (NNS Doc_1687392_339_351_Chemical) (CC and) (NNS Doc_1687392_356_365_Chemical)))) (VP (VBD was) (ADJP (JJ dose-dependent))) (. .)))
1687392	4	(ROOT (S (NP (NP (NNP Combination)) (PP (IN of) (NP (NP (NNS Doc_1687392_401_410_Chemical)) (PP (IN with) (NP (NNS Doc_1687392_416_425_Chemical)))))) (VP (VBD did) (RB not) (VP (VB induce) (NP (NP (NNP Doc_1687392_441_450_Disease) (NNP potentiation) (. .)) (NP (CD 3))))) (. .)))
1687392	5	(ROOT (S (NP (NN D-1) (NN agonist) (NNS Doc_1687392_480_489_Chemical) (CC or) (NN D-2) (NN agonist) (NNS Doc_1687392_505_515_Chemical)) (VP (VBD decreased) (NP (NP (DT the) (NNS Doc_1687392_530_539_Disease)) (VP (VBN induced) (PP (IN by) (NP (NNS Doc_1687392_551_563_Chemical) (, ,) (NNS Doc_1687392_565_574_Chemical) (CC or) (NNS Doc_1687392_578_587_Chemical))) (. .))) (NP (CD 4))) (. .)))
1687392	6	(ROOT (S (NP (NP (NNP Combination)) (PP (IN of) (NP (NP (NNS Doc_1687392_607_616_Chemical)) (PP (IN with) (NP (NNS Doc_1687392_622_632_Chemical)))))) (VP (VBD did) (RB not) (VP (VB cause) (NP (NP (JJ potentiated) (NN inhibitory) (NN effect)) (PP (IN on) (NP (NP (NNS Doc_1687392_680_689_Disease)) (VP (VBN induced) (PP (IN by) (NP (JJ Doc_1687392_701_709_Chemical) (NNS antagonists))) (. .)))) (NP (CD 5))))) (. .)))
1687392	7	(ROOT (S (NP (DT The) (NNS data)) (VP (MD may) (VP (VB indicate) (SBAR (IN that) (S (SBAR (IN although) (S (NP (NN D-2) (NN receptor) (NN blockade)) (VP (VBZ is) (VP (VBN involved) (PP (IN in) (NP (NNS Doc_1687392_799_808_Disease))))))) (, ,) (NP (DT the) (NN D-1) (NN receptor)) (VP (MD may) (VP (VB plan) (NP (DT a) (NN role)))))))) (. .)))
16960342	0	(ROOT (S (NP (NP (JJ Sustained) (JJ clinical) (NN improvement)) (PP (IN of) (NP (NP (DT a) (NN patient)) (PP (IN with) (NP (JJ decompensated) (NNS Doc_16960342_63_74_Disease)))))) (VP (VBD virus-related) (NP (NNS Doc_16960342_89_98_Disease)) (PP (IN after) (NP (NN treatment))) (PP (IN with) (NP (JJ Doc_16960342_120_130_Chemical) (NN monotherapy)))) (. .)))
16960342	1	(ROOT (S (NP (NP (NNP Doc_16960342_144_177_Disease)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ causes) (NP (NNS Doc_16960342_192_207_Disease) (CC and) (NNS Doc_16960342_212_236_Disease))))) (, ,)) (VP (VBZ remains) (NP (NP (DT a) (JJ major) (NN health) (NN problem)) (PP (IN in) (NP (JJ Asian) (NNS countries))))) (. .)))
16960342	2	(ROOT (S (NP (NP (JJ Recent) (NN development)) (PP (IN of) (NP (NP (NN vaccine)) (PP (IN for) (NP (NN prevention)))))) (VP (VBZ is) (VP (VBN reported) (S (VP (TO to) (VP (VB be) (ADJP (JJ successful) (PP (IN in) (S (VP (VBG reducing) (NP (NP (DT the) (NN size)) (PP (IN of) (NP (RB chronically) (JJ infected) (NNS carriers)))))))) (, ,) (SBAR (IN although) (S (NP (DT the) (JJ standard) (JJ medical) (NNS therapies)) (VP (VBP have) (RB not) (VP (VBN been) (VP (VBN established) (PRT (RP up)) (PP (TO to) (NP (RB now))))))))))))) (. .)))
16960342	3	(ROOT (S (PP (IN In) (NP (DT this) (NN report))) (, ,) (NP (PRP we)) (VP (VBD encountered) (NP (DT a) (NN patient)) (PP (IN with) (NP (NP (JJ decompensated) (JJ HBV-related) (NNS Doc_16960342_567_576_Disease)) (SBAR (WHNP (WP who)) (S (VP (VBD exhibited) (NP (DT the) (JJ dramatic) (NNS improvements)) (PP (IN after) (NP (JJ antiviral) (NN therapy))))))))) (. .)))
16960342	4	(ROOT (S (NP (DT The) (NN patient)) (VP (VBD was) (NP (DT a) (JJ 50-year-old) (NN woman))) (. .)))
16960342	5	(ROOT (S (S (NP (JJ Previous) (JJ conventional) (JJ medical) (NNS treatments)) (VP (VBD were) (RB not) (ADJP (JJ effective) (PP (IN for) (NP (DT this) (NN patient)))))) (, ,) (RB thus) (S (NP (DT this) (NN patient)) (VP (VBD had) (VP (VBN been) (VP (VBN referred) (PP (TO to) (NP (PRP$ our) (NN hospital))))))) (. .)))
16960342	6	(ROOT (S (ADVP (RB However)) (, ,) (NP (NP (DT the) (NN administration)) (PP (IN of) (NP (NP (NP (NNS Doc_16960342_841_851_Chemical)) (, ,) (NP (DT a) (JJ reverse) (NN transcriptase) (NN inhibitor)) (, ,)) (PP (IN for) (NP (CD 23) (NNS months)))))) (ADVP (RB dramatically)) (VP (VBD improved) (NP (PRP$ her) (NN liver) (NN severity))) (. .)))
16960342	7	(ROOT (S (PP (IN During) (NP (DT this) (NN period))) (, ,) (S (NP (DT no) (NN drug)) (VP (VBD resistant) (SBAR (S (NP (NNP mutant) (NNP HBV)) (VP (VBD emerged)))))) (, ,) (CC and) (S (NP (DT the) (JJ serum) (JJ HBV-DNA) (NN level)) (VP (VBD was) (VP (ADVP (RB continuously)) (VBN suppressed)))) (. .)))
16960342	8	(ROOT (S (NP (DT These) (JJ virological) (NNS responses)) (VP (VBD were) (ADVP (RB also)) (VP (VBN maintained) (SBAR (RB even) (IN after) (S (NP (DT the) (JJ antiviral) (NN therapy)) (VP (VBD was) (VP (VBN discontinued))))))) (. .)))
16960342	9	(ROOT (S (ADVP (RB Moreover)) (, ,) (NP (NP (DT both) (JJ Doc_16960342_1174_1185_Disease) (NN surface) (NN antigen)) (CC and) (NP (JJ e) (NN antigen))) (VP (VBD were) (ADJP (JJ observed) (S (VP (TO to) (VP (VB have) (VP (VBN disappeared) (PP (IN in) (NP (DT this) (NN patient))))))))) (. .)))
16960342	10	(ROOT (S (NP (NP (DT The) (NN administration)) (PP (IN of) (NP (NP (NNS Doc_16960342_1289_1299_Chemical)) (PP (TO to) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ HBV-related) (NNS Doc_16960342_1329_1338_Disease)))))))) (, ,) (PP (IN like) (NP (PRP$ our) (JJ present) (NN case))) (, ,) (VP (MD should) (VP (VB be) (VP (VBN considered) (PP (PP (IN as) (NP (DT an) (JJ initial) (JJ medical) (JJ therapeutic) (NN option))) (, ,) (RB especially) (PP (IN in) (NP (NP (NNS countries)) (SBAR (WHADVP (WRB where)) (S (NP (NN liver) (NN transplantation)) (VP (VBZ is) (RB not) (ADJP (ADVP (RB reliably)) (JJ available))))))))))) (. .)))
1700207	0	(ROOT (NP (NP (JJ Antiarrhythmic) (NNS effects)) (PP (IN of) (NP (JJ optical) (NNS isomers))) (PP (IN of) (NP (NP (NNS Doc_1700207_45_56_Chemical)) (PP (IN on) (NP (JJ canine) (NNS Doc_1700207_67_90_Disease))))) (. .)))
1700207	1	(ROOT (S (NP (NP (JJ Antiarrhythmic) (NNS effects)) (PP (IN of) (NP (NP (-LRB- -LRB-) (NNP +) (-RRB- -RRB-)) (: -) (NP (NP (NNS Doc_1700207_122_133_Chemical)) (CC and) (NP (-LRB- -LRB-) (NNP -) (-RRB- -RRB-))) (: -) (NP (NNS Doc_1700207_142_153_Chemical))))) (VP (VBD were) (VP (VBN examined) (S (VP (VBG using) (NP (CD two) (JJ canine) (JJ Doc_1700207_185_207_Disease) (NNS models)))))) (. .)))
1700207	2	(ROOT (S (NP (NP (JJ Digitalis) (NNS Doc_1700207_226_236_Disease)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (VP (VBN suppressed) (PP (IN by) (NP (JJ Doc_1700207_261_263_Chemical) (NN channel) (NNS blockers))))))) (, ,)) (VP (VBD was) (VP (VBN induced) (PP (IN by) (S (VP (VBG intermittent) (NP (NP (JJ intravenous) (PRN (-LRB- -LRB-) (NP (NNP i.v.)) (-RRB- -RRB-)) (NN injection)) (PP (IN of) (NP (NP (NNS Doc_1700207_342_349_Chemical)) (PP (IN in) (NP (NN Doc_1700207_353_366_Chemical-anesthetized) (NNS dogs))))))))))) (. .)))
1700207	3	(ROOT (S (NP (NP (JJ Doc_1700207_386_396_Chemical) (NN arrhythmia)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (VP (VBN suppressed) (PP (IN by) (NP (JJ Doc_1700207_432_434_Chemical) (NN channel) (NNS blockers))))))) (, ,)) (VP (VBD was) (VP (VBN induced) (PP (IN by) (NP (NP (JJ Doc_1700207_468_478_Chemical) (NN infusion)) (PP (IN in) (NP (NN Doc_1700207_491_500_Chemical-anesthetized) (NNS dogs))))))) (. .)))
1700207	4	(ROOT (NP (NP (JJ Doc_1700207_520_523_Chemical) (CC and) (CD 5) (NN mg/kg) (NNS i.v.)) (PRN (-LRB- -LRB-) (NP (NNP +)) (-RRB- -RRB-)) (: -) (NP (NP (NNS Doc_1700207_545_556_Chemical)) (VP (VBN suppressed) (NP (ADJP (JJ Doc_1700207_568_577_Chemical) (: -) (CC and) (JJ Doc_1700207_583_593_Chemical-induced)) (NNS Doc_1700207_602_613_Disease)) (, ,) (ADVP (RB respectively)))) (. .)))
1700207	5	(ROOT (NP (NP (NP (NP (DT The) (JJ minimum) (JJ effective) (NN plasma) (NNS concentrations)) (PP (IN of))) (PRN (-LRB- -LRB-) (NP (NNP +)) (-RRB- -RRB-))) (: -) (NP (NP (NNS Doc_1700207_680_691_Chemical)) (PP (IN for) (NP (NP (NP (NNS Doc_1700207_696_705_Chemical)) (PRN (: -) (CC and) (S (NP (NN Doc_1700207_711_721_Chemical-induced) (NNS Doc_1700207_730_741_Disease)) (VP (VBD were) (NP (QP (CD 1.4) (CD +))))) (: /))) (PRN (: -) (NP (NP (CD 0.4)) (CC and) (NP (NNP 2.0) (NNP +))) (: /))))) (: -) (NP (NP (NP (CD 0.6) (NN micrograms/ml)) (, ,) (ADVP (RB respectively))) (PRN (-LRB- -LRB-) (S (VP (VB mean) (NP (NP (NNP +) (NNP /)) (: -) (NP (NP (NNP SD)) (, ,) (VP (VBN n) (S (VP (SYM =) (NP (CD 6))))))))) (-RRB- -RRB-))) (. .)))
1700207	6	(ROOT (S (NP (NP (DT A) (JJR lower) (NN dose)) (PP (IN of) (NP (NP (CD 1) (VBG mg/kg) (NN i.v.)) (PP (IN of) (NP (NP (-LRB- -LRB-) (NNP -) (-RRB- -RRB-)) (: -) (NP (NNS Doc_1700207_861_872_Chemical))))))) (VP (VBD suppressed) (NP (DT the) (NN Doc_1700207_888_897_Chemical-induced) (NNS Doc_1700207_906_916_Disease)) (, ,) (SBAR (IN whereas) (S (NP (CD 5) (NN mg/kg) (NN i.v.)) (VP (VBD was) (VP (VBN needed) (S (VP (TO to) (VP (VB suppress) (NP (NN Doc_1700207_962_972_Chemical-induced) (NNS Doc_1700207_981_992_Disease)))))))))) (. .)))
1700207	7	(ROOT (S (NP (NP (DT The) (JJ minimum) (JJ effective) (NN plasma) (NNS concentrations)) (PP (IN of) (NP (NP (-LRB- -LRB-) (NNP -) (-RRB- -RRB-)) (: -) (NP (NP (NNS Doc_1700207_1045_1056_Chemical)) (PP (IN for) (NP (NNS Doc_1700207_1061_1070_Chemical)))) (: -) (CC and) (NP (NN Doc_1700207_1076_1086_Chemical-induced) (NNS Doc_1700207_1095_1105_Disease))))) (VP (VBD were) (VP (VBG 0.06) (NP (NP (NP (NNP +) (NNP /)) (PRN (: -) (NP (NP (CD 0.04)) (CC and) (NP (CD 0.7) (NNS +))) (: /))) (: -) (NP (CD 0.1) (NN micrograms/ml)) (, ,) (ADVP (RB respectively))) (PRN (-LRB- -LRB-) (S (VP (VB mean) (NP (NP (NNP +) (NNP /)) (: -) (NP (NP (NNP SD)) (, ,) (VP (VBN n) (S (VP (SYM =) (NP (CD 6))))))))) (-RRB- -RRB-)))) (. .)))
1700207	8	(ROOT (S (S (NP (NP (DT The) (ADJP (JJR stronger) (JJ antiarrhythmic)) (NN effect)) (PP (IN of) (NP (NP (-LRB- -LRB-) (NNP -) (-RRB- -RRB-)) (: -) (NP (NNS Doc_1700207_1233_1244_Chemical))))) (VP (VBZ indicates) (NP (NP (DT that)) (PRN (-LRB- -LRB-) (NP (NNP -)) (-RRB- -RRB-)) (: -) (SBAR (S (NP (NN isomer)) (VP (MD may) (VP (VB have) (NP (NP (DT an) (NN effect)) (ADJP (ADJP (NP (QP (RB nearly) (CD 5-20)) (NNS times)) (JJR stronger)) (PP (IN in) (S (VP (VBG suppressing) (NP (JJ Doc_1700207_1332_1334_Chemical) (NNS channels)))))))))))))) (, ,) (CC but) (S (NP (NP (NNS effects)) (PP (IN of) (NP (NP (DT both) (NNS drugs)) (PP (IN on) (NP (JJ Doc_1700207_1374_1376_Chemical) (NNS channels)))))) (VP (MD may) (VP (VB be) (ADJP (RB almost) (JJ equipotent))))) (. .)))
17019386	0	(ROOT (NP (NP (NP (NNP Passage)) (PP (IN of) (NP (NP (NNS Doc_17019386_11_19_Chemical)) (PP (IN into) (NP (NP (DT the) (NN brain)) (PP (IN around) (NP (NNS Doc_17019386_42_49_Disease)))))))) (: :) (NP (NP (DT a) (JJ potential) (NN cause)) (PP (IN of) (NP (NN rebound) (NN phenomenon)))) (. .)))
17019386	1	(ROOT (NP (NP (DT A) (NN study)) (PP (IN on) (NP (CD 21) (NNS patients))) (. .)))
17019386	2	(ROOT (S (NP (NP (JJ Widespread) (NN use)) (PP (IN of) (NP (NNS Doc_17019386_139_147_Chemical) (S (VP (TO to) (VP (VB reduce) (NP (NNS Doc_17019386_158_169_Disease) (CC and) (JJR lower) (NNS Doc_17019386_180_192_Disease)) (PP (IN in) (NP (JJ Doc_17019386_196_207_Disease) (NNS patients))))))))) (VP (VBZ continues) (S (VP (TO to) (VP (VB be) (VP (VBN afflicted) (PP (IN by) (NP (DT the) (JJ so-called) (NN rebound) (NN phenomenon)))))))) (. .)))
17019386	3	(ROOT (S (NP (NP (NNP Leakage)) (PP (IN of) (NP (NP (NNS Doc_17019386_291_299_Chemical)) (PP (IN into) (NP (NP (DT the) (NN brain) (NN parenchyma)) (PP (IN through) (NP (NP (DT an) (JJ altered) (UCP (NN BBB) (CC and) (JJ secondary)) (NN reversal)) (PP (IN of) (NP (JJ osmotic) (NN gradient)))))))))) (VP (VBZ is) (VP (VBN considered) (NP (NP (DT the) (JJ major) (NN cause)) (PP (IN of) (NP (NN rebound)))))) (. .)))
17019386	4	(ROOT (S (NP (DT This)) (VP (VBZ has) (ADVP (RB only)) (VP (VBN been) (VP (VBN demonstrated) (ADVP (RB experimentally)) (PP (IN in) (NP (NNS animals)))))) (. .)))
17019386	5	(ROOT (S (PP (IN As) (NP (NP (DT a) (NN contribution)) (PP (TO to) (NP (DT this) (NN issue))))) (NP (PRP we)) (VP (VBD decided) (S (VP (TO to) (VP (VB research) (NP (NP (DT the) (JJ possible) (NN passage)) (PP (IN of) (NP (NNS Doc_17019386_573_581_Chemical)))) (PP (IN into) (NP (DT the) (NN brain))) (PP (IN after) (NP (NN administration))) (PP (TO to) (NP (CD 21) (JJ Doc_17019386_624_635_Disease) (NNS patients))))))) (. .)))
17019386	6	(ROOT (S (NP (NP (NNP Doc_17019386_655_663_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (CD 18) (NN %) (NN solution)) (: ;) (NP (CD 1) (NN g/kg))) (-RRB- -RRB-))) (VP (VBD was) (VP (VBN administered) (PP (IN as) (NP (DT a) (NNS bolus))) (PP (TO to) (NP (NNS patients))) (PRN (-LRB- -LRB-) (S (NP (CD ten)) (VP (VBD had) (NP (NP (NNS Doc_17019386_736_752_Disease)) (, ,) (NP (CD seven) (NN brain) (NNS Doc_17019386_766_776_Disease)) (CC and) (NP (CD four) (NNS Doc_17019386_786_796_Disease))))) (-RRB- -RRB-)) (PP (NP (QP (RB about) (CD 30)) (NNS minutes)) (IN before) (NP (NN craniotomy))))) (. .)))
17019386	7	(ROOT (S (PP (IN During) (NP (NN resection))) (, ,) (NP (NP (DT a) (NN sample)) (PP (IN of) (NP (DT the) (VBG surrounding) (JJ Doc_17019386_880_889_Disease) (JJ white) (NN matter)))) (VP (VBD was) (VP (VBN taken) (PP (IN at) (NP (NP (DT the) (JJ same) (NN time)) (PP (IN as) (NP (DT a) (CD 10) (NNP ml) (NNS venous) (NN blood) (NN sample))))))) (. .)))
17019386	8	(ROOT (S (NP (JJ Doc_17019386_962_970_Chemical) (NNS concentrations)) (VP (VBD were) (VP (VBN measured) (PP (IN in) (NP (NP (NN plasma)) (CC and) (NP (JJ white) (NN matter)))) (PP (IN by) (NP (NP (DT a) (VBN modified) (NN version)) (PP (IN of) (NP (NP (DT the) (JJ enzyme) (NN assay)) (PP (IN of) (NP (NNP Blonquist) (CC et) (NNP al.))))))))) (. .)))
17019386	9	(ROOT (S (PP (IN In) (NP (JJS most) (JJ Doc_17019386_1106_1112_Disease) (NNS patients))) (, ,) (NP (NP (JJ Doc_17019386_1123_1131_Chemical) (NNS concentrations)) (PP (IN in) (NP (JJ white) (NN matter)))) (VP (VBD were) (ADJP (ADJP (NP (QP (CD 2) (TO to) (CD 6) (NNS times))) (JJR higher)) (PP (IN than) (PP (IN in) (NP (NN plasma))))) (PRN (-LRB- -LRB-) (S (VP (VB mean) (NP (QP (CD 3.5) (NNS times))))) (-RRB- -RRB-))) (. .)))
17019386	10	(ROOT (S (PP (IN In) (NP (JJ Doc_17019386_1224_1234_Disease) (CC and) (JJ Doc_17019386_1239_1249_Disease) (NNS patients))) (NP (NP (NN plasma) (NNS concentrations)) (PP (IN of) (NP (NNS Doc_17019386_1284_1292_Chemical)))) (VP (VBD were) (VP (RBR higher) (PP (IN than) (NP (JJ white) (NN matter) (NNS concentrations))) (PP (IN except) (IN in) (NP (NP (CD three) (NNS cases)) (PP (IN with) (NP (NN infiltration))))) (PP (IN by) (NP (JJ neoplastic) (NNS cells))))) (. .)))
17019386	11	(ROOT (S (NP (NP (DT The) (NNS results)) (PP (IN of) (NP (PRP$ our) (NN study)))) (VP (VBP show) (SBAR (IN that) (RB even) (S (PP (IN after) (NP (DT a) (JJ single) (NNS bolus))) (, ,) (NP (NNS Doc_17019386_1474_1482_Chemical)) (VP (MD may) (VP (VB leak) (PP (IN through) (NP (NP (DT the) (JJ altered) (NN BBB)) (PP (IN near) (NP (NNS Doc_17019386_1521_1528_Disease))))) (, ,) (S (VP (VP (VBG reversing) (NP (DT the) (JJ initial) (JJ plasma-to-blood) (JJ osmotic) (NN gradient))) (, ,) (VP (VBG aggravating) (NP (JJ peritumoral) (NNS Doc_17019386_1610_1615_Disease))) (CC and) (VP (VBG promoting) (NP (NP (NN rebound)) (PP (IN of) (NP (NNP ICP)))))))))))) (. .)))
17042884	0	(ROOT (NP (NP (JJ Placebo-level) (NN incidence)) (PP (IN of) (NP (NNS Doc_17042884_27_50_Disease))) (PRN (-LRB- -LRB-) (NP (NNP Doc_17042884_52_55_Disease)) (-RRB- -RRB-)) (PP (IN with) (NP (NP (NNS Doc_17042884_62_72_Chemical)) (PP (IN in) (NP (NP (JJ controlled) (NNS studies)) (PP (IN of) (NP (NP (NNS patients)) (PP (IN with) (NP (NNS Doc_17042884_112_125_Disease))))))))) (. .)))
17042884	1	(ROOT (S (VP (TO To) (VP (VB evaluate) (NP (NP (NP (NNS Doc_17042884_151_174_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_17042884_176_179_Disease)) (-RRB- -RRB-))) (, ,) (PP (VBG including) (NP (NNS Doc_17042884_192_201_Disease))) (, ,)) (PP (IN with) (NP (NP (NNS Doc_17042884_208_218_Chemical)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NNS Doc_17042884_236_249_Disease))))))))) (. .)))
17042884	2	(ROOT (S (NP (NNP Data)) (VP (VBD were) (VP (VP (VBN analyzed) (PP (IN from) (NP (NP (CD four)) (ADJP (RB similarly) (VBN designed))))) (, ,) (VP (VBN randomized)) (, ,) (VP (VBN double-blind) (, ,) (NP (CD 3))) (: -) (PP (TO to) (NP (JJ 12-week) (NNS studies))))) (. .)))
17042884	3	(ROOT (NP (NP (CD Two) (NNS studies)) (VP (VBN evaluated) (NP (NP (NP (NP (JJ Doc_17042884_380_390_Chemical) (NN monotherapy)) (PRN (-LRB- -LRB-) (NP (QP (IN up) (TO to) (CD 800) (CD mg/day))) (-RRB- -RRB-))) (PRN (-LRB- -LRB-) (VP (VBN n) (S (VP (SYM =) (NP (CD 209))))) (-RRB- -RRB-)) (CC versus) (NP (NP (NN placebo)) (PRN (-LRB- -LRB-) (VP (VBN n) (S (VP (SYM =) (NP (CD 198))))) (-RRB- -RRB-))) (, ,) (PP (IN with) (NP (NNS Doc_17042884_463_470_Chemical)))) (CC or) (NP (NP (JJ Doc_17042884_474_485_Chemical) (NN monotherapy)) (PP (IN as) (NP (JJ respective) (JJ active) (NNS controls)))))) (. .)))
17042884	4	(ROOT (S (NP (CD Two) (NNS studies)) (VP (VBZ evaluated) (NP (NNS Doc_17042884_551_561_Chemical)) (PRN (-LRB- -LRB-) (ADVP (RB up) (PP (TO to) (NP (CD 800)))) (ADJP (JJ mg/day)) (-RRB- -RRB-)) (PP (IN in) (NP (NP (NP (NN combination)) (PP (IN with) (NP (NP (DT a) (NN mood) (NN stabilizer)) (PRN (-LRB- -LRB-) (NP (NP (NNS Doc_17042884_620_627_Chemical) (CC or) (NNS Doc_17042884_631_641_Chemical)) (, ,) (NP (NNP Doc_17042884_643_646_Chemical) (NNP +) (NNP Doc_17042884_649_651_Chemical) (NNP /) (NNP Doc_17042884_652_655_Chemical))) (-RRB- -RRB-))))) (PRN (-LRB- -LRB-) (VP (VBN n) (S (VP (SYM =) (NP (CD 196))))) (-RRB- -RRB-)) (PP (VBN compared) (PP (TO to) (NP (NP (NP (NN placebo) (CC and) (NN mood) (NN stabilizer)) (PRN (-LRB- -LRB-) (NP (JJ Doc_17042884_708_711_Chemical) (NNP +) (NNP Doc_17042884_714_716_Chemical) (NNP /) (NNP Doc_17042884_717_720_Chemical)) (-RRB- -RRB-))) (PRN (-LRB- -LRB-) (VP (VBN n) (S (VP (SYM =) (NP (CD 203))))) (-RRB- -RRB-)))))))) (. .)))
17042884	5	(ROOT (S (NP (NNP Doc_17042884_733_756_Disease)) (VP (VBD were) (VP (VBN evaluated) (S (VP (VBG using) (NP (NP (NP (DT the) (NNP Simpson-Angus) (NNP Scale)) (PRN (-LRB- -LRB-) (NP (NNP SAS)) (-RRB- -RRB-)) (, ,) (NP (NP (DT the) (NNP Barnes) (NNP Akathisia) (NNP Rating) (NNP Scale)) (PRN (-LRB- -LRB-) (NP (NNP BARS)) (-RRB- -RRB-)))) (, ,) (NP (JJ adverse) (NN event) (NNS reports)) (CC and) (NP (JJ anticholinergic) (NN drug) (NN usage))))))) (. .)))
17042884	6	(ROOT (S (NP (NP (DT The) (NN incidence)) (PP (IN of) (NP (JJ Doc_17042884_931_934_Disease-related) (JJ adverse) (NNS events))) (, ,) (PP (VBG including) (NP (NNS Doc_17042884_969_978_Disease))) (, ,)) (VP (VBD was) (NP (NP (DT no) (ADJP (JJ different) (PP (IN with) (NP (NNS Doc_17042884_1002_1012_Chemical)))) (NN monotherapy)) (PRN (-LRB- -LRB-) (NP (CD 12.9) (NN %)) (-RRB- -RRB-))) (ADVP (IN than) (PP (IN with) (NP (NP (NN placebo)) (PRN (-LRB- -LRB-) (NP (CD 13.1) (NN %)) (-RRB- -RRB-)))))) (. .)))
17042884	7	(ROOT (S (ADVP (RB Similarly)) (, ,) (VP (VB Doc_17042884_1071_1074_Disease-related) (NP (NP (JJ adverse) (NNS events)) (PP (IN with) (NP (JJ Doc_17042884_1103_1106_Chemical) (JJ +) (NNS Doc_17042884_1109_1111_Chemical))) (PRN (: /) (S (NP (NP (NNS Doc_17042884_1112_1115_Chemical)) (PRN (-LRB- -LRB-) (NP (QP (CD 21.4) (NN %))) (-RRB- -RRB-))) (VP (VBD were) (ADJP (RB no) (JJ different) (PP (IN than) (PP (IN with) (NP (JJ Doc_17042884_1152_1155_Chemical) (JJ +) (NNS Doc_17042884_1158_1160_Chemical))))))) (: /)) (NP (NP (NNS Doc_17042884_1161_1164_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 19.2) (NN %)) (-RRB- -RRB-))))) (. .)))
17042884	8	(ROOT (S (NP (NP (JJ Adverse) (NNS events)) (VP (VBN related) (PP (TO to) (NP (NNS Doc_17042884_1200_1203_Disease))))) (VP (VBD occurred) (PP (IN in) (NP (NP (CD 59.6) (NN %)) (PP (IN of) (NP (NP (NNS patients)) (VP (VBN treated) (PP (IN with) (NP (NP (NNS Doc_17042884_1247_1258_Chemical)) (PRN (-LRB- -LRB-) (VP (VBN n) (S (VP (SYM =) (NP (CD 99))))) (-RRB- -RRB-)))) (ADVP (RB monotherapy)) (, ,) (SBAR (IN whereas) (S (NP (NP (CD 26.5) (NN %)) (PP (IN of) (NP (NP (NNS patients)) (VP (VBN treated) (PP (IN with) (NP (NNS Doc_17042884_1320_1327_Chemical)))))) (PRN (-LRB- -LRB-) (VP (VBN n) (S (VP (SYM =) (NP (CD 98))))) (-RRB- -RRB-))) (ADVP (RB monotherapy)) (VP (VBD experienced) (NP (NP (JJ adverse) (NNS events)) (VP (VBN related) (PP (TO to) (NP (NNS Doc_17042884_1387_1390_Disease)))))))))))))) (. .)))
17042884	9	(ROOT (S (NP (NP (DT The) (NN incidence)) (PP (IN of) (NP (NNS Doc_17042884_1409_1418_Disease)))) (VP (VBD was) (ADJP (JJ low) (CC and) (JJ similar)) (PP (PP (IN with) (NP (NP (JJ Doc_17042884_1444_1454_Chemical) (NN monotherapy)) (PRN (-LRB- -LRB-) (NP (CD 3.3) (NN %)) (-RRB- -RRB-)) (CC and) (NP (NN placebo)) (PRN (-LRB- -LRB-) (NP (CD 6.1) (NN %)) (-RRB- -RRB-)))) (, ,) (CC and) (PP (IN with) (NP (NP (NNP Doc_17042884_1503_1506_Chemical) (NNP +) (NNP Doc_17042884_1509_1511_Chemical) (PRN (: /) (NP (NP (NP (NP (NNS Doc_17042884_1512_1515_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 3.6) (NN %)) (-RRB- -RRB-))) (CC and) (NP (NNS Doc_17042884_1527_1530_Chemical))) (NP (JJ +) (NNS Doc_17042884_1533_1535_Chemical))) (: /)) (NNS Doc_17042884_1536_1539_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 4.9) (NN %)) (-RRB- -RRB-)))))) (. .)))
17042884	10	(ROOT (S (S (NP (NNP Doc_17042884_1548_1555_Chemical)) (VP (VBD was) (VP (VBN associated) (PP (IN with) (NP (NP (DT a) (ADJP (RB significantly) (JJR higher)) (NN incidence)) (PRN (-LRB- -LRB-) (NP (NNP p) (NNP <) (NNP 0.05)) (-RRB- -RRB-)) (PP (IN of) (NP (NP (NNS Doc_17042884_1623_1629_Disease)) (PRN (-LRB- -LRB-) (NP (CD 18.4) (NN %)) (-RRB- -RRB-)))))) (PP (IN than) (NP (NP (NNS Doc_17042884_1643_1653_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 5.6) (NN %)) (-RRB- -RRB-))))))) (: ;) (S (NP (NP (NN cerebellar) (NNS Doc_17042884_1673_1679_Disease)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (NP (NP (DT a) (VBN known) (JJ adverse) (NN effect)) (PP (IN of) (NP (NNS Doc_17042884_1716_1723_Chemical))))))) (, ,)) (VP (MD may) (VP (VB have) (VP (VBN contributed) (PP (TO to) (NP (NP (DT the) (JJ elevated) (NN rate)) (PP (IN of) (NP (NP (NNS Doc_17042884_1770_1776_Disease)) (PP (IN in) (NP (NNS patients))))))) (S (VP (VBG receiving) (NP (JJ Doc_17042884_1799_1806_Chemical) (NN therapy)))))))) (. .)))
17042884	11	(ROOT (S (NP (NNP Doc_17042884_1816_1827_Chemical)) (VP (VBN induced) (NP (NP (DT a) (ADJP (RB significantly) (JJR higher)) (NN incidence)) (PRN (-LRB- -LRB-) (NP (NNP p) (QP (CD <) (CD 0.001))) (-RRB- -RRB-)) (PP (IN of) (NP (NP (NP (NNS Doc_17042884_1884_1893_Disease)) (PRN (-LRB- -LRB-) (NP (NP (CD 33.3) (NN %)) (CC versus) (NP (CD 5.9) (NN %))) (-RRB- -RRB-))) (, ,) (NP (NP (NNS Doc_17042884_1915_1921_Disease)) (PRN (-LRB- -LRB-) (NP (NP (CD 30.3) (NN %)) (CC versus) (NP (CD 7.8) (NN %))) (-RRB- -RRB-))) (, ,) (CC and) (NP (NP (NNS Doc_17042884_1947_1970_Disease)) (PRN (-LRB- -LRB-) (NP (NP (CD 35.4) (NN %)) (CC versus) (NP (CD 5.9) (NN %))) (-RRB- -RRB-)))))) (PP (IN than) (NP (NNS Doc_17042884_1996_2006_Chemical)))) (. .)))
17042884	12	(ROOT (S (NP (DT No) (JJ significant) (NNS differences)) (VP (VBD were) (VP (VBN observed) (PP (IN between) (NP (NNS Doc_17042884_2057_2067_Chemical) (CC and) (NN placebo))) (PP (IN on) (NP (NNP SAS) (CC and) (NNP BARS) (NNS scores))))) (. .)))
17042884	13	(ROOT (S (NP (JJ Anticholinergic) (NN use)) (VP (VBD was) (ADJP (JJ low) (CC and) (JJ similar)) (PP (IN with) (NP (NNS Doc_17042884_2149_2159_Chemical) (CC or) (NN placebo)))) (. .)))
17042884	14	(ROOT (S (PP (IN In) (NP (NNS Doc_17042884_2188_2201_Disease))) (, ,) (NP (NP (DT the) (NN incidence)) (PP (IN of) (NP (NP (NNS Doc_17042884_2220_2223_Disease)) (, ,) (PP (VBG including) (NP (NP (NNS Doc_17042884_2235_2244_Disease)) (, ,) (PP (IN with) (NP (JJ Doc_17042884_2251_2261_Chemical) (NN therapy)))))))) (VP (VBZ is) (ADJP (JJ similar) (PP (TO to) (NP (NP (DT that)) (PP (IN with) (NP (NN placebo))))))) (. .)))
17049862	0	(ROOT (SQ (VBZ Is) (NP (JJ Doc_17049862_3_12_Chemical) (NN administration)) (NP (NP (JJ safe)) (PP (IN in) (NP (DT a) (JJ hypothermic) (NN child)))) (. ?)))
17049862	1	(ROOT (S (NP (NP (DT A) (JJ male) (NN neonate)) (PP (IN with) (NP (NP (DT a) (NNS Doc_17049862_79_98_Disease)) (CC and) (NP (DT a) (JJ leaking) (NN myelomeningocoele))))) (VP (VBD underwent) (NP (NP (JJ ventriculoperitoneal) (NN shunt) (NN insertion)) (VP (VBN followed) (PP (IN by) (NP (NP (NN repair)) (PP (IN of) (NP (NN myelomeningocoele)))))))) (. .)))
17049862	2	(ROOT (S (PP (IN During) (NP (NN anaesthesia) (CC and) (NN surgery))) (, ,) (NP (PRP he)) (ADVP (RB inadvertently)) (VP (VBD became) (ADJP (RB moderately) (JJ hypothermic))) (. .)))
17049862	3	(ROOT (S (NP (JJ Intravenous) (NNS Doc_17049862_311_320_Chemical)) (VP (VBD was) (VP (VBN administered) (PP (IN during) (NP (NP (DT the) (JJ later) (NN part)) (PP (IN of) (NP (NP (DT the) (NN surgery)) (PP (IN for) (NP (JJ Doc_17049862_379_386_Disease) (NNS prophylaxis))))))))) (. .)))
17049862	4	(ROOT (S (PP (VBG Following) (NP (JJ Doc_17049862_410_419_Chemical) (NN administration))) (, ,) (NP (DT the) (NN patient)) (VP (VBD developed) (NP (JJ acute) (JJ severe) (NNS Doc_17049862_471_482_Disease)) (, ,) (S (VP (VBG refractory) (PP (TO to) (NP (NNS Doc_17049862_498_506_Chemical) (CC and) (NNS Doc_17049862_511_521_Chemical)))))) (. .)))
17049862	5	(ROOT (S (NP (NP (DT The) (JJ cardiac) (NN depressant) (NNS actions)) (PP (IN of) (NP (NNS Doc_17049862_557_566_Chemical) (CC and) (NNS Doc_17049862_571_582_Disease)))) (VP (MD can) (VP (VB be) (ADJP (JJ additive)))) (. .)))
17049862	6	(ROOT (S (NP (NP (NNP Administration)) (PP (IN of) (NP (NP (NNS Doc_17049862_618_627_Chemical)) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NNS Doc_17049862_647_658_Disease)))))))) (VP (MD may) (VP (VB lead) (PP (TO to) (NP (NP (DT an) (JJ adverse) (JJ cardiac) (NN event)) (PP (IN in) (NP (NNS children))))))) (. .)))
17049862	7	(ROOT (S (SBAR (IN As) (S (NP (NNS Doc_17049862_712_721_Chemical)) (VP (VBZ is) (NP (DT a) (ADJP (RB commonly) (VBN used)) (NN drug))))) (, ,) (NP (NNS clinicians)) (VP (VBP need) (S (VP (TO to) (VP (VB be) (ADJP (JJ aware) (PP (IN of) (NP (DT this) (NN interaction)))))))) (. .)))
17074608	0	(ROOT (NP (NP (JJ Doc_17074608_0_9_Chemical-induced) (NNS Doc_17074608_18_24_Disease) (CC and) (NNS Doc_17074608_29_43_Disease)) (PP (IN in) (NP (JJ atypical) (NNS Doc_17074608_56_82_Disease))) (. .)))
17074608	1	(ROOT (S (NP (NNP Doc_17074608_84_110_Disease)) (VP (VBZ is) (NP (NP (DT a) (NN disorder)) (PP (IN of) (NP (JJ Doc_17074608_128_138_Chemical) (NN metabolism))) (SBAR (WHPP (IN in) (WHNP (WDT which))) (S (NP (NP (DT a) (NN defect)) (PP (IN in) (NP (DT the) (JJ Doc_17074608_175_182_Chemical) (NN cleavage) (NN system)))) (VP (VBZ leads) (PP (TO to) (NP (NP (DT an) (NN accumulation)) (PP (IN of) (NP (NP (NNS Doc_17074608_227_234_Chemical)) (PP (IN in) (NP (NP (DT the) (NN brain)) (CC and) (NP (JJ other) (NN body) (NNS compartments))))))))))))) (. .)))
17074608	2	(ROOT (S (PP (IN In) (NP (DT the) (JJ classical) (NN form))) (NP (PRP it)) (VP (VBZ presents) (PP (IN as) (NP (NP (JJ neonatal) (NNS Doc_17074608_323_328_Disease)) (, ,) (NP (JJ intractable) (NNS Doc_17074608_342_350_Disease)) (, ,) (CC and) (NP (NNS Doc_17074608_356_365_Disease)))) (, ,) (VP (VBN followed) (PP (IN by) (NP (JJ significant) (NNS Doc_17074608_391_414_Disease))))) (. .)))
17074608	3	(ROOT (S (NP (NP (DT An) (JJ important) (NN subset)) (PP (IN of) (NP (NP (NNS children)) (PP (IN with) (NP (NNS Doc_17074608_453_479_Disease)))))) (VP (VBP are) (NP (NP (JJ atypical) (NNS variants)) (SBAR (WHNP (WP who)) (S (VP (VBP present) (PP (IN in) (NP (DT a) (JJ heterogeneous) (NN manner)))))))) (. .)))
17074608	4	(ROOT (S (NP (DT This) (NN report)) (VP (VBZ describes) (NP (DT a) (NN patient)) (PP (IN with) (NP (NP (JJ mild) (NNS Doc_17074608_583_597_Disease) (CC and) (NNS Doc_17074608_602_620_Disease)) (, ,) (SBAR (WHNP (WP who)) (S (VP (VBD was) (VP (VBN found) (S (VP (TO to) (VP (VB have) (NP (NP (NNS Doc_17074608_644_670_Disease)) (PP (VBG following) (NP (NP (PRP$ her) (NN presentation)) (PP (IN with) (NP (JJ acute) (NNS Doc_17074608_709_723_Disease) (CC and) (NNS Doc_17074608_728_734_Disease)))))) (PP (RB shortly) (IN after) (NP (NP (NN initiation)) (PP (IN of) (NP (JJ Doc_17074608_763_772_Chemical) (NN therapy))))))))))))))) (. .)))
1711760	0	(ROOT (NP (NP (NP (JJ Delayed) (NN institution)) (PP (IN of) (NP (NP (NNS Doc_1711760_23_35_Disease)) (PP (IN during) (NP (JJ focal) (NNS Doc_1711760_49_66_Disease)))))) (: :) (NP (NP (NN effect)) (PP (IN on) (NP (NNS Doc_1711760_78_89_Disease)))) (. .)))
1711760	1	(ROOT (S (NP (NP (DT The) (NN effect)) (PP (IN of) (NP (JJ induced) (NNS Doc_1711760_113_125_Disease)))) (VP (VBD instituted) (SBAR (IN after) (S (NP (NP (DT a) (JJ 2-h) (NN delay)) (PP (VBG following) (NP (NP (NP (NNS Doc_1711760_165_197_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_1711760_199_203_Disease)) (-RRB- -RRB-))) (PP (IN on) (NP (JJ Doc_1711760_208_219_Disease) (NN formation) (CC and) (NN histochemical) (NN injury)))))) (VP (VBD was) (VP (VBN studied)))))) (. .)))
1711760	2	(ROOT (S (PP (IN Under) (NP (JJ Doc_1711760_274_284_Chemical) (NN anesthesia))) (, ,) (NP (NP (DT the) (NNP MCA)) (PP (IN of) (NP (CD 14) (JJ spontaneously) (JJ Doc_1711760_325_337_Disease) (NNS rats)))) (VP (VBD was) (VP (VBN occluded))) (. .)))
1711760	3	(ROOT (S (PP (IN In) (NP (NP (DT the) (NN control) (NN group)) (PRN (-LRB- -LRB-) (VP (VBN n) (S (VP (SYM =) (NP (CD 7))))) (-RRB- -RRB-)))) (, ,) (NP (NP (DT the) (JJ mean) (JJ arterial) (NN pressure)) (PRN (-LRB- -LRB-) (NP (NNP MAP)) (-RRB- -RRB-))) (VP (VBD was) (RB not) (VP (VBN manipulated))) (. .)))
1711760	4	(ROOT (S (PP (IN In) (NP (NP (DT the) (JJ Doc_1711760_448_460_Disease) (NN group)) (PRN (-LRB- -LRB-) (VP (VBN n) (S (VP (SYM =) (NP (CD 7))))) (-RRB- -RRB-)))) (, ,) (NP (DT the) (NNP MAP)) (VP (VBD was) (VP (VBN elevated) (PP (IN by) (NP (NP (CD 25-30) (NN mm) (NNP Hg)) (PP (VBG beginning) (NP (NP (CD 2) (NN h)) (PP (IN after) (NP (NNS Doc_1711760_532_536_Disease))))))))) (. .)))
1711760	5	(ROOT (S (PP (NP (CD Four) (NNS hours)) (IN after) (NP (NNS Doc_1711760_555_559_Disease))) (, ,) (S (NP (DT the) (NNS rats)) (VP (VBD were) (VP (VBN killed)))) (CC and) (S (NP (DT the) (NNS brains)) (VP (VBN harvested))) (. .)))
1711760	6	(ROOT (S (NP (DT The) (NNS brains)) (VP (VBD were) (VP (VBN sectioned) (PP (IN along) (NP (NP (JJ coronal) (NNS planes)) (VP (VBG spanning) (NP (NP (DT the) (NN distribution)) (PP (IN of) (NP (NP (NNS Doc_1711760_684_692_Disease)) (VP (VBN produced) (PP (IN by) (NP (NNS Doc_1711760_705_709_Disease)))))))))))) (. .)))
1711760	7	(ROOT (S (NP (NP (JJ Specific) (NN gravity)) (PRN (-LRB- -LRB-) (NP (NNP SG)) (-RRB- -RRB-))) (VP (VBD was) (VP (VBN determined) (PP (PP (IN in) (NP (DT the) (NN subcortex))) (CC and) (PP (IN in) (NP (NP (CD two) (NNS sites)) (PP (IN in) (NP (NP (DT the) (NN cortex)) (PRN (-LRB- -LRB-) (NP (NP (NN core) (CC and) (NN periphery)) (PP (IN of) (NP (DT the) (JJ Doc_1711760_823_831_Disease) (NN territory)))) (-RRB- -RRB-))))))))) (. .)))
1711760	8	(ROOT (S (NP (NP (DT The) (NN extent)) (PP (IN of) (NP (NNS Doc_1711760_858_873_Disease)))) (VP (VBD was) (VP (VBN determined) (PP (IN by) (NP (JJ Doc_1711760_892_918_Chemical) (NN staining))))) (. .)))
1711760	9	(ROOT (S (PP (IN In) (NP (DT the) (JJ Doc_1711760_936_944_Disease) (NN core))) (, ,) (NP (EX there)) (VP (VBD was) (NP (NP (DT no) (NN difference)) (PP (IN in) (NP (NNP SG)))) (PP (IN in) (NP (NP (DT the) (NN subcortex) (CC and) (NN cortex)) (PP (IN in) (NP (DT the) (CD two) (NNS groups)))))) (. .)))
1711760	10	(ROOT (S (PP (IN In) (NP (NP (DT the) (NN periphery)) (PP (IN of) (NP (DT the) (JJ Doc_1711760_1052_1060_Disease) (NN territory))))) (, ,) (NP (NP (NNP SG)) (PP (IN in) (NP (DT the) (NN cortex)))) (VP (VBD was) (ADJP (ADJP (ADJP (JJR greater)) (PRN (-LRB- -LRB-) (PP (CC less) (NP (JJ Doc_1711760_1107_1112_Disease) (NN accumulation))) (-RRB- -RRB-))) (PP (IN in) (NP (DT the) (JJ Doc_1711760_1134_1146_Disease) (NN group)))) (PRN (-LRB- -LRB-) (FRAG (FRAG (ADJP (NP (CD 1.041)) (JJ +)) (: /)) (: -) (FRAG (NP (NP (CD 0.001) (NN vs)) (NP (CD 1.039) (JJ +) (NNS /))) (: -) (NP (NP (CD 0.001)) (, ,) (ADJP (JJ P) (ADVP (RBR less) (IN than)) (NP (CD 0.05)))))) (-RRB- -RRB-))) (. .)))
1711760	11	(ROOT (S (NP (NP (NP (DT The) (NN area)) (PP (IN of) (NP (JJ histochemical) (NN injury)))) (PRN (-LRB- -LRB-) (PP (IN as) (NP (NP (DT a) (NN percent)) (PP (IN of) (NP (NP (DT the) (JJ cross-sectional) (NN area)) (PP (IN of) (NP (DT the) (NN hemisphere))))))) (-RRB- -RRB-))) (VP (VBD was) (ADJP (ADJP (JJR less)) (PP (IN in) (NP (DT the) (JJ Doc_1711760_1319_1331_Disease) (NN group)))) (PRN (-LRB- -LRB-) (FRAG (FRAG (ADJP (NP (CD 33)) (JJ +)) (: /)) (: -) (FRAG (FRAG (ADJP (NP (NP (CD 3) (NN %)) (ADJP (JJ vs) (NP (CD 21)))) (JJ +)) (: /)) (: -) (FRAG (ADJP (CD 2) (NN %)) (, ,) (NP (NP (NNP P)) (ADJP (JJR less) (PP (IN than) (NP (CD 0.05)))))))) (-RRB- -RRB-))) (. .)))
1711760	12	(ROOT (S (NP (DT The) (NNS data)) (VP (VBP indicate) (SBAR (IN that) (S (NP (NN Doc_1711760_1405_1418_Chemical-induced) (NNS Doc_1711760_1427_1439_Disease)) (VP (VBD instituted) (NP (CD 2) (NN h)) (SBAR (SBAR (IN after) (S (NP (NNS Doc_1711760_1461_1465_Disease)) (VP (VBZ does) (RB not) (VP (VB aggravate) (NP (NNS Doc_1711760_1485_1490_Disease)) (PP (IN in) (NP (DT the) (JJ Doc_1711760_1498_1506_Disease) (NN core))))))) (, ,) (SBAR (IN that) (S (NP (PRP it)) (VP (VBZ improves) (NP (NP (NNS Doc_1711760_1530_1535_Disease)) (PP (IN in) (NP (NP (DT the) (NN periphery)) (PP (IN of) (NP (DT the) (JJ Doc_1711760_1560_1568_Disease) (NN territory))))))))) (, ,) (CC and) (SBAR (IN that) (S (NP (PRP it)) (VP (VBZ reduces) (NP (NP (DT the) (NN area)) (PP (IN of) (NP (JJ histochemical) (NNS Doc_1711760_1626_1646_Disease)))))))))))) (. .)))
17194457	0	(ROOT (NP (NP (JJ Behavioral) (NNS effects)) (PP (IN of) (NP (JJ pubertal) (JJ anabolic) (JJ androgenic) (NNS Doc_17194457_51_58_Chemical) (NN exposure))) (PP (IN in) (NP (JJ male) (NNS rats))) (PP (IN with) (NP (JJ low) (NNS Doc_17194457_90_99_Chemical))) (. .)))
17194457	1	(ROOT (S (NP (NP (DT The) (NN goal)) (PP (IN of) (NP (DT this) (NN study)))) (VP (VBD was) (S (VP (TO to) (VP (VB assess) (NP (NP (DT the) (JJ interactive) (NNS effects)) (PP (IN of) (NP (JJ chronic) (JJ anabolic) (JJ androgenic) (NNS Doc_17194457_193_200_Chemical))) (PRN (-LRB- -LRB-) (NP (NNP AAS)) (-RRB- -RRB-)) (NP (NP (NP (NN exposure) (CC and) (NN brain) (NNS Doc_17194457_226_235_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (NNS Doc_17194457_237_256_Chemical)) (, ,) (NP (NNS Doc_17194457_258_262_Chemical))) (-RRB- -RRB-))) (VP (VBN depletion) (PP (IN on) (NP (NP (NN behavior)) (PP (IN of) (NP (JJ pubertal) (JJ male) (NNS rats)))))))))))) (. .)))
17194457	2	(ROOT (S (S (NP (NNP Doc_17194457_309_318_Chemical)) (VP (VBD was) (VP (VBN depleted) (PP (VBG beginning) (PP (IN on) (NP (NP (JJ postnatal) (NN day) (CD 26)) (PP (IN with) (NP (NP (NNS Doc_17194457_367_390_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (NNP Doc_17194457_392_396_Chemical) (CD 100) (NN mg/kg)) (, ,) (NP (DT every) (JJ other) (NN day))) (-RRB- -RRB-)))))))))) (: ;) (S (NP (NNS controls)) (VP (VBD received) (ADJP (JJ saline)))) (. .)))
17194457	3	(ROOT (S (PP (IN At) (NP (NP (NN puberty)) (PRN (-LRB- -LRB-) (NP (NNP P40)) (-RRB- -RRB-)))) (, ,) (NP (NP (PDT half) (DT the) (NN Doc_17194457_479_483_Chemical-treated) (NNS rats)) (CC and) (NP (PDT half) (DT the) (JJ saline-treated) (NNS rats))) (VP (VBD began) (NP (NN treatment)) (PP (IN with) (NP (NP (NNS Doc_17194457_551_563_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP T)) (, ,) (NP (CD 5) (NN mg/kg)) (, ,) (NP (CD 5) (NN days/week)) (-RRB- -RRB-))))) (. .)))
17194457	4	(ROOT (S (NP (JJ Behavioral) (NNS measures)) (VP (VBD included) (NP (NP (NN locomotion)) (, ,) (NP (NNS Doc_17194457_632_644_Disease)) (, ,) (NP (NN copulation)) (, ,) (NP (NN partner) (NN preference)) (, ,) (CC and) (NP (NNS Doc_17194457_682_692_Disease)))) (. .)))
17194457	5	(ROOT (S (NP (NNS Animals)) (VP (VBD were) (VP (VBN tested) (PP (IN for) (NP (NP (NNS Doc_17194457_718_728_Disease)) (PP (IN in) (NP (PRP$ their) (NN home) (NN cage)))) (, ,) (PP (DT both) (IN with) (CC and) (IN without) (NP (JJ physical) (NN provocation)))) (PRN (-LRB- -LRB-) (NP (JJ mild) (NN tail) (NN pinch)) (-RRB- -RRB-)))) (. .)))
17194457	6	(ROOT (S (NP (NP (NP (NN Brain) (NNS levels)) (PP (IN of) (NP (NP (NNS Doc_17194457_827_831_Chemical)) (CC and) (NP (PRP$ its) (NN metabolite))))) (, ,) (NP (NP (NNS Doc_17194457_852_878_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_17194457_880_886_Chemical)) (-RRB- -RRB-))) (, ,)) (VP (VBD were) (VP (VBN determined) (S (VP (VBG using) (NP (NNP HPLC)))))) (. .)))
17194457	7	(ROOT (S (NP (NP (ADJP (ADJP (RB Doc_17194457_917_921_Chemical) (RB significantly)) (CC and) (ADJP (RB substantially) (JJ depleted))) (NNS Doc_17194457_963_967_Chemical) (CC and) (NNS Doc_17194457_972_978_Chemical)) (PP (IN in) (NP (DT all) (NN brain) (NNS regions)))) (VP (VBD examined)) (. .)))
17194457	8	(ROOT (S (NP (NNP Chronic) (NNP T) (NN treatment)) (ADVP (RB significantly)) (VP (VBD decreased) (NP (NNS Doc_17194457_1054_1058_Chemical) (CC and) (NNS Doc_17194457_1063_1069_Chemical)) (PP (PP (IN in) (NP (JJ certain) (NN brain) (NNS areas))) (, ,) (CC but) (PP (TO to) (NP (NP (DT a) (ADJP (RB much) (JJR lesser)) (NN extent)) (PP (IN than) (NP (NNS Doc_17194457_1127_1131_Chemical))))))) (. .)))
17194457	9	(ROOT (S (NP (NP (JJ Chronic) (NN exposure)) (PP (TO to) (NP (NNS Doc_17194457_1153_1157_Chemical)))) (VP (VP (ADVP (RB alone)) (ADVP (RB significantly)) (VBD decreased) (NP (NP (NN locomotor) (NN activity)) (CC and) (NP (VBN increased) (NNS Doc_17194457_1221_1233_Disease)))) (CC but) (VP (VBD had) (NP (NP (DT no) (NN effect)) (PP (IN on) (NP (NP (JJ sexual) (NN behavior)) (, ,) (NP (NN partner) (NN preference)) (, ,) (CC or) (NP (NNS Doc_17194457_1295_1305_Disease))))))) (. .)))
17194457	10	(ROOT (S (NP (NNP T)) (ADVP (RB alone)) (VP (VP (VBD had) (NP (NP (DT no) (NN effect)) (PP (IN on) (NP (NP (NN locomotion)) (, ,) (NP (NNS Doc_17194457_1344_1356_Disease)) (, ,) (CC or) (NP (JJ sexual) (NN behavior)))))) (CC but) (VP (VBD increased) (NP (NP (NN partner) (NN preference)) (CC and) (NP (NNS Doc_17194457_1414_1424_Disease))))) (. .)))
17194457	11	(ROOT (S (NP (NP (DT The) (ADJP (RBS most) (JJ striking)) (NN effect)) (PP (IN of) (S (VP (VBG combining) (NP (NNP T+D) (NNS oc_17194457_1466_1470_Chemical)))))) (VP (VBD was) (NP (NP (NP (NP (DT a) (JJ significant) (NN increase)) (PP (IN in) (NP (NN attack) (NN frequency)))) (CONJP (RB as) (RB well) (IN as)) (NP (NP (DT a) (JJ significant) (NN decrease)) (PP (IN in) (NP (DT the) (NN latency) (S (VP (TO to) (VP (VB attack)))))))) (, ,) (RB particularly) (NP (VBG following) (JJ physical) (NN provocation)))) (. .)))
17194457	12	(ROOT (S (PP (VBN Based) (PP (IN on) (NP (DT these) (NNS data)))) (, ,) (NP (PRP it)) (VP (MD can) (VP (VB be) (VP (VBN speculated) (SBAR (IN that) (S (NP (NP (JJ pubertal) (NNP AAS) (NNS users)) (PP (IN with) (NP (JJ low) (JJ central) (NNS Doc_17194457_1706_1710_Chemical)))) (VP (MD may) (VP (VB be) (ADJP (RB especially) (JJ prone) (S (VP (TO to) (VP (VB exhibit) (NP (NNS Doc_17194457_1746_1765_Disease))))))))))))) (. .)))
17241657	0	(ROOT (NP (NP (NP (NNPS Effects)) (PP (IN of) (NP (NP (NNS Doc_17241657_11_16_Chemical)) (CC and) (NP (-LRB- -LRB-) (NNP +) (NNP /) (NNP -) (-RRB- -RRB-))))) (: -) (NP (NP (NP (NNS Doc_17241657_27_32_Chemical)) (, ,) (NP (JJ putative) (JJ sigma2-preferring) (NNS antagonists)) (, ,)) (PP (IN on) (NP (JJ behavioral) (JJ toxic) (CC and) (NN stimulant) (NNS effects))) (PP (IN of) (NP (NP (NNS Doc_17241657_119_126_Chemical)) (PP (IN in) (NP (NNS mice)))))) (. .)))
17241657	1	(ROOT (S (NP (JJR Earlier) (NNS studies)) (VP (VBP have) (VP (VBN demonstrated) (SBAR (IN that) (S (NP (NP (NN antagonism)) (PP (IN of) (NP (JJ sigma1) (NNS receptors)))) (VP (VBZ attenuates) (NP (NP (DT the) (JJ Doc_17241657_221_231_Disease) (, ,) (JJ lethal) (, ,) (JJ locomotor) (NN stimulatory)) (CC and) (NP (NP (JJ rewarding) (NNS actions)) (PP (IN of) (NP (NP (NNS Doc_17241657_288_295_Chemical)) (PP (IN in) (NP (NNS mice)))))))))))) (. .)))
17241657	2	(ROOT (S (PP (IN In) (NP (NN contrast))) (, ,) (NP (NP (DT the) (NN contribution)) (PP (IN of) (NP (JJ sigma2) (NNS receptors)))) (VP (VBZ is) (ADJP (JJ unclear)) (SBAR (IN because) (S (NP (JJ experimental) (NNS tools) (S (VP (TO to) (VP (ADVP (RB selectively)) (VB target) (NP (DT this) (NN subtype)))))) (VP (VBP are) (ADJP (JJ unavailable)))))) (. .)))
17241657	3	(ROOT (S (S (VP (TO To) (VP (VB begin) (S (VP (VBG addressing) (NP (DT this) (NN need))))))) (, ,) (NP (PRP we)) (VP (VP (VBD characterized) (NP (NP (NNS Doc_17241657_493_498_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_17241657_500_540_Chemical)) (-RRB- -RRB-)))) (CC and) (VP (PRN (-LRB- -LRB-) (FRAG (ADJP (RB +) (JJ /)) (: -)) (-RRB- -RRB-)) (VBZ -) (NP (NP (NNP SM) (CD 21)) (PRN (-LRB- -LRB-) (NP (NNP Doc_17241657_559_601_Chemical)) (-RRB- -RRB-)) (PP (IN in) (NP (NP (NN receptor) (VBG binding)) (CC and) (NP (JJ behavioral) (NNS studies))))))) (. .)))
17241657	4	(ROOT (S (NP (JJ Receptor) (JJ binding) (NNS studies)) (VP (VBD confirmed) (SBAR (IN that) (S (NP (NP (NNS Doc_17241657_687_692_Chemical)) (CC and) (NP (PRN (-LRB- -LRB-) (FRAG (ADJP (RB +) (JJ /)) (: -)) (-RRB- -RRB-)) (NNP -) (NNP Doc_17241657_703_708_Chemical))) (VP (VBP display) (NP (JJ preferential) (NN affinity)) (PP (IN for) (NP (NP (NNS sigma2)) (PP (IN over) (NP (JJ sigma1) (NNS receptors))))))))) (. .)))
17241657	5	(ROOT (S (PP (IN In) (NP (JJ behavioral) (NNS studies))) (, ,) (S (NP (NP (NN pretreatment)) (PP (IN of) (NP (NP (JJ Swiss) (NNP Webster) (NNS mice)) (PP (IN with) (NP (NP (NNS Doc_17241657_836_841_Chemical)) (CC or) (PRN (-LRB- -LRB-) (FRAG (ADJP (RB +) (JJ /)) (: -)) (-RRB- -RRB-)) (NP (JJ -) (NNS Doc_17241657_851_856_Chemical))))))) (ADVP (RB significantly)) (VP (VBD attenuated) (NP (NP (NN Doc_17241657_882_889_Chemical-induced) (NNS Doc_17241657_898_909_Disease)) (CC and) (NP (NN locomotor) (NN activity))))) (, ,) (CC but) (FRAG (RB not) (ADVP (RB lethality))) (. .)))
17241657	6	(ROOT (S (SBAR (WHADVP (WRB When)) (S (VP (VBN administered) (ADJP (JJ alone) (, ,) (PRN (-LRB- -LRB-) (FRAG (ADJP (RB +) (JJ /)) (: -)) (-RRB- -RRB-)))))) (: -) (S (NP (NNS Doc_17241657_984_989_Chemical)) (VP (VBD produced) (NP (DT no) (JJ significant) (NNS effects)) (PP (VBN compared) (PP (TO to) (NP (NP (NN control) (NNS injections)) (PP (IN of) (NP (NN saline)))))))) (, ,) (CC but) (S (NP (NNS Doc_17241657_1068_1073_Chemical)) (VP (VBD had) (NP (NN locomotor) (NN depressant) (NNS actions)))) (. .)))
17241657	7	(ROOT (S (ADVP (RB Together)) (, ,) (S (NP (DT the) (NNS data)) (VP (VBP suggest) (SBAR (IN that) (S (NP (JJ sigma2) (NN receptor) (NNS antagonists)) (VP (VBP have) (NP (DT the) (NN potential) (S (VP (TO to) (VP (VB attenuate) (NP (NP (DT some)) (PP (IN of) (NP (NP (DT the) (JJ behavioral) (NNS effects)) (PP (IN of) (NP (NNS Doc_17241657_1234_1241_Chemical))))))))))))))) (, ,) (CC and) (S (NP (NP (JJ further) (NN development)) (PP (IN of) (NP (ADJP (RBR more) (JJ selective) (, ,) (RB high) (JJ affinity)) (NNS ligands)))) (VP (VBP are) (VP (VBN warranted)))) (. .)))
17263743	0	(ROOT (NP (NP (NP (NNP Doc_17263743_0_14_Disease)) (PP (IN in) (NP (NP (DT a) (NN child)) (PP (IN with) (NP (NNS Doc_17263743_31_45_Disease)))))) (VP (VBG undergoing) (NP (NP (JJ Doc_17263743_57_68_Chemical) (NN induction)) (PP (IN of) (NP (NN anesthesia)))) (PP (IN after) (NP (JJ preoperative) (NNS Doc_17263743_112_121_Chemical)))) (. .)))
17263743	1	(ROOT (S (NP (NNP Doc_17263743_123_132_Chemical)) (VP (VBZ is) (NP (NP (DT a) (ADJP (ADVP (RB frequently)) (VBN administered)) (JJ alpha2-adrenergic) (NN agonist)) (SBAR (WHNP (WDT which)) (S (VP (MD can) (VP (VB decrease) (NP (NP (NN heart) (NN rate)) (CC and) (NP (NN blood) (NN pressure))))))))) (. .)))
17263743	2	(ROOT (S (NP (PRP We)) (VP (VBP present) (NP (NP (DT a) (NN case)) (PP (IN of) (NP (NP (DT a) (JJ 5-year-old) (NN child)) (PP (IN with) (NP (NNS Doc_17263743_283_297_Disease) (CC and) (NNS Doc_17263743_302_318_Disease)))))) (, ,) (S (VP (VBG receiving) (NP (NP (NNS Doc_17263743_330_339_Chemical)) (PP (IN for) (NP (NP (NNS Doc_17263743_344_356_Disease)) (, ,) (SBAR (WHNP (WP who)) (S (VP (VBN presented) (PP (IN for) (NP (NP (NN placement)) (PP (IN of) (NP (DT a) (JJ Doc_17263743_391_399_Chemical) (NN pump)))))))))))))) (. .)))
17263743	3	(ROOT (S (PP (IN Without) (NP (NP (DT the) (NN knowledge)) (PP (IN of) (NP (DT the) (JJ medical) (NNS personnel))))) (, ,) (NP (NP (DT the) (NN patient) (POS 's)) (NN mother)) (VP (VBN administered) (S (NP (NP (CD three) (NNS doses)) (PP (IN of) (NP (NP (NP (NNS Doc_17263743_503_512_Chemical)) (PP (IN during) (NP (NP (DT the) (NN evening)) (ADVP (IN before))))) (CC and) (NP (NP (NN morning)) (PP (IN of) (NP (NN surgery))))))) (VP (TO to) (VP (VB reduce) (NP (NNS Doc_17263743_572_579_Disease)))))) (. .)))
17263743	4	(ROOT (S (PP (IN During) (NP (NP (NN induction)) (PP (IN of) (NP (NN anesthesia))))) (, ,) (NP (DT the) (NN patient)) (VP (VBD developed) (NP (NNS Doc_17263743_635_646_Disease) (CC and) (NNS Doc_17263743_651_662_Disease)) (S (VP (VBG requiring) (NP (JJ cardiac) (NN resuscitation))))) (. .)))
17263743	5	(ROOT (S (NP (EX There)) (VP (VBP are) (NP (NP (DT no) (JJ previous) (NNS reports)) (PP (IN of) (NP (NP (NN Doc_17263743_729_738_Chemical-associated) (NNS Doc_17263743_750_764_Disease)) (PP (IN in) (NP (NP (DT a) (NN child)) (VP (VBG undergoing) (NP (NP (NN induction)) (PP (IN of) (NP (NN anesthesia))))))))))) (. .)))
17285209	0	(ROOT (NP (NP (NP (VBG Doc_17285209_0_11_Chemical-converting) (NN enzyme)) (PRN (-LRB- -LRB-) (NP (NNP ACE)) (-RRB- -RRB-))) (NP (NP (JJ inhibitor-associated) (NNS Doc_17285209_57_67_Disease)) (PP (IN of) (NP (NP (DT the) (NN stomach)) (CC and) (NP (JJ small) (NN intestine))))) (: :) (NP (NP (DT a) (NN case)) (NP (NN report))) (. .)))
17285209	1	(ROOT (S (NP (DT This)) (VP (VBZ is) (NP (NP (DT a) (NN case) (NN report)) (PP (IN on) (NP (NP (DT a) (JJ 45-year) (JJ old) (JJ African-American) (NN female)) (PP (IN with) (NP (NP (ADJP (RB newly) (JJ diagnosed)) (NNS Doc_17285209_203_215_Disease)) (, ,) (SBAR (WHNP (WP who)) (S (VP (VBD was) (VP (VBN started) (PP (IN on) (NP (NP (DT a) (NN combination) (NN pill)) (PP (IN of) (NP (NNP Doc_17285209_258_268_Chemical) (NNP /) (NNP Doc_17285209_269_279_Chemical) (NNP 10/5) (NN mg))))))))))))))) (. .)))
17285209	2	(ROOT (S (S (NP (DT The) (ADJP (RB very) (JJ next)) (NN day))) (, ,) (NP (PRP she)) (VP (VBD presented) (PP (IN at) (NP (NP (DT the) (NN emergency) (NN room)) (PRN (-LRB- -LRB-) (NP (NNP ER)) (-RRB- -RRB-)))) (PP (IN with) (NP (NNS Doc_17285209_354_368_Disease) (, ,) (NNS Doc_17285209_370_376_Disease) (CC and) (NNS Doc_17285209_381_389_Disease)))) (. .)))
17285209	3	(ROOT (S (NP (NP (JJ Physical) (NN exam)) (, ,) (NP (JJ complete) (JJ metabolic) (NN panel)) (, ,) (CC and) (NP (NN hemogram))) (VP (VBD were) (PP (IN in) (NP (DT the) (JJ normal) (NN range)))) (. .)))
17285209	4	(ROOT (S (NP (PRP She)) (VP (VBD was) (VP (VBN discharged) (PP (IN from) (NP (DT the) (NNP ER))) (PP (IN after) (NP (NP (DT a) (JJ few) (NNS hours)) (PP (IN of) (NP (NN treatment))))) (PP (IN with) (NP (NN fluid) (CC and) (NNS analgesics))))) (. .)))
17285209	5	(ROOT (S (ADVP (RB However)) (, ,) (NP (PRP she)) (VP (VBD returned) (PP (TO to) (NP (DT the) (NNP ER))) (NP (DT the) (JJ next) (NN day)) (PP (IN with) (NP (DT the) (JJ same) (NNS complaints)))) (. .)))
17285209	6	(ROOT (S (NP (DT This) (NN time)) (NP (DT the) (JJ physical) (NN exam)) (VP (VBD was) (ADJP (JJ significant) (PP (IN for) (NP (NP (DT a) (JJ distended) (NN abdomen)) (PP (IN with) (NP (NN dullness)))))) (PP (TO to) (NP (NN percussion)))) (. .)))
17285209	7	(ROOT (S (NP (NP (NNP CT) (NNP scan)) (PP (IN of) (NP (DT the) (NN abdomen)))) (VP (VBD revealed) (NP (NP (ADJP (RB markedly) (JJ thickened)) (NN antrum)) (PP (IN of) (NP (NP (DT the) (NN stomach) (, ,) (NN duodenum) (CC and) (NN jejunum)) (, ,) (ADVP (IN along) (PP (IN with) (ADJP (JJ fluid))))))) (PP (IN in) (NP (DT the) (JJ abdominal) (CC and) (JJ pelvic) (NN cavity)))) (. .)))
17285209	8	(ROOT (NP (NP (NP (JJ Doc_17285209_877_888_Chemical-converting) (NN enzyme) (NN inhibitor)) (PRN (-LRB- -LRB-) (NP (NNP ACEI)) (-RRB- -RRB-))) (: -) (S (S (NP (JJ induced) (NNS Doc_17285209_932_942_Disease)) (VP (VBD was) (VP (VBN suspected)))) (, ,) (CC and) (S (NP (JJ anti-Doc_17285209_967_979_Disease) (NNS medications)) (VP (VBD were) (VP (VBN discontinued))))) (. .)))
17285209	9	(ROOT (S (S (NP (PRP$ Her) (NNS symptoms)) (VP (VBD improved) (PP (IN within) (NP (DT the) (JJ next) (CD 24) (NNS hours))))) (, ,) (CC and) (S (NP (NP (NNP repeat) (NNP CT)) (PP (IN after) (NP (CD 72) (NNS hours)))) (VP (VBD revealed) (NP (JJ marked) (NN improvement)) (PP (IN in) (NP (NP (NN stomach) (CC and) (JJ small) (NN bowel) (NN thickening)) (CC and) (NP (NP (NN resolution)) (PP (IN of) (NP (NNS Doc_17285209_1172_1179_Disease)))))))) (. .)))
17285209	10	(ROOT (S (NP (NP (DT The) (NN recognition)) (PP (IN of) (NP (NP (NP (NN Doc_17285209_1200_1211_Chemical-converting) (NN enzyme)) (PRN (-LRB- -LRB-) (NP (NNP ACE)) (-RRB- -RRB-))) (CC and) (NP (JJ angiotensin) (NN receptor) (NN blocker) (PRN (-LRB- -LRB-) (NP (NNP ARB)) (-RRB- -RRB-)) (NNS Doc_17285209_1275_1296_Disease))))) (VP (VBZ constitutes) (NP (DT a) (NN challenge)) (PP (TO to) (NP (NP (JJ primary) (NN care) (NNS physicians)) (, ,) (NP (NNS internists)) (, ,) (NP (NN emergency) (NN room) (NN personal)) (CC and) (NP (NNS surgeons))))) (. .)))
1728915	0	(ROOT (NP (CD Doc_1728915_0_13_Chemical-induced) (NNS Doc_1728915_22_41_Disease) (. .)))
1728915	1	(ROOT (NP (NP (NNP Characterization)) (PP (IN of) (NP (CD two) (JJ distinct) (JJ clinical) (NNS syndromes))) (. .)))
1728915	2	(ROOT (S (NP (NP (DT A) (NN patient)) (PP (IN with) (NP (JJ sinus) (NNS Doc_1728915_117_128_Disease) (CC and) (NNS Doc_1728915_133_155_Disease))) (, ,) (VP (VBN induced) (PP (IN by) (NP (NNS Doc_1728915_168_181_Chemical)))) (, ,)) (VP (VBD prompted) (NP (NP (DT an) (JJ extensive) (NN literature) (NN review)) (PP (IN of) (NP (DT all) (ADJP (RB previously) (VBN reported)) (NNS cases))))) (. .)))
1728915	3	(ROOT (S (PP (IN From) (NP (NP (DT the) (NN analysis)) (PP (IN of) (NP (DT these) (NNS cases))))) (, ,) (NP (NP (CD two) (JJ distinct) (NNS forms)) (PP (IN of) (NP (NN Doc_1728915_313_326_Chemical-associated) (NNS Doc_1728915_338_357_Disease)))) (VP (VBD emerged)) (. .)))
1728915	4	(ROOT (S (NP (CD One) (NN patient) (NN group)) (VP (VBD developed) (NP (NNS Doc_1728915_395_413_Disease)) (PP (IN in) (NP (NP (DT the) (NN setting)) (PP (IN of) (NP (DT a) (JJ massive) (JJ Doc_1728915_442_455_Chemical) (NNS Doc_1728915_456_464_Disease)))))) (. .)))
1728915	5	(ROOT (S (NP (DT The) (JJ second) (NN group)) (VP (VBD consisted) (ADVP (RB almost) (RB exclusively)) (PP (IN of) (NP (NP (JJ elderly) (NNS women)) (SBAR (WHNP (WP who)) (S (VP (VP (VBD developed) (NP (ADJP (RB potentially) (JJ life-threatening)) (NNS Doc_1728915_572_588_Disease) (CC or) (NNS Doc_1728915_592_625_Disease))) (, ,) (VP (JJ associated) (PP (IN with) (NP (DT either) (JJ therapeutic)))) (CC or) (VP (ADVP (RB modestly)) (VBD elevated) (NP (JJ Doc_1728915_683_696_Chemical) (NN serum) (NNS levels))))))))) (. .)))
1728915	6	(ROOT (S (SBAR (IN Because) (S (NP (NNS Doc_1728915_719_732_Chemical)) (VP (VBZ is) (ADVP (RB widely)) (VP (VBN used) (PP (IN in) (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (JJ many) (JJ neurologic) (CC and) (JJ Doc_1728915_788_799_Disease) (NNS conditions))))))))) (, ,) (NP (NP (DT the) (NN recognition)) (PP (IN of) (NP (DT the) (JJ latter) (NN syndrome)))) (VP (VBZ has) (NP (NP (JJ important) (NNS implications)) (PP (IN for) (NP (NP (DT the) (NN use)) (PP (IN of) (NP (NP (DT this) (NN drug)) (PP (IN in) (NP (JJ elderly) (NNS patients))))))))) (. .)))
1732442	0	(ROOT (NP (NP (NNP Detection)) (PP (IN of) (NP (JJ abnormal) (JJ cardiac) (JJ adrenergic) (NN neuron) (NN activity))) (PP (IN in) (NP (NN Doc_1732442_60_70_Chemical-induced) (NNS Doc_1732442_79_93_Disease))) (PP (IN with) (NP (NNS Doc_1732442_99_133_Chemical))) (. .)))
1732442	1	(ROOT (S (NP (NP (NNP Doc_1732442_135_171_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_1732442_173_177_Chemical)) (-RRB- -RRB-)) (, ,) (NP (NP (DT an) (NN analog)) (PP (IN of) (NP (NP (NNS Doc_1732442_193_207_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP NE)) (-RRB- -RRB-))))) (, ,)) (VP (VBZ serves) (PP (IN as) (NP (NP (DT an) (NN index)) (PP (IN of) (NP (JJ adrenergic) (NN neuron) (NN integrity) (CC and) (NN function)))))) (. .)))
1732442	2	(ROOT (S (S (VP (VBG Using) (NP (NP (DT a) (NN rat) (NN model)) (PP (IN of) (NP (NN Doc_1732442_299_309_Chemical-induced) (NNS Doc_1732442_318_332_Disease)))))) (, ,) (NP (PRP we)) (VP (VBD tested) (NP (NP (DT the) (NNS hypothesis)) (SBAR (S (NP (DT that) (JJ abnormal) (JJ cardiac) (JJ adrenergic) (NN neuron) (NN activity)) (VP (MD may) (VP (VP (VB appear)) (CC and) (VP (VB be) (VP (VBN exacerbated) (ADVP (RB dose-dependently)) (PP (IN in) (NP (JJ Doc_1732442_458_468_Chemical) (NNS Doc_1732442_469_483_Disease))))))))))) (. .)))
1732442	3	(ROOT (S (NP (NP (DT The) (NN degree)) (PP (IN of) (NP (NNS Doc_1732442_499_540_Disease)))) (VP (VBD was) (VP (VBN analyzed) (PP (IN in) (NP (NN relation))) (PP (TO to) (NP (NP (DT the) (NN duration)) (PP (IN of) (NP (NP (JJ Doc_1732442_585_595_Chemical) (NN treatment)) (PRN (-LRB- -LRB-) (NP (NP (CD 2) (NN mg/kg)) (, ,) (NP (RB once) (DT a) (NN week))) (-RRB- -RRB-)))))))) (. .)))
1732442	4	(ROOT (S (NP (EX There)) (VP (VBD were) (NP (NP (DT no) (NNS abnormalities)) (CC or) (RB only) (NP (NP (NP (NP (VBN isolated) (NN degeneration)) (PP (IN in) (NP (DT the) (CD 1)))) (: -) (CC or) (NP (JJ 2-wk) (NN treatment) (NNS groups))) (, ,) (NP (NP (ADJP (VBN isolated) (CC or) (VBN scattered)) (NN degeneration)) (PP (IN in) (NP (NP (NN half)) (PP (IN of) (NP (DT the) (JJ 3-wk) (NN group)))))) (, ,) (NP (NP (JJ frequent) (JJ scattered) (NN degeneration)) (PP (IN in) (NP (DT the) (JJ 4-wk) (NN group)))) (, ,) (NP (NP (JJ scattered) (CC or) (JJ focal) (NN degeneration)) (PP (IN in) (NP (DT the) (JJ 5-wk) (NN group)))) (, ,) (CC and) (NP (NP (JJ extensive) (NN degeneration)) (PP (IN in) (NP (DT the) (JJ 8-wk) (NN group))))))) (. .)))
1732442	5	(ROOT (S (NP (NP (JJ Myocardial) (NN accumulation)) (PP (IN of) (NP (NNP Doc_1732442_961_971_Chemical) (CD 4)))) (VP (VBP hr) (SBAR (IN after) (S (NP (JJ intravenous) (NN injection)) (VP (VBD did) (RB not) (VP (VB differ) (PP (IN between) (NP (NP (DT the) (NNS controls)) (CC and) (NP (NP (DT the) (NNS groups)) (VP (VBN treated) (UCP (NP (CD 3) (NN wk)) (CC or) (ADJP (JJR less)))))))))))) (. .)))
1732442	6	(ROOT (S (ADVP (RB However)) (, ,) (NP (DT the) (JJ 4-wk) (NN group)) (VP (VBD had) (NP (DT a) (ADJP (RB slightly) (JJR lower)) (NX (NX (NX (NX (NN accumulation)) (PP (IN in) (NP (DT the) (JJ right) (NN ventricular) (NN wall)))) (PRN (-LRB- -LRB-) (NP (NP (CD 82) (NN %)) (PP (IN of) (NP (DT the) (NN control)))) (-RRB- -RRB-))) (CC and) (NX (ADJP (RB significantly) (JJR lower)) (NN accumulation)))) (PP (IN in) (NP (NP (DT the) (JJ left) (NN ventricular) (NN wall)) (PRN (-LRB- -LRB-) (NP (NP (QP (RB about) (CD 66)) (NN %)) (PP (IN of) (NP (NP (DT the) (NN control)) (: :) (NP (NP (NN p)) (NP (QP (JJR less) (IN than) (CD 0.05))))))) (-RRB- -RRB-))))) (. .)))
1732442	7	(ROOT (S (PP (IN In) (NP (DT the) (JJ 5-wk) (NN group))) (, ,) (NP (NP (JJ Doc_1732442_1318_1322_Chemical) (NN accumulation)) (PP (IN in) (NP (DT the) (ADJP (JJ right) (CC and) (JJ left)) (NN ventricular) (NN wall)))) (VP (VBD was) (NP (NP (NP (QP (CD 35) (NN %) (CC and) (CD 27) (NN %))) (PP (IN of) (NP (NP (DT that)) (PP (IN in) (NP (NNS controls))))) (, ,) (ADVP (RB respectively))) (PRN (-LRB- -LRB-) (NP (NNP p) (QP (JJR less) (IN than) (CD 0.001))) (-RRB- -RRB-)))) (. .)))
1732442	8	(ROOT (S (PP (IN In) (NP (DT the) (JJ 8-wk) (NN group))) (, ,) (NP (NP (JJ Doc_1732442_1465_1469_Chemical) (NN accumulation)) (PP (IN in) (NP (DT the) (ADJP (JJ right) (CC and) (JJ left)) (NN ventricular) (NN wall)))) (VP (VBD was) (NP (NP (NP (QP (CD 18) (NN %) (CC and) (CD 14) (NN %))) (PP (IN of) (NP (NP (DT that)) (PP (IN in) (NP (NNS controls))))) (, ,) (ADVP (RB respectively))) (PRN (-LRB- -LRB-) (NP (NNP p) (QP (JJR less) (IN than) (CD 0.001))) (-RRB- -RRB-)))) (. .)))
1732442	9	(ROOT (S (ADVP (RB Thus)) (, ,) (NP (NP (JJ Doc_1732442_1599_1603_Chemical) (NN accumulation)) (PP (IN in) (NP (DT the) (NN myocardium)))) (VP (VBD decreased) (PP (IN in) (NP (DT an) (JJ Doc_1732442_1651_1661_Chemical) (JJ dose-dependent) (NN manner)))) (. .)))
1732442	10	(ROOT (S (NP (NP (DT The) (NN appearance)) (PP (IN of) (NP (VBN impaired) (JJ cardiac) (JJ adrenergic) (NN neuron) (NN activity))) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NP (JJ slight) (NNS Doc_1732442_1773_1794_Disease)) (PRN (-LRB- -LRB-) (NP (NP (JJ scattered)) (CC or) (NP (JJ focal) (NNS Doc_1732442_1815_1836_Disease))) (-RRB- -RRB-))))))) (VP (VBZ indicates) (SBAR (IN that) (S (NP (NNS Doc_1732442_1853_1857_Chemical)) (ADVP (RB scintigraphy)) (VP (MD may) (VP (VB be) (NP (NP (DT a) (JJ useful) (NN method)) (PP (IN for) (NP (NP (NN detection)) (PP (IN of) (NP (NN Doc_1732442_1911_1921_Chemical-induced) (NNS Doc_1732442_1930_1944_Disease))))))))))) (. .)))
17344330	0	(ROOT (S (NP (NP (NNS Doc_17344330_0_7_Disease) (CC and) (NNS Doc_17344330_12_27_Disease)) (PP (IN among) (NP (NNS patients)))) (VP (VBD treated) (PP (IN with) (NP (NP (NNS Doc_17344330_56_65_Chemical)) (PP (IN for) (NP (JJ Doc_17344330_70_76_Chemical) (NN dependence))))) (PP (IN in) (NP (NP (DT the) (NN city)) (PP (IN of) (NP (NNP Copenhagen)))))) (. .)))
17344330	1	(ROOT (S (NP (NNP Doc_17344330_127_136_Chemical)) (VP (VBZ is) (VP (VBN prescribed) (PP (TO to) (NP (JJ Doc_17344330_154_160_Chemical) (NNS addicts))) (S (VP (TO to) (VP (VB decrease) (NP (JJ illicit) (JJ opioid) (NN use))))))) (. .)))
17344330	2	(ROOT (S (NP (NP (NNP Prolongation)) (PP (IN of) (NP (NP (DT the) (NNP QT) (NN interval)) (PP (IN in) (NP (NP (DT the) (NNP ECG)) (PP (IN of) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (NNS Doc_17344330_261_279_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_17344330_281_284_Disease)) (-RRB- -RRB-))))))))))) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (PP (IN in) (NP (JJ Doc_17344330_307_316_Chemical) (NNS users)))))) (. .)))
17344330	3	(ROOT (S (S (SBAR (IN As) (S (NP (JJ Doc_17344330_327_333_Chemical) (NNS addicts)) (ADJP (RB sometimes) (JJ faint) (PP (IN while) (S (VP (VBG using) (NP (JJ illicit) (NNS drugs)))))))) (, ,) (NP (NNS doctors)) (VP (MD might) (VP (VP (VB attribute) (NP (NP (ADJP (RB too) (JJ many)) (NNS episodes)) (PP (IN of) (NP (NNS Doc_17344330_430_437_Disease)))) (PP (TO to) (NP (JJ illicit) (NN drug) (NN use)))) (CC and) (VP (ADVP (RB thereby)) (VB underestimate) (NP (NP (DT the) (NN incidence)) (PP (IN of) (NP (NP (NNS Doc_17344330_501_504_Disease)) (PP (IN in) (NP (DT this) (JJ special) (NN population)))))))))) (, ,) (CC and) (S (NP (NP (DT the) (JJ high) (NN mortality)) (PP (IN in) (NP (DT this) (NN population)))) (VP (MD may) (, ,) (PP (IN in) (NP (NN part))) (, ,) (VP (VB be) (VP (VBN caused) (PP (IN by) (NP (NP (DT the) (JJ proarrhythmic) (NN effect)) (PP (IN of) (NP (NNS Doc_17344330_630_639_Chemical))))))))) (. .)))
17344330	4	(ROOT (S (PP (IN In) (NP (DT this) (JJ cross-sectional) (NN study) (NN interview))) (, ,) (NP (NNS ECGs) (CC and) (NN blood) (NNS samples)) (VP (VBD were) (VP (VBN collected) (PP (IN in) (NP (NP (DT a) (NN population)) (PP (IN of) (NP (NP (JJ adult) (JJ Doc_17344330_754_760_Chemical) (NNS addicts)) (VP (VBN treated) (PP (IN with) (NP (NNS Doc_17344330_782_791_Chemical) (CC or) (NNS Doc_17344330_795_808_Chemical))) (PP (IN on) (NP (DT a) (JJ daily) (NN basis)))))))))) (. .)))
17344330	5	(ROOT (S (PP (IN Of) (NP (NP (DT the) (NNS patients)) (PP (IN at) (NP (NP (DT the) (NNP Drug) (NNP Addiction) (NNP Service)) (PP (IN in) (NP (NP (DT the) (JJ municipal)) (PP (IN of) (NP (NNP Copenhagen))))))))) (, ,) (NP (NP (CD 450)) (PRN (-LRB- -LRB-) (NP (QP (RB approximately) (CD 52)) (NN %)) (-RRB- -RRB-))) (VP (VBD were) (VP (VBN included))) (. .)))
17344330	6	(ROOT (S (NP (DT The) (NNP QT) (NN interval)) (VP (VBD was) (VP (VBN estimated) (PP (IN from) (NP (CD 12) (JJ lead) (NNS ECGs))))) (. .)))
17344330	7	(ROOT (S (NP (DT All) (NNS participants)) (VP (VBD were) (VP (VBN interviewed) (PP (IN about) (NP (NP (DT any) (NN experience)) (PP (IN of) (NP (NNS Doc_17344330_1051_1058_Disease))))))) (. .)))
17344330	8	(ROOT (S (NP (NP (DT The) (NN association)) (PP (IN between) (NP (NP (NP (JJ opioid) (NN dose)) (CC and) (NP (NNP QT))) (, ,) (CC and) (NP (NP (JJ Doc_17344330_1108_1117_Chemical) (NN dose) (CC and) (NN reporting)) (PP (IN of) (NP (NNS Doc_17344330_1140_1147_Disease))))))) (VP (VBD was) (VP (VBN assessed) (S (VP (VBG using) (NP (NP (JJ multivariate) (JJ linear) (NN regression)) (CC and) (NP (NP (JJ logistic) (NN regression)) (, ,) (ADVP (RB respectively)))))))) (. .)))
17344330	9	(ROOT (S (NP (JJ Doc_17344330_1246_1255_Chemical) (NN dose)) (VP (VBD was) (VP (VBN associated) (PP (IN with) (NP (NP (JJR longer) (NNP QT) (NN interval)) (PP (IN of) (NP (NP (CD 0.140) (NN ms/mg)) (PRN (-LRB- -LRB-) (VP (VBN p) (S (VP (SYM =) (NP (CD 0.002))))) (-RRB- -RRB-)))))))) (. .)))
17344330	10	(ROOT (S (NP (NP (DT No) (NN association)) (PP (IN between) (NP (NNP Doc_17344330_1351_1364_Chemical) (CC and) (NNP QTc)))) (VP (VBD was) (VP (VBN found))) (. .)))
17344330	11	(ROOT (S (PP (IN Among) (NP (NP (DT the) (NNS subjects)) (VP (VBN treated) (PP (IN with) (NP (NNS Doc_17344330_1416_1425_Chemical)))))) (, ,) (NP (NP (ADJP (CD 28) (NN %)) (NNS men)) (CC and) (NP (ADJP (CD 32) (NN %)) (NNS women))) (VP (VBD had) (NP (NNS Doc_17344330_1453_1475_Disease))) (. .)))
17344330	12	(ROOT (S (NP (NP (NN None)) (PP (IN of) (NP (NP (DT the) (NNS subjects)) (VP (VBN treated) (PP (IN with) (NP (NNS Doc_17344330_1511_1524_Chemical))))))) (VP (VBD had) (NP (NP (NNP QTc) (NNP interval)) (`` >) (NP (NP (CD 0.440) (NNS s)) (PRN (-LRB- -LRB-) (NP (QP (CD -LRB-) (CD 1/2))) (-RRB- -RRB-))) (-RRB- -RRB-))) (. .)))
17344330	13	(ROOT (S (NP (DT A) (ADJP (NP (CD 50) (NNS mg)) (JJR higher)) (JJ Doc_17344330_1574_1583_Chemical) (NN dose)) (VP (VBD was) (VP (VBN associated) (PP (IN with) (NP (NP (QP (DT a) (CD 1.2))) (PRN (-LRB- -LRB-) (NP (NP (CD 95) (NN %)) (NP (NP (NNP CI)) (NP (QP (CD 1.1) (TO to) (CD 1.4))))) (-RRB- -RRB-)) (PP (CC times) (NP (NP (JJR higher) (NNS odds)) (PP (IN for) (NP (NNS Doc_17344330_1657_1664_Disease))))))))) (. .)))
17344330	14	(ROOT (S (NP (NNP Doc_17344330_1679_1688_Chemical)) (VP (VBZ is) (VP (VBN associated) (PP (IN with) (NP (NP (NNS Doc_17344330_1708_1723_Disease)) (CC and) (NP (NP (JJR higher) (NN reporting)) (PP (IN of) (NP (NP (NNS Doc_17344330_1748_1755_Disease)) (PP (IN in) (NP (NP (DT a) (NN population)) (PP (IN of) (NP (JJ Doc_17344330_1775_1781_Chemical) (NNS addicts)))))))))))) (. .)))
17366349	0	(ROOT (S (NP (NNP Doc_17366349_0_30_Disease)) (VP (VBN induced) (PP (IN by) (NP (NP (NNS Doc_17366349_42_53_Chemical)) (PP (IN on) (NP (NP (DT the) (JJ second) (NN day)) (PP (IN of) (NP (NN treatment)))))))) (. .)))
17366349	1	(ROOT (S (NP (NP (NNP Doc_17366349_86_116_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_17366349_118_121_Disease)) (-RRB- -RRB-))) (VP (VBZ is) (NP (NP (DT the) (JJS rarest) (CC and) (JJS most)) (ADJP (JJ serious)) (PP (IN of) (NP (DT the) (JJ neuroleptic-induced) (NNS Doc_17366349_181_199_Disease))))) (. .)))
17366349	2	(ROOT (S (NP (PRP We)) (VP (VBP describe) (NP (NP (DT a) (NN case)) (PP (IN of) (NP (NP (NNS Doc_17366349_223_253_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_17366349_255_258_Disease)) (-RRB- -RRB-)) (VP (VBN associated) (PP (IN with) (NP (NP (DT the) (NN use)) (PP (IN of) (NP (NNS Doc_17366349_287_298_Chemical)))))))))) (. .)))
17366349	3	(ROOT (S (SBAR (IN Although) (S (NP (JJ conventional) (NNS neuroleptics)) (VP (VBP are) (ADVP (RBR more) (RB frequently)) (VP (VBN associated) (PP (IN with) (NP (NNS Doc_17366349_371_374_Disease))))))) (, ,) (NP (NP (JJ atypical) (JJ antipsychotic) (NNS drugs)) (PP (IN like) (NP (NNS Doc_17366349_410_421_Chemical)))) (VP (MD may) (ADVP (RB also)) (VP (VB be) (NP (DT a) (NN cause)))) (. .)))
17366349	4	(ROOT (S (NP (DT The) (NN patient)) (VP (VBZ is) (NP (NP (DT a) (JJ 24-year-old) (NN male)) (PP (IN with) (NP (NP (DT a) (NN history)) (PP (IN of) (NP (NP (NNS Doc_17366349_495_508_Disease)) (SBAR (WHNP (WP who)) (S (VP (VBD developed) (NP (NP (NNS signs) (CC and) (NNS symptoms)) (PP (IN of) (NP (NNS Doc_17366349_545_548_Disease)))) (PP (IN after) (NP (NP (CD 2) (NNS days)) (PP (IN of) (NP (NN treatment))))) (PP (IN with) (NP (NP (DT an) (JJ 80-mg/day) (NN dose)) (PP (IN of) (NP (ADJP (RB orally) (JJ administrated)) (NNS Doc_17366349_622_633_Chemical)))))))))))))) (. .)))
17366349	5	(ROOT (S (NP (DT This) (NN case)) (VP (VBZ is) (NP (NP (DT the) (JJS earliest) (PRN (-LRB- -LRB-) (NP (NP (JJ second) (NN day)) (PP (IN of) (NP (NN treatment)))) (-RRB- -RRB-))) (ADJP (RB Doc_17366349_687_690_Disease) (JJ due) (PP (TO to) (NP (NP (NNS Doc_17366349_698_709_Chemical)) (VP (VBN reported) (PP (IN in) (NP (DT the) (NN literature))))))))) (. .)))
17490790	0	(ROOT (S (NP (JJ Peripheral) (NNS Doc_17490790_11_23_Chemical)) (VP (VBN induced) (NP (NP (NNS Doc_17490790_32_68_Disease)) (PP (IN in) (NP (NN rat) (NN substantia) (NN nigra))))) (. .)))
17490790	1	(ROOT (S (NP (JJ Doc_17490790_94_98_Chemical) (NN accumulation)) (VP (VBZ is) (VP (VBN considered) (S (VP (TO to) (VP (VB be) (VP (VBN involved) (PP (IN in) (NP (NP (DT the) (NNS pathogenesis)) (PP (IN of) (NP (NNS Doc_17490790_164_183_Disease))))))))))) (. .)))
17490790	2	(ROOT (S (S (VP (TO To) (VP (VB demonstrate) (NP (NP (NP (DT the) (NN relationship)) (PP (IN between) (NP (JJ peripheral) (JJ Doc_17490790_236_240_Chemical) (NN overload)))) (CC and) (NP (NP (NP (JJ dopaminergic) (NN neuron) (NN loss)) (PP (IN in) (NP (NN rat) (NN substantia) (NN nigra)))) (PRN (-LRB- -LRB-) (NP (NNP SN)) (-RRB- -RRB-)) (, ,) (PP (IN in) (NP (DT the) (JJ present) (NN study)))))))) (NP (PRP we)) (VP (VBD used) (NP (NP (NP (JJ fast) (JJ cyclic) (NN voltammetry)) (, ,) (NP (NP (NNS Doc_17490790_363_371_Chemical)) (NP (JJ hydroxylase) (PRN (-LRB- -LRB-) (NP (NNP TH)) (-RRB- -RRB-)) (NN immunohistochemistry)))) (, ,) (NP (NP (NNP Perls) (POS ')) (JJ Doc_17490790_418_422_Chemical) (UCP (VP (VBG staining)) (, ,) (CC and) (ADJP (JJ high))) (NN performance)) (NP (JJ liquid) (JJ chromatography-electrochemical) (NN detection) (S (VP (TO to) (VP (VB study) (NP (DT the) (NNS Doc_17490790_515_551_Disease)))))) (CC and) (NP (NP (VBN increased) (JJ Doc_17490790_566_570_Chemical) (NN content)) (PP (IN in) (NP (DT the) (NNP SN))) (PP (IN of) (NP (JJ Doc_17490790_592_604_Chemical) (JJ overloaded) (NNS animals)))))) (. .)))
17490790	3	(ROOT (S (NP (DT The) (NNS findings)) (VP (VBD showed) (SBAR (IN that) (S (NP (JJ peripheral) (JJ Doc_17490790_661_673_Chemical) (NN overload)) (VP (VP (VBD increased) (NP (DT the) (NNS Doc_17490790_697_701_Chemical)) (S (VP (VBG staining) (NP (JJ positive) (NNS cells))))) (CC and) (VP (VBD reduced) (NP (NP (DT the) (NN number)) (PP (IN of) (NP (JJ TH-immunoreactive) (NNS neurons)))) (PP (IN in) (NP (DT the) (NNP SN)))))))) (. .)))
17490790	4	(ROOT (S (PP (IN As) (NP (DT a) (NN result))) (, ,) (NP (NP (JJ Doc_17490790_802_810_Chemical) (NN release) (CC and) (NN content)) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (PRP$ its) (NNS metabolites) (NNS contents))) (VP (VBD were) (VP (VBN decreased) (PP (IN in) (NP (JJ caudate) (NN putamen))))) (. .)))
17490790	5	(ROOT (S (NP (ADJP (ADVP (RB Even) (RBR more)) (JJ dramatic)) (NNS changes)) (VP (VBD were) (VP (VBN found) (PP (IN in) (NP (JJ chronic) (NN overload) (NN group))))) (. .)))
17490790	6	(ROOT (S (NP (DT These) (NNS results)) (VP (VBP suggest) (SBAR (IN that) (S (NP (JJ peripheral) (NNS Doc_17490790_1006_1018_Chemical)) (VP (MD can) (VP (VB increase) (NP (DT the) (JJ Doc_17490790_1036_1040_Chemical) (NN level)) (PP (IN in) (NP (NP (DT the) (NNP SN)) (, ,) (SBAR (WHADVP (WRB where)) (S (NP (JJ excessive) (NNS Doc_17490790_1074_1078_Chemical)) (VP (VBZ causes) (NP (DT the) (NNS Doc_17490790_1090_1126_Disease)))))))))))) (. .)))
17490790	7	(ROOT (S (NP (DT The) (JJ chronic) (JJ Doc_17490790_1140_1144_Chemical) (NN overload)) (VP (MD may) (VP (VB be) (ADJP (RBR more) (JJ destructive) (PP (TO to) (NP (NP (JJ dopaminergic) (NNS neurons)) (PP (IN than) (NP (DT the) (JJ acute) (JJ Doc_17490790_1217_1221_Chemical) (NN overload)))))))) (. .)))
17490864	0	(ROOT (S (NP (NP (JJ Attenuated) (NN disruption)) (PP (IN of) (NP (NN prepulse)))) (VP (VBN inhibition) (PP (IN by) (NP (JJ dopaminergic) (NN stimulation))) (PP (IN after) (NP (JJ maternal) (NN deprivation) (CC and) (JJ adolescent) (NNS Doc_17490864_115_129_Chemical) (NN treatment))) (PP (IN in) (NP (NNS rats)))) (. .)))
17490864	1	(ROOT (S (NP (NP (DT The) (NN development)) (PP (IN of) (NP (NNS Doc_17490864_168_181_Disease)))) (VP (MD may) (VP (VB include) (NP (NP (DT an) (JJ early) (JJ neurodevelopmental) (NN stress) (NN component)) (SBAR (WHNP (WDT which)) (S (VP (VBZ increases) (NP (NN vulnerability)) (PP (TO to) (NP (RBR later) (JJ stressful) (NN life) (NNS events))) (, ,) (PP (IN in) (NP (NP (NN combination)) (VP (VBG leading) (S (VP (TO to) (VP (VB overt) (NP (NN disease)))))))))))))) (. .)))
17490864	2	(ROOT (S (NP (PRP We)) (VP (VBD investigated) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (DT an) (JJ early) (NN stress)))) (, ,) (PP (IN in) (NP (NP (DT the) (NN form)) (PP (IN of) (NP (JJ maternal) (NN deprivation))) (, ,) (VP (VBN combined) (PP (IN with) (NP (NP (DT a) (JJ later) (NN stress)) (, ,) (NP (ADJP (JJ simulated) (PP (IN by) (NP (JJ chronic) (NN periadolescent) (NNS Doc_17490864_492_506_Chemical)))) (NN treatment)) (, ,))) (PP (IN on) (NP (NP (NN behaviour)) (PP (IN in) (NP (NNS rats))))))))) (. .)))
17490864	3	(ROOT (S (NP (NP (JJ Acute) (NN treatment)) (PP (IN with) (NP (NNS Doc_17490864_561_572_Chemical)))) (VP (VP (VBD caused) (NP (NP (NN disruption)) (PP (IN of) (NP (NP (JJ prepulse) (NN inhibition)) (PRN (-LRB- -LRB-) (NP (NNP PPI)) (-RRB- -RRB-))))) (PP (PP (IN in) (NP (NNS controls))) (CC and) (PP (IN in) (NP (NP (NNS rats)) (SBAR (WHNP (WDT that)) (S (VP (VBD had) (VP (VBN undergone) (NP (NP (DT either) (JJ maternal) (NN deprivation)) (CC or) (NP (JJ Doc_17490864_694_708_Chemical) (NN treatment))))))))))) (, ,) (CC but) (VP (VBD was) (ADJP (RB surprisingly) (JJ absent) (PP (IN in) (NP (NP (NNS rats)) (SBAR (WHNP (WDT that)) (S (VP (VBD had) (VP (VBN undergone) (NP (DT the) (VBN combined) (ADJP (JJ early) (CC and) (JJ late)) (NN stress))))))))))) (. .)))
17490864	4	(ROOT (S (NP (JJ Doc_17490864_811_822_Chemical) (NN treatment)) (ADVP (RB significantly)) (VP (VP (VBD disrupted) (NP (NP (NNP PPI)) (PP (IN in) (NP (DT both) (JJ non-deprived) (NNS groups))))) (, ,) (CC but) (VP (VBD was) (ADJP (JJ absent)) (PP (IN in) (NP (DT both) (JJ maternally) (VBN deprived) (NNS groups))))) (. .)))
17490864	5	(ROOT (S (NP (NP (DT The) (NN Doc_17490864_945_954_Chemical-1A) (NN receptor) (NN agonist)) (, ,) (NP (NNS Doc_17490864_976_985_Chemical)) (, ,)) (VP (VBN induced) (NP (NP (DT a) (JJ significant) (NN disruption)) (PP (IN of) (NP (NNP PPI)))) (PP (IN in) (NP (DT all) (NNS groups)))) (. .)))
17490864	6	(ROOT (S (NP (JJ Doc_17490864_1042_1053_Chemical-induced) (NNS Doc_17490864_1062_1085_Disease)) (VP (VBD was) (ADJP (JJ similar) (PP (IN in) (NP (DT all) (NNS groups))))) (. .)))
17490864	7	(ROOT (S (NP (DT These) (NNS results)) (VP (VBP show) (SBAR (S (NP (NP (DT an) (JJ inhibitory) (NN interaction)) (PP (IN of) (NP (JJ early) (NN stress))) (, ,) (VP (VBN caused) (PP (IN by) (NP (JJ maternal) (NN deprivation))) (, ,) (PP (VBN combined) (PP (IN with) (NP (`` `) (JJ adolescent) ('' ') (NN stress))))) (, ,)) (VP (VBD simulated) (PP (IN by) (NP (JJ Doc_17490864_1255_1269_Chemical) (NN treatment))) (, ,) (PP (IN on) (NP (NP (JJ dopaminergic) (NN regulation)) (PP (IN of) (NP (NNP PPI))))))))) (. .)))
17490864	8	(ROOT (S (NP (NP (DT The) (JJ altered) (NNS effects)) (PP (IN of) (NP (NNS Doc_17490864_1339_1350_Chemical) (CC and) (NNS Doc_17490864_1355_1366_Chemical)))) (VP (MD could) (VP (VB indicate) (NP (NN differential) (NNS changes)) (PP (IN in) (NP (NP (JJ Doc_17490864_1406_1414_Chemical) (NN receptor)) (VP (VBG signalling) (NP (NP (ADJP (JJ leading) (TO to) (JJ functional)) (NN desensitisation)) (, ,) (CC or) (NP (NP (JJ altered) (NN modulation)) (PP (IN of) (NP (NP (JJ sensory) (NN gating)) (PP (IN in) (NP (DT the) (NN nucleus) (NNS accumbens))))))) (PP (IN by) (NP (NP (JJ limbic) (NNS structures)) (PP (JJ such) (IN as) (NP (DT the) (NNS hippocampus)))))))))) (. .)))
17511042	0	(ROOT (NP (NP (DT An) (RB extremely) (JJ rare) (NN case)) (PP (IN of) (NP (NNS Doc_17511042_26_48_Disease))) (PP (IN in) (NP (DT a) (JJ Doc_17511042_54_73_Disease) (ADJP (JJ patient) (PP (IN during) (NP (NNS Doc_17511042_89_118_Chemical) (CC and) (NNS Doc_17511042_123_132_Chemical)))) (NN treatment))) (. .)))
17511042	1	(ROOT (S (PP (IN During) (NP (NP (NN treatment)) (PP (IN of) (NP (NP (JJ Doc_17511042_164_183_Disease) (NNS patients)) (PP (IN with) (NP (NN interferon) (CC and) (NNS Doc_17511042_213_222_Chemical))))))) (, ,) (NP (NP (DT a) (NN lot)) (PP (IN of) (NP (NN side) (NNS effects)))) (VP (VBP are) (VP (VBN described))) (. .)))
17511042	2	(ROOT (S (NP (NP (JJ Twenty-three) (NN percent)) (PP (TO to) (NP (NP (CD 44) (NN %)) (PP (IN of) (NP (NNS patients)))))) (VP (VBP develop) (NP (NNS Doc_17511042_309_319_Disease))) (. .)))
17511042	3	(ROOT (S (NP (NP (DT A) (NN minority)) (PP (IN of) (NP (NNS patients)))) (VP (VB evolve) (PP (TO to) (NP (NNS Doc_17511042_354_363_Disease)))) (. .)))
17511042	4	(ROOT (S (PP (TO To) (NP (NP (DT the) (JJS best)) (PP (IN of) (NP (PRP$ our) (NN knowledge))))) (, ,) (NP (NP (DT no) (NNS cases)) (PP (IN of) (NP (NP (NNS Doc_17511042_407_430_Disease)) (VP (VBG occurring) (PP (IN during) (NP (NN interferon) (NN therapy))))))) (VP (VBP have) (VP (VBN been) (VP (VBN described) (PP (IN in) (NP (DT the) (NN literature)))))) (. .)))
17511042	5	(ROOT (S (NP (PRP We)) (VP (VBP present) (NP (NP (DT a) (JJ 49-year-old) (NN woman)) (SBAR (WHNP (WP who)) (S (VP (VBD developed) (NP (DT a) (NNS Doc_17511042_553_575_Disease)) (PP (IN during) (NP (NN treatment))) (PP (IN with) (NP (JJ Doc_17511042_598_627_Chemical) (NN weekly) (CC and) (NNS Doc_17511042_639_648_Chemical)))))))) (. .)))
17511042	6	(ROOT (S (NP (PRP She)) (VP (VBD complained) (PP (IN of) (S (VP (VBG seeing) (NP (NP (NNS parasites)) (CC and) (NP (NP (DT the) (NN larvae)) (PP (IN of) (NP (NP (NNS fleas)) (PP (IN in) (NP (PRP$ her) (NNS stools))))))))))) (. .)))
17511042	7	(ROOT (S (NP (DT This)) (VP (MD could) (RB not) (VP (VB be) (VP (VBN confirmed) (PP (IN by) (NP (DT any) (JJ technical) (NN examination)))))) (. .)))
17511042	8	(ROOT (S (NP (PDT All) (DT the) (NNS complaints)) (VP (VBD disappeared) (SBAR (IN after) (S (S (VP (VBG stopping) (NP (NNS Doc_17511042_828_857_Chemical)))) (CC and) (S (VP (VBN reappeared) (PP (IN after) (S (VP (VBG restarting) (NP (PRP it)))))))))) (. .)))
17511042	9	(ROOT (S (NP (PRP She)) (VP (VBD had) (NP (DT a) (JJ complete) (VBN sustained) (JJ viral) (NN response))) (. .)))
17574447	0	(ROOT (NP (NP (NP (NNS Hepatonecrosis) (CC and) (NNS Doc_17574447_19_30_Disease)) (VP (VBN related) (PP (TO to) (NP (JJ long-term) (JJ Doc_17574447_52_65_Chemical) (NN therapy))))) (: :) (NP (NP (DT an) (JJ autopsy) (NN report)) (PP (IN of) (NP (CD two) (NNS patients)))) (. .)))
17574447	1	(ROOT (S (S (NP (NP (NNP Doc_17574447_110_123_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP PB)) (-RRB- -RRB-))) (VP (VBZ has) (NP (NP (DT a) (NN reputation)) (PP (IN for) (NP (NN safety)))))) (, ,) (CC and) (S (NP (PRP it)) (VP (VBZ is) (ADVP (RB commonly)) (VP (VBN believed) (SBAR (IN that) (S (NP (NP (JJ PB-related) (NNS increases)) (PP (IN in) (NP (NN serum) (NN aminotransferase) (NNS levels)))) (VP (VBP do) (RB not) (VP (VB indicate) (CC or) (VB predict) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (JJ significant) (JJ chronic) (NNS Doc_17574447_311_324_Disease))))))))))) (. .)))
17574447	2	(ROOT (S (ADVP (RB Here)) (NP (PRP we)) (VP (VBP report) (PP (IN of) (NP (NP (CD two) (JJ adult) (NNS patients)) (PP (IN with) (NP (NP (DT a) (JJ long) (NN history)) (PP (IN of) (NP (NP (NNS Doc_17574447_386_394_Disease)) (VP (VBN treated) (PP (IN with) (NP (NP (NP (NNS Doc_17574447_408_410_Chemical)) (SBAR (WHNP (WP who)) (S (VP (VBD died) (ADVP (RB suddenly)))))) (: :) (NP (NP (CD one)) (PP (IN as) (NP (NP (NN consequence)) (PP (IN of) (NP (NNS Doc_17574447_452_466_Disease)))))) (, ,) (NP (NP (DT the) (JJ other)) (PP (IN of) (NP (JJ acute) (NNS Doc_17574447_487_503_Disease)))))))))))))) (. .)))
17574447	3	(ROOT (S (PP (IN At) (NP (NN autopsy))) (, ,) (NP (NP (NN analysis)) (PP (IN of) (NP (NN liver) (NN parenchyma)))) (VP (VBD revealed) (SBAR (S (NP (NP (JJ rich) (JJ portal) (JJ inflammatory) (NNS infiltrate)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD consisted) (PP (IN of) (NP (JJ mixed) (NN eosinophil) (CC and) (NN monocyte) (NNS cells)))))) (, ,)) (VP (VBN associated) (PP (IN with) (NP (NP (JJ several) (NNS foci)) (PP (IN of) (NP (NP (NNS Doc_17574447_680_688_Disease)) (VP (VBN surrounded) (PP (IN by) (NP (NP (DT a) (JJ hard) (NN ring)) (PP (IN of) (NP (JJ non-specific) (NNS granulomatous) (NN tissue)))))))))))))) (. .)))
17574447	4	(ROOT (S (NP (NP (JJ Inflammatory) (NNS reactions)) (PP (IN of) (NP (ADJP (JJ internal) (CC and) (JJ external)) (JJ hepatic) (NN biliary) (NNS ducts)))) (VP (VBD were) (VP (ADVP (RB also)) (VBN seen))) (. .)))
17574447	5	(ROOT (S (NP (PRP$ Our) (NNS findings)) (VP (VBP illustrate) (SBAR (IN that) (S (NP (NNP PB)) (VP (MD may) (VP (VB be) (VP (VBN associated) (PP (IN with) (NP (NP (JJ chronic) (NNS Doc_17574447_902_914_Disease)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (MD may) (VP (VB lead) (PP (TO to) (NP (ADJP (RBR more) (JJ serious) (CC and) (JJ deleterious)) (NNS consequences))))))))))))))) (. .)))
17574447	6	(ROOT (S (PP (IN For) (NP (DT this) (NN reason))) (, ,) (NP (DT each) (NN clinician)) (VP (MD should) (VP (VB recognize) (NP (DT this) (NN entity)) (PP (IN in) (NP (NP (DT the) (NN differential) (NN diagnosis)) (PP (IN of) (NP (JJ PB-related) (JJ asymptomatic) (NNS Doc_17574447_1095_1129_Disease))))))) (. .)))
17682013	0	(ROOT (NP (NP (JJ Delayed) (NNS Doc_17682013_8_27_Disease)) (PP (IN with) (NP (NN Doc_17682013_33_39_Disease-like) (NN presentation))) (PP (IN in) (NP (JJ chemotherapy) (NNS recipients))) (. .)))
17682013	1	(ROOT (S (NP (DT A) (JJ transient) (JJ Doc_17682013_110_129_Disease) (NN mimicking) (NNS Doc_17682013_140_164_Disease)) (VP (VBZ has) (VP (VBN been) (VP (VBN described) (PP (IN as) (NP (NP (DT a) (NN complication)) (PP (IN of) (NP (NP (NN chemotherapy)) (, ,) (ADVP (RBS most) (RB commonly)))))) (PP (IN in) (NP (NP (NNS recipients)) (PP (IN of) (NP (NP (JJ intrathecal) (NNS Doc_17682013_262_274_Chemical)) (PP (IN for) (NP (NN childhood) (NNS Doc_17682013_289_298_Disease)))))))))) (. .)))
17682013	2	(ROOT (S (ADVP (RB Recently)) (NP (VBN published) (NN neuroimaging) (NNS data)) (VP (VBP suggest) (NP (NP (DT a) (JJ common) (NN pathophysiology)) (VP (VBN associated) (PP (IN with) (NP (NP (DT a) (NN variety)) (PP (IN of) (NP (NP (JJ chemotherapy) (NNS agents) (CC and) (NNS modes)) (PP (IN of) (NP (NN administration)))))))))) (. .)))
17682013	3	(ROOT (S (NP (PRP We)) (VP (VBN reviewed) (NP (NP (NP (DT the) (JJ medical) (NN literature)) (PP (IN for) (NP (JJ single) (NNS reports)))) (CC and) (NP (NP (NN case) (NN series)) (PP (IN of) (NP (NP (NNS patients)) (VP (VBG presenting) (PP (IN with) (NP (NN Doc_17682013_555_561_Disease-like) (NNS episodes))) (PP (IN while) (S (VP (VBG receiving) (NP (JJ systemic) (CC or) (JJ intrathecal) (NN chemotherapy))))))))))) (. .)))
17682013	4	(ROOT (S (NP (PRP We)) (ADVP (RB only)) (VP (VBD included) (NP (NNS studies)) (S (VP (VBG providing) (NP (JJ detailed) (VBG neuroimaging) (NNS data))))) (. .)))
17682013	5	(ROOT (S (NP (NP (NNS Patients)) (PP (IN with) (NP (NNS Doc_17682013_707_732_Disease)))) (VP (VBD were) (VP (VBN excluded))) (. .)))
17682013	6	(ROOT (S (NP (PRP We)) (VP (VBD identified) (NP (NP (CD 27) (NNS reports)) (PP (IN of) (NP (JJ toxic) (NNS Doc_17682013_791_810_Disease)))) (PP (IN in) (NP (NP (NNS patients)) (VP (VBN treated) (PP (IN with) (NP (NP (NNS Doc_17682013_836_848_Chemical)) (PRN (-LRB- -LRB-) (NP (NN intrathecal)) (, ,) (NP (NNP systemic)) (-RRB- -RRB-)) (, ,) (NP (NP (NNS Doc_17682013_874_888_Chemical)) (CC and) (NP (PRP$ its) (JJ derivative) (NNS Doc_17682013_908_916_Chemical))) (, ,) (CC and) (NP (NNS Doc_17682013_922_934_Chemical)))))))) (. .)))
17682013	7	(ROOT (S (NP (NP (NP (JJ Diffusion) (JJ weighted) (NN imaging)) (PRN (-LRB- -LRB-) (NP (NNP DWI)) (-RRB- -RRB-))) (PP (IN of) (NP (DT all) (NNS patients)))) (VP (VBD revealed) (NP (NP (NP (ADJP (RB well) (JJ demarcated)) (NN hyperintense) (NNS Doc_17682013_1023_1066_Disease)) (PP (IN of) (NP (DT the) (JJ cerebral) (NNS hemispheres)))) (CC and) (NP (NP (DT the) (NN corpus) (NN callosum)) (, ,) (NP (JJ corresponding)))) (PP (TO to) (NP (NP (NNS areas)) (PP (IN of) (NP (NP (VBN decreased) (NN proton) (NN diffusion)) (PP (IN on) (NP (NP (JJ apparent) (NN diffusion) (NN coefficient) (PRN (-LRB- -LRB-) (NP (NNP ADC)) (-RRB- -RRB-)) (NNS maps)) (PRN (-LRB- -LRB-) (ADJP (JJ available) (PP (IN in) (NP (CD 21/27) (NNS patients)))) (-RRB- -RRB-))))))))) (. .)))
17682013	8	(ROOT (S (NP (NNS Lesions)) (VP (VBD exceeded) (NP (NP (DT the) (NNS confines)) (PP (IN of) (NP (JJ adjacent) (NN vascular) (NNS territories))))) (. .)))
17682013	9	(ROOT (S (NP (NP (JJ Complete) (NN resolution)) (PP (IN of) (NP (NP (NNS symptoms)) (PP (IN within) (NP (CD 1-4) (NNS days)))))) (VP (VBD was) (VP (VBN accompanied) (PP (IN by) (NP (NP (NN normalisation)) (PP (IN of) (NP (NNP ADC) (NNS abnormalities))))))) (. .)))
17682013	10	(ROOT (S (ADVP (RB However)) (, ,) (NP (NP (ADJP (JJ fluid) (JJ attenuated)) (NN inversion) (NN recovery) (PRN (-LRB- -LRB-) (NP (NNP FLAIR)) (-RRB- -RRB-)) (NNS sequences)) (ADVP (RB frequently))) (VP (VBD revealed) (NP (JJ persistent) (NNS Doc_17682013_1510_1536_Disease))) (. .)))
17682013	11	(ROOT (S (NP (NP (JJ Several) (JJ pathophysiological) (NNS models)) (PP (IN of) (NP (NP (JJ delayed) (NNS Doc_17682013_1596_1615_Disease)) (PP (IN after) (NP (NP (NN exposure)) (PP (TO to) (NP (JJ intrathecal) (CC or) (JJ systemic) (NN chemotherapy)))))))) (VP (VBP have) (VP (VBN been) (VP (VBN proposed)))) (. .)))
17682013	12	(ROOT (S (NP (NP (NNP DWI) (NNS findings)) (PP (IN in) (NP (DT this) (NN cohort)))) (VP (VP (VBP are) (ADJP (JJ indicative) (PP (IN of) (NP (NNS Doc_17682013_1737_1782_Disease))))) (CC and) (VP (VBP lend) (NP (NN support)) (PP (TO to) (NP (NP (DT an) (ADJP (ADVP (ADVP (IN at) (JJS least)) (RB partially)) (JJ reversible)) (JJ metabolic) (NN derangement)) (PP (IN as) (NP (NP (DT the) (NN basis)) (PP (IN for) (NP (DT this) (NN syndrome))))))))) (. .)))
17702969	0	(ROOT (S (NP (NP (JJ Prenatal) (NN exposure)) (PP (TO to) (NP (NNS Doc_17702969_21_31_Chemical)))) (VP (VBZ induces) (NP (NP (NNS Doc_17702969_40_68_Disease)) (PP (IN in) (NP (DT the) (NN rat))))) (. .)))
17702969	1	(ROOT (SINV (ADVP (RB Doc_17702969_92_102_Chemical)) (VBZ is) (NP (DT a) (JJ selective) (JJ Doc_17702969_118_127_Chemical) (NN reuptake) (NN inhibitor) (NN antidepressant)) (ADJP (RB widely) (VBN used)) (PP (IN by) (NP (JJ pregnant) (NNS women))) (. .)))
17702969	2	(ROOT (S (NP (JJ Epidemiological) (NNS data)) (VP (VBP suggest) (SBAR (IN that) (S (NP (JJ Doc_17702969_227_237_Chemical) (NN exposure) (NN prenatally)) (VP (VBZ increases) (NP (NP (DT the) (NN prevalence)) (PP (IN of) (NP (NP (JJ persistent) (NNS Doc_17702969_297_328_Disease)) (PP (IN of) (NP (DT the) (JJ newborn)))))))))) (. .)))
17702969	3	(ROOT (S (NP (NP (DT The) (NN mechanism)) (ADJP (JJ responsible) (PP (IN for) (NP (DT this) (NN effect))))) (VP (VBZ is) (ADJP (JJ unclear) (CC and) (JJ paradoxical)) (, ,) (PP (VBG considering) (NP (NP (DT the) (JJ current) (NN evidence)) (PP (IN of) (NP (NP (DT a) (JJ Doc_17702969_453_475_Disease) (JJ protective) (JJ Doc_17702969_487_497_Chemical) (NN effect)) (PP (IN in) (NP (JJ adult) (NNS rodents)))))))) (. .)))
17702969	4	(ROOT (S (VP (TO To) (VP (VB evaluate) (NP (DT the) (JJ Doc_17702969_551_561_Chemical) (NN effect)) (PP (IN on) (NP (NP (JJ fetal) (NN rat) (JJ pulmonary) (NN vascular) (JJ smooth) (NN muscle) (JJ mechanical) (NNS properties)) (CC and) (NP (NN cell) (NN proliferation) (NN rate)))))) (. .)))
17702969	5	(ROOT (S (NP (JJ Pregnant) (NNS rats)) (VP (VBD were) (VP (VBN treated) (PP (IN with) (NP (NP (NNS Doc_17702969_707_717_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 10) (NN mg/kg)) (-RRB- -RRB-)))) (PP (IN from) (NP (NNP Day) (CD 11))) (PP (IN through) (NP (NP (NNP Day) (CD 21)) (PP (IN of) (NP (NN gestation))))))) (. .)))
17702969	6	(ROOT (S (S (NP (NNP MEASUREMENTS) (CC AND) (NNP MAIN)) (VP (VBZ RESULTS))) (: :) (S (NP (NNP Fetuses)) (VP (VBD were) (VP (VBN delivered) (PP (IN by) (NP (NN cesarean) (NN section)))))) (. .)))
17702969	7	(ROOT (S (PP (IN As) (PP (VBN compared) (PP (IN with) (NP (NNS controls))))) (, ,) (NP (JJ Doc_17702969_872_882_Chemical) (NN exposure)) (VP (VBD resulted) (PP (IN in) (NP (NNS Doc_17702969_904_932_Disease))) (SBAR (IN as) (S (VP (VBN evidenced) (PP (IN by) (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (NP (DT the) (NN weight) (NN ratio)) (PP (IN of) (NP (DT the) (JJ right) (NN ventricle))))))) (PP (PP (TO to) (NP (NP (DT the) (JJ left) (NN ventricle)) (PP (CC plus) (NP (NN septum))))) (PRN (-LRB- -LRB-) (S (VP (VB P) (S (VP (SYM =) (NP (CD 0.02)))))) (-RRB- -RRB-)) (CC and) (PP (IN by) (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (NP (JJ pulmonary) (JJ arterial) (JJ medial) (NN thickness)) (PRN (-LRB- -LRB-) (NP (NNP P) (NNP <) (NNP 0.01)) (-RRB- -RRB-))))))))))) (. .)))
17702969	8	(ROOT (S (S (NP (JJ Postnatal) (NN mortality)) (VP (VBD was) (VP (VBN increased) (PP (IN among) (NP (JJ experimental) (NNS animals)))))) (, ,) (CC and) (S (NP (JJ arterial) (JJ Doc_17702969_1194_1200_Chemical) (NN saturation)) (VP (VBD was) (ADJP (ADJP (NP (CD 96) (NNS +)) (JJ /)) (: -) (ADJP (ADJP (CD 1) (NN %)) (PP (IN in) (NP (JJ 1-day-old) (NN control) (NNS animals)))) (CC and) (ADJP (ADJP (RB significantly) (JJR lower)) (PRN (-LRB- -LRB-) (NP (NNP P) (NNP <) (NNP 0.01)) (-RRB- -RRB-)))) (PP (IN in) (NP (NP (NN Doc_17702969_1293_1303_Chemical-exposed) (NNS pups)) (PRN (-LRB- -LRB-) (NP (CD 79) (NNP +) (NNS /)) (, -) (NP (CD 2) (NN %)) (-RRB- -RRB-)))))) (. .)))
17702969	9	(ROOT (S (PP (IN In) (ADJP (NN vitro))) (, ,) (NP (NNS Doc_17702969_1340_1350_Chemical)) (VP (VBN induced) (NP (NP (NP (JJ pulmonary) (JJ arterial) (NN muscle) (NN contraction)) (PP (IN in) (NP (NNP fetal)))) (, ,) (CONJP (CC but) (RB not)) (NP (NP (NN adult)) (, ,) (NP (NNS animals)) (PRN (-LRB- -LRB-) (S (NP (NNP P)) (VP (VBZ <) (NP (CD 0.01)))) (-RRB- -RRB-))) (CC and) (NP (NP (NP (VBN reduced) (NN Doc_17702969_1453_1462_Chemical-induced) (NN contraction)) (PP (IN at) (NP (DT both) (NNS ages)))) (-LRB- -LRB-) (NP (NNP P) (NNP <) (NNP 0.01)) (-RRB- -RRB-)))) (. .)))
17702969	10	(ROOT (S (PP (IN After) (PP (IN in) (NP (NP (NN utero) (NN exposure)) (PP (TO to) (NP (DT a) (JJ low) (JJ Doc_17702969_1541_1551_Chemical) (NN concentration)))))) (NP (DT the) (JJ pulmonary) (JJ arterial) (JJ smooth) (NN muscle) (NN cell) (NN proliferation) (NN rate)) (VP (VBD was) (ADVP (RB significantly)) (VP (VBN increased) (PP (IN in) (NP (NP (ADJP (ADJP (JJ fetal)) (, ,) (CC but) (ADJP (RB not) (JJ adult)) (, ,)) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NNP P) (NNP <) (NNP 0.01)) (-RRB- -RRB-)))))) (. .)))
17702969	11	(ROOT (S (PP (IN In) (NP (NP (NN contrast)) (PP (TO to) (NP (DT the) (NN adult))))) (, ,) (NP (NP (JJ Doc_17702969_1737_1747_Chemical) (NN exposure)) (PP (IN in) (NP (NN utero)))) (VP (VBZ induces) (NP (NP (NNS Doc_17702969_1774_1796_Disease)) (PP (IN in) (NP (DT the) (JJ fetal) (NN rat)))) (PP (IN as) (NP (NP (DT a) (NN result)) (PP (IN of) (NP (NP (DT a) (JJ developmentally) (JJ regulated) (NN increase)) (PP (IN in) (NP (JJ pulmonary) (NN vascular) (JJ smooth) (NN muscle) (NN proliferation)))))))) (. .)))
17786501	0	(ROOT (NP (NP (JJ Doc_17786501_0_10_Chemical-induced) (JJ transient) (NNS Doc_17786501_29_60_Disease)) (: :) (NP (DT a) (NN case) (NN report)) (. .)))
17786501	1	(ROOT (S (VP (TO To) (VP (VB report) (NP (NP (DT a) (NN case)) (PP (IN of) (NP (NNS Doc_17786501_102_133_Disease)))) (PP (IN after) (NP (NP (JJ chronic) (NN use)) (PP (IN of) (NP (NP (NNS Doc_17786501_155_165_Chemical)) (PP (IN for) (NP (JJ Doc_17786501_170_177_Chemical) (NN dependence) (NN management))))))))) (. .)))
17786501	2	(ROOT (NP (NP (NNP MATERIALS) (CC AND) (NNP METHODS)) (: :) (NP (DT A) (NN case) (NN report)) (. .)))
17786501	3	(ROOT (S (NP (DT A) (JJ 57-year-old) (NN male)) (VP (VBD presented) (PP (IN with) (NP (NP (JJ gradual) (NNS Doc_17786501_290_304_Disease)) (PP (IN in) (NP (DT both) (NNS eyes))))) (PP (IN with) (NP (NP (JJ intermittent) (NNS Doc_17786501_336_345_Disease)) (PP (IN for) (NP (CD 2) (NNS months)))))) (. .)))
17786501	4	(ROOT (S (NP (NNP Doc_17786501_360_362_Chemical)) (ADVP (RB also)) (VP (VBD complained) (PP (IN of) (NP (NN paraesthesia))) (PP (IN with) (NP (NP (NNS Doc_17786501_400_408_Disease)) (PP (IN in) (NP (DT both) (NNS feet)))))) (. .)))
17786501	5	(ROOT (S (NP (JJ Doc_17786501_423_426_Chemical) (NN vision)) (VP (VBD was) (NP (NP (CD 6/15) (CC and) (CD 2/60)) (PP (IN in) (NP (DT the) (ADJP (JJ right) (CC and) (JJ left)) (NNS eyes)))) (, ,) (ADVP (RB respectively))) (. .)))
17786501	6	(ROOT (S (NP (NNP Fundoscopy)) (VP (VBD revealed) (NP (JJ bilaterally) (JJ swollen) (JJ optic) (NN nerve) (NNS heads))) (. .)))
17786501	7	(ROOT (S (NP (JJ Visual) (NN field) (NN testing)) (VP (VBD confirmed) (NP (JJ bilateral) (JJ central-caecal) (NN scotomata))) (. .)))
17786501	8	(ROOT (S (NP (PRP He)) (VP (VBD had) (VP (VBN been) (VP (VBG taking) (NP (NP (NNS Doc_17786501_639_649_Chemical)) (PP (IN for) (NP (JJ Doc_17786501_654_661_Chemical) (NN dependence)))) (PP (IN for) (NP (DT the) (VBG preceding) (CD 3) (NNS years)))))) (. .)))
17786501	9	(ROOT (S (NP (JJ Doc_17786501_700_710_Chemical) (NN discontinuation)) (VP (VBP lead) (PP (TO to) (NP (DT an) (JJ immediate) (JJ symptomatic) (NN improvement)))) (. .)))
17786501	10	(ROOT (S (NP (NP (NNP Physicians)) (VP (VBG initiating) (NP (JJ long-term) (JJ Doc_17786501_817_827_Chemical) (NN therapy)))) (VP (MD should) (VP (VB be) (ADJP (JJ aware) (PP (IN of) (NP (DT these) (JJ adverse) (NNS effects)))))) (. .)))
17786501	11	(ROOT (S (NP (PRP They)) (VP (MD should) (VP (VB recommend) (NP (JJ annual) (JJ ophthalmic) (NNS reviews)) (PP (IN with) (NP (JJ visual) (NN field) (NN testing))))) (. .)))
17786501	12	(ROOT (S (NP (NNS Patients)) (VP (MD should) (VP (VB be) (VP (VBN reassured) (PP (IN with) (NP (NN respect))) (PP (TO to) (NP (NP (DT the) (NN reversibility)) (PP (IN of) (NP (DT these) (JJ adverse) (NNS effects)))))))) (. .)))
17923537	0	(ROOT (S (NP (NP (JJ Intraocular) (NN pressure)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NNS Doc_17923537_38_45_Disease)))))) (VP (VBN treated) (PP (IN with) (NP (JJ Doc_17923537_59_81_Chemical) (NNS implants)))) (. .)))
17923537	1	(ROOT (S (S (VP (TO To) (VP (VB report) (NP (NP (DT the) (NN incidence) (CC and) (NN management)) (PP (IN of) (NP (NP (NNS Doc_17923537_145_174_Disease)) (PRN (-LRB- -LRB-) (NP (NNP IOP)) (-RRB- -RRB-))))) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NNS Doc_17923537_198_205_Disease)))))))) (VP (VBN treated) (PP (IN with) (NP (DT the) (JJ Doc_17923537_223_245_Chemical) (PRN (-LRB- -LRB-) (NP (NNP Doc_17923537_247_249_Chemical)) (-RRB- -RRB-)) (JJ intravitreal) (NN implant)))) (. .)))
17923537	2	(ROOT (S (NP (NP (JJ Pooled) (NNS data)) (PP (IN from) (NP (CD 3) (ADJP (JJ multicenter) (, ,) (JJ double-masked) (, ,) (JJ randomized) (, ,) (JJ controlled) (, ,) (JJ phase)) (JJ 2b/3) (JJ clinical) (NNS trials))) (VP (VBG evaluating) (NP (NP (DT the) (NN safety) (CC and) (NN efficacy)) (PP (IN of) (NP (DT the) (ADJP (JJ 0.59-mg) (CC or) (JJ 2.1-mg)) (NNP FA) (JJ intravitreal) (NN implant) (CC or) (JJ standard) (NN therapy)))))) (VP (VBD were) (VP (VBN analyzed))) (. .)))
17923537	3	(ROOT (S (PP (IN During) (NP (DT the) (JJ 3-year) (NN follow-up))) (, ,) (NP (NP (CD 71.0) (NN %)) (PP (IN of) (NP (JJ implanted) (NNS eyes)))) (VP (VBD had) (NP (NP (NP (DT an) (NNP IOP) (NN increase)) (PP (IN of) (NP (NP (CD 10) (NN mm) (NNP Hg)) (CC or) (NP (NP (QP (JJR more) (IN than) (CD baseline))) (CC and) (NP (QP (CD 55.1) (NN %))))))) (, ,) (NP (CD 24.7) (NN %)) (, ,) (CC and) (NP (NP (CD 6.2) (NN %)) (PP (IN of) (NP (NP (NNS eyes)) (VP (VBN reached) (NP (NP (DT an) (NNP IOP)) (PP (IN of) (NP (NP (CD 30) (NN mm)) (ADJP (ADJP (JJ Hg) (CC or) (JJR more)) (, ,) (ADJP (NP (CD 40) (NNS mm)) (JJ Hg)) (CC or) (ADJP (JJR more)) (, ,) (CC and) (ADJP (NP (CD 50) (NNS mm)) (JJ Hg)) (CC or) (ADJP (JJR more))))))))))) (, ,) (ADVP (RB respectively))) (. .)))
17923537	4	(ROOT (S (S (NP (JJ Topical) (JJ IOP-lowering) (NN medication)) (VP (VBD was) (VP (VBN administered) (PP (IN in) (NP (NP (CD 74.8) (NN %)) (PP (IN of) (NP (JJ implanted) (NNS eyes)))))))) (, ,) (CC and) (S (NP (NP (JJ IOP-lowering) (NNS surgeries)) (, ,) (SBAR (WHNP (JJS most) (WHPP (IN of) (WHNP (WDT which)))) (S (VP (VBD were) (NP (NP (NNS trabeculectomies)) (PRN (-LRB- -LRB-) (NP (CD 76.2) (NN %)) (-RRB- -RRB-)))))) (, ,)) (VP (VBD were) (VP (VBN performed) (PP (IN on) (NP (NP (CD 36.6) (NN %)) (PP (IN of) (NP (JJ implanted) (NNS eyes)))))))) (. .)))
17923537	5	(ROOT (S (NP (JJ Intraocular) (JJ pressure-lowering) (NNS surgeries)) (VP (VBD were) (VP (VBN considered) (NP (NP (DT a) (NN success)) (PRN (-LRB- -LRB-) (NP (NP (NNP postoperative) (NNP IOP)) (PP (IN of) (NP (CD 6-21) (NN mm))) (VP (VBN Hg) (PP (IN with) (CC or) (IN without) (NP (JJ additional) (JJ IOP-lowering) (NN medication))))) (-RRB- -RRB-)) (PP (IN in) (NP (NP (CD 85.1) (NN %)) (PP (IN of) (NP (NP (NNS eyes)) (PP (IN at) (NP (CD 1) (NN year)))))))))) (. .)))
17923537	6	(ROOT (S (NP (NP (DT The) (NN rate)) (PP (IN of) (NP (NNS Doc_17923537_1123_1131_Disease))) (PRN (-LRB- -LRB-) (NP (NNP IOP) (NNP <)) (: /) (NP (NP (NNP =) (CD 5)) (NP (NNP mm) (NNP Hg))) (-RRB- -RRB-)) (PP (VBG following) (NP (NP (JJ IOP-lowering) (NN surgery)) (PRN (-LRB- -LRB-) (NP (CD 42.5) (NN %)) (-RRB- -RRB-))))) (VP (VBD was) (RB not) (ADJP (JJ different) (PP (IN from) (NP (NP (DT that)) (PP (IN of) (NP (NP (JJ implanted) (NNS eyes)) (VP (RB not) (VBN subjected) (PP (TO to) (NP (NP (NP (NN surgery)) (PRN (-LRB- -LRB-) (NP (CD 35.4) (NN %)) (-RRB- -RRB-))) (PRN (-LRB- -LRB-) (NP (NNP P) (QP (CD =) (CD .09))) (-RRB- -RRB-))))))))))) (. .)))
17923537	7	(ROOT (S (NP (NNP Elevated) (NNP IOP)) (VP (VP (VBZ is) (NP (NP (DT a) (JJ significant) (NN complication)) (PP (IN with) (NP (DT the) (NNP FA) (NN intravitreal) (NN implant))))) (CC but) (VP (MD may) (VP (VB be) (VP (VBN controlled) (PP (IN with) (NP (NN medication) (CC and) (NN surgery))))))) (. .)))
17943461	0	(ROOT (S (NP (NNP Myocardial) (NNP Fas)) (VP (VBD ligand) (NP (NN expression) (NNS increases)) (ADVP (RB susceptibility)) (PP (TO to) (NP (NN Doc_17943461_61_64_Chemical-induced) (NNS Doc_17943461_73_87_Disease)))) (. .)))
17943461	1	(ROOT (S (NP (NP (JJ Doc_17943461_101_123_Disease) (-LRB- -LRB-) (NNS Doc_17943461_125_128_Disease) (-RRB- -RRB-)) (CC and) (NP (NNS Doc_17943461_134_145_Disease))) (VP (VBP occur) (PP (IN in) (NP (JJ many) (JJ Doc_17943461_160_172_Disease) (NNS individuals))) (, ,) (S (VP (VBG resulting) (PP (IN in) (NP (NP (JJ symptomatic) (NNS Doc_17943461_211_224_Disease)) (PP (IN in) (NP (NP (QP (IN up) (TO to) (CD 5)) (NN %)) (PP (IN of) (NP (NNS patients)))))))))) (. .)))
17943461	2	(ROOT (S (NP (NP (ADJP (NNP Highly) (JJ active)) (JJ antiretroviral) (NN therapy)) (PRN (-LRB- -LRB-) (NP (NNP HAART)) (-RRB- -RRB-))) (VP (VP (VBZ has) (ADVP (RB significantly)) (VP (VBN reduced) (NP (NP (NN morbidity) (CC and) (NN mortality)) (PP (IN of) (NP (NP (NNS Doc_17943461_348_382_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_17943461_384_388_Disease)) (-RRB- -RRB-))))))) (, ,) (CC but) (VP (VBZ has) (VP (VBN resulted) (PP (IN in) (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (NNS Doc_17943461_426_457_Disease)))))))) (. .)))
17943461	3	(ROOT (FRAG (NP (NNS METHODS) (CC AND) (NNS RESULTS)) (: :) (S (SBAR (IN In) (NN order) (S (VP (TO to) (VP (VP (VB investigate) (SBAR (IN whether) (S (NP (NP (DT the) (JJ HAART) (NN component) (NNS Doc_17943461_532_542_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (NNS Doc_17943461_544_573_Chemical)) (: ;) (NP (NNS Doc_17943461_575_578_Chemical))) (-RRB- -RRB-))) (VP (VBZ triggers) (NP (DT the) (JJ Fas-dependent) (JJ cell-death) (NN pathway)))))) (CC and) (VP (VB cause) (NP (JJ cytoskeletal) (NN disruption)) (PP (IN in) (NP (NP (DT a) (JJ murine) (NN model)) (PP (IN of) (NP (NNS Doc_17943461_681_684_Disease)))))))))) (, ,) (NP (NP (NP (JJ 8-week-old) (NN transgenic)) (PRN (-LRB- -LRB-) (S (NP (NNP expressing) (NNP Fas)) (ADJP (JJ ligand) (PP (IN in) (NP (NP (DT the) (NN myocardium)) (: :) (NP (NNP FasL) (NNP Tg)))))) (-RRB- -RRB-))) (CC and) (NP (ADJP (ADJP (JJ non-transgenic)) (PRN (-LRB- -LRB-) (NP (NNP NTg)) (-RRB- -RRB-))) (NNS mice))) (VP (VBD received) (NP (NP (NN water) (NN ad) (NN libitum)) (VP (VBG containing) (NP (NP (JJ different) (NNS concentrations)) (PP (IN of) (NP (NP (NNS Doc_17943461_854_857_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (CD 0)) (, ,) (NP (CD 0.07)) (, ,) (NP (CD 0.2)) (, ,) (CC and) (NP (CD 0.7) (NN mg/ml))) (-RRB- -RRB-))))))))) (. .)))
17943461	4	(ROOT (S (PP (IN After) (NP (CD 6) (NNS weeks))) (, ,) (NP (JJ cardiac) (NN function)) (VP (VP (VBD was) (VP (VBN assessed) (PP (IN by) (NP (NN echocardiography))))) (CC and) (VP (ADVP (RB morphology)) (VBD was) (VP (VBN assessed) (PP (IN by) (NP (ADJP (JJ histopathologic) (CC and) (JJ immunohistochemical)) (NNS methods)))))) (. .)))
17943461	5	(ROOT (S (NP (NNP NTg) (CC and) (NNP untreated) (NNP FasL) (NNP Tg) (NNS mice)) (VP (VBD showed) (NP (NP (RB little)) (CC or) (NP (DT no) (NN change))) (PP (IN in) (NP (JJ cardiac) (NN structure) (CC or) (NN function)))) (. .)))
17943461	6	(ROOT (S (PP (IN In) (NP (NN contrast))) (, ,) (NP (NNP Doc_17943461_1139_1142_Chemical-treated) (NNP FasL) (NNP Tg) (NNS mice)) (VP (VBD developed) (NP (ADJP (JJ Doc_17943461_1174_1190_Disease) (CC and) (JJ depressed)) (JJ cardiac) (NN function)) (PP (IN in) (NP (DT a) (JJ dose-dependent) (NN manner))) (, ,) (PP (IN with) (NP (NP (JJ concomitant) (JJ inflammatory) (NN infiltration)) (PP (IN of) (NP (DT both) (NNS ventricles)))))) (. .)))
17943461	7	(ROOT (S (NP (DT These) (NNS changes)) (VP (VBD were) (VP (VBN associated) (PP (IN with) (NP (NP (NP (DT an) (VBN increased) (JJ sarcolemmal) (NN expression)) (PP (IN of) (NP (NNP Fas) (CC and) (NNP FasL)))) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (NP (NP (VBN increased) (NN activation)) (PP (IN of) (NP (NNP caspase) (CD 3) (, ,) (CD translocation))) (PP (IN of) (NP (NN calpain) (CD 1))) (PP (TO to) (NP (DT the) (NN sarcolemma) (CC and) (NN sarcomere)))) (, ,) (CC and) (NP (NP (VBN increased) (NNS numbers)) (PP (IN of) (NP (NP (NNS cells)) (VP (VBG undergoing) (NP (NNS apoptosis))))))))))) (. .)))
17943461	8	(ROOT (S (NP (DT These)) (VP (VBD were) (VP (VBN associated) (PP (IN with) (NP (NP (NP (NNS changes)) (PP (IN in) (NP (NN dystrophin) (CC and) (JJ cardiac) (NN troponin) (NN I) (NNS localization)))) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (NP (NN loss)) (PP (IN of) (NP (JJ sarcolemmal) (NN integrity)))))))) (. .)))
17943461	9	(ROOT (NP (NP (DT The) (NN expression)) (PP (IN of) (NP (NP (NNP Fas)) (VP (VBN ligand) (PP (IN in) (NP (DT the) (NN myocardium))) (, ,) (SBAR (IN as) (S (S (VP (VBN identified) (PP (IN in) (NP (JJ HIV-positive) (NNS patients))))) (, ,) (VP (MD might) (VP (VB increase) (NP (DT the) (NN susceptibility)) (PP (TO to) (NP (JJ HAART-induced) (NNS Doc_17943461_1840_1854_Disease)))))))))) (ADJP (JJ due) (PP (TO to) (NP (NP (NN activation)) (PP (IN of) (NP (JJ apoptotic) (NNS pathways)))))) (, ,) (VP (VBG resulting) (PP (IN in) (NP (NNS Doc_17943461_1909_1941_Disease)))) (. .)))
17965424	0	(ROOT (NP (NP (NP (JJ Gastrointestinal) (NN tolerability)) (PP (IN of) (NP (NP (NNS Doc_17965424_33_43_Chemical)) (PP (IN in) (NP (JJ Doc_17965424_47_67_Disease) (NNS patients)))))) (: :) (NP (NP (NNS results)) (PP (IN of) (NP (NP (DT the) (JJ Doc_17965424_93_103_Chemical) (ADJP (NP (CD vs) (NNS Doc_17965424_107_124_Chemical)) (JJ gastrointestinal)) (NN tolerability) (CC and) (NN effectiveness) (NN trial)) (PRN (-LRB- -LRB-) (NP (NNP EDGE-II)) (-RRB- -RRB-))))) (. .)))
17965424	1	(ROOT (NP (NP (DT A) (NN randomised)) (, ,) (NP (JJ double-blind) (NN study) (S (VP (TO to) (VP (VB compare) (NP (NP (DT the) (NN gastrointestinal)) (PRN (-LRB- -LRB-) (NP (NNP GI)) (-RRB- -RRB-)) (ADJP (JJ tolerability) (, ,) (NN safety) (CC and) (JJ efficacy))) (PP (IN of) (NP (NNS Doc_17965424_308_318_Chemical) (CC and) (NNS Doc_17965424_323_333_Chemical))) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (NNS Doc_17965424_351_371_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_17965424_373_375_Disease)) (-RRB- -RRB-)))))))))) (. .)))
17965424	2	(ROOT (FRAG (NP (NNS PATIENTS) (CC AND) (NNS METHODS)) (: :) (S (NP (NP (DT A) (NN total)) (PP (IN of) (NP (NP (CD 4086) (NNS patients)) (PRN (-LRB- -LRB-) (NP (NP (JJ mean) (NN age)) (NP (CD 60.8) (NNS years))) (-RRB- -RRB-))))) (VP (VP (VBD diagnosed) (SBAR (IN with) (S (NP (NNS Doc_17965424_462_464_Disease)) (VP (VBD were) (VP (VBN enrolled)))))) (CC and) (VP (VBD received) (NP (NP (NN Doc_17965424_492_502_Chemical) (CD 90) (NN mg) (NN daily)) (PRN (-LRB- -LRB-) (VP (VBN n) (S (VP (SYM =) (NP (CD 2032))))) (-RRB- -RRB-)) (CC or) (NP (NP (NP (NNS Doc_17965424_529_539_Chemical)) (NP (QP (CD 75) (CD mg)) (RB twice) (RB daily))) (PRN (-LRB- -LRB-) (VP (VBN n) (S (VP (SYM =) (NP (CD 2054))))) (-RRB- -RRB-))))))) (. .)))
17965424	3	(ROOT (S (NP (NP (NN Use)) (PP (IN of) (NP (NP (JJ gastroprotective) (NNS agents)) (CC and) (NP (JJ low-dose) (NNS Doc_17965424_614_621_Chemical))))) (VP (VBD was) (VP (VBN allowed))) (. .)))
17965424	4	(ROOT (S (NP (DT The) (JJ prespecified) (JJ primary) (NN end) (NN point)) (VP (VBD consisted) (PP (IN of) (NP (NP (DT the) (JJ cumulative) (NN rate)) (PP (IN of) (NP (NP (NP (JJ patient) (NNS discontinuations)) (ADJP (JJ due) (PP (TO to) (NP (JJ clinical) (CC and) (NN laboratory) (NN GI) (JJ adverse) (NNS experiences))))) (PRN (-LRB- -LRB-) (NP (NNP AEs)) (-RRB- -RRB-))))))) (. .)))
17965424	5	(ROOT (S (NP (NNP General) (NN safety)) (VP (VBD was) (VP (ADVP (RB also)) (VBN assessed) (, ,) (PP (VBG including) (NP (JJ adjudicated) (JJ Doc_17965424_848_873_Disease) (NN event) (NNS data))))) (. .)))
17965424	6	(ROOT (S (NP (NNP Efficacy)) (VP (VBD was) (VP (VBN evaluated) (S (VP (VBG using) (NP (NP (DT the) (NNP Patient) (NNP Global) (NNP Assessment)) (PP (IN of) (NP (NP (NNP Disease) (NNP Status)) (PRN (-LRB- -LRB-) (NP (NP (NNS PGADS)) (: ;) (NP (CD 0-4) (NN point) (NN scale))) (-RRB- -RRB-))))))))) (. .)))
17965424	7	(ROOT (S (S (NP (NP (JJ Mean) (PRN (-LRB- -LRB-) (NP (NP (NNP SD)) (: ;) (NP (NN maximum))) (-RRB- -RRB-)) (NN duration)) (PP (IN of) (NP (NN treatment)))) (VP (VBD was) (NP (NP (CD 19.3)) (PRN (-LRB- -LRB-) (NP (NP (CD 10.3)) (: ;) (NP (NNP 32.9))) (-RRB- -RRB-))))) (CC and) (S (NP (JJ 19.1) (PRN (-LRB- -LRB-) (NP (NP (CD 10.4)) (: ;) (NP (NNP 33.1))) (-RRB- -RRB-)) (NNS months)) (PP (IN in) (NP (DT the) (NNS Doc_17965424_1097_1107_Chemical) (CC and) (NNS Doc_17965424_1112_1122_Chemical) (NNS groups))) (, ,) (ADVP (RB respectively))) (. .)))
17965424	8	(ROOT (S (NP (NP (DT The) (JJ cumulative) (NN discontinuation) (NN rate)) (ADJP (JJ due) (PP (TO to) (NP (NNS Doc_17965424_1188_1194_Disease))))) (VP (VBD was) (ADJP (RB significantly) (JJR lower)) (PP (IN with) (NP (NP (NNS Doc_17965424_1224_1234_Chemical)) (PP (IN than) (NP (NP (NNS Doc_17965424_1240_1250_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (CD 5.2) (NN vs)) (NP (NP (NP (CD 8.5) (NNS events)) (PP (IN per) (NP (NP (CD 100) (NNS patient-years)) (, ,) (ADVP (RB respectively))))) (: ;) (NP (NP (NN hazard) (NN ratio)) (NP (NP (CD 0.62)) (PRN (-LRB- -LRB-) (FRAG (NP (NP (CD 95) (NN %)) (NP (NNP CI))) (: :) (NP (NP (NP (CD 0.47)) (, ,) (NP (CD 0.81))) (: ;) (NP (NP (NN p) (NNS <)) (CC or) (NP (NNP =) (CD 0.001))))) (-RRB- -RRB-)))))) (-RRB- -RRB-))))))) (. .)))
17965424	9	(ROOT (S (NP (NP (DT The) (NN incidence)) (PP (IN of) (NP (NP (NNS discontinuations)) (PP (IN for) (NP (ADJP (JJ Doc_17965424_1398_1410_Disease-related) (CC and) (JJ Doc_17965424_1423_1429_Disease-related)) (NNP AEs)))))) (VP (VBD were) (ADJP (ADJP (RB significantly) (JJR higher)) (PP (IN with) (NP (NP (NNS Doc_17965424_1473_1483_Chemical)) (PRN (-LRB- -LRB-) (S (NP (NP (CD 2.5) (NN %)) (CC and) (NP (CD 1.1) (NN %))) (ADJP (RB respectively))) (-RRB- -RRB-))))) (PP (VBN compared) (PP (IN with) (NP (NP (NNS Doc_17965424_1527_1537_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (NP (NP (CD 1.5) (NN %)) (CC and) (NP (NP (CD 0.4) (NN %)) (ADVP (RB respectively)))) (: ;) (NP (NP (NN p)) (VP (VBG <) (NP (CD 0.001)) (PP (IN for) (NP (NNS Doc_17965424_1579_1591_Disease)))))) (CC and) (NP (NP (NNP p) (NNP <) (NNP 0.01)) (PP (IN for) (NP (NNS Doc_17965424_1607_1613_Disease))))) (-RRB- -RRB-)))))) (. .)))
17965424	10	(ROOT (S (NP (NP (NNP Doc_17965424_1616_1626_Chemical)) (CC and) (NP (JJ Doc_17965424_1631_1641_Chemical) (NN treatment))) (VP (VBD resulted) (PP (IN in) (NP (JJ similar) (NN efficacy) (PRN (-LRB- -LRB-) (S (NP (NNS PGADS)) (VP (VBP mean) (NP (NNS changes)) (PP (IN from) (NP (NN baseline) (CD -0.62) (NN vs) (CD -0.58))) (, ,) (ADVP (RB respectively)))) (-RRB- -RRB-))))) (. .)))
17965424	11	(ROOT (S (NP (JJ Doc_17965424_1759_1769_Chemical) (CD 90) (NN mg)) (VP (VBD demonstrated) (NP (DT a) (ADJP (RB significantly) (JJR lower)) (NN risk)) (PP (IN for) (S (VP (VBG discontinuing) (NP (NN treatment)) (PP (JJ due) (TO to) (NP (NP (NNS Doc_17965424_1851_1857_Disease)) (PP (VBN compared) (PP (IN with) (NP (QP (CD Doc_17965424_1872_1882_Chemical) (CD 150)) (NN mg)))))))))) (. .)))
17965424	12	(ROOT (S (NP (NP (NNS Discontinuations)) (PP (IN from) (NP (NN renovascular) (NN AEs)))) (, ,) (SBAR (IN although) (S (ADJP (RBR less) (JJ common) (PP (IN than) (NP (NP (NNS discontinuations)) (PP (IN from) (NP (NNS Doc_17965424_1979_1985_Disease)))))))) (, ,) (VP (VBD were) (ADJP (RB significantly) (JJR higher)) (PP (IN with) (NP (NNS Doc_17965424_2018_2028_Chemical)))) (. .)))
17975693	0	(ROOT (NP (NP (JJ Anxiogenic) (NN potential)) (PP (IN of) (NP (NNS Doc_17975693_24_37_Chemical) (CC and) (NNS Doc_17975693_42_53_Chemical))) (PP (IN in) (NP (NNS rats))) (. .)))
17975693	1	(ROOT (S (S (NP (NP (DT The) (JJ possible) (JJ anxiogenic) (NNS effects)) (PP (IN of) (NP (NP (NNS Doc_17975693_112_128_Chemical)) (, ,) (NP (RB namely) (NNS Doc_17975693_137_150_Chemical) (CC and) (NNS Doc_17975693_155_166_Chemical)) (, ,)))) (VP (VBD were) (VP (VBN investigated) (PP (IN in) (NP (NP (JJ adult) (NNP Charles) (NNP Foster) (NN albino) (NNS rats)) (PP (IN of) (NP (DT either) (NN sex))))) (, ,) (S (VP (VBG weighing) (NP (CD 150-200) (NN g.) (NNS METHODS))))))) (: :) (S (S (NP (DT The) (NNS drugs)) (VP (VBD were) (VP (VBN given) (ADVP (RB orally)) (, ,) (PP (IN in) (S (NP (NP (NNS doses)) (PP (IN of) (NP (CD 50)))) (VP (VBG mg/kg) (PP (IN for) (NP (CD five) (JJ consecutive) (NNS days))))))))) (CC and) (S (NP (DT the) (NNS experiments)) (VP (VBD were) (VP (VBN performed) (PP (IN on) (NP (DT the) (JJ fifth) (NN day))))))) (. .)))
17975693	2	(ROOT (S (NP (DT The) (NNS tests)) (VP (VP (VBD included) (NP (JJ open-field) (JJ exploratory) (NN behaviour))) (, ,) (VP (VBD elevated) (PP (CC plus) (NP (NN maze)))) (CC and) (VP (VBD elevated) (NP (NP (CD zero) (NN maze)) (, ,) (NP (JJ social) (NN interaction)) (CC and) (NP (JJ novelty-suppressed) (NN feeding) (NN latency) (NN behaviour))))) (. .)))
17975693	3	(ROOT (S (NP (DT The) (NNS results)) (VP (VBP indicate) (SBAR (IN that) (S (NP (ADJP (JJ Doc_17975693_595_608_Chemical) (: -) (CC and) (JJ Doc_17975693_614_625_Chemical-treated)) (NNS rats)) (VP (VBD showed) (NP (JJ anxious) (NN behaviour)) (PP (IN in) (NP (NN comparison))) (S (VP (TO to) (VP (VB control) (NP (NNS rats)) (PP (IN in) (NP (NP (PDT all) (DT the) (NNS parameters)) (VP (VBN studied))))))))))) (. .)))
17975693	4	(ROOT (S (ADVP (RB However)) (, ,) (NP (ADJP (JJ Doc_17975693_734_747_Chemical) (: -) (CC and) (JJ Doc_17975693_753_764_Chemical-treated)) (NNS rats)) (VP (VBD did) (RB not) (VP (VB differ) (ADVP (RB significantly)) (PP (IN from) (NP (NP (DT each) (JJ other)) (PP (IN in) (NP (JJ various) (JJ behavioural) (NNS parameters))))))) (. .)))
17975693	5	(ROOT (S (NP (DT The) (JJ present) (JJ experimental) (NNS findings)) (VP (VB substantiate) (NP (NP (DT the) (ADJP (RB clinically) (JJ observed)) (JJ anxiogenic) (NN potential)) (PP (IN of) (NP (NNS Doc_17975693_965_978_Chemical) (CC and) (NNS Doc_17975693_983_994_Chemical))))) (. .)))
18006530	0	(ROOT (NP (NP (NN Reduction)) (PP (IN of) (NP (NP (NNS Doc_18006530_13_17_Disease)) (PP (IN during) (NP (NN induction))))) (PP (IN with) (NP (JJ target-controlled) (NNS Doc_18006530_58_66_Chemical) (CC and) (NNS Doc_18006530_71_83_Chemical))) (. .)))
18006530	1	(ROOT (S (NP (NP (NNP Doc_18006530_97_101_Disease)) (PP (IN on) (NP (NP (NN injection)) (PP (IN of) (NP (NNS Doc_18006530_118_126_Chemical)))))) (VP (VBZ is) (ADJP (JJ unpleasant))) (. .)))
18006530	2	(ROOT (S (NP (PRP We)) (VP (VBN hypothesized) (SBAR (IN that) (S (NP (JJ Doc_18006530_163_171_Chemical) (NN infusion) (NNS Doc_18006530_181_185_Disease)) (VP (MD might) (VP (VB be) (VP (VBN prevented) (PP (IN by) (S (VP (VBG infusing) (NP (NNS Doc_18006530_217_229_Chemical)) (PP (IN before) (S (VP (VBG starting) (NP (DT the) (JJ Doc_18006530_250_258_Chemical) (NN infusion)) (PP (IN in) (NP (NP (DT a) (JJ clinical) (NN setting)) (SBAR (WHADVP (WRB where)) (S (NP (NP (NP (JJ target-controlled) (NNS infusions)) (PRN (-LRB- -LRB-) (NP (NNP TCI)) (-RRB- -RRB-))) (PP (IN of) (NP (DT both) (NNS drugs)))) (VP (VBD were) (VP (VBN used))))))))))))))))))) (. .)))
18006530	3	(ROOT (S (NP (DT A) (JJ prospective) (, ,) (ADJP (JJ randomized) (, ,) (JJ double-blind) (, ,) (JJ placebo-controlled)) (NN trial)) (VP (VBD was) (VP (VBN performed) (S (VP (TO to) (VP (VB determine) (NP (NP (NP (DT the) (JJ effect-site) (NN concentration)) (PRN (-LRB- -LRB-) (NP (NNP Ce)) (-RRB- -RRB-))) (PP (IN of) (NP (NNS Doc_18006530_486_498_Chemical)))) (S (VP (TO to) (VP (VB prevent) (NP (DT the) (NNS Doc_18006530_514_518_Disease)) (PP (IN without) (NP (VBG producing) (NNS complications))))))))))) (. .)))
18006530	4	(ROOT (S (NP (NP (DT A) (NN total)) (PP (IN of) (NP (NP (CD 128) (NNS patients)) (VP (VBG undergoing) (NP (JJ general) (NN surgery)))))) (VP (VBD were) (ADVP (RB randomly)) (VP (VBN allocated) (S (VP (TO to) (VP (VB receive) (NP (NP (NP (NP (JJ normal) (NN saline)) (PRN (-LRB- -LRB-) (NP (NN control)) (-RRB- -RRB-))) (CC or) (NP (NP (NNS Doc_18006530_674_686_Chemical)) (PP (TO to) (NP (NP (DT a) (NN target) (NN Ce)) (PP (IN of) (NP (NP (NP (CD 2) (NN ng) (NN ml)) (PRN (-LRB- -LRB-) (NP (CD -1)) (-RRB- -RRB-))) (PRN (-LRB- -LRB-) (NP (NNP R2)) (-RRB- -RRB-)))))))) (, ,) (NP (NP (NP (CD 4) (NN ng) (NN ml)) (PRN (-LRB- -LRB-) (NP (CD -1)) (-RRB- -RRB-))) (PRN (-LRB- -LRB-) (NP (NNP R4)) (-RRB- -RRB-))) (, ,) (CC or) (NP (NP (NP (NP (CD 6) (NN ng) (NN ml)) (PRN (-LRB- -LRB-) (NP (CD -1)) (-RRB- -RRB-))) (PRN (-LRB- -LRB-) (NP (NNP R6)) (-RRB- -RRB-))) (VP (VBN administered) (PP (IN via) (NP (NNP TCI))))))))))) (. .)))
18006530	5	(ROOT (S (SBAR (IN After) (S (NP (DT the) (NN target) (NN Ce)) (VP (VBD was) (VP (VBN achieved))))) (, ,) (NP (NP (DT the) (NN infusion)) (PP (IN of) (NP (NNS Doc_18006530_833_841_Chemical)))) (VP (VBD was) (VP (VBN started))) (. .)))
18006530	6	(ROOT (S (S (NP (JJ Doc_18006530_855_867_Chemical-related) (NNS complications)) (VP (VBD were) (VP (VBN assessed) (PP (IN during) (NP (DT the) (JJ Doc_18006530_915_927_Chemical) (NN infusion)))))) (, ,) (CC and) (S (NP (NP (NNS Doc_18006530_942_946_Disease)) (VP (VBN caused) (PP (IN by) (NP (NNS Doc_18006530_957_965_Chemical))))) (VP (VBD was) (VP (VBN evaluated) (S (VP (VBG using) (NP (DT a) (JJ four-point) (NN scale)) (PP (IN during) (NP (DT the) (JJ Doc_18006530_1016_1024_Chemical) (NN infusion)))))))) (. .)))
18006530	7	(ROOT (S (NP (NP (DT The) (NN incidence)) (PP (IN of) (NP (NNS Doc_18006530_1061_1065_Disease)))) (VP (VBD was) (ADJP (ADJP (RB significantly) (JJR lower) (PP (IN in) (NP (NNS Groups) (NNP R4) (CC and) (NNP R6)))) (PP (IN than) (PP (IN in) (NP (NP (DT the) (NN control)) (CC and) (NP (CD R2) (NNS groups)))))) (PRN (-LRB- -LRB-) (S (NP (CD 12/32) (CC and) (CD 6/31)) (VP (VBP vs) (NP (NP (QP (CD 26/31) (CC and) (CD 25/32))) (, ,) (ADVP (RB respectively)) (, ,) (NP (NP (NNP P) (NNP <)) (NP (CD 0.001)))))) (-RRB- -RRB-))) (. .)))
18006530	8	(ROOT (S (NP (NNP Doc_18006530_1204_1208_Disease)) (VP (VBD was) (ADJP (ADJP (RBR less) (JJ severe) (PP (IN in) (NP (NNS Groups) (NNP R4) (CC and) (NNP R6)))) (PP (IN than) (PP (IN in) (NP (NP (DT the) (NN control)) (CC and) (NP (CD R2) (NNS groups)))))) (PRN (-LRB- -LRB-) (NP (NNP P) (QP (CD <) (CD 0.001))) (-RRB- -RRB-))) (. .)))
18006530	9	(ROOT (S (ADVP (RB However)) (, ,) (NP (NP (DT both) (NN incidence) (CC and) (NN severity)) (PP (IN of) (NP (NNS Doc_18006530_1330_1334_Disease)))) (VP (VBD were) (RB not) (ADJP (JJ different) (PP (IN between) (NP (NNS Groups) (NNP R4) (CC and) (NNP R6))))) (. .)))
18006530	10	(ROOT (S (NP (DT No) (JJ significant) (NNS complications)) (VP (VBD were) (VP (VBN observed) (PP (IN during) (NP (DT the) (NN study))))) (. .)))
18006530	11	(ROOT (S (PP (IN During) (NP (NP (NN induction)) (PP (IN of) (NP (NP (NN anaesthesia)) (PP (IN with) (NP (NP (NNP TCI)) (PP (IN of) (NP (NNS Doc_18006530_1498_1506_Chemical) (CC and) (NNS Doc_18006530_1511_1523_Chemical))))))))) (, ,) (NP (NP (DT a) (JJ significant) (NN reduction)) (PP (IN in) (NP (JJ Doc_18006530_1552_1560_Chemical) (NN infusion) (NNS Doc_18006530_1570_1574_Disease)))) (VP (VBD was) (VP (VBN achieved) (PP (IN without) (NP (JJ significant) (NNS complications))) (PP (IN by) (NP (NP (JJ prior) (NN administration)) (PP (IN of) (NP (NNS Doc_18006530_1649_1661_Chemical))))) (PP (IN at) (NP (NP (DT a) (NN target) (NN Ce)) (PP (IN of) (NP (NP (CD 4) (NN ng) (NN ml)) (PRN (-LRB- -LRB-) (NP (CD -1)) (-RRB- -RRB-)))))))) (. .)))
18086064	0	(ROOT (NP (NP (NP (JJ Doc_18086064_0_15_Chemical) (CC and) (JJ cardiac) (NN protection)) (PP (IN for) (NP (JJ non-cardiac) (NN surgery)))) (: :) (NP (NP (DT a) (NNS meta-analysis)) (PP (IN of) (NP (JJ randomised) (JJ controlled) (NNS trials)))) (. .)))
18086064	1	(ROOT (S (NP (PRP We)) (VP (VBD conducted) (NP (NP (DT a) (JJ systematic) (NN review)) (PP (IN of) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NNS Doc_18086064_164_179_Chemical)))))) (PP (IN on) (NP (NP (JJ cardiac) (NNS outcomes)) (PP (VBG following) (NP (JJ non-cardiac) (NN surgery)))))) (. .)))
18086064	2	(ROOT (S (NP (PRP We)) (VP (VBD included) (NP (NP (JJ prospective) (, ,) (JJ randomised) (JJ peri-operative) (NNS studies)) (PP (IN of) (NP (NP (NNS Doc_18086064_293_308_Chemical)) (SBAR (WHNP (WDT that)) (S (VP (VBD reported) (NP (NP (NN mortality)) (, ,) (NP (JJ cardiac) (NN morbidity)) (CC or) (NP (JJ adverse) (NN drug) (NNS events)))))))))) (. .)))
18086064	3	(ROOT (S (NP (DT A) (NNP PubMed) (NNP Central) (CC and) (NNP EMBASE) (NN search)) (VP (VBD was) (VP (VBN conducted) (PRT (RP up)) (PP (TO to) (NP (NNP July) (CD 2007))))) (. .)))
18086064	4	(ROOT (S (NP (NP (DT The) (NN reference) (NNS lists)) (PP (IN of) (NP (VBN identified) (NNS papers)))) (VP (VBD were) (VP (VBN examined) (PP (IN for) (NP (JJ further) (NNS trials))))) (. .)))
18086064	5	(ROOT (S (PP (IN Of) (NP (NP (CD 425) (NNS studies)) (VP (VBN identified)))) (, ,) (NP (CD 20)) (VP (VBD were) (VP (VBN included) (PP (IN in) (NP (NP (DT the) (NNS meta-analysis)) (PRN (-LRB- -LRB-) (NP (CD 840) (NNS patients)) (-RRB- -RRB-)))))) (. .)))
18086064	6	(ROOT (S (NP (NNP Doc_18086064_598_613_Chemical)) (VP (VBD was) (VP (VBN associated) (PP (IN with) (NP (NP (NP (DT a) (NN trend)) (PP (IN towards) (NP (JJ improved) (JJ cardiac) (NNS outcomes)))) (: ;) (NP (NP (JJ all-cause) (NN mortality)) (PRN (-LRB- -LRB-) (S (NP (NP (NNP OR) (CD 0.27)) (, ,) (NP (NP (ADJP (CD 95) (NN %)) (NNP CI)) (NP (CD 0.01-7) (CD .13))) (, ,)) (VP (VBP p) (S (VP (SYM =) (NP (CD 0.44)))))) (-RRB- -RRB-))) (, ,) (NP (NP (JJ non-fatal) (NNS Doc_18086064_746_767_Disease)) (PRN (-LRB- -LRB-) (NP (NP (NNP OR) (NNP 0.26)) (, ,) (NP (NP (CD 95) (NN %)) (NP (NP (NNP CI) (NNP 0.04-1) (CD .60) (, ,) (CD p)) (SBAR (S (VP (SYM =) (NP (CD 0.14)))))))) (-RRB- -RRB-))) (, ,) (CC and) (NP (NP (NNS Doc_18086064_811_831_Disease)) (PRN (-LRB- -LRB-) (S (NP (NP (NNP OR) (NNP 0.65)) (, ,) (NP (NP (ADJP (CD 95) (NN %)) (NNP CI)) (NP (CD 0.26-1) (CD .63))) (, ,)) (VP (VBP p) (S (VP (SYM =) (NP (CD 0.36)))))) (-RRB- -RRB-))))))) (. .)))
18086064	7	(ROOT (S (NP (NP (NP (JJ Peri-operative) (NNS Doc_18086064_886_897_Disease)) (PRN (-LRB- -LRB-) (NP (NP (CD 26) (NN %)) (, ,) (NP (NNP OR) (NNP 3.80))) (, ,) (NP (NP (CD 95) (NN %)) (NP (NP (NNP CI) (NNP 1.91-7) (CD .54) (, ,) (CD p)) (SBAR (S (VP (SYM =) (NP (CD 0.0001))))))) (-RRB- -RRB-))) (CC and) (NP (NP (NNS Doc_18086064_947_958_Disease)) (PRN (-LRB- -LRB-) (NP (NP (CD 17) (NN %)) (, ,) (NP (NNP OR) (CD 5.45))) (, ,) (NP (NP (CD 95) (NN %)) (NP (NP (NNP CI) (NNP 2.98-9) (CD .95) (, ,) (CD p)) (NP (QP (CD <) (CD 0.00001))))) (-RRB- -RRB-)))) (VP (VBD were) (VP (ADVP (RB significantly)) (VBN increased))) (. .)))
18086064	8	(ROOT (S (NP (DT An) (NN anticholinergic)) (VP (VBD did) (RB not) (VP (VB reduce) (NP (NP (DT the) (NN incidence)) (PP (IN of) (NP (NP (NNS Doc_18086064_1086_1097_Disease)) (PRN (-LRB- -LRB-) (VP (VBN p) (S (VP (SYM =) (NP (CD 0.43))))) (-RRB- -RRB-))))))) (. .)))
18086064	9	(ROOT (S (NP (NP (DT A) (JJ randomised) (JJ placebo-controlled) (NN trial)) (PP (IN of) (NP (NNS Doc_18086064_1151_1166_Chemical)))) (VP (VBZ is) (VP (VBN warranted))) (. .)))
18161408	0	(ROOT (S (S (NP (NP (NNP Doc_18161408_0_21_Disease)) (PP (IN in) (NP (NN pregnancy)))) (VP (VBN associated) (PP (IN with) (NP (NP (NNS Doc_18161408_51_69_Chemical)) (PP (IN for) (NP (NN ovulation) (NN induction))))))) (: :) (S (NP (DT a) (NN case)) (VP (VBP report))) (. .)))
18161408	1	(ROOT (S (NP (NP (NNP Doc_18161408_122_140_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_18161408_142_144_Chemical)) (-RRB- -RRB-))) (VP (VBZ is) (ADVP (RB commonly)) (VP (VBN prescribed) (PP (IN for) (NP (NN ovulation) (NN induction))))) (. .)))
18161408	2	(ROOT (S (NP (PRP It)) (VP (VBZ is) (VP (VBN considered) (ADJP (JJ safe)) (, ,) (PP (IN with) (NP (JJ minimal) (NN side) (NNS effects))))) (. .)))
18161408	3	(ROOT (S (NP (NNP Doc_18161408_244_259_Disease)) (VP (VBZ is) (NP (NP (DT a) (ADJP (JJ rare) (CC but) (JJ life-threatening)) (NN complication)) (SBAR (WHNP (WDT that)) (S (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (PP (IN after) (NP (NN ovulation) (NN induction))) (PP (IN with) (NP (NNP CC)))))))))) (. .)))
18161408	4	(ROOT (S (NP (NP (JJ Spontaneous) (NNS Doc_18161408_374_393_Disease) (CC or) (NNS Doc_18161408_397_412_Disease)) (PP (IN with) (NP (JJ subsequent) (NN clot) (NNS lysis)))) (VP (VBZ has) (VP (VBN been) (VP (VBN suggested) (PP (IN as) (NP (NP (CD one)) (PP (IN of) (NP (NP (DT the) (RBS most) (JJ common) (NNS causes)) (PP (IN of) (NP (NP (NNS Doc_18161408_495_516_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_18161408_518_520_Disease)) (-RRB- -RRB-)))))))) (PP (IN during) (NP (NN pregnancy))) (, ,) (PP (IN with) (NP (DT a) (ADJP (ADVP (RB subsequently)) (JJ normal)) (JJ coronary) (NN angiogram)))))) (. .)))
18161408	5	(ROOT (S (NP (NP (DT A) (JJ 33-year-old) (NN woman)) (PP (IN with) (NP (DT a) (JJ 5-week) (NN gestation)))) (VP (VBD had) (ADVP (RB recently)) (VP (VP (VBN received) (NP (NP (NNS Doc_18161408_659_661_Chemical)) (PP (IN for) (NP (NN ovulation) (NN induction))))) (CC and) (VP (VBN presented) (PP (IN with) (NP (NNS Doc_18161408_705_715_Disease)))))) (. .)))
18161408	6	(ROOT (S (NP (DT An) (NN electrocardiogram)) (VP (VBD showed) (NP (DT a) (NN lateral) (CC and) (NN anterior) (NN wall) (NNS Doc_18161408_773_794_Disease))) (. .)))
18161408	7	(ROOT (S (NP (NNP Cardiac) (NNS enzymes)) (VP (VBD showed) (NP (DT a) (JJ peak) (NN rise)) (PP (IN in) (NP (NN troponin) (NN I))) (PP (TO to) (NP (CD 9.10) (NN ng/mL)))) (. .)))
18161408	8	(ROOT (S (NP (DT An) (JJ initial) (NN exercise) (NN stress) (NN test)) (VP (VBD was) (ADJP (JJ normal))) (. .)))
18161408	9	(ROOT (S (PP (IN At) (NP (NP (DT the) (NN time)) (PP (IN of) (NP (NN admission))))) (, ,) (NP (DT the) (NN patient)) (VP (VBD was) (PP (IN at) (NP (NP (JJ high) (NN risk)) (PP (IN of) (NP (NNS Doc_18161408_962_978_Disease))))) (PP (TO to) (NP (DT the) (NN fetus))) (, ,) (SBAR (IN so) (S (NP (DT a) (JJ coronary) (NN angiogram)) (VP (VBD was) (VP (VBN postponed) (PP (IN until) (NP (DT the) (JJ second) (NN trimester)))))))) (. .)))
18161408	10	(ROOT (S (NP (PRP It)) (VP (VBD showed) (NP (JJ normal) (JJ coronary) (NNS vessels))) (. .)))
18161408	11	(ROOT (S (NP (DT This)) (VP (VBZ appears) (S (VP (TO to) (VP (VB be) (NP (NP (DT the) (JJ first) (JJ reported) (NN case)) (VP (VBG documenting) (NP (NP (DT a) (JJ possible) (NN association)) (PP (IN between) (NP (NNS Doc_18161408_1192_1194_Chemical) (CC and) (NNS Doc_18161408_1199_1220_Disease)))))))))) (. .)))
18161408	12	(ROOT (S (NP (NNP Doc_18161408_1222_1232_Disease)) (VP (MD might) (VP (VB be) (NP (NP (DT a) (ADJP (JJ rare) (CC but) (JJ hazardous)) (NN complication)) (PP (IN of) (NP (NNS Doc_18161408_1279_1281_Chemical)))))) (. .)))
18161408	13	(ROOT (S (PP (VBN Given) (NP (DT this) (ADJP (JJ life-threatening)) (NN complication))) (, ,) (NP (JJ appropriate) (JJ prophylactic) (NNS measures)) (VP (MD should) (VP (VB be) (VP (VBN used) (PP (IN in) (NP (JJ high-risk) (NN woman))) (S (VP (VBG undergoing) (NP (NN ovarian) (NN stimulation))))))) (. .)))
18177388	0	(ROOT (NP (NP (JJ Reverse) (CC or) (JJ inverted) (NNS Doc_18177388_20_63_Disease)) (PRN (-LRB- -LRB-) (NP (JJ reverse) (NNS Doc_18177388_73_97_Disease)) (-RRB- -RRB-)) (PP (IN in) (NP (NP (DT a) (JJ young) (NN woman)) (PP (IN in) (NP (NP (DT the) (NN setting)) (PP (IN of) (NP (JJ Doc_18177388_134_145_Chemical) (NN use))))))) (. .)))
18177388	1	(ROOT (S (NP (JJ Transient) (NNS Doc_18177388_161_204_Disease)) (VP (VBD was) (ADVP (RB first)) (VP (VBN described) (PP (IN in) (NP (NNP Japan))) (PP (IN as) (`` ``) (NP (NNS Doc_18177388_238_262_Disease))))) (. .) ('' '')))
18177388	2	(ROOT (S (NP (DT This) (NN syndrome)) (VP (VBZ has) (VP (VBN been) (VP (VBN identified) (PP (IN in) (NP (JJ many) (JJ other) (NNS countries)))))) (. .)))
18177388	3	(ROOT (S (NP (NP (JJ Many) (NNS variations)) (PP (IN of) (NP (DT this) (NN syndrome)))) (VP (VBP have) (VP (VBN been) (VP (ADVP (RB recently)) (VBN described) (PP (IN in) (NP (DT the) (NN literature)))))) (. .)))
18177388	4	(ROOT (S (NP (NP (CD One)) (PP (IN of) (NP (DT the) (JJS rarest)))) (VP (VBZ is) (NP (NP (DT the) (JJ reverse) (NN type)) (PP (IN of) (NP (DT this) (NN syndrome))) (, ,) (PP (PP (IN with) (NP (NP (JJ hyperdynamic) (NN apex) (CC and) (JJ complete) (NNS Doc_18177388_497_505_Disease)) (PP (IN of) (NP (DT the) (NN base))))) (PRN (-LRB- -LRB-) (ADJP (RB as) (VBN opposed) (PP (TO to) (NP (DT the) (JJ classic) (NNS Doc_18177388_545_562_Disease)))) (-RRB- -RRB-))))) (. .)))
18177388	5	(ROOT (S (PP (IN In) (NP (DT this) (NN article))) (, ,) (NP (PRP we)) (VP (VBP report) (NP (NP (DT an) (JJ interesting) (NN case)) (PP (IN of) (NP (NP (DT a) (JJ young) (NN woman)) (SBAR (WHNP (WP who)) (S (VP (VBD presented) (PP (IN with) (NP (NP (DT this) (JJ rare) (NN type)) (PP (IN of) (NP (JJ reverse) (NNS Doc_18177388_674_700_Disease))))) (S (VP (VBG occurring) (PP (IN after) (NP (JJ Doc_18177388_717_728_Chemical) (NN use)))))))))))) (. .)))
18177388	6	(ROOT (S (NP (DT This) (NN report)) (VP (VBZ is) (VP (VBN followed) (PP (IN by) (NP (NP (NN review)) (PP (IN of) (NP (DT the) (NN literature))))))) (. .)))
18201582	0	(ROOT (NP (NP (NNS Results)) (PP (IN of) (NP (NP (DT a) (JJ comparative) (, ,) (JJ phase) (JJ III) (, ,) (JJ 12-week) (, ,) (JJ multicenter) (, ,) (JJ prospective) (, ,) (JJ randomized) (, ,) (JJ double-blind) (NN assessment)) (PP (IN of) (NP (NP (DT the) (NN efficacy) (CC and) (NN tolerability)) (PP (IN of) (NP (NP (DT a) (JJ fixed-dose) (NN combination)) (PP (IN of) (NP (NNS Doc_18201582_172_183_Chemical) (CC and) (NNS Doc_18201582_188_198_Chemical))))))))) (PP (IN versus) (NP (JJ Doc_18201582_206_216_Chemical) (NN monotherapy))) (PP (IN in) (NP (NP (JJ Indian) (NNS adults)) (PP (IN with) (NP (NN stage) (NNP II) (NNP Doc_18201582_260_272_Disease))))) (. .)))
18201582	1	(ROOT (S (NP (NP (DT The) (NN aim)) (PP (IN of) (NP (DT this) (NN study)))) (VP (VBD was) (S (VP (TO to) (VP (VB evaluate) (NP (NP (DT the) (NN efficacy) (CC and) (NN tolerability)) (PP (IN of) (NP (NP (NP (DT a) (JJ new) (JJ fixed-dose) (NN combination)) (PRN (-LRB- -LRB-) (NP (NNP FDC)) (-RRB- -RRB-))) (PP (IN of) (NP (NP (QP (CD Doc_18201582_394_405_Chemical) (CD 40)) (NN mg) (NN +) (JJ Doc_18201582_414_424_Chemical) (CD 5) (NN mg)) (PRN (-LRB- -LRB-) (NP (NNP T+A)) (-RRB- -RRB-))))))) (PP (VBN compared) (PP (IN with) (NP (NP (NP (JJ Doc_18201582_450_460_Chemical) (JJ 5-mg) (NN monotherapy)) (PRN (-LRB- -LRB-) (NP (NNP A)) (-RRB- -RRB-))) (PP (IN in) (NP (NP (JJ adult) (JJ Indian) (NNS patients)) (PP (IN with) (NP (NN stage) (NNP II) (NNP Doc_18201582_521_533_Disease)))))))))))) (. .)))
18201582	2	(ROOT (S (NP (NP (DT This) (JJ comparative)) (, ,) (NP (NP (NNP Phase) (NNP III)) (, ,) (NP (JJ 12-week) (, ,) (NN multicenter) (, ,) (JJ prospective) (, ,) (JJ randomized) (, ,) (JJ double-blind) (NN study)))) (VP (VBD was) (VP (VBN conducted) (PP (IN in) (NP (NP (JJ Indian) (NNS patients)) (VP (VBN aged) (PP (NP (QP (CD 18) (TO to) (CD 65)) (NNS years)) (IN with) (NP (JJ established) (NN stage) (NNP II) (NNP Doc_18201582_718_730_Disease)))))))) (. .)))
18201582	3	(ROOT (S (S (NP (NNS Patients)) (VP (VBD were) (VP (VBN treated) (PP (IN with) (NP (NP (JJ oral) (NN FDC)) (PP (IN of) (NP (NNP T+A) (CC or) (NNP A) (NNP QD))))) (PP (IN before) (NP (NP (NN breakfast)) (PP (IN for) (NP (CD 12) (NNS weeks)))))))) (: ;) (S (NP (NP (NP (NN blood) (NN pressure)) (PRN (-LRB- -LRB-) (NP (NNP BP)) (-RRB- -RRB-))) (CC and) (NP (NN heart) (NN rate))) (VP (VBD were) (VP (VBN measured) (PP (IN in) (NP (DT the) (VBG sitting) (NN position)))))) (. .)))
18201582	4	(ROOT (S (NP (JJ Primary) (JJ efficacy) (NN end) (NNS points)) (VP (VBD were) (NP (NP (NN reduction)) (PP (IN in) (NP (NP (NP (JJ clinical) (JJ systolic) (NNS BP)) (PRN (-LRB- -LRB-) (NP (NNP SBP)) (-RRB- -RRB-))) (PRN (: /) (NP (NP (NP (JJ diastolic) (NNS BP)) (PRN (-LRB- -LRB-) (NP (NNP DBP)) (-RRB- -RRB-))) (PP (IN from) (NP (NN baseline))))))) (S (VP (TO to) (VP (VB study) (NP (NP (NN end) (CC and) (NN number)) (PP (IN of) (NP (NNS responders))) (PRN (-LRB- -LRB-) (NP (NP (NN ie)) (, ,) (NP (NP (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBD achieved) (NP (NP (NNP target) (NNP SBP) (PRN (: /) (NP (NNP DBP) (QP (CD <) (CD 130))) (: /)) (NNP <)) (ADJP (NP (CD 80) (NNS mm)) (JJ Hg)))))))) (-RRB- -RRB-))) (PP (IN at) (NP (NP (NN end)) (PP (IN of) (NP (NN study)))))))))) (. .)))
18201582	5	(ROOT (S (NP (NNP Tolerability)) (VP (VBD was) (VP (VBN assessed) (PP (IN by) (NP (NP (JJ treatment-emergent) (JJ adverse) (NNS events)) (, ,) (VP (VBN identified) (S (VP (VBG using) (NP (NP (JJ physical) (NN examination)) (, ,) (NP (NN laboratory) (NN analysis)) (, ,) (CC and) (NP (NN electrocardiography)))))))))) (. .)))
18201582	6	(ROOT (S (S (NP (NP (DT A) (NN total)) (PP (IN of) (NP (CD 210) (NNS patients)))) (VP (VBD were) (VP (VBN enrolled) (PP (IN in) (NP (DT the) (NN study)))))) (: ;) (S (NP (NP (CD 203) (NNS patients)) (PRN (-LRB- -LRB-) (NP (CD 143) (NNS men)) (, ,) (NP (CD 60) (NNS women)) (-RRB- -RRB-))) (VP (VBD completed) (NP (DT the) (NN study)) (SBAR (IN while) (S (NP (CD 7)) (VP (VBD were) (VP (VP (VBN lost) (PP (TO to) (NP (NP (NN follow-up)) (PRN (-LRB- -LRB-) (NP (NP (NP (CD 4) (NNS patients)) (PP (IN in) (NP (DT the) (NNP T+A) (NN group)))) (CC and) (NP (NP (CD 3)) (PP (IN in) (NP (DT the) (NNP A) (NN group))))) (-RRB- -RRB-))))) (CC and) (VP (VBN considered) (S (ADJP (JJ with-drawn)))))))))) (. .)))
18201582	7	(ROOT (S (PP (IN At) (NP (NN study) (NN end))) (, ,) (NP (NP (ADJP (RB statistically) (JJ significant)) (NN percentage) (NNS reductions)) (PP (PP (IN from) (NP (NP (NN baseline)) (PP (IN within) (NP (NNS groups))))) (CC and) (PP (IN between) (NP (NNS groups))))) (VP (VBD were) (VP (VBN observed) (PP (IN in) (NP (NP (NP (NNP SBP)) (PRN (-LRB- -LRB-) (NP (NNP T+A) (NNP -LSB-)) (NP (NP (CD -27.4) (NN %) (NNS -RSB-)) (: ;) (NP (DT A) (CD -LSB-) (CD -16.6) (NN %) (NN -RSB-))) (-RRB- -RRB-))) (CC and) (NP (NP (NP (NNP DBP)) (PRN (-LRB- -LRB-) (NP (NNP T+A) (NNP -LSB-)) (NP (NP (CD -20.1) (NN %) (NNS -RSB-)) (: ;) (NP (DT A) (CD -LSB-) (CD -13.3) (NN %) (NN -RSB-))) (-RRB- -RRB-))) (PRN (-LRB- -LRB-) (NP (NP (DT all)) (, ,) (NP (NNP P) (NNP <) (NNP 0.05))) (-RRB- -RRB-))))))) (. .)))
18201582	8	(ROOT (S (NP (NNP Response) (NNS rates)) (VP (VBD were) (NP (NP (NP (NP (CD 87.3) (NN %)) (PRN (-LRB- -LRB-) (NP (CD 89/102)) (-RRB- -RRB-))) (PP (IN in) (NP (DT the) (NNP T+A) (NN group)))) (CC and) (NP (NP (NP (CD 69.3) (NN %)) (PRN (-LRB- -LRB-) (NP (CD 70/101)) (-RRB- -RRB-))) (PP (IN in) (NP (NP (DT the) (NNP A) (NN group)) (PRN (-LRB- -LRB-) (NP (NNP P) (NNP <) (NNP 0.05)) (-RRB- -RRB-))))))) (. .)))
18201582	9	(ROOT (S (NP (NP (DT The) (NNS prevalences)) (PP (IN of) (NP (JJ adverse) (NNS events)))) (VP (VBD were) (RB not) (ADJP (RB significantly) (JJ different) (PP (IN between) (NP (NP (DT the) (CD 2) (NN treatment) (NNS groups)) (PRN (-LRB- -LRB-) (NP (NP (NNP T+A)) (, ,) (NP (NP (CD 16.0) (NN %)) (ADJP (JJ -LSB-) (NP (NP (QP (CD 17/106) (CD -RSB-))) (: ;) (NP (NP (NNP A)) (, ,) (NP (NP (CD 15.4) (NN %)) (VP (VBG -LSB-) (NP (CD 16/104) (NNS -RSB-))))))))) (-RRB- -RRB-)))))) (. .)))
18201582	10	(ROOT (S (S (S (NP (JJ Peripheral) (NNS Doc_18201582_1939_1944_Disease)) (VP (VBD was) (VP (VBN reported) (PP (IN in) (NP (NP (ADJP (CD 8.5) (NN %)) (NNS patients)) (PRN (-LRB- -LRB-) (NP (CD 9/106)) (-RRB- -RRB-)) (PP (IN in) (NP (DT the) (NNP T+A) (NN group))))) (PP (VBN compared) (PP (IN with) (NP (NP (NP (CD 13.5) (NN %)) (PRN (-LRB- -LRB-) (NP (CD 14/104)) (-RRB- -RRB-))) (PP (IN in) (NP (DT the) (NNP A) (NN group))))))))) (, ,) (CC and) (S (NP (NN cough)) (VP (VBD was) (VP (VBN reported) (PP (IN in) (NP (NP (ADJP (CD 3.8) (NN %)) (NNS patients)) (PRN (-LRB- -LRB-) (NP (CD 4/106)) (-RRB- -RRB-)))) (PP (IN in) (NP (DT the) (NNP T+A) (NN group)))))) (CC and) (S (NP (NP (CD 1.0) (NN %)) (PRN (-LRB- -LRB-) (NP (CD 1/104)) (-RRB- -RRB-)) (NNS patients)) (PP (IN in) (NP (DT the) (NNP A) (NN group))))) (: ;) (S (NP (DT these) (NNS differences)) (VP (VBD did) (RB not) (VP (VB reach) (NP (JJ statistical) (NN significance))))) (. .)))
18201582	11	(ROOT (S (NP (NP (DT The) (NNS incidences)) (PP (IN of) (NP (NNS Doc_18201582_2228_2236_Disease) (, ,) (NNS Doc_18201582_2238_2247_Disease) (, ,) (CC and) (NNS Doc_18201582_2253_2261_Disease)))) (VP (VBD were) (ADJP (JJ similar) (PP (IN between) (NP (DT the) (CD 2) (NNS groups))))) (. .)))
18201582	12	(ROOT (S (PP (IN Among) (NP (NP (DT these) (JJ Indian) (NNS patients)) (PP (IN with) (NP (NN stage) (NNP II) (NNP Doc_18201582_2352_2364_Disease))))) (, ,) (S (NP (NP (DT the) (NNP FDC)) (PP (IN of) (NP (NNP T+A)))) (VP (VBD was) (VP (VBN found) (S (VP (TO to) (VP (VB be) (ADJP (ADJP (RB significantly) (RBR more) (JJ effective)) (PRN (, ,) (SBAR (IN with) (S (VP (NN regard) (PP (TO to) (NP (NNP BP) (NNS reductions)))))) (, ,))) (PP (IN than) (NP (NNP A))))))))) (, ,) (CC and) (S (NP (DT both) (NNS treatments)) (VP (VBD were) (ADJP (RB well) (JJ tolerated)))) (. .)))
18239197	0	(ROOT (S (NP (NP (VBN Increased) (NNS Doc_18239197_10_24_Disease)) (VP (VBN associated) (PP (IN with) (NP (DT the) (JJ APOE) (JJ epsilon4) (NN allele))) (PP (IN after) (NP (JJ Doc_18239197_72_87_Chemical) (JJ oral) (NN anticholinergic))))) (VP (VBP challenge) (PP (IN in) (NP (JJ healthy) (NNS elderly)))) (. .)))
18239197	1	(ROOT (S (NP (NP (DT The) (NNS objectives)) (PP (IN of) (NP (DT this) (NN study)))) (VP (VBD were) (S (VP (VP (TO to) (VP (VB examine) (NP (NP (NP (DT the) (NN relationship)) (PP (IN between) (NP (NNP APOE) (CD epsilon4)))) (CC and) (NP (NP (JJ subjective) (NNS effects)) (PP (IN of) (NP (NNS Doc_18239197_261_276_Chemical))))) (PP (IN on) (NP (NP (NNS measures)) (VP (VBG reflecting) (NP (NN sedation) (CC and) (NNS Doc_18239197_313_322_Disease))))))) (CC and) (VP (TO to) (VP (VB investigate) (NP (NP (DT the) (NN relationship)) (PP (IN between) (NP (NP (ADJP (JJ Doc_18239197_367_382_Chemical-induced) (JJ subjective)) (NNS effects)) (CC and) (NP (JJ objective) (NN memory) (NN performance)))))))))) (. .)))
18239197	2	(ROOT (S (NP (DT This)) (VP (VBP study) (NP (NP (ADJP (JJ comprised) (NP (CD 24))) (ADJP (RB cognitively) (JJ intact)) (, ,) (ADJP (NN health) (JJ elderly)) (NNS adults)) (PRN (-LRB- -LRB-) (NP (CD 12) (NNP APOE) (NN epsilon4) (NNS carriers)) (-RRB- -RRB-))) (PP (IN at) (NP (DT an) (JJ outpatient) (JJ geriatric) (NN psychiatry) (NN research) (NN clinic)))) (. .)))
18239197	3	(ROOT (S (NP (DT This)) (VP (VBD was) (NP (NP (DT a) (NN randomized)) (, ,) (RB double) (NP (JJ blind) (, ,) (JJ placebo-controlled) (, ,) (JJ three-way) (, ,) (JJ crossover) (JJ experimental) (NN design)))) (. .)))
18239197	4	(ROOT (S (NP (DT All) (NNS participants)) (VP (VBD received) (NP (NP (QP (CD 1.0) (CD mg) (CC or) (CD 2.0) (CD mg)) (NNS Doc_18239197_744_759_Chemical)) (CC or) (NP (NP (NN placebo)) (VP (VBN administered) (PP (IN in) (NP (NP (JJ counterbalanced) (NNS sequences)) (PP (IN over) (NP (NP (DT a) (NN period)) (PP (IN of) (NP (CD three) (JJ consecutive) (NNS weeks))))))))))) (. .)))
18239197	5	(ROOT (S (NP (NP (NNP Bond)) (CC and) (NP (NP (NP (NNP Lader) (POS 's)) (JJ visual) (JJ analog) (NNS scales)) (CC and) (NP (NP (JJ alternate) (NNS versions)) (PP (IN of) (NP (DT the) (NNP Buschke) (NNP Selective) (NNP Reminding) (NNP Test)))))) (VP (VBD were) (VP (VBN administered) (PP (IN in) (NP (NP (NP (DT a) (VBN repeated) (NNS measures) (NN design)) (PP (IN at) (NP (NNP baseline) (, ,) (CD 1) (, ,) (CD 2.5)))) (, ,) (CC and) (NP (NP (CD 5) (NNS hours)) (VP (VBG postdrug) (NP (NN administration)))))))) (. .)))
18239197	6	(ROOT (S (NP (NP (DT A) (JJ 2.0-mg) (JJ oral) (NN dose)) (PP (IN of) (NP (NNS Doc_18239197_1093_1108_Chemical)))) (VP (VBD resulted) (PP (IN in) (NP (NP (VBN increased) (JJ subjective) (NNS ratings)) (PP (IN of) (NP (NP (NNS Doc_18239197_1153_1168_Disease)) (PP (IN in) (NP (NP (NNS carriers)) (PP (IN of) (NP (DT the) (JJ APOE) (JJ epsilon4) (NN allele) (RB only)))))))))) (. .)))
18239197	7	(ROOT (S (NP (NNP Drug)) (VP (VBZ effects) (SBAR (IN as) (S (S (VP (VBN determined) (PP (IN by) (NP (NP (NP (NN difference) (NNS scores)) (PP (IN between) (NP (QP (CD 2.0) (CD mg)) (NNS Doc_18239197_1278_1293_Chemical)))) (CC and) (NP (NP (NN placebo)) (PP (IN on) (NP (NP (NNS ratings)) (PP (IN of) (NP (NP (NNS Doc_18239197_1320_1335_Disease)) (VP (ADVP (RB significantly)) (VBN correlated) (PP (IN with) (NP (NN total))))))))))))) (CC and) (S (VP (VBN delayed) (NP (NN recall)) (PP (IN on) (NP (DT the) (NNP Buschke) (NNP Selective) (NNP Reminding) (NNP Test))) (PP (IN in) (NP (NP (NNS carriers)) (PP (IN of) (NP (DT the) (JJ APOE) (JJ epsilon4) (NN allele))))) (ADVP (RB only))))))) (. .)))
18239197	8	(ROOT (S (ADVP (RB However)) (, ,) (NP (DT no) (JJ significant) (NNS effects)) (VP (VBD were) (VP (VBN found) (PP (IN with) (NP (NP (JJ other) (JJ visual) (JJ analog) (NNS scales)) (VP (VBG reflecting) (NP (JJ subjective) (NNS sedation) (CC and) (NNS clear-headedness))))))) (. .)))
18239197	9	(ROOT (S (NP (NP (DT The) (JJ epsilon4) (NN allele)) (PP (IN in) (NP (JJ healthy) (NNS elderly)))) (VP (VBD was) (VP (VBN associated) (PP (IN with) (NP (NP (VBN increased) (JJ subjective) (NNS Doc_18239197_1697_1711_Disease)) (PP (IN after) (NP (JJ Doc_18239197_1718_1733_Chemical) (JJ anticholinergic) (NN challenge))))))) (. .)))
18356633	0	(ROOT (NP (NP (DT An) (NN evaluation)) (PP (IN of) (NP (JJ Doc_18356633_17_25_Chemical) (NN nephrotoxicity))) (PP (IN in) (NP (DT the) (JJ hematology/oncology) (NN population))) (. .)))
18356633	1	(ROOT (S (NP (NNP Doc_18356633_80_88_Chemical)) (VP (VBZ is) (ADVP (NP (DT an) (NN Doc_18356633_95_109_Chemical)) (RB commonly)) (VP (VBN used) (S (VP (TO to) (VP (VB provide) (NP (NP (JJ empirical) (JJ double) (JJ gram-negative) (NN treatment)) (PP (IN for) (NP (NP (NNS Doc_18356633_180_199_Disease)) (CC and) (NP (JJ other) (VBN suspected) (NNS Doc_18356633_220_230_Disease)))))))))) (. .)))
18356633	2	(ROOT (S (S (NP (NP (NNS Strategies)) (PP (IN of) (NP (JJ extended-interval) (CC and) (JJ conventional) (NN dosing)))) (VP (VBP have) (VP (VBN been) (VP (VBN utilized) (ADVP (RB extensively)) (PP (IN in) (NP (DT the) (JJ general) (JJ medical) (NN population))))))) (: ;) (S (ADVP (RB however)) (, ,) (NP (NNS data)) (VP (VBP are) (VP (VBG lacking) (S (VP (TO to) (VP (VB support) (NP (NP (DT a) (VBG dosing) (NN strategy)) (PP (IN in) (NP (DT the) (JJ hematology/oncology) (NN population)))))))))) (. .)))
18356633	3	(ROOT (S (S (VP (TO To) (VP (VB evaluate) (NP (NNS Doc_18356633_460_468_Chemical-associated)) (ADVP (RB nephrotoxicity)) (PP (IN in) (NP (NP (DT an) (JJ adult) (NN hematology/oncology) (NN population)) (, ,) (NP (DT a) (JJ prospective) (, ,) (JJ randomized) (, ,) (JJ open-label) (NN trial))))))) (VP (VBD was) (VP (VBN conducted) (PP (IN at) (NP (DT a) (JJ university-affiliated) (JJ medical) (NN center))))) (. .)))
18356633	4	(ROOT (S (NP (NP (JJ Forty) (NNS patients)) (PP (IN with) (NP (NP (DT a) (NN diagnosis)) (ADJP (JJ consistent) (PP (IN with) (NP (NP (DT a) (NNS Doc_18356633_690_720_Disease)) (SBAR (WHNP (WDT that)) (S (VP (VBD required) (NP (NN treatment)) (PP (IN with) (NP (DT an) (NNS Doc_18356633_753_767_Chemical)))))))))))) (VP (VBD were) (VP (VBN randomized) (PP (TO to) (NP (DT either) (JJ conventional) (CC or) (JJ extended-interval) (NNS Doc_18356633_828_836_Chemical))))) (. .)))
18356633	5	(ROOT (S (NP (NP (DT The) (NN occurrence)) (PP (IN of) (NP (NP (NN nephrotoxicity)) (PP (IN by) (NP (NP (NNS means)) (PP (IN of) (NP (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (NN serum) (NNS Doc_18356633_904_914_Chemical)))) (CC and) (NP (NP (NN evaluation)) (PP (IN of) (NP (NP (NN efficacy)) (PP (IN via) (NP (NP (JJ Doc_18356633_946_954_Chemical) (NN serum) (NNS concentrations)) (PP (IN with) (NP (JJ respective) (NNS pathogens))))))))))))))) (VP (VBD were) (VP (VBN assessed))) (. .)))
18356633	6	(ROOT (S (NP (NP (DT The) (NN occurrence)) (PP (IN of) (NP (NN nephrotoxicity)))) (VP (VBD was) (ADJP (JJ similar) (PP (IN between) (NP (NP (NP (NP (DT the) (JJ conventional) (CC and) (JJ extended-interval) (NNS groups)) (, ,) (NP (QP (IN at) (CD 10) (NN %) (CC and) (CD 5) (NN %)))) (, ,) (ADVP (RB respectively))) (PRN (-LRB- -LRB-) (NP (NNP P) (QP (CD =) (CD 1.00))) (-RRB- -RRB-)))))) (. .)))
18356633	7	(ROOT (S (NP (NP (CD Six) (NNS patients)) (PP (IN in) (NP (DT the) (JJ conventional) (NN group)))) (VP (VBD had) (NP (DT a) (JJ positive) (NN culture)) (, ,) (PP (VBN compared) (PP (IN with) (NP (NP (NN none)) (PP (IN in) (NP (NP (DT the) (JJ extended-interval) (NN group)) (PRN (-LRB- -LRB-) (NP (NNP P) (QP (CD =) (CD 0.002))) (-RRB- -RRB-)))))))) (. .)))
18356633	8	(ROOT (S (S (NP (NP (DT The) (NN occurrence)) (PP (IN of) (NP (NN nephrotoxicity)))) (VP (VBD was) (ADJP (JJ similar)) (PP (IN between) (NP (DT the) (CD two) (VBG dosing) (NNS regimens))))) (, ,) (CC but) (S (NP (NP (DT the) (NN distribution)) (PP (IN of) (NP (NN risk) (NNS factors)))) (VP (VBD was) (NP (NP (NN variable)) (PP (IN between) (NP (DT the) (CD two) (NNS groups)))))) (. .)))
18356633	9	(ROOT (S (NP (NNP Efficacy)) (VP (MD could) (RB not) (VP (VB be) (VP (VBN assessed)))) (. .)))
18363626	0	(ROOT (NP (NP (JJ High) (NN dose) (NNS Doc_18363626_10_25_Chemical)) (PP (IN as) (NP (DT the) (JJ sole) (NN sedative))) (PP (IN for) (NP (JJ pediatric) (NNP MRI))) (. .)))
18363626	1	(ROOT (S (NP (DT This) (JJ large-scale) (NN retrospective) (NN review)) (VP (VBZ evaluates) (NP (NP (DT the) (NN sedation) (NN profile)) (PP (IN of) (NP (NNS Doc_18363626_149_164_Chemical))))) (. .)))
18363626	2	(ROOT (S (S (VP (TO To) (VP (VB determine) (NP (DT the) (JJ hemodynamic) (NNS responses))))) (, ,) (NP (NP (JJ efficacy) (CC and) (JJ adverse) (NNS events)) (VP (VBN associated) (PP (IN with) (NP (NP (DT the) (NN use)) (PP (IN of) (NP (JJ high) (NN dose) (NNS Doc_18363626_276_291_Chemical))))) (PP (IN as) (NP (NP (DT the) (JJ sole) (NN sedative)) (PP (IN for) (NP (JJ magnetic) (NN resonance) (NN imaging)))))) (PRN (-LRB- -LRB-) (NP (NNP MRI)) (-RRB- -RRB-))) (VP (VBZ studies)) (. .)))
18363626	3	(ROOT (S (NP (NNP Doc_18363626_371_386_Chemical)) (VP (VBZ has) (VP (VBN been) (VP (VBN used) (PP (IN at) (NP (NP (PRP$ our) (NN institution)) (PP (IN since) (NP (CD 2005))))) (S (VP (TO to) (VP (VB provide) (NP (NN sedation)) (PP (IN for) (NP (JJ pediatric) (JJ radiological) (NN imaging) (NNS studies))))))))) (. .)))
18363626	4	(ROOT (S (PP (IN Over) (NP (NN time))) (, ,) (NP (NP (DT an) (JJ effective) (NN protocol)) (VP (VBG utilizing) (NP (JJ high) (NN dose) (NNS Doc_18363626_548_563_Chemical)) (PP (IN as) (NP (DT the) (JJ sole) (NN sedative) (NN agent))))) (VP (VBZ has) (VP (VBN evolved))) (. .)))
18363626	5	(ROOT (FRAG (NP (NNP METHODS/MATERIALS)) (: :) (S (PP (IN As) (NP (NP (NN part)) (PP (IN of) (NP (DT the) (JJ ongoing) (NNP Quality) (NNP Assurance) (NN process))))) (, ,) (NP (NP (NNS data)) (PP (IN on) (NP (DT all) (NNS sedations)))) (VP (VBP are) (VP (VBN reviewed) (NP (NP (JJ monthly) (CC and) (NNS protocols) (NNS modified)) (ADJP (RB as) (VBN needed)))))) (. .)))
18363626	6	(ROOT (S (NP (NNP Data)) (VP (VBD were) (VP (VBN analyzed) (PP (IN from) (NP (NP (DT all) (CD 747) (JJ consecutive) (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBD received) (NP (NNS Doc_18363626_816_831_Chemical)) (PP (IN for) (NP (NP (NNP MRI) (NNP sedation)) (PP (IN from) (NP (NNP April) (CD 2005))))) (PP (TO to) (NP (NNP April) (CD 2007)))))))))) (. .)))
18363626	7	(ROOT (S (PP (IN Since) (NP (CD 2005))) (, ,) (NP (NP (DT the) (JJ 10-min) (NN loading) (NN dose)) (PP (IN of) (NP (PRP$ our) (JJ Doc_18363626_932_947_Chemical) (NN protocol)))) (VP (VBD increased) (PP (IN from) (NP (QP (CD 2) (TO to) (CD 3)))) (NP (NP (NP (VBG microg.kg)) (PRN (-LRB- -LRB-) (NP (CD -1)) (-RRB- -RRB-))) (, ,) (CC and) (NP (NP (NP (DT the) (NN infusion) (NN rate)) (VP (VBN increased) (PP (IN from) (NP (CD 1))) (PP (TO to) (NP (NP (QP (CD 1.5) (TO to) (CD 2)) (NN microg.kg)) (PRN (-LRB- -LRB-) (NP (CD -1)) (-RRB- -RRB-)))))) (. .) (NP (NP (NN h)) (PRN (-LRB- -LRB-) (NP (CD -1)) (-RRB- -RRB-)))))) (. .)))
18363626	8	(ROOT (S (NP (DT The) (JJ current) (NN sedation) (NN protocol)) (ADVP (RB progressively)) (VP (VBD increased) (NP (NP (DT the) (NN rate)) (PP (IN of) (NP (JJ successful) (NN sedation)))) (PRN (-LRB- -LRB-) (ADJP (JJ able) (S (VP (TO to) (VP (VB complete) (NP (DT the) (NN imaging) (NN study)))))) (-RRB- -RRB-)) (SBAR (WHADVP (WRB when)) (S (VP (VP (VBG using) (NP (NNS Doc_18363626_1200_1215_Chemical)) (ADVP (RB alone)) (PP (IN from) (NP (NP (QP (CD 91.8) (NN %) (TO to) (CD 97.6) (NN %))) (PRN (-LRB- -LRB-) (NP (NNP P) (QP (CD =) (CD 0.009))) (-RRB- -RRB-))))) (, ,) (VP (VBG reducing) (NP (NP (DT the) (NN requirement)) (PP (IN for) (NP (NP (JJ adjuvant) (NNS Doc_18363626_1293_1306_Chemical)) (PP (IN in) (NP (NP (DT the) (NN event)) (PP (IN of) (NP (NP (NN sedation) (NN failure)) (PP (IN with) (NP (NNS Doc_18363626_1345_1360_Chemical)))))))))) (ADVP (RB alone))) (CC and) (VP (VBG decreased) (NP (DT the) (JJ mean) (NN recovery) (NN time)) (PP (IN by) (NP (NP (CD 10) (NN min)) (PRN (-LRB- -LRB-) (NP (NNP P) (QP (CD <) (CD 0.001))) (-RRB- -RRB-))))))))) (. .)))
18363626	9	(ROOT (S (SBAR (IN Although) (S (NP (JJ Doc_18363626_1436_1451_Chemical) (NN sedation)) (VP (VBD was) (VP (VBN associated) (PP (IN with) (NP (NP (DT a) (ADJP (CD 16) (NN %)) (NN incidence)) (PP (IN of) (NP (NNS Doc_18363626_1500_1511_Disease))))))))) (, ,) (NP (DT all) (NN concomitant)) (VP (VBP mean) (SBAR (S (S (NP (JJ arterial) (NN blood) (NNS pressures)) (VP (VBD were) (PP (IN within) (NP (NP (CD 20) (NN %)) (PP (IN of) (NP (JJ age-adjusted) (JJ normal) (NN range))))))) (CC and) (S (NP (JJ Doc_18363626_1608_1614_Chemical) (NNS saturations)) (VP (VBD were) (ADJP (ADJP (CD 95) (NN %)) (CC or) (ADJP (JJR higher)))))))) (. .)))
18363626	10	(ROOT (S (NP (NP (NNP Doc_18363626_1659_1674_Chemical)) (PP (IN in) (NP (JJ high) (NNS doses)))) (VP (VBZ provides) (NP (NP (JJ adequate) (NN sedation)) (PP (IN for) (NP (JJ pediatric) (NNP MRI) (NNS studies))))) (. .)))
18363626	11	(ROOT (S (SBAR (IN While) (S (NP (NP (NN use)) (PP (IN of) (NP (JJ high) (NN dose) (NNS Doc_18363626_1766_1781_Chemical)))) (VP (VBZ is) (VP (VBN associated) (PP (IN with) (NP (NP (NNS decreases)) (PP (IN in) (NP (NP (NN heart) (NN rate) (CC and) (NN blood) (NN pressure)) (PP (IN outside) (NP (DT the) (JJ established) (`` `) (JJ awake) ('' ') (NNS norms))))))))))) (, ,) (NP (DT this) (NN deviation)) (VP (VP (VBZ is) (ADVP (RB generally)) (PP (IN within) (NP (NP (CD 20) (NN %)) (PP (IN of) (NP (NNS norms)))))) (, ,) (CC and) (VP (VBZ is) (RB not) (VP (VBN associated) (PP (IN with) (NP (JJ adverse) (NN sequelae)))))) (. .)))
18363626	12	(ROOT (S (NP (NNP Doc_18363626_1977_1992_Chemical)) (VP (VBZ is) (ADJP (JJ useful) (PP (IN as) (NP (NP (DT the) (JJ sole) (NN sedative)) (PP (IN for) (NP (JJ pediatric) (NNP MRI))))))) (. .)))
18405372	0	(ROOT (NP (NP (NP (NNP Hepatotoxicity)) (VP (VBN associated) (PP (IN with) (NP (NP (NNS Doc_18405372_31_44_Chemical)) (PP (IN in) (NP (JJ inflammatory) (NNS Doc_18405372_61_70_Disease))))))) (: :) (NP (NP (DT A) (NN case) (NN series)) (PP (IN from) (NP (NP (DT a) (JJ local) (NN surveillance)) (PP (IN of) (NP (JJ serious) (JJ adverse) (NNS events)))))) (. .)))
18405372	1	(ROOT (S (NP (NP (NP (JJ Spontaneous) (NN reporting) (NNS systems)) (PP (IN for) (NP (JJ adverse) (NN drug) (NNS reactions)))) (PRN (-LRB- -LRB-) (NP (NNPS ADRs)) (-RRB- -RRB-))) (VP (VBP are) (VP (VBG handicapped) (PP (IN by) (NP (JJ under-reporting) (CC and) (JJ limited) (NN detail))) (PP (IN on) (NP (JJ individual) (NNS cases))))) (. .)))
18405372	2	(ROOT (S (NP (PRP We)) (VP (VBP report) (NP (DT an) (NN investigation)) (PP (IN from) (NP (NP (DT a) (JJ local) (NN surveillance)) (PP (IN for) (NP (NP (JJ serious) (JJ adverse) (NN drug) (NNS reactions)) (VP (VBN associated) (PP (IN with) (NP (NN disease))) (S (VP (VBG modifying) (NP (NP (JJ anti-rheumatic) (NNS drugs)) (SBAR (WHNP (WDT that)) (S (VP (VBD was) (VP (VBN triggered) (PP (IN by) (NP (NP (DT the) (NN occurrence)) (PP (IN of) (NP (NP (NNS Doc_18405372_473_486_Disease)) (PP (IN in) (NP (NP (CD two)) (PP (IN of) (NP (PRP$ our) (NNS patients)))))))))))))))))))))) (. .)))
18405372	3	(ROOT (S (NP (NNP Serious) (NNP ADR) (NNS reports)) (VP (VBP have) (VP (VBN been) (VP (VBN solicited) (PP (IN from) (NP (JJ local) (NNS clinicians))) (PP (IN by) (NP (NP (JJ regular) (NNS postcards)) (PP (IN over) (NP (DT the) (JJ past) (CD seven) (NNS years)))))))) (. .)))
18405372	4	(ROOT (S (NP (NNP Patients) (POS ')) (PRN (, ,) (SBAR (WHNP (WP who)) (S (VP (VP (VBD had) (NP (NP (NN hepatotoxicity)) (PP (IN on) (NP (NNS Doc_18405372_667_680_Chemical))))) (CC and) (VP (VBD met) (NP (NP (DT a) (NN definition)) (PP (IN of) (NP (DT a) (JJ serious) (NNS Doc_18405372_715_718_Chemical)))))))) (, ,)) (VP (VBD were) (VP (VBN identified))) (. .)))
18405372	5	(ROOT (S (NP (NP (CD Two) (NNS clinicians)) (VP (VBN reviewed))) (VP (VP (VBN structured) (NP (NN case) (NNS reports))) (CC and) (VP (VBN assessed) (ADVP (RB causality)) (PP (PP (IN by) (NP (NN consensus))) (CC and) (PP (IN by) (S (VP (VBG using) (NP (DT a) (JJ causality) (NN assessment) (NN instrument)))))))) (. .)))
18405372	6	(ROOT (S (NP (NP (DT The) (JJ likely) (NN frequency)) (PP (IN of) (NP (NP (NN hepatotoxicity)) (PP (IN with) (NP (NNS Doc_18405372_913_926_Chemical)))))) (VP (VBD was) (VP (VBN estimated) (PP (IN by) (S (VP (VBG making) (NP (NP (DT a) (NN series)) (PP (IN of) (NP (JJ conservative) (NNS assumptions))))))))) (. .)))
18405372	7	(ROOT (S (S (NP (CD Ten) (NNS cases)) (VP (VBD were) (VP (VBN identified)))) (: :) (S (NP (CD eight)) (VP (VBD occurred) (PP (IN during) (NP (NN surveillance))))) (. .)))
18405372	8	(ROOT (S (NP (CD Eight) (NNS patients)) (VP (VBD were) (VP (VBN hospitalised) (, ,) (NP (NP (NP (CD two)) (PP (IN in) (NP (NNS Doc_18405372_1102_1117_Disease)))) (: -) (NP (NP (CD one)) (VP (VBN died) (PP (IN after) (NP (DT a) (NN liver) (NN transplant)))))))) (. .)))
18405372	9	(ROOT (S (NP (QP (DT All) (CC but) (CD one)) (NN event)) (VP (VBD occurred) (PP (IN within) (NP (NP (CD 6) (NNS weeks)) (PP (IN of) (NP (NN treatment)))))) (. .)))
18405372	10	(ROOT (S (NP (CD Seven) (NNS patients)) (VP (VBD had) (NP (NP (DT a) (NNS Doc_18405372_1232_1241_Disease)) (, ,) (NP (CD three) (NNS Doc_18405372_1249_1261_Disease)) (CC and) (NP (CD one) (NNS Doc_18405372_1270_1292_Disease)))) (. .)))
18405372	11	(ROOT (S (NP (CD Five) (NNS patients)) (VP (VBD were) (PP (IN of) (NP (NP (NNP Black) (NNP British)) (PP (IN of) (NP (JJ African) (CC or) (JJ Caribbean) (NN descent)))))) (. .)))
18405372	12	(ROOT (S (NP (NNP Liver) (NNS enzymes)) (VP (VBD showed) (NP (DT a) (NN hepatocellular) (NN pattern)) (PP (IN in) (NP (NP (CD four) (NNS cases)) (CC and) (NP (DT a) (JJ mixed) (NN pattern)))) (PP (IN in) (NP (CD six)))) (. .)))
18405372	13	(ROOT (S (NP (JJ Drug-related) (NN hepatotoxicity)) (VP (VBD was) (VP (VBN judged) (ADJP (ADJP (JJ probable)) (CC or) (ADJP (RB highly) (JJ probable))) (PP (IN in) (NP (CD 8) (NNS patients))))) (. .)))
18405372	14	(ROOT (S (NP (NP (DT The) (JJ likely) (NN frequency)) (PP (IN of) (NP (NP (JJ serious) (NN hepatotoxicity)) (PP (IN with) (NP (NNS Doc_18405372_1585_1598_Chemical)))))) (VP (VBD was) (VP (VBN estimated) (PP (IN at) (NP (NP (CD 0.4) (NN %)) (PP (IN of) (NP (JJ treated) (NNS patients))))))) (. .)))
18405372	15	(ROOT (S (S (NP (NP (JJ Serious) (NN hepatotoxicity)) (VP (VBN associated) (PP (IN with) (NP (NNS Doc_18405372_1693_1706_Chemical))))) (VP (VBZ appears) (S (VP (TO to) (VP (VB be) (ADJP (JJ under-appreciated))))))) (CC and) (S (NP (NP (JJ intensive) (NN monitoring) (CC and) (NN vigilance)) (PP (IN in) (NP (NP (DT the) (JJ first) (CD 6) (NNS weeks)) (PP (IN of) (NP (NN treatment)))))) (VP (VBZ is) (ADJP (RB especially) (JJ important)))) (. .)))
18441470	0	(ROOT (S (NP (JJ Complete) (NNS Doc_18441470_9_31_Disease)) (VP (VBZ secondary) (PP (TO to) (NP (JJ Doc_18441470_45_52_Chemical) (NN therapy)))) (. .)))
18441470	1	(ROOT (S (NP (NNP Doc_18441470_62_84_Disease)) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (ADVP (RBS most) (RB frequently)) (PP (IN among) (NP (NP (DT the) (JJ adverse) (JJ cardiovascular) (NNS effects)) (PP (IN of) (NP (NNS Doc_18441470_163_170_Chemical)))))))) (. .)))
18441470	2	(ROOT (S (PP (IN In) (NP (DT the) (JJ present) (NN case))) (, ,) (NP (NP (JJ complete) (NNS Doc_18441470_202_229_Disease)) (PP (IN with) (NP (NNS Doc_18441470_235_251_Disease)))) (VP (VBD developed) (NP (JJ secondary)) (PP (TO to) (NP (JJ Doc_18441470_275_282_Chemical) (NN therapy))) (, ,) (S (VP (VBG necessitating) (NP (JJ permanent) (NN pacemaker) (NN implantation))))) (. .)))
18441470	3	(ROOT (S (NP (JJ Serum) (JJ Doc_18441470_346_353_Chemical) (NNS levels)) (VP (VBD remained) (PP (IN under) (CC or) (IN within) (NP (DT the) (JJ therapeutic) (NN range))) (PP (IN during) (NP (DT the) (NNS Doc_18441470_419_435_Disease)))) (. .)))
18441470	4	(ROOT (S (NP (NNP Doc_18441470_437_444_Chemical)) (VP (MD should) (VP (VB be) (VP (VBN used) (PP (PP (IN with) (NP (JJ extreme) (NN caution))) (, ,) (RB especially) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (JJ mild) (NN disturbance)) (PP (IN of) (NP (NNP AV) (NN conduction))))))))))) (. .)))
18483878	0	(ROOT (X (X (NP (NP (JJ Exaggerated) (NN expression)) (PP (IN of) (NP (NP (JJ inflammatory) (NNS mediators)) (PP (IN in) (NP (JJ vasoactive) (NN intestinal)))))) (NP (JJ polypeptide) (NN knockout)) (NP (NP (PRN (-LRB- -LRB-) (NP (NNP VIP)) (, -) (NP (NNP /) (NNP -)) (-RRB- -RRB-)) (NNS mice)) (PP (IN with) (NP (NP (NNS Doc_18483878_114_130_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP CYP)) (-RRB- -RRB-)))))) (: -) (VP (VBN induced) (NP (NNS Doc_18483878_145_153_Disease))) (. .)))
18483878	1	(ROOT (S (NP (NP (JJ Vasoactive) (JJ intestinal) (NN polypeptide)) (PRN (-LRB- -LRB-) (NP (NNP VIP)) (-RRB- -RRB-))) (VP (VBZ is) (NP (NP (DT an) (JJ immunomodulatory) (NN neuropeptide)) (VP (VBN distributed) (PP (IN in) (NP (NN micturition) (NNS pathways)))))) (. .)))
18483878	2	(ROOT (S (NP (NNP VIP)) (PRN (-LRB- -LRB-) (PP (IN -) (NP (NNP /)) (: -)) (-RRB- -RRB-)) (NP (NNS mice) (NN exhibit)) (VP (VBD altered) (NP (NN bladder) (NN function) (CC and) (NN neurochemical) (NNS properties)) (PP (IN in) (NP (NN micturition) (NNS pathways))) (PP (IN after) (NP (NP (NNS Doc_18483878_374_390_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP CYP)) (-RRB- -RRB-)) (: -) (NP (JJ induced) (NNS Doc_18483878_405_413_Disease))))) (. .)))
18483878	3	(ROOT (S (PP (VBN Given) (NP (NP (NP (NNP VIP) (POS 's)) (NN role)) (PP (IN as) (NP (DT an) (JJ anti-inflammatory) (NN mediator))))) (, ,) (NP (PRP we)) (VP (VBN hypothesized) (SBAR (IN that) (S (NP (NP (NNP VIP)) (PRN (-LRB- -LRB-) (FRAG (ADJP (RB -) (JJ /)) (: -)) (-RRB- -RRB-)) (NNS mice)) (VP (MD would) (VP (VB exhibit) (NP (NP (VBN enhanced) (JJ inflammatory) (NN mediator) (NN expression)) (PP (IN after) (NP (NNS Doc_18483878_563_571_Disease))))))))) (. .)))
18483878	4	(ROOT (S (NP (DT A) (NN mouse) (JJ inflammatory) (NN cytokine) (CC and) (NN receptor) (CD RT2) (NN profiler) (NN array)) (VP (VBD was) (VP (VBN used) (S (VP (TO to) (VP (VP (VB determine) (NP (JJ regulated) (NNS transcripts)) (PP (IN in) (NP (NP (DT the) (JJ urinary) (NN bladder)) (PP (IN of) (NP (NP (JJ wild) (NN type)) (PRN (-LRB- -LRB-) (NP (NNP WT)) (-RRB- -RRB-))))))) (CC and) (VP (VB VIP) (NP (PRN (-LRB- -LRB-) (FRAG (ADJP (RB -) (JJ /)) (: -)) (-RRB- -RRB-)) (NNS mice)) (PP (IN with) (CC or) (IN without) (NP (NP (NN Doc_18483878_754_757_Chemical-induced) (NNS Doc_18483878_766_774_Disease)) (PRN (-LRB- -LRB-) (NP (CD 150) (NN mg/kg)) (: ;) (NP (NP (NN i.p.)) (: ;) (NP (CD 48) (NN h))) (-RRB- -RRB-)))))))))) (. .)))
18483878	5	(ROOT (S (S (NP (CD Four) (JJ binary) (NNS comparisons)) (VP (VBD were) (VP (VBN made)))) (: :) (S (NP (NNP WT)) (VP (VBP control) (PP (FW versus) (NP (NP (NP (NNP CYP) (NN treatment)) (PRN (-LRB- -LRB-) (NP (QP (CD 48) (CD h))) (-RRB- -RRB-))) (, ,) (NP (NP (NNP VIP)) (PRN (-LRB- -LRB-) (FRAG (ADJP (RB -) (JJ /)) (: -)) (-RRB- -RRB-))))) (NP (NP (NP (NN control)) (PP (IN versus) (NP (NP (NNP CYP) (NN treatment)) (PRN (-LRB- -LRB-) (NP (QP (CD 48) (CD h))) (-RRB- -RRB-))))) (, ,) (NP (NP (NNP WT) (NN control)) (PP (IN versus) (NP (NNP VIP) (PRN (-LRB- -LRB-) (FRAG (ADJP (RB -) (JJ /)) (: -)) (-RRB- -RRB-)) (NN control)))) (, ,) (CC and) (NP (NP (NNP WT)) (PP (IN with) (NP (NP (NP (NNP CYP) (NN treatment)) (PRN (-LRB- -LRB-) (NP (QP (CD 48) (CD h))) (-RRB- -RRB-) (PP (FW versus) (NP (NNP VIP))))) (PRN (-LRB- -LRB-) (FRAG (ADJP (RB -) (JJ /)) (: -)) (-RRB- -RRB-)))) (PP (IN with) (NP (NNP CYP) (NN treatment))))) (PRN (-LRB- -LRB-) (ADJP (QP (CD 48) (CD h))) (-RRB- -RRB-)))) (. .)))
18483878	6	(ROOT (S (S (NP (DT The) (NNS genes)) (VP (VBD presented) (VP (VB represent) (NP (NP (LST (-LRB- -LRB-) (LS 1) (-RRB- -RRB-)) (NP (JJR greater)) (PP (IN than) (NP (JJ 1.5-fold) (NN change)))) (PP (IN in) (NP (DT either) (NN direction))))))) (CC and) (S (LST (-LRB- -LRB-) (LS 2) (-RRB- -RRB-)) (NP (DT the) (NN p) (NN value)) (VP (VBZ is) (NP (NP (QP (JJR less) (IN than) (CD 0.05))) (PP (IN for) (NP (NP (DT the) (NN comparison)) (VP (VBG being) (VP (VBN made)))))))) (. .)))
18483878	7	(ROOT (S (NP (JJ Several) (JJ regulated) (NNS genes)) (VP (VBD were) (VP (VBN validated) (S (VP (VBG using) (NP (NP (JJ enzyme-linked) (NNS immunoassays)) (PP (VBG including) (NP (NP (NNS IL-1beta)) (CC and) (NP (NNP CXCL1))))))))) (. .)))
18483878	8	(ROOT (S (S (NP (NP (NP (NNP CYP) (NN treatment)) (ADVP (RB significantly))) (PRN (-LRB- -LRB-) (NP (QP (CD p) (CD <) (CC or) (CD =) (CD 0.001))) (-RRB- -RRB-))) (VP (VBD increased) (NP (NP (NP (NN expression)) (PP (IN of) (NP (NNP CXCL1)))) (CC and) (NP (ADJP (ADJP (JJ IL-1beta) (PP (IN in) (NP (NP (DT the) (JJ urinary) (NN bladder)) (PP (IN of) (NP (NNP WT) (CC and) (NNP VIP)))))) (PRN (-LRB- -LRB-) (FRAG (ADJP (RB -) (JJ /)) (: -)) (-RRB- -RRB-))) (NNS mice))))) (, ,) (CC but) (S (NP (NP (NN expression)) (PP (IN in) (NP (NP (NNP VIP) (PRN (-LRB- -LRB-) (FRAG (ADJP (RB -) (JJ /)) (: -)) (-RRB- -RRB-)) (NNP mice)) (PP (IN with) (NP (NNP CYP) (NN treatment)))))) (VP (VBD was) (ADVP (RB significantly)) (ADJP (ADJP (ADJP (-LRB- -LRB-) (NP (QP (CD p) (CD <) (CC or) (CD =) (CD 0.001))) (-RRB- -RRB-)) (ADJP (ADJP (JJR greater)) (PRN (-LRB- -LRB-) (FRAG (NP (CD 4.2)) (: -) (PP (TO to) (NP (JJ 13-fold) (NN increase)))) (-RRB- -RRB-)))) (PP (IN than) (NP (NP (DT that) (ADJP (JJ observed) (PP (IN in) (NP (NNP WT)))) (NN urinary) (NN bladder)) (PRN (-LRB- -LRB-) (X (NP (CD 3.6)) (: -) (PP (TO to) (NP (JJ 5-fold) (NN increase)))) (-RRB- -RRB-))))))) (. .)))
18483878	9	(ROOT (S (NP (DT The) (NNS data)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NP (ADVP (RB in)) (NNP VIP) (PRN (-LRB- -LRB-) (FRAG (ADJP (RB -) (JJ /)) (: -)) (-RRB- -RRB-)) (NNS mice)) (PP (IN with) (NP (JJ Doc_18483878_1656_1676_Disease) (, ,) (JJ inflammatory) (NNS mediators)))) (VP (VBP are) (VP (VBN increased) (PP (IN above) (SBAR (WHNP (WDT that)) (S (VP (VBD observed) (PP (IN in) (NP (NNP WT))) (PP (IN with) (NP (NNP CYP)))))))))))) (. .)))
18483878	10	(ROOT (S (NP (NP (DT This) (NN shift)) (PP (IN in) (NP (NN balance)))) (VP (MD may) (VP (VB contribute) (PP (TO to) (NP (NP (NP (VBN increased) (NNS Doc_18483878_1801_1820_Disease)) (PP (IN in) (NP (NNP VIP) (PRN (-LRB- -LRB-) (FRAG (ADJP (RB -) (JJ /)) (: -)) (-RRB- -RRB-)) (NNP mice))) (PP (IN with) (NP (NNS Doc_18483878_1843_1863_Disease)))) (CC and) (NP (NP (VBN altered) (JJ neurochemical) (NN expression)) (PP (IN in) (NP (NN micturition) (NNS pathways)))))))) (. .)))
1848636	0	(ROOT (S (NP (NP (JJ Doc_1848636_0_12_Chemical) (NN phenotype)) (CC and) (NP (DT the) (ADJP (JJ pharmacokinetics) (CC and) (JJ beta-2)) (NN receptor))) (VP (VBZ pharmacodynamics) (PP (IN of) (NP (NP (NNS Doc_1848636_88_98_Chemical)) (CC and) (NP (PRP$ its) (NNS enantiomers))))) (. .)))
1848636	1	(ROOT (S (NP (NP (DT The) (NN metabolism)) (PP (IN of) (NP (DT the) (JJ cardioselective) (NN beta-blocker) (NNS Doc_1848636_171_181_Chemical)))) (VP (VBZ is) (PP (IN under) (NP (NP (JJ genetic) (NN control)) (PP (IN of) (NP (DT the) (NNP Doc_1848636_214_226_Chemical) (NNP /) (JJ Doc_1848636_227_236_Chemical) (NN type)))))) (. .)))
1848636	2	(ROOT (S (NP (NP (DT The) (CD two) (JJ metabolic) (NNS phenotypes)) (, ,) (NP (NP (NP (JJ extensive)) (PRN (-LRB- -LRB-) (NP (NNP EM)) (-RRB- -RRB-))) (CC and) (NP (NP (JJ poor) (NNS metabolizers)) (PRN (-LRB- -LRB-) (NP (NNP PM)) (-RRB- -RRB-)))) (, ,)) (VP (VBP show) (NP (JJ different) (NN stereoselective) (NN metabolism)) (, ,) (S (VP (VBG resulting) (PP (IN in) (NP (ADJP (RB apparently) (JJR higher)) (JJ beta-1) (NN adrenoceptor))) (NP (NP (JJ antagonistic) (NN potency)) (PP (IN of) (NP (NP (JJ racemic) (NNS Doc_1848636_442_452_Chemical)) (PP (IN in) (NP (NNP EMs))))))))) (. .)))
1848636	3	(ROOT (S (NP (PRP We)) (VP (VBD investigated) (SBAR (IN if) (S (NP (DT the) (NN latter)) (ADVP (RB also)) (VP (VBZ applies) (PP (TO to) (NP (DT the) (JJ beta-2) (NN adrenoceptor) (NN antagonism))) (PP (IN by) (NP (NNS Doc_1848636_545_555_Chemical))))))) (. .)))
1848636	4	(ROOT (S (NP (NP (DT The) (NN drug) (NN effect)) (VP (VBN studied))) (VP (VBD was) (NP (DT the) (NN antagonism)) (PP (IN by) (NP (NP (NNS Doc_1848636_603_613_Chemical)) (PP (IN of) (NP (NN Doc_1848636_617_628_Chemical-induced) (NNS Doc_1848636_637_648_Disease)))))) (. .)))
1848636	5	(ROOT (S (PP (IN By) (S (VP (VBG using) (NP (JJ pharmacokinetic) (JJ pharmacodynamic) (NN modeling))))) (NP (NP (DT the) (NNS pharmacodynamics)) (PP (IN of) (NP (NP (JJ racemic) (NNS Doc_1848636_732_742_Chemical)) (CC and) (NP (DT the) (JJ active) (NN S-isomer)) (, ,)))) (VP (VBD were) (VP (VBN quantitated) (PP (IN in) (NP (NNP EMs) (CC and) (NNP PMs))) (PP (IN in) (NP (NP (NNS terms)) (PP (IN of) (NP (CD IC50) (NNS values))))) (, ,) (S (VP (VBG representing) (NP (JJ Doc_1848636_838_848_Chemical) (NN plasma) (NNS concentrations)) (S (VP (VBG resulting) (PP (IN in) (NP (JJ half-maximum) (NN receptor) (NN occupancy))))))))) (. .)))
1848636	6	(ROOT (S (NP (NNP Six) (NNP EMs)) (VP (VBD received) (NP (NP (CD 0.5) (NN mg)) (PP (IN of) (NP (JJ Doc_1848636_944_955_Chemical) (NN s.c.)))) (PP (IN on) (NP (NP (CD two) (JJ different) (NNS occasions)) (: :) (NP (LST (LS 1) (-RRB- -RRB-)) (NP (CD 1) (NN hr)) (PP (IN after) (NP (NP (NP (NN administration)) (PP (IN of) (NP (DT a) (NN placebo)))) (CC and) (NP (LST (LS 2) (-RRB- -RRB-)) (NP (CD 1) (NN hr)) (PP (IN after) (NP (NP (CD 150) (NN mg)) (PP (IN of) (NP (NP (NNS Doc_1848636_1059_1069_Chemical)) (SBAR (S (NP (NNP p.o.) (CD Five) (NNP PMs)) (VP (VBD were) (VP (VBN studied) (PP (VBG according) (PP (TO to) (NP (DT the) (JJ same) (NN protocol)))))))))))))))))) (, ,) (PP (IN except) (IN for) (NP (NP (NP (DT a) (JJR higher) (JJ Doc_1848636_1149_1160_Chemical) (NN dose)) (PRN (-LRB- -LRB-) (NP (CD 0.75) (NNS mg)) (-RRB- -RRB-))) (PP (IN on) (NP (NN day) (CD 2)))))) (. .)))
1848636	7	(ROOT (S (NP (NP (NN Blood) (NNS samples)) (PP (IN for) (NP (NP (DT the) (NN analysis)) (PP (IN of) (NP (NP (NN plasma) (NNS Doc_1848636_1227_1236_Chemical)) (, ,) (NP (NP (NNS Doc_1848636_1238_1249_Chemical)) (, ,) (NP (NP (NNS Doc_1848636_1251_1261_Chemical)) (-LRB- -LRB-) (NP (NN racemic)) (, ,) (ADJP (JJ R) (: -) (CC and) (JJ S-isomer)) (-RRB- -RRB-))) (, ,) (CC and) (NP (JJ Doc_1848636_1294_1317_Chemical) (NNS concentrations))))))) (VP (VBD were) (VP (VBN taken) (PP (IN at) (NP (JJ regular) (NN time) (NNS intervals))) (, ,) (PP (IN during) (NP (NP (CD 8) (NN hr)) (PP (IN after) (NP (NNS Doc_1848636_1389_1399_Chemical))))))) (. .)))
1848636	8	(ROOT (S (PP (IN In) (NP (NNP PMs))) (, ,) (NP (NNS Doc_1848636_1409_1419_Chemical)) (VP (VBD increased) (NP (DT the) (JJ Doc_1848636_1434_1445_Chemical) (NN area)) (PP (IN under) (NP (NP (DT the) (NN plasma) (NN concentration)) (PP (IN vs.) (NP (NP (NN time) (NN curve)) (PRN (-LRB- -LRB-) (NP (CD +67) (NN %)) (-RRB- -RRB-))))))) (. .)))
1848636	9	(ROOT (S (NP (NP (JJR Higher) (NNS Doc_1848636_1512_1522_Chemical)) (PRN (: /) (S (NP (NP (JJ Doc_1848636_1523_1546_Chemical) (NNS ratios)) (PP (IN in) (NP (NNP PMs)))) (VP (VBD were) (VP (VBN predictive) (PP (IN for) (NP (JJR higher) (NN R)))))) (: -))) (VP (VBZ /) (NP (NP (JJ S-isomer) (NNS ratios)) (PP (IN of) (NP (JJ unchanged) (NN drug))))) (. .)))
1848636	10	(ROOT (S (NP (EX There)) (VP (VBD was) (NP (NP (DT a) (NN difference)) (PP (IN in) (NP (NP (JJ Doc_1848636_1652_1662_Chemical) (NN potency)) (PP (IN with) (NP (NP (JJR higher) (JJ racemic) (NNS Doc_1848636_1691_1701_Chemical)) (VP (VBG IC50) (NP (NNS values)) (PP (IN in) (NP (NNP PMs))) (PRN (-LRB- -LRB-) (NP (CD 72) (NNP +) (NNS /)) (, -) (NP (CD 7) (NNS ng.ml-1)) (-RRB- -RRB-)) (FRAG (PP (IN than) (NP (NP (NNP EMs)) (PRN (-LRB- -LRB-) (NP (CD 42) (NNP +) (NNS /)) (: -) (NP (NP (CD 8) (NNS ng.ml-1)) (, ,) (NP (NP (NNP P)) (NP (QP (JJR less) (IN than) (CD .001))))) (-RRB- -RRB-)))) (. .))))) (PRN (-LRB- -LRB-) (NP (NP (NNP ABSTRACT) (NNP TRUNCATED) (NNP AT)) (NP (CD 250) (NNS WORDS))) (-RRB- -RRB-))))))))
18513945	0	(ROOT (NP (NP (NP (DT The) (NNS hemodynamics)) (PP (IN of) (NP (NP (JJ Doc_18513945_20_28_Chemical) (CC and) (JJ other) (NN vasoactive) (NNS agents)) (PP (IN during) (NP (NP (JJ neuraxial) (NN anesthesia)) (PP (IN for) (NP (NN cesarean) (NN delivery)))))))) (: :) (NP (NP (NNS findings)) (PP (IN in) (NP (CD six) (NNS cases)))) (. .)))
18513945	1	(ROOT (S (NP (NNP Doc_18513945_131_139_Chemical)) (VP (VBZ is) (NP (DT a) (ADJP (RB commonly) (VBN used)) (NN uterotonic) (SBAR (WHNP (WDT that)) (S (VP (MD can) (VP (VB cause) (NP (ADJP (ADJP (JJ significant)) (CC and) (ADJP (RB even) (JJ fatal))) (NNS Doc_18513945_212_223_Disease))))))) (, ,) (SBAR (RB particularly) (WHADVP (WRB when)) (S (VP (VBN given) (PP (IN as) (NP (DT a) (NNS bolus))))))) (. .)))
18513945	2	(ROOT (S (NP (DT The) (VBG resulting) (NNS Doc_18513945_275_286_Disease)) (VP (MD can) (VP (VB be) (VP (VBN produced) (PP (IN by) (NP (NP (DT a) (NN decrease)) (PP (IN in) (NP (NP (JJ systemic) (NN vascular) (NN resistance)) (CC or) (NP (JJ cardiac) (NN output)))))) (PP (IN through) (NP (NP (DT a) (NN decrease)) (PP (IN in) (NP (JJ venous) (NN return)))))))) (. .)))
18513945	3	(ROOT (S (NP (NP (NNS Parturients)) (PP (IN with) (NP (NP (JJ normal) (NN volume) (NN status)) (, ,) (NP (NN heart) (NNS valves)) (CC and) (NP (JJ pulmonary) (NN vasculature))))) (ADVP (RBS most) (RB often)) (VP (VB respond) (PP (TO to) (NP (DT this) (NNS Doc_18513945_509_520_Disease))) (PP (IN with) (NP (NP (DT a) (ADJP (JJ compensatory)) (NN increase)) (PP (IN in) (NP (NP (NN heart) (NN rate)) (CC and) (NP (JJ Doc_18513945_568_574_Disease) (NN volume))))))) (. .)))
18513945	4	(ROOT (S (NP (NP (JJ Doc_18513945_583_591_Chemical-induced) (NNS Doc_18513945_600_611_Disease)) (PP (IN at) (NP (NN cesarean) (NN delivery)))) (VP (MD may) (VP (VB be) (VP (ADVP (RB incorrectly)) (VBN attributed) (PP (TO to) (NP (NNS Doc_18513945_666_676_Disease)))))) (. .)))
18513945	5	(ROOT (S (NP (NP (NP (JJ Pulse) (NN power) (NN analysis)) (PRN (-LRB- -LRB-) (VP (ADVP (RB also)) (VBN called) (`` ``) (NP (NN pulse) (NN contour) (NN analysis)) ('' '')) (-RRB- -RRB-))) (PP (IN of) (NP (DT an) (JJ arterial) (NN pressure) (NN wave) (NN form)))) (VP (VBZ allows) (NP (NP (JJ continuous) (NN evaluation)) (PP (IN of) (NP (NP (JJ systemic) (NN vascular) (NN resistance)) (CC and) (NP (JJ cardiac) (NN output))))) (PP (IN in) (NP (JJ real) (NN time))) (, ,) (S (ADVP (RB thereby)) (VP (VBG elucidating) (NP (DT the) (JJ causative) (NNS factors)) (PP (IN behind) (NP (NP (NNS changes)) (PP (IN in) (NP (NN blood) (NN pressure)))))))) (. .)))
18513945	6	(ROOT (S (NP (JJ Pulse) (NN power) (NN analysis)) (VP (VBD was) (VP (VBN conducted) (PP (IN in) (NP (NP (CD six) (NNS cases)) (PP (IN of) (NP (NP (NN cesarean) (NN delivery)) (VP (VBN performed) (PP (IN under) (NP (JJ neuraxial) (NN anesthesia)))))))))) (. .)))
18513945	7	(ROOT (S (NP (NP (NNP Doc_18513945_1049_1060_Disease)) (PP (IN in) (NP (NP (NN response)) (PP (TO to) (NP (NNS Doc_18513945_1076_1084_Chemical)))))) (VP (VBD was) (VP (VBN associated) (PP (IN with) (NP (NP (NP (DT a) (NN decrease)) (PP (IN in) (NP (JJ systemic) (NN vascular) (NN resistance)))) (CC and) (NP (NP (DT a) (ADJP (JJ compensatory)) (NN increase)) (PP (IN in) (NP (NP (JJ Doc_18513945_1179_1185_Disease) (NN volume)) (, ,) (NP (NN heart) (NN rate)) (CC and) (NP (JJ cardiac) (NN output))))))))) (. .)))
18513945	8	(ROOT (S (NP (JJ Pulse) (NN power) (NN analysis)) (VP (MD may) (VP (VB be) (ADJP (JJ helpful) (PP (IN in) (S (VP (VP (VBG determining) (NP (NP (DT the) (NN etiology)) (PP (IN of)))) (CC and) (VP (VBG treating) (NP (NNS Doc_18513945_1305_1316_Disease)) (PP (IN during) (NP (NN cesarean) (NN delivery))) (PP (IN under) (NP (JJ neuraxial) (NN anesthesia)))))))))) (. .)))
18541230	0	(ROOT (NP (NP (JJ Protective) (NNS effects)) (PP (IN of) (NP (NN antithrombin))) (PP (IN on) (NP (JJ Doc_18541230_38_63_Chemical) (NNS Doc_18541230_64_73_Disease))) (PP (IN in) (NP (NNS rats))) (. .)))
18541230	1	(ROOT (S (NP (PRP We)) (VP (VBD investigated) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NP (NN antithrombin)) (, ,) (NP (NP (DT a) (NN plasma) (NN inhibitor)) (PP (IN of) (NP (NN coagulation) (NNS factors))))))) (, ,) (PP (IN in) (NP (NP (NNS rats)) (PP (IN with) (NP (NP (NN Doc_18541230_184_209_Chemical-induced) (NNS Doc_18541230_218_227_Disease)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (NP (NP (DT an) (JJ experimental) (NN model)) (PP (IN of) (NP (JJ human) (NNS Doc_18541230_269_287_Disease)))))))))))) (. .)))
18541230	2	(ROOT (S (NP (NP (NNP Antithrombin)) (PRN (-LRB- -LRB-) (NP (NP (NP (QP (CD 50) (CC or) (CD 500))) (NP (NNP IU/kg/i) (. .))) (NP (NNP v.))) (-RRB- -RRB-))) (VP (VBD was) (VP (VBN administered) (PP (TO to) (NP (NP (NNS rats)) (ADVP (RB once) (NP (DT a) (NN day)) (PP (IN for) (ADVP (NP (CD 10) (NNS days)) (RB immediately)))))) (PP (IN after) (NP (NP (DT the) (NN injection)) (PP (IN of) (NP (NP (NNS Doc_18541230_408_433_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (CD 50)) (NP (NP (NNP mg/kg/i) (. .)) (PP (IN v.)))) (-RRB- -RRB-)))))))) (. .)))
18541230	3	(ROOT (S (NP (NP (NNP Treatment)) (PP (IN with) (NP (NN antithrombin)))) (VP (VBD attenuated) (NP (DT the) (NN Doc_18541230_494_519_Chemical-induced) (NNS Doc_18541230_528_555_Disease))) (. .)))
18541230	4	(ROOT (S (NP (JJ Doc_18541230_557_582_Chemical-induced) (NNS Doc_18541230_591_608_Disease) (CC and) (NNS Doc_18541230_613_627_Disease)) (VP (VBD were) (VP (ADVP (RB also)) (VBN suppressed))) (. .)))
18541230	5	(ROOT (S (NP (JJ Histopathological) (NN examination)) (VP (VBD revealed) (SBAR (S (NP (NP (JJ severe) (NNS Doc_18541230_696_708_Disease)) (PP (JJ such) (IN as) (NP (NNS proteinaceous)))) (VP (VBZ casts) (PP (IN in) (NP (NP (NNS tubuli)) (CC and) (NP (NP (JJ tubular) (NN expansion)) (PP (IN in) (NP (NP (DT the) (NN kidney)) (PP (IN of) (NP (NN control) (NNS rats)))))))) (, ,) (SBAR (IN while) (S (NP (NP (DT an) (NN improvement)) (PP (IN of) (NP (DT the) (NN damage)))) (VP (VBD was) (VP (VBN seen) (PP (IN in) (NP (JJ antithrombin-treated) (NNS rats))))))))))) (. .)))
18541230	6	(ROOT (S (PP (IN In) (NP (NN addition))) (, ,) (NP (NN antithrombin) (NN treatment) (NNS markedly)) (VP (VBD suppressed) (NP (NP (NN Doc_18541230_930_955_Chemical-induced) (NNS apoptosis)) (PP (IN of) (NP (JJ renal) (JJ tubular) (JJ epithelial) (NNS cells))))) (. .)))
18541230	7	(ROOT (S (ADVP (RB Furthermore)) (, ,) (NP (NP (NN Doc_18541230_1022_1047_Chemical-induced) (NNS increases)) (PP (IN in) (NP (JJ renal) (NN cytokine) (NN content)))) (VP (VBD were) (VP (ADVP (RB also)) (VBN decreased))) (. .)))
18541230	8	(ROOT (S (NP (DT These) (NNS findings)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NN thrombin)) (VP (VBZ plays) (NP (NP (DT an) (JJ important) (NN role)) (PP (IN in) (NP (NP (DT the) (NNS pathogenesis)) (PP (IN of) (NP (NN Doc_18541230_1197_1222_Chemical-induced) (NNS Doc_18541230_1231_1249_Disease)))))))))) (. .)))
18541230	9	(ROOT (S (NP (NP (NNP Treatment)) (PP (IN with) (NP (NN antithrombin)))) (VP (MD may) (VP (VB be) (ADJP (RB clinically) (JJ effective)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NNS Doc_18541230_1324_1342_Disease))))))) (. .)))
18589141	0	(ROOT (S (VP (VB Doc_18589141_0_7_Chemical-induced) (NP (NN thrombocytopenia)) (PP (IN after) (NP (NN liver) (NN transplantation)))) (. .)))
18589141	1	(ROOT (S (NP (NP (NP (NNP Doc_18589141_74_103_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_18589141_105_108_Chemical)) (-RRB- -RRB-))) (CC or) (NP (NP (JJ low-molecular) (NN weight) (NN heparin)) (PRN (-LRB- -LRB-) (NP (NNP LMWH)) (-RRB- -RRB-)))) (VP (VBZ is) (VP (VBN used) (PP (IN in) (NP (NP (JJ anticoagulant) (NNS protocols)) (PP (IN at) (NP (JJ several) (NNS institutions))))) (S (VP (TO to) (VP (VB prevent) (NP (NNS Doc_18589141_219_229_Disease)) (PP (IN after) (NP (NN liver) (NN transplantation)))))))) (. .)))
18589141	2	(ROOT (S (NP (NP (JJ Doc_18589141_259_266_Chemical-induced) (NN thrombocytopenia)) (PRN (-LRB- -LRB-) (NP (NNP Doc_18589141_293_296_Disease)) (-RRB- -RRB-))) (VP (VBZ is) (NP (NP (DT an) (JJ adverse) (JJ immune-mediated) (NN reaction)) (PP (TO to) (NP (NNS Doc_18589141_340_347_Chemical))) (, ,) (VP (VBG resulting) (PP (IN in) (NP (NP (JJ platelet) (NN count) (NNS decreases)) (PP (IN of) (NP (QP (JJR more) (IN than) (CD 50)) (NN %)))))))) (. .)))
18589141	3	(ROOT (S (NP (NP (DT The) (ADJP (JJ frequencies) (PP (IN of) (NP (NP (NNS Doc_18589141_424_427_Disease)) (PP (IN after) (NP (NP (NN liver) (NN transplantation)) (CC and) (NP (JJ platelet) (NN factor))))))) (JJ 4/heparin-reactive) (NN antibody) (PRN (-LRB- -LRB-) (NP (JJ Doc_18589141_505_508_Disease) (NN antibody)) (-RRB- -RRB-)) (NN positivity)) (PP (IN in) (NP (NN liver) (NN transplantation) (NNS patients)))) (, ,) (ADVP (RB however)) (, ,) (VP (VBP are) (ADJP (JJ unknown))) (. .)))
18589141	4	(ROOT (FRAG (NP (NNS PATIENTS) (CC AND) (NNS METHODS)) (: :) (S (NP (NP (DT The) (CD 32) (NNS men)) (CC and) (NP (CD 20) (NNS women))) (VP (VBD underwent) (NP (VBG living) (NN donor) (NN liver) (NN transplantation)))) (. .)))
18589141	5	(ROOT (S (NP (PRP We)) (VP (VBD started) (NP (NP (NNP LMWH)) (PRN (-LRB- -LRB-) (NP (QP (CD 25) (CD IU/kg/h))) (-RRB- -RRB-))) (PP (IN on) (NP (NP (JJ postoperative) (NN day)) (PRN (-LRB- -LRB-) (NP (NNP POD)) (-RRB- -RRB-)) (NP (CD 1)))) (, ,) (S (VP (VBG switching) (PP (TO to) (NP (NP (NNS Doc_18589141_751_754_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP 5000) (NNP U/d)) (-RRB- -RRB-)))) (PP (IN on) (NP (NNP POD) (CD 2) (CC or) (CD 3)))))) (. .)))
18589141	6	(ROOT (S (NP (NP (DT The) (NN dose)) (PP (IN of) (NP (NNS Doc_18589141_793_796_Chemical)))) (VP (VBD was) (VP (VBN changed) (PP (VBG according) (PP (TO to) (NP (DT the) (VBN activated) (NN clotting) (NN time) (NN level)))))) (. .)))
18589141	7	(ROOT (S (NP (JJ Doc_18589141_857_860_Disease) (NN antibody) (NNS levels)) (VP (VBD were) (VP (VBN measured) (NP (DT the) (NN day)) (PP (PP (IN before) (NP (NN surgery))) (CC and) (PP (IN on) (NP (NNP POD) (CD 7) (CC and) (CD 14)))))) (. .)))
18589141	8	(ROOT (S (NP (JJ Platelet) (NN count)) (VP (VBD was) (VP (VBN measured) (ADVP (RB daily)) (PP (IN for) (NP (CD 3) (NNS weeks))))) (. .)))
18589141	9	(ROOT (S (S (NP (DT The) (JJ average) (NN platelet)) (VP (VBZ counts) (UCP (ADVP (RB preoperatively)) (, ,) (CC and) (PP (IN on) (NP (NNP POD) (CD 7) (, ,) (CD 14)))))) (, ,) (CC and) (S (NP (CD 21)) (VP (VBD were) (NP (NP (CD 65)) (, ,) (NP (CD 88)) (, ,) (NP (CD 149)) (, ,) (CC and) (NP (NP (NP (QP (CD 169) (CD x)) (CD 10)) (PRN (-LRB- -LRB-) (NP (CD 9)) (-RRB- -RRB-))) (NP (NNP /) (NNP L)))) (, ,) (ADVP (RB respectively)))) (. .)))
18589141	10	(ROOT (S (S (NP (CD Two) (NNS patients)) (VP (VBD developed) (NP (JJ hepatic) (NN artery) (NNS Doc_18589141_1149_1159_Disease)) (PP (IN on) (NP (NNP POD) (CD 11) (CC and) (CD 19))) (, ,) (ADVP (RB respectively)) (, ,) (SBAR (IN although) (S (NP (PRP they)) (VP (VBD were) (ADJP (RB Doc_18589141_1211_1214_Disease) (JJ antibody-negative))))))) (CC and) (S (NP (PRP$ their) (NN platelet) (NNS counts)) (VP (VBD were) (ADJP (JJ stable)))) (. .)))
18589141	11	(ROOT (S (PP (IN In) (NP (CD 2) (JJ other) (NNS patients))) (, ,) (NP (DT the) (NN platelet) (NN count)) (VP (VBD decreased) (ADVP (RB suddenly)) (PP (IN from) (NP (NP (NP (CD 107) (NNP x) (CD 10)) (PRN (-LRB- -LRB-) (NP (CD 9)) (-RRB- -RRB-))) (PRN (: /) (FRAG (FRAG (NP (NP (NNP L)) (PP (IN on) (NP (NP (QP (CD POD) (CD 4) (TO to) (CD 65) (CD x) (CD 10))) (PRN (-LRB- -LRB-) (NP (CD 9)) (-RRB- -RRB-))))) (: /) (NP (NP (NNP L)) (PP (PP (IN on) (NP (NNP POD) (CD 6))) (CC and) (PP (IN from) (NP (CD 76))) (NP (NP (QP (CD x) (CD 10))) (PRN (-LRB- -LRB-) (NP (CD 9)) (-RRB- -RRB-)))))) (: /) (FRAG (NP (NP (NNP L)) (PP (IN on) (NP (NP (QP (CD POD) (CD 7) (TO to) (CD 33) (CD x) (CD 10))) (PRN (-LRB- -LRB-) (NP (CD 9)) (-RRB- -RRB-))))) (: /) (NP (NP (NNP L)) (PP (IN on) (NP (NNP POD) (CD 9))))))))) (, ,) (ADVP (RB respectively))) (. .)))
18589141	12	(ROOT (S (NP (DT The) (NN Doc_18589141_1459_1466_Chemical-induced) (NNS Doc_18589141_1475_1495_Disease) (NN test)) (VP (VBD was) (ADJP (JJ negative) (PP (IN in) (NP (DT these) (NNS patients))))) (. .)))
18589141	13	(ROOT (S (NP (NP (DT The) (NN percentage)) (PP (IN of) (NP (JJ Doc_18589141_1551_1554_Disease) (JJ antibody-positive) (NNS patients)))) (VP (VBD was) (NP (NP (NP (ADJP (CD 0.5) (NN %)) (NN preoperatively)) (, ,) (NP (NP (CD 5.6) (NN %)) (PP (IN on) (NP (NNP POD) (CD 7))))) (, ,) (CC and) (NP (NP (CD 5.6) (NN %)) (PP (IN on) (NP (NNP POD) (CD 14)))))) (. .)))
18589141	14	(ROOT (S (NP (NP (NN None)) (PP (IN of) (NP (DT the) (NNS subjects/patients)))) (VP (VBD developed) (NP (JJ UFH-related) (NNS Doc_18589141_1694_1697_Disease))) (. .)))
18589141	15	(ROOT (S (PP (IN In) (NP (PRP$ our) (NN series))) (, ,) (NP (NP (DT the) (NN occurrence)) (PP (IN of) (NP (NP (NNS Doc_18589141_1745_1748_Disease)) (PP (IN after) (NP (NN liver) (NN transplantation)))))) (VP (VBD was) (ADJP (JJ uncommon))) (. .)))
18627295	0	(ROOT (S (NP (JJ Doc_18627295_0_11_Chemical) (NN Doc_18627295_12_26_Disease-induced) (NNS Doc_18627295_35_47_Disease) (CC and) (NNS apoptosis)) (VP (VBP are) (VP (VBN attenuated) (PP (IN by) (NP (NP (NN gene) (NN deletion)) (PP (IN of) (NP (DT the) (NN kinin) (NN B1) (NN receptor))))))) (. .)))
18627295	1	(ROOT (S (NP (NP (JJ Clinical) (NN use)) (PP (IN of) (NP (NP (DT the) (JJ Doc_18627295_140_153_Chemical) (NNS Doc_18627295_154_165_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_18627295_167_170_Chemical)) (-RRB- -RRB-))))) (VP (VBZ is) (VP (VBN limited) (PP (IN by) (NP (NP (PRP$ its) (JJ Doc_18627295_190_201_Disease) (NNS effects)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP are) (VP (VBN attributed) (PP (TO to) (NP (NP (DT the) (NN induction)) (PP (IN of) (NP (NNS apoptosis))))))))))))) (. .)))
18627295	2	(ROOT (S (S (VP (TO To) (VP (VB elucidate) (NP (NP (DT the) (JJ possible) (NN role)) (PP (IN of) (NP (NP (DT the) (JJ kinin) (NN B1) (NN receptor)) (PRN (-LRB- -LRB-) (NP (NNP B1R)) (-RRB- -RRB-))))) (PP (IN during) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (JJ Doc_18627295_351_354_Chemical) (NNS Doc_18627295_355_369_Disease)))))))) (, ,) (NP (PRP we)) (VP (VBD studied) (NP (NP (NP (CD B1R) (NN knockout) (NNS mice)) (-LRB- -LRB-) (NP (NNP B1R)) (PRN (-LRB- -LRB-) (FRAG (ADJP (RB -) (JJ /)) (: -)) (-RRB- -RRB-)) (-RRB- -RRB-)) (PP (IN by) (S (VP (VBG investigating) (NP (JJ cardiac) (NNS Doc_18627295_436_448_Disease) (CC and) (NNS apoptosis)) (PP (IN after) (NP (NP (NN induction)) (PP (IN of) (NP (NN Doc_18627295_482_485_Chemical-induced) (NNS Doc_18627295_494_508_Disease)))))))))) (. .)))
18627295	3	(ROOT (S (NP (JJ Doc_18627295_510_513_Chemical) (NN control) (NNS mice)) (VP (VBD showed) (NP (NP (NNS Doc_18627295_534_553_Disease)) (VP (VBN measured) (PP (IN by) (NP (NP (JJ pressure-volume) (NNS loops)) (PP (IN in) (NP (NN vivo)))))))) (. .)))
18627295	4	(ROOT (S (NP (DT This)) (VP (VBD was) (VP (VBN associated) (PP (IN with) (NP (NP (NP (DT a) (VBN reduced) (NN activation) (NN state)) (PP (IN of) (NP (NNP AKT)))) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (DT an) (VBN increased) (JJ bax/bcl2) (NN ratio)))) (PP (IN in) (NP (JJ Western) (NNS blots))) (, ,) (S (VP (VBG indicating) (NP (NNS Doc_18627295_725_742_Disease)))))) (. .)))
18627295	5	(ROOT (S (ADVP (RB Furthermore)) (, ,) (NP (NP (NN mRNA) (NNS levels)) (PP (IN of) (NP (NP (DT the) (ADJP (RB proinflammatory) (JJ cytokine)) (NN interleukin)) (ADJP (CD 6))))) (VP (VBD were) (VP (VBN increased) (PP (IN in) (NP (DT the) (JJ cardiac) (NN tissue))))) (. .)))
18627295	6	(ROOT (S (PP (IN In) (NP (NNP DOX) (NNP B1R) (PRN (-LRB- -LRB-) (FRAG (ADJP (RB -) (JJ /)) (: -)) (-RRB- -RRB-)) (NNS mice))) (, ,) (NP (NNS Doc_18627295_875_894_Disease)) (VP (VBD was) (VP (VBN improved) (PP (VBN compared) (PP (TO to) (NP (NP (JJ Doc_18627295_920_923_Chemical) (NN control) (NNS mice)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD was) (VP (VBN associated) (PP (IN with) (NP (NP (NP (NN normalization)) (PP (IN of) (NP (NP (DT the) (JJ bax/bcl) (JJ -2) (NN ratio)) (CC and) (NP (NN interleukin) (CD 6))))) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (NNP AKT) (NN activation) (NN state))))))))))))) (. .)))
18627295	7	(ROOT (S (NP (DT These) (NNS findings)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NNP B1R)) (VP (VBZ is) (ADJP (JJ detrimental) (PP (IN in) (NP (NP (JJ Doc_18627295_1103_1106_Chemical) (NNS Doc_18627295_1107_1121_Disease)) (SBAR (WHPP (IN in) (WHNP (WDT that))) (S (NP (PRP it)) (VP (VP (VBZ mediates) (NP (DT the) (JJ inflammatory) (NN response))) (CC and) (VP (VBZ apoptosis)))))))))))) (. .)))
18627295	8	(ROOT (S (NP (DT These) (NNS insights)) (VP (MD might) (VP (VB have) (NP (NP (JJ useful) (NNS implications)) (PP (IN for) (NP (NP (JJ future) (NNS studies)) (VP (VBG utilizing) (NP (NP (CD B1R) (NNS antagonists)) (PP (IN for) (NP (NP (NN treatment)) (PP (IN of) (NP (JJ human) (JJ Doc_18627295_1297_1300_Chemical) (NNS Doc_18627295_1301_1315_Disease)))))))))))) (. .)))
18657397	0	(ROOT (NP (NP (JJ Detailed) (JJ spectral) (NN profile) (NN analysis)) (PP (IN of) (NP (NN Doc_18657397_38_48_Chemical-induced) (NNS Doc_18657397_57_78_Disease))) (PP (IN in) (NP (JJ anesthetized) (NNS rats))) (. .)))
18657397	1	(ROOT (S (NP (JJ Doc_18657397_101_111_Chemical) (NN model)) (VP (VBZ is) (NP (NP (DT a) (ADJP (RB widely) (VBN used)) (JJ experimental) (NN model)) (PP (IN for) (NP (JJ Doc_18657397_158_166_Disease) (NN research))))) (. .)))
18657397	2	(ROOT (S (PP (IN In) (NP (DT the) (JJ present) (NN study))) (NP (PRP we)) (VP (VBD aimed) (S (VP (TO to) (VP (VB portray) (NP (NP (DT a) (JJ detailed) (JJ spectral) (NN analysis)) (PP (IN of) (NP (NN Doc_18657397_250_260_Chemical-induced) (NNS Doc_18657397_269_290_Disease)))) (PP (IN in) (NP (NN comparison))) (PP (IN with) (NP (NP (JJ basal) (NN brain) (NN activity)) (PP (IN in) (NP (JJ anesthetized) (NNP Wistar) (NNS rats))))))))) (. .)))
18657397	3	(ROOT (S (NP (NNP Male) (NNP Wistar) (NNS rats)) (VP (VBD were) (VP (VP (VBN anesthetized) (PP (IN with) (NP (NN i.p.) (NNS Doc_18657397_405_413_Chemical)))) (CC and) (VP (VBN connected) (PP (TO to) (NP (DT an) (NN electrocorticogram) (NN setup)))))) (. .)))
18657397	4	(ROOT (S (PP (IN After) (NP (NP (DT a) (JJ short) (NN period)) (PP (IN of) (NP (JJ basal) (NN activity) (NN recording))))) (, ,) (NP (JJ Doc_18657397_510_519_Disease) (NN focus)) (VP (VBD was) (VP (VBN induced) (PP (IN by) (S (VP (VBG injecting) (NP (CD 400IU/2) (JJ microl) (NN Doc_18657397_566_578_Chemical) (NN potassium)) (PP (IN into) (NP (DT the) (JJ left) (JJ lateral) (NN ventricle))) (SBAR (IN while) (S (NP (DT the) (JJ cortical) (NN activity)) (VP (VBD was) (VP (ADVP (RB continuously)) (VBN recorded)))))))))) (. .)))
18657397	5	(ROOT (S (NP (NP (JJ Basal) (NN activity)) (, ,) (NP (NN latent) (NN period)) (CC and) (NP (DT the) (JJ Doc_18657397_714_724_Chemical-induced) (JJ Doc_18657397_733_754_Disease) (NNS periods))) (VP (VBD were) (ADVP (RB then)) (VP (VBN analyzed) (S (VP (VBG using) (NP (NP (DT both) (JJ conventional) (NNS methods)) (CC and) (NP (JJ spectral) (NN analysis))))))) (. .)))
18657397	6	(ROOT (S (NP (JJ Spectral) (NNS analyses)) (VP (VBD were) (VP (VBN conducted) (PP (IN by) (S (VP (VBG dividing) (NP (DT the) (JJ whole) (NN spectrum)) (PP (IN into) (NP (NP (JJ different) (NN frequency) (NNS bands)) (PP (VBG including) (NP (NP (NP (NN delta)) (, ,) (NP (NP (NN theta)) (PRN (-LRB- -LRB-) (ADJP (JJ slow) (CC and) (JJ fast)) (-RRB- -RRB-)))) (, ,) (NP (NP (NN alpha-sigma)) (, ,) (NP (NP (NN beta)) (PRN (-LRB- -LRB-) (NP (QP (CD 1) (CC and) (CD 2))) (-RRB- -RRB-)))) (CC and) (NP (NP (NN gamma)) (PRN (-LRB- -LRB-) (NP (QP (CD 1) (CC and) (CD 2))) (-RRB- -RRB-)) (NP (NNS bands)))))))))))) (. .)))
18657397	7	(ROOT (S (NP (PRP$ Our) (NNS results)) (VP (VBP show) (SBAR (IN that) (S (S (NP (DT the) (ADJP (RBS most) (JJ affected)) (NN frequency) (NNS bands)) (VP (VBD were) (NP (JJ delta) (, ,) (NNS theta) (, ,) (JJ beta-2) (CC and) (JJ gamma-2) (NNS bands)) (PP (IN during) (NP (DT the) (NNS Doc_18657397_1138_1159_Disease))))) (CC and) (S (NP (EX there)) (VP (VBD were) (VP (VBN marked) (NP (NNS differences)) (PP (IN in) (NP (NP (NNS terms)) (PP (IN of) (NP (NP (JJ spectral) (NNS densities)) (PP (IN between) (NP (NP (QP (CD three) (CD investigated)) (NNS episodes)) (PRN (-LRB- -LRB-) (NP (NP (JJ basal) (NN activity)) (, ,) (NP (NN latent) (NN period)) (CC and) (NP (NNS Doc_18657397_1296_1317_Disease))) (-RRB- -RRB-)))))))))))))) (. .)))
18657397	8	(ROOT (S (S (NP (PRP$ Our) (NNS results)) (VP (MD may) (VP (VB help) (S (VP (TO to) (VP (VB analyze) (NP (NP (NN novel) (NNS data)) (VP (VBN obtained) (S (VP (VBG using) (NP (JJ similar) (JJ experimental) (NNS models)))))))))))) (CC and) (S (NP (NP (DT the) (JJ simple) (NN analysis) (NN method)) (VP (VBN described) (ADVP (RB here)))) (VP (MD can) (VP (VB be) (VP (VBN used) (PP (IN in) (NP (JJ similar) (NNS studies))) (S (VP (TO to) (VP (VB investigate) (NP (NP (NP (DT the) (JJ basic) (JJ neuronal) (NN mechanism)) (PP (IN of) (NP (DT this)))) (CC or) (NP (NP (JJ other) (NNS types)) (PP (IN of) (NP (JJ experimental) (NNS Doc_18657397_1566_1576_Disease)))))))))))) (. .)))
18674790	0	(ROOT (S (NP (JJ High) (JJ fat) (JJ diet-fed) (NN Doc_18674790_18_23_Disease) (NNS rats)) (VP (VBP are) (ADJP (RB highly) (JJ sensitive) (PP (TO to) (NP (NN Doc_18674790_53_64_Chemical-induced) (NNS Doc_18674790_73_87_Disease))))) (. .)))
18674790	1	(ROOT (S (ADVP (RB Often)) (, ,) (NP (NP (NN chemotherapy)) (PP (IN by) (NP (NP (NNS Doc_18674790_112_123_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_18674790_125_135_Chemical)) (-RRB- -RRB-))))) (VP (VBZ is) (ADJP (JJ limited)) (UCP (ADJP (JJ due) (PP (TO to) (NP (NP (NN life)) (VP (VBG threatening) (NP (NP (NNS Doc_18674790_172_186_Disease)) (PP (IN in) (NP (NNS patients)))) (PP (IN during)))))) (CC and) (ADVP (RB posttherapy)))) (. .)))
18674790	2	(ROOT (S (ADVP (RB Recently)) (, ,) (NP (PRP we)) (VP (VBP have) (VP (VBN shown) (SBAR (IN that) (S (NP (JJ moderate) (NN diet) (NN restriction) (NNS remarkably)) (VP (VBZ protects) (PP (IN against) (NP (NN Doc_18674790_306_317_Chemical-induced) (NNS Doc_18674790_326_340_Disease)))))))) (. .)))
18674790	3	(ROOT (S (NP (DT This) (NN cardioprotection)) (VP (VP (VBZ is) (VP (VBN accompanied) (PP (IN by) (NP (NP (VBN decreased) (JJ cardiac) (NN oxidative) (NN stress)) (CC and) (NP (NNS Doc_18674790_421_434_Chemical)))))) (CC and) (VP (VBD increased) (NP (NP (JJ cardiac) (JJ Doc_18674790_457_467_Chemical) (NN oxidation)) (, ,) (NP (JJ Doc_18674790_479_482_Chemical) (NN synthesis)) (, ,) (CC and) (NP (JJ upregulated) (NN JAK/STAT3) (NN pathway))))) (. .)))
18674790	4	(ROOT (S (PP (IN In) (NP (DT the) (JJ current) (NN study))) (, ,) (NP (PRP we)) (VP (VBD investigated) (SBAR (IN whether) (S (NP (NP (DT a) (JJ physiological) (NN intervention)) (PP (IN by) (S (VP (VBG feeding) (NP (CD 40) (NN %)) (NP (NP (ADJP (JJ high) (JJ fat)) (NN diet)) (PRN (-LRB- -LRB-) (NP (NNP HFD)) (-RRB- -RRB-)))))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ induces) (NP (NP (NNS Doc_18674790_654_661_Disease)) (PP (IN in) (NP (NP (JJ male) (JJ Sprague-Dawley) (NNS rats)) (PRN (-LRB- -LRB-) (NP (CD 250-275) (NNS g)) (-RRB- -RRB-)))))))) (, ,)) (VP (VBZ sensitizes) (PP (TO to) (NP (NN Doc_18674790_717_728_Chemical-induced) (NNS Doc_18674790_737_751_Disease))))))) (. .)))
18674790	5	(ROOT (S (NP (NP (DT A) (NNP LD) (PRN (-LRB- -LRB-) (NP (CD 10)) (-RRB- -RRB-)) (NN dose)) (PRN (-LRB- -LRB-) (NP (CD 8) (NNP mg) (NNS Doc_18674790_773_784_Chemical)) (: /) (NP (NP (NN kg)) (, ,) (NP (NN ip))) (-RRB- -RRB-))) (VP (VBN administered) (PP (IN on) (NP (NP (NN day) (CD 43)) (PP (IN of) (NP (NP (DT the) (NNP HFD) (NN feeding) (NN regimen)) (VP (VBN led) (PP (TO to) (NP (NP (JJR higher) (NNS Doc_18674790_857_871_Disease)) (, ,) (NP (NNS Doc_18674790_873_892_Disease)) (, ,) (NP (NN lipid) (NN peroxidation)) (, ,) (CC and) (NP (NP (ADJP (CD 80) (NN %)) (NN mortality)) (PP (IN in) (NP (DT the) (JJ Doc_18674790_939_944_Disease) (PRN (-LRB- -LRB-) (NP (NNP Doc_18674790_946_948_Disease)) (-RRB- -RRB-)) (NNS rats)))))) (PP (IN in) (NP (NP (DT the) (NN absence)) (PP (IN of) (NP (DT any) (JJ significant) (NNS Doc_18674790_989_1014_Disease))))))))))) (. .)))
18674790	6	(ROOT (S (NP (JJ Doc_18674790_1016_1027_Chemical) (NNS toxicokinetics) (NNS studies)) (VP (VBD revealed) (NP (DT no) (NN change)) (PP (IN in) (NP (NP (NN accumulation)) (PP (IN of) (NP (NP (NNS Doc_18674790_1089_1100_Chemical) (CC and) (NNS Doc_18674790_1105_1118_Chemical)) (PRN (-LRB- -LRB-) (NP (JJ toxic) (NN metabolite)) (-RRB- -RRB-)))))) (PP (IN in) (NP (NP (NP (DT the) (JJ normal) (NN diet-fed)) (PRN (-LRB- -LRB-) (NP (NNP ND)) (-RRB- -RRB-))) (CC and) (NP (JJ Doc_18674790_1170_1172_Disease) (NNS hearts))))) (. .)))
18674790	7	(ROOT (S (S (NP (JJ Mechanistic) (NNS studies)) (VP (VBD revealed) (SBAR (IN that) (S (NP (JJ Doc_18674790_1215_1217_Disease) (NNS rats)) (VP (VBP are) (VP (VBN sensitized) (S (ADJP (JJ due) (PP (TO to)))))))))) (: :) (S (LST (-LRB- -LRB-) (LS 1) (-RRB- -RRB-)) (NP (JJR higher) (NN oxyradical)) (VP (VBP stress) (S (VP (VBG leading) (PP (TO to) (NP (NP (NN upregulation)) (PP (IN of) (S (VP (VBG uncoupling) (NP (NP (NP (NNS proteins) (CD 2) (CC and) (CD 3)) (, ,) (NP (LST (-LRB- -LRB-) (LS 2) (-RRB- -RRB-)) (NP (NN downregulation)) (PP (IN of) (NP (NP (JJ cardiac) (NN peroxisome) (NNS proliferators)) (VP (VBN activated) (SBAR (S (NP (NP (NP (NN receptor-alpha)) (, ,) (NP (NP (LST (-LRB- -LRB-) (LS 3) (-RRB- -RRB-)) (VBN decreased) (NN plasma)) (NP (NP (NN adiponectin) (NNS levels)) (, ,) (NP (NP (LST (-LRB- -LRB-) (LS 4) (-RRB- -RRB-)) (VBN decreased) (NN cardiac)) (VP (VBN fatty-acid) (NP (NN oxidation)) (PRN (-LRB- -LRB-) (FRAG (NP (CD 666.9) (CD +)) (: /) (NP (NP (CD -14.0) (JJ nmol/min/g) (NN heart)) (PP (IN in) (NP (NNP ND))) (PP (IN versus) (NP (CD 400.2) (NNS +)))) (: /) (VP (VBN -11.8) (S (VP (VBG nmol/min/g) (NP (NN heart)) (PP (IN in) (NP (NNS Doc_18674790_1573_1575_Disease))))))) (-RRB- -RRB-)))))) (, ,)) (PRN (-LRB- -LRB-) (NP (CD 5)) (-RRB- -RRB-))) (VP (VBD decreased) (NP (ADJP (JJ mitochondrial) (JJ Doc_18674790_1606_1609_Chemical-alpha2)) (NN protein) (NN kinase)))))))))) (, ,) (CC and) (PRN (-LRB- -LRB-) (NP (CD 6)) (-RRB- -RRB-)) (NP (CD 86) (NN %)))))))) (NP (NP (NN drop)) (PP (IN in) (NP (NP (JJ cardiac) (JJ Doc_18674790_1661_1664_Chemical) (NNS levels)) (VP (VBN accompanied) (PP (IN by) (NP (NP (VBN decreased) (NNS Doc_18674790_1697_1700_Chemical)) (VP (VBG /) (NP (JJ Doc_18674790_1701_1704_Chemical) (NN ratio)) (PP (IN after) (NP (JJ Doc_18674790_1717_1728_Chemical) (NN administration)))))))))))))) (. .)))
18674790	8	(ROOT (S (NP (NP (JJ Decreased) (JJ cardiac) (NN erythropoietin)) (CC and) (NP (VBN increased) (NN SOCS3))) (ADVP (RB further)) (VP (VBD downregulated) (NP (DT the) (JJ cardioprotective) (NN JAK/STAT3)) (ADVP (RB pathway))) (. .)))
18674790	9	(ROOT (S (PP (IN In) (NP (NN conclusion))) (, ,) (NP (JJ HFD-induced) (JJ Doc_18674790_1887_1892_Disease) (NNS rats)) (VP (VBP are) (ADJP (RB highly) (JJ sensitized) (PP (TO to) (NP (NN Doc_18674790_1923_1934_Chemical-induced) (NNS Doc_18674790_1943_1957_Disease)))) (PP (IN by) (S (VP (VP (ADVP (RB substantially)) (VBG downregulating) (NP (JJ cardiac) (JJ mitochondrial) (JJ Doc_18674790_2012_2015_Chemical) (NN generation))) (, ,) (VP (VBG increasing) (NP (JJ oxidative) (NN stress))) (CC and) (VP (VBG downregulating) (NP (DT the) (NNP JAK/STAT3) (NN pathway))))))) (. .)))
18808529	0	(ROOT (S (NP (NNP Doc_18808529_0_13_Chemical)) (VP (VBZ induces) (NP (NP (NP (JJ primary) (NN loss)) (PP (IN of) (NP (NP (NN dystrophin)) (PP (IN in) (NP (NN rat) (NNS hearts)))))) (: :) (NP (NP (NN correlation)) (PP (IN with) (NP (NNS Doc_18808529_81_98_Disease)))))) (. .)))
18808529	1	(ROOT (S (S (NP (NP (DT The) (NN mechanism)) (PP (IN of) (NP (NN Doc_18808529_117_130_Chemical-induced) (NNS Doc_18808529_139_156_Disease)))) (VP (VBZ is) (ADJP (JJ unknown)))) (, ,) (CC but) (S (NP (NP (DT a) (NN mismatch)) (PP (IN of) (NP (NP (JJ Doc_18808529_187_193_Chemical) (NN supply)) (PP (IN vs.) (NP (NP (NN demand)) (PP (VBG following) (NP (JJ coronary) (NNS Doc_18808529_231_242_Disease) (CC and) (NNS Doc_18808529_247_271_Disease)))))))) (VP (VBZ is) (NP (NP (DT the) (JJS best) (NN explanation)) (PP (IN for) (NP (NP (DT the) (JJ complex) (JJ morphological) (NNS alterations)) (VP (VBN observed))))))) (. .)))
18808529	2	(ROOT (S (NP (NP (JJ Severe) (NNS alterations)) (PP (IN in) (NP (NP (DT the) (JJ structural) (NN integrity)) (PP (IN of) (NP (NP (DT the) (NN sarcolemma)) (PP (IN of) (NP (NNS cardiomyocytes)))))))) (VP (VBP have) (VP (VBN been) (VP (VBN demonstrated) (S (VP (TO to) (VP (VB be) (VP (VBN caused) (PP (IN by) (NP (NNS Doc_18808529_470_483_Chemical)))))))))) (. .)))
18808529	3	(ROOT (S (S (VP (VBG Taking) (PP (IN into) (NP (NN account))) (SBAR (IN that) (S (NP (DT the) (JJ sarcolemmal) (NN integrity)) (VP (VBZ is) (VP (VBN stabilized) (PP (IN by) (NP (NP (DT the) (JJ dystrophin-glycoprotein) (NN complex)) (PRN (-LRB- -LRB-) (NP (NNP DGC)) (-RRB- -RRB-)) (SBAR (WHNP (WDT that)) (S (VP (VBZ connects) (NP (NN actin) (CC and) (NN laminin)) (PP (PP (IN in) (NP (JJ contractile) (NN machinery) (CC and) (NN extracellular) (NN matrix))) (CC and) (PP (IN by) (NP (NNS integrins))))))))))))))) (, ,) (NP (DT this) (NN study)) (VP (VBZ tests) (NP (DT the) (NNS hypothesis)) (SBAR (IN that) (S (NP (NNS Doc_18808529_732_745_Chemical)) (VP (VP (VBZ affects) (NP (JJ sarcolemmal) (NN stability)) (PP (IN through) (NP (NP (NNS changes)) (PP (IN in) (NP (DT the) (NNP DGC)))))) (CC and) (VP (VBZ integrins)))))) (. .)))
18808529	4	(ROOT (S (NP (PRP We)) (VP (VBD found) (NP (NP (JJ different) (NN sensitivity)) (PP (IN of) (NP (DT the) (UCP (NP (NNP DGC)) (CC and) (ADJP (JJ integrin) (PP (TO to) (NP (JJ Doc_18808529_876_889_Chemical) (NNS subcutaneous))))) (NN administration))))) (. .)))
18808529	5	(ROOT (S (NP (JJ Immunofluorescent) (NN staining)) (VP (VBD revealed) (SBAR (IN that) (S (NP (NN dystrophin)) (VP (VBZ is) (NP (DT the) (ADJP (ADJP (RBS most) (JJ sensitive)) (PP (IN among) (NP (NP (DT the) (NNS structures)) (VP (VBG connecting) (NP (NP (DT the) (NN actin)) (PP (IN in) (NP (NP (DT the) (JJ cardiomyocyte) (NN cytoskeleton)) (CC and) (NP (DT the) (NN extracellular))))))))) (NN matrix)))))) (. .)))
18808529	6	(ROOT (S (NP (DT The) (JJ sarcomeric) (NN actin) (NN dissolution)) (VP (VBD occurred) (PP (IN after) (NP (NP (DT the) (NN reduction) (CC or) (NN loss)) (PP (IN of) (NP (NN dystrophin)))))) (. .)))
18808529	7	(ROOT (S (ADVP (RB Subsequently)) (, ,) (PP (IN after) (NP (NP (NNS lysis)) (PP (IN of) (NP (NNS myofilaments))))) (, ,) (NP (ADJP (JJ gamma-sarcoglycan) (, ,) (JJ beta-dystroglycan) (, ,) (JJ beta1-integrin) (, ,) (CC and) (JJ laminin) (JJ alpha-2)) (NNS expressions)) (VP (VBD were) (VP (VBN reduced) (PP (VBN followed) (PP (IN by) (NP (PRP$ their) (NN breakdown)))) (, ,) (PP (IN as) (NP (NP (NN epiphenomena)) (PP (IN of) (NP (DT the) (JJ myocytolytic) (NN process))))))) (. .)))
18808529	8	(ROOT (S (PP (IN In) (NP (NN conclusion))) (, ,) (NP (NP (NN administration)) (PP (IN of) (NP (NP (NNS Doc_18808529_1433_1446_Chemical)) (PP (TO to) (NP (NNS rats)))))) (VP (VBZ results) (PP (IN in) (NP (NP (NP (JJ primary) (NN loss)) (PP (IN of) (NP (NN dystrophin)))) (, ,) (NP (DT the) (ADJP (ADJP (RBS most) (JJ sensitive)) (PP (IN among) (NP (NP (DT the) (JJ structural) (NNS proteins)) (SBAR (WHNP (WDT that)) (S (VP (VBP form) (NP (NP (DT the) (NNP DGC)) (SBAR (WHNP (WDT that)) (S (VP (VBZ connects) (NP (DT the) (NN extracellular)))))))))))) (NN matrix)) (CC and) (NP (NP (DT the) (NN cytoskeleton)) (PP (IN in) (NP (NN cardiomyocyte))))))) (. .)))
18808529	9	(ROOT (S (NP (NP (DT These) (NNS changes)) (, ,) (VP (VBN related) (PP (TO to) (NP (NNS Doc_18808529_1665_1681_Disease)))) (, ,)) (VP (VBP explain) (NP (NP (DT the) (JJ severe) (NNS alterations)) (PP (IN in) (NP (NP (NP (DT the) (JJ structural) (NN integrity)) (PP (IN of) (NP (NP (DT the) (NN sarcolemma)) (PP (IN of) (NP (NP (NNS cardiomyocytes)) (CC and) (NP (RB hence) (JJ severe))))))) (CC and) (NP (NP (JJ irreversible) (NN injury)) (VP (VBN induced) (PP (IN by) (NP (NNS Doc_18808529_1830_1843_Chemical))))))))) (. .)))
188339	0	(ROOT (S (NP (NP (JJ Etiologic) (NNS factors)) (PP (IN in) (NP (NP (DT the) (NNS pathogenesis)) (PP (IN of) (NP (NNS Doc_188339_41_53_Disease)))))) (VP (VBN associated) (PP (IN with) (NP (NNS Doc_188339_70_89_Chemical)))) (. .)))
188339	1	(ROOT (S (PP (IN Within) (NP (DT the) (JJ last) (JJ several) (NNS years))) (, ,) (NP (ADJP (RB previously) (JJ rare)) (NNS Doc_188339_138_150_Disease)) (VP (VBP have) (VP (VBN been) (VP (VBN seen) (PP (IN in) (NP (JJ young) (NNS women))) (S (VP (VBG using) (NP (JJ Doc_188339_187_205_Chemical) (NNS Doc_188339_206_214_Chemical))))))) (. .)))
188339	2	(ROOT (S (NP (NP (DT The) (NN Registry)) (PP (IN for) (NP (NP (NNP Doc_188339_233_245_Disease) (NNP Associated)) (PP (IN with) (NP (NP (NNS Doc_188339_262_281_Chemical)) (PP (IN at) (NP (NP (DT the) (NNP University)) (PP (IN of) (NP (NNP California) (, ,) (NNP Irvine) (, ,)))))))))) (VP (VBZ has) (ADVP (RB clearly)) (VP (VBN identified) (NP (CD 27) (NNS cases)))) (. .)))
188339	3	(ROOT (S (NP (DT The) (JJ recent) (NN literature)) (VP (VBZ contains) (NP (CD 44) (NN case) (NNS reports))) (. .)))
188339	4	(ROOT (S (NP (NP (NNP Common)) (PP (TO to) (NP (DT these) (CD 71) (NNS cases)))) (VP (VBZ has) (VP (VBN been) (NP (NP (DT a) (JJ histopathologic) (NN diagnosis)) (PP (IN of) (NP (NNS Doc_188339_469_494_Disease) (, ,) (NNS Doc_188339_496_503_Disease) (, ,) (NNS Doc_188339_505_514_Disease) (, ,) (CC and) (NNS Doc_188339_520_528_Disease)))))) (. .)))
188339	5	(ROOT (S (NP (JJ Significant) (JJ statistical) (JJ etiologic) (NNS factors)) (VP (VBP include) (NP (NP (VBN prolonged) (JJ uninterrupted) (NN usage)) (PP (IN of) (NP (JJ Doc_188339_613_631_Chemical) (NNS Doc_188339_632_640_Chemical))))) (. .)))
188339	6	(ROOT (S (NP (NP (CD Eight) (NNS deaths) (CC and) (NN liver) (NNS Doc_188339_665_672_Disease)) (PP (IN in) (NP (CD 18) (NNS patients)))) (VP (VB attest) (PP (TO to) (NP (NP (DT the) (NN seriousness)) (PP (IN of) (NP (DT this) (JJ new) (ADJP (RB potentially) (JJ lethal)) (JJ adverse) (NN phenomenon)))))) (. .)))
1899352	0	(ROOT (S (VP (VB Doc_1899352_0_10_Chemical) (NP (JJ continuous) (NN infusion)) (PP (IN without) (NP (NNS Doc_1899352_39_44_Chemical)))) (. .)))
1899352	1	(ROOT (NP (NP (DT A) (NN phase) (NN I) (NN trial)) (PP (IN of) (NP (DT a) (JJ 14-day) (NN cycle))) (. .)))
1899352	2	(ROOT (S (NP (CD Twenty) (NNS patients)) (VP (VBD received) (NP (NP (CD 27) (NNS courses)) (PP (IN of) (NP (NP (NNS Doc_1899352_120_130_Chemical)) (VP (VBN administered) (PP (IN as) (NP (NP (DT a) (JJ 24-hour) (JJ continuous) (NN infusion)) (PP (IN for) (NP (CD 14) (NNS days))))) (PP (IN without) (NP (NNS Doc_1899352_197_202_Chemical)))))))) (. .)))
1899352	3	(ROOT (S (NP (NP (DT The) (NN goal)) (PP (IN of) (NP (DT the) (NN study)))) (VP (VBD was) (S (VP (TO to) (VP (VB deliver) (NP (NP (DT a) (NN dose) (NN rate) (CC and) (JJ total) (JJ cumulative) (NN dose)) (PP (IN of) (NP (NP (NNS Doc_1899352_282_292_Chemical)) (SBAR (WHNP (WDT that)) (S (VP (MD would) (VP (VB be) (ADJP (JJ comparable) (PP (TO to) (NP (NP (JJ standard) (NNS bolus)) (CC or) (NP (NP (JJ short-term) (NNS infusions)) (VP (VBN administered) (PP (IN with) (NP (NNS Doc_1899352_378_383_Chemical))))))))))))))))))) (. .)))
1899352	4	(ROOT (S (NP (JJ Dose) (NNS escalations)) (VP (VBD proceeded) (PP (IN from) (NP (NP (QP (CD 200) (TO to) (CD 300))) (, ,) (NP (NP (CD 400)) (, ,) (NP (CD 450)) (, ,) (NP (CD 500)) (, ,) (CC and) (NP (CD 550) (NNS mg/m2/d)))))) (. .)))
1899352	5	(ROOT (S (NP (CD Four) (NNS patients)) (VP (VBD developed) (NP (JJ transient) (JJ microscopic) (NNS Doc_1899352_507_516_Disease)) (PP (IN at) (NP (NP (CD 400)) (, ,) (NP (CD 450)) (, ,) (CC and) (NP (CD 500) (NNS mg/m2/d))))) (. .)))
1899352	6	(ROOT (S (NP (EX There)) (VP (VBD were) (NP (NP (DT no) (NNS instances)) (PP (IN of) (NP (JJ macroscopic) (NNS Doc_1899352_586_595_Disease))))) (. .)))
1899352	7	(ROOT (S (PP (IN At) (NP (CD 550) (NNS mg/m2/d))) (, ,) (NP (CD three) (NNS patients)) (VP (VBD experienced) (NP (NP (JJ nonurologic) (NNS Doc_1899352_652_660_Disease)) (: ;) (NP (NP (NP (NNS Doc_1899352_662_671_Disease)) (PRN (-LRB- -LRB-) (NP (CD 1)) (-RRB- -RRB-))) (, ,) (NP (NP (NNS Doc_1899352_677_683_Disease)) (PRN (-LRB- -LRB-) (NP (CD 1)) (-RRB- -RRB-))) (, ,) (CC and) (NP (NP (QP (CD Grade) (CD 2)) (NNS Doc_1899352_701_711_Disease)) (PRN (-LRB- -LRB-) (NP (CD 1)) (-RRB- -RRB-)))))) (. .)))
1899352	8	(ROOT (S (NP (NP (DT The) (VBN recommended) (NN dose)) (PP (IN of) (NP (CD 500) (NNS mg/m2/d)))) (VP (VBZ delivers) (NP (NP (DT a) (JJ total) (NN dose)) (PP (IN of) (NP (NP (CD 7) (NNS g/m2)) (PP (IN per) (NP (NP (NN cycle)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (ADJP (JJ comparable) (PP (TO to) (NP (NP (DT that)) (VP (VBN delivered) (PP (IN in) (NP (NP (JJ clinical) (NN practice)) (PP (IN for) (NP (NP (NNS bolus)) (CC or) (NP (JJ short-term) (NN infusion))))))))))))))))))) (. .)))
1899352	9	(ROOT (S (SBAR (IN Because) (S (NP (JJ few) (NNS patients)) (VP (VBD received) (NP (JJ multiple) (NNS courses)) (PP (IN over) (NP (NN time)))))) (, ,) (NP (DT the) (JJ cumulative) (NNS effects)) (VP (VBP are) (VP (VBG indeterminate) (PP (IN in) (NP (DT the) (JJ present) (NN trial))))) (. .)))
1899352	10	(ROOT (S (S (NP (NP (DT The) (NN frequency) (CC and) (NN predictability)) (PP (IN of) (NP (NNS Doc_1899352_1046_1055_Disease)))) (VP (VBP are) (RB not) (ADJP (JJ precise)))) (, ,) (CC and) (S (NP (NP (ADVP (IN at) (JJS least)) (JJ daily) (NN monitoring)) (PP (IN by) (NP (NNP urine) (NNP Hematest)))) (VP (VBZ is) (ADJP (JJ essential)))) (, ,) (S (VP (VBG adding) (NP (NNS Doc_1899352_1142_1147_Chemical)) (PP (TO to) (NP (NP (DT the) (NN infusate)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ persistent) (NNS Doc_1899352_1192_1201_Disease))))))))) (. .)))
1899352	11	(ROOT (S (NP (NP (DT The) (JJ protracted) (NN infusion) (NN schedule)) (PP (IN for) (NP (NNS Doc_1899352_1240_1250_Chemical)))) (VP (VP (VBZ permits) (NP (JJ convenient) (NN outpatient) (NN administration)) (PP (IN without) (NP (NNS Doc_1899352_1304_1309_Chemical)))) (CC and) (VP (VBZ reduces) (NP (NP (DT the) (NN drug) (NN cost)) (PP (IN of) (NP (NP (JJ clinical) (NN usage)) (PP (IN of) (NP (DT this) (NN agent)))))) (PP (IN by) (NP (NP (QP (IN up) (TO to) (CD 890))) (PP (IN per) (NP (NN cycle))))))) (. .)))
1899352	12	(ROOT (S (S (NP (JJ Clinical) (NN activity)) (VP (VBD was) (VP (VBN demonstrated) (PP (IN in) (NP (DT a) (JJ single) (NN patient)))))) (, ,) (CC but) (S (NP (NP (DT a) (JJ comparative) (NN trial)) (PP (IN of) (NP (NP (JJ standard) (NNS bolus) (NNS schedules)) (PP (IN with) (NP (DT the) (JJ protracted) (NN infusion) (NN schedule)))))) (VP (MD will) (VP (VB be) (ADJP (JJ necessary) (S (VP (TO to) (VP (VB determine) (SBAR (IN if) (S (NP (NP (DT the) (JJ clinical) (NN effectiveness)) (PP (IN of) (NP (DT the) (NN drug)))) (VP (VBZ is) (VP (VBN maintained)))))))))))) (. .)))
18997632	0	(ROOT (S (NP (NP (DT A) (NN case)) (PP (IN of) (NP (NNS Doc_18997632_10_33_Disease)))) (VP (VBN related) (PP (TO to) (NP (JJ Doc_18997632_45_53_Chemical) (NN pretreatment)))) (. .)))
18997632	1	(ROOT (S (NP (JJ Suboptimal) (JJ Doc_18997632_79_86_Disease) (NN duration)) (VP (VBZ is) (ADVP (RB commonly)) (VP (VBN encountered) (PP (PP (IN in) (NP (JJ electroconvulsive) (NN therapy) (NN practice))) (, ,) (RB especially) (PP (IN in) (NP (NP (JJR older) (NNS patients)) (PP (IN with) (NP (JJR higher) (JJ Doc_18997632_200_207_Disease) (NNS thresholds)))))))) (. .)))
18997632	2	(ROOT (S (NP (JJ Intravenous) (NNS Doc_18997632_232_240_Chemical)) (VP (VP (VBZ is) (ADVP (RB commonly)) (VP (VBN used) (S (VP (TO to) (VP (VB improve) (NP (JJ Doc_18997632_269_276_Disease) (NN duration) (CC and) (NN quality)) (PP (IN in) (NP (JJ such) (NNS patients)))))))) (CC and) (VP (VBZ is) (ADVP (RB generally)) (VP (ADVP (RB well)) (VBN tolerated) (PRT (RP aside)) (PP (IN from) (NP (NP (JJ occasional) (NNS reports)) (PP (IN of) (NP (ADJP (RB relatively) (JJ benign)) (NNS Doc_18997632_398_416_Disease)))))))) (. .)))
18997632	3	(ROOT (S (NP (PRP We)) (VP (VBP describe) (NP (NP (DT a) (NN patient)) (PP (IN with) (NP (NP (DT no) (JJ previous) (NN history)) (PP (IN of) (NP (NNS Doc_18997632_468_483_Disease) (CC or) (NNS Doc_18997632_487_497_Disease))))) (SBAR (WHNP (WP who)) (S (VP (VBD developed) (NP (NP (JJ sustained) (NN bigeminy)) (CC and) (NP (NP (CD 2) (JJ brief) (NNS runs)) (PP (IN of) (NP (NNS Doc_18997632_551_574_Disease))))) (PP (IN after) (NP (JJ Doc_18997632_581_589_Chemical) (NN administration)))))))) (. .)))
18997632	4	(ROOT (S (SBAR (IN Although) (S (NP (JJ intravenous) (NNS Doc_18997632_627_635_Chemical)) (VP (VBZ is) (ADVP (RB generally)) (ADJP (RB well) (JJ tolerated))))) (, ,) (NP (DT the) (NN clinician)) (VP (MD should) (VP (VB be) (ADJP (JJ aware) (PP (IN of) (NP (NP (DT the) (NN potential)) (PP (IN for) (NP (ADJP (JJ unpredictable) (CC and) (JJ serious)) (NNS Doc_18997632_742_765_Disease)))))))) (. .)))
19058474	0	(ROOT (S (NP (NP (JJ Fatal) (NN haemopericardium) (CC and) (NNS Doc_19058474_27_55_Disease)) (ADJP (JJ due) (PP (TO to) (NP (NP (JJ possible) (NN interaction)) (PP (IN of) (NP (NN cranberry))))))) (VP (NN juice) (PP (IN with) (NP (NNS Doc_19058474_108_116_Chemical)))) (. .)))
19058474	1	(ROOT (S (NP (PRP We)) (VP (VBP report) (NP (NP (DT a) (NN case)) (PP (IN of) (NP (JJ fatal) (JJ internal) (NNS Doc_19058474_153_164_Disease)))) (PP (IN in) (NP (NP (DT an) (JJ elderly) (NN man)) (SBAR (WHNP (WP who)) (S (VP (VBN consumed) (S (NP (QP (RB only) (CD cranberry))) (VP (NN juice) (PP (IN for) (NP (CD two) (NNS weeks))))) (PP (IN while) (S (VP (VBG maintaining) (NP (NP (PRP$ his) (JJ usual) (NN dosage)) (PP (IN of) (NP (NNS Doc_19058474_269_277_Chemical))))))))))))) (. .)))
19058474	2	(ROOT (S (NP (PRP We)) (VP (VBP propose) (SBAR (IN that) (S (NP (NP (ADJP (RB naturally) (VBG occurring)) (NNS compounds)) (PP (JJ such) (IN as) (NP (NNS Doc_19058474_333_343_Chemical))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP are) (ADJP (JJ present) (PP (IN in) (NP (NN fruit) (NNS juices))))))) (, ,)) (VP (MD may) (VP (VB increase) (NP (NP (DT the) (NN potency)) (PP (IN of) (NP (NNS Doc_19058474_408_416_Chemical)))) (PP (IN by) (S (VP (VBG competing) (PP (IN for) (NP (NP (DT the) (NNS enzymes)) (SBAR (WHNP (WDT that)) (S (ADVP (RB normally)) (VP (VBP inactivate) (NP (NNS Doc_19058474_471_479_Chemical))))))))))))))) (. .)))
19058474	3	(ROOT (S (SBAR (IN While) (S (ADVP (RB traditionally)) (VP (VBN regarded) (PP (IN as) (NP (NNS foodstuffs)))))) (, ,) (NP (NP (NN consumption)) (PP (IN of) (NP (NN fruit) (NNS juices)))) (VP (MD should) (VP (VB be) (VP (VBN considered) (SBAR (WHADVP (WRB when)) (S (NP (NNS patients)) (VP (VBP develop) (NP (JJ adverse) (NN drug) (NNS reactions)))))))) (. .)))
19105845	0	(ROOT (NP (NP (NN Effect)) (PP (IN of) (S (VP (VBG increasing) (NP (JJ intraperitoneal) (NN infusion) (NNS rates)) (PP (IN on) (NP (NP (NN Doc_19105845_55_78_Chemical-induced) (NNS Doc_19105845_87_95_Disease)) (PP (IN in) (NP (NNS mice)))))))) (. .)))
19105845	1	(ROOT (S (NP (PRP It)) (VP (VBZ is) (RB not) (VP (VBN known) (SBAR (IN if) (S (NP (EX there)) (VP (VBZ is) (NP (NP (DT a) (NN relationship)) (PP (IN between) (NP (NN input) (NN rate) (CC and) (NN incidence))) (PP (IN of) (NP (NN Doc_19105845_196_205_Chemical-induced) (NNS Doc_19105845_214_222_Disease))))))))) (. .)))
19105845	2	(ROOT (S (NP (DT This)) (VP (VBZ is) (ADJP (JJ important)) (, ,) (SBAR (IN since) (S (NP (NP (JJ different) (VBN controlled) (NN release) (NNS formulations)) (PP (IN of) (NP (NNS Doc_19105845_294_303_Chemical)))) (VP (VB release) (NP (DT the) (JJ active) (NN drug)) (PP (IN at) (NP (JJ different) (NNS rates))))))) (. .)))
19105845	3	(ROOT (S (NP (PRP We)) (VP (VBD investigated) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (VBG varying) (UCP (NP (NP (DT the) (JJ intraperitoneal) (NN infusion) (NNS rates)) (PP (IN of) (NP (NP (NNP Doc_19105845_433_446_Chemical) (CD 120) (NN mg/kg)) (, ,) (NP (NP (DT a) (JJ known) (JJ Doc_19105845_466_476_Disease) (NN dose)) (NP (NP (CD 50)) (PRN (-LRB- -LRB-) (NP (NNP CD50)) (-RRB- -RRB-))))))) (, ,) (PP (IN on) (NP (DT the) (NN incidence))) (CC and) (NP (NP (NN severity)) (PP (IN of) (NP (NP (NN Doc_19105845_526_535_Chemical-induced) (NNS Doc_19105845_544_555_Disease)) (PP (IN in) (NP (DT the) (JJ Swiss) (NN albino))))))) (NNS mice))))) (. .)))
19105845	4	(ROOT (S (NP (NP (DT A) (NN total)) (PP (IN of) (NP (NP (CD 69) (NNS mice)) (, ,) (NP (NP (QP (RB approximately) (CD 7)) (NNS weeks)) (PP (IN of) (NP (NN age)))) (, ,) (CC and) (S (VP (VBG weighing) (NP (QP (CD 21.0) (TO to) (CD 29.1)) (NN g))))))) (VP (VBD were) (VP (ADVP (RB randomly)) (VBN assigned) (PP (TO to) (NP (QP (CD Doc_19105845_686_699_Chemical) (CD 120)))) (S (VP (VBG mg/kg) (NP (NN treatment)) (PP (IN by) (NP (NP (JJ intraperitoneal) (PRN (-LRB- -LRB-) (NP (NNP IP)) (-RRB- -RRB-)) (NN administration)) (PP (IN in) (NP (NP (CD 7) (NNS groups)) (PRN (-LRB- -LRB-) (NP (NP (QP (CD 9) (TO to) (CD 10)) (NNS animals)) (PP (IN per) (NP (NN group)))) (-RRB- -RRB-)))))))))) (. .)))
19105845	5	(ROOT (S (NP (NNP Doc_19105845_800_813_Chemical)) (VP (VBD was) (VP (VBN infused) (PP (IN through) (NP (NP (DT a) (NNP surgically) (NNP implanted) (NNP IP) (VBG dosing) (NN catheter)) (PP (IN with) (NP (NP (NNS infusions)) (PP (IN in) (NP (NP (DT each) (NN group)) (PP (IN of) (NP (NP (CD 0) (NN min)) (, ,) (NP (CD 15) (NN min)) (, ,) (NP (CD 30) (NN min)) (, ,) (NP (CD 60) (NN min)) (, ,) (NP (CD 90) (NN min)) (, ,) (NP (CD 120) (NN min)) (, ,) (CC and) (NP (CD 240) (NN min)))))))))))) (. .)))
19105845	6	(ROOT (S (NP (NP (DT The) (NN number)) (, ,) (NP (NP (NN time)) (PP (IN of) (NP (NP (NN onset)) (, ,) (NP (NN duration)) (CC and) (NP (DT the) (NN intensity)))) (PP (IN of) (NP (NP (DT the) (NN Doc_19105845_1030_1041_Disease) (CC or) (NN absence)) (PP (IN of) (NP (NNS Doc_19105845_1056_1067_Disease))))))) (VP (VBD were) (VP (VBN recorded))) (. .)))
19105845	7	(ROOT (S (NP (DT The) (NNS results)) (VP (VBD showed) (NP (NP (DT that) (NNP IP) (NN administration)) (PP (IN of) (NP (NNP Doc_19105845_1137_1150_Chemical) (CD 120)))) (S (VP (VBG mg/kg) (PP (IN by) (NP (NP (JJ bolus) (NN injection)) (VP (VBN induced) (NP (NNS Doc_19105845_1188_1199_Disease)) (PP (IN in) (NP (NP (CD 6)) (PP (RB out) (IN of) (NP (NP (CD 10) (NNS mice)) (PRN (-LRB- -LRB-) (NP (NP (CD 60) (NN %)) (PP (IN of) (NP (VBG convulsing) (NNS mice)))) (-RRB- -RRB-))))))))))) (PP (IN in) (NP (NN group) (CD 1)))) (. .)))
19105845	8	(ROOT (S (S (NP (JJ Logistic) (NN regression) (NN analysis)) (VP (VBD revealed) (SBAR (IN that) (S (NP (NN infusion) (NN time)) (VP (VBD was) (ADJP (JJ significant))))))) (PRN (-LRB- -LRB-) (VP (VB p) (NP (NP (QP (CD =) (CD 0.0004))) (: ;) (NP (NP (NNS odds) (NN ratio)) (SBAR (S (VP (SYM =) (NP (CD 0.974)))))))) (-RRB- -RRB-)) (CC and) (S (S (VP (VBG increasing) (NP (NP (DT the) (NNP IP) (NN infusion) (NN time)) (PP (IN of) (NP (NNP Doc_19105845_1402_1415_Chemical) (CD 120) (NN mg/kg)))))) (VP (VBD was) (VP (VBN associated) (PP (IN with) (NP (NP (DT a) (ADJP (CD 91) (NN %)) (JJ reduced) (NNS odds)) (PP (IN of) (NP (NP (NNS Doc_19105845_1468_1479_Disease)) (PP (IN at) (NP (NP (NN infusion) (NNS times)) (PP (IN of) (NP (QP (CD 15) (TO to) (CD 90)) (NN min))))))))) (PP (VBN compared) (PP (TO to) (NP (JJ bolus) (NN injection))))))) (. .)))
19105845	9	(ROOT (S (NP (NP (JJ Further) (NN increase)) (PP (IN in) (NP (NN infusion) (NN time)))) (VP (VBD resulted) (PP (IN in) (NP (NP (JJ further) (NN reduction)) (PP (IN in) (NP (NP (DT the) (NNS odds)) (PP (IN of) (NP (NNS Doc_19105845_1622_1633_Disease))))))) (PP (TO to) (NP (NP (CD 99.8) (NN %) (NN reduction)) (PP (IN at) (NP (CD 240) (NN min)))))) (. .)))
19105845	10	(ROOT (S (PP (IN In) (NP (NN conclusion))) (, ,) (NP (NP (DT the) (NN demonstration)) (PP (IN of) (NP (NP (DT an) (JJ inverse) (NN relationship)) (PP (IN between) (NP (NP (NN infusion) (NN time)) (PP (IN of) (NP (NP (NP (DT a) (JJ fixed) (CC and) (JJ Doc_19105845_1774_1784_Disease) (NN dose)) (PP (IN of) (NP (NNS Doc_19105845_1793_1802_Chemical)))) (CC and) (NP (NP (DT the) (NN risk)) (PP (IN of) (NP (NP (NNS Doc_19105845_1819_1830_Disease)) (PP (IN in) (NP (DT a) (JJ prospective) (NN study))))))))))))) (VP (VBZ is) (ADJP (JJ novel))) (. .)))
19135948	0	(ROOT (S (NP (NP (JJ Doc_19135948_0_25_Disease) (NNS prophylaxis)) (PP (IN with) (NP (NNS Doc_19135948_43_53_Chemical) (CC and) (NNS Doc_19135948_58_68_Chemical)))) (VP (VBZ is) (VP (VBN associated) (PP (IN with) (NP (NP (NP (DT a) (JJ high) (NN incidence)) (PP (IN of) (NP (NNS Doc_19135948_108_139_Disease) (CC and) (NNS Doc_19135948_144_159_Disease)))) (: :) (NP (NP (NNS results)) (PP (IN of) (NP (DT the) (NNP EVTAC) (NN trial)))))))) (. .)))
19135948	1	(ROOT (S (NP (NP (DT A) (NN calcineurin) (NN inhibitor)) (PP (VBN combined) (PP (IN with) (NP (NNS Doc_19135948_227_239_Chemical))))) (VP (VBZ is) (NP (NP (DT the) (JJ standard) (NNS prophylaxis)) (PP (IN for) (NP (NP (NNS Doc_19135948_272_297_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_19135948_299_303_Disease)) (-RRB- -RRB-))))) (SBAR (IN after) (S (NP (JJ allogeneic) (NN hematopoietic)) (VP (VBP stem) (NP (NP (NN cell) (NN transplantation)) (PRN (-LRB- -LRB-) (NP (NNP HSCT)) (-RRB- -RRB-))))))) (. .)))
19135948	2	(ROOT (S (NP (NP (NNP Doc_19135948_370_380_Chemical)) (, ,) (NP (NP (DT a) (NN derivative)) (PP (IN of) (NP (NNS Doc_19135948_398_407_Chemical)))) (, ,)) (VP (VBZ seems) (S (VP (TO to) (VP (VB mediate) (NP (NN antileukemia) (NNS effects)))))) (. .)))
19135948	3	(ROOT (S (NP (PRP We)) (VP (VBP report) (PP (IN on) (NP (NP (DT a) (NN combination)) (PP (IN of) (NP (NNS Doc_19135948_478_488_Chemical) (CC and) (NNS Doc_19135948_493_503_Chemical))))) (PP (IN in) (S (NP (NP (NP (CD 24) (NNS patients)) (PRN (-LRB- -LRB-) (NP (JJ median) (NN age)) (, ,) (NP (CD 62) (NNS years)) (-RRB- -RRB-))) (PP (IN with) (NP (NP (DT either) (NNS Doc_19135948_554_578_Disease)) (PRN (-LRB- -LRB-) (NP (NP (NNS Doc_19135948_580_583_Disease)) (: ;) (NP (NP (NN n)) (SBAR (S (VP (SYM =) (NP (CD 17))))))) (-RRB- -RRB-)) (CC or) (NP (NNS Doc_19135948_596_618_Disease)) (PRN (-LRB- -LRB-) (NP (NP (NNS Doc_19135948_620_623_Disease)) (: ;) (NP (NP (NN n)) (SBAR (S (VP (SYM =) (NP (CD 7))))))) (-RRB- -RRB-))))) (VP (VBG undergoing) (NP (NP (NP (NP (JJ intensive) (NN conditioning)) (VP (VBN followed) (PP (IN by) (NP (NNP HSCT))) (PP (IN from) (ADJP (JJ related))))) (PRN (-LRB- -LRB-) (VP (VBN n) (S (VP (SYM =) (NP (CD 4))))) (-RRB- -RRB-))) (CC or) (NP (ADJP (ADJP (JJ unrelated)) (PRN (-LRB- -LRB-) (VP (VBN n) (S (VP (SYM =) (NP (CD 20))))) (-RRB- -RRB-))) (NNS donors))))))) (. .)))
19135948	4	(ROOT (S (S (NP (DT All) (NNS patients)) (VP (VBD engrafted))) (, ,) (CC and) (S (NP (RB only) (CD 1) (NN patient)) (VP (VBD experienced) (NP (NN grade) (NNP IV) (NNP Doc_19135948_798_807_Disease)))) (. .)))
19135948	5	(ROOT (S (S (NP (NP (CD Nine) (NNS patients)) (PRN (-LRB- -LRB-) (NP (CD 37) (NN %)) (-RRB- -RRB-))) (VP (VBD developed) (NP (JJ acute) (NN grade) (NNP II-IV) (NNP Doc_19135948_857_861_Disease)))) (, ,) (CC and) (S (NP (NP (CD 11)) (PP (IN of) (NP (NP (CD 17) (JJ evaluable) (NNS patients)) (PRN (-LRB- -LRB-) (NP (CD 64) (NN %)) (-RRB- -RRB-))))) (VP (VBD developed) (NP (JJ chronic) (JJ extensive) (NNS Doc_19135948_929_933_Disease)))) (. .)))
19135948	6	(ROOT (S (NP (NP (NNP Doc_19135948_935_977_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_19135948_979_982_Disease)) (-RRB- -RRB-))) (VP (VBD occurred) (PP (IN in) (NP (NP (CD 7) (NNS patients)) (PRN (-LRB- -LRB-) (NP (CD 29) (NN %)) (-RRB- -RRB-)))) (, ,) (PP (IN with) (NP (NP (CD 2) (NNS cases)) (PP (IN of) (NP (NNS Doc_19135948_1030_1049_Disease)))))) (. .)))
19135948	7	(ROOT (S (NP (DT The) (NN study)) (VP (VBD was) (VP (VBN terminated) (ADVP (RB prematurely)) (SBAR (IN because) (S (NP (NP (DT an) (JJ additional) (CD 6) (NNS patients)) (PRN (-LRB- -LRB-) (NP (CD 25) (NN %)) (-RRB- -RRB-))) (VP (VBD developed) (NP (NP (NP (NNS Doc_19135948_1137_1168_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_19135948_1170_1173_Disease)) (-RRB- -RRB-))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD was) (ADJP (JJ fatal) (PP (IN in) (NP (CD 2) (NNS cases))))))))))))) (. .)))
19135948	8	(ROOT (S (PP (IN With) (NP (NP (DT a) (JJ median) (NN follow-up)) (PP (IN of) (NP (CD 26) (NNS months))))) (, ,) (NP (DT the) (JJ 2-year) (JJ overall) (NN survival) (NN rate)) (VP (VBD was) (NP (CD 47) (NN %))) (. .)))
19135948	9	(ROOT (S (SBAR (IN Although) (S (NP (DT this) (JJ new) (NN combination)) (VP (VBZ appears) (S (VP (TO to) (VP (VB be) (ADJP (JJ effective) (PP (IN as) (NP (NP (DT a) (JJ prophylactic) (NN regimen)) (PP (IN for) (NP (JJ acute) (NNS Doc_19135948_1374_1378_Disease)))))))))))) (, ,) (NP (NP (DT the) (NN incidence)) (PP (IN of) (NP (NNS Doc_19135948_1397_1400_Disease) (CC and) (NNS Doc_19135948_1405_1408_Disease)))) (VP (VBZ is) (ADVP (RB considerably)) (VP (ADVP (JJR higher) (IN than)) (VBN seen) (PP (IN with) (NP (JJ other) (NNS regimens))))) (. .)))
19139001	0	(ROOT (S (NP (NP (JJ Longitudinal) (NN assessment)) (PP (IN of) (NP (NN air) (NN conduction)))) (VP (VBZ audiograms) (PP (IN in) (NP (NP (DT a) (NNP phase) (NNP III) (JJ clinical) (NN trial)) (PP (IN of) (NP (NNS Doc_19139001_86_109_Chemical) (CC and) (NNS Doc_19139001_114_122_Chemical))))) (PP (IN for) (NP (NP (NN prevention)) (PP (IN of) (NP (JJ sporadic) (NNS Doc_19139001_150_169_Disease)))))) (. .)))
19139001	1	(ROOT (S (NP (DT A) (NNP phase) (NNP III) (JJ clinical) (NN trial)) (VP (VBD assessed) (NP (NP (NP (DT the) (NN recurrence)) (PP (IN of) (NP (NP (NNS Doc_19139001_225_243_Disease)) (PP (IN after) (NP (NP (NN treatment)) (PP (IN for) (NP (NP (CD 36) (NNS months)) (PP (IN with) (NP (NP (NNS Doc_19139001_279_302_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_19139001_304_308_Chemical)) (-RRB- -RRB-))))))))))) (IN plus) (NP (NP (NNS Doc_19139001_315_323_Chemical)) (CC or) (NP (VBN matched) (NNS placebos))))) (. .)))
19139001	2	(ROOT (S (S (NP (JJ Temporary) (NNS Doc_19139001_355_367_Disease)) (VP (VBZ is) (NP (NP (DT a) (VBN known) (NNS Doc_19139001_379_387_Disease)) (PP (IN of) (NP (NP (NN treatment)) (PP (IN with) (NP (NNS Doc_19139001_406_410_Chemical)))))))) (, ,) (RB thus) (S (NP (DT a) (JJ comprehensive) (NN approach)) (VP (VBD was) (VP (VBN developed) (S (VP (TO to) (VP (VB analyze) (NP (JJ serial) (NN air) (NN conduction) (NNS audiograms)))))))) (. .)))
19139001	3	(ROOT (S (NP (DT The) (JJ generalized) (NN estimating) (NN equation) (NN method)) (VP (VBD estimated) (NP (NP (DT the) (JJ mean) (NN difference)) (PP (IN between) (NP (NN treatment) (NNS arms)))) (PP (IN with) (NP (NN regard))) (S (VP (TO to) (VP (VB change) (PP (IN in) (NP (NN air) (NN conduction) (JJ pure) (NN tone) (NNS thresholds))) (SBAR (IN while) (S (NP (NP (NN accounting)) (PP (IN for) (NP (JJ within-subject) (NN correlation)))) (ADJP (JJ due) (PP (TO to) (NP (NP (JJ repeated) (NNS measurements)) (PP (IN at) (NP (NNS frequencies)))))))))))) (. .)))
19139001	4	(ROOT (S (PP (VBN Based) (PP (IN on) (NP (CD 290) (NNS subjects)))) (, ,) (NP (EX there)) (VP (VBD was) (NP (NP (DT an) (JJ average) (NN difference)) (PP (IN of) (NP (NP (CD 0.50) (NN dB)) (PP (IN between) (NP (NP (NNS subjects)) (VP (VBN treated) (PP (IN with) (NP (NNP Doc_19139001_847_851_Chemical) (CC plus) (NNP Doc_19139001_857_865_Chemical))) (PP (VBN compared) (PP (IN with) (NP (NP (DT those)) (VP (VBN treated) (PP (IN with) (NP (NP (NP (NN placebo)) (PRN (-LRB- -LRB-) (NP (NP (CD 95) (NN %)) (NP (NP (NP (NN confidence) (NN interval)) (, ,) (NP (QP (CD -0.64) (TO to) (CD 1.63)) (NN dB))) (: ;) (NP (NP (NNP P)) (SBAR (S (VP (SYM =) (NP (CD 0.39)))))))) (-RRB- -RRB-))) (, ,) (VP (VBN adjusted) (PP (IN for) (NP (NP (NN baseline) (NNS values)) (, ,) (NP (NN age)) (, ,) (CC and) (NP (NNS frequencies)))))))))))))))))) (. .)))
19139001	5	(ROOT (S (PP (IN In) (NP (NP (DT the) (JJ normal) (NN speech) (NN range)) (PP (IN of) (NP (QP (CD 500) (TO to) (CD 3,000)) (NNS Hz))))) (, ,) (NP (NP (DT an) (VBN estimated) (NN difference)) (PP (IN of) (NP (NP (CD 0.99) (NN dB)) (PRN (-LRB- -LRB-) (NP (NP (CD -0.17)) (PP (TO to) (NP (NP (CD 2.14) (NN dB)) (: ;) (NP (NP (NNP P)) (SBAR (S (VP (SYM =) (NP (CD 0.09))))))))) (-RRB- -RRB-))))) (VP (VBD was) (VP (VBN detected))) (. .)))
19139001	6	(ROOT (S (NP (JJ Dose) (NN intensity)) (VP (VBD did) (RB not) (VP (VB add) (NP (NN information)) (PP (TO to) (NP (NNS models))))) (. .)))
19139001	7	(ROOT (S (NP (EX There)) (VP (VBD were) (NP (NP (NP (QP (CD 14) (IN of) (CD 151))) (PRN (-LRB- -LRB-) (NP (QP (CD 9.3) (NN %))) (-RRB- -RRB-)) (PP (IN in) (NP (NP (DT the) (NNP Doc_19139001_1224_1228_Chemical) (CC plus) (NNP Doc_19139001_1234_1242_Chemical) (NN group)) (CC and) (NP (NP (QP (CD 4) (IN of) (CD 139))) (PRN (-LRB- -LRB-) (NP (CD 2.9) (NN %)) (-RRB- -RRB-)) (PP (IN in) (NP (NP (DT the) (NN placebo) (NN group)) (SBAR (WHNP (WP who)) (S (VP (VBD experienced) (NP (NP (QP (IN at) (JJS least) (CD 15)) (JJ dB) (NN hearing) (NN reduction)) (PP (IN from) (NP (NN baseline)))) (PP (IN in) (NP (NP (QP (CD 2) (CC or) (JJR more)) (JJ consecutive) (NNS frequencies)) (PP (IN across) (NP (NP (DT the) (JJ entire) (NN range)) (VP (VBN tested))))))))))))))) (PRN (-LRB- -LRB-) (VP (VBN P) (S (VP (SYM =) (NP (CD 0.02))))) (-RRB- -RRB-)))) (. .)))
19139001	8	(ROOT (S (NP (NP (JJ Follow-up) (NN air) (NN conduction)) (VP (VBN done) (NP (QP (IN at) (JJS least) (CD 6)) (NNS months)) (PP (IN after) (NP (NP (NN end)) (PP (IN of) (NP (NN treatment))))))) (VP (VBD showed) (NP (DT an) (JJ adjusted) (JJ mean) (NN difference)) (PP (IN in) (NP (NP (NN hearing) (NNS thresholds)) (PP (IN of) (NP (NP (CD 1.08) (NN dB) (PRN (-LRB- -LRB-) (NP (NP (CD -0.81)) (PP (TO to) (NP (NP (CD 2.96) (NN dB)) (: ;) (NP (NNP P) (NNP =) (NNP 0.26))))) (-RRB- -RRB-))) (PP (IN between) (NP (NN treatment) (NNS arms)))))))) (. .)))
19139001	9	(ROOT (S (NP (EX There)) (VP (VBD was) (NP (NP (DT no) (JJ significant) (NN difference)) (PP (IN in) (NP (NP (DT the) (NN proportion)) (PP (IN of) (NP (NP (NNS subjects)) (PP (IN in) (NP (DT the) (NNP Doc_19139001_1698_1702_Chemical) (CC plus) (NNP Doc_19139001_1708_1716_Chemical) (NN group))))))) (SBAR (WHNP (WP who)) (S (VP (VBD experienced) (NP (ADJP (RB clinically) (JJ significant)) (NNS Doc_19139001_1762_1774_Disease)) (PP (VBN compared) (PP (IN with) (NP (DT the) (NN placebo) (NN group))))))))) (. .)))
19139001	10	(ROOT (S (NP (NP (DT The) (VBN estimated) (JJ attributable) (NN risk)) (PP (IN of) (NP (NP (NNS Doc_19139001_1843_1854_Disease)) (PP (IN from) (NP (NP (NN exposure)) (PP (TO to) (NP (DT the) (NN drug)))))))) (VP (VBZ is) (NP (CD 8.4) (NN %)) (PRN (-LRB- -LRB-) (NP (NP (CD 95) (NN %) (NN confidence) (NN interval)) (, ,) (NP (CD -2.0) (NN %))) (PP (TO to) (NP (NP (CD 18.8) (NN %)) (: ;) (NP (NP (NNP P) (NNP =)) (NP (CD 0.12))))) (-RRB- -RRB-))) (. .)))
19139001	11	(ROOT (S (NP (EX There)) (VP (VBZ is) (NP (NP (DT a) (ADJP (QP (CD <) (CD 2))) (NN dB) (NN difference)) (PP (IN in) (NP (NP (JJ mean) (NN threshold)) (PP (IN for) (NP (NP (NNS patients)) (VP (VBN treated) (PP (IN with) (NP (NNP Doc_19139001_2014_2018_Chemical) (CC plus) (NNP Doc_19139001_2024_2032_Chemical))) (PP (VBN compared) (PP (IN with) (NP (NP (DT those)) (VP (VBN treated) (PP (IN with) (NP (NN placebo)))))))))))))) (. .)))
19203554	0	(ROOT (NP (NP (JJ Proteinase) (JJ 3-antineutrophil) (JJ cytoplasmic) (NN antibody)) (: -) (NP (NP (PRN (-LRB- -LRB-) (NP (NNP PR3-ANCA)) (-RRB- -RRB-)) (JJ positive) (NN necrotizing)) (VP (VBN Doc_19203554_81_99_Disease) (PP (IN after) (S (VP (VBG restarting) (NP (JJ Doc_19203554_117_131_Chemical) (NN treatment))))))) (. .)))
19203554	1	(ROOT (S (NP (NP (DT A) (JJ 59-year-old) (NN woman)) (PP (IN with) (NP (NNS Doc_19203554_168_186_Disease)))) (VP (VBD developed) (NP (NNS Doc_19203554_197_205_Disease) (, ,) (NNS Doc_19203554_207_223_Disease) (, ,) (NNS Doc_19203554_225_237_Disease) (CC and) (NNS Doc_19203554_242_263_Disease)) (PP (IN after) (S (VP (VBG restarting) (PP (IN of) (NP (JJ Doc_19203554_284_298_Chemical) (NN treatment))))))) (. .)))
19203554	2	(ROOT (S (NP (NP (JJ Light) (NN microscopy)) (PP (IN of) (NP (DT a) (NN kidney) (NN biopsy)))) (VP (VBD revealed) (NP (NNS Doc_19203554_355_395_Disease)) (PP (IN without) (NP (NP (NN deposition)) (PP (IN of) (NP (NN immunoglobulin) (CC or) (NN complement)))))) (. .)))
19203554	3	(ROOT (S (S (NP (ADJP (JJ Proteinase) (JJ 3-antineutrophil)) (JJ cytoplasmic) (NN antibody) (PRN (-LRB- -LRB-) (NP (NNP PR3-ANCA)) (-RRB- -RRB-)) (NN titer)) (VP (VBD was) (VP (VBD elevated) (PP (IN at) (NP (NP (CD 183) (NNP ELISA) (NNS units)) (PRN (-LRB- -LRB-) (NP (NNP EU)) (-RRB- -RRB-)))) (PP (IN in) (NP (NN sera))) (PRN (-LRB- -LRB-) (NP (NP (JJ normal) (NN range)) (NP (NP (QP (JJR less) (IN than) (CD 10))) (NP (NNP EU)))) (-RRB- -RRB-))))) (, ,) (NP (NN myeloperoxidase-ANCA)) (VP (VBD was) (ADJP (JJ negative))) (. .)))
19203554	4	(ROOT (S (NP (NN PR3-ANCA) (NN titer)) (VP (VBD was) (NP (QP (CD 250) (CC and) (CD 1,070) (CD EU))) (PP (IN in) (NP (NP (NNS Doc_19203554_665_682_Disease)) (PP (IN on) (NP (ADJP (JJ right) (CC and) (JJ left)) (NN side))))) (, ,) (ADVP (RB respectively))) (. .)))
19203554	5	(ROOT (S (S (SBAR (IN Although) (S (NP (NP (NN cessation)) (PP (IN of) (NP (JJ Doc_19203554_743_757_Chemical) (NN treatment)))) (VP (VBD resulted) (PP (IN in) (NP (NNS improvements))) (PP (IN in) (NP (NP (NNS Doc_19203554_796_801_Disease)) (, ,) (NP (NNS Doc_19203554_803_811_Disease)) (, ,) (NP (NNS Doc_19203554_813_823_Disease)) (, ,) (NP (NP (NN titer)) (PP (IN of) (NP (JJ C-reactive) (NN protein)))) (CC and) (NP (NP (NN volume)) (PP (IN of) (NP (DT the) (NNS Doc_19203554_871_888_Disease)))))) (PRN (, ,) (S (NP (PRP we)) (VP (VBD initiated) (NP (JJ Doc_19203554_903_910_Chemical) (NN therapy)))) (, ,)) (SBAR (IN because) (S (NP (NN PR3-ANCA) (NN titer)) (VP (VBD rose) (PP (TO to) (NP (QP (CD 320) (CD EU)))))))))) (, ,) (NP (JJ eosinophil) (NN count)) (VP (VBD increased) (PP (TO to) (NP (CD 1,100) (NN cells/microl))))) (, ,) (CC and) (S (NP (DT the) (NNS Doc_19203554_1017_1033_Disease)) (VP (VBD remained))) (. .)))
19203554	6	(ROOT (S (NP (CD One) (NN month)) (S (PP (IN after) (NP (JJ Doc_19203554_1060_1067_Chemical) (NN therapy))) (, ,) (NP (DT the) (NNS Doc_19203554_1081_1097_Disease)) (VP (VBD disappeared))) (, ,) (CC and) (S (NP (NN PR3-ANCA) (NN titer)) (VP (VBD normalized) (NP (CD 3) (NNS months) (RB later)))) (. .)))
19203554	7	(ROOT (S (NP (DT This) (NN case)) (VP (VBZ suggests) (SBAR (IN that) (S (NP (NNS Doc_19203554_1181_1195_Chemical)) (VP (MD can) (VP (VB induce) (NP (NN PR3-ANCA-positive) (NN necrotizing) (NNS Doc_19203554_1237_1255_Disease))))))) (. .)))
19234905	0	(ROOT (NP (NP (NNP Comparison)) (PP (IN of) (NP (JJ unilateral) (NN pallidotomy) (CC and) (NN subthalamotomy) (NNS findings))) (PP (IN in) (NP (JJ advanced) (NNS Doc_19234905_77_107_Disease))) (. .)))
19234905	1	(ROOT (S (NP (NP (NP (DT A) (JJ prospective) (, ,) (JJ randomized) (, ,) (JJ double-blind) (NN pilot) (NN study)) (S (VP (TO to) (VP (VP (VB compare) (NP (NP (DT the) (NNS results)) (PP (IN of) (NP (JJ stereotactic) (JJ unilateral) (NN pallidotomy))))) (CC and) (VP (VB subthalamotomy) (PP (IN in) (NP (JJ advanced) (NNS Doc_19234905_254_284_Disease))))))) (PRN (-LRB- -LRB-) (NP (NNP Doc_19234905_286_288_Disease)) (-RRB- -RRB-))) (VP (VBG refractory) (PP (TO to) (NP (JJ medical) (NN treatment))))) (VP (VBD was) (VP (VBN designed))) (. .)))
19234905	2	(ROOT (S (NP (NP (NP (NP (CD Ten) (JJ consecutive) (NNS patients)) (PRN (-LRB- -LRB-) (FRAG (NP (NP (JJ mean) (NN age)) (, ,) (NP (CD 58.4) (JJ +) (NNS /))) (: -) (NP (NP (CD 6.8) (NNS years)) (: ;) (NP (NP (CD 7) (NNS men)) (, ,) (NP (CD 3) (NNS women))))) (-RRB- -RRB-))) (PP (IN with) (NP (JJ similar) (NNS characteristics))) (PP (IN at) (NP (DT the) (NN duration))) (PP (IN of) (NP (NP (NN disease)) (PRN (-LRB- -LRB-) (NP (JJ mean) (NN disease) (NN time)) (, ,) (NP (CD 8.4) (NNP +) (NNS /)) (, -) (NP (CD 3.5) (NNS years)) (-RRB- -RRB-)))) (, ,) (NP (NP (VBG disabling) (NN motor) (NNS fluctuations)) (PRN (-LRB- -LRB-) (NP (NP (NNP Hoehn) (NNP _) (NNP Yahr) (NN stage) (CD 3-5)) (PP (IN in) (NP (JJ off-drug) (NNS phases)))) (-RRB- -RRB-)))) (CC and) (NP (NN Doc_19234905_581_589_Chemical-induced) (NNS Doc_19234905_598_609_Disease))) (VP (VBD were) (VP (VBN selected))) (. .)))
19234905	3	(ROOT (S (S (NP (DT All) (NNS patients)) (VP (VBD had) (NP (JJ bilateral) (NNS symptoms)))) (CC and) (S (NP (PRP$ their) (JJ Doc_19234905_671_679_Chemical) (NN equivalent) (NN dosing)) (VP (VBD were) (VP (VBN analysed)))) (. .)))
19234905	4	(ROOT (S (NP (CD Six) (NNS patients)) (VP (VBD were) (VP (VBN operated) (PP (IN on) (IN in) (NP (NP (NP (DT the) (JJ globus) (NNS pallidus) (NN interna)) (PRN (-LRB- -LRB-) (NP (NNP GPi)) (-RRB- -RRB-))) (CC and) (NP (NP (CD four)) (PP (IN in) (NP (NP (DT the) (JJ subthalamic) (NN nucleus)) (PRN (-LRB- -LRB-) (NP (NNP STN)) (-RRB- -RRB-))))))))) (. .)))
19234905	5	(ROOT (S (NP (JJ Clinical) (NN evaluation)) (VP (VBD included) (SBAR (S (NP (NP (NP (NP (DT the) (NN use)) (PP (IN of) (NP (DT the) (NNP Unified) (NNP Doc_19234905_875_894_Disease) (NNP Rating) (NNP Scale)))) (PRN (-LRB- -LRB-) (NP (NNP UPDRS)) (-RRB- -RRB-)) (, ,) (NP (NNP Hoehn_Yahr) (NN score)) (CC and) (NP (NP (NNP Schwab) (NNP England) (NNS activities)) (PP (IN of) (NP (JJ daily) (NN living))))) (PRN (-LRB- -LRB-) (NP (NNP ADL)) (-RRB- -RRB-))) (VP (VP (VBP score) (PP (IN in) (NP (`` `) (NP (IN on)) ('' ') (: -)))) (CC and) (`` `) (ADVP (RB off)) (`` ') (: -) (VP (NP (NN drug) (NNS conditions)) (PP (IN before) (NP (NN surgery)))) (CC and) (VP (NP (CD 6) (NNS months)) (PP (IN after) (NP (NN surgery)))))))) (. .)))
19234905	6	(ROOT (S (NP (EX There)) (VP (VBD was) (NP (ADJP (RB statistically) (JJ significant)) (NN improvement)) (PP (IN in) (NP (NP (DT all) (JJ contralateral) (JJ major) (JJ Doc_19234905_1145_1157_Disease) (NN motor) (NNS signs)) (PP (IN in) (NP (NP (DT all) (NNS patients)) (VP (VBN followed) (PP (IN for) (NP (CD 6) (NNS months))))))))) (. .)))
19234905	7	(ROOT (S (NP (CD Doc_19234905_1209_1217_Chemical) (NN equivalent) (JJ daily) (NN intake)) (VP (VBD was) (ADVP (RB significantly)) (VP (VBN reduced) (PP (IN in) (NP (DT the) (NNP STN) (NN group))))) (. .)))
19234905	8	(ROOT (S (NP (NP (NNS Changes)) (PP (IN in) (NP (NP (NNS UPDRS)) (, ,) (NP (NNP Hoehn) (NNP _) (NNP Yahr)) (CC and) (NP (NNP Schwab) (NNP England) (NNP ADL) (NNS scores))))) (VP (VBD were) (ADJP (JJ similar) (PP (IN in) (NP (DT both) (NNS groups))))) (. .)))
19234905	9	(ROOT (S (NP (JJ Cognitive) (NNS functions)) (VP (VBD were) (ADJP (JJ unchanged) (PP (IN in) (NP (DT both) (NNS groups))))) (. .)))
19234905	10	(ROOT (S (S (NP (NNS Complications)) (VP (VBD were) (VP (VBN observed) (PP (IN in) (NP (CD two) (NNS patients)))))) (: :) (S (NP (PRP one)) (VP (VBD had) (NP (NP (DT a) (JJ left) (NNS Doc_19234905_1487_1509_Disease)) (SBAR (IN after) (S (NP (NP (NN pallidotomy)) (CC and) (NP (DT another) (NN one))) (VP (VBD developed) (NP (JJ left) (JJ hemiballistic) (NNS movements)) (NP (CD 3) (NNS days)) (PP (IN after) (NP (NP (NN subthalamotomy)) (SBAR (WHNP (WDT which)) (S (ADVP (RB partly)) (VP (VBN improved) (PP (IN within) (NP (CD 1)))))))))))) (NP (NN month)) (PP (IN with) (NP (NNP Doc_19234905_1653_1662_Chemical) (CD 1000))) (ADVP (RB mg/day)))) (. .)))
19234905	11	(ROOT (S (NP (NP (DT The) (NNS findings)) (PP (IN of) (NP (DT this) (NN study)))) (VP (VBP suggest) (SBAR (IN that) (S (NP (NP (NNS lesions)) (PP (IN of) (NP (NP (DT the) (JJ unilateral) (NN STN)) (CC and) (NP (NNP GPi))))) (VP (VBP are) (NP (ADJP (RB equally) (JJ effective)) (NN treatment)) (PP (IN for) (NP (NNS patients))) (PP (IN with) (NP (NP (JJ advanced) (NNS Doc_19234905_1813_1815_Disease)) (VP (VBN refractory) (PP (TO to) (NP (JJ medical) (NN treatment)))))))))) (. .)))
19274460	0	(ROOT (FRAG (FRAG (NP (NP (NNP DSMM) (NNP XI)) (NP (NN study))) (: :) (NP (NP (NN dose) (NN definition)) (PP (IN for) (NP (NP (JJ intravenous) (NNS Doc_19274460_47_63_Chemical)) (PP (IN in) (NP (NN combination))))) (PP (IN with) (NP (NNS Doc_19274460_84_94_Chemical))))) (: /) (FRAG (NP (NP (NNS Doc_19274460_95_108_Chemical)) (PP (IN for) (NP (NN remission) (NN induction)))) (PP (IN in) (NP (NNS patients))) (PP (IN with) (NP (ADJP (RB newly) (JJ diagnosed)) (NNS Doc_19274460_166_173_Disease)))) (. .)))
19274460	1	(ROOT (S (NP (DT A) (JJ clinical) (NN trial)) (VP (VBD was) (VP (VBN initiated) (S (VP (TO to) (VP (VB evaluate) (NP (NP (DT the) (JJ recommended) (NN dose)) (PP (IN of) (NP (NP (NNS Doc_19274460_242_258_Chemical)) (PP (IN in) (NP (NN combination)))))) (PP (IN with) (NP (NNS Doc_19274460_279_289_Chemical) (CC and) (NNS Doc_19274460_294_307_Chemical))) (PP (IN as) (NP (NN induction) (NN treatment))) (PP (IN before) (NP (NP (NN stem) (NN cell) (NN transplantation)) (PP (IN for) (NP (NP (JJR younger) (NNS patients)) (PP (IN with) (NP (NP (ADJP (RB newly) (JJ diagnosed)) (NNS Doc_19274460_406_422_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_19274460_424_426_Disease)) (-RRB- -RRB-))))))))))))) (. .)))
19274460	2	(ROOT (S (NP (JJ Thirty) (NNS patients)) (VP (VBD were) (VP (VBN treated) (PP (IN with) (NP (NP (CD three) (JJ 21-day) (NNS cycles)) (PP (IN of) (NP (NP (QP (CD Doc_19274460_486_496_Chemical) (CD 1.3)) (NN mg/m)) (PRN (-LRB- -LRB-) (NP (CD 2)) (-RRB- -RRB-)))))) (PP (IN on) (S (NP (NNS days) (CD 1) (, ,) (CD 4) (, ,) (CD 8) (, ,) (CC and) (CD 11)) (ADVP (CC plus)) (VP (VBG Doc_19274460_538_551_Chemical) (NP (NP (CD 40) (NN mg)) (PP (IN on) (NP (NP (DT the) (NN day)) (PP (IN of) (NP (NP (JJ Doc_19274460_572_582_Chemical) (NN injection)) (CC and) (NP (DT the) (NN day))))))) (PP (IN after) (NP (NP (IN plus) (NNS Doc_19274460_616_632_Chemical)) (PP (IN at) (NP (NP (CD 900)) (, ,) (NP (CD 1,200)) (, ,) (CC or) (NP (CD 1,500) (NN mg/m)) (PRN (-LRB- -LRB-) (NP (CD 2)) (-RRB- -RRB-)))))) (PP (IN on) (NP (NN day) (CD 1)))))))) (. .)))
19274460	3	(ROOT (S (NP (NP (DT The) (JJ maximum) (JJ tolerated) (NN dose)) (PP (IN of) (NP (NNS Doc_19274460_705_721_Chemical)))) (VP (VBD was) (VP (VBN defined) (PP (IN as) (NP (NP (CD 900) (NN mg/m)) (PRN (-LRB- -LRB-) (NP (CD 2)) (-RRB- -RRB-)))))) (. .)))
19274460	4	(ROOT (S (PP (IN At) (NP (DT this) (NN dose) (NN level))) (, ,) (NP (NP (CD 92) (NN %)) (PP (IN of) (NP (NNS patients)))) (VP (VBD achieved) (NP (ADVP (IN at) (JJS least)) (DT a) (JJ partial) (NN response))) (. .)))
19274460	5	(ROOT (S (NP (NP (DT The) (JJ overall) (NN response) (NN rate)) (VP (VBG -LSB-) (NP (NP (JJ complete) (NN response)) (PRN (-LRB- -LRB-) (NP (NNP CR)) (-RRB- -RRB-)) (PP (CC plus) (NP (NP (JJ partial) (NN response)) (PRN (-LRB- -LRB-) (NP (NNP PR)) (-RRB- -RRB-)) (VP (VBN -RSB-) (PP (IN across) (NP (DT all) (NN dose) (NNS levels))))))))) (VP (VBD was) (NP (CD 77) (NN %)) (, ,) (PP (IN with) (NP (DT a) (ADJP (CD 10) (NN %)) (NN CR) (NN rate)))) (. .)))
19274460	6	(ROOT (S (NP (DT No) (NN patient)) (VP (VBD experienced) (NP (JJ progressive) (NN disease))) (. .)))
19274460	7	(ROOT (S (NP (DT The) (ADJP (RBS most) (JJ frequent)) (JJ adverse) (NNS events)) (VP (VBD were) (NP (NP (NNS Doc_19274460_1036_1081_Disease)) (CONJP (RB as) (RB well) (IN as)) (NP (NNS Doc_19274460_1093_1103_Disease)))) (. .)))
19274460	8	(ROOT (S (NP (DT The) (NNS results)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NP (NNS Doc_19274460_1130_1140_Chemical)) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (NP (NNS Doc_19274460_1161_1177_Chemical)) (PP (IN at) (NP (NP (CD 900) (NN mg/m) (PRN (-LRB- -LRB-) (NP (CD 2)) (-RRB- -RRB-))) (CC and) (NP (NNS Doc_19274460_1197_1210_Chemical))))))))) (VP (VBZ is) (NP (NP (DT an) (JJ effective) (NN induction) (NN treatment)) (PP (IN for) (NP (NP (NNS patients)) (PP (IN with) (NP (ADJP (RB newly) (JJ diagnosed)) (NNS Doc_19274460_1281_1283_Disease))))) (SBAR (WHNP (WDT that)) (S (VP (VBZ warrants) (NP (JJ further) (NN investigation)))))))))) (. .)))
1928887	0	(ROOT (NP (NP (NP (JJ Doc_1928887_0_8_Chemical) (NN reversal)) (PP (IN of) (NP (NNS Doc_1928887_21_32_Disease)))) (ADJP (JJ due) (PP (TO to) (NP (JJ Doc_1928887_40_49_Chemical) (NNS Doc_1928887_50_58_Disease)))) (. .)))
1928887	1	(ROOT (S (NP (NP (DT The) (JJ hemodynamic) (NNS effects)) (PP (IN of) (NP (NP (NNS Doc_1928887_87_96_Chemical)) (CC and) (NP (JJ other) (NN Doc_1928887_107_118_Chemical-converting) (NN enzyme) (NNS inhibitors))))) (VP (MD may) (VP (VB be) (VP (VBN mediated) (PP (IN by) (NP (DT the) (JJ endogenous) (JJ opioid) (NN system)))))) (. .)))
1928887	2	(ROOT (S (NP (DT The) (JJ opioid) (NN antagonist) (NNS Doc_1928887_219_227_Chemical)) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB block) (CC or) (VB reverse) (NP (NP (DT the) (JJ Doc_1928887_267_278_Disease) (NNS actions)) (PP (IN of) (NP (NNS Doc_1928887_290_299_Chemical)))))))))) (. .)))
1928887	3	(ROOT (S (NP (PRP We)) (VP (VBP report) (NP (NP (DT a) (NN case)) (PP (IN of) (NP (DT an) (JJ intentional) (JJ Doc_1928887_336_345_Chemical) (NNS Doc_1928887_346_354_Disease))) (, ,) (VP (VBN manifested) (PP (IN by) (NP (JJ marked) (NNS Doc_1928887_377_388_Disease)))) (, ,) (SBAR (WHNP (WDT that)) (S (VP (VBN resolved) (ADVP (RB promptly)) (PP (IN with) (NP (NP (DT the) (NN administration)) (PP (IN of) (NP (NNS Doc_1928887_440_448_Chemical)))))))))) (. .)))
1928887	4	(ROOT (S (PP (TO To) (NP (PRP$ our) (NN knowledge))) (, ,) (NP (DT this)) (VP (VBZ is) (NP (NP (DT the) (JJ first) (JJ reported) (NN case)) (PP (IN of) (NP (NP (NN Doc_1928887_503_512_Chemical-induced) (NNS Doc_1928887_521_532_Disease)) (VP (VBN treated) (PP (IN with) (NP (NNS Doc_1928887_546_554_Chemical)))))))) (. .)))
1928887	5	(ROOT (S (NP (PRP$ Our) (NN experience)) (VP (VBZ demonstrates) (NP (NP (DT a) (JJ possible) (NN role)) (PP (IN of) (NP (NP (NNS Doc_1928887_603_611_Chemical)) (PP (IN in) (NP (NP (DT the) (NN reversal)) (PP (IN of) (NP (NP (NNS Doc_1928887_631_642_Disease)) (VP (VBG resulting) (PP (IN from) (NP (NNS Doc_1928887_658_667_Chemical)))))))))))) (. .)))
19289093	0	(ROOT (NP (NP (NNP Identification)) (PP (IN of) (NP (NP (DT a) (ADJP (JJ simple) (CC and) (JJ sensitive)) (NN microplate) (NN method)) (PP (IN for) (NP (NP (DT the) (NN detection)) (PP (IN of) (NP (JJ oversulfated) (NNS Doc_19289093_93_112_Chemical))))))) (PP (IN in) (NP (JJ Doc_19289093_116_123_Chemical) (NNS products))) (. .)))
19289093	1	(ROOT (S (NP (NNP Doc_19289093_134_141_Chemical)) (VP (VBZ is) (NP (NP (DT a) (ADJP (RB commonly) (JJ implemented)) (NN anticoagulant)) (VP (VBN used) (S (VP (TO to) (VP (VB treat) (NP (ADJP (RB critically) (JJ ill)) (NNS patients)))))))) (. .)))
19289093	2	(ROOT (S (ADVP (RB Recently)) (, ,) (NP (NP (DT a) (NN number)) (PP (IN of) (NP (NP (JJ commercial) (NNS lots)) (PP (IN of) (NP (JJ Doc_19289093_262_269_Chemical) (NNS products)))))) (VP (VBD were) (VP (VBN found) (S (VP (TO to) (VP (VB be) (VP (VBN contaminated) (PP (IN with) (NP (NP (DT an) (NP (NP (JJ oversulfated) (NNS Doc_19289093_330_349_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP OSCS)) (-RRB- -RRB-))) (NN derivative)) (SBAR (WHNP (WDT that)) (S (VP (MD could) (VP (VB elicit) (NP (DT a) (JJ Doc_19289093_388_399_Disease) (NN response)) (PP (IN in) (NP (NP (NNS pigs)) (PP (VBG following) (NP (DT a) (JJ single) (JJ high-dose) (NN infusion))))))))))))))))) (. .)))
19289093	3	(ROOT (S (S (VP (VBG Using) (NP (NP (DT both) (ADJP (VBN contaminated)) (NN heparin) (NNS products)) (CC and) (NP (DT the) (ADJP (RB synthetically) (VBN produced)) (NN derivative))))) (, ,) (NP (PRP we)) (VP (VBD showed) (SBAR (IN that) (S (NP (DT the) (NNS OSCS)) (VP (VBZ produces) (NP (NP (JJ dose-dependent) (NNS Doc_19289093_588_599_Disease)) (PP (IN in) (NP (NNS pigs)))))))) (. .)))
19289093	4	(ROOT (S (NP (NP (NP (DT The) (ADJP (RB no) (JJ observed)) (NN effect) (NN level)) (PRN (-LRB- -LRB-) (NP (NNP NOEL)) (-RRB- -RRB-))) (PP (IN for) (NP (DT this) (NN contaminant)))) (VP (VBZ appears) (S (VP (TO to) (VP (VB be) (ADJP (ADJP (RB approximately) (JJ 1mg/kg)) (, ,) (ADJP (JJ corresponding) (PP (TO to) (NP (NP (DT a) (NN contamination) (NN level)) (PP (IN of) (NP (QP (RB approximately) (CD 3)) (NN %))))))))))) (. .)))
19289093	5	(ROOT (S (NP (PRP We)) (ADVP (RB also)) (VP (VBD demonstrated) (SBAR (IN that) (S (NP (NNS OSCS)) (VP (MD can) (VP (VB be) (VP (VBN identified) (PP (IN in) (NP (NP (NN heparin) (NNS products)) (VP (VBG using) (NP (NP (DT a) (ADJP (JJ simple) (, ,) (JJ inexpensive) (, ,) (RB commercially) (JJ available)) (JJ heparin) (NN enzyme) (NN immunoassay) (PRN (-LRB- -LRB-) (NP (NNP EIA)) (-RRB- -RRB-)) (NN kit)) (SBAR (WHNP (WDT that)) (S (VP (VBZ has) (NP (NP (DT a) (NN limit)) (PP (IN of) (NP (NP (NN detection)) (PP (IN of) (NP (NP (QP (RB approximately) (CD 0.1)) (NN %)) (, ,) (ADVP (RB well) (PP (IN below) (NP (DT the) (NNP NOEL)))))))))))))))))))))) (. .)))
19289093	6	(ROOT (S (NP (DT This) (NN kit)) (VP (MD may) (VP (VB provide) (NP (DT a) (JJ useful) (NN method)) (S (VP (TO to) (VP (VB test) (NP (NP (JJ Doc_19289093_1039_1046_Chemical) (NNS products)) (PP (IN for) (NP (NN contamination)))) (PP (IN with) (NP (JJ oversulfated) (NNP GAG) (NNS derivatives)))))))) (. .)))
19300240	0	(ROOT (NP (NP (CD 5) (NN Doc_19300240_2_14_Chemical-induced) (NNS Doc_19300240_23_49_Disease)) (: :) (NP (DT a) (NN case) (NN report)) (. .)))
19300240	1	(ROOT (S (NP (NP (DT The) (NNS Doc_19300240_70_96_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_19300240_98_101_Disease)) (-RRB- -RRB-))) (VP (VBZ is) (ADVP (DT a) (RB recently)) (VP (VBN described) (NP (NP (JJ stress-mediated) (NNS Doc_19300240_143_165_Disease)) (VP (VBN characterized) (PP (IN by) (NP (JJ transient) (JJ wall-motion) (NNS abnormalities))) (S (VP (VBG involving) (NP (UCP (NP (DT the) (NN apex)) (CC and) (ADJP (JJ midventricle) (PP (IN with) (NP (NP (NNS Doc_19300240_260_272_Disease)) (PP (IN of) (NP (NP (DT the) (ADJP (JJ basal) (NN left)) (NN ventricular)) (PRN (-LRB- -LRB-) (NP (NNP LV)) (-RRB- -RRB-)))))))) (NNS segments)) (PP (IN without) (NP (JJ obstructive) (NNS Doc_19300240_337_364_Disease))))))))) (. .)))
19300240	2	(ROOT (S (NP (NNP Doc_19300240_366_380_Disease)) (VP (VBZ is) (RB not) (NP (NP (DT an) (JJ uncommon) (JJ adverse) (NN effect)) (PP (IN of) (NP (JJ chemotherapeutic) (NNS agents))))) (. .)))
19300240	3	(ROOT (S (ADVP (RB However)) (, ,) (NP (EX there)) (VP (VBP are) (NP (NP (DT no) (NNS reports)) (PP (IN of) (NP (JJ Doc_19300240_476_479_Disease) (ADJP (JJ secondary) (TO to) (JJ chemotherapeutic)) (NNS agents))))) (. .)))
19300240	4	(ROOT (S (NP (PRP We)) (VP (VBP describe) (NP (NP (DT the) (NN case)) (PP (IN of) (NP (NP (DT a) (NN woman)) (SBAR (WHNP (WP who)) (S (VP (VBD developed) (NP (DT the) (NN syndrome)) (PP (IN after) (NP (NN chemotherapy))) (PP (IN for) (NP (JJ metastatic) (NNS Doc_19300240_611_617_Disease)))))))))) (. .)))
19300240	5	(ROOT (S (NP (NP (DT A) (JJ 79-year-old) (NN woman)) (VP (VBN presented) (PP (IN with) (NP (JJ typical) (JJ Doc_19300240_662_670_Disease) (NNS Doc_19300240_671_681_Disease))))) (, ,) (VP (VBD elevated) (NP (JJ cardiac) (NNS enzymes)) (PP (IN with) (NP (JJ significant) (JJ ST-segment) (NNS abnormalities))) (PP (IN on) (NP (PRP$ her) (NN electrocardiogram)))) (. .)))
19300240	6	(ROOT (S (NP (PRP She)) (VP (VBD underwent) (NP (JJ recent) (NN chemotherapy)) (PP (IN with) (NP (NNS Doc_19300240_815_827_Chemical))) (PP (IN for) (NP (JJ metastatic) (NNS Doc_19300240_843_860_Disease)))) (. .)))
19300240	7	(ROOT (S (NP (NNP Echocardiography)) (VP (VBD revealed) (NP (NP (DT a) (JJ wall-motion) (NN abnormality)) (PP (VBG involving) (NP (NP (DT the) (ADJP (JJ apical) (CC and) (JJ periapical)) (NNS segments)) (SBAR (WHNP (WDT which)) (S (VP (VBD appeared) (NP (NNS Doc_19300240_974_982_Disease))))))))) (. .)))
19300240	8	(ROOT (S (NP (NNP Coronary)) (ADVP (RB angiography)) (VP (VBD revealed) (NP (DT no) (JJ obstructive) (JJ coronary) (NNS lesions))) (. .)))
19300240	9	(ROOT (S (NP (DT The) (NN patient)) (VP (VBD was) (VP (VBN stabilized) (PP (IN with) (NP (JJ medical) (NN therapy))))) (. .)))
19300240	10	(ROOT (S (NP (CD Four) (NNS weeks) (RB later)) (NP (PRP she)) (VP (VBD remained) (ADJP (RB completely) (JJ asymptomatic))) (. .)))
19300240	11	(ROOT (S (NP (NNP Echocardiogram)) (VP (VBD revealed) (NP (NP (DT a) (JJ normal) (NN ejection) (NN fraction)) (CC and) (NP (NP (DT a) (NN resolution)) (PP (IN of) (NP (DT the) (JJ apical) (NNS akinesis)))))) (. .)))
19300240	12	(ROOT (S (NP (NP (JJ Pathogenetic) (NNS mechanisms)) (PP (IN of) (NP (NP (NNS Doc_19300240_1270_1291_Disease)) (PP (IN in) (NP (NP (JJ Doc_19300240_1295_1301_Disease) (NNS patients)) (VP (VBG undergoing) (ADVP (RB chemotherapy)))))))) (VP (VBP include) (NP (JJ Doc_19300240_1343_1361_Disease) (, ,) (JJ endothelial) (NN damage) (CC and) (JJ consequent) (NNS Doc_19300240_1397_1405_Disease) (NN formation))) (. .)))
19300240	13	(ROOT (S (PP (IN In) (NP (PRP$ our) (NN patient))) (, ,) (NP (NP (DT both) (JJ supraphysiologic) (NNS levels)) (PP (IN of) (NP (NP (NN plasma) (NNS Doc_19300240_1472_1486_Chemical)) (CC and) (NP (NP (NN stress) (VBN related) (NNS neuropeptides)) (VP (VBN caused) (PP (IN by) (NP (NP (JJ Doc_19300240_1530_1536_Disease) (NN diagnosis)) (CONJP (RB as) (RB well) (IN as)) (NP (NN chemotherapy))))))))) (VP (MD may) (VP (VB have) (VP (VBN contributed) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (NNS Doc_19300240_1611_1614_Disease))))))) (. .)))
19319147	0	(ROOT (S (NP (NP (NNP Rapid) (NN reversal)) (PP (IN of) (NP (NN anticoagulation)))) (VP (VBZ reduces) (NP (JJ Doc_19319147_42_52_Disease) (NN volume)) (PP (IN in) (NP (NP (DT a) (NN mouse) (NN model)) (PP (IN of) (NP (NN Doc_19319147_80_88_Chemical-associated) (NNS Doc_19319147_100_124_Disease)))))) (. .)))
19319147	1	(ROOT (S (NP (NP (JJ Doc_19319147_126_134_Chemical-associated) (NNS Doc_19319147_146_170_Disease)) (PRN (-LRB- -LRB-) (NP (NNP W-ICH)) (-RRB- -RRB-))) (VP (VBZ is) (NP (NP (DT a) (JJ severe) (NN type)) (PP (IN of) (NP (NNS Doc_19319147_199_205_Disease))))) (. .)))
19319147	2	(ROOT (S (NP (EX There)) (VP (VBZ is) (NP (NP (DT no) (NN consensus)) (PP (IN on) (NP (NP (DT the) (JJ optimal) (NN treatment)) (PP (IN for) (NP (NNP W-ICH))))))) (. .)))
19319147	3	(ROOT (S (S (VP (VBG Using) (NP (DT a) (NN mouse) (NN model)))) (, ,) (NP (PRP we)) (VP (VBD tested) (SBAR (IN whether) (S (NP (NP (DT the) (JJ rapid) (NN reversal)) (PP (IN of) (NP (NP (NN anticoagulation)) (VP (VBG using) (NP (JJ human) (NN prothrombin) (NN complex)))))) (VP (VBP concentrate) (SBAR (S (-LRB- -LRB-) (NP (NNS Doc_19319147_387_390_Chemical)) (-RRB- -RRB-) (VP (MD can) (VP (VB reduce) (NP (JJ hemorrhagic) (NN blood) (NN volume)))))))))) (. .)))
19319147	4	(ROOT (S (NP (JJ Male) (NN CD-1) (NNS mice)) (VP (VBD were) (VP (VBN treated) (PP (IN with) (NP (NP (NNS Doc_19319147_462_470_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (CD 2) (NN mg/kg)) (PP (IN over) (NP (CD 24) (NN h)))) (-RRB- -RRB-)))) (, ,) (S (VP (VBG resulting) (PP (IN in) (NP (NP (DT a) (NN mean)) (PRN (-LRB- -LRB-) (NP (NNP +) (NNP /)) (, -) (NP (NNP s.d.)) (-RRB- -RRB-)))) (NP (NP (NNP International) (NNP Normalized) (NNP Ratio)) (PP (IN of) (NP (NP (QP (CD 3.5) (CD +))) (PRN (: /) (NP (CD -0.9)))))))))) (. .)))
19319147	5	(ROOT (S (ADVP (RB First)) (, ,) (NP (PRP we)) (VP (VBD showed) (SBAR (IN that) (S (NP (NP (DT an) (JJ intravenous) (NN administration)) (PP (IN of) (NP (JJ human) (NNS Doc_19319147_628_631_Chemical)))) (ADVP (RB rapidly)) (VP (VBD reversed) (NP (NN anticoagulation)) (PP (IN in) (NP (NNS mice))))))) (. .)))
19319147	6	(ROOT (S (ADVP (LS Second)) (, ,) (NP (NP (DT a) (JJ stereotactic) (NN injection)) (PP (IN of) (NP (NN collagenase)))) (VP (VBD was) (VP (VBN administered) (S (VP (TO to) (VP (VB induce) (NP (NNS Doc_19319147_749_759_Disease)) (PP (IN in) (NP (DT the) (JJ right) (NN striatum)))))))) (. .)))
19319147	7	(ROOT (S (NP (CD Forty-five) (NNS minutes) (RB later)) (, ,) (NP (DT the) (NNS animals)) (VP (VBD were) (ADVP (RB randomly)) (VP (VBN treated) (PP (IN with) (NP (NP (NP (NNS Doc_19319147_848_851_Chemical)) (PRN (-LRB- -LRB-) (NP (QP (CD 100) (CD U/kg))) (-RRB- -RRB-))) (CC or) (NP (NP (JJ saline) (NN i.v.)) (PRN (-LRB- -LRB-) (VP (VBN n) (S (VP (SYM =) (NP (CD 12)))) (PP (IN per) (NP (NN group)))) (-RRB- -RRB-))))))) (. .)))
19319147	8	(ROOT (S (NP (NP (JJ Twenty-four) (NNS hours)) (PP (IN after) (NP (NP (JJ Doc_19319147_920_930_Disease) (NN induction)) (, ,) (NP (JJ hemorrhagic) (NN blood) (NN volume))))) (VP (VBD was) (VP (VBN quantified) (S (VP (VBG using) (NP (DT a) (JJ photometric) (NN hemoglobin) (NN assay)))))) (. .)))
19319147	9	(ROOT (S (NP (DT The) (JJ mean) (JJ hemorrhagic) (NN blood) (NN volume)) (VP (VBD was) (VP (VBN reduced) (PP (IN in) (NP (NP (NP (NN Doc_19319147_1069_1072_Chemical-treated) (NNS animals)) (PRN (-LRB- -LRB-) (NP (CD 6.5) (NNS +)) (: /) (NP (NP (CD -3.1)) (NP (NN microL))) (-RRB- -RRB-))) (PP (VBN compared) (PP (IN with) (NP (JJ saline) (NNS controls)))) (PRN (-LRB- -LRB-) (NP (CD 15.3) (NNS +)) (: /) (NP (NP (CD -11.2) (NN microL)) (, ,) (NP (NNP P) (NNP =) (NNP 0.015))) (-RRB- -RRB-)))))) (. .)))
19319147	10	(ROOT (S (PP (IN In) (NP (DT the) (JJ saline) (NN group))) (, ,) (NP (NP (CD 45) (NN %)) (PP (IN of) (NP (DT the) (NNS mice)))) (VP (VBD developed) (NP (NP (JJ large) (NNS Doc_19319147_1222_1231_Disease)) (PRN (-LRB- -LRB-) (FW i.e.) (, ,) (ADJP (NP (NNP >) (CD 15)) (JJ microL)) (-RRB- -RRB-)))) (. .)))
19319147	11	(ROOT (S (PP (IN In) (NP (NN contrast))) (, ,) (NP (JJ such) (JJ extensive) (NNS lesions)) (VP (VBD were) (ADVP (RB never)) (VP (VBN found) (PP (IN in) (NP (DT the) (NNP PCC) (NN group))))) (. .)))
19319147	12	(ROOT (S (NP (PRP We)) (VP (VBP provide) (NP (NP (JJ experimental) (NNS data)) (VP (VBG suggesting) (NP (NNS Doc_19319147_1363_1366_Chemical)) (S (VP (TO to) (VP (VB be) (NP (NP (DT an) (ADJP (JJ effective) (JJ acute)) (NN treatment)) (PP (IN for) (NP (NNP W-ICH))) (PP (IN in) (NP (NP (NNS terms)) (PP (IN of) (S (VP (VBG reducing) (NP (JJ hemorrhagic) (NN blood) (NN volume)))))))))))))) (. .)))
19319147	13	(ROOT (S (NP (JJ Future) (NNS studies)) (VP (VBP are) (VP (VBN needed) (S (VP (TO to) (VP (VB assess) (NP (NP (DT the) (JJ therapeutic) (NN potential)) (VP (VBG emerging) (PP (IN from) (NP (NP (PRP$ our) (NN finding)) (PP (IN for) (NP (JJ human) (NNS W-ICH)))))))))))) (. .)))
19370593	0	(ROOT (NP (NP (JJ Long) (NN term) (NN hormone) (NN therapy)) (PP (IN for) (NP (ADJP (JJ perimenopausal) (CC and) (JJ postmenopausal)) (NNS women))) (. .)))
19370593	1	(ROOT (S (NP (NP (JJ Hormone) (NN therapy)) (PRN (-LRB- -LRB-) (NP (NNP HT)) (-RRB- -RRB-))) (VP (VP (VBZ is) (ADVP (RB widely)) (VP (VBN used) (PP (IN for) (NP (VBG controlling) (JJ menopausal) (NNS symptoms))))) (CC and) (VP (VBZ has) (ADVP (RB also)) (VP (VBN been) (VP (VBN used) (PP (IN for) (NP (NP (DT the) (NN management) (CC and) (NN prevention)) (PP (IN of) (NP (NNS Doc_19370593_215_237_Disease) (, ,) (NNS Doc_19370593_239_251_Disease) (CC and) (NNS Doc_19370593_256_264_Disease))))) (PP (IN in) (NP (JJR older) (NNS women))))))) (. .)))
19370593	2	(ROOT (S (NP (DT This)) (VP (VBZ is) (NP (NP (DT an) (VBN updated) (NN version)) (PP (IN of) (NP (NP (DT the) (JJ original) (NNP Cochrane) (NN review)) (VP (ADVP (RB first)) (VBN published) (PP (IN in) (NP (CD 2005)))))))) (. .)))
19370593	3	(ROOT (S (VP (TO To) (VP (VB assess) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (JJ long-term) (NNP HT)))) (PP (IN on) (NP (NP (NN mortality)) (, ,) (NP (JJ cardiovascular) (NNS outcomes)) (, ,) (NP (NNS Doc_19370593_453_459_Disease)) (, ,) (NP (NNS Doc_19370593_461_480_Disease)) (, ,) (NP (NN cognition)) (, ,) (NP (NNS Doc_19370593_493_502_Disease)) (CC and) (NP (NP (NN quality)) (PP (IN of) (NP (NN life)))))))) (. .)))
19370593	4	(ROOT (NP (NP (NNP SEARCH) (NNP STRATEGY)) (: :) (S (NP (PRP We)) (VP (VBD searched) (NP (DT the) (NP (NP (VBG following) (NNS databases)) (PP (TO to) (NP (NNP November) (CD 2007)))) (: :) (NP (NP (NNP Trials) (NNP Register)) (PP (IN of) (NP (DT the) (NNP Cochrane) (NNP Doc_19370593_627_646_Disease) (CC and) (NNP Subfertility) (NNP Group)))) (, ,) (NP (NP (NNP Cochrane) (NNP Central) (NNP Register)) (PP (IN of) (NP (NNP Controlled) (NNP Trials) (, ,) (NNP MEDLINE) (, ,) (NNP EMBASE) (, ,) (JJ Biological) (NNP Abstracts))))))) (. .)))
19370593	5	(ROOT (S (ADVP (RB Also)) (NP (JJ relevant) (JJ non-indexed) (NNS journals) (CC and) (NN conference)) (VP (VBZ abstracts)) (. .)))
19370593	6	(ROOT (NP (NP (NNP SELECTION) (NNP CRITERIA)) (: :) (NP (NP (JJ Randomised) (JJ double-blind) (NNS trials)) (PP (IN of) (NP (NNP HT) (CC versus) (NNP placebo))) (, ,) (VP (VBN taken) (PP (IN for) (NP (QP (IN at) (JJS least) (CD one)))) (NP (NN year)) (PP (IN by) (NP (JJ perimenopausal) (CC or) (JJ postmenopausal) (NNS women))))) (. .)))
19370593	7	(ROOT (S (NP (NNP HT)) (VP (VBD included) (NP (NNS Doc_19370593_975_985_Chemical)) (, ,) (PP (IN with) (CC or) (IN without) (NP (NNS progestogens))) (, ,) (PP (IN via) (NP (JJ oral) (, ,) (ADJP (JJ transdermal) (, ,) (JJ subcutaneous) (CC or) (JJ transnasal)) (NNS routes)))) (. .)))
19370593	8	(ROOT (NP (NP (NNP DATA) (NNP COLLECTION) (CC AND) (NNP ANALYSIS)) (: :) (NP (NP (CD Two) (NNS authors)) (VP (VP (ADVP (RB independently)) (VBN assessed) (NP (NN trial) (NN quality))) (CC and) (VP (VBN extracted) (NP (NNS data))))) (. .)))
19370593	9	(ROOT (NP (NP (NNP MAIN) (NNP RESULTS)) (: :) (NP (NP (JJ Nineteen) (NNS trials)) (VP (VBG involving) (NP (NP (CD 41,904) (NNS women)) (SBAR (S (VP (VBD were) (VP (VBN included)))))))) (. .)))
19370593	10	(ROOT (S (PP (IN In) (NP (ADJP (RB relatively) (JJ healthy)) (NNS women))) (, ,) (NP (JJ combined) (JJ continuous) (NN HT)) (ADVP (RB significantly)) (VP (VBD increased) (NP (NP (NP (DT the) (NN risk)) (PP (IN of) (NP (NNS Doc_19370593_1330_1353_Disease)))) (CC or) (NP (NP (NP (JJ coronary) (NN event)) (PRN (-LRB- -LRB-) (PP (IN after) (NP (NP (CD one) (NN year) (POS 's)) (NN use))) (-RRB- -RRB-)) (, ,) (NP (NNS Doc_19370593_1396_1402_Disease))) (PRN (-LRB- -LRB-) (PP (IN after) (NP (CD three) (NNS years))) (-RRB- -RRB-)) (, ,) (NP (NNS Doc_19370593_1424_1437_Disease)) (CC and) (NP (NNS Doc_19370593_1442_1461_Disease))))) (. .)))
19370593	11	(ROOT (S (NP (JJ Long-term) (NN Doc_19370593_1473_1482_Chemical-only) (NNP HT)) (ADVP (RB significantly)) (VP (VP (VBD increased) (NP (DT the) (NN risk)) (PP (IN of) (NP (NNS Doc_19370593_1527_1550_Disease) (, ,) (NNS Doc_19370593_1552_1558_Disease) (CC and) (NNS Doc_19370593_1563_1582_Disease))) (PRN (-LRB- -LRB-) (PP (PP (IN after) (NP (NP (QP (CD one) (TO to) (CD two)) (NNS years)) (, ,) (NP (CD three) (NNS years)) (CC and) (NP (NP (CD seven) (NNS years) (POS ')) (NN use)))) (ADVP (RB respectively))) (-RRB- -RRB-))) (, ,) (CC but) (VP (VBD did) (RB not) (VP (ADVP (RB significantly)) (VB increase) (NP (NP (DT the) (NN risk)) (PP (IN of) (NP (NNS Doc_19370593_1703_1716_Disease))))))) (. .)))
19370593	12	(ROOT (S (NP (NP (DT The) (ADJP (RB only) (RB statistically) (JJ significant)) (NNS benefits)) (PP (IN of) (NP (NNP HT)))) (VP (VBD were) (NP (NP (DT a) (VBN decreased) (NN incidence)) (PP (IN of) (NP (NP (NNS Doc_19370593_1798_1807_Disease)) (CC and) (PRN (-LRB- -LRB-) (PP (IN for) (NP (JJ combined) (NNP HT))) (-RRB- -RRB-)) (NP (NNS Doc_19370593_1830_1842_Disease))))) (, ,) (PP (IN with) (NP (JJ long-term) (NN use)))) (. .)))
19370593	13	(ROOT (S (PP (IN Among) (NP (NP (NNS women)) (VP (VP (VBN aged) (PP (IN over) (NP (NP (CD 65)) (SBAR (WHNP (WP who)) (S (VP (VBD were) (ADJP (RB relatively) (JJ healthy)) (PRN (-LRB- -LRB-) (S (NP (NNP i.e.)) (VP (ADVP (RB generally)) (VBP fit) (, ,) (PP (IN without) (NP (JJ overt) (NN disease))))) (-RRB- -RRB-)))))))) (CC and) (VP (VBG taking) (NP (JJ continuous) (JJ combined) (NN HT)))))) (, ,) (NP (EX there)) (VP (VBD was) (NP (NP (DT a) (ADJP (RB statistically) (JJ significant)) (NN increase)) (PP (IN in) (NP (NP (DT the) (NN incidence)) (PP (IN of) (NP (NNS Doc_19370593_2063_2071_Disease))))))) (. .)))
19370593	14	(ROOT (S (PP (IN Among) (NP (NP (NNS women)) (PP (IN with) (NP (NNS Doc_19370593_2090_2112_Disease))))) (, ,) (NP (NP (JJ long-term) (NN use)) (PP (IN of) (NP (JJ combined) (JJ continuous) (NN HT)))) (ADVP (RB significantly)) (VP (VBD increased) (NP (NP (DT the) (NN risk)) (PP (IN of) (NP (NNS Doc_19370593_2190_2213_Disease))))) (. .)))
19370593	15	(ROOT (S (NP (CD One) (NN trial)) (VP (VBD analysed) (NP (NP (NNS subgroups)) (PP (IN of) (NP (CD 2839) (ADJP (RB relatively) (JJ healthy) (PP (NP (QP (CD 50) (TO to) (CD 59))) (NP (NN year)))) (JJ old) (NNS women)))) (S (VP (VBG taking) (NP (NP (VBN combined) (JJ continuous) (NN HT)) (CC and) (NP (NP (CD 1637)) (VP (VBG taking) (NP (NP (NNP Doc_19370593_2340_2349_Chemical-only) (NNP HT)) (, ,) (CC versus) (NP (JJ similar-sized) (NN placebo) (NNS groups))))))))) (. .)))
19370593	16	(ROOT (S (S (NP (DT The) (ADJP (RB only) (RB significantly) (JJ increased)) (NN risk)) (VP (VBD reported) (SBAR (S (VP (VBD was) (PP (IN for) (NP (NP (NNS Doc_19370593_2451_2474_Disease)) (PP (IN in) (NP (NP (NNS women)) (VP (VBG taking) (NP (JJ combined) (JJ continuous) (NN HT)))))))))))) (: :) (S (NP (PRP$ their) (JJ absolute) (NN risk)) (VP (VBD remained) (ADJP (JJ low)) (, ,) (PP (IN at) (NP (QP (JJR less) (IN than) (CD 1/500)))))) (. .)))
19370593	17	(ROOT (S (ADVP (RB However)) (, ,) (NP (DT this) (NN study)) (VP (VBD was) (RB not) (VP (VBN powered) (S (VP (TO to) (VP (VB detect) (NP (NP (NNS differences)) (PP (IN between) (NP (NP (NNS groups)) (PP (IN of) (NP (JJR younger) (NNS women))))))))))) (. .)))
19370593	18	(ROOT (S (S (NP (NNP AUTHORS) (POS ')) (VP (VBZ CONCLUSIONS))) (: :) (S (NP (NNP HT)) (VP (VBZ is) (RB not) (VP (VBN indicated) (PP (IN for) (NP (NP (DT the) (JJ routine) (NN management)) (PP (IN of) (NP (JJ chronic) (NN disease)))))))) (. .)))
19370593	19	(ROOT (S (NP (PRP We)) (VP (VBP need) (NP (JJR more) (NN evidence)) (PP (IN on) (NP (NP (DT the) (NN safety)) (PP (IN of) (NP (NP (NNP HT)) (PP (IN for) (NP (JJ menopausal) (NN symptom) (NN control))))))) (, ,) (SBAR (IN though) (S (NP (JJ short-term) (NN use)) (VP (VBZ appears) (S (VP (TO to) (VP (VB be) (ADJP (RB relatively) (JJ safe) (PP (IN for) (NP (JJ healthy) (JJR younger) (NNS women))))))))))) (. .)))
19642243	0	(ROOT (S (VP (VB Doc_19642243_0_19_Disease) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (NNS Doc_19642243_37_41_Disease)) (PP (IN on) (NP (NNS Doc_19642243_45_54_Chemical))))))) (SBAR (IN while) (S (VP (VBG receiving) (NP (NP (VBN prolonged) (JJ Doc_19642243_81_91_Chemical) (NN course)) (PP (IN for) (NP (NNS Doc_19642243_103_116_Disease)))))))) (. .)))
19642243	1	(ROOT (S (NP (NNP Doc_19642243_118_131_Disease)) (VP (VBD developed) (PP (IN after) (NP (NP (DT a) (JJ prolonged) (NN course)) (PP (IN of) (NP (JJ Doc_19642243_170_180_Chemical) (NN therapy))))) (PP (IN in) (NP (NP (CD 2) (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBD were) (VP (VBG receiving) (NP (NNS Doc_19642243_222_251_Chemical)) (PP (IN as) (NP (NP (NN part)) (PP (IN of) (NP (DT an) (JJ antiretroviral) (NN regimen)))))))))))) (. .)))
19642243	2	(ROOT (S (NP (NNP Doc_19642243_290_299_Chemical)) (VP (VBZ has) (VP (VBN been) (VP (VBN implicated) (PP (IN in) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (NP (NNS Doc_19642243_342_358_Disease) (CC and) (NNS Doc_19642243_363_382_Disease)) (PP (RB because) (IN of) (NP (PRP$ its) (NNS effects))))))) (PP (IN on) (NP (DT the) (JJ proximal) (JJ renal) (NN tubule)))))) (. .)))
19642243	3	(ROOT (S (NP (NNP Doc_19642243_436_446_Chemical)) (ADVP (RB nephrotoxicity)) (VP (VP (VBZ is) (ADJP (JJ infrequent))) (CC but) (VP (MD may) (VP (VB result) (PP (IN from) (NP (NN coadministration))) (PP (IN with) (NP (DT a) (JJ nephrotoxic) (NN agent)))))) (. .)))
19642243	4	(ROOT (S (NP (NNS Clinicians)) (VP (MD should) (VP (VB be) (ADJP (JJ aware)) (SBAR (IN that) (S (NP (NNS Doc_19642243_571_580_Chemical)) (VP (MD may) (VP (VB raise) (NP (NP (DT the) (NN risk)) (PP (IN of) (NP (NNS Doc_19642243_603_616_Disease)))) (PP (IN during) (NP (NP (VBN prolonged) (NN administration)) (PP (IN of) (NP (NNS Doc_19642243_652_662_Chemical))))))))))) (. .)))
19674115	0	(ROOT (S (NP (JJ Recurrent) (NNS Doc_19674115_10_18_Disease)) (VP (VBN induced) (PP (IN by) (NP (NNS Doc_19674115_30_42_Chemical)))) (. .)))
19674115	1	(ROOT (S (NP (NNP Doc_19674115_44_56_Chemical)) (VP (MD can) (VP (VB have) (NP (NP (JJ adverse) (NNS effects)) (PP (JJ such) (IN as) (NP (NNS Doc_19674115_90_106_Disease) (, ,) (NNS Doc_19674115_108_121_Disease) (CC or) (NN digestive) (NNS disorders)))))) (. .)))
19674115	2	(ROOT (S (PP (IN In) (NP (JJ rare) (NNS cases))) (, ,) (NP (NP (NNS alterations)) (PP (IN in) (NP (NN taste) (CC and) (NN smell) (NN function)))) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (PP (IN for) (NP (NNS Doc_19674115_224_236_Chemical))) (SBAR (WHADVP (WRB when)) (S (VP (VBN combined) (PP (IN with) (NP (JJ other) (NNS drugs))))))))) (. .)))
19674115	3	(ROOT (S (NP (PRP We)) (VP (VBP report) (NP (NP (DT a) (NN case)) (PP (IN of) (NP (NP (JJ reversible) (NNS Doc_19674115_300_318_Disease)) (VP (VBN related) (PP (TO to) (NP (NP (NNS Doc_19674115_330_342_Chemical)) (PP (IN in) (NP (DT a) (NN woman))))) (, ,) (PP (IN with) (NP (DT a) (JJ positive) (NN rechallenge)))))))) (. .)))
19674115	4	(ROOT (S (NP (DT The) (NN patient)) (VP (VBD presented) (NP (NP (NP (DT every) (NN day)) (DT a) (NN sensation)) (PP (IN of) (S (VP (VBG smelling) (NP (NN something)) (S (VP (VBG burning) (NP (CD 15) (NN min)) (PP (IN after) (NP (NN drug) (NN intake)))))))))) (. .)))
19674115	5	(ROOT (S (NP (NNP Doc_19674115_484_492_Disease)) (VP (VP (VBD disappeared) (ADVP (RB completely)) (PP (IN after) (NP (JJ Doc_19674115_522_534_Chemical) (NN withdrawal)))) (CC and) (VP (VBD recurred) (PP (IN after) (NP (PRP$ its) (NN rechallenge))))) (. .)))
19674115	6	(ROOT (S (NP (DT The) (NN case)) (VP (VBD was) (VP (VBN reported) (PP (TO to) (NP (NP (DT the) (NNP Tunisian) (NNP Centre)) (PP (IN of) (NP (NNP Pharmacovigilance))))))) (. .)))
19692487	0	(ROOT (S (NP (NP (NNS Mice)) (VP (VBG lacking) (ADJP (JJ mPGES-1)))) (VP (VBP are) (ADJP (JJ resistant) (PP (TO to) (NP (NN Doc_19692487_38_45_Chemical-induced) (NNS Doc_19692487_54_62_Disease))))) (. .)))
19692487	1	(ROOT (S (NP (JJ Cyclooxygenase-2) (NN activity)) (VP (VBZ is) (VP (VBN required) (PP (IN for) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (NN Doc_19692487_125_132_Chemical-induced) (NNS Doc_19692487_141_149_Disease))))))) (. .)))
19692487	2	(ROOT (S (ADVP (RB However)) (, ,) (NP (NP (DT the) (NN involvement)) (PP (IN of) (NP (DT a) (JJ specific) (, ,) (NN terminal) (NNP Doc_19692487_200_213_Chemical) (PRN (-LRB- -LRB-) (NP (NNP Doc_19692487_215_217_Chemical)) (-RRB- -RRB-)) (NN isomerase)))) (VP (VBZ has) (RB not) (VP (VBN been) (VP (VBN evaluated)))) (. .)))
19692487	3	(ROOT (S (NP (DT The) (JJ present) (NN study)) (VP (VBD was) (VP (VBN undertaken) (S (VP (TO to) (VP (VB assess) (NP (NN Doc_19692487_296_303_Chemical-induced) (NNS Doc_19692487_312_320_Disease)) (PP (IN in) (NP (NP (NNS mice) (NN deficient)) (PP (IN in) (NP (NP (JJ microsomal) (NNS Doc_19692487_353_368_Chemical)) (ADJP (ADJP (JJ synthase-1)) (PRN (-LRB- -LRB-) (ADJP (JJ mPGES-1)) (-RRB- -RRB-)))))))))))) (. .)))
19692487	4	(ROOT (FRAG (NP (NP (DT A) (JJ 2-wk) (NN administration)) (PP (IN of) (NP (NP (NP (NNS Doc_19692487_416_420_Chemical)) (-LRB- -LRB-) (NP (NP (NP (NP (CD 4)) (VP (VBG mmol.kg))) (PRN (-LRB- -LRB-) (NP (CD -1)) (-RRB- -RRB-))) (. .) (NP (NP (NN day)) (PRN (-LRB- -LRB-) (NP (CD -1)) (-RRB- -RRB-)) (NP (NN ip)))) (-RRB- -RRB-)) (PP (IN in) (NP (JJ mPGES-1) (NNS +)))))) (: /) (S (NP (JJ +) (NNS mice)) (VP (VBD led) (PP (TO to) (NP (DT a) (JJ marked) (NNS Doc_19692487_484_492_Disease))) (PP (IN with) (NP (JJ hyposmotic) (NN urine))))) (. .)))
19692487	5	(ROOT (S (NP (DT This)) (VP (VBD was) (VP (VBN associated) (PP (IN with) (NP (NP (JJ elevated) (JJ renal) (JJ mPGES-1) (NN protein) (NN expression)) (CC and) (NP (VBN increased) (NN urine) (JJ Doc_19692487_603_609_Chemical) (NN excretion)))))) (. .)))
19692487	6	(ROOT (S (PP (IN In) (NP (NN contrast))) (, ,) (NP (JJ mPGES-1) (PRN (: -) (NP (NNP /)) (: -)) (NNS mice)) (VP (VBD were) (ADJP (RB largely) (JJ resistant) (PP (TO to) (NP (NP (NN Doc_19692487_677_684_Chemical-induced) (NNS Doc_19692487_693_701_Disease)) (CC and) (NP (DT a) (NN urine))))) (S (VP (VBG concentrating) (NP (NP (NN defect)) (, ,) (VP (VBN accompanied) (PP (IN by) (NP (NP (ADJP (RB nearly) (JJ complete)) (NN blockade)) (PP (IN of) (NP (JJ high) (NN urine) (NNS Doc_19692487_790_796_Chemical) (CC and) (NNS Doc_19692487_801_805_Chemical) (NN output)))))))))) (. .)))
19692487	7	(ROOT (S (NP (NP (NP (NN Immunoblotting)) (, ,) (ADVP (RB immunohistochemistry))) (, ,) (CC and) (NP (JJ quantitative) (PRN (-LRB- -LRB-) (NP (NN q)) (-RRB- -RRB-)) (NN RT-PCR))) (ADVP (RB consistently)) (VP (VBD detected) (NP (DT a) (JJ significant) (NN decrease)) (PP (IN in) (NP (ADJP (ADJP (JJ aquaporin-2)) (PRN (-LRB- -LRB-) (NP (NNP AQP2)) (-RRB- -RRB-))) (NN protein) (NN expression))) (PP (IN in) (NP (NP (PDT both) (DT the) (JJ renal) (NN cortex) (CC and) (NN medulla)) (PP (IN of) (NP (NNP Doc_19692487_1006_1013_Chemical-treated) (NNP +) (NNP /) (NNP +) (NNS mice)))))) (. .)))
19692487	8	(ROOT (S (NP (DT This) (NN decrease)) (VP (VBD was) (ADVP (RB significantly)) (VP (VBN attenuated) (PP (IN in) (NP (NP (DT the) (: -) (NNS /)) (: -) (NP (NNS mice)))))) (. .)))
19692487	9	(ROOT (S (NP (NN qRT-PCR)) (VP (VBD detected) (NP (NP (JJ similar) (NNS patterns)) (PP (IN of) (NP (NNS changes)))) (PP (PP (IN in) (NP (NP (NNP AQP2) (NNP mRNA)) (PP (IN in) (NP (DT the) (NN medulla))))) (CONJP (CC but) (RB not)) (PP (IN in) (NP (DT the) (NN cortex))))) (. .)))
19692487	10	(ROOT (S (ADVP (RB Similarly)) (, ,) (NP (NP (DT the) (JJ total) (NN protein) (NN abundance)) (PP (IN of) (NP (UCP (NP (NP (NP (DT the) (NN Doc_19692487_1234_1236_Chemical-Doc_19692487_1237_1242_Chemical) (NN cotransporter)) (PRN (-LRB- -LRB-) (NP (NNP NKCC2)) (-RRB- -RRB-))) (PP (IN in) (NP (DT the) (NN medulla)))) (CC but) (PP (RB not) (IN in) (NP (NP (DT the) (NN cortex)) (PP (IN of) (NP (DT the) (NNP +) (NNP /) (NNP +)))))) (NNS mice)))) (VP (VBD was) (ADVP (RB significantly)) (VP (VBN reduced) (PP (IN by) (NP (JJ Doc_19692487_1347_1354_Chemical) (NN treatment))))) (. .)))
19692487	11	(ROOT (S (PP (IN In) (NP (NN contrast))) (, ,) (NP (NP (DT the) (NN dowregulation)) (PP (IN of) (NP (JJ renal) (NN medullary) (NN NKCC2) (NN expression)))) (VP (VBD was) (ADVP (RB significantly)) (VP (VBN attenuated) (PP (IN in) (NP (NP (DT the) (: -) (NNS /)) (: -) (NP (NNS mice)))))) (. .)))
19692487	12	(ROOT (S (NP (PRP We)) (VP (VBP conclude) (SBAR (IN that) (S (NP (JJ mPGES-1-derived) (NNS Doc_19692487_1512_1518_Chemical)) (VP (VBZ mediates) (S (NP (NN Doc_19692487_1528_1535_Chemical-induced) (NNS Doc_19692487_1544_1552_Disease)) (ADJP (JJ likely) (PP (IN via) (NP (NP (NN inhibition)) (PP (IN of) (NP (NN AQP2) (CC and) (NN NKCC2) (NN expression))))))))))) (. .)))
1969772	0	(ROOT (S (NP (NP (NNP Preservation)) (PP (IN of) (NP (JJ renal) (NN blood)))) (VP (NN flow) (PP (IN during) (NP (NP (NNS Doc_1969772_40_51_Disease)) (VP (VBN induced) (PP (IN with) (NP (NP (NNS Doc_1969772_65_75_Chemical)) (PP (IN in) (NP (NNS dogs))))))))) (. .)))
1969772	1	(ROOT (S (NP (NP (DT The) (NN introduction)) (PP (IN of) (NP (NP (NNS drugs)) (SBAR (WHNP (WDT that)) (S (VP (MD could) (VP (VB induce) (NP (NNS Doc_1969772_129_140_Disease)) (PP (IN with) (NP (JJ different) (JJ pharmacological) (NNS actions)))))))))) (VP (MD would) (VP (VB be) (ADJP (JJ advantageous)) (SBAR (IN because) (S (NP (NP (NN side) (NNS effects)) (ADJP (JJ unique) (PP (TO to) (NP (DT a) (JJ specific) (NN drug))))) (VP (MD could) (VP (VB be) (VP (VBN minimized) (PP (IN by) (S (VP (VBG selecting) (NP (JJ appropriate) (NN therapy)))))))))))) (. .)))
1969772	2	(ROOT (S (NP (JJ Specific) (NNS Doc_1969772_311_319_Chemical-1)) (, ,) (NP (NP (-LRB- -LRB-) (NNP DA1) (-RRB- -RRB-)) (CC and) (NP (NNS Doc_1969772_333_341_Chemical-2))) (PRN (-LRB- -LRB-) (NP (NNP DA2)) (-RRB- -RRB-)) (NP (NN receptor) (NNS agonists)) (VP (VBP are) (ADVP (RB now)) (PP (IN under) (NP (JJ clinical) (NN investigation)))) (. .)))
1969772	3	(ROOT (S (NP (NNP Doc_1969772_406_425_Chemical)) (VP (VBZ is) (NP (NP (DT a) (JJ specific) (NNP DA1) (NN receptor) (NN agonist)) (SBAR (WHNP (WDT that)) (S (VP (VBZ lowers) (NP (NN blood) (NN pressure)) (PP (IN by) (NP (NN vasodilatation)))))))) (. .)))
1969772	4	(ROOT (S (NP (NP (DT The) (NNS hypothesis)) (SBAR (IN that) (S (NP (NNS Doc_1969772_527_537_Chemical)) (VP (MD could) (VP (VB be) (VP (VBN used) (S (VP (TO to) (VP (VP (VB induce) (NP (NNS Doc_1969772_562_573_Disease))) (CC and) (VP (VB preserve) (NP (NN blood) (NN flow)) (PP (TO to) (NP (DT the) (NN kidney))))))))))))) (VP (VBD was) (VP (VBN tested))) (. .)))
1969772	5	(ROOT (S (NP (NP (JJ Systemic) (JJ aortic) (NN blood) (NN pressure)) (CC and) (NP (JJ renal) (NN blood) (NN flow))) (VP (VBD were) (VP (VBN measured) (S (ADJP (RB continuously) (PP (IN with) (NP (NP (DT a) (JJ carotid) (JJ arterial) (NN catheter)) (CC and) (NP (DT an) (JJ electromagnetic) (NN flow) (NN probe)))))) (ADVP (RB respectively)) (, ,) (SBAR (IN in) (NN order) (S (VP (TO to) (VP (VB compare) (NP (NP (DT the) (JJ cardiovascular) (CC and) (JJ renal) (NN vascular) (NNS effects)) (PP (IN of) (NP (NNS Doc_1969772_853_863_Chemical) (CC and) (NNS Doc_1969772_868_888_Chemical)))) (PP (IN in) (NP (CD ten) (NNS dogs))) (PP (IN under) (NP (JJ Doc_1969772_907_916_Chemical) (JJ general) (NN anaesthesia))))))))) (. .)))
1969772	6	(ROOT (S (NP (JJ Mean) (JJ arterial) (NN pressure)) (VP (VBD was) (VP (VBN decreased) (NP (NP (NP (CD 30) (NNS +)) (PRN (: /) (NP (NP (QP (CD -) (CD 8))) (PP (IN per) (NP (NP (NN cent)) (PP (IN from) (NP (NP (NN control)) (PP (IN with) (NP (NP (NN infusion)) (PP (IN of) (NP (NP (NP (NNS Doc_1969772_1023_1033_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 3.4) (NNP +) (NNS /)) (, -) (NP (NNP 2.0) (NNP micrograms.kg-1) (. .) (NN min-1)) (-RRB- -RRB-))) (CC and) (NP (CD 34) (NNS +))))))))))) (: /))) (: -) (NP (NP (CD 4)) (PP (IN per) (NP (NN cent))))) (PP (IN with) (NP (NP (NN infusion)) (PP (IN of) (NP (NP (NP (NNS Doc_1969772_1109_1129_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP 5.9) (NNP micrograms.kg-1) (. .) (NN min-1)) (-RRB- -RRB-))) (PRN (-LRB- -LRB-) (NP (NNP NS)) (-RRB- -RRB-)))))))) (. .)))
1969772	7	(ROOT (S (NP (NP (JJ Renal) (NN blood) (NN flow)) (PRN (-LRB- -LRB-) (NP (NNP RBF)) (-RRB- -RRB-))) (VP (VBD increased) (PP (IN during) (NP (NP (NP (NN Doc_1969772_1204_1214_Chemical-induced) (NNS Doc_1969772_1223_1234_Disease)) (PRN (NP (CD 11) (NNP +) (NNS /))) (PRN (: -) (NP (NP (CD 7)) (PP (IN per) (NP (NP (NN cent)) (CC and) (NP (VBN decreased) (CD 21) (NN +))))) (: /))) (: -) (NP (NP (CD 8)) (PP (IN per) (NP (NP (NN cent)) (PP (IN during) (NP (NP (NN Doc_1969772_1292_1312_Chemical-induced) (NNS Doc_1969772_1321_1332_Disease)) (PRN (-LRB- -LRB-) (NP (NNP P) (QP (JJR less) (IN than) (CD 0.01))) (-RRB- -RRB-)))))))))) (. .)))
1969772	8	(ROOT (S (NP (NNP Doc_1969772_1353_1373_Chemical)) (VP (VBZ is) (NP (NP (DT a) (JJ non-selective) (NN arteriolar) (CC and) (NNS venous) (NN vasodilator)) (SBAR (WHNP (WDT that)) (S (VP (MD can) (VP (VB produce) (NP (NP (NN redistribution)) (PP (IN of) (NP (NN blood) (NN flow)))) (PP (RB away) (IN from) (NP (NP (DT the) (NN kidney)) (PP (IN during) (NP (JJ induced) (NNS Doc_1969772_1509_1520_Disease))))))))))) (. .)))
1969772	9	(ROOT (S (NP (NNP Doc_1969772_1522_1532_Chemical)) (VP (VBZ is) (NP (NP (DT a) (ADJP (ADJP (JJ selective) (JJ Doc_1969772_1548_1556_Chemical-1)) (PRN (-LRB- -LRB-) (NP (NNP DA1)) (-RRB- -RRB-))) (NN receptor) (NN agonist)) (SBAR (WHNP (WDT that)) (S (VP (VP (VBZ causes) (NP (NN vasodilatation)) (PP (TO to) (NP (NP (DT the) (NN kidney)) (CC and) (NP (NP (JJ other) (NNS organs)) (PP (IN with) (NP (CD DA1) (NNS receptors))))))) (CC and) (VP (VBZ preserves) (NP (NN blood) (NN flow)) (PP (TO to) (NP (NP (DT the) (NN kidney)) (PP (IN during) (NP (JJ induced) (NNS Doc_1969772_1713_1724_Disease))))))))))) (. .)))
19707748	0	(ROOT (NP (NP (NP (NNP Doc_19707748_0_8_Disease)) (VP (VBN associated) (PP (IN with) (NP (NNS Doc_19707748_25_37_Chemical))))) (: :) (NP (NP (NN case) (NN presentation)) (CC and) (NP (NN literature) (NN review))) (. .)))
19707748	1	(ROOT (S (NP (PRP We)) (VP (VBP present) (NP (NP (DT a) (NN case)) (PP (IN of) (NP (NP (NP (DT a) (NN patient)) (SBAR (WHNP (WP who)) (S (VP (VBD developed) (NP (NNS Doc_19707748_134_142_Disease)) (UCP (PP (RB shortly) (IN after) (S (VP (VBG initiating) (NP (NN treatment)) (PP (IN with) (NP (NNS Doc_19707748_183_195_Chemical)))))) (CC and) (S (VP (TO to) (VP (VB discuss) (NP (DT the) (JJ potential) (JJ drug-drug) (NNS interactions)))))))))) (ADJP (VBN related) (PP (PP (TO to) (NP (NP (DT the) (NN inhibition)) (PP (IN of) (NP (NP (NNP cytochrome) (NNP P450) (PRN (-LRB- -LRB-) (NP (NNP CYP)) (-RRB- -RRB-)) (NNP 1A2)) (PP (IN in) (NP (DT this) (NN case))))))) (, ,) (CONJP (RB as) (RB well) (IN as)) (PP (IN in) (NP (JJ other) (NNS cases))))) (, ,) (PP (IN of) (NP (NN Doc_19707748_347_359_Chemical-induced) (NNS Doc_19707748_368_376_Disease))))))) (. .)))
19707748	2	(ROOT (S (NP (JJ Several) (JJ biomedical) (NNS databases)) (VP (VBD were) (VP (VBN searched) (PP (VBG including) (NP (NNP MEDLINE) (, ,) (NNP Cochrane) (CC and) (NNP Ovid))))) (. .)))
19707748	3	(ROOT (S (NP (DT The) (JJ main) (NN search) (NNS terms) (NN utilized)) (VP (VBD were) (NP (NP (NN case) (NN report)) (CC and) (NP (NNS Doc_19707748_520_532_Chemical)))) (. .)))
19707748	4	(ROOT (S (NP (DT The) (NN search)) (VP (VBD was) (VP (VBN limited) (PP (TO to) (NP (NP (NNS studies)) (VP (VBN published) (PP (IN in) (NP (NNP English)))))))) (. .)))
19707748	5	(ROOT (S (NP (NP (CD Six) (NNS cases)) (PP (IN of) (NP (NN Doc_19707748_612_624_Chemical-induced) (NNS Doc_19707748_633_641_Disease)))) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (PP (IN in) (NP (DT the) (NN literature)))))) (. .)))
19707748	6	(ROOT (S (NP (NP (JJ Drug-drug) (NNS interactions)) (VP (VBN related) (PP (TO to) (NP (NP (DT the) (NN inhibition)) (PP (IN of) (NP (NNP CYP1A2))))) (PP (IN by) (NP (NNS Doc_19707748_742_754_Chemical))))) (VP (VBP are) (ADVP (RB likely)) (VP (VBN involved) (PP (IN in) (NP (NP (DT the) (JJ clinical) (NN outcome)) (PP (IN of) (NP (DT these) (NNS cases))))))) (. .)))
19707748	7	(ROOT (S (NP (NNS Clinicians)) (VP (VBP are) (VP (VBN exhorted) (S (VP (TO to) (VP (VB pay) (NP (JJ close) (NN attention)) (SBAR (WHADVP (WRB when)) (S (VP (VBG initiating) (NP (JJ Doc_19707748_891_903_Chemical) (NN therapy)) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG taking) (NP (NNS medications)) (PP (IN with) (NP (NP (JJ epileptogenic) (NNS properties)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (NP (CD CYP1A2) (NNS substrates)))))))))))))))))) (. .)))
19719056	0	(ROOT (NP (NP (JJ Doc_19719056_0_7_Chemical-Doc_19719056_8_16_Chemical) (NNS conjugates)) (: :) (NP (NN synthesis)) (, ,) (PP (IN in) (NP (UCP (ADJP (NN vitro)) (CC and) (PP (IN in) (NP (NN vivo)))) (NN evaluation))) (. .)))
19719056	1	(ROOT (S (NP (NP (NNP Doc_19719056_73_81_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP E)) (-RRB- -RRB-)) (, ,)) (VP (VBZ is) (NP (DT a) (JJ non-narcotic) (ADJP (JJ analgesic) (CC and) (JJ antiinflammatory)) (NN drug))) (. .)))
19719056	2	(ROOT (S (NP (DT A) (NNP biodegradable) (NNP polymer) (NN dextran)) (VP (VBZ has) (VP (VBN been) (VP (VBN utilized) (PP (IN as) (NP (NP (DT a) (NN carrier)) (PP (IN for) (NP (NP (NN synthesis)) (PP (IN of) (NP (NP (NN Doc_19719056_222_230_Chemical-Doc_19719056_231_238_Chemical) (NNS conjugates)) (PRN (-LRB- -LRB-) (NP (NNP ED)) (-RRB- -RRB-)))))))) (S (VP (TO to) (VP (VP (VB improve) (NP (PRP$ its) (NNS aqueous)) (ADVP (RB solubility))) (CC and) (VP (VB reduce) (NP (JJ gastrointestinal) (NN side) (NNS effects))))))))) (. .)))
19719056	3	(ROOT (S (NP (NP (DT An) (VBN activated) (NN moiety)) (, ,) (NP (NP (CD i.e.) (NNS Doc_19719056_357_372_Chemical) (JJ derivative)) (PP (IN of) (NP (NP (NNS Doc_19719056_387_395_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_19719056_397_400_Chemical)) (-RRB- -RRB-))))) (, ,)) (VP (VBD was) (VP (VBN condensed) (PP (IN with) (NP (NP (DT the) (JJ polysaccharide) (NNP polymer) (NN dextran)) (PP (IN of) (NP (NP (JJ different) (JJ molecular) (NNS weights)) (PRN (-LRB- -LRB-) (NP (NP (CD 40000)) (, ,) (NP (CD 60000)) (, ,) (NP (CD 110000) (CC and) (CD 200000))) (-RRB- -RRB-)))))))) (. .)))
19719056	4	(ROOT (S (NP (NNP IR) (NN spectral) (NNS data)) (VP (VBD confirmed) (NP (NP (NN formation)) (PP (IN of) (NP (JJ Doc_19719056_563_568_Chemical) (NN bonding)))) (PP (IN in) (NP (DT the) (NNS conjugates)))) (. .)))
19719056	5	(ROOT (S (NP (JJ Doc_19719056_596_604_Chemical) (NNS contents)) (VP (VBD were) (VP (VBN evaluated) (PP (IN by) (NP (NNP UV-spectrophotometric) (NN analysis))))) (. .)))
19719056	6	(ROOT (S (NP (DT The) (JJ molecular) (NNS weights)) (VP (VBD were) (VP (VBN determined) (PP (IN by) (S (VP (VBG measuring) (NP (NN viscosity)) (S (VP (VBG using) (NP (DT the) (JJ Mark-Howink-Sakurada) (NN equation))))))))) (. .)))
19719056	7	(ROOT (SINV (PP (IN In) (NP (NP (JJ vitro) (NNS hydrolysis)) (PP (IN of) (NP (NNP ED))))) (VP (VBD was) (VP (VBN done) (PP (PP (IN in) (NP (NP (JJ aqueous) (NNS buffers)) (PRN (-LRB- -LRB-) (NP (NP (NNP pH) (CD 1.2) (, ,) (CD 7.4)) (, ,) (NP (CD 9))) (-RRB- -RRB-)))) (CC and) (PP (IN in) (NP (NP (CD 80) (NN %)) (PRN (-LRB- -LRB-) (NP (NN v/v)) (-RRB- -RRB-))))))) (NP (NP (JJ human) (NN plasma)) (PRN (-LRB- -LRB-) (NP (QP (CD pH) (CD 7.4))) (-RRB- -RRB-))) (. .)))
19719056	8	(ROOT (S (PP (IN At) (NP (NNP pH) (CD 9))) (, ,) (NP (NP (DT a) (JJR higher) (NN rate)) (PP (IN of) (NP (NP (JJ Doc_19719056_903_911_Chemical) (NN release)) (PP (IN from) (NP (NNP ED)))))) (VP (VBD was) (VP (VBN observed) (PP (IN as)) (PP (VBN compared) (PP (TO to) (NP (NP (NP (JJ aqueous) (NN buffer)) (PP (IN of) (NP (NNP pH) (CD 7.4)))) (CC and) (NP (NP (ADJP (CD 80) (NN %)) (JJ human) (NN plasma)) (PRN (-LRB- -LRB-) (NP (QP (CD pH) (CD 7.4))) (-RRB- -RRB-)))))) (, ,) (PP (VBG following) (NP (JJ first-order) (NNS kinetics))))) (. .)))
19719056	9	(ROOT (S (PP (IN In) (NP (NN vivo))) (NP (NNS investigations)) (VP (VBD were) (VP (VBN performed) (PP (IN in) (NP (NNS animals))))) (. .)))
19719056	10	(ROOT (S (NP (JJ Acute) (JJ analgesic) (CC and) (JJ antiinflammatory) (NNS activities)) (VP (VBD were) (VP (VBN ascertained) (S (VP (VBG using) (NP (NP (NP (NP (NNS Doc_19719056_1165_1176_Chemical)) (VP (VBN induced) (S (VP (VBG writhing) (NP (NN model)))))) (-LRB- -LRB-) (NP (NNS mice)) (-RRB- -RRB-)) (CC and) (NP (NP (JJ carrageenan-induced) (NN rat) (NN paw)) (NP (JJ Doc_19719056_1239_1244_Disease) (NN model)) (, ,) (ADVP (RB respectively)))))))) (. .)))
19719056	11	(ROOT (S (PP (IN In) (NP (NP (NN comparison)) (PP (TO to) (NP (NN control))))) (, ,) (NP (NNP E) (CC and) (NNP ED1-ED4)) (VP (VBD showed) (NP (NP (ADJP (RB highly) (JJ significant)) (JJ analgesic) (CC and) (NN antiinflammatory) (NNS activities)) (PRN (-LRB- -LRB-) (NP (NNP p) (QP (CD <) (CD 0.001))) (-RRB- -RRB-)))) (. .)))
19719056	12	(ROOT (S (NP (JJ Biological) (NN evaluation)) (VP (VBD suggested) (SBAR (IN that) (S (NP (NP (NNS conjugates)) (PRN (-LRB- -LRB-) (NP (NNP ED1-ED4)) (-RRB- -RRB-))) (VP (VBD retained) (NP (JJ comparable) (JJ analgesic) (CC and) (JJ antiinflammatory) (NNS activities)) (PP (IN with) (ADJP (RB remarkably) (JJ reduced) (RB ulcerogenicity))) (PP (IN as)) (PP (VBN compared) (PP (TO to) (NP (NP (PRP$ their) (NN parent) (NN drug)) (: --) (NP (NNS Doc_19719056_1579_1587_Chemical))))))))) (. .)))
19721134	0	(ROOT (NP (NP (DT The) (JJ antiarrhythmic) (NN effect) (CC and) (JJ possible) (NN ionic) (NNS mechanisms)) (PP (IN of) (NP (NNS Doc_19721134_59_70_Chemical))) (PP (IN on) (NP (NN animal) (NNS models))) (. .)))
19721134	1	(ROOT (S (NP (DT This) (NN study)) (VP (VBD was) (VP (VBN designed) (S (VP (TO to) (VP (VP (VB evaluate) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NNS Doc_19721134_140_151_Chemical))))) (CC and) (VP (VB explore) (NP (DT the) (JJ underlying) (JJ ionic) (NN mechanism)) (, ,) (S (VP (VBG using) (NP (DT both) (NN Doc_19721134_207_216_Chemical-induced) (NN rat) (CC and) (NN Doc_19721134_233_240_Chemical-induced) (NN guinea) (NN pig))))) (NP (JJ Doc_19721134_260_270_Disease) (NNS models))))))) (. .)))
19721134	2	(ROOT (S (NP (NNP Confocal)) (ADVP (RB microscopy)) (VP (VBD was) (VP (VBN used) (S (VP (TO to) (VP (VB measure) (NP (NP (NP (JJ intracellular) (JJ free-Doc_19721134_338_345_Chemical) (NNS concentrations)) (-LRB- -LRB-) (NP (NNP -LSB-) (NNP Doc_19721134_363_369_Chemical) (NNP -RSB-)) (PRN (-LRB- -LRB-) (NP (NNP i)) (-RRB- -RRB-)) (-RRB- -RRB-)) (PP (IN in) (NP (VBN isolated) (NNS myocytes))))))))) (. .)))
19721134	3	(ROOT (S (NP (DT The) (JJ current) (NNS data)) (VP (VBD showed) (SBAR (IN that) (S (S (NP (NNS Doc_19721134_426_437_Chemical)) (ADVP (RB significantly)) (VP (VP (VBD delayed) (NP (NP (NN onset)) (PP (IN of) (NP (NNS Doc_19721134_469_480_Disease))))) (, ,) (VP (VBD decreased) (NP (NP (DT the) (NN time) (NN course)) (PP (IN of) (NP (JJ Doc_19721134_511_551_Disease) (, ,) (VBN reduced) (NNS Doc_19721134_561_571_Disease) (NN score))))) (, ,) (CC and) (VP (VBD increased) (NP (NP (DT the) (NN survival) (NN time)) (PP (IN of) (NP (JJ arrhythmic) (NNS rats))))))) (CC and) (S (NP (NP (NN guinea) (NNS pigs)) (. .) (S (VP (VBG -LSB-) (NP (NP (NNP Doc_19721134_648_654_Chemical) (NNP -RSB-) (PRN (-LRB- -LRB-) (NP (NNP i)) (-RRB- -RRB-)) (NNP overload)) (VP (VBN induced) (PP (IN by) (NP (NNS Doc_19721134_679_688_Chemical) (CC or) (NNS Doc_19721134_692_699_Chemical)))))))) (VP (VBD was) (VP (VBN reduced) (PP (IN in) (NP (NP (VBN isolated) (NNS myocytes)) (VP (VBN pretreated) (PP (IN with) (NP (NNS Doc_19721134_749_760_Chemical)))))))))))) (. .)))
19721134	4	(ROOT (S (ADVP (RB Moreover)) (, ,) (NP (NP (NP (NP (NNP M)) (PRN (-LRB- -LRB-) (NP (CD 3)) (-RRB- -RRB-))) (: -) (NP (NP (JJ muscarinic) (JJ Doc_19721134_788_801_Chemical) (NN receptor)) (PRN (-LRB- -LRB-) (NP (NN mAChR)) (-RRB- -RRB-)) (NP (JJ antagonist) (NNS Doc_19721134_830_836_Chemical)))) (PRN (-LRB- -LRB-) (NP (NNP Doc_19721134_838_885_Chemical)) (-RRB- -RRB-))) (ADVP (RB partially)) (VP (VBD abolished) (NP (NP (DT the) (JJ beneficial) (NNS effects)) (PP (IN of) (NP (NNS Doc_19721134_933_944_Chemical))))) (. .)))
19721134	5	(ROOT (S (NP (DT These) (NNS data)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NNS Doc_19721134_970_981_Chemical)) (VP (VBD produced) (NP (JJ antiarrhythmic) (NNS actions)) (PP (IN on) (NP (NP (JJ arrhythmic) (NN rat) (CC and) (NN guinea) (NN pig) (NNS models)) (VP (VBN induced) (PP (IN by) (NP (NP (NNS Doc_19721134_1065_1074_Chemical) (CC or) (NNS Doc_19721134_1078_1085_Chemical)) (PP (IN via) (S (VP (VBG stimulating) (NP (NP (DT the) (JJ cardiac) (NNP M)) (PRN (-LRB- -LRB-) (NP (CD 3)) (-RRB- -RRB-)) (: -) (NP (NN mAChR))))))))))))))) (. .)))
19721134	6	(ROOT (S (NP (DT The) (NN mechanism)) (VP (MD may) (VP (VB be) (VP (VBN related) (PP (TO to) (NP (NP (DT the) (NN improvement)) (PP (IN of) (NP (JJ Doc_19721134_1177_1183_Chemical) (NN handling)))))))) (. .)))
19761039	0	(ROOT (S (NP (NP (NN Effect)) (PP (IN of) (NP (NP (NNS Doc_19761039_10_32_Chemical)) (PP (IN on) (NP (NP (NNS Doc_19761039_36_45_Chemical-induced)) (ADJP (JJ neurobehavioral) (CC and) (JJ biochemical))))))) (VP (VBZ alterations) (PP (IN in) (NP (NNS rats)))) (. .)))
19761039	1	(ROOT (S (NP (NP (NN Effect)) (PP (IN of) (NP (NP (JJ methanolic) (NNS extract)) (PP (IN of) (NP (NP (NNS Doc_19761039_139_161_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 100-300) (NN mg/kg)) (-RRB- -RRB-))))))) (VP (VBD was) (VP (VBN studied) (PP (IN on) (NP (NP (NN Doc_19761039_193_202_Chemical-induced) (NN orofacial) (NNS Doc_19761039_221_231_Disease)) (CC and) (NP (JJ neurochemical) (NNS alterations)))))) (. .)))
19761039	2	(ROOT (S (NP (DT The) (NNS rats)) (VP (VBD were) (VP (VBN treated) (PP (IN with) (NP (NP (NP (JJ intraperitoneal) (NNS Doc_19761039_306_315_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (CD 1) (NN mg/kg)) (, ,) (NP (NN ip))) (-RRB- -RRB-))) (PP (IN for) (NP (NP (CD 3) (NNS days)) (NP (DT every) (JJ other) (NN day)))))))) (. .)))
19761039	3	(ROOT (S (PP (IN On) (NP (NN day) (CD 5))) (, ,) (NP (NP (NNS vacuous) (VBG chewing) (NNS movements)) (CC and) (NP (NN tongue) (NNS protrusions))) (VP (VBD were) (VP (VBN counted) (PP (IN for) (NP (CD 5) (NN min))))) (. .)))
19761039	4	(ROOT (S (NP (NP (NNP Doc_19761039_441_450_Chemical)) (VP (VBN treated) (NP (NP (JJ rats) (ADJP (RB significantly) (JJ developed)) (NNS vacuous)) (VP (VBG chewing) (NP (NNS movements) (CC and) (NN tongue) (NNS protrusions)) (ADVP (RB however)) (, ,) (S (NP (NP (NN coadministration)) (PP (IN of) (NP (JJ Doc_19761039_566_588_Chemical) (NNS roots)))) (VP (VB extract)))) (PRN (-LRB- -LRB-) (NP (NP (CD 100)) (, ,) (NP (NP (QP (CD 200) (CC and) (CD 300))) (NP (NN mg/kg))) (, ,) (PP (IN per) (NP (NN orally)))) (-RRB- -RRB-))))) (VP (VBD attenuated) (NP (DT the) (NNS effects))) (. .)))
19761039	5	(ROOT (S (NP (NP (JJ Biochemical) (NN analysis)) (PP (IN of) (NP (NN brain)))) (VP (VBD revealed) (SBAR (IN that) (S (NP (DT the) (JJ Doc_19761039_712_721_Chemical) (NN treatment)) (ADVP (RB significantly)) (VP (VBD increased) (NP (NP (NN lipid) (NN peroxidation) (CC and) (VBN decreased) (NNS levels)) (PP (IN of) (NP (NP (NP (NP (JJ Doc_19761039_799_809_Chemical) (NN dismutase)) (PRN (-LRB- -LRB-) (NP (NNP SOD)) (-RRB- -RRB-))) (, ,) (NP (NP (NN catalase)) (PRN (-LRB- -LRB-) (NP (NNP CAT)) (-RRB- -RRB-))) (CC and) (NP (NP (JJ Doc_19761039_846_857_Chemical) (NN reductase)) (PRN (-LRB- -LRB-) (NP (NNP Doc_19761039_869_872_Chemical)) (-RRB- -RRB-)))) (, ,) (NP (NP (DT an) (NN index)) (PP (IN of) (NP (JJ oxidative) (NN stress) (NN process))))))))))) (. .)))
19761039	6	(ROOT (S (NP (NP (NNP Coadministration)) (PP (IN of) (NP (NNP extract)))) (VP (VP (ADVP (RB significantly)) (VBD reduced) (NP (DT the) (NN lipid) (NN peroxidation))) (CC and) (VP (VBD reversed) (NP (DT the) (NN decrease)) (PP (IN in) (NP (NP (NN brain) (NN SOD)) (, ,) (NP (NNP CAT)) (CC and) (NP (JJ Doc_19761039_1034_1037_Chemical) (NNS levels)))))) (. .)))
19761039	7	(ROOT (S (NP (NP (DT The) (NNS results)) (PP (IN of) (NP (DT the) (JJ present) (NN study)))) (VP (VBD suggested) (SBAR (IN that) (S (NP (NNS Doc_19761039_1094_1116_Chemical)) (VP (VBD had) (NP (NP (DT a) (JJ protective) (NN role)) (PP (IN against) (NP (NP (NN Doc_19761039_1147_1156_Chemical-induced) (NN orofacial) (NNS Doc_19761039_1175_1185_Disease)) (CC and) (NP (JJ oxidative) (NN stress))))))))) (. .)))
19893084	0	(ROOT (NP (NP (NNP Dynamic) (NN response)) (PP (IN of) (NP (NN blood) (NN vessel))) (PP (IN in) (NP (NNS Doc_19893084_36_55_Disease))) (. .)))
19893084	1	(ROOT (S (PP (IN In) (NP (DT this) (NN study))) (NP (PRP we)) (VP (VBD postulated) (NP (DT that)) (PP (IN during) (NP (NP (NNS Doc_19893084_97_116_Disease)) (VP (VBN induced) (PP (IN by) (NP (NNS Doc_19893084_128_138_Chemical))) (SBAR (SBAR (S (NP (NP (DT the) (JJ transient) (CC or) (JJ dynamic) (NN response)) (PP (IN of) (NP (NN blood) (NNS vessels)))) (VP (MD could) (VP (VB be) (VP (VBN affected)))))) (, ,) (CC and) (SBAR (IN that) (S (NP (NNS antioxidants)) (VP (MD can) (VP (VB prevent) (NP (DT the) (NNS changes)) (PP (IN in) (NP (NP (JJ dynamic) (NNS responses)) (PP (IN of) (NP (NN blood) (NNS vessels)))))))))))))) (. .)))
19893084	2	(ROOT (S (NP (DT The) (JJ new) (NN approach) (S (VP (TO to) (VP (VB ex) (NP (NP (NP (JJ vivo) (NN blood) (NN vessel) (NNS experiments)) (SBAR (WHPP (IN in) (WHNP (WDT which))) (S (NP (RB not) (NP (NP (RB only) (DT the) (NN end) (NNS points)) (PP (IN of) (NP (NP (NNS vessels) (NN response)) (PP (IN within) (NP (DT the) (NN time) (NN interval))))))) (VP (VBZ is) (VP (VBN considered)))))) (, ,) (CONJP (CC but) (RB also)) (NP (NP (NNS dynamics)) (PP (IN of) (NP (DT this) (NN response))))))))) (, ,) (VP (VBD was) (VP (VBN used) (PP (IN in) (NP (DT this) (NN paper))))) (. .)))
19893084	3	(ROOT (S (NP (PRP$ Our) (NNS results)) (VP (VBP confirm) (NP (NP (DT the) (NN alteration)) (PP (IN in) (NP (NP (JJ dynamic) (NN response)) (PP (IN of) (NP (NN blood) (NNS vessels)))))) (PP (IN during) (NP (NP (DT the) (NN change)) (PP (IN of) (NP (NP (NN pressure)) (PP (IN in) (NP (NN Doc_19893084_605_615_Chemical-treated) (NNS animals)))))))) (. .)))
19893084	4	(ROOT (S (NP (NP (DT The) (JJ beneficial) (NNS effects)) (PP (IN of) (NP (NP (JJ Doc_19893084_659_668_Chemical) (NN administration)) (PP (TO to) (NP (NN Doc_19893084_687_697_Chemical-treated) (NNS animals)))))) (VP (VBP are) (ADVP (RB also)) (VP (VBN confirmed) (PP (IN through) (NP (NP (: :) (NP (NP (JJR lower) (NN level)) (PP (IN of) (NP (NN blood) (NNS Doc_19893084_763_767_Chemical)))) (CC and) (NP (NP (NNS Doc_19893084_772_782_Chemical)) (CC and) (NP (JJR higher) (NN level)))) (PP (IN of) (NP (NNS Doc_19893084_803_812_Chemical))))))) (. .)))
19893084	5	(ROOT (S (NP (NP (DT The) (NN pressure) (JJ dynamic) (NNS responses)) (PP (IN of) (NP (VBN isolated) (NN blood) (NNS vessels)))) (VP (VBP show) (NP (NP (DT a) (JJR faster) (NN pressure) (NN change)) (PP (IN in) (NP (NP (NN Doc_19893084_904_914_Chemical-treated) (NNS animals)) (PRN (-LRB- -LRB-) (NP (CD 8.07) (NNP +) (NNS /)) (: -) (NP (NP (QP (CD 1.7) (CD s))) (PP (IN vs.) (NP (NP (QP (CD 5.64) (CD +)) (NNS /)) (: -) (NP (CD 0.18) (NNS s))))) (-RRB- -RRB-)))))) (. .)))
19893084	6	(ROOT (S (NP (NP (JJ Doc_19893084_969_978_Chemical) (NN administration)) (VP (VBN induced) (NP (NP (NN slowdown)) (PP (IN of) (NP (NN pressure)))))) (VP (VBP change) (ADVP (RB back)) (PP (TO to) (NP (DT the) (NN control) (NNS values)))) (. .)))
19893084	7	(ROOT (S (NP (NP (DT The) (NN pressure) (JJ dynamic) (NNS properties)) (, ,) (VP (ADVP (RB quantitatively)) (VBN defined) (PP (IN by) (NP (NP (JJ comparative) (NN pressure) (NN dynamic)) (CC and) (NP (JJ total) (NN pressure) (NN dynamic))))) (, ,)) (VP (VBP confirm) (NP (NP (DT the) (NN alteration)) (PP (IN in) (NP (NP (JJ dynamic) (NN response)) (PP (IN of) (NP (NN blood) (NNS vessels)))))) (PP (IN during) (NP (NP (DT the) (NN change)) (PP (IN of) (NP (NP (NP (NN pressure)) (PP (IN in) (NP (NN Doc_19893084_1267_1277_Chemical-treated) (NNS animals)))) (CC and) (NP (NP (JJ beneficial) (NNS effects)) (PP (IN of) (NP (JJ Doc_19893084_1320_1329_Chemical) (NN administration))))))))) (. .)))
19917396	0	(ROOT (NP (NP (JJ Reversible) (NNS Doc_19917396_11_33_Disease)) (VP (VBN induced) (PP (IN by) (NP (NP (NNS Doc_19917396_45_55_Chemical)) (PP (IN in) (NP (DT a) (JJ pediatric) (NN heart) (NN transplant)))))) (X (X (SYM recipient)) (: :) (NP (NN case) (NN report)) (. .))))
19917396	1	(ROOT (S (NP (NNP Doc_19917396_112_122_Chemical)) (VP (VBZ is) (NP (NP (DT a) (JJ potent) (NN immunosuppressant)) (SBAR (WHNP (WDT that)) (S (VP (VBZ is) (ADVP (RB frequently)) (VP (VBN used) (PP (IN in) (NP (NN organ) (NN transplantation))))))))) (. .)))
19917396	2	(ROOT (S (ADVP (RB However)) (, ,) (NP (JJ adverse) (NNS effects)) (VP (VBP include) (NP (NNS Doc_19917396_236_252_Disease))) (. .)))
19917396	3	(ROOT (S (VP (VB Herein) (S (NP (PRP we)) (VP (VB describe) (NP (NP (JJ transient) (NNS Doc_19917396_283_305_Disease)) (VP (VBN induced) (PP (IN by) (NP (NNS Doc_19917396_317_327_Chemical))) (PP (IN after) (NP (NN heart) (NN transplantation)))))))) (. .)))
19917396	4	(ROOT (S (NP (DT The) (NNS Doc_19917396_361_372_Disease)) (VP (VP (VBD caused) (NP (DT no) (JJ clinical) (NNS symptoms))) (CC but) (VP (VBD was) (VP (VP (VBN noted) (PP (RB because) (IN of) (NP (NP (NN elevation)) (PP (IN of) (NP (JJ plasma) (NN brain) (JJ natriuretic) (NN peptide) (NN concentration)))))) (CC and) (VP (VBN confirmed) (PP (IN at) (NP (NN echocardiography))))))) (. .)))
19917396	5	(ROOT (S (S (ADVP (RB Initially)) (, ,) (NP (NN allograft) (NN rejection)) (VP (VBD was) (VP (VBN feared)))) (: ;) (S (ADVP (RB however)) (, ,) (NP (JJ myocardial) (NN biopsy) (NNS samples)) (VP (VBD revealed) (NP (NP (RB only) (JJ interstitial) (NNS Doc_19917396_626_631_Disease)) (CC and) (NP (JJ mild) (NNS Doc_19917396_641_663_Disease))))) (: ;) (S (NP (CC neither) (NP (JJ cellular)) (CC nor) (NP (JJ humoral) (NN rejection))) (VP (VBD was) (VP (VBN detected)))) (. .)))
19917396	6	(ROOT (S (S (NP (DT The) (NN blood) (NNS Doc_19917396_728_738_Chemical) (NN concentration)) (VP (VBD was) (ADJP (ADVP (JJR higher) (IN than)) (JJ usual) (PP (IN at) (NP (DT that) (NN time)))))) (: ;) (S (ADVP (RB thus)) (, ,) (NP (JJ Doc_19917396_795_805_Chemical) (NN dosage)) (VP (VBD was) (VP (VBN reduced)))) (. .)))
19917396	7	(ROOT (S (NP (NNP Doc_19917396_826_848_Disease)) (ADVP (RB completely)) (VP (VP (VBD resolved) (PP (IN upon) (S (VP (VBG reducing) (NP (NP (DT the) (NN target) (NN concentration)) (PP (IN of) (NP (NNS Doc_19917396_911_921_Chemical)))))))) (CC and) (VP (VBD did) (RB not) (VP (VB recur))) (, ,) (PP (IN as) (UCP (VP (VBN confirmed) (PP (IN at) (NP (NN echocardiography)))) (CC and) (ADJP (JJ myocardial) (RB biopsy))))) (. .)))
19917396	8	(ROOT (S (ADVP (RB Thus)) (, ,) (NP (PRP we)) (VP (VBP conclude) (SBAR (IN that) (S (NP (NNS Doc_19917396_1020_1030_Chemical)) (VP (VBZ induces) (NP (JJ reversible) (NNS Doc_19917396_1050_1072_Disease)))))) (. .)))
19917396	9	(ROOT (S (PP (IN In) (S (NP (NNS patients)) (VP (VBG receiving) (NP (JJ Doc_19917396_1096_1106_Chemical) (NN therapy))))) (, ,) (NP (NN blood) (NN concentration)) (VP (MD should) (VP (VB be) (UCP (ADJP (RB carefully) (VBN controlled)) (CC and) (NP (NP (JJ extreme) (NN attention)) (VP (VBN paid) (PP (TO to) (NP (JJ cardiac) (NN involvement)))))))) (. .)))
19923525	0	(ROOT (S (NP (NNP Doc_19923525_0_10_Chemical)) (VP (VBZ prevents) (NP (NP (NNS Doc_19923525_20_37_Disease)) (VP (VBN caused) (PP (IN by) (NP (NP (NN Doc_19923525_48_61_Chemical-induced) (NNS Doc_19923525_70_81_Disease)) (PP (IN in) (NP (JJ adult) (NNS mice)))))))) (. .)))
19923525	1	(ROOT (S (NP (NP (NNP Doc_19923525_109_120_Disease)) (CC and) (NP (NP (DT a) (JJ resultant) (NN decrease)) (PP (IN in) (NP (JJ cerebral) (NN blood) (NN flow))))) (VP (VBP have) (VP (VBN been) (VP (VBN implicated) (PP (IN in) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (NNS Doc_19923525_212_233_Disease)))))))) (. .)))
19923525	2	(ROOT (S (S (NP (PRP We)) (VP (VBD tested) (NP (DT the) (NNS hypothesis)) (SBAR (IN that) (S (NP (NP (NNS Doc_19923525_265_275_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_19923525_277_281_Chemical)) (-RRB- -RRB-))) (VP (VBN administered) (PP (IN at) (NP (NP (DT the) (NN onset)) (PP (IN of) (NP (NP (NNS Doc_19923525_312_325_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_19923525_327_330_Chemical)) (-RRB- -RRB-))))))))))) (: -) (S (NP (JJ induced) (NNS Doc_19923525_340_351_Disease)) (VP (MD would) (VP (VB preserve) (NP (JJ long-term) (NN associative) (NN memory))))) (. .)))
19923525	3	(ROOT (S (NP (DT The) (JJ passive) (FW avoidance) (PRN (-LRB- -LRB-) (NP (NNP PA)) (-RRB- -RRB-)) (NN paradigm)) (VP (VBD was) (VP (VBN used) (S (VP (TO to) (VP (VB assess) (NP (NN memory) (NN retention))))))) (. .)))
19923525	4	(ROOT (S (PP (IN For) (NP (NNP PA) (NN training))) (, ,) (NP (NP (NNS latencies)) (PRN (-LRB- -LRB-) (NP (NNS seconds)) (-RRB- -RRB-))) (VP (VBD were) (VP (VBN recorded) (PP (IN for) (NP (NP (NN entry)) (PP (IN from) (NP (DT a) (JJ suspended) (NN platform))))) (PP (IN into) (NP (DT a) (NNP Plexiglas) (NN tube))) (SBAR (WHADVP (WRB where)) (S (NP (DT a) (NN shock)) (VP (VBD was) (VP (ADVP (RB automatically)) (VBN delivered))))))) (. .)))
19923525	5	(ROOT (S (NP (NNS Latencies)) (VP (VBD were) (VP (VBN recorded) (PP (ADVP (NP (CD 48) (NN h)) (RBR later)) (IN for) (NP (DT a) (NN testing) (NN trial))))) (. .)))
19923525	6	(ROOT (S (NP (NP (JJ Ninety-six) (JJ Swiss-Webster) (NNS mice)) (PRN (-LRB- -LRB-) (NP (NP (CD 30-35) (NN g)) (, ,) (NP (CD 6-8) (NN wk))) (-RRB- -RRB-)) (, ,)) (VP (VBD were) (VP (VBN randomized) (PP (IN into) (NP (NP (NP (CD 6) (NP (NNS groups) (CD 1)) (-RRB- -RRB-) (NNS saline)) (PRN (-LRB- -LRB-) (NP (NN control)) (-RRB- -RRB-))) (, ,) (NP (LST (LS 2) (-RRB- -RRB-)) (NP (NNS Doc_19923525_790_793_Chemical)) (PP (ADVP (RB immediately)) (IN after) (NP (NP (NP (NN learning)) (, ,) (NP (LST (LS 3) (-RRB- -RRB-)) (NP (NNP NTG) (CD 3) (NN h)) (PP (IN after) (S (VP (VBG learning) (NP (NP (, ,) (NP (CD 4)) (-RRB- -RRB-) (NNS Doc_19923525_852_855_Chemical)) (CC and) (NP (NP (NNS Doc_19923525_860_864_Chemical)) (, ,) (ADJP (CD 5)) (-RRB- -RRB-)) (NP (NP (NN vehicle)) (, ,) (CC and) (NP (CD 6)))))))) (-RRB- -RRB-)) (VP (VBG Doc_19923525_885_889_Chemical) (ADVP (RB alone)))))))))) (. .)))
19923525	7	(ROOT (S (NP (NP (DT The) (NN extent)) (PP (IN of) (NP (NP (NNS Doc_19923525_911_922_Disease) (CC and) (NNS changes)) (PP (IN in) (NP (NP (NP (NN brain) (NN tissue) (NN oxygenation)) (-LRB- -LRB-) (NP (NNP PbtO)) (PRN (-LRB- -LRB-) (NP (CD 2)) (-RRB- -RRB-)) (-RRB- -RRB-)) (CC and) (NP (IN in) (JJ cerebral) (NN blood) (NN flow))))))) (VP (VBD were) (VP (VBN studied) (PP (IN in) (NP (NP (DT a) (JJ separate) (NN group)) (PP (IN of) (NP (NNS animals))))))) (. .)))
19923525	8	(ROOT (S (NP (DT All) (NNS groups)) (VP (VBD exhibited) (NP (NP (JJ similar) (NN training) (NNS latencies)) (PRN (-LRB- -LRB-) (NP (CD 17.0) (NNP +) (NNS /)) (, -) (NP (CD 4.6) (NNS s)) (-RRB- -RRB-)))) (. .)))
19923525	9	(ROOT (S (NP (NP (NNS Mice)) (VP (VBN subjected) (PP (TO to) (NP (JJ Doc_19923525_1138_1149_Disease) (NNS episodes))))) (VP (VBD showed) (NP (DT a) (JJ significant) (NN decrease)) (PP (IN in) (NP (NP (JJ latency) (NN time)) (PRN (-LRB- -LRB-) (NP (CD 178) (NNP +) (NNS /)) (, -) (NP (CD 156) (NNS s)) (-RRB- -RRB-)))) (PP (VBN compared) (PP (IN with) (NP (NP (NP (DT those)) (VP (VBN injected) (PP (IN with) (NP (JJ saline) (, ,) (JJ Doc_19923525_1263_1266_Chemical) (JJ +) (NNS Doc_19923525_1269_1273_Chemical))))) (, ,) (CC or) (NP (NP (VBN delayed) (NNS Doc_19923525_1286_1289_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (NP (NP (QP (CD 580) (CD +)) (NNS /)) (PRN (: -) (NP (NP (CD 81) (NNS s)) (, ,) (NP (NP (QP (CD 557) (CD +)) (NNS /)) (: -) (NP (QP (CD 67) (CD s)))) (, ,) (CC and) (NP (CD 493) (NNS +))) (: /))) (: -) (NP (QP (CD 146) (CD s)))) (, ,) (ADVP (RB respectively))) (-RRB- -RRB-))))))) (. .)))
19923525	10	(ROOT (S (NP (NP (DT A) (NNP Kruskal-Wallis) (JJ 1-way) (NN analysis)) (PP (IN of) (NP (NN variance)))) (VP (VBD indicated) (NP (DT a) (JJ significant) (NN difference)) (PP (IN among) (NP (NP (DT the) (CD 4) (NN treatment) (NNS groups)) (PRN (-LRB- -LRB-) (NP (NP (NNP H) (NNP =) (NNP 15.34)) (: ;) (NP (NNP P) (NNP <) (NNP 0.001))) (-RRB- -RRB-))))) (. .)))
19923525	11	(ROOT (S (PP (IN In) (NP (NP (DT a) (JJ separate) (NN group)) (PP (IN of) (NP (NP (NNS mice)) (VP (RB not) (VBN subjected) (PP (TO to) (NP (JJ behavioral) (NNS studies)))))))) (, ,) (NP (NP (NP (NP (DT the) (JJ same) (NN dose)) (PP (IN of) (NP (NNS Doc_19923525_1567_1570_Chemical)))) (PRN (-LRB- -LRB-) (VP (VBN n) (S (VP (SYM =) (NP (CD 3))))) (-RRB- -RRB-))) (CC and) (NP (NP (JJ Doc_19923525_1583_1586_Chemical) (JJ +) (NNS Doc_19923525_1589_1593_Chemical)) (PRN (-LRB- -LRB-) (VP (VBN n) (S (VP (SYM =) (NP (CD 3))))) (-RRB- -RRB-)))) (VP (VBD caused) (VP (VB mean) (NP (JJ arterial) (NN blood) (NN pressure)) (S (VP (TO to) (VP (VB decrease) (PP (PP (IN from) (NP (NP (CD 85.9) (JJ +) (NNS /)) (PRN (: -) (NP (NP (CD 3.8) (JJ mm) (NNP Hg) (NN sem)) (PP (TO to) (NP (CD 31.6) (NNS +)))) (: /)) (: -) (NP (CD 0.8) (JJ mm) (NNP Hg) (NN sem)))) (CC and) (PP (IN from) (NP (NP (NP (CD 86.2) (JJ +) (NNS /)) (PRN (: -) (NP (NP (CD 3.7) (NN mm) (NNP Hg)) (VP (VBN sem) (PP (TO to) (NP (QP (CD 32.6) (CD +)))))) (: /))) (: -) (NP (NP (CD 0.2) (NN mm)) (NP (NNP Hg) (NNP sem)) (, ,) (ADVP (RB respectively))))))))))) (. .)))
19923525	12	(ROOT (NP (NP (NP (NP (JJ Mean) (JJ arterial) (NN blood) (NN pressure)) (PP (IN in) (NP (NP (NNS mice)) (VP (VBN treated) (PP (IN with) (NP (NP (NNS Doc_19923525_1827_1831_Chemical)) (VP (ADVP (RB alone)) (VBN decreased) (PP (IN from) (NP (QP (CD 88.1) (CD +)) (NNS /)))))))))) (PRN (: -) (NP (NP (CD 3.8) (NN mm)) (VP (VBN Hg) (PP (TO to) (NP (QP (CD 80.0) (CD +)))))) (: /))) (: -) (NP (NP (CD 2.9) (NN mm)) (NP (NNP Hg))) (. .)))
19923525	13	(ROOT (S (NP (DT The) (NN intergroup) (NN difference)) (VP (VBD was) (ADJP (RB statistically) (JJ significant)) (PRN (-LRB- -LRB-) (ADVP (RB P)) (ADJP (JJ <) (NP (CD 0.05))) (-RRB- -RRB-))) (. .)))
19923525	14	(ROOT (S (S (NP (NNP Doc_19923525_1963_1970_Chemical)) (VP (VBD decreased) (PP (PP (IN from) (NP (NP (NP (CD 51.7) (JJ +) (NNS /)) (PRN (: -) (NP (NP (CD 4.5) (NN mm) (NNP Hg)) (VP (VBN sem) (PP (TO to) (NP (QP (CD 33.8) (CD +)))))) (: /))) (: -) (NP (NP (CD 5.2) (JJ mm) (NNP Hg) (NN sem)) (PP (IN in) (NP (DT the) (NNP NTG) (NN group)))))) (CC and) (PP (IN from) (NP (NP (QP (CD 38.6) (CD +)) (NNS /)) (PRN (: -) (NP (NP (CD 6.1) (NN mm) (NNP Hg)) (VP (VBN sem) (PP (TO to) (NP (QP (CD 25.4) (CD +)))))) (: /))))))) (: -) (S (NP (QP (CD 2.0) (CD mm)) (NNP Hg) (NNPS sem)) (PP (IN in) (NP (DT the) (JJ Doc_19923525_2117_2120_Chemical) (JJ +) (JJ Doc_19923525_2123_2127_Chemical) (NNS groups))) (, ,) (ADVP (RB respectively))) (. .)))
19923525	15	(ROOT (S (NP (EX There)) (VP (VBD were) (NP (NP (DT no) (JJ significant) (NNS differences)) (PP (IN among) (NP (NNS groups))))) (. .)))
19923525	16	(ROOT (S (PP (IN In) (NP (DT a) (NNP PA) (NN retention) (NN paradigm))) (, ,) (NP (NP (DT the) (NN injection)) (PP (IN of) (S (VP (VBG Doc_19923525_2259_2262_Chemical) (ADVP (RB immediately)) (PP (IN after) (S (VP (VBG learning)))))))) (VP (VBD produced) (NP (NP (DT a) (JJ significant) (NN impairment)) (PP (IN of) (NP (JJ long-term) (NN associative) (NN memory)))) (PP (IN in) (NP (NNS mice))) (, ,) (SBAR (IN whereas) (S (NP (JJ delayed) (NN induced) (NNS Doc_19923525_2389_2400_Disease)) (VP (VBD had) (NP (DT no) (NN effect)))))) (. .)))
19923525	17	(ROOT (S (NP (NNP Doc_19923525_2416_2420_Chemical)) (VP (VP (VBD attenuated) (NP (DT the) (NN disruption)) (PP (IN in) (NP (NP (NN consolidation)) (PP (IN of) (NP (NP (JJ long-term) (NN memory)) (VP (VBN caused) (PP (IN by) (NP (NNS Doc_19923525_2494_2497_Chemical))))))))) (CC but) (VP (VBD did) (RB not) (VP (VB improve) (ADVP (RB latency)) (PP (IN in) (NP (NP (DT the) (NN absence)) (PP (IN of) (NP (NNS Doc_19923525_2544_2555_Disease)))))))) (. .)))
19923525	18	(ROOT (S (NP (NP (DT The) (ADJP (JJ observed)) (NN effect)) (PP (IN of) (NP (NNS Doc_19923525_2580_2584_Chemical)))) (VP (MD may) (VP (VB have) (VP (VBN been) (ADJP (JJ attributable) (PP (TO to) (NP (NP (DT the) (NN preservation)) (PP (IN of) (NP (JJ Doc_19923525_2635_2642_Chemical) (NNS homeostasis)))))) (PP (IN during) (NP (NNS Doc_19923525_2662_2673_Disease))) (, ,) (SBAR (IN because) (S (NP (EX there)) (VP (VBD were) (NP (NP (DT no) (NNS differences)) (PP (IN in) (NP (DT the) (NNP PbtO) (PRN (-LRB- -LRB-) (NP (CD 2)) (-RRB- -RRB-)) (NNS indices)))) (PP (IN among) (NP (NNS groups))))))))) (. .)))
19940105	0	(ROOT (S (NP (JJ Metabotropic) (NN Doc_19940105_13_22_Chemical) (CD 7) (NN receptor) (NN subtype)) (VP (VBZ modulates) (NP (NN motor) (NNS symptoms)) (PP (IN in) (NP (NP (JJ rodent) (NNS models)) (PP (IN of) (NP (NNS Doc_19940105_87_106_Disease)))))) (. .)))
19940105	1	(ROOT (S (NP (NP (JJ Metabotropic) (NNS Doc_19940105_121_130_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP mGlu)) (-RRB- -RRB-)) (NNS receptors)) (VP (VP (VBP modulate) (NP (JJ synaptic) (NN transmission)) (PP (IN in) (NP (DT the) (JJ central) (JJ nervous) (NN system)))) (CC and) (VP (VBP represent) (NP (JJ promising) (JJ therapeutic) (NNS targets)) (PP (IN for) (NP (NP (JJ symptomatic) (NN treatment)) (PP (IN of) (NP (NP (NNS Doc_19940105_282_301_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_19940105_303_305_Disease)) (-RRB- -RRB-)))))))) (. .)))
19940105	2	(ROOT (S (S (PP (IN Among) (NP (DT the) (CD eight) (JJ mGlu) (NN receptor) (NNS subtypes))) (, ,) (NP (JJ mGlu7) (NN receptor)) (VP (VBZ is) (ADVP (RB prominently)) (VP (VBN expressed) (PP (IN in) (NP (DT the) (JJ basal) (NN ganglia)))))) (, ,) (CC but) (S (NP (NP (PRP$ its) (NN role)) (PP (IN in) (S (VP (VBG restoring) (NP (NN motor) (NN function)) (PP (IN in) (NP (NP (NN animal) (NNS models)) (PP (IN of) (NP (NNS Doc_19940105_471_473_Disease))))))))) (VP (VBZ is) (RB not) (VP (VBN known)))) (. .)))
19940105	3	(ROOT (S (NP (NP (NP (DT The) (NNS effects)) (PP (IN of) (NP (NP (NNS Doc_19940105_503_554_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_19940105_556_562_Chemical)) (-RRB- -RRB-))))) (, ,) (NP (NP (DT the) (JJ first) (JJ selective) (JJ allosteric) (NN activator)) (PP (IN of) (NP (JJ mGlu7) (NNS receptors)))) (, ,)) (VP (VBD were) (ADVP (RB thus)) (VP (VBN tested) (PP (IN in) (NP (NP (JJ different) (NN rodent) (NNS models)) (PP (IN of) (NP (NNS Doc_19940105_673_675_Disease))))))) (. .)))
19940105	4	(ROOT (S (ADVP (RB Here)) (, ,) (NP (PRP we)) (VP (VBP show) (SBAR (IN that) (S (NP (NP (NP (JJ oral)) (PRN (-LRB- -LRB-) (NP (CD 5) (NN mg/kg)) (-RRB- -RRB-))) (CC or) (NP (NP (NP (JJ intrastriatal) (NN administration)) (PRN (-LRB- -LRB-) (NP (NP (CD 0.1)) (CC and) (NP (CD 0.5) (NN nmol))) (-RRB- -RRB-))) (PP (IN of) (NP (NNS Doc_19940105_765_771_Chemical))))) (VP (VBZ reverses) (NP (NP (NN Doc_19940105_781_792_Chemical-induced) (NNS Doc_19940105_801_810_Disease)) (PP (IN in) (NP (NNS rats)))))))) (. .)))
19940105	5	(ROOT (S (NP (NP (NNP Doc_19940105_820_826_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (CD 2.5)) (CC and) (NP (CD 5) (NN mg/kg))) (-RRB- -RRB-))) (VP (VBZ reduces) (NP (NN Doc_19940105_853_864_Chemical-induced) (NNS rotations)) (PP (IN in) (NP (NP (JJ unilateral) (NNS Doc_19940105_897_914_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_19940105_916_922_Chemical)) (-RRB- -RRB-)) (: -) (NP (JJ lesioned) (NNS rats))))) (. .)))
19940105	6	(ROOT (S (PP (IN In) (NP (NP (DT a) (ADJP (RBR more) (JJ complex)) (NN task)) (VP (ADVP (RB commonly)) (VBN used) (S (VP (TO to) (VP (VB evaluate) (NP (NP (JJ major) (JJ Doc_19940105_994_1002_Disease) (NNS symptoms)) (PP (IN of) (NP (JJ Doc_19940105_1015_1017_Disease) (NNS patients)))))))))) (, ,) (NP (CD 5) (JJ mg/kg) (NNS Doc_19940105_1036_1042_Chemical)) (VP (VBZ reverses) (NP (DT the) (VBN increased) (NN reaction) (NN time)) (S (VP (TO to) (VP (VB respond) (PP (TO to) (NP (NP (DT a) (NN cue)) (PP (IN of) (NP (JJ bilateral) (NN Doc_19940105_1113_1119_Chemical-lesioned) (NNS rats))))))))) (. .)))
19940105	7	(ROOT (S (PP (IN In) (NP (NN addition))) (, ,) (NP (NNS Doc_19940105_1148_1154_Chemical)) (VP (VBZ reduces) (NP (NP (NP (DT the) (NN duration)) (PP (IN of) (NP (NP (NN Doc_19940105_1179_1190_Chemical-induced) (NNS Doc_19940105_1199_1208_Disease)) (PP (IN in) (NP (NP (DT a) (JJ mGlu7) (JJ receptor-dependent) (NN manner)) (PP (IN in) (NP (NN wild-type)))))))) (CONJP (CC but) (RB not)) (NP (JJ mGlu7) (NN receptor) (NN knockout) (NNS mice)))) (. .)))
19940105	8	(ROOT (S (NP (NP (JJR Higher) (NNS doses)) (PP (IN of) (NP (NP (NNS Doc_19940105_1313_1319_Chemical)) (PRN (-LRB- -LRB-) (NP (QP (CD 10) (CC and) (CD 20)) (NN mg/kg) (NN p.o.)) (-RRB- -RRB-))))) (VP (VBP have) (NP (NP (DT no) (NN effect)) (PP (IN on) (NP (NP (DT the) (JJ same) (NNS models)) (PP (IN of) (NP (NNS Doc_19940105_1380_1382_Disease))))))) (. .)))
19940105	9	(ROOT (S (ADVP (RB Overall)) (NP (DT these) (NNS findings)) (VP (VBP suggest) (SBAR (IN that) (S (NP (JJ mGlu7) (NN receptor) (NN activation)) (VP (MD can) (VP (VB reverse) (NP (NP (NN motor) (NN dysfunction)) (VP (VBN associated) (PP (IN with) (NP (JJ reduced) (JJ Doc_19940105_1500_1508_Chemical) (NN activity)))))))))) (. .)))
19940105	10	(ROOT (S (NP (NP (JJ Selective) (NNS ligands)) (PP (IN of) (NP (JJ mGlu7) (NN receptor) (NNS subtypes)))) (VP (MD may) (ADVP (RB thus)) (VP (VB be) (VP (VBN considered) (PP (IN as) (NP (NP (JJ promising) (NNS compounds)) (PP (IN for) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (JJ antiparkinsonian) (JJ therapeutic) (NNS strategies)))))))))) (. .)))
19944333	0	(ROOT (FRAG (ADJP (NP (CD Doc_19944333_0_9_Chemical-induced) (NNS Doc_19944333_18_45_Disease)) (JJ due) (PP (TO to) (NP (NNS Doc_19944333_53_74_Disease)))) (. .)))
19944333	1	(ROOT (S (NP (NP (DT A) (JJ 65-year-old) (NN man)) (PP (IN with) (NP (JJ advanced) (NNS Doc_19944333_108_128_Disease)))) (VP (VBD was) (VP (VBN admitted) (PP (JJ due) (TO to) (NP (NP (VBG continuing) (NNS Doc_19944333_160_170_Disease)) (PP (IN at) (NP (NN rest))))))) (. .)))
19944333	2	(ROOT (S (PP (NP (CD Two) (NNS weeks)) (IN before) (NP (PRP$ his) (NN admission))) (, ,) (NP (NNS Doc_19944333_212_221_Chemical)) (VP (VBD had) (VP (VBN been) (VP (VBN started)))) (. .)))
19944333	3	(ROOT (S (NP (PRP He)) (VP (VBD was) (VP (VBN diagnosed) (PP (IN with) (NP (JJ non-ST-elevation) (NNS Doc_19944333_279_300_Disease))) (PP (IN by) (NP (NP (NN laboratory) (NNS data)) (CC and) (NP (NN electrocardiogram)))))) (. .)))
19944333	4	(ROOT (S (NP (JJ Enhanced) (NN heart) (JJ magnetic) (NN resonance) (NNS imaging)) (ADVP (RB also)) (VP (VBD showed) (NP (NNS Doc_19944333_397_422_Disease))) (. .)))
19944333	5	(ROOT (S (ADVP (RB However)) (, ,) (NP (EX there)) (VP (VBD was) (NP (NP (DT no) (NNS stenosis)) (PP (IN in) (NP (NP (JJ coronary) (NNS arteries)) (PP (IN on) (NP (NN angiography))))))) (. .)))
19944333	6	(ROOT (S (NP (NNP Doc_19944333_492_513_Disease)) (VP (VBD was) (VP (VBN induced) (PP (IN by) (NP (DT a) (JJ provocative) (NN test))))) (. .)))
19944333	7	(ROOT (S (NP (NP (NNP Cessation)) (PP (IN of) (NP (NNS Doc_19944333_562_571_Chemical) (CC and) (NN administration))) (PP (IN of) (NP (NN Doc_19944333_594_596_Chemical-channel) (NN blocker) (CC and) (NNS Doc_19944333_617_625_Chemical)))) (VP (VP (VBD ameliorated) (NP (PRP$ his) (NNS symptoms))) (, ,) (CC but) (VP (ADVP (RB relapse)) (VBD occurred) (PP (IN after) (NP (NP (NN resumption)) (PP (IN of) (NP (NNS Doc_19944333_693_702_Chemical))))))) (. .)))
19944333	8	(ROOT (S (NP (NP (NNP Addition)) (PP (IN of) (NP (JJ oral) (NNS Doc_19944333_721_731_Chemical)))) (VP (VP (VBD reduced) (NP (PRP$ his) (NNS symptoms))) (CC and) (VP (VBD maintained) (NP (JJ Doc_19944333_768_781_Disease) (NN status)))) (. .)))
19944333	9	(ROOT (S (NP (PRP We)) (VP (VBP report) (NP (NP (DT the) (JJ first) (NN case)) (PP (IN of) (NP (NN Doc_19944333_818_827_Chemical-induced) (NNS Doc_19944333_836_857_Disease))))) (. .)))
19944333	10	(ROOT (S (NP (NNP Doc_19944333_859_868_Chemical)) (VP (VBZ is) (NP (NP (DT a) (JJ multikinase) (NN inhibitor)) (SBAR (WHNP (WDT that)) (S (VP (VBZ targets) (S (VP (VBG signaling) (S (NP (NNS pathways)) (ADJP (JJ necessary) (PP (IN for) (NP (JJ cellular) (NN proliferation) (CC and) (NN survival)))))))))))) (. .)))
19944333	11	(ROOT (S (PP (IN On) (NP (DT the) (JJ other) (NN hand))) (, ,) (NP (DT the) (NNP Rho/ROCK) (NN pathway)) (VP (VBZ has) (NP (NP (DT an) (JJ important) (NN role)) (PP (IN in) (NP (NP (DT the) (NNS pathogenesis)) (PP (IN of) (NP (NNS Doc_19944333_1064_1085_Disease))))))) (. .)))
19944333	12	(ROOT (S (NP (PRP$ Our) (NN report)) (VP (MD may) (VP (VB show) (NP (NP (DT an) (JJ adverse) (NN effect)) (PP (IN on) (NP (DT the) (NNP Rho/ROCK) (NN pathway)))) (PP (IN by) (NP (JJ Doc_19944333_1152_1161_Chemical) (NN use))))) (. .)))
19944736	0	(ROOT (S (NP (DT A) (NN novel) (NN animal) (NN model)) (VP (TO to) (VP (VB evaluate) (NP (NP (DT the) (NN ability)) (PP (IN of) (NP (DT a) (NN drug) (NN delivery) (NN system)))) (S (VP (TO to) (VP (VB promote) (NP (DT the) (NN passage)) (PP (IN through) (NP (DT the) (NNP BBB)))))))) (. .)))
19944736	1	(ROOT (S (NP (NP (DT The) (NN purpose)) (PP (IN of) (NP (DT this) (NN investigation)))) (VP (VBD was) (S (VP (TO to) (VP (VB explore) (NP (NP (DT the) (NN potentiality)) (PP (IN of) (NP (DT a) (NN novel) (NN animal) (NN model)))) (S (VP (TO to) (VP (VB be) (VP (VBN used) (PP (IN for) (NP (NP (DT the) (RB in) (JJ vivo) (NN evaluation)) (PP (IN of) (NP (NP (DT the) (NN ability)) (PP (IN of) (NP (DT a) (NN drug) (NN delivery) (NN system))))))) (S (VP (VP (TO to) (VP (VB promote) (NP (DT the) (NN passage)) (PP (IN through) (NP (NP (DT the) (JJ blood-brain) (NN barrier)) (PRN (-LRB- -LRB-) (NP (NNP BBB)) (-RRB- -RRB-)))))) (CC and/or) (VP (TO to) (VP (VB improve) (NP (DT the) (NN brain) (NN localization)))) (PP (IN of) (NP (DT a) (JJ bioactive) (NN compound))))))))))))) (. .)))
19944736	2	(ROOT (S (NP (DT A) (NN Doc_19944736_409_417_Chemical-coated) (NNS Doc_19944736_425_443_Chemical) (NNS nanoparticles)) (VP (VBD was) (VP (VBN used) (PP (IN as) (NP (NP (DT a) (NN model)) (PP (IN of) (NP (NP (JJ colloidal) (NN drug) (NN delivery) (NN system)) (, ,) (NP (ADJP (JJ able) (PP (TO to) (NP (NN trespass)))) (DT the) (NN BBB)))))))) (. .)))
19944736	3	(ROOT (S (NP (NP (NNP Doc_19944736_539_546_Chemical)) (, ,) (VP (VBN administered) (PP (IN in) (NP (JJ Doc_19944736_564_568_Chemical) (JJ pre-treated) (NNS rats)))) (, ,)) (VP (VBZ induces) (NP (NP (JJ electrocorticographic) (NNS Doc_19944736_617_625_Disease)) (CC and) (NP (VBN delayed) (NNS Doc_19944736_638_656_Disease)))) (. .)))
19944736	4	(ROOT (S (NP (NP (DT The) (JJ toxic) (NNS effects)) (PP (IN of) (NP (NP (NP (JJ Doc_19944736_679_686_Chemical-loaded) (JJ Doc_19944736_694_712_Chemical) (NNS nanoparticles)) (PRN (-LRB- -LRB-) (NP (NNP 5mg/kg)) (-RRB- -RRB-))) (, ,) (NP (NP (DT a) (JJ saline) (NN solution)) (PP (IN of) (NP (NNS Doc_19944736_758_765_Chemical))) (PRN (-LRB- -LRB-) (NP (NNP 5mg/kg)) (-RRB- -RRB-))) (CC and) (NP (DT an) (ADJP (JJ empty) (JJ colloidal)) (NN nanoparticle) (NN suspension))))) (VP (VBD were) (VP (VBN compared) (PP (VBG following) (NP (NP (NN i.p.) (NN administration)) (PP (IN in) (NP (NNP Doc_19944736_869_873_Chemical-pre-treated) (NNP Wistar) (NNS rats))))))) (. .)))
19944736	5	(ROOT (S (NP (NP (PDT All) (DT the) (NNS animals)) (VP (VBN treated) (PP (IN with) (NP (NN Doc_19944736_928_935_Chemical-loaded) (NNS nanoparticles))))) (VP (VBD showed) (NP (NP (DT an) (JJR earlier) (NN outcome)) (PP (IN of) (NP (NP (NNP CNS) (JJ adverse) (NNS symptoms)) (, ,) (NP (JJ i.e.) (JJ Doc_19944736_1013_1022_Disease) (NN onset)) (, ,)))) (PP (IN with) (NP (NP (NN respect)) (PP (TO to) (NP (NP (DT those) (NNS animals)) (VP (VBN treated) (PP (IN with) (NP (NP (DT the) (JJ free) (NN compound)) (PRN (-LRB- -LRB-) (NP (NP (CD 10) (NN min)) (PP (IN vs.) (NP (CD 22))) (VP (VBN min) (ADVP (RB respectively)))) (-RRB- -RRB-)))))))))) (. .)))
19944736	6	(ROOT (S (PP (IN In) (NP (NN addition))) (, ,) (NP (NNS Doc_19944736_1138_1145_Chemical-loaded)) (VP (VBZ nanoparticles) (NP (NP (NN administration)) (VP (VBN induced) (NP (NP (NNS Doc_19944736_1190_1214_Disease)) (PP (IN in) (NP (NP (CD CA1) (NN field)) (PP (IN of) (NP (NP (DT the) (NNS hippocampus)) (PP (IN in) (NP (DT all) (JJ treated) (NNS animals)))))))) (, ,) (SBAR (IN while) (S (NP (NP (DT the) (JJ saline) (NN solution)) (PP (IN of) (NP (NNS Doc_19944736_1300_1307_Chemical)))) (ADVP (RB only)) (PP (IN in) (NP (NP (CD 60) (NN %)) (PP (IN of) (NP (NNS animals)))))))))) (. .)))
19944736	7	(ROOT (S (NP (JJ Empty) (NNS nanoparticles)) (VP (VBD provided) (NP (JJ similar) (NNS results)) (S (VP (TO to) (VP (VB control) (NP (NP (-LRB- -LRB-) (JJ saline-treated) (-RRB- -RRB-) (NN group)) (PP (IN of) (NP (NNS animals)))))))) (. .)))
19944736	8	(ROOT (S (S (PP (IN In) (NP (NN conclusion))) (, ,) (NP (NP (DT the) (NN evaluation)) (PP (IN of) (NP (NP (NP (NN time-to-onset)) (PP (IN of) (NP (NNS symptoms)))) (CC and) (NP (NP (DT the) (NN severity)) (PP (IN of) (NP (NN neurodegenerative))))))) (VP (VBZ processes) (VP (VBN induced) (PP (IN by) (NP (NP (DT the) (NN Doc_19944736_1545_1552_Chemical-Doc_19944736_1553_1560_Chemical) (NN model)) (PP (IN of) (NP (NP (NNS Doc_19944736_1570_1578_Disease)) (PP (IN in) (NP (DT the) (NN rat)))))))))) (, ,) (VP (MD could) (VP (VB be) (VP (VBN used) (S (VP (TO to) (VP (VB evaluate) (ADVP (RB preliminarily)) (NP (NP (DT the) (NN capability)) (PP (IN of) (NP (NP (DT a) (NN drug) (NN delivery) (NN system)) (PP (TO to) (NP (NP (NN trespass)) (PRN (-LRB- -LRB-) (NP (QP (CC or) (RB not))) (-RRB- -RRB-))))))))))))) (NP (NP (DT the) (NNP BBB)) (PP (IN in) (NP (NN vivo)))) (. .)))
19996135	0	(ROOT (S (NP (JJ High-dose) (NNS Doc_19996135_10_25_Chemical)) (VP (VBZ is) (VP (VBN associated) (PP (IN with) (NP (NP (JJ nonischemic) (JJ clinical) (NNS Doc_19996135_66_74_Disease)) (PP (IN in) (NP (JJ cardiac) (JJ surgical) (NNS patients))))))) (. .)))
19996135	1	(ROOT (S (PP (IN In) (NP (CD 2) (JJ separate) (NNS centers))) (, ,) (NP (PRP we)) (VP (VBD observed) (NP (DT a) (JJ notable) (NN increase)) (PP (IN in) (NP (NP (DT the) (NN incidence)) (PP (IN of) (NP (JJ postoperative) (JJ Doc_19996135_205_215_Disease) (NNS Doc_19996135_216_224_Disease))))) (PP (IN from) (NP (QP (CD 1.3) (NN %) (TO to) (CD 3.8) (NN %)))) (PP (IN in) (S (NP (NNS patients)) (VP (VBG having) (VP (VBN undergone) (NP (JJ major) (JJ cardiac) (JJ surgical) (NNS procedures))))))) (. .)))
19996135	2	(ROOT (S (NP (DT These) (NNS events)) (VP (VBD were) (NP (ADJP (RB temporally) (JJ coincident) (PP (IN with) (NP (NP (DT the) (JJ initial) (NN use)) (PP (IN of) (NP (NP (JJ high-dose) (NNS Doc_19996135_381_396_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_19996135_398_401_Chemical)) (-RRB- -RRB-))))))) (NN therapy)) (PP (IN after) (NP (NP (NN withdrawal)) (PP (IN of) (NP (NP (NN aprotinin)) (PP (IN from) (NP (JJ general) (JJ clinical) (NN usage)))))))) (. .)))
19996135	3	(ROOT (S (NP (NP (DT The) (NN purpose)) (PP (IN of) (NP (DT this) (NN review)))) (VP (VBD was) (S (VP (TO to) (VP (VB perform) (NP (DT a) (NN retrospective) (NN analysis)) (S (VP (TO to) (VP (VB examine) (SBAR (IN whether) (S (NP (EX there)) (VP (VBD was) (NP (NP (DT a) (NN relation)) (PP (IN between) (NP (JJ Doc_19996135_585_588_Chemical) (NN usage) (CC and) (NNS Doc_19996135_599_607_Disease)))) (PP (IN after) (NP (JJ cardiac) (NN surgery))))))))))))) (. .)))
19996135	4	(ROOT (S (NP (DT An) (JJ in-depth) (NN chart) (NN review)) (VP (VBD was) (VP (VBN undertaken) (PP (IN in) (NP (NP (DT all) (CD 24) (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBD developed) (NP (JJ perioperative) (NNS Doc_19996135_727_735_Disease))))))))) (. .)))
19996135	5	(ROOT (S (S (NP (JJ Electroencephalographic) (NN activity)) (VP (VBD was) (VP (VBN recorded) (PP (IN in) (NP (NP (CD 11)) (PP (IN of) (NP (DT these) (NNS patients)))))))) (, ,) (CC and) (S (NP (DT all) (NNS patients)) (VP (VBD had) (NP (NP (DT a) (JJ formal) (JJ neurological) (NN evaluation)) (CC and) (NP (NN brain) (NN imaging) (NNS studies))))) (. .)))
19996135	6	(ROOT (S (S (NP (NP (CD Twenty-one)) (PP (IN of) (NP (DT the) (CD 24) (NNS patients)))) (VP (VBD did) (RB not) (VP (VB have) (NP (NP (NN evidence)) (PP (IN of) (NP (JJ new) (NNS Doc_19996135_957_981_Disease))))))) (, ,) (CC but) (S (NP (NNS Doc_19996135_987_995_Disease)) (VP (VBD were) (ADJP (RB likely) (JJ due) (PP (TO to) (NP (NP (NNS Doc_19996135_1015_1036_Disease)) (PP (IN in) (NP (CD 3) (NNS patients)))))))) (. .)))
19996135	7	(ROOT (S (NP (NP (DT All) (NNS patients)) (PP (IN with) (NP (NNS Doc_19996135_1070_1078_Disease)))) (VP (VBD did) (RB not) (VP (VB have) (NP (JJ permanent) (NNS Doc_19996135_1102_1128_Disease)))) (. .)))
19996135	8	(ROOT (S (S (NP (NP (DT All) (CD 24) (NNS patients)) (PP (IN with) (NP (NNS Doc_19996135_1151_1159_Disease)))) (VP (VBD received) (SBAR (S (NP (NP (JJ high) (NNS doses)) (PP (IN of) (NP (NP (NNS Doc_19996135_1183_1186_Chemical)) (VP (ADVP (RB intraoperatively)) (VBG ranging) (PP (IN from) (NP (QP (CD 61) (TO to) (CD 259)) (NN mg/kg))))))) (, ,) (VP (VBD had) (NP (NP (DT a) (JJ mean) (NN age)) (PP (IN of) (NP (CD 69.9) (NNS years))))))))) (, ,) (CC and) (S (NP (NP (CD 21)) (PP (IN of) (NP (CD 24)))) (VP (VBD had) (VP (VBN undergone) (NP (NP (JJ open) (NN chamber)) (CONJP (RB rather) (IN than)) (NP (JJ coronary) (NN bypass) (NNS procedures)))))) (. .)))
19996135	9	(ROOT (S (NP (QP (DT All) (CC but) (CD one)) (NN patient)) (VP (VBD were) (VP (VBN managed) (S (VP (VBG using) (NP (JJ cardiopulmonary) (NN bypass)))))) (. .)))
19996135	10	(ROOT (S (NP (NP (DT No) (NN evidence)) (PP (IN of) (NP (NP (JJ Doc_19996135_1422_1436_Disease) (, ,) (ADJP (JJ metabolic) (, ,) (CC or) (JJ Doc_19996135_1452_1464_Disease-induced)) (NNS causes)) (PP (IN for) (NP (PRP$ their) (NNS Doc_19996135_1490_1498_Disease)))))) (VP (VBD was) (ADJP (JJ apparent))) (. .)))
19996135	11	(ROOT (S (NP (PRP$ Our) (NNS results)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NP (NN use)) (PP (IN of) (NP (NP (JJ high-dose) (NNS Doc_19996135_1567_1570_Chemical)) (PP (IN in) (NP (NP (JJR older) (NNS patients)) (PP (IN in) (NP (NP (NN conjunction)) (PP (IN with) (NP (NP (JJ cardiopulmonary) (NN bypass)) (CC and) (NP (JJ open-chamber) (JJ cardiac) (NN surgery))))))))))) (VP (VBZ is) (VP (VBN associated) (PP (IN with) (NP (NP (JJ clinical) (NNS Doc_19996135_1693_1701_Disease)) (PP (IN in) (NP (ADJP (JJ susceptible)) (NNS patients)))))))))) (. .)))
2004	0	(ROOT (NP (NP (NP (JJ Electrocardiographic) (NNS changes) (CC and) (NNS Doc_2004_33_52_Disease)) (PP (IN in) (NP (NNS patients)))) (VP (VBG receiving) (NP (JJ psychotropic) (NNS drugs))) (. .)))
2004	1	(ROOT (S (NP (CD Eight) (NNS patients)) (VP (VBD had) (NP (NP (JJ cardiac) (NNS manifestations)) (SBAR (WHNP (WDT that)) (S (VP (VBD were) (ADJP (JJ life-threatening) (PP (IN in) (NP (CD five)))) (PP (IN while) (S (VP (VBG taking) (NP (NP (JJ psychotropic) (NNS drugs)) (, ,) (NP (DT either) (NNS Doc_2004_212_226_Chemical)) (CC or) (NP (JJ tricyclic) (NNS antidepressants))))))))))) (. .)))
2004	2	(ROOT (S (SBAR (IN Although) (S (NP (JJS most) (NNS patients)) (VP (VBD were) (VP (VBG receiving) (NP (JJ several) (NNS drugs)))))) (, ,) (NP (NP (NNS Doc_2004_310_318_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_2004_320_332_Chemical)) (-RRB- -RRB-))) (VP (VBD appeared) (S (VP (TO to) (VP (VB be) (ADJP (JJ responsible) (PP (IN for) (NP (NP (CD five) (NNS cases)) (PP (IN of) (NP (NP (NNS Doc_2004_379_402_Disease)) (, ,) (SBAR (WHNP (CD one) (WHPP (IN of) (WHNP (WDT which)))) (S (VP (VBD was) (ADJP (JJ fatal) (PP (IN in) (NP (DT a) (ADJP (CD 35) (NN year) (JJ old)) (NN woman)))))))))))))))) (. .)))
2004	3	(ROOT (S (NP (NNP Doc_2004_451_479_Disease)) (VP (VBD developed) (PP (IN in) (NP (NP (CD one) (JJ patient) (NN receiving) (NNS Doc_2004_515_524_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_2004_526_540_Chemical)) (-RRB- -RRB-))))) (. .)))
2004	4	(ROOT (S (NP (NP (NP (NNP Doc_2004_543_550_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_2004_552_565_Chemical)) (-RRB- -RRB-))) (CC and) (NP (NP (NNS Doc_2004_571_577_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_2004_579_592_Chemical)) (-RRB- -RRB-)))) (DT each) (VP (VBD produced) (NP (NNS Doc_2004_608_632_Disease)) (PP (IN in) (NP (DT a) (ADJP (NP (CD 73) (NN year)) (JJ old)) (NN woman)))) (. .)))
2004	5	(ROOT (S (NP (NNP Electrocardiographic) (NNP T) (CC and) (NNP U) (NN wave) (NNS abnormalities)) (VP (VBD were) (ADJP (JJ present) (PP (IN in) (NP (JJS most) (NNS patients))))) (. .)))
2004	6	(ROOT (S (S (NP (DT The) (NNS Doc_2004_740_763_Disease)) (VP (VBD responded) (PP (PP (TO to) (NP (NP (JJ intravenous) (NN administration)) (PP (IN of) (NP (NNS Doc_2004_807_816_Chemical))))) (CC and) (PP (TO to) (NP (JJ direct) (JJ current) (JJ electric) (NN shock)))))) (: ;) (S (NP (NN ventricular) (NN pacing)) (VP (VBD was) (VP (VBN required) (PP (IN in) (NP (NP (DT some) (NNS instances) (CC and) (JJ intravenous) (NN administration)) (PP (IN of) (NP (NNS Doc_2004_939_950_Chemical))))) (PP (VBN combined) (PP (IN with) (NP (NP (NN ventricular) (NN pacing)) (PP (IN in) (NP (CD one))))))))) (. .)))
2004	7	(ROOT (S (NP (DT The) (NNS Doc_2004_996_1012_Disease)) (ADVP (RB generally)) (VP (VBD subsided) (PP (IN within) (NP (CD 48) (NNS hours))) (SBAR (IN after) (S (NP (NP (NN administration)) (PP (IN of) (NP (DT the) (NNS drugs)))) (VP (VBD was) (VP (VBN stopped)))))) (. .)))
2004	8	(ROOT (S (S (NP (NP (CD Five)) (PP (IN of) (NP (DT the) (CD eight) (NNS patients)))) (VP (VBD were) (NP (NP (CD 50) (NNS years)) (PP (IN of) (NP (NP (NN age)) (CC or) (NP (JJR younger))))))) (: ;) (S (NP (RB only) (CD one)) (ADVP (RB clearly)) (VP (VBD had) (NP (JJ antecedent) (NNS Doc_2004_1187_1200_Disease)))) (. .)))
2004	9	(ROOT (S (NP (JJ Major) (NNS Doc_2004_1208_1227_Disease)) (VP (VBP are) (NP (NP (DT a) (JJ potential) (NN hazard)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN without) (NP (NP (NNS Doc_2004_1271_1284_Disease)) (SBAR (WHNP (WP who)) (S (VP (VBP are) (VP (VBG receiving) (NP (NP (JJ customary) (JJ therapeutic) (NNS doses)) (PP (IN of) (NP (JJ psychotropic) (NNS drugs)))))))))))))) (. .)))
2004	10	(ROOT (S (NP (DT A) (JJ prospective) (JJ clinical) (NN trial)) (VP (VBZ is) (VP (VBN suggested) (S (VP (TO to) (VP (VB quantify) (NP (NP (DT the) (NN risk)) (PP (IN of) (NP (NNS Doc_2004_1420_1441_Disease)))) (PP (TO to) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NP (NNS Doc_2004_1464_1478_Chemical)) (CC or) (NP (JJ tricyclic) (NN antidepressant) (NNS drugs))))))))))) (. .)))
2004015	0	(ROOT (S (NP (NP (NNP Sensitivity)) (PP (IN of) (NP (NP (JJ erythroid) (NN progenitor) (NNS colonies)) (PP (TO to) (NP (NP (NN erythropoietin)) (PP (IN in) (NP (NNS Doc_2004015_66_80_Chemical)))))))) (VP (VBD treated) (NP (JJ Doc_2004015_89_104_Disease) (NNS mice))) (. .)))
2004015	1	(ROOT (S (NP (NP (DT The) (NNS Doc_2004015_115_122_Disease)) (VP (VBN induced) (PP (IN by) (NP (NNS Doc_2004015_134_161_Chemical)))) (PRN (-LRB- -LRB-) (NP (NNP Doc_2004015_163_166_Chemical)) (-RRB- -RRB-))) (VP (VBZ is) (ADVP (RB poorly)) (VP (VBN understood))) (. .)))
2004015	2	(ROOT (S (NP (PRP We)) (VP (VBP have) (VP (VBN used) (NP (NP (DT a) (JJ murine) (NN model)) (PP (IN of) (NP (NP (NNS Doc_2004015_221_225_Disease)) (, ,) (NP (NP (NNS Doc_2004015_227_236_Disease)) (PP (IN of) (NP (JJ female) (NN C57BL/6) (NNS mice))))))) (PP (IN with) (NP (ADJP (JJ LP-BM5) (JJ murine)) (JJ Doc_2004015_279_288_Disease) (PRN (-LRB- -LRB-) (NP (NNP MuLV)) (-RRB- -RRB-)) (NN virus))) (, ,) (S (VP (TO to) (VP (VB determine) (SBAR (IN if) (S (NP (NN Doc_2004015_319_322_Chemical-induced) (NNS Doc_2004015_331_338_Disease)) (VP (VBZ is) (ADJP (JJ due)) (, ,) (PP (IN in) (NP (NN part))) (, ,) (PP (TO to) (NP (NP (VBN decreased) (NNS responsiveness)) (PP (IN of) (NP (NP (NP (JJ erythropoietic) (NNS precursors)) (PRN (-LRB- -LRB-) (NP (NNP BFU-e)) (-RRB- -RRB-))) (PP (TO to) (NP (NP (NN erythropoietin)) (PRN (-LRB- -LRB-) (NP (NNP EPO)) (-RRB- -RRB-)))))))))))))))) (. .)))
2004015	3	(ROOT (S (NP (NP (NNS Mice)) (PP (IN in) (NP (NP (DT the) (JJ early) (NN stage)) (PP (IN of) (NP (NNP LP-BM5) (NNP MuLV) (NN disease)))))) (VP (VBD were) (VP (VBN given) (NP (NP (NNS Doc_2004015_504_507_Chemical)) (PP (IN in) (NP (PRP$ their) (NN drinking) (NN water)))) (PP (IN at) (NP (QP (CD 1.0) (CC and) (CD 2.5)) (NN mg/ml))))) (. .)))
2004015	4	(ROOT (S (NP (NNP Doc_2004015_554_557_Chemical)) (VP (VBD produced) (NP (NNS Doc_2004015_567_574_Disease)) (PP (IN in) (NP (DT both) (NNS groups))) (, ,) (PP (IN in) (NP (DT a) (JJ dose-dependent) (NN fashion)))) (. .)))
2004015	5	(ROOT (S (PP (IN Despite) (NP (DT the) (NNS Doc_2004015_632_639_Disease))) (, ,) (NP (NP (DT the) (NN number)) (PP (IN of) (NP (NP (NN splenic) (CC and) (NN bone) (NN marrow) (NN BFU-e)) (PP (IN in) (NP (NP (NNS Doc_2004015_688_691_Chemical)) (VP (VBN treated) (NP (NP (NNS mice)) (VP (VBN increased) (PRT (RP up)) (PP (TO to) (NP (NP (JJ five-fold)) (PP (IN over) (NP (NNS levels))))))))))))) (VP (VBD observed) (PP (IN in) (NP (ADJP (JJ infected) (JJ untreated)) (NNS animals))) (PP (IN after) (NP (NP (CD 15) (NNS d)) (PP (IN of) (NP (NN treatment)))))) (. .)))
2004015	6	(ROOT (S (NP (NP (NN Colony) (NN formation)) (PP (IN by) (NP (NN splenic) (CC and) (NN bone) (NN marrow) (NN BFUe)))) (VP (VBD was) (VP (VBN stimulated) (PP (IN at) (NP (NP (JJR lower) (NNS concentrations)) (PP (IN of) (NP (NNP EPO))))) (PP (IN in) (NP (NP (NNS mice)) (VP (VBG receiving) (NP (NP (NNS Doc_2004015_920_923_Chemical)) (PP (IN for) (NP (CD 15) (NNS d)))) (PP (IN than) (PP (IN for) (NP (ADJP (JJ infected) (, ,) (JJ untreated)) (NNS mice))))))))) (. .)))
2004015	7	(ROOT (S (PP (IN By) (NP (NN day) (CD 30))) (, ,) (NP (NP (NN sensitivity)) (PP (IN of) (NP (NP (DT both) (NN splenic) (CC and) (NN bone) (NN marrow) (NN BFU-e)) (PP (IN of) (NP (JJ treated) (NNS animals)))))) (VP (VBD returned) (PP (TO to) (NP (NP (DT that)) (VP (VBN observed) (PP (IN from) (NP (NP (NNS cells)) (PP (IN of) (NP (ADJP (JJ infected) (JJ untreated)) (NNS animals))))))))) (. .)))
2004015	8	(ROOT (S (NP (NP (DT The) (JJ mean) (NN plasma) (NNS levels)) (PP (IN of) (NP (NNP EPO)))) (VP (VBD observed) (PP (IN in) (NP (NP (NNS Doc_2004015_1158_1161_Chemical)) (VP (VBN treated) (SBAR (S (NP (NNS mice)) (VP (VBD were) (ADJP (JJ appropriate)) (SBAR (IN for) (S (NP (NP (DT the) (NN degree)) (PP (IN of) (NP (NNS Doc_2004015_1210_1217_Disease)))) (VP (VBD observed) (SBAR (WHADVP (WRB when)) (S (VP (VBN compared) (PP (IN with) (NP (NP (NNS Doc_2004015_1246_1261_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_2004015_1263_1266_Chemical)) (-RRB- -RRB-)) (VP (VBN treated) (NP (NNS mice)))))))))))))))))) (. .)))
2004015	9	(ROOT (S (NP (NP (NP (DT The) (NNS numbers)) (PP (IN of) (NP (NNP BFU-e)))) (CC and) (NP (NP (DT the) (NN percentage)) (PP (IN of) (NP (NN bone) (NN marrow) (NNS erythroblasts))))) (VP (VBD observed) (SBAR (S (VP (VBD were) (ADJP (JJ comparable) (PP (IN in) (NP (NP (NNS Doc_2004015_1379_1382_Chemical) (CC and) (NNS Doc_2004015_1387_1390_Chemical)) (VP (VBN treated) (NP (NNS mice)) (PP (IN with) (NP (NP (JJ similar) (NNS degrees)) (PP (IN of) (NP (NNS Doc_2004015_1428_1435_Disease))))))))))))) (. .)))
2004015	10	(ROOT (S (ADVP (RB However)) (, ,) (NP (NNS Doc_2004015_1446_1461_Disease)) (VP (VBD was) (ADJP (JJ inappropriate) (PP (IN for) (NP (NP (DT the) (NN degree)) (PP (IN of) (NP (NP (NNS Doc_2004015_1498_1505_Disease)) (VP (VBN observed) (PP (IN in) (NP (NP (NNS Doc_2004015_1518_1521_Chemical)) (VP (VBN treated) (NP (JJ infected) (NNS mice)))))))))))) (. .)))
2004015	11	(ROOT (S (NP (NP (JJ Doc_2004015_1545_1548_Chemical-induced) (JJ peripheral) (NNS Doc_2004015_1568_1575_Disease)) (PP (IN in) (NP (NP (DT the) (NN face)) (PP (IN of) (NP (NP (NP (VBN increased) (NNS numbers)) (PP (IN of) (NP (NNP BFU-e)))) (CC and) (NP (NP (VBN increased) (NNS levels)) (PP (IN of) (NP (NNP plasma) (NNP EPO))))))))) (VP (VBP suggest) (NP (NP (DT a) (NN lesion)) (PP (IN in) (NP (NN terminal) (NN differentiation))))) (. .)))
20042557	0	(ROOT (NP (NP (NP (NP (NN Sedation) (NN depth)) (PP (IN during) (NP (JJ spinal) (NN anesthesia)))) (CC and) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (NP (NNS Doc_20042557_63_85_Disease)) (PP (IN in) (NP (JJ elderly) (NNS patients))))))) (VP (VBG undergoing) (NP (JJ Doc_20042557_117_129_Disease) (NN repair))) (. .)))
20042557	1	(ROOT (S (S (VP (TO To) (VP (VB determine) (SBAR (IN whether) (S (S (VP (VBG limiting) (NP (JJ intraoperative) (NN sedation) (NN depth)) (PP (IN during) (NP (NP (JJ spinal) (NN anesthesia)) (PP (IN for) (NP (NNS Doc_20042557_238_250_Disease))))))) (VP (VBP repair) (PP (IN in) (NP (JJ elderly) (NNS patients))))))))) (VP (MD can) (VP (VB decrease) (NP (NP (DT the) (NN prevalence)) (PP (IN of) (NP (NNS Doc_20042557_309_331_Disease)))))) (. .)))
20042557	2	(ROOT (FRAG (NP (NNS PATIENTS) (CC AND) (NNS METHODS)) (: :) (S (NP (PRP We)) (VP (VBD performed) (NP (DT a) (JJ double-blind) (, ,) (JJ randomized) (JJ controlled) (NN trial)) (PP (IN at) (NP (NP (DT an) (JJ academic) (JJ medical) (NN center)) (PP (IN of) (NP (JJ elderly) (NNS patients))))) (PRN (-LRB- -LRB-) (S (VP (VBG >) (CC or) (VBG =) (NP (CD 65) (NNS years)))) (-RRB- -RRB-)) (PP (IN without) (NP (NP (JJ preoperative) (NNS Doc_20042557_498_506_Disease)) (CC or) (NP (NP (JJ severe) (NNS Doc_20042557_517_525_Disease)) (SBAR (WHNP (WP who)) (S (VP (VBD underwent) (NP (JJ Doc_20042557_540_552_Disease) (NN repair)) (PP (IN under) (NP (JJ spinal) (NN anesthesia))) (PP (IN with) (NP (JJ Doc_20042557_589_597_Chemical) (NN sedation))))))))))) (. .)))
20042557	3	(ROOT (S (S (NP (NN Sedation) (NN depth)) (VP (VBD was) (VP (VBN titrated) (S (VP (VBG using) (NP (NP (VBN processed) (NN electroencephalography)) (PP (IN with) (NP (NP (DT the) (JJ bispectral) (NN index)) (PRN (-LRB- -LRB-) (NP (NNP BIS)) (-RRB- -RRB-)))))))))) (, ,) (CC and) (S (NP (NNS patients)) (VP (VBD were) (VP (VBN randomized) (S (VP (TO to) (VP (VB receive) (NP (NP (RB either) (JJ deep) (PRN (-LRB- -LRB-) (NP (NP (NNP BIS)) (, ,) (NP (RB approximately) (CD 50))) (-RRB- -RRB-))) (CC or) (NP (JJ light) (PRN (-LRB- -LRB-) (NP (NP (NNP BIS)) (, ,) (NP (NNP >)) (CC or) (NP (NNP =) (CD 80))) (-RRB- -RRB-)) (NN sedation))))))))) (. .)))
20042557	4	(ROOT (S (NP (NNP Doc_20042557_817_839_Disease)) (VP (VBD was) (VP (VBN assessed) (SBAR (IN as) (S (VP (VBN defined) (PP (IN by) (S (NP (NP (NNP Diagnostic) (CC and) (NNP Statistical) (NNP Manual)) (PP (IN of) (NP (JJ Doc_20042557_904_920_Disease) (PRN (-LRB- -LRB-) (NP (NNP Third) (NNP Edition) (NNP Revised)) (-RRB- -RRB-)) (NNS criteria)))) (VP (VBG using) (NP (DT the) (NN Confusion) (NNP Assessment) (NNP Method) (NN beginning)) (PP (IN at) (NP (NP (DT any) (NN time)) (PP (IN from) (NP (DT the) (JJ second) (NN day))))) (PP (IN after) (NP (NN surgery))))))))))) (. .)))
20042557	5	(ROOT (S (PP (IN From) (NP (NP (NNP April) (CD 2) (, ,) (CD 2005) (, ,)) (PP (IN through) (NP (NNP October) (CD 30) (, ,) (CD 2008))))) (, ,) (NP (NP (DT a) (NN total)) (PP (IN of) (NP (CD 114) (NNS patients)))) (VP (VBD were) (VP (VBN randomized))) (. .)))
20042557	6	(ROOT (S (NP (NP (DT The) (NN prevalence)) (PP (IN of) (NP (NNS Doc_20042557_1163_1185_Disease)))) (VP (VBD was) (ADJP (RB significantly) (JJR lower)) (PP (IN in) (NP (NP (DT the) (JJ light) (NN sedation) (NN group)) (PRN (-LRB- -LRB-) (NP (NP (CD 11/57)) (NP (NP (NP (JJ -LSB-) (ADJP (CD 19) (NN %)) (NN -RSB-) (NN vs) (CD 23/57) (ADJP (QP (CD -LSB-) (CD 40)) (NN %)) (NN -RSB-)) (PP (IN in) (NP (DT the) (JJ deep) (NN sedation) (NN group)))) (: ;) (NP (NP (NNP P)) (SBAR (S (VP (SYM =) (NP (CD .02)))))))) (-RRB- -RRB-)))) (, ,) (S (VP (VBG indicating) (SBAR (IN that) (S (NP (NP (CD 1) (NN incident)) (PP (IN of) (NP (NNS Doc_20042557_1332_1340_Disease)))) (VP (MD will) (VP (VB be) (VP (VBN prevented) (PP (IN for) (NP (NP (DT every) (CD 4.7) (NNS patients)) (VP (VBN treated) (PP (IN with) (NP (JJ light) (NN sedation)))))))))))))) (. .)))
20042557	7	(ROOT (FRAG (NP (DT The) (JJ mean) (NNP +) (NNP /)) (: -) (S (NP (NP (NNP SD) (NN number)) (PP (IN of) (NP (NP (NNS days)) (PP (IN of) (NP (NP (NNS Doc_20042557_1445_1453_Disease)) (PP (IN during) (NP (NN hospitalization)))))))) (VP (VBD was) (ADJP (ADJP (JJR lower) (PP (IN in) (NP (DT the) (JJ light) (NN sedation) (NN group)))) (PP (IN than) (PP (IN in) (NP (DT the) (JJ deep) (NN sedation) (NN group))))) (PRN (-LRB- -LRB-) (FRAG (FRAG (NP (CD 0.5)) (NP (NNP +))) (: /) (FRAG (NP (NP (CD -1.5) (NNS days)) (NP (NN vs) (CD 1.4) (NNP +))) (: /) (NP (NP (CD -4.0) (NNS days)) (: ;) (NP (NP (NNP P)) (SBAR (S (VP (SYM =) (NP (CD .01))))))))) (-RRB- -RRB-)))) (. .)))
20042557	8	(ROOT (S (NP (NP (DT The) (NN use)) (PP (IN of) (NP (JJ light) (JJ Doc_20042557_1619_1627_Chemical) (NN sedation)))) (VP (VBD decreased) (NP (NP (DT the) (NN prevalence)) (PP (IN of) (NP (NNS Doc_20042557_1665_1687_Disease)))) (PP (IN by) (NP (NP (CD 50) (NN %)) (PP (VBN compared) (PP (IN with) (NP (JJ deep) (NN sedation))))))) (. .)))
20042557	9	(ROOT (S (S (VP (VBG Limiting) (NP (NP (NN depth)) (PP (IN of) (NP (NN sedation)))) (PP (IN during) (NP (JJ spinal) (NN anesthesia))))) (VP (VBZ is) (NP (NP (DT a) (JJ simple) (, ,) (ADJP (JJ safe) (, ,) (CC and) (JJ cost-effective)) (NN intervention)) (PP (IN for) (S (VP (VBG preventing) (NP (NP (NNS Doc_20042557_1842_1864_Disease)) (PP (IN in) (NP (JJ elderly) (NNS patients))) (SBAR (WHNP (WDT that)) (S (VP (MD could) (VP (VB be) (VP (ADVP (RB widely) (CC and) (RB readily)) (VBN adopted)))))))))))) (. .)))
20103708	0	(ROOT (NP (NP (DT The) (JJ protective) (NN role)) (PP (IN of) (NP (NNS Nrf2))) (PP (IN in) (NP (NN Doc_20103708_31_45_Chemical-induced) (NNS Doc_20103708_54_74_Disease))) (. .)))
20103708	1	(ROOT (S (NP (NNP Doc_20103708_87_107_Disease)) (VP (VBZ is) (NP (NP (CD one)) (PP (IN of) (NP (NP (DT the) (JJ major) (NNS causes)) (PP (IN of) (NP (NP (NNS Doc_20103708_138_151_Disease)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (VP (VBN accompanied) (PP (IN by) (NP (NP (DT the) (NN production)) (PP (IN of) (NP (NP (JJ reactive) (JJ Doc_20103708_204_210_Chemical) (NNS species)) (PRN (-LRB- -LRB-) (NP (NNP ROS)) (-RRB- -RRB-)))))))))))))))) (. .)))
20103708	2	(ROOT (S (NP (NNP Nrf2)) (VP (VBZ is) (NP (NP (DT the) (JJ primary) (NN transcription) (NN factor)) (SBAR (WHNP (WDT that)) (S (VP (VBZ controls) (S (NP (DT the) (NN antioxidant) (NN response)) (ADJP (JJ essential) (PP (IN for) (S (VP (VBG maintaining) (NP (JJ cellular) (NN redox) (NNS homeostasis)))))))))))) (. .)))
20103708	3	(ROOT (S (ADVP (RB Here)) (, ,) (NP (PRP we)) (VP (VBP report) (NP (PRP$ our) (NNS findings)) (S (VP (VBG demonstrating) (NP (NP (DT a) (JJ protective) (NN role)) (PP (IN of) (NP (NP (NNS Nrf2)) (PP (IN against) (NP (NNS Doc_20103708_437_457_Disease))))))))) (. .)))
20103708	4	(ROOT (NP (NP (NNP RESEARCH) (NNP DESIGN) (CC AND) (NNP METHODS)) (: :) (S (NP (PRP We)) (VP (VB explore) (NP (NP (DT the) (JJ protective) (NN role)) (PP (IN of) (NP (NP (NNS Nrf2)) (PP (IN against) (NP (NP (NNS Doc_20103708_535_555_Disease)) (VP (VBG using) (NP (NP (NP (JJ human) (NN kidney) (NN biopsy) (NNS tissues)) (PP (IN from) (NP (JJ Doc_20103708_595_615_Disease) (NNS patients)))) (, ,) (NP (NP (DT a) (NN Doc_20103708_628_642_Chemical-induced) (NNS Doc_20103708_651_671_Disease) (NN model)) (PP (IN in) (NP (JJ Nrf2) (PRN (-LRB- -LRB-) (FRAG (ADJP (RB -) (JJ /)) (: -)) (-RRB- -RRB-)) (NNS mice)))) (, ,) (CC and) (NP (JJ cultured) (JJ human) (JJ mesangial) (NNS cells))))))))))) (. .)))
20103708	5	(ROOT (S (NP (NP (DT The) (NN glomeruli)) (PP (IN of) (NP (JJ human) (JJ Doc_20103708_765_785_Disease) (NNS patients)))) (VP (VP (VBD were) (PP (IN under) (NP (JJ oxidative) (NN stress)))) (CC and) (VP (VBD had) (NP (JJ elevated) (JJ Nrf2) (NNS levels)))) (. .)))
20103708	6	(ROOT (S (PP (IN In) (NP (DT the) (NN animal) (NN study))) (, ,) (NP (NNS Nrf2)) (VP (VBD was) (VP (VBN demonstrated) (S (VP (TO to) (VP (VB be) (ADJP (JJ crucial) (PP (IN in) (S (VP (VBG ameliorating) (NP (NN Doc_20103708_926_940_Chemical-induced) (NNS Doc_20103708_949_961_Disease))))))))))) (. .)))
20103708	7	(ROOT (S (NP (DT This)) (VP (VBZ is) (ADJP (JJ evident) (PP (IN by) (NP (JJ Nrf2) (PRN (-LRB- -LRB-) (FRAG (ADJP (RB -) (JJ /)) (: -)) (-RRB- -RRB-)) (NNS mice)))) (S (VP (VP (VBG having) (NP (JJR higher) (NNP ROS) (NN production))) (CC and) (VP (VBG suffering) (PP (IN from) (NP (NP (JJR greater) (JJ oxidative) (NN DNA) (NN damage)) (CC and) (NP (NNS Doc_20103708_1078_1090_Disease)))) (PP (VBN compared) (PP (IN with) (NP (JJ Nrf2) (PRN (-LRB- -LRB-) (NP (NNP +) (NNP /) (NNP +)) (-RRB- -RRB-)) (NNS mice)))))))) (. .)))
20103708	8	(ROOT (S (NP (NP (JJ Mechanistic) (NNS studies)) (PP (IN in) (NP (ADJP (PP (DT both) (PP (IN in) (NP (NN vivo))) (CC and) (PP (IN in))) (NN vitro)) (NNS systems)))) (VP (VBD showed) (SBAR (IN that) (S (NP (NP (DT the) (NN Nrf2-mediated) (NN protection)) (PP (IN against) (NP (NNS Doc_20103708_1227_1247_Disease)))) (VP (VBZ is) (, ,) (ADVP (IN at) (JJS least)) (, ,) (PP (ADVP (RB partially)) (IN through) (NP (NP (NP (NN inhibition)) (PP (IN of) (NP (NP (JJ transforming) (NN growth) (NN factor-beta1)) (PRN (-LRB- -LRB-) (NP (NNP TGF-beta1)) (-RRB- -RRB-))))) (CC and) (NP (NP (NN reduction)) (PP (IN of) (NP (NN extracellular) (NN matrix) (NN production)))))))))) (. .)))
20103708	9	(ROOT (S (PP (IN In) (NP (JJ human) (JJ renal) (JJ mesangial) (NNS cells))) (, ,) (NP (JJ high) (NNS Doc_20103708_1426_1433_Chemical)) (VP (VBN induced) (NP (NP (NNP ROS) (NN production)) (CC and) (NP (NP (VBN activated) (NN expression)) (PP (IN of) (NP (NP (NNS Nrf2)) (CC and) (NP (PRP$ its) (JJ downstream) (NNS genes))))))) (. .)))
20103708	10	(ROOT (S (ADVP (RB Furthermore)) (, ,) (NP (NP (NN activation) (CC or) (NN overexpression)) (PP (IN of) (NP (NNS Nrf2)))) (VP (VBD inhibited) (NP (NP (DT the) (NN promoter) (NN activity)) (PP (IN of) (NP (ADJP (JJ TGF-beta1) (PP (IN in) (NP (NP (DT a) (JJ dose-dependent) (NN manner)) (, ,) (SBAR (IN whereas) (S (NP (NP (NN knockdown)) (PP (IN of) (NP (NP (NNS Nrf2)) (PP (IN by) (NP (NN siRNA)))))) (VP (VBD enhanced))))))) (NNS TGF-beta1) (NN transcription) (CC and) (NN fibronectin) (NN production))))) (. .)))
20103708	11	(ROOT (S (NP (DT This) (NN work)) (ADVP (RB clearly)) (VP (VBZ indicates) (NP (NP (DT a) (JJ protective) (NN role)) (PP (IN of) (NP (NP (NNS Nrf2)) (PP (IN in) (NP (NNS Doc_20103708_1805_1825_Disease)))))) (, ,) (S (VP (VBG suggesting) (SBAR (IN that) (S (NP (NP (NN dietary) (CC or) (JJ therapeutic) (NN activation)) (PP (IN of) (NP (NNS Nrf2)))) (VP (MD could) (VP (VB be) (VP (VBN used) (PP (IN as) (NP (DT a) (NN strategy))) (S (VP (TO to) (VP (VP (VB prevent)) (CC or) (VP (VB slow) (PRT (RP down)) (NP (NP (DT the) (NN progression)) (PP (IN of) (NP (NNS Doc_20103708_1956_1976_Disease)))))))))))))))) (. .)))
20164825	0	(ROOT (S (NP (NNP Doc_20164825_0_9_Chemical)) (VP (VBZ prevents) (NP (JJ experimental) (NN Doc_20164825_32_42_Chemical-induced) (NNS Doc_20164825_51_62_Disease)) (PP (IN by) (NP (DT a) (JJ mitochondria-dependent) (NN pathway)))) (. .)))
20164825	1	(ROOT (S (NP (DT The) (JJ antidiabetic) (NN drug) (NNS Doc_20164825_122_131_Chemical)) (VP (MD can) (VP (VP (VB diminish) (NP (NP (NNS apoptosis)) (VP (VBN induced) (PP (IN by) (NP (NP (JJ oxidative) (NN stress)) (PP (IN in) (NP (JJ endothelial) (NNS cells)))))))) (CC and) (VP (VB prevent) (NP (NNS Doc_20164825_216_236_Disease)) (ADVP (RB even)) (PP (IN in) (NP (JJ nondiabetic) (NNS patients)))))) (. .)))
20164825	2	(ROOT (S (ADVP (RB Here)) (NP (PRP we)) (VP (VBD tested) (SBAR (IN whether) (S (NP (PRP it)) (VP (VBZ has) (NP (NP (DT a) (JJ beneficial) (NN effect)) (PP (IN in) (NP (NP (DT a) (NN rat) (NN model)) (PP (IN of) (NP (JJ Doc_20164825_335_345_Chemical) (NNS Doc_20164825_346_354_Disease)))))))))) (. .)))
20164825	3	(ROOT (S (NP (UCP (NP (JJ Mitochondrial) (NN analysis)) (, ,) (NP (NN respiration) (NN intensity)) (, ,) (VP (NP (NNS levels)) (PP (IN of) (NP (NP (JJ reactive) (JJ Doc_20164825_422_428_Chemical) (NNS species)) (, ,) (NP (JJ permeability) (NN transition)) (, ,)))) (CC and) (ADJP (JJ cytochrome)) (NP (SYM c))) (NN release)) (VP (VBD were) (VP (VBN assessed) (NP (QP (CD 3) (CC and) (CD 6)) (NNS days)) (PP (IN after) (NP (JJ Doc_20164825_521_531_Chemical) (NN administration))))) (. .)))
20164825	4	(ROOT (S (NP (JJ Doc_20164825_548_557_Chemical) (NN treatment)) (ADVP (RB fully)) (VP (VBD blocked) (NP (NN Doc_20164825_582_592_Chemical-mediated) (NNS Doc_20164825_602_621_Disease))) (. .)))
20164825	5	(ROOT (S (NP (DT This)) (VP (VBD was) (VP (VBN accompanied) (PP (IN by) (NP (NP (DT a) (JJR lower) (NN activity)) (PP (IN of) (NP (NNS Doc_20164825_667_675_Chemical-beta-D-glucosaminidase)))) (, ,) (ADVP (RB together))) (PP (IN with) (NP (NP (DT a) (NN decrease)) (PP (IN of) (NP (NN lipid) (NN peroxidation) (CC and) (NN increase))) (PP (IN of) (NP (JJ antioxidant) (NNS systems))))))) (. .)))
20164825	6	(ROOT (S (NP (NNP Doc_20164825_784_793_Chemical)) (ADVP (RB also)) (VP (VBD protected) (NP (DT the) (NN kidney)) (PP (IN from) (NP (NP (JJ histological) (NN damage)) (NP (CD 6) (NNS days)))) (PP (IN after) (NP (JJ Doc_20164825_858_868_Chemical) (NN administration)))) (. .)))
20164825	7	(ROOT (S (NP (NP (DT These)) (PP (IN in) (NP (NP (NP (NN vivo) (NNS markers)) (PP (IN of) (NP (NNS Doc_20164825_910_928_Disease)))) (CC and) (NP (NP (PRP$ their) (NN correction)) (PP (IN by) (NP (NNS Doc_20164825_953_962_Chemical))))))) (VP (VBD were) (VP (VBN complemented) (PP (IN by) (NP (NP (ADJP (IN in) (NN vitro)) (NNS studies)) (PP (IN of) (NP (JJ mitochondrial) (NN function))))))) (. .)))
20164825	8	(ROOT (S (NP (PRP We)) (VP (VBD found) (SBAR (IN that) (S (NP (NP (JJ Doc_20164825_1042_1052_Chemical) (NN treatment)) (VP (VBN depleted) (S (S (ADVP (RB respiratory)) (NP (NP (NNS components)) (PRN (-LRB- -LRB-) (NP (NP (JJ cytochrome) (NN c)) (, ,) (NP (NNS Doc_20164825_1110_1114_Chemical))) (-RRB- -RRB-)))) (, ,) (S (ADVP (RB probably)) (ADJP (JJ due) (PP (TO to) (NP (NP (DT the) (NN opening)) (PP (IN of) (NP (JJ mitochondrial) (NN transition)))))))))) (VP (VBZ pores))))) (. .)))
20164825	9	(ROOT (S (NP (NP (DT These) (NNS injuries)) (, ,) (VP (ADVP (RB partly)) (VBN mediated) (PP (IN by) (NP (NP (DT a) (NN rise)) (PP (IN in) (NP (JJ reactive) (JJ Doc_20164825_1234_1240_Chemical) (NNS species))))) (PP (IN from) (NP (DT the) (NN electron) (NN transfer) (NN chain)))) (, ,)) (VP (VBD were) (ADVP (RB significantly)) (VP (VBN decreased) (PP (IN by) (NP (NNS Doc_20164825_1315_1324_Chemical))))) (. .)))
20164825	10	(ROOT (S (ADVP (RB Thus)) (, ,) (NP (PRP$ our) (NN study)) (VP (VBZ suggests) (SBAR (IN that) (S (NP (NP (JJ pleiotropic) (NNS effects)) (PP (IN of) (NP (NNS Doc_20164825_1379_1388_Chemical)))) (VP (MD can) (VP (VP (VB lessen) (NP (NNS Doc_20164825_1400_1410_Chemical)) (ADVP (RB nephrotoxicity))) (CC and) (VP (VB improve) (NP (JJ mitochondrial) (NNS homeostasis)))))))) (. .)))
20195852	0	(ROOT (NP (NP (NN Risk)) (PP (IN of) (NP (NNS Doc_20195852_8_19_Disease))) (PP (IN after) (NP (NN consumption))) (PP (IN of) (NP (JJ nonionic) (NN contrast) (NNS media))) (PP (IN by) (NP (NP (NNS children)) (VP (VBG undergoing) (NP (NP (JJ cardiac) (NN angiography)) (: :) (NP (DT a) (JJ prospective) (NN study)))))) (. .)))
20195852	1	(ROOT (S (PP (IN Despite) (S (VP (VBG increasing) (NP (NNS reports)) (PP (IN on) (NP (NP (NP (JJ nonionic) (NNS Doc_20195852_169_203_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_20195852_205_208_Disease)) (-RRB- -RRB-))) (PP (IN in) (NP (JJ hospitalized) (NN adult) (NNS patients))))) (PP (IN during) (NP (JJ cardiac) (NNS procedures)))))) (, ,) (NP (NP (DT the) (NNS studies)) (PP (IN in) (NP (NNS pediatrics)))) (VP (VBP are) (VP (VBN limited) (, ,) (PP (IN with) (NP (NP (NP (ADJP (RB even) (JJR less)) (NN focus)) (PP (IN on) (NP (JJ possible) (NN predisposing) (NNS factors)))) (CC and) (NP (NP (JJ preventive) (NNS measures)) (PP (IN for) (NP (NP (NNS patients)) (VP (VBG undergoing) (NP (JJ cardiac) (NN angiography)))))))))) (. .)))
20195852	2	(ROOT (S (NP (DT This) (JJ prospective) (NN study)) (VP (VP (VBD determined) (NP (NP (DT the) (NN incidence)) (PP (IN of) (NP (NP (NP (NNS Doc_20195852_481_484_Disease)) (PP (IN for) (NP (CD two) (JJ nonionic) (NN contrast) (NNS media)))) (PRN (-LRB- -LRB-) (NP (NNP CM)) (-RRB- -RRB-)) (, ,) (NP (NNS Doc_20195852_523_532_Chemical) (CC and) (NNS Doc_20195852_537_544_Chemical)) (, ,)))) (PP (IN among) (NP (NP (NP (CD 80) (NNS patients)) (JJR younger)) (PP (IN than) (NP (CD 18) (NNS years)))))) (CC and) (VP (VBD compared) (NP (DT the) (NNS rates)) (PP (IN for) (NP (NP (DT this) (NN complication)) (PP (IN in) (NP (NN relation))))) (PP (TO to) (NP (NP (NP (DT the) (NN type) (CC and) (NN dosage)) (PP (IN of) (NP (NNP CM)))) (CC and) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NNS Doc_20195852_692_700_Disease)))))))) (. .)))
20195852	3	(ROOT (S (NP (NP (DT The) (CD 80) (NNS patients)) (PP (IN in) (NP (DT the) (NN study)))) (ADVP (RB consecutively)) (VP (VBD received) (NP (NP (NP (DT either) (NNS Doc_20195852_761_770_Chemical)) (-LRB- -LRB-) (NP (NP (NN group) (NN A)) (, ,) (VP (VBN n) (S (VP (SYM =) (NP (CD 40)))))) (-RRB- -RRB-)) (CC or) (NP (NP (NNS Doc_20195852_792_799_Chemical)) (-LRB- -LRB-) (NP (NP (NN group) (NN B)) (, ,) (VP (VBN n) (S (VP (SYM =) (NP (CD 40)))))) (-RRB- -RRB-)))) (. .)))
20195852	4	(ROOT (S (S (NP (NP (NP (NP (JJ Serum) (NNS Doc_20195852_825_831_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_20195852_833_835_Chemical)) (-RRB- -RRB-))) (, ,) (NP (NP (NNS Doc_20195852_838_847_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_20195852_849_850_Chemical)) (-RRB- -RRB-))) (, ,) (CC and) (NP (NNS Doc_20195852_857_867_Chemical))) (PRN (-LRB- -LRB-) (NP (NNP Doc_20195852_869_871_Chemical)) (-RRB- -RRB-))) (VP (VBD were) (VP (VBN measured) (X (NP (CD 24) (NN h)) (PP (IN before) (NP (NP (NN angiography)) (PP (IN as) (NP (NP (NP (NN baseline) (NNS values)) (, ,) (NP (NP (RB then)) (VP (VBN measured) (ADVP (RB again)) (PP (IN at) (NP (CD 12))))) (: -)) (, ,) (NP (CD 24)))))) (: -))))) (, ,) (CC and) (S (NP (NP (JJ 48-h) (NNS intervals)) (PP (IN after) (NP (NNP CM)))) (VP (VBP use))) (. .)))
20195852	5	(ROOT (S (NP (NP (JJ Urine) (NNS samples)) (PP (IN for) (NP (NNS Doc_20195852_1015_1017_Chemical) (CC and) (NNS Doc_20195852_1022_1024_Chemical)))) (ADVP (RB also)) (VP (VBD were) (VP (VBN checked) (PP (IN at) (NP (DT the) (JJ same) (NNS intervals))))) (. .)))
20195852	6	(ROOT (S (NP (NP (NP (NN Risk)) (PP (IN of) (NP (NNS Doc_20195852_1074_1087_Disease) (, ,) (NNS Doc_20195852_1089_1109_Disease) (, ,) (NNS Doc_20195852_1111_1137_Disease) (, ,) (NNS Doc_20195852_1139_1162_Disease) (, ,) (CC and) (NN End-stage) (NNS Doc_20195852_1178_1190_Disease)))) (PRN (-LRB- -LRB-) (NP (JJ RIFLE) (NNS criteria)) (-RRB- -RRB-))) (VP (VBD were) (VP (VBN used) (S (VP (TO to) (VP (VB define) (NP (NP (NNS Doc_20195852_1228_1231_Disease)) (CC and) (NP (PRP$ its) (NN incidence))) (PP (IN in) (NP (DT the) (NN study) (NN population)))))))) (. .)))
20195852	7	(ROOT (S (ADVP (RB Accordingly)) (, ,) (PP (IN among) (NP (NP (DT the) (CD 15) (JJ Doc_20195852_1301_1304_Disease) (NNS patients)) (PRN (-LRB- -LRB-) (NP (CD 18.75) (NN %)) (-RRB- -RRB-)))) (, ,) (NP (NP (CD 7.5) (NN %)) (PP (IN of) (NP (NP (DT the) (NNS patients)) (PP (IN in) (NP (NN group) (NN A)))))) (VP (VBD had) (VP (VBN increased) (SBAR (S (NP (NP (NN risk)) (CC and) (NP (CD 3.75) (NN %))) (VP (VBD had) (NP (NNS Doc_20195852_1389_1401_Disease)) (, ,) (SBAR (IN whereas) (S (NP (NP (CD 5) (NN %)) (PP (IN of) (NP (NN group) (NN B)))) (VP (VBD had) (VP (VBN increased) (SBAR (S (NP (NP (NN risk)) (CC and) (NP (CD 2.5) (NN %))) (VP (VBD had) (NP (NNS Doc_20195852_1457_1469_Disease)))))))))))))) (. .)))
20195852	8	(ROOT (S (SBAR (IN Whereas) (S (NP (NP (CD 33.3) (NN %)) (PP (IN of) (NP (NP (DT the) (NNS patients)) (PP (IN with) (NP (NNS Doc_20195852_1506_1509_Disease)))))) (VP (VBD were) (PP (IN among) (NP (NP (DT those)) (SBAR (WHNP (WP who)) (S (VP (VBD received) (NP (NP (DT the) (JJ proper) (NN dosage)) (PP (IN of) (NP (NNP CM)))))))))))) (, ,) (NP (DT the) (NN percentage)) (VP (VBD increased) (PP (TO to) (NP (CD 66.6) (NN %))) (PP (IN among) (NP (NP (DT those)) (SBAR (WHNP (WP who)) (S (VP (VBD received) (NP (JJR larger) (NNS doses)) (, ,) (PP (IN with) (NP (NP (DT a) (JJ significant) (NN difference)) (PP (IN in) (NP (NP (DT the) (NN incidence)) (PP (IN of) (NP (NP (NNS Doc_20195852_1688_1691_Disease)) (VP (VBN related) (PP (TO to) (NP (NP (DT the) (JJ different) (NNS dosages)) (PP (IN of) (NP (NNP CM))) (PRN (-LRB- -LRB-) (VP (VBN p) (S (VP (SYM =) (NP (CD 0.014))))) (-RRB- -RRB-))))))))))))))))) (. .)))
20195852	9	(ROOT (S (S (PP (IN Among) (NP (NP (DT the) (CD 15) (NNS patients)) (PP (IN with) (NP (NNS Doc_20195852_1771_1774_Disease))))) (, ,) (NP (CD 6)) (VP (VBD had) (NP (JJ cyanotic) (NNS Doc_20195852_1791_1816_Disease)))) (, ,) (CC but) (S (NP (DT the) (NN incidence)) (VP (VBD did) (RB not) (VP (VB differ) (ADVP (RB significantly)) (PP (IN from) (NP (NP (DT that)) (PP (IN for) (NP (NP (DT the) (JJ noncyanotic) (NNS patients)) (PRN (-LRB- -LRB-) (VP (VBN p) (S (VP (SYM =) (NP (CD 0.243))))) (-RRB- -RRB-))))))))) (. .)))
20195852	10	(ROOT (S (SBAR (IN Although) (FRAG (ADJP (RB clinically) (JJ silent)))) (, ,) (NP (NNS Doc_20195852_1945_1948_Disease)) (VP (VBZ is) (RB not) (ADJP (JJ rare) (PP (IN in) (NP (NNS pediatrics))))) (. .)))
20195852	11	(ROOT (S (S (NP (DT The) (NN incidence)) (VP (VP (VBZ depends) (PP (PP (IN on) (NP (NN dosage))) (CONJP (CC but) (RB not)) (PP (IN on) (NP (NP (DT the) (NN type)) (PP (IN of) (NP (JJ consumed) (JJ nonionic) (NNS Doc_20195852_2049_2051_Chemical))))))) (, ,) (CC nor) (VP (PP (IN on) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NNS Doc_20195852_2076_2084_Disease)))))))) (, ,) (CC and) (S (SBAR (IN although) (S (NP (NNS Doc_20195852_2099_2102_Disease)) (ADVP (RB usually)) (VP (VBZ is) (ADJP (JJ reversible))))) (, ,) (NP (JJR more) (NN concern)) (VP (VBZ is) (VP (VBN needed) (PP (IN for) (NP (NP (DT the) (NN prevention)) (PP (IN of) (NP (NP (PDT such) (DT a) (NN complication)) (PP (IN in) (NP (NNS children)))))))))) (. .)))
2021202	0	(ROOT (S (VP (VB Renal) (NP (NN function) (CC and) (NNS hemodynamics)) (PP (IN during) (NP (NP (VBN prolonged) (NN Doc_2021202_49_59_Chemical-induced) (NNS Doc_2021202_68_79_Disease)) (PP (IN in) (NP (NNS humans)))))) (. .)))
2021202	1	(ROOT (S (NP (NP (DT The) (NN effect)) (PP (IN of) (NP (NP (NN Doc_2021202_105_115_Chemical-induced) (NNS Doc_2021202_124_135_Disease)) (PP (IN on) (NP (NP (NN glomerular) (NN function)) (CC and) (NP (JJ renal) (NN blood) (NN flow))))))) (VP (VBD was) (VP (VBN investigated) (PP (IN in) (NP (CD 20) (JJ human) (NNS subjects))))) (. .)))
2021202	2	(ROOT (S (NP (NP (NP (JJ Glomerular) (NN filtration) (NN rate)) (PRN (-LRB- -LRB-) (NP (NNP GFR)) (-RRB- -RRB-))) (CC and) (NP (NP (JJ effective) (JJ renal) (NN plasma) (NN flow)) (PRN (-LRB- -LRB-) (NP (NNP ERPF)) (-RRB- -RRB-)))) (VP (VBD were) (VP (VBN measured) (PP (IN by) (NP (NP (NN inulin)) (CC and) (NP (JJ Doc_2021202_319_338_Chemical) (PRN (-LRB- -LRB-) (NP (NNP Doc_2021202_340_343_Chemical)) (-RRB- -RRB-)) (NN clearance)))) (, ,) (ADVP (RB respectively)))) (. .)))
2021202	3	(ROOT (S (NP (NNP Anesthesia)) (VP (VBD was) (VP (VBN maintained) (PP (IN with) (NP (NNS Doc_2021202_401_409_Chemical) (, ,) (NNS Doc_2021202_411_424_Chemical) (, ,) (NNS Doc_2021202_426_432_Chemical) (, ,) (CC and) (NNS Doc_2021202_438_448_Chemical))))) (. .)))
2021202	4	(ROOT (S (NP (NNP Doc_2021202_450_461_Disease)) (VP (VBD was) (VP (VBN induced) (PP (IN for) (NP (NP (NP (CD 236.9) (JJ +) (NNS /)) (PRN (: -) (NP (NP (JJ 15.1) (NN min)) (PP (IN by) (S (VP (VBG increasing) (SBAR (S (NP (DT the) (NNS Doc_2021202_515_525_Chemical)) (VP (VBD inspired) (NP (NN concentration)) (S (VP (TO to) (VP (VB maintain) (NP (NP (DT a) (JJ mean) (JJ arterial) (NN pressure)) (PP (IN of) (NP (QP (CD 59.8) (CD +))))))))))))))) (: /))) (: -) (NP (NP (CD 0.4)) (VP (VBG mmHg))))))) (. .)))
2021202	5	(ROOT (S (NP (NNP GFR) (CC and) (NNP ERPF)) (VP (VP (VBD decreased) (PP (IN with) (NP (NP (DT the) (NN induction)) (PP (IN of) (NP (NN anesthesia)))))) (CC but) (VP (RB not) (ADJP (ADJP (RB significantly) (JJR more)) (PP (IN during) (NP (NNS Doc_2021202_698_709_Disease)))))) (. .)))
2021202	6	(ROOT (S (ADVP (RB Postoperatively)) (, ,) (NP (NNP ERPF)) (VP (VBD returned) (S (VP (TO to) (VP (VB preoperative) (NP (NNS values))))) (, ,) (SBAR (IN whereas) (S (NP (NNP GFR)) (VP (VBD was) (ADJP (JJR higher)) (PP (IN than) (NP (JJ preoperative) (NNS values))))))) (. .)))
2021202	7	(ROOT (S (NP (JJ Renal) (NN vascular) (NN resistance)) (VP (VP (VBD increased) (PP (IN during) (NP (NN anesthesia)))) (CC but) (VP (VBD decreased) (SBAR (WHADVP (WRB when)) (S (NP (NNS Doc_2021202_888_899_Disease)) (VP (VBD was) (VP (VBN induced) (, ,) (S (VP (VBG allowing) (NP (NP (DT the) (NN maintenance)) (PP (IN of) (NP (JJ renal) (NN blood) (NN flow)))))))))))) (. .)))
2021202	8	(ROOT (S (NP (PRP We)) (VP (VBP conclude) (SBAR (SBAR (IN that) (S (NP (JJ renal) (NN compensatory) (NNS mechanisms)) (VP (VBP are) (VP (VBN preserved) (PP (IN during) (NP (NN Doc_2021202_1027_1037_Chemical-induced) (NNS Doc_2021202_1046_1057_Disease))))))) (CC and) (SBAR (IN that) (S (NP (NP (JJ renal) (NN function)) (CC and) (NP (NNS hemodynamics))) (ADVP (RB quickly)) (VP (VB return) (PP (TO to) (ADJP (JJ normal))) (SBAR (WHADVP (WRB when)) (S (NP (NN normotension)) (VP (VBZ is) (VP (VBN resumed)))))))))) (. .)))
20304337	0	(ROOT (S (NP (NP (NNP Doc_20304337_0_20_Disease)) (PP (IN in) (NP (DT an) (JJ infant) (NN prenatally)))) (VP (VBN exposed) (PP (TO to) (NP (NNS Doc_20304337_56_63_Chemical)))) (. .)))
20304337	1	(ROOT (S (NP (JJ Many) (NNS authors)) (VP (VBD described) (NP (DT the) (NNS effects)) (PP (IN on) (NP (NP (DT the) (NN fetus)) (PP (IN of) (NP (JJ maternal) (JJ Doc_20304337_125_132_Chemical) (NN abuse))))) (PP (IN during) (NP (NN pregnancy)))) (. .)))
20304337	2	(ROOT (S (NP (NNP Vasoconstriction)) (VP (VBZ appears) (S (VP (TO to) (VP (VB be) (NP (NP (DT the) (JJ common) (NN mechanism)) (PP (IN of) (NP (NP (NN action)) (VP (VBG leading) (PP (TO to) (NP (NP (DT a) (JJ wide) (NN range)) (PP (IN of) (NP (NNS Doc_20304337_246_261_Disease))))))))))))) (. .)))
20304337	3	(ROOT (S (NP (PRP We)) (VP (VBP report) (PP (IN on) (NP (NP (DT an) (NN infant)) (PP (IN with) (NP (NP (NNS Doc_20304337_291_325_Disease)) (ADJP (JJ attributable) (PP (TO to) (NP (NNS Doc_20304337_342_362_Disease)))) (, ,) (VP (VBN born) (PP (TO to) (NP (DT a) (NN Doc_20304337_374_381_Chemical-addicted) (NN mother))))))))) (. .)))
20331935	0	(ROOT (S (NP (NP (DT A) (JJ cross-sectional) (NN evaluation)) (PP (IN of) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (JJ Doc_20331935_46_57_Chemical) (CC and) (JJ selective) (NNS Doc_20331935_72_81_Chemical)))))) (VP (VBP reuptake) (NP (NNS inhibitors)) (PP (IN on) (NP (NP (NN bone) (NN mineral) (NN density)) (PP (IN in) (NP (NNS boys)))))) (. .)))
20331935	1	(ROOT (S (NP (NP (DT The) (NN aim)) (PP (IN of) (NP (DT the) (JJ present) (NN study)))) (VP (VBD was) (S (VP (TO to) (VP (VB investigate) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (NN Doc_20331935_208_219_Chemical-induced) (NNS Doc_20331935_228_246_Disease)))) (PP (IN on) (NP (NP (NP (NN trabecular) (NN bone) (NN mineral) (NN density)) (PRN (-LRB- -LRB-) (NP (NNP BMD)) (-RRB- -RRB-))) (PP (IN in) (NP (NNS children) (CC and) (NNS adolescents))))))))) (. .)))
20331935	2	(ROOT (FRAG (ADJP (ADJP (RB Medically) (JJ healthy)) (SBAR (X (NP (CD 7)) (: -) (PP (TO to) (NP (JJ 17-year-old) (NNS males)))) (S (NP (NNP chronically)) (VP (VBD treated))))) (, ,) (PP (IN in) (NP (DT a) (JJ naturalistic) (NN setting))) (, ,) (SBAR (IN with) (S (NP (NNS Doc_20331935_420_431_Chemical)) (VP (VBD were) (VP (VBN recruited) (PP (IN for) (NP (DT this) (JJ cross-sectional) (NN study))) (PP (IN through) (NP (NP (NN child) (NN psychiatry) (NN outpatient) (NNS clinics)) (PP (IN between) (NP (NP (NNP November) (CD 2005)) (CC and) (NP (NNP June) (CD 2007)))))))))) (. .)))
20331935	3	(ROOT (S (NP (NP (JJ Anthropometric) (NNS measurements)) (CC and) (NP (NN laboratory) (NN testing))) (VP (VBD were) (VP (VBN conducted))) (. .)))
20331935	4	(ROOT (S (S (NP (DT The) (JJ clinical) (NNS diagnoses)) (VP (VBD were) (VP (VBN based) (PP (IN on) (NP (NN chart) (NN review)))))) (, ,) (CC and) (S (NP (NP (JJ developmental)) (CC and) (NP (NN treatment) (NN history))) (VP (VBD was) (VP (VBN obtained) (PP (IN from) (NP (DT the) (JJ medical) (NN record)))))) (. .)))
20331935	5	(ROOT (S (S (NP (NP (NNP Volumetric) (NNP BMD)) (PP (IN of) (NP (DT the) (JJ ultradistal) (NNS radius)))) (VP (VBD was) (VP (VBN measured) (S (VP (VBG using) (NP (JJ peripheral) (JJ quantitative) (NN computed)) (ADVP (RB tomography))))))) (, ,) (CC and) (S (NP (NP (NNP areal) (NNP BMD)) (PP (IN of) (NP (DT the) (NN lumbar) (NN spine)))) (VP (VBD was) (VP (VBN estimated) (S (VP (VBG using) (NP (JJ dual-energy) (JJ x-ray) (NN absorptiometry))))))) (. .)))
20331935	6	(ROOT (S (NP (NNP Doc_20331935_957_975_Disease)) (VP (VBD was) (ADJP (JJ present) (PP (IN in) (NP (NP (NP (CD 49) (NN %)) (PP (IN of) (NP (CD 83) (NNS boys)))) (PRN (-LRB- -LRB-) (VP (VBN n) (S (VP (SYM =) (NP (CD 41))))) (-RRB- -RRB-)) (VP (VBN treated) (PP (IN with) (NP (NP (NNS Doc_20331935_1028_1039_Chemical)) (PP (IN for) (NP (NP (DT a) (NN mean)) (PP (IN of) (NP (CD 2.9) (NNS years)))))))))))) (. .)))
20331935	7	(ROOT (S (NP (JJ Serum) (JJ Doc_20331935_1071_1083_Chemical) (NN concentration)) (VP (VP (VBD increased) (PP (IN with) (NP (JJ pubertal) (NN status)))) (CC but) (VP (VBD was) (RB not) (VP (VBN affected) (PP (IN by) (NP (NNS Doc_20331935_1153_1171_Disease)))))) (. .)))
20331935	8	(ROOT (S (SBAR (IN As) (S (VP (VBN expected)))) (, ,) (NP (NP (NN bone) (NN mineral) (NN content)) (CC and) (NP (NNP BMD))) (VP (VBD increased) (PP (IN with) (NP (JJ sexual) (NN maturity)))) (. .)))
20331935	9	(ROOT (S (PP (IN After) (S (VP (VBG adjusting) (PP (IN for) (NP (NP (DT the) (NN stage)) (PP (IN of) (NP (JJ sexual) (NN development) (CC and) (NN height) (CC and) (NNP BMI) (NNP z) (NNS scores)))))))) (, ,) (NP (NN serum) (NN prolactin)) (VP (VBD was) (ADVP (RB negatively)) (VP (VBN associated) (PP (IN with) (NP (NP (NN trabecular) (JJ volumetric) (NN BMD)) (PP (IN at) (NP (NP (DT the) (JJ ultradistal) (NNS radius)) (PRN (-LRB- -LRB-) (NP (NNP P) (QP (CD <) (CD .03))) (-RRB- -RRB-)))))))) (. .)))
20331935	10	(ROOT (S (S (S (VP (VBG Controlling) (PP (IN for) (NP (JJ relevant) (NNS covariates))))) (, ,) (NP (PRP we)) (ADVP (RB also)) (VP (VBD found) (NP (NN treatment)) (PP (IN with) (NP (NP (JJ selective) (JJ Doc_20331935_1514_1523_Chemical) (NN reuptake) (NNS inhibitors)) (PRN (-LRB- -LRB-) (NP (NNP SSRIs)) (-RRB- -RRB-)))) (S (VP (TO to) (VP (VB be) (VP (VBN associated) (PP (IN with) (NP (NP (JJR lower) (NN trabecular) (NN BMD)) (PP (IN at) (NP (DT the) (NNS radius))))))))))) (PRN (-LRB- -LRB-) (S (VP (VB P) (S (VP (SYM =) (NP (CD .03)))))) (-RRB- -RRB-)) (CC and) (S (NP (NNP BMD) (NNP z)) (VP (VBP score) (PP (IN at) (NP (NP (DT the) (NN lumbar) (NN spine)) (PRN (-LRB- -LRB-) (NP (NNP P) (QP (CD <) (CD .05))) (-RRB- -RRB-)))))) (. .)))
20331935	11	(ROOT (S (NP (DT These) (NNS findings)) (VP (VBD became) (ADJP (RBR more) (JJ marked)) (SBAR (WHADVP (WRB when)) (S (NP (DT the) (NN analysis)) (VP (VBD was) (VP (VBN restricted) (PP (TO to) (NP (ADJP (JJ non-Hispanic) (JJ white)) (NNS patients)))))))) (. .)))
20331935	12	(ROOT (S (PP (IN Of) (NP (CD 13) (VBN documented) (NNS Doc_20331935_1782_1791_Disease))) (, ,) (S (NP (CD 3)) (VP (VBD occurred) (SBAR (IN after) (S (NP (NNS Doc_20331935_1810_1821_Chemical) (CC and) (NNS SSRIs)) (VP (VBD were) (VP (VBN started))))))) (, ,) (CC and) (S (NP (NN none)) (VP (VBD occurred) (PP (IN in) (NP (NNS patients))) (PP (IN with) (NP (NNS Doc_20331935_1881_1899_Disease))))) (. .)))
20331935	13	(ROOT (S (NP (DT This)) (VP (VBZ is) (NP (DT the) (JJ first) (NN study) (S (VP (TO to) (VP (VB link) (S (NP (NP (NN Doc_20331935_1946_1957_Chemical-induced) (NNS Doc_20331935_1966_1984_Disease)) (CC and) (NP (CD SSRI) (NN treatment))) (VP (TO to) (VP (VB lower) (NP (NP (NNP BMD)) (PP (IN in) (NP (NNS children) (CC and) (NNS adolescents)))))))))))) (. .)))
20331935	14	(ROOT (S (NP (JJ Future) (NN research)) (VP (MD should) (VP (VB evaluate) (NP (NP (DT the) (JJ longitudinal) (NN course)) (PP (IN of) (NP (DT this) (JJ adverse) (NN event)))) (SBAR (SBAR (S (VP (TO to) (VP (VB determine) (NP (PRP$ its) (JJ temporal) (NN stability)))))) (CC and) (SBAR (IN whether) (S (NP (DT a) (JJR higher) (NN fracture) (NN rate)) (VP (VBZ ensues))))))) (. .)))
20394767	0	(ROOT (S (NP (NP (JJ Fear-potentiated) (NNS Doc_20394767_17_24_Disease)) (, ,) (CONJP (CC but) (RB not)) (NP (JJ light-enhanced) (NNS Doc_20394767_49_56_Disease)) (, ,)) (VP (VBZ is) (VP (VBN enhanced) (PP (IN by) (NP (JJ anxiogenic) (NNS drugs))))) (. .)))
20394767	1	(ROOT (NP (NP (NNP RATIONALE) (CC AND) (NNP OBJECTIVES)) (: :) (S (NP (NP (DT The) (JJ light-enhanced) (JJ Doc_20394767_136_143_Disease) (NN paradigm)) (PRN (-LRB- -LRB-) (NP (NNP LES)) (-RRB- -RRB-))) (VP (VBZ is) (VP (VBN suggested) (PP (PP (TO to) (NP (NN model) (NNS Doc_20394767_181_188_Disease))) (, ,) (RB because) (PP (IN of) (NP (NP (DT the) (JJ non-specific) (NN cue)) (CC and) (NP (DT the) (JJ long-term) (NN effect)))))))) (. .)))
20394767	2	(ROOT (S (PP (IN In) (NP (NN contrast))) (, ,) (NP (NP (DT the) (JJ fear-potentiated) (NNS Doc_20394767_282_289_Disease)) (PRN (-LRB- -LRB-) (NP (NNP FPS)) (-RRB- -RRB-))) (VP (VBZ is) (VP (VBN suggested) (S (VP (TO to) (VP (VB model) (NP (JJ conditioned) (NN fear))))))) (. .)))
20394767	3	(ROOT (S (ADVP (RB However)) (, ,) (NP (NP (DT the) (JJ pharmacological) (NNS profiles)) (PP (IN of) (NP (DT these) (CD two) (NNS paradigms)))) (VP (VBP are) (ADJP (RB very) (JJ similar))) (. .)))
20394767	4	(ROOT (S (NP (DT The) (JJ present) (NN study)) (VP (VP (VBD investigated) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (JJ putative) (JJ anxiogenic) (NNS drugs)))) (PP (IN on) (NP (NNP LES) (CC and) (NNP FPS)))) (CC and) (VP (VBN aimed) (PP (PP (IN at) (S (VP (VBG determining) (NP (NP (DT the) (NN sensitivity)) (PP (IN of) (NP (NNP LES)))) (PP (IN for) (NP (JJ anxiogenic) (NNS drugs)))))) (CC and) (PP (TO to) (S (VP (ADVP (RB potentially)) (VBG showing) (NP (NP (DT a) (JJ pharmacological) (NN differentiation)) (PP (IN between) (NP (DT these) (CD two) (NNS paradigms)))))))))) (. .)))
20394767	5	(ROOT (S (NP (NNP Male) (NNP Wistar) (NNS rats)) (VP (VP (VBD received) (NP (NP (DT each) (NN dose)) (PP (IN of) (NP (NP (NP (DT the) (NN alpha)) (PRN (-LRB- -LRB-) (NP (CD 2)) (-RRB- -RRB-))) (: -) (NP (NP (NN adrenoceptor) (NN antagonist) (NNS Doc_20394767_746_755_Chemical)) (-LRB- -LRB-) (NP (CD 0.25-1) (CD .0) (NN mg/kg)) (-RRB- -RRB-)) (, ,) (NP (NP (DT the) (JJ Doc_20394767_777_781_Chemical) (PRN (-LRB- -LRB-) (NP (CD 2C)) (-RRB- -RRB-)) (NN receptor) (NN agonist) (NNS Doc_20394767_803_827_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (NNS Doc_20394767_829_833_Chemical)) (, ,) (NP (CD 0.5-2) (CD .0) (NN mg/kg))) (-RRB- -RRB-))) (CC or) (NP (NP (DT the) (JJ Doc_20394767_856_860_Chemical) (PRN (-LRB- -LRB-) (NP (NNP A)) (-RRB- -RRB-)) (NN inverse) (NN receptor) (NN agonist) (NNS Doc_20394767_889_907_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (NNS Doc_20394767_909_912_Chemical)) (, ,) (NP (JJ 3-30mg) (JJ /) (NN kg))) (-RRB- -RRB-))))))) (CC and) (VP (VBD were) (VP (ADVP (RB subsequently)) (VBN tested) (PP (IN in) (NP (DT either) (NNP LES) (CC or) (NNP FPS)))))) (. .)))
20394767	6	(ROOT (S (NP (NP (NN None)) (PP (IN of) (NP (DT the) (NNS drugs)))) (VP (VBD enhanced) (NP (NNP LES)) (, ,) (SBAR (IN whereas) (S (NP (NNS Doc_20394767_1025_1029_Chemical)) (VP (VBD increased) (SBAR (S (NP (NP (NN percentage) (NN FPS)) (CC and) (NP (NNS Doc_20394767_1059_1068_Chemical))) (VP (VBD increased) (NP (JJ absolute) (NNP FPS) (NNS values))))))))) (. .)))
20394767	7	(ROOT (S (ADVP (RB Furthermore)) (, ,) (S (NP (NNS Doc_20394767_1113_1122_Chemical)) (VP (VBD increased) (SBAR (S (NP (NN baseline) (NNS Doc_20394767_1142_1149_Disease)) (VP (VBP amplitude) (PP (IN in) (NP (DT the) (NNP LES))) (, ,) (SBAR (IN while) (S (NP (NNS Doc_20394767_1178_1182_Chemical)) (VP (VBD suppressed) (NP (NN baseline) (NNS Doc_20394767_1203_1210_Disease)) (PP (IN in) (NP (PDT both) (DT the) (NNP LES) (CC and) (NNP FPS))))))))))) (CC and) (S (NP (NNS Doc_20394767_1239_1242_Chemical)) (VP (VBD suppressed) (NP (NN baseline) (NNS Doc_20394767_1263_1270_Disease)) (PP (IN in) (NP (DT the) (NNP FPS))))) (. .)))
20394767	8	(ROOT (S (PP (IN In) (NP (NP (NN contrast)) (PP (TO to) (NP (NP (NNS findings)) (PP (IN in) (NP (DT the) (NNP FPS) (NN paradigm))))))) (, ,) (NP (NP (NN none)) (PP (IN of) (NP (DT the) (NNS drugs)))) (VP (VBD were) (ADJP (JJ able) (S (VP (TO to) (VP (VB exacerbate) (NP (DT the) (NNP LES) (NN response))))))) (. .)))
20394767	9	(ROOT (S (ADVP (RB Thus)) (, ,) (NP (DT a) (ADJP (JJ clear) (JJ pharmacological)) (NN differentiation)) (VP (VBD was) (VP (VBN found) (PP (IN between) (NP (NNP LES) (CC and) (NNP FPS))))) (. .)))
20466178	0	(ROOT (S (NP (NNP Rosaceiform) (NNP Doc_20466178_12_22_Disease)) (VP (VBN associated) (PP (IN with) (NP (JJ topical) (JJ Doc_20466178_47_57_Chemical) (NN treatment)))) (. .)))
20466178	1	(ROOT (S (NP (PRP We)) (VP (VBP describe) (VP (VB herein) (NP (NP (NP (CD 3) (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBD developed) (NP (NN Doc_20466178_113_120_Disease-like) (NNS Doc_20466178_126_136_Disease)) (NP (JJ Doc_20466178_137_146_Disease) (NN while)) (S (VP (VBG using) (NP (CD 0.03) (NN %)))))))) (CC or) (NP (NP (ADJP (CD 0.1) (NN %)) (JJ Doc_20466178_173_183_Chemical) (NN ointment)) (PP (IN for) (NP (NNS Doc_20466178_197_214_Disease))))))) (. .)))
20466178	2	(ROOT (S (NP (NNP Skin) (NN biopsy) (NNS specimens)) (VP (VBD showed) (NP (JJ Doc_20466178_245_259_Disease) (CC and) (NN noncaseating) (JJ epithelioid) (NNS granulomatous) (NN tissue) (NN formation)) (PP (IN in) (NP (DT the) (NN papillary))) (PP (TO to) (NP (JJ mid) (NNS dermis)))) (. .)))
20466178	3	(ROOT (S (NP (NP (JJ Continuous) (JJ topical) (NN use)) (PP (IN of) (NP (NP (NNS immunomodulators)) (PP (JJ such) (IN as) (NP (NNS Doc_20466178_403_413_Chemical) (CC or) (NNS Doc_20466178_417_429_Chemical)))))) (VP (MD should) (VP (VB be) (VP (VBN regarded) (PP (IN as) (NP (NP (DT a) (JJ potential) (NN cause)) (PP (IN of) (NP (NN rosaceiform) (NNS Doc_20466178_485_495_Disease))))) (, ,) (SBAR (IN although) (S (NP (JJ many) (NNS cases)) (VP (VBP have) (RB not) (VP (VBN been) (VP (VBN reported))))))))) (. .)))
20510337	0	(ROOT (S (NP (JJ Doc_20510337_0_12_Chemical) (NN treatment)) (VP (VBZ ameliorates) (NP (JJ acute) (NNS Doc_20510337_41_50_Chemical)) (ADVP (RB nephrotoxicity)) (PP (IN in) (NP (NNS mice)))) (. .)))
20510337	1	(ROOT (S (NP (NP (DT The) (JJ nephroprotective) (NN effect)) (PP (IN of) (NP (NNS Doc_20510337_106_118_Chemical)))) (VP (VBD was) (VP (VBN investigated) (PP (IN in) (NP (NNS mice))) (PP (IN with) (NP (NP (NNS Doc_20510337_149_167_Disease)) (VP (VBN induced) (PP (IN by) (NP (NP (DT a) (JJ single) (NN i.p.) (NN injection)) (PP (IN of) (NP (NP (NNS Doc_20510337_206_215_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 5) (NN mg/kg)) (-RRB- -RRB-))))))))))) (. .)))
20510337	2	(ROOT (S (NP (NP (JJ Doc_20510337_227_239_Chemical) (NN treatment)) (PRN (-LRB- -LRB-) (NP (CD 10) (NN mg/kg/day)) (, ,) (NP (NNP i.p.)) (-RRB- -RRB-))) (VP (VBD was) (VP (VBN applied) (PP (IN for) (NP (CD 6) (JJ consecutive) (NNS days))) (, ,) (PP (VBG starting) (PP (NP (CD 1) (NN day)) (IN before) (NP (JJ Doc_20510337_329_338_Chemical) (NN administration)))))) (. .)))
20510337	3	(ROOT (S (NP (NNP Doc_20510337_355_367_Chemical)) (ADVP (RB significantly)) (VP (VBD reduced) (NP (NNS Doc_20510337_390_409_Chemical) (CC and) (NN serum) (NNS Doc_20510337_420_430_Chemical)) (NP (NP (NNS levels)) (SBAR (WHNP (WDT which)) (S (VP (VBD were) (VP (VBN increased) (PP (IN by) (NP (NNS Doc_20510337_462_471_Chemical))))))))) (. .)))
20510337	4	(ROOT (S (NP (NP (JJ Doc_20510337_473_485_Chemical) (ADJP (RB significantly) (JJ compensated)) (NNS deficits)) (PP (IN in) (NP (NP (DT the) (JJ antioxidant) (NN defense) (NNS mechanisms)) (PRN (-LRB- -LRB-) (NP (NP (JJ reduced) (JJ Doc_20510337_568_579_Chemical) (NN level)) (CC and) (NP (JJ Doc_20510337_590_600_Chemical) (NN dismutase) (NN activity))) (-RRB- -RRB-)))) (, ,) (VP (VBN suppressed) (NP (NN lipid) (NN peroxidation))) (, ,)) (VP (VP (VBD decreased) (NP (NP (DT the) (NNS elevations)) (PP (IN of) (NP (NP (JJ Doc_20510337_681_686_Disease) (JJ Doc_20510337_687_695_Disease) (NN factor-alpha)) (, ,) (NP (NNS Doc_20510337_710_722_Chemical)) (CC and) (NP (JJ Doc_20510337_727_735_Chemical) (NN ion) (NN concentration)))))) (, ,) (CC and) (VP (VBD attenuated) (NP (NP (DT the) (NNS reductions)) (PP (IN of) (NP (JJ Doc_20510337_788_796_Chemical) (CC and) (JJ Doc_20510337_801_805_Chemical) (NNS ions)))) (PP (IN in) (NP (NP (JJ renal) (NN tissue)) (VP (VBN resulted) (PP (IN from) (NP (JJ Doc_20510337_841_850_Chemical) (NN administration)))))))) (. .)))
20510337	5	(ROOT (S (ADVP (RB Also)) (, ,) (NP (NP (JJ histopathological) (NNS Doc_20510337_891_910_Disease)) (VP (VBN mediated) (PP (IN by) (NP (NNS Doc_20510337_923_932_Chemical))))) (VP (VBD was) (VP (VBN ameliorated) (PP (IN by) (NP (JJ Doc_20510337_952_964_Chemical) (NN treatment))))) (. .)))
20510337	6	(ROOT (S (NP (JJ Immunohistochemical) (NN analysis)) (VP (VBD revealed) (SBAR (IN that) (S (NP (NNS Doc_20510337_1019_1031_Chemical)) (ADVP (RB significantly)) (VP (VBD decreased) (NP (NP (DT the) (NN Doc_20510337_1060_1069_Chemical-induced) (NN overexpression)) (PP (IN of) (NP (NP (JJ inducible) (JJ Doc_20510337_1106_1118_Chemical) (NN synthase)) (, ,) (NP (JJ nuclear) (NN factor-kappaB)) (, ,) (NP (JJ caspase-3)) (CC and) (NP (NN p53))))) (PP (IN in) (NP (JJ renal) (NN tissue))))))) (. .)))
20510337	7	(ROOT (S (NP (PRP It)) (VP (VBD was) (VP (VBN concluded) (SBAR (IN that) (S (NP (NNS Doc_20510337_1209_1221_Chemical)) (VP (VBZ represents) (NP (DT a) (JJ potential) (JJ therapeutic) (NN option)) (S (VP (TO to) (VP (VB protect) (PP (IN against) (NP (NP (JJ acute) (JJ Doc_20510337_1289_1298_Chemical) (NN nephrotoxicity)) (VP (ADVP (RB commonly)) (VBN encountered) (PP (IN in) (NP (JJ clinical) (NN practice)))))))))))))) (. .)))
2051906	0	(ROOT (NP (NP (JJ Reversible) (NNS Doc_2051906_11_22_Disease)) (PP (IN with) (NP (NP (NNS Doc_2051906_28_44_Disease)) (PP (VBG following) (NP (JJ Doc_2051906_55_67_Chemical) (NN therapy))))) (. .)))
2051906	1	(ROOT (S (NP (DT A) (NN case)) (VP (VBP report)) (. .)))
2051906	2	(ROOT (S (NP (NP (DT A) (JJ 67-year-old) (NN patient)) (, ,) (PP (PP (IN with) (NP (JJ primary) (NNS Doc_2051906_128_140_Disease))) (CC and) (PP (IN without) (NP (NP (JJ previous) (NN evidence)) (PP (IN of) (NP (NNS Doc_2051906_174_187_Disease)))))) (, ,)) (VP (VBD developed) (NP (NP (JJ clinical) (CC and) (JJ biochemical) (NNS features)) (PP (IN of) (NP (NP (JJ severe) (NNS Doc_2051906_243_254_Disease)) (NP (CD 3) (NNS months))))) (PP (IN after) (NP (NP (NN initiation)) (PP (IN of) (NP (JJ Doc_2051906_284_296_Chemical) (NN therapy)))))) (. .)))
2051906	3	(ROOT (S (NP (NNP Liver)) (ADVP (RB biopsy)) (VP (VBD showed) (NP (NNS Doc_2051906_326_337_Disease)) (PP (IN with) (NP (NP (DT both) (NN cytological)) (CC and) (NP (NP (JJ architectural) (NNS alterations)) (PP (IN of) (NP (NN interlobular) (NN bile) (NNS ducts))))))) (. .)))
2051906	4	(ROOT (S (NP (JJ Doc_2051906_418_430_Chemical) (NN withdrawal)) (VP (VBD resulted) (PP (IN after) (NP (CD 7) (NNS weeks))) (PP (IN in) (NP (NP (DT the) (NN resolution)) (PP (IN of) (NP (JJ clinical) (CC and) (JJ biochemical) (NNS abnormalities)))))) (. .)))
2051906	5	(ROOT (S (NP (PRP It)) (VP (VBZ is) (VP (VBN believed) (SBAR (IN that) (S (NP (DT this)) (VP (VBZ is) (NP (NP (DT the) (JJ first) (JJ reported) (NN case)) (PP (IN of) (NP (NP (JJ reversible) (NN Doc_2051906_592_604_Chemical-induced) (NNS Doc_2051906_613_624_Disease)) (VP (VBN associated) (PP (IN with) (NP (NP (JJ histological) (NN evidence)) (PP (IN of) (NP (NNS Doc_2051906_666_682_Disease)))))))))))))) (. .)))
20533999	0	(ROOT (S (NP (NNP Doc_20533999_0_8_Chemical)) (VP (VBZ is) (RB not) (ADJP (JJ essential) (PP (IN for) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (NN Doc_20533999_49_64_Chemical-induced) (NNS Doc_20533999_73_86_Disease))))))) (. .)))
20533999	1	(ROOT (S (NP (PRP It)) (VP (VBZ is) (ADVP (RB widely)) (VP (VBN believed) (SBAR (IN that) (S (NP (NP (NNS Doc_20533999_115_123_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_20533999_125_127_Chemical)) (-RRB- -RRB-))) (VP (VBZ mediates) (NP (NP (NP (NNS Doc_20533999_138_153_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_20533999_155_159_Chemical)) (-RRB- -RRB-))) (: -) (NP (NP (JJ induced) (NNS Doc_20533999_169_177_Disease)) (PP (TO to) (NP (NN brain) (NN dopaminergic) (NNS neurons)))) (, ,)) (PP (IN because) (NP (NP (NNS drugs)) (SBAR (WHNP (WDT that)) (S (VP (VBP interfere) (PP (IN with) (NP (NNP DA) (NN neurotransmission) (NN decrease) (NNS Doc_20533999_273_281_Disease))) (, ,) (SBAR (IN whereas) (S (NP (NP (NNS drugs)) (SBAR (WHNP (WDT that)) (S (VP (VB increase) (NP (NNP DA) (NN neurotransmission)))))) (VP (VB enhance) (NP (NNS Doc_20533999_340_348_Disease))))))))))))))) (. .)))
20533999	2	(ROOT (S (ADVP (RB However)) (, ,) (NP (NP (NN temperature) (NNS effects)) (PP (IN of) (NP (NP (NNS drugs)) (SBAR (WHNP (WDT that)) (S (VP (VBP have) (VP (VBN been) (VP (VBN used) (S (VP (TO to) (VP (VB manipulate) (NP (NN brain) (NNS Doc_20533999_428_430_Chemical))))))))))))) (VP (VBP neurotransmission) (NP (NP (JJ confound) (NN interpretation)) (PP (IN of) (NP (DT the) (NNS data))))) (. .)))
20533999	3	(ROOT (S (ADVP (RB Here)) (NP (PRP we)) (VP (VBP show) (SBAR (IN that) (S (NP (NP (DT the) (ADJP (RB recently) (VBN reported)) (NN ability)) (PP (IN of) (NP (NNS Doc_20533999_537_561_Chemical) (S (VP (TO to) (VP (VB reverse) (NP (NP (DT the) (JJ protective) (NN effect)) (PP (IN of) (NP (NP (NNS Doc_20533999_598_624_Chemical)) (PP (IN on) (NP (NNP Doc_20533999_628_632_Chemical-induced) (NNP DA) (NNP Doc_20533999_644_657_Disease)))))))))))) (VP (VBZ is) (ADVP (RB also)) (VP (VBN confounded) (PP (IN by) (NP (NP (NN drug) (NNS effects)) (PP (IN on) (NP (NN body) (NN temperature)))))))))) (. .)))
20533999	4	(ROOT (S (RBR Further) (, ,) (NP (PRP we)) (VP (VBP show) (SBAR (SBAR (IN that) (S (NP (NP (NNS mice)) (ADJP (RB genetically) (VBN engineered) (S (VP (TO to) (VP (VB be) (VP (VBN deficient) (PP (IN in) (NP (NN brain) (NN DA))))))))) (VP (VB develop) (NP (JJ Doc_20533999_800_804_Chemical) (NNS Doc_20533999_805_818_Disease))))) (, ,) (ADVP (RB as) (RB long)) (SBAR (IN as) (S (NP (NP (DT the) (JJ thermic) (NNS effects)) (PP (IN of) (NP (NNS Doc_20533999_854_858_Chemical)))) (VP (VBP are) (VP (VBN preserved))))))) (. .)))
20533999	5	(ROOT (S (PP (IN In) (NP (NN addition))) (, ,) (NP (PRP we)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP (NP (NNS mice)) (ADJP (RB genetically) (VBN engineered))) (VP (TO to) (VP (VB have) (S (NP (JJ unilateral) (NN brain) (NNS Doc_20533999_960_962_Chemical) (NNS deficits)) (VP (VB develop) (NP (NP (NN Doc_20533999_980_984_Chemical-induced) (NNS Doc_20533999_993_1014_Disease)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (PP (IN of) (NP (NP (JJ comparable) (NN magnitude)) (PP (IN on) (NP (NP (DT both) (NNS sides)) (PP (IN of) (NP (DT the) (NN brain)))))))))))))))))) (. .)))
20533999	6	(ROOT (S (S (VP (VBN Taken) (ADVP (RB together)))) (, ,) (NP (DT these) (NNS findings)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP (NNP DA)) (VP (VP (VBZ is) (RB not) (ADJP (JJ essential) (PP (IN for) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (ADJP (JJ Doc_20533999_1167_1171_Chemical-induced) (JJ dopaminergic)) (NNS Doc_20533999_1193_1206_Disease))))))) (CC and) (VP (VBP suggest) (SBAR (IN that) (S (NP (NP (NNS mechanisms) (JJ independent)) (PP (IN of) (NP (NNP DA)))) (VP (VBP warrant) (NP (ADJP (RBR more) (JJ intense)) (NN investigation)))))))))) (. .)))
20552622	0	(ROOT (NP (NP (NP (NNP Doc_20552622_0_41_Disease)) (VP (VBN triggered) (PP (IN by) (NP (NNS Doc_20552622_55_65_Chemical))))) (: :) (NP (NP (NN case) (NN report) (CC and) (NN review)) (PP (IN of) (NP (DT the) (NN literature)))) (. .)))
20552622	1	(ROOT (S (NP (DT A) (JJ 49-year-old) (NN patient)) (VP (VBD experienced) (NP (NN chest) (NN discomfort)) (PP (IN while) (S (VP (VBG swallowing))))) (. .)))
20552622	2	(ROOT (S (S (PP (IN On) (NP (NN electrocardiogram))) (, ,) (NP (NP (NNS episodes)) (PP (IN of) (NP (NNS Doc_20552622_218_240_Disease)))) (VP (VBD were) (VP (VBN recorded) (ADVP (RB immediately)) (PP (IN after) (S (VP (VBG swallowing))))))) (: ;) (S (NP (JJ 24-hour) (NN Holter) (NN monitoring)) (VP (VBD recorded) (NP (JJ several) (NNS events)))) (. .)))
20552622	3	(ROOT (S (NP (DT The) (NNS Doc_20552622_340_350_Disease)) (VP (VP (VBD resolved) (PP (IN after) (NP (NN therapy))) (PP (IN with) (NP (NNS Doc_20552622_379_387_Chemical)))) (, ,) (CC but) (VP (VBD recurred) (NP (DT a) (NN year)) (ADVP (RB later)))) (. .)))
20552622	4	(ROOT (S (NP (DT The) (NN patient)) (VP (VBD noticed) (SBAR (IN that) (S (PP (IN before) (NP (DT these) (NNS episodes))) (NP (PRP he)) (VP (VBD had) (VP (VBN been) (VP (VBG using) (NP (NP (DT an) (NN inhalator)) (PP (IN of) (NP (NNS Doc_20552622_497_507_Chemical)))))))))) (. .)))
20552622	5	(ROOT (S (PP (IN After) (S (VP (VP (VBG stopping) (NP (DT the) (NN beta-agonist))) (, ,) (CC and) (VP (PP (IN after) (NP (DT a) (NN week))) (PP (IN with) (NP (DT the) (NNS Doc_20552622_568_576_Chemical))))))) (, ,) (NP (DT the) (NNS Doc_20552622_582_592_Disease)) (VP (VBD disappeared)) (. .)))
20552622	6	(ROOT (S (NP (NP (NNP Doc_20552622_618_659_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_20552622_661_665_Disease)) (-RRB- -RRB-))) (VP (VBZ is) (NP (DT a) (JJ rare) (NN phenomenon))) (. .)))
20552622	7	(ROOT (S (NP (NP (JJR Fewer)) (PP (IN than) (NP (NP (CD 50) (NNS cases)) (PP (IN of) (NP (NNS Doc_20552622_712_716_Disease)))))) (VP (VBP have) (VP (VBN been) (VP (VBN described) (PP (IN in) (NP (DT the) (NN literature)))))) (. .)))
20552622	8	(ROOT (S (NP (DT This) (NN article)) (VP (VBZ summarizes) (SBAR (S (NP (PDT all) (DT the) (NNS cases)) (VP (VBD published) (, ,) (S (VP (VBG creating) (NP (NP (DT a) (JJ comprehensive) (NN review)) (PP (IN of) (NP (DT the) (JJ current) (NN knowledge) (CC and) (NN approach)))) (PP (TO to) (NP (NNS Doc_20552622_878_882_Disease))))))))) (. .)))
20552622	9	(ROOT (S (NP (PRP It)) (VP (VBZ discusses) (NP (NP (NP (NNS demographics)) (, ,) (NP (NP (JJ clinical) (NNS characteristics) (CC and) (NNS types)) (PP (IN of) (NP (NNS Doc_20552622_949_959_Disease))))) (, ,) (NP (NP (JJ postulated) (NNS mechanisms)) (PP (IN of) (NP (NNS Doc_20552622_986_990_Disease)))) (, ,) (CC and) (NP (NP (JJ different) (NN treatment) (NNS possibilities)) (PP (JJ such) (IN as) (NP (NP (NNS medications)) (, ,) (NP (NN surgery)) (, ,) (CC and) (NP (NP (JJ radiofrequency) (NN catheter) (NN ablation)) (PRN (-LRB- -LRB-) (NP (NNP RFCA)) (-RRB- -RRB-)))))))) (. .)))
20552622	10	(ROOT (S (NP (NNP Doc_20552622_1117_1127_Chemical)) (VP (VBZ is) (VP (VBN presented) (ADVP (RB here)) (PP (IN as) (NP (NP (DT a) (JJ possible) (NN trigger)) (PP (IN for) (NP (NNS Doc_20552622_1172_1176_Disease))))))) (. .)))
20552622	11	(ROOT (S (SBAR (IN Although) (S (NP (PRP it)) (VP (VBZ is) (ADJP (JJ difficult) (S (VP (TO to) (VP (VB define) (ADVP (RB causality)) (PP (IN in) (NP (DT a) (NN case) (NN report)))))))))) (, ,) (NP (PRP it)) (VP (VBZ is) (ADJP (JJ logical) (S (VP (TO to) (VP (VB think) (SBAR (IN that) (S (NP (NP (DT a) (NN beta-agonist)) (PP (IN like) (NP (NP (NNS Doc_20552622_1289_1299_Chemical)) (PRN (-LRB- -LRB-) (VP (VBN known) (S (VP (TO to) (VP (VB induce) (NP (NNS Doc_20552622_1317_1328_Disease)))))) (-RRB- -RRB-))))) (VP (MD may) (VP (VB be) (NP (NP (DT the) (NN trigger)) (PP (IN of) (NP (NP (JJ adrenergic) (NNS reflexes)) (VP (VBG originating) (PP (IN in) (NP (DT the) (NNS esophagus))) (SBAR (SBAR (IN while) (S (VP (VBG swallowing)))) (CC and) (SBAR (IN that) (S (NP (NP (DT a) (NN beta-blocker)) (PP (JJ such) (IN as) (NP (NP (NNS Doc_20552622_1450_1458_Chemical)) (PRN (-LRB- -LRB-) (SBAR (WHNP (WDT that)) (S (VP (VBZ blocks) (NP (DT the) (JJ adrenergic) (NN activity))))) (-RRB- -RRB-))))) (VP (MD may) (VP (VB relieve) (NP (PRP it)))))))))))))))))))) (. .)))
2055425	0	(ROOT (S (NP (NP (DT The) (NN ability)) (PP (IN of) (NP (NN insulin) (NN treatment))) (S (VP (TO to) (VP (VB reverse) (CC or) (VB prevent) (NP (NP (DT the) (NNS changes)) (PP (IN in) (NP (JJ urinary) (NN bladder) (NN function)))))))) (VP (VBD caused) (PP (IN by) (NP (NP (NNP Doc_2055425_105_119_Chemical-induced) (NNP Doc_2055425_128_145_Disease) (. .)) (NP (CD 1))))) (. .)))
2055425	1	(ROOT (S (NP (NP (DT The) (NNS effects)) (PP (IN of) (NP (NP (NN insulin) (NN treatment)) (PP (PP (IN on) (PP (IN in) (NP (NN vivo)))) (CC and) (PP (IN in) (NP (NP (ADJP (NN vitro) (RB urinary)) (NN bladder) (NN function)) (PP (IN in) (NP (NN Doc_2055425_235_249_Chemical-Doc_2055425_250_258_Disease) (NNS rats))))))))) (VP (VBD were) (NP (NP (NNP investigated) (. .)) (NP (CD 2)))) (. .)))
2055425	2	(ROOT (S (NP (NP (NNP Doc_2055425_286_294_Disease)) (PP (IN of) (NP (CD 2) (NNS months) (NN duration)))) (VP (VP (VBD resulted) (PP (IN in) (NP (NP (NNS decreases)) (PP (IN in) (NP (NN body) (NN weight)))))) (CC and) (VP (VBZ increases) (PP (IN in) (NP (NP (JJ fluid) (NN consumption)) (, ,) (NP (NN urine) (NN volume)) (, ,) (NP (NP (NN frequency)) (PP (IN of) (NP (NN micturition)))) (, ,) (CC and) (NP (NP (NP (JJ average) (NN volume)) (PP (IN per) (NP (NN micturition)))) (: ;) (NP (NP (NNS effects)) (SBAR (WHNP (WDT which)) (S (VP (VBD were) (VP (VBN prevented) (PP (IN by) (NP (NN insulin) (NN treatment))) (. .)))))))))) (NP (CD 3))) (. .)))
2055425	3	(ROOT (S (NP (NN Insulin) (NN treatment)) (ADVP (RB also)) (VP (VBD prevented) (NP (DT the) (NNS increases)) (PP (IN in) (NP (NP (JJ contractile) (NNS responses)) (PP (IN of) (NP (NN bladder) (NN body) (NNS strips))))) (PP (IN from) (NP (JJ Doc_2055425_619_627_Disease) (NNS rats))) (PP (TO to) (NP (NP (NN nerve) (NN stimulation)) (, ,) (NP (NNS Doc_2055425_655_658_Chemical)) (, ,) (CC and) (NP (NP (NNP Doc_2055425_664_675_Chemical) (. .)) (NP (CD 4)))))) (. .)))
2055425	4	(ROOT (S (NP (NP (NNP Doc_2055425_680_688_Disease)) (PP (IN of) (NP (CD 4) (NNS months) (NN duration)))) (VP (VP (ADVP (RB also)) (VBD resulted) (PP (IN in) (NP (NP (NNS decreases)) (PP (IN in) (NP (NN body) (NN weight)))))) (, ,) (CC and) (VP (VBZ increases) (PP (IN in) (NP (NP (JJ fluid) (NN consumption)) (, ,) (NP (NN urine) (NN volume)) (, ,) (NP (NP (NN frequency)) (PP (IN of) (NP (NN micturition)))) (, ,) (CC and) (NP (NP (JJ average) (NN volume)) (PP (IN per) (NP (NP (NN micturition)) (, ,) (NP (NP (NNS effects)) (SBAR (WHNP (WDT which)) (S (VP (VBD were) (VP (VBN reversed) (PP (IN by) (NP (NN insulin) (NN treatment))) (PP (IN for) (NP (NP (DT the) (JJ final) (CD 2) (NNS months)) (PP (IN of) (NP (DT the) (NN study))))) (. .)))))))) (NP (CD 5))))))) (. .)))
2055425	5	(ROOT (S (NP (NN Insulin) (NN treatment)) (VP (VBD reversed) (NP (DT the) (NNS increases)) (PP (IN in) (NP (NP (JJ contractile) (NNS responses)) (PP (IN of) (NP (NN bladder) (NN body) (NNS strips))))) (PP (IN from) (NP (JJ Doc_2055425_1048_1056_Disease) (NNS rats))) (PP (TO to) (NP (NP (NN nerve) (NN stimulation)) (, ,) (NP (NNS Doc_2055425_1084_1087_Chemical)) (, ,) (CC and) (NP (NP (NNP Doc_2055425_1093_1104_Chemical) (. .)) (NP (CD 6)))))) (. .)))
2055425	6	(ROOT (S (NP (DT The) (NNS data)) (VP (VBP indicate) (SBAR (IN that) (S (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NP (NN Doc_2055425_1147_1161_Chemical-induced) (NNS Doc_2055425_1170_1178_Disease)) (PP (IN on) (NP (JJ urinary) (NN bladder) (NN function)))))) (VP (VBP are) (ADVP (DT both)) (VP (VBN prevented) (CC and) (VBN reversed) (PP (IN by) (NP (NN insulin) (NN treatment)))))))) (. .)))
20558148	0	(ROOT (S (NP (NP (JJ Glutamatergic) (NN neurotransmission)) (VP (VBN mediated) (PP (IN by) (NP (NP (JJ Doc_20558148_44_48_Chemical) (NNS receptors)) (PP (IN in) (NP (DT the) (JJ inferior) (NNS colliculus))))))) (VP (MD can) (VP (VB modulate) (NP (NN Doc_20558148_99_110_Chemical-induced) (NNS Doc_20558148_119_128_Disease)))) (. .)))
20558148	1	(ROOT (S (S (NP (NP (DT The) (JJ inferior) (NNS colliculus)) (PRN (-LRB- -LRB-) (NP (NNP IC)) (-RRB- -RRB-))) (VP (VBZ is) (ADVP (RB primarily)) (VP (VBN involved) (PP (IN in) (NP (NP (DT the) (NN processing)) (PP (IN of) (NP (JJ auditory) (NN information)))))))) (, ,) (CC but) (S (NP (PRP it)) (VP (VBZ is) (ADJP (JJ distinguished) (PP (IN from) (NP (NP (JJ other) (NN auditory) (NNS nuclei)) (PP (IN in) (NP (NP (DT the) (NN brainstem)) (PP (IN by) (NP (PRP$ its) (NNS connections)))))))) (PP (IN with) (NP (NP (NNS structures)) (PP (IN of) (NP (DT the) (NN motor) (NN system))))))) (. .)))
20558148	2	(ROOT (S (NP (NP (JJ Functional) (NN evidence)) (VP (VBG relating) (NP (DT the) (NNP IC)) (PP (TO to) (NP (NN motor) (NN behavior))))) (VP (VBZ derives) (PP (IN from) (NP (NP (NNS experiments)) (VP (VBG showing) (SBAR (IN that) (S (NP (NP (NN activation)) (PP (IN of) (NP (NP (DT the) (NNP IC)) (PP (IN by) (NP (JJ electrical) (NN stimulation) (CC or) (NN excitatory) (NNS Doc_20558148_501_511_Chemical) (NN microinjection)))))) (VP (VBZ causes) (NP (NP (NN freezing)) (, ,) (NP (JJ escape-like) (NN behavior)) (, ,) (CC and) (NP (NN immobility)))))))))) (. .)))
20558148	3	(ROOT (S (ADVP (RB However)) (, ,) (NP (NP (DT the) (NN nature)) (PP (IN of) (NP (DT this) (NN immobility)))) (VP (VBZ is) (ADVP (RB still)) (ADJP (JJ unclear))) (. .)))
20558148	4	(ROOT (S (NP (DT The) (JJ present) (NN study)) (VP (VBD examined) (NP (NP (DT the) (NN influence)) (PP (IN of) (NP (NP (ADJP (RB excitatory) (JJ Doc_20558148_694_704_Chemical-mediated)) (NNS mechanisms)) (PP (IN in) (NP (NP (DT the) (NNP IC)) (PP (IN on) (NP (NP (DT the) (NNS Doc_20558148_742_751_Disease)) (VP (VBN induced) (PP (IN by) (NP (NP (DT the) (JJ Doc_20558148_767_775_Chemical) (NN receptor) (NN blocker) (NNS Doc_20558148_793_804_Chemical)) (VP (VBN administered) (ADVP (RB systemically)))))))))) (PRN (-LRB- -LRB-) (NP (QP (CD 1) (CC or) (CD 0.5) (CD mg/kg))) (-RRB- -RRB-))))) (PP (IN in) (NP (NNS rats)))) (. .)))
20558148	5	(ROOT (S (NP (JJ Doc_20558148_857_868_Chemical-induced) (NNS Doc_20558148_877_886_Disease)) (VP (VBD was) (VP (VBN challenged) (PP (IN with) (NP (NP (JJ prior) (NN intracollicular) (NNS microinjections)) (PP (IN of) (NP (NP (JJ Doc_20558148_948_957_Chemical) (JJ Doc_20558148_958_962_Chemical) (NN receptor) (NNS antagonists)) (, ,) (NP (NP (UCP (NP (NP (NP (NNS Doc_20558148_985_991_Chemical)) (PRN (-LRB- -LRB-) (NP (QP (CD 15) (CC or) (CD 30) (CD mmol/0) (CD .5) (CD microl))) (-RRB- -RRB-))) (CC and) (NP (NP (NNS Doc_20558148_1023_1026_Chemical)) (PRN (-LRB- -LRB-) (NP (QP (CD 10) (CC or) (CD 20) (CD nmol/0) (CD .5) (CD microl))) (-RRB- -RRB-)))) (, ,) (CC or) (PP (IN of) (NP (DT the) (JJ Doc_20558148_1065_1069_Chemical) (NN receptor)))) (NN agonist) (NNS Doc_20558148_1087_1107_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (NNS Doc_20558148_1109_1113_Chemical)) (, ,) (NP (CD 20)) (CC or) (NP (NP (CD 30) (NNS nmol/0)) (NP (CD .5) (NN microl)))) (-RRB- -RRB-))))))))) (. .)))
20558148	6	(ROOT (S (NP (DT The) (NNS results)) (VP (VBD showed) (SBAR (IN that) (S (NP (NP (NP (NP (NN intracollicular) (NN microinjection)) (PP (IN of) (NP (NNS Doc_20558148_1200_1206_Chemical) (CC and) (NNS Doc_20558148_1211_1214_Chemical)))) (JJ previous)) (PP (TO to) (NP (NP (JJ systemic) (NNS injections)) (PP (IN of) (NP (NNS Doc_20558148_1250_1261_Chemical)))))) (ADVP (RB significantly)) (VP (VBD attenuated) (NP (DT the) (NNS Doc_20558148_1291_1300_Disease)) (, ,) (SBAR (IN as) (S (VP (VBD indicated) (PP (IN by) (NP (DT a) (VBN reduced) (NN latency) (S (VP (TO to) (VP (VB step) (PRT (RP down)) (PP (IN from) (NP (DT a) (JJ horizontal) (NN bar))))))))))))))) (. .)))
20558148	7	(ROOT (S (ADVP (RB Accordingly)) (, ,) (NP (NP (NN intracollicular) (NN microinjection)) (PP (IN of) (NP (NNS Doc_20558148_1419_1423_Chemical)))) (VP (VBD increased) (NP (DT the) (NN latency) (S (VP (TO to) (VP (VB step) (PRT (RP down)) (NP (DT the) (NN bar))))))) (. .)))
20558148	8	(ROOT (S (NP (DT These) (NNS findings)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NP (NN Doc_20558148_1496_1505_Chemical-mediated) (NNS mechanisms)) (PP (IN in) (NP (NP (DT the) (JJ neural) (NNS circuits)) (PP (IN at) (NP (DT the) (NNP IC) (NN level)))))) (VP (VP (VB influence) (NP (NN Doc_20558148_1575_1586_Chemical-induced) (NNS Doc_20558148_1595_1604_Disease))) (CC and) (VP (VB participate) (PP (IN in) (NP (NP (DT the) (NN regulation)) (PP (IN of) (NP (NN motor) (NN activity)))))))))) (. .)))
20635749	0	(ROOT (NP (NP (NP (JJ Severe) (JJ Doc_20635749_7_31_Disease) (NN patient)) (PP (IN on) (NP (NP (NNS Doc_20635749_43_53_Chemical)) (VP (VBG presenting) (PP (IN with) (NP (NNS Doc_20635749_70_84_Disease))))))) (: :) (NP (NP (DT a) (NN case)) (NP (NN report))) (. .)))
20635749	1	(ROOT (S (NP (DT This)) (VP (VBZ is) (NP (NP (DT a) (NN case) (NN report)) (PP (IN of) (NP (NP (JJ Doc_20635749_126_139_Disease) (ADJP (JJ secondary) (TO to) (JJ Doc_20635749_153_163_Chemical-induced)) (NNS Doc_20635749_172_186_Disease)) (PP (IN in) (NP (NP (DT a) (NN patient)) (PP (IN with) (NP (NP (JJ severe) (NNS Doc_20635749_212_236_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_20635749_238_241_Disease)) (-RRB- -RRB-)))))))))) (. .)))
20635749	2	(ROOT (S (PP (PP (TO To) (NP (PRP$ our) (NN knowledge))) (CC and) (PP (IN after) (S (VP (VBG reviewing) (NP (DT the) (NN literature)))))) (NP (EX there)) (VP (VBZ is) (NP (NP (CD one) (NN case) (NN report)) (PP (IN of) (NP (NP (NNS Doc_20635749_324_337_Disease)) (PP (IN during) (NP (JJ long) (NN term) (NNS Doc_20635749_355_365_Chemical) (NN therapy))))))) (. .)))
20635749	3	(ROOT (S (NP (NNP Doc_20635749_375_388_Disease)) (VP (VBZ is) (NP (NP (DT a) (NN life)) (VP (VBG threatening) (NP (NP (NN condition)) (SBAR (WHNP (WDT that)) (S (VP (VBZ carries) (NP (NP (DT a) (NN mortality)) (VP (VBG reaching) (ADVP (RB as) (JJ high) (PP (IN as) (NP (CD 20) (NN %)))) (PP (IN with) (NP (NN treatment)))))))))))) (. .)))
20635749	4	(ROOT (S (NP (DT The) (NN condition)) (VP (VBZ is) (VP (VBN treated) (PP (IN with) (NP (NP (JJ intravenous) (NNS Doc_20635749_528_537_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP T4)) (-RRB- -RRB-)) (CC or) (NP (JJ intravenous) (NNS Doc_20635749_558_576_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP T3)) (-RRB- -RRB-)))))) (. .)))
20635749	5	(ROOT (S (NP (NP (NNS Patients)) (PP (IN with) (NP (NP (NNS Doc_20635749_597_600_Disease)) (PP (IN on) (NP (NNS Doc_20635749_604_614_Chemical)))))) (VP (VP (MD may) (VP (VB suffer) (NP (JJ serious) (NN morbidity) (CC and) (NN mortality)) (PP (IN from) (NP (NNS Doc_20635749_663_677_Disease))))) (, ,) (CC and) (VP (ADVP (RB thus)) (MD may) (ADVP (RB deserve) (RBR closer)) (VP (VB follow) (PRT (RP up)) (PP (IN for) (NP (NP (NN thyroid)) (VP (VBG stimulating) (NP (JJ hormone) (PRN (-LRB- -LRB-) (NP (NNP TSH)) (-RRB- -RRB-)) (NNS levels)))))))) (. .)))
20635749	6	(ROOT (S (NP (DT This) (NN case) (NN report)) (VP (VBZ carries) (NP (NP (DT an) (JJ important) (JJ clinical) (NN application)) (VP (VBN given) (NP (NP (DT the) (JJ frequent) (NN usage)) (PP (IN of) (NP (NNS Doc_20635749_850_860_Chemical)))) (PP (IN among) (NP (JJ Doc_20635749_867_870_Disease) (NNS patients)))))) (. .)))
20635749	7	(ROOT (S (NP (NP (DT The) (JJ myriad) (JJ clinical) (NN presentation)) (PP (IN of) (NP (NP (NNS Doc_20635749_917_930_Disease)) (CC and) (NP (PRP$ its) (JJ serious) (NN morbidity) (CC and) (NN mortality))))) (VP (VBZ stresses) (NP (DT the) (NN need) (S (VP (TO to) (VP (VB suspect) (NP (DT this) (JJ clinical) (NN syndrome)) (PP (IN among) (NP (NP (JJ Doc_20635749_1029_1032_Disease) (NNS patients)) (VP (VBG presenting) (PP (IN with) (NP (NP (NNS Doc_20635749_1058_1069_Disease)) (, ,) (NP (NNS Doc_20635749_1071_1079_Disease)) (CC or) (NP (JJ other) (JJ unexplained) (NNS symptoms)))))))))))) (. .)))
20683499	0	(ROOT (S (NP (NP (NNPS Effects)) (PP (IN of) (NP (NP (JJ active) (NNS constituents)) (PP (IN of) (NP (NNP Crocus)))))) (VP (VBZ sativus) (NP (NP (NNP L.) (, ,) (NNP Doc_20683499_53_59_Chemical)) (PP (IN on) (NP (NP (NN Doc_20683499_63_75_Chemical-induced) (NN model)) (PP (IN of) (NP (NP (JJ sporadic) (NNS Doc_20683499_102_121_Disease)) (PP (IN in) (NP (JJ male) (NNS rats))))))))) (. .)))
20683499	1	(ROOT (S (NP (NP (NP (DT The) (NN involvement)) (PP (IN of) (NP (JJ water-soluble) (NNS carotenoids)))) (, ,) (NP (NNS Doc_20683499_194_201_Chemical)) (, ,) (SBAR (IN as) (S (NP (NP (DT the) (JJ main) (CC and) (JJ active) (NNS components)) (PP (IN of) (NP (NNP Crocus)))) (VP (VBZ sativus) (S (NP (NNP L.)) (VP (VB extract) (PP (IN in) (NP (NN learning) (CC and) (NN memory) (NNS processes))))))))) (VP (VBZ has) (VP (VBN been) (VP (VBN proposed)))) (. .)))
20683499	2	(ROOT (S (PP (IN In) (NP (DT the) (JJ present) (NN study))) (, ,) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (NP (NNS Doc_20683499_354_361_Chemical)) (PP (IN on) (NP (NP (JJ sporadic) (NNS Doc_20683499_374_393_Disease)) (VP (VBN induced) (PP (IN by) (NP (NP (JJ intracerebroventricular) (PRN (-LRB- -LRB-) (NP (NN icv)) (-RRB- -RRB-)) (NN Doc_20683499_435_447_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_20683499_449_452_Chemical)) (-RRB- -RRB-)))) (PP (IN in) (NP (JJ male) (NNS rats))))))))) (VP (VBD was) (VP (VBN investigated))) (. .)))
20683499	3	(ROOT (S (NP (NP (JJ Male) (JJ adult) (NNP Wistar) (NNS rats)) (PRN (-LRB- -LRB-) (VP (VBN n) (S (VP (SYM =) (NP (CD 90) (CC and) (CD 260-290) (NNS g))))) (-RRB- -RRB-))) (VP (VBD were) (VP (VBN divided) (PP (IN into) (NP (NP (NP (NP (CD 1)) (, ,) (NP (NN control))) (: ;) (NP (NP (CD 2) (CC and) (CD 3)) (, ,) (NP (NP (NNS Doc_20683499_579_586_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (CD 15)) (CC and) (NP (CD 30) (NN mg/kg))) (-RRB- -RRB-)))) (: ;) (NP (NP (CD 4)) (, ,) (NP (NNS Doc_20683499_609_612_Chemical))) (: ;) (NP (NP (CD 5)) (CC and) (NP (CD 6)))) (, ,) (NP (NNP Doc_20683499_623_626_Chemical) (NNP +) (NNP Doc_20683499_629_636_Chemical) (PRN (-LRB- -LRB-) (NP (NP (CD 15)) (CC and) (NP (CD 30) (NN mg/kg))) (-RRB- -RRB-)) (NNS groups)))))) (. .)))
20683499	4	(ROOT (S (PP (IN In) (NP (JJ Doc_20683499_666_685_Disease) (NNS groups))) (, ,) (S (NP (NNS rats)) (VP (VBD were) (VP (VBN injected) (PP (IN with) (NP (NP (NP (NN Doc_20683499_718_721_Chemical-icv) (NN bilaterally)) (PRN (-LRB- -LRB-) (NP (CD 3) (NN mg/kg)) (-RRB- -RRB-))) (PP (IN in) (NP (JJ first) (NN day)))))))) (CC and) (S (NP (CD 3) (NNS days) (RB later)) (, ,) (NP (DT a) (JJ similar) (NN Doc_20683499_789_792_Chemical-icv) (NN application)) (VP (VBD was) (VP (VBN repeated)))) (. .)))
20683499	5	(ROOT (S (PP (IN In) (NP (JJ Doc_20683499_826_829_Chemical) (NNP +) (JJ Doc_20683499_832_838_Chemical) (NN animal) (NNS groups))) (, ,) (NP (NNS Doc_20683499_854_860_Chemical)) (VP (VBD was) (VP (VP (VBN applied) (PP (IN in) (NP (NP (NP (NNS doses)) (PP (IN of) (NP (CD 15)))) (CC and) (NP (NP (CD 30) (NN mg/kg)) (, ,) (NP (NN i.p.)) (, ,) (NP (CD one) (NN day) (NN pre-surgery)))))) (CC and) (VP (VBN continued) (PP (IN for) (NP (CD three) (NNS weeks)))))) (. .)))
20683499	6	(ROOT (S (NP (NP (NNP Prescription)) (PP (IN of) (NP (NP (NNS Doc_20683499_975_981_Chemical)) (PP (IN in) (NP (DT each) (NN dose)))))) (VP (VBD was) (VP (VBN repeated) (ADVP (RB once)) (PP (IN for) (NP (CD two) (NNS days))))) (. .)))
20683499	7	(ROOT (S (ADVP (RB However)) (, ,) (S (NP (DT the) (NN learning) (CC and) (NN memory) (NN performance)) (VP (VBD was) (VP (VBN assessed) (S (VP (VBG using) (NP (JJ passive) (NN avoidance) (NN paradigm))))))) (, ,) (CC and) (S (PP (IN for) (NP (JJ spatial) (NN cognition) (NN evaluation))) (, ,) (NP (JJ Y-maze) (NN task)) (VP (VBD was) (VP (VBN used)))) (. .)))
20683499	8	(ROOT (S (S (NP (PRP It)) (VP (VBD was) (VP (VBN found) (PP (IN out) (NP (NP (DT that) (NNS Doc_20683499_1210_1216_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 30) (NN mg/kg)) (-RRB- -RRB-))))))) (: -) (S (NP (JJ treated) (NN Doc_20683499_1236_1239_Chemical-injected) (NNS rats)) (VP (VBP show) (NP (NP (ADJP (JJR higher) (JJ correct)) (NNS choices)) (CC and) (NP (NP (JJR lower) (NNS errors)) (PP (IN in) (NP (NNP Y-maze))))) (PP (IN than) (NP (JJ vehicle-treated) (NN Doc_20683499_1330_1333_Chemical-injected) (NNS rats))))) (. .)))
20683499	9	(ROOT (S (PP (IN In) (NP (NN addition))) (, ,) (NP (NP (NNS Doc_20683499_1362_1368_Chemical)) (PP (IN in) (NP (DT the) (JJ mentioned) (NN dose)))) (VP (MD could) (ADVP (RB significantly)) (VP (VB attenuated) (NP (NNS Doc_20683499_1422_1452_Disease)) (PP (IN in) (NP (NP (JJ treated) (NN Doc_20683499_1464_1467_Chemical-injected) (NN group)) (PP (IN in) (NP (JJ passive) (NN avoidance) (NN test))))))) (. .)))
20683499	10	(ROOT (S (ADVP (RB Therefore)) (, ,) (NP (DT these) (NNS results)) (VP (VBP demonstrate) (NP (NP (DT the) (NN effectiveness)) (PP (IN of) (NP (NP (NNS Doc_20683499_1580_1586_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 30) (NN mg/kg)) (-RRB- -RRB-))))) (PP (IN in) (S (VP (VBG antagonizing) (NP (NP (DT the) (NNS Doc_20683499_1618_1636_Disease)) (VP (VBN caused) (PP (IN by) (NP (NP (NNS Doc_20683499_1647_1650_Chemical-icv)) (PP (IN in) (NP (NP (NNS rats)) (CC and) (NP (PRP$ its) (NN potential)))))) (PP (IN in) (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (NP (NNS Doc_20683499_1701_1727_Disease)) (PP (JJ such) (IN as) (NP (NNS Doc_20683499_1736_1755_Disease))))))))))))) (. .)))
20705401	0	(ROOT (S (NP (QP (CD Doc_20705401_0_9_Chemical) (CD 6)) (NN receptor) (NN gene)) (VP (VBZ is) (VP (VBN associated) (PP (IN with) (NP (NP (NN Doc_20705401_45_60_Chemical-induced) (NNS Doc_20705401_69_78_Disease)) (PP (IN in) (NP (DT a) (JJ Japanese) (NN population))))))) (. .)))
20705401	1	(ROOT (S (NP (JJ Altered) (JJ serotonergic) (JJ neural) (NN transmission)) (VP (VBZ is) (VP (VBN hypothesized) (S (VP (TO to) (VP (VB be) (NP (NP (DT a) (JJ susceptibility) (NN factor)) (PP (IN for) (NP (NP (NNS Doc_20705401_208_227_Disease)) (PP (JJ such) (IN as) (NP (NNS Doc_20705401_236_249_Disease))))))))))) (. .)))
20705401	2	(ROOT (S (S (NP (DT The) (ADJP (ADJP (QP (CD Doc_20705401_255_264_Chemical) (CD 6))) (PRN (-LRB- -LRB-) (NP (CD 5-HT6)) (-RRB- -RRB-))) (NN receptor)) (VP (VBZ is) (ADVP (RB therapeutically)) (VP (VBN targeted) (PP (IN by) (NP (NP (JJ several) (JJ second) (NN generation) (NNS antipsychotics)) (, ,) (PP (JJ such) (IN as) (NP (NNS Doc_20705401_365_374_Chemical) (CC and) (NNS Doc_20705401_379_389_Chemical)))))))) (, ,) (CC and) (S (NP (NP (NN Doc_20705401_395_408_Chemical-induced) (NNS Doc_20705401_417_430_Disease)) (PP (IN in) (NP (NNS rats)))) (VP (VBZ is) (VP (VBN corrected) (PP (IN with) (NP (NP (DT the) (NN use)) (PP (IN of) (NP (DT a) (JJ selective) (CD 5-HT6) (NN receptor) (NN antagonist)))))))) (. .)))
20705401	3	(ROOT (S (PP (IN In) (NP (NN addition))) (, ,) (NP (NP (DT the) (JJ disrupted) (NN prepulse) (NN inhibition)) (VP (VBN induced) (PP (IN by) (NP (NNS Doc_20705401_565_578_Chemical) (CC or) (NNS Doc_20705401_582_595_Chemical))))) (VP (VBD was) (VP (VBN restored) (PP (IN by) (NP (NP (CD 5-HT6) (NN receptor) (NN antagonist)) (PP (IN in) (NP (DT an) (NN animal) (NN study))))) (S (VP (VBG using) (NP (NNS rats)))))) (. .)))
20705401	4	(ROOT (S (S (NP (DT These) (NN animal) (NNS models)) (VP (VBD were) (VP (VBN considered) (S (VP (TO to) (VP (VB reflect) (NP (NP (DT the) (JJ positive) (NNS symptoms)) (PP (IN of) (NP (NNS Doc_20705401_741_754_Disease)))))))))) (, ,) (CC and) (S (NP (DT the) (JJ above) (NN evidence)) (VP (VBZ suggests) (SBAR (IN that) (S (NP (JJ altered) (JJ Doc_20705401_801_805_Chemical6) (NNS receptors)) (VP (VBP are) (VP (VBN involved) (PP (IN in) (NP (NP (DT the) (NN pathophysiology)) (PP (IN of) (NP (NNS Doc_20705401_856_875_Disease))))))))))) (. .)))
20705401	5	(ROOT (S (NP (NP (DT The) (NNS symptoms)) (PP (IN of) (NP (NP (NNS Doc_20705401_893_908_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_20705401_910_914_Chemical)) (-RRB- -RRB-)) (: -) (NP (JJ induced) (NNS Doc_20705401_924_933_Disease))))) (VP (VBP are) (ADJP (JJ similar) (PP (TO to) (NP (NP (DT those)) (PP (IN of) (NP (NNS Doc_20705401_958_985_Disease))))))) (. .)))
20705401	6	(ROOT (S (ADVP (RB Therefore)) (, ,) (NP (PRP we)) (VP (VBD conducted) (NP (NP (DT an) (NN analysis)) (PP (IN of) (NP (NP (DT the) (NN association)) (PP (IN of) (NP (NP (DT the) (JJ Doc_20705401_1049_1053_Chemical6) (NN gene)) (PRN (-LRB- -LRB-) (NP (NNP HTR6)) (-RRB- -RRB-))))))) (PP (IN with) (NP (NN Doc_20705401_1072_1076_Chemical-induced) (NNS Doc_20705401_1085_1094_Disease)))) (. .)))
20705401	7	(ROOT (S (S (VP (VBG Using) (NP (NP (CD five) (JJ tagging) (NNS SNPs)) (PRN (-LRB- -LRB-) (NP (NP (NNS rs6693503)) (, ,) (NP (NNPS rs1805054) (, ,) (NNPS rs4912138) (, ,) (NNPS rs3790757) (CC and) (NNPS rs9659997))) (-RRB- -RRB-))))) (, ,) (NP (PRP we)) (VP (VBD conducted) (NP (NP (DT a) (JJ genetic) (NN association) (NN analysis)) (PP (IN of) (NP (JJ case-control) (NNS samples)))) (PRN (-LRB- -LRB-) (NP (NP (CD 197) (JJ Doc_20705401_1261_1265_Chemical-induced) (JJ Doc_20705401_1274_1283_Disease) (NNS patients)) (CC and) (NP (JJ 337) (NNS controls))) (-RRB- -RRB-)) (PP (IN in) (NP (DT the) (JJ Japanese) (NN population)))) (. .)))
20705401	8	(ROOT (S (NP (NP (DT The) (NN age) (CC and) (NN sex)) (PP (IN of) (NP (DT the) (NN control) (NNS subjects)))) (VP (VBD did) (RB not) (VP (VB differ) (PP (IN from) (NP (NP (DT those)) (PP (IN of) (NP (DT the) (JJ Doc_20705401_1412_1427_Chemical) (NN dependence) (NNS patients))))))) (. .)))
20705401	9	(ROOT (S (NP (NNS rs6693503)) (VP (VBD was) (VP (VBN associated) (PP (IN with) (NP (NP (JJ Doc_20705401_1488_1492_Chemical-induced) (JJ Doc_20705401_1501_1510_Disease) (NNS patients)) (PP (IN in) (NP (DT the) (JJ allele/genotype-wise) (NN analysis))))))) (. .)))
20705401	10	(ROOT (S (ADVP (RB Moreover)) (, ,) (NP (DT this) (NN association)) (VP (VBD remained) (ADJP (JJ significant)) (PP (IN after) (NP (NNP Bonferroni) (NN correction)))) (. .)))
20705401	11	(ROOT (S (PP (IN In) (NP (DT the) (JJ haplotype-wise) (NN analysis))) (, ,) (NP (PRP we)) (VP (VBD detected) (NP (NP (DT an) (NN association)) (PP (IN between) (NP (NP (CD two) (NNS markers)) (PRN (-LRB- -LRB-) (NP (JJ rs6693503) (CC and) (JJ rs1805054)) (-RRB- -RRB-)) (CC and) (NP (CD three) (NNS markers)) (PRN (-LRB- -LRB-) (NP (NNP rs6693503)) (, ,) (NP (JJ rs1805054) (CC and) (JJ rs4912138)) (-RRB- -RRB-))))) (PP (IN in) (NP (NN HTR6) (CC and) (NN Doc_20705401_1807_1811_Chemical-induced) (NNS Doc_20705401_1820_1829_Disease) (NNS patients))) (, ,) (ADVP (RB respectively))) (. .)))
20705401	12	(ROOT (S (NP (NNP HTR6)) (VP (MD may) (VP (VB play) (NP (DT an) (JJ important) (NN role)) (PP (IN in) (NP (NP (DT the) (NN pathophysiology)) (PP (IN of) (NP (NP (NN Doc_20705401_1924_1928_Chemical-induced) (NNS Doc_20705401_1937_1946_Disease)) (PP (IN in) (NP (DT the) (JJ Japanese) (NN population))))))))) (. .)))
20727411	0	(ROOT (S (NP (NP (JJ Neural) (NNS correlates)) (PP (IN of) (NP (NNS Doc_20727411_21_31_Chemical)))) (VP (VBN induced) (NP (NNS Doc_20727411_40_49_Disease)) (PP (IN during) (NP (JJ overt) (JJ continuous) (JJ verbal) (NN fluency)))) (. .)))
20727411	1	(ROOT (S (NP (DT The) (NP (NP (JJ glutamatergic) (NNS Doc_20727411_108_128_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_20727411_130_134_Chemical)) (-RRB- -RRB-))) (NN receptor)) (VP (VBZ has) (VP (VBN been) (VP (VBN implicated) (PP (IN in) (NP (NP (DT the) (NN pathophysiology)) (PP (IN of) (NP (NNS Doc_20727411_191_204_Disease)))))))) (. .)))
20727411	2	(ROOT (S (S (VP (VBN Administered) (PP (TO to) (NP (JJ healthy) (NNS volunteers))))) (, ,) (NP (NP (DT a) (JJ subanesthetic) (NN dose)) (PP (IN of) (NP (DT the) (JJ non-competitive) (JJ Doc_20727411_286_290_Chemical) (NN receptor) (NN antagonist) (NNS Doc_20727411_311_319_Chemical)))) (VP (VBZ leads) (S (VP (TO to) (VP (VB psychopathological) (S (NP (NNS symptoms)) (ADJP (JJ similar) (PP (TO to) (NP (NP (DT those)) (VP (VBN observed) (PP (IN in) (NP (NNS Doc_20727411_386_399_Disease)))))))))))) (. .)))
20727411	3	(ROOT (S (PP (IN In) (NP (NP (NNS patients)) (PP (IN with) (NP (NNS Doc_20727411_418_431_Disease))))) (, ,) (NP (NNS Doc_20727411_433_441_Chemical)) (VP (VBZ exacerbates) (NP (NP (DT the) (JJ core) (NNS symptoms)) (PP (IN of) (NP (NN illness)))) (, ,) (S (VP (VBG supporting) (NP (NP (DT the) (NNS hypothesis)) (PP (IN of) (NP (DT a) (NNS Doc_20727411_515_540_Disease))))))) (. .)))
20727411	4	(ROOT (S (PP (IN In) (NP (DT a) (JJ counterbalanced) (, ,) (JJ placebo-controlled) (, ,) (JJ double-blind) (NN study) (NN design))) (, ,) (NP (JJ healthy) (NNS subjects)) (VP (VBD were) (VP (VBN administered) (NP (DT a) (JJ continuous) (JJ subanesthetic) (JJ Doc_20727411_673_683_Chemical) (NN infusion)) (SBAR (IN while) (S (NP (NP (NNS differences)) (PP (IN in) (NP (NP (JJ BOLD) (NNS responses)) (VP (VBN measured) (PP (IN with) (NP (NNS fMRI))))))) (VP (VBD were) (VP (VBN detected))))))) (. .)))
20727411	5	(ROOT (S (PP (IN During) (NP (DT the) (JJ scanning) (NN period))) (, ,) (NP (NNS subjects)) (VP (VBD performed) (NP (NP (ADJP (JJ continuous) (JJ overt)) (JJ verbal) (JJ fluency) (NNS tasks)) (PRN (-LRB- -LRB-) (NP (NN phonological)) (, ,) (NP (JJ lexical) (CC and) (JJ semantic)) (-RRB- -RRB-)))) (. .)))
20727411	6	(ROOT (S (NP (JJ Doc_20727411_886_894_Chemical-induced) (JJ psychopathological) (NNS symptoms)) (VP (VBD were) (VP (VBN assessed) (PP (IN with) (NP (NP (DT the) (JJ Positive) (CC and) (JJ Negative) (NN Syndrome) (NN Scale)) (PRN (-LRB- -LRB-) (NP (NNP PANSS)) (-RRB- -RRB-)))))) (. .)))
20727411	7	(ROOT (S (NP (NNP Doc_20727411_1000_1008_Chemical)) (VP (VBD elicited) (NP (NNS Doc_20727411_1018_1027_Disease)) (PP (IN like) (NP (NN psychopathology)))) (. .)))
20727411	8	(ROOT (S (NP (NNP Post-hoc) (NNS t-tests)) (VP (VBD revealed) (NP (NP (JJ significant) (NNS differences)) (PP (IN between) (NP (NN placebo) (CC and) (NNS Doc_20727411_1120_1128_Chemical)))) (PP (IN for) (NP (NP (DT the) (NNS amounts)) (PP (IN of) (NP (NP (NNS words)) (VP (VBN generated) (PP (IN during) (NP (NP (ADJP (JJ lexical) (CC and) (JJ semantic)) (JJ verbal) (NN fluency)) (, ,) (SBAR (IN while) (S (NP (DT the) (JJ phonological) (NN domain)) (VP (VBD remained) (ADJP (JJ unaffected))))))))))))) (. .)))
20727411	9	(ROOT (S (NP (NNP Doc_20727411_1259_1267_Chemical)) (VP (VBD led) (PP (TO to) (NP (NP (JJ enhanced) (JJ cortical) (NNS activations)) (PP (IN in) (NP (NN supramarginal) (CC and) (JJ frontal) (NN brain) (NNS regions))))) (PP (PP (IN for) (NP (ADJP (JJ phonological) (CC and) (JJ lexical)) (JJ verbal) (NN fluency))) (, ,) (CC but) (RB not) (PP (IN for) (NP (JJ semantic) (JJ verbal) (NN fluency))))) (. .)))
20727411	10	(ROOT (S (NP (NNP Doc_20727411_1430_1438_Chemical)) (VP (VBZ induces) (S (NP (NP (NN activation) (NNS changes)) (PP (IN in) (NP (JJ healthy) (NNS subjects)))) (ADJP (JJ similar) (PP (TO to) (NP (NP (DT those)) (VP (VBN observed) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NNS Doc_20727411_1529_1542_Disease)))) (, ,) (ADVP (RB particularly))) (PP (IN in) (NP (JJ frontal) (CC and) (JJ temporal) (NN brain) (NNS regions))))))))) (. .)))
20727411	11	(ROOT (S (NP (PRP$ Our) (NNS results)) (VP (VBP provide) (NP (JJ further) (NN support)) (PP (IN for) (NP (NP (DT the) (NNS hypothesis)) (PP (IN of) (NP (NP (DT an) (JJ Doc_20727411_1657_1661_Chemical) (NN receptor) (NN dysfunction)) (PP (IN in) (NP (NP (DT the) (NN pathophysiology)) (PP (IN of) (NP (NNS Doc_20727411_1709_1722_Disease)))))))))) (. .)))
20735774	0	(ROOT (NP (NP (JJ Long-term) (NN prognosis)) (PP (IN for) (NP (JJ transplant-free) (NNS survivors))) (PP (IN of) (NP (NN Doc_20735774_53_64_Chemical-induced) (NNS Doc_20735774_73_92_Disease))) (. .)))
20735774	1	(ROOT (S (NP (NP (DT The) (NN prognosis)) (PP (IN for) (NP (NP (JJ transplant-free) (NNS survivors)) (PP (IN of) (NP (NN Doc_20735774_153_164_Chemical-induced) (NNS Doc_20735774_173_192_Disease)))))) (VP (VBZ remains) (ADJP (JJ unknown))) (. .)))
20735774	2	(ROOT (S (VP (TO To) (VP (VB examine) (SBAR (IN whether) (S (NP (NN Doc_20735774_234_245_Chemical-induced) (NNS Doc_20735774_254_273_Disease)) (VP (VBZ increases) (NP (JJ long-term) (NN mortality))))))) (. .)))
20735774	3	(ROOT (S (NP (PRP We)) (VP (VBD followed) (PRT (RP up)) (NP (NP (DT all) (JJ transplant-free) (NNS survivors)) (PP (IN of) (NP (NP (NN Doc_20735774_362_373_Chemical-induced) (NNS Doc_20735774_382_400_Disease)) (, ,) (VP (VBN hospitalized) (PP (IN in) (NP (DT a) (JJ Danish) (JJ national) (NN referral) (NN centre))) (PP (IN during) (NP (CD 1984-2004)))))))) (. .)))
20735774	4	(ROOT (S (NP (PRP We)) (VP (VBD compared) (NP (JJ age-specific) (NN mortality) (NNS rates)) (PP (IN from) (NP (CD 1) (NN year) (NN post-discharge))) (PP (IN through) (NP (NP (CD 2008)) (PP (IN between) (NP (NP (DT those)) (SBAR (WHPP (IN in) (WHNP (WP whom))) (S (NP (DT the) (NNS Doc_20735774_577_589_Disease)) (VP (VBD led) (PP (TO to) (NP (NP (DT an) (NNS Doc_20735774_600_619_Disease)) (CC and) (NP (DT those)))) (PP (IN in) (SBAR (WHNP (WP whom)) (S (NP (PRP it)) (VP (VBD did) (RB not))))))))))))) (. .)))
20735774	5	(ROOT (S (NP (PRP We)) (VP (VBD included) (NP (CD 641) (NNS patients))) (. .)))
20735774	6	(ROOT (S (S (PP (IN On) (NP (NN average))) (, ,) (NP (JJ age-specific) (NN mortality) (NNS rates)) (VP (VBD were) (ADJP (RB slightly) (JJR higher)) (PP (IN for) (NP (NP (DT the) (CD 101) (NNS patients)) (SBAR (WP$ whose) (S (NP (NN Doc_20735774_774_785_Chemical-induced) (NNS Doc_20735774_794_806_Disease)) (VP (VBD had) (VP (VBN caused) (NP (NP (DT an) (NNS Doc_20735774_821_840_Disease)) (PRN (-LRB- -LRB-) (VP (VBN adjusted) (NP (NP (NP (NN mortality) (NN rate) (NN ratio)) (SBAR (S (VP (SYM =) (NP (CD 1.70)))))) (, ,) (ADJP (CD 95) (NN %)) (S (VP (VB CI) (NP (CD 1.02-2) (CD .85)))))) (-RRB- -RRB-))))))))))) (, ,) (CC but) (S (S (NP (DT the) (NN association)) (VP (VBD was) (ADJP (JJ age-dependent)))) (, ,) (CC and) (S (NP (NP (DT no) (NNS survivors)) (PP (IN of) (NP (NNS Doc_20735774_958_977_Disease)))) (VP (VBD died) (PP (IN of) (NP (NNS Doc_20735774_986_999_Disease))) (, ,) (SBAR (IN whereas) (S (NP (NNS suicides)) (VP (VBD were) (ADJP (JJ frequent) (PP (IN in) (NP (DT both) (NNS groups)))))))))) (. .)))
20735774	7	(ROOT (S (NP (DT These) (NNS observations)) (VP (VBP speak) (PP (IN against) (NP (NP (JJ long-term) (NNS effects)) (PP (IN of) (NP (NNS Doc_20735774_1102_1121_Disease)))))) (. .)))
20735774	8	(ROOT (S (S (ADJP (RBR More) (JJ likely))) (, ,) (NP (DT the) (JJ elevated) (NN mortality) (NN rate) (NN ratio)) (VP (VBD resulted) (PP (IN from) (NP (NP (JJ incomplete) (NN adjustment)) (PP (IN for) (NP (NP (DT the) (JJR greater) (NN prevalence)) (PP (IN of) (NP (NNS Doc_20735774_1236_1251_Disease))))))) (PP (IN among) (NP (NP (NNS survivors)) (PP (IN of) (NP (NNS Doc_20735774_1271_1290_Disease)))))) (. .)))
20735774	9	(ROOT (S (NP (JJ Doc_20735774_1305_1316_Chemical-induced) (NNS Doc_20735774_1325_1344_Disease)) (VP (VBD did) (RB not) (VP (VB affect) (NP (JJ long-term) (NN mortality)))) (. .)))
20735774	10	(ROOT (S (NP (NNP Clinical) (NNP follow-up)) (VP (MD may) (VP (VB be) (ADJP (JJ justified) (PP (PP (IN by) (NP (NP (DT the) (NN cause)) (PP (IN of) (NP (DT the) (NNS Doc_20735774_1437_1450_Disease))))) (, ,) (CC but) (RB not) (PP (IN by) (NP (NP (DT the) (NNS Doc_20735774_1467_1480_Disease)) (ADVP (PRP itself)))))))) (. .)))
20973483	0	(ROOT (FRAG (PP (IN In) (NP (NP (NN vivo) (NN characterization)) (PP (IN of) (NP (DT a) (JJ dual) (NNS Doc_20973483_35_48_Chemical))))) (: /) (NP (NP (NN A1) (NN receptor) (NN antagonist)) (PP (IN in) (NP (NN animal) (NNS models))) (PP (IN of) (NP (NNS Doc_20973483_92_111_Disease)))) (. .)))
20973483	1	(ROOT (FRAG (NP (NP (DT The) (RB in) (JJ vivo) (NN characterization)) (PP (IN of) (NP (DT a) (JJ dual) (NNS Doc_20973483_152_167_Chemical)))) (: /) (S (NP (NP (DT A) (PRN (-LRB- -LRB-) (NP (CD 1)) (-RRB- -RRB-)) (NN receptor) (NN antagonist)) (PP (IN in) (NP (NP (JJ several) (NN animal) (NNS models)) (PP (IN of) (NP (NNS Doc_20973483_221_240_Disease)))))) (VP (VBZ is) (VP (VBN described)))) (. .)))
20973483	2	(ROOT (S (NP (NP (NNP Discovery)) (CC and) (NP (NP (JJ scale-up) (NNS syntheses)) (PP (IN of) (NP (JJ compound) (CD 1))))) (VP (VBP are) (VP (VBN described) (PP (IN in) (NP (NN detail))) (, ,) (S (VP (VBG highlighting) (NP (NP (NN optimization) (NNS steps)) (SBAR (WHNP (WDT that)) (S (VP (VBD increased) (NP (NP (DT the) (JJ overall) (NN yield)) (PP (IN of) (NP (CD 1)))) (PP (IN from) (NP (QP (CD 10.0) (NN %) (TO to) (CD 30.5) (NN %)))))))))))) (. .)))
20973483	3	(ROOT (S (NP (NN Compound) (CD 1)) (VP (VBZ is) (NP (NP (NP (DT a) (JJ potent) (NN A)) (PRN (-LRB- -LRB-) (NP (CD 2A)) (-RRB- -RRB-))) (VP (VBN /) (NP (NP (DT A) (PRN (-LRB- -LRB-) (NP (CD 1)) (-RRB- -RRB-)) (NN receptor) (NN antagonist)) (PP (IN in) (NP (NNP vitro))))) (PRN (-LRB- -LRB-) (NP (NP (DT A) (-LRB- -LRB-) (NN 2A) (-RRB- -RRB-)) (SBAR (S (NP (NP (NP (NNP K)) (PRN (-LRB- -LRB-) (NP (NNP i)) (-RRB- -RRB-))) (VP (VBG =) (NP (NP (QP (CD 4.1) (CD nM))) (: ;) (NP (NP (NNP A) (PRN (-LRB- -LRB-) (NP (CD 1)) (-RRB- -RRB-)) (NNP K)) (PRN (-LRB- -LRB-) (NP (NNP i)) (-RRB- -RRB-)))))) (VP (SYM =) (NP (CD 17.0) (NN nM)))))) (-RRB- -RRB-)) (SBAR (WHNP (WDT that)) (S (VP (VBZ has) (NP (JJ excellent) (NN activity)) (, ,) (PP (IN after) (NP (NP (JJ oral) (NN administration)) (, ,) (PP (IN across) (NP (NP (DT a) (NN number)) (PP (IN of) (NP (NP (NN animal) (NNS models)) (PP (IN of) (NP (NP (NNS Doc_20973483_616_635_Disease)) (PP (VBG including) (NP (NP (NP (NN mouse) (CC and) (NN rat) (NNS models)) (PP (IN of) (NP (NN Doc_20973483_670_681_Chemical-induced) (NNS Doc_20973483_690_699_Disease)))) (, ,) (NP (NP (NN mouse) (NN model)) (PP (IN of) (NP (NP (NN Doc_20973483_716_725_Chemical-induced) (NNS Doc_20973483_734_742_Disease)) (, ,) (NP (NN rat) (NNS Doc_20973483_748_765_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_20973483_767_773_Chemical)) (-RRB- -RRB-)) (NP (NP (NN lesion) (NN model)) (PP (IN of) (NP (JJ drug-induced) (NN rotation))))))) (, ,) (CC and) (NP (NP (NNS Doc_20973483_818_822_Chemical-treated)) (NP (JJ non-human) (NN primate) (NN model)))))))))))))))))) (. .)))
21294084	0	(ROOT (NP (NP (NP (NNPS Effects)) (PP (IN of) (NP (NP (DT the) (JJ hippocampal) (JJ deep) (NN brain) (NN stimulation)) (PP (IN on) (NP (NP (JJ cortical) (JJ Doc_21294084_62_71_Disease) (NNS discharges)) (PP (IN in) (NP (NNS Doc_21294084_86_96_Chemical)))))))) (: -) (NP (NP (JJ induced) (JJ Doc_21294084_107_115_Disease) (NN model)) (PP (IN in) (NP (NNS rats)))) (. .)))
21294084	1	(ROOT (S (S (NP (JJ Experimental) (CC and) (JJ clinical) (NNS studies)) (VP (VBP have) (VP (VBN revealed) (SBAR (IN that) (S (NP (NNP hippocampal) (NNP DBS)) (VP (MD can) (VP (VB control) (NP (JJ Doc_21294084_217_226_Disease) (NN activity))))))))) (, ,) (CC but) (S (NP (NP (DT the) (NN mechanism)) (PP (IN of) (NP (NN action)))) (VP (VBZ is) (NP (NP (ADJP (JJ obscure) (CC and) (JJ optimal)) (NN stimulation) (NNS parameters)) (VP (VBP are) (RB not) (ADVP (RB clearly)) (VBN defined))))) (. .)))
21294084	2	(ROOT (S (NP (DT The) (NN aim)) (VP (VBD was) (S (VP (TO to) (VP (VB evaluate) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (JJ high) (NN frequency) (NN hippocampal) (NN stimulation)))) (PP (IN on) (NP (NP (JJ cortical) (JJ Doc_21294084_426_435_Disease) (NN activity)) (PP (IN in) (NP (JJ Doc_21294084_448_458_Chemical-induced) (JJ Doc_21294084_467_475_Disease) (NN model))))))))) (. .)))
21294084	3	(ROOT (NP (NP (NNP MATERIAL) (CC AND) (NNP METHODS)) (: :) (S (NP (CD Twenty-five) (JJ Sprague-Dawley) (NNS rats)) (VP (VBD were) (VP (VBN implanted) (NP (NNP DBS) (NNS electrodes))))) (. .)))
21294084	4	(ROOT (S (PP (IN In) (ADJP (JJ group-1))) (PRN (-LRB- -LRB-) (S (VP (VB n) (S (VP (SYM =) (NP (CD 10)))))) (-RRB- -RRB-)) (NP (NNP hippocampal) (NNP DBS)) (VP (VBD was) (ADVP (IN off) (CC and) (IN in)) (NP (NP (DT the) (NN group-2)) (PRN (-LRB- -LRB-) (VP (VBN n) (S (VP (SYM =) (NP (CD 10))))) (-RRB- -RRB-)) (SBAR (S (NP (NNP hippocampal) (NNP DBS)) (VP (VBD was) (PP (IN on) (PRN (-LRB- -LRB-) (NP (NP (CD 185) (NNS Hz)) (, ,) (NP (CD 0.5) (NNS V)) (, ,) (NP (CD 1V) (, ,) (CD 2V) (, ,) (CC and) (CD 5V))) (PP (IN for) (NP (CD 60) (NN sec))) (-RRB- -RRB-))) (PP (VBG following) (NP (JJ Doc_21294084_711_723_Chemical) (NN injection))))))) (ADVP (RB intracortically))) (. .)))
21294084	5	(ROOT (S (PP (IN In) (NP (DT the) (NN control) (NN group))) (NP (NNP hippocampal) (NNP DBS)) (VP (VBD was) (PP (IN on) (S (VP (VBG following) (NP (CD 8) (JJ l) (NN saline) (NN injection)) (ADVP (RB intracortically)))))) (. .)))
21294084	6	(ROOT (S (NP (NNP EEG) (NNS recordings)) (VP (VBD were) (VP (VBN obtained) (PP (PP (IN before) (NP (NP (QP (CC and) (CD 15)) (NNS minutes)) (PP (VBG following) (NP (JJ Doc_21294084_905_917_Chemical) (NN injection))))) (, ,) (CC and) (PP (IN at) (NP (NP (JJ 10th) (NNS minutes)) (PP (VBG following) (NP (NP (DT each) (NN stimulus)) (PP (IN for) (NP (NP (NN analysis)) (PP (IN in) (NP (NP (NNS terms)) (PP (IN of) (NP (NN frequency) (, ,) (NN amplitude) (, ,) (CC and) (NN power) (NN spectrum)))))))))))))) (. .)))
21294084	7	(ROOT (S (NP (NNP High) (NN frequency) (NNP hippocampal) (NNP DBS)) (VP (VBD suppressed) (NP (NP (DT the) (ADJP (JJ acute) (JJ Doc_21294084_1101_1111_Chemical-induced)) (NN cortical) (NNS Doc_21294084_1129_1138_Disease) (NN activity)) (ADJP (JJ independent) (PP (IN from) (NP (NN stimulus) (NN intensity)))))) (. .)))
21294084	8	(ROOT (S (PP (IN In) (NP (DT the) (NN control) (NN group))) (, ,) (NP (JJ hippocampal) (NN stimulation)) (ADVP (RB alone)) (VP (VBP lead) (ADVP (RB only)) (S (VP (TO to) (VP (VB diffuse) (NP (NP (NN slowing)) (PP (IN of) (NP (JJ cerebral) (JJ bioelectrical) (NN activity)))) (PP (IN at) (NP (CD 5V) (NN stimulation))))))) (. .)))
21294084	9	(ROOT (S (NP (PRP$ Our) (NNS results)) (VP (VBD revealed) (SBAR (IN that) (S (NP (NP (JJ continuous) (JJ high) (NN frequency) (NN stimulation)) (PP (IN of) (NP (DT the) (NNS hippocampus)))) (VP (VBD suppressed) (NP (ADJP (JJ acute) (JJ cortical)) (JJ Doc_21294084_1441_1450_Disease) (NN activity)) (PP (ADVP (RB effectively)) (IN without) (S (VP (VBG causing) (NP (JJ secondary) (JJ Doc_21294084_1498_1507_Disease) (NNS discharges))))))))) (. .)))
21294084	10	(ROOT (S (NP (DT These) (NNS results)) (VP (VBP are) (ADJP (JJ important) (PP (IN in) (NP (NP (NNS terms)) (PP (IN of) (S (VP (VBG defining) (NP (NP (DT the) (JJ optimal) (NNS parameters)) (PP (IN of) (NP (JJ hippocampal) (NNP DBS)))) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NNS Doc_21294084_1628_1636_Disease)))))))))))) (. .)))
21418164	0	(ROOT (NP (NP (NP (NNP Doc_21418164_0_4_Chemical) (PRN (-LRB- -LRB-) (NP (NNP Doc_21418164_6_15_Chemical)) (-RRB- -RRB-)) (NNP Doc_21418164_17_25_Disease)) (PP (IN in) (NP (NNS dogs)))) (: :) (NP (NP (DT a) (ADJP (JJ retrospective)) (NN study)) (PRN (-LRB- -LRB-) (NP (CD 2002-07)) (-RRB- -RRB-))) (. .)))
21418164	1	(ROOT (S (VP (TO To) (VP (VB describe) (NP (NP (DT the) (NN incidence)) (PP (IN of) (NP (NNS Doc_21418164_108_170_Disease)))) (PP (IN in) (NP (NP (JJ tumour-bearing) (NNS dogs)) (VP (VBG receiving) (NP (NP (NNS Doc_21418164_204_248_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_21418164_250_254_Chemical)) (-RRB- -RRB-)))))))) (. .)))
21418164	2	(ROOT (S (NP (NP (DT The) (JJ medical) (NNS records)) (PP (IN of) (NP (NP (CD 206) (NNS dogs)) (SBAR (WHNP (WDT that)) (S (VP (VBD were) (VP (VBN treated) (PP (IN with) (NP (NP (NNS Doc_21418164_320_324_Chemical)) (PP (IN at) (NP (DT the) (NNP Melbourne) (NNP Veterinary) (NNP Specialist) (NNP Centre))))) (PP (IN between) (NP (NP (NNP February) (CD 2002)) (CC and) (NP (NNP December) (CD 2007))))))))))) (VP (VBD were) (VP (ADVP (RB retrospectively)) (VBN evaluated))) (. .)))
21418164	3	(ROOT (S (PP (IN Of) (NP (NP (DT the) (CD 206) (NNS dogs)) (VP (VBN treated) (PP (IN with) (NP (NNS Doc_21418164_481_485_Chemical)))))) (, ,) (NP (CD 185)) (VP (VBD met) (NP (DT the) (NN inclusion) (NNS criteria)) (PP (IN for) (NP (NP (QP (IN at) (JJS least) (CD one)) (NN class)) (PP (IN of) (NP (NNS Doc_21418164_544_552_Disease)))))) (. .)))
21418164	4	(ROOT (S (NP (NNP Doc_21418164_554_558_Chemical)) (VP (VBD was) (VP (VBN used) (ADVP (RBS most) (RB commonly)) (PP (IN in) (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (NNS Doc_21418164_602_610_Disease) (, ,) (NNS Doc_21418164_612_628_Disease) (, ,) (NNS Doc_21418164_630_642_Disease) (, ,) (NNS Doc_21418164_644_663_Disease) (CC and) (NNS Doc_21418164_668_692_Disease))))))) (. .)))
21418164	5	(ROOT (S (PP (IN Throughout) (NP (NN treatment))) (, ,) (NP (NP (CD 56.9) (NN %)) (PP (IN of) (NP (NNS dogs)))) (VP (VBD experienced) (NP (NP (JJ Doc_21418164_742_753_Disease) (, ,) (ADJP (NP (CD 34.2) (NN %)) (JJ experienced)) (NNS Doc_21418164_773_780_Disease)) (CC and) (NP (ADJP (NP (CD 14.2) (NN %)) (JJ experienced)) (NNS Doc_21418164_803_819_Disease)))) (. .)))
21418164	6	(ROOT (S (NP (NNP Doc_21418164_821_847_Disease)) (VP (VBD was) (VP (VBN detected) (PP (IN in) (NP (NP (CD 37.8) (NN %)) (PP (IN of) (NP (NP (NNS dogs)) (, ,) (NP (NP (DT the) (ADJP (RBS most) (JJ common)) (NN sign)) (PP (IN of) (SBAR (WHNP (WDT which)) (S (VP (VBD was) (NP (NP (NNS Doc_21418164_913_921_Disease)) (PRN (-LRB- -LRB-) (NP (CD 24.3) (NN %)) (-RRB- -RRB-)))))))))))))) (. .)))
21418164	7	(ROOT (S (NP (NP (JJ Potential) (JJ renal) (NNS Doc_21418164_947_955_Disease)) (CC and) (NP (NP (JJ elevated) (NNS Doc_21418164_969_976_Chemical)) (NP (JJ transaminase) (PRN (-LRB- -LRB-) (NP (NNP ALT)) (-RRB- -RRB-)) (NN concentration)))) (VP (VBD were) (VP (VBN reported) (PP (IN in) (NP (NP (CD 12.2) (NN %)) (CC and) (NP (NP (CD 48.8) (NN %)) (PP (IN of) (NP (NNS dogs)))))) (, ,) (ADVP (RB respectively)))) (. .)))
21418164	8	(ROOT (S (NP (NP (DT The) (NN incidence)) (PP (IN of) (NP (NNS Doc_21418164_1083_1098_Disease)))) (VP (VBD was) (NP (CD 1.2) (NN %))) (. .)))
21418164	9	(ROOT (S (NP (NP (JJ Doc_21418164_1122_1126_Chemical-associated) (NNS Doc_21418164_1138_1146_Disease)) (PP (IN in) (NP (NNS dogs)))) (VP (VP (VBZ is) (ADJP (JJ common))) (, ,) (CC but) (VP (VBZ is) (NP (RB usually) (RB not) (NN life)) (S (VP (VBG threatening))))) (. .)))
2220369	0	(ROOT (NP (NP (NNP Central)) (NP (NP (NNS Doc_2220369_8_23_Disease)) (CC and) (NP (JJ topical) (NNS Doc_2220369_36_57_Chemical))) (. .)))
2220369	1	(ROOT (S (NP (DT A) (NN report)) (VP (VBZ is) (VP (VBN given) (PP (IN on) (NP (NP (DT an) (JJ 83-year-old) (NN female)) (SBAR (WHNP (WP who)) (S (VP (VBD acquired) (NP (JJ central) (NNS Doc_2220369_123_138_Disease)) (PP (IN in) (S (NP (PRP her)) (VP (VBG seeing) (NP (NN eye)) (PP (NP (CD one) (NN day)) (IN after) (S (VP (VBG having) (VP (VBN started) (NP (JJ topical) (NN medication)) (PP (IN with) (NP (NP (NNS Doc_2220369_210_231_Chemical)) (PP (IN for) (NP (NP (JJ advanced) (NNS Doc_2220369_245_253_Disease)) (VP (VBN discovered) (PP (IN in) (NP (DT the) (JJ other) (NN eye)))))))))))))))))))))) (. .)))
2220369	2	(ROOT (S (PP (IN From) (NP (NP (JJ present) (NN knowledge)) (PP (IN about) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NP (JJ adrenergic) (NN eye) (NNS drops)) (PP (IN on) (NP (NN ocular) (NN blood) (NN circulation))))))))) (, ,) (NP (PRP it)) (VP (VBZ is) (ADJP (JJ difficult) (S (VP (TO to) (VP (VB suggest) (NP (NP (DT an) (NN association)) (PP (IN between) (NP (NP (DT the) (CD two) (NNS events)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (MD may) (VP (VB be) (ADJP (JJ coincidental)) (ADVP (RB only)))))))))))))) (. .)))
2257294	0	(ROOT (S (NP (NNP Doc_2257294_0_19_Chemical)) (VP (VBZ reverses) (NP (NN Doc_2257294_29_43_Chemical-induced) (NNS Doc_2257294_52_70_Disease)) (PP (IN without) (NP (NP (NN impairment)) (PP (IN of) (NP (JJ anti-human) (JJ Doc_2257294_104_120_Disease) (NN virus) (NN activity)))))) (. .)))
2257294	1	(ROOT (S (NP (NP (VBN Increased) (NN extracellular) (NNS concentrations)) (PP (IN of) (NP (NP (NNS Doc_2257294_179_186_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_2257294_188_191_Chemical)) (-RRB- -RRB-))))) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (S (VP (TO to) (VP (VB reduce) (, ,) (PP (IN in) (NP (NP (ADJP (ADJP (NN vitro)) (, ,) (ADJP (ADJP (JJ Doc_2257294_233_247_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_2257294_249_252_Chemical)) (-RRB- -RRB-))) (: -)) (JJ induced) (NN inhibition)) (PP (IN of) (NP (JJ human) (JJ granulocyte-macrophage) (NN progenitor) (NNS cells))))) (PP (IN without) (NP (NP (NN impairment)) (PP (IN of) (NP (PRP$ its) (JJ antihuman) (NNS Doc_2257294_358_374_Disease) (NN virus) (PRN (-LRB- -LRB-) (NP (NNP HIV)) (-RRB- -RRB-)) (NN activity))))))))))) (. .)))
2257294	2	(ROOT (S (PP (IN Because) (IN of) (NP (NP (DT the) (JJ clinical) (NNS Doc_2257294_421_431_Disease)) (VP (VBN associated) (PP (IN with) (NP (NP (JJ chronic) (JJ Doc_2257294_456_459_Chemical) (NN administration)) (, ,) (NP (NP (DT the) (NN ability)) (PP (IN of) (NP (NP (NNS Doc_2257294_491_510_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_2257294_512_515_Chemical)) (-RRB- -RRB-))))))) (PP (TO to) (NP (NN effect))) (, ,) (PP (IN in) (NP (NN vivo)))))) (, ,) (NP (NN Doc_2257294_537_540_Chemical-induced) (NNS Doc_2257294_549_555_Disease) (CC and) (NNS Doc_2257294_560_570_Disease)) (VP (VBD was) (VP (VBN assessed))) (. .)))
2257294	3	(ROOT (S (S (NP (DT This) (NN agent)) (VP (VBZ inhibits) (NP (JJ Doc_2257294_605_608_Chemical) (NN catabolism)))) (CC and) (, ,) (S (PP (IN in) (NP (NN vivo))) (, ,) (VP (VBZ increases) (NP (NP (DT the) (NN plasma) (NN concentration)) (PP (IN of) (NP (NP (NNS Doc_2257294_672_675_Chemical)) (PP (IN in) (NP (DT a) (JJ dose-dependent) (NN manner)))))) (, ,) (PP (IN without) (NP (NN Doc_2257294_712_715_Chemical-related) (NNS Doc_2257294_724_732_Disease))))) (. .)))
2257294	4	(ROOT (S (PP (IN In) (NP (NP (NNS mice)) (VP (VBN rendered) (ADJP (JJ anemic) (CC and) (JJ leukopenic)) (PP (IN by) (NP (NP (DT the) (NN administration)) (PP (IN of) (NP (NP (NNS Doc_2257294_798_801_Chemical)) (PP (IN for) (NP (NP (CD 28) (NNS days)) (PP (IN in) (NP (NP (NN drinking) (NN water)) (PRN (-LRB- -LRB-) (NP (QP (CD 1.5) (CD mg/mL))) (-RRB- -RRB-))))))))))))) (, ,) (NP (NP (DT the) (JJ continued) (NN administration)) (PP (IN of) (NP (NP (NNS Doc_2257294_877_880_Chemical)) (CC plus) (NP (JJ daily) (NNS Doc_2257294_892_895_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (CD 300) (NN mg/kg)) (, ,) (NP (NN orally))) (-RRB- -RRB-))))) (ADVP (RB partially)) (VP (VBD reversed) (NP (NP (NN Doc_2257294_935_938_Chemical-induced) (NNS Doc_2257294_947_953_Disease)) (CC and) (NP (NP (NP (NNS Doc_2257294_958_968_Disease)) (PRN (-LRB- -LRB-) (NP (NNP P) (QP (JJR less) (IN than) (CD .05))) (-RRB- -RRB-))) (, ,) (NP (NP (JJ increased) (JJ peripheral) (NNS reticulocytes)) (PRN (-LRB- -LRB-) (PP (TO to) (NP (NP (CD 4.9) (NN %)) (, ,) (NP (NP (NNP P)) (NP (QP (JJR less) (IN than) (CD .01)))))) (-RRB- -RRB-))) (, ,) (NP (NP (VBN increased) (NN cellularity)) (PP (IN in) (NP (DT the) (NN marrow)))) (, ,) (CC and) (NP (JJ improved) (NNS megaloblastosis))))) (. .)))
2257294	5	(ROOT (S (SBAR (WHADVP (WRB When)) (S (VP (VBD coadministered) (PP (IN with) (NP (NNS Doc_2257294_1143_1146_Chemical))) (PP (IN from) (NP (NP (DT the) (NN onset)) (PP (IN of) (NP (NN drug) (NN administration)))))))) (, ,) (NP (NNS Doc_2257294_1186_1189_Chemical)) (VP (VBD reduced) (NP (NN Doc_2257294_1198_1201_Chemical-induced) (NNS Doc_2257294_1210_1225_Disease))) (. .)))
2257294	6	(ROOT (S (PP (IN In) (ADJP (NN vitro))) (, ,) (PP (IN at) (NP (NP (DT a) (NN concentration)) (PP (IN of) (NP (CD 100) (NN mumol/L))))) (, ,) (NP (NNP BAU)) (VP (VP (VBZ possesses) (NP (JJ minimal) (JJ anti-HIV) (NN activity))) (CC and) (VP (VBZ has) (NP (NP (DT no) (NN effect)) (PP (IN on) (NP (NP (DT the) (NN ability)) (PP (IN of) (NP (NNS Doc_2257294_1348_1351_Chemical) (S (VP (TO to) (VP (VB reverse) (NP (DT the) (JJ HIV-induced) (JJ cytopathic) (NN effect)) (PP (IN in) (NP (CD MT4) (NNS cells))))))))))))) (. .)))
2257294	7	(ROOT (S (NP (NP (DT The) (JJ clinical) (CC and) (JJ biochemical) (NNS implications)) (PP (IN of) (NP (DT these) (NNS findings)))) (VP (VBP are) (VP (VBN discussed))) (. .)))
2320800	0	(ROOT (NP (NP (NNP Lethal) (NNP Doc_2320800_7_13_Disease)) (VP (VBG complicating) (NP (JJ high) (NN dose) (NNS Doc_2320800_37_47_Chemical)) (ADVP (RB chemotherapy)) (PP (IN in) (NP (NP (DT a) (JJ Doc_2320800_66_79_Disease) (NN patient)) (PP (IN with) (NP (DT an) (NNS Doc_2320800_96_119_Disease)))))) (. .)))
2320800	1	(ROOT (S (NP (NP (DT A) (JJ sixty-year-old) (NN woman)) (PP (IN with) (NP (JJ advanced) (NNS Doc_2320800_158_171_Disease))) (, ,) (VP (ADVP (RB previously)) (VBN treated) (PP (IN with) (NP (NNS Doc_2320800_197_206_Chemical)))) (, ,)) (VP (VBD developed) (NP (DT an) (JJ irreversible) (JJ lethal) (NNS Doc_2320800_241_254_Disease)) (PP (IN with) (NP (NP (NNS Doc_2320800_260_266_Disease)) (, ,) (NP (DT the) (NN day)))) (PP (IN after) (NP (CD 5) (JJ g/m2) (NNS bolus) (NNS Doc_2320800_295_305_Chemical)))) (. .)))
2320800	2	(ROOT (S (NP (NNP Doc_2320800_307_324_Disease)) (VP (VBD was) (VP (VBN excluded) (PP (IN by) (NP (NN echography))))) (. .)))
2320800	3	(ROOT (S (NP (DT A) (JJ prerenal) (NN component)) (VP (MD could) (VP (VB have) (VP (VBN contributed) (PP (PP (TO to) (NP (NP (NNS Doc_2320800_400_413_Disease)) (PP (RB because) (IN of) (NP (DT a) (JJ transient) (NNS Doc_2320800_437_448_Disease))))) (, ,) (RB due) (PP (TO to) (NP (NP (DT an) (VBG increasing) (NNS ascitis)) (, ,) (VP (VBG occurring) (ADVP (RB just)) (PP (IN before) (NP (NNS Doc_2320800_502_508_Disease)))))))))) (. .)))
2320800	4	(ROOT (S (ADVP (RB However)) (, ,) (NP (NP (NN correction)) (PP (IN of) (NP (DT the) (JJ hemodynamic) (NNS parameters)))) (VP (VBD did) (RB not) (VP (VB improve) (NP (JJ renal) (NN function)))) (. .)))
2320800	5	(ROOT (S (NP (NNP Doc_2320800_592_602_Chemical)) (VP (VBZ is) (NP (NP (DT a) (VBN known) (JJ nephrotoxic) (NN drug)) (PP (IN with) (NP (JJ demonstrated) (NNS Doc_2320800_649_662_Disease))))) (. .)))
2320800	6	(ROOT (S (NP (PRP We)) (ADVP (RB strongly)) (VP (VBP suspect) (SBAR (IN that) (S (NP (DT this) (JJ lethal) (NNS Doc_2320800_701_707_Disease)) (VP (VBD was) (ADVP (RB mainly)) (ADJP (JJ due) (PP (TO to) (NP (NNS Doc_2320800_726_736_Chemical)))) (, ,) (S (VP (VBG occurring) (PP (IN in) (NP (NP (DT a) (JJ patient) (UCP (S (VP (VBG having) (VP (VBN received) (NP (JJ previous) (NNS Doc_2320800_786_795_Chemical)) (ADVP (RB chemotherapy))))) (CC and) (PP (IN with) (NP (JJ poor) (NN kidney)))) (NN perfusion)) (ADJP (JJ due) (PP (TO to) (NP (JJ transient) (NNS Doc_2320800_857_868_Disease)))))))))))) (. .)))
2320800	7	(ROOT (S (NP (PRP We)) (VP (VBP recommend) (NP (NP (JJ careful) (NN use)) (PP (IN of) (NP (NP (NNS Doc_2320800_898_908_Chemical)) (PP (IN in) (NP (NP (NNS patients)) (VP (VBN pretreated) (PP (IN with) (NP (NP (JJ nephrotoxic) (NN chemotherapy)) (CC and) (NP (JJ inadequate) (JJ renal) (NN perfusion))))))))))) (. .)))
2322844	0	(ROOT (S (NP (NP (JJ Nociceptive) (NNS effects)) (VP (VBN induced) (PP (IN by) (NP (NP (JJ intrathecal) (NN administration)) (PP (IN of) (NP (NNS Doc_2322844_61_77_Chemical) (, ,) (NNP E2) (, ,) (CC or) (NNP F2))))))) (VP (VBZ alpha) (PP (TO to) (NP (JJ conscious) (NNS mice)))) (. .)))
2322844	1	(ROOT (S (NP (NP (DT The) (NNS effects)) (PP (IN of) (NP (NP (JJ intrathecal) (NN administration)) (PP (IN of) (NP (NP (NNS Doc_2322844_159_173_Chemical)) (PP (IN on) (NP (NP (JJ Doc_2322844_177_181_Disease) (NNS responses)) (PP (IN in) (NP (JJ conscious) (NNS mice)))))))))) (VP (VBD were) (VP (VBN evaluated) (PP (IN by) (S (VP (VBG using) (NP (JJ hot) (NN plate) (CC and) (JJ Doc_2322844_248_259_Chemical) (NN writhing) (NNS tests))))))) (. .)))
2322844	2	(ROOT (S (NP (NP (NNP Doc_2322844_276_292_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 0.5-3) (NN ng/mouse)) (-RRB- -RRB-))) (VP (VBD had) (NP (NP (DT a) (JJ Doc_2322844_316_328_Disease) (NN action)) (PP (IN on) (NP (DT the) (NN response)))) (PP (TO to) (NP (DT a) (JJ hot) (NN plate))) (PP (IN during) (NP (DT a) (CD 3-60) (NN min) (NN period))) (PP (IN after) (NP (NN injection)))) (. .)))
2322844	3	(ROOT (S (S (NP (NNP Doc_2322844_409_425_Chemical)) (VP (VBD showed) (NP (DT a) (JJ Doc_2322844_435_447_Disease) (NN effect)) (PP (IN at) (NP (NP (NNS doses)) (PP (IN of) (NP (CD 1) (NN pg))))) (PP (TO to) (NP (CD 10) (NN ng/mouse))))) (, ,) (CC but) (S (NP (DT the) (NN effect)) (VP (VBD lasted) (NP (NP (JJR shorter) (PRN (-LRB- -LRB-) (NP (CD 3-30) (NNS min)) (-RRB- -RRB-))) (PP (IN than) (NP (NP (DT that)) (PP (IN of) (NP (NNS Doc_2322844_542_558_Chemical)))))))) (. .)))
2322844	4	(ROOT (S (NP (JJ Similar) (NNS results)) (VP (VBD were) (VP (VBN obtained) (PP (IN by) (NP (NP (NNS Doc_2322844_593_604_Chemical)) (VP (VBG writhing) (NP (NNS tests))))))) (. .)))
2322844	5	(ROOT (S (NP (NP (DT The) (JJ Doc_2322844_625_637_Disease) (NN effect)) (PP (IN of) (NP (NNS Doc_2322844_648_664_Chemical)))) (VP (VBD was) (VP (VBN blocked) (PP (PP (IN by) (NP (NP (JJ simultaneous) (NN injection)) (PP (IN of) (NP (NP (DT a) (NN substance) (NNP P) (NN antagonist)) (PRN (-LRB- -LRB-) (ADJP (ADJP (JJR greater) (PP (IN than))) (CC or) (ADJP (JJ equal) (PP (TO to) (NP (CD 100) (NN ng))))) (-RRB- -RRB-)))))) (CONJP (CC but) (RB not)) (PP (IN by) (NP (NP (NNS Doc_2322844_776_782_Chemical)) (, ,) (NP (DT a) (JJ prostanoid) (NN EP1-receptor) (NN antagonist))))))) (. .)))
2322844	6	(ROOT (S (ADVP (RB Conversely)) (, ,) (NP (NN Doc_2322844_834_850_Chemical-induced) (NNS Doc_2322844_859_871_Disease)) (VP (VBD was) (VP (VBN blocked) (PP (PP (IN by) (NP (NP (NNS Doc_2322844_887_893_Chemical)) (PRN (-LRB- -LRB-) (ADJP (ADJP (JJR greater) (PP (IN than))) (CC or) (ADJP (JJ equal) (PP (TO to) (NP (CD 500) (NN ng))))) (-RRB- -RRB-)))) (CONJP (CC but) (RB not)) (PP (IN by) (NP (DT the) (NN substance) (NN P) (NN antagonist)))))) (. .)))
2322844	7	(ROOT (S (NP (NNP Doc_2322844_967_989_Chemical)) (VP (VBD had) (NP (NP (JJ little) (NN effect)) (PP (IN on) (NP (JJ Doc_2322844_1011_1015_Disease) (NNS responses))))) (. .)))
2322844	8	(ROOT (S (NP (DT These) (NNS results)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP (DT both) (NNS Doc_2322844_1063_1079_Chemical) (CC and) (NNS Doc_2322844_1084_1100_Chemical)) (VP (VP (VBP exert) (NP (NP (NNS Doc_2322844_1107_1119_Disease)) (PP (IN in) (NP (DT the) (JJ spinal) (NN cord))))) (, ,) (CC but) (VP (PP (IN in) (NP (JJ different) (NNS ways)))))))) (. .)))
2334179	0	(ROOT (S (VP (VB Doc_2334179_0_15_Chemical) (PP (IN in) (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (NNS Doc_2334179_36_57_Disease)))))) (. .)))
2334179	1	(ROOT (S (NP (NNP Doc_2334179_59_80_Disease)) (VP (VP (VBZ has) (NP (DT no) (VBN recognized) (JJ internal) (NN organ) (NN involvement))) (CC but) (VP (MD may) (VP (VP (VB be) (VP (VBG disfiguring) (CC and) (VBG disabling) (SBAR (WHADVP (WRB when)) (S (NP (DT the) (JJ cutaneous) (NNS lesions)) (VP (VBP are) (ADJP (JJ extensive))))))) (CC or) (VP (VB affect) (NP (NNS children)))))) (. .)))
2334179	2	(ROOT (S (NP (EX There)) (VP (VBZ is) (NP (NP (DT no) (JJ accepted) (CC or) (JJ proven) (NN treatment)) (PP (IN for) (NP (NNS Doc_2334179_269_290_Disease))))) (. .)))
2334179	3	(ROOT (S (NP (NP (NN Case) (NNS reports)) (PP (IN of) (NP (NP (CD 11) (NNS patients)) (PP (IN with) (NP (JJ severe) (, ,) (JJ extensive) (NNS Doc_2334179_343_364_Disease))) (SBAR (WHNP (WP who)) (S (VP (VBD were) (VP (VBN treated) (PP (IN with) (NP (NNS Doc_2334179_387_402_Chemical)))))))))) (VP (VBP are) (VP (VBG summarized) (PP (IN in) (NP (DT this) (NN article))))) (. .)))
2334179	4	(ROOT (S (NP (DT This) (NN drug)) (VP (VBD was) (VP (VBN judged) (S (VP (TO to) (VP (VB have) (NP (NP (DT a) (JJ favorable) (NN effect)) (PP (IN on) (NP (DT the) (NN disease) (NN course)))) (PP (IN in) (NP (NP (NP (CD 7)) (PRN (-LRB- -LRB-) (NP (CD 64) (NN %)) (-RRB- -RRB-))) (PP (IN of) (NP (CD 11) (NNS patients)))))))))) (. .)))
2334179	5	(ROOT (S (NP (NNP Improvement)) (VP (VP (VBD began) (PP (IN within) (NP (QP (CD 3) (TO to) (CD 6)) (NNS months)))) (CC and) (VP (VBD consisted) (PP (IN of) (NP (NP (NN cessation)) (PP (IN of) (NP (NP (NP (JJ active) (NNS cutaneous) (NNS lesions)) (PP (IN in) (NP (DT all) (CD 7) (NNS patients)))) (, ,) (NP (NP (NN skin) (NN softening)) (PP (IN in) (NP (CD 5)))) (, ,) (CC and) (NP (NP (JJR more) (JJ normal) (NN growth)) (PP (IN of) (NP (DT the) (JJ affected) (NN limb)))))))) (PP (IN in) (NP (NP (CD 2)) (PP (IN of) (NP (CD 3) (NNS children))))))) (. .)))
2334179	6	(ROOT (S (NP (JJ Joint) (NNS stiffness) (CC and) (NNS Doc_2334179_750_762_Disease)) (ADVP (RB also)) (VP (VBD improved)) (. .)))
2334179	7	(ROOT (S (NP (NP (DT The) (NN dose)) (PP (IN of) (NP (NP (NNS Doc_2334179_790_805_Chemical)) (VP (VBN associated) (PP (IN with) (NP (DT a) (JJ favorable) (NN response))))))) (VP (VBD was) (NP (QP (RB as) (JJ low) (IN as) (CD 2))) (PP (TO to) (NP (NP (CD 5) (NN mg/kg)) (PP (IN per) (NP (NN day))))) (PP (VBN given) (PP (IN over) (NP (NP (DT a) (NN period)) (VP (VBG ranging) (PP (IN from) (NP (QP (CD 15) (TO to) (CD 53)) (NNS months)))))))) (. .)))
2334179	8	(ROOT (S (S (NP (NNP Doc_2334179_928_943_Chemical)) (VP (VBD caused) (NP (NNS Doc_2334179_951_969_Disease)) (PP (IN in) (NP (CD 1) (ADJP (JJ patient) (CC and) (JJ milder)) (JJ reversible) (NNS Doc_2334179_1005_1016_Disease))) (PP (IN in) (NP (CD 3) (JJ other) (NNS patients))))) (: ;) (S (NP (NN none)) (VP (VBD developed) (NP (NNS Doc_2334179_1053_1072_Disease)))) (. .)))
2334179	9	(ROOT (S (NP (DT These) (NNS data)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NNS Doc_2334179_1098_1113_Chemical)) (VP (MD may) (VP (VB be) (ADJP (JJ effective) (PP (IN in) (NP (NP (JJ severe) (NNS cases)) (PP (IN of) (NP (NNS Doc_2334179_1150_1171_Disease))))))))))) (. .)))
2339463	0	(ROOT (S (VP (VB Doc_2339463_0_25_Disease) (PP (IN as) (NP (NP (DT a) (JJ potential) (NN hazard)) (PP (IN of) (NP (NP (JJ antifibrinolytic) (NN treatment)) (PP (IN in) (NP (NNS Doc_2339463_81_92_Disease)))))))) (. .)))
2339463	1	(ROOT (S (NP (PRP We)) (VP (VBP describe) (NP (NP (DT a) (JJ 42-year-old) (NN woman)) (SBAR (WHNP (WP who)) (S (VP (VBD developed) (NP (NP (JJ superior) (NNS Doc_2339463_149_194_Disease)) (VP (VBN associated) (PP (IN with) (NP (NP (VBN prolonged) (JJ Doc_2339463_221_246_Chemical) (NN therapy)) (PP (IN for) (NP (NNS Doc_2339463_259_270_Disease)))))))))))) (. .)))
2339463	2	(ROOT (S (NP (DT This) (JJ antifibrinolytic) (NN agent)) (VP (VBZ has) (VP (VBN been) (VP (VBN used) (PP (IN in) (NP (NP (NNS women)) (PP (IN with) (NP (NNS Doc_2339463_328_339_Disease))))) (S (VP (TO to) (VP (VP (VB promote) (NP (NN clotting))) (CC and) (VP (VB reduce) (NP (NNS Doc_2339463_371_381_Disease))))))))) (. .)))
2339463	3	(ROOT (S (SBAR (IN Although) (S (NP (NP (VBN increased) (NN risk)) (PP (IN of) (NP (NNS Doc_2339463_410_432_Disease)))) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (PP (IN during) (NP (NN treatment))) (PP (IN with) (NP (NNS Doc_2339463_473_498_Chemical)))))))) (, ,) (NP (NNS Doc_2339463_500_525_Disease)) (VP (VBZ has) (RB not) (VP (VBN been) (VP (ADVP (RB previously)) (VBN described)))) (. .)))
2339463	4	(ROOT (S (NP (NP (JJ Careful) (NN use)) (PP (IN of) (NP (JJ Doc_2339463_576_601_Chemical) (NN therapy)))) (VP (VBZ is) (VP (VBN recommended))) (. .)))
2343592	0	(ROOT (NP (NP (NP (JJ Doc_2343592_0_7_Disease) (NN activity)) (PP (IN with) (NP (JJ Doc_2343592_22_30_Chemical) (NN therapy)))) (: :) (NP (NP (NN incidence)) (CC and) (NP (NN risk) (NNS factors))) (. .)))
2343592	1	(ROOT (S (NP (NP (CD Two) (JJ elderly) (NNS patients)) (PP (IN with) (NP (NP (NP (DT a) (NN history)) (PP (IN of) (NP (NP (RB either) (JJ Doc_2343592_114_140_Disease) (-LRB- -LRB-) (NNS Doc_2343592_142_145_Disease) (-RRB- -RRB-)) (CC or) (NP (NNS Doc_2343592_150_161_Disease))))) (CC and) (NP (NP (DT no) (NN evidence)) (PP (IN of) (NP (NNS Doc_2343592_181_194_Disease))))))) (VP (VBD developed) (NP (NNS Doc_2343592_205_213_Disease)) (PP (IN while) (S (VP (VBG receiving) (NP (NP (JJ maximum) (NNS doses)) (PP (IN of) (NP (JJ Doc_2343592_247_255_Chemical) (JJ /) (NNS Doc_2343592_256_266_Chemical)))))))) (. .)))
2343592	2	(ROOT (S (NP (DT Neither) (NN patient)) (VP (VP (VBD had) (VP (VBN reported) (NP (NP (JJ previous) (NNS Doc_2343592_306_314_Disease)) (CC or) (NP (NN Doc_2343592_318_325_Disease-like) (NN activity))))) (CC nor) (VP (VBD was) (VP (VBG receiving) (NP (JJ anticonvulsant) (NNS agents))))) (. .)))
2343592	3	(ROOT (S (NP (DT All) (NNS Doc_2343592_385_393_Disease)) (VP (VBD were) (VP (VBN controlled) (PP (IN with) (NP (NP (JJ therapeutic) (NNS doses)) (PP (IN of) (NP (NNS Doc_2343592_436_445_Chemical))))))) (. .)))
2343592	4	(ROOT (S (NP (DT Both) (NNS patients)) (VP (VBD had) (VP (VBN received) (NP (NP (JJ maximum) (NNS doses)) (PP (IN of) (NP (JJ other) (JJ Doc_2343592_497_508_Chemical) (NNS antibiotics)))) (PP (IN without) (NP (NP (NN evidence)) (PP (IN of) (NP (JJ Doc_2343592_541_548_Disease) (NN activity))))))) (. .)))
2422478	0	(ROOT (S (NP (NP (JJ Midline) (NNP B3) (NN Doc_2422478_11_20_Chemical) (NNS nerves)) (PP (IN in) (NP (NN rat) (NN medulla)))) (VP (VBP are) (VP (VBN involved) (PP (IN in) (NP (NP (JJ Doc_2422478_59_70_Disease) (NN effect)) (PP (IN of) (NP (NNS Doc_2422478_81_91_Chemical))))))) (. .)))
2422478	1	(ROOT (S (NP (NP (JJ Previous) (NNS experiments)) (PP (IN in) (NP (DT this) (NN laboratory)))) (VP (VBP have) (VP (VBN shown) (SBAR (IN that) (S (NP (NP (NN microinjection)) (PP (IN of) (NP (NP (NNS Doc_2422478_167_177_Chemical)) (PP (IN onto) (NP (NP (DT the) (JJ ventrolateral) (NNS cells)) (PP (IN of) (NP (NP (DT the) (CD B3) (JJ Doc_2422478_217_226_Chemical) (NNS neurons)) (PP (IN in) (NP (DT the) (NN medulla)))))))))) (VP (VBZ elicits) (NP (NP (DT a) (JJ Doc_2422478_260_271_Disease) (NN response)) (VP (VBN mediated) (PP (IN by) (NP (NP (DT a) (NN projection)) (VP (VBG descending) (PP (IN into) (NP (DT the) (JJ spinal) (NN cord))))))))))))) (. .)))
2422478	2	(ROOT (S (NP (DT The) (JJ present) (NNS experiments)) (VP (VBD were) (VP (VBN designed) (S (VP (TO to) (VP (VB investigate) (NP (NP (DT the) (NN role)) (PP (IN of) (NP (NP (DT the) (JJ midline) (NNS cells)) (PP (IN of) (NP (DT the) (CD B3) (JJ Doc_2422478_432_441_Chemical) (NNS neurons)))))) (PP (IN in) (NP (DT the) (NN medulla))) (, ,) (S (VP (VBG coinciding) (PP (IN with) (NP (DT the) (JJ raphe) (NNS magnus)))))))))) (. .)))
2422478	3	(ROOT (S (PP (IN In) (NP (JJ spontaneously) (NNS Doc_2422478_517_529_Disease))) (, ,) (NP (NP (NN Doc_2422478_531_537_Disease-prone) (NNS rats)) (, ,) (NP (NP (NN microinjection)) (PP (IN of) (NP (NP (NNS Doc_2422478_568_578_Chemical)) (PP (IN into) (NP (NP (DT the) (NN area)) (PP (IN of) (NP (NP (DT the) (JJ midline) (NNP B3) (NNP Doc_2422478_611_620_Chemical) (NN cell) (NN group)) (PP (IN in) (NP (DT the) (JJ ventral) (NN medulla))))))))))) (VP (VBD caused) (NP (NP (DT a) (JJ potent) (NNS Doc_2422478_671_682_Disease)) (PP (IN of) (NP (NP (CD 30-40) (NN mm) (NNP Hg)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VP (VBD was) (ADJP (JJ maximal) (NP (CD 2-3) (NNS h))) (PP (IN after) (NP (NN administration)))) (CC and) (VP (VBD was) (VP (VBN abolished) (PP (IN by) (NP (NP (DT the) (JJ Doc_2422478_769_778_Chemical) (NN neurotoxin) (NNS Doc_2422478_790_813_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_2422478_815_822_Chemical)) (-RRB- -RRB-)) (VP (VBN injected) (ADVP (RB intracerebroventricularly)))))))))))))) (. .)))
2422478	4	(ROOT (S (ADVP (RB However)) (, ,) (NP (NP (JJ intraspinal) (NN injection)) (PP (IN of) (NP (NNS Doc_2422478_894_901_Chemical) (S (VP (TO to) (VP (VB produce) (NP (NP (DT a) (ADJP (RBR more) (JJ selective)) (NN lesion)) (PP (IN of) (NP (NP (JJ only) (VBG descending) (JJ Doc_2422478_956_965_Chemical) (NNS projections)) (PP (IN in) (NP (DT the) (JJ spinal) (NN cord)))))))))))) (VP (VBD did) (RB not) (VP (VB affect) (NP (DT this) (NNS Doc_2422478_1017_1028_Disease)))) (. .)))
2422478	5	(ROOT (S (ADVP (RB Further)) (, ,) (NP (NP (JJ Doc_2422478_1039_1046_Chemical) (NN lesion)) (PP (IN of) (NP (NP (JJ Doc_2422478_1057_1066_Chemical) (NNS nerves)) (VP (VBG travelling) (PP (IN in) (NP (NP (DT the) (JJ median) (NN forebrain) (NN bundle)) (, ,) (NP (NP (CD one)) (PP (IN of) (NP (DT the) (JJ main) (CD ascending) (NNS pathways))) (PP (IN from) (NP (DT the) (CD B3) (JJ Doc_2422478_1164_1173_Chemical) (NNS cells)))) (, ,))))))) (VP (VBD did) (RB not) (VP (VB affect) (NP (DT the) (NN fall)) (PP (IN in) (NP (NP (NN blood) (NN pressure)) (VP (VBN associated) (PP (IN with) (NP (DT a) (JJ midline) (NNP B3) (NNP Doc_2422478_1252_1261_Chemical) (JJ Doc_2422478_1262_1272_Chemical) (NN injection)))))))) (. .)))
2422478	6	(ROOT (S (NP (PRP It)) (VP (VBZ is) (VP (VBN concluded) (ADVP (RB therefore)) (SBAR (IN that) (, ,) (S (PP (IN unlike) (NP (NP (DT the) (JJ ventrolateral) (CD B3) (NNS cells)) (SBAR (WHNP (WDT which)) (S (VP (VB mediate) (NP (NP (DT a) (NN Doc_2422478_1366_1376_Chemical-induced) (NNS Doc_2422478_1385_1396_Disease)) (PP (IN via) (NP (VBG descending) (NNS projections))))))))) (, ,) (NP (NP (DT the) (JJ midline) (NN serotonin) (NN B3) (NNS cells)) (PP (IN in) (NP (DT the) (NN medulla)))) (VP (VBP contribute) (PP (PP (TO to) (NP (NP (DT the) (JJ Doc_2422478_1489_1500_Disease) (NN action)) (PP (IN of) (NP (NNS Doc_2422478_1511_1521_Chemical))))) (, ,) (CC either) (PP (IN by) (NP (NP (NN way)) (PP (IN of) (NP (NP (DT an) (JJ ascending) (NN projection)) (SBAR (WHNP (WDT which)) (S (VP (VBZ does) (RB not) (VP (VB pass) (PP (IN through) (NP (DT the) (JJ median) (NN forebrain) (NN bundle))))))))))) (, ,) (CC or) (PP (IN through) (NP (NP (DT a) (NN projection)) (VP (VBN restricted) (PP (TO to) (NP (DT the) (JJ caudal) (NN brainstem)))))))))))) (. .)))
2435991	0	(ROOT (NP (NP (JJ Antiarrhythmic) (NN plasma) (NNS concentrations)) (PP (IN of) (NP (NNS Doc_2435991_40_51_Chemical))) (PP (IN on) (NP (JJ canine) (NNS Doc_2435991_62_85_Disease))) (. .)))
2435991	1	(ROOT (S (S (S (VP (VP (VBG Using) (NP (JJ two-stage) (JJ coronary) (NN ligation))) (PRN (: -) (FRAG (, ,) (NP (NNS Doc_2435991_123_132_Chemical))) (: -)))) (, ,) (CC and) (S (NP (NNS Doc_2435991_139_149_Chemical-induced)) (NP (JJ canine) (NNS Doc_2435991_165_188_Disease)))) (, ,) (S (NP (NP (JJ antiarrhythmic) (NNS effects)) (PP (IN of) (NP (NNS Doc_2435991_216_227_Chemical)))) (VP (VBD were) (VP (VBN examined)))) (CC and) (S (NP (NP (DT the) (JJ minimum) (JJ effective) (NN plasma) (NN concentration)) (PP (IN for) (NP (DT each) (JJ Doc_2435991_298_308_Disease) (NN model)))) (VP (VBD was) (VP (VBN determined)))) (. .)))
2435991	2	(ROOT (S (S (NP (NNP Doc_2435991_331_342_Chemical)) (VP (VBD suppressed) (NP (PDT all) (DT the) (NNS Doc_2435991_362_373_Disease)))) (, ,) (CC and) (S (NP (NP (DT the) (JJ minimum) (JJ effective) (NN plasma) (NNS concentrations)) (PP (IN for) (NP (NP (NNS Doc_2435991_427_438_Disease)) (VP (VBN induced) (PP (IN by) (NP (NP (JJ 24-h) (JJ coronary) (NN ligation)) (, ,) (NP (JJ 48-h) (JJ coronary) (NN ligation)) (, ,) (NP (NNS Doc_2435991_498_507_Chemical)) (, ,) (CC and) (NP (NNS Doc_2435991_513_523_Chemical)))))))) (VP (VBD were) (NP (NP (QP (CD 1.9) (CD +)) (NNS /)) (: -) (NP (NP (NP (CD 0.9)) (PRN (-LRB- -LRB-) (PP (IN by) (NP (CD 8) (NN mg/kg) (NN i.v.))) (-RRB- -RRB-)) (, ,) (NP (NP (QP (CD 1.6) (CD +)) (NNS /)) (PRN (: -) (NP (NP (NP (CD 0.5)) (PRN (-LRB- -LRB-) (PP (IN by) (NP (CD 8) (NN mg/kg) (NN i.v.))) (-RRB- -RRB-))) (, ,) (NP (CD 0.6) (NNS +))) (: /)))) (: -) (NP (NP (NP (CD 0.2)) (PRN (-LRB- -LRB-) (PP (IN by) (NP (CD 2) (NN mg/kg) (NN i.v.))) (-RRB- -RRB-))) (, ,) (CC and) (NP (QP (CD 3.5) (CD +)) (NNS /))) (: -) (NP (NP (CD 1.3)) (PRN (-LRB- -LRB-) (PP (IN by) (NP (CD 5) (NN mg/kg) (NN i.v.))) (-RRB- -RRB-)) (NP (NN micrograms/ml)))) (, ,)) (ADVP (RB respectively)))) (PRN (-LRB- -LRB-) (VP (VB mean) (NP (NP (NNP +) (NNP /)) (: -) (NP (NP (NNP SDM)) (, ,) (VP (VBN n) (S (VP (SYM =) (NP (CD 6-7)))))))) (-RRB- -RRB-)) (. .)))
2435991	3	(ROOT (S (NP (NP (DT The) (NN concentration)) (PP (IN for) (NP (NN Doc_2435991_731_741_Chemical-induced) (NNS Doc_2435991_750_760_Disease)))) (VP (VBD was) (ADJP (RB significantly) (JJR higher)) (PP (IN than) (NP (NP (DT those)) (PP (IN for) (NP (NP (DT the) (JJ other) (NNS types)) (PP (IN of) (NP (NNS Doc_2435991_820_831_Disease)))))))) (. .)))
2435991	4	(ROOT (S (S (NP (DT This) (JJ pharmacological) (NN profile)) (VP (VBZ is) (ADJP (JJ similar) (PP (TO to) (NP (NP (DT those)) (PP (IN of) (NP (NNS Doc_2435991_885_895_Chemical) (CC and) (NNS Doc_2435991_900_909_Chemical)))))))) (, ,) (CC and) (S (NP (DT all) (CD three) (NNS drugs)) (VP (VBP have) (NP (NP (NP (JJ central) (JJ nervous) (NN system)) (PRN (-LRB- -LRB-) (NP (NNP CNS)) (-RRB- -RRB-))) (VP (VBG stimulant) (NP (NN action)))))) (. .)))
2435991	5	(ROOT (S (SBAR (IN Because) (S (NP (NNS Doc_2435991_991_1002_Chemical)) (VP (VBD had) (NP (RB only) (JJ weak) (NNS Doc_2435991_1017_1028_Disease) (CC and) (NNS sinus))))) (VP (VP (VBP node) (NP (JJ Doc_2435991_1044_1054_Disease) (NNS effects))) (CC and) (VP (VBD was) (VP (VBN found) (S (VP (TO to) (VP (VB be) (ADJP (RB orally) (JJ active)) (SBAR (WHADVP (WRB when)) (S (PP (VBN given) (PP (TO to) (NP (JJ coronary) (NN ligation) (NN Doc_2435991_1129_1139_Disease) (NNS dogs)))) (, ,) (NP (PRP$ its) (JJ clinical) (NN usefulness)) (VP (VBZ is) (VP (VBN expected))))))))))) (. .)))
2466960	0	(ROOT (NP (NP (NNP Continuous) (NNP ambulatory) (NNP ECG)) (VP (VBG monitoring) (PP (IN during) (NP (NP (JJ Doc_2466960_44_56_Chemical) (NN therapy)) (: :) (NP (DT a) (JJ prospective) (NN study))))) (. .)))
2466960	1	(ROOT (S (SBAR (IN Although) (S (NP (EX there)) (VP (VBP have) (VP (VBN been) (NP (NP (JJ anecdotal) (NNS reports)) (PP (IN of) (NP (NP (NNS Doc_2466960_133_149_Disease)) (VP (VBN associated) (PP (IN with) (NP (NNP Doc_2466960_166_178_Chemical) (PRN (-LRB- -LRB-) (NP (NNP Doc_2466960_180_184_Chemical)) (-RRB- -RRB-)) (NN therapy))))))))))) (, ,) (NP (DT this) (NN phenomenon)) (VP (VBZ has) (RB not) (VP (VBN been) (VP (VBN studied) (PP (IN in) (NP (DT a) (JJ systematic) (NN fashion)))))) (. .)))
2466960	2	(ROOT (S (NP (PRP We)) (ADVP (RB prospectively)) (VP (VBD performed) (NP (NP (JJ continuous) (JJ ambulatory) (NN ECG) (NN monitoring)) (PP (IN on) (NP (NP (CD 25) (NNS patients)) (VP (VBG undergoing) (NP (JJ Doc_2466960_347_351_Chemical) (NN infusion)) (PP (IN for) (NP (NP (NN treatment)) (PP (IN of) (NP (JJ solid) (NNS Doc_2466960_384_390_Disease))))) (SBAR (IN in) (NN order) (S (VP (TO to) (VP (VB assess) (NP (NP (DT the) (NN incidence)) (PP (IN of) (NP (JJ Doc_2466960_427_435_Disease) (NNP ST) (NNS changes))))))))))))) (. .)))
2466960	3	(ROOT (S (NP (NNS Patients)) (VP (VBD were) (VP (VBN monitored) (PP (IN for) (NP (NP (NP (CD 23) (JJ +) (NNS /)) (PRN (: -) (NP (NP (CD 4) (NNS hours)) (PP (IN before) (NP (JJ Doc_2466960_498_502_Chemical) (NN infusion))) (, ,) (CC and) (NP (CD 98) (NNS +))) (: /))) (: -) (NP (NP (CD 9) (NNS hours)) (PP (IN during) (NP (JJ Doc_2466960_539_543_Chemical) (NN infusion)))))))) (. .)))
2466960	4	(ROOT (S (S (NP (JJ Anginal) (NNS episodes)) (VP (VBD were) (ADJP (JJ rare)))) (: :) (S (NP (RB only) (CD one) (NN patient)) (VP (VBD had) (NP (NP (NNS Doc_2466960_603_609_Disease)) (PRN (-LRB- -LRB-) (PP (IN during) (NP (JJ Doc_2466960_618_622_Chemical) (NN infusion))) (-RRB- -RRB-))))) (. .)))
2466960	5	(ROOT (S (S (ADVP (RB However)) (, ,) (NP (NP (JJ asymptomatic) (NNP ST) (NNS changes)) (PRN (-LRB- -LRB-) (ADJP (ADJP (JJR greater) (PP (IN than))) (CC or) (ADJP (JJ equal) (PP (TO to) (NP (CD 1) (NNP mm) (NNP ST) (NN deviation))))) (-RRB- -RRB-))) (VP (VBD were) (ADJP (JJ common)))) (: :) (S (NP (NP (CD six)) (PP (IN of) (NP (NP (CD 25) (NNS patients)) (PRN (-LRB- -LRB-) (NP (CD 24) (NN %)) (-RRB- -RRB-))))) (VP (VBD had) (NP (NNP ST) (NNS changes)) (SBAR (IN before) (S (NP (JJ Doc_2466960_772_776_Chemical) (NN infusion)) (VP (VBP v) (NP (NP (NP (CD 17)) (PRN (-LRB- -LRB-) (NP (CD 68) (NN %)) (-RRB- -RRB-))) (PP (IN during) (NP (NP (JJ Doc_2466960_804_808_Chemical) (NN infusion)) (PRN (-LRB- -LRB-) (NP (NNP P) (QP (JJR less) (IN than) (CD .002))) (-RRB- -RRB-)))))))))) (. .)))
2466960	6	(ROOT (S (S (NP (NP (DT The) (NN incidence)) (PP (IN of) (NP (NP (JJ Doc_2466960_855_863_Disease) (NNS episodes)) (PP (IN per) (NP (NP (NN patient)) (PP (IN per) (NP (NN hour)))))))) (VP (VBD was) (NP (NP (NP (CD 0.05) (NNS +)) (PRN (: /) (FRAG (: -) (ADVP (ADVP (NP (CD 0.02)) (RB prior)) (PP (TO to) (NP (JJ Doc_2466960_921_925_Chemical) (NN infusion) (NN v)))) (NP (NP (CD 0.13) (JJ +) (NNS /)) (: -) (NP (NP (CD 0.03)) (PP (IN during) (NP (JJ Doc_2466960_958_962_Chemical) (NN infusion)))))))) (PRN (-LRB- -LRB-) (NP (NNP P) (QP (JJR less) (IN than) (CD .001))) (-RRB- -RRB-))))) (: ;) (S (NP (NP (DT the) (NN duration)) (PP (IN of) (NP (NNP ECG) (NNS changes)))) (VP (VBD was) (NP (NP (NP (NP (CD 0.6) (JJ +) (NNS /)) (PRN (: -) (NP (NP (CD 0.3) (NNS minutes)) (PP (IN per) (NP (NN patient))) (PP (IN per) (NP (NN hour)))) (SBAR (IN before) (S (NP (NNS Doc_2466960_1072_1076_Chemical)) (VP (VBP v) (NP (QP (CD 1.9) (CD +)))))) (: /))) (: -) (NP (NP (CD 0.5) (NNS minutes)) (PP (IN per) (NP (NP (NN patient)) (PP (IN per) (NP (NP (NN hour)) (PP (IN during) (NP (NNS Doc_2466960_1127_1131_Chemical))))))))) (PRN (-LRB- -LRB-) (NP (NNP P) (QP (JJR less) (IN than) (CD .01))) (-RRB- -RRB-))))) (. .)))
2466960	7	(ROOT (S (NP (NNP ECG) (NNS changes)) (VP (VBD were) (ADJP (RBR more) (JJ common) (PP (IN among) (NP (NP (NNS patients)) (PP (IN with) (NP (VBN known) (NNS Doc_2466960_1206_1229_Disease))))))) (. .)))
2466960	8	(ROOT (S (NP (EX There)) (VP (VBD were) (NP (NP (CD two) (NNS cases)) (PP (IN of) (NP (NP (NNS Doc_2466960_1255_1267_Disease)) (, ,) (SBAR (WHNP (DT both) (WHPP (IN of) (WHNP (WDT which)))) (S (VP (VBD occurred) (PP (IN at) (NP (NP (DT the) (NN end)) (PP (IN of) (NP (DT the) (JJ chemotherapy) (NN course)))))))))))) (. .)))
2466960	9	(ROOT (S (NP (PRP We)) (VP (VBP conclude) (SBAR (IN that) (S (NP (JJ Doc_2466960_1348_1352_Chemical) (NN infusion)) (VP (VBZ is) (VP (VBN associated) (PP (IN with) (NP (NP (DT a) (JJ significant) (NN increase)) (PP (IN in) (NP (JJ silent) (NNP ST) (NN segment) (NN deviation) (NN suggestive))) (PP (IN of) (NP (NNS Doc_2466960_1449_1457_Disease)))) (, ,) (ADVP (RB particularly))) (PP (IN among) (NP (NP (NNS patients)) (PP (IN with) (NP (NNS Doc_2466960_1492_1515_Disease)))))))))) (. .)))
2466960	10	(ROOT (S (NP (NP (DT The) (NN mechanism) (CC and) (JJ clinical) (NN significance)) (PP (IN of) (NP (DT these) (NNP ECG) (NNS changes)))) (VP (VBP remain) (S (VP (TO to) (VP (VB be) (VP (VBN determined)))))) (. .)))
2528969	0	(ROOT (NP (NP (NP (NN Nature) (, ,) (NN time) (NN course) (CC and) (NN dose) (NN dependence)) (PP (IN of) (NP (NN Doc_2528969_43_53_Chemical-related) (NN side) (NNS effects)))) (: :) (NP (NP (NNS results)) (PP (IN from) (NP (DT the) (NNP Multicenter) (NNP Canadian) (NNP Doc_2528969_114_128_Chemical) (NNP Trial)))) (. .)))
2528969	1	(ROOT (S (S (VP (TO To) (VP (VB characterize) (NP (NP (DT the) (NN nature) (, ,) (NN time) (NN course) (CC and) (NN dose) (NNS dependency)) (PP (IN of) (NP (NN Doc_2528969_199_209_Chemical-related) (NN side) (NNS effects))))))) (, ,) (NP (PRP we)) (VP (VBD undertook) (NP (DT a) (JJ multicenter) (, ,) (JJ prospective) (, ,) (JJ dose-range) (NN finding) (NN study))) (. .)))
2528969	2	(ROOT (S (NP (PRP$ Our) (NN study) (NN group)) (VP (VBD consisted) (PP (IN of) (NP (NP (CD 74) (JJ HIV-positive) (JJ homosexual) (NNS men)) (VP (VBG belonging) (PP (TO to) (NP (NP (NNS groups) (NNP II) (NNP B) (, ,) (NNP III) (CC and) (NNP IV) (NNP C2)) (PP (IN from) (NP (DT the) (NNPS Centers))))) (PP (IN for) (NP (NP (NNP Disease) (NNP Control) (PRN (-LRB- -LRB-) (NP (NNP CDC)) (-RRB- -RRB-)) (NNP classification)) (PP (IN of) (NP (NNS Doc_2528969_460_471_Disease))))))))) (. .)))
2528969	3	(ROOT (S (PP (VBG Following) (NP (DT a) (JJ 3-week) (NN observation) (NN period))) (, ,) (NP (NNS volunteers)) (VP (VBD were) (VP (VBN treated) (PP (IN with) (NP (QP (CD Doc_2528969_541_551_Chemical) (CD 600))) (ADVP (RB mg/day))) (PP (IN for) (NP (NP (CD 18) (NNS weeks)) (, ,) (NP (NP (CD 900) (NN mg/day)) (PP (IN for) (NP (CD 9) (NNS weeks)))) (CC and) (NP (NP (CD 1200) (NN mg/day)) (PP (IN for) (NP (CD 9) (NNS weeks)))))) (, ,) (PP (VBN followed) (PP (IN by) (NP (NP (DT a) (JJ washout) (NN period)) (PP (IN of) (NP (NP (CD 6) (NNS weeks)) (SBAR (WHPP (IN after) (WHNP (WDT which))) (S (NP (PRP they)) (VP (VBD were) (VP (VBN re-started) (PP (IN on) (NP (NP (CD 1200) (NN mg/day)) (CC or) (NP (DT the) (JJS highest) (JJ tolerated) (NN dose)))) (PP (IN at) (NP (JJ 8-hourly) (NNS intervals)))))))))))))) (. .)))
2528969	4	(ROOT (S (NP (NNS Subjects)) (VP (VBD were) (ADVP (RB randomly)) (VP (VBN assigned) (PP (TO to) (NP (JJ 4-hourly) (CC or) (JJ 8-hourly) (NNS regimens))) (PP (IN within) (NP (NNP CDC) (NNS groups))) (SBAR (IN while) (S (VP (VBG taking) (NP (CD 600) (CC and) (CD 1200)) (ADVP (RB mg/day))))))) (. .)))
2528969	5	(ROOT (S (NP (NN Clinical) (CC and) (NN laboratory) (NNS evaluations)) (VP (VBD were) (VP (VBN performed) (PP (IN at) (NP (JJ 3-week) (NNS intervals))))) (. .)))
2528969	6	(ROOT (S (NP (JJ Symptomatic) (JJ adverse) (NNS effects)) (VP (VBD were) (ADJP (JJ present) (PP (IN in) (NP (NP (CD 96) (NN %)) (PP (IN of) (NP (NP (NNS subjects)) (, ,) (ADVP (RBS most) (RB commonly)) (NP (NP (NP (NNS Doc_2528969_1034_1040_Disease)) (PRN (-LRB- -LRB-) (NP (CD 64) (NN %)) (-RRB- -RRB-))) (, ,) (NP (NP (NNS Doc_2528969_1048_1055_Disease)) (PRN (-LRB- -LRB-) (NP (CD 55) (NN %)) (-RRB- -RRB-))) (CC and) (NP (NP (NNS Doc_2528969_1066_1074_Disease)) (PRN (-LRB- -LRB-) (NP (CD 49) (NN %)) (-RRB- -RRB-)))))))))) (. .)))
2528969	7	(ROOT (S (NP (DT These)) (VP (VBD were) (ADJP (RB generally) (JJ self-limited)) (, ,) (S (VP (VBG reappearing) (ADVP (RB briefly)) (PP (IN at) (NP (DT each) (NN dose) (NN increment)))))) (. .)))
2528969	8	(ROOT (S (NP (NP (DT A) (NN decrease)) (PP (IN in) (NP (NN hemoglobin)))) (VP (VBD occurred) (ADVP (RB shortly)) (PP (IN after) (NP (NP (NN initiation)) (PP (IN of) (NP (NN therapy)))))) (. .)))
2528969	9	(ROOT (S (NP (DT This)) (VP (VP (VBD was) (RB not) (VP (VBN dose) (S (ADJP (JJ dependent))))) (CC and) (VP (VBD reversed) (ADVP (RB rapidly)) (PP (IN upon) (NP (NP (NN discontinuation)) (PP (IN of) (NP (NN treatment))))))) (. .)))
2528969	10	(ROOT (S (NP (NP (DT A) (JJ red) (NN blood) (NN cell) (NN count) (NN decrease)) (, ,) (NP (DT a) (JJ mean) (NN cell) (NN volume) (NN increase)) (CC and) (NP (DT a) (JJ granulocyte) (NN count) (NN decrease))) (VP (VBD developed) (ADVP (RB early)) (PP (IN in) (NP (DT a) (JJ dose-independent) (NN fashion))) (, ,) (S (VP (VBG reverting) (ADVP (ADVP (IN at) (JJS least) (RB partially)) (PP (IN during) (NP (DT the) (JJ washout) (NN phase))))))) (. .)))
2528969	11	(ROOT (S (NP (NP (DT The) (NN decrease)) (PP (IN in) (NP (JJ reticulocyte) (NN count)))) (VP (VBD was) (NP (NP (NN dose)) (VP (VBN related) (NP (QP (IN between) (CD 600) (CC and) (CD 900))) (PP (ADVP (RB mg/day)) (IN with) (NP (NP (DT no) (JJ further) (NN change)) (SBAR (WHADVP (WRB when)) (S (NP (DT the) (NN dose)) (VP (VBD was) (VP (VBN escalated) (PP (TO to) (NP (CD 1200) (NN mg/day)))))))))))) (. .)))
2528969	12	(ROOT (S (NP (JJ Bone) (NN marrow) (NNS changes)) (VP (VBD occurred) (VP (ADVP (RB rapidly) (RB as)) (VBN demonstrated) (PP (IN by) (NP (NP (NNS megaloblastosis)) (PP (IN in) (NP (NP (NP (CD 95) (NN %)) (PP (IN of) (NP (CD 65) (NNS specimens))) (X (ADVP (IN at) (NN week)) (NP (CD 18)) (. .))) (PRN (-LRB- -LRB-) (NP (NP (NNP ABSTRACT) (NNP TRUNCATED) (NNP AT)) (NP (CD 250) (NNS WORDS))) (-RRB- -RRB-))))))))))
2533791	0	(ROOT (S (NP (NNP National)) (VP (VBP project) (PP (IN on) (NP (NP (DT the) (NN prevention)) (PP (IN of) (NP (NP (JJ mother-to-infant) (NNS Doc_2533791_55_85_Disease)) (PP (IN in) (NP (NNP Japan)))))))) (. .)))
2533791	1	(ROOT (S (PP (IN In) (NP (NNP Japan))) (, ,) (NP (NP (DT a) (JJ nationwide) (NN prevention) (NN program)) (PP (IN against) (NP (NP (JJ mother-to-infant) (NNS Doc_2533791_163_193_Disease)) (PRN (-LRB- -LRB-) (NP (NNP HBV)) (-RRB- -RRB-))))) (VP (VBD started) (PP (IN in) (NP (CD 1985)))) (. .)))
2533791	2	(ROOT (S (NP (DT This) (NN program)) (VP (VBZ consists) (PP (IN of) (NP (NP (JJ double) (NNS screenings)) (PP (IN of) (NP (NP (JJ pregnant) (NNS women)) (CC and) (NP (JJ prophylactic) (NN treatment)))))) (PP (TO to) (NP (NP (DT the) (NNS infants)) (VP (VBN born) (PP (TO to) (NP (NP (NP (DT both) (NNS Doc_2533791_333_360_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP HBsAg)) (-RRB- -RRB-))) (CC and) (NP (NP (NNS Doc_2533791_373_394_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_2533791_396_401_Chemical)) (-RRB- -RRB-)) (NP (JJ positive) (NNS mothers))))))))) (. .)))
2533791	3	(ROOT (S (S (NP (DT These) (NNS infants)) (VP (VBP are) (VP (VBN treated) (PP (IN with) (NP (NP (CD two) (NNS injections)) (PP (IN of) (NP (NP (JJ Doc_2533791_470_481_Disease) (JJ immune) (NN globulin)) (PRN (-LRB- -LRB-) (NP (NNP HBIG)) (-RRB- -RRB-))))))))) (CC and) (S (NP (NP (QP (IN at) (JJS least) (CD three)) (NNS injections)) (PP (IN of) (NP (NN plasma)))) (VP (VBD derived) (NP (JJ Doc_2533791_553_564_Disease) (NN vaccine)))) (. .)))
2533791	4	(ROOT (S (S (NP (PRP We)) (VP (VBD sent) (X (X (NP (NP (NNS questionnaires)) (PP (IN about) (NP (NP (DT the) (NNS numbers)) (PP (IN of) (NP (NP (DT each) (NN procedure) (CC or) (NN examination)) (PP (IN during) (NP (NP (CD nine) (NNS months)) (PP (IN of) (NP (NN investigation)))))))))) (NP (NP (NN period)) (PP (TO to) (NP (NP (DT each) (JJ local) (NN government)) (PP (IN in) (NP (CD 1986) (CC and) (CD 1987)))))) (. .)) (NP (NP (CD 93.4) (NN %)) (SBAR (S (NP (JJ pregnant) (NNS women)) (VP (VBD had) (NP (DT the) (NN chance) (S (VP (TO to) (VP (VB be) (VP (VBN examined) (PP (IN for) (NP (NNP HBsAg))))))))))))))) (, ,) (CC and) (S (NP (DT the) (JJ positive) (NN rate)) (VP (VBD was) (NP (QP (CD 1.4) (TO to) (CD 1.5)) (NN %)))) (. .)))
2533791	5	(ROOT (S (NP (NP (DT The) (JJ Doc_2533791_839_844_Chemical) (JJ positive) (NN rate)) (PP (IN in) (S (VP (VBG HBsAg) (ADJP (JJ positive)))))) (VP (VBD was) (NP (QP (CD 23) (TO to) (CD 26)) (NN %))) (. .)))
2533791	6	(ROOT (S (NP (NP (DT The) (NNP HBsAg) (JJ positive) (NN rate)) (PP (PP (IN in) (NP (NNS neonates))) (CC and) (PP (IN in) (NP (NP (NNS infants)) (PP (IN before) (NP (CD two) (NNS months))))))) (VP (VBD were) (NP (QP (CD 3) (NN %) (CC and) (CD 2)) (NN %)) (ADVP (RB respectively))) (. .)))
2533791	7	(ROOT (S (NP (DT Some) (NNS problems)) (VP (MD may) (VP (VB arise) (, ,) (SBAR (IN because) (S (NP (NP (QP (CD 27) (TO to) (CD 30)) (NN %)) (PP (IN of) (NP (NNS infants)))) (VP (VBP need) (NP (NP (DT the) (JJ fourth) (NN vaccination)) (PP (IN in) (NP (DT some) (VBN restricted) (NNS areas))))))))) (. .)))
2557556	0	(ROOT (NP (NP (NNP Involvement)) (PP (IN of) (NP (DT the) (JJ mu-opiate) (NN receptor))) (PP (IN in) (NP (JJ peripheral) (NNS Doc_2557556_52_61_Disease))) (. .)))
2557556	1	(ROOT (S (NP (NP (DT The) (JJ intradermal) (NN injection)) (PP (IN of) (NP (NP (NP (NN mu)) (PRN (-LRB- -LRB-) (NP (NP (NNS Doc_2557556_96_104_Chemical)) (, ,) (NP (NNS Doc_2557556_106_109_Chemical-Doc_2557556_110_134_Chemical) (CC and) (NNS Doc_2557556_139_151_Chemical))) (-RRB- -RRB-))) (, ,) (NP (NP (NN kappa)) (PRN (-LRB- -LRB-) (NP (NNP Doc_2557556_161_236_Chemical)) (-RRB- -RRB-))) (CC and) (NP (NP (NN delta)) (PRN (-LRB- -LRB-) (FRAG (NP (NP (JJ -LSB-) (NNS D-Pen2)) (NP (CD .5) (NNS -RSB-))) (: -) (NP (NP (NN enkephalin)) (CC and) (NP (NNS Doc_2557556_275_303_Chemical)))) (-RRB- -RRB-)) (NP (JJ selective) (NNS opioid-agonists)))))) (, ,) (PP (IN by) (NP (PRP themselves))) (, ,) (VP (VBD did) (RB not) (ADVP (RB significantly)) (VP (VB affect) (NP (DT the) (JJ mechanical) (NN nociceptive) (NN threshold)) (PP (IN in) (NP (NP (DT the) (NN hindpaw)) (PP (IN of) (NP (DT the) (NN rat))))))) (. .)))
2557556	2	(ROOT (S (NP (NP (NP (JJ Intradermal) (NN injection)) (PP (IN of) (NP (NN mu)))) (, ,) (CONJP (CC but) (RB not)) (NP (NN delta) (CC or) (NN kappa) (NNS opioid-agonists))) (, ,) (ADVP (RB however)) (, ,) (VP (VBD produced) (NP (NP (JJ dose-dependent) (NN inhibition)) (PP (IN of) (NP (NN Doc_2557556_556_572_Chemical-induced) (NNS Doc_2557556_581_593_Disease))))) (. .)))
2557556	3	(ROOT (S (NP (NP (DT The) (JJ analgesic) (NN effect)) (PP (IN of) (NP (DT the) (JJ mu-agonist) (NNS Doc_2557556_634_642_Chemical)))) (VP (VBD was) (ADVP (RB dose-dependently)) (VP (VP (VBN antagonized) (PP (IN by) (NP (NNS Doc_2557556_679_687_Chemical)))) (CC and) (VP (VBN prevented) (PP (IN by) (NP (NP (NN co-injection)) (PP (IN of) (NP (NN pertussis) (NN toxin)))))))) (. .)))
2557556	4	(ROOT (S (NP (NNP Doc_2557556_738_746_Chemical)) (VP (VBD did) (RB not) (PRN (, ,) (ADVP (RB however)) (, ,)) (VP (VB alter) (NP (NP (DT the) (NNS Doc_2557556_775_787_Disease)) (VP (VBN induced) (PP (IN by) (NP (NNS Doc_2557556_799_837_Chemical))))))) (. .)))
2557556	5	(ROOT (S (NP (PRP We)) (VP (VBP conclude) (SBAR (SBAR (IN that) (S (NP (NP (DT the) (JJ analgesic) (NN action)) (PP (IN of) (NP (NP (NNS opioids)) (PP (IN on) (NP (NP (DT the) (JJ peripheral) (NNS terminals)) (PP (IN of) (NP (JJ primary) (NNS afferents)))))))) (VP (VBZ is) (PP (IN via) (NP (NP (DT a) (VBG binding) (NN site)) (PP (IN with) (NP (NP (NNS characteristics)) (PP (IN of) (NP (DT the) (JJ mu-opioid) (NN receptor)))))))))) (CC and) (SBAR (IN that) (S (NP (DT this) (NN action)) (VP (VBZ is) (VP (VBN mediated) (PP (IN by) (NP (NP (NN inhibition)) (PP (IN of) (NP (DT the) (JJ Doc_2557556_1060_1090_Chemical) (JJ second) (NN messenger) (NN system))))))))))) (. .)))
2564649	0	(ROOT (S (NP (NP (NNP Involvement)) (PP (IN of) (NP (NNS locus)))) (VP (VP (VBZ coeruleus)) (CC and) (VP (NP (JJ noradrenergic) (NN neurotransmission)) (PP (IN in) (NP (NP (NN Doc_2564649_70_78_Chemical-induced) (NNS Doc_2564649_87_104_Disease)) (PP (IN in) (NP (DT the) (NN rat))))))) (. .)))
2564649	1	(ROOT (S (SBAR (IN Whereas) (S (NP (NNS Doc_2564649_125_142_Disease)) (VP (VBZ is) (NP (NP (DT a) (JJ well-known) (NN side) (NN effect)) (SBAR (WHNP (WDT that)) (S (VP (VBZ is) (VP (VBN associated) (PP (IN with) (NP (JJ high-dose) (JJ Doc_2564649_205_213_Chemical) (NN anesthesia))))))))))) (, ,) (NP (NP (DT a) (NN paucity)) (PP (IN of) (NP (NN information)))) (VP (VBZ exists) (PP (IN with) (NP (NN regard))) (PP (TO to) (NP (NP (PRP$ its) (JJ underlying) (NN mechanism)) (PRN (-LRB- -LRB-) (PRP s) (-RRB- -RRB-))))) (. .)))
2564649	2	(ROOT (S (NP (PRP We)) (VP (VBD investigated) (PP (IN in) (NP (DT this) (NN study))) (NP (NP (DT the) (JJ possible) (NN engagement)) (PP (IN of) (NP (NP (JJ locus) (NNS coeruleus)) (PP (IN of) (NP (NP (DT the) (NNS pons)) (PP (IN in) (NP (DT this) (NN phenomenon)))))))) (, ,) (S (VP (VBG using) (NP (JJ male) (JJ Sprague-Dawley) (NNS rats) (JJ anesthetized)) (PP (IN with) (NP (NNS Doc_2564649_456_464_Chemical)))))) (. .)))
2564649	3	(ROOT (S (PP (IN Under) (NP (NP (JJ proper) (NN control)) (PP (IN of) (NP (NP (NN respiration)) (, ,) (NP (NN body) (NN temperature)) (CC and) (NP (JJ end-tidal) (NNS Doc_2564649_534_537_Chemical)))))) (, ,) (NP (NP (JJ intravenous) (NN administration)) (PP (IN of) (NP (NP (NNS Doc_2564649_569_577_Chemical)) (PRN (-LRB- -LRB-) (NP (QP (CD 50) (CC or) (CD 100) (CD micrograms/kg))) (-RRB- -RRB-))))) (ADVP (RB consistently)) (VP (VBD promoted) (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (NP (JJ electromyographic) (NN activity)) (VP (VBN recorded) (PP (IN from) (NP (DT the) (NNS gastrocnemius) (CC and) (NN abdominal) (NNS rectus) (NNS muscles)))))))) (. .)))
2564649	4	(ROOT (S (NP (NP (PDT Such) (DT an) (JJ induced) (NNS Doc_2564649_746_763_Disease)) (PP (IN by) (NP (DT the) (JJ narcotic) (NN agent)))) (VP (VBD was) (ADJP (ADJP (RB significantly) (JJ antagonized)) (CC or) (ADJP (RB even) (JJ reduced))) (PP (IN by) (NP (NP (JJ prior) (JJ electrolytic) (NNS lesions)) (PP (IN of) (NP (DT the) (JJ locus) (NNS coeruleus) (CC or) (NN pretreatment))))) (PP (IN with) (NP (NP (DT the) (JJ alpha-adrenoceptor) (NN blocker)) (, ,) (NP (NNS Doc_2564649_938_946_Chemical))))) (. .)))
2564649	5	(ROOT (S (NP (NP (NNP Microinjection)) (PP (IN of) (NP (NP (NP (NNS Doc_2564649_966_974_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 2.5) (NN micrograms/50) (NN nl)) (-RRB- -RRB-))) (ADVP (RB directly) (PP (IN into) (NP (DT this) (JJ pontine) (NN nucleus)))))) (, ,) (PP (IN on) (NP (DT the) (JJ other) (NN hand))) (, ,)) (VP (VBD elicited) (NP (JJ discernible) (JJ electromyographic) (NN excitation))) (. .)))
2564649	6	(ROOT (S (NP (PRP It)) (VP (VBZ is) (VP (VBN speculated) (SBAR (IN that) (S (NP (NP (DT the) (NN induction)) (PP (IN of) (NP (NP (NNS Doc_2564649_1143_1160_Disease)) (PP (IN by) (NP (NNS Doc_2564649_1164_1172_Chemical)))))) (VP (MD may) (VP (VB involve) (NP (DT the) (JJ coerulospinal) (JJ noradrenergic) (NNS fibers)) (PP (TO to) (NP (DT the) (JJ spinal) (NNS motoneurons))))))))) (. .)))
2569282	0	(ROOT (S (NP (NNP Doc_2569282_0_15_Chemical)) (, ,) (S (VP (VBG acting) (PP (IN through) (NP (JJ central) (JJ alpha-2) (NNS adrenoceptors))))) (, ,) (VP (VBZ prevents) (NP (NP (JJ opiate-induced) (NNS Doc_2569282_87_102_Disease)) (PP (IN in) (NP (DT the) (NN rat))))) (. .)))
2569282	1	(ROOT (S (NP (NP (DT The) (JJ highly-selective) (JJ alpha-2) (JJ adrenergic) (NN agonist) (NNS Doc_2569282_163_178_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_2569282_180_185_Chemical)) (-RRB- -RRB-))) (VP (VBZ is) (ADJP (JJ capable) (PP (IN of) (S (VP (VBG inducing) (NP (NNS Doc_2569282_210_227_Disease) (CC and) (NN anesthesia)) (PP (IN in) (NP (NNS rats) (CC and) (NNS dogs)))))))) (. .)))
2569282	2	(ROOT (S (NP (JJ Intense) (JJ generalized) (NNS Doc_2569282_281_296_Disease)) (VP (VBZ is) (NP (NP (DT an) (JJ undesirable) (NN side) (NN effect)) (PP (IN of) (NP (JJ potent) (NN opiate) (NNS agonists))))) (. .)))
2569282	3	(ROOT (S (SBAR (IN Although) (S (NP (NP (DT the) (NN neurochemistry)) (PP (IN of) (NP (JJ opiate-induced) (NNS Doc_2569282_400_408_Disease)))) (VP (VBZ has) (ADVP (RB yet)) (S (VP (TO to) (VP (VB be) (ADJP (RB fully) (JJ elucidated)))))))) (, ,) (NP (JJ recent) (NN work)) (VP (VBZ suggests) (NP (NP (DT a) (NN role)) (PP (IN for) (NP (DT a) (JJ central) (JJ adrenergic) (NN mechanism))))) (. .)))
2569282	4	(ROOT (S (PP (IN In) (NP (DT the) (JJ present) (NN study))) (, ,) (NP (DT the) (NNS authors)) (VP (VBD determined) (SBAR (IN if) (S (NP (NP (NN treatment)) (PP (IN with) (NP (NNS Doc_2569282_568_573_Chemical)))) (VP (VBZ prevents) (SBAR (S (NP (DT the) (NNS Doc_2569282_587_602_Disease)) (VP (VBD caused) (PP (IN by) (NP (JJ high-dose) (JJ Doc_2569282_623_633_Chemical) (NN anesthesia))) (PP (IN in) (NP (DT the) (NN rat)))))))))) (. .)))
2569282	5	(ROOT (S (S (NP (NP (NNS Animals)) (PRN (-LRB- -LRB-) (VP (VBN n) (S (VP (SYM =) (NP (CD 42))))) (-RRB- -RRB-))) (VP (VBD were) (VP (VP (VBN treated) (ADVP (RB intraperitoneally)) (PP (IN with) (NP (NP (CD one)) (PP (IN of) (NP (NP (DT the) (JJ following) (CD six) (NNS regimens)) (: :) (NP (CD 1)) (-RRB- -RRB-) (ADJP (ADJP (JJ L-MED)) (PRN (-LRB- -LRB-) (NP (NP (DT the) (JJ inactive) (NN L-isomer)) (PP (IN of) (NP (NNS Doc_2569282_780_792_Chemical)))) (-RRB- -RRB-)))))))) (, ,) (VP (PRN (NP (NP (CD 30) (NN micrograms/kg)) (: ;) (NP (CD 2))) (-RRB- -RRB-)) (VBN D-MED)) (, ,) (NP (NP (CD 10) (NP (CD micrograms/kg) (: ;) (CD 3)) (-RRB- -RRB-) (NNS Doc_2569282_844_849_Chemical)) (, ,) (NP (CD 30) (NN micrograms/kg)))))) (: ;) (S (LST (LS 4) (-RRB- -RRB-)) (NP (NNS Doc_2569282_872_877_Chemical)) (VP (VBZ -LSB-) (NP (NP (NP (CD 30) (JJ micrograms/kg) (NNS -RSB-)) (CC and) (NP (DT the) (JJ central-acting) (JJ alpha-2) (NN antagonist))) (, ,) (NP (NP (JJ Doc_2569282_940_948_Chemical) (ADJP (ADJP (QP (CD -LSB-) (CD 10))) (PRN (NP (NP (JJ mg/kg) (NNS -RSB-)) (: ;) (NP (CD 5))) (-RRB- -RRB-))) (NN Doc_2569282_964_969_Chemical) (NN -LSB-) (CD 30) (NN micrograms/kg) (NN -RSB-)) (CC and) (NP (NP (DT the) (JJ peripheral-acting) (JJ alpha-2) (NN antagonist) (NNS Doc_2569282_1034_1041_Chemical)) (NP (QP (CD -LSB-) (CD 10)) (JJ mg/kg) (NNS -RSB-)))) (, ,) (CC or) (NP (, ;) (NP (CD 6)) (-RRB- -RRB-) (NNS saline))))) (. .)))
2569282	6	(ROOT (S (NP (JJ Baseline) (JJ electromyographic) (NN activity)) (VP (VBD was) (VP (VBN recorded) (PP (IN from) (NP (DT the) (JJ gastrocnemius) (NN muscle))) (PP (IN before) (CC and) (IN after) (NP (NN drug) (NN treatment))))) (. .)))
2569282	7	(ROOT (S (NP (DT Each) (NN rat)) (VP (VBD was) (ADVP (RB then)) (VP (VBN injected) (PP (IN with) (NP (NP (NNS Doc_2569282_1213_1223_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_2569282_1225_1228_Chemical)) (, ,) (NP (CD 0.5) (NN mg/kg) (NN sc)) (-RRB- -RRB-)))))) (. .)))
2569282	8	(ROOT (S (NP (JJ Doc_2569282_1245_1248_Chemical) (NN injection)) (VP (VBD resulted) (PP (IN in) (NP (NP (DT a) (JJ marked) (NN increase)) (PP (IN in) (NP (JJ hindlimb) (NNP EMG) (NN activity))))) (PP (IN in) (NP (NP (DT the) (NNP L-MED) (NN treatment) (NN group)) (SBAR (WHNP (WDT which)) (S (VP (VBD was) (ADJP (JJ indistinguishable) (PP (IN from) (NP (NP (DT that)) (VP (VBN seen) (PP (IN in) (NP (NP (NNS animals)) (VP (VBN treated) (PP (IN with) (NP (NN saline)))))))))))))))) (. .)))
2569282	9	(ROOT (S (PP (IN In) (NP (NN contrast))) (, ,) (NP (NNS Doc_2569282_1431_1436_Chemical)) (VP (VBD prevented) (NP (NN Doc_2569282_1447_1457_Chemical-induced) (NNS Doc_2569282_1466_1481_Disease)) (PP (IN in) (NP (DT a) (JJ dose-dependent) (NN fashion)))) (. .)))
2569282	10	(ROOT (S (NP (NP (DT The) (JJ small) (NNP EMG) (NNS values)) (VP (VBN obtained) (PP (IN in) (NP (DT the) (JJ high-dose) (JJ Doc_2569282_1558_1563_Chemical) (NN group))))) (VP (VBD were) (ADJP (JJ comparable) (PP (IN with) (NP (NP (DT those)) (VP (VBN recorded) (PP (IN in) (NP (NP (JJR earlier) (NNS studies)) (PP (IN from) (NP (NN control) (NNS animals))))) (PP (RB not) (PP (VBN given) (NP (DT any) (NN opiate))))))))) (. .)))
2569282	11	(ROOT (S (NP (DT The) (JJ high-dose) (JJ Doc_2569282_1682_1687_Chemical) (NNS animals)) (VP (VP (VBD were) (VP (VBN flaccid))) (, ,) (VP (VBZ Doc_2569282_1710_1718_Disease)) (, ,) (CC and) (VP (VBD lacked) (NP (DT a) (JJ Doc_2569282_1733_1740_Disease) (NN response)) (PP (IN during) (FRAG (NP (DT the) (JJ entire) (JJ experimental) (NN period)) (. .))) (PRN (-LRB- -LRB-) (NP (NP (NNP ABSTRACT) (NNP TRUNCATED) (NNP AT)) (NP (CD 250) (NNS WORDS))) (-RRB- -RRB-))))))
2576810	0	(ROOT (NP (NP (DT Some) (JJ central) (NNS effects)) (PP (IN of) (NP (NP (VBN repeated) (NN treatment)) (PP (IN with) (NP (NNS Doc_2576810_48_59_Chemical))))) (. .)))
2576810	1	(ROOT (S (NP (PRP We)) (VP (VBD investigated) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (VBN repeated) (NN treatment)))) (PP (IN with) (NP (NP (NNS Doc_2576810_115_126_Chemical)) (, ,) (NP (DT a) (JJ selective) (JJ Doc_2576810_140_149_Chemical) (NN uptake) (NN inhibitor)) (, ,))) (PP (PP (IN on) (NP (NP (JJ behavioral) (NNS effects)) (PP (IN of) (NP (NNS dopaminomimetics) (CC and) (NNS Doc_2576810_214_225_Chemical))))) (CC and) (PP (IN on) (NP (NP (DT the) (NN animal) (NN behavior)) (PP (IN in) (NP (DT the) (`` ``) (JJ behavioral) (NN despair) ('' ''))))) (NP (NN test)))) (. .)))
2576810	2	(ROOT (S (NP (NP (DT A) (VBN repeated) (NN treatment)) (PP (IN with) (NP (NP (NNS Doc_2576810_313_324_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (RB twice) (JJ daily)) (PP (IN for) (NP (CD 14) (NNS days)))) (-RRB- -RRB-))))) (VP (VBD potentiated) (PP (PP (IN in) (NP (NNS mice))) (CC and) (PP (IN in) (NP (NP (NNS rats)) (PRN (-LRB- -LRB-) (ADJP (JJR weaker)) (-RRB- -RRB-)))) (NP (DT the) (NN Doc_2576810_396_407_Chemical-induced) (NNS Doc_2576810_416_429_Disease)))) (. .)))
2576810	3	(ROOT (S (NP (NP (DT The) (NNS Doc_2576810_435_448_Disease)) (VP (VBN induced) (PP (IN by) (NP (NP (NNS Doc_2576810_460_471_Chemical)) (PP (IN in) (NP (NNS mice))))))) (VP (VBD remained) (ADJP (JJ unaffected)) (PP (IN by) (NP (NNS Doc_2576810_503_514_Chemical)))) (. .)))
2576810	4	(ROOT (S (NP (NP (DT The) (NN stimulation)) (PP (IN of) (NP (NP (NN locomotor) (NN activity)) (PP (IN by) (NP (ADJP (RB intracerebroventricularly) (VBN administered)) (NNS Doc_2576810_596_607_Chemical)))))) (VP (VBD was) (RB not) (VP (VBN affected) (PP (IN by) (NP (NP (VBN repeated) (NN treatment)) (PP (IN with) (NP (NNS Doc_2576810_652_663_Chemical))))))) (. .)))
2576810	5	(ROOT (SINV (PP (VBN Given) (NP (QP (CD three) (NNS times)) (NNS Doc_2576810_683_694_Chemical))) (VP (VBD had) (NP (NP (DT no) (NN effect)) (PP (IN on) (NP (DT the) (NN immobilization) (NN time)))) (PP (IN in) (NP (DT the) (`` ``) (JJ behavioral) (NN despair) ('' '')))) (NP (NP (NN test)) (PP (IN in) (NP (NNS rats)))) (. .)))
2576810	6	(ROOT (S (NP (DT The) (NNS results)) (VP (VBP indicate) (SBAR (IN that) (S (NP (NP (NNS Doc_2576810_804_815_Chemical)) (VP (VBN given) (ADVP (RB repeatedly)))) (VP (VP (VBZ acts) (ADVP (RB differently)) (PP (IN than) (NP (NP (NNS Doc_2576810_855_865_Chemical)) (, ,) (NP (DT another) (JJ selective) (JJ Doc_2576810_885_894_Chemical) (NN uptake) (NN inhibitor)) (, ,)))) (CC and) (VP (VBZ differs) (ADVP (RB also)) (PP (IN from) (NP (JJ other) (NN antidepressant) (NNS drugs)))))))) (. .)))
2594614	0	(ROOT (NP (NP (JJ Protective) (NN effect)) (PP (IN of) (NP (NP (DT a) (JJ specific) (JJ platelet-activating) (NN factor) (NN antagonist)) (, ,) (NP (NNS Doc_2594614_71_79_Chemical)) (, ,))) (PP (IN on) (NP (NN Doc_2594614_84_95_Chemical-induced) (NNS Doc_2594614_104_130_Disease))) (PP (IN in) (NP (NNS rats))) (. .)))
2594614	1	(ROOT (S (NP (NP (NP (NNP Administration)) (PP (IN of) (NP (DT the) (JJ local) (JJ anaesthetic) (NNS Doc_2594614_180_191_Chemical)))) (PRN (-LRB- -LRB-) (NP (NP (QP (CD 1.5) (CC or) (CD 2)) (NN mg/kg)) (, ,) (NP (NN i.v.))) (-RRB- -RRB-)) (PP (TO to) (NP (NNS rats)))) (VP (VBD elicited) (NP (NP (DT a) (JJ marked) (NN decrease)) (PP (IN of) (NP (NP (JJ mean) (JJ arterial) (NN blood) (NN pressure)) (PRN (-LRB- -LRB-) (NP (NNP MBP)) (-RRB- -RRB-)) (CC and) (NP (NN heart) (NN rate)) (PRN (-LRB- -LRB-) (NP (NNP HR)) (-RRB- -RRB-)))) (VP (VBG leading) (PP (TO to) (NP (NP (NN death)) (PRN (-LRB- -LRB-) (NP (NP (QP (IN in) (CD 67) (NN %) (CC or) (CD 90) (NN %))) (PP (IN of) (NP (NP (NNS animals)) (ADVP (RB respectively))))) (-RRB- -RRB-))))))) (. .)))
2594614	2	(ROOT (SINV (VP (VBZ Intravenous) (NP (NP (NN injection)) (PP (IN of) (NP (NP (DT the) (JJ specific) (JJ platelet-activating) (NN factor)) (PRN (-LRB- -LRB-) (NP (NNP PAF)) (-RRB- -RRB-)))))) (NP (NP (JJ antagonist) (NNS Doc_2594614_448_456_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 10) (NN mg/kg)) (-RRB- -RRB-))) (, ,) (S (NP (NP (CD 30) (NN min)) (PP (IN before) (NP (NP (JJ Doc_2594614_483_494_Chemical) (NN administration)) (PRN (-LRB- -LRB-) (NP (CD 2) (NN mg/kg) (NN i.v.)) (-RRB- -RRB-))))) (VP (VBD suppressed) (NP (PDT both) (DT the) (NNS Doc_2594614_545_567_Disease)))) (. .)))
2594614	3	(ROOT (S (PP (IN In) (NP (NN contrast))) (, ,) (NP (NP (NNS doses)) (PP (IN of) (NP (NP (CD 1) (JJ mg/kg) (NNS Doc_2594614_599_607_Chemical)) (VP (VBN given) (NP (CD 30) (NN min)) (PP (IN before) (NP (QP (CC or) (CD 10)))) (VP (VBG mg/kg) (S (VP (VBN administered) (NP (QP (CD 5) (CD min))) (PP (IN before) (NP (NP (NN i.v.) (NN injection)) (PP (IN of) (NP (NNS Doc_2594614_684_695_Chemical)))))))))))) (VP (VBD were) (ADJP (JJ ineffective))) (. .)))
2594614	4	(ROOT (S (SBAR (WHADVP (WRB When)) (S (NP (NP (NNS Doc_2594614_719_727_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 20) (NN mg/kg) (NN i.v.)) (-RRB- -RRB-))) (VP (VBD was) (VP (VBN injected) (ADVP (RB immediately)) (PP (IN after) (NP (NP (NNS Doc_2594614_775_786_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 2) (NN mg/kg)) (-RRB- -RRB-)))))))) (, ,) (NP (NP (DT a) (JJ partial) (NN reversion)) (PP (IN of) (NP (DT the) (NNS Doc_2594614_825_847_Disease)))) (VP (VBD was) (ADJP (JJ observed)) (, ,) (SBAR (IN whereas) (S (NP (NP (DT the) (NN dose)) (PP (IN of) (NP (CD 10) (NN mg/kg)))) (VP (VBD was) (ADJP (JJ ineffective)))))) (. .)))
2594614	5	(ROOT (S (NP (NP (DT A) (JJ partial) (NN recovery)) (PP (IN of) (NP (NNP Doc_2594614_930_941_Chemical-induced) (NNP ECG) (NNS alterations)))) (VP (VBD was) (VP (VBN observed) (PP (IN after) (NP (NP (NN pretreatment)) (PP (IN of) (NP (DT the) (NNS rats))))) (PP (IN with) (NP (NNS Doc_2594614_1015_1023_Chemical))))) (. .)))
2594614	6	(ROOT (S (SBAR (IN Since) (S (NP (NP (NP (DT the) (NN administration)) (PP (IN of) (NP (NNS Doc_2594614_1053_1061_Chemical)))) (, ,) (ADVP (IN at) (DT all)) (NP (NP (NNS doses)) (VP (VBN studied))) (, ,)) (VP (VBD did) (RB not) (VP (VB alter) (NP (NNP MBP) (CC and) (NNP HR)) (PP (IN at) (NP (NP (DT the) (NNS doses)) (VP (VBN used)))))))) (, ,) (NP (NP (DT the) (NN bulk)) (PP (IN of) (NP (DT these) (NNS results)))) (ADVP (RB clearly)) (VP (VBP demonstrate) (NP (NP (DT a) (JJ protective) (NN action)) (PP (IN of) (NP (NP (NNS Doc_2594614_1198_1206_Chemical)) (, ,) (NP (NP (DT a) (JJ specific) (NN antagonist)) (PP (IN of) (NP (NNP PAF)))) (, ,)))) (PP (IN against) (NP (NN Doc_2594614_1246_1257_Chemical-induced) (NNS Doc_2594614_1266_1289_Disease)))) (. .)))
2594614	7	(ROOT (S (ADVP (RB Thus)) (, ,) (ADJP (JJ consistent) (PP (IN with) (NP (NP (PRP$ its) (JJ direct) (NN effect)) (PP (IN on) (NP (NN heart)))))) (, ,) (NP (NNP PAF)) (VP (VBZ appears) (S (VP (TO to) (VP (VB be) (VP (VBN implicated) (PP (IN in) (NP (NN Doc_2594614_1373_1384_Chemical-induced) (NNS Doc_2594614_1393_1419_Disease)))))))) (. .)))
2598570	0	(ROOT (NP (NP (DT The) (NN epidemiology)) (PP (IN of) (NP (DT the) (JJ acute) (JJ Doc_2598570_30_40_Disease) (NN syndrome))) (PP (IN from) (NP (NNS Doc_2598570_55_63_Chemical))) (. .)))
2598570	1	(ROOT (S (NP (NP (NNP Doc_2598570_65_73_Chemical)) (, ,) (NP (DT a) (JJ new) (JJ nonsteroidal) (JJ anti-inflammatory) (NN drug)) (, ,)) (VP (VBD was) (VP (VBN marketed) (PP (IN in) (NP (NP (RB early) (CD 1986)) (PP (IN as) (NP (DT an) (JJ analgesic) (NN agent))))))) (. .)))
2598570	2	(ROOT (S (SBAR (IN Until) (S (NP (NNS physicians)) (VP (VBD began) (S (VP (VBG reporting) (NP (DT an) (ADJP (JJ unusual) (JJ acute)) (JJ Doc_2598570_218_228_Disease) (NN syndrome)) (PP (TO to) (NP (DT the) (JJ spontaneous) (NN reporting) (NN system)))))))) (, ,) (NP (CD 700,000) (NNS persons)) (VP (VBD used) (NP (DT the) (NN drug)) (PP (IN in) (NP (DT the) (NNP United) (NNPS States)))) (. .)))
2598570	3	(ROOT (S (PP (IN Through) (NP (NNP August) (CD 1986))) (, ,) (NP (NP (DT a) (NN total)) (PP (IN of) (NP (NP (CD 163) (NNS cases)) (PP (IN of) (NP (DT this) (NN syndrome)))))) (VP (VBD were) (VP (VBN reported))) (. .)))
2598570	4	(ROOT (S (S (VP (TO To) (VP (VB elucidate) (NP (NP (DT the) (NN epidemiology)) (PP (IN of) (NP (DT the) (NN syndrome))))))) (, ,) (NP (DT a) (JJ case-control) (NN study)) (VP (VBD was) (VP (VBN performed) (, ,) (S (VP (VBG comparing) (NP (NP (CD 62)) (PP (IN of) (NP (DT the) (NN case) (NNS patients))) (SBAR (WHNP (WP who)) (S (VP (VBD had) (VP (VBN been) (VP (VBN reported) (PP (TO to) (NP (DT the) (JJ spontaneous) (NN reporting) (NN system))) (PP (TO to) (NP (NP (CD 185) (NN Doc_2598570_583_591_Chemical-exposed) (NN control) (NNS subjects)) (SBAR (WHNP (WP who)) (S (VP (VBD did) (RB not) (VP (VB have) (NP (DT the) (NN syndrome)))))))))))))))))) (. .)))
2598570	5	(ROOT (S (NP (NN Case) (NNS patients)) (VP (VBD were) (ADJP (RBR more) (JJ likely) (S (VP (VP (TO to) (VP (VP (VB be) (NP (NP (NNS men)) (PRN (-LRB- -LRB-) (NP (NP (NNS odds) (NN ratio)) (, ,) (NP (NP (CD 3.8)) (: ;) (NP (ADJP (CD 95) (NN %)) (NN confidence) (NN interval))) (, ,) (NP (CD 1.2-12) (CD .1))) (-RRB- -RRB-)))) (, ,) (VP (VB suffer) (PP (PP (IN from) (NP (NP (NNS Doc_2598570_755_764_Disease) (CC and) (NNS Doc_2598570_769_775_Disease)) (PRN (-LRB- -LRB-) (NP (NP (NNS odds) (NN ratio)) (, ,) (NP (NP (CD 3.4)) (: ;) (NP (ADJP (CD 95) (NN %)) (NN confidence) (NN interval))) (, ,) (NP (CD 1.0-11) (CD .9))) (-RRB- -RRB-)) (: ;) (S (VP (TO to) (VP (VB participate) (PP (IN in) (NP (NP (JJ regular) (NN exercise)) (PRN (-LRB- -LRB-) (NP (NP (NNS odds) (NN ratio)) (, ,) (NP (NP (CD 5.9)) (: ;) (NP (ADJP (CD 95) (NN %)) (NN confidence) (NN interval))) (, ,) (NP (CD 1.1-30) (CD .7))) (-RRB- -RRB-))))))))) (, ,) (RB especially) (IN in) (NP (NP (DT the) (NN use)) (PP (IN of) (NP (JJ Nautilus) (NN equipment))) (PRN (-LRB- -LRB-) (VP (VBN p) (S (VP (SYM =) (NP (CD 0.02))))) (-RRB- -RRB-))))))) (: ;) (CC and) (VP (TO to) (VP (VB use) (NP (NP (NNS Doc_2598570_986_993_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (NNS odds) (NN ratio)) (, ,) (NP (NP (CD 4.4)) (: ;) (NP (ADJP (CD 95) (NN %)) (NN confidence) (NN interval))) (, ,) (NP (CD 1.1-17) (CD .5))) (-RRB- -RRB-))))))))) (. .)))
2598570	6	(ROOT (S (NP (JJ Possible) (NN risk) (NNS factors)) (VP (VBD included) (S (NP (NP (JJ young) (NN age)) (, ,) (NP (NP (JJ concurrent) (NN use)) (PP (IN of) (NP (NP (JJ other) (JJ analgesic) (NNS agents)) (PRN (-LRB- -LRB-) (NP (RB especially) (NN Doc_2598570_1143_1152_Chemical)) (-RRB- -RRB-))))) (, ,)) (VP (VBG preexisting) (NP (NP (NP (NNS Doc_2598570_1167_1180_Disease)) (, ,) (NP (NP (DT a) (NN history)) (PP (IN of) (NP (NNS Doc_2598570_1195_1208_Disease))))) (, ,) (NP (NP (DT a) (NN history)) (PP (IN of) (NP (NNS Doc_2598570_1223_1227_Disease)))) (, ,) (NP (NP (DT a) (JJ recent) (NN increase)) (PP (IN in) (NP (NN activity)))) (, ,) (NP (NP (DT a) (JJ recent) (NN increase)) (PP (IN in) (NP (NN sun) (NN exposure)))) (, ,) (CC and) (NP (NP (NN residence)) (PP (IN in) (NP (DT the) (NNP Sunbelt)))))))) (. .)))
2598570	7	(ROOT (S (NP (DT These)) (VP (VBD were) (NP (NP (NNS findings)) (SBAR (WHNP (WDT that)) (S (VP (VP (VBD were) (ADJP (JJ suggestive))) (CC but) (VP (VBD did) (RB not) (VP (VB reach) (NP (JJ conventional) (JJ statistical) (NN significance))))))))) (. .)))
2598570	8	(ROOT (S (NP (DT These) (NNS findings)) (VP (VBP are) (ADJP (JJ consistent) (PP (IN with) (NP (NP (NP (DT the) (JJ postulated) (NN mechanism)) (PP (IN for) (NP (DT this) (JJ unusual) (NN syndrome)))) (: :) (NP (NP (JJ acute) (NN diffuse) (NN crystallization)) (PP (IN of) (NP (NP (NNS Doc_2598570_1543_1552_Chemical)) (PP (IN in) (NP (JJ renal) (NNS tubules)))))))))) (. .)))
2709684	0	(ROOT (S (NP (JJ Doc_2709684_0_9_Chemical-induced) (NNS Doc_2709684_18_28_Disease)) (VP (VBZ does) (RB not) (VP (VB prevent) (NP (JJ Doc_2709684_46_56_Chemical) (NN nephrotoxicity)) (PP (IN in) (NP (NNS rats))))) (. .)))
2709684	1	(ROOT (S (SBAR (IN Because) (S (NP (NP (NNS rats)) (PP (IN with) (NP (NP (NN Doc_2709684_99_113_Chemical-induced) (NNS Doc_2709684_122_139_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_2709684_141_143_Disease)) (-RRB- -RRB-))))) (VP (VBP have) (NP (NP (DT a) (ADJP (JJ high) (JJ solute)) (NNS diuresis)) (PRN (-LRB- -LRB-) (NP (NP (NNS Doc_2709684_174_184_Disease)) (PP (IN of) (NP (QP (CD 10) (TO to) (CD 12)) (NN g/day)))) (-RRB- -RRB-)))))) (, ,) (NP (PRP we)) (VP (VBP have) (VP (VBN suggested) (SBAR (IN that) (S (NP (DT this)) (VP (MD may) (PP (IN in) (NP (NN part))) (VP (VB be) (ADJP (JJ responsible) (PP (IN for) (NP (PRP$ their) (NN resistance)))) (PP (TO to) (NP (NP (NN Doc_2709684_284_294_Chemical-induced) (NNS Doc_2709684_303_322_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_2709684_324_327_Disease)) (-RRB- -RRB-)))))))))) (. .)))
2709684	2	(ROOT (S (NP (NP (DT The) (NN protection)) (PP (IN from) (NP (NNS Doc_2709684_350_360_Chemical)))) (ADVP (RB nephrotoxicity)) (VP (VBD was) (VP (VBN studied) (PP (IN in) (NP (JJ non-Doc_2709684_395_403_Disease) (NNS rats))) (PP (IN with) (NP (NP (JJ chronic) (NN solute) (NNS diuresis)) (VP (VBN induced) (PP (IN by) (NP (NP (NN blockage)) (PP (IN of) (NP (JJ tubular) (JJ Doc_2709684_469_476_Chemical) (NN reabsorption))))) (PP (IN with) (NP (NP (NNS Doc_2709684_495_504_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP P)) (-RRB- -RRB-))))))))) (. .)))
2709684	3	(ROOT (S (NP (NP (NP (JJ Doc_2709684_510_512_Disease) (NNS rats)) (PP (IN with) (NP (JJ mild) (NNS Doc_2709684_528_538_Disease)))) (PRN (-LRB- -LRB-) (ADJP (JJ similar) (PP (IN in) (NP (NN degree))) (PP (TO to) (NP (NP (DT that)) (PP (IN of) (NP (DT the) (NNP P) (NNP treated) (NNS animals)))))) (-RRB- -RRB-))) (VP (VBD were) (VP (ADVP (RB also)) (VBN studied))) (. .)))
2709684	4	(ROOT (S (NP (JJ Unanesthetized) (NN adult) (NN female) (, ,) (JJ Sprague-Dawley) (NNS rats)) (VP (VBD were) (VP (VP (VBN divided) (PP (IN in) (NP (CD four) (NNS groups)))) (CC and) (VP (VBN studied) (PP (IN for) (NP (CD 15) (NNS days)))))) (. .)))
2709684	5	(ROOT (S (NP (NP (NNP Group) (CD 1)) (PRN (-LRB- -LRB-) (S (NP (NNP P)) (ADJP (RB alone))) (-RRB- -RRB-))) (VP (VBD received) (NP (NP (NP (NP (NP (NNS Doc_2709684_740_741_Chemical)) (, ,) (NP (CD 360) (NN mg/day)) (, ,)) (PP (IN for) (NP (CD 15) (NNS days)))) (: ;) (NP (NP (NNP Group) (NNP II)) (PRN (-LRB- -LRB-) (NP (JJ Doc_2709684_778_779_Chemical) (JJ +) (NNS Doc_2709684_782_792_Chemical)) (-RRB- -RRB-))) (: ;) (NP (NP (NP (NNP Group) (NNP III)) (PRN (-LRB- -LRB-) (S (NP (NNS Doc_2709684_806_816_Chemical)) (ADJP (RB alone))) (-RRB- -RRB-))) (CC and) (NP (NNP Group) (NNP IV)))) (PRN (-LRB- -LRB-) (NP (JJ mild) (NNP Doc_2709684_843_845_Disease) (NNP +) (NNP Doc_2709684_848_858_Chemical)) (-RRB- -RRB-)))) (. .)))
2709684	6	(ROOT (S (NP (NP (NP (JJ Nephrotoxic) (NNS doses)) (-LRB- -LRB-) (NP (CD 40) (JJ mg/kg) (NN body) (NN wt/day)) (-RRB- -RRB-)) (PP (IN of) (NP (NNS Doc_2709684_905_915_Chemical)))) (VP (VBD were) (VP (VBN injected) (PP (IN during) (NP (NP (DT the) (JJ last) (CD nine) (NNS days)) (PP (IN of) (NP (NN study))))) (PP (TO to) (NP (NP (DT the) (NNS animals)) (PP (IN of) (NP (NNS groups) (CD II) (TO to) (CD IV))))))) (. .)))
2709684	7	(ROOT (S (PP (IN In) (NP (NNP Group) (NNP I))) (, ,) (NP (NNP P)) (VP (VBN induced) (NP (NP (NP (DT a) (ADJP (JJ moderate) (CC and) (JJ stable)) (NNS Doc_2709684_1044_1054_Disease)) (PRN (-LRB- -LRB-) (NP (CD 3.9) (NNP +) (NNS /)) (, -) (NP (CD 0.1) (NN g/day)) (, ,) (NP (NNP SE)) (-RRB- -RRB-))) (, ,) (CC and) (NP (NP (DT no) (ADJP (JJ functional) (CC or) (JJ morphologic)) (NN evidence)) (PP (IN of) (NP (NP (NNS Doc_2709684_1125_1142_Disease)) (PRN (-LRB- -LRB-) (NP (JJ baseline) (NNP CCr) (NNP 2.1) (NNP +) (NNP /)) (: -) (NP (NP (CD 0.1) (NN ml/min)) (, ,) (NP (JJ undetectable) (NN lysozymuria))) (-RRB- -RRB-)) (CC or) (NP (NN damage)) (PRN (-LRB- -LRB-) (NP (JJ Doc_2709684_1214_1230_Disease) (NN score) (NN -LSB-) (NN maximum)) (NP (NP (CD 4) (NNS -RSB-)) (, ,) (NP (CD zero))) (-RRB- -RRB-))))))) (. .)))
2709684	8	(ROOT (S (PP (IN In) (NP (NNP Group) (NNP II))) (, ,) (NP (NNS Doc_2709684_1270_1271_Chemical)) (VP (VBD did) (RB not) (VP (VB prevent) (NP (NP (NNS Doc_2709684_1288_1298_Chemical-Doc_2709684_1299_1302_Disease)) (PRN (-LRB- -LRB-) (NP (NP (NP (NP (JJ maximal) (NN decrease)) (PP (IN in) (NP (NP (NNP CCr)) (PP (IN at) (NP (NN day)))))) (NP (CD 9.89) (NN %))) (, ,) (ADVP (RB P)) (NP (NP (NP (NP (QP (JJR less) (IN than) (CD 0.001))) (PRN (: ;) (NP (NP (JJ peak) (NN lysozymuria)) (, ,) (NP (CD 1863) (NNS +))) (: /))) (: -) (NP (CD 321) (NN micrograms/day) (PRN (: ;) (CC and) (NP (NP (JJ Doc_2709684_1412_1428_Disease) (NN score)) (, ,) (NP (CD 3.9) (NNS +))) (: /)))) (: -) (NP (CD 0.1)))) (-RRB- -RRB-))))) (. .)))
2709684	9	(ROOT (S (NP (DT These) (NNS values)) (VP (VBD were) (RB not) (ADJP (JJ different) (PP (IN from) (NP (NP (NP (DT those)) (PP (IN of) (NP (NP (NNP Group) (NNP III)) (: :) (NP (NP (JJ maximal) (NN decrease)) (PP (IN in) (NP (NP (NP (QP (CD CCr) (CD 73)) (NN %)) (PRN (-LRB- -LRB-) (NP (NNP P) (QP (JJR less) (IN than) (CD 0.001))) (-RRB- -RRB-))) (PRN (: ;) (NP (NP (NN lysozymuria)) (, ,) (NP (CD 2147) (NNS +))) (: /))))) (: -) (NP (CD 701) (NN micrograms/day)) (: ;) (NP (JJ Doc_2709684_1598_1614_Disease) (NN score)) (, ,) (NP (CD 3.8) (NNS +)))) (X (X (SYM /)) (: -) (NP (CD 0.1)) (. .))) (PRN (-LRB- -LRB-) (NP (NP (NNP ABSTRACT) (NNP TRUNCATED) (NNP AT)) (NP (CD 250) (NNS WORDS))) (-RRB- -RRB-))))))))
2716967	0	(ROOT (NP (NP (NP (NNP Doc_2716967_0_9_Disease)) (VP (VBN induced) (PP (IN by) (NP (NP (NNS combinations)) (PP (IN of) (NP (NNS Doc_2716967_37_45_Chemical) (CC and) (NNS Doc_2716967_50_58_Chemical))))))) (: :) (NP (NP (NN potentiation) (, ,) (NN antagonism) (, ,) (NN tolerance) (CC and) (NN cross-tolerance)) (PP (IN in) (NP (DT the) (NN rat)))) (. .)))
2716967	1	(ROOT (S (NP (JJ Previous) (NNS studies)) (VP (VBD demonstrated) (SBAR (IN that) (S (NP (DT both) (NNS Doc_2716967_168_176_Chemical) (CC and) (NNS Doc_2716967_181_189_Chemical)) (VP (VBN induced) (NP (NNS Doc_2716967_198_207_Disease) (CC and) (NNS Doc_2716967_212_221_Disease)) (PP (IN in) (NP (DT the) (NN rat))))))) (. .)))
2716967	2	(ROOT (S (S (NP (NP (NN Pre-treatment)) (PP (IN with) (NP (NNS Doc_2716967_253_261_Chemical)))) (VP (VBD produced) (NP (NN cross-tolerance)) (PP (TO to) (NP (NNS Doc_2716967_290_298_Chemical))) (, ,) (SBAR (IN whereas) (S (NP (NP (NN pretreatment)) (PP (IN with) (NP (NNS Doc_2716967_326_334_Chemical)))) (VP (VBD did) (RB not) (VP (VP (VB induce) (ADJP (JJ cross-tolerance) (PP (TO to) (NP (NNS Doc_2716967_369_377_Chemical))))) (CONJP (CC but) (RB rather)) (VP (VB augmented) (NP (DT the) (JJ Doc_2716967_403_413_Disease) (NN response))))))))) (: ;) (S (NP (DT this) (NN augmentation)) (VP (VBD was) (VP (VBN attributed) (PP (TO to) (NP (NP (JJ residual) (NNS Doc_2716967_469_477_Chemical)) (PP (IN in) (NP (DT the) (NN brain)))))))) (. .)))
2716967	3	(ROOT (S (NP (DT The) (JJ present) (NNS studies)) (VP (VBD explored) (NP (NP (DT the) (NN duration)) (PP (IN of) (NP (NP (DT the) (NN loss)) (PP (IN of) (S (VP (VBG righting) (NP (JJ reflex) (NNS induced)) (PP (IN by) (NP (JJ sub-effective) (NNS doses)))))))) (PP (IN of) (NP (NNS Doc_2716967_599_607_Chemical) (CC and) (NNS Doc_2716967_612_620_Chemical))) (, ,) (VP (VBN administered) (ADVP (RB simultaneously))))) (. .)))
2716967	4	(ROOT (S (S (NP (EX There)) (VP (VBD was) (NP (NP (JJ mutual) (NN potentiation)) (PP (IN between) (NP (NP (JJ sub-effective) (NNS doses)) (PP (IN of) (NP (NNS Doc_2716967_712_720_Chemical) (CC and) (NNS Doc_2716967_725_733_Chemical)))))))) (, ,) (CC but) (S (NP (NP (JJ sub-effective) (NNS doses)) (PP (IN of) (NP (NNS Doc_2716967_762_770_Chemical)))) (ADVP (RB partly)) (VP (VBD antagonized) (NP (NP (JJ fully-effective) (NNS doses)) (PP (IN of) (NP (NNS Doc_2716967_815_823_Chemical)))))) (. .)))
2716967	5	(ROOT (S (NP (NP (NNP Latency)) (PP (TO to) (NP (NP (DT the) (NN loss)) (PP (IN of) (S (VP (VBG righting) (NP (JJ reflex) (, ,) (NNS Doc_2716967_865_873_Disease) (CC and) (NN behavior)) (PP (IN on) (NP (NN recovery))))))))) (, ,) (VP (VBD reflected) (NP (NP (DT the) (JJ relative) (NN predominance)) (PP (IN of) (NP (NNS Doc_2716967_939_947_Chemical) (CC or) (NNS Doc_2716967_951_959_Chemical)))) (PP (IN in) (NP (DT each) (NN combination)))) (. .)))
2716967	6	(ROOT (S (NP (NNP Doc_2716967_981_989_Chemical)) (VP (VBD inhibited) (NP (DT the) (JJ induced) (JJ Doc_2716967_1012_1022_Disease) (NNS effects))) (. .)))
2716967	7	(ROOT (S (NP (NP (DT The) (NN degree) (CC and) (NN time) (NN course)) (PP (IN of) (NP (NP (NN development)) (PP (IN of) (NP (NP (NN tolerance)) (PP (TO to) (NP (NP (JJ daily) (NN administration)) (PP (IN of) (NP (NP (JJ sub-effective) (NN dose) (NNS combinations)) (PP (IN of) (NP (NNS Doc_2716967_1149_1157_Chemical) (CC and) (NNS Doc_2716967_1162_1170_Chemical)))))))))))) (VP (VBD were) (ADJP (JJ similar))) (. .)))
2716967	8	(ROOT (S (NP (NP (NNS Rats)) (, ,) (NP (ADJP (JJ tolerant) (TO to) (JJ Doc_2716967_1203_1211_Chemical-dominant)) (NNS combinations)) (, ,)) (VP (VBD were) (ADJP (JJ cross-tolerant)) (PP (TO to) (NP (DT both) (NNS drugs))) (, ,) (SBAR (IN while) (S (NP (NP (DT those) (NN tolerant)) (PP (TO to) (NP (NN Doc_2716967_1294_1302_Chemical-dominant) (NNS combinations)))) (VP (VP (VBD were) (ADJP (JJ cross-tolerant)) (PP (TO to) (NP (NNS Doc_2716967_1348_1356_Chemical)))) (CC but) (VP (VBD showed) (NP (CC either) (NP (DT no) (NN cross-tolerance)) (CC or) (NP (DT an) (JJ augmented) (NN response))) (PP (TO to) (NP (NNS Doc_2716967_1422_1430_Chemical)))))))) (. .)))
2716967	9	(ROOT (S (SBAR (IN While) (S (NP (DT the) (JJ mutual) (NN potentiation) (, ,) (NN antagonism) (CC and) (NN tolerance)) (VP (VBP suggest) (NP (NP (JJ common) (NNS mechanisms)) (PP (IN for) (NP (DT the) (JJ induced) (NNS Doc_2716967_1530_1539_Disease))))))) (, ,) (NP (NP (NP (NNS differences)) (PP (IN in) (NP (NN latency) (, ,) (NNS Doc_2716967_1565_1573_Disease) (CC and) (NN behavior)))) (, ,) (NP (NP (NN asymmetry)) (PP (IN of) (NP (NN cross-tolerance)))) (CC and) (NP (NP (DT a) (JJ widely-different) (NN ID50)) (PP (IN for) (NP (NNS Doc_2716967_1649_1657_Chemical))))) (VP (MD would) (VP (VB argue) (PP (IN against) (NP (NP (DT an) (NN action)) (PP (IN at) (NP (DT a) (JJ single) (JJ opioid) (NN site))))))) (. .)))
2722224	0	(ROOT (NP (NP (NP (JJ Doc_2722224_0_14_Chemical-induced) (NNS Doc_2722224_23_35_Disease)) (PP (IN in) (NP (NNS humans)))) (: :) (NP (NP (NN pressor) (NNS responsiveness)) (CC and) (NP (JJ sympathetic) (NN function))) (. .)))
2722224	1	(ROOT (S (NP (JJ Oral) (NNS Doc_2722224_101_115_Chemical)) (VP (VP (VBZ increases) (NP (NN blood) (NN pressure))) (CC and) (VP (VBZ enhances) (NP (NN pressor) (NNS responsiveness)) (PP (IN in) (NP (JJ normal) (JJ human) (NNS subjects))))) (. .)))
2722224	2	(ROOT (S (NP (PRP We)) (VP (VBD studied) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NP (CD 1) (NN week)) (PP (IN of) (NP (NP (JJ oral) (NNS Doc_2722224_244_258_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 200) (NN mg/day)) (-RRB- -RRB-))))))) (PP (IN on) (NP (NP (NN blood) (NN pressure)) (, ,) (NP (JJ cardiac) (NN output)) (, ,) (NP (JJ total) (JJ peripheral) (NN resistance)) (, ,) (NP (NN forearm) (NN vascular) (NN resistance)) (, ,) (CC and) (NP (JJ Doc_2722224_369_383_Chemical) (NN spillover)))) (PP (TO to) (NP (NP (NN plasma)) (PP (IN in) (NP (CD eight) (JJ healthy) (JJ male) (NNS volunteers)))))) (. .)))
2722224	3	(ROOT (S (SBAR (IN Although) (S (NP (JJ diastolic) (NN blood) (NN pressure)) (VP (VBD remained) (ADJP (JJ unchanged))))) (, ,) (NP (JJ systolic) (NN blood) (NN pressure)) (VP (VBD increased) (PP (IN from) (NP (NP (QP (CD 119) (TO to) (CD 135)) (JJ mm) (NNS Hg)) (PRN (-LRB- -LRB-) (NP (NP (NNP SED) (NNP +) (NNP /)) (: -) (NP (NP (CD 3.4)) (, ,) (NP (NP (NN p)) (NP (QP (JJR less) (IN than) (CD 0.01)))))) (-RRB- -RRB-)))) (, ,) (S (VP (VBN associated) (PP (IN with) (NP (DT an) (NNS Doc_2722224_600_624_Disease))) (PRN (-LRB- -LRB-) (FRAG (NP (NP (CD 5.85-7) (CD .73) (NN l/min)) (, ,) (NP (NNP SED) (NNP +) (NNP /))) (: -) (NP (NP (CD 0.46)) (, ,) (ADJP (JJ p) (ADVP (RBR less) (IN than)) (NP (CD 0.01))))) (-RRB- -RRB-))))) (. .)))
2722224	4	(ROOT (S (NP (JJ Total) (JJ peripheral) (NN vascular) (NN resistance)) (VP (VBD fell) (PP (IN from) (NP (NP (QP (CD 15.1) (TO to) (CD 12.2)) (NNP mm) (NNP Hg/l/min)) (PRN (-LRB- -LRB-) (NP (NP (NNP SED) (NNP +) (NNP /)) (: -) (NP (CD 1.03))) (, ,) (PP (ADVP (NP (CD p)) (RBR less)) (IN than) (NP (CD 0.05))) (-RRB- -RRB-))))) (. .)))
2722224	5	(ROOT (S (S (NP (JJ Resting) (NN forearm) (NN vascular) (NN resistance)) (VP (VBD remained) (ADJP (JJ unchanged)))) (, ,) (CC but) (S (NP (NP (DT the) (JJ reflex) (NN response)) (PP (TO to) (NP (DT the) (JJ cold) (NN pressor) (NN test)))) (VP (VBD was) (VP (VBN accentuated) (, ,) (NP (NP (DT the) (NN rise)) (PP (IN in) (NP (NP (NN resistance)) (VP (VBG increasing) (PP (IN from) (NP (CD 10.5) (NN mm) (NNS Hg/ml/100))) (NP (NP (NN ml/min)) (PRN (-LRB- -LRB-) (NP (NN R) (NNS units)) (-RRB- -RRB-))) (PP (IN before) (NP (NN treatment))) (PP (TO to) (NP (QP (CD 32.6) (CD R)) (NNS units))) (PP (IN after) (NP (NP (NN treatment)) (PRN (-LRB- -LRB-) (NP (NP (NNP SED) (NNP +) (NNP /)) (: -) (NP (NP (CD 6.4)) (, ,) (NP (NP (NN p)) (NP (QP (JJR less) (IN than) (CD 0.025)))))) (-RRB- -RRB-))))))))))) (. .)))
2722224	6	(ROOT (S (NP (NP (DT The) (NN rise)) (PP (IN in) (NP (NP (NP (NN forearm) (NN vascular) (NN resistance)) (JJ accompanying) (JJ intra-arterial) (NNS Doc_2722224_1129_1143_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (CD 25)) (, ,) (NP (CD 50)) (, ,) (CC and) (NP (CD 100) (NN ng/min))) (-RRB- -RRB-))))) (VP (VBD was) (ADVP (RB also)) (ADJP (RB significantly) (JJR greater)) (PP (IN after) (NP (NP (NNS Doc_2722224_1206_1220_Chemical)) (, ,) (NP (NP (NP (VBG increasing)) (PP (IN from) (NP (DT an) (NN average))) (PP (IN of) (NP (CD 14.9) (NNS +))) (PRN (: /) (VP (VBG -) (NP (CD 2.4) (NN R) (NNS units)) (PP (IN before) (NP (NN treatment))) (PP (TO to) (NP (QP (CD 35.1) (CD +))))) (: /))) (: -) (NP (NP (CD 5.5) (NN R) (NNS units)) (PP (IN after) (NP (NP (NNS Doc_2722224_1320_1334_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (NNP SED) (NNP +) (NNP /)) (: -) (NP (CD 6.0))) (, ,) (PP (ADVP (NP (CD p)) (RBR less)) (IN than) (NP (CD 0.05))) (-RRB- -RRB-))))))))) (. .)))
2722224	7	(ROOT (S (NP (NP (DT A) (NN shift)) (PP (TO to) (NP (NP (DT the) (NN left)) (PP (IN in) (NP (NP (DT the) (JJ dose-response) (NN relation) (CC and) (NN fall)) (PP (IN in) (NP (NN threshold)))))))) (VP (VBD suggested) (NP (JJ increased) (NN sensitivity)) (PP (TO to) (NP (NNS Doc_2722224_1475_1489_Chemical))) (PP (IN after) (NP (NN treatment)))) (. .)))
2722224	8	(ROOT (S (NP (NP (NNP Measurement)) (PP (IN of) (NP (NP (JJ resting) (JJ Doc_2722224_1530_1544_Chemical) (NN spillover) (NN rate)) (PP (TO to) (NP (NN plasma) (CC and) (NN Doc_2722224_1574_1588_Chemical) (NN uptake)))))) (VP (VBD indicated) (SBAR (S (NP (DT that) (JJ overall) (JJ resting) (JJ sympathetic) (JJ nervous) (NN system) (NN activity)) (VP (VBD was) (RB not) (VP (VBN increased)))))) (. .)))
2722224	9	(ROOT (S (NP (NP (DT The) (NNS Doc_2722224_1686_1716_Disease)) (PP (IN with) (NP (NNS Doc_2722224_1722_1736_Chemical)))) (VP (VBZ is) (VP (VP (VBN associated) (PP (PP (IN with) (NP (DT an) (NNS Doc_2722224_1759_1783_Disease))) (PRN (-LRB- -LRB-) (ADVP (RB presumably)) (ADJP (JJ due) (PP (TO to) (NP (JJ increased) (NN blood) (NN volume)))) (-RRB- -RRB-))) (. .)) (PRN (-LRB- -LRB-) (S (NP (NNP ABSTRACT)) (VP (VBD TRUNCATED) (NP (QP (CD AT) (CD 250)) (NNS WORDS)))) (-RRB- -RRB-))))))
2750819	0	(ROOT (S (VP (VB Doc_2750819_0_22_Disease) (PP (IN with) (NP (NNS Doc_2750819_28_45_Chemical) (CC and) (NNS Doc_2750819_50_60_Chemical)))) (. .)))
2750819	1	(ROOT (S (NP (NP (DT A) (NN patient)) (SBAR (WHNP (WP who)) (S (VP (VBD received) (NP (NNS tocolysis)) (PP (IN with) (NP (JJ Doc_2750819_100_110_Chemical) (JJ developed) (NNS Doc_2750819_121_143_Disease))) (PP (IN after) (NP (NP (CD 500) (NN mg)) (PP (IN of) (NP (NNS Doc_2750819_160_177_Chemical))))))))) (VP (VBD was) (VP (VBN administered))) (. .)))
2750819	2	(ROOT (S (NP (DT This) (NN reaction)) (VP (VBZ demonstrates) (SBAR (IN that) (S (NP (NNS Doc_2750819_228_238_Chemical)) (VP (MD can) (ADVP (RB seriously)) (VP (VB potentiate) (NP (NP (DT the) (NNS Doc_2750819_268_276_Disease)) (PP (IN of) (NP (NNS Doc_2750819_280_289_Chemical))))))))) (. .)))
2750819	3	(ROOT (S (NP (NN Caution)) (VP (MD should) (VP (VB be) (VP (VBN exercised) (SBAR (WHADVP (WRB when)) (S (NP (DT these) (CD two) (NNS tocolytics)) (VP (VBP are) (VP (VBN combined)))))))) (. .)))
2790457	0	(ROOT (S (NP (NNP Chronic) (NNP Doc_2790457_8_21_Chemical)) (VP (VBZ inhibits) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (NP (JJ local) (JJ anesthetic) (NNS Doc_2790457_67_75_Disease)) (VP (VBN kindled) (PP (IN by) (NP (NNS Doc_2790457_87_94_Chemical) (CC and) (NNS Doc_2790457_99_108_Chemical)))))))) (. .)))
2790457	1	(ROOT (S (NP (NP (DT The) (NNS effects)) (PP (IN of) (NP (NP (JJ Doc_2790457_125_138_Chemical) (PRN (-LRB- -LRB-) (NP (NNP Doc_2790457_140_143_Chemical)) (-RRB- -RRB-)) (NN treatment)) (PP (IN on) (NP (NP (JJ local) (JJ anesthetic-kindled) (NNS Doc_2790457_183_191_Disease)) (CC and) (NP (NN lethality))))))) (VP (VBD were) (VP (VBN evaluated) (PP (PP (IN in) (NP (NP (JJ different) (NNS stages)) (PP (IN of) (NP (DT the) (JJ kindling) (NN process))))) (CC and) (PP (IN under) (NP (NP (JJ different) (NNS methods)) (PP (IN of) (NP (JJ Doc_2790457_296_299_Chemical) (NN administration)))))))) (. .)))
2790457	2	(ROOT (S (NP (JJ Chronic) (JJ oral) (NNS Doc_2790457_329_332_Chemical)) (VP (VP (VBD inhibited) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (DT both) (ADJP (JJ Doc_2790457_367_376_Chemical) (: -) (CC and) (JJ Doc_2790457_382_389_Chemical-induced)) (NNS Doc_2790457_398_406_Disease))))) (, ,) (CC but) (VP (VBD had) (NP (NP (JJ little) (NN effect)) (PP (IN on) (NP (DT the) (ADJP (RB fully) (JJ developed)) (JJ local) (JJ anesthetic) (NNS Doc_2790457_470_478_Disease)))))) (. .)))
2790457	3	(ROOT (S (NP (NNP Chronic) (NNP Doc_2790457_488_491_Chemical)) (ADVP (RB also)) (VP (VBD decreased) (NP (NP (DT the) (NN incidence)) (PP (IN of) (NP (NN Doc_2790457_524_531_Disease-related) (NN mortality)))) (PP (IN in) (NP (DT the) (NN Doc_2790457_557_564_Chemical-injected) (NNS rats)))) (. .)))
2790457	4	(ROOT (S (NP (NP (JJ Acute) (NNS Doc_2790457_586_589_Chemical)) (PP (IN over) (NP (NP (DT a) (NN range)) (PP (IN of) (NP (NP (NNS doses)) (PRN (-LRB- -LRB-) (NP (CD 15-50) (NN mg/kg)) (-RRB- -RRB-))))))) (VP (VBD had) (NP (NP (DT no) (NN effect)) (PP (IN on) (NP (NP (VBN completed) (NNS Doc_2790457_653_662_Chemical-kindled)) (CC or) (NP (ADJP (JJ acute) (JJ Doc_2790457_680_687_Chemical-induced)) (NNS Doc_2790457_696_704_Disease)))))) (. .)))
2790457	5	(ROOT (S (NP (NP (JJ Repeated) (NN i.p.) (NN injection)) (PP (IN of) (NP (NP (NNS Doc_2790457_733_736_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 15) (NN mg/kg)) (-RRB- -RRB-))))) (ADVP (RB also)) (VP (VBD was) (PP (IN without) (NP (NP (NN effect)) (PP (IN on) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (JJ Doc_2790457_794_803_Chemical) (: -) (CC or) (NN Doc_2790457_808_815_Chemical-kindled) (NNS Doc_2790457_824_832_Disease)))))))) (. .)))
2790457	6	(ROOT (S (NP (NP (DT The) (NN differential) (NNS effects)) (PP (IN of) (NP (NNS Doc_2790457_862_865_Chemical)))) (PP (VBG depending) (PP (IN upon) (NP (NP (NN stage)) (PP (IN of) (NP (JJ Doc_2790457_890_897_Disease) (NN development)))))) (VP (VBP suggest) (SBAR (IN that) (S (NP (JJ distinct) (NNS mechanisms)) (VP (VB underlie) (NP (NP (DT the) (NN development)) (PP (IN versus) (NP (NP (NN maintenance)) (PP (IN of) (NP (JJ local) (JJ anesthetic-kindled) (NNS Doc_2790457_1015_1023_Disease)))))))))) (. .)))
2790457	7	(ROOT (S (NP (NP (DT The) (NN effectiveness)) (PP (IN of) (NP (NP (NN chronic)) (CONJP (CC but) (RB not)) (NP (NP (JJ repeated) (, ,) (JJ intermittent) (NNS injections)) (PP (IN of) (NP (NNS Doc_2790457_1099_1102_Chemical))))))) (VP (VBZ suggests) (SBAR (IN that) (S (NP (JJ different) (JJ biochemical) (NNS consequences)) (VP (VBP result) (PP (IN from) (NP (DT the) (JJ different) (NN treatment) (NNS regimens))))))) (. .)))
2790457	8	(ROOT (S (NP (NP (DT The) (JJ possible) (NN utility)) (PP (IN of) (NP (NP (JJ chronic) (NNS Doc_2790457_1230_1233_Chemical)) (PP (IN in) (S (VP (VBG preventing) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (JJ toxic) (NN side) (NNS effects)))) (PP (IN in) (NP (JJ human) (JJ Doc_2790457_1295_1302_Chemical) (NNS users))))))))) (VP (VP (VBZ is) (VP (VBN suggested) (PP (IN by) (NP (DT these) (NNS data))))) (, ,) (CC but) (VP (VBZ remains) (S (VP (TO to) (VP (VB be) (VP (ADVP (RB directly)) (VBN evaluated))))))) (. .)))
2819587	0	(ROOT (S (NP (NP (JJ Magnetic) (NN resonance) (NN imaging)) (PP (IN of) (NP (JJ cerebral) (NNS Doc_2819587_39_56_Disease)))) (VP (VBZ secondary) (S (VP (TO to) (VP (`` ``) (VB low-dose) ('' '') (NP (NN birth) (NN control) (NNS pills)))))) (. .)))
2819587	1	(ROOT (S (NP (NP (DT The) (JJ clinical) (CC and) (JJ radiographic) (NNS features)) (PP (IN of) (NP (NP (JJ cerebral) (NNS Doc_2819587_153_175_Disease)) (PP (IN in) (NP (DT a) (JJ 21-year-old) (JJ white) (NN woman)))))) (VP (VBP are) (VP (VBN presented))) (. .)))
2819587	2	(ROOT (S (NP (DT This) (NNS nulliparous) (NN patient)) (VP (VP (VBN presented) (PP (IN with) (NP (ADJP (RB relatively) (JJ mild)) (JJ clinical) (NNS symptoms)))) (CC and) (VP (VBG progressing) (NP (JJ mental) (NN status) (NNS changes)))) (. .)))
2819587	3	(ROOT (S (NP (DT The) (ADJP (RB only) (VBN known)) (NN risk) (NN factor)) (VP (VBD was) (NP (`` ``) (JJ low-dose) ('' '') (JJ Doc_2819587_375_393_Chemical) (NNS pills))) (. .)))
2819587	4	(ROOT (S (NP (NP (DT The) (JJ magnetic) (NN resonance) (NN image)) (PRN (-LRB- -LRB-) (NP (NNP MRI)) (-RRB- -RRB-))) (VP (VBD showed) (NP (NP (NP (VBN increased) (NN signal) (NN intensity)) (PP (IN from) (NP (DT the) (JJ internal) (JJ cerebral) (NNS veins)))) (, ,) (NP (NP (NN vein)) (PP (IN of) (NP (NNP Galen)))) (, ,) (CC and) (NP (JJ straight) (NNS sinus)))) (. .)))
2819587	5	(ROOT (S (NP (DT The) (NN diagnosis)) (VP (VBD was) (VP (VBN confirmed) (PP (IN by) (NP (JJ arterial) (NN angiography))))) (. .)))
2826064	0	(ROOT (S (VP (VB Beta-2-adrenoceptor-mediated) (NP (NP (NNS Doc_2826064_29_40_Disease)) (CC and) (NP (PRP$ its) (NN abolishment))) (PP (IN by) (NP (NNS Doc_2826064_64_74_Chemical)))) (. .)))
2826064	1	(ROOT (S (NP (NP (DT The) (NN time) (NN course) (CC and) (NN concentration-effect) (NN relationship)) (PP (IN of) (NP (NN Doc_2826064_133_144_Chemical-induced) (NNS Doc_2826064_153_164_Disease)))) (VP (VBD was) (VP (VBN studied) (, ,) (S (VP (VBG using) (NP (JJ computer-aided) (JJ pharmacokinetic-dynamic) (NN modeling)))))) (. .)))
2826064	2	(ROOT (S (ADVP (RB Subsequently)) (NP (PRP we)) (VP (VBD investigated) (NP (NP (DT the) (NN efficacy)) (PP (IN of) (NP (NNS Doc_2826064_278_288_Chemical)))) (PP (IN in) (S (VP (VBG antagonizing) (NP (JJ such) (NNS Doc_2826064_310_321_Disease))))) (, ,) (ADVP (RB together)) (PP (IN with) (NP (NP (DT the) (JJ pharmacokinetic) (NN interaction)) (PP (IN between) (NP (DT both) (NNS drugs)))))) (. .)))
2826064	3	(ROOT (S (NP (CD Six) (JJ healthy) (NNS subjects)) (VP (VBD were) (VP (VP (VBN given) (NP (DT a) (CD 0.5) (NN mg) (NNS subcutaneous)) (NP (NP (NN dose)) (PP (IN of) (NP (NP (NNS Doc_2826064_451_462_Chemical)) (PP (IN on) (NP (CD two) (NNS occasions))))))) (: :) (NP (NP (CD 1) (NN hour)) (PP (PP (IN after) (NP (NP (JJ oral) (NN administration)) (PP (IN of) (NP (DT a) (NN placebo))))) (CC and) (PP (NP (CD 1) (NN hour)) (IN after) (NP (CD 80) (NN mg) (NNS Doc_2826064_550_560_Chemical))) (ADVP (RB orally)))))) (. .)))
2826064	4	(ROOT (S (PP (IN In) (NP (NP (DT the) (JJ 7-hour) (NN period)) (PP (IN after) (NP (JJ Doc_2826064_596_607_Chemical) (NN administration))))) (, ,) (NP (NN plasma) (NNS samples)) (VP (VBD were) (VP (VBN taken) (PP (IN for) (NP (NP (NN determination)) (PP (IN of) (NP (NN plasma) (NN Doc_2826064_678_687_Chemical) (NNS levels) (CC and) (NN drug) (NNS concentrations))))))) (. .)))
2826064	5	(ROOT (S (NP (DT The) (JJ sigmoid) (NNP Emax) (NN model)) (VP (VBD offered) (NP (NP (DT a) (JJ good) (NN description)) (PP (IN of) (NP (NP (DT the) (NN relation)) (PP (IN between) (NP (NP (JJ Doc_2826064_794_805_Chemical) (NNS concentrations)) (CC and) (NP (JJ Doc_2826064_825_834_Chemical) (NNS effects)))))))) (. .)))
2826064	6	(ROOT (S (NP (NNP Doc_2826064_844_854_Chemical)) (VP (VBD caused) (NP (NP (NP (NNS decreases)) (PP (IN of) (NP (CD 65) (NN %)))) (CC and) (NP (NP (CD 56) (NN %)) (PP (IN of) (NP (NP (NP (JJ Doc_2826064_890_901_Chemical) (NN volume)) (PP (IN of) (NP (NN distribution) (CC and) (NN clearance)))) (, ,) (ADVP (RB respectively))))) (, ,) (CC and) (NP (NP (DT an) (NN increase)) (PP (IN of) (NP (NP (CD 130) (NN %)) (PP (IN of) (NP (PRP$ its) (NN AUC)))))))) (. .)))
2826064	7	(ROOT (S (PP (IN In) (NP (NP (NN spite)) (PP (IN of) (NP (NP (JJR higher) (JJ Doc_2826064_1009_1020_Chemical) (NNS concentrations)) (PP (IN after) (NP (JJ Doc_2826064_1042_1052_Chemical) (NN pretreatment))))))) (, ,) (NP (DT the) (NNS Doc_2826064_1071_1082_Disease)) (VP (VBD was) (ADVP (RB almost) (RB completely)) (VP (VBN antagonized) (PP (IN by) (NP (DT the) (JJ beta) (JJ 2-blocking) (NN action))))) (. .)))
2840807	0	(ROOT (S (NP (NP (DT A) (NN Doc_2840807_2_10_Disease-like) (NN syndrome)) (PP (IN after) (NP (NP (JJ neuropeptide) (PRN (-LRB- -LRB-) (NP (NNP MSH/ACTH)) (-RRB- -RRB-)) (NN stimulation)) (PP (IN of) (NP (DT the) (NN rat)))))) (VP (VBZ locus) (NP (NNS ceruleus))) (. .)))
2840807	1	(ROOT (S (S (NP (NP (DT The) (NNS Doc_2840807_98_115_Disease)) (VP (VBN investigated) (PP (IN in) (NP (DT these) (NNS studies))))) (VP (VBZ has) (NP (NP (DT some) (NNS features)) (PP (IN in) (NP (NP (JJ common)) (PP (IN with) (NP (JJ human) (JJ idiopathic) (NNS Doc_2840807_196_204_Disease)))))))) (, ,) (CC and) (S (NP (NP (NN information)) (VP (VBN obtained) (PP (IN in) (NP (DT these) (NNS studies))))) (VP (MD may) (VP (VB be) (PP (IN of) (NP (JJ potential) (JJ clinical) (NN benefit)))))) (. .)))
2840807	2	(ROOT (S (NP (DT The) (JJ present) (JJ experimental) (NNS results)) (VP (VBD indicated) (SBAR (IN that) (S (NP (NP (JJ peptidergic) (NN stimulation)) (PP (IN of) (NP (DT the) (NNP LC)))) (VP (VBD resulted) (PP (IN in) (NP (NP (DT a) (JJ NE-mediated) (NN inhibition)) (PP (IN of) (NP (NP (NN cerebellar) (NN Purkinje) (NNS cells)) (VP (VBN located) (PP (IN at) (NP (NP (NNS terminals)) (PP (IN of) (NP (DT the) (JJ ceruleo-cerebellar) (NN pathway)))))))))))))) (. .)))
2840807	3	(ROOT (S (S (ADVP (RB However)) (, ,) (NP (PRP it)) (VP (VBZ is) (RB not) (ADJP (JJ certain) (PP (IN as) (PP (TO to) (NP (DT the) (NN following))))))) (: :) (S (LST (-LRB- -LRB-) (DT a) (-RRB- -RRB-)) (SBAR (WHNP (WP what)) (S (S (NP (NNS receptors)) (VP (VBD were) (VP (VBN stimulated) (PP (IN by) (NP (DT the) (NNP ACTH) (NNP N-terminal) (NNS fragments))) (PP (IN at) (NP (NP (DT the) (NNP LC)) (SBAR (WHNP (WDT that)) (S (VP (VBD resulted) (PP (IN in) (NP (DT this) (NN disorder))))))))))) (: ;) (S (LST (-LRB- -LRB-) (NN b) (-RRB- -RRB-)) (SBAR (IN whether) (S (VP (VBP NE)))) (, ,) (S (VP (VBN released) (PP (IN onto) (NP (NP (JJ Purkinje) (NN cell) (NNS synapses)) (VP (VBN located) (PP (IN at) (NP (NP (NNS terminals)) (PP (IN of) (NP (DT the) (JJ ceruleo-cerebellar) (NN pathway)))))))))) (, ,) (VP (VBD did) (RB indeed) (VP (VB cause) (NP (DT the) (JJ long-term) (NNS Doc_2840807_788_798_Disease)) (PP (IN at) (NP (NP (JJ Purkinje) (NN cell) (NNS synapses)) (PRN (-LRB- -LRB-) (VP (ADVP (RB previously)) (VBN described) (PP (IN by) (NP (NNS others)))) (-RRB- -RRB-)) (SBAR (WHNP (WDT that)) (S (VP (VBD resulted) (PP (IN in) (NP (NP (DT the) (JJ long) (NN duration)) (PP (IN of) (NP (DT the) (NNS Doc_2840807_900_917_Disease))))))))))))) (: ;) (S (LST (-LRB- -LRB-) (NN c) (-RRB- -RRB-)) (SBAR (IN whether) (S (NP (NP (DT the) (NN inhibition)) (PP (IN of) (NP (JJ inhibitory) (NNP Purkinje) (NNS cells)))) (VP (VBD resulted) (PP (IN in) (NP (NP (NN disinhibition)) (CC or) (NP (NP (VBN increased) (NN excitability)) (PP (IN of) (NP (DT the) (JJ unilateral) (NN cerebellar) (NN fastigial) (CC or) (NNS interpositus) (NN nuclei))))))))) (, ,) (NP (NP (DT the) (NN output) (NNS targets)) (PP (IN of) (NP (DT the) (NNP Purkinje) (NN cell)))) (VP (VBZ axons))))) (, ,) (NP (DT that)) (VP (MD may) (VP (VB have) (VP (VBN been) (NP (NP (DT an) (JJ important) (JJ contributing) (NN factor)) (PP (TO to) (NP (DT this) (NN disorder)))))))) (. .)))
2840807	4	(ROOT (S (NP (DT These) (NNS questions)) (VP (VBP are) (ADVP (RB currently)) (VP (VBG being) (VP (VBN investigated)))) (. .)))
2886572	0	(ROOT (S (NP (NP (JJ Enhanced) (JJ stimulus-induced) (NN neurotransmitter) (NN overflow)) (PP (IN in) (NP (JJ Doc_2886572_55_66_Chemical-induced) (JJ Doc_2886572_75_87_Disease) (NNS rats)))) (VP (VBZ is) (RB not) (VP (VBN mediated) (PP (IN by) (NP (JJ prejunctional) (JJ beta-adrenoceptor) (NN activation))))) (. .)))
2886572	1	(ROOT (S (NP (DT The) (JJ present) (NN study)) (VP (VBZ examines) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (JJ 6-day) (JJ Doc_2886572_203_214_Chemical) (NN treatment))) (PRN (-LRB- -LRB-) (NP (NP (CD 100) (NN micrograms/kg)) (PP (IN per) (NP (NP (NN h)) (, ,) (NP (NN s.c.))))) (-RRB- -RRB-))) (PP (IN on) (NP (JJ stimulus-induced) (PRN (-LRB- -LRB-) (NP (CD 1) (NNS Hz)) (-RRB- -RRB-)) (NNS endogenous))) (NP (NP (NN neurotransmitter) (NN overflow)) (PP (IN from) (NP (NP (DT the) (VBN isolated) (JJ perfused) (NN kidney)) (PP (IN of) (NP (ADJP (NN vehicle) (: -) (CC and) (JJ Doc_2886572_371_382_Chemical-treated)) (NNS rats))))))) (. .)))
2886572	2	(ROOT (S (NP (NP (JJ Renal) (JJ Doc_2886572_403_416_Chemical) (NNS stores)) (CC and) (NP (NP (JJ stimulus-induced) (NN overflow)) (PP (IN in) (NP (DT the) (JJ vehicle-treated) (NN group))))) (VP (VBD consisted) (PP (IN of) (NP (NNS Doc_2886572_496_510_Chemical))) (ADVP (RB only))) (. .)))
2886572	3	(ROOT (S (ADVP (RB However)) (, ,) (NP (JJ Doc_2886572_526_537_Chemical) (NN treatment)) (VP (VBD resulted) (PP (IN in) (NP (NP (DT the) (NN incorporation)) (PP (IN of) (NP (NNS Doc_2886572_581_592_Chemical))))) (PP (IN into) (NP (JJ renal) (JJ Doc_2886572_604_617_Chemical) (NNS stores))) (PP (JJ such)) (SBAR (IN that) (S (NP (NP (QP (RB approximately) (CD 40)) (NN %)) (PP (IN of) (NP (DT the) (JJ Doc_2886572_660_673_Chemical) (NN present)))) (VP (VBD was) (NP (NNS Doc_2886572_686_697_Chemical)) (SBAR (IN while) (S (NP (DT the) (JJ Doc_2886572_708_722_Chemical) (NN content)) (VP (VBD was) (VP (VBN reduced) (PP (IN by) (NP (DT a) (JJ similar) (NN degree))))))))))) (. .)))
2886572	4	(ROOT (S (NP (NP (JJ Total) (NN tissue) (NNS Doc_2886572_777_790_Chemical) (NN content)) (PP (IN of) (NP (NP (DT the) (NN kidney)) (PP (IN on) (NP (DT a) (NN molar) (NN basis)))))) (VP (VBD was) (ADJP (JJ unchanged))) (. .)))
2886572	5	(ROOT (S (NP (NP (JJ Stimulus-induced) (JJ fractional) (NN overflow)) (PP (IN of) (NP (NP (NN neurotransmitter)) (PP (IN from) (NP (DT the) (NN Doc_2886572_911_922_Chemical-treated) (NNS kidneys)))))) (VP (VBD was) (UCP (ADJP (RB approximately) (RB twice) (JJ normal)) (CC and) (VP (VBN consisted) (PP (IN of) (NP (NP (DT both) (NNS Doc_2886572_992_1006_Chemical) (CC and) (NNS Doc_2886572_1011_1022_Chemical)) (PP (IN in) (NP (NP (NNS proportions)) (ADJP (JJ similar) (PP (TO to) (NP (NP (DT those)) (VP (VBN found) (PP (IN in) (NP (DT the) (NN kidney)))))))))))))) (. .)))
2886572	6	(ROOT (S (NP (NP (DT This) (NN difference)) (PP (IN in) (NP (NP (JJ fractional) (NN overflow)) (PP (IN between) (NP (NNS groups)))))) (VP (VBD was) (RB not) (VP (VBN affected) (PP (IN by) (NP (ADJP (JJ neuronal) (CC and) (JJ extraneuronal)) (NN uptake) (NN blockade))))) (. .)))
2886572	7	(ROOT (S (NP (NNP Doc_2886572_1194_1205_Chemical)) (VP (VBD had) (NP (NP (DT no) (NN effect)) (PP (IN on) (NP (JJ stimulus-induced) (NN overflow)))) (PP (IN in) (NP (DT either) (NN group)))) (. .)))
2886572	8	(ROOT (S (NP (NNP Doc_2886572_1266_1278_Chemical)) (VP (VBD increased) (NP (JJ stimulus-induced) (NN overflow)) (PP (IN in) (NP (DT both) (NNS groups))) (SBAR (IN although) (S (NP (NP (DT the) (NN increment)) (PP (IN in) (NP (NN overflow)))) (VP (VBD was) (ADJP (JJR greater)) (PP (IN in) (NP (DT the) (NN Doc_2886572_1384_1395_Chemical-treated) (NN group))))))) (. .)))
2886572	9	(ROOT (S (PP (IN In) (NP (NN conclusion))) (, ,) (NP (JJ chronic) (JJ Doc_2886572_1434_1445_Chemical) (NN treatment)) (VP (VBZ results) (PP (IN in) (NP (VBN enhanced) (JJ fractional) (NN neurotransmitter) (NN overflow)))) (. .)))
2886572	10	(ROOT (S (ADVP (RB However)) (, ,) (NP (NP (DT neither) (NNS alterations)) (PP (IN in) (NP (NP (JJ prejunctional) (JJ beta-adrenoceptor) (NNS influences)) (CC nor) (NP (NP (NNS alterations)) (PP (IN in) (NP (ADJP (JJ neuronal) (CC and) (JJ extraneuronal)) (NN uptake) (NNS mechanisms))))))) (VP (VBP appear) (S (VP (TO to) (VP (VB be) (ADJP (JJ responsible) (PP (IN for) (NP (DT this) (NN alteration)))))))) (. .)))
2886572	11	(ROOT (S (ADVP (RB Furthermore)) (, ,) (NP (NP (NNS data)) (VP (VBN obtained) (PP (IN with) (NP (NNS Doc_2886572_1731_1743_Chemical))))) (ADVP (RB alone)) (VP (VBP do) (RB not) (VP (VB suggest) (NP (JJ alpha-adrenoceptor) (NN desensitization)) (PP (IN as) (NP (NP (DT the) (NN cause)) (PP (IN of) (NP (DT the) (JJ enhanced) (NN neurotransmitter) (NN overflow))))) (PP (IN after) (NP (JJ Doc_2886572_1861_1872_Chemical) (NN treatment))))) (. .)))
2893236	0	(ROOT (S (NP (NP (JJ Doc_2893236_0_4_Chemical) (NN involvement)) (PP (IN in) (NP (NP (JJ Doc_2893236_20_28_Chemical) (JJ induced) (NN reversal)) (PP (IN of) (NP (NNS Doc_2893236_49_70_Disease)))))) (VP (VBD produced) (PP (IN by) (NP (NNS Doc_2893236_83_93_Chemical)))) (. .)))
2893236	1	(ROOT (S (NP (DT No) (NN agent)) (VP (VBZ is) (ADVP (RB yet)) (ADJP (JJ available) (S (VP (TO to) (VP (VB reverse) (NP (NP (NNS Doc_2893236_132_153_Disease)) (VP (VBN produced) (PP (IN by) (NP (NNP CNS) (NNS depressants)))) (, ,) (PP (JJ such) (IN as) (NP (JJ general) (NNS anesthetics))))))))) (. .)))
2893236	2	(ROOT (S (PP (IN In) (NP (DT this) (NN study))) (NP (NNS Doc_2893236_226_234_Chemical)) (VP (VBD reversed) (SBAR (S (NP (NP (NNS Doc_2893236_244_265_Disease)) (VP (VBN induced) (PP (IN by) (NP (NP (NP (NNS Doc_2893236_277_287_Chemical)) (PP (IN in) (NP (NNS rats))) (. .) (NP (CD 25) (NN mg/kg)) (, ,)) (SBAR (S (NP (NN i.v.) (NNS Doc_2893236_312_322_Chemical)) (VP (VP (VBD produced) (NP (NN anesthesia)) (PP (IN without) (S (VP (VBG altering) (NP (JJ respiratory) (NN rate)))))) (, ,) (VP (VBD increased) (NP (NNS Doc_2893236_388_392_Chemical))) (, ,) (VP (VBD decreased) (NP (NNS Doc_2893236_404_413_Chemical))) (, ,) (CC and) (VP (VBD had) (NP (NP (DT no) (NN effect)) (PP (IN on) (NP (JJ Doc_2893236_436_445_Chemical) (CC or) (JJ Doc_2893236_449_456_Chemical) (NNS levels)))))))))) (PP (VBN compared) (PP (TO to) (NP (NP (NNS controls)) (PP (IN in) (NP (NN rat) (NN cortex) (CC and) (NN brain)))))))) (VP (VBP stem))))) (. .)))
2893236	3	(ROOT (S (S (NP (NP (NNP Pretreatment)) (PP (IN of) (NP (NP (NNS rats)) (PP (IN with) (NP (NP (NNS Doc_2893236_541_558_Chemical)) (PP (IN for) (NP (CD 30) (NNS minutes)))))))) (VP (VBD abolished) (NP (NP (DT the) (JJ anesthetic) (NN action)) (CONJP (RB as) (RB well) (IN as)) (NP (NP (DT the) (JJ respiratory) (NN depressant) (NN action)) (PP (IN of) (NP (NP (NNP Doc_2893236_654_664_Chemical) (. .)) (ADJP (CD 50) (JJ mg/kg)))))))) (, ,) (S (NP (NN i.v.) (NNS Doc_2893236_681_691_Chemical)) (VP (VBD produced) (NP (NNS Doc_2893236_701_719_Disease)) (PP (IN with) (NP (JJ further) (NN increase))) (PP (IN in) (NP (NNS Doc_2893236_745_749_Chemical))))) (CC and) (S (NP (NP (NN decrease)) (PP (IN in) (NP (NP (NNS Doc_2893236_766_775_Chemical)) (PP (ADVP (RB again)) (IN in) (NP (NN cortex) (CC and) (NN brain)))))) (VP (VBP stem) (PP (IN without) (S (VP (VBG affecting) (NP (NP (DT any)) (PP (IN of) (NP (NP (DT the) (NNS Doc_2893236_836_847_Chemical)) (VP (VBN studied) (PP (IN in) (NP (NP (CD four) (NNS regions)) (PP (IN of) (NP (NN rat) (NN brain)))))))))))))) (. .)))
2893236	4	(ROOT (S (NP (NP (NNP Doc_2893236_886_894_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 2.5) (NN mg/kg)) (, ,) (NP (NNP i.v.)) (-RRB- -RRB-))) (VP (VBD reversed) (NP (NNS Doc_2893236_922_943_Disease) (, ,) (JJ Doc_2893236_945_954_Chemical) (CC and) (JJ Doc_2893236_959_963_Chemical) (NNS levels)) (PP (TO to) (NP (NP (NN control) (NNS values)) (PP (IN in) (NP (NN brain) (NN stem) (CC and) (NN cortex))))) (PP (IN with) (NP (NP (DT no) (NNS changes)) (PP (IN in) (NP (NN caudate) (CC or) (NN cerebellum)))))) (. .)))
2893236	5	(ROOT (S (NP (DT These) (NNS data)) (VP (VBP suggest) (SBAR (S (NP (NNS Doc_2893236_1075_1083_Chemical)) (VP (VBZ reverses) (SBAR (S (NP (NNS Doc_2893236_1093_1114_Disease)) (VP (VP (VBD produced) (PP (IN by) (NP (NNS Doc_2893236_1127_1137_Chemical)))) (CC and) (VP (VBZ involves) (NP (NNS Doc_2893236_1151_1155_Chemical)) (PP (IN in) (NP (PRP$ its) (NN action))))))))))) (. .)))
2894433	0	(ROOT (S (NP (NNP Doc_2894433_0_8_Chemical)) (VP (VBZ facilitates) (NP (NP (JJ reflex) (NNS Doc_2894433_28_39_Disease)) (PP (IN in) (NP (JJ conscious) (NNS rats))))) (. .)))
2894433	1	(ROOT (S (NP (NP (DT The) (NNS effects)) (PP (IN of) (NP (NP (NNS Doc_2894433_74_82_Chemical)) (PP (IN on) (NP (JJ cardiovascular) (NN function)))))) (VP (VBD were) (VP (VBN assessed) (PP (IN in) (NP (JJ conscious) (NNS rats))))) (. .)))
2894433	2	(ROOT (S (NP (NP (JJ Intravenous) (NN administration)) (PP (IN of) (NP (NP (NNS Doc_2894433_173_181_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 1-30) (NN mg) (NN kg-1)) (-RRB- -RRB-))))) (VP (VBD produced) (NP (DT a) (JJ dose-dependent) (NN decrease)) (PP (IN in) (NP (PDT both) (NP (DT the) (JJ mean) (JJ arterial) (NN pressure)) (CC and) (NP (DT the) (NN heart) (NN rate))))) (. .)))
2894433	3	(ROOT (S (ADVP (RB Also)) (, ,) (NP (JJ reflex) (NNS Doc_2894433_300_311_Disease)) (VP (VBD was) (VP (VBN produced) (PP (IN in) (NP (NNS rats))) (PP (IN by) (NP (NP (JJ intravenous) (NN infusion)) (PP (IN of) (NP (NP (NNS Doc_2894433_360_370_Chemical)) (PRN (-LRB- -LRB-) (ADJP (NP (QP (CD 1.25-2) (CD .5)) (NNS micrograms)) (JJ kg-1)) (-RRB- -RRB-)))))))) (. .)))
2894433	4	(ROOT (S (NP (NP (JJ Intravenous) (NN pretreatment)) (PP (IN of) (NP (NP (DT the) (NNS rats)) (PP (IN with) (NP (NNS Doc_2894433_441_449_Chemical))))) (, ,) (SBAR (IN although) (S (VP (VBG causing) (NP (DT no) (NN change)) (PP (IN in) (NP (DT the) (NN Doc_2894433_485_495_Chemical-induced) (NN pressor) (NN effect)))))) (, ,)) (VP (VBD did) (VP (VB enhance) (NP (DT the) (JJ Doc_2894433_536_546_Chemical-induced) (JJ reflex) (NNS Doc_2894433_562_573_Disease)))) (. .)))
2894433	5	(ROOT (S (ADVP (RB However)) (, ,) (NP (NP (DT the) (JJ Doc_2894433_588_596_Chemical) (NN enhancement)) (PP (IN of) (NP (JJ Doc_2894433_612_622_Chemical-induced) (JJ reflex) (NNS Doc_2894433_638_649_Disease)))) (VP (VBD was) (VP (VBN antagonized) (PP (IN by) (NP (NP (NN pretreatment)) (PP (IN of) (NP (NNS rats))))) (PP (IN with) (NP (NP (DT an) (JJ intravenous) (NN dose)) (PP (IN of) (NP (NP (NNS Doc_2894433_718_728_Chemical)) (PRN (-LRB- -LRB-) (S (NP (DT an) (NN agent)) (VP (VBZ blocks) (NP (JJ Doc_2894433_746_754_Chemical) (NNS channels)) (PP (IN by) (NP (ADJP (JJ binding) (PP (TO to) (NP (NP (NNS sites)) (VP (VBN associated) (PP (IN with) (NP (DT the) (NN Doc_2894433_804_818_Chemical-Doc_2894433_819_823_Chemical-Doc_2894433_824_832_Chemical) (NN channel) (NN macromolecular))))))) (NN complex))))) (-RRB- -RRB-)))))))) (. .)))
2894433	6	(ROOT (S (NP (DT The) (NNS data)) (VP (VBP indicate) (SBAR (IN that) (S (NP (NNS Doc_2894433_889_897_Chemical)) (VP (VBZ acts) (PP (IN through) (NP (NP (DT the) (NN Doc_2894433_915_929_Chemical-Doc_2894433_930_934_Chemical-Doc_2894433_935_943_Chemical) (NN channel) (NN macromolecular) (NN complex)) (PP (IN within) (NP (DT the) (JJ central) (JJ nervous) (NN system))))) (S (VP (TO to) (VP (VB facilitate) (NP (NP (JJ reflex) (NNS Doc_2894433_1030_1041_Disease)) (VP (VBN mediated) (PP (IN through) (NP (NP (NN baroreceptor) (NNS reflexes)) (PP (IN in) (NP (NN response))))) (PP (TO to) (NP (NP (DT an) (JJ acute) (NN increase)) (PP (IN in) (NP (JJ arterial) (NN pressure)))))))))))))) (. .)))
28952	0	(ROOT (NP (NP (NP (JJ Initial) (JJ Doc_28952_8_17_Chemical) (NN loss)) (CC and) (NP (NP (NN hypokalaemia)) (PP (IN during) (NP (NP (JJ Doc_28952_47_61_Chemical) (NN administration)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ essential) (NNS Doc_28952_104_116_Disease))))))))) (: :) (NP (NP (DT the) (NN influence)) (PP (IN of) (NP (JJ dietary) (JJ Doc_28952_143_149_Chemical) (NN restriction)))) (. .)))
28952	1	(ROOT (S (S (VP (TO To) (VP (VB investigate) (NP (NP (DT the) (JJ initial) (NNS Doc_28952_190_199_Chemical) (NN loss) (CC and) (NN development)) (PP (IN of) (NP (NN hypokalaemia)))) (PP (IN during) (NP (NP (DT the) (NN administration)) (PP (IN of) (NP (DT an) (JJ oral) (NN diuretic)))))))) (, ,) (NP (JJ metabolic) (NN balance) (NNS studies)) (VP (VBD were) (VP (VBN performed) (PP (IN in) (NP (CD ten) (NNS patients))) (PP (IN with) (NP (NP (JJ essential) (NNS Doc_28952_356_368_Disease)) (SBAR (WHNP (WP who)) (S (VP (VBD had) (VP (VBN shown) (NP (NN hypokalaemia)) (PP (IN under) (NP (JJ prior) (JJ oral) (JJ diuretic) (NN treatment))))))))))) (. .)))
28952	2	(ROOT (S (NP (NP (NNP Doc_28952_433_447_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 50) (NN mg) (NN daily)) (-RRB- -RRB-))) (VP (VBD was) (VP (VBN given) (PP (IN for) (NP (CD 14) (NNS days))))) (. .)))
28952	3	(ROOT (S (NP (CD Six) (NNS patients)) (VP (VBD received) (NP (NP (DT a) (JJ normal-Doc_28952_516_522_Chemical) (NN diet)) (CC and) (NP (NP (CD four)) (NP (DT a) (ADJP (JJ low-Doc_28952_543_549_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 17) (NN mmol/day)) (-RRB- -RRB-)) (NN diet))))) (. .)))
28952	4	(ROOT (S (NP (DT All) (NNS patients)) (VP (VBD had) (NP (NP (DT a) (JJ normal) (JJ initial) (JJ total) (NN body) (NNS Doc_28952_615_624_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 40K)) (-RRB- -RRB-)))) (. .)))
28952	5	(ROOT (S (NP (NP (DT The) (JJ electrolyte) (NNS balances)) (, ,) (NP (NN weight)) (, ,) (NP (JJ bromide) (NN space)) (, ,) (NP (NN plasma) (NN renin) (NN activity)) (, ,) (CC and) (NP (JJ Doc_28952_708_719_Chemical) (NN secretion) (NN rate))) (VP (VBD were) (VP (VBN measured))) (. .)))
28952	6	(ROOT (S (PP (IN In) (NP (DT both) (NNS groups))) (NP (DT a) (JJ Doc_28952_767_776_Chemical) (NN deficit)) (VP (VBD developed) (, ,) (PP (IN with) (NP (ADJP (RB proportionally) (JJR larger)) (NNS losses))) (PP (IN from) (NP (DT the) (NN extracellular))) (PP (IN than) (PP (IN from) (NP (DT the) (NN intracellular) (NN compartment))))) (. .)))
28952	7	(ROOT (S (S (PP (IN In) (NP (DT the) (JJ normal-Doc_28952_908_914_Chemical) (NN group))) (NP (DT the) (JJS highest)) (VP (VBP mean) (SBAR (S (NP (JJ Doc_28952_938_947_Chemical) (NN deficit)) (VP (VBD was) (NP (NP (CD 176) (NN mmol)) (PP (IN on) (NP (NP (NN day) (CD 9)) (, ,) (SBAR (WHPP (IN after) (WHNP (WDT which))) (S (NP (DT some) (NNS Doc_28952_996_1005_Chemical)) (VP (VBD was) (VP (VBN regained))))))))))))) (: ;) (S (PP (IN in) (NP (DT the) (JJ low-Doc_28952_1031_1037_Chemical) (NN group))) (NP (DT the) (JJS highest) (NN deficit)) (VP (VBD was) (NP (NP (CD 276) (NN mmol)) (PP (IN on) (NP (NN day) (CD 13)))))) (. .)))
28952	8	(ROOT (S (S (NP (DT The) (JJ normal-Doc_28952_1099_1105_Chemical) (NN group)) (VP (VBD showed) (NP (NP (DT an) (ADJP (JJ immediate) (CC but) (JJ temporary)) (NN rise)) (PP (IN of) (NP (NP (DT the) (NN renin)) (CC and) (NP (JJ Doc_28952_1168_1179_Chemical) (NNS levels))))))) (: ;) (S (PP (IN in) (NP (DT the) (JJ low-Doc_28952_1199_1205_Chemical) (NN group))) (NP (NNS renin) (CC and) (NNS Doc_28952_1222_1233_Chemical)) (VP (VP (VBD increased) (ADVP (RBR more) (RB slowly))) (CC but) (VP (VBD remained) (NP (JJ elevated))))) (. .)))
28952	9	(ROOT (S (NP (PRP It)) (VP (VBZ is) (VP (VBN concluded) (SBAR (IN that) (S (NP (JJ dietary) (JJ Doc_28952_1308_1314_Chemical) (NN restriction) (NNS increases)) (VP (VBD diuretic-induced) (NP (JJ Doc_28952_1354_1363_Chemical) (NN loss)) (, ,) (PP (ADVP (RB presumably)) (IN by) (NP (NP (DT an) (JJ increased) (NN activity)) (PP (IN of) (NP (DT the) (JJ renin-angiotensin-Doc_28952_1431_1442_Chemical) (NN system))))) (, ,) (SBAR (IN while) (S (NP (NP (JJ Doc_28952_1457_1463_Chemical) (NN delivery)) (PP (TO to) (NP (DT the) (JJ distal) (JJ renal) (NNS tubules)))) (VP (VBZ remains) (ADJP (RB sufficiently) (JJ high) (S (VP (TO to) (VP (VB allow) (NP (JJ increased) (JJ Doc_28952_1546_1555_Chemical) (NN secretion)))))))))))))) (. .)))
2907585	0	(ROOT (NP (NP (NNP Reversal)) (PP (IN of) (NP (JJ neuroleptic-induced) (NNS Doc_2907585_32_41_Disease))) (PP (IN by) (NP (JJ novel) (JJ Doc_2907585_51_66_Chemical) (JJ anxiolytic) (NNS drugs))) (. .)))
2907585	1	(ROOT (S (NP (NP (DT The) (JJ novel) (JJ anxiolytic) (NN drug)) (, ,) (NP (NNS Doc_2907585_112_121_Chemical)) (, ,)) (VP (VBZ reverses) (NP (NP (NNS Doc_2907585_132_141_Disease)) (VP (VBN induced) (PP (IN by) (NP (NNS Doc_2907585_153_164_Chemical)))))) (. .)))
2907585	2	(ROOT (S (NP (NP (DT A) (NN series)) (PP (IN of) (NP (NP (JJ Doc_2907585_178_193_Chemical) (NNS analogues)) (PP (IN of) (NP (JJ Doc_2907585_207_216_Chemical) (CC and) (JJ other) (NNS Doc_2907585_227_259_Chemical)))))) (VP (VBD were) (VP (VBN tested) (PP (IN for) (NP (PRP$ their) (NN ability) (S (VP (TO to) (VP (VB reverse) (NP (JJ Doc_2907585_301_312_Chemical) (JJ induced) (NNS Doc_2907585_321_330_Disease))))))))) (. .)))
2907585	3	(ROOT (S (NP (NP (DT Those) (NNS drugs)) (PP (IN with) (NP (NP (JJ strong) (NN affinity)) (PP (IN for) (NP (JJ Doc_2907585_369_388_Chemical1a) (NNS receptors)))))) (VP (VBD were) (ADJP (JJ able) (S (VP (TO to) (VP (VB reverse) (NP (NNS Doc_2907585_422_431_Disease))))))) (. .)))
2907585	4	(ROOT (S (NP (NP (NNS Drugs)) (PP (IN with) (NP (NP (NN affinity)) (PP (IN for) (NP (NP (JJ other) (JJ Doc_2907585_463_467_Chemical) (NNS receptors)) (CC or) (NP (JJ weak) (NN affinity))))))) (VP (VBD were) (ADJP (JJ ineffective))) (. .)))
2907585	5	(ROOT (S (ADVP (RB However)) (, ,) (NP (NP (NN inhibition)) (PP (IN of) (NP (JJ postsynaptic) (NNS Doc_2907585_549_553_Chemical)))) (VP (VP (VBZ receptors) (NP (NP (ADJP (CC neither) (JJ inhibited) (CC nor) (JJ potentiated)) (NN reversal)) (PP (IN of) (NP (NNS Doc_2907585_610_619_Disease))))) (CC and) (VP (VBZ leaves) (ADJP (JJ open) (PP (ADVP (NP (DT the) (NN question)) (RB as)) (TO to) (NP (NP (DT the) (NN site) (CC or) (NN mechanism)) (PP (IN for) (NP (DT this) (NN effect)))))))) (. .)))
2917114	0	(ROOT (NP (NP (JJ Doc_2917114_0_14_Chemical) (NNS requirements)) (PP (IN for) (NP (NN antagonism))) (PP (IN of) (NP (DT the) (JJ muscarinic) (NN side) (NNS effects))) (PP (IN of) (NP (NNS Doc_2917114_77_88_Chemical))) (. .)))
2917114	1	(ROOT (S (NP (PRP We)) (VP (VBP have) (VP (VBN compared) (, ,) (PP (IN in) (NP (CD 60) (JJ adult) (NNS patients))) (, ,) (NP (NP (DT the) (JJ cardiovascular) (NNS effects)) (PP (IN of) (NP (NNS Doc_2917114_160_174_Chemical))) (ADJP (ADJP (NP (CD 5) (NNS micrograms)) (JJ kg-1)) (CC and) (ADJP (NP (CD 10) (NNS micrograms)) (JJ kg-1))) (VP (VBN given) (S (UCP (DT either) (ADVP (RB simultaneously)) (CC or) (NP (CD 1) (NN min)))) (PP (IN before) (NP (NP (NNS Doc_2917114_260_271_Chemical)) (ADJP (NP (CD 1) (NNS mg)) (JJ kg-1)))))))) (. .)))
2917114	2	(ROOT (S (NP (NP (JJ Significant) (NNS differences)) (PP (IN between) (NP (DT the) (CD four) (NNS groups)))) (VP (VBD were) (VP (VBN detected) (PRN (-LRB- -LRB-) (NP (NNP P) (QP (JJR less) (IN than) (CD 0.001))) (-RRB- -RRB-)))) (. .)))
2917114	3	(ROOT (S (NP (NP (DT Both) (NNS groups)) (VP (VBG receiving) (ADJP (NP (CD 10) (NNS micrograms)) (JJ kg-1)))) (VP (VBD showed) (NP (NNS increases)) (PP (IN in) (NP (NP (NN heart) (NN rate)) (PP (IN of) (NP (NP (QP (IN up) (TO to) (CD 30)) (NN beat) (NN min-1)) (PRN (-LRB- -LRB-) (S (NP (NP (ADJP (CD 95) (NN %)) (NN confidence) (NNS limits)) (ADJP (NP (CD 28-32)) (JJ beat))) (ADJP (JJ min-1))) (-RRB- -RRB-))))))) (. .)))
2917114	4	(ROOT (S (NP (NP (NN Use)) (PP (IN of) (NP (NP (NNS Doc_2917114_510_524_Chemical)) (ADJP (NP (CD 5) (NNS micrograms)) (JJ kg-1))))) (VP (VP (VBD provided) (NP (JJR greater) (JJ cardiovascular) (NN stability))) (CC and) (PRN (, ,) (PP (VBN given) (NP (NP (CD 1) (NN min)) (PP (IN before) (NP (DT the) (NNS Doc_2917114_613_624_Chemical))))) (, ,)) (VP (VBD was) (ADJP (JJ sufficient) (S (VP (TO to) (VP (VB minimize) (NP (JJ early) (, ,) (NN Doc_2917114_660_671_Chemical-induced) (NNS Doc_2917114_680_692_Disease)))))))) (. .)))
2917114	5	(ROOT (S (NP (NP (DT This) (JJ low) (NN dose)) (PP (IN of) (NP (NNS Doc_2917114_711_725_Chemical)))) (VP (VBD provided) (NP (NP (JJ good) (NN control)) (PP (IN of) (NP (JJ oropharyngeal) (NNS secretions))))) (. .)))
2980315	0	(ROOT (S (VP (VB Selective) (NP (NP (NN injection)) (PP (IN of) (NP (NNS Doc_2980315_23_31_Chemical) (, ,) (NNS Doc_2980315_33_40_Chemical) (CC and) (NNS Doc_2980315_45_55_Chemical)))) (PP (IN into) (NP (NP (DT the) (JJ left) (JJ coronary) (NN artery)) (PP (IN of) (NP (DT the) (NN dog)))))) (. .)))
2980315	1	(ROOT (NP (NP (NNP Induction)) (PP (IN of) (NP (NNS Doc_2980315_111_135_Disease) (CC and) (NN decrease))) (PP (IN of) (NP (JJ aortic) (NN pressure))) (. .)))
2980315	2	(ROOT (S (PP (IN In) (NP (CD twenty) (JJ beagle) (NNS dogs))) (NP (JJ selective) (NNS injections)) (VP (VBD were) (VP (VBN made) (PP (IN into) (NP (NP (DT the) (JJ left) (JJ coronary) (NN artery)) (PP (IN with) (NP (NNS Doc_2980315_257_265_Chemical) (, ,) (NNS Doc_2980315_267_274_Chemical) (CC and) (NNS Doc_2980315_279_289_Chemical))))) (PP (IN in) (NP (NP (NNS doses)) (PP (IN of) (NP (NP (CD 4) (NN ml)) (, ,) (NP (CD 8) (NN ml)) (CC and) (NP (CD 16) (NN ml)))))))) (. .)))
2980315	3	(ROOT (S (NP (NP (JJ Thirty-six) (JJ Doc_2980315_335_343_Chemical) (NNS injections)) (, ,) (NP (CD 35) (JJ Doc_2980315_359_366_Chemical) (NNS injections)) (CC and) (NP (CD 37) (JJ Doc_2980315_385_395_Chemical) (NNS injections))) (VP (VBD were) (VP (VBN made))) (. .)))
2980315	4	(ROOT (S (NP (NP (NNS Frequencies)) (PP (IN of) (NP (NNS Doc_2980315_433_457_Disease)))) (VP (VBD were) (ADJP (ADJP (ADJP (RB significantly) (JJR lower)) (PRN (-LRB- -LRB-) (NP (NNP p) (QP (JJR less) (IN than) (CD 0.05))) (-RRB- -RRB-))) (PP (IN after) (NP (NP (NNS Doc_2980315_508_516_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 0) (NN %)) (-RRB- -RRB-)) (CC and) (NP (NNS Doc_2980315_526_533_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 3) (NN %)) (-RRB- -RRB-))))) (PP (IN than) (PP (IN after) (NP (NP (NNS Doc_2980315_550_560_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 22) (NN %)) (-RRB- -RRB-)))))) (. .)))
2980315	5	(ROOT (S (NP (NNS Doc_2980315_568_576_Chemical) (CC and) (NNS Doc_2980315_581_588_Chemical)) (ADVP (RB also)) (VP (VBD produced) (NP (ADJP (RB significantly) (JJR less)) (NN decrease)) (PP (IN in) (NP (JJ aortic) (NN blood) (NN pressure))) (PP (IN than) (NP (NP (NNS Doc_2980315_661_671_Chemical)) (PP (IN at) (NP (DT the) (JJ different) (NNS doses)))))) (. .)))
3001299	0	(ROOT (S (VP (VB Thyroid) (NP (NN function) (CC and) (NN urine-concentrating) (NN ability)) (PP (IN during) (NP (JJ Doc_3001299_56_63_Chemical) (NN treatment)))) (. .)))
3001299	1	(ROOT (S (NP (PRP It)) (VP (VBZ has) (VP (VBN been) (VP (VBN suggested) (SBAR (IN that) (S (NP (JJ Doc_3001299_102_111_Chemical) (NN cyclase) (NN inhibition)) (VP (MD may) (VP (VB be) (ADJP (JJ important) (PP (IN in) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (DT both) (NNS Doc_3001299_175_205_Disease) (CC and) (NNS Doc_3001299_210_224_Disease)))))) (PP (IN during) (NP (JJ Doc_3001299_232_239_Chemical) (NN treatment)))))))))) (. .)))
3001299	2	(ROOT (S (NP (PRP We)) (VP (VBD measured) (NP (NP (NN serum) (JJ Doc_3001299_269_278_Chemical) (CC and) (JJ urine-concentrating) (NN ability)) (PRN (-LRB- -LRB-) (NP (NNP Umax)) (-RRB- -RRB-))) (PP (IN in) (NP (NN response))) (PP (TO to) (NP (NP (NNS Doc_3001299_333_345_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP DDAVP)) (-RRB- -RRB-)))) (PP (IN in) (NP (NP (CD 85) (NNS patients)) (VP (VBG receiving) (NP (NNS Doc_3001299_379_386_Chemical)))))) (. .)))
3001299	3	(ROOT (S (NP (NNP Doc_3001299_388_402_Disease)) (VP (VBD developed) (PP (IN in) (NP (CD eight) (NNS patients))) (SBAR (IN while) (S (NP (PRP they)) (VP (VBD were) (VP (VBG taking) (NP (NNS Doc_3001299_454_461_Chemical))))))) (. .)))
3001299	4	(ROOT (S (NP (NNP Impaired) (NNP Umax)) (VP (VBD was) (VP (VBN found) (PP (IN in) (NP (DT both) (JJ euthyroid) (CC and) (JJ Doc_3001299_509_520_Disease) (NNS patients))) (SBAR (IN while) (S (NP (DT some) (JJ Doc_3001299_541_552_Disease) (NNS patients)) (VP (VBD concentrated) (NP (PRP$ their) (NN urine)) (ADVP (RB well))))))) (. .)))
3001299	5	(ROOT (S (NP (PRP It)) (VP (VBZ is) (VP (VBN concluded) (SBAR (IN that) (S (NP (NP (DT the) (JJ dominant) (NNS mechanisms)) (SBAR (WHPP (IN by) (WHNP (WDT which))) (S (NP (NNS Doc_3001299_647_654_Chemical)) (VP (VBZ exerts) (NP (DT these) (CD two) (NNS effects)))))) (VP (VBP are) (ADJP (JJ different))))))) (. .)))
3015327	0	(ROOT (NP (NP (NN Remodelling)) (PP (IN of) (NP (NN nerve) (NN structure))) (PP (IN in) (NP (JJ experimental) (JJ Doc_3015327_47_56_Chemical) (NNS Doc_3015327_57_67_Disease))) (PP (IN in) (NP (DT the) (NN rat))) (. .)))
3015327	1	(ROOT (S (NP (NP (DT The) (NNS Doc_3015327_84_94_Disease)) (VP (VBN caused) (PP (IN by) (NP (NP (DT a) (JJ single) (NN dose)) (PP (IN of) (NP (NP (NNS Doc_3015327_122_131_Chemical)) (PP (IN in) (NP (NNS rats))))))))) (VP (VBD was) (VP (VBN studied) (PP (IN with) (NP (DT a) (JJ computer-assisted) (JJ morphometric) (NN method))))) (. .)))
3015327	2	(ROOT (S (NP (NP (NP (JJ Scatter) (NNS diagrams)) (PP (IN of) (NP (DT the) (NN g) (NN ratio)))) (PRN (-LRB- -LRB-) (NP (JJ quotient) (NN fibre) (NN diameter/axon) (NN diameter)) (-RRB- -RRB-))) (S (VP (VB define) (NP (NP (VBG regenerating) (NNS fibres)) (PP (IN as) (NP (DT a) (JJ distinct) (NN population)))))) (, ,) (VP (VBP distinguishable) (PP (IN from) (NP (DT the) (VBG surviving) (NNS fibres))) (PP (IN by) (NP (NP (VBN reduced) (NN sheath) (NN thickness)) (CC and) (NP (VBN reduced) (NN axon) (NN calibre))))) (. .)))
3015327	3	(ROOT (S (NP (EX There)) (VP (VBD was) (ADVP (RB also)) (NP (NP (NN evidence)) (PP (IN of) (NP (NP (DT a) (JJ subtle) (JJ direct) (JJ toxic) (NN effect)) (PP (IN on) (NP (DT the) (JJ entire) (NN fibre) (NN population)))))) (, ,) (S (VP (VBG causing) (NP (NP (NN axon) (NN shrinkage)) (VP (VBN masked) (PP (IN by) (NP (NP (NN readjustment)) (PP (IN of) (NP (DT the) (NN myelin) (NN sheath)))))))))) (. .)))
3057041	0	(ROOT (NP (NP (JJ Multicenter) (, ,) (JJ double-blind) (, ,) (JJ multiple-dose) (, ,) (JJ parallel-groups) (NN efficacy) (CC and) (NN safety) (NN trial)) (PP (IN of) (NP (NNS Doc_3057041_87_97_Chemical) (, ,) (NNS Doc_3057041_99_115_Chemical) (, ,) (CC and) (NN placebo))) (PP (IN in) (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (NNS Doc_3057041_149_173_Disease))))) (. .)))
3057041	1	(ROOT (S (NP (NP (NNP Doc_3057041_175_185_Chemical)) (, ,) (NP (DT a) (JJ novel) (JJ antiallergic) (NN medication)) (, ,)) (VP (VBD was) (VP (VBN compared) (PP (IN with) (NP (NNS Doc_3057041_238_262_Chemical) (CC and) (NN placebo))) (PP (IN for) (NP (NN efficacy) (CC and) (NN safety))) (PP (IN in) (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (NP (NNS Doc_3057041_319_343_Disease)) (PP (IN in) (NP (DT a) (JJ multicenter) (, ,) (JJ double-blind) (, ,) (JJ multiple-dose) (, ,) (JJ parallel-groups) (NN study))))))))) (. .)))
3057041	2	(ROOT (S (NP (QP (CD One) (CD hundred)) (JJ fifty-five) (NNS subjects)) (VP (VBD participated)) (. .)))
3057041	3	(ROOT (S (NP (NNS Subjects)) (VP (VP (VBD ranged) (PP (IN in) (NP (NN age))) (PP (IN from) (NP (NP (QP (CD 18) (TO to) (CD 60)) (NNS years)) (PP (IN of) (NP (NN age)))))) (CC and) (VP (VBD had) (NP (NP (ADVP (IN at) (JJS least)) (DT a) (JJ 2-year) (NN history)) (PP (IN of) (NP (NP (NNS Doc_3057041_547_571_Disease)) (, ,) (VP (VBN confirmed) (PP (IN by) (NP (JJ positive) (NN skin) (NN test))) (PP (TO to) (NP (NN spring) (NNS aeroallergens))))))))) (. .)))
3057041	4	(ROOT (S (S (NP (NNS Medications)) (VP (VBD were) (VP (VBN given) (NP (CD four) (NNS times) (RB daily))))) (: ;) (S (NP (DT the) (JJ Doc_3057041_675_685_Chemical) (NNS groups)) (VP (VBD received) (NP (NP (CD 0.5) (, ,) (CD 1.0) (, ,) (CC or) (CD 2.0)) (VP (VBN mg) (PP (IN in) (NP (NP (DT the) (NN morning) (CC and) (NN evening)) (PP (IN with) (NP (NN placebo))))) (PP (IN in) (NP (DT the) (JJ early) (CC and) (JJ late) (NN afternoon))))))) (: ;) (S (NP (DT the) (JJ Doc_3057041_799_815_Chemical) (NN group)) (VP (VBD received) (NP (QP (CD 4.0) (CD mg))) (NP (CD four) (NNS times) (RB daily)))) (. .)))
3057041	5	(ROOT (S (NP (JJ Daily) (NN subject) (NN symptom) (NNS cards)) (VP (VBD were) (VP (VBN completed) (PP (PP (IN during) (NP (DT a) (NN screening) (NN period) (S (VP (TO to) (VP (VB assess) (NP (JJ pretreatment) (NNS symptoms))))))) (CC and) (PP (IN during) (NP (NP (DT a) (JJ 4-week) (NN treatment) (NN period)) (SBAR (IN while) (S (NP (NNS subjects)) (VP (VBD received) (NP (NN study) (NNS medications)))))))))) (. .)))
3057041	6	(ROOT (S (NP (NP (JJ Individual) (NNS symptoms)) (, ,) (NP (JJ total) (NNS symptoms)) (, ,) (CC and) (NP (JJ major) (NNS symptoms))) (VP (VBD were) (VP (VBN compared) (S (VP (TO to) (VP (VB determine) (NP (NP (NN efficacy)) (PP (IN of) (NP (NN medication))))))))) (. .)))
3057041	7	(ROOT (S (S (VP (VBN Elicited))) (, ,) (VP (VP (VBD volunteered)) (, ,) (CC and) (VP (VBD observed) (SBAR (S (NP (JJ adverse) (NNS experiences)) (VP (VBD were) (VP (VP (VBN recorded) (PP (IN for) (NP (DT each) (NN subject)))) (CC and) (VP (VBN compared) (PP (IN among) (NP (NNS groups)))))))))) (. .)))
3057041	8	(ROOT (S (NP (NP (JJ Vital) (NNS signs)) (, ,) (NP (NN body) (NNS weights)) (, ,) (NP (NN serum) (NN chemistry) (NNS values)) (, ,) (NP (JJ complete) (NN blood) (NN cell) (NNS counts)) (, ,) (NP (NN urine) (NNS studies)) (, ,) (CC and) (NP (NNS electrocardiograms))) (VP (VBD were) (VP (VP (VBN obtained) (PP (IN for) (NP (DT each) (NN subject)))) (CC and) (VP (VBN compared) (PP (IN among) (NP (NNS groups)))))) (. .)))
3057041	9	(ROOT (S (NP (NP (JJ Symptoms) (NN relief)) (PP (IN in) (NP (NP (DT the) (NN group)) (VP (VBG receiving) (NP (NP (DT the) (JJS highest) (NN concentration)) (PP (IN of) (NP (NNS Doc_3057041_1501_1511_Chemical)))))))) (PRN (-LRB- -LRB-) (S (NP (NNP 2.0)) (VP (VBP mg) (ADVP (RB twice)) (ADVP (RB daily)))) (-RRB- -RRB-)) (VP (VBD was) (ADJP (ADJP (RB statistically) (JJR greater)) (PP (IN than) (PP (IN in) (NP (DT the) (NN placebo) (NN group))))) (PP (IN during) (NP (NP (DT all) (NNS weeks)) (PP (IN of) (NP (DT the) (NN study)))))) (. .)))
3057041	10	(ROOT (S (NP (NP (JJR Lower) (NNS doses)) (PP (IN of) (NP (NNS Doc_3057041_1631_1641_Chemical)))) (VP (VBD were) (ADJP (ADJP (RB statistically) (RBR more) (JJ effective)) (PP (IN than) (NP (NN placebo)))) (PP (RB only) (IN during) (NP (NP (NNS portions)) (PP (IN of) (NP (DT the) (JJ first) (CD 3) (NNS weeks))) (PP (IN of) (NP (DT the) (NN study)))))) (. .)))
3057041	11	(ROOT (S (PP (IN In) (NP (NN contrast))) (, ,) (SBAR (IN although) (S (NP (DT the) (JJ Doc_3057041_1771_1787_Chemical) (NN group)) (VP (VBD did) (VP (VB have) (NP (NP (JJR fewer) (NNS symptoms)) (PP (IN than) (NP (DT the) (NN placebo) (NN group)))) (PP (IN during) (NP (DT the) (NN study))))))) (, ,) (NP (DT the) (NN difference)) (ADVP (RB never)) (VP (VBD reached) (NP (JJ statistical) (NN significance)) (PP (IN during) (NP (NP (DT any) (NN week)) (PP (IN of) (NP (DT the) (NN study)))))) (. .)))
3057041	12	(ROOT (S (NP (EX There)) (VP (VBD were) (NP (NP (DT no) (JJ serious) (NN side) (NNS effects)) (PP (IN in) (NP (NP (DT any)) (PP (IN of) (NP (DT the) (NN treatment) (NNS groups))))))) (. .)))
3057041	13	(ROOT (S (NP (NNS Drowsiness) (CC and) (NNS Doc_3057041_2025_2049_Disease)) (VP (VBD were) (VP (VBN increased) (ADVP (RB significantly)) (PP (IN over) (NP (NP (NN placebo) (RB only)) (PP (IN in) (NP (DT the) (JJ high-dose) (JJ Doc_3057041_2114_2124_Chemical) (NN group))))))) (. .)))
3057041	14	(ROOT (S (NP (NNP Doc_3057041_2132_2142_Chemical)) (VP (VBZ appears) (S (VP (TO to) (VP (VB be) (NP (NP (DT a) (JJ safe) (, ,) (JJ efficacious) (NN medication)) (PP (IN for) (NP (NNS Doc_3057041_2192_2218_Disease)))))))) (. .)))
3084782	0	(ROOT (S (VP (VB Doc_3084782_0_8_Disease) (ADJP (JJ due) (S (VP (TO to) (VP (VB remission) (S (VP (VBG inducing) (NP (NNS drugs)) (PP (IN in) (NP (NNS Doc_3084782_44_64_Disease)))))))))) (. .)))
3084782	1	(ROOT (S (NP (NP (NNP Association)) (PP (IN with) (NP (NN HLA-B35) (CC and) (NNS Cw4)))) (VP (VBZ antigens)) (. .)))
3084782	2	(ROOT (S (NP (NP (CD Twenty-five) (NNS patients)) (PP (IN with) (NP (NP (NNS Doc_3084782_135_155_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_3084782_157_159_Disease)) (-RRB- -RRB-)) (SBAR (WHNP (WP who)) (S (VP (VBD developed) (NP (NNS Doc_3084782_175_183_Disease)) (SBAR (IN while) (S (S (VP (VBG taking) (NP (NN remission)) (S (VP (VBG inducing) (NP (NP (NNS drugs)) (CC and) (NP (CD 30))) (PP (IN without) (NP (NNS Doc_3084782_237_245_Disease))))))) (VP (VBD were) (VP (VBN studied) (PP (IN for) (NP (JJ possible) (NNS associations))) (PP (IN with) (NP (NP (NN class) (NN I)) (CC and) (NP (NNP II) (NNP HLA)))))))))))))) (VP (VBZ antigens)) (. .)))
3084782	3	(ROOT (S (NP (DT A) (JJ strong) (NN association)) (VP (VBZ has) (VP (VBN been) (VP (VBN found) (PP (IN between) (NP (NP (NNS Doc_3084782_363_372_Disease) (CC and) (NNS Doc_3084782_377_387_Disease)) (ADJP (JJ due) (PP (PP (TO to) (NP (NP (NP (NNS Doc_3084782_395_404_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (DT a) (NNS Doc_3084782_408_423_Chemical)) (PP (IN like) (NP (NN compound)))) (-RRB- -RRB-))) (CC and) (NP (NP (NN class)) (SBAR (S (NP (PRP I)) (VP (VBZ antigens) (ADJP (JJ B35-Cw4)))))))) (, ,) (CC and) (PP (IN between) (NP (NP (NNS Doc_3084782_481_491_Disease)) (ADJP (JJ due) (PP (TO to) (NP (NNP Doc_3084782_499_516_Chemical) (CC and) (NNP B35))))))))))))) (. .)))
3084782	4	(ROOT (S (PP (VBN Compared) (PP (TO to) (NP (JJ healthy) (NNS controls)))) (NP (DT a) (JJR lower) (NNP DR5) (NN frequency)) (VP (VBD was) (VP (VBN observed) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NNS Doc_3084782_607_609_Disease))))) (PP (IN except) (PP (IN for) (NP (DT the) (JJ Doc_3084782_625_634_Chemical) (JJ related) (NNS Doc_3084782_643_652_Disease) (NN group)))))) (. .)))
3088349	0	(ROOT (S (NP (NP (JJ Transient) (NNS Doc_3088349_10_32_Disease)) (PP (VBG following) (NP (JJ unilateral) (NNS Doc_3088349_54_77_Disease)))) (VP (VBZ reflects) (NP (NP (NN susceptibility)) (PP (IN of) (NP (NP (DT the) (JJ nigrostriatal) (NN system)) (PP (TO to) (NP (NN exhaustion)))))) (PP (IN by) (NP (NNS Doc_3088349_147_158_Chemical)))) (. .)))
3088349	1	(ROOT (S (PP (VBG Following) (NP (NP (JJ unilateral) (NNS Doc_3088349_181_187_Chemical)) (VP (VBN induced) (NP (NNS Doc_3088349_196_205_Disease))))) (, ,) (NP (NP (DT a) (JJ transient) (NN period)) (PP (IN of) (NP (NNS Doc_3088349_229_251_Disease)))) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (S (VP (TO to) (VP (VB precede) (NP (DT the) (JJ predominant) (NNS Doc_3088349_297_317_Disease)))))))) (. .)))
3088349	2	(ROOT (S (SBAR (IN In) (NN order) (S (VP (TO to) (VP (VB clarify) (NP (NP (DT the) (NN nature)) (PP (IN of) (NP (DT this) (JJ initial) (NNS Doc_3088349_366_388_Disease)))))))) (NP (PRP we)) (VP (VBD examined) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (NP (DT the) (NN duration)) (PP (IN of) (NP (NN recovery) (NN period)))))) (PP (IN after) (NP (DT the) (NN lesion))) (, ,) (PP (IN on) (NP (NN Doc_3088349_468_479_Chemical-induced) (NNS Doc_3088349_488_507_Disease)))) (. .)))
3088349	3	(ROOT (S (NP (NP (CD Three) (NNS days)) (NP (NN post) (NN lesion))) (, ,) (NP (JJS most) (NNS rats)) (VP (VBD circled) (ADJP (RB predominantly) (JJ contralaterally)) (PP (TO to) (NP (DT the) (NN lesion)))) (. .)))
3088349	4	(ROOT (S (NP (JJ Such) (NNS Doc_3088349_601_623_Disease)) (VP (MD may) (VP (VB result) (PP (IN from) (NP (NP (NP (DT either) (JJ degeneration-induced) (NN breakdown)) (PP (IN of) (NP (DT the) (NNP DA) (NN pool)))) (, ,) (CC or) (NP (NP (JJ lesion-induced) (NN increase)) (PP (IN of) (NP (NNP DA) (NN turnover)))))) (PP (IN in) (NP (DT the) (JJ spared) (NNS neurons))))) (. .)))
3088349	5	(ROOT (S (NP (NP (DT A) (JJ substantial) (NN degree)) (PP (IN of) (NP (JJ contralateral) (NN preference)))) (VP (VBD was) (ADVP (RB still)) (ADJP (JJ evident)) (SBAR (WHADVP (WRB when)) (S (NP (NNS Doc_3088349_831_842_Chemical)) (VP (VBD was) (VP (VBN administered) (PP (IN for) (NP (DT the) (JJ first) (NN time))) (PP (NP (CD 24) (NNS days)) (IN after) (S (VP (VBG lesioning) (, ,) (VBG indicating) (NP (NP (NN involvement)) (PP (IN of) (NP (NP (JJ spared) (NNS cells)) (PP (IN in) (NP (DT the) (NNS Doc_3088349_950_972_Disease)))))))))))))) (. .)))
3088349	6	(ROOT (S (ADVP (RB However)) (, ,) (S (ADVP (RB regardless) (PP (IN of) (NP (NP (DT the) (NN duration)) (PP (IN of) (NP (NP (NN recovery)) (PRN (-LRB- -LRB-) (CC and) (ADVP (RB irrespective) (PP (IN of) (NP (DT either) (NN lesion)))) (NP (NP (NN volume)) (, ,) (NP (JJ Doc_3088349_1065_1076_Chemical) (NN dose)) (, ,) (CC or) (NP (JJ post-lesion) (NN motor) (NN exercise))) (-RRB- -RRB-))))))) (, ,) (NP (NN Doc_3088349_1115_1126_Chemical-induced) (NNS Doc_3088349_1135_1143_Disease)) (VP (VBD tended) (S (VP (TO to) (VP (VB become) (ADJP (ADVP (RB gradually) (RBR more)) (JJ ipsilateral)) (SBAR (IN as) (S (NP (DT the) (NN observation) (NN session)) (VP (VBD progressed))))))))) (, ,) (CC and) (S (NP (DT all) (NNS rats)) (VP (VBD circled) (ADVP (RB ipsilaterally)) (PP (TO to) (NP (NP (DT the) (NN lesion)) (PP (IN in) (NP (NN response))))) (PP (TO to) (NP (JJ further) (JJ Doc_3088349_1299_1310_Chemical) (NNS injections))))) (. .)))
3088349	7	(ROOT (S (NP (DT These) (NNS findings)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NNS Doc_3088349_1351_1362_Chemical)) (VP (VBZ has) (NP (NP (DT an) (JJ irreversible) (NN effect)) (PP (IN on) (NP (NP (DT the) (JJ post-lesion) (NNP DA) (NN pool)) (VP (VBG contributing) (PP (TO to) (NP (NNS Doc_3088349_1433_1455_Disease))))))))))) (. .)))
3108839	0	(ROOT (S (NP (NNP Doc_3108839_0_11_Chemical)) (VP (JJ associated) (NP (NNS Doc_3108839_23_48_Disease))) (. .)))
3108839	1	(ROOT (S (NP (NP (JJ Doc_3108839_50_61_Chemical) (JJ associated) (NNS Doc_3108839_73_98_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_3108839_100_103_Disease)) (-RRB- -RRB-))) (VP (VBZ is) (NP (NP (DT a) (ADJP (ADJP (RB potentially) (JJ fatal)) (CC but) (ADJP (JJ uncommon))) (NN condition)) (SBAR (WHNP (WDT that)) (S (VP (VBZ is) (RB not) (ADVP (RB yet)) (ADJP (RB widely) (VBN recognised))))))) (. .)))
3108839	2	(ROOT (S (NP (PRP It)) (VP (VP (VBZ consists) (PP (IN of) (NP (NP (JJ microangiopathic) (NNS Doc_3108839_218_234_Disease)) (, ,) (NP (NNS Doc_3108839_236_252_Disease)) (CC and) (NP (NP (JJ progressive) (NNS Doc_3108839_269_282_Disease)) (VP (VBN associated) (PP (IN with) (NP (JJ Doc_3108839_299_310_Chemical) (NN treatment)))))))) (CC and) (VP (VBZ affects) (NP (NP (QP (RB about) (CD 10)) (NN %)) (PP (IN of) (NP (NP (NNS patients)) (VP (VBN treated) (PP (IN with) (NP (DT this) (NN agent))))))))) (. .)))
3108839	3	(ROOT (S (NP (DT The) (NNS Doc_3108839_384_397_Disease)) (ADVP (RB usually)) (VP (VBZ develops) (PP (IN about) (NP (CD 8-10) (NN mth))) (SBAR (IN after) (S (NP (NP (NN start)) (PP (IN of) (NP (NP (JJ Doc_3108839_445_456_Chemical) (NN treatment)) (CC and) (NP (DT the) (NN mortality))))) (VP (VBZ is) (NP (NP (QP (RB approximately) (CD 60)) (NN %)) (PP (IN from) (NP (NNS Doc_3108839_511_524_Disease) (CC or) (NNS Doc_3108839_528_543_Disease)))))))) (. .)))
3108839	4	(ROOT (SINV (S (NP (NNP Doc_3108839_545_558_Disease)) (VP (VP (VBP are) (ADJP (JJ similar) (PP (TO to) (NP (NP (DT those)) (VP (VBN seen) (PP (IN in) (NP (JJ idiopathic) (NNS Doc_3108839_599_602_Disease)))))))) (CC and) (VP (VBP include) (NP (NN arteriolar) (NN fibrin) (NNS thrombi))))) (, ,) (VP (VBD expanded) (NP (JJ subendothelial) (NNS zones)) (PP (IN in) (NP (NN glomerular)))) (NP (NP (JJ capillary) (NNS walls)) (, ,) (NP (NP (JJ Doc_3108839_703_711_Disease) (NN wrinkling)) (PP (IN of) (NP (NN glomerular) (NN basement) (NNS membranes) (CC and) (NNS mesangiolysis))))) (. .)))
3108839	5	(ROOT (S (NP (NP (DT The) (NN mechanism)) (PP (IN of) (NP (NN action)))) (VP (VBZ is) (VP (VBN postulated) (PP (IN as) (NP (ADJP (JJ Doc_3108839_815_826_Chemical-induced) (JJ endothelial)) (NN cell) (NN damage))))) (. .)))
3108839	6	(ROOT (S (NP (PRP We)) (VP (VBP describe) (NP (NP (DT the) (JJ clinical) (NN course)) (CC and) (NP (NP (JJ pathological) (NNS findings)) (PP (IN in) (NP (DT a) (CD 65) (JJ yr-old) (NN man))))) (PP (IN with) (NP (NP (NNS Doc_3108839_942_964_Disease)) (SBAR (WHNP (WP who)) (S (VP (VP (VBD developed) (NP (NNS Doc_3108839_979_992_Disease) (CC and) (NNS Doc_3108839_997_1013_Disease)) (NP (NN while)) (PP (IN on) (NP (NP (NN treatment)) (PP (IN with) (NP (NNS Doc_3108839_1038_1049_Chemical)))))) (CC and) (VP (VBD died) (PP (IN in) (NP (NNS Doc_3108839_1062_1077_Disease)))))))))) (. .)))
3115150	0	(ROOT (S (NP (JJ Doc_3115150_0_10_Chemical) (NN pretreatment)) (VP (VBZ reverses) (NP (NN Doc_3115150_33_43_Chemical-induced) (NNS Doc_3115150_52_67_Disease))) (. .)))
3115150	1	(ROOT (S (NP (NP (NP (JJ Systemic) (NN pretreatment)) (PP (IN with) (NP (NNS Doc_3115150_96_106_Chemical)))) (, ,) (NP (DT a) (ADJP (RB relatively) (JJ specific)) (JJ type-2) (NN Doc_3115150_137_146_Chemical) (NN receptor) (NN antagonist)) (, ,)) (ADVP (RB significantly)) (VP (VBD attenuated) (SBAR (S (NP (DT the) (NNS Doc_3115150_197_212_Disease)) (VP (VBD produced) (PP (IN in) (NP (NNS rats))) (PP (IN by) (NP (DT the) (JJ potent) (JJ short-acting) (NN opiate) (NN agonist) (NNS Doc_3115150_272_282_Chemical))))))) (. .)))
3115150	2	(ROOT (S (PP (VBG Following) (PP (NP (NP (NN placement)) (PP (IN of) (NP (JJ subcutaneous) (NNS electrodes)))) (IN in) (NP (NP (DT each) (NN animal) (POS 's)) (JJ left) (NNS gastrocnemius) (NN muscle)))) (, ,) (NP (NNS Doc_3115150_375_383_Disease)) (VP (VBD was) (VP (VBN assessed) (PP (IN by) (S (VP (VBG analyzing) (NP (JJ root-mean-square) (JJ electromyographic) (NN activity))))))) (. .)))
3115150	3	(ROOT (S (NP (NP (JJ Intraperitoneal) (JJ Doc_3115150_471_481_Chemical) (NN administration)) (PP (IN at) (NP (NP (NNS doses)) (PP (IN of) (NP (QP (CD 0.63) (CC and) (CD 2.5)) (NN mg/kg)))))) (VP (VBD prevented) (NP (DT the) (NN Doc_3115150_542_552_Chemical-induced) (NN increase)) (PP (IN in) (NP (JJ electromyographic) (NN activity))) (PP (VBN compared) (PP (IN with) (NP (NP (NNS animals)) (VP (VBN pretreated) (PP (IN with) (NP (NN saline)))))))) (. .)))
3115150	4	(ROOT (S (NP (NP (NNP Doc_3115150_646_662_Chemical)) (PP (IN at) (NP (NP (NNS doses)) (ADVP (RB up) (PP (TO to) (NP (CD 10) (NN mg/kg))))))) (VP (VBD failed) (S (VP (TO to) (VP (ADVP (RB significantly)) (VB influence) (NP (NP (DT the) (NNS Doc_3115150_725_733_Disease)) (VP (VBN produced) (PP (IN by) (NP (NNS Doc_3115150_746_756_Chemical))))))))) (. .)))
3115150	5	(ROOT (S (PP (IN Despite) (NP (NP (DT the) (NN absence)) (PP (IN of) (NP (NNS Doc_3115150_781_789_Disease))))) (, ,) (NP (NP (NNS animals)) (SBAR (WHNP (WDT that)) (S (VP (VBD received) (NP (NP (NNS Doc_3115150_813_823_Chemical)) (PRN (-LRB- -LRB-) (NP (QP (JJR greater) (IN than) (CD 0.31)) (NN mg/kg) (NN i.p.)) (-RRB- -RRB-)) (VP (VBN followed) (PP (IN by) (NP (NNS Doc_3115150_867_877_Chemical))))))))) (VP (VBD were) (ADJP (ADJP (JJ motionless)) (, ,) (ADJP (JJ flaccid)) (, ,) (CC and) (ADJP (RBR less) (JJ responsive) (PP (TO to) (NP (JJ external) (NNS stimuli))))) (SBAR (IN than) (S (VP (VBD were) (NP (NP (NNS animals)) (VP (VBG receiving) (NP (NNS Doc_3115150_972_982_Chemical)) (ADVP (RB alone)))))))) (. .)))
3115150	6	(ROOT (S (NP (NP (NNS Rats)) (SBAR (WHNP (WDT that)) (S (VP (VBD received) (SBAR (S (NP (NNS Doc_3115150_1009_1019_Chemical) (CC and) (NNS Doc_3115150_1024_1034_Chemical)) (VP (VBD exhibited) (NP (NP (JJR less) (NN rearing) (CC and) (JJ exploratory) (NN behavior)) (PP (IN at) (NP (NP (DT the) (NN end)) (PP (IN of) (NP (DT the) (JJ 60-min) (NN recording) (NN period)))))) (PP (IN than))))))))) (VP (VBD did) (NP (NP (NNS animals)) (SBAR (WHNP (WDT that)) (S (VP (VBD received) (NP (NNS Doc_3115150_1156_1166_Chemical)) (ADVP (RB alone))))))) (. .)))
3115150	7	(ROOT (S (NP (NP (DT These) (NNS results)) (, ,) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (JJ previous) (NN work))))) (, ,)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NP (NNS Doc_3115150_1237_1252_Disease)) (, ,) (NP (NP (DT a) (ADJP (RB clinically) (JJ relevant)) (NN side-effect)) (PP (IN of) (NP (JJ parenteral) (JJ narcotic) (NN administration)))) (, ,)) (VP (MD may) (VP (VB be) (VP (ADVP (RB partly)) (VBN mediated) (PP (IN via) (NP (JJ serotonergic) (NNS pathways))))))))) (. .)))
3115150	8	(ROOT (S (NP (NP (NNP Pretreatment)) (PP (IN with) (NP (JJ type-2) (JJ Doc_3115150_1402_1411_Chemical) (NNS antagonists)))) (VP (MD may) (VP (VB be) (ADJP (RB clinically) (JJ useful) (PP (IN in) (S (VP (VBG attenuating) (NP (JJ opiate-induced) (NNS Doc_3115150_1479_1487_Disease)))))) (, ,) (SBAR (IN although) (S (NP (JJ further) (NNS studies)) (VP (MD will) (VP (VB be) (ADJP (JJ necessary) (S (VP (TO to) (VP (VB assess) (NP (NP (DT the) (NN interaction)) (PP (IN of) (NP (NP (ADJP (RB possibly) (VBN enhanced)) (NNP CNS)) (, ,) (NP (NNS Doc_3115150_1584_1626_Disease))))))))))))))) (. .)))
3120485	0	(ROOT (S (NP (NP (NNP Antagonism)) (PP (IN of) (NP (NNS Doc_3120485_14_22_Chemical-induced)))) (VP (VBD sedative) (NP (NNS effects)) (PP (IN by) (NP (NP (NNS Doc_3120485_51_60_Chemical)) (PP (IN in) (NP (NNS patients))))) (PP (IN after) (NP (NN surgery))) (PP (IN under) (NP (NN lumbar) (NN epidural) (NN block)))) (. .)))
3120485	1	(ROOT (NP (NP (DT A) (JJ double-blind) (JJ placebo-controlled) (NN investigation)) (PP (IN of) (NP (NN efficacy) (CC and) (NN safety))) (. .)))
3120485	2	(ROOT (S (NP (NP (DT The) (NN aim)) (PP (IN of) (NP (DT this) (NN study)))) (VP (VBD was) (S (VP (VP (TO to) (VP (VB assess) (NP (NP (DT the) (NN efficacy)) (PP (IN of) (NP (NP (NNS Doc_3120485_240_249_Chemical)) (CC and) (NP (DT a) (NN placebo))))) (PP (IN in) (S (VP (VBG reversing) (NP (NN Doc_3120485_277_285_Chemical-induced) (NNS effects)) (PP (IN after) (NP (NN surgery))) (PP (IN under) (NP (JJ epidural) (NN block)))))))) (, ,) (CC and) (VP (TO to) (VP (VB evaluate) (NP (NP (DT the) (JJ local) (NN tolerance) (CC and) (JJ general) (NN safety)) (PP (IN of) (NP (NNS Doc_3120485_396_405_Chemical))))))))) (. .)))
3120485	3	(ROOT (S (NP (JJ Fifty-seven) (NNS patients)) (VP (VBD were) (VP (VBN sedated) (PP (IN with) (NP (NP (NNS Doc_3120485_446_454_Chemical)) (PP (IN for) (NP (NN surgery))))) (PP (IN under) (NP (JJ epidural) (NN anaesthesia))))) (. .)))
3120485	4	(ROOT (S (NP (NP (NNP Antagonism)) (PP (IN of) (NP (NP (NN Doc_3120485_509_517_Chemical-induced) (NNS effects)) (PP (IN by) (NP (NNS Doc_3120485_537_546_Chemical)))))) (VP (VBD was) (VP (VBN investigated) (ADVP (RB postoperatively)) (PP (IN in) (NP (DT a) (JJ double-blind) (JJ placebo-controlled) (NN trial))))) (. .)))
3120485	5	(ROOT (S (NP (NP (NP (NP (DT The) (NN patient) (POS 's)) (JJ subjective) (NN assessment)) (PP (IN of) (NP (NN mood) (NN rating)))) (, ,) (NP (NP (DT an) (JJ objective) (NN test)) (PP (IN of) (NP (NN performance)))) (, ,) (NP (NP (DT a) (NN test)) (PP (IN for) (NP (NNS Doc_3120485_721_728_Disease)))) (, ,) (CC and) (NP (JJ vital) (NNS signs))) (VP (VBD were) (VP (VBN recorded) (PP (IN for) (NP (QP (IN up) (TO to) (CD 300)) (NN min))) (PP (IN after) (NP (NP (NN administration)) (PP (IN of) (NP (DT the) (NN trial) (NN drug))))))) (. .)))
3120485	6	(ROOT (S (NP (NP (DT No) (JJ significant) (NNS differences)) (PP (IN between) (NP (DT the) (CD two) (NNS groups)))) (VP (VBD were) (VP (VBN observed) (PP (IN for) (NP (NP (NN mood) (NN rating)) (, ,) (NP (NNS Doc_3120485_899_906_Disease)) (, ,) (CC or) (NP (JJ vital) (NNS signs)))))) (. .)))
3120485	7	(ROOT (S (NP (DT The) (JJ Doc_3120485_928_937_Chemical) (NN group)) (VP (VBD showed) (NP (DT a) (JJ significant) (NN improvement)) (PP (IN in) (NP (NP (DT the) (NN performance) (NN test)) (ADVP (RB up) (PP (TO to) (NP (CD 120) (NN min)))))) (PP (IN after) (NP (NP (NN administration)) (PP (IN of) (NP (DT the) (NN drug)))))) (. .)))
3120485	8	(ROOT (S (NP (EX There)) (VP (VBD was) (NP (NP (DT no) (NN evidence)) (PP (IN of) (NP (NP (NN reaction)) (PP (IN at) (NP (DT the) (NN injection) (NN site))))))) (. .)))
3123611	0	(ROOT (S (NP (NNP Doc_3123611_0_6_Disease)) (VP (VBN associated) (PP (IN with) (NP (JJ oral) (NN contraception)))) (. .)))
3123611	1	(ROOT (S (NP (CD Three) (NNS patients)) (VP (VBD developed) (NP (NNS Doc_3123611_68_74_Disease)) (PP (IN while) (S (VP (VBG receiving) (NP (NNS Doc_3123611_91_110_Chemical)))))) (. .)))
3123611	2	(ROOT (S (NP (CD Two)) (VP (VBD were) (NP (NP (JJ young) (NNS patients)) (SBAR (WP$ whose) (S (NP (NNS Doc_3123611_142_148_Disease)) (VP (VBD developed) (SBAR (RB long) (IN after) (S (NP (NN treatment)) (VP (VBD had) (VP (VBN been) (VP (VBN started) (CC and) (VBN disappeared) (ADVP (RB soon)) (SBAR (IN after) (S (NP (PRP it)) (VP (VBD had) (VP (VBN been) (VP (VBN discontinued)))))))))))))))) (. .)))
3123611	3	(ROOT (S (NP (DT The) (JJ third) (NN patient)) (VP (VBD had) (NP (ADJP (JJ acute) (JJ Doc_3123611_278_289_Chemical-induced)) (NNS Doc_3123611_298_304_Disease)) (PP (IN after) (NP (JJ prolonged) (NNS Doc_3123611_321_339_Chemical)))) (. .)))
3123611	4	(ROOT (S (NP (NP (JJ Prolonged) (NN administration)) (PP (IN of) (NP (JJ female) (NN sex) (NNS hormones)))) (VP (VBZ is) (NP (NP (DT a) (JJ possible) (NN cause)) (PP (IN of) (NP (NP (NNS Doc_3123611_412_418_Disease)) (PP (IN in) (NP (NP (NNS women)) (SBAR (WHNP (WP who)) (S (VP (VBP have) (RB not) (ADVP (RB previously)) (VP (VBN had) (NP (NNS Doc_3123611_456_462_Disease) (CC or) (NNS Doc_3123611_466_481_Disease)))))))))))) (. .)))
3131282	0	(ROOT (S (NP (NP (JJ Doc_3131282_0_2_Chemical-carcinogenic) (NN effect)) (PP (IN of) (NP (NP (NNS Doc_3131282_26_41_Chemical)) (PP (IN on) (NP (NP (NNS Doc_3131282_45_71_Disease)) (PP (IN of) (NP (JJ male) (NN F344) (NNS rats)))))))) (VP (VBN induced) (PP (IN with) (NP (NNS Doc_3131282_103_127_Chemical)))) (. .)))
3131282	1	(ROOT (S (NP (NP (DT The) (JJ potential) (NN modifying) (NN effect)) (PP (IN of) (NP (NNS Doc_3131282_163_178_Chemical))) (PRN (-LRB- -LRB-) (NP (NNP Doc_3131282_180_182_Chemical)) (-RRB- -RRB-)) (PP (IN on) (NP (NP (NNS Doc_3131282_187_211_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_3131282_213_216_Chemical)) (-RRB- -RRB-)) (: -) (NP (JJ induced) (NN rat) (NNS Doc_3131282_230_255_Disease))))) (VP (VBD was) (VP (VBN examined))) (. .)))
3131282	2	(ROOT (S (NP (NP (JJ Male) (NN F344) (NNS rats)) (, ,) (NP (NP (CD 5) (NNS weeks)) (PP (IN of) (NP (NN age)))) (, ,)) (VP (VBD were) (VP (VP (VBN maintained) (PP (IN on) (NP (NN diet))) (S (VP (VBG containing) (NP (QP (CD 1) (NN %) (CC or) (CD 2) (NN %)) (NNS Doc_3131282_346_349_Chemical)) (PP (IN by) (NP (NN weight)))))) (CC and) (VP (ADVP (RB simultaneously) (PP (IN on) (NP (NN drinking) (NN water)))) (VBN supplemented) (PP (IN with) (NP (NNP RA))) (PP (IN at) (NP (NP (NP (JJ various) (NNS concentrations)) (PRN (-LRB- -LRB-) (NP (NN w/v)) (-RRB- -RRB-))) (PP (IN for) (NP (CD 52) (NNS weeks)))))))) (. .)))
3131282	3	(ROOT (S (PP (IN In) (NP (NP (NNS groups)) (VP (VBN given) (NP (ADJP (CD 2) (NN %)) (NNS Doc_3131282_483_486_Chemical)) (, ,) (SBAR (IN although) (S (NP (NP (JJ marked) (JJ hyperplastic) (NNS changes)) (PP (IN of) (NP (DT the) (JJ forestomach) (NN epithelium)))) (VP (VBD were) (VP (VBN observed) (PP (IN in) (NP (DT all) (NNS animals)))))))))) (, ,) (NP (NP (NN co-administration)) (PP (IN of) (NP (ADJP (CD 0.25) (NN %)) (NNP RA) (NNP significantly) (PRN (-LRB- -LRB-) (NP (NNP P) (QP (JJR less) (IN than) (CD 0.05))) (-RRB- -RRB-))))) (VP (VBD increased) (NP (NP (DT the) (NN incidence)) (PP (IN of) (NP (NP (NNS Doc_3131282_675_693_Disease)) (PRN (-LRB- -LRB-) (NP (JJ Doc_3131282_695_718_Disease) (CC and) (JJ Doc_3131282_723_732_Disease)) (-RRB- -RRB-))))) (PP (TO to) (NP (NP (CD 60) (NN %)) (PRN (-LRB- -LRB-) (NP (NP (CD 9/15) (, ,) (CD 2) (NNS rats)) (PP (IN with) (NP (NNS Doc_3131282_760_769_Disease)))) (-RRB- -RRB-)))) (PP (IN from) (NP (CD 15) (NN %))) (PP (PRN (-LRB- -LRB-) (NP (NP (CD 3/20)) (, ,) (NP (CD one) (NN rat))) (PP (IN with) (NP (NNS Doc_3131282_800_809_Disease))) (-RRB- -RRB-)) (IN in) (NP (DT the) (NN group) (VBN given) (NNP RA-free) (NN water)))) (. .)))
3131282	4	(ROOT (S (PP (IN In) (NP (NP (NNS rats)) (VP (VBN given) (NP (CD 1) (NN %)) (NP (NP (NNS Doc_3131282_862_865_Chemical)) (, ,) (NP (NP (NNP RA)) (VP (VBN co-administered) (PP (IN at) (NP (NP (DT a) (NN dose)) (PP (IN of) (NP (CD 0.05))))))))))) (, ,) (NP (NP (CD 0.1)) (, ,) (NP (CD 0.2)) (CC or) (NP (CD 0.25) (NN %))) (VP (VBD showed) (NP (DT a) (JJ dose-dependent) (JJ enhancing) (NN effect)) (PP (IN on) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (DT the) (NN Doc_3131282_990_993_Chemical-induced) (NNS Doc_3131282_1002_1024_Disease)))))) (. .)))
3131282	5	(ROOT (S (NP (NP (NNP Doc_3131282_1026_1032_Disease)) (, ,) (NP (DT all) (NNS Doc_3131282_1038_1048_Disease)) (, ,)) (VP (VBD were) (VP (VBN induced) (PP (IN in) (NP (NP (CD 3) (NNS rats)) (PRN (-LRB- -LRB-) (NP (CD 17) (NN %)) (-RRB- -RRB-)))) (PP (PP (IN with) (NP (ADJP (CD 0.25) (NN %)) (NNP RA))) (CC and) (PP (IN in) (NP (NP (CD one) (NN rat) (PRN (-LRB- -LRB-) (NP (CD 10) (NN %)) (-RRB- -RRB-))) (PP (IN with) (NP (CD 0.05) (NN %))))) (NP (JJ Doc_3131282_1125_1127_Chemical) (NN co-administration))))) (. .)))
3131282	6	(ROOT (S (NP (NNP Doc_3131282_1147_1149_Chemical)) (ADVP (RB alone)) (VP (VBD did) (RB not) (VP (VB induce) (NP (JJ hyperplastic) (NNS changes)) (PP (IN in) (NP (DT the) (NN forestomach))))) (. .)))
3131282	7	(ROOT (S (NP (DT These) (NNS findings)) (VP (VBP indicate) (SBAR (IN that) (S (NP (NNP RA)) (VP (VBD acted) (PP (IN as) (NP (DT a) (NN co-carcinogen))) (PP (IN in) (NP (NP (DT the) (JJ Doc_3131282_1276_1279_Chemical) (NNS Doc_3131282_1280_1306_Disease)) (PP (IN of) (NP (DT the) (NN rat))))))))) (. .)))
3137399	0	(ROOT (S (NP (NP (DT A) (JJ prospective) (NN study)) (PP (IN on) (NP (NP (DT the) (NN dose) (NN dependency)) (PP (IN of) (NP (NNS Doc_3137399_46_60_Disease)))))) (VP (VBN induced) (PP (IN by) (NP (NNS Doc_3137399_72_83_Chemical)))) (. .)))
3137399	1	(ROOT (S (PP (IN Since) (NP (CD 1975))) (NP (NP (NNS Doc_3137399_96_107_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_3137399_109_112_Chemical)) (-RRB- -RRB-))) (VP (VBZ has) (VP (VBN been) (VP (VBN suggested) (S (VP (TO to) (VP (VB be) (NP (NNS Doc_3137399_139_150_Disease)) (, ,) (SBAR (WHADVP (RB especially) (WRB when)) (S (VP (VP (VBN combined) (PP (IN with))) (CC or) (VP (VBN given) (PP (VBG following) (NP (NNS Doc_3137399_201_212_Chemical))))))))))))) (. .)))
3137399	2	(ROOT (S (NP (NP (NNP Data)) (PP (IN on) (NP (NP (NN dose)) (UCP (NN dependency) (CC or) (JJ incidence)))) (PP (VBG concerning) (NP (DT this) (NN side) (NN effect)))) (VP (VBD were) (RB not) (VP (VBN known))) (. .)))
3137399	3	(ROOT (S (NP (PRP We)) (VP (VBP have) (VP (VBN initiated) (NP (DT a) (JJ prospective) (NN study)) (S (VP (TO to) (VP (VB obtain) (NP (DT some) (JJR more) (NN data)) (PP (IN on) (NP (DT these) (NNS subjects)))))))) (. .)))
3137399	4	(ROOT (S (S (NP (JJ Forty-four) (NN Doc_3137399_388_391_Chemical-treated) (NNS patients)) (VP (VBD were) (VP (VBN studied)))) (, ,) (NP (NP (CD 37)) (PP (IN of) (NP (PRP them)))) (VP (MD could) (VP (VB be) (VP (VBN evaluated)))) (. .)))
3137399	5	(ROOT (S (NP (DT All) (NNS patients)) (VP (VBD were) (VP (VBN studied) (PP (IN by) (NP (NP (NP (NP (JJ repeated) (JJ physical) (NNS examinations)) (, ,) (NP (NN chest) (NNS X-rays)) (, ,)) (NN electro)) (: -) (CC and) (NP (ADJP (JJ echocardiography) (CC and) (JJ radionuclide)) (JJ left) (NN ventricular) (NN ejection) (NN fraction) (PRN (-LRB- -LRB-) (NP (NNP EF)) (-RRB- -RRB-)) (NNS determinations)))))) (. .)))
3137399	6	(ROOT (S (NP (DT The) (NNS results)) (VP (VBD were) (VP (VBN evaluated) (PP (IN per) (NP (JJ cumulative) (NN dose) (NN level))))) (. .)))
3137399	7	(ROOT (S (NP (NP (CD One)) (PP (IN of) (NP (DT the) (NNS patients)))) (VP (VBD developed) (NP (NNS Doc_3137399_716_731_Disease)) (PP (IN after) (NP (NP (QP (CD 30) (CD mg)) (JJ m-2) (NNS Doc_3137399_748_751_Chemical)) (CC and) (NP (QP (RB only) (CD 150) (CD mg)) (JJ m-2) (NNS Doc_3137399_772_783_Chemical))))) (. .)))
3137399	8	(ROOT (S (NP (DT The) (NNS Doc_3137399_789_804_Disease)) (VP (VBD was) (VP (VBN predicted) (PP (IN by) (NP (NP (DT a) (NN drop)) (PP (IN in) (NP (NP (NNP EF)) (VP (VBN determined) (PP (IN during) (NP (DT a) (JJ cold) (NN pressor) (NN test)))))))))) (. .)))
3137399	9	(ROOT (S (NP (NP (NN None)) (PP (IN of) (NP (DT the) (JJ other) (NNS patients)))) (VP (VP (VBD developed) (NP (JJ clinical) (NNS Doc_3137399_920_934_Disease))) (, ,) (CC nor) (VP (VBD did) (NP (DT the) (JJ studied) (NNS parameters) (NN change)))) (. .)))
3137399	10	(ROOT (S (NP (NP (DT The) (NN literature)) (PP (IN on) (NP (DT this) (NN subject)))) (VP (VBD was) (VP (ADVP (RB also)) (VBN reviewed))) (. .)))
3137399	11	(ROOT (S (PP (VBN Based) (PP (IN on) (NP (NP (DT the) (VBN combined) (NNS data)) (PP (IN from) (NP (NP (DT the) (JJ present) (NN study)) (CC and) (NP (DT the) (NN literature))))))) (, ,) (NP (PRP we)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NN Doc_3137399_1111_1114_Chemical-related) (NNS Doc_3137399_1123_1137_Disease)) (VP (VBZ is) (VP (VBN dose) (S (ADJP (JJ dependent))) (, ,) (S (VP (VBG occurring) (PP (IN at) (NP (NP (JJ cumulative) (NN dose) (NNS levels)) (PP (IN of) (NP (NP (CD 30) (NN mg)) (ADJP (JJ m-2) (CC or) (JJR more))))) (, ,) (ADVP (RB mainly))) (PP (IN in) (NP (NP (NNS patients)) (VP (ADVP (ADVP (RB also)) (PRN (-LRB- -LRB-) (ADVP (RB previously) (CC or) (RB simultaneously)) (-RRB- -RRB-))) (VBN treated) (PP (IN with) (NP (NNS Doc_3137399_1283_1294_Chemical))))))))))))) (. .)))
3137399	12	(ROOT (S (NP (DT The) (NN incidence)) (VP (VBZ is) (ADJP (JJ likely) (S (VP (TO to) (VP (VB be) (NP (NP (QP (JJR less) (IN than) (CD 10)) (NN %)) (PP (RB even) (IN for) (NP (DT this) (NN risk) (NN group))))))))) (. .)))
3183120	0	(ROOT (NP (NP (NP (JJ Reversible) (NNS Doc_3183120_11_27_Disease)) (VP (VBN associated) (PP (IN with) (NP (JJ Doc_3183120_44_54_Chemical) (NN usage))))) (: :) (NP (NP (NNP MR)) (NP (NN demonstration))) (. .)))
3183120	1	(ROOT (S (NP (NNP Doc_3183120_80_90_Chemical)) (VP (VBZ is) (NP (NP (DT an) (JJ experimental) (JJ chemotherapeutic) (NN agent)) (VP (ADVP (RB currently)) (VBG undergoing) (NP (JJ clinical) (NN evaluation))))) (. .)))
3183120	2	(ROOT (S (NP (PRP We)) (VP (VBP report) (NP (PRP$ our) (NNS results)) (PP (IN with) (NP (NP (NP (JJ magnetic) (NN resonance)) (PRN (-LRB- -LRB-) (NP (NNP MR)) (-RRB- -RRB-))) (PP (IN in) (S (VP (VBG demonstrating) (S (NP (JJ reversible) (NNS Doc_3183120_254_276_Disease)) (ADJP (JJ concurrent) (PP (IN with) (NP (NP (DT the) (NN use)) (PP (IN of) (NP (DT this) (NN drug))))))))))))) (. .)))
3183120	3	(ROOT (S (NP (NP (DT The) (NNS abnormalities)) (PP (IN on) (NP (NNP MR)))) (VP (VBD were) (VP (VBN correlated) (PP (PP (IN with) (NP (NP (NNS findings)) (PP (IN on) (NP (NNP CT))))) (CONJP (RB as) (RB well) (IN as)) (PP (IN with) (NP (JJ cerebral) (NN angiography)))))) (. .)))
3183120	4	(ROOT (S (NP (NP (DT The) (NN utility)) (PP (IN of) (NP (NP (NNP MR)) (PP (IN in) (NP (NP (DT the) (NN evaluation)) (PP (IN of) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (DT this) (JJ new) (NN agent)))))))))) (VP (VBZ is) (VP (VBN illustrated))) (. .)))
3220106	0	(ROOT (NP (NP (JJ Receptor) (NNS mechanisms)) (PP (IN of) (NP (NN Doc_3220106_23_31_Chemical-induced) (NNS Doc_3220106_40_63_Disease))) (PP (IN in) (NP (JJ chronic) (NN Doc_3220106_75_83_Chemical-treated) (NNS rats))) (. .)))
3220106	1	(ROOT (S (NP (NNS Rats)) (VP (VBD were) (VP (VBN pretreated) (PP (IN with) (NP (NP (NN saline) (CC or) (NNS Doc_3220106_134_142_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (CD 1.5) (NN mg/kg)) (PP (IN per) (NP (NN day)))) (-RRB- -RRB-)))) (PP (IN by) (S (ADVP (RB subcutaneously)) (VP (VBG implanting) (NP (NP (DT each) (NN animal)) (PP (IN with) (NP (DT an) (NNP Alzet) (JJ osmotic) (NN mini-pump))) (SBAR (WHNP (WDT which)) (S (ADVP (RB continuously)) (VP (VBD released) (NP (NN saline) (CC or) (NNS Doc_3220106_274_282_Chemical)) (PP (IN for) (NP (CD 1) (, ,) (CD 5) (CC and) (CD 14))) (NP (NNS days))))))))))) (. .)))
3220106	2	(ROOT (S (PP (IN At) (NP (NP (DT the) (NN end)) (PP (IN of) (NP (DT each) (JJ pretreatment) (NN period))))) (, ,) (NP (NNS animals)) (VP (VBD were) (VP (VBN used) (PP (IN for) (S (-LRB- -LRB-) (NP (FW i)) (-RRB- -RRB-) (VP (VP (VP (VBG determining) (NP (PRP$ their) (NN locomotor) (NN response)) (PP (TO to) (NP (NP (ADJP (RB acutely) (JJ injected)) (NNS Doc_3220106_428_436_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 0.2) (NN mg/kg)) (, ,) (NP (NNP s.c.)) (-RRB- -RRB-))))) (CC and) (PRN (-LRB- -LRB-) (S (VP (VB ii))) (-RRB- -RRB-)) (VP (VBG measuring) (NP (NP (DT the) (NN density)) (PP (IN of) (NP (NNS Doc_3220106_489_503_Chemical)))))) (CC and) (VP (VBG -LSB-) (NP (NP (CD 3H) (JJ -RSB-) (JJ Doc_3220106_512_521_Chemical) (JJ binding) (NNS sites)) (PP (IN in) (NP (DT the) (NN striatum)))))))))) (. .)))
3220106	3	(ROOT (S (S (NP (PRP We)) (VP (VBD observed) (NP (DT no) (NNS changes)) (PP (IN in) (NP (NP (NN Doc_3220106_579_587_Chemical-induced) (NN locomotor) (NN response)) (, ,) (NP (NNP striatal) (NNP L)))))) (: -) (S (NP (NP (QP (CD -LSB-) (CD 3H)) (JJ -RSB-) (NNS Doc_3220106_631_639_Chemical)) (CC and) (NP (NP (QP (CD -LSB-) (CD 3H)) (JJ -RSB-) (NNS Doc_3220106_648_657_Chemical)) (ADJP (JJ binding) (PP (IN in) (NP (DT the) (NNS animals)))))) (VP (VBD pretreated) (PP (IN with) (NP (NP (NNS Doc_3220106_697_705_Chemical)) (PP (IN for) (NP (CD 1))))) (NP (NN day)))) (. .)))
3220106	4	(ROOT (S (PP (IN In) (NP (NP (NNS rats)) (SBAR (WHNP (WDT which)) (S (VP (VBD were) (VP (VBN pretreated) (PP (IN with) (NP (NP (NNS Doc_3220106_752_760_Chemical)) (PP (IN for) (NP (CD 5) (NNS days))))))))))) (, ,) (NP (EX there)) (VP (VBD was) (NP (NP (DT a) (JJ significant) (NN increase)) (PP (IN in) (NP (DT the) (NN Doc_3220106_813_821_Chemical-stimulated) (NN locomotor) (NN response))) (SBAR (WHNP (WDT which)) (S (VP (VBD was) (VP (VP (VBN associated) (PP (IN with) (NP (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (NP (DT the) (NN number)) (PP (IN of) (NP (NNP L)))))) (: -) (NP (QP (CD -LSB-) (CD 3H)) (NNP -RSB-) (JJ Doc_3220106_913_921_Chemical) (VBG binding) (NNS sites))))) (CC and) (VP (ADVP (RB also)) (PP (IN with) (NP (NP (DT an) (NP (NP (JJ elevated) (NNS Doc_3220106_962_970_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP DA)) (-RRB- -RRB-))) (NN level)) (PP (IN in) (NP (DT the) (NN striatum)))))))))))) (. .)))
3220106	5	(ROOT (S (NP (NP (DT The) (NN number)) (PP (IN of) (NP (JJ striatal) (JJ -LSB-) (CD 3H) (ADJP (NP (CD -RSB-) (NNS Doc_3220106_1026_1035_Chemical)) (JJ binding)) (NNS sites)))) (VP (VBD was) (RB not) (VP (VBN affected))) (. .)))
3220106	6	(ROOT (S (PP (IN In) (NP (NP (NNS animals)) (VP (VBN pretreated) (PP (IN with) (NP (NP (NNS Doc_3220106_1095_1103_Chemical)) (PP (IN for) (NP (CD 14) (NNS days)))))))) (, ,) (NP (DT the) (NN Doc_3220106_1121_1129_Chemical-induced) (NN locomotor) (NN response)) (VP (VBD remained) (S (VP (TO to) (VP (VB be) (VP (VBN potentiated)))))) (. .)))
3220106	7	(ROOT (S (ADVP (RB However)) (, ,) (NP (DT this) (NN response)) (VP (VBD was) (VP (VBN correlated) (PP (IN with) (NP (NP (DT an) (JJ elevated) (NN number)) (PP (IN of) (NP (NP (JJ striatal) (JJ -LSB-) (CD 3H) (ADJP (NP (CD -RSB-) (NNS Doc_3220106_1263_1272_Chemical)) (JJ binding)) (NNS sites)) (, ,) (SBAR (IN whereas) (S (NP (NP (DT the) (NN number)) (PP (IN of) (NP (NP (NNP striatal) (NNP L)) (: -) (NP (NP (QP (CD -LSB-) (CD 3H)) (NNP -RSB-) (JJ Doc_3220106_1325_1333_Chemical) (VBG binding) (NNS sites)) (CC and) (NP (DT the) (JJ striatal) (NNP DA) (NN level)))))) (VP (VBD were) (ADJP (JJ normal))))))))))) (. .)))
3220106	8	(ROOT (S (NP (DT These) (NNS results)) (VP (VBP suggest) (SBAR (IN that) (S (NP (JJ chronic) (NN Doc_3220106_1422_1430_Chemical-treated) (NNS rats)) (VP (VBP develop) (NP (NP (NNS Doc_3220106_1452_1475_Disease)) (PP (IN in) (NP (NN response)))) (PP (TO to) (NP (NP (NP (NNS Doc_3220106_1491_1499_Chemical)) (ADVP (RB initially))) (ADJP (JJ due) (PP (TO to) (NP (NP (NNS increases)) (PP (IN of) (NP (NP (PDT both) (DT the) (NN density)) (PP (IN of) (NP (NP (JJ nicotinic) (NNS receptors)) (CC and) (NP (NNP DA) (NN concentration))))))))) (, ,) (VP (VBN followed) (PP (IN by) (S (VP (VBG inducing) (NP (NNP DA) (NN receptor)) (ADVP (RB supersensitivity)) (PP (IN in) (NP (DT the) (NN striatum))))))))))))) (. .)))
326460	0	(ROOT (NP (NP (NNP Amelioration)) (PP (IN of) (NP (NN Doc_326460_16_30_Chemical-induced) (NNS Doc_326460_39_50_Disease))) (PP (IN by) (NP (NNS Doc_326460_54_61_Chemical))) (. .)))
326460	1	(ROOT (S (NP (NP (DT The) (JJ beta) (JJ adrenergic) (NN blocking) (NN drug)) (, ,) (NP (NNS Doc_326460_98_105_Chemical)) (, ,)) (VP (VBD tended) (SBAR (SBAR (S (VP (TO to) (VP (VB correct) (NP (NP (DT the) (NNS Doc_326460_129_140_Disease)) (PP (IN of) (NP (NP (JJ short-term) (JJ Doc_326460_155_169_Chemical) (NN treatment)) (PP (IN in) (NP (ADJP (CD 6) (JJ healthy) (NN male)) (NNS subjects)))))))))) (CC and) (SBAR (IN although) (S (NP (DT the) (NN effect)) (VP (VBD was) (ADJP (JJ small) (SBAR (S (NP (PRP it)) (VP (VBD was) (ADJP (JJ significant))))))))))) (. .)))
326460	2	(ROOT (S (NP (NNP Doc_326460_261_268_Chemical)) (ADVP (RB also)) (VP (VP (VBD reduced) (NP (NP (DT the) (NN rise)) (PP (IN in) (NP (NN plasma) (NNS Doc_326460_301_312_Chemical) (CC and) (NN urine) (NNS Doc_326460_323_332_Chemical)))) (NP (JJ excretion) (JJ following) (NNS Doc_326460_353_367_Chemical))) (CC and) (VP (VBD increased) (NP (DT the) (ADJP (NP (CD urine) (NNS Doc_326460_392_398_Chemical)) (JJ /)) (JJ Doc_326460_399_408_Chemical) (NN ratio)))) (. .)))
326460	3	(ROOT (S (NP (EX There)) (VP (VBD was) (NP (NP (DT no) (NN evidence)) (PP (IN of) (NP (NP (DT a) (NN shift)) (PP (IN of) (NP (NP (NNS Doc_326460_452_461_Chemical)) (PP (IN from) (NP (NP (DT the) (NN intracellular)) (PP (TO to) (NP (DT the) (NN extracellular) (NN space))))))))))) (. .)))
3300918	0	(ROOT (NP (NP (NP (NNP St.) (NNP Doc_3300918_4_18_Disease)) (, ,) (ADVP (RB then) (CC and) (RB now))) (: :) (NP (NP (DT a) (NN case) (NN report)) (CC and) (NP (JJ historical) (NN review))) (. .)))
3300918	1	(ROOT (S (NP (NP (NP (DT A) (JJ rare) (NN case)) (PP (IN of) (NP (JJ morbid) (NNS Doc_3300918_93_102_Disease)))) (, ,) (RRC (ADVP (RB together)) (PP (IN with) (NP (JJ striking) (JJ angiographic) (NNS findings)))) (, ,)) (VP (VBZ is) (VP (VBN described) (ADJP (JJ secondary) (PP (TO to) (NP (NP (DT the) (NN ingestion)) (PP (IN of) (NP (NNS Doc_3300918_193_205_Chemical)))))) (PP (IN by) (NP (DT a) (JJ 48-year-old) (NN woman))))) (. .)))
3300918	2	(ROOT (S (NP (NP (DT A) (JJ brief) (NN review)) (PP (IN of) (NP (NP (DT the) (NN literature)) (PP (IN on) (NP (JJ similar) (NNS cases)))))) (VP (VBZ is) (VP (VBN presented))) (. .)))
3300918	3	(ROOT (S (NP (NP (DT A) (NN discussion)) (PP (IN of) (NP (NP (DT the) (NN history)) (PP (IN of) (NP (NN ergot)))))) (VP (VBZ includes) (NP (NP (PRP$ its) (JJ original) (NN discovery)) (, ,) (NP (NP (DT the) (NNS epidemics)) (PP (IN of) (NP (NN gangrene))))) (SBAR (IN that) (S (NP (PRP it)) (VP (VBZ has) (VP (VBN caused) (PP (IN through) (NP (NP (DT the) (NNS ages)) (CC and) (NP (NP (PRP$ its) (ADJP (NN past) (CC and) (NN present)) (NN role)) (PP (IN in) (NP (NP (DT the) (NN management)) (PP (IN of) (NP (JJ Doc_3300918_477_485_Disease) (NNS Doc_3300918_486_494_Disease))))))))))))) (. .)))
3300918	4	(ROOT (S (PP (IN Despite) (NP (NP (DT the) (NN advent)) (PP (IN of) (NP (NP (JJ Doc_3300918_518_525_Chemical) (NN channel) (NNS blockers)) (CC and) (NP (JJ beta-adrenergic) (NNS antagonists)))))) (, ,) (NP (NN ergot) (NNS preparations)) (VP (VBP continue) (S (VP (TO to) (VP (VB play) (NP (DT a) (JJ major) (NN role)) (PP (IN in) (NP (JJ Doc_3300918_628_636_Disease) (NN therapy))) (, ,) (SBAR (RB so) (IN that) (S (NP (NP (DT the) (NN danger)) (PP (IN of) (NP (NNP St.) (NNP Doc_3300918_672_686_Disease)))) (VP (VBZ persists)))))))) (. .)))
3311455	0	(ROOT (NP (NP (NNP Cardiac) (NNP transplantation)) (: :) (NP (NP (VBN improved) (NN quality)) (PP (IN of) (NP (NP (NN survival)) (PP (IN with) (NP (DT a) (VBN modified) (NN immunosuppressive) (NN protocol)))))) (. .)))
3311455	1	(ROOT (S (NP (NP (DT The) (NNS effects)) (PP (IN on) (NP (NP (JJ renal) (NN function)) (PP (IN on) (NP (CD two) (JJ different) (NN immunosuppressive) (NNS protocols)))))) (VP (VBD were) (VP (VBN evaluated) (ADVP (RB retrospectively)) (PP (IN in) (NP (NP (CD two) (JJ subsequent) (NNS groups)) (PP (IN of) (NP (NN heart) (NN transplant) (NNS recipients))))))) (. .)))
3311455	2	(ROOT (S (PP (IN In) (NP (NN group) (NN I))) (, ,) (NP (NNS Doc_3311455_273_285_Chemical)) (VP (VBD was) (VP (VP (VBN given) (PP (IN before) (NP (NP (DT the) (NN procedure)) (PP (IN at) (NP (NP (DT a) (NN loading) (NN dose)) (PP (IN of) (NP (CD 17.5) (NN mg/kg)))))))) (CC and) (VP (ADVP (RB then)) (VBN continued) (PP (IN after) (NP (DT the) (NN procedure))) (S (VP (TO to) (VP (VB keep) (NP (DT a) (JJ whole) (NN blood) (NN level)) (PP (IN about) (NP (CD 1000) (NN ng/ml))))))))) (. .)))
3311455	3	(ROOT (S (PP (IN In) (NP (NN group) (NNP II))) (, ,) (NP (NNS Doc_3311455_447_459_Chemical)) (VP (VP (VBD was) (VP (VBN started) (ADVP (RB only)) (PP (IN after) (NP (NP (DT the) (NN procedure)) (PP (IN at) (NP (DT a) (JJR lower) (NN dosage))))))) (CC and) (VP (VBD was) (VP (VBN complemented) (PP (IN by) (NP (NP (NNS Doc_3311455_539_551_Chemical)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD was) (VP (VBN used) (PP (IN for) (NP (DT the) (JJ first) (NN postoperative))) (NP (NN week))))))))))) (. .)))
3311455	4	(ROOT (S (NP (NNP Group) (NNP II)) (VP (VBD showed) (NP (DT a) (ADJP (RBR better) (JJ perioperative)) (JJ renal) (NN function)) (PP (IN as) (NP (ADJP (VBN determined) (PP (IN by) (NP (NN serum) (NNS Doc_3311455_679_698_Chemical) (CC and) (NN serum) (NNS Doc_3311455_709_719_Chemical)))) (NNS levels)))) (. .)))
3311455	5	(ROOT (S (NP (NNP Group) (NNP II)) (ADVP (RB also)) (VP (VBD showed) (NP (NP (DT a) (JJ significant) (NN decrease)) (PP (IN of) (NP (JJ chronic) (NN nephrotoxicity) (JJ secondary)))) (PP (TO to) (NP (JJ long-term) (NN therapy))) (PP (IN with) (NP (NNS Doc_3311455_834_846_Chemical)))) (. .)))
3311455	6	(ROOT (S (PP (IN Despite) (NP (NP (DT this) (NN improvement)) (PP (IN in) (NP (JJ late) (JJ renal) (NN function))))) (, ,) (NP (NN group) (NNP II)) (ADVP (RB still)) (VP (VBZ shows) (NP (NP (DT a) (JJ slow) (NN rise)) (PP (IN in) (NP (NN serum) (NNS Doc_3311455_939_949_Chemical))))) (. .)))
3311455	7	(ROOT (S (NP (PRP We)) (VP (VBP think) (SBAR (SBAR (IN that) (S (ADVP (RB even)) (NP (NP (DT these) (JJR lower) (NNS dosages)) (PP (IN of) (NP (NNS Doc_3311455_993_1005_Chemical)))) (VP (MD can) (VP (VB cause) (NP (JJ chronic) (NN nephrotoxicity)))))) (CC and) (SBAR (IN that) (S (NP (NP (JJ further) (NN modification)) (PP (IN of) (NP (DT the) (JJ immunosuppressive) (NN regimen)))) (VP (VBZ is) (VP (VBN required) (S (VP (TO to) (VP (ADVP (RB completely)) (VB abolish) (NP (DT this) (JJ toxic) (NN side) (NN effect))))))))))) (. .)))
33969	0	(ROOT (NP (NP (NNS Doc_33969_0_13_Chemical) (CC and) (NNS Doc_33969_18_29_Chemical)) (PP (IN in) (NP (JJ neuroleptic-induced) (NNS Doc_33969_53_65_Disease))) (. .)))
33969	1	(ROOT (S (PP (IN In) (NP (DT a) (JJ 12-week) (JJ controlled) (NN study))) (NP (NNS Doc_33969_97_110_Chemical)) (VP (VBD was) (PP (VBN compared) (PP (TO to) (NP (NP (NNS Doc_33969_127_138_Chemical)) (PP (IN in) (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (NP (NNS Doc_33969_159_171_Disease)) (VP (VBN induced) (PP (IN by) (NP (NP (NNS Doc_33969_183_205_Chemical)) (PP (IN in) (NP (CD 60) (JJ Doc_33969_212_225_Disease) (NNS outpatients)))))))))))))) (. .)))
33969	2	(ROOT (S (NP (NNS Doc_33969_239_252_Chemical) (CC and) (NNS Doc_33969_257_268_Chemical)) (VP (VP (VBD were) (VP (VBN found) (S (VP (TO to) (VP (VB be) (ADJP (RB equally) (JJ effective) (PP (IN in) (NP (VBG controlling) (NNS Doc_33969_319_340_Disease))))))))) (CC and) (VP (VBD were) (ADJP (RB as) (JJ efficacious)) (PP (IN as) (NP (NP (NNS Doc_33969_368_380_Chemical)) (, ,) (NP (PRP$ their) (JJ previous) (NN antiparkinsonian) (NN drug)))))) (. .)))
33969	3	(ROOT (S (ADVP (RB However)) (, ,) (S (NP (NNS Doc_33969_429_440_Chemical)) (VP (VBD treated) (SBAR (S (NP (NNS patients)) (VP (VBD had) (NP (NP (DT a) (JJ significant) (NN increase)) (PP (IN in) (NP (NNS Doc_33969_488_506_Disease)))) (PP (VBN compared) (PP (TO to) (NP (NP (PRP$ their) (NN condition)) (PP (IN during) (NP (JJ Doc_33969_542_555_Chemical) (NN treatment))))))))))) (, ,) (CC and) (S (NP (NP (ADJP (RB significantly) (JJR more)) (NNS Doc_33969_590_597_Disease) (CC and) (NNS Doc_33969_602_612_Disease)) (PP (IN than) (NP (NNS Doc_33969_618_631_Chemical)))) (VP (VBD treated) (NP (NNS patients)))) (. .)))
33969	4	(ROOT (S (NP (DT This)) (VP (VBZ suggests) (SBAR (IN that) (S (NP (NNS Doc_33969_669_680_Chemical)) (VP (VBZ is) (RB not) (NP (NP (DT the) (JJ anticholinergic) (NN drug)) (PP (IN of) (NP (NN choice)))) (PP (PP (IN in) (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (JJ neuroleptic-induced) (NNS Doc_33969_763_784_Disease))))) (, ,) (RB because) (PP (IN of) (NP (NP (PRP$ its) (ADJP (RBR more) (JJ toxic)) (NN central)) (CC and) (NP (JJ peripheral) (JJ atropinic) (NN effect))))))))) (. .)))
3411101	0	(ROOT (NP (NP (JJ Doc_3411101_0_32_Chemical-induced) (NN fulminant) (NNS Doc_3411101_51_60_Disease)) (PP (IN in) (NP (DT a) (JJ pregnant) (NN woman))) (. .)))
3411101	1	(ROOT (S (NP (DT A) (NN case)) (VP (VBP report)) (. .)))
3411101	2	(ROOT (S (NP (PRP We)) (VP (VBP report) (NP (NP (DT the) (NN case)) (PP (IN of) (NP (NP (DT a) (JJ 19-year-old) (JJ Laotian) (NN patient)) (VP (VBN affected) (PP (IN by) (NP (JJ fulminant) (NNS Doc_3411101_171_180_Disease))) (PP (IN during) (NP (NP (DT the) (JJ third) (NN trimester)) (PP (IN of) (NP (PRP$ her) (NN pregnancy))))) (PP (IN after) (NP (NP (DT a) (JJ 1-month) (NN administration)) (PP (IN of) (NP (NNS Doc_3411101_259_291_Chemical)))))))))) (. .)))
3411101	3	(ROOT (S (PP (IN After) (NP (NN delivery))) (, ,) (NP (DT the) (NN patient)) (VP (VBD underwent) (NP (JJ orthotopic) (NN liver) (NN transplantation))) (. .)))
3411101	4	(ROOT (S (NP (DT The) (NN patient)) (VP (VBD was) (PP (IN in) (NP (JJ good) (NN condition))) (NP (CD 16) (NNS months)) (PP (IN after) (NP (NN liver) (NN transplantation)))) (. .)))
3411101	5	(ROOT (S (ADVP (RB Doc_3411101_438_447_Chemical)) (NP (PRP itself) (CC or) (NNS Doc_3411101_458_480_Chemical)) (VP (MD may) (VP (VB be) (ADJP (JJ responsible) (PP (IN for) (NP (NP (JJ fulminant) (NNS Doc_3411101_514_523_Disease)) (PP (IN in) (NP (DT this) (NN patient)))))))) (. .)))
3413271	0	(ROOT (NP (NP (NP (NNPS Mechanisms)) (PP (IN of) (NP (NP (NNS Doc_3413271_14_33_Disease)) (VP (VBN induced) (PP (IN by) (NP (NNS Doc_3413271_45_56_Chemical))))))) (: :) (NP (NP (NN comparison)) (PP (IN with) (NP (JJ exercise-induced) (NNS Doc_3413271_91_99_Disease)))) (. .)))
3413271	1	(ROOT (S (NP (NP (DT The) (NN role)) (PP (IN of) (NP (NP (NNS Doc_3413271_113_124_Chemical)) (PP (IN in) (NP (VBG eliciting) (NNS Doc_3413271_138_157_Disease)))))) (VP (VBD was) (VP (VBN examined) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NNS Doc_3413271_188_211_Disease))))))) (. .)))
3413271	2	(ROOT (S (NP (NP (JJ Objective) (NNS signs)) (PP (IN of) (NP (NP (NNS Doc_3413271_232_240_Disease) (CC and) (NNS factors)) (VP (VBG increasing) (NP (JJ myocardial) (JJ Doc_3413271_275_281_Chemical) (NN consumption)))))) (VP (VBD were) (VP (VBN compared) (PP (IN during) (NP (JJ Doc_3413271_315_326_Chemical) (NN infusion) (CC and) (NN supine) (NN bicycle) (NN exercise))))) (. .)))
3413271	3	(ROOT (S (NP (NP (DT Both) (NNS Doc_3413271_370_381_Chemical)) (CC and) (NP (NN exercise))) (VP (VBD produced) (NP (NNS Doc_3413271_404_423_Disease)) (PP (IN as) (NP (NNP evidenced))) (PP (IN by) (NP (NNP ST) (NN segment) (NNS Doc_3413271_451_461_Disease) (CC and) (NNS Doc_3413271_466_472_Disease)))) (. .)))
3413271	4	(ROOT (S (ADVP (RB However)) (, ,) (NP (NP (DT the) (NNS mechanisms)) (PP (IN of) (NP (NP (NNS Doc_3413271_501_520_Disease)) (VP (VBN induced) (PP (IN by) (NP (NNS Doc_3413271_532_543_Chemical))))))) (VP (VBD were) (ADJP (RB significantly) (JJ different)) (PP (IN from) (NP (NP (DT those)) (PP (IN of) (NP (NN exercise)))))) (. .)))
3413271	5	(ROOT (S (NP (JJ Exercise-induced) (NNS Doc_3413271_614_633_Disease)) (VP (VBD was) (VP (VBN marked) (ADVP (RB predominantly)) (PP (IN by) (NP (NP (VBN increased) (NN heart) (NN rate)) (CC and) (NP (NP (JJ rate-pressure) (NN product)) (PP (IN with) (NP (NP (DT a) (JJ minor) (NN contribution)) (PP (IN of) (NP (JJ end-diastolic) (NN volume)))))))) (, ,) (SBAR (IN while) (S (NP (NN Doc_3413271_766_777_Chemical-induced) (NNS Doc_3413271_786_794_Disease)) (VP (VBD was) (VP (VBN characterized) (PP (IN by) (NP (NP (NP (DT a) (JJ marked) (NN increase)) (PP (IN in) (NP (NN contractility)))) (CC and) (NP (NP (DT a) (ADJP (RBR less) (JJ pronounced)) (NN increase)) (PP (IN in) (NP (NP (NN heart) (NN rate)) (CC and) (NP (JJ rate-pressure) (NN product))))))))))))) (. .)))
3413271	6	(ROOT (S (NP (DT These) (NNS findings)) (VP (VBP indicate) (SBAR (IN that) (S (NP (NP (NNS Doc_3413271_952_960_Disease)) (VP (VBN produced) (PP (IN by) (NP (NNS Doc_3413271_973_984_Chemical)))) (, ,) (SBAR (IN as) (S (VP (MD may) (VP (VB occur) (PP (IN during) (NP (NP (NNS states)) (PP (IN of) (NP (JJ emotional) (NN distress))))))))) (, ,)) (VP (VBZ has) (NP (NP (DT a) (NN mechanism)) (ADJP (JJ distinct) (PP (IN from) (NP (DT that) (ADJP (JJ due) (TO to) (JJ physical)) (NN exertion))))))))) (. .)))
3431591	0	(ROOT (S (NP (NP (JJ Recent) (JJ preclinical) (CC and) (JJ clinical) (NNS studies)) (PP (IN with) (NP (DT the) (NN thymidylate)))) (VP (VBP synthase) (NP (NP (NN inhibitor) (NNS Doc_3431591_80_115_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_3431591_117_124_Chemical)) (-RRB- -RRB-)))) (. .)))
3431591	1	(ROOT (S (NP (NP (NNP Doc_3431591_127_134_Chemical)) (, ,) (NP (NNS Doc_3431591_136_171_Chemical)) (, ,)) (VP (VBZ is) (NP (NP (NP (DT a) (JJ tight-binding) (NN inhibitor)) (PP (IN of) (NP (JJ thymidylate) (NN synthase)))) (PRN (-LRB- -LRB-) (NP (NNP TS)) (-RRB- -RRB-)) (SBAR (WP$ whose) (S (NP (NNS Doc_3431591_237_249_Disease)) (VP (VBZ is) (VP (VBN mediated) (ADVP (RB solely)) (PP (IN through) (NP (NP (DT the) (NN inhibition)) (PP (IN of) (NP (DT this) (NN enzyme))))))))))) (. .)))
3431591	2	(ROOT (S (NP (JJ Recent) (JJ preclinical) (NNS studies)) (VP (VBP have) (VP (VBN focused) (PP (IN on) (NP (NP (DT the) (NN intracellular) (NN formation)) (PP (IN of) (NP (JJ Doc_3431591_382_389_Chemical) (NNS polyglutamates))))))) (. .)))
3431591	3	(ROOT (S (PP (VBG Following) (NP (NP (DT a) (JJ 12-hour) (NN exposure)) (PP (IN of) (NP (NP (CD L1210) (NNS cells)) (PP (TO to) (NP (CD 50) (JJ microM) (JJ -LSB-) (CD 3H) (JJ -RSB-) (NNS Doc_3431591_467_474_Chemical))))))) (, ,) (NP (NP (CD 30) (NN %)) (PP (IN of) (NP (DT the) (JJ extractable) (NN radioactivity)))) (VP (MD could) (VP (VB be) (VP (VBN accounted) (PP (IN for) (NP (ADJP (ADJP (RB as) (RB Doc_3431591_539_546_Chemical) (JJ tetra)) (: -) (CC and) (ADJP (JJ Doc_3431591_558_572_Chemical)) (, ,) (IN as) (ADJP (JJ determined) (PP (IN by) (NP (JJ high-pressure) (JJ liquid) (NN chromatography))))) (PRN (-LRB- -LRB-) (NP (NNP HPLC)) (-RRB- -RRB-)) (NNS analyses)))))) (. .)))
3431591	4	(ROOT (S (S (SBAR (IN As) (S (FRAG (ADJP (JJ inhibitors) (PP (IN of) (NP (JJ isolated) (NNP L1210) (NNP TS)))) (, ,) (NP (NNP Doc_3431591_680_687_Chemical) (NNP di)) (: -)) (, ,) (FRAG (ADVP (RB tri)) (: -)))) (, ,) (NP (NP (NN tetra)) (: -) (CC and) (NP (NNS Doc_3431591_710_724_Chemical))) (VP (VBP are) (NP (NP (NP (NP (CD 26) (NNS -)) (, ,) (NP (CD 87) (NNS -)) (, ,)) (ADJP (JJ 119) (: -) (CC and) (JJ 114-fold))) (ADJP (RBR more) (JJ potent))) (PP (IN than) (NP (NNS Doc_3431591_774_781_Chemical))) (, ,) (ADVP (RB respectively)))) (, ,) (CC and) (S (NP (PRP$ their) (NN formation)) (VP (MD may) (, ,) (ADVP (RB therefore)) (, ,) (VP (VB be) (NP (NP (DT an) (JJ important) (NN determinant)) (PP (IN of) (NP (JJ Doc_3431591_864_871_Chemical) (NNS Doc_3431591_872_884_Disease))))))) (. .)))
3431591	5	(ROOT (S (PP (IN In) (NP (NP (JJ early) (JJ clinical) (NNS studies)) (PP (IN with) (NP (NNS Doc_3431591_917_924_Chemical))))) (, ,) (NP (NN activity)) (VP (VBZ has) (VP (VBN been) (VP (VBN seen) (PP (IN in) (NP (NNS Doc_3431591_952_965_Disease) (, ,) (NNS Doc_3431591_967_981_Disease) (, ,) (NNS Doc_3431591_983_991_Disease) (, ,) (CC and) (NNS Doc_3431591_997_1009_Disease)))))) (. .)))
3431591	6	(ROOT (S (NP (NNP Doc_3431591_1011_1021_Disease)) (VP (VBD included) (NP (NN hepatotoxicity) (, ,) (NN malaise) (, ,) (CC and) (NN dose-limiting)) (ADVP (RB nephrotoxicity))) (. .)))
3431591	7	(ROOT (S (NP (DT This) (JJ latter) (NN effect)) (VP (VBZ is) (VP (VBN thought) (S (VP (TO to) (VP (VB be) (ADJP (JJ due) (PP (TO to) (NP (NP (NN drug) (NN precipitation)) (PP (IN within) (NP (DT the) (JJ renal) (NN tubule)))))) (PP (IN as) (NP (NP (DT a) (NN result)) (PP (IN of) (NP (NP (DT the) (JJ poor) (NN solubility)) (PP (IN of) (NP (NNS Doc_3431591_1214_1221_Chemical))))))) (PP (IN under) (NP (JJ acidic) (NNS conditions)))))))) (. .)))
3431591	8	(ROOT (S (PP (IN In) (NP (DT an) (NN attempt) (S (VP (TO to) (VP (VB overcome) (NP (DT this) (NN problem))))))) (, ,) (NP (NP (DT a) (JJ clinical) (NN trial)) (PP (IN of) (NP (NP (NNS Doc_3431591_1307_1314_Chemical)) (VP (VBN administered) (PP (IN with) (NP (JJ alkaline) (NNS diuresis))))))) (VP (VBZ is) (PP (IN under) (NP (NN way)))) (. .)))
3431591	9	(ROOT (S (NP (NP (JJ Preliminary) (NNS results)) (PP (IN at) (NP (QP (CD 400) (CC and) (CD 500)) (NNS mg/m2)))) (VP (VBP suggest) (SBAR (IN that) (S (NP (NP (DT a) (NN reduction)) (PP (IN in) (NP (NN nephrotoxicity)))) (VP (MD may) (VP (VB have) (VP (VBN been) (VP (VBN achieved) (PP (IN with) (NP (NP (RB only) (CD 1) (NN instance)) (PP (IN of) (NP (NP (NNS Doc_3431591_1496_1510_Disease)) (PP (IN in) (NP (CD 10) (NNS patients)))))))))))))) (. .)))
3431591	10	(ROOT (S (NP (NN Hepatotoxicity) (CC and) (NN malaise)) (VP (VBP are) (ADVP (RB again)) (NP (DT the) (RBS most) (JJ frequent) (NN side) (NNS effects))) (. .)))
3431591	11	(ROOT (S (NP (NP (NN Evidence)) (PP (IN of) (NP (NN antitumor) (NN activity)))) (VP (VBZ has) (VP (VBN been) (VP (VBN seen) (PP (IN in) (NP (CD 3) (NNS patients)))))) (. .)))
3431591	12	(ROOT (S (NP (JJ Pharmacokinetic) (NNS investigations)) (VP (VBP have) (VP (VBN shown) (SBAR (SBAR (IN that) (S (NP (JJ alkaline) (NNS diuresis)) (VP (VBZ does) (RB not) (VP (VB alter) (NP (JJ Doc_3431591_1736_1743_Chemical) (NN plasma) (NNS levels) (CC or) (NN urinary) (NNS excretion)))))) (CC and) (SBAR (IN that) (S (NP (JJ satisfactory) (NN urinary) (NN alkalinization)) (VP (MD can) (VP (VB be) (VP (ADVP (RB readily)) (VBN achieved))))))))) (. .)))
343678	0	(ROOT (NP (NP (NP (NNP Doc_343678_0_16_Disease)) (PP (IN after) (NP (JJ needle-stick) (NN exposure)))) (: :) (NP (NP (NN prevention)) (PP (IN with) (NP (JJ Doc_343678_62_73_Disease) (JJ immune) (NN globulin)))) (. .)))
343678	1	(ROOT (NP (NP (JJ Final) (NN report)) (PP (IN of) (NP (DT the) (NNP Veterans) (NNP Administration) (NNP Cooperative) (NNP Study))) (. .)))
343678	2	(ROOT (S (NP (NP (NP (JJ Doc_343678_154_165_Disease) (JJ immune) (NN globulin)) (PRN (-LRB- -LRB-) (NP (NNP HBIG)) (-RRB- -RRB-))) (CC and) (NP (NP (JJ immune) (NN serum) (NN globulin)) (PRN (-LRB- -LRB-) (NP (NNP ISG)) (-RRB- -RRB-)))) (VP (VBD were) (VP (VBN examined) (PP (IN in) (NP (DT a) (JJ randomized) (, ,) (JJ double-blind) (NN trial))) (S (VP (TO to) (VP (VB assess) (NP (PRP$ their) (JJ relative) (NNS efficacies)) (PP (IN in) (S (VP (VBG preventing) (NP (NNS Doc_343678_321_337_Disease)) (PP (IN after) (NP (JJ needle-stick) (NN exposure))) (PP (TO to) (NP (NP (NNS Doc_343678_369_396_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_343678_398_403_Chemical)) (-RRB- -RRB-)) (: -) (NP (JJ positive) (NNS donors)))))))))))) (. .)))
343678	3	(ROOT (S (S (NP (JJ Clinical) (NNS Doc_343678_431_440_Disease)) (VP (VBN developed) (PP (PP (IN in) (NP (NP (CD 1.4) (NN %)) (PP (IN of) (NP (NNP HBIG))))) (CC and) (PP (IN in) (NP (NP (CD 5.9) (NN %)) (PP (IN of) (NP (NNP ISG) (NNS recipients)))))) (PRN (-LRB- -LRB-) (NP (NNP P) (QP (CD =) (CD 0.016))) (-RRB- -RRB-)))) (, ,) (CC and) (S (NP (NP (NN seroconversion)) (PRN (-LRB- -LRB-) (NP (NNS anti-HBs)) (-RRB- -RRB-))) (VP (VBD occurred) (PP (IN in) (NP (NP (CD 5.6) (NN %)) (CC and) (NP (CD 20.7) (NN %)))) (PP (IN of) (NP (PRP them)) (ADVP (RB respectively))) (PRN (-LRB- -LRB-) (NP (NNP P) (QP (JJR less) (IN than) (CD 0.001))) (-RRB- -RRB-)))) (. .)))
343678	4	(ROOT (S (NP (JJ Mild) (CC and) (JJ transient) (NNS side-effects)) (VP (VBD were) (VP (VBN noted) (PP (PP (IN in) (NP (NP (CD 3.0) (NN %)) (PP (IN of) (NP (NNP ISG))))) (CC and) (PP (IN in) (NP (NP (CD 3.2) (NN %)) (PP (IN of) (S (VP (VBG HBIG) (NP (NNS recipients)))))))))) (. .)))
343678	5	(ROOT (S (NP (JJ Available) (NN donor) (NN sera)) (VP (VBD were) (VP (VBN examined) (PP (IN for) (NP (NP (NNP DNA) (NNP polymerase)) (PRN (-LRB- -LRB-) (NP (NNP DNAP)) (-RRB- -RRB-)) (CC and) (NP (JJ e) (NN antigen) (CC and) (NN antibody)) (PRN (-LRB- -LRB-) (NP (NP (NNS Doc_343678_788_793_Chemical)) (: ;) (NP (NN anti-HBE))) (-RRB- -RRB-)))))) (. .)))
343678	6	(ROOT (S (NP (DT Both) (NNP DNAP) (CC and) (NNP Doc_343678_820_825_Chemical)) (VP (VBD showed) (NP (DT a) (ADJP (RB highly) (RB statistically) (JJ significant)) (NN correlation)) (PP (IN with) (NP (NP (DT the) (NN infectivity)) (PP (IN of) (NP (NN Doc_343678_904_909_Chemical-positive) (NNS donors)))))) (. .)))
343678	7	(ROOT (S (NP (JJ Doc_343678_927_938_Disease) (JJ immune) (NN globulin)) (VP (VBD remained) (ADJP (RB significantly) (JJ superior) (PP (TO to) (NP (NNP ISG)))) (PP (IN in) (S (VP (VBG preventing) (NP (NNS Doc_343678_1008_1024_Disease)) (SBAR (RB even) (WHADVP (WRB when)) (S (NP (DT the) (NN analysis)) (VP (VBD was) (VP (VBN confined) (PP (TO to) (NP (DT these) (CD two) (JJ high-risk) (NNS subgroups))))))))))) (. .)))
343678	8	(ROOT (S (NP (NP (DT The) (NN efficacy)) (PP (IN of) (NP (NP (NNP ISG)) (PP (IN in) (S (VP (VBG preventing) (NP (NNS Doc_343678_1129_1145_Disease)))))))) (VP (MD can) (RB not) (VP (VB be) (VP (VBN ascertained) (SBAR (IN because) (S (NP (DT a) (JJ true) (NN placebo) (NN group)) (VP (VBD was) (RB not) (VP (VBN included)))))))) (. .)))
3461217	0	(ROOT (S (NP (NP (NN Production)) (PP (IN of) (NP (NNS autochthonous)))) (VP (VBD Doc_3461217_28_43_Disease) (PP (IN in) (NP (JJ Lobund-Wistar) (NNS rats))) (PP (IN by) (NP (NP (NNS treatments)) (PP (IN with) (NP (NNS Doc_3461217_85_107_Chemical) (CC and) (NNS Doc_3461217_112_124_Chemical)))))) (. .)))
3461217	1	(ROOT (S (NP (NP (NP (QP (JJR More) (IN than) (CD 50)) (NN %)) (PP (IN of) (NP (NNP Lobund-Wistar)))) (PRN (-LRB- -LRB-) (NP (NNP L-W)) (-RRB- -RRB-))) (VP (VBP strain) (SBAR (S (NP (NNS rats)) (VP (VBD developed) (SBAR (S (NP (NP (NP (NP (JJ large) (, ,) (JJ palpable) (NNS Doc_3461217_201_225_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_3461217_227_230_Disease)) (-RRB- -RRB-))) (PP (VBG following) (NP (NP (NNS treatments)) (PP (IN with) (NP (NP (NP (NNS Doc_3461217_258_280_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (NNP CAS)) (: :) (NP (CD 684-93-5))) (-RRB- -RRB-))) (CC and) (NP (NNP Doc_3461217_301_324_Chemical) (NNP -LSB-) (PRN (-LRB- -LRB-) (NP (NNP TP)) (-RRB- -RRB-)) (NNP CAS))))))) (: :) (NP (CD 57-85-2) (NNS -RSB-)) (, ,) (CC and) (NP (NP (JJS most)) (PP (IN of) (NP (DT the) (NN Doc_3461217_362_367_Disease-bearing) (NNS rats))))) (VP (VBD manifested) (NP (JJ metastatic) (NNS lesions))))))))) (. .)))
3461217	2	(ROOT (S (NP (DT The) (NN incubation) (NNS periods)) (VP (VBD averaged) (NP (CD 10.6) (NNS months))) (. .)))
3461217	3	(ROOT (S (PP (IN Within) (NP (DT the) (JJ same) (NN timeframe))) (, ,) (NP (DT no) (JJ L-W) (NN rat)) (VP (VBD developed) (NP (DT a) (JJ similar) (NN palpable) (NNS Doc_3461217_524_526_Disease)) (SBAR (WHADVP (WRB when)) (S (VP (VBN treated) (ADVP (RB only)) (PP (IN with) (NP (NNP TP))))))) (. .)))
3461217	4	(ROOT (S (PP (IN In) (NP (JJ L-W) (NNS rats))) (, ,) (NP (NNP TP)) (VP (VBD acted) (PP (IN as) (NP (DT a) (JJ Doc_3461217_581_586_Disease) (NN enhancement) (NN agent))) (, ,) (PP (IN with) (NP (JJ primary) (NN emphasis))) (PP (IN on) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (NNS Doc_3461217_650_665_Disease)))))) (. .)))
3535719	0	(ROOT (NP (NP (JJ Relative) (NN efficacy) (CC and) (NNS Doc_3535719_22_30_Disease)) (PP (IN of) (NP (NNS Doc_3535719_34_44_Chemical) (CC and) (NNS Doc_3535719_49_59_Chemical))) (PP (IN in) (NP (JJ oncology) (NNS patients))) (. .)))
3535719	1	(ROOT (S (NP (PRP We)) (ADVP (RB prospectively)) (VP (VBD compared) (NP (NP (DT the) (NN efficacy) (CC and) (NN safety)) (PP (IN of) (NP (NNS Doc_3535719_135_153_Chemical) (CC or) (NNS Doc_3535719_157_175_Chemical)))) (PP (IN in) (NP (NN conjunction))) (PP (IN with) (NP (NP (NNS Doc_3535719_196_215_Chemical)) (PP (IN in) (NP (CD 118) (JJ immunocompromised) (NNS patients))))) (PP (IN with) (NP (VBN presumed) (JJ severe) (NNS Doc_3535719_271_281_Disease)))) (. .)))
3535719	2	(ROOT (S (NP (DT The) (CD two) (NN treatment) (NNS regimens)) (VP (VBD were) (ADJP (RB equally) (JJ efficacious))) (. .)))
3535719	3	(ROOT (S (NP (NNP Nephrotoxicity)) (VP (VBD occurred) (PP (IN in) (NP (NP (DT a) (JJ similar) (NN proportion)) (PP (IN in) (NP (NP (NP (NNS patients)) (VP (VBN treated) (PP (IN with) (NP (NNS Doc_3535719_409_419_Chemical) (CC and) (NNS Doc_3535719_424_434_Chemical))))) (PRN (-LRB- -LRB-) (NP (NP (CD 17) (NN %)) (VP (VBN vs) (NP (CD 11) (NN %)))) (-RRB- -RRB-))))))) (. .)))
3535719	4	(ROOT (S (NP (NNP Doc_3535719_449_460_Disease)) (VP (VBD occurred) (PP (PP (IN in) (NP (NP (NP (CD four)) (PRN (-LRB- -LRB-) (NP (CD 9.5) (NN %)) (-RRB- -RRB-))) (PP (IN of) (NP (NP (CD 42) (NNS Doc_3535719_491_501_Chemical)) (CC and) (NP (NNS Doc_3535719_506_518_Chemical)))))) (CC and) (PP (IN in) (NP (NP (NP (CD 12)) (PRN (-LRB- -LRB-) (NP (CD 22) (NN %)) (-RRB- -RRB-))) (PP (IN of) (NP (NP (CD 54) (NNS Doc_3535719_541_551_Chemical)) (CC and) (NP (NN Doc_3535719_556_568_Chemical-treated) (NNS patients)))))))) (. .)))
3535719	5	(ROOT (S (PP (IN Of) (NP (NP (DT those)) (VP (VBN evaluated) (PP (IN with) (NP (JJ posttherapy) (NNS audiograms)))))) (, ,) (NP (NP (CD three)) (PP (IN of) (NP (NP (CD four) (NNS Doc_3535719_649_659_Chemical)) (CC and) (NP (NN Doc_3535719_664_676_Chemical-treated) (NNS patients))))) (VP (VBD had) (NP (ADJP (RB auditory) (JJ thresholds)) (NN return)) (PP (TO to) (NP (NN baseline))) (PP (VBN compared) (PP (IN with) (NP (NP (CD one)) (PP (IN of) (NP (NP (CD nine) (NNS Doc_3535719_763_773_Chemical)) (CC and) (NP (NN Doc_3535719_778_790_Chemical-treated) (NNS patients)))))))) (. .)))
3535719	6	(ROOT (NP (NP (NP (DT The) (NN number)) (PP (IN of) (NP (NP (ADJP (ADJP (JJR greater) (PP (IN than))) (CC or) (ADJP (JJ equal) (TO to) (JJ 15-dB))) (NNS increases)) (PP (IN in) (NP (JJ auditory) (NN threshold))))) (SBAR (IN as) (S (NP (NP (DT a) (NN proportion)) (PP (IN of) (NP (NP (JJ total) (ADJP (ADJP (JJR greater) (PP (IN than))) (CC or) (ADJP (JJ equal) (TO to) (JJ 15-dB))) (NNS changes)) (PRN (-LRB- -LRB-) (NP (NP (NNS increases)) (CC and) (NP (NNS decreases))) (-RRB- -RRB-))))) (VP (VBD was) (ADJP (RB significantly) (JJR lower)) (PP (IN in) (NP (NNS Doc_3535719_1003_1013_Chemical) (CC and) (NNS Doc_3535719_1018_1030_Chemical))))))) (: -) (NP (NP (NN vs) (NNS Doc_3535719_1035_1045_Chemical)) (CC and) (NP (NP (NN Doc_3535719_1050_1062_Chemical-treated) (NNS patients)) (PRN (-LRB- -LRB-) (NP (NP (CD 18)) (PP (IN of) (NP (NP (CD 78) (NNP vs) (CD 67)) (PP (IN of) (NP (CD 115)))))) (-RRB- -RRB-)))) (. .)))
3535719	7	(ROOT (S (NP (PRP We)) (VP (VBP conclude) (SBAR (IN that) (S (NP (NN Doc_3535719_1122_1136_Chemical-associated) (NNS Doc_3535719_1148_1159_Disease)) (VP (VBD was) (ADJP (ADJP (RBR less) (JJ severe)) (CC and) (ADJP (RBR more) (RB often) (JJ reversible))) (PP (IN with) (NP (NNS Doc_3535719_1207_1217_Chemical))) (PP (IN than) (PP (IN with) (NP (NNS Doc_3535719_1228_1238_Chemical)))))))) (. .)))
3653576	0	(ROOT (NP (NP (JJ Urinary) (NNS enzymes) (CC and) (NN protein) (NNS patterns)) (PP (IN as) (NP (NNS indicators))) (PP (IN of) (NP (NNS Doc_3653576_54_95_Disease))) (. .)))
3653576	1	(ROOT (S (NP (NP (NNP Doc_3653576_97_138_Disease)) (PP (TO to) (NP (NP (DT the) (JJ proximal) (NN tubular)) (, ,) (NP (NN glomerular)) (, ,) (CC and) (NP (NP (JJ papillary) (NNS regions)) (PP (IN of) (NP (DT the) (NN rat))))))) (VP (VBD were) (VP (VBN produced) (PP (IN by) (NP (NP (NN administration)) (PP (IN of) (NP (NP (NP (NNS Doc_3653576_244_268_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_3653576_270_274_Chemical)) (-RRB- -RRB-))) (, ,) (NP (NP (NNS Doc_3653576_277_302_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_3653576_304_307_Chemical)) (-RRB- -RRB-))) (, ,) (CC and) (NP (NP (NNS Doc_3653576_314_331_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_3653576_333_336_Chemical)) (-RRB- -RRB-))))))) (, ,) (ADVP (RB respectively)))) (. .)))
3653576	2	(ROOT (S (NP (NP (NP (JJ Several) (JJ routine) (NNS indicators)) (PP (IN of) (NP (NN nephrotoxicity)))) (, ,) (NP (NP (DT the) (JJ enzymes) (NN alkaline)) (ADJP (JJ phosphatase) (CC and) (JJ Doc_3653576_436_444_Chemical-beta-glucosaminidase))) (, ,) (CC and) (NP (NP (DT the) (JJ molecular) (NN weight)) (PP (IN of) (NP (NNS Doc_3653576_495_512_Disease))))) (VP (VBD were) (VP (VBN determined) (PP (IN on) (NP (NN urine) (NNS samples))))) (. .)))
3653576	3	(ROOT (S (NP (NP (JJ Tubular) (NN damage)) (VP (VBN produced) (PP (IN by) (NP (NNS Doc_3653576_574_578_Chemical) (CC or) (NNS Doc_3653576_582_585_Chemical))))) (VP (VBD was) (VP (VBN discriminated) (UCP (DT both) (ADVP (RB quantitatively)) (CC and) (PP (ADVP (RB qualitatively)) (IN from) (NP (NP (NNS Doc_3653576_647_664_Disease)) (VP (VBN produced) (PP (IN by) (NP (NNS Doc_3653576_677_680_Chemical))))))))) (. .)))
3653576	4	(ROOT (S (NP (DT The) (NN latter)) (VP (VBD was) (VP (VBN characterized) (PP (IN by) (NP (NP (DT a) (JJ pronounced) (NN increase)) (PP (IN in) (NP (NP (NNS Doc_3653576_739_756_Disease)) (, ,) (ADVP (RB especially) (NP (NNS proteins)) (PP (IN with) (NP (JJ molecular) (NN weight)))) (NP (QP (JJR greater) (IN than) (CD 40,000)) (NNS Da)))))))) (. .)))
3653576	5	(ROOT (S (PP (IN In) (NP (NN contrast))) (, ,) (NP (NP (NNS Doc_3653576_837_854_Disease)) (PP (IN in) (NP (JJ tubular) (NN damage)))) (VP (VBD was) (VP (VP (VBN raised) (ADVP (RB only) (RB slightly))) (CC and) (VP (VBN characterized) (PP (IN by) (NP (NP (NNS Doc_3653576_919_940_Disease)) (PP (IN of) (NP (NP (DT a) (JJ wide) (NN range)) (PP (IN of) (NP (JJ molecular) (NNS weights)))))))))) (. .)))
3653576	6	(ROOT (S (NP (NP (JJ Proximal) (JJ tubular) (NN damage)) (VP (VBN caused) (PP (IN by) (NP (NP (NNS Doc_3653576_1013_1017_Chemical)) (CC and) (NP (NP (JJ papillary) (NN damage)) (VP (VBN caused) (PP (IN by) (NP (NNS Doc_3653576_1049_1052_Chemical))))))))) (VP (VBD were) (ADJP (JJ distinguished)) (PP (DT both) (PP (IN by) (NP (NP (JJ conventional) (NNS urinalysis)) (PRN (-LRB- -LRB-) (NP (NP (NN volume)) (CC and) (NP (JJ specific) (NN gravity))) (-RRB- -RRB-)))) (CC and) (PP (IN by) (NP (NP (NN measurement)) (PP (IN of) (NP (DT the) (CD two) (JJ urinary) (NNS enzymes))))))) (. .)))
3653576	7	(ROOT (S (S (NP (JJ Alkaline) (NN phosphatase) (CC and) (NNS Doc_3653576_1206_1213_Chemical)) (VP (VP (VBD were) (ADJP (JJ markedly))) (CC and) (VP (ADVP (RB transiently)) (VBD elevated) (PP (IN in) (NP (JJ proximal) (JJ tubular) (NN damage)))))) (CC and) (S (NP (NNS Doc_3653576_1284_1292_Chemical-beta-glucosaminidase)) (VP (VBD showed) (NP (DT a) (JJ sustained) (NN elevation)) (PP (IN in) (NP (JJ papillary) (NN damage))))) (. .)))
3653576	8	(ROOT (S (NP (PRP It)) (VP (VBZ is) (VP (VBN concluded) (SBAR (IN that) (S (NP (NP (DT both) (JJ selective) (JJ urinary) (NNS enzymes)) (CC and) (NP (NP (DT the) (JJ molecular) (NN weight) (NN pattern)) (PP (IN of) (NP (JJ urinary) (NNS proteins))))) (VP (MD can) (VP (VB be) (VP (VBN used) (S (VP (TO to) (VP (VB provide) (NP (JJ diagnostic) (NN information)) (PP (IN about) (NP (NP (DT the) (JJ possible) (NN site)) (PP (IN of) (NP (NNS Doc_3653576_1542_1554_Disease))))))))))))))) (. .)))
3670965	0	(ROOT (NP (NP (DT A) (NN catch)) (PP (IN in) (NP (DT the) (NNS Doc_3670965_15_19_Disease))) (. .)))
3670965	1	(ROOT (S (NP (NP (JJ Twenty-six) (NNS cases)) (PP (IN of) (NP (NP (NNS Doc_3670965_41_54_Disease)) (PP (IN from) (NP (NP (DT The) (NNP Children) (POS 's)) (NNP Hospital) (PRN (, ,) (NP (NNP Camperdown)) (, ,)) (NNP Australia))) (, ,) (VP (VBG occurring) (PP (IN between) (NP (CD 1973) (CC and) (CD 1982))))))) (VP (VBD were) (VP (VBN reviewed))) (. .)))
3670965	2	(ROOT (S (PP (IN Of) (NP (DT these))) (, ,) (NP (CD 20) (NNS cases)) (VP (VBD met) (NP (DT the) (NNP US) (NNP Public) (NNP Health) (NNP Service) (NNPS Centers)) (PP (IN for) (NP (NNP Disease) (NNP Control) (NNS criteria))) (PP (IN for) (NP (NP (DT the) (NN diagnosis)) (PP (IN of) (NP (NNS Doc_3670965_265_278_Disease)))))) (. .)))
3670965	3	(ROOT (S (S (NP (NP (NNP Doc_3670965_280_287_Chemical)) (CC or) (NP (JJ Doc_3670965_291_301_Chemical) (NN ingestion))) (VP (VBD had) (VP (VBN occurred) (PP (IN in) (NP (NP (RB only) (CD one)) (PP (IN of) (NP (NP (DT the) (CD 20) (NNS cases)) (PRN (-LRB- -LRB-) (NP (CD 5) (NN %)) (-RRB- -RRB-))))))))) (, ,) (CC and) (S (NP (NP (NNS Doc_3670965_363_374_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_3670965_376_389_Chemical)) (-RRB- -RRB-))) (VP (VBD had) (VP (VBN been) (VP (VBN administered) (PP (IN in) (NP (NP (QP (RB only) (CD six))) (PP (IN of) (NP (NP (DT the) (NNS cases)) (PRN (-LRB- -LRB-) (NP (CD 30) (NN %)) (-RRB- -RRB-)))))))))) (. .)))
3670965	4	(ROOT (S (NP (NP (JJ Pathologic) (NN confirmation)) (PP (IN of) (NP (NP (DT the) (NN diagnosis)) (PP (IN of) (NP (NNS Doc_3670965_489_502_Disease)))))) (VP (VBD was) (VP (VBN accomplished) (PP (IN in) (NP (NP (CD 90) (NN %)) (PP (IN of) (NP (DT the) (NNS cases))))))) (. .)))
3670965	5	(ROOT (S (NP (NP (DT The) (NN incidence)) (PP (IN of) (NP (NP (NNS Doc_3670965_558_571_Disease)) (PP (IN in) (NP (NP (NNP New) (NNP South) (NNP Wales)) (, ,) (NP (NNP Australia)) (, ,)))))) (VP (VBZ is) (VP (VBN estimated) (PP (IN from) (NP (DT this) (NN study))) (S (VP (TO to) (VP (VB be) (NP (NP (QP (RB approximately) (CD nine)) (NNS cases)) (PP (IN per) (NP (QP (CD 1) (CD million)) (NNS children))))))) (PP (VBN compared) (PP (IN with) (NP (NP (JJ recent) (NNP US) (NNS data)) (PP (IN of) (NP (NP (NP (QP (CD ten) (TO to) (CD 20)) (NNS cases)) (PP (IN per) (NP (QP (CD 1) (CD million)) (NNS children)))) (CC and) (NP (NP (QP (CD three) (TO to) (CD seven)) (NNS cases)) (PP (IN per) (NP (NP (QP (CD 1) (CD million)) (NNS children)) (PP (IN in) (NP (NNP Great) (NNP Britain))))))))))))) (. .)))
3670965	6	(ROOT (S (NP (NP (DT The) (NN mortality)) (PP (IN for) (NP (NP (DT these) (JJ Doc_3670965_847_860_Disease) (NNS cases)) (PP (IN in) (NP (NNP Australia)))))) (VP (VBD was) (ADVP (NP (CD 45) (NN %)) (RB as)) (PP (VBN compared) (PP (IN with) (NP (NP (DT a) (ADJP (CD 32) (NN %)) (JJ case-fatality) (NN rate)) (PP (IN in) (NP (DT the) (NNP United) (NNPS States))))))) (. .)))
3670965	7	(ROOT (S (PP (IN In) (NP (NNP Australia))) (, ,) (NP (NP (DT the) (JJ pediatric) (NN usage)) (PP (IN of) (NP (NNS Doc_3670965_989_996_Chemical)))) (VP (VBZ has) (VP (VBN been) (ADJP (RB extremely) (JJ low) (PP (IN for) (NP (NP (DT the) (JJ past) (CD 25) (NNS years)) (PRN (-LRB- -LRB-) (S (NP (NP (QP (JJR less) (IN than) (CD 1)) (NN %)) (PP (IN of) (NP (JJ total) (NN dosage) (NNS units)))) (VP (VBD sold))) (-RRB- -RRB-))))) (, ,) (PP (IN with) (S (NP (NP (NNS Doc_3670965_1090_1101_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_3670965_1103_1116_Chemical)) (-RRB- -RRB-))) (VP (VBG dominating) (NP (DT the) (JJ pediatric) (ADJP (JJ analgesic) (CC and) (JJ antipyretic)) (NN market))))))) (. .)))
3670965	8	(ROOT (S (NP (NNP Doc_3670965_1177_1190_Disease)) (VP (MD may) (VP (VB be) (VP (VBG disappearing) (PP (IN from) (NP (NNP Australia))) (PP (IN despite) (NP (NP (DT a) (JJ total) (NN lack)) (PP (IN of) (NP (NP (NN association)) (PP (IN with) (NP (NNS Doc_3670965_1267_1278_Chemical) (CC or) (NNS Doc_3670965_1282_1289_Chemical) (NN ingestion))))))) (, ,) (SBAR (IN since) (S (NP (EX there)) (VP (VBD were) (NP (NP (DT no) (NNS cases)) (VP (VBN found) (PP (IN at) (NP (NP (NP (DT The) (NNP Children) (POS 's)) (NN Hospital)) (PP (IN in) (NP (NP (CD 1983)) (, ,) (NP (CD 1984)) (, ,) (CC or) (NP (CD 1985)))))))))))))) (. .)))
3686155	0	(ROOT (S (NP (NNP Postpartum) (NNP Doc_3686155_11_20_Disease)) (VP (VBN induced) (PP (IN by) (NP (NNS Doc_3686155_32_45_Chemical)))) (. .)))
3686155	1	(ROOT (S (NP (NP (CD Two) (NN multigravida) (NNS patients)) (PP (IN with) (NP (DT no) (JJ prior) (JJ Doc_3686155_87_98_Disease) (NN history)))) (VP (VBD were) (VP (VBN seen) (PP (IN with) (NP (NN postpartum) (NNS Doc_3686155_133_142_Disease))) (, ,) (S (VP (VBG having) (VP (VBN received) (NP (NP (NNS Doc_3686155_160_173_Chemical)) (PP (IN for) (NP (NNS Doc_3686155_178_201_Disease))))))))) (. .)))
3686155	2	(ROOT (S (NP (NP (NNP Doc_3686155_203_216_Chemical)) (PP (VBN given) (PP (IN in) (NP (JJ high) (NNS doses))))) (VP (VBZ has) (VP (VBN been) (VP (VBN associated) (PP (IN with) (NP (NP (NNS Doc_3686155_262_271_Disease)) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NP (DT the) (NN drug)) (PP (IN for) (NP (NNS Doc_3686155_307_326_Disease)))))))))))) (. .)))
3686155	3	(ROOT (S (NP (DT These) (NNS cases)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP (NNS Doc_3686155_357_370_Chemical)) (VP (MD may) (VP (VB cause) (NP (NNS Doc_3686155_381_390_Disease)) (SBAR (RB even) (WHADVP (WRB when)) (S (VP (VBN given) (PP (IN in) (NP (JJ low) (NNS doses))))))))))) (. .)))
3703509	0	(ROOT (NP (NP (NN Doc_3703509_0_27_Disease) (CC and) (NN death)) (PP (IN in) (NP (NNS Doc_3703509_41_62_Disease))) (. .)))
3703509	1	(ROOT (S (NP (DT This) (NN paper)) (VP (VBZ presents) (NP (DT the) (JJ clinical) (CC and) (JJ metabolic) (NNS findings)) (PP (IN in) (NP (NP (CD two) (JJ young) (NNS boys)) (PP (IN with) (NP (JJ long-standing) (NNS Doc_3703509_157_178_Disease)))))) (. .)))
3703509	2	(ROOT (S (PP (VBG Following) (NP (NP (JJ short) (NN exposure)) (PP (TO to) (NP (JJ oral) (NNS Doc_3703509_213_223_Chemical))))) (, ,) (NP (DT both) (NNS boys)) (VP (VBD developed) (NP (NP (NNS Doc_3703509_245_253_Disease)) (, ,) (NP (JJ increasing) (NNS Doc_3703509_266_276_Disease)) (, ,) (NP (NNS Doc_3703509_278_288_Disease)) (, ,) (NP (NNS Doc_3703509_290_300_Disease)) (, ,) (CC and) (NP (NNS Doc_3703509_306_314_Disease)))) (. .)))
3703509	3	(ROOT (S (NP (DT Both)) (VP (VBD presented) (PP (IN in) (NP (DT the) (NN emergency) (NN room))) (PP (IN with) (NP (NP (JJ profound) (NNS Doc_3703509_367_371_Disease)) (, ,) (NP (NNS Doc_3703509_373_384_Disease)) (, ,) (NP (JJ severe) (NNS Doc_3703509_393_406_Disease)) (, ,) (CC and) (NP (NNS Doc_3703509_412_420_Disease))))) (. .)))
3703509	4	(ROOT (S (S (NP (NNP Nonketotic) (NNP Doc_3703509_433_448_Disease)) (VP (VBD was) (ADJP (JJ present) (PP (IN in) (NP (CD one)))))) (CC and) (S (NP (NP (NNS Doc_3703509_472_479_Disease)) (PP (IN without) (NP (DT a) (JJ known) (NN serum) (NNS Doc_3703509_502_509_Chemical) (NN level)))) (VP (VBD was) (ADJP (JJ present) (PP (IN in) (NP (DT the) (JJ other)))))) (. .)))
3703509	5	(ROOT (S (S (NP (NNP Doc_3703509_542_561_Disease)) (ADVP (RB rapidly)) (VP (VBD ensued))) (CC and) (S (NP (DT both) (NNS patients)) (VP (VBD expired) (PP (IN in) (NP (NP (NN spite)) (PP (IN of) (NP (NNS efforts))))) (PP (IN at) (NP (NN resuscitation))))) (. .)))
3703509	6	(ROOT (S (NP (PRP We)) (VP (VBP believe) (SBAR (S (NP (DT these) (CD two) (NNS cases)) (VP (VBP represent) (NP (NP (DT a) (ADJP (RB newly) (JJ described) (CC and) (JJ catastrophic)) (NNS Doc_3703509_713_740_Disease)) (PP (IN in) (NP (DT the) (NNS Doc_3703509_748_769_Disease)))))))) (. .)))
3708922	0	(ROOT (NP (NP (JJ Experimental) (JJ Doc_3708922_13_25_Chemical) (NN nephrotoxicity)) (: :) (NP (NP (NN risk)) (PP (IN of) (NP (JJ concomitant) (NN chemotherapy)))) (. .)))
3708922	1	(ROOT (S (NP (NP (DT The) (NN role)) (PP (PP (IN of) (NP (NP (NNS Doc_3708922_88_100_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_3708922_102_105_Chemical)) (-RRB- -RRB-))) (ADVP (RB alone))) (CC or) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (NP (JJ various) (NNS chemotherapeutics)) (PP (IN in) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (NNS Doc_3708922_184_198_Disease))))))))))) (VP (VBD was) (VP (VBN evaluated) (PP (IN in) (NP (NNS rats))))) (. .)))
3708922	2	(ROOT (S (NP (NP (NNP Administration)) (PP (IN of) (NP (NP (CD 20) (JJ mg/kg/day) (NNS Doc_3708922_253_256_Chemical)) (PP (IN for) (NP (CD 4) (NNS weeks)))))) (VP (VBD caused) (SBAR (S (NP (NP (JJ renal) (ADJP (JJ functional) (CC and) (JJ structural)) (NNS changes)) (ADJP (JJ similar) (PP (TO to) (NP (DT those))))) (VP (VBD reported) (PP (IN in) (NP (NN man))))))) (. .)))
3708922	3	(ROOT (S (NP (NP (NP (DT The) (VBN combined) (NN administration)) (PP (IN of) (NP (NP (NNS Doc_3708922_381_384_Chemical)) (CC and) (NP (JJ various) (JJ chemotherapeutic) (NNS drugs)))) (PP (IN with) (NP (DT a) (JJ nephrotoxic) (NN potential))) (, ,)) (PP (JJ such) (IN as) (NP (NP (NNS Doc_3708922_458_468_Chemical)) (PRN (-LRB- -LRB-) (PP (IN at) (NP (JJ therapeutic) (NNS doses))) (-RRB- -RRB-)) (, ,) (NP (NNS Doc_3708922_493_508_Chemical)) (CC and) (NP (NNS Doc_3708922_513_525_Chemical)))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP are) (ADVP (RB frequently)) (VP (VBN used) (PP (IN in) (NP (JJ immunosuppressed) (NNS patients))))))) (, ,)) (VP (VBD did) (RB not) (VP (VB aggravate) (NP (NP (DT the) (JJ Doc_3708922_605_608_Chemical) (CD induced) (NNS Doc_3708922_617_625_Disease)) (PP (IN in) (NP (DT the) (NN rat) (NN model)))))) (. .)))
3708922	4	(ROOT (S (NP (NP (NNP Doc_3708922_644_654_Chemical)) (PP (IN at) (NP (JJ toxic) (NNS doses)))) (, ,) (ADVP (RB however)) (, ,) (VP (VBD increased) (NP (NNS Doc_3708922_690_693_Chemical)) (ADVP (RB nephrotoxicity))) (. .)))
3708922	5	(ROOT (S (ADVP (RB Thus)) (, ,) (NP (NP (DT the) (NN nephrotoxicity)) (VP (VBN induced) (PP (IN by) (NP (NNS Doc_3708922_746_749_Chemical))))) (VP (VBZ has) (NP (DT a) (JJ different) (JJ pathogenetic) (NN mechanism))) (. .)))
3732088	0	(ROOT (NP (NP (NNS Diuretics) (, ,) (NNS Doc_3732088_11_20_Chemical) (CC and) (NNS Doc_3732088_25_36_Disease)) (PP (IN in) (NP (JJ Doc_3732088_40_52_Disease) (NNS Doc_3732088_53_69_Disease))) (. .)))
3732088	1	(ROOT (S (NP (PRP It)) (VP (VBZ has) (VP (VBN been) (VP (VBN proposed) (SBAR (IN that) (S (NP (NP (JJ modest) (NNS changes)) (PP (IN in) (NP (NN plasma) (NNS Doc_3732088_122_131_Chemical)))) (VP (MD can) (VP (VB alter) (NP (NP (DT the) (NN tendency)) (PP (IN towards) (NP (NNS Doc_3732088_163_182_Disease))))))))))) (. .)))
3732088	2	(ROOT (S (SBAR (IN If) (S (NP (DT this)) (VP (VBD were) (ADVP (RB so))))) (, ,) (NP (NP (NNS patients)) (PP (IN with) (NP (NNS Doc_3732088_215_238_Disease)))) (VP (MD might) (VP (VB be) (ADJP (RB especially) (JJ susceptible)))) (. .)))
3732088	3	(ROOT (S (ADVP (RB Thus)) (, ,) (NP (JJ myocardial) (JJ electrical) (NN excitability)) (VP (VBD was) (VP (VP (VBN measured) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ mild) (JJ essential) (NNS Doc_3732088_358_370_Disease)))))) (CC and) (VP (VBN known) (NP (NNS Doc_3732088_381_404_Disease)) (PP (IN after) (NP (NP (CD 8) (NNS weeks)) (PP (IN of) (NP (NN treatment))))) (PP (IN with) (NP (NP (NP (DT a) (NN Doc_3732088_439_448_Chemical-conserving) (NN diuretic)) (PRN (-LRB- -LRB-) (NP (NNP Doc_3732088_470_479_Chemical)) (-RRB- -RRB-))) (CC and) (NP (NP (DT a) (JJ similar) (NN period)) (PP (IN on) (NP (NP (NP (DT a) (NN Doc_3732088_507_516_Chemical-losing) (NN diuretic)) (PRN (-LRB- -LRB-) (NP (NNP Doc_3732088_534_548_Chemical)) (-RRB- -RRB-))) (PP (IN in) (NP (DT a) (JJ randomised) (NN study))))))))))) (. .)))
3732088	4	(ROOT (S (NP (NNP Plasma) (NNP Doc_3732088_580_589_Chemical) (NNS concentrations)) (VP (VBD were) (PP (IN on) (NP (NN average))) (PP (ADVP (NP (CD 1) (NN mmol/L)) (RBR lower)) (IN during) (NP (NP (DT the) (JJ Doc_3732088_647_661_Chemical) (NN phase)) (PP (VBN compared) (PP (TO to) (NP (JJ Doc_3732088_680_689_Chemical) (NN therapy))))))) (. .)))
3732088	5	(ROOT (S (NP (NP (NNP Blood) (NN pressure) (CC and) (NN volume) (NNS states)) (PP (IN as) (NP (ADJP (JJ assessed) (PP (IN by) (NP (NN bodyweight) (, ,) (NN plasma) (NN renin) (CC and) (NNS Doc_3732088_776_789_Chemical)))) (PRN (-LRB- -LRB-) (NP (NNP Doc_3732088_791_805_Chemical)) (-RRB- -RRB-)) (NNS concentrations)))) (VP (VBD were) (ADJP (JJ similar) (PP (IN on) (NP (DT the) (CD 2) (NNS regimens))))) (. .)))
3732088	6	(ROOT (S (PP (VBN Compared) (PP (TO to) (NP (JJ Doc_3732088_866_875_Chemical) (NN treatment)))) (, ,) (NP (DT the) (JJ Doc_3732088_891_905_Chemical) (NN phase)) (VP (VBD was) (VP (VBN associated) (PP (IN with) (NP (NP (NP (DT an) (VBN increased) (NN frequency)) (PP (IN of) (NP (NP (NP (NNS Doc_3732088_958_983_Disease)) (PRN (-LRB- -LRB-) (NP (JJ 24-hour) (NN Holter) (NN monitoring)) (-RRB- -RRB-))) (CC and) (NP (DT a) (JJR higher) (NNP Lown) (NN grading))))) (, ,) (NP (NP (VBN increased) (NN upslope) (CC and) (NN duration)) (PP (IN of) (NP (DT the) (JJ monophasic) (NN action) (NN potential)))) (, ,) (NP (NP (JJ prolonged) (NN ventricular)) (NP (JJ effective) (JJ refractory) (NN period))) (, ,) (CC and) (NP (NP (VBN increased) (JJ electrical) (NN instability)) (PP (IN during) (NP (JJ programmed) (NN ventricular) (NN stimulation)))))))) (. .)))
3732088	7	(ROOT (S (NP (DT The) (JJ above) (NNS results)) (VP (VBP indicate) (SBAR (IN that) (S (SBAR (IN because) (S (NP (JJ Doc_3732088_1277_1286_Chemical-losing) (JJ diuretic) (NN therapy)) (VP (MD can) (VP (VB increase) (NP (JJ myocardial) (JJ electrical) (NN excitability)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NNS Doc_3732088_1376_1399_Disease))))))))) (, ,) (NP (RB even) (JJ minor)) (VP (VBZ falls) (PP (IN in) (NP (NP (NN plasma) (NNS Doc_3732088_1428_1437_Chemical)) (SBAR (S (NP (NNS concentrations)) (VP (VBP are) (ADVP (RB probably)) (VP (RBS best) (VBN avoided) (PP (IN in) (NP (JJ such) (NNS patients))))))))))))) (. .)))
3762968	0	(ROOT (S (VP (VB Transketolase) (ADVP (RB abnormality)) (PP (IN in) (NP (NN Doc_3762968_29_39_Chemical-induced) (NNS Doc_3762968_48_73_Disease)))) (. .)))
3762968	1	(ROOT (S (NP (PRP We)) (VP (VBD studied) (SBAR (S (NP (DT a) (NN Doc_3762968_88_96_Chemical-dependent)) (VP (VBP enzyme) (, ,) (VBP transketolase) (, ,) (PP (IN from) (NP (NP (NNS fibroblasts)) (PP (IN of) (NP (NP (DT a) (JJ Doc_3762968_152_160_Disease) (NN patient)) (SBAR (WHNP (WP who)) (S (VP (VBD developed) (NP (NNS Doc_3762968_183_208_Disease)) (SBAR (WHADVP (WRB when)) (S (VP (VBN treated) (PP (IN with) (NP (NNS Doc_3762968_227_237_Chemical))) (, ,) (SBAR (IN in) (NN order) (S (VP (TO to) (VP (VB delineate) (SBAR (IN if) (S (NP (DT this) (NN patient)) (ADVP (RB also)) (VP (VBD had) (NP (NP (JJ transketolase) (ADJP (RB abnormality) (JJ -LSB-)) (JJ high) (NNS Km)) (PP (IN for) (NP (NNP Doc_3762968_325_347_Chemical) (PRN (-LRB- -LRB-) (NP (NNP Doc_3762968_349_352_Chemical)) (-RRB- -RRB-)) (NNP -RSB-)))) (, ,) (ADVP (RB as) (RB previously)) (VP (VBN reported) (PP (IN in) (NP (JJ postalcoholic) (NNS Doc_3762968_396_423_Disease))))))))))))))))))))))))) (. .)))
3762968	2	(ROOT (S (PP (IN In) (NP (NP (NN addition)) (PP (TO to) (NP (DT this) (NN patient))))) (, ,) (NP (PRP we)) (ADVP (RB also)) (VP (VBD studied) (NP (DT this) (NN enzyme)) (PP (IN from) (NP (CD three) (JJ Doc_3762968_493_501_Disease) (NNS kindreds))) (PP (PP (IN without) (NP (NP (DT any) (NN history)) (PP (IN of) (NP (NNS Doc_3762968_534_559_Disease))))) (CC and) (PP (IN from) (NP (CD four) (JJ normal) (NNS controls))))) (. .)))
3762968	3	(ROOT (S (NP (PRP We)) (VP (VBD found) (SBAR (IN that) (S (NP (NP (DT the) (JJ above-mentioned) (NN patient)) (CC and) (NP (NP (CD one)) (PP (IN of) (NP (NP (DT the) (JJ Doc_3762968_648_656_Disease) (NNS kindreds)) (PP (IN with) (NP (NP (DT no) (NN history)) (PP (IN of) (NP (NNS Doc_3762968_685_710_Disease))))))))) (VP (VBD had) (ADVP (NP (JJ abnormal) (NN transketolase)) (RB as)) (VP (VBN determined) (PP (IN by) (NP (NP (PRP$ its) (NN Km)) (PP (IN for) (NP (NNS Doc_3762968_766_769_Chemical)))))))))) (. .)))
3762968	4	(ROOT (S (NP (DT These) (NNS data)) (VP (VBP suggest) (NP (NP (NP (DT a) (NN similarity)) (PP (IN between) (NP (JJ postalcoholic) (NNS Doc_3762968_825_852_Disease)))) (CC and) (NP (NP (DT the) (NN patient)) (PP (IN with) (NP (NN Doc_3762968_874_884_Chemical-induced) (NNS Doc_3762968_893_918_Disease))))) (PP (IN from) (NP (NP (DT the) (NN standpoint)) (PP (IN of) (NP (JJ transketolase) (NN abnormality)))))) (. .)))
3769769	0	(ROOT (S (VP (VB Doc_3769769_0_11_Disease) (ADJP (JJ due) (PP (TO to) (NP (NNS Doc_3769769_19_48_Chemical))))) (. .)))
3769769	1	(ROOT (S (NP (DT A) (JJ chronic) (JJ Doc_3769769_60_73_Disease) (NN patient)) (VP (VBD was) (VP (VBN treated) (PP (IN with) (NP (NP (DT an) (JJ anticholinergic) (NN drug)) (, ,) (NP (NNS Doc_3769769_124_153_Chemical)))))) (. .)))
3769769	2	(ROOT (S (NP (NP (DT The) (NN patient)) (VP (VBN developed))) (, ,) (ADVP (RB paradoxically)) (, ,) (VP (VBZ sinus) (NP (NNS Doc_3769769_199_210_Disease))) (. .)))
3769769	3	(ROOT (S (NP (DT The) (NN reaction)) (VP (VBD was) (ADJP (JJ specific) (S (VP (TO to) (VP (VB Doc_3769769_241_256_Chemical) (CC and) (RB not) (PP (TO to) (NP (JJ other) (JJ anticholinergic) (NNS drugs)))))))) (. .)))
3769769	4	(ROOT (S (S (NP (DT This) (JJ antidyskinetic) (NN drug)) (VP (VBZ is) (ADVP (RB widely)) (VP (VBN used) (PP (IN in) (NP (JJ clinical) (JJ Doc_3769769_349_360_Disease) (NN practice)))))) (CC and) (S (NP (NNS physicians)) (VP (MD should) (VP (VB be) (ADJP (JJ aware) (PP (IN of) (NP (DT this) (NN side) (NN effect))))))) (. .)))
3780697	0	(ROOT (NP (NP (JJ Post-operative) (NNS Doc_3780697_15_23_Disease)) (PP (IN after) (NP (JJ Doc_3780697_30_38_Chemical) (NN administration))) (. .)))
3780697	1	(ROOT (S (NP (NP (DT A) (NN case)) (PP (IN of) (NP (NP (JJ thoraco-abdominal) (NNS Doc_3780697_83_91_Disease)) (VP (VBG leading) (PP (TO to) (NP (NNS Doc_3780697_103_122_Disease))))))) (VP (VBZ is) (VP (VBN described) (PP (IN in) (NP (NP (DT the) (JJ post-operative) (NN period)) (PP (IN in) (NP (NP (DT an) (JJ elderly) (NN patient)) (SBAR (WHNP (WP who)) (S (VP (VBD received) (NP (NP (DT a) (JJ moderate) (NN dose)) (PP (IN of) (NP (NNS Doc_3780697_219_227_Chemical))))))))))))) (. .)))
3780697	2	(ROOT (S (NP (DT This)) (VP (VBD was) (ADVP (RB successfully)) (VP (VBN reversed) (PP (IN by) (NP (NNS Doc_3780697_263_271_Chemical))))) (. .)))
3780697	3	(ROOT (S (NP (NP (DT The) (NNS mechanisms)) (VP (ADVP (RB possibly)) (VBN implicated) (PP (IN in) (NP (DT this) (NN accident))))) (VP (VBP are) (VP (VBN discussed))) (. .)))
3780814	0	(ROOT (S (NP (NP (JJ Anti-carcinogenic) (NN action)) (PP (IN of) (NP (NNS Doc_3780814_28_41_Chemical)))) (VP (VBN given) (ADVP (RB simultaneously)) (PP (IN with) (NP (NP (NNS Doc_3780814_68_86_Chemical)) (PP (IN in) (NP (DT the) (NN rat)))))) (. .)))
3780814	1	(ROOT (S (NP (DT The) (JJ present) (NN work)) (VP (VBZ has) (VP (VBN been) (VP (VBN planned) (PP (IN in) (NP (NN order))) (S (VP (TO to) (VP (VB elucidate) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (NP (NP (NNS Doc_3780814_169_182_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (NNP PB)) (: :) (NP (NP (CD 15) (NN mg)) (PP (IN per) (NP (NP (NN rat)) (PP (IN of) (NP (JJ ingested) (NN dose))))))) (-RRB- -RRB-))) (PP (IN on) (NP (NP (NNS Doc_3780814_223_237_Disease)) (SBAR (WHADVP (WRB when)) (S (NP (PRP it)) (VP (VBZ is) (VP (VBN administered) (ADVP (RB simultaneously)) (PP (IN with) (NP (NNS Doc_3780814_282_300_Chemical))))))))) (PRN (-LRB- -LRB-) (NP (NP (NNS Doc_3780814_302_305_Chemical)) (: :) (NP (CD 10) (NN mg/kg/day))) (-RRB- -RRB-))))))))))) (. .)))
3780814	2	(ROOT (S (NP (NP (JJ Wistar) (NNS rats)) (PRN (-LRB- -LRB-) (NP (QP (CD 180) (CD g))) (-RRB- -RRB-))) (VP (VBD were) (VP (VBN treated) (PP (IN by) (NP (JJ Doc_3780814_358_361_Chemical) (UCP (ADVP (RB alone)) (CC or) (PP (IN by) (NP (NP (JJ Doc_3780814_374_377_Chemical) (JJ +) (NNS Doc_3780814_380_382_Chemical)) (PP (IN during) (NP (CD 2) (, ,) (CD 4) (CC and) (CD 6)))))) (NNS weeks))) (PP (VBG according) (PP (TO to) (NP (NP (PRP$ our) (NN schedule)) (PP (IN for) (NP (NNS hepatocarcinogenesis)))))))) (. .)))
3780814	3	(ROOT (S (PP (IN After) (NP (NP (DT the) (NN end)) (PP (IN of) (NP (DT the) (NN treatment))))) (, ,) (NP (NP (DT the) (NN number)) (CC and) (NP (NP (DT the) (NN size)) (PP (IN of) (NP (NNP induced) (NNP PAS) (JJ positive) (NNS Doc_3780814_539_557_Disease))))) (VP (VBD was) (ADVP (RB significantly)) (VP (VBN reduced) (SBAR (WHADVP (WRB when)) (S (NP (NNP PB)) (VP (VBD was) (VP (VBN given) (ADVP (RB simultaneously)) (PP (IN with) (NP (NP (NNS Doc_3780814_622_625_Chemical)) (PP (IN for) (NP (QP (CD 4) (CC and) (CD 6)) (NNS weeks))))))))))) (. .)))
3780814	4	(ROOT (S (NP (NP (DT The) (JJ mitotic) (NN inhibition)) (CC and) (NP (NP (DT the) (NN production)) (PP (IN of) (NP (NNS micronuclei))))) (ADVP (RB normally)) (VP (VBD observed) (SBAR (IN after) (S (NP (NP (JJ partial) (NN hepatectomy)) (PP (IN in) (NP (NNP DEN)))) (VP (VBD treated) (SBAR (S (NP (NNS rats)) (VP (VBD were) (ADVP (RB also)) (VP (ADVP (RB significantly)) (VBN decreased) (PP (IN in) (NP (NP (JJ Doc_3780814_803_806_Chemical) (JJ +) (NNS Doc_3780814_809_811_Chemical)) (VP (VBN treated) (NP (NNS rats))))))))))))) (. .)))
3780814	5	(ROOT (S (SBAR (WHADVP (WRB When)) (S (NP (DT the) (NN treatment)) (VP (VB last) (NP (QP (RB only) (CD 2)) (NNS weeks))))) (, ,) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NNP PB)))) (VP (VBD did) (RB not) (VP (VB change) (NP (RB significantly) (DT the) (JJ last) (NNS parameters)))) (. .)))
3780814	6	(ROOT (S (PP (IN In) (NP (NP (JJ Doc_3780814_936_939_Chemical) (JJ +) (NNS Doc_3780814_942_944_Chemical)) (VP (VBN treated) (NP (NNS rats))))) (, ,) (S (NP (DT the) (NN survival)) (VP (VBD was) (ADJP (JJ prolonged)))) (CC and) (S (NP (DT the) (JJ Doc_3780814_994_999_Disease) (NN incidence)) (VP (VBD decreased) (PP (IN as)) (PP (VBN compared) (PP (IN with) (NP (NP (DT the) (NNS results)) (VP (VBN obtained) (PP (IN by) (NP (NNS Doc_3780814_1061_1064_Chemical))) (ADVP (RB alone)))))))) (. .)))
3780814	7	(ROOT (S (NP (PRP It)) (VP (VBZ is) (VP (VBN concluded) (SBAR (IN that) (S (NP (NP (NNP PB)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ promotes) (NP (NNS Doc_3780814_1112_1126_Disease)) (SBAR (WHADVP (WRB when)) (S (VP (VBN administered) (PP (IN after) (NP (DT the) (JJ Doc_3780814_1155_1158_Chemical) (NN treatment))))))))) (, ,)) (VP (VBZ reduces) (NP (DT the) (NN carcinogen) (NN effect)) (SBAR (WHADVP (WRB when)) (S (VP (VBN given) (ADVP (RB simultaneously)) (PP (IN with) (NP (NNS Doc_3780814_1231_1234_Chemical))))))))))) (. .)))
3780814	8	(ROOT (S (NP (DT This) (`` `) (NN anti-carcinogen) ('' ') (NN effect)) (VP (VBZ acts) (PP (PP (IN on) (NP (DT the) (NN initiation))) (CONJP (RB as) (RB well) (IN as)) (PP (IN on) (NP (NP (DT the) (NN promotion)) (PP (IN of) (NP (DT the) (NNS Doc_3780814_1324_1344_Disease))))))) (. .)))
3780814	9	(ROOT (S (NP (JJ Biochemical) (NNS investigations)) (VP (VBP are) (PP (IN in) (NP (NN progress))) (S (VP (TO to) (VP (VB obtain) (NP (JJR more) (NN information)) (PP (IN about) (NP (DT this) (`` `) (NN paradoxical) ('' ') (NN PB) (NN effect))))))) (. .)))
384871	0	(ROOT (S (VP (VB Doc_384871_0_26_Disease) (ADJP (JJ due) (PP (TO to) (NP (NP (VBN combined) (NNS Doc_384871_43_53_Chemical)) (CC and) (NP (JJ Doc_384871_58_67_Chemical) (NN treatment)))))) (. .)))
384871	1	(ROOT (S (NP (NP (DT The) (NN case)) (PP (IN of) (NP (NP (DT a) (JJ 40-year-old) (NN patient)) (SBAR (WHNP (WP who)) (S (VP (VP (VBD underwent) (NP (DT an) (JJ unsuccessful) (NN cadaver) (NN kidney) (NN transplantation))) (CC and) (VP (VBD was) (VP (VBN treated) (PP (IN with) (NP (NNS Doc_384871_195_205_Chemical) (CC and) (NNS Doc_384871_210_219_Chemical))))))))))) (VP (VBZ is) (VP (VBN reported))) (. .)))
384871	2	(ROOT (S (NP (NP (DT A) (NNS Doc_384871_235_267_Disease)) (PP (IN with) (NP (DT an) (JJ unusual) (JJ central) (NN bitemporal) (JJ hemianopic) (NNS Doc_384871_314_321_Disease)))) (VP (VBD was) (VP (VBN found))) (. .)))
384871	3	(ROOT (S (S (NP (NNP Doc_384871_333_343_Chemical)) (VP (VBD was) (VP (VBN stopped)))) (CC and) (S (NP (NP (RB only) (JJ small) (NN improvement)) (PP (IN of) (NP (DT the) (JJ visual) (NN acuity)))) (VP (VBD followed))) (. .)))
384871	4	(ROOT (S (NP (NNP Doc_384871_414_423_Chemical)) (VP (VBD was) (VP (VBN discontinued) (ADVP (RB later)) (, ,) (PP (VBN followed) (PP (IN by) (NP (NP (DT a) (JJ dramatic) (NN improvement)) (PP (IN in) (NP (DT the) (JJ visual) (NN acuity)))))))) (. .)))
384871	5	(ROOT (S (NP (NP (DT The) (NNS hazards)) (PP (IN of) (NP (NP (JJ optic) (NN nerve) (NNS Doc_384871_532_540_Disease)) (ADJP (JJ due) (PP (TO to) (NP (NNS Doc_384871_548_558_Chemical))))))) (VP (VBP are) (VP (VBN known))) (. .)))
384871	6	(ROOT (S (NP (PRP We)) (VP (VB emphasize) (NP (DT the) (JJ potential) (NN danger)) (PP (IN in) (NP (NP (DT the) (NN use)) (PP (IN of) (NP (NNS Doc_384871_618_628_Chemical) (CC and) (NNS Doc_384871_633_642_Chemical)))))) (. .)))
3934126	0	(ROOT (S (NP (NP (DT A) (JJ prospective) (NN study)) (PP (IN of) (NP (JJ adverse) (NNS reactions)))) (VP (VBN associated) (PP (IN with) (NP (JJ Doc_3934126_57_67_Chemical) (NN therapy)))) (. .)))
3934126	1	(ROOT (S (NP (NP (DT A) (JJ prospective) (NN evaluation)) (PP (IN of) (NP (NP (DT the) (NN efficacy) (CC and) (NN safety)) (PP (IN of) (NP (NNS Doc_3934126_132_142_Chemical)))))) (VP (VBD was) (VP (VBN conducted) (PP (IN in) (NP (NP (CD 54) (JJ consecutive) (NNS patients)) (PP (IN over) (NP (DT a) (JJ 16-month) (NN period))))))) (. .)))
3934126	2	(ROOT (S (NP (NNP Doc_3934126_208_218_Chemical)) (VP (VBD was) (ADJP (JJ curative) (PP (IN in) (NP (NP (CD 95) (NN %)) (PP (IN of) (NP (NP (CD 43) (NNS patients)) (PP (IN with) (NP (VBN proven) (NNS Doc_3934126_266_275_Disease))))))))) (. .)))
3934126	3	(ROOT (S (S (NP (NNS Drugs)) (VP (VBD were) (VP (VBN ceased) (PP (IN in) (NP (NP (CD six) (NNS patients)) (PP (RB because) (IN of) (NP (JJ adverse) (NNS reactions)))))))) (: ;) (S (PP (IN in) (NP (NP (CD three)) (PP (IN of) (NP (DT these))))) (NP (NNS Doc_3934126_359_369_Chemical)) (VP (VBD was) (VP (VBN considered) (NP (DT the) (JJ likely) (NN cause))))) (. .)))
3934126	4	(ROOT (S (NP (NNS Reactions)) (VP (VBD included) (NP (NP (NP (NP (NNS Doc_3934126_422_438_Disease)) (PRN (-LRB- -LRB-) (NP (NP (CD 20)) (PP (IN of) (NP (CD 54) (NNS patients)))) (-RRB- -RRB-))) (, ,) (NP (NP (NNS Doc_3934126_460_464_Disease)) (PRN (-LRB- -LRB-) (NP (QP (CD 4) (IN of) (CD 54))) (-RRB- -RRB-))) (, ,) (NP (NP (NN nephrotoxicity)) (PRN (-LRB- -LRB-) (NP (QP (CD 4) (IN of) (CD 50))) (-RRB- -RRB-))) (, ,) (NP (NP (NNS Doc_3934126_502_513_Disease)) (PRN (-LRB- -LRB-) (NP (QP (CD 1) (IN of) (CD 50))) (-RRB- -RRB-))) (CC and) (NP (NNS Doc_3934126_528_539_Disease))) (PRN (-LRB- -LRB-) (NP (NP (CD 1)) (PP (IN of) (NP (CD 11) (NNS patients))) (VP (VBN tested) (PP (IN by) (NP (NN audiometry))))) (-RRB- -RRB-)))) (. .)))
3934126	5	(ROOT (S (S (NP (NNP Doc_3934126_581_597_Disease)) (VP (VBD occurred) (ADVP (RB only)) (PP (IN with) (NP (NN infusion))) (PP (IN through) (NP (JJ peripheral) (NN cannulae))))) (: ;) (S (NP (NN nephrotoxicity) (CC and) (NNS Doc_3934126_674_685_Disease)) (VP (VBD were) (VP (VBN confined) (PP (TO to) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NP (DT an) (NNS Doc_3934126_725_739_Chemical)) (PP (CC plus) (NP (NNS Doc_3934126_745_755_Chemical)))))))))) (. .)))
3934126	6	(ROOT (S (NP (PRP We)) (VP (VBP conclude) (SBAR (IN that) (S (NP (NP (NNS Doc_3934126_774_784_Chemical)) (, ,) (VP (VBN administered) (ADVP (RB appropriately))) (, ,)) (VP (VBZ constitutes) (NP (ADJP (JJ safe) (, ,) (JJ effective)) (NN therapy)) (PP (IN for) (NP (NP (NNS Doc_3934126_854_864_Disease)) (VP (VBN caused) (PP (IN by) (NP (ADJP (JJ susceptible)) (NNS bacteria)))))))))) (. .)))
3950060	0	(ROOT (S (NP (NNS Factors)) (VP (VBN associated) (PP (IN with) (NP (JJ nephrotoxicity) (CC and) (JJ clinical) (NN outcome))) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NNS Doc_3950060_82_90_Chemical)))))) (. .)))
3950060	1	(ROOT (S (NP (NP (NNP Data)) (PP (IN from) (NP (NP (CD 60) (NNS patients)) (VP (VBN treated) (PP (IN with) (NP (NNS Doc_3950060_127_135_Chemical))))))) (VP (VBD were) (VP (VBN analyzed) (PP (IN for) (NP (NP (NNS factors)) (VP (VBN associated) (PP (IN with) (NP (NN nephrotoxicity)))))))) (. .)))
3950060	2	(ROOT (S (PP (IN In) (NP (NP (CD 42)) (PP (IN of) (NP (DT these) (NNS patients))))) (, ,) (NP (NNS data)) (VP (VBD were) (VP (VBN examined) (PP (IN for) (NP (NP (NNS factors)) (VP (VBN associated) (PP (IN with) (NP (JJ clinical) (NN outcome)))))))) (. .)))
3950060	3	(ROOT (S (NP (NNP Variables) (NNP evaluated)) (VP (VBD included) (S (NP (NP (JJ patient) (NN weight) (, ,) (NN age) (, ,) (NN sex) (, ,) (NN serum) (NN Doc_3950060_345_355_Chemical) (NN level)) (, ,) (NP (JJ Doc_3950060_363_373_Chemical) (NN clearance)) (, ,) (NP (NP (NN duration)) (PP (IN of) (NP (NN therapy)))) (, ,) (NP (JJ total) (NN dose)) (, ,)) (VP (VP (VB mean) (NP (JJ daily) (NN dose))) (, ,) (VP (VB organism) (NP (NP (JJ minimum) (NN inhibitory) (NN concentration)) (PRN (-LRB- -LRB-) (NP (NNP MIC)) (-RRB- -RRB-)))) (, ,) (VP (VP (VB mean) (NP (JJ peak) (NNS levels))) (, ,) (VP (VB mean) (NP (NN trough) (NNS levels))) (, ,) (VP (VB mean) (NP (NN area)) (PP (IN under) (NP (NP (DT the) (JJ serum) (JJ concentration-time) (NN curve)) (PRN (-LRB- -LRB-) (NP (NNP AUC)) (-RRB- -RRB-))))) (, ,) (VP (VB total) (NP (NNP AUC))) (, ,) (VP (VB mean) (S (NP (NNP AUC)) (ADJP (ADJP (JJR greater) (PP (IN than) (NP (NNP MIC)))) (, ,) (ADJP (NP (JJ total) (NNP AUC)) (JJR greater)))) (PP (IN than) (NP (NNP MIC)))) (, ,) (VP (VB mean) (NP (NP (NP (NNP Schumacher) (POS 's)) (NN intensity) (NN factor)) (PRN (-LRB- -LRB-) (NP (NNP IF)) (-RRB- -RRB-)))) (, ,) (VP (VB total) (NP (NNS IF)) (, ,) (FRAG (PP (IN In) (NP (-LRB- -LRB-) (JJ mean) (JJ maximum) (NN concentration) (NNP -LSB-) (NNP Cmax) (NNP -RSB-))) (: /) (ADVP (RB MIC)))))))) (-RRB- -RRB-) (. .)))
3950060	4	(ROOT (S (NP (JJ Model-dependent) (JJ pharmacokinetic) (NNS parameters)) (VP (VBD were) (VP (VBN calculated) (PP (IN by) (NP (NN computer))) (PP (VBN based) (PP (IN on) (NP (DT a) (JJ one-compartment) (NN model)))))) (. .)))
3950060	5	(ROOT (S (SBAR (WHADVP (WRB When)) (S (NP (DT the) (NNS parameters)) (VP (VBD were) (VP (VBN examined) (ADVP (RB individually)))))) (, ,) (NP (NP (NN duration)) (PP (IN of) (NP (NN therapy) (CC and) (NN total) (NN AUC)))) (VP (VBD correlated) (ADVP (ADVP (RB significantly)) (PRN (-LRB- -LRB-) (NP (NNP P) (QP (JJR less) (IN than) (CD .05))) (-RRB- -RRB-))) (PP (IN with) (NP (NN nephrotoxicity)))) (. .)))
3950060	6	(ROOT (S (PP (IN In) (NP (NN contrast))) (, ,) (NP (DT a) (JJ stepwise) (NN discriminant) (NN function) (NN analysis)) (VP (VBD identified) (NP (NP (JJ only) (NN duration)) (PP (IN of) (NP (NN therapy)))) (PRN (-LRB- -LRB-) (NP (NNP P) (QP (JJR less) (IN than) (CD .001))) (-RRB- -RRB-)) (PP (IN as) (NP (DT an) (JJ important) (NN factor)))) (. .)))
3950060	7	(ROOT (S (PP (VBN Based) (PP (PP (IN on) (NP (DT this) (NN model))) (CC and) (PP (IN on) (NP (NP (NNP Bayes) (POS ')) (NN theorem))))) (, ,) (NP (NP (DT the) (JJ predictive) (NN accuracy)) (PP (IN of) (S (VP (VBG identifying) (NP (`` ``) (JJ nephrotoxic) ('' '') (NNS patients)))))) (VP (VBD increased) (PP (IN from) (NP (CD 0.17))) (PP (TO to) (NP (CD 0.39)))) (. .)))
3950060	8	(ROOT (S (SBAR (WHADVP (WRB When)) (S (VP (VBD examined) (ADVP (RB individually))))) (, ,) (NP (NP (JJ mean) (NNS IF)) (, ,) (NP (NNP MIC)) (, ,) (NP (JJ total) (NN dose)) (, ,) (NP (JJ mean) (JJ daily) (NN dose)) (, ,) (CC and) (NP (NN ln))) (PRN (-LRB- -LRB-) (VP (VB mean) (NP (NNP Cmax/MIC))) (-RRB- -RRB-)) (VP (VBN correlated) (ADVP (ADVP (RB significantly)) (PRN (-LRB- -LRB-) (NP (NNP P) (QP (JJR less) (IN than) (CD .05))) (-RRB- -RRB-))) (PP (IN with) (NP (NN cure)))) (. .)))
3950060	9	(ROOT (S (PP (IN In) (NP (NN contrast))) (, ,) (NP (DT a) (JJ simultaneous) (NN multivariable) (NN analysis)) (VP (VBD identified) (NP (NP (NNP IF)) (, ,) (NP (NNP MIC)) (, ,) (CC and) (NP (JJ total) (NN dose))) (PP (VBG according) (PP (TO to) (NP (NP (CD one) (NN model)) (CC and) (NP (NN ln)))))) (PRN (-LRB- -LRB-) (VP (VB mean) (NP (NNP Cmax/MIC))) (-RRB- -RRB-)) (PP (VBG according) (PP (TO to) (NP (NP (DT a) (JJ second) (JJ statistical) (NN model)) (PP (IN of) (NP (NP (NNS parameters)) (VP (VBN selected) (S (VP (TO to) (VP (VB have) (NP (DT the) (JJS greatest) (JJ prospective) (NN value))))))))))) (. .)))
3950060	10	(ROOT (S (PP (VBN Based) (PP (IN on) (NP (NP (NP (NNP Bayes) (POS ')) (NN theorem)) (CC and) (NP (DT the) (JJ first) (NN model))))) (, ,) (NP (NP (DT the) (JJ predictive) (NN accuracy)) (PP (IN of) (S (VP (VBG identifying) (NP (NP (NNS patients)) (VP (RB not) (VBN cured))))))) (VP (VBD increased) (PP (IN from) (NP (CD 0.19))) (PP (TO to) (NP (CD 0.83)))) (. .)))
3950060	11	(ROOT (S (PP (IN For) (NP (DT the) (JJ second) (NN model))) (, ,) (NP (DT the) (JJ predictive) (NN accuracy)) (VP (VBD increased) (PP (IN from) (NP (CD 0.19))) (PP (TO to) (NP (NP (NNP 0.50) (. .)) (PRN (-LRB- -LRB-) (NP (NP (NNP ABSTRACT) (NNP TRUNCATED) (NNP AT)) (NP (CD 250) (NNS WORDS))) (-RRB- -RRB-)))))))
3952818	0	(ROOT (NP (NP (NNP Doc_3952818_0_16_Disease)) (PP (IN of) (NP (NNS Doc_3952818_20_34_Chemical))) (. .)))
3952818	1	(ROOT (NP (NP (NNP Report)) (PP (IN of) (NP (DT a) (NN case))) (PP (IN of) (NP (JJ spontaneous) (NNS Doc_3952818_68_74_Disease))) (. .)))
3952818	2	(ROOT (S (NP (PRP We)) (VP (VBP report) (NP (NP (DT a) (NN case)) (PP (IN of) (NP (DT a) (ADJP (JJ patient) (PP (IN with) (NP (NP (NNS Doc_3952818_111_126_Disease) (CC and) (NN liver) (NNS Doc_3952818_137_147_Disease)) (SBAR (WHNP (WP who)) (S (VP (VBD presented) (NP (NNS Doc_3952818_162_172_Disease)) (PP (IN after) (NP (NP (NNS Doc_3952818_179_193_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_3952818_195_199_Chemical)) (-RRB- -RRB-)))))))))) (NN administration))))) (. .)))
3952818	3	(ROOT (S (S (NP (JJ Clinical) (JJ electrocardiographic) (NN evolution)) (VP (VBD was) (ADJP (JJ similar) (PP (TO to) (SBAR (WHNP (WDT that)) (S (VP (VBD observed) (PP (IN in) (NP (NNS Doc_3952818_289_308_Disease)))))))))) (, ,) (CC and) (S (NP (NNS Doc_3952818_314_324_Disease)) (ADVP (RB promptly)) (VP (VBN resolved) (PP (IN with) (NP (NNS Doc_3952818_348_358_Chemical))))) (. .)))
3952818	4	(ROOT (S (NP (DT These) (NNS data)) (VP (VBP suggest) (SBAR (SBAR (IN that) (S (NP (NNS Doc_3952818_384_398_Disease)) (VP (MD may) (VP (VB be) (NP (NP (DT the) (NN cause)) (PP (IN of) (NP (NP (NNS Doc_3952818_419_433_Disease)) (ADJP (JJ due) (PP (TO to) (NP (NNS Doc_3952818_441_445_Chemical))))))))))) (, ,) (CC and) (SBAR (IN that) (S (NP (JJ Doc_3952818_456_463_Chemical) (NNS antagonists)) (VP (MD may) (ADVP (RB probably)) (VP (VB be) (VP (VBN used) (PP (IN in) (NP (NP (DT the) (NN prevention) (CC or) (NN treatment)) (PP (IN of) (NP (JJ Doc_3952818_531_535_Chemical) (NNS Doc_3952818_536_550_Disease)))))))))))) (. .)))
3961813	0	(ROOT (S (NP (NP (JJ Dose-related) (ADJP (JJ beneficial) (CC and) (JJ adverse)) (NNS effects)) (PP (IN of) (NP (NP (JJ dietary) (NNS Doc_3961813_55_69_Chemical)) (PP (IN on) (NP (NNS Doc_3961813_73_89_Chemical-induced)))))) (VP (VBD delayed) (NP (NNS Doc_3961813_106_116_Disease)) (PP (IN in) (NP (NNS chickens)))) (. .)))
3961813	1	(ROOT (S (NP (NP (NNP Doc_3961813_130_155_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_3961813_157_161_Chemical)) (-RRB- -RRB-)) (, ,) (NP (NP (CD 360) (NN mg/kg)) (, ,) (NP (NN po)) (, ,) (CC and) (NP (NP (NNS Doc_3961813_183_219_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_3961813_221_224_Chemical)) (-RRB- -RRB-)))) (, ,) (NP (CD 1) (JJ mg/kg) (NN sc)) (, ,)) (VP (VBD were) (VP (VBN administered) (PP (TO to) (NP (JJ adult) (NNP White) (NNP Leghorn) (NNS chickens))) (SBAR (NP (CD 24) (NN hr)) (IN after) (S (NP (PRP they)) (VP (VBD were) (VP (VBN placed) (PP (IN on) (NP (NP (NNS diets)) (VP (VBG containing) (NP (CD 0)) (PP (TO to) (NP (CD 300) (NN ppm) (NNS Doc_3961813_351_365_Chemical)))))))))))) (. .)))
3961813	2	(ROOT (S (NP (JJ Supplemented) (NNS diets)) (VP (VBD were) (VP (VBN continued) (SBAR (IN until) (S (NP (NP (JJ clinical) (NNS signs) (CC and) (NNS lesions)) (PP (IN of) (NP (JJ delayed) (NNS Doc_3961813_445_455_Disease)))) (VP (VBD appeared)))))) (. .)))
3961813	3	(ROOT (S (SBAR (IN Although) (S (NP (NP (NP (JJ low) (NNS concentrations)) (PRN (-LRB- -LRB-) (ADJP (ADJP (JJR less) (PP (IN than))) (CC or) (ADJP (JJ equal) (PP (TO to) (NP (CD 50) (NN ppm))))) (-RRB- -RRB-))) (PP (IN of) (NP (NNS Doc_3961813_528_542_Chemical)))) (VP (VBD had) (NP (NP (JJ beneficial) (NNS effects)) (PP (IN on) (NP (NN Doc_3961813_569_573_Chemical-induced) (NNS Doc_3961813_582_592_Disease))))))) (, ,) (NP (ADJP (ADJP (JJR greater) (PP (IN than))) (CC or) (ADJP (JJ equal) (PP (TO to) (NP (CD 200))))) (NN ppm)) (VP (VBD exacerbated) (NP (JJ clinical) (NNS signs)) (PP (IN in) (NP (NP (NNS chickens)) (VP (VBN given) (PP (CC either) (NP (NNS Doc_3961813_679_683_Chemical) (CC or) (NNS Doc_3961813_687_690_Chemical))))))) (. .)))
3961813	4	(ROOT (S (NP (NN Doc_3961813_692_702_Disease) (NN esterase) (NNS activities) (NX (CD 24))) (VP (VBP hr) (SBAR (IN after) (S (NP (NNS Doc_3961813_735_739_Chemical) (CC or) (NNS Doc_3961813_743_746_Chemical)) (VP (VBD were) (NP (NP (QP (JJR less) (IN than) (CD 20)) (NN %)) (PP (IN of) (NP (NP (NNS values)) (VP (VBN measured) (PP (IN in) (NP (NP (NNS chickens)) (PP (RB not) (NP (VBN given) (JJ Doc_3961813_807_824_Chemical) (NNS compounds))))))))))))) (. .)))
3961813	5	(ROOT (S (NP (NP (NNS Chickens)) (VP (VBN given) (NP (CD 200) (NN ppm) (NNS Doc_3961813_859_873_Chemical)) (PP (IN without) (NP (NNS Doc_3961813_882_886_Chemical) (CC or) (NNS Doc_3961813_890_893_Chemical))))) (VP (VP (VBD had) (NP (NP (RB significantly) (JJ elevated) (NN activity)) (PP (IN of) (NP (NN plasma) (NN cholinesterase))))) (CC and) (VP (ADVP (RB significantly)) (VBD inhibited) (NP (NP (NN activity)) (PP (IN of) (NP (NN liver) (NN carboxylesterase)))))) (. .)))
3961813	6	(ROOT (S (NP (NNP Doc_3961813_1019_1049_Disease)) (VP (VBD were) (ADVP (RB also)) (ADJP (JJ evident)) (PP (IN in) (NP (NP (JJ distal) (NNS levels)) (PP (IN of) (NP (NP (DT the) (JJ peripheral) (NNS nerves)) (PP (IN of) (NP (JJ chickens) (VBN given) (NNS Doc_3961813_1128_1132_Chemical) (CC or) (NNS Doc_3961813_1136_1139_Chemical)))))))) (. .)))
3962737	0	(ROOT (NP (NP (NNP Hepatotoxicity)) (PP (IN of) (NP (NNS Doc_3962737_18_28_Chemical))) (. .)))
3962737	1	(ROOT (S (NP (NNP Doc_3962737_30_40_Chemical)) (VP (VBZ has) (VP (VBN proved) (ADJP (RB very) (JJ effective)) (PP (IN in) (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (ADJP (RB otherwise) (JJ resistant)) (JJ cardiac) (NNS Doc_3962737_115_131_Disease))))))) (. .)))
3962737	2	(ROOT (NP (NP (NP (DT The) (NN use)) (PP (IN of) (NP (NP (NNS Doc_3962737_144_154_Chemical)) (SBAR (S (VP (VBZ has) (PRN (, ,) (ADVP (RB however)) (, ,)))))))) (VP (VBN been) (VP (VBN limited) (S (ADJP (JJ due) (PP (TO to) (NP (PRP$ its) (JJ serious) (NNS side-effects))))))) (. .)))
3962737	3	(ROOT (S (S (NP (NP (DT A) (NN patient)) (PP (IN with) (NP (NP (NNS Doc_3962737_230_251_Disease)) (ADJP (JJ due) (PP (TO to) (NP (JJ Doc_3962737_259_269_Chemical) (NN treatment))))))) (VP (VBZ is) (VP (VBN presented) (ADVP (RB below))))) (CC and) (S (NP (NP (DT a) (NN review)) (PP (IN of) (NP (NP (DT the) (NN hepatotoxicity)) (PP (IN of) (NP (NNS Doc_3962737_337_347_Chemical)))))) (VP (VBZ is) (VP (VBN given)))) (. .)))
3962737	4	(ROOT (S (NP (PRP It)) (VP (VBZ is) (VP (VBN concluded) (SBAR (IN that) (S (NP (JJ solid) (NN evidence)) (VP (VBZ exists) (PP (IN of) (NP (NP (NNS Doc_3962737_404_418_Disease)) (ADJP (JJ due) (PP (TO to) (NP (JJ Doc_3962737_426_436_Chemical) (NN treatment)))) (, ,) (PP (VBG including) (NP (NP (NNS Doc_3962737_458_467_Disease)) (, ,) (NP (NP (NNS alterations)) (VP (VBG resembling) (NP (NNS Doc_3962737_492_511_Disease) (, ,) (NNS Doc_3962737_513_534_Disease) (CC and) (NN micronodular) (NNS Doc_3962737_552_574_Disease))))))))))))) (. .)))
3962737	5	(ROOT (S (NP (NP (NNS Patients)) (VP (VBG receiving) (NP (NNS Doc_3962737_595_605_Chemical)))) (VP (MD should) (VP (VB be) (VP (ADVP (RB regularly)) (VBN screened) (PP (IN with) (NP (NN respect))) (PP (TO to) (NP (JJ hepatic) (NN enzyme) (NNS levels)))))) (. .)))
3962737	6	(ROOT (S (NP (NNP Therapy)) (VP (MD should) (VP (VB be) (VP (VBN discontinued) (PP (IN on) (NP (NP (DT the) (NN suspicion)) (PP (IN of) (NP (NNS Doc_3962737_725_743_Disease) (CC or) (NNS Doc_3962737_747_759_Disease)))))))) (. .)))
3969369	0	(ROOT (NP (NP (JJ Promotional) (NNS effects)) (PP (IN of) (NP (UCP (NP (NNS Doc_3969369_23_35_Chemical)) (CC and) (ADJP (RB dietary) (JJ fat) (PP (IN on) (NP (NN prostate))))) (NNS Doc_3969369_64_78_Disease))) (PP (IN in) (NP (ADJP (RB genetically) (JJ susceptible)) (NNS rats))) (. .)))
3969369	1	(ROOT (S (NP (NNP Germfree)) (PRN (-LRB- -LRB-) (NP (NNP GF)) (-RRB- -RRB-)) (NP (NP (NNP Lobund) (NNP strain) (NNP Wistar) (PRN (-LRB- -LRB-) (NP (NNP LW)) (-RRB- -RRB-)) (NNS rats)) (, ,) (NP (NN fed) (NN vegetable) (NN diet) (NN L-485)) (, ,)) (VP (VBP have) (VP (VBD developed) (NP (NNS Doc_3969369_199_223_Disease)) (ADVP (RB spontaneously)) (PRN (-LRB- -LRB-) (NP (NP (CD 10) (NN %)) (NP (NN incidence))) (-RRB- -RRB-)) (PP (IN at) (NP (NP (JJ average) (NN age)) (NP (CD 34) (NNS months)))))) (. .)))
3969369	2	(ROOT (S (NP (NP (JJ Conventional) (NNP LW) (NNS rats)) (, ,) (VP (VBN implanted) (PP (IN with) (NP (NP (NNS Doc_3969369_317_329_Chemical)) (PP (IN at) (NP (NN age))) (NP (CD 4) (NNS months))))) (, ,)) (VP (VBD developed) (NP (NP (DT a) (JJR higher) (NN incidence)) (PP (IN of) (NP (NNS Doc_3969369_379_394_Disease)))) (PP (IN after) (NP (NP (NP (DT an) (JJ average) (NN interval)) (PP (IN of) (NP (CD 14) (NNS months)))) (: :) (NP (NP (CD 24) (NN %)) (SBAR (S (VP (VBD had) (VP (VBN developed) (NP (JJ gross) (NNS Doc_3969369_459_465_Disease))))))) (, ,) (CC and) (NP (NP (CD 40) (NN %)) (SBAR (WHADVP (WRB when)) (S (NP (PRP it)) (VP (VBD included) (NP (JJ microscopic) (NNS Doc_3969369_504_510_Disease))))))))) (. .)))
3969369	3	(ROOT (S (NP (JJ Preliminary) (NNS results)) (VP (VBP indicate) (SBAR (IN that) (S (NP (NNS Doc_3969369_546_558_Chemical-treated)) (VP (VBP LW) (NP (NP (NNS rats)) (SBAR (WHNP (WDT that)) (S (VP (VBD were) (VP (VBN fed) (SBAR (S (NP (NP (DT the) (JJ same) (NN diet)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD was) (VP (VBN supplemented) (PP (IN with) (NP (NN corn) (NN oil))) (ADVP (RB up) (PP (TO to) (NP (ADJP (CD 20) (NN %)) (NN fat)))))))) (, ,)) (VP (VBD developed) (NP (NNS Doc_3969369_666_681_Disease)) (PP (IN after) (NP (NP (NNS intervals)) (PP (IN of) (NP (CD 6-12) (NNS months))))))))))))))))) (. .)))
3969369	4	(ROOT (S (NP (NP (NNP Aged) (NNP GF) (NNP Sprague-Dawley)) (PRN (-LRB- -LRB-) (NP (NNP SD)) (-RRB- -RRB-)) (NNS rats)) (VP (VBP have) (RB not) (VP (VBN developed) (NP (NNS Doc_3969369_766_781_Disease)) (ADVP (RB spontaneously)))) (. .)))
3969369	5	(ROOT (S (NP (NP (JJ Conventional) (NNP SD) (NNS rats)) (VP (VP (VBN fed) (NP (NN diet) (NN L-485))) (CC and) (VP (VBN treated) (PP (IN with) (NP (NNS Doc_3969369_850_862_Chemical)))))) (VP (VBD developed) (NP (JJ only) (NNS Doc_3969369_878_889_Disease))) (. .)))
3969369	6	(ROOT (S (NP (JJ Experimental) (NNS designs)) (VP (MD should) (VP (VB consider) (NP (JJ genetic) (NN susceptibility)) (PP (IN as) (NP (NP (DT a) (JJ basic) (NN prerequisite)) (PP (IN for) (NP (NP (NNS studies)) (PP (IN on) (NP (JJ experimental) (NNS Doc_3969369_1003_1018_Disease))))))))) (. .)))
3973521	0	(ROOT (S (NP (NP (NNP Time) (NN course) (NNS alterations)) (PP (IN of) (NP (NNP QTC)))) (VP (VBP interval) (ADJP (JJ due) (PP (TO to) (NP (NNS Doc_3973521_47_57_Chemical))))) (. .)))
3973521	1	(ROOT (S (NP (NP (JJ Sequential) (NN measurement)) (PP (IN of) (NP (NP (NNP QT) (NNP interval)) (PP (IN during) (NP (JJ left) (NN ventricular)))))) (ADVP (RB angiography)) (VP (VBD was) (VP (VBN made) (NP (NP (CD 30) (NNS seconds)) (CC and) (NP (CD one) (, ,) (CD three) (, ,) (CD five) (CC and) (CD ten) (NNS minutes))) (PP (IN after) (NP (NP (NN injection)) (PP (IN of) (NP (NNS Doc_3973521_209_219_Chemical))))))) (. .)))
3973521	2	(ROOT (S (NP (DT The) (NNS subjects)) (VP (VBD were) (NP (NP (CD ten) (NNS patients)) (VP (VBN found) (S (VP (TO to) (VP (VB have) (NP (NP (JJ normal) (JJ left) (NNS ventricles)) (CC and) (NP (JJ coronary) (NNS arteries))))))))) (. .)))
3973521	3	(ROOT (S (NP (JJ Significant) (NNS Doc_3973521_324_340_Disease)) (VP (VBD occurred) (PP (IN in) (NP (CD 30) (NNS seconds))) (PP (TO to) (NP (NP (CD one) (NN minute)) (PP (IN in) (NP (NN association))))) (PP (IN with) (NP (NP (VBN marked) (NNS Doc_3973521_405_416_Disease) (CC and) (NN elevation)) (PP (IN of) (NP (JJ cardiac) (NN output)))))) (. .)))
4038130	0	(ROOT (S (NP (NNP Rat)) (VP (VBP extraocular) (NP (NN muscle) (NN regeneration))) (. .)))
4038130	1	(ROOT (NP (NP (NNP Repair)) (PP (IN of) (NP (JJ local) (JJ anesthetic-induced) (NN damage))) (. .)))
4038130	2	(ROOT (S (NP (NP (NP (JJ Local) (NNS anesthetics)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (ADVP (RB commonly)) (VP (VBN used) (PP (IN in) (NP (JJ ophthalmic) (NN surgery)))))))) (PRN (-LRB- -LRB-) (NP (NP (NP (CD 0.75) (NN %)) (NP (NNS Doc_4038130_150_175_Chemical))) (, ,) (NP (NP (CD 2.0) (NN %)) (NP (NNS Doc_4038130_182_207_Chemical))) (, ,) (CC and) (NP (NP (ADJP (CD 2.0) (NN %)) (NNS Doc_4038130_218_241_Chemical)) (CC plus) (NP (CD 1:100,000) (NNS Doc_4038130_257_268_Chemical)))) (-RRB- -RRB-))) (VP (VBD were) (VP (VBN injected) (PP (IN into) (NP (NP (DT the) (NN retrobulbar) (NN area)) (PP (IN of) (NP (NN rat) (NNS eyes))))))) (. .)))
4038130	3	(ROOT (S (NP (NNS Controls)) (VP (VBD were) (VP (VBN injected) (PP (IN with) (NP (JJ physiological) (NN saline))))) (. .)))
4038130	4	(ROOT (S (NP (DT All) (CD three) (NNS anesthetics)) (VP (VBD produced) (NP (NP (JJ massive) (NN degeneration)) (PP (IN of) (NP (DT the) (NN extraocular) (NNS muscles))))) (. .)))
4038130	5	(ROOT (S (NP (NNP Doc_4038130_453_472_Disease)) (VP (VBZ is) (VP (VBN followed) (PP (IN by) (NP (NP (NN regeneration)) (PP (IN of) (NP (DT the) (VBN damaged) (NN muscle) (NNS fibers))))))) (. .)))
4038130	6	(ROOT (S (PP (IN In) (NP (NP (NN addition)) (PP (TO to) (NP (NNS Doc_4038130_546_559_Disease))))) (, ,) (NP (JJ severe) (NN damage)) (VP (VBD was) (ADVP (RB also)) (VP (VBN seen) (PP (PP (IN in) (NP (NN harderian) (NNS glands))) (, ,) (RB especially) (PP (IN after) (NP (NN exposure)))) (PP (TO to) (NP (NP (NNS Doc_4038130_639_650_Chemical)) (CC and) (NP (NNP Doc_4038130_655_664_Chemical) (CC plus) (NNP Doc_4038130_670_681_Chemical)))))) (. .)))
4038130	7	(ROOT (S (PP (IN With) (NP (NP (DT these) (NNS findings)) (PP (IN in) (NP (NNS rats))))) (, ,) (NP (PRP it)) (VP (VBZ is) (VP (VBN hypothesized) (SBAR (IN that) (S (NP (NP (DT the) (JJ temporary) (NNS Doc_4038130_750_758_Disease)) (VP (ADVP (RB sometimes)) (VBN seen) (PP (IN in) (NP (NNS patients))) (PP (IN after) (NP (JJ ophthalmic) (NN surgery))))) (VP (MD might) (VP (VB be) (ADJP (JJ due) (PP (TO to) (NP (JJ anesthetic-induced) (NN damage)))) (PP (TO to) (NP (DT the) (NN extraocular) (NNS muscles))))))))) (. .)))
4069770	0	(ROOT (NP (NP (JJ Doc_4069770_0_10_Chemical) (NNS Doc_4069770_11_22_Disease)) (PP (IN in) (NP (DT a) (NN neonate))) (. .)))
4069770	1	(ROOT (S (NP (NP (DT The) (JJ clinical) (CC and) (JJ autopsy) (NNS findings)) (PP (IN in) (NP (NP (DT a) (JJ premature) (NN baby)) (SBAR (WHNP (WP who)) (S (VP (VBD died) (PP (IN of) (NP (NNS Doc_4069770_103_122_Disease))) (PP (IN after) (NP (NN therapy))) (PP (IN with) (NP (NP (NP (NNS Doc_4069770_142_152_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 5) (NN mg/kg/day)) (-RRB- -RRB-))) (CC and) (NP (NNS Doc_4069770_171_181_Chemical)))))))))) (VP (VBP are) (VP (VBN presented))) (. .)))
4069770	2	(ROOT (S (NP (DT The) (NN serum) (NNS Doc_4069770_207_217_Chemical) (NN concentration)) (VP (VBD had) (VP (VBN reached) (NP (JJ toxic) (NNS levels)) (SBAR (WHADVP (WRB when)) (S (NP (NNS Doc_4069770_262_268_Disease)) (VP (VBD developed)))))) (. .)))
4069770	3	(ROOT (S (NP (JJ Numerous) (NNS Doc_4069770_289_302_Chemical)) (VP (VBZ Schiff) (PRN (-LRB- -LRB-) (NP (NNP PAS)) (-RRB- -RRB-)) (NP (NP (JJ positive) (, ,) (ADJP (JJ diastase) (JJ resistant)) (JJ cytoplasmic) (NN inclusion) (NNS bodies)) (SBAR (WHNP (WDT which)) (S (VP (VBD appeared) (SBAR (IN as) (S (NP (NP (NN myelin) (NNS figures)) (PP (IN in) (NP (NP (NNS cytosegresomes)) (PP (IN under) (NP (DT the) (NN electron) (NN microscope)))))) (VP (VBD were) (VP (VBN identified) (PP (IN in) (NP (DT the) (ADJP (JJ proximal) (JJ convoluted)) (NNS tubules)))))))))))) (. .)))
4069770	4	(ROOT (S (NP (NP (DT The) (JJ pathological) (NNS changes)) (VP (VBN induced) (PP (IN by) (NP (NP (NNS Doc_4069770_543_553_Chemical)) (PP (IN in) (NP (DT the) (JJ human) (JJ neonatal) (NNS kidneys))))))) (VP (VBP have) (RB not) (VP (VBN been) (VP (ADVP (RB previously)) (VBN reported)))) (. .)))
4090988	0	(ROOT (S (VP (VBN Induction) (PP (IN by) (NP (NP (NNS Doc_4090988_13_24_Chemical)) (PP (IN of) (NP (NP (NNS Doc_4090988_28_53_Disease)) (PP (IN in) (NP (DT the) (NN rat)))))))) (. .)))
4090988	1	(ROOT (NP (NP (NNPS Effects)) (PP (IN on) (NP (JJ hepatocyte) (NN fine) (NN structure))) (. .)))
4090988	2	(ROOT (S (NP (NP (NNS Groups)) (PP (IN of) (NP (ADJP (NN male) (CC and) (JJ female)) (JJ inbred) (JJ Leeds) (NN strain) (NNS rats)))) (VP (VBD were) (VP (VBN fed) (NP (NNS diets)) (S (VP (VBG containing) (NP (DT either) (ADJP (QP (CD 0.5) (NN %) (CC or) (CD 1.0) (NN %))) (NN Doc_4090988_201_212_Chemical)) (PP (IN by) (NP (NP (NN weight)) (PP (IN for) (NP (QP (IN up) (TO to) (CD 18)) (NNS months))))))))) (. .)))
4090988	3	(ROOT (S (PP (IN At) (NP (DT the) (CD 1.0) (NN %) (NNS dosage) (NN level))) (, ,) (NP (NP (CD 20) (NN %)) (PP (IN of) (NP (NP (NNS rats)) (PP (IN of) (NP (DT both) (NNS sexes)))))) (VP (VBD developed) (NP (NP (JJ neoplastic) (NNS nodules)) (PP (IN of) (NP (NP (DT the) (NN liver)) (, ,) (NP (DT a) (ADJP (RB statistically) (JJ significant)) (NN incidence)))))) (. .)))
4090988	4	(ROOT (S (NP (DT These) (NNS rats)) (ADVP (RB also)) (VP (VBD showed) (NP (NP (JJ gross) (NN enlargement)) (PP (IN of) (NP (NP (PRP$ their) (NNS livers)) (CC and) (NP (DT an) (NN increase))))) (PP (IN in) (NP (NP (NNS foci)) (PP (IN of) (NP (NP (JJ cellular) (NN alteration)) (, ,) (NP (NP (DT the) (NN latter)) (VP (ADVP (RB also)) (VBG being) (VP (VBN observed) (PP (IN in) (NP (DT the) (JJ low) (NN dosage) (NN male) (NNS rats))))))))))) (. .)))
4090988	5	(ROOT (S (S (NP (NP (NNP Doc_4090988_543_553_Disease)) (PP (IN of) (NP (NP (DT the) (JJ transitional) (NN epithelium)) (PP (IN of) (NP (DT the) (NN bladder)))))) (VP (VBD developed) (PP (IN in) (NP (DT all) (NN Doc_4090988_617_628_Chemical-treated) (NNS groups))))) (, ,) (CC and) (S (NP (CD three) (NNS rats)) (VP (VBD bore) (NP (NNS Doc_4090988_665_683_Disease)))) (. .)))
4090988	6	(ROOT (S (ADVP (RB However)) (, ,) (NP (NP (JJ significant) (NNS yields)) (PP (IN of) (NP (NNS Doc_4090988_716_731_Disease)))) (VP (VBD were) (ADVP (RB only)) (VP (VBN obtained) (PP (IN from) (NP (NP (JJ low) (NN dosage) (NNS females)) (CC and) (NP (JJ high) (NN dosage) (NNS males)))))) (. .)))
4090988	7	(ROOT (S (ADVP (RB Additionally)) (, ,) (NP (NP (QP (CD 20) (TO to) (CD 25)) (NN %)) (PP (IN of) (NP (NN Doc_4090988_825_836_Chemical-treated) (NNS rats)))) (VP (VBD developed) (NP (NP (NNS Doc_4090988_860_871_Disease)) (PP (IN of) (NP (NP (DT the) (NN bladder) (NN epithelium)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD was) (RB not) (VP (VBN coincident) (PP (IN with) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NNS Doc_4090988_945_960_Disease))))))))))))) (. .)))
4090988	8	(ROOT (S (NP (NP (DT A) (JJ low) (NN yield)) (PP (IN of) (NP (NP (NNS Doc_4090988_977_984_Disease)) (PP (IN at) (NP (JJ various) (JJ other) (NNS sites)))))) (ADVP (RB also)) (VP (VBD arose) (PP (VBG following) (NP (JJ Doc_4090988_1029_1040_Chemical) (NN feeding)))) (. .)))
4090988	9	(ROOT (S (NP (NP (DT An) (JJ electron) (NN microscope) (NN study)) (PP (IN of) (NP (NP (DT the) (NNS livers)) (PP (IN of) (NP (NN Doc_4090988_1096_1107_Chemical-treated) (NNS rats)))))) (VP (VBD revealed) (NP (JJ ultrastructural) (NNS changes)) (PP (IN in) (NP (NP (DT the) (NNS hepatocytes)) (SBAR (WHNP (WDT that)) (S (VP (VBP resemble) (NP (NP (DT those)) (SBAR (WHNP (WDT that)) (S (VP (VBP result) (PP (IN from) (NP (NN exposure))) (PP (TO to) (NP (NP (DT a) (NN variety)) (PP (IN of) (NP (JJ known) (NNS hepatocarcinogens))))))))))))))) (. .)))
430165	0	(ROOT (NP (NP (JJ Transient) (NNS Doc_430165_10_21_Disease)) (: :) (NP (NP (DT a) (JJ rare) (NN manifestation)) (PP (IN of) (NP (JJ Doc_430165_47_64_Chemical) (NNS Doc_430165_65_73_Disease)))) (. .)))
430165	1	(ROOT (NP (NP (NNP Report)) (PP (IN of) (NP (CD two) (NNS cases))) (. .)))
430165	2	(ROOT (S (PP (IN Among) (NP (NP (DT the) (JJ common) (NN side) (NNS effects)) (PP (IN of) (NP (JJ Doc_430165_129_146_Chemical) (PRN (-LRB- -LRB-) (NP (NNP Doc_430165_148_151_Chemical)) (-RRB- -RRB-)) (NNS Doc_430165_153_161_Disease))))) (, ,) (NP (DT the) (JJS most)) (ADVP (RB frequently)) (VP (VBD encountered) (SBAR (S (NP (JJ neurological) (NNS signs)) (VP (VBP are) (NP (NP (DT those)) (PP (IN of) (NP (NNS Doc_430165_227_249_Disease)))))))) (. .)))
430165	3	(ROOT (S (ADVP (RB Very)) (ADVP (RB rarely)) (, ,) (NP (NP (DT the) (JJ toxic) (JJ neurological) (NNS manifestations)) (PP (IN of) (NP (DT this) (NN drug)))) (VP (VBP are) (PP (IN of) (NP (JJ cerebral) (NN origin)))) (. .)))
430165	4	(ROOT (S (NP (CD Two) (NNS patients)) (VP (VBP are) (VP (VBN presented) (SBAR (WHNP (WP who)) (S (VP (VBD suffered) (S (NP (JJ progressive) (NNS Doc_430165_391_402_Disease)) (ADJP (JJ due) (PP (TO to) (NP (JJ Doc_430165_410_413_Chemical) (NNS Doc_430165_414_422_Disease)))))))))) (. .)))
430165	5	(ROOT (S (NP (DT Both)) (VP (VBD had) (NP (NP (NN brain) (NN surgery)) (PP (IN before) (NP (JJ Doc_430165_454_457_Chemical) (NN treatment))))) (. .)))
430165	6	(ROOT (S (NP (PRP It)) (VP (VBZ is) (VP (VBN assumed) (SBAR (IN that) (S (NP (NP (NNS patients)) (PP (IN with) (NP (DT some) (NNS Doc_430165_507_522_Disease)))) (VP (VBP are) (ADJP (JJ liable) (S (VP (TO to) (VP (VB manifest) (NP (JJ Doc_430165_546_549_Chemical) (NNS Doc_430165_550_558_Disease)) (PP (IN as) (NP (JJ focal) (JJ neurological) (NNS signs)))))))))))) (. .)))
458486	0	(ROOT (S (VP (VB Doc_458486_0_8_Chemical) (PP (IN in) (NP (NN Doc_458486_12_20_Chemical-induced) (NNS Doc_458486_29_50_Disease)))) (. .)))
458486	1	(ROOT (S (NP (NP (NNP Doc_458486_52_60_Chemical)) (, ,) (NP (NP (DT a) (JJ substituted) (JJ Doc_458486_76_85_Chemical) (NN derivative)) (ADJP (RB closely) (VBN related) (PP (TO to) (NP (NNS Doc_458486_116_130_Chemical))))) (, ,)) (VP (VBD reduced) (NP (JJ Doc_458486_140_148_Chemical-induced) (JJ peak) (NN dose) (NNS Doc_458486_167_188_Disease)) (PP (IN in) (NP (CD 16) (NNS patients))) (PP (IN with) (NP (NNS Doc_458486_209_239_Disease)))) (. .)))
458486	2	(ROOT (S (ADVP (RB However)) (, ,) (NP (NP (DT an) (ADJP (JJ unacceptable)) (NN increase)) (PP (IN in) (NP (NP (NN disability)) (PP (IN from) (NP (NP (NNS Doc_458486_294_306_Disease)) (PP (IN with) (NP (NP (NN aggravation)) (PP (IN of) (NP (JJ end-of-dose) (NNS Doc_458486_339_347_Disease)))))))))) (VP (VBD led) (PP (TO to) (NP (PRP$ its) (NN cessation))) (PP (IN in) (NP (CD 14) (NNS patients)))) (. .)))
458486	3	(ROOT (S (NP (NNP Doc_458486_385_393_Chemical)) (VP (VBD had) (NP (NP (DT no) (NN effect)) (PP (IN on) (NP (NP (NNS Doc_458486_411_419_Chemical-induced)) (NP (JJ early) (NN morning)) (PP (IN of) (NP (`` ``) (JJ off-period) ('' '') (NN segmental) (NNS Doc_458486_468_476_Disease))))))) (. .)))
458486	4	(ROOT (S (NP (DT These) (NNS results)) (VP (VBP fail) (S (VP (TO to) (VP (VB support) (NP (DT the) (NN notion)) (SBAR (IN that) (S (NP (NN Doc_458486_524_532_Chemical-induced) (NNS Doc_458486_541_552_Disease)) (VP (VBP are) (VP (VBN caused) (PP (IN by) (NP (NP (NN overstimulation)) (PP (IN of) (NP (NP (DT a) (JJ separate) (NN group)) (PP (IN of) (NP (JJ Doc_458486_606_614_Chemical) (NNS receptors))))))))))))))) (. .)))
48362	0	(ROOT (NP (CD Doc_48362_0_9_Chemical) (NNS Doc_48362_10_19_Disease) (. .)))
48362	1	(ROOT (S (NP (NP (JJ Long-term) (NN administration)) (PP (IN of) (NP (NNS Doc_48362_49_58_Chemical)))) (VP (VBD was) (VP (VBN associated) (PP (IN with) (NP (NP (JJ persistent) (NN elevation)) (PP (IN of) (NP (NP (NN serum) (NNS concentrations)) (PP (IN of) (NP (NP (NNP SGOT)) (, ,) (NP (JJ Doc_48362_133_144_Chemical) (NN dehydrogenase)) (, ,) (CC and) (NP (JJ alkaline) (NN phosphatase)))))))))) (. .)))
48362	2	(ROOT (S (NP (NNP Liver)) (ADVP (RB biopsy)) (VP (VBD showed) (NP (JJ active) (NNS Doc_48362_213_222_Disease))) (. .)))
48362	3	(ROOT (S (NP (NP (NNP Discontinuance)) (PP (IN of) (NP (JJ Doc_48362_242_251_Chemical) (NN therapy)))) (VP (VBD led) (PP (TO to) (NP (NP (NN normalization)) (PP (IN of) (NP (NN liver) (NN function) (NNS tests)))))) (. .)))
48362	4	(ROOT (S (NP (NP (DT A) (NN challenge) (NN dose)) (PP (IN of) (NP (NNS Doc_48362_326_335_Chemical)))) (VP (VBD caused) (NP (NP (JJ clinical) (NNS symptoms)) (CC and) (NP (NP (JJ abrupt) (NN elevation)) (PP (IN of) (NP (NP (NNP SGOT)) (, ,) (NP (JJ alkaline) (NN phosphatase)) (, ,) (CC and) (NP (JJ Doc_48362_417_428_Chemical) (NN dehydrogenase) (NNS values))))))) (. .)))
48362	5	(ROOT (S (NP (PRP We)) (VP (VBD concluded) (SBAR (IN that) (S (NP (DT this) (NN patient)) (VP (VP (VBD had) (NP (NNS Doc_48362_486_495_Chemical)) (ADVP (RB hepatotoxicity))) (CC and) (VP (VBP believe) (SBAR (IN that) (S (NP (DT this)) (VP (VBZ is) (NP (NP (DT the) (JJ first) (NN case)) (VP (VBN reported) (PP (IN with) (NP (NN liver) (NN biopsy) (NN documentation))))))))))))) (. .)))
48362	6	(ROOT (S (NP (DT This) (NN report)) (ADVP (RB also)) (VP (VBZ suggests) (SBAR (IN that) (S (, ,) (PP (RB even) (IN after) (NP (JJ long-term) (NN administration))) (, ,) (NP (DT the) (NNS Doc_48362_666_682_Disease)) (VP (VBZ is) (ADJP (JJ reversible)))))) (. .)))
591536	0	(ROOT (S (S (NP (NP (JJ Arterial) (NNS Doc_591536_9_24_Disease)) (PP (IN in) (NP (NNS patients)))) (VP (VBG receiving) (NP (JJ systemic) (JJ Doc_591536_56_63_Chemical) (NN therapy)))) (: :) (S (NP (DT a) (NN complication)) (VP (VBN associated) (PP (IN with) (NP (NN Doc_591536_104_111_Chemical-induced) (NNS Doc_591536_120_136_Disease))))) (. .)))
591536	1	(ROOT (S (NP (JJ Arterial) (NNS Doc_591536_147_162_Disease)) (VP (VBZ is) (NP (NP (DT a) (VBN recognized) (NN complication)) (PP (IN of) (NP (JJ systemic) (JJ Doc_591536_204_211_Chemical) (NN therapy))))) (. .)))
591536	2	(ROOT (S (NP (NP (NNP Characteristic)) (PP (IN of) (NP (DT the) (NN entity)))) (VP (VBZ is) (ADJP (JJ Doc_591536_253_271_Disease) (PP (IN by) (NP (NP (JJ platelet-fibrin) (NNS thrombi)) (PP (IN with) (NP (JJ distal) (NNS Doc_591536_311_319_Disease)))))) (S (VP (VBG occurring) (NP (CD four)) (PP (TO to) (NP (CD twenty) (NNS days))) (PP (IN after) (NP (NP (DT the) (NN initiation)) (PP (IN of) (NP (JJ Doc_591536_374_381_Chemical) (NN therapy))) (, ,) (VP (VBN preceded) (PP (IN by) (NP (JJ profound) (NNS Doc_591536_412_428_Disease))) (PP (IN with) (NP (NP (JJ platelet) (NNS counts)) (PP (IN in) (NP (NP (DT the) (NN range)) (PP (IN of) (NP (NP (QP (CD 30,000) (TO to) (CD 40,000))) (PP (IN per) (NP (JJ cubic) (NN millimeter))))))))))))))) (. .)))
591536	3	(ROOT (S (NP (DT The) (ADJP (RB clinically) (JJ apparent)) (NN occlusion)) (VP (MD may) (VP (VB be) (VP (VBN preceded) (PP (IN by) (NP (NP (NNS Doc_591536_558_603_Disease)) (SBAR (WHNP (WDT that)) (S (VP (VP (VBP appear) (S (VP (TO to) (VP (VB be) (NP (NP (NNS Doc_591536_622_630_Disease)) (PP (IN in) (NP (NN origin)))))))) (, ,) (CC and) (VP (MD might) (VP (VB serve) (S (VP (TO to) (VP (VB warn) (NP (NP (DT the) (NN clinician)) (PP (IN of) (NP (DT these) (NNS complications))))))))))))))))) (. .)))
591536	4	(ROOT (S (NP (NP (JJ Previous) (NNS reports)) (PP (IN of) (NP (NP (DT these) (NNS phenomena)) (CONJP (RB as) (RB well) (IN as)) (NP (NP (JJ recent) (NNS studies)) (PP (IN of) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (NNS Doc_591536_783_790_Chemical))))))))) (VP (VBP are) (VP (VBN reviewed))) (. .)))
591536	5	(ROOT (S (NP (NP (DT The) (JJ common) (NN factor)) (VP (VBG relating) (NP (NNS Doc_591536_832_847_Disease) (CC and) (NNS Doc_591536_852_868_Disease)))) (VP (VBZ is) (NP (NN Doc_591536_872_879_Chemical-induced) (NNS Doc_591536_888_908_Disease))) (. .)))
591536	6	(ROOT (S (NP (JJ Appropriate) (NN treatment)) (VP (VBZ consists) (PP (IN of) (NP (NP (NP (NN discontinuation)) (PP (IN of) (NP (NNS Doc_591536_963_970_Chemical)))) (, ,) (CC and) (NP (NP (NN anticoagulation)) (PP (IN with) (NP (NP (NNS Doc_591536_997_1012_Chemical)) (ADJP (IN if) (JJ necessary)))))))) (. .)))
591536	7	(ROOT (S (NP (NNP Vascular) (NNS procedures)) (VP (VBP are) (VP (VBN performed) (PP (IN as) (NP (JJ indicated))))) (. .)))
6111982	0	(ROOT (S (ADVP (RB Pharmacology)) (PP (IN of) (NP (NNS Doc_6111982_16_27_Chemical))) (PRN (-LRB- -LRB-) (NP (NP (NNS Doc_6111982_29_42_Chemical)) (, ,) (NP (NNS Doc_6111982_44_51_Chemical))) (-RRB- -RRB-)) (NP (DT a) (JJ new) (JJ potent) (NN beta-adrenergic)) (VP (VBP antagonist)) (. .)))
6111982	1	(ROOT (S (NP (NP (DT The) (JJ compound) (NNS Doc_6111982_107_118_Chemical)) (, ,) (PP (IN as) (NP (DT a) (JJ beta-adrenergic) (NN antagonist))) (, ,)) (VP (VBZ is) (ADJP (ADJP (NP (CD 3-8) (NNS times)) (RBR more) (JJ potent)) (PP (IN than) (NP (NP (NNS Doc_6111982_183_194_Chemical)) (PP (IN in) (UCP (ADJP (NN vitro)) (CC and) (PP (IN in) (NP (NN vivo))))))))) (. .)))
6111982	2	(ROOT (S (NP (PRP$ Its) (JJ antiarrhythmic) (NN effectiveness)) (VP (VBZ surpasses) (NP (NP (DT that)) (PP (IN of) (NP (NNS Doc_6111982_268_279_Chemical) (CC and) (NNS Doc_6111982_284_292_Chemical))) (VP (VBG inhibiting) (NP (NP (DT the) (JJ Doc_6111982_308_315_Chemical) (NNS Doc_6111982_316_326_Disease)) (PP (IN in) (NP (NNS dogs) (CC and) (NNS cats))))))) (. .)))
6111982	3	(ROOT (S (S (NP (NNP Doc_6111982_345_356_Chemical)) (VP (VBZ has) (NP (DT a) (JJ negligible) (NN cardiodepressant) (NN activity)))) (: ;) (S (NP (PRP it)) (VP (VBZ is) (RB not) (ADJP (JJ cardioselective)))) (. .)))
6111982	4	(ROOT (S (NP (DT The) (NN compound)) (VP (VBZ shows) (NP (DT a) (ADJP (JJ rapid) (CC and) (JJ long)) (JJ lasting) (NN effect))) (. .)))
6111982	5	(ROOT (S (NP (EX There)) (VP (VBD was) (NP (NP (DT a) (VBN prolonged) (NN elimination)) (PP (IN of) (NP (NP (DT the) (NN radioactivity)) (PP (IN after) (NP (NP (DT the) (NN injection)) (PP (IN of) (NP (NP (NNS Doc_6111982_558_568_Chemical)) (PP (TO to) (NP (NNS rats) (CC and) (NNS dogs))))))))))) (. .)))
6111982	6	(ROOT (S (NP (NP (DT The) (JJ half) (NN life)) (PP (IN of) (NP (NP (DT the) (ADJP (JJ unlabeled)) (NN substance)) (PP (IN in) (NP (NNS humans)))))) (VP (VBD was) (NP (QP (JJR more) (IN than) (CD 10)) (NNS hours))) (. .)))
6115999	0	(ROOT (NP (NP (JJ Adverse) (NNS reactions)) (PP (TO to) (NP (NNS Doc_6115999_21_35_Chemical) (CC and) (NNS Doc_6115999_40_51_Chemical))) (PP (IN for) (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (JJ mild) (NNS Doc_6115999_78_90_Disease))))) (. .)))
6115999	1	(ROOT (NP (NP (NNP Report)) (PP (IN of) (NP (NP (NNP Medical) (NNP Research) (NNP Council) (NNP Working) (NNP Party)) (PP (IN on) (NP (NNP Mild))))) (PP (TO to) (NP (NNP Moderate) (NNP Doc_6115999_161_173_Disease))) (. .)))
6115999	2	(ROOT (S (NP (NP (NNS Participants)) (PP (IN in) (NP (NP (DT the) (NNP Medical) (NNP Research) (NNP Council) (NN treatment) (NN trial)) (PP (IN for) (NP (JJ mild) (NNS Doc_6115999_245_257_Disease)))))) (VP (VBP are) (ADVP (RB randomly)) (VP (VBN allocated) (PP (TO to) (NP (NP (NP (CD one)) (PP (IN of) (NP (CD four) (NN treatment) (NNS groups)))) (: :) (NP (NP (NNS Doc_6115999_314_328_Chemical)) (, ,) (NP (NNS Doc_6115999_330_341_Chemical))) (, ,) (CC or) (NP (NP (DT a) (NN placebo)) (PP (IN for) (NP (NP (DT either)) (PP (IN of) (NP (DT these) (NNS drugs)))))))))) (. .)))
6115999	3	(ROOT (S (S (NP (DT The) (NN trial)) (VP (VBZ is) (ADJP (JJ single-blind))) (. .)) (NP (NP (QP (CD 23) (CD 582)) (NNS patient-years)) (PP (IN of) (NP (NN observation)))) (VP (VBP have) (VP (VBN been) (VP (VBN completed) (ADVP (RB so) (RB far)) (, ,) (NP (NP (NP (QP (CD 10) (CD 684))) (PP (IN on) (NP (JJ active) (NNS drugs)))) (CC and) (NP (NP (QP (CD 12) (CD 898))) (PP (IN on) (NP (NNS placebos)))))))) (. .)))
6115999	4	(ROOT (S (S (NP (DT The) (NNS results)) (VP (VBP show) (NP (NP (DT an) (NN association)) (PP (IN between) (NP (JJ Doc_6115999_561_575_Chemical) (NN treatment) (CC and) (NNS Doc_6115999_590_599_Disease)))))) (, ,) (CC and) (S (NP (NNS Doc_6115999_605_614_Disease)) (ADVP (RB also)) (VP (VBD occurred) (ADVP (RBR more) (RB frequently)) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG taking) (NP (NNS Doc_6115999_664_675_Chemical)) (PP (IN than) (IN in) (NP (NP (DT those)) (VP (VBG taking) (NP (NNS placebos)))))))))) (. .)))
6115999	5	(ROOT (S (S (NP (NP (JJ Other) (JJ adverse) (NNS reactions)) (VP (ADVP (RB significantly)) (VBN linked) (PP (IN with) (NP (JJ active) (NNS drugs))))) (VP (VBP include) (NP (NP (NP (VBN impaired) (JJ Doc_6115999_787_794_Chemical) (NN tolerance)) (PP (IN in) (NP (NNS men) (CC and) (NNS women)))) (CC and) (NP (NP (NNS Doc_6115999_826_830_Disease)) (PP (IN in) (NP (NP (NNS men)) (, ,) (VP (VBN associated) (PP (IN with) (NP (JJ Doc_6115999_855_869_Chemical) (NN treatment)))))))))) (, ,) (CC and) (S (NP (NP (NNS Doc_6115999_885_905_Disease) (CC and) (NNS dyspnoea)) (PP (IN in) (NP (NNS men) (CC and) (NNS women)))) (VP (VBG taking) (NP (NNS Doc_6115999_943_954_Chemical)))) (. .)))
6115999	6	(ROOT (S (NP (DT No) (NNS Doc_6115999_959_974_Disease)) (VP (VBZ is) (VP (VBN known) (S (VP (TO to) (VP (VB have) (VP (VBN occurred) (PP (IN in) (NP (DT the) (JJ Doc_6115999_1008_1019_Chemical) (NN group))))))))) (. .)))
6115999	7	(ROOT (S (S (NP (NN Mean) (NN serum) (NNS Doc_6115999_1038_1047_Chemical) (NN level)) (VP (VBD fell))) (, ,) (CC and) (S (NP (NNS Doc_6115999_1064_1068_Chemical) (CC and) (NNS Doc_6115999_1073_1082_Chemical) (NNS levels)) (VP (VBD rose) (, ,) (PP (IN in) (NP (NP (NNS men) (CC and) (NNS women)) (VP (VBG taking) (NP (NNS Doc_6115999_1120_1134_Chemical))))))) (. .)))
6115999	8	(ROOT (S (S (PP (IN In) (NP (DT the) (JJ Doc_6115999_1143_1154_Chemical) (NN group))) (, ,) (NP (NP (NN serum) (NNS Doc_6115999_1168_1177_Chemical)) (CC and) (NP (JJ Doc_6115999_1182_1191_Chemical) (NNS levels))) (VP (VBD rose) (PP (IN in) (NP (DT both) (NNS sexes))))) (, ,) (CC but) (S (NP (DT the) (JJ Doc_6115999_1227_1231_Chemical) (NN level)) (VP (VBD rose) (ADVP (RB significantly)) (PP (IN in) (NP (NNS women) (RB only))))) (. .)))
6118280	0	(ROOT (S (NP (NNP Serotonergic) (NNS drugs) (, ,) (NNS Doc_6118280_20_35_Chemical) (CC and) (NNS Doc_6118280_40_48_Chemical)) (VP (VBP block) (NP (NN Doc_6118280_55_63_Chemical-induced) (NNS Doc_6118280_72_87_Disease)) (PP (IN in) (NP (NP (DT a) (NN strain)) (PP (IN of) (NP (NNS mice)))))) (. .)))
6118280	1	(ROOT (S (PP (IN In) (NP (JJ male) (JJ Swiss) (NNS mice))) (, ,) (NP (NNS Doc_6118280_129_137_Chemical)) (VP (VBD produced) (NP (NNS Doc_6118280_147_162_Disease))) (. .)))
6118280	2	(ROOT (S (NP (NP (NP (DT A) (ADJP (CD 3) (JJ mg/kg)) (PRN (-LRB- -LRB-) (NP (NNP i.p.)) (-RRB- -RRB-)) (NN dose)) (VP (VBN induced) (NP (DT this) (NN response)) (PP (IN in) (NP (NP (DT all)) (PP (IN of) (NP (NP (DT the) (NNS mice)) (VP (VBN tested)))))))) (CC and) (NP (NP (DT the) (JJ peak) (NN response)) (PP (IN of) (NP (NP (CD 73) (NNS jerks)) (PP (IN per) (NP (NN min))))))) (VP (VBD was) (VP (VBN observed) (PP (IN between) (NP (NP (CD 27)) (CC and) (NP (CD 45) (NN min)))))) (. .)))
6118280	3	(ROOT (S (S (VP (VBG Increasing) (NP (DT the) (NN brain) (NNS Doc_6118280_333_342_Chemical) (NNS levels)) (PP (IN by) (NP (NP (DT the) (NN administration)) (PP (IN of) (NP (NP (NP (NNS Doc_6118280_375_394_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 80-160) (NN mg/kg)) (-RRB- -RRB-))) (PP (IN in) (NP (NN combination))))))) (PP (IN with) (NP (DT a) (JJ peripheral) (NN decarboxylase) (NN inhibitor))))) (VP (VBD resulted) (PP (IN in) (NP (NP (DT an) (NN inhibition)) (PP (IN of) (NP (DT the) (JJ Doc_6118280_500_508_Chemical) (NN effect)))))) (. .)))
6118280	4	(ROOT (S (ADVP (RB However)) (, ,) (PP (IN in) (NP (DT a) (JJ similar) (NN experiment))) (NP (NP (NNS Doc_6118280_550_556_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 80-160) (NN mg/kg)) (-RRB- -RRB-))) (VP (VBD was) (PP (IN without) (NP (NN effect)))) (. .)))
6118280	5	(ROOT (S (PP (IN In) (NP (NP (NNS doses)) (PP (IN of) (NP (CD 3-10) (NN mg/kg))))) (, ,) (NP (DT the) (JJ Doc_6118280_620_629_Chemical) (NN receptor) (NN agonist) (NNS Doc_6118280_647_653_Chemical)) (VP (VBD caused) (NP (NP (DT a) (JJ dose-dependent) (NN blockade)) (PP (IN of) (NP (NP (DT the) (NN response)) (PP (IN of) (NP (NNS Doc_6118280_706_714_Chemical))))))) (. .)))
6118280	6	(ROOT (S (PP (IN Of) (NP (DT the) (NNS Doc_6118280_723_738_Chemical))) (, ,) (NP (NP (NNS Doc_6118280_740_750_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 0.1-0) (NN .3) (NN mg/kg)) (-RRB- -RRB-))) (VP (VBD was) (VP (VBN found) (S (VP (TO to) (VP (VB be) (ADJP (ADJP (NP (JJ several) (NNP fold)) (RBR more) (JJ potent)) (PP (IN than) (NP (NP (NNS Doc_6118280_813_821_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 0.3-3) (NN mg/kg)) (-RRB- -RRB-))))) (PP (IN in) (S (VP (VBG blocking) (NP (DT the) (NNS Doc_6118280_852_867_Disease)))))))))) (. .)))
6118280	7	(ROOT (S (SBAR (IN While) (S (NP (NP (NP (-LRB- -LRB-) (NNP -) (-RRB- -RRB-)) (: -) (NP (NNS Doc_6118280_879_887_Chemical))) (PRN (-LRB- -LRB-) (NP (CD 1-3) (NN mg/kg)) (-RRB- -RRB-))) (VP (VBD proved) (S (VP (TO to) (VP (VB be) (NP (NP (DT an) (JJ effective) (NN antagonist)) (PP (IN of) (NP (NNS Doc_6118280_940_948_Chemical)))))))))) (, ,) (NP (PRP$ its) (PRN (-LRB- -LRB-) (NP (NNP +)) (-RRB- -RRB-)) (JJ -) (NNS isomer)) (PRN (-LRB- -LRB-) (NP (CD 5-20) (NN mg/kg)) (-RRB- -RRB-)) (VP (VBD lacked) (NP (DT this) (NN property))) (. .)))
6118280	8	(ROOT (S (PP (VBG Considering) (NP (NP (DT the) (NN fact)) (SBAR (IN that) (S (NP (NP (NNS Doc_6118280_1026_1031_Chemical)) (CC and) (NP (DT the) (NNS Doc_6118280_1040_1055_Chemical))) (VP (VBP have) (VP (VBN been) (VP (VBN found) (S (VP (TO to) (VP (VB be) (ADJP (JJ beneficial) (PP (IN in) (NP (NP (DT the) (NN management)) (PP (IN of) (NP (JJ clinical) (NNS Doc_6118280_1119_1128_Disease)))))))))))))))) (, ,) (NP (DT the) (NN Doc_6118280_1134_1142_Chemical-induced) (NNS Doc_6118280_1151_1160_Disease)) (VP (VBZ seems) (S (VP (TO to) (VP (VB be) (NP (NP (DT a) (JJ satisfactory) (NN animal) (NN model)) (SBAR (WHNP (WDT that)) (S (VP (MD may) (VP (VB prove) (ADJP (JJ useful) (PP (IN for) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (JJ new) (NN drug) (NNS treatments)))))) (PP (IN for) (NP (DT this) (NN condition)))))))))))) (. .)))
6118280	9	(ROOT (S (NP (PRP$ Our) (JJ present) (NN study)) (VP (VBD indicated) (NP (NP (NP (DT the) (JJ possible) (NN value)) (PP (IN of) (NP (NP (NNS Doc_6118280_1336_1342_Chemical)) (CC and) (NP (-LRB- -LRB-) (NNP -) (-RRB- -RRB-))))) (: -) (NP (NP (NNS Doc_6118280_1351_1359_Chemical)) (PP (IN in) (NP (NP (DT the) (NN management)) (PP (IN of) (NP (JJ clinical) (NNS Doc_6118280_1390_1399_Disease)))))))) (. .)))
6127992	0	(ROOT (NP (NP (NP (JJ Adverse) (NN interaction)) (PP (IN between) (NP (NNS Doc_6127992_28_58_Chemical) (CC and) (NNS Doc_6127992_63_72_Chemical)))) (: --) (NP (NP (NN report)) (PP (IN of) (NP (CD three) (NNS cases)))) (. .)))
6127992	1	(ROOT (S (NP (NP (CD Three) (NNS patients)) (PP (IN with) (NP (NNS Doc_6127992_117_140_Disease)))) (VP (VBD developed) (NP (JJ profound) (NNS Doc_6127992_160_175_Disease) (, ,) (NNS Doc_6127992_177_188_Disease) (CC and) (NNS Doc_6127992_193_204_Disease)) (PP (IN during) (NP (NP (VBN combined) (NN therapy)) (PP (IN with) (NP (NNS Doc_6127992_234_243_Chemical) (CC and) (NNS Doc_6127992_248_278_Chemical)))))) (. .)))
6127992	2	(ROOT (S (NP (DT This) (JJ clinical) (NN picture)) (VP (VBD resolved) (ADVP (RB completely)) (PP (IN with) (NP (NP (NN cessation)) (PP (IN of) (NP (DT the) (VBN combined) (NN therapy)))))) (. .)))
6127992	3	(ROOT (S (NP (NP (JJ Baseline) (JJ left) (NN ventricular) (NN function)) (, ,) (VP (VBN assessed) (PP (IN by) (NP (NP (JJ cardiac) (NN catheterisation)) (CC or) (NP (JJ nuclear) (NN angiography))))) (, ,)) (VP (VBD was) (ADJP (ADJP (JJ normal) (PP (IN in) (NP (CD two) (NNS patients)))) (CC and) (ADJP (RB only) (RB mildly) (JJ reduced))) (PP (IN in) (NP (DT the) (JJ other)))) (. .)))
6127992	4	(ROOT (S (NP (NP (JJ Simultaneously) (NN administration)) (PP (IN of) (NP (NNS Doc_6127992_556_586_Chemical) (CC and) (NNS Doc_6127992_591_600_Chemical)))) (VP (VP (MD may) (VP (VB result) (PP (IN in) (NP (JJ profound) (JJ adverse) (NNS interactions))))) (CC and) (VP (MD should) (ADVP (RB only)) (VP (VB be) (VP (VBN administered) (PP (IN with) (NP (JJ great) (NN caution))))))) (. .)))
6150641	0	(ROOT (NP (NP (NNP Comparison)) (PP (IN of) (NP (DT the) (NN effectiveness))) (PP (IN of) (NP (NNS Doc_6150641_35_45_Chemical) (CC and) (NNS Doc_6150641_50_60_Chemical))) (PP (IN in) (S (VP (VBG inhibiting) (NP (JJ acid) (NN secretion)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ gastric) (NN hypersecretory) (NNS states)))))))) (. .)))
6150641	1	(ROOT (S (NP (DT The) (NN H2-Doc_6150641_145_154_Chemical) (NN receptor)) (VP (VBD antagonists) (SBAR (S (NP (NNS Doc_6150641_176_186_Chemical) (CC and) (NNS Doc_6150641_191_201_Chemical)) (VP (VBD were) (VP (VBN compared) (PP (IN for) (NP (PRP$ their) (NNS abilities) (S (VP (TO to) (VP (VB control) (NP (JJ gastric) (JJ acid) (NN hypersecretion)) (PP (IN on) (NP (NP (DT a) (ADJP (JJ short) (: -) (CC and) (JJ long-term)) (NN basis)) (PP (IN in) (NP (NP (CD 22) (NNS patients)) (PP (IN with) (NP (JJ gastric) (JJ acid) (NN hypersecretory) (NNS states))))))))))))))))) (. .)))
6150641	2	(ROOT (S (S (NP (NN Nineteen) (NNS patients)) (VP (VBD had) (NP (NNS Doc_6150641_385_411_Disease)))) (PRN (, ,) (S (NP (CD one) (NN patient)) (VP (VBD had) (NP (NNS Doc_6150641_429_450_Disease)))) (, ,)) (CC and) (S (NP (CD two) (NNS patients)) (VP (VBD had) (NP (JJ idiopathic) (NN hypersecretion)))) (. .)))
6150641	3	(ROOT (S (NP (NP (DT The) (NNS rates)) (PP (IN of) (NP (NP (NN onset)) (PP (IN of) (NP (NP (DT the) (NN action)) (PP (IN of) (NP (NNS Doc_6150641_536_546_Chemical) (CC and) (NNS Doc_6150641_551_561_Chemical)))))))) (VP (VBD were) (NP (DT the) (JJ same))) (. .)))
6150641	4	(ROOT (S (S (NP (NP (DT The) (NNS actions)) (PP (IN of) (NP (DT both) (NNS drugs)))) (VP (VBD were) (VP (VBN increased) (PP (IN by) (NP (JJ anticholinergic) (NNS agents)))))) (, ,) (CC and) (S (NP (EX there)) (VP (VBD was) (NP (NP (DT a) (JJ close) (NN correlation)) (PP (IN between) (NP (NP (DT the) (JJ daily) (NN maintenance) (NN dose)) (PP (IN of) (NP (NP (DT each) (NN drug)) (VP (VBN needed) (S (VP (TO to) (VP (VB control) (NP (JJ acid) (NN secretion))))))))))))) (. .)))
6150641	5	(ROOT (S (ADVP (RB However)) (, ,) (NP (NNS Doc_6150641_770_780_Chemical)) (VP (VBD was) (ADVP (RB threefold)) (ADJP (RBR more) (JJ potent)) (PP (IN than) (NP (NP (NNS Doc_6150641_812_822_Chemical)) (PP (DT both) (PP (IN in) (NP (JJ acute) (NN inhibition) (NNS studies))) (CC and) (PP (IN in) (NP (NP (DT the) (JJ median) (NN maintenance) (NN dose)) (VP (VBN needed) (PRN (-LRB- -LRB-) (NP (NP (NP (CD 1.2) (NN g)) (PP (IN per) (NP (NP (NN day)) (PP (IN for) (NP (NNS Doc_6150641_917_927_Chemical)))))) (CC and) (NP (NP (CD 3.6) (NN g)) (PP (IN per) (NP (NP (NN day)) (PP (IN for) (NP (NNS Doc_6150641_950_960_Chemical))))))) (-RRB- -RRB-))))))))) (. .)))
6150641	6	(ROOT (S (S (NP (NP (CD Sixty) (NN percent)) (PP (IN of) (NP (DT the) (NNS males)))) (VP (VBD developed) (NP (NN breast) (NNS changes) (CC or) (NNS Doc_6150641_1018_1027_Disease)) (PP (IN while) (S (VP (VBG taking) (NP (NNS Doc_6150641_1041_1051_Chemical))))))) (CC and) (S (PP (IN in) (NP (DT all) (NNS cases))) (NP (DT these) (NNS changes)) (VP (VBD disappeared) (SBAR (WHADVP (WRB when)) (S (NP (NNS Doc_6150641_1100_1110_Chemical)) (VP (VBD was) (VP (VBN replaced) (PP (IN by) (NP (NNS Doc_6150641_1127_1137_Chemical))))))))) (. .)))
6150641	7	(ROOT (S (S (NP (NP (NNP Treatment)) (PP (IN with) (NP (NP (JJ high) (NNS doses)) (PP (IN of) (NP (NP (NNS Doc_6150641_1168_1178_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (CD one)) (PP (TO to) (NP (NP (CD 60) (NNS months)) (: ;) (NP (NP (NN median)) (, ,) (NP (CD 11) (NNS months)))))) (-RRB- -RRB-)) (CC or) (NP (NNS Doc_6150641_1220_1230_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (CD two)) (PP (TO to) (NP (NP (CD 31) (NNS months)) (: ;) (NP (NP (NN median)) (, ,) (NP (CD 14) (NNS months)))))) (-RRB- -RRB-))))))) (VP (VBD was) (RB not) (VP (VBN associated) (PP (IN with) (NP (NP (NNS Doc_6150641_1293_1324_Disease) (CC or) (NNS alterations)) (PP (IN of) (NP (NN serum) (NN gastrin) (NNS concentrations)))))))) (, ,) (CC but) (S (NP (JJ Doc_6150641_1377_1387_Chemical) (NN therapy)) (VP (VBD was) (VP (VBN associated) (PP (IN with) (NP (NP (DT a) (ADJP (RB significantly) (JJR lower)) (NN serum) (NNS Doc_6150641_1444_1454_Chemical) (NN level)) (VP (ADVP (IN than)) (VBN seen) (PP (IN with) (NP (JJ Doc_6150641_1476_1486_Chemical) (NN therapy))))))))) (. .)))
6150641	8	(ROOT (S (NP (DT The) (NNS results)) (VP (VBP show) (SBAR (IN that) (S (NP (DT both) (NNS drugs)) (VP (MD can) (ADVP (RB adequately)) (VP (VB inhibit) (NP (JJ acid) (NN secretion)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ gastric) (NN hypersecretory) (NNS states)))))))))) (. .)))
6150641	9	(ROOT (S (S (NP (DT Both)) (VP (VBP are) (ADJP (JJ safe) (PP (IN at) (NP (JJ high) (NNS doses)))))) (, ,) (CC but) (S (NP (NNS Doc_6150641_1648_1658_Chemical)) (VP (VP (VBZ is) (ADVP (RB threefold)) (ADJP (RBR more) (JJ potent))) (CC and) (VP (VBZ does) (RB not) (VP (VB cause) (NP (NP (DT the) (JJ antiandrogen) (NN side) (NNS effects)) (VP (ADVP (RB frequently)) (VBN seen) (PP (IN with) (NP (NP (JJ high) (NNS doses)) (PP (IN of) (NP (NNS Doc_6150641_1768_1778_Chemical))))))))))) (. .)))
6153967	0	(ROOT (NP (NP (JJ Epileptogenic) (NNS properties)) (PP (IN of) (NP (NP (NNS Doc_6153967_28_37_Chemical)) (CC and) (NP (PRP$ their) (JJ clinical) (NN interpretation)))) (. .)))
6153967	1	(ROOT (S (NP (NP (CD Three) (NNS cases)) (PP (IN of) (NP (NP (NNP EEG) (NNS changes)) (VP (VBN induced) (PP (IN by) (NP (JJ single) (NN exposure))) (PP (TO to) (NP (JJ Doc_6153967_130_139_Chemical) (NN anesthesia))))))) (VP (VBP are) (VP (VBN reported))) (. .)))
6153967	2	(ROOT (S (PP (IN In) (NP (CD one) (NN patient))) (, ,) (NP (NP (NNS Doc_6153967_181_190_Chemical)) (VP (VBN administered) (PP (IN during) (NP (DT a) (NN donor) (NN nephrectomy))))) (VP (VBD resulted) (PP (IN in) (NP (JJ unexpected) (JJ partial) (NN motor) (NNS Doc_6153967_268_276_Disease)))) (. .)))
6153967	3	(ROOT (S (SBAR (IN Until) (S (NP (NP (DT the) (NN cause)) (PP (IN of) (NP (DT the) (NNS Doc_6153967_301_309_Disease)))) (VP (VBD was) (VP (ADVP (RB correctly)) (VBN identified))))) (, ,) (NP (DT the) (NN patient)) (VP (VBD was) (ADVP (RB inappropriately)) (VP (VBN treated) (PP (IN with) (NP (NNS anticonvulsants))))) (. .)))
6153967	4	(ROOT (S (NP (CD Two) (JJ other) (NNS patients)) (VP (VBD suffered) (PP (IN from) (NP (ADJP (JJ partial) (, ,) (JJ complex) (CC and) (JJ generalized)) (JJ Doc_6153967_464_472_Disease) (NNS uncontrolled))) (PP (IN by) (NP (NN medication)))) (. .)))
6153967	5	(ROOT (S (S (NP (NP (JJ Doc_6153967_501_510_Disease) (NNS foci)) (VP (VBN delineated) (CC and) (VBN activated) (PP (IN by) (NP (NNS Doc_6153967_544_553_Chemical))))) (VP (VBD were) (VP (ADVP (RB surgically)) (VBN ablated)))) (CC and) (S (NP (DT the) (NNS patients)) (VP (VBP are) (ADVP (RB now)) (ADJP (JJ Doc_6153967_603_610_Disease-free)))) (. .)))
6153967	6	(ROOT (S (NP (NP (JJ Previous) (NNS exposures)) (PP (TO to) (NP (NNS Doc_6153967_639_648_Chemical)))) (VP (VBP have) (S (VP (TO to) (VP (VB be) (VP (VBN disclosed) (S (VP (TO to) (VP (VB avoid) (NP (NNS mistakes)) (PP (IN in) (NP (NP (JJ clinical) (NN interpretation)) (PP (IN of) (NP (DT the) (NNP EEG))))))))))))) (. .)))
6153967	7	(ROOT (S (PP (IN On) (NP (DT the) (JJ other) (NN hand))) (, ,) (NP (NNS Doc_6153967_746_755_Chemical)) (VP (MD may) (VP (VB prove) (S (VP (TO to) (VP (VB be) (NP (NP (DT a) (ADJP (JJ safe) (JJ fast)) (JJ acting) (NN activator)) (PP (IN of) (NP (JJ Doc_6153967_804_813_Disease) (NNS foci)))) (PP (IN during) (NP (NN corticography) (CC or) (NN depth) (NN electrode) (JJ intraoperative) (NNS recordings)))))))) (. .)))
6203632	0	(ROOT (NP (NP (NNP Development)) (PP (IN of) (NP (NN Doc_6203632_15_28_Chemical-induced) (NNS Doc_6203632_37_56_Disease))) (. .)))
6203632	1	(ROOT (S (NP (NP (DT The) (NN development)) (PP (IN of) (NP (NNS Doc_6203632_77_96_Disease)))) (VP (VBD was) (VP (VBN studied) (PP (IN in) (NP (NP (JJ adult) (JJ female) (NNP Wistar) (NNS rats)) (PP (VBG following) (NP (NP (JJ daily) (NNS subcutaneous) (NNS injections)) (PP (IN of) (NP (NP (NP (NNS Doc_6203632_180_193_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_6203632_195_198_Chemical)) (-RRB- -RRB-))) (PRN (-LRB- -LRB-) (NP (JJ 0.3) (NN mg/kg) (NN body) (NN weight)) (-RRB- -RRB-)))))))))) (. .)))
6203632	2	(ROOT (S (NP (DT A) (NN time) (NN course)) (VP (VBD was) (VP (VBN established) (PP (IN for) (NP (NP (NP (DT the) (NN change)) (PP (IN in) (NP (NP (NN tissue) (NN mass)) (, ,) (NP (NNP RNA)) (CC and) (NP (NN DNA) (NN content))))) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (JJ Doc_6203632_318_332_Chemical) (NN content)))))) (. .)))
6203632	3	(ROOT (S (NP (NNP Heart) (NN weight)) (VP (VBD increased) (NP (CD 44) (NN %)) (PP (IN after) (NP (NP (CD 8) (NNS days)) (PP (IN of) (NP (NN treatment))))) (PP (IN with) (NP (NP (DT a) (JJ half) (NN time)) (PP (IN of) (NP (CD 3.4) (NNS days)))))) (. .)))
6203632	4	(ROOT (S (NP (NNP Ventricular) (NNP RNA) (NN content)) (VP (VBD was) (VP (VP (VBN elevated) (NP (CD 26) (NN %)) (PP (IN after) (NP (NP (CD 24) (NN h)) (PP (IN of) (NP (DT a) (JJ single) (NN injection)))))) (CC and) (VP (VBN reached) (NP (NP (DT a) (JJ maximal) (NN level)) (PP (VBG following) (NP (NP (CD 8) (NNS days)) (PP (IN of) (NP (NN therapy))))))))) (. .)))
6203632	5	(ROOT (S (NP (NP (DT The) (JJ half) (NN time)) (PP (IN for) (NP (NNP RNA) (NN accumulation)))) (VP (VBD was) (NP (JJ 2.0) (NNS days))) (. .)))
6203632	6	(ROOT (S (NP (NP (DT The) (JJ total) (NN content)) (PP (IN of) (NP (NNS Doc_6203632_626_640_Chemical)))) (VP (VP (VBD remained) (ADJP (JJ stable)) (PP (IN during) (NP (NP (DT the) (JJ first) (CD 2) (NNS days)) (PP (IN of) (NP (NN treatment)))))) (CC but) (VP (VBD increased) (NP (CD 46) (NN %)) (PP (IN after) (NP (NP (CD 4) (NNS days)) (PP (IN of) (NP (NN therapy))))))) (. .)))
6203632	7	(ROOT (S (NP (NNP Ventricular) (NNP DNA) (NN content)) (VP (VP (VBD was) (ADJP (JJ unchanged)) (PP (IN during) (NP (NP (NP (DT the) (JJ early) (NN stage)) (PRN (-LRB- -LRB-) (NP (CD 1-4) (NNS days)) (-RRB- -RRB-))) (PP (IN of) (NP (JJ Doc_6203632_812_824_Disease) (NN growth)))))) (CC but) (VP (VBD increased) (PP (TO to) (NP (NP (DT a) (JJ new) (JJ steady-state) (NN level)) (ADJP (CD 19) (NN %)))) (PP (IN above) (NP (DT the) (NNS controls))) (PP (IN after) (NP (NP (CD 8) (NNS days)) (PP (IN of) (NP (NN treatment))))))) (. .)))
6203632	8	(ROOT (S (NP (NP (JJ Intraventricular) (NNS pressures)) (CC and) (NP (JJ coronary) (NN flow) (NNS measures))) (VP (VBD were) (ADJP (JJ similar) (PP (IN for) (NP (NP (NN control) (CC and) (JJ experimental) (NNS animals)) (PP (VBG following) (NP (NP (CD 4) (NNS days)) (PP (IN of) (NP (JJ developed) (NNS Doc_6203632_1058_1069_Disease))))))))) (. .)))
6203632	9	(ROOT (S (ADVP (RB However)) (, ,) (NP (NP (NN dP/dt)) (PP (IN in) (NP (DT the) (NN Doc_6203632_1093_1096_Chemical-treated) (NNS hearts)))) (VP (VP (VBD was) (ADVP (RB slightly))) (CC but) (ADVP (ADVP (RB significantly)) (PRN (-LRB- -LRB-) (NP (NNP P) (QP (JJR less) (IN than) (CD 0.05))) (-RRB- -RRB-))) (VP (VBD elevated))) (. .)))
6203632	10	(ROOT (S (NP (DT These) (NNS data)) (VP (VBP indicate) (SBAR (IN that) (S (NP (NP (DT the) (JJ adaptive) (NN response)) (PP (TO to) (NP (NNS Doc_6203632_1222_1225_Chemical)))) (VP (VBZ shows) (NP (NP (DT an) (JJ early) (JJ Doc_6203632_1241_1253_Disease) (NN phase)) (PRN (-LRB- -LRB-) (NP (CD 1-4) (NNS days)) (-RRB- -RRB-)) (VP (VBN characterized) (PP (IN by) (NP (NP (NP (DT a) (JJ substantial) (NN increase)) (PP (IN in) (NP (NNP RNA) (NN content)))) (CC and) (NP (NP (JJ cardiac) (NN mass)) (PP (IN in) (NP (NP (DT the) (NN absence)) (PP (IN of) (NP (NP (NNS changes)) (PP (IN in) (NP (NNP DNA)))))))))))))))) (. .)))
6203632	11	(ROOT (S (ADVP (RB However)) (, ,) (NP (NP (JJ prolonged) (NN stimulation)) (PRN (-LRB- -LRB-) (NP (CD 8-12) (NNS days)) (-RRB- -RRB-))) (VP (VBZ appears) (S (VP (TO to) (VP (VB represent) (NP (NP (DT a) (JJ complex) (NN integration)) (PP (IN of) (NP (DT both) (JJ cellular) (NNS Doc_6203632_1480_1491_Disease) (CC and) (NNS Doc_6203632_1496_1507_Disease)))) (PP (IN within) (NP (DT the) (NN heart))))))) (. .)))
6216862	0	(ROOT (NP (NP (JJ Multiple) (NN side) (NNS effects)) (PP (IN of) (NP (JJ Doc_6216862_25_38_Chemical) (NN therapy))) (PP (IN in) (NP (NP (CD one) (NN patient)) (PP (IN with) (NP (NNS Doc_6216862_67_87_Disease))))) (. .)))
6216862	1	(ROOT (S (ADVP (RB Doc_6216862_89_100_Disease)) (, ,) (NP (NP (NNS Doc_6216862_102_113_Disease)) (, ,) (NP (NNS Doc_6216862_115_143_Disease)) (, ,) (NP (NNS Doc_6216862_145_157_Disease)) (CC and) (NP (NNS Doc_6216862_162_179_Disease))) (VP (VBP have) (RB all) (VP (VBN been) (VP (VBN recorded) (PP (IN as) (NP (NP (NNS complications)) (PP (IN of) (NP (JJ Doc_6216862_223_236_Chemical) (NN therapy))))) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NNS Doc_6216862_262_282_Disease)))))))) (. .)))
6216862	2	(ROOT (S (NP (NP (DT A) (NN patient)) (SBAR (WHNP (WP who)) (S (VP (VBD had) (VP (VBN developed) (NP (QP (DT all) (CD 5)))))))) (VP (VBZ is) (ADVP (RB now)) (VP (VBN described))) (. .)))
6216862	3	(ROOT (S (NP (DT The) (NNS Doc_6216862_340_351_Disease)) (VP (VBD resembled) (NP (NP (NNS Doc_6216862_362_393_Disease)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (PP (PP (IN as) (NP (NP (DT a) (JJ rare) (NN side) (NN effect)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NNS Doc_6216862_458_474_Disease))))))) (CONJP (CC but) (RB not)) (PP (IN in) (NP (NNS patients)))) (PP (IN with) (NP (NP (NNS Doc_6216862_500_520_Disease)) (VP (VBN treated) (PP (IN with) (NP (NNS Doc_6216862_534_547_Chemical))))))))))))) (. .)))
625456	0	(ROOT (S (NP (ADJP (JJ Obsolete) (CC but) (JJ dangerous)) (NN antacid)) (VP (VBZ preparations)) (. .)))
625456	1	(ROOT (S (NP (NP (NP (CD One) (NN case)) (PP (IN of) (NP (JJ acute) (NN hypercalcaemia)))) (CC and) (NP (NP (CD two)) (PP (IN of) (NP (JJ recurrent) (NNS Doc_625456_99_114_Disease))))) (VP (VBP are) (VP (VBN reported) (PP (IN in) (NP (NP (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBD had) (ADVP (RB regularly)) (VP (VBN consumed) (NP (NP (JJ large) (NNS amounts)) (PP (IN of) (NP (NN Doc_625456_184_202_Chemical-Doc_625456_203_221_Chemical) (NNS powders)))) (PP (IN for) (NP (QP (JJR more) (IN than) (CD 20)) (NNS years))))))))))) (. .)))
625456	2	(ROOT (S (NP (DT The) (NNS powders)) (VP (VBD had) (VP (VBN been) (VP (VBN obtained) (PP (IN from) (NP (NP (NNS pharmacists)) (ADJP (JJ unknown) (PP (TO to) (NP (NP (DT the) (NNS patients) (POS ')) (JJ medical) (NNS practitioners))))))))) (. .)))
625456	3	(ROOT (S (NP (PRP It)) (VP (VBZ is) (VP (VBN suggested) (SBAR (SBAR (IN that) (S (NP (DT these) (NNS preparations)) (VP (VBD were) (ADJP (JJ responsible) (PP (IN for) (NP (NP (DT the) (NN patient) (POS 's)) (NNS problems))))))) (, ,) (CC and) (SBAR (IN that) (S (NP (JJ such) (NNS powders)) (VP (MD should) (ADVP (RB no) (RB longer)) (VP (VB be) (ADJP (RB freely) (JJ obtainable))))))))) (. .)))
6292680	0	(ROOT (NP (NP (JJ Doc_6292680_0_11_Chemical) (NNS Doc_6292680_12_26_Disease)) (PP (IN in) (NP (NNS children))) (PP (IN with) (NP (JJ left-sided) (NNS Doc_6292680_55_66_Disease))) (. .)))
6292680	1	(ROOT (S (NP (NP (CD Two) (NNS children)) (PP (IN with) (NP (NP (NNS Doc_6292680_86_97_Disease)) (PP (IN of) (NP (DT the) (JJ left) (NN kidney)))))) (VP (VBD experienced) (NP (JJ severe) (JJ Doc_6292680_136_149_Chemical) (NNS Doc_6292680_150_164_Disease)) (PP (IN after) (NP (NN irradiation))) (PP (TO to) (NP (NP (DT the) (JJ Doc_6292680_190_195_Disease) (NN bed) (CC and) (JJ conventional) (NN dosage)) (PP (IN of) (NP (NNS Doc_6292680_227_238_Chemical)))))) (. .)))
6292680	2	(ROOT (S (NP (DT The) (NNS Doc_6292680_244_258_Disease)) (VP (VBZ is) (VP (VBN attributed) (SBAR (S (NP (CD 1)) (-RRB- -RRB-) (VP (TO to) (VP (NP (NP (DT the) (NN fact)) (SBAR (IN that) (S (NP (NP (NN radiation) (NNS fields)) (PP (IN for) (NP (JJ left) (NNS Doc_6292680_319_330_Disease)))) (VP (VBP include) (NP (NP (DT the) (JJR lower) (NN portion)) (PP (IN of) (NP (NP (DT the) (NN heart)) (CC and) (NP (CD 2)) (-RRB- -RRB-)))))))) (PP (TO to) (NP (NP (DT the) (NN interaction)) (PP (IN of) (NP (NNS Doc_6292680_399_410_Chemical) (CC and) (NN irradiation))))) (PP (IN on) (NP (JJ cardiac) (NN muscle))))))))) (. .)))
6292680	3	(ROOT (S (NP (PRP It)) (VP (VBZ is) (VP (VBN recommended) (SBAR (IN that) (S (NP (JJ Doc_6292680_469_480_Chemical) (NN dosage)) (VP (VB be) (VP (ADVP (RB sharply)) (VBN restricted) (PP (IN in) (NP (NNS children))) (PP (IN with) (NP (NP (NNS Doc_6292680_527_538_Disease)) (PP (IN of) (NP (NP (DT the) (JJ left) (NN kidney)) (SBAR (WHNP (WP who)) (S (VP (VBP receive) (NP (JJ postoperative) (NN irradiation))))))))))))))) (. .)))
6293644	0	(ROOT (NP (NP (NP (NNPS Effects)) (PP (IN of) (NP (NP (NNS Doc_6293644_11_21_Chemical)) (PP (IN on) (NP (NN rat) (NN extrapyramidal) (NN motor) (NN system)))))) (: :) (NP (NP (JJ behavioral)) (CC and) (NP (JJ biochemical) (NNS data))) (. .)))
6293644	1	(ROOT (S (NP (NP (DT The) (NNS effects)) (PP (IN of) (NP (NP (NN i.v.c.) (NN injection)) (PP (IN of) (NP (NP (JJ human) (CC and) (NN salmon) (NN calcitonin)) (PP (IN on) (NP (JJ biochemical) (CC and) (JJ behavioral) (NNS parameters))))))) (VP (VBN related) (PP (TO to) (NP (DT the) (JJ extrapyramidal) (NN motor) (NN system))))) (, ,) (VP (VBD were) (VP (VBN investigated) (PP (IN in) (NP (JJ male) (NNS rats))))) (. .)))
6293644	2	(ROOT (S (NP (JJ Doc_6293644_271_281_Chemical) (NN injection)) (VP (VBD resulted) (PP (IN in) (NP (NP (NP (DT a) (NN potentiation)) (PP (IN of) (NP (NN Doc_6293644_322_333_Chemical-induced) (NNS Doc_6293644_342_351_Disease)))) (CC and) (NP (NP (DT a) (JJ partial) (NN prevention)) (PP (IN of) (NP (NN Doc_6293644_380_391_Chemical-induced) (NNS Doc_6293644_400_413_Disease))))))) (. .)))
6293644	3	(ROOT (S (ADVP (RB Moreover)) (NP (NN calcitonin)) (VP (VBZ induced) (NP (NP (NP (DT a) (JJ significant) (NN decrease)) (PP (IN in) (NP (JJ nigral) (NNP GAD) (NN activity)))) (CC but) (NP (DT no) (NAC (NN change) (PP (IN in) (NP (NP (NNP striatal) (NNP DA)) (CC and) (NP (NNS Doc_6293644_522_527_Chemical))))) (NN concentration) (CC or) (NN GAD) (NN activity)))) (. .)))
6293644	4	(ROOT (S (NP (DT The) (NNS results)) (VP (VBP are) (VP (VBN discussed) (PP (IN in) (NP (NP (NN view)) (PP (IN of) (NP (NP (DT a) (JJ primary) (NN action)) (PP (IN of) (NP (NN calcitonin))))))) (PP (IN on) (NP (NP (DT the) (JJ striatonigral) (JJ GABAergic) (NN pathway)) (VP (VBG mediating) (NP (NP (DT the) (JJ Doc_6293644_680_682_Chemical-related) (JJ behavioral) (NNS messages)) (PP (IN of) (NP (JJ striatal) (NN origin))))))))) (. .)))
6308526	0	(ROOT (S (NP (JJ Doc_6308526_0_10_Chemical) (NN pretreatment)) (VP (VBZ modifies) (NP (NP (NN cardiorespiratory)) (, ,) (NP (NN temperature)) (, ,) (CC and) (NP (NP (JJ behavioral) (NNS effects)) (PP (IN of) (NP (NNS Doc_6308526_91_99_Chemical)))))) (. .)))
6308526	1	(ROOT (S (NP (NP (JJ Behavioral) (CC and) (JJ cardiorespiratory) (NNS responses)) (PP (TO to) (NP (NP (DT a) (JJ lethal) (NN dose)) (PP (IN of) (NP (NNS Doc_6308526_164_172_Chemical)))))) (VP (VBD were) (VP (VBN evaluated) (PP (IN in) (NP (NP (NNS rats)) (VP (VBN pretreated) (PP (IN with) (NP (NP (NN saline) (CC or) (NNS Doc_6308526_222_232_Chemical)) (, ,) (NP (NP (DT an) (NN antagonist)) (PP (IN of) (NP (JJ high-affinity) (NN mu) (CD 1) (JJ opioid) (NNS receptors))))))))))) (. .)))
6308526	2	(ROOT (S (NP (NP (NNP Pretreatment)) (PP (IN with) (NP (NNS Doc_6308526_306_316_Chemical)))) (ADVP (RB significantly)) (VP (VBD blocked) (NP (JJ Doc_6308526_339_347_Chemical) (NNS Doc_6308526_348_357_Disease) (, ,) (NNS Doc_6308526_359_368_Disease) (CC and) (NNS Doc_6308526_373_384_Disease)) (PP (IN at) (NP (NP (DT a) (NN dose)) (SBAR (WHNP (WDT which)) (S (ADVP (RB completely)) (VP (VBD eliminated) (NP (NP (JJ high-affinity) (VBG binding)) (PP (IN in) (NP (NN brain) (NNS membranes)))))))))) (. .)))
6308526	3	(ROOT (S (ADVP (RB Moreover)) (, ,) (NP (NNS Doc_6308526_475_485_Chemical)) (ADVP (RB significantly)) (VP (VBD attenuated) (NP (DT the) (JJ Doc_6308526_515_523_Chemical-induced) (NNS Doc_6308526_532_543_Disease) (CC and) (NNS Doc_6308526_548_570_Disease)) (, ,) (SBAR (IN whereas) (S (NP (NN Doc_6308526_580_588_Chemical-induced) (NNS Doc_6308526_597_608_Disease)) (VP (VBD was) (ADJP (RBR less) (JJ affected)))))) (. .)))
6308526	4	(ROOT (S (NP (NNS Results)) (VP (VBP indicate) (SBAR (IN that) (S (NP (NP (NNS subpopulations)) (PP (IN of) (NP (NN mu) (NNS receptors)))) (VP (MD may) (VP (VB mediate) (NP (JJ selective) (JJ behavioral) (CC and) (JJ cardiorespiratory) (NNS responses)) (PP (TO to) (NP (NNS Doc_6308526_749_757_Chemical)))))))) (. .)))
6323692	0	(ROOT (NP (NP (NNP Modification)) (PP (IN of) (NP (NN drug) (NN action))) (PP (IN by) (NP (NNS Doc_6323692_31_45_Disease))) (. .)))
6323692	1	(ROOT (S (S (NP (NP (NNP Pretreatment)) (PP (IN with) (ADVP (NP (NP (NNS Doc_6323692_65_81_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_6323692_83_88_Chemical)) (-RRB- -RRB-)) (PRN (-LRB- -LRB-) (NP (CD 6) (NN mmol/kg) (NN s.c.)) (-RRB- -RRB-))) (RB approximately)))) (VP (VBD doubled) (SBAR (S (NP (DT the) (NN time) (NN Doc_6323692_138_146_Chemical-treated) (NNS mice)) (VP (VP (VBD remained) (PP (IN on) (NP (DT a) (JJ hot) (NN surface)))) (CC and) (VP (ADVP (RB similarly)) (VBD increased) (NP (JJ muscular) (NNS Doc_6323692_219_233_Disease)) (PP (IN by) (NP (NNS Doc_6323692_237_245_Chemical))))))))) (, ,) (CC but) (S (NP (JJ Doc_6323692_251_256_Chemical) (NN treatment)) (ADVP (RB alone)) (VP (VBD had) (NP (DT no) (NN effect)))) (. .)))
6323692	2	(ROOT (S (ADVP (RB Thus)) (, ,) (NP (NNS Doc_6323692_294_308_Disease)) (VP (VP (VBZ is) (ADJP (JJ capable) (PP (IN of) (S (VP (VBG altering) (NP (NN drug) (NN action))))))) (CC and) (VP (MD must) (VP (VB be) (VP (VBN considered) (PRT (RP along)) (PP (IN with) (NP (NP (VBN impaired) (NN drug) (NN metabolism)) (PP (IN in) (NP (NP (JJ enhanced) (NN drug) (NNS responses)) (VP (VBN associated) (PP (IN with) (NP (NNS Doc_6323692_446_459_Disease)))))))))))) (. .)))
6323692	3	(ROOT (S (NP (NP (NNS Experiments)) (PP (IN in) (NP (NNP vitro)))) (VP (VBD showed) (SBAR (IN that) (S (S (NP (NP (NN Doc_6323692_494_507_Chemical-induced) (JJ Doc_6323692_516_529_Chemical) (NN release)) (PP (IN from) (NP (JJ bovine) (JJ adrenal) (NN medulla)))) (VP (VBZ is) (VP (VBN depressed) (NP (QP (RB as) (JJ much) (IN as) (CD 50)) (NN %)) (PP (IN by) (NP (CD 0.3) (NN mM) (NNS Doc_6323692_604_609_Chemical)))))) (CC and) (S (NP (NP (NN Doc_6323692_614_617_Chemical-induced) (NNS contractions)) (PP (IN of) (NP (JJ guinea-pig) (NN ileum)))) (VP (VBD were) (VP (VBG inhibited) (NP (CD 20) (NN %)) (PP (IN by) (NP (CD 5) (NN mM) (NNS Doc_6323692_686_691_Chemical))))))))) (. .)))
6323692	4	(ROOT (S (S (NP (NP (NNP Addition)) (PP (IN of) (NP (JJ excess) (NNS Doc_6323692_712_719_Chemical)))) (VP (VBD reversed) (NP (DT the) (NNS Doc_6323692_733_743_Disease)) (PP (IN in) (NP (DT both) (NNS tissues))))) (, ,) (CC but) (S (NP (NP (NN Doc_6323692_765_772_Chemical-independent) (JJ Doc_6323692_785_798_Chemical) (NN release)) (PP (IN by) (NP (NNS Doc_6323692_810_822_Chemical)))) (VP (VBD was) (RB not) (VP (VBN blocked) (PP (IN by) (NP (NNS Doc_6323692_842_847_Chemical)))))) (. .)))
6323692	5	(ROOT (S (NP (DT These) (NNS results)) (VP (VBD suggested) (SBAR (IN that) (S (NP (NNS Doc_6323692_878_885_Chemical)) (VP (VBZ blocks) (NP (JJ Doc_6323692_893_900_Chemical) (NNS channels)))))) (. .)))
6323692	6	(ROOT (S (NP (NP (NNS Parallels)) (PP (IN in) (NP (NP (DT the) (NNS actions)) (PP (IN of) (NP (NP (NNS Doc_6323692_939_944_Chemical)) (CC and) (NP (DT the) (JJ Doc_6323692_953_960_Chemical) (NN channel) (NN blocker) (NNS Doc_6323692_977_986_Chemical))))))) (VP (VBP support) (NP (DT this) (NN concept))) (. .)))
6323692	7	(ROOT (S (S (NP (NP (NP (DT Both) (NNS Doc_6323692_1014_1023_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 10) (NN mg/kg) (NN i.p.)) (-RRB- -RRB-))) (CC and) (NP (JJ Doc_6323692_1044_1049_Chemical) (NN pretreatment))) (VP (VBD enhanced) (NP (NP (JJ Doc_6323692_1072_1080_Chemical) (ADJP (JJ Doc_6323692_1081_1090_Disease) (: -) (CC and) (JJ Doc_6323692_1096_1104_Chemical-induced)) (JJ muscular) (NNS Doc_6323692_1122_1136_Disease)) (CC and) (NP (JJ antagonized) (NN Doc_6323692_1153_1164_Chemical-induced) (NN motor) (NN activity))))) (, ,) (CC and) (S (NP (CC neither) (NP (NNS Doc_6323692_1201_1210_Chemical)) (CC nor) (NP (NNS Doc_6323692_1215_1220_Chemical))) (VP (VBD affected) (NP (NP (DT the) (JJ convulsant) (NN action)) (PP (IN of) (NP (NNS Doc_6323692_1255_1263_Chemical)))))) (. .)))
6323692	8	(ROOT (S (NP (DT The) (NNS data)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NNS Doc_6323692_1287_1301_Disease)) (VP (VBZ exerts) (NP (NP (DT a) (JJ Doc_6323692_1311_1318_Chemical) (NN channel)) (VP (VBG blocking) (NP (NP (NN action)) (SBAR (WHNP (WDT which)) (S (VP (VBZ enhances) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NP (JJ central) (JJ nervous) (NN system) (NNS depressants)) (CC and) (NP (JJ certain) (JJ opioid) (NNS analgesics))))))))))))))) (. .)))
6381653	0	(ROOT (S (VP (VB Doc_6381653_0_8_Chemical-induced) (NP (NNS Doc_6381653_17_27_Disease) (CC and) (NN thalamotomy))) (. .)))
6381653	1	(ROOT (S (NP (NP (JJ Doc_6381653_45_53_Chemical-induced) (NNS Doc_6381653_62_72_Disease)) (PP (IN of) (NP (NP (DT the) (NNS limbs)) (PP (IN in) (NP (NP (NN thirteen) (NNS cases)) (PP (IN of) (NP (NNS Doc_6381653_107_119_Disease))))))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD was) (NP (JJ choreic) (, ,) (NNS ballistic) (CC or) (NNS Doc_6381653_153_161_Disease)) (PP (IN in) (NP (NN type)))))) (, ,)) (VP (VBD was) (VP (VBN alleviated) (ADVP (ADVP (RB almost) (RB completely)) (PP (IN by) (NP (JJ stereotaxic) (NN surgery)))) (UCP (VP (VBG using) (NP (DT a) (JJ microelectrode) (NN technique)) (PP (IN for) (NP (NP (DT the) (JJ ventralis) (NNS oralis) (NN anterior) (CC and) (NN posterior) (NN nuclei)) (PP (IN of) (NP (DT the) (NNS thalamus)))))) (, ,) (CC but) (ADJP (ADJP (RB much) (JJR less)) (PP (IN by) (NP (DT the) (JJ ventralis) (NNS intermedius) (NN nucleus))))))) (. .)))
6381653	2	(ROOT (S (NP (NP (NNP Control)) (PP (IN of) (NP (NP (NN Doc_6381653_395_403_Chemical-induced) (NNS Doc_6381653_412_423_Disease)) (PP (IN by) (NP (NP (NNS Doc_6381653_427_443_Disease)) (PP (IN in) (NP (NP (DT the) (NN course)) (PP (IN of) (NP (NP (JJ routine) (NN treatment)) (PP (IN of) (NP (NNS Doc_6381653_482_494_Disease)))))))))))) (VP (VBZ is) (VP (VBN discussed))) (. .)))
6402369	0	(ROOT (S (NP (NP (NNP Treatment)) (PP (IN of) (NP (NNS Doc_6402369_13_23_Chemical-induced)))) (VP (VBD Doc_6402369_32_51_Disease) (PP (IN by) (NP (NP (JJ oral) (NN administration)) (PP (IN of) (NP (NP (NNS Doc_6402369_78_112_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_6402369_114_119_Chemical)) (-RRB- -RRB-)))))) (PP (TO to) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ inoperable) (NNS Doc_6402369_149_160_Disease)))))) (. .)))
6402369	1	(ROOT (S (NP (NP (DT The) (JJ protective) (NN effect)) (PP (IN of) (NP (NP (JJ oral) (NN administration)) (PP (IN of) (NP (DT the) (JJ Doc_6402369_214_219_Chemical) (JJ compound) (NNS Doc_6402369_229_263_Chemical))))) (PRN (-LRB- -LRB-) (NP (NNP Doc_6402369_265_270_Chemical)) (-RRB- -RRB-)) (PP (IN against) (NP (NP (NNS Doc_6402369_280_299_Disease)) (VP (VBN induced) (PP (IN by) (NP (NP (NNS Doc_6402369_311_321_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_6402369_323_325_Chemical)) (-RRB- -RRB-)))))))) (VP (VBD was) (VP (VBN tested) (PP (IN in) (NP (NP (DT a) (NN group)) (PP (IN of) (NP (NP (CD 45) (NNS patients)) (PP (IN with) (NP (JJ inoperable) (NNS Doc_6402369_380_391_Disease))))))) (PP (IN under) (NP (NP (NP (NN treatment)) (PP (IN with) (NP (NNS Doc_6402369_413_415_Chemical)))) (PRN (-LRB- -LRB-) (NP (NP (CD 2250) (NNS mg/m2)) (PP (IN on) (NP (NNS days))) (VP (VBN 2-5))) (-RRB- -RRB-)) (PP (IN as) (NP (NP (NN part)) (PP (IN of) (NP (NP (DT a) (JJ polychemotherapy) (NN regimen)) (VP (VBN repeated) (PP (IN in) (NP (DT a) (JJ 4-week) (NN cycle)))))))))))) (. .)))
6402369	2	(ROOT (S (NP (NNP Doc_6402369_507_512_Chemical)) (VP (VBD was) (VP (VBN given) (NP (NP (NN orally)) (PP (IN on) (NP (NP (DT the) (NNS days)) (PP (IN of) (NP (NN treatment)))))) (PP (IN with) (S (VP (VBG IF) (PP (IN in) (NP (NP (CD 3) (NNS doses)) (PP (IN of) (NP (CD 840) (NNS mg/m2)))))))) (, ,) (NP (NP (DT each)) (VP (VBN administered) (PP (IN at) (NP (NP (CD 0) (NN hr) (PRN (-LRB- -LRB-) (NP (NP (JJ =) (NN injection)) (PP (IN of) (NP (NNP IF)))) (-RRB- -RRB-))) (, ,) (NP (CD 4) (NN hr)) (CC and) (NP (NP (CD 8) (NN hr) (NN p.i.) (NNS Out)) (PP (IN of) (NP (NP (DT a) (NN total)) (PP (IN of) (NP (NP (CD 88) (NNS courses)) (PP (IN of) (NP (NP (DT this) (NN treatment)) (SBAR (S (NP (PRP we)) (VP (VBD observed) (NP (NP (NP (CD 10) (NNS episodes)) (PP (IN of) (NP (JJ asymptomatic) (JJ microscopic) (NN haematuria)))) (CC and) (NP (NP (DT no) (NNS episodes)) (PP (IN of) (NP (JJ gross) (NN haematuria))))))))))))))))))))) (. .)))
6402369	3	(ROOT (S (PP (IN In) (NP (NP (DT this) (NN group)) (PP (IN of) (NP (NP (CD 45) (NNS patients)) (PP (IN under) (NP (NP (NN protection)) (PP (IN with) (NP (NNS Doc_6402369_852_857_Chemical))))))))) (NP (EX there)) (VP (VBD were) (NP (NP (NP (CD 5) (JJ complete) (NNS remissions)) (CC and) (NP (CD 9) (JJ partial) (NNS remissions))) (PRN (-LRB- -LRB-) (S (VP (VB total) (NP (CD 31) (NN %)))) (-RRB- -RRB-)))) (. .)))
6402369	4	(ROOT (S (NP (NP (DT A) (JJ further) (NN group)) (PP (IN of) (NP (NP (CD 25) (NNS patients)) (PP (IN under) (NP (NP (NN polychemotherapy)) (PP (IN with) (NP (NNS Doc_6402369_988_990_Chemical)))))))) (VP (VBD were) (VP (VBN treated) (PP (IN by) (NP (NP (JJ conventional) (JJ prophylactic) (NNS measures)) (PRN (-LRB- -LRB-) (VP (VBN raised) (NP (NP (JJ fluid) (NN intake)) (CC and) (NP (VBN forced) (NNS diuresis)))) (-RRB- -RRB-)))))) (. .)))
6402369	5	(ROOT (S (S (PP (IN In) (NP (DT this) (NN group))) (NP (EX there)) (VP (VBD were) (NP (NP (CD 1) (ADJP (ADJP (JJ complete)) (CC and) (ADJP (CD 5) (JJ partial))) (NNS remissions)) (PRN (-LRB- -LRB-) (NP (QP (JJ total) (CD 24)) (NN %)) (-RRB- -RRB-))))) (, ,) (CC but) (S (NP (QP (RB nearly) (DT all)) (NNS patients)) (VP (VBD developed) (NP (NP (DT either) (JJ gross) (NN haematuria) (NN and/or) (NNS symptoms)) (PP (IN of) (NP (NP (NNS Doc_6402369_1236_1254_Disease)) (PRN (-LRB- -LRB-) (NP (NP (NNS Doc_6402369_1256_1264_Disease)) (CC and) (NP (NN pollakisuria))) (-RRB- -RRB-))))))) (. .)))
6402369	6	(ROOT (S (NP (EX There)) (VP (VBD were) (NP (NP (NP (DT no) (JJ appreciable) (NNS differences)) (PP (IN between) (NP (DT the) (JJ Doc_6402369_1334_1339_Chemical) (NN series)))) (CC and) (NP (NP (DT the) (JJ conventional) (NNS prophylaxis) (NN series)) (PP (IN with) (NP (NN respect))))) (PP (TO to) (NP (NP (DT either) (NN haematological)) (CC or) (NP (NP (JJ systemic) (NNS Doc_6402369_1437_1445_Disease)) (PP (IN of) (NP (DT the) (JJ cytostatic) (NN treatment))))))) (. .)))
6402369	7	(ROOT (S (NP (PRP$ Our) (NNS results)) (VP (VBP support) (NP (DT the) (NN view)) (SBAR (IN that) (S (NP (NP (NNS Doc_6402369_1509_1514_Chemical)) (, ,) (VP (VBN given) (ADVP (RB orally)) (PP (IN in) (NP (NN conjunction))) (PP (IN with) (NP (NP (JJ combined) (JJ cytostatic) (NNS regimens)) (SBAR (WHNP (WDT which)) (S (VP (VBP include) (NP (NNS Doc_6402369_1592_1594_Chemical)))))))) (, ,)) (VP (VP (VBZ simplifies) (NP (DT the) (NN treatment))) (CC and) (VP (VBZ provides) (NP (JJ optimum) (NN protection)) (PP (IN for) (NP (DT the) (JJ urinary) (NN epithelium)))))))) (. .)))
6402369	8	(ROOT (S (NP (NP (NNP Protection)) (PP (IN with) (NP (JJ oral) (NNS Doc_6402369_1702_1707_Chemical)))) (VP (VBZ is) (ADJP (RB particularly) (JJ suitable) (PP (IN for) (NP (NNS outpatients))))) (. .)))
6415512	0	(ROOT (NP (NP (JJ Doc_6415512_0_39_Disease) (VBG following) (NN institution)) (PP (IN of) (NP (NP (JJ Doc_6415512_65_78_Chemical) (NN therapy)) (PP (IN in) (NP (NNS children))))) (. .)))
6415512	1	(ROOT (S (NP (NP (CD Five) (NNS children)) (, ,) (VP (VBN aged) (NP (NP (QP (CD 3) (TO to) (CD 11)) (NNS years)) (, ,) (VP (VBN treated) (PP (IN with) (NP (NP (NNS Doc_6415512_148_161_Chemical)) (PP (IN for) (NP (NNS Doc_6415512_166_174_Disease)))))))) (, ,)) (VP (VBD had) (NP (NP (DT an) (JJ acute) (NN aberrant) (NN reaction)) (VP (VBN characterized) (PP (IN by) (NP (NP (DT the) (NN onset)) (PP (IN of) (NP (NP (NNS Doc_6415512_237_301_Disease)) (PP (IN within) (NP (DT a) (JJ few) (NNS days)))))))))) (. .)))
6415512	2	(ROOT (S (SBAR (WHADVP (WRB When)) (S (NP (DT the) (NNS Doc_6415512_330_343_Chemical)) (VP (VBD was) (VP (VBN discontinued))))) (, ,) (S (NP (NP (CD two)) (PP (IN of) (NP (DT the) (NNS children)))) (VP (VBD returned) (PP (TO to) (NP (PRP$ their) (JJ former) (NN state))) (ADVP (RB very) (RB quickly)))) (PRN (, ,) (S (NP (CD two)) (VP (VBD had) (NP (NP (DT the) (JJ minor) (NN motor) (NN Doc_6415512_451_459_Disease) (NN resolve)) (PP (IN in) (NP (QP (CD 3) (CC and) (CD 6)) (NNS months)))))) (, ,)) (CC and) (S (NP (PRP one)) (VP (VBD had) (S (NP (DT the) (NNS Doc_6415512_503_511_Disease)) (VP (VB persist))))) (. .)))
6415512	3	(ROOT (S (NP (NP (DT The) (NN child)) (SBAR (WHPP (IN in) (WHNP (WP whom))) (S (NP (DT the) (NNS Doc_6415512_543_551_Disease)) (VP (VBD persisted))))) (VP (VBD was) (ADVP (RB later)) (VP (VBN found) (S (VP (TO to) (VP (VB have) (NP (NNS Doc_6415512_586_607_Disease))))))) (. .)))
6415512	4	(ROOT (S (NP (DT The) (JJ other) (NNS children)) (VP (VBP are) (VP (VBG doing) (ADVP (RB well)) (PP (IN on) (NP (JJ other) (NNS anticonvulsants))))) (. .)))
6433367	0	(ROOT (S (NP (NP (NN Effect)) (PP (IN of) (NP (JJ Doc_6433367_10_23_Chemical) (NN synthetase)))) (VP (VBZ inhibitors) (PP (IN on) (S (ADVP (RB experimentally)) (VP (VBG induced) (NP (NNS Doc_6433367_72_83_Disease)) (PP (IN in) (NP (NNS rats))))))) (. .)))
6433367	1	(ROOT (S (S (VP (TO To) (VP (VB investigate) (NP (NP (DT the) (NN relationship)) (PP (IN of) (NP (NP (NNS Doc_6433367_128_142_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_6433367_144_147_Chemical)) (-RRB- -RRB-))))) (PP (TO to) (NP (JJ Doc_6433367_152_159_Disease) (NN induction)))))) (, ,) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NP (CD six) (NNP PG) (JJ synthetase) (NNS inhibitors)) (PP (IN on) (NP (NP (NNS Doc_6433367_218_229_Disease)) (VP (VBN induced) (PP (IN by) (NP (NP (NNS Doc_6433367_241_250_Chemical)) (, ,) (NP (NNS Doc_6433367_252_262_Chemical)) (, ,) (NP (JJ Doc_6433367_264_275_Chemical) (-LRB- -LRB-) (NNS Doc_6433367_277_280_Chemical) (-RRB- -RRB-)) (, ,) (NP (NN electroshock)) (CC or) (NP (NNS Doc_6433367_299_310_Chemical)))))))))) (VP (VBD were) (VP (VBN evaluated))) (. .)))
6433367	2	(ROOT (S (S (NP (NP (NNP Doc_6433367_327_336_Chemical)) (, ,) (NP (NNS Doc_6433367_338_346_Chemical)) (, ,) (NP (NNS Doc_6433367_348_362_Chemical)) (, ,) (CC and) (NP (JJ low) (NN dose) (NNS Doc_6433367_377_394_Chemical))) (VP (VP (VBD increased) (NP (DT the) (NN latency-to-onset)) (PP (IN in) (NP (DT the) (NNS Doc_6433367_433_442_Chemical)))) (CC and/or) (VP (VBZ Doc_6433367_450_453_Chemical) (NP (NNS models))))) (: ;) (S (NP (NP (DT the) (NN electroshock)) (, ,) (NP (NNS Doc_6433367_480_490_Chemical)) (CC and) (NP (JJ Doc_6433367_495_506_Chemical) (NNS models))) (VP (VBD were) (RB not) (VP (ADVP (RB significantly)) (VBN affected) (PP (IN by) (NP (NP (DT any)) (PP (IN of) (NP (DT the) (JJ pretreatment) (NNS agents)))))))) (. .)))
6433367	3	(ROOT (S (NP (DT These) (NNS results)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NNS Doc_6433367_608_611_Chemical)) (VP (VBP are) (VP (VBN involved) (PP (IN in) (NP (NP (DT the) (NN mechanism)) (PRN (-LRB- -LRB-) (PRP s) (-RRB- -RRB-)))) (NP (NP (NP (VBG underlying) (NNS Doc_6433367_656_665_Chemical)) (PRN (: -) (CC and) (NP (NP (NP (NN Doc_6433367_671_674_Chemical-induced) (NNS Doc_6433367_683_694_Disease)) (PRN (, ,) (CC but) (ADJP (RB not) (JJ Doc_6433367_704_714_Chemical)) (, -))) (, ,) (NP (NN electroshock))) (: -))) (, ,) (CC or) (NP (ADJP (JJ Doc_6433367_735_746_Chemical-induced)) (NNS Doc_6433367_755_766_Disease)))))))) (. .)))
6436733	0	(ROOT (S (NP (NP (JJ Acute) (NNS changes)) (PP (IN of) (NP (NN blood) (NNS Doc_6436733_23_30_Chemical)))) (VP (MD may) (VP (VB predict) (NP (NP (JJ short-term) (JJ adverse) (NNS effects)) (PP (IN of) (NP (NNS Doc_6436733_73_86_Chemical)))))) (. .)))
6436733	1	(ROOT (S (NP (NP (NNP Doc_6436733_88_101_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_6436733_103_106_Chemical)) (-RRB- -RRB-))) (VP (VBD was) (VP (VBN given) (PP (TO to) (NP (NP (CD 24) (JJ Doc_6436733_124_133_Disease) (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBD were) (ADVP (RB already)) (VP (VBG being) (VP (VBN treated) (PP (IN with) (NP (JJ other) (JJ antiepileptic) (NNS drugs)))))))))))) (. .)))
6436733	2	(ROOT (S (S (NP (NP (DT A) (JJ standardized) (NN loading) (NN dose)) (PP (IN of) (NP (NNS Doc_6436733_237_240_Chemical)))) (VP (VBD was) (VP (VBN administered)))) (, ,) (CC and) (S (NP (JJ venous) (NN blood)) (VP (VBD was) (VP (VBN sampled) (PP (IN at) (NP (NP (CD 0)) (, ,) (NP (CD 1)) (, ,) (NP (CD 2)) (, ,) (NP (CD 3)) (, ,) (CC and) (NP (CD 4) (NNS hours))))))) (. .)))
6436733	3	(ROOT (S (NP (NP (NNP Doc_6436733_316_323_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_6436733_325_328_Chemical)) (-RRB- -RRB-))) (VP (VBD was) (ADJP (JJR higher)) (PP (IN in) (NP (NP (NNS patients)) (SBAR (WHNP (WP who)) (S (, ,) (PP (IN during) (NP (JJ continuous) (NN therapy))) (, ,) (VP (VBD complained) (PP (IN of) (NP (NP (NNS drowsiness)) (PRN (-LRB- -LRB-) (NP (CD 7) (NNS patients)) (-RRB- -RRB-)))) (PP (IN than) (IN in) (NP (NP (DT those)) (SBAR (WHNP (WP who)) (S (VP (VBD were) (ADJP (JJ symptom-free)))))))))) (PRN (-LRB- -LRB-) (NP (CD 17) (NNS patients)) (-RRB- -RRB-)))) (, ,) (SBAR (IN although) (S (NP (JJ Doc_6436733_483_486_Chemical) (NN plasma) (NNS levels)) (VP (VBD were) (ADJP (JJ similar) (PP (IN in) (NP (DT both) (NNS groups)))))))) (. .)))
6436733	4	(ROOT (S (PP (IN By) (S (VP (VBG measuring) (S (NP (NP (NN Doc_6436733_543_546_Chemical-induced) (NNS changes)) (PP (IN of) (NP (NN blood) (NNS Doc_6436733_572_575_Chemical)))) (ADJP (JJ content)))))) (, ,) (NP (PRP it)) (VP (MD may) (VP (VB be) (ADJP (JJ possible) (S (VP (TO to) (VP (VB identify) (NP (NNS patients)) (PP (IN at) (NP (NP (JJR higher) (NN risk)) (PP (IN of) (NP (NN obtundation))))))))) (SBAR (WHADVP (WRB when)) (S (NP (NNS Doc_6436733_660_663_Chemical)) (VP (VBZ is) (VP (VBN given) (S (ADJP (JJ chronically))))))))) (. .)))
6454943	0	(ROOT (NP (NP (NN Effect)) (PP (IN of) (NP (NP (NNS Doc_6454943_10_19_Chemical)) (PP (IN on) (NP (JJ pre-existing) (CC and) (JJ Doc_6454943_40_55_Chemical-induced) (NNS Doc_6454943_64_75_Disease))))) (PP (IN in) (NP (JJ spontaneously) (JJ Doc_6454943_93_105_Disease) (NNS rats))) (. .)))
6454943	1	(ROOT (S (NP (NNP Doc_6454943_112_123_Disease)) (VP (VBZ is) (NP (NP (DT a) (NN side) (NN effect)) (PP (IN of) (NP (NP (JJ Doc_6454943_144_153_Chemical) (NN treatment)) (PP (IN in) (NP (JJ Doc_6454943_167_179_Disease) (NNS patients))))))) (. .)))
6454943	2	(ROOT (S (NP (NP (DT The) (NN possibility)) (PP (IN of) (S (VP (VBG reproducing) (NP (DT the) (JJ same) (NNS Doc_6454943_230_247_Disease)) (PP (IN with) (NP (NNS Doc_6454943_253_262_Chemical))))))) (VP (VBD was) (VP (VBN examined) (PP (IN in) (NP (NNP SHR))))) (. .)))
6454943	3	(ROOT (S (NP (NP (JJ Oral) (NN administration)) (PP (IN of) (NP (NP (NNS Doc_6454943_307_316_Chemical)) (PP (IN at) (NP (NP (CD 100) (NN mg/kg)) (PP (IN for) (NP (CD 14) (NNS days)))))))) (VP (VBD failed) (S (VP (TO to) (VP (VB aggravate) (NP (NP (NNP Doc_6454943_362_373_Disease) (NNP pre-existing)) (PP (IN in) (NP (NNP SHR)))))))) (. .)))
6454943	4	(ROOT (S (ADVP (RB Also)) (, ,) (NP (JJ Doc_6454943_401_410_Chemical) (NN treatment)) (VP (VBD failed) (S (VP (TO to) (VP (VB potentiate) (CC or) (VB facilitate) (NP (NP (NN development)) (PP (IN of) (NP (NP (JJ massive) (NNS Doc_6454943_479_490_Disease)) (VP (VBN invoked) (PP (IN by) (NP (NP (NNS Doc_6454943_502_527_Chemical)) (PP (IN in) (NP (NNP SHR))))))))))))) (. .)))
6454943	5	(ROOT (S (NP (NNP Doc_6454943_536_545_Chemical)) (VP (VBD had) (NP (RB little) (ADVP (CC or) (RB no)) (NP (NP (JJ demonstrable) (NNS effects)) (PP (IN on) (NP (NN serum) (NN electrolyte) (NNS concentrations)))) (, ,) (NP (NP (NN excretion)) (PP (IN of) (NP (NN urine) (, ,) (NNS Doc_6454943_641_647_Chemical) (CC and) (NNS Doc_6454943_652_661_Chemical)))) (, ,) (NP (NP (JJ endogenous) (JJ Doc_6454943_674_684_Chemical) (NN clearance)) (, ,) (NP (NN body) (NN weight)) (, ,) (CC and) (NP (NN food) (CC and) (NN water) (NN consumption))))) (. .)))
6454943	6	(ROOT (S (ADVP (RB However)) (, ,) (NP (JJ Doc_6454943_750_756_Chemical) (NNS bodies)) (VP (VBD were) (ADVP (RB consistently)) (ADJP (JJ present)) (PP (IN in) (NP (NP (NN urine) (CC and) (JJ several) (NNS lethalities)) (VP (VBN occurred) (PP (IN during) (NP (NP (JJ multiple) (NN dosing)) (PP (IN of) (NP (NP (NNS Doc_6454943_858_867_Chemical)) (PP (IN in) (NP (NNP SHR))))))))))) (. .)))
6496797	0	(ROOT (NP (NP (JJ Complete) (NNS Doc_6496797_9_20_Disease)) (PP (VBG following) (NP (NP (DT a) (JJ single) (NN dose)) (PP (IN of) (NP (NNS Doc_6496797_48_57_Chemical))))) (. .)))
6496797	1	(ROOT (S (PP (NP (CD Forty) (NNS minutes)) (IN after) (S (VP (VBG receiving) (NP (NP (DT a) (JJ single) (JJ starting) (NN dose)) (PP (IN of) (NP (NNS Doc_6496797_115_124_Chemical))))))) (, ,) (NP (DT a) (NN patient)) (VP (VBD developed) (NP (JJ complete) (NNS Doc_6496797_155_166_Disease))) (. .)))
6496797	2	(ROOT (S (NP (DT The) (NN case)) (VP (VBZ illustrates) (SBAR (IN that) (, ,) (S (PP (IN despite) (NP (NP (DT the) (NNS results)) (PP (IN of) (NP (JJR earlier) (NNS studies))))) (, ,) (NP (NP (NP (NNP Doc_6496797_235_244_Chemical) (POS 's)) (NN effect)) (PP (IN on) (NP (JJ cardiac) (NN conduction)))) (VP (MD may) (VP (VB be) (ADJP (JJ severe) (PP (IN in) (NP (NP (NNS individuals)) (PP (IN at) (NP (NN risk)))))) (PP (IN for) (NP (NN conduction) (NN delay)))))))) (. .)))
6504332	0	(ROOT (NP (NP (JJ Doc_6504332_0_13_Chemical-induced) (NNS Doc_6504332_22_32_Disease)) (PP (IN in) (NP (DT a) (JJ Doc_6504332_38_61_Disease) (NN child))) (. .)))
6504332	1	(ROOT (S (NP (NP (DT A) (JJ 2-year-old) (NN child)) (PP (IN with) (NP (JJ known) (NNS Doc_6504332_99_120_Disease)))) (VP (VBD developed) (NP (DT a) (NNS Doc_6504332_133_143_Disease)) (ADVP (RB soon)) (PP (IN after) (S (VP (VBG starting) (NP (JJ Doc_6504332_164_177_Chemical) (NN therapy)) (PP (IN for) (NP (NNS Doc_6504332_190_198_Disease))))))) (. .)))
6504332	2	(ROOT (S (NP (NP (JJ Known) (NNS causes)) (PP (IN of) (NP (NNS Doc_6504332_216_234_Disease)))) (VP (VBD were) (VP (VBN eliminated) (PP (IN after) (NP (NN evaluation))))) (. .)))
6504332	3	(ROOT (S (PP (IN On) (NP (NP (NN repeat) (NN challenge)) (PP (IN with) (NP (NNS Doc_6504332_294_307_Chemical))))) (, ,) (NP (DT the) (NNS Doc_6504332_313_323_Disease)) (VP (VBD recurred)) (. .)))
6504332	4	(ROOT (S (NP (NNP Doc_6504332_334_347_Chemical)) (VP (MD should) (VP (VB be) (VP (VBN added) (PP (TO to) (NP (NP (DT the) (NN list)) (PP (IN of) (NP (JJ anticonvulsant) (NNS drugs))) (SBAR (WHNP (WDT that)) (S (VP (MD can) (VP (VB cause) (NP (NNS Doc_6504332_415_433_Disease))))))))))) (. .)))
6540303	0	(ROOT (S (NP (NP (NNPS Effects)) (PP (IN of) (NP (NNS Doc_6540303_11_16_Chemical)))) (VP (VBP pretreatment) (PP (IN on) (NP (NP (JJ Doc_6540303_33_41_Chemical) (NNS Doc_6540303_42_51_Disease)) (PP (IN in) (NP (ADJP (JJ pinealectomized) (CC or) (JJ hypophysectomized)) (NNS animals)))))) (. .)))
6540303	1	(ROOT (S (NP (DT The) (JJ present) (NNS studies)) (VP (VBD were) (VP (VBN designed) (S (VP (TO to) (VP (VP (VB clarify) (NP (NP (DT the) (NN role)) (PP (IN of) (NP (JJ Doc_6540303_158_172_Chemical) (CC and) (JJ pineal) (NNS idolamines)))) (PP (IN on) (NP (NP (NN Doc_6540303_198_206_Chemical-induced) (NNS Doc_6540303_215_224_Disease)) (PP (IN in) (NP (DT the) (ADJP (JJ intact) (, ,) (JJ pinealectomized) (CC or) (JJ hypophysectomized)) (NN chick)))))) (CC and) (VP (VB rat))))))) (. .)))
6540303	2	(ROOT (S (S (PP (IN In) (NP (DT the) (JJ pinealectomized) (NN chick))) (, ,) (NP (NP (NN pretreatment)) (PP (IN with) (NP (NNS Doc_6540303_340_348_Chemical)))) (VP (VBD increased) (NP (NP (DT the) (NN duration)) (PP (IN of) (NP (NP (NNS Doc_6540303_375_384_Disease)) (PRN (-LRB- -LRB-) (NP (NNP DOC)) (-RRB- -RRB-))))) (PP (IN after) (NP (NNS Doc_6540303_397_405_Chemical))))) (, ,) (CC but) (S (NP (NP (NN pretreatment)) (PP (IN with) (NP (NNS Doc_6540303_429_443_Chemical)))) (VP (VBD did) (RB not))) (. .)))
6540303	3	(ROOT (S (NP (DT The) (JJ pineal) (NNS Doc_6540303_464_475_Chemical)) (VP (VBD exhibited) (NP (JJ mixed) (NNS actions))) (. .)))
6540303	4	(ROOT (S (NP (NP (NNS Doc_6540303_501_510_Chemical) (CC and) (NNS Doc_6540303_515_533_Chemical)) (SBAR (WHNP (WDT which)) (S (VP (VBD augmented) (NP (NNP Doc_6540303_550_558_Chemical) (NNP DOC)))))) (, ,) (VP (VBD did) (RB not) (VP (VB do) (ADVP (RB so)) (PP (IN in) (NP (NP (DT the) (NN absence)) (PP (IN of) (NP (DT the) (JJ pineal) (NN gland))))) (, ,) (SBAR (IN whereas) (S (NP (NNS Doc_6540303_622_631_Chemical)) (VP (VBD potentiated) (NP (DT the) (JJ Doc_6540303_648_656_Chemical) (NN DOC)) (PP (IN in) (NP (PDT both) (DT the) (JJ intact) (CC and) (JJ pinealectomized) (NN chick)))))))) (. .)))
6540303	5	(ROOT (S (S (S (NP (NNP Doc_6540303_707_715_Chemical)) (VP (VBD was) (ADJP (RBR more) (JJ potent)) (PP (IN in) (NP (DT the) (JJ hypophysectomized) (NN chick))))) (CC and) (S (NP (DT the) (NN circadian) (NN rhythm)) (VP (VBD noted) (SBAR (IN in) (S (NP (DT the) (JJ intact) (NN chick)) (VP (VBD was) (ADJP (JJ absent)))))))) (: ;) (S (ADVP (RB furthermore)) (, ,) (NP (NNS Doc_6540303_839_848_Chemical)) (VP (VBD did) (RB not) (VP (VB augment) (NP (DT the) (JJ Doc_6540303_869_877_Chemical) (NN DOC)) (SBAR (IN whereas) (S (NP (NNS Doc_6540303_890_898_Chemical)) (VP (VBD continued) (S (VP (TO to) (VP (VB do) (ADVP (RB so))))))))))) (. .)))
6540303	6	(ROOT (S (NP (DT This) (NN study)) (VP (VBD did) (RB not) (VP (VB demonstrate) (NP (NP (DT a) (NN species) (NN difference)) (PP (VBG regarding) (NP (NP (DT the) (NN role)) (PP (IN of) (NP (NP (DT the) (NNS Doc_6540303_997_1003_Chemical)) (PP (IN on) (NP (NP (DT the) (NN pineal)) (PP (IN in) (NP (NP (NN spite)) (PP (IN of) (NP (NP (NP (DT the) (JJ immature) (JJ blood-brain) (NN barrier)) (PP (IN in) (NP (DT the) (JJ young) (NN chick)))) (CC and) (NP (NP (DT the) (JJ intact) (NN barrier)) (PP (IN in) (NP (DT the) (NN rat))))))))))))))))) (. .)))
6540303	7	(ROOT (S (PP (IN In) (NP (NN addition))) (, ,) (NP (DT these) (NNS data)) (VP (VBP indicate) (NP (NP (DT a) (JJ direct) (NN role)) (PP (IN of) (NP (NP (DT the) (NN pituitary)) (PP (IN in) (NP (NP (DT the) (NN augmentation)) (PP (IN of) (NP (NP (NNP Doc_6540303_1204_1212_Chemical) (NNP DOC)) (VP (VBN induced) (PP (IN by) (NP (NNS Doc_6540303_1228_1237_Chemical)))))))))))) (. .)))
6540303	8	(ROOT (S (ADVP (RB Furthermore)) (, ,) (NP (NNS Doc_6540303_1252_1260_Chemical)) (VP (VBD appeared) (S (VP (TO to) (VP (VB act) (PP (IN on) (NP (NP (NNS systems)) (ADJP (RBR more) (RB closely) (VBN involved)))) (PP (PP (IN with) (NP (NP (DT the) (NN induction)) (PP (IN of) (NP (JJ Doc_6540303_1332_1340_Chemical) (NNS Doc_6540303_1341_1350_Disease))))) (CONJP (RB rather) (IN than)) (PP (ADVP (RB directly)) (IN on) (NP (DT the) (NN pituitary)))))))) (. .)))
6615052	0	(ROOT (NP (NP (JJ Doc_6615052_0_7_Chemical-induced) (NNS Doc_6615052_16_32_Disease)) (, ,) (NP (NP (NNS Doc_6615052_34_44_Disease)) (, ,) (CC and) (NP (NNS Doc_6615052_50_60_Disease))) (. .)))
6615052	1	(ROOT (S (NP (NP (JJ Sixty-two) (NNS patients)) (PP (IN with) (NP (DT a) (NN Doc_6615052_88_95_Chemical-induced) (NNS Doc_6615052_104_120_Disease)))) (VP (VBP are) (VP (VBN reported))) (. .)))
6615052	2	(ROOT (S (NP (NP (JJ Clinical) (NNS manifestations)) (PP (IN of) (NP (DT this) (NN disorder)))) (VP (VBP include) (NP (NP (NNS Doc_6615052_184_194_Disease)) (CC or) (PRN (, ,) (ADVP (RBR more) (RB frequently)) (, ,)) (NP (JJ Doc_6615052_216_230_Disease) (NNS events))) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NN heparin)))))) (. .)))
6615052	3	(ROOT (S (NP (NNP Laboratory) (NN testing)) (VP (VBZ has) (VP (VBN revealed) (NP (NP (NP (NNS Doc_6615052_301_325_Disease)) (, ,) (NP (NP (VBN increased) (NN resistance)) (PP (TO to) (NP (NNS Doc_6615052_351_358_Chemical))))) (, ,) (CC and) (NP (NP (NN aggregation)) (PP (IN of) (NP (NP (NNS platelets)) (PP (IN by) (NP (NP (DT the) (NN patient) (POS 's)) (NN plasma))))) (SBAR (WHADVP (WRB when)) (S (NP (NN heparin)) (VP (VBZ is) (VP (VBN added))))))))) (. .)))
6615052	4	(ROOT (S (NP (JJ Immunologic) (NN testing)) (VP (VBZ has) (VP (VBN demonstrated) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (DT a) (JJ heparin-dependent) (NN platelet) (NN membrane) (NN antibody)))))) (. .)))
6615052	5	(ROOT (S (NP (NP (DT The) (CD 20) (NNS deaths)) (, ,) (NP (CD 52) (NNS Doc_6615052_555_599_Disease)) (, ,) (CC and) (NP (NP (CD 21) (JJ surgical) (NNS procedures)) (SBAR (S (VP (TO to) (VP (VB manage) (NP (DT the) (NNS complications)))))))) (VP (VBP confirm) (NP (NP (DT the) (NN seriousness)) (PP (IN of) (NP (DT the) (NN disorder))))) (. .)))
6615052	6	(ROOT (S (S (NP (JJ Specific) (NN risk) (NNS factors)) (VP (VBP have) (RB not) (VP (VBN been) (VP (VBN identified))))) (: ;) (S (ADVP (RB therefore)) (, ,) (NP (DT all) (NNS patients) (NN receiving) (NN heparin)) (VP (MD should) (VP (VB be) (VP (VBN monitored))))) (. .)))
6615052	7	(ROOT (S (SBAR (IN If) (S (NP (DT the) (NN platelet) (NN count)) (VP (VBZ falls) (PP (TO to) (NP (QP (JJR less) (IN than) (CD 100,000) (CD /)) (NNS mm3))) (, ,) (SBAR (IN while) (S (NP (DT the) (NN patient)) (VP (VBZ is) (VP (VBG receiving) (NP (NNS Doc_6615052_893_900_Chemical))))))))) (, ,) (NP (NP (JJ Doc_6615052_902_922_Disease) (NN testing)) (, ,) (VP (VBG using) (NP (NP (DT the) (NN patient) (POS 's)) (NN plasma))) (, ,)) (VP (VBZ is) (VP (VBN indicated))) (. .)))
6615052	8	(ROOT (S (NP (NNP Management)) (VP (VBZ consists) (PP (IN of) (NP (NP (NN cessation)) (PP (IN of) (NP (NP (NNS Doc_6615052_1010_1017_Chemical)) (, ,) (NP (JJ platelet) (JJ anti-aggregating) (NNS agents)) (, ,) (CC and) (NP (NP (JJ alternate) (NNS forms)) (PP (IN of) (NP (NN anticoagulation)))))))) (SBAR (WHADVP (WRB when)) (S (VP (VBD indicated))))) (. .)))
663266	0	(ROOT (S (VP (VB Doc_663266_0_24_Disease) (PP (IN from) (NP (NNS Doc_663266_30_41_Chemical))) (PP (IN with) (CC and) (IN without) (S (VP (VBG chelating) (NP (NNS agents)))))) (. .)))
663266	1	(ROOT (S (NP (NP (DT The) (NNS Doc_663266_81_89_Disease)) (PP (IN of) (NP (QP (CD Doc_663266_93_103_Chemical) (CD 76)) (NN %)))) (VP (VBD was) (VP (VBN compared) (PP (IN with) (NP (NP (DT that)) (PP (IN of) (NP (CD Doc_663266_134_144_Chemical) (NN %))))) (PP (IN by) (NP (NP (JJ selective) (NN injection)) (PP (IN of) (NP (DT each))))) (PP (IN into) (NP (NP (DT the) (JJ right) (JJ coronary) (NN artery)) (PP (IN of) (NP (NNS dogs))))))) (. .)))
663266	2	(ROOT (SINV (ADJP (JJ Doc_663266_217_227_Chemical)) (VP (VBZ contains) (NP (DT the) (VBG chelating) (NNS agents))) (NP (NP (NNS Doc_663266_258_272_Chemical) (CC and) (NNS Doc_663266_277_293_Chemical)) (, ,) (SBAR (IN while) (S (NP (NNP Hypaque)) (VP (VBZ contains) (NP (NP (NNS Doc_663266_318_342_Chemical)) (CC and) (NP (DT no) (NNS Doc_663266_350_364_Chemical))))))) (. .)))
663266	3	(ROOT (S (NP (NNP Doc_663266_366_390_Disease)) (VP (VBD occurred) (ADVP (RB significantly) (RBR more) (RB often)) (PP (IN with) (NP (NNS Doc_663266_430_440_Chemical))) (, ,) (S (VP (VBG suggesting) (SBAR (IN that) (S (NP (VBG chelating) (NNS agents)) (VP (VBP contribute) (PP (TO to) (NP (NP (NNS Doc_663266_489_497_Disease)) (PP (IN in) (NP (JJ coronary) (NN angiography))))))))))) (. .)))
6637851	0	(ROOT (NP (NP (JJ Long-term) (NN efficacy) (CC and) (NNS Doc_6637851_23_31_Disease)) (PP (IN of) (NP (JJ high-dose) (JJ Doc_6637851_45_55_Chemical) (NN therapy))) (PP (IN for) (NP (NNS Doc_6637851_68_91_Disease) (CC or) (NNS Doc_6637851_95_119_Disease))) (. .)))
6637851	1	(ROOT (S (NP (NNP Doc_6637851_121_131_Chemical)) (VP (VBD was) (VP (VBN administered) (PP (TO to) (NP (CD 154) (NNS patients))) (SBAR (SBAR (WHNP (WP who)) (S (VP (VBD had) (VP (VBN sustained) (, ,) (NP (NP (NP (NP (JJ symptomatic) (NNS Doc_6637851_196_219_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_6637851_221_223_Disease)) (-RRB- -RRB-))) (PRN (-LRB- -LRB-) (VP (VBN n) (S (VP (SYM =) (NP (CD 118))))) (-RRB- -RRB-))) (CC or) (NP (NP (DT a) (NNS Doc_6637851_240_254_Disease)) (PRN (-LRB- -LRB-) (VP (VBN n) (S (VP (SYM =) (NP (CD 36))))) (-RRB- -RRB-)))))))) (CC and) (SBAR (WHNP (WP who)) (S (VP (VBD were) (VP (VBN refractory) (PP (TO to) (NP (JJ conventional) (JJ antiarrhythmic) (NNS drugs)))))))))) (. .)))
6637851	2	(ROOT (S (S (NP (DT The) (NN loading) (NN dose)) (VP (VBD was) (NP (NP (CD 800) (NN mg/day)) (PP (IN for) (NP (CD 6) (NNS weeks)))))) (CC and) (S (NP (DT the) (NN maintenance) (NN dose)) (VP (VBD was) (NP (CD 600) (NN mg/day)))) (. .)))
6637851	3	(ROOT (S (NP (NP (JJ Sixty-nine) (NN percent)) (PP (IN of) (NP (NNS patients)))) (VP (VP (VBD continued) (NP (NN treatment)) (PP (IN with) (NP (NNS Doc_6637851_467_477_Chemical)))) (CC and) (VP (VBD had) (NP (NP (DT no) (NN recurrence)) (PP (IN of) (NP (NP (NP (JJ symptomatic) (NNS Doc_6637851_515_517_Disease) (CC or) (NNS Doc_6637851_521_545_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_6637851_547_549_Disease)) (-RRB- -RRB-))) (PP (IN over) (NP (NP (DT a) (NN follow-up)) (PP (IN of) (NP (QP (CD 6) (TO to) (CD 52)) (NNS months))))) (PRN (-LRB- -LRB-) (S (VP (VB mean) (NP (NP (NNP +) (NNP /)) (PRN (: -) (NP (NP (JJ standard) (NN deviation)) (NP (CD 14.2) (NNS +))) (: /)) (: -) (NP (CD 8.2))))) (-RRB- -RRB-))))))) (. .)))
6637851	4	(ROOT (S (NP (NP (CD Six) (NN percent)) (PP (IN of) (NP (DT the) (NNS patients)))) (VP (VP (VBD had) (NP (NP (DT a) (JJ nonfatal) (NN recurrence)) (PP (IN of) (NP (NNS Doc_6637851_687_689_Disease))))) (CC and) (VP (VBD were) (VP (ADVP (RB successfully)) (VBN managed) (PP (IN by) (NP (NP (VBG continuing) (NNS Doc_6637851_734_744_Chemical)) (PP (PP (IN at) (NP (DT a) (JJR higher) (NN dose))) (CC or) (PP (IN by) (NP (NP (DT the) (NN addition)) (PP (IN of) (NP (DT a) (JJ conventional) (JJ antiarrhythmic) (NN drug))))))))))) (. .)))
6637851	5	(ROOT (S (NP (QP (CD One) (CC or) (JJR more)) (JJ adverse) (NN drug) (NNS reactions)) (VP (VBD occurred) (PP (IN in) (NP (NP (CD 51) (NN %)) (PP (IN of) (NP (NNS patients)))))) (. .)))
6637851	6	(ROOT (S (NP (JJ Adverse) (NNS effects)) (VP (VBD forced) (NP (DT a) (NN reduction)) (PP (IN in) (NP (NP (DT the) (NN dose)) (PP (IN of) (NP (NP (NP (NNS Doc_6637851_934_944_Chemical)) (PP (IN in) (NP (CD 41) (NN %)))) (CC and) (NP (NP (NN discontinuation)) (PP (IN of) (NP (NNS Doc_6637851_975_985_Chemical)))))))) (PP (IN in) (NP (NP (CD 10) (NN %)) (PP (IN of) (NP (NNS patients)))))) (. .)))
6637851	7	(ROOT (S (NP (DT The) (JJS most) (JJ common) (NN symptomatic) (JJ adverse) (NNS reactions)) (VP (VBD were) (NP (NP (NNS Doc_6637851_1057_1063_Disease)) (CC or) (NP (NP (NP (NNS Doc_6637851_1067_1073_Disease)) (PRN (-LRB- -LRB-) (NP (CD 35) (NN %)) (-RRB- -RRB-))) (, ,) (NP (NP (NNS Doc_6637851_1081_1087_Disease) (CC and) (NNS Doc_6637851_1092_1100_Disease)) (PRN (-LRB- -LRB-) (NP (CD 8) (NN %)) (-RRB- -RRB-))) (, ,) (NP (NP (NNS Doc_6637851_1107_1131_Disease)) (PRN (-LRB- -LRB-) (NP (CD 6) (NN %)) (-RRB- -RRB-))) (, ,) (NP (NP (NNS Doc_6637851_1138_1168_Disease)) (PRN (-LRB- -LRB-) (NP (CD 6) (NN %)) (-RRB- -RRB-))) (CC and) (NP (NP (NNS Doc_6637851_1178_1212_Disease)) (PRN (-LRB- -LRB-) (NP (CD 5) (NN %)) (-RRB- -RRB-)))))) (. .)))
6637851	8	(ROOT (S (SBAR (IN Although) (S (NP (JJ large-dose) (NNS Doc_6637851_1239_1249_Chemical)) (VP (VBZ is) (ADJP (RB highly) (JJ effective) (PP (IN in) (NP (NP (DT the) (JJ long-term) (NN treatment)) (PP (IN of) (NP (NNS Doc_6637851_1300_1302_Disease) (CC or) (NNS Doc_6637851_1306_1308_Disease)))))) (S (VP (VBG refractory) (PP (TO to) (NP (JJ conventional) (JJ antiarrhythmic) (NNS drugs)))))))) (, ,) (NP (PRP it)) (VP (VBZ causes) (NP (JJ significant) (NNS Doc_6637851_1380_1388_Disease)) (PP (IN in) (NP (NP (QP (RB approximately) (CD 50)) (NN %)) (PP (IN of) (NP (NNS patients)))))) (. .)))
6637851	9	(ROOT (S (ADVP (RB However)) (, ,) (SBAR (WHADVP (WRB when)) (S (NP (DT the) (NN dose)) (VP (VBZ is) (VP (VBN adjusted) (PP (VBN based) (PP (IN on) (NP (NP (JJ clinical) (NN response)) (CC or) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (JJ adverse) (NNS effects))))))))))) (, ,) (NP (NP (CD 75) (NN %)) (PP (IN of) (NP (NP (NNS patients)) (PP (IN with) (NP (NNS Doc_6637851_1545_1547_Disease) (CC or) (NNS Doc_6637851_1551_1553_Disease)))))) (VP (MD can) (VP (VB be) (VP (ADVP (RB successfully)) (VBN managed) (PP (IN with) (NP (NNS Doc_6637851_1587_1597_Chemical)))))) (. .)))
6674249	0	(ROOT (SBARQ (WHADVP (WRB Why)) (SQ (VP (MD may) (VP (VB Doc_6674249_8_33_Chemical) (S (-LRB- -LRB-) (NP (NNS Doc_6674249_35_39_Chemical)) (-RRB- -RRB-) (VP (VB induce) (NP (NNS Doc_6674249_48_56_Disease)) (PP (IN in) (NP (NN man)))))))) (. ?)))
6674249	1	(ROOT (NP (NP (NNP Report)) (PP (IN of) (NP (DT a) (NN case) (CC and) (NN literature) (NN review))) (. .)))
6674249	2	(ROOT (S (NP (NP (DT A) (NN case)) (PP (IN of) (NP (NP (JJ Doc_6674249_115_135_Disease) (ADJP (JJ due) (PP (TO to) (NP (NP (DT a) (JJ short) (NNS Doc_6674249_151_176_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_6674249_178_182_Chemical)) (-RRB- -RRB-))))) (NN treatment)) (PP (IN in) (NP (DT a) (CD 72) (JJ year-old) (NN patient))) (PP (IN with) (NP (NP (NNS Doc_6674249_224_248_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_6674249_250_253_Disease)) (-RRB- -RRB-))))))) (VP (VBZ is) (VP (VBN described))) (. .)))
6674249	3	(ROOT (S (NP (JJ Pathogenetic) (NNS hypotheses)) (VP (VBP are) (VP (VBN discussed))) (. .)))
6695415	0	(ROOT (S (NP (NNP Doc_6695415_0_19_Disease)) (VP (VBN associated) (PP (IN with) (NP (NP (NNS Doc_6695415_36_55_Chemical)) (PP (IN in) (NP (NN combination))))) (PP (IN with) (NP (NNS Doc_6695415_76_84_Chemical)))) (. .)))
6695415	1	(ROOT (S (NP (NP (NNP Doc_6695415_86_105_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_6695415_107_110_Chemical)) (-RRB- -RRB-))) (VP (VBZ is) (NP (NP (DT a) (NN drug)) (SBAR (WHNP (WDT that)) (S (VP (VBZ has) (VP (VBN been) (VP (VBN associated) (PP (IN with) (NP (NP (JJ serious) (NN side) (NNS effects)) (PP (VBG including) (NP (NNS Doc_6695415_183_189_Disease)))))))))))) (. .)))
6695415	2	(ROOT (S (NP (PRP It)) (VP (VBZ is) (ADVP (RB often)) (VP (VBN combined) (PP (IN with) (NP (NP (NNS Doc_6695415_217_225_Chemical)) (PP (IN in) (NP (NP (NN diet) (NNS preparations)) (CC and) (NP (`` ``) (JJ look-alike) ('' '') (NNS pills)))))))) (. .)))
6695415	3	(ROOT (S (SBAR (IN In) (NN order) (S (VP (TO to) (VP (VB determine) (SBAR (IN if) (S (NP (JJ Doc_6695415_296_299_Chemical) (NN /) (NNS Doc_6695415_300_308_Chemical)) (VP (MD can) (VP (VB lead) (PP (TO to) (NP (NP (NNS Doc_6695415_321_327_Disease)) (PP (IN in) (NP (JJ normotensive) (NNP and/or) (NNP Doc_6695415_351_363_Disease) (NNS rats))))))))))))) (, ,) (NP (PRP we)) (VP (VBZ administered) (NP (NP (DT the) (NN combination)) (PP (IN in) (NP (NP (QP (CD six) (NNS times))) (NP (NP (DT the) (JJ allowed) (JJ human) (NN dose)) (VP (VBN calculated) (PP (IN on) (NP (NP (DT a) (FW per) (NN weight) (NN basis)) (PP (IN for) (NP (NP (DT the) (NNS rats)) (NP (CD two) (NNS times)) (PP (IN per) (NP (NP (NN day)) (PP (IN for) (NP (CD five) (NNS days))))))))))))))) (. .)))
6695415	4	(ROOT (S (NP (NNP Doc_6695415_517_553_Disease)) (VP (VBD was) (VP (VBN noted) (PP (IN in) (NP (NP (CD 18) (NN %)) (PP (IN of) (NP (DT the) (JJ Doc_6695415_578_590_Disease) (NNS rats))))))) (. .)))
6695415	5	(ROOT (FRAG (NP (DT A) (JJ single) (NNS Doc_6695415_606_609_Chemical)) (: /) (S (NP (NP (JJ Doc_6695415_610_618_Chemical) (NN administration)) (PRN (-LRB- -LRB-) (NP (JJ same) (NN dose)) (-RRB- -RRB-))) (VP (VBP lead) (PP (TO to) (NP (NP (JJ acute) (NNS Doc_6695415_660_672_Disease)) (PP (IN in) (NP (PDT both) (DT the) (JJ normotensive) (CC and) (JJ Doc_6695415_702_714_Disease) (NNS animals))))))) (. .)))
6695415	6	(ROOT (S (NP (DT These) (NNS results)) (VP (VBP suggest) (SBAR (IN that) (S (NP (JJ Doc_6695415_751_754_Chemical) (NN /) (NNS Doc_6695415_755_763_Chemical)) (VP (MD can) (VP (VB lead) (PP (TO to) (NP (NP (NNS Doc_6695415_776_795_Disease)) (PP (IN in) (NP (RB previously) (JJ Doc_6695415_810_822_Disease) (NNS animals))))) (SBAR (WHADVP (WRB when)) (S (VP (VBN administered) (PP (IN in) (NP (NP (JJR greater)) (PP (IN than) (NP (DT the) (JJ allowed) (NN dosage))))))))))))) (. .)))
6695415	7	(ROOT (S (NP (NP (DT An) (JJ acute) (NN elevation)) (PP (IN in) (NP (NN blood) (NN pressure)))) (VP (MD may) (VP (VB be) (NP (DT a) (JJ contributing) (NN factor)))) (. .)))
6699841	0	(ROOT (S (VP (VB Doc_6699841_0_24_Disease) (ADJP (JJ due) (PP (TO to) (NP (NNS Doc_6699841_32_40_Chemical))))) (. .)))
6699841	1	(ROOT (S (NP (NP (DT A) (JJ 31-year-old) (NN man)) (PP (IN with) (NP (NNS Doc_6699841_65_85_Disease))) (, ,) (SBAR (WHNP (WP who)) (S (VP (VBD had) (ADVP (RB previously)) (VP (VBN been) (VP (VBN treated) (PP (IN with) (NP (NP (NNS Doc_6699841_124_132_Chemical)) (, ,) (NP (NNS Doc_6699841_134_152_Chemical)) (, ,) (NP (JJ high) (NN dose) (NNS Doc_6699841_164_175_Chemical)) (CC and) (NP (NNS Doc_6699841_180_190_Chemical))))))))) (, ,)) (VP (VBD developed) (NP (NP (NP (NNS Doc_6699841_202_226_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_6699841_228_231_Disease)) (-RRB- -RRB-))) (NP (CD 4) (NNS months))) (PP (IN after) (NP (NP (NN institution)) (PP (IN of) (NP (JJ Doc_6699841_263_271_Chemical) (NN therapy)))))) (. .)))
6699841	2	(ROOT (S (NP (NP (DT No) (JJ other) (NN factor)) (VP (VBG predisposing) (PP (TO to) (NP (NNS Doc_6699841_313_316_Disease))))) (VP (MD could) (VP (VB be) (VP (VBN discovered)))) (. .)))
6699841	3	(ROOT (S (NP (NNP Doc_6699841_338_346_Chemical)) (VP (VBD was) (VP (VBN substituted) (PP (IN for) (NP (NP (NNS Doc_6699841_367_375_Chemical)) (CC and) (NP (NP (DT no) (JJ further) (JJ adverse) (JJ renal) (NNS effects)) (VP (VBN occurred) (PP (IN over) (NP (DT the) (JJ next) (CD 12) (NNS months))))))))) (. .)))
6699841	4	(ROOT (S (NP (PRP We)) (VP (VBP review) (NP (NP (JJ previous) (NNS reports)) (VP (VBG linking) (NP (NNS Doc_6699841_482_485_Disease)) (S (VP (TO to) (VP (VP (VB antiinflammatory) (NP (NN drug) (NN use))) (CC and) (VP (VB discuss) (NP (NP (JJ possible) (NNS advantages)) (PP (IN of) (NP (NNS Doc_6699841_550_558_Chemical)))) (PP (IN in) (NP (NP (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBP have) (VP (VBN experienced) (NP (NNS Doc_6699841_592_606_Disease)) (PP (IN from) (NP (JJ other) (NN antiinflammatory) (NNS agents)))))))))))))))) (. .)))
6728084	0	(ROOT (NP (NP (JJ Nephrotoxic) (NNS effects)) (PP (IN of) (NP (JJ Doc_6728084_23_37_Chemical) (NN treatment))) (PP (IN on) (NP (JJ renal) (NN protein) (NN reabsorption) (CC and) (NN accumulation))) (. .)))
6728084	1	(ROOT (S (S (VP (TO To) (VP (VB quantify) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NNS Doc_6728084_123_133_Chemical) (, ,) (NNS Doc_6728084_135_144_Chemical) (CC and) (NNS Doc_6728084_149_159_Chemical)))) (PP (IN on) (NP (NP (JJ renal) (NN protein) (NN reabsorption)) (CC and) (NP (NN accumulation))))))) (, ,) (NP (DT these) (NNS drugs)) (VP (VBD were) (VP (VBN administered) (PP (TO to) (NP (NP (NP (NNS rats) (NN intraperitoneally)) (PRN (-LRB- -LRB-) (NP (CD 30) (NN mg/kg/day)) (-RRB- -RRB-))) (PP (IN for) (NP (CD 7) (, ,) (CD 14) (CC or) (CD 21))))) (NP (NNS days)))) (. .)))
6728084	2	(ROOT (S (S (VP (VBG Scanning) (NP (NP (NN electron) (NN microscopy)) (PP (IN of) (NP (DT the) (NN glomerular) (NN endothelia)))))) (, ,) (NP (NP (JJ urinary) (NNS measurements)) (PP (IN of) (NP (NP (NNS Doc_6728084_384_390_Chemical)) (, ,) (NP (NNS Doc_6728084_392_401_Chemical)) (, ,)))) (VP (VBZ endogenous) (NP (NP (NN lysozyme)) (, ,) (NP (NP (NNP N-acetyl-beta-D-glucosaminidase)) (PRN (-LRB- -LRB-) (NP (NNP NAG)) (-RRB- -RRB-))) (CONJP (RB as) (RB well) (IN as)) (NP (NN clearance) (CC and) (NN accumulation) (NNS experiments))) (SBAR (IN after) (S (NP (NP (NN i.v.) (NN administration)) (PP (IN of) (NP (NP (JJ egg-white) (NN lysozyme) (CC and) (NNS measurements)) (PP (IN of) (NP (NP (NN inulin) (NN clearance)) (PRN (-LRB- -LRB-) (NP (NNP GFR)) (-RRB- -RRB-))))))) (VP (VBD were) (VP (VBN done) (PP (IN in) (NP (DT each) (NN treatment) (NN group)))))))) (. .)))
6728084	3	(ROOT (S (NP (JJ Doc_6728084_638_648_Chemical) (NN administration)) (VP (VBD decreased) (NP (NP (NN diameter) (, ,) (NN density) (CC and) (NN shape)) (PP (IN of) (NP (JJ endothelial) (NN fenestrae))))) (. .)))
6728084	4	(ROOT (S (NP (NNS Doc_6728084_728_737_Chemical) (CC and) (NNS Doc_6728084_742_752_Chemical)) (VP (VBD appeared) (S (VP (TO to) (VP (VB have) (NP (NP (DT no) (NN effect)) (PP (IN at) (NP (NP (DT the) (NN dose)) (VP (VBN used))))))))) (. .)))
6728084	5	(ROOT (S (NP (DT All) (CD three) (NNS Doc_6728084_808_823_Chemical)) (VP (VBD decreased) (NP (NP (NNP GFR)) (CC and) (NP (NP (VBN increased) (JJ urinary) (NN excretion)) (PP (IN of) (NP (NNS Doc_6728084_873_879_Chemical) (CC and) (NNS Doc_6728084_884_893_Chemical)))))) (. .)))
6728084	6	(ROOT (S (SBAR (IN While) (S (NP (NNS Doc_6728084_901_911_Chemical) (CC and) (NNS Doc_6728084_916_925_Chemical)) (VP (VBD decreased) (NP (NP (DT the) (NN percentage) (NN reabsorption) (CC and) (NN accumulation)) (PP (IN of) (NP (NN lysozyme)))) (PP (IN after) (NP (NP (NN i.v.) (NN administration)) (PP (IN of) (NP (JJ egg-white) (NN lysozyme) (NNS Doc_6728084_1041_1051_Chemical)))))))) (VP (VBD had) (NP (DT no) (NN effect))) (. .)))
6728084	7	(ROOT (S (NP (NP (JJ Daily) (NN excretion)) (PP (IN of) (NP (NP (JJ total) (NN protein)) (, ,) (NP (JJ endogenous) (NN lysozyme)) (CC and) (NP (NNP NAG))))) (VP (VBD increased) (ADVP (RB only)) (PP (IN after) (NP (NN treatment))) (PP (IN with) (NP (NNS Doc_6728084_1165_1174_Chemical) (CC and) (NNS Doc_6728084_1179_1189_Chemical)))) (. .)))
6728084	8	(ROOT (S (ADVP (RB Thus)) (, ,) (NP (NNS Doc_6728084_1197_1212_Chemical)) (VP (MD may) (VP (VB act) (PP (IN as) (S (NP (NP (NNS nephrotoxicants)) (PP (IN at) (NP (NN glomerular) (NNP and/or) (JJ tubular) (NN level)))) (VP (VBG inducing) (NP (NP (NNS Doc_6728084_1284_1316_Disease) (CC and) (NN accumulation)) (PP (IN of) (NP (NNS proteins))))))))) (. .)))
6732043	0	(ROOT (NP (NP (NNP Induction)) (PP (IN of) (NP (DT the) (NNS Doc_6732043_17_49_Disease))) (PP (IN in) (NP (NP (DT a) (NN woman)) (PP (IN by) (NP (JJ exogenous) (JJ Doc_6732043_74_82_Chemical) (NN administration))))) (. .)))
6732043	1	(ROOT (S (NP (PRP We)) (VP (VBN documented) (ADJP (RB airway) (JJ occlusion) (PP (IN during) (NP (NP (NN sleep)) (CC and) (NP (NP (DT an) (ADJP (RB abnormally) (JJ high)) (JJ supraglottic) (NN resistance)) (SBAR (IN while) (FRAG (ADJP (RB awake)))))))) (PP (IN in) (NP (NP (DT a) (JJ 54-yr-old) (NN woman)) (SBAR (WHNP (WP who)) (S (VP (VBD had) (VP (VBN developed) (NP (NP (JJ physical) (NNS changes)) (CC and) (NP (DT the) (NNS Doc_6732043_266_301_Disease))) (SBAR (IN while) (S (S (VP (VBG being) (VP (VBN administered)))) (VP (VBZ exogenous) (NP (NNS Doc_6732043_337_346_Chemical)))))))))))) (. .)))
6732043	2	(ROOT (S (SBAR (WHADVP (WRB When)) (S (NP (DT the) (NNS Doc_6732043_357_366_Chemical)) (VP (VBD were) (VP (VBN withdrawn))))) (, ,) (S (NP (NP (NP (DT the) (NN patient) (POS 's)) (JJ physical) (NNS changes)) (, ,) (NP (NNS symptoms)) (, ,)) (VP (VBP sleep) (NP (NN study)))) (, ,) (CC and) (S (NP (JJ supraglottic) (NN resistance)) (ADVP (DT all)) (VP (VBD returned) (PP (TO to) (ADJP (JJ normal))))) (. .)))
6732043	3	(ROOT (S (NP (NP (DT A) (NN rechallenge)) (PP (IN with) (NP (NNS Doc_6732043_509_517_Chemical)))) (VP (VBD produced) (NP (NP (NNS symptoms)) (PP (IN of) (NP (NP (NNS Doc_6732043_539_562_Disease)) (SBAR (WHNP (WDT that)) (S (VP (VBN abated) (PP (IN upon) (NP (NP (NN withdrawal)) (PP (IN of) (NP (DT the) (NN hormone)))))))))))) (. .)))
6732043	4	(ROOT (S (NP (JJ Previous) (NNS reports)) (VP (VBP have) (VP (VBN favored) (NP (NP (DT a) (NN role)) (PP (IN of) (NP (NNS Doc_6732043_647_656_Chemical)))) (PP (IN in) (NP (NP (DT the) (NNS pathogenesis)) (PP (IN of) (NP (NNS Doc_6732043_680_691_Disease))))))) (. .)))
6732043	5	(ROOT (S (NP (PRP$ Our) (NN report)) (VP (VBZ provides) (NP (NP (JJ direct) (NN evidence)) (PP (IN for) (NP (DT this) (NN role))))) (. .)))
6732043	6	(ROOT (S (NP (ADJP (JJ Structural) (CC and) (JJ functional)) (NNS measurements)) (VP (VBP indicate) (SBAR (IN that) (S (NP (NNS Doc_6732043_797_806_Chemical)) (VP (VBP exert) (NP (NP (DT a) (ADJP (JJ permissive) (CC or) (JJ necessary)) (NN action)) (PP (IN on) (NP (NP (DT the) (JJ structural) (NN configuration)) (PP (IN of) (NP (NP (DT the) (NN oropharynx)) (SBAR (WHNP (WDT that)) (S (VP (VBZ predisposes) (PP (TO to) (NP (NN obstruction))) (PP (IN during) (NP (NN sleep))))))))))))))) (. .)))
6732043	7	(ROOT (S (NP (NP (NNP Development)) (PP (IN of) (NP (DT the) (NNS Doc_6732043_961_993_Disease)))) (VP (MD must) (VP (VB be) (VP (VBN considered) (NP (NP (DT a) (JJ possible) (NN side) (NN effect)) (PP (IN of) (NP (JJ Doc_6732043_1039_1047_Chemical) (NN therapy))))))) (. .)))
6769133	0	(ROOT (S (NP (NP (NNP Doc_6769133_0_11_Disease)) (CC and) (NP (NP (NP (NP (JJ possible) (JJ leukemogenic) (NNS effects)) (PP (IN of) (SBAR (WHNP (NP (JJ Doc_6769133_49_59_Chemical)) (PP (IN in) (NP (NN nonhuman) (NNS primates)) (. .))) (S (NP (NP (CD 10) (NNS monkeys)) (PRN (-LRB- -LRB-) (NP (NNS macaques)) (-RRB- -RRB-))) (VP (VBD received) (NP (NNS Doc_6769133_113_123_Chemical)) (PP (IN by) (NP (JJ monthly) (JJ intravenous) (NNS injections))) (PP (IN at) (NP (CD 12) (NNS mg/m2)))))))) (-LRB- -LRB-) (NP (CD 1) (NN mg/kg)) (-RRB- -RRB-)) (. .) (NP (NP (CD 8)) (PP (IN of) (NP (DT the) (CD 10) (NNS monkeys)))))) (VP (VBD developed) (NP (NNS Doc_6769133_211_235_Disease)) (PP (IN at) (NP (NP (DT an) (JJ average) (JJ cumulative) (JJ Doc_6769133_261_271_Chemical) (NN dose)) (PRN (-LRB- -LRB-) (NP (QP (CD 310) (CD mg/m2))) (-RRB- -RRB-)))) (PP (RB well) (IN below) (NP (NP (DT that)) (VP (VBN considered) (NP (NP (DT the) (JJ safe) (JJ upper) (NN limit)) (PRN (-LRB- -LRB-) (NP (CD 550) (NNS mg/m2)) (-RRB- -RRB-))) (PP (IN in) (NP (NN man))))))) (. .)))
6769133	1	(ROOT (S (ADVP (RB Histologically)) (, ,) (NP (DT the) (NNS Doc_6769133_377_395_Disease)) (VP (VBD resembled) (SBAR (S (NP (DT those)) (VP (VBD found) (PP (IN in) (NP (JJ human) (NNS Doc_6769133_427_440_Chemical-induced))) (NP (NP (NNP Doc_6769133_449_463_Disease) (. .)) (SBAR (S (NP (NP (CD 1)) (PP (IN of) (NP (DT the) (CD 10) (NNS monkeys)))) (VP (VBD developed) (NP (NNS Doc_6769133_495_522_Disease)) (PP (IN after) (S (VP (VBG receiving) (NP (NP (NP (NP (JJ 324) (NNS mg/m2)) (PP (IN of) (NP (NNS Doc_6769133_552_562_Chemical)))) (: ;) (S (NP (DT the) (JJ 10th) (NN monkey)) (VP (VBZ is) (ADJP (JJ alive))))) (CC and) (ADVP (RB well) (NP (CD 26) (NNS months)) (PP (IN after) (NP (NP (DT the) (JJ last) (NN dose)) (PP (IN of) (NP (NN drug)))))))))))))))))) (. .)))
6769133	2	(ROOT (S (NP (PRP$ Our) (NNS results)) (VP (VBP suggest) (SBAR (SBAR (IN that) (S (NP (NNS Doc_6769133_662_672_Chemical)) (VP (VBZ is) (NP (NP (DT a) (ADJP (RBR more) (JJ potent)) (NN cardiotoxin)) (PP (IN in) (NP (NP (NNS monkeys)) (PP (IN than) (PP (IN in) (NP (NN man)))))))))) (, ,) (CC and) (SBAR (IN that) (S (NP (NNS Doc_6769133_735_743_Disease)) (VP (MD may) (VP (VB be) (NP (NP (DT a) (NN consequence)) (PP (IN of) (NP (NP (VBN prolonged) (NN treatment)) (PP (IN with) (NP (DT this) (NN drug)))))))))))) (. .)))
6794356	0	(ROOT (NP (NP (JJ Doc_6794356_0_29_Disease) (CC and) (JJ Doc_6794356_34_51_Chemical) (NNS Doc_6794356_52_60_Disease)) (PP (IN in) (NP (DT a) (JJ newborn) (NN infant))) (. .)))
6794356	1	(ROOT (S (NP (DT A) (ADJP (JJ newborn) (PP (IN with) (NP (NP (JJ massive) (NNS Doc_6794356_105_128_Disease)) (, ,) (NP (NNS Doc_6794356_130_144_Disease)) (, ,) (NP (NNS Doc_6794356_146_170_Disease)) (, ,) (CC and) (NP (DT a) (JJ high) (NN serum))))) (JJ Doc_6794356_189_196_Chemical) (NN level)) (VP (VBZ is) (VP (VBN described))) (. .)))
6794356	2	(ROOT (S (S (NP (DT This)) (VP (VBZ is) (NP (DT the) (JJ first) (NN patient) (S (VP (TO to) (VP (ADVP (RB initially)) (VB manifest) (NP (NNS Doc_6794356_265_288_Disease) (CC and) (NNS Doc_6794356_293_307_Disease)))))))) (, ,) (CC and) (S (NP (DT the) (NN 11th)) (VP (VBD described) (NP (NN patient)) (PP (IN with) (NP (NNS Doc_6794356_345_360_Disease))) (PP (IN among) (NP (NP (NNS infants)) (VP (VBN exposed) (PP (TO to) (NP (JJ Doc_6794356_386_393_Chemical) (NNS compounds))) (PP (IN in) (NP (NP (DT the) (JJ first) (NN trimester)) (PP (IN of) (NP (NN pregnancy)))))))))) (. .)))
6794356	3	(ROOT (S (NP (NP (JJ Sixty-three) (NN percent)) (PP (IN of) (NP (DT these) (NNS infants)))) (VP (VBD had) (VP (VBN tricuspid) (NP (NN valve) (NN involvement)))) (. .)))
6794356	4	(ROOT (S (NP (NNP Doc_6794356_511_528_Chemical)) (VP (MD may) (VP (VB be) (NP (NP (DT a) (NN factor)) (PP (IN in) (NP (NP (DT the) (VBG increasing) (NN incidence)) (PP (IN of) (NP (NNS Doc_6794356_576_600_Disease)))))) (SBAR (WHADVP (WRB when)) (S (VP (VBN taken) (PP (IN during) (NP (JJ early) (NN pregnancy)))))))) (. .)))
6794356	5	(ROOT (S (NP (PRP It)) (ADVP (RB also)) (VP (VBZ causes) (NP (NP (NNS Doc_6794356_651_672_Disease)) (, ,) (NP (NNS Doc_6794356_674_682_Disease)) (, ,) (CC and) (NP (NNS Doc_6794356_688_706_Disease))) (SBAR (WHADVP (WRB when)) (S (VP (VBN consumed) (PP (RB prior) (PP (TO to) (NP (NN delivery)))))))) (. .)))
6817363	0	(ROOT (NP (NP (NNPS Effects)) (PP (IN of) (NP (DT the) (JJ novel) (JJ compound) (NNS Doc_6817363_30_40_Chemical))) (PRN (-LRB- -LRB-) (NP (NNP Doc_6817363_42_52_Chemical)) (-RRB- -RRB-)) (PP (IN upon) (NP (NP (NNS Doc_6817363_59_87_Disease)) (PP (IN in) (NP (NNS rodents))))) (. .)))
6817363	1	(ROOT (S (NP (NP (DT The) (NN effect)) (PP (IN of) (NP (NP (NNS Doc_6817363_114_124_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (NNS Doc_6817363_126_136_Chemical)) (, ,) (NP (NNS Doc_6817363_138_163_Chemical))) (-RRB- -RRB-))))) (VP (VBD was) (VP (VP (VBN studied) (PP (IN on) (NP (NP (JJ various) (NNS forms)) (PP (IN of) (NP (NP (NP (JJ experimentally) (NNS Doc_6817363_212_240_Disease)) (PRN (-LRB- -LRB-) (NP (NP (NN learning)) (CC and) (NP (NN memory))) (-RRB- -RRB-))) (PP (IN in) (NP (NNS rodents)))))))) (CC and) (VP (VBN produced) (NP (NP (DT the) (VBG following) (NNS effects)) (: :) (NP (NP (LST (-LRB- -LRB-) (LS 1) (-RRB- -RRB-)) (NP (RB almost) (JJ complete) (NN prevention)) (PP (IN of) (NP (NP (DT the) (ADJP (JJ incapacity) (S (VP (TO to) (VP (VB learn) (NP (DT a) (JJ discrete) (NN escape) (NN response)) (PP (IN in) (NP (NP (NNS rats)) (VP (VBN exposed) (S (VP (TO to) (VP (VB sublethal) (NP (NNS Doc_6817363_424_435_Disease)) (PP (ADVP (RB immediately)) (IN before) (NP (DT the) (NN acquisition) (NN session))) (: ;) (PRN (-LRB- -LRB-) (NP (CD 2)) (-RRB- -RRB-)) (NP (NP (JJ partial) (-LRB- -LRB-) (NNS rats) (-RRB- -RRB-)) (CC or) (NP (NP (JJ complete) (PRN (-LRB- -LRB-) (NP (NNS mice)) (-RRB- -RRB-)) (NN prevention)) (PP (IN of) (NP (DT the) (JJ Doc_6817363_536_547_Chemical-induced) (JJ short-term) (NNS Doc_6817363_567_574_Disease))))) (PP (IN for) (NP (NP (DT a) (JJ passive) (NN avoidance) (NN task)) (: ;) (NP (NP (LST (-LRB- -LRB-) (LS 3) (-RRB- -RRB-)) (NP (JJ complete) (NN protection)) (PP (IN against) (NP (NP (NNS Doc_6817363_637_644_Disease)) (PP (IN for) (NP (NP (DT a) (JJ passive) (NN avoidance) (NN task)) (PP (IN in) (NP (NP (NNS rats)) (VP (VBN submitted) (S (VP (TO to) (VP (VB electroconvulsive) (NP (NN shock)) (ADVP (RB immediately)) (PP (IN after) (NP (NN avoidance) (NN acquisition)))))))))))))) (: ;) (NP (LST (-LRB- -LRB-) (LS 4) (-RRB- -RRB-)) (NP (NN prevention)) (PP (IN of) (NP (DT the) (JJ long-term) (NN retention)))) (: -) (CC or) (NP (NP (NN retrieval-deficit)) (PP (IN for) (NP (NP (DT a) (JJ passive) (NN avoidance) (NN task)) (VP (VBN induced) (PP (IN in) (NP (NNS rats) (CC and) (NNS mice))) (PP (IN by) (NP (NP (NNS Doc_6817363_881_896_Chemical) (CC or) (NNS Doc_6817363_900_913_Chemical)) (VP (VBN administered) (ADVP (RB immediately)) (PP (IN after) (NP (NN acquisition))))))))))) (: ;))))))))) (PRN (-LRB- -LRB-) (NP (CD 5)) (-RRB- -RRB-)))))) (NN reversal)) (, ,) (SBAR (WHADVP (WRB when)) (S (NP (NP (ADJP (VBN administered) (PP (IN as) (NP (NP (JJ late)) (PP (IN as) (NP (NP (CD 1) (NN h)) (PP (IN before) (NP (DT the) (NN retention) (NN test))) (, ,) (PP (IN of) (NP (NP (DT the) (NN deficit)) (PP (IN in) (NP (NN retention) (CC or) (NN retrieval))) (PP (IN of) (NP (NP (DT a) (JJ passive) (NN avoidance) (NN task)) (VP (VBN induced) (PP (IN by) (NP (NP (NNS Doc_6817363_1112_1125_Chemical)) (VP (VBN injected) (NP (CD 2) (NNS days) (RB previously)))))))))) (: ;))) (PRN (-LRB- -LRB-) (NP (CD 6)) (-RRB- -RRB-))))) (NN prevention)) (PP (IN of) (NP (NP (DT the) (NN deficit)) (PP (IN in) (NP (NP (DT the) (NN retrieval)) (PP (IN of) (NP (DT an) (JJ active) (NN avoidance) (NN task))))))) (VP (VBN induced) (PP (IN in) (NP (NNS mice))) (PP (IN by) (NP (JJ subconvulsant) (NN electroshock) (CC or) (NNS Doc_6817363_1278_1289_Disease))))) (VP (VBD applied) (ADVP (RB immediately)) (PP (IN before) (NP (NN retrieval) (NN testing))))))))) (PRN (-LRB- -LRB-) (NP (NP (CD 24) (NN h)) (PP (IN after) (NP (NN acquisition)))) (-RRB- -RRB-))))))) (. .)))
6817363	2	(ROOT (S (NP (NP (DT These) (NNS improvements) (CC or) (NNS normalizations)) (PP (IN of) (NP (NNS Doc_6817363_1401_1429_Disease)))) (VP (VBD were) (VP (VBN seen) (PP (IN at) (NP (NP (JJ oral) (JJ Doc_6817363_1448_1458_Chemical) (NNS doses)) (PP (IN of) (NP (CD 10-100) (NN mg/kg))))))) (. .)))
6817363	3	(ROOT (S (ADVP (RB Generally)) (, ,) (NP (DT the) (JJ dose-response) (NNS curves)) (VP (VBD were) (ADJP (JJ bell-shaped))) (. .)))
6817363	4	(ROOT (S (NP (NP (DT The) (NNS mechanisms)) (VP (VBG underlying) (NP (NP (DT the) (NN activity)) (PP (IN of) (NP (NP (NNS Doc_6817363_1578_1588_Chemical)) (CC and) (NP (PRP$ its) (`` `) (JJ therapeutic) (NN window) ('' '))))))) (VP (VBP are) (ADJP (JJ unknown))) (. .)))
6817363	5	(ROOT (S (ADVP (RB Doc_6817363_1631_1640_Chemical)) (, ,) (NP (DT another) (JJ Doc_6817363_1650_1663_Chemical) (NN derivative)) (VP (VBD was) (VP (VBN used) (PP (IN for) (NP (NN comparison))))) (. .)))
6817363	6	(ROOT (S (NP (PRP It)) (VP (VP (VBD was) (ADJP (JJ active)) (PP (RB only) (IN in) (NP (NP (CD six)) (PP (IN of) (NP (CD nine) (NNS tests)))))) (CC and) (VP (VBD had) (NP (NP (QP (RB about) (CD one-tenth)) (DT the) (NN potency)) (PP (IN of) (NP (NNS Doc_6817363_1779_1789_Chemical)))))) (. .)))
6817363	7	(ROOT (S (NP (DT The) (NNS results)) (VP (VBP indicate) (SBAR (IN that) (S (NP (NNS Doc_6817363_1817_1827_Chemical)) (VP (VBZ improves) (NP (NP (JJ cognitive) (NNS functions)) (SBAR (WHNP (WDT which)) (S (VP (VBP are) (VP (VBN impaired) (PP (PP (IN by) (NP (JJ different) (NN procedure))) (CC and) (PP (IN in) (NP (NP (JJ different) (NNS phases)) (PP (IN of) (NP (DT the) (NN learning) (CC and) (NN memory) (NN process))))))))))))))) (. .)))
6892185	0	(ROOT (S (NP (NP (NN Effect)) (PP (IN of) (NP (NP (NNS Doc_6892185_10_26_Chemical)) (PP (IN on) (NP (JJ gross) (JJ behavioural) (NNS changes)))))) (VP (VBD produced) (PP (IN by) (NP (NNS Doc_6892185_68_77_Chemical) (CC and) (NNS Doc_6892185_82_89_Chemical))) (PP (IN in) (NP (NNS cats)))) (. .)))
6892185	1	(ROOT (S (NP (NP (DT The) (NN effect)) (PP (IN of) (NP (NP (NP (NP (NNS Doc_6892185_113_129_Chemical)) (VP (VBN injected) (PP (IN into) (NP (NP (DT the) (JJ cerebral) (NNS ventricles)) (PP (IN of) (NP (JJ group-housed) (JJ unanaesthetized) (NNS cats))))) (PP (IN upon) (NP (NN vocalization))))) (-LRB- -LRB-) (NP (NN rage) (, ,) (NN hissing) (CC and) (NN snarling)) (-RRB- -RRB-)) (, ,) (NP (NP (VBG fighting)) (PRN (-LRB- -LRB-) (NP (NP (NP (NN attack)) (PP (IN with) (NP (NNS paws) (CC and) (NNS claws)))) (, ,) (NP (NP (NN defense)) (PP (IN with) (NP (NNS paws) (CC and) (NNS claws)))) (CC and) (NP (NNP biting))) (-RRB- -RRB-))) (, ,) (NP (NP (NNS Doc_6892185_332_341_Disease) (, ,) (NNS Doc_6892185_343_349_Disease) (CC and) (NNS Doc_6892185_354_378_Disease)) (VP (VBN produced) (PP (IN by) (NP (NP (NNS Doc_6892185_391_400_Chemical) (CC and) (NNS Doc_6892185_405_412_Chemical)) (VP (VBN injected) (ADVP (RB similarly)))))))))) (VP (VBD was) (VP (VBN investigated))) (. .)))
6892185	2	(ROOT (S (NP (NNP Doc_6892185_450_466_Chemical)) (VP (VP (VBD depressed)) (CC or) (VP (VP (ADVP (RB almost) (RB completely)) (VBD abolished) (NP (DT the) (NN vocalization))) (CC and) (VP (VBG fighting) (ADJP (JJ due) (PP (TO to) (NP (NNS Doc_6892185_545_554_Chemical) (CC and) (NNS Doc_6892185_559_566_Chemical))))))) (. .)))
6892185	3	(ROOT (S (PP (IN On) (NP (DT the) (JJ other) (NN hand))) (, ,) (NP (NP (NNS Doc_6892185_587_596_Disease) (, ,) (NNS Doc_6892185_598_604_Disease) (CC and) (NNS Doc_6892185_609_633_Disease)) (VP (VBN evoked) (PP (IN by) (NP (NNS Doc_6892185_644_653_Chemical) (CC and) (NNS Doc_6892185_658_665_Chemical))))) (VP (VBD were) (RB not) (VP (ADVP (RB significantly)) (VBN changed) (PP (IN by) (NP (NNS Doc_6892185_700_716_Chemical))))) (. .)))
6892185	4	(ROOT (S (NP (PRP It)) (VP (VBZ is) (ADJP (JJ apparent)) (SBAR (IN that) (S (NP (NNS Doc_6892185_738_754_Chemical)) (VP (MD can) (VP (`` ``) (VB dissociate) ('' '') (NP (NN vocalization) (CC and) (NN fighting)) (PP (IN from) (NP (NP (NN autonomic) (CC and) (NN motor) (NNS phenomena)) (PP (JJ such) (IN as) (NP (NP (NNS Doc_6892185_841_850_Disease) (, ,) (NNS Doc_6892185_852_858_Disease) (CC and) (NNS Doc_6892185_863_887_Disease)) (VP (VBN caused) (PP (IN by) (NP (NNS Doc_6892185_898_907_Chemical) (CC and) (NNS Doc_6892185_912_919_Chemical))))))))))))) (. .)))
6892185	5	(ROOT (S (NP (NNP Doc_6892185_921_937_Chemical)) (VP (VBD inhibited) (SBAR (S (NP (DT the) (NN vocalization) (CC and) (NN fighting)) (VP (VBD produced) (PP (IN by) (NP (NNS Doc_6892185_990_999_Chemical) (CC and) (NNS Doc_6892185_1004_1011_Chemical))) (ADVP (RBS most) (RB probably)) (PP (IN by) (NP (NP (DT a) (JJ nonspecific) (VBG stabilizing) (NN action)) (PP (IN on) (NP (JJ central) (JJ muscarinic) (NN cholinoceptive) (NNS sites))))))))) (. .)))
6892185	6	(ROOT (S (NP (DT These) (NNS results)) (ADVP (RB further)) (VP (VBP support) (NP (DT the) (NN view)) (SBAR (IN that) (S (NP (NP (JJ Doc_6892185_1150_1157_Chemical) (NNS ions)) (PP (IN in) (NP (NN excess)))) (VP (VBP have) (NP (DT an) (NN Doc_6892185_1181_1189_Chemical-like) (NN action)) (ADVP (RB also)) (PP (IN in) (NP (DT the) (JJ central) (JJ nervous) (NN system))))))) (. .)))
6942642	0	(ROOT (NP (NP (JJ Doc_6942642_0_8_Chemical) (NNS diuretics)) (, ,) (NP (NNS Doc_6942642_20_31_Disease) (CC and) (NNS Doc_6942642_36_55_Disease)) (. .)))
6942642	1	(ROOT (S (NP (JJ Doc_6942642_57_65_Chemical) (NNS diuretics)) (VP (VBP are) (ADVP (RB widely)) (VP (VBN accepted) (PP (IN as) (NP (NP (DT the) (NN cornerstone)) (PP (IN of) (NP (JJ antihypertensive) (NN treatment) (NNS programs))))))) (. .)))
6942642	2	(ROOT (S (NP (NNP Doc_6942642_155_166_Disease)) (VP (VBZ is) (NP (NP (DT a) (ADJP (RB commonly) (JJ encountered)) (JJ metabolic) (NN consequence)) (PP (IN of) (NP (JJ chronic) (JJ Doc_6942642_226_234_Chemical) (NN therapy))))) (. .)))
6942642	3	(ROOT (S (NP (PRP We)) (VP (VBD treated) (NP (NP (NP (CD 38) (NNS patients)) (PRN (-LRB- -LRB-) (NP (NP (CD 22) (JJ low) (NN renin)) (, ,) (NP (CD 16) (JJ normal) (NN renin))) (-RRB- -RRB-))) (PP (IN with) (NP (JJ moderate) (NNS Doc_6942642_313_335_Disease)))) (PP (IN with) (NP (NP (NNS Doc_6942642_341_360_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_6942642_362_366_Chemical)) (-RRB- -RRB-)) (VP (VBN administered) (PP (IN on) (NP (DT a) (RB twice) (JJ daily) (NN schedule))))))) (. .)))
6942642	4	(ROOT (S (S (NP (JJ Initial) (NN dose)) (VP (VBD was) (NP (CD 50) (NN mg)))) (CC and) (S (NP (DT the) (NN dose)) (VP (VBD was) (VP (VBN increased) (PP (IN at) (NP (JJ monthly) (NNS intervals))) (PP (TO to) (NP (NP (CD 100) (NN mg)) (, ,) (NP (CD 150) (NN mg)) (CC and) (NP (CD 200) (NN mg)))) (SBAR (ADVP (RB daily)) (IN until) (S (NP (NN blood) (NN pressure)) (VP (VBD normalized))))))) (. .)))
6942642	5	(ROOT (S (S (NP (NP (DT The) (NNP serum) (NNP K)) (PP (IN during) (NP (DT the) (NN control) (NN period)))) (VP (VBD was) (NP (NP (QP (CD 4.5) (CD +)) (NNS /)) (PRN (: -) (NP (NP (ADJP (CD 0.2) (JJ mEq/l)) (DT an)) (PP (IN on) (NP (NP (CD 50) (, ,) (CD 100) (, ,) (CD 150) (CC and) (CD 200) (NN mg) (NNS Doc_6942642_637_641_Chemical)) (ADVP (RB daily) (NP (CD 3.9) (NNS +)))))) (: /))))) (: -) (FRAG (FRAG (NP (CD 0.3)) (, ,) (NP (CD 3.4) (CD +)) (: /)) (: -) (FRAG (FRAG (NP (CD 0.2)) (, ,) (NP (CD 2.9) (CD +)) (: /)) (: -) (FRAG (FRAG (NP (CD 0.2)) (, ,) (PP (CC and) (NP (CD 2.4) (NNS +))) (: /)) (: -) (FRAG (NP (CD 0.3) (NN mEq/l)) (, ,) (ADVP (RB respectively)))))) (. .)))
6942642	6	(ROOT (S (S (VP (VBG Corresponding) (NP (NNS figures)) (PP (IN for) (NP (JJ whole) (NN body))))) (NP (NNP K)) (VP (VBD were) (NP (NP (ADJP (ADJP (QP (CD 4107) (CD +))) (PRN (: /) (FRAG (FRAG (ADJP (NP (NNP -) (CD 208) (, ,) (CD 3722)) (JJ +)) (: /)) (: -) (FRAG (FRAG (INTJ (UH 319)) (, ,) (NP (CD 3628) (CD +)) (: /)) (: -) (FRAG (INTJ (UH 257)) (, ,) (NP (CD 3551) (CD +)) (: /)))) (: -))) (NNS 336)) (, ,) (CC and) (NP (NP (QP (CD 3269) (CD +)) (NNS /)) (: -) (NP (QP (CD 380) (CD mEq))))) (, ,) (ADVP (RB respectively))) (. .)))
6942642	7	(ROOT (S (PP (IN In) (NP (CD 13) (NNS patients))) (NP (PRP we)) (VP (VBD observed) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NP (JJ Doc_6942642_902_906_Chemical) (NN therapy)) (PRN (-LRB- -LRB-) (NP (CD 100) (NN mg) (NN daily)) (-RRB- -RRB-))))) (PP (IN on) (NP (NP (DT the) (NN occurrence)) (PP (IN of) (NP (NNP PVC) (POS 's))))) (PP (PP (IN during) (NP (NN rest))) (CONJP (RB as) (RB well) (IN as)) (PP (IN during) (NP (JJ static) (CC and) (JJ dynamic) (NN exercise))))) (. .)))
6942642	8	(ROOT (S (PP (IN During) (NP (NN rest))) (NP (PRP we)) (VP (VBD observed) (NP (NP (NP (NP (NP (CD 0.6) (JJ +) (NNS /)) (PRN (: -) (NP (CD 0.08) (NNP PVC) (NN beats/min) (NNS +)) (: /))) (PRN (: -) (UCP (ADVP (RB SEM)) (CC and) (PP (IN during) (NP (JJ static) (CC and) (JJ dynamic) (NN exercise) (NN 0.6) (NNS +)))) (: /))) (PRN (: -) (NP (NP (CD 0.06)) (CC and) (NP (CD 0.8) (NNS +))) (: /))) (: -) (NP (CD 0.15)) (, ,)) (ADVP (RB respectively))) (. .)))
6942642	9	(ROOT (S (NP (NP (JJ Corresponding) (NNS figures)) (PP (IN during) (NP (JJ Doc_6942642_1188_1192_Chemical) (NN therapy) (CD 100) (NN mg)))) (ADVP (RB daily)) (VP (VBD were) (NP (NP (NP (NP (QP (CD 1.4) (CD +)) (NNS /)) (PRN (: -) (NP (NP (CD 0.1)) (, ,) (NP (CD 3.6) (NNS +))) (: /))) (PRN (: -) (NP (NP (CD 0.7)) (CC and) (NP (CD 5.7) (CD 4))) (: /))) (: -) (NP (CD 0.8)) (, ,)) (ADVP (RB respectively))) (. .)))
6942642	10	(ROOT (S (NP (NP (DT The) (NN occurrence)) (PP (IN of) (NP (NP (NNP PVC) (POS 's)) (JJ correlated) (ADJP (RB significantly) (PP (IN with) (NP (NP (DT the) (NN fall)) (PP (IN in) (NP (NNP serum) (NNP K)))))) (NN +)))) (VP (VBD observed) (S (NP (SYM r)) (VP (SYM =) (NP (CD 0.72)))) (, ,) (S (VP (VB p) (NP (QP (JJR less) (IN than) (CD 0.001)))))) (. .)))
6942642	11	(ROOT (S (PP (IN In) (NP (NN conclusion))) (NP (PRP we)) (VP (VBD found) (SBAR (IN that) (S (NP (NNS Doc_6942642_1416_1424_Chemical)) (VP (VBZ diuretics) (NP (NP (NN cause) (NNS Doc_6942642_1441_1452_Disease) (CC and) (NN depletion)) (PP (IN of) (NP (NN body) (NNS Doc_6942642_1475_1484_Chemical)))))))) (. .)))
6942642	12	(ROOT (NP (NP (DT The) (JJR more) (JJ profound) (NNS Doc_6942642_1504_1515_Disease)) (, ,) (NP (NP (DT the) (JJR greater)) (NP (NP (DT the) (NN propensity)) (PP (IN for) (NP (NP (DT the) (NN occurrence)) (PP (IN of) (NP (NNP PVC) (POS 's))))))) (. .)))
7007443	0	(ROOT (S (VP (VBG Circulating) (NP (JJ lysosomal) (NNS enzymes) (CC and) (NNS Doc_7007443_34_56_Disease))) (. .)))
7007443	1	(ROOT (S (NP (NP (DT The) (NNS activities)) (PP (IN of) (NP (NP (DT the) (JJ lysosomal) (NNS enzymes) (NN acid) (CC and) (JJ neutral) (NN protease)) (, ,) (NP (NNP N-acetylglucosaminidase)) (, ,) (CC and) (NP (JJ acid) (NN phosphatase))))) (VP (VBD were) (VP (VBN measured) (PP (IN in) (NP (NP (DT the) (NN serum)) (PP (IN of) (NP (NP (NNS patients)) (PP (IN with) (NP (NNS Doc_7007443_215_240_Disease))))))))) (. .)))
7007443	2	(ROOT (S (NP (ADJP (ADJP (JJ Acid) (JJ protease)) (PRN (-LRB- -LRB-) (NP (NNP cathepsin) (NNP D)) (-RRB- -RRB-))) (NN activity)) (VP (VBD was) (VP (VP (VBN increased) (PP (IN about) (ADVP (RB tenfold))) (PP (IN in) (NP (NP (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBD died))))))) (CC and) (VP (ADVP (RB nearly)) (VBN fourfold) (PP (IN in) (NP (NP (DT those)) (SBAR (WHNP (WP who)) (S (VP (VBD survived) (NP (NNS Doc_7007443_370_395_Disease)) (PP (IN after) (NP (JJ Doc_7007443_402_413_Chemical) (NNS Doc_7007443_414_422_Disease))) (, ,) (SBAR (IN whereas) (S (NP (NNS activities)) (VP (VBD were) (VP (VBN increased) (ADVP (RB equally)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (NNS Doc_7007443_483_508_Disease)) (ADJP (JJ due) (PP (TO to) (NP (NNS Doc_7007443_516_531_Disease)))))))) (SBAR (IN whether) (CC or) (RB not) (S (NP (PRP they)) (VP (VBD survived)))))))))))))))) (. .)))
7007443	3	(ROOT (S (S (NP (DT A) (NN correlation)) (VP (VBD was) (VP (VBN found) (PP (IN between) (NP (NN serum) (JJ acid) (JJ protease) (NN activity) (CC and) (NN prothrombin) (NN time)))))) (, ,) (CC and) (S (NP (NP (DT the) (NN increase)) (PP (IN in) (NP (JJ cathepsin) (NNP D) (NN activity)))) (VP (VBD was) (VP (VBN sustained) (PP (IN over) (NP (JJ several) (NNS days))) (PP (VBN compared) (PP (IN with) (NP (NP (JJ Doc_7007443_732_741_Chemical) (NN aminotransferase)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD showed) (NP (NP (DT a) (JJ sharp) (JJ early) (NN peak)) (CC and) (ADVP (RB then)) (NP (DT a) (NN fall)))))))))))) (. .)))
7007443	4	(ROOT (S (S (NP (VBG Circulating) (JJ lysosomal) (NNS proteases)) (VP (MD can) (VP (VB damage) (NP (JJ other) (NNS organs))))) (, ,) (CC and) (S (NP (NP (NN measurement)) (PP (IN of) (NP (PRP$ their) (NN activity)))) (VP (MD may) (ADVP (RB therefore)) (VP (VB be) (PP (IN of) (NP (VBN added) (NN value))) (PP (IN in) (S (VP (VBG assessing) (NP (NN prognosis)) (PP (IN in) (NP (DT this) (NN condition))))))))) (. .)))
7053705	0	(ROOT (S (NP (NNP Doc_7053705_0_30_Disease)) (VP (VBD caused) (PP (IN by) (NP (NNS Doc_7053705_41_54_Chemical)))) (. .)))
7053705	1	(ROOT (S (NP (ADJP (RB Clinically) (JJ reversible)) (NNS Doc_7053705_78_113_Disease)) (VP (VBD developed) (PP (IN in) (NP (NP (DT a) (JJ 23-year-old) (NN man)) (PP (IN with) (NP (NNS Doc_7053705_150_176_Disease))))) (PP (IN after) (NP (NP (CD 10) (NNS months)) (PP (IN of) (NP (NN maintenance) (NN therapy))))) (PP (IN with) (NP (NNS Doc_7053705_221_234_Chemical)))) (. .)))
7053705	2	(ROOT (S (NP (JJ Serial) (NN liver) (NNS biopsies)) (VP (VBD showed) (NP (NP (DT the) (NN development) (CC and) (NN resolution)) (PP (IN of) (NP (JJ intense) (JJ sinusoidal) (NN engorgement))))) (. .)))
7053705	3	(ROOT (S (SBAR (IN Although) (S (NP (DT this) (NN disease)) (VP (VBD was) (ADJP (RB clinically) (JJ reversible))))) (, ,) (NP (NP (DT some) (JJ subintimal) (NNS Doc_7053705_396_404_Disease)) (PP (IN about) (NP (DT the) (ADJP (JJ terminal) (JJ hepatic)) (NNS veins)))) (VP (VBD persisted)) (. .)))
7053705	4	(ROOT (S (NP (DT This) (NN case)) (VP (VP (VBD presented) (NP (DT a) (JJ unique) (NN opportunity)) (S (VP (TO to) (VP (VB observe) (NP (NP (DT the) (JJ histologic) (NNS features)) (PP (IN of) (NP (ADJP (RB clinically) (JJ reversible)) (NNS Doc_7053705_550_580_Disease)))) (PP (IN over) (NP (NN time))))))) (, ,) (CC and) (VP (MD may) (VP (VB be) (NP (NP (DT the) (JJ first) (NN case)) (PP (IN of) (NP (NP (NN veno-occlusive)) (VP (VBN related) (ADVP (RB solely)) (PP (TO to) (NP (NNS Doc_7053705_654_667_Chemical)))))))))) (. .)))
7059267	0	(ROOT (NP (CD Doc_7059267_0_14_Chemical-induced) (NNS Doc_7059267_23_39_Disease) (. .)))
7059267	1	(ROOT (S (NP (NP (DT A) (JJ 65-year-old) (NN woman)) (PP (IN with) (NP (NP (NNS Doc_7059267_66_86_Disease)) (VP (VBN treated) (PP (IN with) (NP (NP (NNS Doc_7059267_100_114_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_7059267_116_125_Chemical)) (-RRB- -RRB-)))))))) (VP (VBD had) (NP (NP (DT a) (NNS Doc_7059267_133_155_Disease)) (SBAR (WHNP (WDT that)) (S (VP (VBN resolved) (PP (IN with) (NP (NP (NN discontinuation)) (PP (IN of) (NP (JJ Doc_7059267_194_208_Chemical) (NN therapy)))))))))) (. .)))
7059267	2	(ROOT (S (S (NP (NNP Doc_7059267_218_229_Disease)) (VP (VBZ occurs) (PP (IN in) (NP (NP (NNS Doc_7059267_240_249_Disease)) (PP (IN for) (NP (NP (DT a) (NN variety)) (PP (IN of) (NP (NNS reasons))))))))) (, ,) (CC and) (S (NP (ADJP (JJ accurate)) (NN diagnosis)) (VP (VBZ is) (ADJP (JJ necessary) (S (VP (TO to) (VP (VB institute) (NP (JJ appropriate) (NN therapy)))))))) (. .)))
7059267	3	(ROOT (S (NP (NP (DT The) (NN possibility)) (PP (IN of) (NP (DT a) (JJ drug-induced) (NNS Doc_7059267_380_396_Disease)))) (VP (MD should) (VP (VB be) (VP (VBN considered) (PP (IN in) (NP (NP (DT the) (NN differential) (NN diagnosis)) (PP (IN of) (NP (NP (NNS Doc_7059267_451_462_Disease)) (PP (IN in) (NP (NNS Doc_7059267_466_475_Disease)))))))))) (. .)))
7066357	0	(ROOT (S (NP (NP (NNP Plasma)) (CC and) (NP (NP (JJ urinary) (NNS lipids) (CC and) (NNS lipoproteins)) (PP (IN during) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (NNS Doc_7066357_69_87_Disease))))))) (VP (VBN induced) (PP (IN in) (NP (DT the) (NN rat))) (PP (IN by) (NP (NNS Doc_7066357_110_135_Chemical)))) (. .)))
7066357	1	(ROOT (S (NP (DT This) (NN study)) (VP (VBD was) (VP (VBN undertaken) (S (VP (TO to) (VP (VB ascertain) (SBAR (IN whether) (S (NP (NP (DT the) (NNS alterations)) (PP (IN of) (NP (NP (NN plasma) (NNS lipoproteins)) (VP (VBN found) (PP (IN in) (NP (NP (NNS Doc_7066357_232_250_Disease)) (VP (VBN induced) (PP (IN by) (NP (NNS Doc_7066357_262_287_Chemical)))))))))) (VP (VBD were) (ADJP (JJ due) (S (VP (TO to) (VP (VB Doc_7066357_300_318_Disease) (UCP (ADVP (FW per) (FW se)) (, ,) (CC or) (PRN (, ,) (PP (ADVP (IN at) (JJS least)) (IN in) (NP (NN part))) (, ,)) (PP (TO to) (NP (DT the) (NNS Doc_7066357_356_371_Chemical)))))))))))))))) (. .)))
7066357	2	(ROOT (S (NP (NP (DT The) (NN purpose)) (PP (IN of) (NP (DT the) (JJ present) (NN study)))) (VP (VBD was) (S (VP (TO to) (VP (VB investigate) (NP (NP (DT the) (NNS changes)) (PP (IN in) (NP (NN plasma) (CC and) (NN urinary) (NNS lipoproteins)))) (PP (IN during) (NP (NP (NP (DT the) (NN administration)) (PP (IN of) (NP (NP (NNS Doc_7066357_501_526_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (CD 20) (NN mg/kg)) (PP (IN for) (NP (CD 7) (NNS days)))) (-RRB- -RRB-))))) (CC and) (NP (NP (DT the) (JJ subsequent) (NN development)) (PP (IN of) (NP (NNS Doc_7066357_583_601_Disease)))))))))) (. .)))
7066357	3	(ROOT (S (SBAR (IN Since) (S (NP (JJ massive) (NNS Doc_7066357_617_628_Disease)) (VP (VBD occurred) (PP (IN after) (NP (NP (CD 6) (NNS days)) (PP (IN of) (NP (NN treatment)))))))) (, ,) (NP (DT the) (JJ time-course) (NN study)) (VP (VBD was) (VP (VBN divided) (PP (IN into) (NP (NP (CD two) (NNS stages)) (: :) (NP (NP (NP (JJ pre-Doc_7066357_720_729_Disease) (NN stage)) (PRN (-LRB- -LRB-) (NP (NN day) (CD 1-5)) (-RRB- -RRB-))) (CC and) (NP (NP (JJ Doc_7066357_750_759_Disease) (NN stage)) (PRN (-LRB- -LRB-) (NP (NN day) (CD 6-11)) (-RRB- -RRB-)))))))) (. .)))
7066357	4	(ROOT (S (PP (IN In) (NP (JJ pre-Doc_7066357_785_794_Disease) (NN stage))) (NP (NP (DT the) (NN plasma) (NN level)) (PP (IN of) (NP (NNP Doc_7066357_821_832_Chemical) (, ,) (NNP Doc_7066357_834_849_Chemical) (CC and) (NNP VLDL)))) (VP (VBD decreased) (SBAR (IN while) (S (NP (NP (DT that)) (PP (IN of) (NP (NNP phospholipid) (, ,) (NNP Doc_7066357_897_915_Chemical) (CC and) (NNP HDL)))) (VP (VBD remained) (ADJP (JJ constant)))))) (. .)))
7066357	5	(ROOT (S (NP (NNP Plasma) (NNP apolipoprotein) (NNP A-I)) (VP (VBD tended) (S (VP (TO to) (VP (VB increase) (PRN (-LRB- -LRB-) (NP (NP (ADJP (CD 40) (NN %)) (NN increase)) (PP (IN at) (NP (NN day) (CD 5)))) (-RRB- -RRB-)))))) (. .)))
7066357	6	(ROOT (S (PP (IN At) (NP (NP (DT the) (NN beginning)) (PP (IN of) (NP (NP (JJ Doc_7066357_1033_1042_Disease) (NN stage)) (PRN (-LRB- -LRB-) (NP (NN day) (CD 6)) (-RRB- -RRB-)))))) (NP (NP (DT the) (NN concentration)) (PP (IN of) (NP (NN plasma) (NN albumin)))) (VP (VBD dropped) (PP (TO to) (NP (DT a) (ADJP (RB very) (JJ low)) (NN level))) (, ,) (SBAR (IN while) (S (NP (NP (DT that)) (PP (IN of) (NP (NNP apolipoprotein) (NNP A-I)))) (VP (VP (VBN increased) (ADVP (RB abruptly)) (PRN (-LRB- -LRB-) (NP (JJ 4-fold) (NN increase)) (-RRB- -RRB-))) (CC and) (VP (VBN continued) (S (VP (TO to) (VP (VB rise) (PP (PRN (, ,) (SBAR (IN although) (FRAG (ADJP (RBR less) (JJ steeply)))) (, ,)) (IN in) (NP (DT the) (VBG following) (NNS days))))))))))) (. .)))
7066357	7	(ROOT (S (NP (NP (DT The) (NN plasma) (NN concentration)) (PP (IN of) (NP (NNP HDL)))) (VP (VBD followed) (NP (DT the) (JJ same) (NN pattern))) (. .)))
7066357	8	(ROOT (S (NP (NNP Plasma) (NNP VLDL) (CC and) (NNP LDL)) (VP (VBD increased) (PP (IN at) (NP (NP (DT a) (JJ later) (NN stage)) (PRN (-LRB- -LRB-) (NP (NN day) (CD 9)) (-RRB- -RRB-))))) (. .)))
7066357	9	(ROOT (S (NP (NNP Plasma) (NNP apolipoprotein) (NNP A-I)) (VP (VBD was) (VP (VBN found) (PP (CONJP (RB not) (JJ only)) (PP (IN in) (NP (NNP HDL))) (PRN (-LRB- -LRB-) (S (NP (CD 1.063-1) (CD .210)) (VP (VBP g/ml))) (-RRB- -RRB-)) (CC but) (RB also) (PP (IN in) (NP (NP (DT the) (NNP LDL) (NN density) (NN class)) (PRN (-LRB- -LRB-) (S (NP (CD 1.025-1) (CD .050)) (VP (VBP g/ml))) (-RRB- -RRB-))))))) (. .)))
7066357	10	(ROOT (S (PP (IN In) (NP (DT the) (JJ pre-Doc_7066357_1512_1521_Disease) (NN stage))) (NP (NN lipoproteinuria)) (VP (VBD was) (ADJP (JJ negligible)) (, ,) (SBAR (IN while) (S (PP (IN in) (NP (DT the) (JJ early) (JJ Doc_7066357_1579_1588_Disease) (NN stage))) (NP (NP (DT the) (JJ urinary) (NN loss)) (PP (IN of) (NP (NN plasma) (NNS lipoproteins)))) (VP (VBD consisted) (ADVP (RB mainly)) (PP (IN of) (NP (NNP HDL))))))) (. .)))
7066357	11	(ROOT (S (NP (DT These) (NNS observations)) (VP (VBP indicate) (SBAR (IN that) (S (NP (NNS Doc_7066357_1693_1718_Chemical)) (VP (VBZ alters) (NP (NN plasma) (NNS lipoproteins)) (PP (IN by) (S (VP (VP (VBG lowering) (NP (NNP VLDL))) (CC and) (VP (VBG increasing) (NP (NNP HDL)))))))))) (. .)))
7066357	12	(ROOT (S (NP (PRP It)) (VP (VBZ is) (ADJP (JJ likely)) (SBAR (IN that) (S (NP (NP (DT the) (ADJP (JJ early) (CC and) (JJ striking)) (NN increase)) (PP (IN of) (NP (NP (NNP plasma) (NNP HDL)) (VP (VBN found) (PP (IN in) (NP (JJ Doc_7066357_1856_1865_Disease) (NNS rats))))))) (VP (VBZ is) (ADJP (VBN related) (PP (TO to) (NP (NP (DT a) (JJ direct) (NN effect)) (PP (IN of) (NP (NP (DT the) (NN drug)) (PP (IN on) (NP (NNP HDL) (NN metabolism)))))))))))) (. .)))
7072798	0	(ROOT (NP (NP (JJ Fatal) (NNS Doc_7072798_6_21_Disease)) (PP (VBG following) (NP (NP (JJ topical) (NN administration)) (PP (IN of) (NP (JJ ophthalmic) (NNS Doc_7072798_69_84_Chemical))))) (. .)))
7072798	1	(ROOT (S (NP (DT A) (JJ 73-year-old) (NN woman)) (VP (VBD died) (PP (IN of) (NP (NNS Doc_7072798_114_129_Disease))) (SBAR (NP (QP (JJR less) (IN than) (CD two)) (NNS months)) (IN after) (S (S (VP (VBG undergoing) (NP (JJ Doc_7072798_168_176_Disease) (NN extraction)))) (CC and) (S (VP (VBG beginning) (NP (JJ topical) (NN therapy)) (PP (IN with) (NP (NNS Doc_7072798_223_238_Chemical)))))))) (. .)))
7072798	2	(ROOT (S (NP (NP (DT The) (JJ first) (NNS signs)) (PP (IN of) (NP (NNS Doc_7072798_259_271_Disease)))) (VP (VBD began) (PP (IN within) (NP (NP (CD one) (NN month)) (PP (IN of) (NP (DT the) (NN surgery)))))) (. .)))
7072798	3	(ROOT (S (NP (NP (DT The) (NN pattern)) (PP (IN of) (NP (DT the) (NNS Doc_7072798_330_345_Disease)))) (VP (VBD was) (VP (VBN associated) (PP (IN with) (NP (DT an) (JJ idiosyncratic) (NN response))) (PP (TO to) (NP (NNS Doc_7072798_395_410_Chemical))))) (. .)))
7072798	4	(ROOT (S (NP (DT This)) (VP (VBD was) (NP (NP (DT the) (JJ second) (NN report)) (PP (IN of) (NP (JJ fatal) (NNS Doc_7072798_448_463_Disease)))) (PP (IN after) (NP (NP (JJ topical) (NN treatment)) (PP (IN with) (NP (NP (NNS Doc_7072798_493_508_Chemical)) (PP (IN for) (NP (NN ocular) (NNS conditions))))))) (, ,) (SBAR (IN although) (S (NP (NP (CD two) (NNS cases)) (PP (IN of) (NP (JJ reversible) (NNS Doc_7072798_565_587_Disease)))) (VP (VBP have) (ADVP (RB also)) (VP (VBN been) (VP (VBN reported))))))) (. .)))
7072798	5	(ROOT (S (NP (NP (DT Any) (JJ other) (VBN suspected) (NNS cases)) (PP (IN of) (NP (NP (NNS Doc_7072798_642_657_Disease)) (VP (VBN associated) (PP (IN with) (NP (JJ topically) (JJ applied) (NNS Doc_7072798_692_707_Chemical))))))) (VP (MD should) (VP (VB be) (VP (VBN reported) (PP (TO to) (NP (NP (DT the) (NNP National) (NNP Registry)) (PP (IN of) (NP (NP (JJ Drug-Induced) (NNP Ocular) (NNP Side) (NNPS Effects)) (, ,) (NP (NP (NNP Oregon) (NNP Health) (NNPS Sciences)) (NP (NAC (NNP University) (, ,) (NNP Portland) (, ,)) (NNP OR) (NNP 97201)))))))))) (. .)))
7102237	0	(ROOT (S (NP (NNP Doc_7102237_0_9_Chemical)) (VP (VBD compared) (PP (IN with) (NP (NNS Doc_7102237_24_35_Chemical))) (PP (IN as) (NP (DT an) (NN induction) (NN agent)))) (. .)))
7102237	1	(ROOT (S (PP (IN In) (NP (NP (NNS patients)) (VP (VBN premedicated) (PP (IN with) (NP (JJ Doc_7102237_89_100_Chemical) (JJ +) (NNS Doc_7102237_103_111_Chemical))) (PRN (-LRB- -LRB-) (NP (NP (CD +5) (NN mg) (NNS Doc_7102237_119_129_Chemical)) (NP (DT the) (NN evening))) (PP (IN before) (NP (NN surgery))) (-RRB- -RRB-))))) (, ,) (NP (NP (DT the) (JJ sleep-inducing) (NN effect)) (PP (IN of) (NP (NN Doc_7102237_188_197_Chemical) (CD 0.15) (NN mg/kg) (NN i.v.)))) (VP (VBD was) (ADJP (ADJP (RB clearly) (JJR slower)) (PP (IN in) (NP (NN onset)))) (PP (IN than) (S (NP (NP (DT that)) (PP (IN of) (NP (NNP Doc_7102237_255_266_Chemical) (CD 4.67)))) (VP (VBG mg/kg) (NP (NP (NNP i.v.) (NNP Somewhat)) (SBAR (S (S (NP (NP (JJR fewer) (JJ cardiovascular)) (CC and) (NP (JJ local) (NN sequelae))) (VP (VBD were) (VP (VBN found) (PP (IN in) (NP (DT the) (JJ Doc_7102237_350_359_Chemical) (NN group)))))) (, ,) (CC but) (, ,) (S (SBAR (IN although) (S (NP (NN apnoea)) (VP (VBD occurred) (ADVP (RBR less) (RB often)) (PP (IN in) (NP (DT the) (JJ Doc_7102237_415_424_Chemical) (NN group)))))) (NP (PRP it)) (VP (VBD lasted) (ADVP (RBR longer))))))))))) (. .)))
7102237	2	(ROOT (S (PP (IN On) (NP (DT the) (NN whole))) (, ,) (NP (NP (DT the) (NNS differences)) (PP (IN between) (NP (NNS Doc_7102237_487_496_Chemical) (CC and) (NNS Doc_7102237_501_512_Chemical)))) (VP (VBD had) (NP (DT no) (JJ apparent) (JJ clinical) (NNS consequences))) (. .)))
7102237	3	(ROOT (S (NP (NNP Doc_7102237_552_561_Chemical)) (VP (VBZ is) (NP (NP (DT a) (JJ new) (NN alternative) (NN agent)) (PP (IN for) (NP (NP (NN induction)) (PP (IN in) (NP (NN combination) (NN anaesthesia))))))) (. .)))
7161250	0	(ROOT (NP (NP (NP (JJ Extrapyramidal) (NN side) (NNS effects)) (CC and) (NP (JJ oral) (NNS Doc_7161250_37_48_Chemical))) (: :) (NP (NP (DT an) (NN analysis)) (PP (IN of) (NP (JJ explanatory) (NN patient) (CC and) (NN treatment) (NNS characteristics)))) (. .)))
7161250	1	(ROOT (S (NP (NP (NP (DT The) (NN incidence)) (PP (IN of) (NP (JJ extrapyramidal) (NN side) (NNS effects)))) (PRN (-LRB- -LRB-) (NP (NNP EPS)) (-RRB- -RRB-))) (VP (VBD was) (VP (VBN evaluated) (PP (IN in) (NP (NP (CD 98) (NNS patients)) (VP (VBN treated) (PP (IN with) (NP (NNS Doc_7161250_209_220_Chemical)))))))) (. .)))
7161250	2	(ROOT (S (NP (NP (DT The) (NN incidence)) (PP (IN of) (NP (NNS Doc_7161250_239_251_Disease)))) (VP (VBD was) (ADJP (JJR higher)) (PP (PP (IN at) (NP (NP (JJR higher) (NNS doses)) (PP (IN of) (NP (NNS Doc_7161250_282_293_Chemical))))) (CC and) (PP (IN in) (NP (JJR younger) (NNS patients))))) (. .)))
7161250	3	(ROOT (S (NP (JJ Prophylactic) (NN antiparkinsonian) (NN medication)) (VP (VBD was) (ADJP (JJ effective)) (PP (PP (IN in) (NP (JJR younger))) (CONJP (CC but) (RB not)) (PP (IN in) (NP (JJR older) (NNS patients))))) (. .)))
7161250	4	(ROOT (S (ADVP (RB However)) (, ,) (NP (DT these) (NNS medications)) (VP (VBD were) (ADJP (RBR more) (JJ effective) (PP (IN in) (NP (ADJP (DT both) (JJ young) (CC and) (JJ old)) (NNS patients)))) (SBAR (WHADVP (WRB when)) (S (VP (VBN given) (PP (IN after) (NP (NP (NNS Doc_7161250_507_519_Disease)) (VP (VBN developed)))))))) (. .)))
7161250	5	(ROOT (S (NP (NNP Doc_7161250_531_540_Disease)) (VP (VBD was) (VP (VBN controlled) (PP (IN by) (NP (NP (DT the) (JJ Doc_7161250_563_577_Chemical) (NNS Doc_7161250_578_587_Chemical)) (PP (IN in) (NP (NP (CD 14)) (PP (RB out) (IN of) (NP (CD 16) (NNS patients))))))) (, ,) (SBAR (IN while) (S (NP (JJ prophylactic) (NNS antiparkinsonians)) (VP (VBD were) (ADJP (JJ ineffective))))))) (. .)))
7161250	6	(ROOT (S (NP (DT The) (JJ present) (NN study)) (VP (VBZ points) (PP (TO to) (NP (NP (JJ patient) (NNS characteristics)) (SBAR (WHNP (WDT that)) (S (VP (MD may) (VP (VB be) (PP (IN of) (NP (NN significance))) (PP (IN in) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (NP (NNP EPS)) (ADJP (JJ due) (PP (TO to) (NP (NNS Doc_7161250_782_793_Chemical))))))))))))))) (. .)))
7189975	0	(ROOT (NP (NP (NNP Deaths)) (PP (IN from) (NP (JJ local) (JJ anesthetic-induced) (NNS Doc_7189975_37_48_Disease))) (PP (IN in) (NP (NNS mice))) (. .)))
7189975	1	(ROOT (S (NP (NP (NP (JJ Median) (NN convulsant)) (PRN (-LRB- -LRB-) (NP (NNP CD50)) (-RRB- -RRB-))) (CC and) (NP (NP (JJ median) (ADJP (ADJP (JJ lethal)) (PRN (-LRB- -LRB-) (NP (NNP LD50)) (-RRB- -RRB-))) (NNS doses)) (PP (IN of) (NP (CD three) (JJ representative) (JJ local) (NNS anesthetics))))) (VP (VBD were) (VP (VBN determined) (PP (IN in) (NP (JJ adult) (NNS mice))) (S (VP (TO to) (VP (VB evaluate) (NP (DT the) (NN threat)) (PP (TO to) (NP (NP (NN life)) (PP (IN of) (NP (JJ local) (JJ anesthetic-induced) (NNS Doc_7189975_245_256_Disease)))))))))) (. .)))
7189975	2	(ROOT (S (NP (DT The) (NNP CD50) (CC and) (NNP LD50)) (, ,) (ADVP (RB respectively)) (, ,) (VP (VBD were) (NP (NP (QP (CD 57.7) (CC and) (CD 58.7))) (VP (VBG mg/kg) (PP (IN for) (NP (NP (NP (NNS Doc_7189975_320_331_Chemical)) (, ,) (NP (NP (QP (CD 111.0) (CC and) (CD 133.1)) (NN mg/kg)) (PP (IN for) (NP (NNS Doc_7189975_359_368_Chemical))))) (, ,) (CC and) (NP (QP (CD 243.4) (CC and) (CD 266.5))))) (S (VP (VBG mg/kg) (PP (IN for) (NP (NNS Doc_7189975_400_414_Chemical)))))))) (. .)))
7189975	3	(ROOT (S (SBAR (WHADVP (WRB When)) (S (VP (VBN given) (ADVP (RB intraperitoneally))))) (, ,) (NP (NNS Doc_7189975_446_457_Chemical)) (ADVP (RB thus)) (VP (VBD was) (ADJP (ADVP (RB only) (NP (QP (RB about) (JJ twice) (IN as) (CD toxic))) (PP (IN as) (NP (NP (NNS Doc_7189975_496_505_Chemical)) (CC and) (NP (CD four) (NNS times))))) (RB as) (JJ toxic)) (PP (IN as) (NP (NNS Doc_7189975_533_547_Chemical)))) (. .)))
7189975	4	(ROOT (S (NP (NNP Doc_7189975_549_560_Disease)) (ADVP (RB always)) (VP (VBN preceded) (NP (NN death)) (, ,) (PP (IN except) (IN after) (NP (NP (JJ precipitous) (NNS Doc_7189975_609_631_Disease)) (PP (IN from) (NP (JJ extreme) (NNS doses)))))) (. .)))
7189975	5	(ROOT (S (NP (NP (NP (DT A) (NN CD50) (NN dose)) (PP (IN of) (NP (JJ local) (NN anesthetic)))) (PRN (-LRB- -LRB-) (NP (NP (VBG causing) (NNS Doc_7189975_693_704_Disease)) (PP (IN in) (NP (NP (CD 50) (NN %)) (PP (IN of) (NP (NNS mice)))))) (-RRB- -RRB-))) (VP (VBD was) (ADJP (JJ fatal) (PP (IN in) (NP (NP (CD 90) (NN %)) (PP (IN of) (NP (NN Doc_7189975_741_752_Chemical-induced) (NNS Doc_7189975_761_769_Disease)))))) (, ,) (PP (PP (IN in) (NP (NP (CD 57) (NN %)) (PP (IN of) (NP (DT the) (JJ Doc_7189975_785_799_Chemical) (NN group))))) (, ,) (CC and) (PP (IN in) (NP (NP (CD 6) (NN %)) (PP (IN of) (NP (DT the) (JJ Doc_7189975_824_833_Chemical) (NN group))))))) (. .)))
7189975	6	(ROOT (S (NP (NP (DT The) (JJ narrow) (NN gap)) (PP (IN between) (NP (NP (ADJP (JJ convulsant) (CC and) (JJ lethal)) (NNS doses)) (PP (IN of) (NP (JJ local) (NNS anesthetics)))))) (VP (VBZ indicates) (SBAR (IN that) (S (NP (JJ untreated) (NNS Doc_7189975_938_949_Disease)) (ADJP (JJ present) (ADVP (RB much) (RBR more)) (PP (IN of) (NP (DT a) (NN threat))) (PP (TO to) (NP (NP (NN life)) (SBAR (IN than) (FRAG (RB heretofore)))))) (S (VP (VBN appreciated)))))) (. .)))
7197363	0	(ROOT (S (NP (NNP Doc_7197363_0_21_Disease)) (VP (VBZ changes) (NP (JJ behavioral) (NN response)) (PP (TO to) (NP (NP (ADJP (JJ catecholaminergic) (CC and) (JJ serotonergic)) (NN receptor) (NN activation)) (PP (IN in) (NP (NNS rats)))))) (. .)))
7197363	1	(ROOT (S (NP (NP (DT The) (NNS effects)) (PP (IN of) (NP (NP (NP (NNS Doc_7197363_132_153_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_7197363_155_159_Disease)) (-RRB- -RRB-))) (PP (IN on) (NP (NN Doc_7197363_164_175_Chemical-induced) (NNS Doc_7197363_184_198_Disease) (CC and) (NN Doc_7197363_203_212_Chemical-induced) (NNS Doc_7197363_221_234_Disease))) (PP (IN in) (NP (NNS rats)))))) (VP (VBD were) (VP (VBN determined))) (. .)))
7197363	2	(ROOT (S (NP (NP (JJ Forty-eight) (NN hr)) (PP (IN of) (NP (NNS Doc_7197363_278_282_Disease)))) (VP (VP (VP (VBD increased) (NP (NN Doc_7197363_293_304_Chemical-induced) (NNS Doc_7197363_313_327_Disease))) (, ,) (CC and) (VP (VBN reduced) (PRN (-LRB- -LRB-) (ADVP (RB immediately) (PP (IN after) (S (VP (VBG completing) (PP (IN of) (NP (NNS Doc_7197363_374_378_Disease))))))) (-RRB- -RRB-)))) (CC or) (VP (VBD increased) (NP (PRN (-LRB- -LRB-) (NP (NP (CD 96) (NN hr)) (PP (IN after) (NP (NNP completing))) (PP (IN of) (NP (NNS Doc_7197363_420_424_Disease)))) (-RRB- -RRB-)) (JJ Doc_7197363_426_435_Chemical-induced) (NNS Doc_7197363_444_457_Disease)))) (. .)))
7197363	3	(ROOT (S (NP (NNS Results)) (VP (VBP are) (VP (VBN discussed) (PP (IN in) (NP (NP (NNS terms)) (PP (IN of) (NP (NN similarity))))) (PP (TO to) (NP (NP (JJ pharmacological) (NNS effects)) (PP (IN of) (NP (JJ other) (NN antidepressive) (NNS treatments))))))) (. .)))
7263204	0	(ROOT (NP (NP (NP (JJ Fatal) (NNS Doc_7263204_6_21_Disease)) (ADJP (JJ due) (PP (TO to) (NP (NNS Doc_7263204_29_41_Chemical))))) (: --) (NP (NP (JJ lymphocyte) (NN transformation) (NNS tests)) (PP (IN in) (NP (NNP vitro)))) (. .)))
7263204	1	(ROOT (S (SBAR (IN Although) (S (NP (NNS Doc_7263204_94_106_Chemical)) (VP (VBZ has) (VP (VBN been) (VP (VBN implicated) (PP (IN as) (NP (NP (DT a) (JJ possible) (NN cause)) (PP (IN of) (NP (NP (NNS Doc_7263204_150_165_Disease)) (PP (IN on) (NP (NP (DT the) (NN basis)) (PP (IN of) (NP (DT a) (JJ few) (JJ clinical) (NNS observations)))))))))))))) (, ,) (NP (PRP$ its) (NN role)) (VP (VBZ has) (RB not) (VP (VBN been) (VP (ADVP (RB definitely)) (VBN established)))) (. .)))
7263204	2	(ROOT (S (NP (NP (DT A) (NN case)) (PP (IN of) (NP (JJ fatal) (NNS Doc_7263204_273_288_Disease)))) (VP (VBZ is) (VP (VBN described) (PP (IN in) (SBAR (WHNP (WDT which)) (S (NP (DT no) (NNS drugs)) (ADVP (JJ other) (PP (IN than) (NP (NNS Doc_7263204_331_342_Chemical) (CC and) (NNS Doc_7263204_347_359_Chemical)))) (VP (VBD were) (VP (VBN given)))))))) (. .)))
7263204	3	(ROOT (S (NP (NNP Doc_7263204_372_384_Chemical)) (VP (VBD was) (ADVP (RB first)) (VP (VBN given) (PP (ADVP (NP (CD four) (NNS weeks)) (RB prior)) (TO to) (NP (NP (DT the) (NN onset)) (PP (IN of) (NP (NNS symptoms))))))) (. .)))
7263204	4	(ROOT (S (NP (NP (DT A) (JJ positive) (JJ lymphocyte) (NN transformation) (NN test)) (PP (IN with) (NP (NP (NNS Doc_7263204_491_503_Chemical)) (PP (IN in) (NP (NNP vitro)))))) (ADVP (RB further)) (VP (VBZ substantiates) (NP (NP (DT the) (JJ potential) (NN role)) (PP (IN of) (NP (NP (DT this) (NN drug)) (PP (IN in) (S (VP (VBG causing) (NP (NNS Doc_7263204_578_593_Disease)) (PP (IN in) (NP (DT a) (ADJP (JJ susceptible)) (NN patient)))))))))) (. .)))
7263204	5	(ROOT (S (ADVP (RB Fortunately)) (, ,) (NP (DT this)) (VP (VBZ seems) (S (VP (TO to) (VP (VB be) (NP (DT a) (ADJP (RB very) (JJ rare)) (NN complication)))))) (. .)))
7282516	0	(ROOT (NP (NP (JJ Dose-effect) (CC and) (JJ structure-function) (NNS relationships)) (PP (IN in) (NP (JJ Doc_7282516_52_63_Chemical) (NNS Doc_7282516_64_78_Disease))) (. .)))
7282516	1	(ROOT (S (NP (NP (NP (DT The) (NNS Doc_7282516_84_98_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_7282516_100_102_Disease)) (-RRB- -RRB-))) (VP (VBN produced) (PP (IN by) (NP (NP (NP (DT the) (JJ anticancer) (NN drug) (NNS Doc_7282516_136_147_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_7282516_149_152_Chemical)) (-RRB- -RRB-))) (PRN (-LRB- -LRB-) (NP (NNP Doc_7282516_155_165_Chemical)) (-RRB- -RRB-)))))) (VP (VBZ provides) (NP (DT a) (JJ unique) (NN opportunity) (S (VP (TO to) (VP (VB analyze) (NP (JJ dose-effect) (CC and) (JJ structure-function) (NNS relationships)) (PP (IN during) (NP (NP (NN development)) (PP (IN of) (NP (NNS Doc_7282516_279_297_Disease)))))))))) (. .)))
7282516	2	(ROOT (S (NP (PRP We)) (VP (VBD measured) (NP (NP (DT the) (NN degree)) (PP (IN of) (NP (JJ morphologic) (NN damage)))) (PP (IN by) (NP (NP (NP (JJ ultrastructural) (NN examination)) (PP (IN of) (NP (JJ endomyocardial) (NN biopsy)))) (CC and) (NP (NP (DT the) (NN degree)) (PP (IN of) (NP (NN performance) (NN abnormally)))))) (PP (IN by) (NP (JJ right) (NN heart) (NN catheterization))) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NNS Doc_7282516_494_497_Chemical)))))) (. .)))
7282516	3	(ROOT (S (NP (JJ Morphologic) (NN damage)) (VP (VP (VBD was) (ADJP (JJ variable))) (CC but) (VP (VBD was) (VP (VBN proportional) (PP (TO to) (NP (NP (DT the) (JJ total) (JJ cumulative) (JJ Doc_7282516_576_579_Chemical) (NN dose)) (PP (IN between) (NP (QP (CD 100) (CC and) (CD 600)) (NNS mg/m2)))))))) (. .)))
7282516	4	(ROOT (S (NP (NNP Performance) (NNS abnormalities)) (VP (VP (VBD correlated) (ADVP (RB weakly)) (PP (IN with) (NP (NN dose)))) (, ,) (VP (VBD exhibited) (NP (DT a) (NN curvilinear) (NN relationship))) (, ,) (CC and) (VP (VBD had) (NP (NP (DT a) (`` ``) (NN threshold) ('' '')) (PP (IN for) (NP (NN expression)))))) (. .)))
7282516	5	(ROOT (S (S (NP (NN Catheterization) (NNS abnormalities)) (VP (VBD correlated) (ADVP (RB well)) (PP (IN with) (NP (JJ morphologic) (NN damage) (PRN (-LRB- -LRB-) (VP (VBN r) (S (VP (SYM =) (NP (CD 0.57)))) (PP (TO to) (NP (CD 0.78)))) (-RRB- -RRB-)))) (PP (IN in) (NP (NP (DT a) (NN subgroup)) (PP (IN of) (NP (NP (NNS patients)) (SBAR (WHPP (IN in) (WHNP (WP whom))) (S (NP (NN exercise) (NNS hemodynamics)) (VP (VBD were) (VP (VBN measured))))))))))) (, ,) (CC and) (S (NP (DT this) (NN relationship)) (ADVP (RB also)) (VP (VBD exhibited) (NP (DT a) (NN curvilinear) (, ,) (NN threshold) (NN configuration)))) (. .)))
7282516	6	(ROOT (S (PP (IN In) (NP (NNS DXR-Doc_7282516_987_989_Disease))) (NP (NNS Doc_7282516_990_1007_Disease)) (VP (VBZ is) (ADJP (JJ proportional) (PP (TO to) (NP (NP (DT the) (NN degree)) (PP (IN of) (NP (NP (JJ cytotoxic) (NN insult)) (PRN (-LRB- -LRB-) (NP (JJ Doc_7282516_1059_1062_Chemical) (NN dose)) (-RRB- -RRB-))))))) (SBAR (IN while) (S (NP (JJ myocardial) (NN function)) (VP (VBZ is) (VP (VBN preserved) (SBAR (IN until) (S (NP (NP (DT a) (JJ critical) (NN dose) (CC or) (NN degree)) (PP (IN of) (NP (NN damage)))) (VP (VBZ is) (VP (VBN reached) (, ,) (PP (IN after) (SBAR (WHNP (WDT which)) (S (NP (JJ myocardial) (NN performance)) (VP (VBZ deteriorates) (ADVP (RB rapidly))))))))))))))) (. .)))
7337133	0	(ROOT (NP (NP (NP (JJ Massive) (NNS Doc_7337133_8_22_Disease)) (VP (VBN associated) (PP (IN with) (NP (NP (NNS Doc_7337133_39_64_Disease)) (PP (IN in) (NP (JJ Doc_7337133_68_81_Chemical) (NNS Doc_7337133_82_90_Disease))))))) (: :) (NP (NP (JJ possible) (NN role)) (PP (IN of) (NP (JJ cranial) (NN decompression)))) (. .)))
7337133	1	(ROOT (S (NP (NNP Doc_7337133_132_146_Disease)) (VP (MD may) (VP (VB complicate) (NP (NP (DT the) (NN course)) (PP (IN of) (NP (NNS Doc_7337133_176_201_Disease)))))) (. .)))
7337133	2	(ROOT (S (NP (NP (NNP Response)) (PP (TO to) (NP (JJ conventional) (NN therapy)))) (VP (VBZ has) (VP (VBN been) (ADJP (JJ disappointing)))) (. .)))
7337133	3	(ROOT (S (NP (PRP We)) (VP (VBP present) (NP (DT a) (NN patient)) (PP (IN with) (NP (JJ fatal) (NN Doc_7337133_292_305_Chemical-induced) (NNS Doc_7337133_314_339_Disease))) (, ,) (PP (IN with) (NP (NP (NNS signs) (CC and) (NNS symptoms)) (PP (IN of) (NP (NNS Doc_7337133_368_382_Disease))))) (, ,) (ADJP (JJ unresponsive) (PP (TO to) (NP (JJ conventional) (JJ medical) (NN therapy))))) (. .)))
7337133	4	(ROOT (S (NP (JJ Cranial) (NN decompression)) (VP (VBD was) (VP (VBN carried) (PRT (RP out)))) (. .)))
7337133	5	(ROOT (S (NP (NP (DT A) (NN justification)) (PP (IN of) (NP (NP (DT the) (NN need)) (PP (IN for) (NP (NP (JJ further) (NN evaluation)) (PP (IN of) (NP (NP (JJ cranial) (NN decompression)) (PP (IN in) (NP (JJ such) (NNS patients)))))))))) (VP (VBZ is) (VP (VBN presented))) (. .)))
7416947	0	(ROOT (NP (NP (JJ Subjective) (NN assessment)) (PP (IN of) (NP (NP (NNS Doc_7416947_25_43_Disease)) (PP (IN of) (NP (NP (NNS patients)) (PP (IN on) (NP (JJ long-term) (NN administration))))))) (PP (IN of) (NP (NNS Doc_7416947_87_94_Chemical))) (. .)))
7416947	1	(ROOT (S (NP (JJ Various) (NNS data)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NP (JJ male) (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBP have) (VP (VBN received) (NP (NNS Doc_7416947_154_161_Chemical)) (PP (IN on) (NP (DT a) (JJ longterm) (NN basis)))))))) (VP (VBP have) (VP (VBN increased) (NP (NP (NP (NNS levels)) (PP (IN of) (NP (NN serum) (NNS Doc_7416947_213_221_Chemical)))) (CC and) (NP (NP (VBN decreased) (NNS levels)) (PP (IN of) (NP (NN plasma) (NNS Doc_7416947_253_265_Chemical)))) (CC and) (NP (NP (VBG luteinizing) (NN hormone)) (PRN (-LRB- -LRB-) (NP (NNP LH)) (-RRB- -RRB-))))))))) (. .)))
7416947	2	(ROOT (S (NP (DT This) (NN study)) (VP (VBD was) (VP (VBN undertaken) (S (VP (TO to) (VP (VB investigate) (NP (NP (NP (DT the) (NNS links)) (PP (IN between) (NP (NP (DT the) (JJ long-term) (NN administration)) (PP (IN of) (NP (NP (JJ Doc_7416947_387_394_Chemical) (NN therapy)) (CC and) (NP (JJ sexual) (NN behavior))))))) (, ,) (CC and) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (NNS Doc_7416947_442_449_Chemical))))) (PP (IN on) (NP (NP (NN plasma) (NNS levels)) (PP (IN of) (NP (NNS Doc_7416947_470_479_Chemical) (, ,) (NNP Doc_7416947_481_493_Chemical) (, ,) (CC and) (NNP LH)))))))))) (. .)))
7416947	3	(ROOT (S (NP (NP (DT The) (NNS patients)) (PP (IN of) (NP (NP (DT the) (NN study) (CC and) (NN control) (NN group)) (PRN (-LRB- -LRB-) (PP (IN without) (NP (NNS Doc_7416947_556_563_Chemical))) (-RRB- -RRB-))))) (VP (VP (VBD were) (PP (IN of) (NP (NP (JJ similar) (JJ cardiac) (NN functional) (NN capacity)) (CC and) (NP (NP (NN age)) (PRN (-LRB- -LRB-) (NP (CD 25-40) (NNS years)) (-RRB- -RRB-)))))) (CC and) (VP (VBD were) (VP (ADVP (RB randomly)) (VBN selected) (PP (IN from) (NP (DT the) (JJ Doc_7416947_667_690_Disease) (NNS patients)))))) (. .)))
7416947	4	(ROOT (S (NP (NP (DT A) (JJ subjective) (NN assessment)) (PP (IN of) (NP (NP (JJ sexual) (NN behavior)) (PP (IN in) (NP (DT the) (NN study) (CC and) (NN control) (NNS groups)))))) (VP (VBD was) (VP (VBN carried) (PRT (RP out)) (, ,) (S (VP (VBG using) (NP (NP (NNS parameters)) (PP (JJ such) (IN as) (NP (NP (JJ sexual) (NN desire)) (, ,) (NP (JJ sexual) (NN excitement)) (, ,) (CC and) (NP (NP (NN frequency)) (PP (IN of) (NP (JJ sexual) (NNS relations))))))))))) (. .)))
7416947	5	(ROOT (S (NP (NP (JJ Personal) (NNS interviews)) (CC and) (NP (DT a) (NN questionnaire))) (VP (VBD were) (ADVP (RB also)) (VP (VBN used) (PP (IN for) (NP (NP (DT the) (NN evaluation)) (PP (IN of) (NP (JJ sexual) (NN behavior))))))) (. .)))
7416947	6	(ROOT (S (NP (DT The) (NNS findings)) (VP (VBP support) (NP (NP (DT the) (NNS reports)) (PP (VBG concerning) (NP (NP (JJ Doc_7416947_1025_1032_Chemical) (NN effect)) (PP (IN on) (NP (NP (NN plasma) (NNS Doc_7416947_1050_1059_Chemical)) (, ,) (NP (NNS Doc_7416947_1061_1073_Chemical)) (, ,) (CC and) (NP (NNP LH)))))))) (. .)))
7416947	7	(ROOT (S (NP (NP (DT The) (NNS differences)) (PP (IN in) (NP (DT the) (NNS means)))) (VP (VBD were) (ADJP (JJ significant))) (. .)))
7416947	8	(ROOT (S (NP (NP (NNS Tests)) (VP (VBN used) (S (VP (TO to) (VP (VB evaluate) (NP (DT the) (NNS changes)) (PP (IN in) (NP (JJ sexual) (NN behavior)))))))) (VP (VBD showed) (NP (NP (NP (DT a) (JJ significant) (JJ Doc_7416947_1205_1230_Disease) (, ,) (JJ sexual) (NN excitement) (NN phase)) (PRN (-LRB- -LRB-) (NP (NN erection)) (-RRB- -RRB-))) (, ,) (CC and) (NP (NP (NN frequency)) (PP (IN of) (NP (JJ sexual) (NNS relations))))) (PP (IN in) (NP (DT the) (NN study) (NN group)))) (. .)))
7421734	0	(ROOT (S (VP (VB Doc_7421734_0_21_Disease) (PP (IN after) (NP (NP (NNS Doc_7421734_28_43_Disease)) (PP (IN in) (NP (NN childhood)))))) (. .)))
7421734	1	(ROOT (S (NP (DT A) (JJ 34-year-old) (NN patient)) (VP (VBD developed) (NP (JJ metastic) (NNS Doc_7421734_99_120_Disease)) (PP (IN after) (NP (NNS Doc_7421734_127_142_Disease))) (PP (IN in) (NP (NN childhood)))) (. .)))
7421734	2	(ROOT (S (S (NP (PRP She)) (VP (VBD had) (VP (VBN Doc_7421734_165_180_Disease) (PP (IN after) (NP (JJ abdominal) (NN irradiation) (CC and) (NN chemotherapy))) (PP (IN for) (NP (NNS Doc_7421734_230_245_Disease)))))) (, ,) (CC and) (S (NP (VBN received) (NNS exogenous) (NNS Doc_7421734_270_279_Chemical)) (, ,) (NP (DT a) (NN treatment)) (VP (VBN implicated) (PP (IN in) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (NP (NNS Doc_7421734_326_344_Disease)) (PP (IN in) (NP (JJ menopausal) (NNS women))))))))) (. .)))
7421734	3	(ROOT (S (NP (NP (JJ Young) (NNS women)) (PP (IN on) (NP (NP (NN replacement) (NNS Doc_7421734_393_402_Chemical)) (PP (IN for) (NP (NP (NNS Doc_7421734_407_422_Disease)) (PP (IN after) (NP (JJ Doc_7421734_429_435_Disease) (NN therapy)))))))) (VP (VP (MD may) (ADVP (RB also)) (VP (VB have) (NP (NP (VBN increased) (NN risk)) (PP (IN of) (NP (NNS Doc_7421734_476_497_Disease)))))) (CC and) (VP (MD should) (VP (VB be) (VP (VBN examined) (ADVP (RB periodically)))))) (. .)))
7437994	0	(ROOT (NP (NP (JJ Long-term) (NNS Doc_7437994_10_17_Chemical)) (NP (NP (NN treatment)) (CC and) (NP (DT the) (NN kidney))) (. .)))
7437994	1	(ROOT (S (NP (NNP Interim)) (VP (VBP report) (PP (IN on) (NP (JJ fifty) (NNS patients)))) (. .)))
7437994	2	(ROOT (S (NP (DT This)) (VP (VBZ is) (NP (NP (DT a) (NN report)) (PP (IN on) (NP (NP (DT the) (JJ first) (NN part)) (PP (IN of) (NP (NP (PRP$ our) (NN study)) (PP (IN of) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NP (JJ long-term) (JJ Doc_7437994_154_161_Chemical) (NN treatment)) (PP (IN on) (NP (DT the) (NN kidney))))))))))))) (. .)))
7437994	3	(ROOT (S (NP (NP (JJ Doc_7437994_187_197_Chemical) (NN clearance)) (, ,) (NP (JJ maximum) (NN urinary) (NN osmolality)) (CC and) (NP (CD 24) (NN hour) (NN urine) (NN volume))) (VP (VBP have) (VP (VBN been) (VP (VBN tested) (PP (IN in) (NP (NP (CD 50) (JJ affectively) (JJ ill) (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBP have) (VP (VBN been) (PP (IN on) (NP (NP (JJ long-term) (NNS Doc_7437994_336_343_Chemical)) (PP (IN for) (NP (QP (JJR more) (IN than) (CD one)))))) (NP (NN year))))))))))) (. .)))
7437994	4	(ROOT (S (NP (DT These) (NNS findings)) (VP (VBP have) (VP (VBN been) (VP (VP (VBN compared) (PP (IN with) (NP (NNS norms)))) (CC and) (VP (PP (IN with) (NP (NP (NNS values)) (PP (IN of) (NP (NP (DT the) (JJ same) (NNS tests)) (PP (IN from) (NP (NN screening))))))) (ADVP (RB prior) (PP (TO to) (NP (NNS Doc_7437994_471_478_Chemical))))) (, ,) (VP (ADJP (JJ available)) (PP (IN for) (NP (NP (JJS most)) (PP (IN of) (NP (PRP$ our) (NNS patients))))))))) (. .)))
7437994	5	(ROOT (S (NP (DT No) (NN evidence)) (VP (VBD was) (VP (VBN found) (PP (IN for) (NP (NP (DT any) (NN reduction)) (PP (IN of) (NP (NN glomerular) (NN filtration))))) (PP (IN during) (NP (JJ Doc_7437994_588_595_Chemical) (NN treatment))))) (. .)))
7437994	6	(ROOT (S (NP (NP (NNP Low) (NN clearance) (NNS values)) (VP (VBN found) (PP (IN in) (NP (JJ several) (NNS patients))))) (VP (MD could) (VP (VB be) (VP (VBN accounted) (PP (IN for) (IN by) (NP (NP (PRP$ their) (NN age)) (CC and) (NP (PRP$ their) (JJ pre-Doc_7437994_704_711_Chemical) (NNS values))))))) (. .)))
7437994	7	(ROOT (S (S (ADVP (RB Urinary)) (NP (NN concentration) (NN defect)) (VP (VBD appeared) (ADJP (JJ frequent)))) (CC but) (S (NP (NP (DT the) (NN extent)) (PP (IN of) (NP (DT the) (NN impairment)))) (VP (VBZ is) (ADJP (JJ difficult) (S (VP (TO to) (VP (VB assess) (PP (RB because) (IN of) (NP (NP (DT the) (NN uncertainty)) (PP (IN about) (NP (NP (DT the) (NNS norms)) (ADJP (JJ applicable) (PP (TO to) (NP (NP (DT this) (NN group)) (PP (IN of) (NP (NNS patients)))))))))))))))) (. .)))
7437994	8	(ROOT (S (NP (DT The) (NN concentration) (NN defect)) (VP (VBD appeared) (ADJP (JJ reversible)) (, ,) (PP (ADVP (IN at) (JJS least)) (IN in) (NP (NN part)))) (. .)))
7437994	9	(ROOT (S (NP (NP (NNP Doc_7437994_968_976_Disease)) (PP (IN above) (NP (CD 3) (JJ litres/24) (NNS hours)))) (VP (VBD was) (VP (VBN found) (PP (IN in) (NP (NP (CD 10) (NN %)) (PP (IN of) (NP (NNS patients))))))) (. .)))
7437994	10	(ROOT (S (NP (DT An) (NN attempt)) (VP (VBZ is) (VP (VBN made) (S (VP (TO to) (VP (VB draw) (NP (JJ practical) (NNS conclusions)) (PP (IN from) (NP (DT the) (JJ preliminary) (NNS findings)))))))) (. .)))
7542793	0	(ROOT (NP (NP (NP (NNP Nephrotoxicity)) (PP (IN of) (NP (NNS Doc_7542793_18_31_Chemical) (CC and) (NNS Doc_7542793_36_41_Chemical)))) (: :) (NP (NP (NN inhibition)) (PP (IN of) (NP (NN calcineurin) (NN phosphatase)))) (. .)))
7542793	1	(ROOT (S (NP (NP (NP (NP (NNP Doc_7542793_82_95_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (NNS Doc_7542793_97_100_Chemical)) (: ;) (NP (CD 50) (NN mg/kg))) (-RRB- -RRB-))) (CC and) (NP (NP (NNS Doc_7542793_116_126_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (NNS Doc_7542793_128_133_Chemical)) (: ;) (NP (CD 5) (NN mg/kg))) (-RRB- -RRB-)))) (, ,) (ADVP (RB but) (RB not)) (NP (NP (DT the) (VBN related) (JJ Doc_7542793_165_174_Chemical) (NN immunosuppressant) (NN Doc_7542793_193_202_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 5) (NN mg/kg)) (-RRB- -RRB-))) (, ,)) (VP (VBD caused) (NP (NP (NP (DT a) (NN reduction)) (PP (IN of) (NP (NN glomerular) (NN filtration) (NN rate)))) (, ,) (NP (NP (JJ degenerative) (NNS changes)) (PP (IN of) (NP (JJ proximal) (JJ tubular) (NN epithelium)))) (, ,) (CC and) (NP (NP (NNS Doc_7542793_321_332_Disease)) (PP (IN of) (NP (NP (DT the) (NN juxtaglomerular) (NN apparatus)) (PP (IN in) (NP (JJ male) (NNP Wistar) (NNS rats))))))) (SBAR (WHADVP (WRB when)) (S (VP (VBN given) (PP (IN for) (NP (CD 10) (NNS days))))))) (. .)))
7542793	2	(ROOT (S (NP (NP (DT The) (JJ molecular) (NNS mechanisms)) (PP (IN of) (NP (JJ Doc_7542793_438_441_Chemical) (CC and) (JJ Doc_7542793_446_451_Chemical) (NNS Doc_7542793_452_460_Disease)))) (VP (VBD were) (VP (VBN investigated))) (. .)))
7542793	3	(ROOT (S (NP (NP (NNP Cyclophilin) (NNP A)) (CC and) (NP (NP (NN Doc_7542793_498_503_Chemical-binding) (NN protein)) (, ,) (NP (NP (DT the) (JJ main) (JJ intracytoplasmic) (NNS receptors)) (PP (IN for) (NP (NNS Doc_7542793_561_564_Chemical) (CC and) (NNS Doc_7542793_569_574_Chemical)))))) (, ,) (ADVP (RB respectively)) (, ,) (VP (VBD were) (DT each) (VP (VBN detected) (PP (IN in) (NP (JJ renal) (NN tissue) (NNS extract))))) (. .)))
7542793	4	(ROOT (S (PP (IN In) (NP (DT the) (NN kidney))) (, ,) (NP (NP (JJ high) (NNS levels)) (PP (IN of) (NP (ADJP (ADJP (JJ immunoreactive)) (CC and) (ADJP (RB enzymatically) (JJ active))) (NN calcineurin)))) (VP (VBD were) (VP (VBN found) (SBAR (WHNP (WDT which)) (S (VP (VBD were) (ADJP (JJ inhibited) (PP (PP (IN by) (NP (DT the) (JJ immunosuppressants) (NNS Doc_7542793_774_777_Chemical) (CC and) (NNS Doc_7542793_782_787_Chemical))) (, ,) (CC but) (RB not) (PP (IN by) (NP (NNS Doc_7542793_800_809_Chemical)))))))))) (. .)))
7542793	5	(ROOT (S (ADVP (RB Finally)) (, ,) (NP (JJ specific) (JJ immunophilin-drug-calcineurin) (NNS complexes)) (VP (VBD formed) (ADVP (RB only)) (PP (IN in) (NP (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NNS Doc_7542793_900_903_Chemical) (CC and) (NNS Doc_7542793_908_913_Chemical)))) (, ,) (CONJP (CC but) (RB not)) (NP (NNS Doc_7542793_923_932_Chemical))))) (. .)))
7542793	6	(ROOT (S (NP (DT These) (NNS results)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NP (DT the) (JJ nephrotoxic) (NNS effects)) (PP (IN of) (NP (NNS Doc_7542793_988_991_Chemical) (CC and) (NNS Doc_7542793_996_1001_Chemical)))) (VP (VBZ is) (ADJP (RB likely) (JJ mediated) (PP (IN through) (NP (ADJP (JJ binding) (PP (TO to) (NP (NP (JJ renal) (NN immunophilin)) (CC and) (NP (VBG inhibiting) (NN calcineurin))))) (NN phosphatase)))))))) (. .)))
7565311	0	(ROOT (S (VP (VB Doc_7565311_0_19_Disease) (PP (IN in) (NP (JJ high) (NN dose) (NNS Doc_7565311_33_44_Chemical))) (ADVP (RB chemotherapy))) (. .)))
7565311	1	(ROOT (S (NP (NNP Doc_7565311_59_70_Chemical)) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (S (VP (TO to) (VP (VB cause) (NP (NNS Doc_7565311_98_117_Disease)) (SBAR (WHADVP (WRB when)) (S (VP (VBN administered) (PP (IN in) (NP (JJ high) (NNS doses))) (PP (TO to) (NP (JJ adult) (NNS patients)))))))))))) (. .)))
7565311	2	(ROOT (S (NP (PRP We)) (VP (VBP report) (NP (NP (DT a) (CD 4 1/2)) (: -) (NP (NP (JJ year-old) (NN girl)) (SBAR (WHNP (WP who)) (S (VP (VBD was) (VP (VBN treated) (PP (IN with) (NP (NP (JJ high-dose) (NNS Doc_7565311_232_243_Chemical)) (PP (IN for) (NP (JJ metastatic) (JJ parameningeal) (NNS Doc_7565311_273_299_Disease)))))))))))) (. .)))
7565311	3	(ROOT (S (NP (NNP Doc_7565311_301_320_Disease)) (VP (VBD developed) (PP (VBN followed) (PP (IN by) (NP (NP (DT a) (JJ slow) (JJ partial) (NN recovery)) (PP (IN of) (NP (JJ renal) (NN function))))))) (. .)))
7565311	4	(ROOT (S (NP (JJ Possible) (JJ contributing) (NNS factors)) (VP (VBP are) (VP (VBN discussed))) (. .)))
7596955	0	(ROOT (NP (NP (JJ Clinical) (NN evaluation)) (PP (IN on) (NP (NP (VBN combined) (NN administration)) (PP (IN of) (NP (NP (JJ oral) (JJ Doc_7596955_55_67_Chemical) (JJ analogue) (NNS Doc_7596955_77_86_Chemical)) (CC and) (NP (JJ phosphodiesterase) (NN inhibitor) (NNS Doc_7596955_119_129_Chemical)))))) (. .)))
7596955	1	(ROOT (S (PP (IN Among) (NP (JJ various) (JJ oral) (NNS antiplatelets))) (, ,) (NP (NP (DT a) (NN combination)) (PP (IN of) (NP (NP (DT a) (JJ novel) (JJ Doc_7596955_190_202_Chemical) (JJ analogue) (NNS Doc_7596955_212_221_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_7596955_223_226_Chemical)) (-RRB- -RRB-)) (CC and) (NP (DT a) (JJ potent) (JJ phosphodiesterase) (NN inhibitor) (NNS Doc_7596955_269_279_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_7596955_281_284_Chemical)) (-RRB- -RRB-))))) (VP (MD may) (VP (VB result) (PP (IN in) (NP (NP (NP (JJ untoward) (JJ clinical) (NNS effects)) (ADJP (JJ due) (PP (TO to) (NP (NP (JJ possible) (JJ synergistic) (NN elevation)) (PP (IN of) (NP (NN intracellular) (NNS Doc_7596955_381_385_Chemical))))))) (PRN (-LRB- -LRB-) (NP (NNP Doc_7596955_387_423_Chemical)) (-RRB- -RRB-)))))) (. .)))
7596955	2	(ROOT (S (ADVP (RB Thereby)) (, ,) (NP (NP (DT a) (JJ clinical) (NN study)) (PP (IN of) (NP (NP (DT the) (VBN combined) (NN administration)) (PP (IN of) (NP (DT the) (CD two) (NNS agents)))))) (VP (VBD was) (VP (VBN attempted))) (. .)))
7596955	3	(ROOT (S (NP (CD Twelve) (JJ healthy) (NNS volunteers)) (VP (VBD were) (VP (VBN assigned) (S (VP (TO to) (VP (VB take) (NP (NNS Doc_7596955_564_567_Chemical)) (PRN (: /) (NP (NP (NNS Doc_7596955_568_571_Chemical)) (PP (IN in) (NP (NP (DT the) (JJ following) (NN schedule)) (: ;) (NP (NNS Doc_7596955_599_602_Chemical)) (: :) (NP (NP (CD 40) (NNS micrograms)) (PP (IN at) (NP (NN day) (CD 1)))) (CC and) (NP (CD 120) (NNS micrograms)))) (VP (VBN t.i.d.) (PP (IN from) (NP (NN day)))))) (NP (NP (QP (CD 7) (TO to) (CD 14))) (, ,) (NP (NP (NNS Doc_7596955_671_674_Chemical)) (: :) (NP (CD 200) (NN mg) (NN t.i.d.)))) (PP (IN from) (NP (NN day) (CD 3))) (PP (TO to) (NP (CD 14)))))))) (. .)))
7596955	4	(ROOT (S (PP (IN At) (NP (JJ various) (NN time) (NNS intervals))) (, ,) (NP (NP (NP (JJ physical) (NN examination) (CC and) (NN blood) (NN collection)) (PP (IN for) (NP (JJ ex) (NN vivo) (NNS Doc_7596955_789_809_Disease)))) (CC and) (NP (NP (NN determination)) (PP (IN of) (NP (JJ intraplatelet) (NNS Doc_7596955_845_849_Chemical))))) (VP (VBD were) (VP (VBN performed))) (. .)))
7596955	5	(ROOT (S (PP (IN Throughout) (NP (DT the) (NN observation) (NN period))) (, ,) (NP (NP (DT no) (JJ significant) (NN alteration)) (PP (IN in) (NP (JJ vital) (NNS signs)))) (VP (VBD was) (ADJP (JJ observed))) (. .)))
7596955	6	(ROOT (S (NP (NP (CD Seven)) (PP (RB out) (IN of) (NP (CD 12) (NNS subjects)))) (VP (VBD experienced) (NP (NP (NNS Doc_7596955_993_1001_Disease)) (PP (IN of) (NP (DT a) (JJ short) (NN duration) (VBG accompanying) (NNS Doc_7596955_1035_1047_Disease)))) (PP (IN in) (NP (NP (CD one)) (CC and) (NP (NNS Doc_7596955_1059_1065_Disease)))) (PP (IN in) (NP (CD one))) (, ,) (ADVP (RB especially)) (PP (IN after) (NP (NP (NN ingestion)) (PP (IN of) (NP (NNS Doc_7596955_1104_1107_Chemical)))))) (. .)))
7596955	7	(ROOT (S (S (NP (NP (DT All)) (PP (IN of) (NP (DT these) (NNS symptoms))) (, ,) (VP (ADVP (RB probably)) (VBN caused) (PP (IN by) (NP (NP (DT the) (VBG vasodilating) (NN effect)) (PP (IN of) (NP (DT the) (CD two) (NNS agents)))))) (, ,)) (VP (VBD were) (PP (IN of) (NP (JJ mild) (NN degree))))) (CC and) (S (NP (DT no) (JJ special) (NN treatment)) (VP (VBD was) (VP (VBN required)))) (. .)))
7596955	8	(ROOT (S (NP (JJ Intraplatelet) (JJ Doc_7596955_1267_1271_Chemical) (NN content)) (VP (VBD was) (ADVP (RB gradually) (CC but) (RB significantly)) (VP (VBN increased) (PP (TO to) (NP (UCP (ADJP (NP (CD 9.84) (NNS +)) (JJ /)) (: -) (NP (NP (JJ 4.59) (NN pmol)) (PP (IN per) (NP (NP (CD 10)) (PRN (-LRB- -LRB-) (NP (CD 9)) (-RRB- -RRB-)))))) (NNS platelets))) (PP (IN at) (NP (NP (NN day) (CD 14)) (PP (IN in) (NP (NN comparison))))) (PP (IN with) (NP (NP (DT the) (JJ initial) (NN value)) (PRN (-LRB- -LRB-) (NP (NP (CD 6.87) (JJ +) (NNS /)) (: -) (NP (CD 2.25) (NN pmol))) (-RRB- -RRB-)))))) (. .)))
7596955	9	(ROOT (S (S (NP (DT The) (NN platelet)) (ADVP (RB aggregability)) (VP (VBD was) (ADVP (RB significantly)) (VP (VBN suppressed) (PP (IN at) (NP (JJ various) (NN time) (NNS intervals)))))) (CC but) (S (NP (NP (DT no) (ADJP (JJ additive) (CC or) (JJ synergistic)) (NN inhibitory) (NN effect)) (PP (IN by) (NP (DT the) (VBN combined) (NN administration)))) (VP (VBD was) (VP (VBN noted)))) (. .)))
7596955	10	(ROOT (S (PP (IN In) (NP (NN conclusion))) (, ,) (NP (NP (DT the) (VBN combined) (NN administration)) (PP (IN of) (NP (JJ Doc_7596955_1652_1655_Chemical) (JJ /) (NNS Doc_7596955_1656_1659_Chemical)))) (VP (VBZ is) (ADJP (JJ safe) (PP (IN at) (NP (NP (NNS doses)) (VP (VBN used) (PP (IN in) (NP (DT the) (NN study))))))) (, ,) (SBAR (IN though) (S (NP (NP (DT the) (JJ beneficial) (JJ clinical) (NN effect)) (PP (IN of) (NP (DT the) (VBN combined) (NN administration)))) (VP (VBZ has) (ADVP (RB yet)) (S (VP (TO to) (VP (VB be) (VP (VBN elucidated))))))))) (. .)))
7604176	0	(ROOT (NP (CD Doc_7604176_0_11_Chemical-associated) (NNS Doc_7604176_23_31_Disease) (. .)))
7604176	1	(ROOT (NP (NP (NNP Report)) (PP (IN of) (NP (DT a) (NN case))) (. .)))
7604176	2	(ROOT (S (NP (NP (DT A) (NN case)) (PP (IN of) (NP (NP (JJ acute) (NNS Doc_7604176_67_88_Disease)) (VP (VBN associated) (PP (IN with) (NP (NP (DT the) (NN use)) (PP (IN of) (NP (NNS Doc_7604176_116_127_Chemical))))))))) (PRN (, ,) (S (NP (DT a) (JJ new) (JJ hydrophilic) (JJ 3-hydroxy-3) (NN methylglutaril)) (VP (VBP coenzyme) (NP (DT A) (JJ reductase) (NN inhibitor)))) (, ,)) (VP (VBZ is) (VP (VBN reported))) (. .)))
7604176	3	(ROOT (S (NP (NP (DT The) (NN patient)) (, ,) (NP (DT a) (JJ 69-year-old) (NN man))) (VP (VBD was) (VP (VBN affected) (PP (IN by) (NP (NNS Doc_7604176_266_305_Disease) (CC and) (NNS Doc_7604176_310_322_Disease))))) (. .)))
7604176	4	(ROOT (S (NP (PRP He)) (VP (VBD assumed) (NP (NP (NP (NNS Doc_7604176_335_346_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 20) (NN mg/day)) (-RRB- -RRB-))) (PP (RB because) (IN of) (NP (NNS Doc_7604176_370_390_Disease))))) (. .)))
7604176	5	(ROOT (S (NP (PRP He)) (VP (VBD was) (VP (VBN admitted) (PP (IN with) (NP (NP (JJ acute) (NNS Doc_7604176_419_427_Disease)) (PP (IN of) (NP (DT the) (JJR lower) (NNS limbs))) (SBAR (WHNP (WDT which)) (S (VP (VBN resolved) (PP (IN in) (NP (DT a) (JJ few) (NNS days))) (PP (IN after) (NP (JJ Doc_7604176_482_493_Chemical) (NN discontinuation)))))))))) (. .)))
7604176	6	(ROOT (S (NP (NP (DT A) (ADJP (RB previously) (JJ unknown)) (NNS Doc_7604176_532_546_Disease)) (, ,) (RRC (ADVP (RB probably)) (ADJP (JJ due) (PP (TO to) (NP (JJ chronic) (NNS Doc_7604176_572_594_Disease))))) (, ,)) (VP (VBD was) (VP (VBN evidenced))) (. .)))
7604176	7	(ROOT (S (NP (NP (JJ Muscle) (NN biopsy)) (PRN (-LRB- -LRB-) (NP (JJ left) (NNS gastrocnemius)) (-RRB- -RRB-))) (VP (VBD revealed) (NP (DT a) (ADJP (JJ perimysial) (CC and) (JJ endomysial)) (JJ inflammatory) (NN infiltrate)) (PP (IN with) (NP (NP (DT a) (NN prevalence)) (PP (IN of) (NP (QP (CD CD4) (CD +)) (NNS lymphocytes)))))) (. .)))
7604176	8	(ROOT (S (SBAR (IN While) (S (NP (NNS Doc_7604176_752_762_Chemical) (CC and) (NNS Doc_7604176_767_778_Chemical)) (VP (VBP have) (VP (VBN been) (VP (VBN associated) (PP (IN with) (NP (JJ toxic) (NNS Doc_7604176_811_819_Disease)))))))) (, ,) (NP (NN Doc_7604176_821_832_Chemical-associated) (NNS Doc_7604176_844_852_Disease)) (VP (MD could) (VP (VB represent) (NP (DT a) (JJ distinct) (, ,) (JJ inflammatory) (NN entity)))) (. .)))
761833	0	(ROOT (NP (NP (NP (NNP Reversal)) (PP (IN of) (NP (NP (JJ Doc_761833_12_19_Chemical) (NNS Doc_761833_20_24_Disease)) (PP (IN in) (NP (NP (NNS rats)) (PP (IN by) (NP (NNS Doc_761833_36_42_Chemical)))))))) (: :) (NP (DT a) (JJ peripheral) (NN effect)) (. .)))
761833	1	(ROOT (S (NP (NNP Ammonia) (NNP Doc_761833_73_77_Disease)) (VP (VBD was) (VP (VBN produced) (PP (IN in) (NP (NP (NNS rats)) (PP (IN within) (NP (NP (QP (CD 10) (TO to) (CD 15)) (NNS minutes)) (PP (IN of) (NP (NP (DT an) (NN intraperitonealinjection)) (PP (IN of) (NP (CD 1.7) (JJ mmol) (NNS Doc_761833_166_171_Chemical))))))))))) (. .)))
761833	2	(ROOT (S (NP (DT This) (NNS Doc_761833_178_182_Disease)) (VP (VBD was) (VP (VBN prevented) (PP (IN with) (NP (JJ 1.68) (JJ mmol) (NNS Doc_761833_212_218_Chemical))) (PP (VBN given) (PP (IN by) (NP (NP (JJ gastric) (NN intubation)) (NP (CD 15) (NNS minutes)) (PP (IN before) (NP (DT the) (JJ Doc_761833_269_282_Chemical) (NN injection)))))))) (. .)))
761833	3	(ROOT (S (NP (NP (DT The) (NN effect)) (PP (IN of) (NP (NNS Doc_761833_308_314_Chemical)))) (VP (VBD was) (VP (VBN correlated) (PP (IN with) (NP (NP (NP (DT a) (NN decrease)) (PP (IN in) (NP (NN blood) (CC and) (NN brain) (NNS Doc_761833_365_372_Chemical)))) (, ,) (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (NN brain) (NNS Doc_761833_395_403_Chemical)))) (, ,) (CC and) (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (NP (JJ renal) (NN excretion)) (PP (IN of) (NP (NNS Doc_761833_443_450_Chemical) (CC and) (NNS Doc_761833_455_459_Chemical)))))))))) (. .)))
761833	4	(ROOT (S (NP (NP (JJ Intraventricular) (NN infusion)) (PP (IN of) (NP (NP (NNS Doc_761833_490_498_Chemical)) (ADJP (JJ sufficient) (S (VP (TO to) (VP (VB raise) (NP (DT the) (NN brain) (NNS Doc_761833_529_537_Chemical)) (PP (TO to) (NP (DT the) (JJ same) (NN extent)))))))))) (VP (VP (VBD did) (RB not) (VP (VB prevent) (NP (DT the) (JJ Doc_761833_577_584_Chemical) (NNS Doc_761833_585_589_Disease)))) (CC nor) (VP (VBP affect) (NP (DT the) (NN blood) (CC and) (NN brain) (NNS Doc_761833_621_628_Chemical) (NNS concentrations)))) (. .)))
761833	5	(ROOT (S (S (NP (NNP Bilateral)) (ADVP (RB nephrectomy)) (VP (VBD eliminated) (NP (NP (DT the) (JJ beneficial) (NN effect)) (PP (IN of) (NP (NNS Doc_761833_703_709_Chemical)))) (PP (IN on) (NP (NN blood) (CC and) (NN brain) (NNS Doc_761833_729_736_Chemical))))) (CC and) (S (NP (DT the) (JJ Doc_761833_745_752_Chemical) (NNS Doc_761833_753_757_Disease)) (VP (VBD was) (RB not) (VP (VBN prevented)))) (. .)))
761833	6	(ROOT (S (ADVP (RB Thus)) (, ,) (NP (NP (NP (DT the) (NN reduction)) (PP (IN in) (NP (NN blood) (CC and) (NN brain) (NNS Doc_761833_816_823_Chemical)))) (CC and) (NP (NP (DT the) (NN prevention)) (PP (IN of) (NP (NP (JJ Doc_761833_846_853_Chemical) (NNS Doc_761833_854_858_Disease)) (PP (IN after) (NP (NNS Doc_761833_865_871_Chemical))))))) (, ,) (VP (MD can) (VP (VB be) (VP (VBN accounted) (PP (IN for) (IN by) (NP (NP (DT the) (JJ peripheral) (NN effect)) (PP (IN of) (NP (NP (NP (NNS Doc_761833_922_930_Chemical)) (PP (IN on) (NP (JJ renal) (NN function)))) (CONJP (RB rather) (IN than)) (NP (PRP$ its) (JJ central) (NN action))))))))) (. .)))
761833	7	(ROOT (S (NP (DT These) (NNS results)) (VP (VBP provide) (SBAR (S (NP (NP (DT a) (JJ reasonable) (NN explanation)) (PP (IN for) (NP (DT the) (JJ beneficial) (NNS effects)))) (VP (VBD observed) (PP (IN in) (NP (DT some) (JJ encephalopathic) (NNS patients))) (S (VP (VBG receiving) (NP (NNS Doc_761833_1107_1113_Chemical)))))))) (. .)))
7619765	0	(ROOT (NP (CD Doc_7619765_0_9_Chemical-related) (NNS Doc_7619765_18_39_Disease) (. .)))
7619765	1	(ROOT (S (NP (NP (DT The) (NN occurrence)) (PP (IN of) (NP (DT a) (NNS Doc_7619765_61_82_Disease)))) (VP (VBZ is) (VP (VBN reported) (PP (IN after) (S (ADVP (RB chemotherapy)) (VP (VBG containing) (NP (NNS Doc_7619765_125_134_Chemical)) (, ,) (PP (IN in) (NP (NP (DT a) (NN man)) (PP (IN with) (NP (NP (DT no) (NN risk) (NNS factors)) (PP (IN for) (NP (NNS Doc_7619765_170_192_Disease)))))))))))) (. .)))
7619765	2	(ROOT (S (NP (JJ Possible) (JJ causal) (NNS mechanisms)) (VP (VBP are) (VP (VBN discussed))) (. .)))
7647582	0	(ROOT (S (NP (JJ Halogenated) (NNS anesthetics)) (VP (VP (VBP form) (NP (NN liver) (NNS adducts))) (CC and) (VP (VBZ antigens) (NP (DT that) (NN cross-react)) (PP (IN with) (NP (NN Doc_7647582_78_87_Chemical-induced) (NNS antibodies))))) (. .)))
7647582	1	(ROOT (S (NP (NP (CD Two) (JJ halogenated) (NNS anesthetics)) (, ,) (NP (NNS Doc_7647582_137_146_Chemical) (CC and) (NNS Doc_7647582_151_161_Chemical)) (, ,)) (VP (VBP have) (VP (VBN been) (VP (VBN associated) (PP (IN with) (NP (NP (DT an) (JJ allergic-type) (NNS Doc_7647582_206_220_Disease)) (UCP (DT both) (ADVP (RB alone)) (CC and) (PP (VBG following) (NP (NP (JJ previous) (NN exposure)) (PP (TO to) (NP (NNS Doc_7647582_267_276_Chemical))))))))))) (. .)))
7647582	2	(ROOT (S (NP (JJ Doc_7647582_278_287_Chemical) (NNS Doc_7647582_288_297_Disease)) (VP (VBZ appears) (S (VP (TO to) (VP (VB involve) (NP (DT an) (JJ aberrant) (JJ immune) (NN response)))))) (. .)))
7647582	3	(ROOT (S (NP (NP (NP (DT An) (NN antibody) (NN response)) (PP (TO to) (NP (DT a) (JJ protein-bound) (NN biotransformation) (NN product)))) (PRN (-LRB- -LRB-) (NP (JJ Doc_7647582_413_428_Chemical) (NN adduct)) (-RRB- -RRB-))) (VP (VBZ has) (VP (VBN been) (VP (VBN detected) (PP (IN on) (NP (JJ Doc_7647582_458_467_Chemical) (JJ Doc_7647582_468_477_Disease) (NNS patients)))))) (. .)))
7647582	4	(ROOT (S (NP (DT This) (NN study)) (VP (VBD was) (VP (VBN performed) (S (VP (TO to) (VP (VB determine) (NP (NP (NN cross-reactivity)) (PP (IN between) (NP (NNS Doc_7647582_551_560_Chemical) (CC and) (NNS Doc_7647582_565_575_Chemical)))) (PP (IN with) (NP (NP (DT the) (NNS Doc_7647582_585_601_Disease)) (VP (VBN induced) (PP (IN by) (NP (NNS Doc_7647582_613_622_Chemical))))))))))) (. .)))
7647582	5	(ROOT (S (S (NP (NP (DT The) (NN subcellular) (CC and) (NN lobular) (NN production)) (PP (IN of) (NP (JJ hepatic) (NNS neoantigens)))) (VP (VBD recognized) (PP (IN by) (NP (NP (NN Doc_7647582_700_709_Chemical-induced) (NNS antibodies)) (PP (VBG following) (NP (NNS Doc_7647582_739_748_Chemical) (CC and) (NNS Doc_7647582_753_763_Chemical))))))) (, ,) (CC and) (S (NP (NP (DT the) (JJ biochemical) (NN nature)) (PP (IN of) (NP (DT these) (NNS neoantigens)))) (VP (VBD was) (VP (VBN investigated) (PP (IN in) (NP (CD two) (NN animal) (NNS models)))))) (. .)))
7647582	6	(ROOT (S (NP (JJ Doc_7647582_852_861_Chemical) (NN administration)) (VP (VBD resulted) (PP (IN in) (NP (NP (NNS neoantigens)) (VP (VBN detected) (PP (PP (IN in) (NP (NP (CC both) (DT the) (ADJP (JJ microsomal) (CC and) (JJ cytosolic)) (NN fraction)) (PP (IN of) (NP (NN liver) (NNS homogenates))))) (CC and) (PP (IN in) (NP (NP (DT the) (NN centrilobular) (NN region)) (PP (IN of) (NP (DT the) (NN liver)))))))))) (. .)))
7647582	7	(ROOT (S (PP (IN In) (NP (DT the) (JJ same) (NN liver))) (, ,) (NP (JJ biochemical) (NN analysis)) (VP (VBD detected) (NP (NP (JJ fluorinated) (NN liver) (NNS adducts)) (SBAR (WHNP (WDT that)) (S (VP (VBD were) (ADVP (RB up) (PP (TO to) (ADJP (JJ 20-fold)))) (ADJP (ADJP (JJR greater)) (PP (IN in) (NP (NN guinea) (NNS pigs)))) (PP (IN than) (PP (IN in) (NP (NNS rats))))))))) (. .)))
7647582	8	(ROOT (S (NP (DT This)) (VP (VBZ supports) (CC and) (VBZ extends) (NP (NP (JJ previous) (NN evidence)) (PP (IN for) (NP (NP (DT a) (NN mechanism)) (SBAR (WHPP (IN by) (WHNP (WDT which))) (S (NP (JJ Doc_7647582_1228_1237_Chemical) (NN and/or) (NNS Doc_7647582_1245_1255_Chemical)) (VP (MD could) (VP (VP (VB produce) (NP (DT a) (JJ Doc_7647582_1272_1288_Disease) (NN condition)) (UCP (ADJP (JJ similar) (PP (TO to) (NP (NP (DT that)) (PP (IN of) (NP (JJ Doc_7647582_1318_1327_Chemical) (NNS Doc_7647582_1328_1337_Disease)))))) (CC either) (ADVP (RB alone)))) (CC or) (VP (ADJP (JJ subsequent)) (PP (TO to) (NP (JJ Doc_7647582_1368_1377_Chemical) (NN administration)))))))))))) (. .)))
7647582	9	(ROOT (S (NP (DT The) (NN guinea) (NN pig)) (VP (MD would) (VP (VB appear) (S (VP (TO to) (VP (VB be) (NP (NP (DT a) (JJ useful) (NN model)) (PP (IN for) (NP (NP (JJ further) (NNS investigations)) (PP (IN of) (NP (NP (DT the) (JJ immunological) (NN response)) (PP (TO to) (NP (DT these) (NNS antigens))))))))))))) (. .)))
7650771	0	(ROOT (S (NP (NP (JJ Cholinergic) (NNS Doc_7650771_12_20_Disease)) (VP (VBG resulting) (PP (IN from) (NP (NP (NN ocular) (NN instillation)) (PP (IN of) (NP (JJ Doc_7650771_59_79_Chemical) (NN eye))))))) (VP (VBZ drops)) (. .)))
7650771	1	(ROOT (S (NP (DT A) (NN patient)) (VP (VP (VBD developed) (NP (DT a) (JJ severe) (JJ cholinergic) (NN syndrome)) (PP (IN from) (NP (NP (DT the) (NN use)) (PP (IN of) (NP (JJ Doc_7650771_157_177_Chemical) (JJ ophthalmic) (NNS drops)))))) (, ,) (VP (VBD presented) (PP (IN with) (NP (JJ profound) (NNS Doc_7650771_220_235_Disease)))) (CC and) (VP (VBD was) (ADVP (RB initially)) (VP (VBN given) (NP (NP (DT the) (NN diagnosis)) (PP (IN of) (NP (NNS Doc_7650771_277_294_Disease))))))) (. .)))
7650771	2	(ROOT (S (S (NP (NP (JJ Red) (NN blood) (NN cell)) (CC and) (NP (NN serum) (NN cholinesterase) (NNS levels))) (VP (VBD were) (ADJP (RB severely) (JJ depressed)))) (CC and) (S (NP (NP (NNS symptoms)) (VP (VBN resolved) (ADVP (RB spontaneously)) (PP (VBG following) (NP (NP (NN discontinuation)) (PP (IN of) (NP (DT the) (NN eye))))))) (VP (VBZ drops))) (. .)))
7651879	0	(ROOT (S (VP (VB Doc_7651879_0_7_Disease) (PP (IN after) (NP (NP (JJ Doc_7651879_14_24_Chemical) (NN administration)) (PP (IN in) (NP (DT a) (JJ pediatric) (NN patient)))))) (. .)))
7651879	1	(ROOT (S (NP (NNP Doc_7651879_64_74_Chemical)) (VP (VBZ is) (NP (NP (DT a) (JJ Doc_7651879_80_94_Chemical) (NN receptor) (NN antagonist)) (VP (VBN used) (S (VP (TO to) (VP (VB reverse) (NP (NP (NN sedation) (CC and) (NNS Doc_7651879_144_166_Disease)) (VP (VBN induced) (PP (IN by) (NP (NNS Doc_7651879_178_193_Chemical))))))))))) (. .)))
7651879	2	(ROOT (S (NP (NNS Doc_7651879_195_203_Disease) (CC and) (NNS Doc_7651879_208_227_Disease)) (VP (VBP have) (VP (VBN complicated) (NP (PRP$ its) (NN use)) (PP (IN in) (NP (JJ adult) (NNS patients))))) (. .)))
7651879	3	(ROOT (S (NP (NP (JJ Doc_7651879_272_280_Disease) (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBP have) (VP (VBN coingested) (NP (JJ tricyclic) (NNS antidepressants))))))) (VP (VBP have) (NP (NP (DT a) (JJR higher) (NN risk)) (PP (IN of) (NP (DT these) (NNS complications))))) (. .)))
7651879	4	(ROOT (S (NP (JJ Little) (NN information)) (VP (VBZ exists) (S (VP (VBG concerning) (NP (NP (JJ adverse) (NNS effects)) (PP (IN of) (NP (NP (NNS Doc_7651879_435_445_Chemical)) (PP (IN in) (NP (NNS children))))))))) (. .)))
7651879	5	(ROOT (S (NP (PRP We)) (VP (VBP report) (NP (NP (DT the) (NN occurrence)) (PP (IN of) (NP (DT a) (JJ generalized) (NNS Doc_7651879_501_521_Disease)))) (PP (IN in) (NP (NP (DT a) (JJ pediatric) (NN patient)) (PP (VBG following) (NP (NP (DT the) (NN administration)) (PP (IN of) (NP (NNS Doc_7651879_577_587_Chemical)))))))) (. .)))
7707116	0	(ROOT (NP (NP (NN Phase) (NN I) (NN trial)) (PP (IN of) (NP (NP (NNS Doc_7707116_17_37_Chemical)) (PP (IN in) (NP (NP (NNS children)) (PP (IN with) (NP (NP (NNS Doc_7707116_55_68_Disease)) (PP (VBG following) (NP (NN bone) (NN marrow) (NN transplantation))))))))) (. .)))
7707116	1	(ROOT (S (NP (NP (NNP Treatment)) (PP (IN of) (NP (NP (JJ Doc_7707116_130_143_Disease) (NN cell) (NNS lines)) (PP (IN with) (NP (NP (NNS Doc_7707116_160_180_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_7707116_182_188_Chemical)) (-RRB- -RRB-))))))) (VP (MD can) (VP (VB cause) (NP (NP (VBN sustained) (NN inhibition)) (PP (IN of) (NP (NN proliferation)))))) (. .)))
7707116	2	(ROOT (S (SBAR (IN Since) (S (NP (NNS Doc_7707116_245_251_Chemical)) (VP (VBZ has) (VP (VBN demonstrated) (NP (JJ clinical) (NNS responses)) (PP (IN in) (NP (JJ Doc_7707116_291_304_Disease) (NNS patients))))))) (, ,) (NP (PRP it)) (VP (MD may) (VP (VB be) (ADJP (JJ effective) (PP (IN in) (S (VP (VBG preventing) (NP (NN relapse)) (PP (IN after) (NP (JJ cytotoxic) (NN therapy))))))))) (. .)))
7707116	3	(ROOT (S (NP (DT This) (NN phase) (NN I) (NN trial)) (VP (VBD was) (VP (VBN designed) (S (VP (TO to) (VP (VB determine) (NP (NP (NP (DT the) (JJ maximal-tolerated) (NN dosage)) (PRN (-LRB- -LRB-) (NP (NNP MTD)) (-RRB- -RRB-)) (, ,) (NP (NNS Doc_7707116_463_473_Disease))) (, ,) (CC and) (NP (NP (NNS pharmacokinetics)) (PP (IN of) (NP (NP (NNS Doc_7707116_499_505_Chemical)) (VP (VBN administered) (PP (IN on) (NP (NP (DT an) (JJ intermittent) (NN schedule)) (PP (IN in) (NP (NNS children))))) (PP (IN with) (NP (NP (NNS Doc_7707116_564_577_Disease)) (PP (VBG following) (NP (NP (NN bone) (NN marrow) (NN transplantation)) (PRN (-LRB- -LRB-) (NP (NNP BMT)) (-RRB- -RRB-)))))))))))))))) (. .)))
7707116	4	(ROOT (FRAG (NP (NNS PATIENTS) (CC AND) (NNS METHODS)) (: :) (S (NP (NP (JJ Fifty-one) (NN assessable) (NNS patients)) (, ,) (NP (NP (QP (CD 2) (TO to) (CD 12)) (NNS years)) (PP (IN of) (NP (NN age)))) (, ,)) (VP (VBD were) (VP (VBN treated) (PP (IN with) (NP (NP (JJ oral) (NNS Doc_7707116_721_727_Chemical)) (VP (VBN administered) (PP (IN in) (NP (CD two))) (NP (ADJP (RB equally) (VBN divided)) (NNS doses))))) (ADVP (RB daily)) (PP (IN for) (NP (CD 2) (NNS weeks))) (, ,) (VP (VBN followed) (PP (IN by) (NP (DT a) (JJ 2-week) (NN rest) (NN period)))) (, ,) (PP (IN for) (NP (QP (IN up) (TO to) (CD 12)) (NNS courses)))))) (. .)))
7707116	5	(ROOT (S (NP (DT The) (NN dose)) (VP (VBD was) (VP (VBN escalated) (PP (IN from) (NP (QP (CD 100) (TO to) (CD 200)) (NNS mg/m2/d))) (SBAR (IN until) (S (NP (NP (JJ dose-limiting) (NNS Doc_7707116_912_920_Disease)) (PRN (-LRB- -LRB-) (NP (NNP DLT)) (-RRB- -RRB-))) (VP (VBD was) (ADJP (JJ observed))))))) (. .)))
7707116	6	(ROOT (S (NP (DT A) (JJ single) (NN intrapatient) (NN dose) (NN escalation)) (VP (VBD was) (VP (VBN permitted))) (. .)))
7707116	7	(ROOT (S (NP (NP (DT The) (NNP MTD)) (PP (IN of) (NP (NNS Doc_7707116_1014_1020_Chemical)))) (VP (VBD was) (NP (CD 160) (NNS mg/m2/d))) (. .)))
7707116	8	(ROOT (S (NP (NP (JJ Dose-limiting) (NNS Doc_7707116_1052_1062_Disease)) (PP (IN in) (NP (NP (CD six)) (PP (IN of) (NP (NP (CD nine) (NNS patients)) (PP (IN at) (NP (CD 200) (NNS mg/m2/d)))))))) (VP (VBD included) (NP (NP (NP (NNS Doc_7707116_1111_1124_Disease)) (PRN (-LRB- -LRB-) (VP (VBN n) (S (VP (SYM =) (NP (CD 3))))) (-RRB- -RRB-))) (, ,) (NP (NP (NNS Doc_7707116_1134_1138_Disease)) (PRN (-LRB- -LRB-) (VP (VBN n) (S (VP (SYM =) (NP (CD 2))))) (-RRB- -RRB-))) (, ,) (CC and) (NP (NP (NNP Doc_7707116_1152_1158_Disease) (NNP /) (NNP Doc_7707116_1159_1175_Disease) (PRN (: /) (NP (NNP Doc_7707116_1176_1182_Disease)) (: /)) (NNS Doc_7707116_1183_1187_Disease)) (PRN (-LRB- -LRB-) (VP (VBN n) (S (VP (SYM =) (NP (CD 1))))) (-RRB- -RRB-))))) (. .)))
7707116	9	(ROOT (S (NP (DT All) (NNS Doc_7707116_1201_1211_Disease)) (VP (VBD resolved) (SBAR (IN after) (S (NP (NNS Doc_7707116_1227_1233_Chemical)) (VP (VBD was) (VP (VBN discontinued)))))) (. .)))
7707116	10	(ROOT (S (NP (CD Three) (JJ complete) (NNS responses)) (VP (VBD were) (VP (VBN observed) (PP (IN in) (NP (NN marrow) (NNS Doc_7707116_1301_1311_Disease))))) (. .)))
7707116	11	(ROOT (FRAG (NP (NP (JJ Serum) (NNS levels)) (PP (IN of) (NP (NP (QP (CD 7.4) (CD +)) (NNS /)) (: -) (NP (CD 3.0) (NN mumol/L) (PRN (-LRB- -LRB-) (NP (NN peak)) (-RRB- -RRB-))) (CC and) (NP (QP (CD 4.0) (CD +)) (NNS /))))) (: -) (S (NP (NP (CD 2.8) (NN mumol/L) (PRN (-LRB- -LRB-) (NP (NN trough)) (-RRB- -RRB-))) (PP (IN at) (NP (DT the) (NNP MTD)))) (VP (VBD were) (VP (VBN maintained) (PP (IN during) (NP (NP (CD 14) (NNS days)) (PP (IN of) (NP (NN therapy)))))))) (. .)))
7707116	12	(ROOT (S (NP (DT The) (NNP DLT)) (VP (VBD correlated) (PP (IN with) (NP (NN serum) (NNS levels))) (S (VP (VBG >) (CC or) (VBG =) (NP (CD 10) (NN mumol/L))))) (. .)))
7707116	13	(ROOT (S (NP (NP (DT The) (NNP MTD)) (PP (IN of) (NP (NP (NNS Doc_7707116_1522_1528_Chemical)) (PP (VBN given) (PP (IN on) (NP (DT this) (JJ intermittent) (NN schedule))))))) (VP (VBD was) (NP (CD 160) (NNS mg/m2/d))) (. .)))
7707116	14	(ROOT (S (NP (NP (JJ Serum) (NNS levels)) (VP (VBN known) (S (VP (TO to) (VP (VB be) (ADJP (JJ effective) (PP (IN against) (NP (NP (NNS Doc_7707116_1625_1638_Disease)) (PP (IN in) (NP (NNP vitro))))))))))) (VP (VBD were) (VP (VBN achieved) (PP (IN at) (NP (DT this) (NN dose))))) (. .)))
7707116	15	(ROOT (S (NP (DT The) (NNP DLT)) (VP (VP (VBD included) (NP (NNS Doc_7707116_1693_1706_Disease))) (, ,) (CC and) (VP (MD may) (VP (VB be) (VP (VBN predicted) (PP (IN by) (NP (JJ serum) (JJ Doc_7707116_1738_1744_Chemical) (NNS levels))))))) (. .)))
7707116	16	(ROOT (S (NP (NP (NN Monitoring)) (PP (IN of) (NP (NN serum) (NNS Doc_7707116_1773_1780_Chemical) (CC and) (NNS Doc_7707116_1785_1791_Chemical) (NNS levels)))) (VP (VBZ is) (VP (VBN indicated) (PP (IN in) (NP (JJ future) (NNS trials))))) (. .)))
7710775	0	(ROOT (NP (NP (NN Time) (NN dependence)) (PP (IN of) (NP (NP (NN plasma) (NNS Doc_7710775_26_41_Chemical)) (, ,) (NP (NNS Doc_7710775_43_53_Chemical)) (, ,) (CC and) (NP (NNS Doc_7710775_59_70_Chemical)))) (PP (IN during) (NP (JJ incomplete) (NNS Doc_7710775_89_106_Disease))) (PP (IN in) (NP (DT the) (NN rat))) (. .)))
7710775	1	(ROOT (S (NP (NP (JJ Incomplete) (NNS Doc_7710775_130_147_Disease)) (PRN (-LRB- -LRB-) (NP (QP (CD 30) (CD min))) (-RRB- -RRB-))) (VP (VBD was) (VP (VBN induced) (PP (IN in) (NP (DT the) (NN rat))) (PP (IN by) (S (ADVP (RB bilaterally)) (VP (VBG clamping) (NP (DT the) (JJ common) (JJ carotid) (NNS arteries))))))) (. .)))
7710775	2	(ROOT (S (NP (JJ Peripheral) (JJ venous) (NN blood) (NNS samples)) (VP (VBD were) (VP (VBN withdrawn) (PP (IN from) (NP (DT the) (JJ femoral) (NN vein))) (NP (CD four) (NNS times)) (PRN (-LRB- -LRB-) (SBAR (IN once) (S (NP (DT every) (CD 5)) (VP (VBP min)))) (-RRB- -RRB-)) (PP (IN before) (NP (NP (NP (NNS Doc_7710775_339_347_Disease)) (PRN (-LRB- -LRB-) (NP (CD 0) (NN time)) (-RRB- -RRB-))) (CC and) (NP (NP (CD 5) (, ,) (CD 15) (, ,) (CC and) (CD 30)) (VP (VBN min) (PP (IN after) (NP (NNS Doc_7710775_385_393_Disease))))))))) (. .)))
7710775	3	(ROOT (S (NP (NNP Plasma) (NNS extracts)) (VP (VBD were) (VP (VBN analyzed) (PP (IN by) (NP (NP (DT a) (ADJP (RB highly) (JJ sensitive)) (JJ high-performance) (NN liquid) (NN chromatographic) (NN method)) (PP (IN for) (NP (NP (DT the) (JJ direct) (NN determination)) (PP (IN of) (NP (NNS Doc_7710775_526_541_Chemical) (, ,) (NNS Doc_7710775_543_553_Chemical) (, ,) (CC and) (NNS Doc_7710775_559_570_Chemical))))))))) (. .)))
7710775	4	(ROOT (S (PP (IN During) (NP (NNS Doc_7710775_579_587_Disease))) (, ,) (NP (NP (DT a) (JJ time-dependent) (NN increase)) (PP (IN of) (NP (NN plasma) (NNS Doc_7710775_625_635_Chemical) (CC and) (NNS Doc_7710775_640_651_Chemical)))) (VP (VBD was) (ADJP (JJ observed))) (. .)))
7710775	5	(ROOT (S (NP (NP (NNP Plasma) (NNP Doc_7710775_673_688_Chemical)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD was) (ADJP (JJ present) (PP (IN in) (NP (JJ minimal) (NN amount)))) (PP (IN at) (NP (NP (CD zero) (NN time)) (PRN (-LRB- -LRB-) (NP (NP (CD 0.058) (NN mumol/liter) (NN plasma)) (: ;) (NP (NNP SD) (CD 0.015))) (-RRB- -RRB-))))))) (, ,)) (VP (VBD increased) (PP (IN after) (NP (NP (CD 5) (NN min)) (PP (IN of) (NP (NNS Doc_7710775_802_810_Disease))))) (, ,) (S (VP (VBG resulting) (PP (IN in) (NP (DT a) (JJ fivefold) (NN increase))) (PP (IN after) (NP (NP (CD 30) (NN min)) (PP (IN of) (NP (NP (JJ carotid) (NN occlusion)) (PRN (-LRB- -LRB-) (NP (NP (CD 0.298) (NN mumol/liter) (NN plasma)) (: ;) (NP (NNP SD) (CD 0.078))) (-RRB- -RRB-))))))))) (. .)))
7710775	6	(ROOT (S (NP (VBN Increased) (NN plasma) (NNS Doc_7710775_934_949_Chemical)) (VP (VBD was) (ADVP (RB also)) (VP (VBN recorded) (PP (IN in) (NP (NP (CD two) (JJ other) (NNS groups)) (PP (IN of) (NP (NP (NNS animals)) (VP (VBN subjected) (PP (TO to) (NP (NP (DT the) (JJ same) (JJ experimental) (NN model)) (, ,) (NP (NP (CD one)) (VP (VBG receiving) (NP (NP (CD 20) (JJ mg/kg) (NN b.w.)) (PP (IN of) (NP (DT the) (JJ cyclooxygenase) (NN inhibitor) (NNS Doc_7710775_1101_1117_Chemical) (NN intravenously)))) (ADVP (RB immediately)) (PP (IN before) (NP (NP (NNS Doc_7710775_1151_1159_Disease)) (, ,) (NP (NP (DT the) (JJ other) (NN receiving) (CD 650) (NN micrograms/kg) (NN b.w.)) (PP (IN of) (NP (DT the) (JJ Doc_7710775_1211_1222_Disease) (NN drug) (NNS Doc_7710775_1228_1241_Chemical)))))) (PP (IN at) (NP (NP (DT a) (NN flow) (NN rate)) (PP (IN of) (NP (NP (CD 103) (NN microliters/min) (NN intravenously)) (PP (IN during) (NP (NNS Doc_7710775_1301_1309_Disease))))))) (, ,) (SBAR (IN although) (S (PP (IN in) (NP (DT this) (JJ latter) (NN group))) (NP (NNS Doc_7710775_1341_1356_Chemical)) (VP (VBD was) (ADJP (RB significantly) (JJR higher)))))))))))))))) (. .)))
7710775	7	(ROOT (S (NP (DT The) (JJ present) (NNS data)) (VP (VBP indicate) (SBAR (IN that) (S (NP (NP (DT the) (NN determination)) (PP (IN of) (NP (NP (NNS Doc_7710775_1435_1450_Chemical)) (, ,) (NP (NNS Doc_7710775_1452_1462_Chemical)) (, ,) (CC and) (NP (NP (NNS Doc_7710775_1468_1479_Chemical)) (PP (IN in) (NP (JJ peripheral) (NN blood)))) (, ,)))) (VP (MD may) (VP (VB be) (VP (VBN used) (S (VP (TO to) (VP (VB monitor) (NP (NP (DT the) (JJ metabolic) (NNS alterations)) (PP (IN of) (NP (NP (NNS tissues)) (VP (VBG occurring) (PP (IN during) (NP (NP (NNP Doc_7710775_1578_1586_Disease) (NNP phenomena) (. .)) (PRN (-LRB- -LRB-) (NP (NP (NNP ABSTRACT) (NNP TRUNCATED) (NNP AT)) (NP (CD 250) (NNS WORDS))) (-RRB- -RRB-)))))))))))))))))))
7724492	0	(ROOT (NP (NP (NP (JJ Acute) (NNS Doc_7724492_6_20_Disease)) (PP (IN of) (NP (NP (NNS Doc_7724492_24_35_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_7724492_37_47_Chemical)) (-RRB- -RRB-))))) (: -) (NP (NP (JJ loaded) (NNS Doc_7724492_56_69_Chemical)) (NP (NNS nanoparticles))) (. .)))
7724492	1	(ROOT (S (NP (NP (JJ Acute) (NN Doc_7724492_91_102_Chemical-loaded) (NN nanoparticle)) (PRN (-LRB- -LRB-) (NP (NNP DXNP)) (-RRB- -RRB-)) (NNS Doc_7724492_130_144_Disease)) (VP (VBD was) (VP (VBN explored) (PP (IN in) (NP (NP (DT both) (JJ normal) (NNS rats) (CC and) (NNS rats)) (PP (IN with) (NP (JJ experimental) (NNS Doc_7724492_205_223_Disease))))))) (. .)))
7724492	2	(ROOT (S (PP (IN In) (NP (JJ normal) (NNS rats))) (, ,) (NP (NP (CD 2/6) (NNS rats)) (VP (VBN given) (NP (NP (NP (JJ free) (NNS Doc_7724492_261_272_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_7724492_274_276_Chemical)) (-RRB- -RRB-))) (PRN (-LRB- -LRB-) (NP (CD 5) (NN mg/kg)) (-RRB- -RRB-))))) (VP (VBD died) (PP (IN within) (NP (CD one))) (NP (NN week)) (, ,) (SBAR (IN whereas) (S (NP (DT all)) (VP (VBP control) (S (NP (NP (NNS animals)) (CC and) (NP (DT all) (NNS rats))) (VP (VBG having) (VP (VBN received) (ADJP (JJ free) (SBAR (S (NP (NNP NP) (CC or) (NNP DXNP)) (VP (VBD survived)))))))))))) (. .)))
7724492	3	(ROOT (S (NP (DT A) (ADJP (NP (CD 3) (NNS times)) (JJR higher)) (NNS Doc_7724492_410_421_Disease)) (VP (VBD appeared) (PP (IN in) (NP (NP (NNS animals)) (VP (VBN treated) (PP (IN with) (NP (NNP DXNP))) (PP (IN than) (IN in) (NP (NP (DT those)) (VP (VBN treated) (PP (IN with) (NP (NNP DX)))))))))) (. .)))
7724492	4	(ROOT (S (NP (NNP Free) (NNP NP)) (VP (VBD did) (RB not) (VP (VB provoke) (NP (DT any) (NNS Doc_7724492_519_530_Disease)))) (. .)))
7724492	5	(ROOT (S (S (ADJP (NP (CD Two) (NNS hr)) (JJ post-injection))) (, ,) (NP (NNP DXNP)) (VP (VBD was) (ADJP (ADJP (QP (CD 2.7) (NNS times)) (RBR more) (JJ concentrated)) (PP (IN in) (NP (NP (NNS kidneys)) (PP (IN than) (NP (JJ free) (NNS Doc_7724492_613_615_Chemical)))))) (PRN (-LRB- -LRB-) (ADVP (RB p)) (ADJP (JJ <) (NP (CD 0.025))) (-RRB- -RRB-))) (. .)))
7724492	6	(ROOT (S (PP (IN In) (NP (NP (NNS rats)) (PP (IN with) (NP (JJ immune) (JJ experimental) (NNS Doc_7724492_662_680_Disease))))) (, ,) (NP (NP (CD 5/6) (NNS rats)) (VP (VBN given) (NP (NNS Doc_7724492_697_699_Chemical)))) (VP (VBD died) (PP (IN within) (NP (CD 7) (NNS days))) (, ,) (PP (IN in) (NP (NP (NN contrast)) (PP (TO to) (NP (NP (NNS animals)) (VP (VBN treated) (PP (IN by) (NP (NNP DXNP) (, ,) (NNP NP) (, ,) (CC or) (NNP untreated)))) (, ,) (SBAR (WHNP (WDT which)) (S (RB all) (VP (VBN survived))))))))) (. .)))
7724492	7	(ROOT (S (NP (NNP Doc_7724492_798_809_Disease)) (VP (VP (VBD appeared) (PP (IN in) (NP (DT all) (NN series)))) (, ,) (CC but) (VP (VBD was) (ADJP (ADJP (ADJP (QP (CD 2-5) (NNS times)) (RBR more) (JJ intense)) (PRN (-LRB- -LRB-) (NP (NNP p) (QP (CD >) (CD 0.001))) (-RRB- -RRB-))) (CC and) (ADJP (JJ prolonged) (PP (IN after) (NP (NP (JJ Doc_7724492_897_908_Chemical) (NN treatment)) (PRN (-LRB- -LRB-) (NP (CD 400-700) (NN mg/day)) (-RRB- -RRB-))))) (, ,)) (PP (IN without) (NP (NP (JJ significant) (NN difference)) (PP (IN between) (NP (NNP DXNP) (CC and) (NNP DX))))))) (. .)))
7724492	8	(ROOT (S (NP (NP (NNS Rats)) (VP (VBN treated) (PP (IN by) (NP (NNP unloaded) (NNP NP))))) (VP (VBD behaved) (PP (IN as) (NP (NNS controls)))) (. .)))
7724492	9	(ROOT (S (NP (DT These) (NNS results)) (VP (VBP demonstrate) (SBAR (IN that) (S (, ,) (PP (IN in) (NP (DT these) (JJ experimental) (NNS conditions))) (, ,) (NP (NNP DXNP)) (VP (VBD killed) (NP (JJR less) (NNS animals)) (PP (IN than) (NP (JJ free) (NNP DX))) (, ,) (PP (IN despite) (IN of) (NP (NP (DT an) (VBN enhanced) (NNS Doc_7724492_1166_1180_Disease)) (PP (IN of) (NP (DT the) (JJ former))))))))) (. .)))
7724492	10	(ROOT (S (NP (NP (DT Both) (NNS effects)) (PRN (-LRB- -LRB-) (NP (NP (JJR better) (NN survival)) (CC and) (NP (NNS Doc_7724492_1230_1239_Disease))) (-RRB- -RRB-))) (VP (VBP are) (ADJP (ADVP (RBS most) (RB probably)) (VBN related) (PP (TO to) (NP (NP (DT an) (JJ enhanced) (NN capture)) (PP (IN of) (NP (NNP DXNP)))))) (PP (IN by) (NP (NP (NNS cells)) (PP (IN of) (NP (DT the) (NN mononuclear) (NN phagocyte) (NN system))) (, ,) (PP (VBG including) (NP (JJ mesangial) (NNS cells)))))) (. .)))
7752389	0	(ROOT (NP (NP (NP (JJ Doc_7752389_0_16_Chemical-induced) (NNS Doc_7752389_25_46_Disease)) (PP (IN in) (NP (JJ normal) (, ,) (JJ conscious) (NNS rats)))) (: :) (NP (NP (NN involvement)) (PP (IN of) (NP (NNS Doc_7752389_89_100_Chemical)))) (. ?)))
7752389	1	(ROOT (S (PP (IN In) (NP (NP (JJ normal) (JJ conscious) (NNS rats)) (VP (VBN investigated) (PP (IN by) (NP (JJ continuous) (NN cystometry)))))) (, ,) (NP (ADJP (RB intravesically) (JJ instilled)) (NNS Doc_7752389_191_212_Chemical)) (VP (VBD facilitated) (NP (NP (NN micturition)) (CC and) (NP (VBN increased) (JJ basal) (NN intravesical) (NN pressure)))) (. .)))
7752389	2	(ROOT (S (NP (DT The) (NN effect)) (VP (VBD was) (VP (VBN attenuated) (PP (IN by) (S (NP (NP (PDT both) (DT the) (NN NK1) (JJ receptor) (JJ selective) (NN antagonist) (NNS Doc_7752389_352_361_Chemical)) (CC and) (NP (NP (DT the) (NN NK2) (NN receptor)) (NP (JJ selective) (NN antagonist) (NNS Doc_7752389_404_413_Chemical)))) (, ,) (PP (VBN given) (NP (NN intra-arterially))) (, ,) (VP (VBG suggesting) (SBAR (IN that) (S (NP (PRP it)) (VP (VBD was) (VP (VBN mediated) (PP (IN by) (NP (NP (NN stimulation)) (PP (IN of) (NP (DT both) (NNP NK1) (CC and) (NNP NK2) (NNS receptors)))))))))))))) (. .)))
7752389	3	(ROOT (S (NP (JJ Intra-arterially) (VBN given) (NNS Doc_7752389_540_544_Chemical)) (VP (VBD produced) (NP (DT a) (JJ distinct) (NN increase)) (PP (IN in) (NP (NN bladder) (NN pressure))) (PP (IN before) (S (VP (VBG initiating) (NP (DT a) (NN micturition) (NN reflex))))) (, ,) (S (VP (VBG indicating) (SBAR (IN that) (S (NP (DT the) (NNP PG)) (VP (VBD had) (NP (NP (DT a) (JJ direct) (NN contractant) (NN effect)) (PP (IN on) (NP (DT the) (JJ detrusor) (JJ smooth) (NN muscle)))))))))) (. .)))
7752389	4	(ROOT (S (NP (NP (DT The) (NN effect)) (PP (IN of) (NP (JJ intra-arterial) (NNS Doc_7752389_749_753_Chemical)))) (VP (MD could) (RB not) (VP (VB be) (VP (VBN blocked) (PP (IN by) (NP (NP (JJ intra-arterial) (NNS Doc_7752389_793_802_Chemical)) (CC or) (NP (NP (NNP SR) (CD 48,968)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ opens) (NP (DT the) (NN possibility)) (SBAR (IN that) (S (NP (NP (DT the) (JJ micturition) (JJ reflex) (NN elicited)) (PP (IN by) (NP (JJ intra-arterial) (NNS Doc_7752389_900_904_Chemical)))) (VP (VBD was) (VP (VBN mediated) (PP (IN by) (NP (NP (NNS pathways)) (PP (JJ other) (IN than) (NP (NP (DT the) (NN reflex)) (VP (VBN initiated) (SBAR (WHADVP (WRB when)) (S (NP (DT the) (NNP PG)) (VP (VBD was) (VP (VBN given) (ADVP (RB intravesically)))))))))))))))))))))))) (. .)))
7752389	5	(ROOT (S (NP (DT The) (JJ present) (NNS results)) (ADVP (RB thus)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NP (JJ intra-arterial) (NNS Doc_7752389_1053_1057_Chemical)) (, ,) (VP (VBN given) (PP (IN near) (NP (DT the) (NN bladder)))) (, ,)) (VP (MD may) (VP (VB initiate) (NP (NP (NN micturition)) (PP (IN in) (NP (DT the) (JJ normal) (NN rat)))) (PP (ADVP (RB chiefly)) (IN by) (S (VP (ADVP (RB directly)) (VBG contracting) (NP (NP (DT the) (JJ smooth) (NN muscle)) (PP (IN of) (NP (DT the) (NN detrusor)))))))))))) (. .)))
7752389	6	(ROOT (S (ADVP (RB However)) (, ,) (SBAR (WHADVP (WRB when)) (S (VP (VBN given) (ADVP (RB intravesically))))) (, ,) (NP (NNS Doc_7752389_1229_1233_Chemical)) (VP (MD may) (VP (VB stimulate) (NP (NN micturition)) (PP (IN by) (S (VP (VBG releasing) (NP (NNS Doc_7752389_1273_1284_Chemical)) (PP (IN from) (NP (NP (NNS nerves)) (PP (IN in) (S (VP (VBG and/or) (ADVP (RB immediately)) (PP (IN below) (NP (DT the) (NN urothelium))))))))))))) (. .)))
7752389	7	(ROOT (S (NP (NP (DT These) (NNS Doc_7752389_1347_1358_Chemical)) (, ,) (PP (IN in) (NP (NN turn))) (, ,)) (VP (VBP initiate) (NP (DT a) (NN micturition) (NN reflex)) (PP (IN by) (S (VP (VBG stimulating) (NP (NNP NK1) (CC and) (NNP NK2) (NNS receptors)))))) (. .)))
7752389	8	(ROOT (S (NP (NNP Doc_7752389_1437_1448_Chemical)) (VP (MD may) (, ,) (PP (IN via) (NP (NP (NN release)) (PP (IN of) (NP (NNS Doc_7752389_1469_1480_Chemical))))) (, ,) (VP (VB contribute) (PP (TO to) (NP (NP (DT both) (NN urge) (CC and) (NNS Doc_7752389_1510_1531_Disease)) (VP (VBN seen) (PP (IN in) (NP (NP (JJ inflammatory) (NNS conditions)) (PP (IN of) (NP (DT the) (JJR lower) (NN urinary) (NN tract)))))))))) (. .)))
7785794	0	(ROOT (S (ADVP (RB Refractory)) (VP (VB Doc_7785794_11_28_Disease) (CC and) (VB complete) (NP (NNS Doc_7785794_42_53_Disease)) (PP (IN after) (NP (NP (NNP Doc_7785794_60_69_Chemical) (NNP SR)) (CC and) (NP (JJ Doc_7785794_77_87_Chemical) (NN treatment))))) (. .)))
7785794	1	(ROOT (S (NP (DT A) (NN case)) (VP (VBP report)) (. .)))
7785794	2	(ROOT (S (NP (DT A) (JJ seventy-eight-year-old) (NN woman)) (VP (VBD presented) (PP (IN with) (NP (NP (JJ complete) (NNS Doc_7785794_169_180_Disease)) (CC and) (NP (JJ refractory) (NNS Doc_7785794_196_207_Disease)))) (NP (CD two) (NNS days)) (PP (IN after) (NP (NP (DT a) (JJ therapeutic) (NN dose)) (PP (IN of) (NP (NP (JJ sustained-release) (NNS Doc_7785794_263_272_Chemical)) (PP (IN with) (NP (NP (JJ concomitant) (NN use)) (PP (IN of) (NP (NNS Doc_7785794_297_307_Chemical)))))))))) (. .)))
7785794	3	(ROOT (S (NP (DT The) (NN patient)) (VP (VBD continued) (S (VP (TO to) (VP (VB remain) (NP (NNS Doc_7785794_341_352_Disease)) (PP (PP (IN with) (NP (JJ complete) (NNS Doc_7785794_367_378_Disease))) (, ,) (RB even) (PP (IN with) (NP (NP (NP (JJ multiple) (NNS uses)) (PP (IN of) (NP (JJ intravenous) (NNS Doc_7785794_419_427_Chemical)))) (CONJP (RB as) (RB well) (IN as)) (NP (NP (JJ high) (NNS doses)) (PP (IN of) (NP (NP (NN pressor) (NNS agents)) (PP (JJ such) (IN as) (NP (NNS Doc_7785794_476_484_Chemical) (CC and) (NNS Doc_7785794_489_499_Chemical))))))))))))) (. .)))
7785794	4	(ROOT (S (ADVP (RB However)) (, ,) (PP (RB shortly) (IN after) (NP (NP (DT the) (NN use)) (PP (IN of) (NP (JJ intravenous) (NNS Doc_7785794_547_563_Chemical))))) (, ,) (NP (NP (DT the) (JJ refractory) (NNS Doc_7785794_580_591_Disease)) (CC and) (NP (JJ complete) (NNS Doc_7785794_605_616_Disease))) (VP (VBN resolved)) (. .)))
7791169	0	(ROOT (S (NP (NP (JJ Protective) (NN effect)) (PP (IN of) (NP (NP (NNS Doc_7791169_21_32_Chemical)) (PP (IN on) (NP (NNS Doc_7791169_36_48_Chemical)))))) (VP (VBN induced) (NP (NP (NNS Doc_7791169_57_74_Disease)) (PP (IN in) (NP (JJ elderly) (NNS patients))))) (. .)))
7791169	1	(ROOT (S (S (VP (TO To) (VP (VB evaluate) (NP (NP (DT the) (JJ possible) (JJ protective) (NNS effects)) (PP (IN of) (NP (NP (NNS Doc_7791169_154_165_Chemical)) (PP (IN on) (NP (JJ renal) (NN function)))))) (PP (IN in) (NP (JJ hospitalized) (JJ elderly) (NNS patients)))))) (VP (VBN treated) (PP (IN with) (NP (NNS Doc_7791169_230_242_Chemical)))) (. .)))
7791169	2	(ROOT (S (NP (NP (NNP Forty-five)) (VP (VBN hospitalized) (NP (NP (JJ elderly) (NNS patients)) (PRN (-LRB- -LRB-) (ADJP (NP (QP (CD >) (CD 65)) (NNS years)) (JJ old)) (-RRB- -RRB-)) (SBAR (WHNP (WP who)) (S (VP (VBD required) (NP (NN therapy)) (PP (IN with) (NP (JJ nonsteroidal) (NN antiinflammatory) (NNS drugs)))))))) (PRN (-LRB- -LRB-) (NP (NNP NSAID)) (-RRB- -RRB-))) (VP (VBD were) (ADVP (RB randomly)) (VP (VBN assigned) (S (VP (TO to) (VP (VB receive) (NP (NP (DT either) (NNS Doc_7791169_422_434_Chemical)) (, ,) (NP (CD 150) (NN mg/day) (PRN (-LRB- -LRB-) (NP (NNP Group) (NNP A)) (-RRB- -RRB-))) (, ,) (CC or) (NP (NP (QP (CD Doc_7791169_461_473_Chemical) (CD 150)) (JJ mg/day) (NN plus) (NNS Doc_7791169_490_501_Chemical)) (PP (IN at) (NP (NP (CD 0.6) (NN mg/day)) (PRN (-LRB- -LRB-) (NP (NNP Group) (NNP B)) (-RRB- -RRB-))))))))))) (. .)))
7791169	3	(ROOT (S (NP (NP (NNP Laboratory) (NNS variables)) (PP (IN of) (NP (NP (JJ renal) (NN function) (NN -LSB-) (NN serum) (NNS Doc_7791169_573_583_Chemical)) (, ,) (NP (NP (NN blood) (NNS Doc_7791169_591_595_Chemical)) (NP (NP (NNS Doc_7791169_596_604_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP BUN)) (-RRB- -RRB-)))) (CC and) (NP (JJ electrolytes) (NNS -RSB-))))) (VP (VBD were) (VP (VBN evaluated) (PP (IN before) (NP (NP (NN initiation)) (PP (IN of) (NP (NP (NN therapy)) (CC and) (NP (DT every) (CD 2) (NNS days)))))) (, ,) (PP (IN until) (NP (NP (NN termination)) (PP (IN of) (NP (NP (DT the) (NN study)) (PRN (-LRB- -LRB-) (NP (NP (DT a) (NN period)) (PP (IN of) (NP (QP (IN at) (JJS least) (CD 6)) (NNS days)))) (-RRB- -RRB-)))))))) (. .)))
7791169	4	(ROOT (S (NP (NP (NNP Response)) (PP (TO to) (NP (NN treatment)))) (VP (VBD was) (VP (VBN estimated) (PP (IN by) (NP (NP (DT the) (JJ visual) (JJ analog) (NN scale)) (PP (IN for) (NP (NP (NN severity)) (PP (IN of) (NP (NNS Doc_7791169_832_836_Disease))))))))) (. .)))
7791169	5	(ROOT (S (S (NP (JJ Forty-two) (NNS patients)) (VP (VBD completed) (NP (NP (DT the) (NN study)) (, ,) (NP (NP (CD 22)) (PP (IN in) (NP (NNP Group) (NNP A)))) (CC and) (NP (NP (CD 20)) (PP (IN in) (NP (NNP Group) (NNP B.) (NNP BUN))))))) (CC and) (S (NP (NNS Doc_7791169_928_938_Chemical)) (VP (VBD increased) (PP (IN by) (NP (NP (NP (QP (CD >) (CD 50)) (NN %)) (PP (IN of) (NP (NP (NN baseline) (NNS levels)) (PP (IN in) (NP (CD 54)))))) (CC and) (NP (NP (CD 45) (NN %)) (PP (IN of) (NP (NNP Group) (NNP A) (NNS patients)))))) (, ,) (ADVP (RB respectively)) (, ,) (PP (VBN compared) (PP (TO to) (NP (NP (QP (RB only) (CD 20) (CC and) (CD 10)) (NN %)) (PP (IN of) (NP (NNP Group) (NNP B) (NNS patients))) (PRN (-LRB- -LRB-) (VP (VBN p) (NP (CD <) (CD 0.05))) (-RRB- -RRB-))))))) (. .)))
7791169	6	(ROOT (S (NP (NP (JJ Doc_7791169_1086_1095_Chemical) (PRN (-LRB- -LRB-) (NP (NNP Doc_7791169_1097_1098_Chemical)) (-RRB- -RRB-)) (NN increment)) (PP (IN of) (NP (NP (CD 0.6) (NN mEq/l)) (CC or) (NP (JJR more))))) (VP (VBD was) (VP (VBN observed) (PP (PP (IN in) (NP (NP (CD 50) (NN %)) (PP (IN of) (NP (NNP Group) (NNP A))))) (, ,) (CC but) (PP (IN in) (NP (NP (QP (RB only) (CD 15)) (NN %)) (PP (IN of) (NP (NNP Group) (NNP B) (NNS patients))) (PRN (-LRB- -LRB-) (VP (VBN p) (NP (CD <) (CD 0.05))) (-RRB- -RRB-))))))) (. .)))
7791169	7	(ROOT (S (S (NP (NP (DT The) (JJ mean) (NNS increments)) (PP (IN in) (NP (NNP BUN) (, ,) (NNP Doc_7791169_1239_1249_Chemical) (, ,) (CC and) (NNP K)))) (VP (VBD were) (VP (VBN reduced) (PP (IN by) (NP (NP (CD 63)) (, ,) (NP (CD 80))))))) (, ,) (CC and) (S (NP (NP (NP (CD 42) (NN %)) (, ,) (ADVP (RB respectively)) (, ,)) (PP (IN in) (NP (NP (NNP Group) (NNP B) (NNS patients)) (PP (VBN compared) (PP (TO to) (NP (NP (NNP Group) (NNP A.) (NNP Response)) (PP (TO to) (NP (NN treatment))))))))) (VP (VBD did) (RB not) (VP (VB differ) (ADVP (RB significantly)) (PP (IN between) (NP (DT the) (CD 2) (NNS groups)))))) (. .)))
7791169	8	(ROOT (S (NP (JJ Hospitalized) (JJ elderly) (NNS patients)) (VP (VBP are) (PP (IN at) (NP (NP (NN risk)) (PP (IN for) (NP (VBG developing) (JJ Doc_7791169_1487_1499_Chemical) (VBN related) (NNS Doc_7791169_1508_1525_Disease)))))) (. .)))
7791169	9	(ROOT (S (NP (NP (NNP Addition)) (PP (IN of) (NP (NNS Doc_7791169_1539_1550_Chemical)))) (VP (MD can) (VP (VB minimize) (NP (DT this) (NNS Doc_7791169_1569_1585_Disease)) (PP (IN without) (S (VP (VBG affecting) (NP (JJ Doc_7791169_1604_1608_Disease) (NN control))))))) (. .)))
7803371	0	(ROOT (NP (NP (NP (NNP Doc_7803371_0_23_Disease)) (PP (IN from) (NP (NP (JJ long-term) (NN abuse)) (PP (IN of) (NP (NNS Doc_7803371_48_64_Chemical)))))) (: :) (NP (DT a) (NN case) (NN report)) (. .)))
7803371	1	(ROOT (S (NP (NP (NNP Doc_7803371_81_97_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP DM)) (-RRB- -RRB-)) (, ,) (NP (NP (DT the) (JJ dextrorotatory) (NN isomer)) (PP (IN of) (NP (NNS Doc_7803371_133_160_Chemical)))) (, ,)) (VP (VBZ is) (NP (NP (DT the) (JJ main) (NN ingredient)) (PP (IN in) (NP (NP (DT a) (NN number)) (PP (IN of) (NP (ADJP (RB widely) (JJ available)) (, ,) (JJ over-the-counter) (NN antitussives))))))) (. .)))
7803371	2	(ROOT (S (NP (NP (JJ Initial) (NNS studies)) (PRN (-LRB- -LRB-) (NP (NNP Bornstein) (CD 1968)) (-RRB- -RRB-))) (VP (VBD showed) (SBAR (IN that) (S (NP (PRP it)) (VP (VBD possessed) (NP (NP (DT no) (ADJP (RB respiratory) (JJ suppressant)) (NNS effects)) (CC and) (NP (DT no) (NN addiction) (NN liability))))))) (. .)))
7803371	3	(ROOT (S (ADVP (RB Subsequently)) (, ,) (ADVP (RB however)) (, ,) (NP (NP (JJ several) (NNS articles)) (VP (VBG reporting) (NP (NP (NN abuse)) (PP (IN of) (NP (DT this) (NN drug)))))) (VP (VBP have) (VP (VBN appeared) (PP (IN in) (NP (DT the) (NN literature))))) (. .)))
7803371	4	(ROOT (S (NP (DT The) (NN drug)) (VP (VBZ is) (VP (VBN known) (S (VP (TO to) (VP (VB cause) (NP (NP (DT a) (NN variety)) (PP (IN of) (NP (JJ acute) (JJ toxic) (NNS effects)))) (, ,) (S (VP (VBG ranging) (PP (IN from) (NP (NP (NNS Doc_7803371_546_552_Disease)) (, ,) (NP (NNS Doc_7803371_554_566_Disease)) (, ,) (NP (NNS Doc_7803371_568_576_Disease)) (, ,) (NP (NNS Doc_7803371_578_584_Disease)) (, ,) (NP (JJ slurred) (NN speech)) (CC and) (NP (NNS Doc_7803371_605_614_Disease)))) (PP (TO to) (NP (NP (NN mood) (NNS changes)) (, ,) (NP (JJ perceptual) (NNS alterations)) (, ,) (NP (NN inattention)) (, ,) (NP (NN disorientation)) (CC and) (NP (NP (NNS Doc_7803371_688_707_Disease)) (-LRB- -LRB-) (NP (NP (NP (NNP Rammer) (CC et) (NNP al)) (NP (CD 1988))) (: ;) (NP (NP (NNP Katona)) (CC and) (NP (NNP Watson) (CD 1986))) (: ;) (NP (NP (NNP Isbell)) (CC and) (NP (NNP Fraser) (CD 1953))) (: ;) (NP (NP (NNP Devlin) (CC et) (NNP al)) (NP (CD 1985))) (: ;) (NP (NP (NNP McCarthy)) (NP (CD 1971))) (: ;) (NP (NP (NNP Dodds)) (CC and) (NP (NNP Revai) (CD 1967))) (: ;) (NP (NP (NNP Degkwitz)) (NP (CD 1964))) (: ;) (NP (NP (NNP Hildebrand) (CC et) (NNP al)) (NP (CD 1989)))) (-RRB- -RRB-))))))))))) (. .)))
7803371	5	(ROOT (S (NP (EX There)) (VP (VBP have) (ADVP (RB also)) (VP (VBN been) (NP (NP (CD two) (VBN reported) (NNS fatalities)) (PP (IN from) (NP (NP (NNP DM) (NNS overdoses)) (PRN (-LRB- -LRB-) (NP (NNP Fleming) (CD 1986)) (-RRB- -RRB-))))))) (. .)))
7803371	6	(ROOT (S (ADVP (RB However)) (, ,) (NP (EX there)) (VP (VBP are) (NP (NP (DT no) (NNS reports)) (VP (VBG describing) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (JJ chronic) (NN abuse))))))) (. .)))
7803371	7	(ROOT (S (NP (DT This) (NN report)) (VP (VBZ describes) (NP (NP (DT a) (NN case)) (PP (IN of) (NP (NP (NNS Doc_7803371_1053_1076_Disease)) (VP (VBG resulting) (PP (IN from) (NP (NP (VBN prolonged) (NN use)) (PP (IN of) (NP (NNP DM)))))))))) (. .)))
783197	0	(ROOT (S (NP (NP (NNPS Effects)) (PP (IN of) (NP (NP (NNS Doc_783197_11_18_Chemical)) (PP (IN on) (NP (JJ myocardial) (NNS Doc_783197_33_39_Chemical)))))) (VP (VBP supply) (CC and) (VBP demand) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ chronic) (NNS Doc_783197_83_106_Disease)))))) (. .)))
783197	1	(ROOT (NP (NP (DT A) (NN hemodynamic)) (, ,) (NP (NP (ADJP (JJ volumetric) (, ,) (CC and) (JJ metabolic)) (NN study)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN without) (NP (NNS Doc_783197_175_188_Disease)))))) (. .)))
783197	2	(ROOT (S (NP (NP (DT The) (NNS effects)) (PP (IN of) (NP (NP (NNS Doc_783197_205_225_Chemical)) (PP (IN on) (NP (NP (JJ myocardial) (JJ Doc_783197_240_246_Chemical) (NN supply)) (CC and) (NP (NN demand))))))) (VP (VP (VBP are) (PP (IN of) (NP (NP (JJ particular) (NN interest)) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (JJ obstructive) (NNS Doc_783197_323_346_Disease)))))))) (, ,) (CC but) (VP (VBP have) (RB not) (VP (VBN been) (VP (VBN measured) (ADVP (RB previously)) (PP (IN in) (NP (NN man))))))) (. .)))
783197	3	(ROOT (S (NP (PRP We)) (VP (VBD assessed) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NP (NP (NNS Doc_783197_421_428_Chemical)) (-LRB- -LRB-) (NP (CD 0.015) (JJ mg/kg) (NN body) (NN weight)) (-RRB- -RRB-)) (PP (IN on) (NP (JJ hemodynamic) (, ,) (ADJP (JJ volumetric) (, ,) (CC and) (JJ metabolic)) (NNS parameters)))))) (PP (IN in) (NP (NP (CD 11) (NNS patients)) (PP (IN with) (NP (JJ severe) (JJ chronic) (NNS Doc_783197_543_566_Disease))))) (PP (IN without) (NP (JJ clinical) (NNS Doc_783197_584_608_Disease)))) (. .)))
783197	4	(ROOT (S (SBAR (IN Because) (S (NP (DT the) (NN protocol)) (VP (VBD was) (NP (NP (ADJP (JJ long) (CC and) (VBN involved)) (NNS interventions)) (SBAR (WHNP (WDT which)) (S (VP (MD might) (VP (VB affect) (NP (DT the) (NNS determinations)))))))))) (, ,) (NP (PRP we)) (ADVP (RB also)) (VP (VBD studied) (PP (IN in) (NP (NP (CD nine) (NNS patients)) (VP (VBG using) (NP (DT an) (JJ identical) (NN protocol)) (SBAR (IN except) (S (NP (DT that) (JJ Doc_783197_779_786_Chemical) (NN administration)) (VP (VBD was) (VP (VBN omitted))))))))) (. .)))
783197	5	(ROOT (S (NP (NNP Left)) (VP (VP (VBP ventricular) (NP (JJ end-diastolic) (NN pressure))) (CC and) (VP (VBD left) (SBAR (S (NP (JJ ventricular) (JJ end-diastolic) (NN volume)) (VP (VBD fell) (PP (IN in) (NP (DT each) (JJ patient) (JJ given) (NNS Doc_783197_924_931_Chemical))) (, ,) (SBAR (RB even) (IN though) (S (NP (PRP they)) (VP (VBD were) (ADVP (RB initially)) (VP (VBN elevated) (PP (IN in) (NP (RB only) (CD two) (NNS patients)))))))))))) (. .)))
783197	6	(ROOT (SINV (VP (VBN Left) (SBAR (S (NP (JJ ventricular) (JJ end-diastolic) (NN pressure)) (VP (VP (VBD fell) (PP (IN from) (NP (NP (ADJP (QP (CD 11.5) (CD +))) (PRN (: /) (NP (NP (NP (CD -1.4)) (PRN (-LRB- -LRB-) (NP (JJ mean) (JJ +) (NNS /)) (, -) (NP (NNP SE)) (-RRB- -RRB-))) (PP (TO to) (NP (CD 5.6) (NNS +)))) (: /)) (NN -0.9) (NN mm) (NNS Hg)) (PRN (-LRB- -LRB-) (NP (NNP P) (QP (JJR less) (IN than) (CD 0.001))) (-RRB- -RRB-))))) (CC and) (VP (VBD left) (NP (JJ ventricular) (JJ end-diastolic) (NN volume))))))) (VP (VBD fell) (PP (IN from) (NP (NP (QP (CD 100) (CD +))) (PRN (: /) (NP (QP (CD -17) (TO to) (CD 82)) (NNS +)) (: /))))) (NP (NP (CD -12) (NNS ml/m2)) (PRN (-LRB- -LRB-) (NP (NNP P) (QP (JJR less) (IN than) (CD 0.01))) (-RRB- -RRB-)) (NP (NP (CD 1) (NN h)) (SBAR (IN after) (S (NP (JJ Doc_783197_1215_1222_Chemical) (NN infusion)) (VP (VBD was) (VP (VBN completed))))))) (. .)))
783197	7	(ROOT (S (NP (NP (DT The) (JJ maximum) (NN velocity)) (PP (IN of) (NP (JJ contractile) (NN element) (NN shortening)))) (VP (VP (VBD increased) (PP (IN from) (NP (NP (ADJP (QP (CD 1.68) (CD +))) (PRN (: /) (NP (NP (CD -0.11) (NNS ml/s)) (PP (TO to) (NP (CD 2.18) (NNS +)))) (: /)) (NN -0.21) (NNS muscle-lengths/s)) (PRN (-LRB- -LRB-) (NP (NNP P) (QP (JJR less) (IN than) (CD 0.05))) (-RRB- -RRB-))))) (CC and) (VP (VBZ is) (ADJP (JJ consistent) (PP (IN with) (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (NN contractility)))))))) (. .)))
783197	8	(ROOT (S (NP (NP (DT No) (JJ significant) (NN change)) (PP (IN in) (NP (DT these) (NNS parameters)))) (VP (VBD occurred) (PP (IN in) (NP (DT the) (NN control) (NNS patients)))) (. .)))
783197	9	(ROOT (S (S (NP (NP (DT No) (JJ significant) (NN change)) (PP (IN in) (NP (JJ myocardial) (JJ Doc_783197_1550_1556_Chemical) (NN consumption)))) (VP (VBD occurred) (PP (IN after) (NP (JJ Doc_783197_1584_1591_Chemical) (NN administration))))) (CC but) (S (NP (DT this)) (VP (MD may) (VP (VB be) (VP (VBN related) (PP (TO to) (NP (NP (DT a) (JJR greater) (NN decrease)) (PP (IN in) (NP (NP (JJ mean) (JJ arterial) (NN pressure)) (PP (IN in) (NP (DT the) (NN ouabain) (NNS patients))))))) (PP (IN than) (PP (IN in) (NP (DT the) (NN control) (NNS patients)))))))) (. .)))
783197	10	(ROOT (S (NP (PRP We)) (VP (VBP conclude) (NP (NP (DT that)) (PP (IN in) (NP (NNS patients)))) (PP (IN with) (NP (NP (JJ chronic) (NNS Doc_783197_1775_1798_Disease)) (SBAR (WHNP (WP who)) (S (VP (VBP are) (RB not) (PP (IN in) (NP (JJ clinical) (JJ Doc_783197_1823_1847_Disease) (NNS Doc_783197_1848_1891_Disease))) (PP (IN after) (NP (NP (JJ Doc_783197_1898_1905_Chemical) (NN administration)) (SBAR (WHADVP (RB even) (WRB when)) (S (NP (PRP it)) (VP (VBZ is) (ADVP (RB initially)) (ADJP (JJ normal))))))))))))) (. .)))
783197	11	(ROOT (S (SBAR (IN Though) (S (NP (DT this) (NN fall)) (VP (MD would) (VP (VB be) (VP (VBN associated) (PP (IN with) (NP (NP (NP (DT a) (NN decrease)) (PP (IN in) (NP (NN wall) (NN tension)))) (, ,) (CC and) (, ,) (ADVP (RB therefore)) (, ,) (PP (IN of) (NP (JJ myocardial) (JJ Doc_783197_2055_2061_Chemical) (NN consumption)))))))))) (, ,) (NP (PRP it)) (VP (MD may) (RB not) (VP (VB be) (PP (IN of) (NP (JJ sufficient) (NN magnitude))) (S (VP (TO to) (VP (VB prevent) (NP (DT a) (JJ net) (NN increase)) (PP (IN in) (NP (JJ myocardial) (JJ Doc_783197_2153_2159_Chemical) (NN consumption)))))))) (. .)))
783197	12	(ROOT (S (ADVP (RB Nevertheless)) (, ,) (NP (JJ compensatory) (NNS mechanisms)) (VP (VBP prevent) (NP (NP (DT a) (NN deterioration)) (PP (IN of) (NP (JJ resting) (JJ myocardial) (NN metabolism))))) (. .)))
7843916	0	(ROOT (NP (NP (JJ Doc_7843916_0_13_Chemical-induced) (NNS Doc_7843916_22_41_Disease)) (PP (IN in) (NP (JJ perfusion-cultured) (JJ human) (NNS eyes))) (. .)))
7843916	1	(ROOT (S (NP (JJ Glucocorticoid) (NN administration)) (VP (MD can) (VP (VB lead) (PP (TO to) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (NNS Doc_7843916_146_165_Disease) (CC and) (NNS Doc_7843916_170_193_Disease))))) (PP (IN in) (NP (NP (DT a) (NN subset)) (PP (IN of) (NP (DT the) (NN population))))) (PP (IN through) (NP (NP (DT a) (NN decrease)) (PP (IN in) (NP (DT the) (JJ aqueous) (NN humor) (NN outflow) (NN facility))))))) (. .)))
7843916	2	(ROOT (S (NP (NP (DT The) (NN purpose)) (PP (IN of) (NP (DT this) (NN study)))) (VP (VBD was) (S (VP (TO to) (VP (VB determine) (SBAR (IN whether) (S (NP (JJ glucocorticoid) (NN treatment)) (VP (MD can) (ADVP (RB directly)) (VP (VB affect) (NP (NP (DT the) (NN outflow) (NN facility)) (PP (IN of) (NP (JJ isolated) (, ,) (JJ perfusion-cultured) (JJ human) (NNS eyes)))))))))))) (. .)))
7843916	3	(ROOT (S (NP (NP (DT The) (NN anterior) (NNS segments)) (PP (IN of) (NP (NP (JJ human) (NN donor) (NNS eyes)) (PP (IN from) (NP (JJ regional) (NN eye) (NNS banks)))))) (VP (VBD were) (VP (VBN placed) (PP (IN in) (NP (NP (DT a) (JJ constant) (NN flow)) (, ,) (NP (JJ variable) (NN pressure) (NN perfusion) (NN culture) (NN system)))))) (. .)))
7843916	4	(ROOT (S (NP (JJ Paired) (NNS eyes)) (VP (VBD were) (VP (VBN perfused) (PP (IN in) (NP (NP (JJ serum-free) (NNS media)) (PP (PP (IN with)) (CC or) (PP (IN without) (NP (CD 10))) (NP (PRN (-LRB- -LRB-) (NP (CD -7)) (-RRB- -RRB-)) (NNP M) (NNS Doc_7843916_665_678_Chemical))))) (PP (IN for) (NP (CD 12) (NNS days))))) (. .)))
7843916	5	(ROOT (S (NP (JJ Intraocular) (NN pressure)) (VP (VBD was) (VP (VBN monitored) (ADVP (RB daily)))) (. .)))
7843916	6	(ROOT (S (PP (IN After) (NP (NN incubation))) (, ,) (NP (DT the) (NNS eyes)) (VP (VBD were) (ADJP (JJ morphologically) (S (S (VP (VBN characterized) (PP (IN by) (NP (NP (JJ light) (NN microscopy)) (, ,) (NP (NN transmission)) (CC and) (NP (JJ scanning) (NN electron) (NN microscopy)))))) (, ,) (CC and) (S (VP (VBG scanning) (NP (NN laser) (NN confocal)) (ADVP (RB microscopy))))))) (. .)))
7843916	7	(ROOT (NP (NP (NP (DT A) (JJ significant) (NN increase)) (PP (IN in) (NP (NP (JJ intraocular) (NN pressure)) (VP (VBN developed) (PP (IN in) (NP (NP (CD 13)) (PP (IN of) (NP (NP (DT the) (CD 44) (NNS pairs)) (PP (IN of) (NP (NP (NNS eyes)) (VP (VBN perfused) (PP (IN with) (NP (NP (NNS Doc_7843916_1014_1027_Chemical)) (PP (IN with) (NP (NP (DT an) (JJ average) (NN pressure) (NN rise)) (PP (IN of) (NP (CD 17.5) (JJ +) (NNS /)))))))))))))))))) (: -) (NP (NP (CD 3.8) (NN mm) (NNP Hg)) (PP (IN after) (NP (NP (CD 12) (NNS days)) (PP (IN of) (NP (JJ Doc_7843916_1097_1110_Chemical) (NN exposure)))))) (. .)))
7843916	8	(ROOT (S (NP (NP (DT The) (JJ contralateral) (NN control) (NNS eyes)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD did) (RB not) (VP (VB receive) (NP (NNS Doc_7843916_1175_1188_Chemical)))))) (, ,)) (VP (VBD maintained) (NP (DT a) (JJ stable) (JJ intraocular) (NN pressure)) (PP (IN during) (NP (DT the) (JJ same) (NN period)))) (. .)))
7843916	9	(ROOT (S (NP (NP (DT The) (NN outflow) (NN pathway)) (PP (IN of) (NP (DT the) (JJ untreated) (NNS eyes)))) (VP (VBD appeared) (ADJP (RB morphologically) (JJ normal))) (. .)))
7843916	10	(ROOT (S (PP (IN In) (NP (NN contrast))) (, ,) (NP (DT the) (NN Doc_7843916_1347_1360_Chemical-treated) (NNS Doc_7843916_1369_1386_Disease)) (VP (VBD had) (VP (VBN thickened) (NP (NP (NP (NN trabecular) (NNS beams)) (, ,) (NP (VBN decreased) (NN intertrabecular) (NNS spaces)) (, ,) (NP (NP (JJ thickened) (NN juxtacanalicular) (NN tissue)) (, ,) (NP (VBN activated) (NN trabecular) (NN meshwork) (NNS cells)) (, ,)) (CC and) (NP (NP (VBN increased) (NNS amounts)) (PP (IN of) (NP (NN amorphogranular) (NN extracellular) (NN material))))) (, ,) (ADJP (RB especially) (PP (PP (IN in) (NP (DT the) (NN juxtacanalicular) (NN tissue))) (CC and) (PP (IN beneath) (NP (NP (DT the) (JJ endothelial) (NN lining)) (PP (IN of) (NP (NP (DT the) (NN canal)) (PP (IN of) (NP (NNP Schlemm)))))))))))) (. .)))
7843916	11	(ROOT (S (NP (DT The) (NN Doc_7843916_1696_1709_Chemical-treated) (NN nonresponder) (NNS eyes)) (VP (VBD appeared) (S (VP (TO to) (VP (VB be) (ADJP (RB morphologically) (JJ similar) (PP (TO to) (NP (DT the) (JJ untreated) (NNS eyes)))) (, ,) (SBAR (IN although) (S (NP (JJ several) (JJ subtle) (NN Doc_7843916_1822_1835_Chemical-induced) (NN morphologic) (NNS changes)) (VP (VBD were) (ADJP (JJ evident))))))))) (. .)))
7843916	12	(ROOT (S (NP (NP (JJ Doc_7843916_1890_1903_Chemical) (NN treatment)) (PP (IN of) (NP (JJ isolated) (, ,) (JJ perfusion-cultured) (JJ human) (NNS eyes)))) (VP (VBD led) (PP (TO to) (NP (NP (DT the) (NN generation)) (PP (IN of) (NP (NNS Doc_7843916_1982_2001_Disease))))) (PP (IN in) (NP (NP (QP (RB approximately) (CD 30)) (NN %)) (PP (IN of) (NP (DT the) (NN Doc_7843916_2030_2043_Chemical-treated) (NNS eyes)))))) (. .)))
7843916	13	(ROOT (S (NP (NP (JJ Doc_7843916_2058_2065_Chemical) (NN treatment)) (VP (VBN resulted) (PP (IN in) (NP (NP (JJ morphologic) (NNS changes)) (PP (IN in) (NP (DT the) (NN trabecular))))))) (VP (VBP meshwork) (ADJP (JJ similar) (PP (TO to) (NP (NP (DT those)) (VP (VBN reported) (PP (IN for) (NP (NNS Doc_7843916_2165_2188_Disease) (CC and) (NNS Doc_7843916_2193_2212_Disease)))))))) (. .)))
7843916	14	(ROOT (S (NP (DT This) (NN system)) (VP (MD may) (VP (VB provide) (NP (DT an) (JJ acute) (NN model)) (PP (IN in) (SBAR (WHNP (WDT which)) (S (VP (TO to) (VP (VB study) (NP (NP (DT the) (JJ pathogenic) (NNS mechanisms)) (VP (VBN involved) (PP (IN in) (NP (NNS Doc_7843916_2309_2325_Disease) (CC and) (NNS Doc_7843916_2330_2357_Disease)))))))))))) (. .)))
7880714	0	(ROOT (S (NP (NP (JJ Auditory) (NN disturbance)) (VP (VBN associated) (PP (IN with) (NP (JJ interscalene) (JJ brachial) (NNS plexus))))) (VP (VBP block)) (. .)))
7880714	1	(ROOT (S (NP (PRP We)) (VP (VBD performed) (NP (DT an) (JJ audiometric) (NN study)) (PP (IN in) (NP (NP (CD 20) (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBD underwent) (NP (NP (NN surgery)) (PP (IN of) (NP (DT the) (NN shoulder) (NN region)))) (PP (IN under) (NP (NP (DT an) (JJ interscalene) (JJ brachial) (NNS plexus) (NN block)) (PRN (-LRB- -LRB-) (NP (NNP IBPB)) (-RRB- -RRB-)))))))))) (. .)))
7880714	2	(ROOT (S (NP (NP (CD Doc_7880714_219_230_Chemical) (CD 0.75) (NN %)) (PP (IN with) (NP (NNS Doc_7880714_242_252_Chemical)))) (VP (VBD was) (VP (VBN given) (PP (VBN followed) (PP (IN by) (NP (NP (DT a) (JJ 24-hr) (JJ continuous) (NN infusion)) (PP (IN of) (NP (ADJP (CD 0.25) (NN %)) (NNS Doc_7880714_312_323_Chemical)))))))) (. .)))
7880714	3	(ROOT (S (NP (NP (CD Three) (JJ audiometric) (NN threshold) (NNS measurements)) (PRN (-LRB- -LRB-) (NP (CD 0.25-18) (NNS kHz)) (-RRB- -RRB-))) (VP (VBD were) (VP (VBN made) (NP (NP (: :) (NP (NP (DT the) (JJ first)) (PP (IN before) (NP (NNP IBPB)))) (, ,) (NP (NP (DT the) (JJ second) (JJ 2-6) (NN h)) (PP (IN after) (NP (NN surgery))))) (CC and) (NP (NP (DT the) (JJ third)) (PP (IN on) (NP (DT the) (JJ first) (NN day))))) (PP (IN after) (NP (NN operation))))) (. .)))
7880714	4	(ROOT (S (PP (IN In) (NP (CD four) (NNS patients))) (NP (NP (NNS Doc_7880714_510_528_Disease)) (PP (IN on) (NP (NP (DT the) (NN side)) (PP (IN of) (NP (DT the) (NN block)))))) (VP (VBD was) (VP (VBN demonstrated) (PP (IN after) (NP (NN operation))) (, ,) (PP (PP (IN in) (NP (NP (CD three) (NNS measurements)) (PP (IN on) (NP (NP (DT the) (NN day)) (PP (IN of) (NP (NN surgery))))))) (CC and) (PP (IN in) (NP (NP (CD one)) (PP (IN on) (NP (DT the) (VBG following) (NN day)))))))) (. .)))
7880714	5	(ROOT (S (S (NP (NP (DT The) (NNS frequencies)) (SBAR (WHPP (IN at) (WHNP (WDT which))) (S (NP (DT the) (NN impairment)) (VP (VBD occurred))))) (VP (VBD varied) (PP (IN between) (NP (NNS patients))))) (: ;) (S (PP (IN in) (NP (CD one) (RB only))) (NP (NP (JJ low) (NNS frequencies)) (PRN (-LRB- -LRB-) (NP (CD 0.25-0) (NN .5) (NN kHz)) (-RRB- -RRB-))) (VP (VBD were) (VP (VBN involved)))) (. .)))
7880714	6	(ROOT (S (NP (NP (DT The) (JJ maximum) (NN change)) (PP (IN in) (NP (NN threshold)))) (VP (VBD was) (NP (NP (CD 35) (NN dB)) (PP (IN at) (NP (NP (CD 6) (NN kHz)) (VP (VBN measured) (PP (IN at) (NP (NP (DT the) (NN end)) (PP (IN of) (NP (NP (DT the) (JJ continuous) (NN infusion)) (PP (IN of) (NP (NNS Doc_7880714_898_909_Chemical)))))))))))) (. .)))
7880714	7	(ROOT (S (NP (DT This) (NN patient)) (VP (VBD had) (NP (NP (NN hearing) (NN threshold) (NNS changes)) (PRN (-LRB- -LRB-) (NP (CD 15-20) (NNS dB)) (-RRB- -RRB-))) (PP (IN at) (NP (NP (CD 6-10) (NN kHz)) (PP (IN on) (NP (DT the) (JJ opposite) (NN side))))) (ADVP (RB also))) (. .)))
7880714	8	(ROOT (S (NP (NNP IBPB)) (VP (MD may) (VP (VB cause) (NP (NP (JJ transient) (NNS Doc_7880714_1029_1049_Disease)) (PP (IN in) (NP (NP (DT the) (JJ ipsilateral) (NN ear)) (, ,) (ADVP (RB possibly)))) (PP (IN via) (NP (NP (DT an) (NN effect)) (PP (IN on) (NP (JJ sympathetic) (NN innervation)))))))) (. .)))
7905523	0	(ROOT (NP (NP (DT The) (NN safety) (CC and) (NN efficacy)) (PP (IN of) (NP (NP (NP (NN combination) (NNS Doc_7905523_39_63_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_7905523_65_73_Chemical)) (-RRB- -RRB-))) (CC and) (NP (NP (NNS Doc_7905523_79_89_Chemical)) (PP (IN in) (NP (NNS patients)))))) (PP (IN with) (NP (NP (NNS Doc_7905523_107_122_Disease)) (CC and) (NP (CD 200-500) (NN CD4) (NNS cells/mm3)))) (. .)))
7905523	1	(ROOT (S (NP (PRP We)) (VP (VBD conducted) (NP (DT a) (JJ double-blind) (, ,) (JJ randomized) (NN phase) (NNP II) (NN study)) (S (VP (TO to) (VP (VB evaluate) (NP (NP (DT the) (NN safety) (CC and) (NN activity)) (PP (IN of) (NP (NP (NP (NN combination) (NN therapy)) (PP (IN with) (NP (NP (NP (NNS Doc_7905523_269_293_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_7905523_295_303_Chemical)) (-RRB- -RRB-))) (PRN (-LRB- -LRB-) (NP (DT an) (JJ alpha-glucosidase) (NN I) (NN inhibitor)) (-RRB- -RRB-))))) (CC and) (NP (NP (NNS Doc_7905523_344_354_Chemical)) (PP (IN versus) (NP (NNS Doc_7905523_362_372_Chemical))))))) (ADVP (RB alone)))))) (. .)))
7905523	2	(ROOT (S (NP (NP (NNS Patients)) (PP (IN with) (NP (NP (QP (CD 200) (TO to) (CD 500)) (NNP CD4) (NNS cells/mm3)) (SBAR (WHNP (WP who)) (S (VP (VBD tolerated) (NP (NP (QP (CD <) (CC or) (CD =) (CD 12)) (NNS weeks)) (PP (IN of) (NP (JJ prior) (JJ Doc_7905523_458_468_Chemical) (NN therapy)))))))))) (VP (VBD received) (NP (NP (NP (NP (NNS Doc_7905523_486_494_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (CD 1000) (NN mg)) (NP (DT every) (CD 8) (NN h))) (-RRB- -RRB-))) (CC and) (NP (NP (NNS Doc_7905523_519_529_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (CD 100) (NN mg)) (NP (DT every) (CD 8) (NN h))) (-RRB- -RRB-)))) (CC or) (NP (NP (NNS Doc_7905523_552_562_Chemical)) (CC and) (NP (NN placebo))))) (. .)))
7905523	3	(ROOT (S (NP (CD Sixty) (NNS patients)) (VP (VBD received) (NP (NP (NN combination) (NN therapy)) (CC and) (NP (NP (CD 58)) (, ,) (NP (NNS Doc_7905523_628_638_Chemical)) (CC and) (NP (NN placebo))))) (. .)))
7905523	4	(ROOT (NP (NP (NP (NP (NP (NP (JJ Twenty-three) (NNS patients)) (PRN (-LRB- -LRB-) (NP (CD 38) (NN %)) (-RRB- -RRB-))) (CC and) (NP (CD 15))) (PRN (-LRB- -LRB-) (NP (CD 26) (NN %)) (-RRB- -RRB-)) (, ,) (PP (IN in) (NP (DT the) (NN combination)))) (CC and) (NP (NP (JJ Doc_7905523_717_727_Chemical) (NNS groups)) (, ,) (ADVP (RB respectively)))) (, ,) (NP (NP (VBN discontinued) (NN therapy)) (PRN (-LRB- -LRB-) (VP (VBN p) (S (VP (SYM =) (NP (CD 0.15))))) (-RRB- -RRB-))) (. .)))
7905523	5	(ROOT (S (NP (NP (DT The) (JJ mean) (JJ Doc_7905523_792_800_Chemical) (JJ steady-state) (NN trough) (NN level)) (PRN (-LRB- -LRB-) (NP (NP (CD 4.04) (JJ +) (NNS /)) (: -) (NP (CD 0.99) (NN micrograms/ml))) (-RRB- -RRB-))) (VP (VBD was) (PP (IN below) (NP (NP (DT the) (ADJP (IN in) (NN vitro)) (NN inhibitory) (NN concentration)) (PP (IN for) (NP (NP (JJ human) (JJ Doc_7905523_915_931_Disease) (NN virus)) (PRN (-LRB- -LRB-) (NP (NNP HIV)) (-RRB- -RRB-))))))) (. .)))
7905523	6	(ROOT (S (NP (NP (DT The) (JJ mean) (NN increase)) (PP (IN in) (NP (NP (CD CD4) (NNS cells)) (PP (IN at) (NP (NN week) (CD 4)))))) (VP (VBD was) (VP (VBN 73.8) (NP (JJ cells/mm3) (CC and) (JJ 52.4) (NNS cells/mm3)) (PP (IN for) (NP (NP (DT the) (NN combination)) (CC and) (NP (JJ Doc_7905523_1048_1058_Chemical) (NNS groups))) (, ,) (ADVP (RB respectively))) (PRN (-LRB- -LRB-) (ADVP (RB p)) (ADJP (JJ >) (NP (CD 0.36))) (-RRB- -RRB-)))) (. .)))
7905523	7	(ROOT (S (PP (IN For) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ prior) (JJ Doc_7905523_1116_1126_Chemical) (NN therapy))))) (, ,) (NP (NP (DT the) (JJ mean) (NN change)) (PP (IN in) (NP (NP (CD CD4) (NNS cells)) (PP (IN in) (NP (NP (DT the) (NN combination)) (CC and) (NP (JJ Doc_7905523_1188_1198_Chemical) (NNS groups))))))) (VP (VBD was) (NP (NP (NP (CD 63.7) (NNS cells/mm3)) (CC and) (NP (NP (CD 4.9) (NNS cells/mm3)) (PP (IN at) (NP (NN week) (CD 8)))) (CC and) (NP (CD 6.8) (NNS cells/mm3))) (CC and) (NP (NP (CD -45.1) (NNS cells/mm3)) (PP (IN at) (NP (NN week) (CD 16))))) (, ,) (ADVP (RB respectively))) (. .)))
7905523	8	(ROOT (S (NP (NP (DT The) (NN number)) (PP (IN of) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (NN suppression)) (PP (IN of) (NP (NP (NN HIV) (JJ p24) (NN antigenemia)) (PP (IN in) (NP (NP (DT the) (NN combination)) (CC and) (NP (JJ Doc_7905523_1403_1413_Chemical) (NNS groups))))))))))) (VP (VBD was) (NP (NP (NP (NP (NP (CD six)) (PRN (-LRB- -LRB-) (NP (CD 40) (NN %)) (-RRB- -RRB-))) (CC and) (NP (NP (NP (CD two)) (PRN (-LRB- -LRB-) (NP (CD 11) (NN %)) (-RRB- -RRB-))) (PP (IN at) (NP (NN week) (CD 4))))) (PRN (-LRB- -LRB-) (VP (VBN p) (S (VP (SYM =) (NP (CD 0.10))))) (-RRB- -RRB-))) (CC and) (NP (NP (NP (NP (CD five)) (PRN (-LRB- -LRB-) (NP (CD 45) (NN %)) (-RRB- -RRB-))) (CC and) (NP (NP (NP (CD two)) (PRN (-LRB- -LRB-) (NP (CD 14) (NN %)) (-RRB- -RRB-))) (PP (IN at) (NP (NN week) (CD 24))))) (PRN (-LRB- -LRB-) (VP (VBN p) (S (VP (SYM =) (NP (CD 0.08))))) (-RRB- -RRB-)))) (, ,) (ADVP (RB respectively))) (. .)))
7905523	9	(ROOT (S (ADVP (RB Doc_7905523_1536_1544_Disease)) (, ,) (NP (NNP Doc_7905523_1546_1556_Disease) (, ,) (NNP Doc_7905523_1558_1572_Disease) (, ,) (CC and) (NNP Doc_7905523_1578_1589_Disease)) (VP (VBD were) (ADJP (JJ common) (SBAR (IN for) (FRAG (NP (NN combination) (NNS recipients)) (. .)))) (PRN (-LRB- -LRB-) (NP (NP (NNP ABSTRACT) (NNP TRUNCATED) (NNP AT)) (NP (CD 250) (NNS WORDS))) (-RRB- -RRB-)))))
7910951	0	(ROOT (S (NP (NP (JJ Prolonged) (NNS Doc_7910951_10_19_Disease)) (ADJP (JJ due) (TO to) (JJ nondepolarizing))) (VP (VBP neuromuscular) (S (VP (VBG blocking) (NP (NNS agents) (CC and) (NNS Doc_7910951_77_92_Chemical))))) (. .)))
7910951	1	(ROOT (S (NP (NP (DT The) (JJ long-term) (NN use)) (PP (IN of) (NP (NP (VBG nondepolarizing) (NN neuromuscular)) (VP (VBG blocking) (NP (NP (NNS agents)) (PRN (-LRB- -LRB-) (NP (NNP Doc_7910951_162_169_Chemical)) (-RRB- -RRB-))))))) (VP (VBZ has) (ADVP (RB recently)) (VP (VBN been) (VP (VBN implicated) (PP (IN as) (NP (NP (DT a) (NN cause)) (PP (IN of) (NP (JJ prolonged) (NNS Doc_7910951_224_239_Disease))))) (, ,) (SBAR (IN although) (S (NP (NP (DT the) (NN site)) (PP (IN of) (NP (NP (DT the) (NN lesion)) (CC and) (NP (DT the) (VBG predisposing) (NNS factors))))) (VP (VBP have) (VP (VBN been) (ADJP (JJ unclear))))))))) (. .)))
7910951	2	(ROOT (S (NP (PRP We)) (VP (VBP report) (NP (NP (CD 3) (NNS patients)) (PRN (-LRB- -LRB-) (NP (NP (NN age)) (NP (CD 37-52) (NNS years))) (-RRB- -RRB-))) (PP (IN with) (NP (NP (JJ acute) (NNS Doc_7910951_371_396_Disease)) (SBAR (WHNP (WP who)) (S (VP (VBD developed) (NP (NP (VBN prolonged) (NNS Doc_7910951_421_429_Disease)) (PP (VBG following) (NP (NP (DT the) (NN discontinuation)) (PP (IN of) (NP (NNS Doc_7910951_463_471_Chemical)))))))))))) (. .)))
7910951	3	(ROOT (S (NP (CD Two) (NNS patients)) (ADVP (RB also)) (VP (VBD received) (NP (JJ intravenous) (NNS Doc_7910951_512_527_Chemical))) (. .)))
7910951	4	(ROOT (S (S (NP (JJ Renal) (NN function)) (VP (VBD was) (ADJP (JJ normal)))) (CC but) (S (S (NP (JJ hepatic) (NN function)) (VP (VBD was) (VP (VBN impaired) (PP (IN in) (NP (DT all) (NNS patients)))))) (, ,) (CC and) (S (NP (DT all)) (VP (VBD had) (NP (NNS Doc_7910951_618_626_Disease))))) (. .)))
7910951	5	(ROOT (S (NP (JJ Electrophysiologic) (NNS studies)) (VP (VBD revealed) (NP (NP (JJ low) (NN amplitude) (NN compound) (NN motor) (NN action) (NNS potentials)) (, ,) (NP (JJ normal) (JJ sensory) (NNS studies)) (, ,) (CC and) (NP (NNS fibrillations)))) (. .)))
7910951	6	(ROOT (S (NP (NP (JJ Repetitive) (NN stimulation)) (PP (IN at) (NP (CD 2) (NNS Hz)))) (VP (VBD showed) (NP (DT a) (JJ decremental) (NN response)) (PP (IN in) (NP (CD 2) (NNS patients)))) (. .)))
7910951	7	(ROOT (S (NP (NP (DT The) (JJ serum) (JJ Doc_7910951_841_851_Chemical) (NN level)) (VP (VBN measured) (PP (IN in) (NP (CD 1) (NN patient))) (NP (CD 14) (NNS days)) (SBAR (IN after) (S (NP (DT the) (NN drug)) (VP (VBD had) (VP (VBN been) (VP (VBN discontinued)))))))) (VP (VBD was) (ADJP (RB 172) (JJ ng/mL))) (. .)))
7910951	8	(ROOT (S (NP (NP (DT A) (NN muscle) (NN biopsy)) (PP (IN in) (NP (DT this) (NN patient)))) (VP (VBD showed) (NP (NNS Doc_7910951_979_1010_Disease))) (. .)))
7910951	9	(ROOT (S (NP (NP (DT The) (NNS Doc_7910951_1016_1024_Disease)) (PP (IN in) (NP (DT these) (NNS patients)))) (VP (VBZ is) (ADJP (JJ due) (PP (TO to) (NP (NP (NNS Doc_7910951_1053_1097_Disease)) (PRN (-LRB- -LRB-) (ADJP (ADVP (RBS most) (RB likely)) (JJ due) (PP (TO to) (NP (NNS Doc_7910951_1118_1125_Chemical)))) (-RRB- -RRB-)) (CC and) (NP (NN muscle)) (PRN (-LRB- -LRB-) (ADJP (ADVP (RBS most) (RB likely)) (JJ due) (PP (TO to) (NP (NNS Doc_7910951_1158_1173_Chemical)))) (-RRB- -RRB-)))))) (. .)))
7910951	10	(ROOT (S (NP (NNS Doc_7910951_1176_1195_Disease) (CC and) (NNS Doc_7910951_1200_1208_Disease)) (VP (VBP are) (VP (VBG contributing) (NP (NN risk) (NNS factors)))) (. .)))
8012887	0	(ROOT (NP (NP (NN Failure)) (PP (IN of) (NP (NN ancrod))) (PP (IN in) (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (NN Doc_8012887_38_45_Chemical-induced) (NN arterial) (NNS Doc_8012887_63_73_Disease))))) (. .)))
8012887	1	(ROOT (S (NP (NP (DT The) (NN morbidity) (CC and) (NN mortality)) (VP (VBN associated) (PP (IN with) (NP (NN Doc_8012887_119_126_Chemical-induced) (NNS Doc_8012887_135_145_Disease))))) (VP (VBP remain) (ADJP (JJ high)) (PP (IN despite) (NP (JJ numerous) (JJ empirical) (NNS therapies)))) (. .)))
8012887	2	(ROOT (S (S (NP (NNP Ancrod)) (VP (VBZ has) (VP (VBN been) (VP (VBN used) (ADVP (RB successfully)) (PP (IN for) (NP (NP (NNS prophylaxis)) (PP (IN against) (NP (NP (NN development)) (PP (IN of) (NP (NP (NNS Doc_8012887_269_279_Disease)) (PP (IN in) (NP (NNS patients))))))))) (PP (IN with) (NP (NP (JJ Doc_8012887_297_304_Chemical) (JJ induced) (NNS Doc_8012887_313_333_Disease)) (SBAR (WHNP (WP who)) (S (VP (VBP require) (NP (JJ brief) (NN reexposure)) (PP (TO to) (NP (NNS Doc_8012887_366_373_Chemical)))))))))))) (, ,) (CC but) (S (NP (NP (PRP$ its) (NN success)) (PP (IN in) (NP (NP (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBP have) (VP (VBN developed) (NP (DT the) (JJ Doc_8012887_426_436_Disease) (NN syndrome))))))))) (VP (VBZ is) (RB not) (VP (ADVP (RB well)) (VBN defined)))) (. .)))
8012887	3	(ROOT (S (NP (DT The) (NNS authors)) (VP (VBP present) (NP (NP (DT a) (NN case)) (PP (IN of) (NP (NP (NN failure)) (PP (IN of) (NP (NP (JJ ancrod) (NN treatment)) (PP (IN in) (NP (NP (DT a) (NN patient)) (PP (IN with) (NP (NN Doc_8012887_543_550_Chemical-induced) (NNS Doc_8012887_559_569_Disease))))))))))) (. .)))
803783	0	(ROOT (S (NP (NNP Doc_803783_0_18_Disease)) (VP (VBN associated) (PP (IN with) (NP (JJ Doc_803783_35_43_Chemical) (NN administration))) (PP (IN during) (NP (JJ saline-induced) (NNS Doc_803783_81_89_Disease)))) (. .)))
803783	1	(ROOT (S (NP (NP (CD Four) (NNS cases)) (PP (IN of) (NP (NP (NNS Doc_803783_105_123_Disease)) (PP (IN in) (NP (NP (NN connection)) (PP (IN with) (NP (NP (JJ Doc_803783_143_151_Chemical) (NN administration)) (PP (IN during) (NP (JJ saline-induced) (NNS Doc_803783_189_198_Disease)))))))))) (VP (VBP are) (VP (VBN described))) (. .)))
803783	2	(ROOT (S (NP (NP (DT The) (NN mechanism)) (PP (IN of) (NP (NNS Doc_803783_231_249_Disease)))) (VP (VBZ is) (VP (VBN discussed) (PP (IN in) (NP (NN regard))) (PP (TO to) (NP (DT these) (NNS cases))))) (. .)))
803783	3	(ROOT (S (NP (NP (JJ Doc_803783_289_297_Chemical) (NN administration)) (PP (IN during) (NP (JJ midtrimester-induced) (NNS Doc_803783_341_350_Disease)))) (VP (VBZ is) (VP (VBN advocated) (SBAR (RB only) (IN if) (S (NP (PRP it)) (VP (MD can) (VP (VP (VB be) (VP (VBN carried) (PRT (RP out)) (PP (IN under) (NP (NP (JJ careful) (NNS observations)) (PP (IN of) (NP (DT an) (JJ alert) (NN nursing) (NN staff))))))) (, ,) (VP (VP (ADJP (JJ aware)) (PP (IN of) (NP (NP (DT the) (NNS symptoms)) (PP (IN of) (NP (NNS Doc_803783_473_491_Disease)))))) (CC and) (VP (VBN instructed) (S (VP (TO to) (VP (VB watch) (NP (DT the) (NNS diuresis))))))) (CC and) (VP (VB report) (NP (NP (JJ such) (JJ early) (NNS signs)) (PP (IN of) (NP (DT the) (NN syndrome)))) (PP (IN as) (NP (NP (NNS Doc_803783_576_584_Disease)) (, ,) (NP (JJ muscular) (NNS Doc_803783_595_607_Disease)) (, ,) (CC or) (NP (NNS Doc_803783_612_621_Disease))))))))))) (. .)))
803783	4	(ROOT (S (NP (DT The) (NNS Doc_803783_627_635_Chemical)) (VP (MD should) (VP (VB be) (VP (VBN given) (PP (RB only) (PP (IN in) (NP (NNP Ringers) (NNP Doc_803783_668_675_Chemical))) (CC or) (PRN (, ,) (ADVP (RB alternately)) (, ,)) (PP (IN in) (NP (NP (NNP Ringers) (NNP Doc_803783_704_711_Chemical)) (CC and) (NP (NP (DT a) (CD 5)) (PP (IN per) (NP (NN cent) (NNS Doc_803783_729_737_Chemical) (CC and) (NN water) (NNS solutions)))))))))) (. .)))
803783	5	(ROOT (S (S (NP (DT The) (JJ urinary) (NN output)) (VP (MD should) (VP (VB be) (VP (VBN monitored))))) (CC and) (S (NP (NP (DT the) (NNP Doc_803783_806_814_Chemical) (NN administration) (VBN discontinued)) (CC and) (NP (DT the) (NN serum) (NNS electrolytes))) (VP (VBD checked) (SBAR (IN if) (S (NP (DT the) (JJ urinary) (NN output)) (VP (VBZ decreases)))))) (. .)))
803783	6	(ROOT (S (NP (DT The) (NNS Doc_803783_915_923_Chemical)) (VP (MD should) (RB not) (VP (VB be) (VP (VBN administered) (PP (IN in) (NP (NP (NN excess)) (PP (IN of) (NP (CD 36) (NNS hours)))))))) (. .)))
803783	7	(ROOT (S (SBAR (IN If) (S (NP (DT the) (NN patient)) (VP (VBZ has) (RB not) (VP (VBN aborted) (PP (IN by) (NP (RB then))))))) (NP (DT the) (NNS Doc_803783_1017_1025_Chemical)) (VP (MD should) (VP (VB be) (VP (VBN discontinued) (PP (IN for) (NP (QP (CD 10) (TO to) (CD 12)) (NNS hours))) (SBAR (IN in) (NN order) (S (VP (TO to) (VP (VP (VB perform) (NP (JJ electrolyte) (NNS determinations))) (CC and) (VP (VB correct) (NP (DT any) (JJ electrolyte) (NN imbalance)))))))))) (. .)))
804391	0	(ROOT (S (NP (NP (JJ Light) (NN chain) (NNS Doc_804391_12_23_Disease)) (CC and) (NP (NP (JJ cellular) (JJ mediated) (NN immunity)) (PP (IN in) (NP (NNS Doc_804391_58_66_Chemical))))) (VP (VBD treated) (NP (NNS patients)) (PP (IN with) (NP (NNS Doc_804391_89_101_Disease)))) (. .)))
804391	1	(ROOT (S (NP (JJ Light) (NN chain) (NNS Doc_804391_115_126_Disease)) (VP (VBD was) (VP (VBN found) (PP (IN in) (NP (NP (CD 9)) (PP (IN of) (NP (NP (CD 17) (JJ Doc_804391_148_160_Disease) (NNS patients)) (VP (VBN treated) (PP (IN with) (NP (NNS Doc_804391_183_191_Chemical)))))))))) (. .)))
804391	2	(ROOT (S (NP (NP (JJ Concomitant) (NN assay)) (PP (IN of) (NP (NP (JJ cellular) (JJ mediated) (NN immunity)) (PP (IN in) (NP (NP (DT these) (NNS patients)) (VP (VBG using) (NP (NP (NN skin) (NN test) (NN antigen)) (CC and) (NP (NP (DT a) (NN lymphokine)) (PP (IN in) (NP (JJ vitro) (NN test))))))))))) (VP (VBD provided) (NP (NP (NNS results)) (SBAR (WHNP (WDT that)) (S (VP (VBD were) (ADJP (JJ different))))))) (. .)))
804391	3	(ROOT (S (S (NP (NP (NNP Response)) (PP (TO to) (NP (JJ Varidase) (NN skin) (NN test) (NN antigen)))) (VP (VBD was) (ADJP (JJ negative) (PP (IN for) (NP (NP (DT all) (CD eight) (JJ Doc_804391_418_430_Disease) (NNS patients)) (VP (VBN tested))))))) (, ,) (CC but) (S (NP (EX there)) (VP (VBD occurred) (NP (DT a) (NNS hyper-responsiveness)) (PP (PP (IN of) (NP (NP (DT the) (NNS lymphocytes)) (PP (IN of) (NP (DT these) (CD eight) (NNS patients))) (S (VP (TO to) (VP (VB phytomitogen) (FRAG (-LRB- -LRB-) (NP (NNS Doc_804391_550_555_Chemical)) (-RRB- -RRB-) (. .))))))) (CONJP (RB as) (RB well) (IN as)) (PP (IN of) (NP (NP (DT those)) (PP (IN of) (NP (CD seven) (JJ other) (JJ Doc_804391_593_604_Disease) (NNS patients)))))))) (. .)))
804391	4	(ROOT (S (NP (DT This) (JJ last) (NN finding)) (VP (VP (MD may) (VP (VB be) (VP (VBN related) (PP (TO to) (NP (NP (NN time)) (PP (IN of) (NP (NN testing)))))))) (CC and/or) (VP (VBZ endogenous) (NP (NP (NN serum) (VBG binding)) (PP (IN of) (NP (NNS Doc_804391_702_710_Chemical))) (SBAR (WHNP (WDT which)) (S (VP (MD could) (VP (VB have) (VP (VBD inhibited) (NP (NN mitogen) (NN activity)) (PP (IN for) (NP (DT the) (NN lymphocyte))))))))))) (. .)))
8045270	0	(ROOT (NP (NP (NNP Doc_8045270_0_7_Chemical)) (: :) (NP (NP (DT a) (JJ novel) (JJ selective) (NNP Doc_8045270_27_36_Chemical) (NNP A2A) (NN receptor) (NN antagonist)) (PP (IN with) (NP (JJ anticataleptic) (NN activity)))) (. .)))
8045270	1	(ROOT (S (NP (NNP Doc_8045270_91_98_Chemical)) (VP (VBZ is) (NP (DT a) (ADJP (JJ novel) (JJ selective)) (NNP Doc_8045270_120_129_Chemical) (NNP A2A) (NN receptor) (NN antagonist))) (. .)))
8045270	2	(ROOT (S (NP (NP (JJ Oral) (NN administration)) (PP (IN of) (NP (NP (NNS Doc_8045270_178_185_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (CD 2.5)) (, ,) (NP (CD 10.0)) (CC and) (NP (CD 30.0) (NN mg/kg))) (-RRB- -RRB-))))) (ADVP (RB significantly)) (VP (VBD ameliorated) (NP (NP (DT the) (JJ Doc_8045270_243_253_Disease) (NNS responses)) (VP (VBN induced) (PP (IN by) (NP (NP (NN intracerebroventricular) (NN administration)) (PP (IN of) (NP (NP (DT an) (NNP Doc_8045270_320_329_Chemical) (NNP A2A) (NN receptor) (NN agonist)) (, ,) (NP (NP (NNS Doc_8045270_352_361_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 10) (NNS micrograms)) (-RRB- -RRB-))) (, ,))))) (PP (IN in) (NP (DT a) (JJ dose-dependent) (NN manner)))))) (. .)))
8045270	3	(ROOT (S (NP (NNP Doc_8045270_407_414_Chemical)) (ADVP (RB also)) (VP (VBD reduced) (NP (NP (DT the) (NNS Doc_8045270_432_441_Disease)) (VP (VBN induced) (PP (PP (IN by) (NP (NP (NNS Doc_8045270_453_464_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 1) (NN mg/kg) (NN i.p.)) (-RRB- -RRB-)))) (CC and) (PP (IN by) (NP (NP (NNS Doc_8045270_487_496_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 5) (NN mg/kg) (NN i.p.)) (-RRB- -RRB-)))))))) (. .)))
8045270	4	(ROOT (S (NP (DT These) (JJ anticataleptic) (NNS effects)) (VP (VBD were) (VP (VBN exhibited) (NP (NN dose) (NN dependently)) (PP (IN at) (NP (NP (NNS doses)) (PP (IN from) (NP (NP (QP (CD 0.625) (CC and) (CD 2.5)) (VBG mg/kg) (NN p.o.)) (, ,) (ADVP (RB respectively)))))))) (. .)))
8045270	5	(ROOT (S (ADVP (RB Moreover)) (, ,) (NP (NP (NNS Doc_8045270_638_645_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 0.625) (NN mg/kg) (NN p.o.)) (-RRB- -RRB-))) (VP (VBD potentiated) (NP (NP (NP (DT the) (JJ anticataleptic) (NNS effects)) (PP (IN of) (NP (NP (DT a) (JJ subthreshold) (NN dose)) (PP (IN of) (NP (NP (NNS Doc_8045270_730_758_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (NNS Doc_8045270_760_766_Chemical)) (: ;) (NP (CD 25) (JJ mg/kg) (NN i.p.))) (-RRB- -RRB-))))))) (CC plus) (NP (NP (NNS Doc_8045270_788_799_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 6.25) (NN mg/kg) (NN i.p.)) (-RRB- -RRB-))))) (. .)))
8045270	6	(ROOT (S (NP (DT These) (NNS results)) (VP (VBD suggested) (SBAR (SBAR (IN that) (S (NP (NNS Doc_8045270_848_855_Chemical)) (VP (VBZ is) (NP (DT a) (ADJP (RB centrally) (JJ active)) (NNP Doc_8045270_878_887_Chemical) (NNP A2A) (NN receptor) (NN antagonist))))) (CC and) (SBAR (IN that) (S (NP (NP (DT the) (JJ dopaminergic) (NN function)) (PP (IN of) (NP (DT the) (JJ nigrostriatal) (NN pathway)))) (VP (VBZ is) (VP (VBN potentiated) (PP (IN by) (NP (JJ Doc_8045270_994_1003_Chemical) (NNP A2A) (NN receptor) (NNS antagonists))))))))) (. .)))
8045270	7	(ROOT (S (ADVP (RB Furthermore)) (, ,) (NP (NNS Doc_8045270_1043_1050_Chemical)) (VP (MD may) (VP (VB be) (NP (NP (DT a) (JJ useful) (NN drug)) (PP (IN in) (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (NNS Doc_8045270_1092_1104_Disease)))))))) (. .)))
8106150	0	(ROOT (NP (NP (NN Effect)) (PP (IN of) (NP (JJ nondopaminergic) (NNS drugs))) (PP (IN on) (NP (NN Doc_8106150_35_41_Chemical-induced) (NNS Doc_8106150_50_61_Disease))) (PP (IN in) (NP (NN Doc_8106150_65_69_Chemical-treated) (NNS monkeys))) (. .)))
8106150	1	(ROOT (S (NP (NP (DT A) (NN group)) (PP (IN of) (NP (CD four) (NNS monkeys)))) (VP (VBD was) (VP (VBN rendered) (NP (NNS Doc_8106150_124_136_Disease)) (PP (IN with) (NP (DT the) (NN toxin) (NNS Doc_8106150_152_156_Chemical))))) (. .)))
8106150	2	(ROOT (S (NP (PRP They)) (VP (VBD were) (ADVP (RB then)) (VP (VBN treated) (NP (ADJP (RB chronically) (PP (IN with) (NP (JJ Doc_8106150_198_204_Chemical) (NNS /)))) (JJ Doc_8106150_205_216_Chemical) (ADJP (QP (CD 50/12) (CD .5))) (NN mg/kg)) (PP (VBN given) (PP (ADVP (RB orally)) (ADVP (RB daily)) (IN for) (NP (CD 2) (NNS months)))))) (. .)))
8106150	3	(ROOT (S (S (NP (DT This) (NN dose)) (VP (VBD produced) (NP (DT a) (JJ striking) (NN antiparkinsonian) (NN effect)))) (, ,) (CC but) (S (NP (DT all) (NNS animals)) (VP (VBD manifested) (NP (NNS Doc_8106150_346_356_Disease)))) (. .)))
8106150	4	(ROOT (S (NP (NP (DT A) (NN series)) (PP (IN of) (NP (NP (NNS agents)) (VP (VBG acting) (ADVP (RB primarily)) (PP (IN on) (NP (NP (NNS neurotransmitters)) (PP (JJ other) (IN than) (NP (NNS Doc_8106150_426_434_Chemical))))))))) (VP (VBD were) (VP (ADVP (RB then)) (VBN tested) (PP (IN in) (NP (NN combination))) (PP (IN with) (NP (NNS Doc_8106150_472_478_Chemical))) (S (VP (TO to) (VP (VB see) (SBAR (IN if) (S (NP (DT the) (JJ Doc_8106150_493_503_Disease) (NNS movements)) (VP (MD would) (VP (VB be) (VP (VBN modified))))))))))) (. .)))
8106150	5	(ROOT (S (NP (JJ Several) (NNS drugs)) (, ,) (PP (VBG including) (NP (NNS Doc_8106150_558_567_Chemical) (, ,) (NNS Doc_8106150_569_582_Chemical) (, ,) (NNS Doc_8106150_584_596_Chemical) (, ,) (NNS Doc_8106150_598_604_Chemical) (, ,) (NNS Doc_8106150_606_617_Chemical) (, ,) (CC and) (NNS Doc_8106150_623_629_Chemical))) (, ,) (NP (NNP markedly)) (VP (VBD reduced) (NP (DT the) (JJ Doc_8106150_652_662_Disease) (NNS movements)) (PP (CC but) (IN at) (NP (NP (DT the) (NN cost)) (PP (IN of) (NP (NP (DT a) (NN return)) (PP (IN of) (NP (JJ Doc_8106150_704_716_Disease) (NN symptomatology)))))))) (. .)))
8106150	6	(ROOT (S (ADVP (RB However)) (, ,) (NP (NNS Doc_8106150_742_751_Chemical) (CC and) (NNS Doc_8106150_756_766_Chemical)) (VP (VBD reduced) (ADVP (RB predominantly)) (NP (DT the) (JJ Doc_8106150_793_803_Disease) (NNS movements))) (. .)))
8106150	7	(ROOT (S (NP (NNP Doc_8106150_815_823_Chemical)) (VP (VBD was) (ADVP (RB also)) (ADJP (JJ useful) (PP (IN in) (NP (NP (CD one) (NN monkey)) (PP (IN against) (NP (NP (DT a) (JJR more) (JJ Doc_8106150_869_877_Disease) (NN form)) (PP (IN of) (NP (NNS Doc_8106150_886_896_Disease))))))))) (. .)))
8106150	8	(ROOT (S (NP (NNP Doc_8106150_898_906_Chemical)) (VP (VBD converted) (NP (DT the) (JJ Doc_8106150_921_929_Disease) (NNS movements)) (PP (IN into) (NP (NNS Doc_8106150_945_951_Disease)))) (. .)))
8111719	0	(ROOT (S (NP (NNS Doc_8111719_0_14_Disease) (CC and) (NNS Doc_8111719_19_29_Chemical-induced)) (VP (VBZ Doc_8111719_38_51_Disease)) (. .)))
8111719	1	(ROOT (S (NP (NP (NNP Doc_8111719_65_79_Disease)) (PP (IN as) (NP (NP (DT a) (NN symptom)) (PP (IN of) (NP (JJ central) (NNS Doc_8111719_104_117_Disease)))))) (VP (VBP are) (NP (NP (DT a) (ADJP (ADJP (JJ known)) (CC but) (ADJP (RB poorly) (JJ described))) (NN side) (NN effect)) (PP (IN of) (NP (NNS Doc_8111719_166_176_Chemical))))) (. .)))
8111719	2	(ROOT (S (NP (NP (JJS Most) (NNS cases)) (PP (IN of) (NP (NN Doc_8111719_192_202_Chemical-induced) (NNS Doc_8111719_211_225_Disease)))) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (PP (IN with) (NP (JJ other) (JJ mental) (NN status) (NNS changes)))))) (. .)))
8111719	3	(ROOT (S (NP (DT The) (NNS authors)) (VP (VBD interviewed) (NP (CD six) (NNS persons)) (PP (IN with) (NP (NN Doc_8111719_329_339_Chemical-induced) (NNS Doc_8111719_348_362_Disease))) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (DT a) (JJ clear) (NN sensorium)))))) (. .)))
8111719	4	(ROOT (S (NP (DT All) (NNS patients)) (VP (VBD were) (VP (VBG receiving) (NP (JJ high-dose) (NNS Doc_8111719_439_449_Chemical)) (PP (IN as) (NP (NP (NN part)) (PP (IN of) (NP (PRP$ their) (NN bone) (NN marrow) (NN transplant) (NN procedure))))))) (. .)))
8111719	5	(ROOT (S (NP (NNP Doc_8111719_510_524_Disease)) (VP (VBD occurred) (ADVP (RB only)) (SBAR (WHADVP (WRB when)) (S (NP (NP (DT the) (NN patient) (POS 's)) (NNS eyes)) (VP (VBD were) (VP (VP (VBN closed)) (CC and) (PRN (, ,) (PP (IN in) (NP (QP (DT all) (CC but) (CD one)) (NN case))) (, ,)) (VP (VBD were) (VP (VBN reported) (S (ADJP (RB as) (JJ disturbing) (CC or) (JJ frightening)))))))))) (. .)))
8111719	6	(ROOT (S (NP (NP (NN Underreporting)) (PP (IN of) (NP (NP (DT these) (NNS Doc_8111719_669_683_Disease)) (PP (IN by) (NP (NNS patients)))))) (VP (VBZ is) (ADJP (JJ likely))) (. .)))
8111719	7	(ROOT (S (NP (NNP Doc_8111719_720_734_Disease)) (VP (MD may) (VP (VB be) (NP (NP (DT the) (JJ sole) (CC or) (JJ first) (NN manifestation)) (PP (IN of) (NP (NNS Doc_8111719_777_790_Disease)))))) (. .)))
8111719	8	(ROOT (S (NP (DT The) (NN incidence)) (VP (MD may) (VP (VB be) (NP (NP (NN dose) (CC and) (NN infusion-time)) (VP (VBN related))))) (. .)))
8111719	9	(ROOT (S (NP (DT The) (NN clinician)) (VP (MD should) (VP (VB be) (VP (VBN alerted) (PP (IN for) (NP (NP (JJ possible) (NN Doc_8111719_890_900_Chemical-induced) (NNS Doc_8111719_909_923_Disease)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (MD may) (VP (VB occur) (PP (IN without) (NP (NP (JJ other) (NNS signs)) (PP (IN of) (NP (NP (NNP Doc_8111719_964_977_Disease) (. .)) (SBAR (S (NP (ADJP (`` ``) (JJ Eyes-closed) ('' '') (JJ hallucinatory)) (NNS experiences)) (VP (VBP appear) (S (VP (TO to) (VP (VB be) (NP (NP (DT an) (JJ unusual) (NN feature)) (PP (IN of) (NP (DT this) (NN presentation))))))))))))))))))))))) (. .)))
8111719	10	(ROOT (S (NP (NP (NNS Patients)) (ADJP (JJ anxious) (PP (IN about) (NP (DT this) (NN experience))))) (VP (VBP respond) (ADVP (RB well) (PP (TO to) (NP (NN support) (CC and) (NN education)))) (PP (IN about) (NP (DT this) (NN occurrence)))) (. .)))
8111719	11	(ROOT (S (NP (NP (JJ Optimal) (JJ pharmacologic) (NN management)) (PP (IN of) (NP (JJ disturbed) (NNS patients)))) (VP (VBZ is) (ADJP (JJ unclear))) (. .)))
8111719	12	(ROOT (S (SBAR (IN If) (S (NP (NNS Doc_8111719_1243_1252_Disease)) (VP (VBZ becomes) (ADJP (JJ marked))))) (, ,) (NP (NP (JJ high-potency) (NNS neuroleptics)) (PRN (-LRB- -LRB-) (FW i.e.) (, ,) (ADJP (JJ Doc_8111719_1302_1313_Chemical)) (-RRB- -RRB-))) (VP (MD may) (VP (VB be) (ADJP (JJ effective)))) (. .)))
8251368	0	(ROOT (NP (NP (JJ Photodistributed) (NNS Doc_8251368_17_27_Chemical-induced)) (NP (JJ facial) (NNS Doc_8251368_43_57_Disease)) (. .)))
8251368	1	(ROOT (S (PP (NP (CD Five) (NNS months)) (IN after) (S (VP (VBG starting) (NP (NP (NNS Doc_8251368_86_96_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_8251368_98_104_Chemical)) (-RRB- -RRB-)))))) (, ,) (NP (CD two) (NNS patients)) (VP (VBD developed) (NP (NP (JJ photodistributed) (JJ facial) (NNS Doc_8251368_154_168_Disease)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD became) (NP (JJR more) (NNS noticeable)) (PP (IN with) (NP (NN time)))))))) (. .)))
8251368	2	(ROOT (S (NP (DT Neither) (NN patient)) (VP (VBD complained) (PP (IN of) (NP (NN photosensitivity) (CC or) (NNS Doc_8251368_260_268_Disease)))) (. .)))
8251368	3	(ROOT (S (NP (DT Both) (NNS patients)) (VP (VBD reported) (NP (DT a) (JJ significant) (JJ cosmetic) (NN improvement)) (PP (IN after) (S (VP (VBG discontinuing) (NP (DT the) (NN drug)))))) (. .)))
8251368	4	(ROOT (S (NP (PRP One)) (VP (VBD commenced) (NP (DT the) (ADJP (RB closely) (JJ related)) (NN drug) (NNS Doc_8251368_397_407_Chemical)) (NP (CD 3) (NNS years) (RB later)) (, ,) (PP (IN with) (NP (NP (NN recurrence)) (PP (IN of) (NP (NNS Doc_8251368_442_456_Disease)))))) (. .)))
8251368	5	(ROOT (S (NP (NP (DT The) (NN photodistribution)) (PP (IN of) (NP (DT the) (NNS Doc_8251368_487_501_Disease)))) (VP (VBZ suggests) (NP (DT a) (JJ significant) (NN drug/light) (NN interaction))) (. .)))
8267029	0	(ROOT (NP (NP (JJ Doc_8267029_0_13_Chemical-induced) (NNS Doc_8267029_22_60_Disease)) (PP (IN in) (NP (DT a) (NN patient))) (PP (IN with) (NP (NNS Doc_8267029_79_99_Disease))) (. .)))
8267029	1	(ROOT (S (NP (NP (DT A) (JJ 67-year-old) (NN woman)) (PP (IN with) (NP (NNS Doc_8267029_126_146_Disease)))) (VP (VBD presented) (NP (NP (NNS Doc_8267029_157_195_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_8267029_197_201_Disease)) (-RRB- -RRB-))) (PP (IN after) (NP (NP (CD 5) (NNS months)) (PP (IN of) (NP (NNP Doc_8267029_221_236_Chemical) (PRN (-LRB- -LRB-) (NP (CD 250) (NN mg/day)) (-RRB- -RRB-)) (NN treatment)))))) (. .)))
8267029	2	(ROOT (S (NP (JJ Light) (NN microscopy) (NN study)) (VP (VBD showed) (NP (JJ severe) (NNS Doc_8267029_298_316_Disease)) (PP (IN with) (NP (NP (JJ crescent) (NN formation)) (PP (IN in) (NP (NP (CD 60) (NN %)) (PP (IN of) (NP (NP (DT the) (NN glomeruli) (CC and) (NN infiltration)) (PP (IN of) (NP (JJ inflammatory) (NNS cells))))))))) (PP (IN in) (NP (NP (DT the) (NN wall)) (PP (IN of) (NP (DT an) (NN arteriole)))))) (. .)))
8267029	3	(ROOT (S (NP (NNP Immunofluorescence)) (VP (VBD revealed) (NP (JJ scanty) (JJ granular) (NN IgG) (, ,) (NNP IgA) (CC and) (NNP C3) (NNS deposits)) (PP (IN along) (NP (DT the) (JJ capillary) (NNS walls) (CC and) (NN mesangium)))) (. .)))
8267029	4	(ROOT (S (NP (DT The) (NN patient)) (VP (VBD was) (VP (VBN treated) (PP (IN with) (NP (JJ Doc_8267029_572_579_Chemical) (NN pulse) (, ,) (NNS plasmapheresis) (, ,) (NNS Doc_8267029_603_619_Chemical) (CC and) (NN antiplatelet) (NNS agents))))) (. .)))
8267029	5	(ROOT (S (NP (NP (DT A) (JJ complete) (NN recovery)) (PP (IN of) (NP (JJ renal) (NN function)))) (VP (VBD was) (VP (VBN achieved) (PP (IN in) (NP (DT a) (JJ few) (NNS weeks))))) (. .)))
8267029	6	(ROOT (S (NP (NP (DT This) (JJ new) (NN case)) (PP (IN of) (NP (NP (NNS Doc_8267029_729_733_Disease)) (PP (IN in) (NP (NP (DT the) (NN course)) (PP (IN of) (NP (JJ Doc_8267029_751_766_Chemical) (NN treatment)))))))) (VP (VBZ emphasizes) (NP (NP (DT the) (NN need)) (PP (IN for) (NP (NP (JJ frequent) (NN monitoring)) (PP (IN of) (NP (JJ renal) (NN function) (CC and) (NN evaluation))))) (PP (IN of) (NP (JJ urinary) (NN sediment) (CC and) (NNS Doc_8267029_878_889_Disease)))) (PP (IN in) (NP (DT these) (NNS patients)))) (. .)))
8267029	7	(ROOT (S (NP (NP (DT The) (JJ prompt) (NN discontinuation)) (PP (IN of) (NP (NP (NNS Doc_8267029_939_954_Chemical)) (CC and) (NP (JJ vigorous) (NN treatment) (NNS measures))))) (VP (MD could) (VP (VB allow) (PP (IN for) (NP (NP (DT a) (JJ good) (NN prognosis)) (PP (RB as) (IN in) (NP (DT this) (NN case))))))) (. .)))
8268147	0	(ROOT (S (NP (NP (DT A) (NN case)) (PP (IN of) (NP (NP (NNS Doc_8268147_10_22_Disease)) (PP (IN in) (NP (NP (DT a) (NN patient)) (PP (IN with) (NP (NNS Doc_8268147_41_66_Disease)))))))) (VP (VBN treated) (PP (IN with) (NP (NNS Doc_8268147_80_95_Chemical)))) (. .)))
8268147	1	(ROOT (S (SBAR (IN Although) (S (NP (NNS Doc_8268147_106_121_Chemical)) (VP (VBZ has) (VP (VBN been) (VP (VBN used) (PP (IN for) (NP (JJ many) (NNS Doc_8268147_145_167_Disease)))))))) (, ,) (NP (NNS Doc_8268147_169_177_Disease)) (VP (VBZ limits) (NP (PRP$ its) (NN usefulness)) (PP (IN in) (NP (JJ many) (NNS patients)))) (. .)))
8268147	2	(ROOT (FRAG (NP (NNP Doc_8268147_218_230_Disease)) (: /) (S (S (NP (NNS Doc_8268147_231_246_Disease)) (VP (MD can) (VP (VB develop) (PP (IN as) (NP (NP (CD one)) (PP (IN of) (NP (NP (DT the) (JJ autoimmune) (NNS complications)) (PP (IN of) (NP (JJ Doc_8268147_301_316_Chemical) (NN treatment)))))))))) (, ,) (CC but) (S (NP (PRP$ its) (JJ exact) (NNS pathogenesis)) (VP (VBZ remains) (ADJP (JJ unclear))))) (. .)))
8268147	3	(ROOT (S (NP (PRP We)) (VP (VBP report) (NP (DT a) (NN patient)) (PP (IN with) (NP (NP (NNS Doc_8268147_397_422_Disease)) (, ,) (SBAR (WHNP (WP who)) (S (VP (VBD developed) (NP (NNS Doc_8268147_438_450_Disease)) (PP (IN while) (S (VP (VBG receiving) (NP (JJ Doc_8268147_467_482_Chemical) (NN therapy))))))))))) (. .)))
8268147	4	(ROOT (S (NP (PRP We)) (VP (VBD described) (NP (NP (DT the) (JJ special) (JJ clinical) (NN course)) (PP (IN of) (NP (DT the) (NN patient))))) (. .)))
8268147	5	(ROOT (S (NP (NP (NNS Patients)) (VP (VBG receiving) (NP (JJ Doc_8268147_568_583_Chemical) (NN therapy)))) (VP (MD should) (VP (VB be) (VP (VBN followed) (ADVP (RB carefully)) (PP (IN for) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (JJ autoimmune) (NNS complications))))) (PP (IN like) (NP (JJ Doc_8268147_674_686_Disease) (JJ /) (NNS Doc_8268147_687_702_Disease)))))) (. .)))
8278214	0	(ROOT (S (NP (NP (NNS Doc_8278214_0_12_Disease) (CC and) (NNS Doc_8278214_17_26_Disease)) (PP (IN in) (NP (NN terminal) (NNS Doc_8278214_39_45_Disease) (NNS patients)))) (VP (VBN treated) (PP (IN with) (NP (JJ continuous) (JJ intravenous) (NNS Doc_8278214_91_99_Chemical)))) (. .)))
8278214	1	(ROOT (S (NP (NP (CD Eight) (JJ Doc_8278214_107_113_Disease) (NNS patients)) (PP (IN in) (NP (NP (DT the) (NN terminal) (NNS stages)) (PP (IN of) (NP (NP (DT the) (NN disease)) (VP (VBN treated) (PP (IN with) (NP (NP (JJ high) (NNS doses)) (PP (IN of) (NP (JJ intravenous) (NNS Doc_8278214_200_208_Chemical))))))))))) (VP (VBD developed) (NP (NNS Doc_8278214_219_231_Disease))) (. .)))
8278214	2	(ROOT (S (NP (DT All) (NNS cases)) (VP (VBD were) (ADVP (RB retrospectively)) (VP (VBN sampled) (PP (IN from) (NP (NP (CD three) (JJ different) (NNS hospitals)) (PP (IN in) (NP (NNP Copenhagen))))))) (. .)))
8278214	3	(ROOT (S (NP (CD Five) (NNS patients)) (VP (VBD developed) (NP (NP (JJ universal) (NNS Doc_8278214_352_364_Disease) (CC and) (NNS Doc_8278214_369_382_Disease)) (SBAR (WHNP (WDT which)) (S (PP (IN in) (NP (CD 2) (NNS cases))) (VP (VBD were) (VP (VBN accompanied) (PP (IN by) (NP (NNS Doc_8278214_420_429_Disease))))))))) (. .)))
8278214	4	(ROOT (S (S (PP (IN In) (NP (CD 3) (NNS patients))) (NP (DT a) (JJ pre-existing) (NNS Doc_8278214_460_469_Disease)) (VP (VBD increased) (S (VP (TO to) (VP (VB excruciating) (NP (NN intensity))))))) (CC and) (S (PP (IN in) (NP (NP (CD 2)) (PP (IN of) (NP (DT these) (NNS cases))))) (NP (NNS Doc_8278214_530_539_Disease)) (VP (VBD occurred) (ADVP (RB simultaneously)))) (. .)))
8278214	5	(ROOT (S (SBAR (IN Although) (S (NP (NP (QP (RB only) (JJ few)) (JJ clinical) (NNS descriptions)) (PP (IN of) (NP (NP (NP (DT the) (NN relationship)) (PP (IN between) (NP (JJ Doc_8278214_633_645_Disease) (JJ /) (NNS Doc_8278214_646_655_Disease)))) (CC and) (NP (NP (JJ high) (NNS doses)) (PP (IN of) (NP (NNS Doc_8278214_674_682_Chemical))))))) (VP (VBP are) (ADJP (JJ available))))) (, ,) (NP (NP (JJ experimental) (NN support)) (PP (IN from) (NP (NN animal) (NNS studies)))) (VP (VBZ indicates) (SBAR (IN that) (S (NP (NP (NNS Doc_8278214_754_762_Chemical)) (, ,) (CC or) (NP (PRP$ its) (NNS metabolites)) (, ,)) (VP (VBZ plays) (NP (NP (DT a) (JJ causative) (NN role)) (PP (IN for) (NP (DT the) (ADJP (JJ observed) (JJ behavioural)) (NN syndrome)))))))) (. .)))
8278214	6	(ROOT (S (S (NP (DT The) (JJ possible) (NNS mechanisms)) (VP (VBP are) (VP (VBN discussed)))) (CC and) (S (NP (NP (NN treatment) (NNS proposals)) (VP (VBN given) (S (VP (VBG suggesting) (NP (NP (DT the) (NN use)) (PP (IN of) (NP (JJR more) (NNS efficacious)))))))) (VP (VBZ opioids) (PP (IN with) (NP (NP (JJR less) (NN excitatory) (NN potency)) (PP (IN in) (NP (DT these) (NNS situations))))))) (. .)))
8305357	0	(ROOT (NP (NP (NP (JJ Liposomal) (NNS Doc_8305357_10_22_Chemical)) (PP (IN in) (NP (JJ advanced) (NNS Doc_8305357_35_51_Disease)))) (: :) (NP (NP (DT a) (NN phase)) (NP (NNP II) (NN study))) (. .)))
8305357	1	(ROOT (S (NP (PRP We)) (VP (VBP report) (S (NP (DT a) (JJ non-randomized) (NNP Phase) (NNP II) (JJ clinical) (NN trial)) (VP (TO to) (VP (VB assess) (NP (NP (DT the) (NN efficacy) (CC and) (NN safety)) (PP (IN of) (NP (NP (JJ liposomal) (NNS Doc_8305357_169_181_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP DaunoXome)) (-RRB- -RRB-))))) (PP (IN in) (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (JJ Doc_8305357_214_218_Disease) (VBN related) (NNS Doc_8305357_227_243_Disease))))))))) (. .)))
8305357	2	(ROOT (S (NP (NP (CD Eleven) (JJ homosexual) (NNS men)) (PP (IN with) (NP (JJ advanced) (NNS Doc_8305357_281_297_Disease)))) (VP (VBD were) (VP (VBN entered) (PP (IN in) (NP (DT the) (NN trial))))) (. .)))
8305357	3	(ROOT (S (NP (NP (NNS Changes)) (PP (IN in) (NP (NP (NN size) (, ,) (NN colour) (CC and) (JJ associated) (NNS Doc_8305357_364_370_Disease)) (PP (IN of) (NP (JJ selected) (`` `) (NN target) ('' ') (NNS lesions)))))) (VP (VBD were) (VP (VBN measured))) (. .)))
8305357	4	(ROOT (S (NP (JJ Clinical) (, ,) (NN biochemical) (CC and) (NN haematological) (NNS Doc_8305357_456_466_Disease)) (VP (VBD were) (VP (VBN assessed))) (. .)))
8305357	5	(ROOT (S (NP (CD Ten) (NNS subjects)) (VP (VBD were) (VP (VBN evaluated))) (. .)))
8305357	6	(ROOT (S (NP (DT A) (JJ partial) (NN response)) (VP (VBD was) (VP (VBN achieved) (PP (IN in) (NP (NP (CD four)) (, ,) (SBAR (WHPP (IN of) (WHNP (WP whom))) (S (NP (CD two)) (ADVP (RB subsequently)) (VP (VBD relapsed)))))))) (. .)))
8305357	7	(ROOT (S (NP (NP (NNP Stabilization)) (PP (IN of) (NP (NNS Doc_8305357_604_620_Disease)))) (VP (VBD occurred) (PP (IN in) (NP (NP (DT the) (JJ remaining) (CD six)) (, ,) (VP (VBN maintained) (PP (IN until) (NP (NP (DT the) (NN end)) (PP (IN of) (NP (NP (DT the) (NN trial) (NN period)) (PP (IN in) (NP (CD four))))))))))) (. .)))
8305357	8	(ROOT (S (NP (DT The) (NN drug)) (VP (VBD was) (ADJP (RB generally) (RB well) (JJ tolerated)) (, ,) (PP (IN with) (NP (NP (JJ few) (JJ mild) (NNS symptoms)) (PP (IN of) (NP (NNS Doc_8305357_771_779_Disease)))))) (. .)))
8305357	9	(ROOT (S (NP (DT The) (JJ main) (NN problem)) (VP (VBD encountered) (SBAR (S (VP (VBD was) (NP (JJ haematological) (NNS Doc_8305357_829_837_Disease)) (, ,) (PP (IN with) (NP (NP (CD three) (NNS subjects)) (VP (VBG experiencing) (NP (NP (JJ severe) (NNS Doc_8305357_879_890_Disease)) (PRN (-LRB- -LRB-) (NP (NP (JJ neutrophil) (NN count)) (NP (NP (QP (CD <) (CD 0.5)) (QP (CD x) (CD 10))) (PRN (-LRB- -LRB-) (NP (CD 9)) (-RRB- -RRB-)) (NP (JJ /) (NN l)))) (-RRB- -RRB-)))))))))) (. .)))
8305357	10	(ROOT (S (NP (EX There)) (VP (VBD was) (NP (NP (DT no) (NN evidence)) (PP (IN of) (NP (NNS Doc_8305357_952_966_Disease))))) (. .)))
8305357	11	(ROOT (S (PP (IN In) (NP (DT this) (JJ small) (NN patient) (NN sample))) (, ,) (NP (JJ liposomal) (NNS Doc_8305357_1008_1020_Chemical)) (VP (VBD was) (NP (NP (DT an) (ADJP (ADJP (JJ effective)) (CC and) (ADJP (RB well) (JJ tolerated))) (NN agent)) (PP (IN in) (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (NNS Doc_8305357_1083_1099_Disease))))))) (. .)))
8384253	0	(ROOT (NP (NP (JJ Long-term) (NNS effects)) (PP (IN of) (NP (NNS Doc_8384253_21_32_Chemical))) (PP (IN on) (NP (DT the) (JJ peripheral) (JJ nervous) (NN system))) (. .)))
8384253	1	(ROOT (S (NP (NP (NP (JJ Forty) (NNS patients)) (PP (IN with) (NP (NP (NNS Doc_8384253_87_109_Disease)) (VP (VBN treated) (PP (IN with) (NP (NP (NNS Doc_8384253_123_134_Chemical)) (PP (IN between) (NP (CD 1984) (CC and) (CD 1990))))))))) (PRN (-LRB- -LRB-) (NP (NP (JJ cumulative) (NN dose)) (NP (NP (CD 12) (NN mg)) (PP (IN in) (NP (CD 18-24) (NNS weeks))))) (-RRB- -RRB-))) (VP (VBD were) (VP (VBN investigated) (PP (IN in) (NP (NN order))) (S (VP (TO to) (VP (VB evaluate) (NP (NP (DT the) (JJ long) (NN term) (NNS effects)) (PP (IN of) (NP (NP (NNS Doc_8384253_260_271_Chemical)) (PP (IN on) (NP (DT the) (JJ peripheral) (JJ nervous) (NN system))))))))))) (. .)))
8384253	2	(ROOT (S (NP (DT The) (NNS patients)) (VP (VBD were) (VP (VBN interviewed) (PP (IN with) (NP (NP (NN emphasis)) (PP (IN on) (NP (NNS Doc_8384253_353_373_Disease))))))) (. .)))
8384253	3	(ROOT (S (S (NP (NP (NNP Physical)) (CC and) (NP (NP (JJ quantitative) (JJ sensory) (NN examination)) (PP (IN with) (NP (NP (NN determination)) (PP (IN of) (NP (JJ vibratory) (NN perception) (CC and) (JJ thermal) (NN discrimination) (NNS thresholds))))))) (VP (VBD were) (VP (VBN performed)))) (, ,) (S (NP (NP (QP (CD four) (TO to) (CD 77)) (NNS months)) (PRN (-LRB- -LRB-) (NP (NP (NN median)) (NP (CD 34) (NNS months))) (-RRB- -RRB-))) (PP (IN after) (NP (JJ Doc_8384253_561_572_Chemical) (NN treatment)))) (. .)))
8384253	4	(ROOT (S (NP (JJ Twenty-seven) (NNS patients)) (VP (VBD reported) (NP (NNS Doc_8384253_615_635_Disease))) (. .)))
8384253	5	(ROOT (S (PP (IN In) (NP (NP (CD 13)) (PP (IN of) (NP (DT these) (CD 27) (NNS patients))))) (NP (NNS symptoms)) (VP (VBD were) (ADVP (RB still)) (ADJP (JJ present) (PP (IN at) (NP (NP (DT the) (NN time)) (PP (IN of) (NP (NN examination))))))) (. .)))
8384253	6	(ROOT (S (PP (IN In) (NP (DT these) (NNS patients))) (NP (JJ sensory) (NNS signs) (CC and) (NNS symptoms)) (VP (VBD predominated)) (. .)))
8384253	7	(ROOT (S (PP (IN In) (NP (DT the) (JJ other) (CD 14) (NNS patients))) (NP (NNS symptoms)) (VP (VBD had) (VP (VBN been) (ADJP (JJ present)) (PP (IN in) (NP (DT the) (NN past))))) (. .)))
8384253	8	(ROOT (S (NP (NNS Symptoms)) (VP (VBD persisted) (ADVP (RB maximally)) (NP (CD 40) (NNS months)) (PP (IN since) (NP (NP (NN cessation)) (PP (IN of) (NP (NN therapy)))))) (. .)))
8384253	9	(ROOT (S (NP (EX There)) (VP (VBD was) (NP (NP (DT no) (NN age) (NN difference)) (PP (IN between) (NP (NNS patients)))) (PP (IN with) (CC and) (IN without) (NP (NNS complaints))) (PP (IN at) (NP (NP (DT the) (NN time)) (PP (IN of) (NP (NN examination)))))) (. .)))
8384253	10	(ROOT (S (NP (JJ Normal) (NNS reflexes)) (VP (VBD were) (VP (VBN found) (PP (IN in) (NP (NP (CD two) (NN third)) (PP (IN of) (NP (NNS patients))))))) (. .)))
8384253	11	(ROOT (S (NP (JJ Neuropathic) (NNS complaints)) (VP (VBD were) (RB not) (ADJP (RB very) (JJ troublesome) (PP (IN on) (NP (DT the) (JJ long) (NN term))))) (. .)))
8384253	12	(ROOT (S (NP (PRP It)) (VP (VBZ is) (VP (VBN concluded) (SBAR (IN that) (S (S (PP (IN with) (NP (DT the) (JJ above) (CD mentioned) (NNS Doc_8384253_1177_1188_Chemical))) (NP (NP (JJ dose) (NN schedule) (NNS signs) (CC and) (NNS symptoms)) (PP (IN of) (NP (JJ Doc_8384253_1225_1236_Chemical) (NNS Doc_8384253_1237_1247_Disease)))) (VP (VBP are) (ADJP (JJ reversible) (PP (IN for) (NP (DT a) (JJ great) (NN deal)))))) (CC and) (S (NP (NN prognosis)) (VP (VBZ is) (ADJP (RB fairly) (JJ good)))))))) (. .)))
839274	0	(ROOT (NP (NP (NP (JJ Hepatic) (NNS Doc_839274_8_16_Disease) (CC and) (NNS Doc_839274_21_46_Disease)) (PP (IN of) (NP (NP (DT the) (NN liver)) (PP (IN in) (NP (NP (JJ young) (NNS women)) (PP (IN on) (NP (NNS Doc_839274_78_97_Chemical)))))))) (: :) (NP (NN case) (NNS reports)) (. .)))
839274	1	(ROOT (S (NP (NP (CD Two) (NNS cases)) (PP (IN of) (NP (NP (JJ hepatic) (NNS Doc_839274_134_141_Disease)) (CC and) (NP (NP (CD one)) (PP (IN of) (NP (NP (NNS Doc_839274_153_178_Disease)) (VP (ADVP (RB presumably)) (VBN associated) (PP (IN with) (NP (NP (DT the) (NN use)) (PP (IN of) (NP (NNS Doc_839274_217_236_Chemical)))))))))))) (, ,) (VP (VBP are) (VP (VBN reported))) (. .)))
839274	2	(ROOT (S (NP (JJ Special) (NN reference)) (VP (VBZ is) (VP (VBN made) (PP (TO to) (NP (NP (PRP$ their) (JJ clinical) (NN presentation)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (MD may) (VP (VB be) (ADJP (RB totally) (JJ asymptomatic)))))))))) (. .)))
839274	3	(ROOT (S (S (NP (JJ Liver-function) (NNS tests)) (VP (VBP are) (PP (IN of) (NP (JJ little) (JJ diagnostic) (NN value))))) (, ,) (CC but) (S (NP (JJ valuable) (NN information)) (VP (MD may) (VP (VB be) (VP (VBN obtained) (PP (IN from) (NP (NP (DT both) (NN liver) (NN scanning)) (CC and) (NP (JJ hepatic) (NN angiography)))))))) (. .)))
839274	4	(ROOT (S (NP (NP (JJ Histologic) (NNS differences)) (CC and) (NP (NP (JJ clinical) (NNS similarities)) (PP (IN between) (NP (NP (JJ hepatic) (NNS Doc_839274_554_561_Disease) (CC and) (NNS Doc_839274_566_591_Disease)) (PP (IN of) (NP (DT the) (NN liver))))))) (VP (VBP are) (VP (VBN discussed))) (. .)))
8410199	0	(ROOT (S (NP (NP (NN Loss)) (PP (IN of) (NP (NP (JJ Doc_8410199_8_17_Chemical) (JJ decarboxylase) (JJ mRNA-containing) (NNS neurons)) (PP (IN in) (NP (DT the) (NN rat) (NN dentate)))))) (VP (VBZ gyrus) (NP (JJ following) (NN Doc_8410199_91_102_Chemical-induced) (NNS Doc_8410199_111_119_Disease))) (. .)))
8410199	1	(ROOT (S (PP (IN In) (NP (JJ situ) (NN hybridization))) (NP (NNS methods)) (VP (VBD were) (VP (VBN used) (S (VP (TO to) (VP (VB determine) (SBAR (IN if) (S (NP (NP (JJ Doc_8410199_177_190_Chemical) (JJ decarboxylase) (PRN (-LRB- -LRB-) (NP (NNP GAD)) (-RRB- -RRB-)) (NN mRNA-containing) (NNS neurons)) (PP (IN within) (NP (NP (DT the) (NNS hilus)) (PP (IN of) (NP (DT the) (JJ dentate) (NNS gyrus)))))) (VP (VBP are) (ADJP (JJ vulnerable) (S (VP (TO to) (VP (VB Doc_8410199_291_298_Disease-induced) (NP (NN damage)) (PP (IN in) (NP (NP (DT a) (NN model)) (PP (IN of) (NP (JJ chronic) (NNS Doc_8410199_336_344_Disease))))))))))))))))) (. .)))
8410199	2	(ROOT (S (S (NP (JJ Sprague-Dawley) (NNS rats)) (VP (VBD were) (VP (VBN injected) (ADVP (RB intraperitoneally)) (PP (IN with) (NP (NNS Doc_8410199_403_414_Chemical)))))) (, ,) (CC and) (S (NP (DT the) (JJ hippocampal) (NN formation)) (VP (VBD was) (VP (VBN studied) (ADVP (RB histologically)) (PP (IN at) (NP (NP (CD 1)) (, ,) (NP (CD 2)) (, ,) (NP (CD 4)) (, ,) (CC and) (NP (CD 8) (NN week) (NNS intervals)))) (PP (IN after) (NP (NN Doc_8410199_512_523_Chemical-induced) (NNS Doc_8410199_532_540_Disease)))))) (. .)))
8410199	3	(ROOT (S (PP (IN In) (NP (JJ situ) (NN hybridization) (NN histochemistry))) (, ,) (S (VP (VBG using) (NP (DT a) (JJ Doc_8410199_588_599_Chemical-labeled) (NNP GAD) (NN cRNA) (NN probe)))) (, ,) (VP (VBD demonstrated) (NP (DT a) (JJ substantial) (NN decrease)) (PP (IN in) (NP (NP (DT the) (NN number)) (PP (IN of) (NP (NNP GAD) (JJ mRNA-containing) (NNS neurons))))) (PP (IN in) (NP (NP (DT the) (NNS hilus)) (PP (IN of) (NP (NP (DT the) (JJ dentate) (NNS gyrus)) (PP (IN in) (NP (DT the) (JJ Doc_8410199_746_757_Chemical-treated) (NNS rats) (IN as))))))) (PP (VBN compared) (PP (TO to) (NP (NP (NNS controls)) (PP (IN at) (NP (DT all) (NN time) (NNS intervals))))))) (. .)))
8410199	4	(ROOT (S (NP (NP (JJ Additional) (JJ neuronanatomical) (NNS studies)) (, ,) (PP (VBG including) (NP (NP (JJ Doc_8410199_865_878_Chemical) (NN staining)) (, ,) (NP (JJ Doc_8410199_889_910_Disease) (NNS methods)) (, ,) (CC and) (NP (NP (JJ histochemical) (NN localization)) (PP (IN of) (NP (JJ glial) (JJ fibrillary) (JJ acidic) (NN protein)))))) (, ,)) (VP (VBD suggested) (SBAR (IN that) (S (NP (NP (DT the) (NN decrease)) (PP (IN in) (NP (NP (DT the) (NN number)) (PP (IN of) (NP (NNP GAD) (JJ mRNA-containing) (NNS neurons)))))) (VP (VBD was) (VP (VBN related) (PP (PP (TO to) (NP (NNS Doc_8410199_1075_1088_Disease))) (CONJP (RB rather) (IN than)) (PP (TO to) (NP (NP (DT a) (NN decrease)) (PP (IN in) (NP (NNP GAD) (NN mRNA) (NNS levels))))))))))) (. .)))
8410199	5	(ROOT (S (NP (NP (DT The) (NN loss)) (PP (IN of) (NP (NP (NNP GAD) (JJ mRNA-containing) (NNS neurons)) (PP (IN in) (NP (DT the) (NNS hilus)))))) (VP (VBN contrasted) (PP (IN with) (NP (NP (DT the) (JJ relative) (NN preservation)) (PP (IN of) (NP (NP (JJ labeled) (JJ putative) (NN basket) (NNS cells)) (PP (IN along) (NP (NP (DT the) (JJ inner) (NN margin)) (PP (IN of) (NP (DT the) (JJ granule) (NN cell) (NN layer)))))))))) (. .)))
8410199	6	(ROOT (S (NP (NP (JJ Quantitative) (NNS analyses)) (PP (IN of) (NP (NP (JJ labeled) (NNS neurons)) (PP (IN in) (NP (NP (CD three) (NNS regions)) (PP (IN of) (NP (NP (DT the) (JJ dentate) (NNS gyrus)) (PP (IN in) (NP (DT the) (QP (CD 1) (CC and) (CD 2)) (NN week) (NNS groups)))))))))) (VP (VBD showed) (NP (ADJP (RB statistically) (JJ significant)) (NNS decreases)) (PP (IN in) (NP (NP (DT the) (JJ mean) (NN number)) (PP (IN of) (NP (NNP GAD) (JJ mRNA-containing) (NNS neurons))))) (PP (IN in) (NP (NP (DT the) (NNS hilus)) (PP (IN of) (NP (NP (DT both) (NNS groups)) (PP (IN of) (NP (JJ experimental) (NNS animals)))))))) (. .)))
8410199	7	(ROOT (S (NP (DT No) (JJ significant) (NNS differences)) (VP (VBD were) (VP (VBN found) (PP (IN in) (NP (NP (DT the) (JJ molecular) (NN layer)) (CC or) (NP (NP (DT the) (JJ granule) (NN cell) (NN layer)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD included) (NP (JJ labeled) (NNS neurons)) (PP (IN along) (NP (NP (DT the) (JJR lower) (NN margin)) (PP (IN of) (NP (DT the) (JJ granule) (NN cell) (NN layer))))))))))))) (. .)))
8410199	8	(ROOT (S (NP (DT The) (NNS results)) (VP (VBP indicate) (SBAR (IN that) (S (, ,) (PP (IN in) (NP (DT this) (NN model))) (, ,) (NP (NP (DT a) (NN subpopulation)) (PP (IN of) (NP (NNP GAD) (JJ mRNA-containing) (NNS neurons)))) (PP (IN within) (NP (DT the) (JJ dentate) (NNS gyrus))) (VP (VBZ is) (ADVP (RB selectively)) (ADJP (JJ vulnerable) (PP (TO to) (NP (NN Doc_8410199_1877_1884_Disease-induced) (NN damage)))))))) (. .)))
8410199	9	(ROOT (S (NP (JJ Such) (NN differential) (NN vulnerability)) (VP (VBZ appears) (S (VP (TO to) (VP (VB be) (NP (NP (DT another) (NN indication)) (PP (IN of) (NP (NP (DT the) (NN heterogeneity)) (PP (IN of) (NP (JJ Doc_8410199_1990_1994_Chemical) (NNS neurons)))))))))) (. .)))
8424298	0	(ROOT (S (NP (NP (NNPS Effects)) (PP (IN of) (NP (ADJP (JJ deliberate)) (NNS Doc_8424298_22_33_Disease)))) (VP (VBN induced) (PP (IN by) (NP (NP (NNS Doc_8424298_45_54_Chemical)) (PP (IN with) (NP (NP (NNS Doc_8424298_60_70_Chemical)) (PP (IN on) (NP (JJ neuropsychological) (NN function)))))))) (. .)))
8424298	1	(ROOT (S (NP (NP (DT The) (NN effect)) (PP (IN of) (NP (NP (ADJP (JJ deliberate)) (NNS Doc_8424298_128_139_Disease)) (PP (IN on) (NP (NP (NN brain) (NN function)) (VP (VBN measured) (PP (IN by) (NP (JJ neuropsychological) (NNS tests))))))))) (VP (VBD was) (VP (VBN studied) (PP (IN in) (NP (CD 41) (JJ adult) (NNS patients))))) (. .)))
8424298	2	(ROOT (S (NP (NN Twenty-four) (NNS patients)) (VP (VBD were) (VP (VBN anaesthetized) (PP (IN for) (NP (JJ middle-ear) (NN surgery))) (PP (IN with) (NP (NP (ADJP (JJ deliberate)) (NNS Doc_8424298_308_319_Disease)) (VP (VBN induced) (PP (IN by) (NP (NP (NNS Doc_8424298_331_340_Chemical)) (PP (IN with) (NP (NP (NNS Doc_8424298_346_356_Chemical)) (PRN (-LRB- -LRB-) (NP (JJ Doc_8424298_358_369_Disease) (NN group)) (-RRB- -RRB-))))))))))) (. .)))
8424298	3	(ROOT (S (NP (NP (CD Seventeen) (NNS patients)) (PP (IN without) (NP (NNS Doc_8424298_405_416_Disease)))) (VP (VBD served) (PP (IN as) (NP (DT a) (NN control) (NN group)))) (. .)))
8424298	4	(ROOT (S (NP (DT The) (JJ mean) (JJ arterial) (NN pressure)) (VP (VBD was) (ADJP (ADJP (ADJP (ADJP (CD 77) (JJ +)) (PRN (: /) (FRAG (: -) (ADVP (NP (NP (CD 2) (NN mmHg)) (PRN (-LRB- -LRB-) (NP (NP (CD 10.3) (JJ +) (NNS /)) (: -) (NP (CD 0.3) (NN kPa))) (-RRB- -RRB-))) (RB before)) (NP (NP (NNS Doc_8424298_515_526_Disease)) (CC and) (NP (CD 50) (NNS +)))) (: /))) (PRN (: -) (NP (NP (CD 0) (NN mmHg) (PRN (-LRB- -LRB-) (NP (NP (CD 6.7) (JJ +) (NNS /)) (: -) (NP (CD 0.0) (NN kPa))) (-RRB- -RRB-))) (PP (IN during) (NP (NP (NP (NNS Doc_8424298_570_581_Disease)) (PP (IN in) (NP (DT the) (JJ Doc_8424298_589_600_Disease) (NN group)))) (, ,) (CC and) (NP (QP (CD 86) (CD +)))))) (: /))) (: -) (ADJP (ADJP (CD 2) (JJ mmHg)) (PRN (-LRB- -LRB-) (NP (NP (CD 11.5) (JJ +) (NNS /)) (: -) (NP (CD 0.3) (NN kPa))) (-RRB- -RRB-)))) (PP (IN during) (NP (NP (NN anaesthesia)) (PP (IN in) (NP (DT the) (NN control) (NN group)))))) (. .)))
8424298	5	(ROOT (S (NP (DT The) (JJ following) (JJ psychological) (NNS tests)) (VP (VBD were) (VP (VBN performed) (: :) (NP (NP (NP (NP (CD four) (NNS subtests)) (PP (IN of) (NP (DT the) (NNP Wechsler) (NNP Adult) (NNP Intelligence) (NNP Scale)))) (PRN (-LRB- -LRB-) (NP (NP (NNS similarities)) (, ,) (NP (JJ digit) (NN span) (, ,) (NN vocabulary) (CC and) (NN digit) (NN symbol))) (-RRB- -RRB-)) (, ,) (NP (NNP Trail-Making) (NNP tests) (NNP A)) (CC and) (NP (NNP B))) (, ,) (NP (NP (VBG Zung) (NNS tests)) (PRN (-LRB- -LRB-) (NP (NP (JJ self-rating) (JJ Doc_8424298_900_907_Disease) (NN scale)) (CC and) (NP (JJ self-rating) (JJ Doc_8424298_930_940_Disease) (NN scale))) (-RRB- -RRB-))) (CC and) (NP (NP (JJ two-part) (NN memory) (NN test) (NN battery)) (PP (IN with) (NP (JJ immediate) (CC and) (JJ delayed) (NN recall))))))) (. .)))
8424298	6	(ROOT (S (NP (DT The) (NNS tests)) (VP (VBD were) (UCP (VP (VBN performed) (ADVP (RB preoperatively))) (CC and) (ADJP (NP (CD 2) (NNS days)) (JJ postoperatively)))) (. .)))
8424298	7	(ROOT (S (NP (EX There)) (VP (VBD were) (NP (NP (DT no) (ADJP (RB statistically) (JJ significant)) (NNS differences)) (PP (IN between) (NP (NP (DT the) (NNS groups)) (PP (IN in) (NP (NP (DT any)) (PP (IN of) (NP (NP (DT the) (NNS tests)) (PP (IN in) (NP (DT the) (NNS changes)))))))))) (PP (IN from) (NP (JJ preoperative) (NN value))) (S (VP (TO to) (VP (VB postoperative) (NP (NN value)))))) (. .)))
8424298	8	(ROOT (S (NP (DT The) (NNS results)) (VP (VBP indicate) (SBAR (IN that) (S (NP (NP (NNS Doc_8424298_1264_1275_Disease)) (VP (VBN induced) (PP (IN by) (NP (NP (NNS Doc_8424298_1287_1296_Chemical)) (PP (IN with) (NP (NNS Doc_8424298_1302_1312_Chemical))))))) (VP (VBZ has) (NP (NP (DT no) (JJ significant) (JJ harmful) (NNS effects)) (PP (IN on) (NP (NP (JJ mental) (NNS functions)) (PP (VBN compared) (PP (TO to) (NP (JJ normotensive) (NN anaesthesia))))))))))) (. .)))
8441146	0	(ROOT (NP (NP (JJ Apparent) (NN cure)) (PP (IN of) (NP (NNS Doc_8441146_17_37_Disease))) (PP (IN by) (NP (NN bone) (NN marrow) (NN transplantation))) (. .)))
8441146	1	(ROOT (S (NP (PRP We)) (VP (VBP describe) (NP (NP (NP (DT the) (NN induction)) (PP (IN of) (NP (JJ sustained) (NNS remissions)))) (CC and) (NP (NP (JJ possible) (NN cure)) (PP (IN of) (NP (NP (JJ severe) (NN erosive) (NNS Doc_8441146_156_176_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_8441146_178_180_Disease)) (-RRB- -RRB-)))))) (PP (IN by) (NP (NP (NP (NN bone) (NN marrow) (NN transplantation)) (PRN (-LRB- -LRB-) (NP (NNP BMT)) (-RRB- -RRB-))) (PP (IN in) (NP (CD 2) (NNS patients)))))) (. .)))
8441146	2	(ROOT (S (NP (NNP BMT)) (VP (VBD was) (VP (VBN used) (S (VP (TO to) (VP (VB treat) (NP (NP (JJ severe) (NNS Doc_8441146_263_278_Disease)) (SBAR (WHNP (WDT which)) (S (VP (VBD was) (VP (VBN caused) (PP (IN by) (NP (NP (NP (NN gold)) (PP (IN in) (NP (CD one) (NN case)))) (CC and) (NP (NP (NNS Doc_8441146_320_335_Chemical)) (PP (IN in) (NP (DT the) (JJ other)))))))))))))))) (. .)))
8441146	3	(ROOT (S (PP (IN In) (NP (NP (DT the) (CD 8) (CC and) (CD 6) (NNS years)) (PP (IN since) (NP (DT the) (NNS transplants))) (PRN (-LRB- -LRB-) (VP (VBG representing) (NP (NP (CD 8) (CC and) (CD 4) (NNS years)) (PP (IN since) (NP (NP (NN cessation)) (PP (IN of) (NP (DT all) (JJ immunosuppressive) (NN therapy)))))) (, ,) (ADVP (RB respectively))) (-RRB- -RRB-)))) (, ,) (NP (NP (DT the) (NNS Doc_8441146_490_492_Disease)) (PP (IN in) (NP (DT each) (NN case)))) (VP (VBZ has) (VP (VBN been) (ADJP (RB completely) (JJ quiescent)))) (. .)))
8441146	4	(ROOT (S (SBAR (IN Although) (S (NP (NP (JJ short) (NN term) (NN remission)) (PP (IN of) (NP (NP (JJ severe) (NNS Doc_8441146_577_579_Disease)) (PP (VBG following) (NP (NNP BMT)))))) (VP (VBZ has) (VP (VBN been) (VP (VBN reported)))))) (, ,) (NP (DT these)) (VP (VBP are) (NP (NP (DT the) (JJ first) (NNS cases)) (SBAR (WHPP (IN for) (WHNP (WDT which))) (S (NP (VBN prolonged) (NN followup)) (VP (VBZ has) (VP (VBN been) (ADJP (JJ available)))))))) (. .)))
8441146	5	(ROOT (S (NP (DT This) (NN experience)) (VP (VBZ raises) (NP (NP (DT the) (NN question)) (PP (IN of) (NP (NP (DT the) (NN role)) (PP (IN of) (NP (NNP BMT))) (ADVP (PRP itself))))) (PP (IN as) (NP (NP (DT a) (JJ therapeutic) (NN option)) (PP (IN for) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ uncontrolled) (JJ destructive) (NNS Doc_8441146_817_826_Disease)))))))) (. .)))
8473723	0	(ROOT (S (NP (NNP Doc_8473723_0_8_Disease)) (VP (VBN induced) (PP (IN by) (NP (VBN combined) (NN Doc_8473723_29_44_Chemical-Doc_8473723_45_56_Chemical) (NN treatment)))) (. .)))
8473723	1	(ROOT (S (NP (PRP We)) (VP (VBP report) (NP (NP (DT a) (NN case)) (PP (IN of) (NP (VBN combined) (NN Doc_8473723_97_112_Chemical-Doc_8473723_113_124_Chemical) (JJ treatment-induced) (NNS Doc_8473723_143_151_Disease))))) (. .)))
8473723	2	(ROOT (S (NP (PRP It)) (VP (VBZ seems) (SBAR (IN that) (S (NP (NP (VBN combined) (NN treatment)) (PP (IN of) (NP (NP (NNS Doc_8473723_189_200_Chemical)) (PP (IN with) (NP (NNS Doc_8473723_206_220_Chemical)))))) (VP (MD may) (VP (VB possess) (NP (JJ proconvulsive) (NN activity))))))) (. .)))
8475949	0	(ROOT (NP (NP (NN Case) (NN report)) (: :) (NP (NP (JJ Doc_8475949_13_24_Chemical) (CC and) (JJ polymorphic) (NNS Doc_8475949_41_64_Disease)) (VP (VBN revisited))) (. .)))
8475949	1	(ROOT (S (NP (NNP Doc_8475949_76_99_Chemical)) (VP (VBZ has) (VP (VBN been) (VP (VBN associated) (PP (IN with) (NP (NP (NNS Doc_8475949_125_153_Disease)) (, ,) (PP (VBG including) (NP (NNS Doc_8475949_165_183_Disease)))))))) (. .)))
8475949	2	(ROOT (S (NP (DT This) (NN article)) (VP (VP (VBZ reports) (NP (NP (CD two) (NNS cases)) (PP (IN of) (NP (DT this) (NN complication))))) (CC and) (VP (VBZ reviews) (NP (DT all) (VBN reported) (NNS cases)) (PP (TO to) (NP (NN date))))) (. .)))
8475949	3	(ROOT (S (NP (JJ Doc_8475949_277_288_Chemical-induced) (NNS Doc_8475949_297_315_Disease)) (VP (MD may) (VP (VB be) (VP (VBN related) (S (VP (TO to) (VP (VB serum) (SBAR (S (NP (JJ Doc_8475949_340_349_Chemical) (NNS levels) (CC and) (NNS Doc_8475949_361_375_Disease)) (VP (MD may) (ADVP (RB synergistically)) (VP (VB induce) (NP (NN torsade)))))))))))) (. .)))
8475949	4	(ROOT (S (NP (NNP Doc_8475949_412_430_Disease)) (VP (VBD occurred) (PP (IN after) (NP (NP (DT an) (NN average)) (PP (IN of) (NP (NP (CD 10) (NNS days)) (PP (IN of) (NP (NN treatment))))))) (PP (IN with) (NP (NNS Doc_8475949_486_497_Chemical)))) (. .)))
8475949	5	(ROOT (S (PP (IN In) (NP (DT these) (NNS patients))) (, ,) (NP (NP (DT no) (JJ other) (JJ acute) (NN side) (NNS effects)) (PP (IN of) (NP (NNS Doc_8475949_549_560_Chemical)))) (VP (VBD were) (ADJP (JJ observed))) (. .)))
8475949	6	(ROOT (S (NP (NNP Doc_8475949_576_594_Disease)) (VP (MD can) (VP (VB be) (VP (VBN treated) (SBAR (WHADVP (WRB when)) (S (VP (VBD recognized) (ADVP (RB early)) (, ,) (ADVP (RB possibly)) (PP (IN without) (NP (NP (NN discontinuation)) (PP (IN of) (NP (NNS Doc_8475949_669_680_Chemical))))))))))) (. .)))
8475949	7	(ROOT (S (SBAR (WHADVP (WRB When)) (S (NP (NNS Doc_8475949_687_712_Disease)) (VP (VBZ is) (ADJP (JJ observed))))) (, ,) (NP (JJ early) (JJ Doc_8475949_732_741_Chemical) (NN supplementation)) (VP (VBZ is) (VP (VBN advocated))) (. .)))
8480959	0	(ROOT (NP (NP (NN Efficacy) (CC and) (NN tolerability)) (PP (IN of) (NP (NP (NNS Doc_8480959_29_39_Chemical)) (PP (IN in) (NP (CD 3390) (NNS women))))) (PP (IN with) (NP (JJ moderate) (NNS Doc_8480959_68_88_Disease))) (. .)))
8480959	1	(ROOT (S (VP (TO To) (VP (VB evaluate) (NP (NP (DT the) (NN efficacy) (CC and) (NN safety)) (PP (IN of) (NP (NP (NNS Doc_8480959_140_150_Chemical)) (PP (IN in) (NP (NNS women)))))) (PP (IN with) (NP (JJ moderate) (NNS Doc_8480959_174_194_Disease))))) (. .)))
8480959	2	(ROOT (S (NP (NP (NP (DT The) (NNP Expanded) (NNP Clinical) (NNP Evaluation)) (PP (IN of) (NP (NNP Doc_8480959_240_250_Chemical) (PRN (-LRB- -LRB-) (NP (NNP EXCEL)) (-RRB- -RRB-)) (NNP Study)))) (, ,) (NP (DT a) (NN multicenter)) (, ,) (NP (NP (JJ double-blind) (, ,) (ADJP (JJ diet) (: -) (CC and) (JJ placebo-controlled)) (NN trial)) (, ,) (SBAR (WHPP (IN in) (WHNP (WDT which))) (S (NP (NNS participants)) (VP (VBD were) (ADVP (RB randomly)) (VP (VBN assigned) (S (VP (TO to) (VP (VB receive) (NP (NN placebo) (CC or) (NNS Doc_8480959_398_408_Chemical)) (PP (IN at) (NP (NP (NP (NNS doses)) (PP (IN of) (NP (NP (QP (CD 20) (CC or) (CD 40)) (NN mg)) (ADVP (RB once) (JJ daily))))) (, ,) (CC or) (NP (QP (CD 20) (CC or) (CD 40)))))))))))))) (VP (VBP mg) (NP (NP (RB twice) (JJ daily)) (PP (IN for) (NP (CD 48) (NNS weeks))))) (. .)))
8480959	3	(ROOT (S (NP (JJ Ambulatory) (NNS patients)) (VP (VBD recruited) (PP (IN by) (NP (CD 362))) (S (VP (VBG participating) (NP (NNS centers)) (PP (IN throughout) (NP (DT the) (NNP United) (NNPS States)))))) (. .)))
8480959	4	(ROOT (NP (NP (NNP Women)) (PRN (-LRB- -LRB-) (NP (NNP n) (QP (CD =) (CD 3390))) (-RRB- -RRB-)) (PP (IN from) (NP (NP (DT the) (JJ total) (NN cohort)) (PP (IN of) (NP (CD 8245) (NNS volunteers))))) (. .)))
8480959	5	(ROOT (S (NP (NP (NP (NNP Plasma)) (NP (NN total))) (, ,) (NP (NP (NP (NP (NN low-density) (NN lipoprotein)) (PRN (-LRB- -LRB-) (NP (NNP LDL)) (-RRB- -RRB-))) (, ,) (CC and) (NP (JJ high-density) (NN lipoprotein) (PRN (-LRB- -LRB-) (NP (NNP HDL)) (-RRB- -RRB-)) (NNS Doc_8480959_747_758_Chemical))) (, ,) (CC and) (NP (NNS Doc_8480959_764_777_Chemical))) (: ;) (CC and) (NP (NP (NN laboratory) (CC and) (JJ clinical) (NN evidence)) (PP (IN of) (NP (JJ adverse) (NNS events))))) (VP (VBD monitored) (ADVP (RB periodically)) (PP (IN throughout) (NP (DT the) (NN study)))) (. .)))
8480959	6	(ROOT (S (PP (IN Among) (NP (NNS women))) (, ,) (NP (NP (NNS Doc_8480959_901_911_Chemical)) (PRN (-LRB- -LRB-) (NP (QP (CD 20) (TO to) (CD 80) (CD mg/d))) (-RRB- -RRB-))) (VP (VBD produced) (NP (NP (NP (JJ sustained)) (PRN (-LRB- -LRB-) (X (NP (CD 12)) (: -) (PP (TO to) (ADJP (JJ 48-week)))) (-RRB- -RRB-)) (, ,) (NP (NP (JJ dose-related) (NNS changes)) (PRN (-LRB- -LRB-) (NP (NNP P) (QP (CD <) (CD 0.001))) (-RRB- -RRB-)))) (: :) (NP (NP (NNS decreases)) (PP (IN in) (NP (NP (NNP LDL) (NNP Doc_8480959_1016_1027_Chemical)) (PRN (-LRB- -LRB-) (NP (QP (CD 24) (NN %) (TO to) (CD 40) (NN %))) (-RRB- -RRB-)) (CC and) (NP (NNS Doc_8480959_1045_1058_Chemical)) (PRN (-LRB- -LRB-) (NP (QP (CD 9) (NN %) (TO to) (CD 18) (NN %))) (-RRB- -RRB-))))) (, ,) (CC and) (NP (NP (NNS increases)) (PP (IN in) (NP (NP (NNP HDL) (NNP Doc_8480959_1093_1104_Chemical)) (PRN (-LRB- -LRB-) (NP (QP (CD 6.7) (NN %) (TO to) (CD 8.6) (NN %))) (-RRB- -RRB-))))))) (. .)))
8480959	7	(ROOT (S (PP (VBG Depending) (PP (IN on) (NP (DT the) (NN dose)))) (, ,) (NP (NP (QP (IN from) (CD 82) (NN %) (TO to) (CD 95) (NN %))) (PP (IN of) (NP (NN Doc_8480959_1163_1173_Chemical-treated) (NNS women)))) (VP (VBD achieved) (SBAR (S (NP (NP (DT the) (NNP National) (NNP Doc_8480959_1210_1221_Chemical) (NNP Education) (NN Program) (NN goal)) (PP (IN of) (NP (NP (NP (NNP LDL) (NNP Doc_8480959_1252_1263_Chemical) (NNS levels)) (NP (NP (QP (JJR less) (IN than) (CD 4.14)) (NN mmol/L)) (PRN (-LRB- -LRB-) (NP (QP (CD 160) (CD mg/dL))) (-RRB- -RRB-)))) (, ,) (CC and) (NP (QP (CD 40) (NN %) (TO to) (CD 87) (NN %)))))) (VP (VBD achieved) (NP (NP (DT the) (NN goal)) (PP (IN of) (NP (NP (CD 3.36) (NN mmol/L)) (PRN (-LRB- -LRB-) (NP (CD 130) (NN mg/dL)) (-RRB- -RRB-))))))))) (. .)))
8480959	8	(ROOT (S (NP (NP (NP (JJ Successive) (NN transaminase) (NNS elevations)) (NP (QP (JJR greater) (IN than) (CD three) (NNS times)) (DT the) (JJ upper) (NN limit))) (PP (IN of) (NP (JJ normal)))) (VP (VP (VBD occurred) (PP (IN in) (NP (NP (CD 0.1) (NN %)) (PP (IN of) (NP (NNS women)))))) (CC and) (VP (VBD were) (ADJP (RB dose) (JJ dependent)) (PP (IN above) (NP (DT the) (JJ 20-mg) (NN dose))))) (. .)))
8480959	9	(ROOT (S (NP (NP (NNP Doc_8480959_1525_1533_Disease)) (, ,) (VP (VBN defined) (PP (IN as) (NP (NP (NN muscle) (NNS symptoms)) (PP (IN with) (NP (JJ Doc_8480959_1567_1575_Chemical) (NN kinase) (NNS elevations))))) (NP (NP (QP (JJR greater) (IN than) (CD 10) (NNS times)) (DT the) (JJ upper) (NN limit)) (PP (IN of) (NP (JJ normal))))) (, ,)) (VP (VBD was) (UCP (ADJP (JJ rare)) (CC and) (VP (VBN associated) (PP (IN with) (NP (NP (DT the) (JJS highest) (JJ recommended) (JJ daily) (NN dose)) (PP (IN of) (NP (NP (NNS Doc_8480959_1710_1720_Chemical)) (PRN (-LRB- -LRB-) (NP (QP (CD 80) (CD mg))) (-RRB- -RRB-))))))))) (. .)))
8480959	10	(ROOT (S (NP (JJ Doc_8480959_1730_1738_Chemical-replacement) (NN therapy)) (VP (VBD appeared) (S (VP (TO to) (VP (VB have) (NP (NP (DT no) (NN effect)) (PP (IN on) (NP (CC either) (DT the) (JJ efficacy) (CC or) (NN safety) (NN profile))) (PP (IN of) (NP (NNS Doc_8480959_1830_1840_Chemical)))))))) (. .)))
8480959	11	(ROOT (S (NP (NNP Doc_8480959_1854_1864_Chemical)) (VP (VBZ is) (ADJP (ADJP (RB highly) (JJ effective)) (CC and) (ADJP (RB generally) (RB well) (JJ tolerated))) (PP (IN as) (NP (NP (NN therapy)) (PP (IN for) (NP (NP (JJ primary) (NNS Doc_8480959_1937_1957_Disease)) (PP (IN in) (NP (NNS women)))))))) (. .)))
8492347	0	(ROOT (NP (NP (NP (NNS Doc_8492347_0_6_Disease) (CC and) (NNS Doc_8492347_11_25_Disease)) (ADJP (JJ due) (PP (TO to) (NP (JJ surreptitious) (NNS Doc_8492347_47_57_Chemical))))) (: --) (NP (NP (NN importance)) (PP (IN of) (NP (JJ Doc_8492347_73_82_Chemical) (NN supplementation)))) (. .)))
8492347	1	(ROOT (S (NP (NNS Diuretics)) (VP (MD may) (VP (VB induce) (NP (NNS Doc_8492347_121_132_Disease) (, ,) (NNS Doc_8492347_134_146_Disease) (CC and) (NNS Doc_8492347_151_165_Disease)))) (. .)))
8492347	2	(ROOT (S (SBAR (IN While) (S (NP (JJ severe) (NNS Doc_8492347_180_191_Disease)) (VP (MD may) (VP (VB cause) (NP (NNS Doc_8492347_202_217_Disease)))))) (, ,) (NP (JJ severe) (NNS Doc_8492347_226_240_Disease)) (VP (VBZ is) (VP (VBN associated) (PP (IN with) (NP (NP (NNS Doc_8492347_260_273_Disease) (CC and) (NNS Doc_8492347_278_284_Disease)) (SBAR (WHNP (WDT which)) (S (VP (MD can) (RB not) (VP (VB be) (VP (VBN corrected) (PP (IN by) (NP (NP (NNS Doc_8492347_314_323_Chemical) (CC and) (NNS Doc_8492347_328_335_Chemical)) (VP (VBN supplementation) (ADVP (RB alone)) (PRN (-LRB- -LRB-) (NP (CD 1,2)) (-RRB- -RRB-)))))))))))))) (. .)))
8492347	3	(ROOT (S (NP (JJ Surreptitious) (JJ diuretic) (NN ingestion)) (VP (VBZ has) (VP (VBN been) (VP (VBN described) (, ,) (PP (ADVP (RB mainly)) (IN in) (NP (NP (NNS women)) (SBAR (WHNP (WP who)) (S (VP (VBP are) (ADJP (VBN concerned) (SBAR (IN that) (S (NP (PRP they)) (VP (VBP are) (NP (NNS Doc_8492347_466_471_Disease) (CC or) (NNS Doc_8492347_475_484_Disease)))))))))))))) (. .)))
8492347	4	(ROOT (S (S (S (NP (NNP Symptomatic) (NNP Doc_8492347_498_509_Disease)) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (PP (IN in) (NP (NP (JJ such) (NNS patients)) (PRN (-LRB- -LRB-) (NP (CD 3-7)) (-RRB- -RRB-)))))))) (CC and) (S (PP (IN in) (NP (CD one))) (NP (NN case) (NNS Doc_8492347_567_579_Disease)) (VP (VBD was) (ADJP (JJ observed)) (PRN (-LRB- -LRB-) (NP (CD 8)) (-RRB- -RRB-))))) (, ,) (CC but) (S (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (JJ Doc_8492347_617_626_Chemical) (NN depletion)))) (VP (VBD were) (RB not) (VP (VBN noted) (PP (IN in) (NP (DT these) (NNS patients)))))) (. .)))
8494478	0	(ROOT (S (VP (VB Doc_8494478_0_13_Chemical-induced) (ADVP (RB nephrotoxicity)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NNS Doc_8494478_54_60_Disease)))))) (. .)))
8494478	1	(ROOT (S (S (VP (ADVP (RB Nephrotoxicity)) (VBN associated) (PP (IN with) (NP (NNS Doc_8494478_93_106_Chemical))))) (VP (VBZ is) (ADJP (JJ uncommon))) (. .)))
8494478	2	(ROOT (S (NP (NP (CD Five) (NNS patients)) (PP (IN with) (NP (NP (NNS Doc_8494478_139_145_Disease)) (SBAR (WHNP (WP who)) (S (VP (VBD developed) (NP (NP (NP (NNS Doc_8494478_160_179_Disease)) (SBAR (WHNP (WDT that)) (S (VP (VBD followed) (SBAR (S (NP (NP (NN treatment)) (PP (IN with) (NP (NNS Doc_8494478_209_222_Chemical)))) (VP (VBP are) (VP (VBN described))))))))) (CC and) (NP (NP (DT an) (JJ additional) (CD 15) (NNS cases)) (VP (VBN reported) (PP (IN in) (NP (DT the) (NN literature)))))))))))) (VP (VBP are) (VP (VBN reviewed))) (. .)))
8494478	3	(ROOT (S (NP (NP (JJ Other)) (PP (IN than) (NP (NP (NN elevation)) (PP (IN of) (NP (NP (JJ serum) (JJ Doc_8494478_335_345_Chemical) (NNS levels)) (, ,) (NP (JJ characteristic) (JJ clinical) (NNS manifestations)) (CC and) (NP (JJ abnormal) (NN laboratory) (NNS findings))))))) (VP (VBP are) (RB not) (ADVP (RB frequently)) (ADJP (JJ present))) (. .)))
8494478	4	(ROOT (S (NP (NNP Allergic) (NNP Doc_8494478_463_485_Disease)) (VP (VBZ is) (VP (VBN believed) (S (VP (TO to) (VP (VB be) (NP (DT the) (VBG underlying) (NNS pathological-process))))))) (. .)))
8494478	5	(ROOT (S (NP (JJ Definitive) (NN diagnosis)) (VP (VBZ requires) (NP (NP (NN performance)) (PP (IN of) (NP (JJ renal) (NN biopsy)))) (, ,) (SBAR (IN although) (S (NP (DT this)) (VP (VBZ is) (RB not) (ADJP (RB always) (JJ feasible)))))) (. .)))
8494478	6	(ROOT (S (NP (NP (DT An) (NN improvement)) (PP (IN in) (NP (NP (JJ renal) (NN function)) (SBAR (WHNP (WDT that)) (S (VP (VBD followed) (NP (NP (DT the) (NN discontinuation)) (PP (IN of) (NP (DT the) (JJ offending) (NN antibiotic)))))))))) (VP (VBZ supports) (NP (NP (DT the) (JJ presumptive) (NN diagnosis)) (PP (IN of) (NP (NN Doc_8494478_771_784_Chemical-induced) (NNS Doc_8494478_793_812_Disease))))) (. .)))
8514073	0	(ROOT (NP (NP (NNP Doc_8514073_0_20_Disease)) (PP (IN of) (NP (NNS Doc_8514073_24_33_Chemical))) (PP (IN versus) (NP (NNS Doc_8514073_41_49_Chemical))) (. .)))
8514073	1	(ROOT (S (SBAR (IN Although) (S (NP (DT some) (NNS studies)) (VP (VBP have) (VP (VBN suggested) (SBAR (S (NP (JJR fewer) (NNS Doc_8514073_94_114_Disease)) (VP (VBP are) (VP (VBN associated) (PP (IN with) (NP (NNS Doc_8514073_135_144_Chemical))) (PP (IN than) (IN with) (NP (NP (NNS Doc_8514073_155_163_Chemical)) (PP (IN for) (NP (JJ endoscopic) (NNS procedures))))))))))))) (, ,) (NP (DT this) (NN variable)) (VP (VBZ has) (RB not) (VP (VBN been) (ADJP (RB well) (VBN documented)))) (. .)))
8514073	2	(ROOT (S (NP (PRP We)) (ADVP (RB prospectively)) (VP (VBN evaluated) (NP (NP (DT the) (NN incidence)) (PP (IN of) (NP (NNS Doc_8514073_279_299_Disease)))) (PP (IN after) (NP (NP (JJ intravenous) (NN injection)) (PP (IN of) (NP (NNS Doc_8514073_331_339_Chemical) (CC or) (NNS Doc_8514073_343_352_Chemical))))) (PP (IN in) (NP (NP (CD 122) (JJ consecutive) (NNS patients)) (VP (VBG undergoing) (ADJP (JJ colonoscopy) (CC and) (JJ esophagogastroduodenoscopy)))))) (. .)))
8514073	3	(ROOT (S (ADVP (RB Overall)) (, ,) (NP (NNS Doc_8514073_445_465_Disease)) (VP (VBD were) (ADJP (RBR more) (JJ frequent) (PP (IN with) (NP (NP (NNS Doc_8514073_490_498_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (CD 22)) (PP (IN of) (NP (CD 62) (NNS patients)))) (-RRB- -RRB-))))) (PP (IN than) (PP (IN with) (NP (NP (NP (NNS Doc_8514073_529_538_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (CD 4)) (PP (IN of) (NP (CD 60) (NNS patients)))) (-RRB- -RRB-))) (PRN (-LRB- -LRB-) (NP (NNP p) (QP (CD <) (CD 0.001))) (-RRB- -RRB-)))))) (. .)))
8514073	4	(ROOT (S (NP (DT A) (JJ palpable) (NNS venous) (NN cord)) (VP (VBD was) (ADJP (JJ present)) (PP (IN in) (NP (NP (NP (CD 23) (NN %)) (PRN (-LRB- -LRB-) (NP (QP (CD 14) (IN of) (CD 62))) (-RRB- -RRB-))) (PP (IN of) (NP (NP (NNS patients)) (PP (IN in) (NP (DT the) (JJ Doc_8514073_643_651_Chemical) (NN group))))))) (, ,) (PP (VBN compared) (PP (IN with) (NP (NP (NP (CD 2) (NN %)) (PRN (-LRB- -LRB-) (NP (NP (CD 1)) (PP (IN of) (NP (CD 60) (NNS patients)))) (-RRB- -RRB-))) (PP (IN in) (NP (NP (DT the) (JJ Doc_8514073_702_711_Chemical) (NN group)) (PRN (-LRB- -LRB-) (NP (NNP p) (QP (CD <) (CD 0.002))) (-RRB- -RRB-)))))))) (. .)))
8514073	5	(ROOT (S (NP (NP (NNP Doc_8514073_731_735_Disease)) (PP (IN at) (NP (DT the) (NN injection) (NN site)))) (VP (VBD occurred) (PP (IN in) (NP (NP (NP (CD 35) (NN %)) (PRN (-LRB- -LRB-) (NP (QP (CD 22) (IN of) (CD 62))) (-RRB- -RRB-))) (PP (IN of) (NP (NP (NNS patients)) (PP (IN in) (NP (DT the) (JJ Doc_8514073_804_812_Chemical) (NN group))))))) (PP (VBN compared) (PP (IN with) (NP (NP (NP (CD 7) (NN %)) (PRN (-LRB- -LRB-) (NP (NP (CD 4)) (PP (IN of) (NP (CD 60) (NNS patients)))) (-RRB- -RRB-))) (PP (IN in) (NP (NP (DT the) (JJ Doc_8514073_862_871_Chemical) (NN group)) (PRN (-LRB- -LRB-) (NP (NNP p) (QP (CD <) (CD 0.001))) (-RRB- -RRB-)))))))) (. .)))
8514073	6	(ROOT (S (NP (NP (NN Doc_8514073_891_899_Disease) (CC and) (NN warmth)) (PP (IN at) (NP (DT the) (NN injection) (NN site)))) (VP (VBD were) (RB not) (ADJP (RB significantly) (JJ different) (PP (IN between) (NP (DT the) (CD two) (NNS groups))))) (. .)))
8514073	7	(ROOT (S (NP (NP (NN Smoking)) (, ,) (NP (JJ nonsteroidal) (JJ anti-inflammatory) (NN drug) (NN use)) (, ,) (NP (JJ intravenous) (NN catheter) (NN site)) (, ,) (NP (NP (JJ dwell) (NN time)) (PP (IN of) (NP (DT the) (NN needle)))) (, ,) (NP (JJ Doc_8514073_1093_1100_Chemical) (NN use)) (, ,) (CC and) (NP (NP (NNS Doc_8514073_1110_1114_Disease)) (PP (IN during) (NP (DT the) (NN injection))))) (VP (VBD had) (NP (NP (DT no) (NN effect)) (PP (IN on) (NP (NP (DT the) (NN incidence)) (PP (IN of) (NP (NNS Doc_8514073_1170_1190_Disease))))))) (. .)))
8546130	0	(ROOT (NP (NP (JJ Doc_8546130_0_14_Chemical-associated) (NNS Doc_8546130_26_47_Disease)) (PP (IN in) (NP (DT a) (NN patient))) (PP (IN with) (NP (NP (NNS Doc_8546130_66_87_Disease)) (PP (IN on) (NP (JJ continuous) (JJ ambulatory) (JJ peritoneal) (NN dialysis))))) (. .)))
8546130	1	(ROOT (S (NP (NNP Doc_8546130_134_155_Disease)) (VP (VBP are) (UCP (NP (NP (DT a) (JJ rare) (NN event)) (PP (IN in) (NP (NNS Doc_8546130_176_197_Disease)))) (CC and) (RRC (ADJP (RB not) (JJ related) (PP (TO to) (NP (NNS Doc_8546130_217_223_Disease)))) (ADVP (FW per) (FW se))))) (. .)))
8546130	2	(ROOT (S (NP (NP (JJ Unreported)) (PP (IN in) (NP (DT the) (NN literature)))) (VP (VBZ is) (NP (NP (NNS Doc_8546130_264_285_Disease)) (VP (VBG occurring) (PP (IN in) (NP (NN association))) (PP (IN with) (NP (NP (DT the) (JJ new) (JJ Doc_8546130_324_333_Chemical) (NN antibiotic)) (, ,) (NP (NNS Doc_8546130_346_360_Chemical))))))) (. .)))
8546130	3	(ROOT (S (NP (PRP We)) (VP (VBP describe) (NP (PDT such) (DT a) (NN case)) (PP (IN in) (NP (NP (DT a) (NN patient)) (PP (IN with) (NP (NP (NNS Doc_8546130_404_427_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_8546130_429_433_Disease)) (-RRB- -RRB-)) (VP (VBN maintained) (PP (IN on) (NP (NP (JJ continuous) (JJ ambulatory) (JJ peritoneal) (NN dialysis)) (PRN (-LRB- -LRB-) (NP (NNP CAPD)) (-RRB- -RRB-)))))))))) (. .)))
8546130	4	(ROOT (S (NP (NP (DT The) (NN combination)) (PP (IN of) (NP (NP (DT a) (ADJP (RB relatively) (JJ high)) (NN dose)) (PP (IN of) (NP (NP (NNS Doc_8546130_544_558_Chemical)) (PP (IN in) (NP (NP (NN face)) (PP (IN of) (NP (NP (NNS Doc_8546130_570_591_Disease)) (PP (IN in) (NP (DT a) (ADJP (RB functionally) (JJ anephric)) (NN patient))))))))))) (, ,) (PP (IN with) (NP (VBG underlying) (JJ Doc_8546130_644_652_Chemical) (NN intoxication))) (, ,)) (VP (MD may) (VP (VB have) (VP (VBN facilitated) (NP (NP (DT the) (NN appearance)) (PP (IN of) (NP (DT this) (JJ Doc_8546130_711_721_Disease) (NN side) (NN effect))))))) (. .)))
8546130	5	(ROOT (S (NP (PRP It)) (VP (VBZ is) (ADJP (JJ important) (S (VP (TO to) (VP (VB understand) (NP (NP (DT the) (NNS pharmacokinetics)) (PP (IN of) (NP (NNS medications)))) (PP (IN in) (NP (NP (NP (NN face)) (PP (IN of) (NP (NNS Doc_8546130_812_833_Disease)))) (, ,) (NP (NP (DT the) (NN possibility)) (PP (IN of) (NP (NN drug) (NNS interactions)))) (, ,) (CC and) (SBAR (WHADVP (WRB how)) (S (NP (DT these) (NNS factors)) (VP (MD should) (VP (VB help) (NP (NP (NN guide) (NN medication) (NN therapy)) (PP (IN in) (NP (DT the) (JJ Doc_8546130_939_943_Disease) (NN patient))))))))))))))) (. .)))
85485	0	(ROOT (S (NP (NP (NNS Changes)) (PP (IN in) (NP (NP (NP (NNS peroxisomes)) (PP (IN in) (NP (JJ preneoplastic) (NN liver)))) (CC and) (NP (NP (NNS Doc_85485_50_58_Disease)) (PP (IN of) (NP (NNS mice))))))) (VP (VBN induced) (PP (IN by) (NP (NNS Doc_85485_78_104_Chemical)))) (. .)))
85485	1	(ROOT (S (NP (NP (NNS Peroxisomes)) (PP (IN in) (NP (NP (NNS Doc_85485_121_130_Disease)) (CC and) (NP (NP (JJ hyperplastic) (JJ preneoplastic) (NNS Doc_85485_162_175_Disease)) (VP (VBN induced) (PP (IN in) (NP (NNS mice))) (PP (IN by) (NP (CD 500) (NN ppm) (NNS Doc_85485_203_229_Chemical)))))))) (VP (VBD were) (VP (VP (VBN examined) (ADVP (RB histochemically))) (CC and) (VP (VBN electron) (ADVP (RB microscopically))))) (. .)))
85485	2	(ROOT (S (SBAR (IN Although) (S (NP (NP (JJS most)) (PP (IN of) (NP (DT the) (NNS Doc_85485_311_320_Disease)))) (VP (VP (VBD were) (NP (JJ well-differentiated) (NNS Doc_85485_346_352_Disease))) (CC and) (VP (VBD contained) (NP (NP (DT a) (JJ considerable) (NN number)) (PP (IN of) (NP (NNS peroxisomes)))))))) (, ,) (NP (DT the) (JJ Doc_85485_409_414_Disease) (NNS cells)) (VP (VBD did) (RB not) (VP (VB respond) (PP (TO to) (NP (NP (NNS Doc_85485_440_478_Chemical)) (PP (IN with) (NP (NP (NN proliferation)) (PP (IN of) (NP (NNS peroxisomes))))))))) (. .)))
85485	3	(ROOT (S (PP (IN At) (NP (NP (DT the) (JJ 16th) (NN week)) (PP (IN of) (NP (NN carcinogen) (NN feeding))))) (, ,) (NP (JJ hyperplastic) (NNS nodules)) (VP (VBD appeared) (CC and) (VBD advanced) (PP (TO to) (NP (JJ further) (NNS stages)))) (. .)))
85485	4	(ROOT (S (NP (NP (DT A) (NN majority)) (PP (IN of) (NP (DT the) (NNS nodules)))) (VP (VBD showed) (NP (NP (NP (DT a) (JJ considerable) (NN number)) (PP (IN of) (NP (NNS peroxisomes)))) (CC and) (NP (NP (DT the) (JJ inductive) (NN proliferation)) (PP (IN of) (NP (NNS peroxisomes)))))) (. .)))
85485	5	(ROOT (S (PP (IN Within) (NP (DT the) (NNS nodules))) (, ,) (NP (NP (NNS foci)) (PP (IN of) (NP (NP (NN proliferation)) (PP (IN of) (NP (NP (DT the) (NNS cells)) (SBAR (WHNP (WDT that)) (S (VP (VBD showed) (NP (NP (DT no) (NN inducibility)) (PP (IN of) (NP (NP (NN proliferation)) (PP (IN of) (NP (NNS peroxisomes)))))))))))))) (VP (VBD appeared)) (. .)))
85485	6	(ROOT (S (S (NP (DT These) (NNS cells)) (VP (VBN proliferated) (ADVP (RBR further)) (, ,) (S (VP (VBG replacing) (NP (NP (DT the) (JJS most) (NN part)) (PP (IN of) (NP (DT the) (NNS nodules)))))))) (, ,) (CC and) (S (PP (IN with) (NP (DT this) (NN process))) (NP (NNS Doc_85485_955_964_Disease)) (VP (VBD appeared) (S (VP (TO to) (VP (VB have) (VP (VBN been) (VP (VBN formed)))))))) (. .)))
85485	7	(ROOT (S (NP (NP (DT No) (JJ abnormal) (JJ matrical) (NNS inclusions)) (PP (IN of) (NP (NNS peroxisomes)))) (VP (VBD were) (VP (VBN formed) (PP (IN in) (NP (NP (DT the) (NNS cells)) (PP (IN of) (NP (JJ hyperplastic) (NNS nodules))))) (PP (IN by) (NP (NNS Doc_85485_1094_1132_Chemical))) (PP (IN unlike) (IN in) (NP (NP (DT the) (NN case)) (PP (IN of) (NP (NNS rats))))))) (. .)))
8586822	0	(ROOT (S (NP (NP (NNP Contribution)) (PP (IN of) (NP (NP (DT the) (ADJP (JJ sympathetic) (JJ nervous)) (NN system)) (PP (TO to) (NP (NP (NN salt-sensitivity)) (PP (IN in) (NP (NN lifetime) (NNS Doc_8586822_79_88_Chemical-treated)))))))) (ADVP (RB spontaneously)) (VP (VBZ Doc_8586822_111_123_Disease) (NP (NNS rats))) (. .)))
8586822	1	(ROOT (S (S (VP (TO To) (VP (VB test) (NP (NP (DT the) (NNS hypothesis)) (SBAR (WHNP (WDT that)) (, ,) (PP (IN in) (NP (NN lifetime) (NNS Doc_8586822_182_191_Chemical-treated))) (S (ADVP (RB spontaneously)) (VP (VBZ Doc_8586822_214_226_Disease) (NP (NP (NNS rats)) (PRN (-LRB- -LRB-) (NP (NNP SHR)) (-RRB- -RRB-)))))))))) (, ,) (NP (DT the) (JJ sympathetic) (JJ nervous) (NN system)) (VP (VBZ contributes) (ADVP (RB importantly) (PP (TO to) (NP (NP (DT the) (JJ Doc_8586822_301_313_Disease) (NN effect)) (PP (IN of) (NP (JJ Doc_8586822_324_347_Chemical) (NN supplementation))))))) (. .)))
8586822	2	(ROOT (NP (NP (NNP Male) (NNP SHR)) (PRN (-LRB- -LRB-) (VP (VBN aged) (NP (CD 6) (NNS weeks))) (-RRB- -RRB-)) (SBAR (WHNP (WDT that)) (S (VP (VP (VBD had) (VP (VBN been) (VP (VBN treated) (PP (IN from) (NP (NP (NN conception)) (VP (VBN onward) (PP (IN with) (NP (NP (DT either) (NN Doc_8586822_455_464_Chemical) (CC or) (NN vehicle)) (VP (VBN remained) (PP (IN on) (NP (DT a) (JJ basal) (JJ Doc_8586822_496_511_Chemical) (NN diet)))))))))))) (CC or) (VP (VBD were) (VP (VBN fed) (NP (DT a) (JJ high) (JJ Doc_8586822_536_551_Chemical) (NN diet))))))) (. .)))
8586822	3	(ROOT (S (PP (IN After) (NP (CD 2) (NNS weeks))) (, ,) (NP (DT the) (NNS rats)) (VP (VBD were) (VP (VP (VBN subjected) (PP (TO to) (NP (JJ ganglionic) (NN blockade)))) (CC and) (VP (NP (CD 2) (NNS days) (RB later)) (, ,) (NP (NP (DT an) (NN infusion)) (PP (IN of) (NP (NNS Doc_8586822_653_662_Chemical))))))) (. .)))
8586822	4	(ROOT (S (NP (JJ Lifetime) (JJ Doc_8586822_682_691_Chemical) (NN treatment)) (ADVP (RB significantly)) (VP (VBD lowered) (VP (VB mean) (NP (JJ arterial) (NN pressure)) (PP (IN in) (NP (DT both) (NNS groups))))) (. .)))
8586822	5	(ROOT (S (NP (NP (JJ Intravenous) (NN infusion)) (PP (IN of) (NP (DT the) (JJ ganglionic) (NN blocker) (NNS Doc_8586822_810_823_Chemical)))) (VP (VBD resulted) (PP (IN in) (NP (NP (DT a) (JJ rapid) (NN decline)) (PP (IN in) (NP (NNP MAP))) (SBAR (WHNP (WDT that)) (S (VP (VBD eliminated) (NP (NP (DT the) (ADJP (RB dietary) (JJ Doc_8586822_887_902_Chemical-induced)) (NN increase)) (PP (IN in) (NP (NNP MAP)))) (PP (IN in) (NP (DT both) (NNS groups))))))))) (. .)))
8586822	6	(ROOT (S (NP (NP (NNP Infusion)) (PP (IN of) (NP (DT the) (JJ central) (JJ nervous) (NN system) (NNS Doc_8586822_982_1016_Chemical) (NNS Doc_8586822_1017_1026_Chemical)))) (ADVP (RB also)) (VP (VBD resulted) (PP (IN in) (NP (NP (DT a) (JJR greater) (NN reduction)) (PP (IN in) (NP (NNP MAP))))) (PP (IN in) (NP (NP (DT both) (NNS groups)) (PP (IN of) (NP (NNP SHR))) (SBAR (WHNP (WDT that)) (S (VP (VBD were) (VP (VBN fed) (NP (DT the) (JJ high) (PRN (-LRB- -LRB-) (PP (VBN compared) (PP (IN with) (NP (DT the) (NN basal)))) (-RRB- -RRB-)) (NN Doc_8586822_1142_1157_Chemical) (NN diet))))))))) (. .)))
8586822	7	(ROOT (S (PP (IN In) (NP (DT both) (NN lifetime) (NN Doc_8586822_1194_1203_Chemical-treated) (CC and) (NN control) (NN SHR))) (, ,) (NP (DT the) (ADJP (JJ sympathetic) (JJ nervous)) (NN system)) (VP (VBZ contributes) (PP (TO to) (NP (NP (DT the) (NN pressor) (NNS effects)) (PP (IN of) (NP (DT a) (JJ high) (JJ Doc_8586822_1305_1320_Chemical) (NN diet)))))) (. .)))
8599504	0	(ROOT (S (NP (NNP Doc_8599504_0_10_Disease)) (VP (VBN associated) (PP (IN with) (NP (JJ Doc_8599504_27_37_Chemical) (NN administration)))) (. .)))
8599504	1	(ROOT (S (NP (NP (NNP Doc_8599504_54_64_Disease)) (, ,) (VP (ADVP (RB also)) (VBN known) (PP (IN as) (NP (NNS Doc_8599504_80_99_Disease) (CC or) (NNS Doc_8599504_103_120_Disease)))) (, ,)) (VP (VBZ is) (NP (NP (DT a) (ADJP (JJ well-demarcated) (, ,) (JJ localized)) (NNS Doc_8599504_154_159_Disease)) (PP (VBG involving) (NP (NP (DT the) (JJ subcutaneous) (NNS tissues)) (SBAR (WHNP (WDT that)) (S (VP (MD may) (VP (VB cause) (NP (NNS Doc_8599504_210_234_Disease)))))))))) (. .)))
8599504	2	(ROOT (S (NP (PRP We)) (VP (VBP report) (NP (NP (DT the) (NN case)) (PP (IN of) (NP (DT a) (ADJP (RB previously) (JJ healthy)) (JJ 19-year-old) (NN man)))) (PP (IN with) (NP (NP (ADJP (RB no) (VBN known)) (NNS Doc_8599504_309_323_Disease)) (SBAR (WHPP (IN in) (WHNP (WP whom))) (S (NP (NP (NNS Doc_8599504_332_342_Disease)) (PP (IN with) (NP (JJ significant) (NNS Doc_8599504_360_375_Disease) (CC and) (NN protrusion)))) (VP (VBD developed) (PP (IN within) (NP (NP (CD 10) (NNS minutes)) (PP (IN of) (NP (NP (DT the) (NN administration)) (PP (IN of) (NP (NP (DT a) (JJ single) (NNP IV) (NN dose)) (PP (IN of) (NP (NNS Doc_8599504_464_474_Chemical))))))))))))))) (. .)))
8600333	0	(ROOT (NP (NP (JJ Late) (NNS Doc_8600333_5_19_Disease)) (PP (IN after) (NP (NN treatment))) (PP (IN for) (NP (DT a) (JJ malignant) (NNS Doc_8600333_52_62_Disease))) (. .)))
8600333	1	(ROOT (S (NP (NNP Cardiac) (NN function)) (VP (VBD was) (VP (VBN assessed) (PP (IN in) (NP (NP (JJ long-term) (NNS survivors)) (PP (IN of) (NP (JJ malignant) (NNS Doc_8600333_130_141_Disease))) (SBAR (WHNP (WP who)) (S (VP (VBD were) (VP (VBN treated) (PP (VBG according) (PP (TO to) (NP (NP (NP (NNP Rosen) (POS 's)) (NN T5) (CC or) (NN T10) (NN protocol)) (, ,) (NP (NP (DT both)) (PP (VBG including) (NP (NNS Doc_8600333_215_226_Chemical))))))))))))))) (. .)))
8600333	2	(ROOT (S (NP (JJ Thirty-one) (NNS patients)) (, ,) (NP (NP (NN age)) (NP (CD 10-45) (NNS years))) (PRN (-LRB- -LRB-) (NP (NP (JJ median) (NN age)) (NP (CD 17.8) (NNS years))) (-RRB- -RRB-)) (VP (VBD were) (VP (VBN evaluated) (NP (NP (QP (CD 2.3-14) (CD .1)) (NNS years)) (PRN (-LRB- -LRB-) (NP (NP (NN median)) (NP (CD 8.9) (NNS years))) (-RRB- -RRB-)) (PP (VBG following) (NP (NP (NN completion)) (PP (IN of) (NP (NN treatment)))))))) (. .)))
8600333	3	(ROOT (S (NP (NP (JJ Cumulative) (NNS doses)) (PP (IN of) (NP (NNS Doc_8600333_393_404_Chemical)))) (VP (VBD were) (NP (NP (CD 225-550) (NNS mg/m2)) (PRN (-LRB- -LRB-) (NP (JJ median) (NN dose) (NN 360)) (-RRB- -RRB-)))) (. .)))
8600333	4	(ROOT (S (S (NP (DT The) (NN evaluation)) (VP (VBD consisted) (PP (IN of) (NP (NP (DT a) (NN history)) (, ,) (NP (JJ physical) (NN examination)) (, ,) (NP (NN electrocardiogram)) (PRN (-LRB- -LRB-) (NP (NNP ECG)) (-RRB- -RRB-)))))) (, ,) (NP (NN signal)) (VP (VBD averaged) (NP (NP (NP (NNP ECG)) (, ,) (NP (JJ 24-hour) (JJ ambulatory) (NN ECG)) (, ,)) (ADJP (JJ echocardiography) (CC and) (JJ radionuclide))) (ADVP (RB angiography))) (. .)))
8600333	5	(ROOT (S (S (NP (NP (CD Eighteen)) (PP (IN of) (NP (NP (CD 31)) (PRN (-LRB- -LRB-) (NP (CD 58) (NN %)) (-RRB- -RRB-))))) (PRN (S (NP (NNS patients)) (VP (VBD showed) (NP (NNS Doc_8600333_658_674_Disease)))) (, ,)) (VP (VBN defined) (PP (IN as) (S (VP (VBG having) (NP (NP (QP (CD one) (CC or) (JJR more))) (PP (IN of) (NP (DT the) (JJ following) (NNS abnormalities))))))))) (: :) (S (NP (NP (JJ late) (NNS potentials)) (, ,) (NP (JJ complex) (NNS Doc_8600333_763_786_Disease)) (, ,)) (VP (VBD left) (NP (NP (NNS Doc_8600333_793_813_Disease)) (, ,) (NP (VBN decreased) (NN shortening) (NN fraction)) (, ,) (CC or) (NP (VBN decreased) (NN ejection) (NN fraction))))) (. .)))
8600333	6	(ROOT (S (NP (NP (DT The) (NN incidence)) (PP (IN of) (NP (NNS Doc_8600333_895_916_Disease)))) (VP (VBD increased) (PP (IN with) (NP (NP (NN length)) (PP (IN of) (NP (NP (NN follow-up)) (PRN (-LRB- -LRB-) (NP (NP (NNP P) (NNP <)) (CC or) (NP (NNP =) (CD .05))) (-RRB- -RRB-))))))) (. .)))
8600333	7	(ROOT (S (NP (DT No) (NN correlation)) (VP (MD could) (VP (VB be) (VP (VBN demonstrated) (PP (IN between) (NP (NP (JJ cumulative) (NN dose)) (PP (IN of) (NP (NP (NNS Doc_8600333_1031_1042_Chemical)) (CC and) (NP (JJ cardiac) (NN status)))))) (, ,) (PP (IN except) (PP (IN for) (NP (NN heart) (NN rate) (NN variability))))))) (. .)))
8600333	8	(ROOT (S (SBAR (WHADVP (WRB When)) (S (VP (VBN adjusted) (PP (TO to) (NP (NN body) (NN surface) (NN area)))))) (, ,) (NP (NP (DT the) (JJ left) (NN ventricular) (NN posterior) (NN wall) (NN thickness)) (PRN (-LRB- -LRB-) (NP (NNP LVPW) (NN index)) (-RRB- -RRB-))) (VP (VBD was) (VP (VBN decreased) (PP (IN in) (NP (DT all) (NNS patients))))) (. .)))
8600333	9	(ROOT (S (NP (NP (DT The) (NN incidence)) (PP (IN of) (NP (NN Doc_8600333_1241_1252_Chemical-induced) (NNS Doc_8600333_1261_1275_Disease)))) (VP (VP (VBZ is) (ADJP (JJ high))) (CC and) (VP (VBZ increases) (PP (IN with) (NP (NP (NN follow-up)) (, ,) (ADVP (RB irrespective) (PP (IN of) (NP (JJ cumulative) (NN dose)))))))) (. .)))
8600333	10	(ROOT (S (NP (NP (JJ Life-long) (JJ cardiac) (NN follow-up)) (PP (IN in) (NP (DT these) (NNS patients)))) (VP (VBZ is) (VP (VBN warranted))) (. .)))
8600333	11	(ROOT (S (NP (NP (DT The) (NNS results)) (PP (IN of) (NP (PRP$ our) (NN study)))) (VP (VBP suggest) (SBAR (IN that) (S (NP (NP (NN heart) (NN rate) (NN variability)) (CC and) (NP (JJ LVPW) (NN index))) (VP (MD could) (VP (VB be) (NP (NP (JJ sensitive) (NNS indicators)) (PP (IN for) (NP (NNS Doc_8600333_1517_1531_Disease))))))))) (. .)))
8607407	0	(ROOT (S (VP (VB Acute) (NP (NN blood) (NN pressure) (NNS elevations)) (PP (IN with) (NP (NP (NNS Doc_8607407_37_45_Chemical)) (PP (IN in) (NP (NP (NNS men)) (PP (IN with) (NP (JJ borderline) (JJ systemic) (NNS Doc_8607407_78_90_Disease)))))))) (. .)))
8607407	1	(ROOT (S (SBAR (IN Whether) (S (NP (NP (DT the) (JJ vasoconstrictive) (NNS actions)) (PP (IN of) (NP (NNS Doc_8607407_132_140_Chemical)))) (VP (VBP are) (VP (VBN enhanced) (PP (IN in) (NP (JJ Doc_8607407_157_169_Disease) (NNS persons))))))) (VP (VBZ has) (RB not) (VP (VBN been) (VP (VBN demonstrated)))) (. .)))
8607407	2	(ROOT (S (ADVP (RB Thus)) (, ,) (NP (NP (NP (NNS Doc_8607407_211_219_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 3.3) (NN mg/kg)) (-RRB- -RRB-))) (PP (IN versus) (NP (NN placebo)))) (VP (VBD was) (VP (VBN tested) (PP (IN in) (NP (NP (NP (CD 48) (JJ healthy) (NNS men)) (PRN (-LRB- -LRB-) (VP (VBN aged) (NP (QP (CD 20) (TO to) (CD 35)) (NNS years))) (-RRB- -RRB-))) (VP (VBN selected) (PP (IN after) (S (VP (VBG screening) (PP (IN on) (NP (CD 2) (JJ separate) (NNS occasions))))))))))) (. .)))
8607407	3	(ROOT (S (NP (NP (JJ Borderline) (JJ Doc_8607407_359_371_Disease) (NNS men)) (PRN (-LRB- -LRB-) (VP (VBN n) (S (VP (SYM =) (NP (CD 24))))) (-RRB- -RRB-))) (VP (VBD were) (VP (VBN selected) (PP (IN with) (S (VP (VP (VBG screening) (NP (NP (NP (JJ systolic) (NN blood) (NN pressure)) (PRN (-LRB- -LRB-) (NP (NNP BP)) (-RRB- -RRB-))) (PP (IN of) (NP (QP (CD 140) (TO to) (CD 160)) (NN mm) (NN Hg))))) (CC and/or) (VP (VBG diastolic) (NP (NP (NNP BP) (CD 90)) (PP (TO to) (NP (CD 99) (NN mm) (NNP Hg)))))))))) (. .)))
8607407	4	(ROOT (S (NP (NP (JJ Low-risk) (NNS controls)) (PRN (-LRB- -LRB-) (VP (VBN n) (S (VP (SYM =) (NP (CD 24))))) (-RRB- -RRB-))) (VP (VP (VBD reported) (NP (NP (DT no) (JJ parental) (NN history)) (PP (IN of) (NP (NNS Doc_8607407_558_570_Disease))))) (CC and) (VP (VBD had) (S (VP (VBG screening) (NP (NNP BP) (NNP <) (CD 130/85) (NN mm) (NNS Hg)))))) (. .)))
8607407	5	(ROOT (S (S (NP (NNS Participants)) (VP (VBD were) (ADVP (RB then)) (VP (VBN tested) (PP (IN on) (NP (CD 2) (NNS occasions))) (PP (IN after) (NP (JJ 12-hour) (NN abstinence))) (PP (IN from) (NP (NP (NNS Doc_8607407_683_691_Chemical)) (PP (IN in) (NP (NP (DT each)) (PP (IN of) (NP (CD 2) (NNS protocols)))))))))) (: ;) (S (NP (DT this)) (VP (VBD required) (NP (NP (DT a) (NN total)) (PP (IN of) (NP (CD 4) (NN laboratory) (NNS visits)))))) (. .)))
8607407	6	(ROOT (S (NP (NP (JJ Doc_8607407_762_770_Chemical-induced) (NNS changes)) (PP (IN in) (NP (JJ diastolic) (NNP BP)))) (VP (VP (VBD were) (ADJP (ADJP (NP (QP (CD 2) (TO to) (CD 3) (NNS times))) (JJR larger)) (PP (IN in) (NP (JJ borderline) (NNS subjects)))) (PP (IN than) (PP (IN in) (NP (NP (NNS controls)) (PRN (-LRB- -LRB-) (NP (NP (CD +8.4) (CD vs) (CD +3.8) (NNP mm) (NNP Hg)) (, ,) (NP (NNP p) (NNP <) (NNP 0.0001))) (-RRB- -RRB-)))))) (, ,) (CC and) (VP (VBD were) (ADJP (JJ attributable) (PP (TO to) (NP (JJR larger) (NNS changes)))) (PP (IN in) (NP (NP (JJ impedance-derived) (NNS measures)) (PP (IN of) (NP (NP (JJ systemic) (NN vascular) (NN resistance)) (PRN (-LRB- -LRB-) (NP (NP (CD +135) (NN vs)) (NP (NP (CD +45) (JJ dynes.s.cm-5) (, ,) (JJ p) (NNS <)) (NP (CD 0.004)))) (-RRB- -RRB-)))))))) (. .)))
8607407	7	(ROOT (S (NP (DT These) (NNS findings)) (VP (VP (VBD were) (ADJP (JJ consistent))) (CC and) (VP (VBD reached) (NP (NN significance)) (PP (IN in) (NP (DT both) (NNS protocols))))) (. .)))
8607407	8	(ROOT (S (NP (NP (DT The) (NN percentage)) (PP (IN of) (NP (NP (JJ borderline) (NNS subjects)) (SBAR (WHPP (IN in) (WHNP (WP whom))) (S (NP (JJ diastolic) (NNP BP) (NNS changes)) (VP (VBD exceeded) (NP (DT the) (JJ median) (NN control) (NN response)))))))) (VP (VBD was) (NP (CD 96) (NN %))) (. .)))
8607407	9	(ROOT (S (ADVP (RB Consequently)) (PRN (, ,) (SBAR (IN whereas) (S (NP (DT all) (NNS participants)) (VP (VBD exhibited) (NP (JJ normotensive) (NNS levels)) (PP (IN during) (NP (DT the) (JJ resting) (NN predrug) (NN baseline)))))) (, ,)) (NP (NP (CD 33) (NN %)) (PP (IN of) (NP (JJ borderline) (NNS subjects)))) (VP (VBD achieved) (NP (JJ Doc_8607407_1373_1385_Disease) (NNP BP) (NNS levels)) (PP (IN after) (NP (JJ Doc_8607407_1402_1410_Chemical) (NN ingestion)))) (. .)))
8607407	10	(ROOT (S (ADVP (RB Thus)) (, ,) (PP (IN in) (NP (JJ borderline) (JJ Doc_8607407_1442_1454_Disease) (NNS men))) (, ,) (NP (JJ exaggerated) (NNS responses)) (VP (PP (TO to) (NP (NNS Doc_8607407_1485_1493_Chemical))) (VP (VBD were)) (: :) (VP (ADJP (JJ selective)) (PP (IN for) (NP (JJ diastolic) (NNP BP)))) (, ,) (VP (ADJP (JJ consistent)) (PP (IN with) (NP (JJR greater) (NN vasoconstriction)))) (, ,) (S (VP (VBN replicated) (PP (IN in) (NP (NP (QP (CD 2) (CD protocols))) (, ,) (CC and) (NP (NP (NN representative)) (PP (IN of) (NP (QP (RB nearly) (DT all)) (JJ borderline) (NNS Doc_8607407_1641_1654_Disease))))))))) (. .)))
8607407	11	(ROOT (S (NP (PRP We)) (VP (VBP suspect) (SBAR (IN that) (S (NP (NP (DT the) (NN potential)) (PP (IN for) (NP (NNS Doc_8607407_1690_1698_Chemical) (S (VP (TO to) (VP (VB stabilize) (NP (JJ high) (NN resistance) (NNS states)) (PP (IN in) (NP (ADJP (JJ susceptible)) (NNS persons))))))))) (VP (VBZ suggests) (SBAR (IN that) (S (NP (PRP$ its) (NN use)) (VP (MD may) (VP (VP (VB facilitate) (NP (PRP$ their) (NN disease) (NN progression))) (, ,) (CONJP (RB as) (RB well) (IN as)) (VP (VB hinder) (NP (ADJP (JJ accurate)) (NN diagnosis) (CC and) (NN treatment))))))))))) (. .)))
8617710	0	(ROOT (NP (NP (NNP Absence)) (PP (IN of) (NP (NN effect))) (PP (IN of) (NP (NP (NNS Doc_8617710_21_31_Chemical)) (PP (IN on) (NP (JJ time-based) (NN sensitization))))) (PP (IN of) (NP (NP (NNS Doc_8617710_63_83_Disease)) (PP (IN with) (NP (NNS Doc_8617710_89_100_Chemical))))) (. .)))
8617710	1	(ROOT (S (NP (NP (NP (DT This) (JJ double-blind) (, ,) (JJ randomized) (, ,) (JJ placebo-controlled) (NN study)) (VP (VBN evaluated) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NNS Doc_8617710_183_194_Chemical)))) (ADVP (RB alone)))) (CC and) (NP (NP (NNP Doc_8617710_205_216_Chemical) (CC plus) (NNP Doc_8617710_222_232_Chemical)) (PP (IN on) (NP (NN cognitive) (CC and) (NN psychomotor))))) (VP (VBP function) (PP (IN in) (NP (ADJP (CD 24) (JJ healthy) (NN male)) (NNS subjects)))) (. .)))
8617710	2	(ROOT (S (NP (DT All) (NNS subjects)) (VP (VBD received) (NP (NN placebo)) (PP (IN on) (NP (NN Day) (CD 1) (CC and) (JJ Doc_8617710_351_362_Chemical) (CD 2) (NN mg))) (PP (IN on) (NP (NNS Days) (CD 2) (CC and) (CD 25)))) (. .)))
8617710	3	(ROOT (S (S (PP (IN From) (NP (NNS Days) (CD 9) (TO to) (CD 25))) (, ,) (NP (NNS subjects)) (VP (VBD were) (ADVP (RB randomly)) (VP (VBN assigned) (PP (TO to) (NP (NP (DT either) (NNS Doc_8617710_447_457_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 12) (NNS subjects)) (-RRB- -RRB-)) (CC or) (NP (NN placebo)) (PRN (-LRB- -LRB-) (NP (CD 12) (NNS subjects)) (-RRB- -RRB-))))))) (: ;) (S (NP (DT the) (JJ Doc_8617710_502_512_Chemical) (NN dose)) (VP (VP (VBD was) (VP (VBN titrated) (PP (IN from) (NP (QP (CD 50) (TO to) (CD 200))) (ADVP (RB mg/day))) (PP (IN from) (NP (NNS Days) (CD 9) (TO to) (CD 16))))) (, ,) (CC and) (VP (VBD remained) (PP (IN at) (NP (CD 200) (NN mg/day))) (PP (IN for) (NP (NP (DT the) (JJ final) (CD 10) (NNS days)) (PP (IN of) (NP (DT the) (NN drug) (NN administration) (NN period)))))))) (. .)))
8617710	4	(ROOT (S (NP (JJ Cognitive) (NN function) (NN testing)) (VP (VBD was) (VP (VBN performed) (PP (PP (IN before) (NP (NN dosing))) (CC and) (PP (IN over) (NP (DT a) (JJ 24-hour) (NN period)))) (PP (IN after) (S (VP (VBG dosing) (PP (IN on) (NP (NP (NNS Days)) (NP (CD 1) (, ,) (CD 2) (, ,) (CC and) (CD 25))))))))) (. .)))
8617710	5	(ROOT (S (NP (NNP Doc_8617710_781_813_Disease)) (VP (VP (VBD was) (VP (VBN observed) (NP (QP (CD 6) (TO to) (CD 8)) (NNS hours)) (PP (IN after) (NP (NP (NN administration)) (PP (IN of) (NP (NP (NNS Doc_8617710_864_875_Chemical)) (PP (IN on) (NP (NNP Day) (CD 2))))))))) (CC but) (VP (VBD was) (RB not) (ADJP (JJ evident)) (PP (NP (CD 23) (NNS hours)) (IN after) (S (VP (VBG dosing)))))) (. .)))
8617710	6	(ROOT (S (SBAR (WHADVP (WRB When)) (S (NP (JJ single-dose) (NNS Doc_8617710_945_956_Chemical)) (VP (VBD was) (VP (VBN given) (ADVP (RB again)) (NP (CD 25) (NNS days) (RB later)))))) (, ,) (NP (NP (JJR greater) (NN impairment)) (PP (IN with) (NP (JJR earlier) (NN onset)))) (VP (VBD was) (VP (VBN noted) (PP (IN in) (NP (JJ several) (NNS tests))) (PP (IN in) (NP (DT both) (NN treatment) (NNS groups))) (, ,) (S (VP (VBG suggesting) (NP (NP (NN enhancement)) (PP (IN of) (NP (DT this) (NN effect)))))))) (. .)))
8617710	7	(ROOT (S (NP (EX There)) (VP (VBD was) (NP (DT no) (NN indication)) (SBAR (IN that) (S (NP (NNS Doc_8617710_1147_1157_Chemical)) (VP (VBD exacerbated) (SBAR (S (NP (DT the) (NN impairment)) (VP (VBD produced) (PP (IN by) (NP (NNS Doc_8617710_1197_1208_Chemical))) (SBAR (IN since) (S (NP (DT an) (NN equivalent) (NN effect)) (ADVP (RB also)) (VP (VBD occurred) (PP (IN in) (NP (DT the) (NN placebo) (NN group))))))))))))) (. .)))
8617710	8	(ROOT (S (NP (NP (CD Three) (NNS subjects)) (PRN (-LRB- -LRB-) (NP (NP (NP (CD 2)) (PP (IN on) (NP (NNS Doc_8617710_1293_1303_Chemical)))) (CC and) (NP (NP (CD 1)) (PP (IN on) (NP (NN placebo))))) (-RRB- -RRB-))) (VP (VBD withdrew) (PP (IN from) (NP (NP (DT the) (NN study)) (PP (RB because) (IN of) (NP (NN side) (NNS effects)))))) (. .)))
8617710	9	(ROOT (S (NP (NP (CD Ten) (NNS subjects)) (PP (IN in) (NP (DT each) (NN group)))) (VP (VBD reported) (NP (NP (NN side) (NNS effects)) (VP (VBN related) (PP (TO to) (NP (NN treatment)))))) (. .)))
8617710	10	(ROOT (S (NP (NP (DT The) (NN side)) (UCP (NP (NP (NN effect) (NNS profiles)) (PP (IN of) (NP (NNS Doc_8617710_1470_1480_Chemical)))) (CC and) (PP (IN of) (NP (NN placebo))))) (VP (VBD were) (ADJP (JJ similar))) (. .)))
8617710	11	(ROOT (S (NP (NNP Doc_8617710_1522_1533_Chemical)) (VP (VBD produced) (NP (NP (DT a) (JJ clear) (NN profile)) (PP (IN of) (NP (NP (NNS Doc_8617710_1562_1582_Disease)) (SBAR (WHNP (WDT that)) (S (VP (VBD was) (RB not) (VP (VBN worsened) (PP (IN by) (NP (JJ concomitant) (JJ Doc_8617710_1620_1630_Chemical) (NN administration))))))))))) (. .)))
8638876	0	(ROOT (S (NP (NP (NNP Coexistence)) (PP (IN of) (NP (NNS Doc_8638876_15_75_Disease)))) (VP (VBN associated) (PP (IN with) (NP (JJ exogenous) (NN sex) (NNS hormones)))) (. .)))
8638876	1	(ROOT (S (NP (DT A) (NN case)) (VP (VBP report)) (. .)))
8638876	2	(ROOT (S (NP (DT A) (JJ forty-six) (JJ year-old) (NN premenopausal) (NN woman)) (VP (VBD developed) (SBAR (S (NP (NNS Doc_8638876_182_190_Disease) (, ,) (NNS Doc_8638876_192_198_Disease) (CC and) (NNS Doc_8638876_203_211_Disease) (, ,)) (VP (VBD left) (NP (NNS Doc_8638876_218_229_Disease) (CC and) (NNS Doc_8638876_234_241_Disease)) (NP (CD two) (NNS days)) (PP (IN after) (NP (NP (JJ parenteral) (NN use)) (PP (IN of) (NP (NNS Doc_8638876_275_287_Chemical) (CC and) (NNS Doc_8638876_292_301_Chemical))))))))) (. .)))
8638876	3	(ROOT (S (NP (NP (NNP Doc_8638876_303_320_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_8638876_322_324_Disease)) (-RRB- -RRB-))) (VP (VBD was) (VP (VBN found) (PP (IN during) (NP (NN admission))))) (. .)))
8638876	4	(ROOT (S (NP (NNP Computed)) (ADVP (RB tomography)) (VP (VBD showed) (NP (DT a) (NNS Doc_8638876_383_402_Disease)) (PP (IN in) (NP (NP (DT the) (JJ right) (JJ frontal) (NN lobe)) (CC and) (NP (NP (VBN increased) (NN density)) (PP (IN in) (NP (NP (DT the) (ADJP (JJ superior) (JJ sagittal)) (NNS sinus)) (PRN (-LRB- -LRB-) (NP (NNP SSS)) (-RRB- -RRB-)))))))) (. .)))
8638876	5	(ROOT (S (NP (NNP Left)) (VP (VBD carotid) (NP (NP (ADJP (RB angiography) (VBN found)) (NNS Doc_8638876_520_565_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_8638876_567_570_Chemical)) (-RRB- -RRB-)))) (. .)))
8638876	6	(ROOT (S (NP (NNP Right)) (VP (VBD carotid) (SBAR (S (NP (NNS angiograms)) (VP (VBD failed) (S (VP (TO to) (VP (VB show) (NP (NP (DT the) (NNP SSS) (CC and) (JJ inferior) (NN sagittal) (NNS sinus)) (, ,) (NP (NP (NN suggestive)) (PP (IN of) (NP (NNS Doc_8638876_664_687_Disease)))))))))))) (. .)))
8638876	7	(ROOT (S (NP (NP (NNP Coexistence)) (PP (IN of) (NP (DT the) (NNS Doc_8638876_708_754_Disease)))) (VP (VBZ has) (VP (VBN been) (VP (VBN described) (ADVP (RB infrequently))))) (. .)))
8638876	8	(ROOT (S (PP (IN In) (NP (DT this) (NN case))) (, ,) (NP (DT the) (NNS authors)) (VP (VBP postulate) (SBAR (IN that) (S (NP (NP (DT the) (NN use)) (PP (IN of) (NP (NP (NP (NNS Doc_8638876_840_849_Chemical) (CC and) (NNS Doc_8638876_854_866_Chemical)) (CC and) (NP (DT the) (VBG underlying) (JJ Doc_8638876_886_888_Disease) (VBN increased) (NN vascular) (NN thrombogenicity))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD provided) (NP (DT a) (JJ common) (NN denominator)) (PP (IN for) (NP (NP (NNS thrombosis)) (PP (IN of) (NP (NP (PDT both) (DT the) (NNS Doc_8638876_988_991_Chemical)) (CC and) (NP (DT the) (NNS venous)))))))))))) (VP (VBZ sinus))))) (. .)))
8643966	0	(ROOT (NP (NP (NP (NNP Chemotherapy)) (PP (IN of) (NP (NP (ADJP (JJ advanced) (JJ inoperable)) (NNS Doc_8643966_36_62_Disease)) (PP (IN with) (NP (NNS Doc_8643966_68_78_Chemical)))))) (: :) (NP (NP (DT a) (NN phase)) (NP (NNP II) (NN trial))) (. .)))
8643966	1	(ROOT (S (NP (NP (NNP Doc_8643966_98_108_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (NNS Doc_8643966_110_115_Chemical)) (: ;) (NP (NNP Bristol-Myers) (NNP Squibb) (NNP Company))) (, ,) (NP (NP (NNP Princeton)) (, ,) (NP (NNP NJ))) (-RRB- -RRB-))) (VP (VBZ has) (VP (VBN demonstrated) (NP (JJ significant) (JJ antineoplastic) (NN activity)) (PP (IN against) (NP (NP (JJ different) (JJ Doc_8643966_233_238_Disease) (NNS types)) (, ,) (RB notably) (NP (NNS Doc_8643966_254_282_Disease)))))) (. .)))
8643966	2	(ROOT (S (NP (NP (NP (CD Two) (NN phase) (NNP II) (NNS trials)) (PP (IN of) (NP (NP (JJ 24-hour) (JJ Doc_8643966_315_325_Chemical) (NNS infusions)) (PP (IN in) (NP (NP (JJ chemotherapy-naive) (NNS patients)) (PP (IN with) (NP (NP (NN stage) (NNS IIIB)) (CC or) (NP (NNP IV) (NNP Doc_8643966_389_415_Disease))))))))) (PRN (-LRB- -LRB-) (NP (NNP Doc_8643966_417_422_Disease)) (-RRB- -RRB-))) (VP (VBD reported) (NP (NP (NN response) (NNS rates)) (PP (IN of) (NP (NP (CD 21) (NN %)) (CC and) (NP (CD 24) (NN %)))))) (. .)))
8643966	3	(ROOT (S (S (NP (NNP Doc_8643966_464_474_Disease)) (VP (VBD was) (NP (NP (NN dose)) (VP (VBG limiting))))) (: :) (S (NP (NP (QP (RB as) (JJ many) (IN as) (CD 62.5)) (NN %)) (PP (IN of) (NP (NNS patients)))) (VP (VBD experienced) (NP (QP (CD grade) (CD 4)) (NNS Doc_8643966_543_553_Disease)))) (. .)))
8643966	4	(ROOT (S (NP (PRP We)) (VP (VBD investigated) (NP (NP (DT the) (NN efficacy) (CC and) (NNS Doc_8643966_588_596_Disease)) (PP (IN of) (NP (NP (DT a) (JJ 3-hour) (JJ Doc_8643966_609_619_Chemical) (NN infusion)) (PP (IN in) (NP (NP (DT a) (NN phase) (NNP II) (NN trial)) (PP (IN in) (NP (NNS patients)))))))) (PP (IN with) (NP (JJ inoperable) (NN stage) (NNP IIIB) (CC or) (NNP IV) (NNS Doc_8643966_694_699_Disease)))) (. .)))
8643966	5	(ROOT (S (NP (NP (DT The) (CD 58) (NNS patients)) (VP (VBN treated)) (PRN (-LRB- -LRB-) (NP (NP (CD 41) (NNS men)) (CC and) (NP (CD 17) (NNS women))) (-RRB- -RRB-))) (VP (VBD had) (NP (NP (DT a) (JJ median) (NN age)) (PP (IN of) (NP (NP (CD 59) (NNS years) (PRN (-LRB- -LRB-) (NP (NP (NN age) (NN range)) (, ,) (NP (CD 25) (TO to) (CD 75))) (-RRB- -RRB-))) (CC and) (NP (NP (DT a) (NN performance) (NN status)) (PP (IN of) (NP (CD 0))))))) (PP (IN through) (NP (CD 2)))) (. .)))
8643966	6	(ROOT (S (NP (NP (JJS Most) (NNS patients)) (PRN (-LRB- -LRB-) (NP (CD 72.4) (NN %)) (-RRB- -RRB-))) (VP (VBD had) (VP (NN stage) (NP (NNP IV) (NNS Doc_8643966_874_879_Disease)))) (. .)))
8643966	7	(ROOT (S (NP (QP (CD Doc_8643966_881_891_Chemical) (CD 225)) (NNS mg/m2)) (VP (VBD was) (VP (VBN infused) (PP (IN over) (NP (CD 3) (NNS hours))) (NP (DT every) (CD 3) (NNS weeks)) (PP (IN with) (NP (JJ standard) (JJ prophylactic) (NN premedication))))) (. .)))
8643966	8	(ROOT (S (PP (IN Of) (NP (NP (CD 50) (NNS patients) (JJ evaluable)) (PP (IN for) (NP (NN response))))) (, ,) (S (NP (NP (CD 12)) (PRN (-LRB- -LRB-) (NP (CD 24) (NN %)) (-RRB- -RRB-))) (VP (VBD had) (NP (JJ partial) (NN remission)))) (, ,) (S (NP (NP (CD 26)) (PRN (-LRB- -LRB-) (NP (CD 52) (NN %)) (-RRB- -RRB-))) (VP (VBD had) (NP (DT no) (NN change)))) (, ,) (CC and) (S (NP (CD 12)) (VP (VBD had) (NP (NP (NN disease) (NN progression)) (PRN (-LRB- -LRB-) (NP (CD 24) (NN %)) (-RRB- -RRB-))))) (. .)))
8643966	9	(ROOT (S (S (NP (NNP Hematologic) (NNP Doc_8643966_1128_1138_Disease)) (VP (VBD were) (ADJP (JJ mild)))) (: :) (S (NP (NP (RB only) (CD one) (NN patient)) (PRN (-LRB- -LRB-) (NP (CD 2) (NN %)) (-RRB- -RRB-))) (VP (VBD developed) (NP (NP (NN grade) (CD 3)) (CC or) (NP (CD 4) (NNS Doc_8643966_1195_1206_Disease))) (, ,) (SBAR (IN while) (S (NP (CD 29) (NN %)) (VP (VBD had) (NP (NP (NN grade) (CD 1)) (CC or) (NP (CD 2)))))))) (. .)))
8643966	10	(ROOT (S (NP (NP (NNP Grade) (CD 1)) (CC or) (NP (CD 2) (NNS Doc_8643966_1249_1263_Disease))) (VP (VBD affected) (NP (NP (CD 56) (NN %)) (PP (IN of) (NP (NNS patients)))) (SBAR (IN while) (S (NP (NP (RB only) (CD one)) (PRN (-LRB- -LRB-) (NP (CD 2) (NN %)) (-RRB- -RRB-))) (VP (VBD experienced) (NP (JJ severe) (NNS Doc_8643966_1328_1342_Disease)))))) (. .)))
8643966	11	(ROOT (S (ADVP (RB Similarly)) (, ,) (NP (UCP (NP (NN grade) (CD 1)) (CC or) (ADJP (NP (CD 2) (NNS Doc_8643966_1368_1375_Disease)) (JJ /))) (NNS Doc_8643966_1376_1386_Disease)) (VP (VBD was) (ADJP (JJ observed) (PP (IN in) (NP (UCP (NP (NP (CD 63.2) (NN %)) (PP (IN of) (NP (NNS patients)))) (, ,) (CC but) (ADJP (NP (QP (RB only) (CD 14.3)) (NN %)) (JJ experienced))) (NN grade))) (NP (CD 3) (CC or) (CD 4)))) (. .)))
8643966	12	(ROOT (S (NP (NNS Doc_8643966_1463_1469_Disease) (CC and) (NNS Doc_8643966_1474_1482_Disease)) (VP (VBD were) (ADJP (JJ infrequent)) (, ,) (PP (IN with) (S (NP (NP (CD 14) (NN %)) (PP (IN of) (NP (NNS patients)))) (VP (VP (VBG experiencing) (NP (NN grade)) (NP (CD 1) (CC or) (CD 2))) (CC and) (ADVP (RB only) (NP (CD 2) (NN %))) (VP (VBG experiencing) (NP (NN grade)) (NP (CD 3) (CC or) (CD 4))))))) (. .)))
8643966	13	(ROOT (S (NP (NNP Doc_8643966_1586_1596_Chemical)) (VP (VBZ is) (ADVP (RB thus)) (NP (NP (DT an) (JJ active) (JJ single) (NN agent)) (PP (IN in) (NP (DT this) (JJ patient) (NN population)))) (, ,) (PP (IN with) (NP (NP (DT a) (JJ 3-hour) (NN infusion)) (VP (VBG proving) (ADJP (ADJP (RB comparably) (JJ effective) (PP (TO to) (NP (DT a) (JJ 24-hour) (NN infusion)))) (CC and) (ADJP (JJ superior) (PP (IN in) (NP (NP (NNS terms)) (PP (IN of) (NP (NP (DT the) (NN incidence)) (PP (IN of) (NP (ADJP (JJ hematologic) (CC and) (JJ nonhematologic)) (NNS Doc_8643966_1803_1811_Disease))))))))))))) (. .)))
8643966	14	(ROOT (S (S (NP (NP (JJ Further) (NN phase) (NNP II) (NNS studies)) (PP (IN with) (NP (NP (NNS Doc_8643966_1843_1853_Chemical)) (VP (VBN combined) (PP (IN with) (NP (NP (JJ other) (NNS drugs)) (ADJP (JJ active) (PP (IN against) (NP (NNS Doc_8643966_1895_1900_Disease)))))))))) (VP (VBP are) (VP (VBN indicated)))) (, ,) (CC and) (S (NP (NP (NN phase) (NNP III) (NNS studies)) (VP (VBG comparing) (NP (NNS Doc_8643966_1948_1958_Chemical)) (PP (IN with) (NP (JJ standard) (NN chemotherapy))))) (VP (VBP remain) (S (VP (TO to) (VP (VB be) (VP (VBN completed))))))) (. .)))
8643973	0	(ROOT (S (NP (NNP Doc_8643973_0_10_Chemical)) (VP (VBD combined) (PP (IN with) (NP (NNS Doc_8643973_25_36_Chemical))) (PP (IN in) (NP (NP (DT the) (JJ first-line) (NN treatment)) (PP (IN of) (NP (JJ advanced) (NNS Doc_8643973_77_91_Disease)))))) (. .)))
8643973	1	(ROOT (S (PP (IN In) (NP (DT a) (NN phase))) (NP (PRP I)) (VP (VBP study) (S (VP (TO to) (VP (VB determine) (NP (NP (DT the) (JJ maximum) (JJ tolerated) (NN dose)) (PP (IN of) (NP (NP (NNS Doc_8643973_155_165_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (NNS Doc_8643973_167_172_Chemical)) (: ;) (NP (NNP Bristol-Myers) (NNP Squibb) (NNP Company))) (, ,) (NP (NP (NNP Princeton)) (, ,) (NP (NNP NJ))) (-RRB- -RRB-))))) (PP (VBN given) (PP (IN as) (NP (NP (DT a) (JJ 3-hour) (NN infusion)) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (NP (NNS Doc_8643973_266_277_Chemical)) (VP (VBN administered) (NP (DT every) (CD 21) (NNS days)) (PP (TO to) (NP (NNS women))) (PP (IN with) (NP (NP (JJ advanced) (NNS Doc_8643973_328_342_Disease)) (, ,) (NP (NP (NP (JJ Doc_8643973_344_354_Chemical) (NNS doses)) (SBAR (S (VP (VBD were) (VP (VBN escalated) (SBAR (IN as) (S (VP (VBZ follows))))))))) (: :) (NP (NP (NN level) (CD 1)) (, ,) (NP (CD 135) (NNS mg/m2))) (: ;) (NP (NP (NN level) (CD 2)) (, ,) (NP (CD 160) (NNS mg/m2))) (: ;) (NP (NP (NN level) (CD 3)) (, ,) (NP (CD 185) (NNS mg/m2))) (: ;) (CC and) (NP (NP (NN level)) (NP (CD 4,210) (NNS mg/m2)))))))))))))))))) (. .)))
8643973	2	(ROOT (S (NP (NP (DT The) (VBN fixed) (NN dose)) (PP (IN of) (NP (NP (NNS Doc_8643973_489_500_Chemical)) (PP (IN at) (NP (NP (NNS levels) (CD 1)) (PP (IN through) (NP (CD 4)))))))) (VP (VBD was) (VP (VBN given) (S (VP (TO to) (VP (VB achieve) (NP (DT an) (NN area)) (PP (IN under) (S (NP (NP (NP (DT the) (JJ concentration-time) (NN curve)) (PRN (-LRB- -LRB-) (NP (NNP AUC)) (-RRB- -RRB-))) (PP (IN of) (NP (CD 5)))) (VP (VBG using) (NP (DT the) (NNP Calvert) (NN formula)))))))))) (. .)))
8643973	3	(ROOT (S (PP (IN In) (NP (NNS levels) (CD 5) (CC and) (CD 6))) (NP (DT the) (JJ Doc_8643973_647_658_Chemical) (NN dose)) (VP (VBD was) (VP (VBN targeted) (PP (IN at) (NP (NP (NNP AUCs)) (PP (IN of) (NP (CD 6) (CC and) (CD 7.5))))) (, ,) (ADVP (RB respectively)) (, ,) (PP (VBN combined) (PP (IN with) (NP (NP (DT a) (VBN fixed) (JJ Doc_8643973_735_745_Chemical) (NN dose)) (PP (IN of) (NP (CD 185) (NNS mg/m2)))))))) (. .)))
8643973	4	(ROOT (S (PP (TO To) (NP (NP (NN date)) (, ,) (NP (CD 30) (ADJP (RB previously) (JJ untreated)) (NNS patients)))) (, ,) (NP (NP (DT all)) (PP (IN with) (NP (NP (DT a) (JJ good) (NN performance) (NN status)) (PRN (-LRB- -LRB-) (NP (NP (NNP Eastern) (NNP Cooperative) (NNP Oncology) (NNP Group) (NNP 0)) (PP (TO to) (NP (CD 2)))) (-RRB- -RRB-))))) (VP (VBP have) (VP (VBN been) (VP (VBN entered) (PP (IN into) (NP (DT this) (JJ ongoing) (NN study)))))) (. .)))
8643973	5	(ROOT (S (NP (NP (DT The) (JJ dose-limiting) (NNS Doc_8643973_948_956_Disease)) (PP (IN of) (NP (DT the) (NN combination)))) (VP (VBD was) (ADJP (JJ myelosuppression)) (PRN (-LRB- -LRB-) (NP (NP (NNS Doc_8643973_998_1008_Disease)) (, ,) (NP (NNS Doc_8643973_1010_1026_Disease)) (, ,) (CC and) (NP (NNS Doc_8643973_1032_1048_Disease))) (-RRB- -RRB-))) (. .)))
8643973	6	(ROOT (S (NP (NNP Doc_8643973_1051_1064_Disease)) (VP (VBD was) (ADJP (RB largely) (JJ moderate))) (. .)))
8643973	7	(ROOT (S (S (ADVP (IN So) (RB far)) (, ,) (NP (CD 14) (NNS patients)) (VP (VBP are) (ADJP (JJ evaluable) (PP (IN for) (NP (NN response)))))) (: ;) (S (PP (IN of) (NP (DT these))) (, ,) (NP (NP (CD eight)) (PRN (-LRB- -LRB-) (NP (CD 57) (NN %)) (-RRB- -RRB-))) (VP (VBD showed) (NP (NP (JJ objective) (PRN (-LRB- -LRB-) (NP (JJ complete) (CC or) (JJ partial)) (-RRB- -RRB-)) (NN response)) (CC and) (NP (NP (NN disease)) (VP (VBN stabilized) (PP (IN in) (NP (CD six) (NNS patients)))))))) (. .)))
8643973	8	(ROOT (S (NP (DT No) (NN patient)) (VP (VBD had) (NP (NN disease) (NN progression))) (. .)))
8643973	9	(ROOT (S (NP (PRP We)) (VP (VBP conclude) (SBAR (IN that) (S (NP (NP (DT the) (NN combination)) (PP (IN of) (NP (NP (QP (CD Doc_8643973_1317_1327_Chemical) (CD 185)) (NNS mg/m2)) (VP (VBN administered) (PP (IN as) (NP (NP (DT a) (JJ 3-hour) (NN infusion)) (VP (VBN followed) (ADVP (RB immediately)) (PP (IN by) (NP (NP (DT a) (JJ 1-hour) (NN infusion)) (PP (IN of) (NP (NNS Doc_8643973_1417_1428_Chemical))))) (PP (IN at) (NP (NP (DT an) (NNP AUC)) (PP (IN of) (NP (CD 6)))))))))))) (VP (MD can) (VP (VB be) (VP (VBN administered) (ADVP (RB safely)) (PP (IN in) (NP (NP (DT a) (JJ 21-day) (NN schedule)) (PP (IN in) (NP (DT the) (NN outpatient) (NN setting))))))))))) (. .)))
8643973	10	(ROOT (S (NP (NP (DT The) (VBN recommended) (NN dose)) (PP (IN for) (NP (NN phase) (NNP III) (NNS studies)))) (VP (VBZ is) (NP (NP (QP (CD Doc_8643973_1565_1575_Chemical) (CD 185)) (NNS mg/m2)) (CC and) (NP (NP (NNP Doc_8643973_1590_1601_Chemical) (NNP AUC)) (NP (CD 6))))) (. .)))
8665051	0	(ROOT (NP (NP (NNPS Effects)) (PP (IN of) (NP (JJ acute) (JJ Doc_8665051_17_24_Chemical) (NN administration))) (PP (IN on) (NP (JJ ventilatory) (CC and) (JJ peripheral) (NNS muscles))) (PP (IN in) (NP (NNS rats))) (. .)))
8665051	1	(ROOT (S (NP (JJ Occasional) (NN case) (NNS reports)) (VP (VBP have) (VP (VBN shown) (SBAR (IN that) (S (NP (JJ acute) (NNS Doc_8665051_133_141_Disease)) (VP (MD may) (VP (VB occur) (PP (IN in) (NP (NP (NNS patients)) (VP (VBN treated) (PP (IN with) (NP (NP (JJ massive) (NNS doses)) (PP (IN of) (NP (NNS Doc_8665051_194_209_Chemical)))))))))))))) (. .)))
8665051	2	(ROOT (S (NP (NP (DT The) (NN mechanism)) (PP (IN of) (NP (DT this) (NNS Doc_8665051_233_241_Disease)))) (VP (VBZ is) (ADVP (RB poorly)) (VP (VBN understood))) (. .)))
8665051	3	(ROOT (S (ADVP (RB Therefore)) (, ,) (NP (CD 60) (JJ male) (NNS rats)) (VP (VBD were) (ADVP (RB randomly)) (VP (VBN assigned) (S (VP (TO to) (VP (VB receive) (NP (NP (NP (JJ daily) (NN injection)) (PP (IN of) (NP (NP (NN saline)) (PRN (-LRB- -LRB-) (NP (NNP C)) (-RRB- -RRB-))))) (, ,) (NP (NP (NNS Doc_8665051_353_371_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP M)) (-RRB- -RRB-))) (, ,) (CC or) (NP (NP (NNS Doc_8665051_380_393_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_8665051_395_396_Chemical)) (-RRB- -RRB-)) (SBAR (S (NP (NP (CD 80) (NN mg/kg/d)) (PP (IN for) (NP (CD 5) (NNP d.) (NNP Nutritional) (NN intake))) (, ,) (VP (VBN measured) (ADVP (RB daily)) (PP (IN in) (NP (CD 15) (NNS animals)))) (, ,)) (VP (VBD showed) (NP (DT a) (JJ significant) (NNS Doc_8665051_489_513_Disease)) (PP (IN in) (NP (DT the) (NN Doc_8665051_521_528_Chemical-treated) (NNS groups))) (PRN (-LRB- -LRB-) (NP (NP (NP (CD -50)) (CC and) (NP (NP (CD -79) (NN %)) (PP (IN in) (NP (NNP M) (CC and) (NNP T))))) (, ,) (ADVP (RB respectively))) (-RRB- -RRB-)))))))))))) (. .)))
8665051	4	(ROOT (S (NP (DT This)) (VP (VBD was) (VP (VBN associated) (PP (IN with) (NP (DT a) (JJ similar) (NNS Doc_8665051_620_639_Disease))))) (. .)))
8665051	5	(ROOT (S (PP (IN In) (NP (DT the) (CD 45) (VBG remaining) (NNS animals))) (, ,) (NP (NP (JJ diaphragm) (ADJP (JJ contractility) (CC and) (JJ histopathologic)) (NNS features)) (PP (IN of) (NP (JJ several) (NNS muscles)))) (VP (VBD were) (VP (VBN studied))) (. .)))
8665051	6	(ROOT (S (NP (NP (NNS Weights)) (PP (IN of) (NP (JJ respiratory) (CC and) (JJ peripheral) (NNS muscles)))) (VP (VBD were) (ADVP (RB similarly)) (VP (VBN decreased) (PP (IN after) (NP (JJ Doc_8665051_833_840_Chemical) (NN treatment))))) (. .)))
8665051	7	(ROOT (S (NP (NP (JJ Maximal) (NNS twitches)) (PP (IN of) (NP (DT the) (NN diaphragm)))) (VP (VBD were) (ADJP (JJR lower)) (PP (IN in) (NP (NP (DT the) (NNP C) (NN group)) (PRN (-LRB- -LRB-) (NP (NP (CD 653) (JJ +) (NNS /)) (: -) (NP (NP (NP (NP (CD 174) (NN g/cm)) (PRN (-LRB- -LRB-) (NP (CD 2)) (-RRB- -RRB-)) (-RRB- -RRB-)) (PP (IN than) (PP (IN in) (NP (NP (DT the) (NNP M) (NN group)) (PRN (-LRB- -LRB-) (ADVP (RB 837)) (NP (NNP +)) (: /)))))) (: -) (NP (NP (JJ 171) (NN g/cm)) (PRN (-LRB- -LRB-) (NP (CD 2)) (-RRB- -RRB-))) (: ;) (NP (NP (NN p) (NNS <)) (NP (CD 0.05))))) (-RRB- -RRB-)) (CC and) (NP (DT the) (NNP T) (NN group)) (PRN (-LRB- -LRB-) (NP (NNP 765) (NNP +) (NNP /)) (: -) (NP (NP (CD 145) (NN g/cm) (PRN (-LRB- -LRB-) (NP (CD 2)) (-RRB- -RRB-))) (, ,) (NP (NNP NS))) (-RRB- -RRB-))))) (. .)))
8665051	8	(ROOT (S (S (NP (JJ Half-relaxation) (NN time)) (VP (VBD was) (ADJP (JJ prolonged) (PP (IN in) (NP (DT both) (JJ Doc_8665051_1072_1079_Chemical) (NNS groups)))))) (, ,) (CC and) (S (NP (NP (NN time)) (PP (TO to) (NP (JJ peak) (NN tension)))) (VP (VBD was) (ADVP (RB longer) (PP (IN with) (NP (NNP M)))) (, ,) (SBAR (IN whereas) (S (NP (JJ tetanic) (NNS tensions)) (VP (VBD were) (ADJP (JJ similar))))))) (. .)))
8665051	9	(ROOT (S (NP (JJ Doc_8665051_1171_1178_Chemical) (NN treatment)) (ADVP (RB also)) (VP (VBN induced) (NP (NP (DT a) (JJ leftward) (NN shift)) (PP (IN of) (NP (DT the) (JJ force-frequency) (NN curve)))) (PP (IN at) (NP (CD 25) (CC and) (CD 50) (NNS Hz))) (SBAR (WHADVP (WRB when)) (S (VP (VBN compared) (PP (IN with) (NP (JJ saline) (NN treatment))) (PRN (-LRB- -LRB-) (ADVP (RB p)) (ADJP (JJ <) (NP (CD 0.05))) (-RRB- -RRB-)))))) (. .)))
8665051	10	(ROOT (S (NP (NP (JJ ATPase) (NN staining)) (PP (IN of) (NP (NP (DT the) (NN diaphragm)) (, ,) (NP (JJ scalenus) (NNS medius)) (, ,) (CC and) (NP (NNS gastrocnemius))))) (VP (VBD showed) (NP (NN type) (NN IIb) (NN fiber) (NNS Doc_8665051_1403_1410_Disease)) (PP (IN in) (NP (DT the) (UCP (NP (JJ Doc_8665051_1418_1425_Chemical) (NNS groups)) (CC and) (ADJP (ADVP (RB also)) (JJ diaphragmatic))) (NN type) (NN IIa) (NNS Doc_8665051_1465_1472_Disease))) (PP (IN with) (NP (NNP T))) (, ,) (SBAR (IN whereas) (S (NP (JJ histologic) (NNS examinations)) (VP (VBD revealed) (NP (DT a) (JJ normal) (JJ muscular) (NN pattern)) (PP (IN with) (NP (NP (NN absence)) (PP (IN of) (NP (NNS Doc_8665051_1564_1572_Disease))))))))) (. .)))
8665051	11	(ROOT (S (ADVP (RB Finally)) (, ,) (NP (NP (DT a) (ADJP (JJ pair-fed)) (PRN (-LRB- -LRB-) (NP (NNP PF)) (-RRB- -RRB-)) (NN study)) (, ,) (VP (VBN performed) (PP (IN in) (NP (NP (CD 18) (NNS rats)) (PRN (-LRB- -LRB-) (NP (NP (NNP C)) (, ,) (NP (NNP T)) (, ,) (CC and) (NP (NNP PF))) (-RRB- -RRB-))))) (, ,)) (VP (VBD showed) (SBAR (IN that) (S (NP (NNS Doc_8665051_1655_1669_Disease)) (VP (VBD was) (ADJP (ADJP (RB considerably) (RBR less) (JJ pronounced) (PP (IN in) (NP (NNP PF) (NNS animals)))) (PP (IN than) (PP (IN in) (NP (JJ T-treated) (NNS animals))))))))) (. .)))
8665051	12	(ROOT (S (S (NP (PRP We)) (VP (VBP conclude) (SBAR (IN that) (S (NP (NP (LST (-LRB- -LRB-) (LS 1) (-RRB- -RRB-)) (NP (JJ short-term) (NN treatment)) (PP (IN with) (NP (NP (JJ massive) (NNS doses)) (PP (IN of) (NP (NP (NNS Doc_8665051_1808_1816_Chemical)) (VP (VBN induced) (NP (JJ severe) (JJ respiratory) (CC and) (NN limb) (NN muscle) (NN wasting)))))))) (: ;) (NP (LST (-LRB- -LRB-) (LS 2) (-RRB- -RRB-)) (NP (DT both) (NNS types)) (PP (IN of) (NP (NNS Doc_8665051_1887_1895_Chemical))))) (VP (VBN induced) (NP (NP (ADJP (RB predominantly) (NN type)) (NN IIb) (NNS Doc_8665051_1927_1934_Disease)) (, ,) (VP (VBG resulting) (PP (IN in) (NP (NP (DT the) (VBN expected) (NNS alterations)) (PP (IN in) (NP (NN diaphragm) (NN contractile) (NNS properties)))))))))))) (: ;) (S (LST (-LRB- -LRB-) (LS 3) (-RRB- -RRB-)) (NP (DT neither) (NNS Doc_8665051_2023_2030_Chemical)) (VP (VBD caused) (NP (NN muscle) (NNS Doc_8665051_2045_2053_Disease)))) (: ;) (S (LST (-LRB- -LRB-) (LS 4) (-RRB- -RRB-)) (NP (NN type) (NN IIb) (NNS Doc_8665051_2068_2075_Disease)) (VP (VBD was) (RB not) (VP (VBN caused) (PP (IN by) (NP (ADJP (JJ acute) (JJ nutritional)) (NN deprivation)) (ADVP (RB alone)))))) (. .)))
8677458	0	(ROOT (S (NP (NNS Continuous)) (VP (VBZ subcutaneous) (S (NP (NP (NN administration)) (PP (IN of) (NP (NNS Doc_8677458_42_47_Chemical)))) (VP (TO to) (VP (VB prevent) (NP (NN Doc_8677458_59_69_Chemical-induced) (NNS Doc_8677458_78_98_Disease)))))) (. .)))
8677458	1	(ROOT (S (NP (NNP Doc_8677458_100_120_Disease)) (VP (VBZ is) (NP (NP (DT a) (JJ major) (JJ potential) (NNS Doc_8677458_142_150_Disease)) (PP (IN of) (NP (NP (NNS Doc_8677458_154_164_Chemical)) (SBAR (WHNP (WDT that)) (S (VP (MD can) (VP (VB be) (VP (VBN prevented) (PP (IN by) (S (VP (VBG administering) (NP (NNS Doc_8677458_204_209_Chemical)) (PRT (RP along)) (PP (IN with) (NP (DT the) (JJ cytotoxic) (NN agent))))))))))))))) (. .)))
8677458	2	(ROOT (S (NP (NNP Doc_8677458_242_247_Chemical)) (VP (VBZ is) (ADJP (RB generally) (VBN administered) (PP (IN by) (NP (DT the) (JJ intravenous) (NN route)))) (, ,) (SBAR (IN although) (S (NP (NP (NN experience)) (PP (IN with) (NP (NP (JJ oral) (NN delivery)) (PP (IN of) (NP (DT the) (NN drug)))))) (VP (VBZ has) (VP (VBN increased)))))) (. .)))
8677458	3	(ROOT (S (NP (NP (DT The) (JJ continuous) (NNS subcutaneous) (NN administration)) (PP (IN of) (NP (NNS Doc_8677458_412_417_Chemical)))) (VP (VBZ has) (NP (NP (DT the) (NN advantage)) (PP (IN of) (S (RB not) (VP (VBG requiring) (NP (JJ intravenous) (NN access))))))) (. .)))
8677458	4	(ROOT (S (PP (IN In) (NP (NN addition))) (, ,) (NP (NP (JJ subcutaneous) (NN delivery)) (PP (IN of) (NP (DT the) (JJ neutralizing) (NN agent)))) (VP (MD will) (RB not) (VP (VB be) (VP (VBN associated) (PP (IN with) (NP (NP (DT the) (NN risk)) (PP (IN of) (NP (JJ inadequate) (JJ urinary) (JJ Doc_8677458_593_598_Chemical) (NNS concentrations))))) (, ,) (PP (JJ such) (PP (IN as) (IN in) (NP (NP (DT a) (NN patient)) (VP (VBG taking) (NP (NP (JJ oral) (NNS Doc_8677458_648_653_Chemical)) (SBAR (WHNP (WP who)) (S (VP (VP (VBZ experiences) (NP (JJ severe) (NN Doc_8677458_677_687_Chemical-induced) (NNS Doc_8677458_696_702_Disease))) (CC and) (VP (VBZ is) (ADJP (JJ unable) (S (VP (TO to) (VP (VB absorb) (NP (DT the) (NN drug)))))))))))))))))) (. .)))
8677458	5	(ROOT (S (NP (NP (JJ Limited) (JJ clinical) (NN experience)) (PP (IN with) (NP (JJ continuous) (NNS subcutaneous) (NNS Doc_8677458_794_799_Chemical) (NN administration)))) (VP (VBZ suggests) (SBAR (S (NP (PRP it)) (VP (VBZ is) (NP (NP (DT a) (JJ safe) (, ,) (ADJP (JJ practical) (, ,) (CC and) (JJ economic)) (NN method)) (PP (IN of) (NP (NP (NN drug) (NN delivery)) (SBAR (WHNP (WDT that)) (S (VP (VBZ permits) (S (NP (NNS Doc_8677458_899_909_Chemical)) (VP (TO to) (VP (VB be) (VP (VBN administered) (ADVP (RB successfully)) (PP (IN in) (NP (DT the) (NN outpatient) (NN setting))))))))))))))))) (. .)))
8686832	0	(ROOT (FRAG (ADJP (JJ Doc_8686832_0_17_Disease) (PP (IN after) (NP (JJ spinal) (NN anaesthesia)))) (S (VP (VBG involving) (NP (JJ hyperbaric) (ADJP (CD 5) (NN %)) (NNS Doc_8686832_67_77_Chemical)))) (. .)))
8686832	1	(ROOT (S (NP (NP (JJ Fifty-four) (NNS patients)) (, ,) (VP (VBN aged) (NP (NP (CD 27-90) (NNS years)) (, ,) (SBAR (WHNP (WP who)) (S (VP (VBD were) (VP (VBN given) (NP (NP (NNS Doc_8686832_133_143_Chemical)) (ADJP (CD 5) (NN %)) (PP (IN in) (NP (CD 6.8) (NN %)))) (NP (NP (JJ Doc_8686832_155_162_Chemical) (NN solution)) (PP (IN for) (NP (JJ spinal) (NN anaesthesia))))))))))) (VP (VBD were) (VP (VBN studied))) (. .)))
8686832	2	(ROOT (S (NP (NP (NNP Thirteen)) (PP (IN of) (NP (DT these) (NNS patients)))) (VP (VBD experienced) (NP (NNS Doc_8686832_248_276_Disease)) (PP (IN after) (NP (NN recovery))) (PP (IN from) (NP (NN anaesthesia)))) (. .)))
8686832	3	(ROOT (S (S (NP (NP (DT The) (NNS patients)) (VP (VBN affected))) (VP (VBD were) (NP (JJR younger)))) (PRN (-LRB- -LRB-) (VP (VB p) (NP (CD <) (CD 0.05))) (-RRB- -RRB-)) (CC and) (S (NP (NP (DT the) (NN site)) (PP (IN of) (NP (DT the) (JJ dural) (NN puncture)))) (VP (VBD was) (ADJP (ADJP (ADJP (JJR higher)) (PRN (-LRB- -LRB-) (ADVP (RB p)) (ADJP (JJ <) (NP (CD 0.01))) (-RRB- -RRB-))) (PP (IN than) (NP (DT those) (NNS individuals)))) (PP (IN without) (NP (NNS Doc_8686832_444_448_Disease))))) (. .)))
8686832	4	(ROOT (S (NP (NP (CD Five)) (PP (IN of) (NP (NP (NP (NP (DT the) (CD 13) (NNS patients)) (PRN (-LRB- -LRB-) (NP (CD 38) (NN %)) (-RRB- -RRB-))) (PP (IN with) (NP (NNS Doc_8686832_485_489_Disease)))) (CC and) (NP (NP (CD seven)) (PP (IN of) (NP (NP (NP (DT the) (CD 41) (NNS patients)) (PRN (-LRB- -LRB-) (NP (CD 17) (NN %)) (-RRB- -RRB-))) (PP (IN without) (NP (NNS Doc_8686832_533_537_Disease))))))))) (VP (VBD admitted) (PP (TO to) (NP (NP (DT a) (JJ high) (JJ Doc_8686832_557_564_Chemical) (NN intake)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (MD might) (VP (VB be) (NP (DT a) (JJ contributing) (NN factor))))))))) (. .)))
8686832	5	(ROOT (S (NP (NNP Doc_8686832_611_631_Disease)) (VP (VBZ is) (VP (VBN associated) (PP (IN with) (NP (NP (DT the) (JJ intrathecal) (NN use)) (PP (IN of) (NP (JJ hyperbaric) (ADJP (CD 5) (NN %)) (NNS Doc_8686832_688_698_Chemical))))))) (. .)))
871943	0	(ROOT (S (NP (NP (DT The) (NN use)) (PP (IN of) (NP (NN serum)))) (VP (VBP cholinesterase) (PP (IN in) (NP (JJ Doc_871943_35_50_Chemical) (NN apnoea)))) (. .)))
871943	1	(ROOT (S (NP (NP (NN Fifteen) (NNS patients)) (VP (VBG demonstrating) (NP (NP (JJ unexpected) (VBN prolonged) (NN apnoea) (VBG lasting) (JJ several) (NNS hours)) (PP (IN after) (NP (NNS Doc_871943_146_161_Chemical)))))) (VP (VBP have) (VP (VBN been) (VP (VBN treated) (PP (IN by) (NP (NP (DT a) (JJ new) (NN preparation)) (PP (IN of) (NP (JJ human) (NN serum) (NN cholinesterase)))))))) (. .)))
871943	2	(ROOT (S (NP (JJ Adequate) (JJ spontaneous) (NN respiration)) (VP (VBD was) (VP (VBN re-established) (PP (IN in) (NP (NP (DT an) (JJ average) (NN period)) (PP (IN of) (NP (CD ten) (NNS minutes))))) (PP (IN after) (NP (DT the) (NN injection))))) (. .)))
871943	3	(ROOT (S (PP (IN In) (NP (CD 12) (NNS patients))) (NP (JJ biochemical) (JJ genetic) (NNS examinations)) (VP (VBD confirmed) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (DT an) (JJ atypical) (NN serum) (NN cholinesterase))))) (. .)))
871943	4	(ROOT (S (PP (IN In) (NP (CD three) (NNS patients))) (NP (NP (NN none)) (PP (IN of) (NP (DT the) (JJ usual) (NNS variants)))) (VP (VBD were) (VP (VBN found))) (. .)))
871943	5	(ROOT (S (NP (PRP It)) (VP (VBZ is) (ADVP (RB therefore)) (VP (VBN supposed) (SBAR (IN that) (S (NP (NP (JJ other) (JJ unknown) (NNS variants)) (PP (IN of) (NP (NN serum) (NN cholinesterase)))) (VP (VBP exist) (SBAR (WHNP (WDT which)) (S (VP (MD can) (RB not) (VP (VB hydrolyze) (NP (NNS Doc_871943_612_627_Chemical))))))))))) (. .)))
871943	6	(ROOT (S (NP (NP (DT The) (NN use)) (PP (IN of) (NP (NP (NN serum) (NN cholinesterase)) (PP (IN in) (NP (JJ Doc_871943_664_679_Chemical) (NN apnoea)))))) (VP (VBD provided) (NP (JJ considerable) (NN relief)) (PP (TO to) (NP (DT both) (NN patient) (CC and) (NN anaesthetist)))) (. .)))
873132	0	(ROOT (NP (NP (VBN Increased) (NN sulfation) (CC and) (VBN decreased) (NNS 7alpha-hydroxylation)) (PP (IN of) (NP (NP (NNS Doc_873132_58_74_Chemical)) (PP (IN in) (NP (NP (NN Doc_873132_78_95_Chemical-induced) (NNS Doc_873132_104_115_Disease)) (PP (IN in) (NP (NNS rats))))))) (. .)))
873132	1	(ROOT (S (NP (NP (JJ Doc_873132_125_141_Chemical) (NN conjugation)) (, ,) (NP (NN transport) (NN capacity)) (, ,) (CC and) (NP (NN metabolism))) (VP (VBD were) (VP (VBN compared) (PP (IN in) (NP (NN control) (CC and) (NN Doc_873132_219_236_Chemical-treated) (NNS rats))))) (. .)))
873132	2	(ROOT (S (S (NP (NNP Control) (NNS rats)) (VP (VBD were) (VP (VBN found) (S (VP (TO to) (VP (VB have) (NP (DT a) (JJR lower) (NN capacity) (S (VP (TO to) (VP (VB transport) (NP (NNS Doc_873132_313_329_Chemical)) (PP (IN than) (NP (NNS Doc_873132_335_356_Chemical))))))))))))) (, ,) (CC and) (S (NP (DT both)) (VP (VBD were) (VP (VBN decreased) (PP (IN by) (NP (JJ Doc_873132_385_402_Chemical) (NN treatment)))))) (. .)))
873132	3	(ROOT (S (S (PP (IN During) (NP (CD -LSB-) (CD 24-14C) (JJ -RSB-) (NNS Doc_873132_429_448_Chemical))) (NP (NN infusion) (, ,) (NNP -LSB-) (CD 14C) (NNP -RSB-) (JJ biliary) (NNS Doc_873132_472_481_Chemical) (NN secretion)) (VP (VBD increased))) (, ,) (CC but) (S (NP (NN bile) (NN flow)) (VP (VBD did) (RB not) (VP (VB change) (ADVP (RB significantly)) (PP (IN in) (NP (DT either) (NN control) (CC or) (NN Doc_873132_567_584_Chemical-treated) (NNS rats)))))) (. .)))
873132	4	(ROOT (S (NP (JJ Doc_873132_599_616_Chemical-treated) (NNS animals)) (VP (VBD excreted) (ADVP (RB significantly)) (ADVP (RBR less) (NP (CD 14C))) (PP (IN as) (NP (NNS Doc_873132_668_684_Chemical))) (SBAR (IN than) (SINV (VBD did) (NP (NP (NN control) (NNS animals)) (, ,) (ADJP (JJ consistent) (PP (IN with) (NP (NP (DT an) (NN impairment)) (PP (IN of) (NP (NP (JJ 7alpha-hydroxylation)) (PP (IN of) (NP (NNS Doc_873132_768_789_Chemical)))))))))))) (. .)))
873132	5	(ROOT (S (NP (JJ Doc_873132_791_808_Chemical) (NN treatment)) (VP (VP (VBD did) (RB not) (VP (VB impair) (NP (NP (NN conjugation)) (PP (IN of) (NP (NNS Doc_873132_849_865_Chemical)))))) (, ,) (CC but) (VP (VBD did) (NP (NN result)) (PP (IN in) (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (NP (NN sulfation)) (PP (IN of) (NP (NP (NNS Doc_873132_913_934_Chemical)) (PP (IN from) (NP (NP (CD 1.5) (NN %)) (PP (IN in) (NP (NNS controls))))))))))) (PP (TO to) (NP (NP (QP (RB nearly) (CD 4.0)) (NN %)) (PRN (-LRB- -LRB-) (NP (NNP P) (QP (JJR less) (IN than) (CD 0.01))) (-RRB- -RRB-)))))) (. .)))
873132	6	(ROOT (S (NP (DT These) (NNS results)) (VP (VBP are) (ADJP (JJ consistent) (PP (IN with) (NP (DT the) (NNS hypothesis)))) (SBAR (IN that) (S (NP (DT the) (NN rat)) (VP (VBZ has) (NP (NP (DT a) (JJR poorer) (NN tolerance)) (PP (IN for) (NP (NP (NNS Doc_873132_1081_1097_Chemical)) (SBAR (IN than) (S (VP (VBP do) (NP (JJ certain) (JJ other) (NNS species)))))))))))) (. .)))
873132	7	(ROOT (S (ADVP (RB Furthermore)) (, ,) (NP (DT the) (NN rat)) (VP (VBZ converts) (NP (NP (NP (NNS Doc_873132_1159_1175_Chemical)) (, ,) (NP (DT a) (JJ poor) (NN choleretic)) (, ,)) (PP (TO to) (NP (NP (NNS Doc_873132_1199_1215_Chemical)) (, ,) (NP (DT a) (JJ good) (NN choleretic)))))) (. .)))
873132	8	(ROOT (S (SBAR (WHADVP (WRB When)) (S (NP (DT this) (NN conversion)) (VP (VBZ is) (VP (VBN impaired) (PP (IN with) (NP (JJ Doc_873132_1274_1291_Chemical) (NN treatment))))))) (, ,) (NP (NN sulfation)) (VP (MD may) (VP (VB be) (NP (NP (DT an) (JJ important) (JJ alternate) (NN pathway)) (PP (IN for) (NP (NP (NN excretion)) (PP (IN of) (NP (DT this) (ADJP (RB potentially) (JJ harmful)) (NNS Doc_873132_1393_1402_Chemical)))))))) (. .)))
8742498	0	(ROOT (S (NP (NP (NNP Influence)) (PP (IN of) (NP (NN diet)))) (VP (JJ free) (PP (IN of) (NP (NP (NNS Doc_8742498_26_29_Chemical-precursors)) (PP (IN on) (NP (JJ Doc_8742498_44_57_Chemical) (NN hepatotoxicity))))) (PP (IN in) (NP (NNS mice)))) (. .)))
8742498	1	(ROOT (S (ADVP (RB Recently)) (, ,) (NP (PRP we)) (VP (VBD demonstrated) (NP (NP (DT the) (JJ hepatoprotective) (NNS effects)) (PP (IN of) (NP (NP (NNS Doc_8742498_140_160_Chemical)) (, ,) (NP (NP (DT a) (JJ selective) (NN inhibitor)) (PP (IN of) (NP (NP (NP (JJ Doc_8742498_187_203_Chemical) (NN polymerase)) (PRN (-LRB- -LRB-) (NP (NP (NNP PARP)) (: ;) (NP (NNP EC) (CD 2.4.2.30))) (-RRB- -RRB-))) (PP (IN on) (NP (NP (NNS mice)) (VP (VBG suffering) (PP (IN from) (NP (NP (NNS Doc_8742498_258_271_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_8742498_273_276_Chemical)) (-RRB- -RRB-)) (: -) (NP (NNS Doc_8742498_278_287_Disease))))))))))))) (, ,) (S (VP (VBG suggesting) (SBAR (IN that) (S (NP (DT the) (NN Doc_8742498_309_312_Chemical-induced) (NNS Doc_8742498_321_333_Disease)) (VP (VBZ involves) (NP (NP (DT a) (NN step)) (SBAR (WHNP (WDT which)) (S (VP (VBZ depends) (PP (IN on) (NP (NN adenoribosylation))))))))))))) (. .)))
8742498	2	(ROOT (S (NP (DT The) (JJ present) (NN study)) (VP (VP (VBZ investigates) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NP (DT a) (NN diet)) (ADVP (JJ free)) (PP (IN of) (NP (NP (NNS precursors)) (PP (IN of) (NP (NNS Doc_8742498_461_464_Chemical))))) (, ,) (NP (NP (DT the) (NN substrate)) (SBAR (WHPP (IN on) (WHNP (WDT which))) (S (NP (NNP PARP)) (VP (VBZ acts) (, ,) (PP (IN in) (NP (JJ female) (NNP NMRI) (NNS mice))) (PP (IN with) (NP (JJ Doc_8742498_525_528_Chemical) (NNS Doc_8742498_529_538_Disease))))))))))) (CC and) (VP (VBZ evaluates) (NP (NP (DT the) (NN influence)) (PP (IN of) (NP (JJ simultaneous) (JJ Doc_8742498_583_590_Chemical) (NN consumption)))) (PP (IN in) (NP (DT these) (NNS animals))))) (. .)))
8742498	3	(ROOT (S (NP (NNP Doc_8742498_621_635_Disease)) (VP (VBD were) (VP (VBN quantified) (PP (IN as) (NP (NP (NN serum) (NNS activities)) (PP (IN of) (NP (NP (NN Doc_8742498_675_684_Chemical-Doc_8742498_685_697_Chemical) (NN transaminase)) (PRN (-LRB- -LRB-) (NP (NNP GOT)) (-RRB- -RRB-)) (CC and) (NP (NN Doc_8742498_721_730_Chemical-Doc_8742498_731_739_Chemical) (NN transaminase)) (PRN (-LRB- -LRB-) (NP (NNP GPT)) (-RRB- -RRB-)))))))) (. .)))
8742498	4	(ROOT (S (SBAR (IN While) (S (NP (NNS Doc_8742498_766_769_Chemical)) (VP (VP (VBD caused) (NP (NP (DT a) (JJ 117-fold) (NN elevation)) (PP (IN of) (NP (NN serum) (NN transaminase) (NNS activities)))) (PP (IN in) (NP (NP (NNS mice)) (VP (VBN kept) (PP (IN on) (NP (NP (DT a) (JJ standard) (NN laboratory) (NN diet)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD was) (ADVP (RB significantly)) (VP (VBN exacerbated) (PP (IN by) (NP (NNS Doc_8742498_914_921_Chemical))))))))))))) (CC and) (VP (VBD inhibited) (PP (IN by) (NP (NP (NNS Doc_8742498_939_959_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_8742498_961_964_Chemical)) (-RRB- -RRB-)))))))) (, ,) (NP (JJ adverse) (NNS effects)) (VP (VBD were) (VP (VBN noted) (PP (IN in) (NP (NP (NNS animals)) (VP (VBN fed) (NP (NP (DT a) (NN diet)) (PP (ADVP (JJ free)) (IN of) (NP (NP (NNS precursors)) (PP (IN of) (NP (NNS Doc_8742498_1038_1041_Chemical))))))))))) (. .)))
8742498	5	(ROOT (S (PP (IN In) (NP (DT these) (NNS animals))) (, ,) (S (NP (NP (RB only) (JJ minor) (NNS increases)) (PP (IN of) (NP (NN serum) (NN transaminase) (NNS activities)))) (VP (VBD were) (VP (VBN measured) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NNS Doc_8742498_1148_1151_Chemical)))))))) (, ,) (CC and) (S (PP (IN unlike) (NP (NP (DT the) (NN exacerbation)) (VP (VBN caused) (PP (IN by) (NP (NP (NNS Doc_8742498_1191_1198_Chemical)) (PP (IN in) (NP (NP (NNS mice)) (PP (IN on) (NP (DT a) (JJ standard) (NN diet)))))))))) (, ,) (NP (DT the) (NNS Doc_8742498_1231_1243_Disease)) (VP (VBD was) (VP (VBN inhibited) (PP (IN by) (NP (CD 50) (NN %))) (PP (IN by) (NP (NNS Doc_8742498_1268_1275_Chemical)))))) (. .)))
8742498	6	(ROOT (S (NP (NP (DT A) (JJ further) (CD 64) (NN %) (NN reduction)) (PP (IN of) (NP (NNS Doc_8742498_1304_1313_Disease)))) (VP (VBD was) (ADJP (JJ observed)) (, ,) (SBAR (WHADVP (WRB when)) (S (NP (NNS Doc_8742498_1333_1336_Chemical)) (VP (VBD was) (VP (VBN given) (PP (TO to) (NP (NNP Doc_8742498_1350_1357_Chemical) (NNP /) (NNP AAP-mice)))))))) (. .)))
8742498	7	(ROOT (S (NP (PRP$ Our) (NNS results)) (VP (VBP provide) (NP (NN evidence)) (SBAR (IN that) (S (NP (NP (DT the) (NN Doc_8742498_1406_1409_Chemical-induced) (NNS Doc_8742498_1418_1427_Disease)) (CC and) (NP (NP (PRP$ its) (NN exacerbation)) (PP (IN by) (NP (NNS Doc_8742498_1452_1459_Chemical))))) (VP (MD can) (RB either) (VP (VB be) (VP (VBN reduced) (PP (IN by) (NP (NP (JJ end-product) (NN inhibition)) (PP (IN of) (NP (NNP PARP))))) (PP (PP (IN by) (NP (NNS Doc_8742498_1519_1522_Chemical))) (CC or) (PP (IN by) (NP (NP (JJ dietary) (NN depletion)) (PP (IN of) (NP (NP (DT the) (NN enzyme) (POS 's)) (JJ substrate) (NNS Doc_8742498_1573_1576_Chemical)))))))))))) (. .)))
8742498	8	(ROOT (S (NP (PRP We)) (VP (VBP see) (NP (NP (DT the) (JJ main) (NN application)) (PP (IN of) (NP (NP (NNS Doc_8742498_1609_1612_Chemical)) (PP (RB as) (IN for) (NP (NP (DT the) (JJ combinational) (NN use)) (PP (IN in) (NP (NP (JJ pharmaceutical) (NNS preparations)) (PP (IN of) (NP (NNS Doc_8742498_1676_1689_Chemical)))))))))) (SBAR (IN in) (NN order) (S (VP (TO to) (VP (VB avoid) (NP (NNS Doc_8742498_1708_1722_Disease)) (PP (IN in) (NP (NP (NNS patients)) (VP (VBN treated) (PP (IN with) (NP (DT this) (ADJP (RB widely) (VBN used)) (NN analgesic))))))))))) (. .)))
8766220	0	(ROOT (S (NP (NP (NNS Nightmares) (CC and) (NNS Doc_8766220_15_29_Disease)) (PP (IN after) (NP (NP (JJ long-term) (NN intake)) (PP (IN of) (NP (NNS Doc_8766220_56_64_Chemical)))))) (VP (VBN combined) (PP (IN with) (NP (NNS antidepressants)))) (. .)))
8766220	1	(ROOT (S (NP (NNP Doc_8766220_96_104_Chemical)) (VP (VBZ is) (NP (NP (DT a) (JJ weak) (NN opioid)) (PP (IN with) (NP (NP (NNS effects)) (PP (IN on) (NP (ADJP (JJ adrenergic) (CC and) (JJ serotonergic)) (NN neurotransmission))))) (SBAR (WHNP (WDT that)) (S (VP (VBZ is) (VP (VBN used) (S (VP (TO to) (VP (VB treat) (NP (NP (JJ Doc_8766220_206_212_Disease) (NNS Doc_8766220_213_217_Disease)) (CC and) (NP (JJ chronic) (JJ non) (JJ malignant) (NNS Doc_8766220_244_248_Disease)))))))))))) (. .)))
8766220	2	(ROOT (S (NP (DT This) (NN drug)) (VP (VBD was) (VP (VBN initiated) (PP (IN in) (NP (NN association))) (PP (IN with) (NP (NNS Doc_8766220_294_304_Chemical) (CC and) (NNS Doc_8766220_309_333_Chemical))) (PP (IN in) (NP (NP (DT a) (JJ tetraparetic) (NN patient)) (PP (IN with) (NP (NNS Doc_8766220_365_377_Disease))))))) (. .)))
8766220	3	(ROOT (S (PP (NP (CD Fifty-six) (NNS days)) (IN after) (NP (NP (NN initiation)) (PP (IN of) (NP (DT the) (NN treatment))))) (NP (DT the) (NN patient)) (VP (VBD presented) (NP (NP (NNS Doc_8766220_450_464_Disease)) (SBAR (WHNP (WDT that)) (S (ADVP (RB only)) (VP (VBN stopped) (PP (IN after) (NP (NP (DT the) (NN withdrawal)) (PP (IN of) (NP (JJ psycho-active) (NNS drugs) (CC and) (NNS Doc_8766220_531_539_Chemical)))))))))) (. .)))
8766220	4	(ROOT (S (NP (DT The) (NN case) (NN report)) (VP (VBZ questions) (NP (NP (DT the) (JJ long) (NN term) (NN use)) (PP (IN of) (NP (JJ Doc_8766220_588_592_Disease) (NNS killers)))) (PP (VBN combined) (PP (IN with) (NP (NP (JJ psycho-active) (NNS drugs)) (PP (IN in) (NP (JJ chronic) (JJ non) (JJ malignant) (NNS Doc_8766220_660_664_Disease)))))) (, ,) (SBAR (RB especially) (IN if) (S (NP (NNS Doc_8766220_680_684_Disease)) (VP (VBZ is) (PP (IN under) (NP (NN control))))))) (. .)))
8800187	0	(ROOT (NP (NP (NN Effect)) (PP (IN of) (NP (NNS Doc_8800187_10_26_Chemical) (CC and) (NNS Doc_8800187_31_46_Chemical) (NN therapy))) (PP (IN on) (NP (JJ Doc_8800187_58_69_Chemical) (NNS Doc_8800187_70_78_Disease))) (PP (IN in) (NP (NNS rats))) (. .)))
8800187	1	(ROOT (S (NP (NNP Doc_8800187_100_111_Disease)) (VP (VBZ is) (NP (NP (DT a) (JJ major) (NN contributor)) (PP (TO to) (NP (NP (NN mortality)) (PP (IN in) (NP (JJ tricyclic) (NN antidepressant) (NNS Doc_8800187_176_184_Disease))))))) (. .)))
8800187	2	(ROOT (S (NP (JJ Recent) (NNS data)) (VP (VBP suggest) (SBAR (IN that) (S (NP (JJ tricyclic) (NNS antidepressants)) (VP (VBP inhibit) (NP (NP (JJ Doc_8800187_245_252_Chemical) (NN influx)) (PP (IN in) (NP (DT some) (NNS tissues)))))))) (. .)))
8800187	3	(ROOT (S (NP (DT This) (NN study)) (VP (VBD addressed) (NP (NP (DT the) (JJ potential) (NN role)) (PP (IN of) (NP (JJ Doc_8800187_320_327_Chemical) (NN channel) (NN blockade)))) (PP (IN in) (NP (JJ tricyclic) (JJ antidepressant-induced) (NNS Doc_8800187_381_392_Disease)))) (. .)))
8800187	4	(ROOT (S (NP (CD Two) (NNS interventions)) (VP (VBD were) (VP (VBN studied) (SBAR (IN that) (S (VP (VBP have) (VP (VBN been) (VP (VBN shown) (ADVP (RB previously)) (S (VP (TO to) (VP (VB improve) (NP (NN blood) (NN pressure)) (PP (IN with) (NP (JJ Doc_8800187_497_504_Chemical) (NN channel) (NN blocker) (NNS Doc_8800187_521_529_Disease))))))))))))) (. .)))
8800187	5	(ROOT (S (VP (VB Doc_8800187_531_536_Chemical) (CC and) (VB Doc_8800187_541_556_Chemical)) (. .)))
8800187	6	(ROOT (S (NP (JJ Anesthetized) (NNS rats)) (VP (VBD received) (SBAR (S (NP (DT the) (JJ tricyclic) (NN antidepressant) (NNS Doc_8800187_614_625_Chemical)) (VP (VBP IP) (S (VP (TO to) (VP (VB produce) (NP (NP (NNS Doc_8800187_640_651_Disease)) (, ,) (NP (NNP QRS) (NNP prolongation)) (, ,) (CC and) (NP (NNS Doc_8800187_675_686_Disease)))))))))) (. .)))
8800187	7	(ROOT (S (ADVP (NP (CD Fifteen) (NN min)) (RB later)) (, ,) (NP (NNS animals)) (VP (VBD received) (NP (NP (NNS Doc_8800187_724_729_Chemical)) (, ,) (NP (NNS Doc_8800187_731_737_Chemical)) (, ,) (CC or) (NP (NN saline)))) (. .)))
8800187	8	(ROOT (S (PP (IN In) (NP (DT a) (JJ second) (NN experiment))) (, ,) (NP (NNS rats)) (VP (VBD received) (SBAR (S (NP (JJ tricyclic) (NN antidepressant) (NNP Doc_8800187_813_824_Chemical) (NNP IP)) (VP (VBD followed) (PP (IN in) (NP (CD 15) (NN min))) (PP (IN by) (NP (NNS Doc_8800187_850_865_Chemical) (CC or) (NN saline))))))) (. .)))
8800187	9	(ROOT (S (NP (NP (NNP Doc_8800187_886_892_Chemical) (NNP briefly)) (PRN (-LRB- -LRB-) (NP (QP (CD 5) (CD min))) (-RRB- -RRB-))) (VP (VBD reversed) (NP (NP (NNS Doc_8800187_918_929_Disease)) (CC and) (NP (NNP QRS) (NNP prolongation)))) (. .)))
8800187	10	(ROOT (S (NP (NNS Doc_8800187_952_957_Chemical) (CC and) (NNS Doc_8800187_962_977_Chemical)) (VP (VBD failed) (S (VP (TO to) (VP (VB improve) (NP (NN blood) (NN pressure)))))) (. .)))
8800187	11	(ROOT (S (NP (NP (DT The) (NN incidence)) (PP (IN of) (NP (NP (NP (NNS Doc_8800187_1029_1052_Disease)) (PRN (-LRB- -LRB-) (VP (VBN p) (S (VP (SYM =) (NP (CD 0.004))))) (-RRB- -RRB-))) (CC and) (NP (NP (NNS Doc_8800187_1069_1077_Disease)) (PRN (-LRB- -LRB-) (VP (VBN p) (S (VP (SYM =) (NP (CD 0.03))))) (-RRB- -RRB-))))) (PP (IN in) (NP (DT the) (JJ Doc_8800187_1096_1101_Chemical) (NN group)))) (VP (VBD was) (ADJP (JJR higher)) (PP (IN than) (NP (DT the) (JJ other) (NNS groups)))) (. .)))
8800187	12	(ROOT (S (NP (NP (DT The) (NN administration)) (PP (IN of) (NP (NNS Doc_8800187_1176_1181_Chemical) (CC or) (NNS Doc_8800187_1185_1200_Chemical)))) (VP (VBD did) (RB not) (VP (VB reverse) (NP (JJ tricyclic) (JJ antidepressant-induced) (NNS Doc_8800187_1250_1261_Disease)) (PP (IN in) (NP (NNS rats))))) (. .)))
8800187	13	(ROOT (S (NP (JJ Doc_8800187_1271_1276_Chemical) (NN therapy)) (VP (MD may) (ADVP (RB possibly)) (VP (VB worsen) (NP (DT both) (NNS Doc_8800187_1310_1360_Disease)))) (. .)))
8800187	14	(ROOT (S (NP (DT These) (NNS findings)) (VP (VBP do) (RB not) (VP (VB support) (NP (NP (DT a) (NN role)) (PP (IN for) (NP (JJ Doc_8800187_1403_1410_Chemical) (NN channel) (NN inhibition)))) (PP (IN in) (NP (NP (DT the) (NNS pathogenesis)) (PP (IN of) (NP (JJ tricyclic) (JJ antidepressant-induced) (NNS Doc_8800187_1486_1497_Disease))))))) (. .)))
8841157	0	(ROOT (NP (NP (NP (NNP Doc_8841157_0_9_Chemical)) (, ,) (NP (NP (DT a) (JJ new) (NNP angiotensin) (NNP II) (NN antagonist)) (PP (IN for) (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (JJ essential) (NNS Doc_8841157_74_86_Disease))))))) (: :) (NP (NP (DT a) (JJ comparative) (NN study)) (PP (IN of) (NP (NP (DT the) (NN efficacy) (CC and) (NN safety)) (PP (IN against) (NP (NNS Doc_8841157_143_153_Chemical)))))) (. .)))
8841157	1	(ROOT (S (S (VP (TO To) (VP (VB compare) (NP (NP (DT the) (JJ antihypertensive) (NN efficacy)) (PP (IN of) (NP (DT a) (JJ new) (JJ Doc_8841157_216_230_Chemical) (NN antagonist))))))) (, ,) (NP (NP (NNS Doc_8841157_243_252_Chemical)) (, ,) (PP (IN with) (NP (DT a) (NN reference) (NN therapy))) (, ,)) (VP (VBZ Doc_8841157_280_290_Chemical)) (. .)))
8841157	2	(ROOT (S (NP (NP (CD One) (CD hundred) (NN sixty-eight) (NN adult) (NNS outpatients)) (PP (IN with) (NP (ADJP (JJ mild) (TO to) (JJ moderate)) (NNS Doc_8841157_365_377_Disease)))) (VP (VBD were) (VP (ADVP (RB randomly)) (VBN allocated) (PP (IN in) (NP (NP (JJ double-blind) (NN fashion)) (CC and) (NP (JJ equal) (NN number)))) (S (VP (TO to) (VP (VB receive) (NP (NP (CD 80) (NN mg) (NNS Doc_8841157_460_469_Chemical) (CC or) (CD 5) (NN mg) (NNS Doc_8841157_478_488_Chemical)) (PP (IN for) (NP (CD 12) (NNS weeks))))))))) (. .)))
8841157	3	(ROOT (S (PP (IN After) (NP (NP (CD 8) (NNS weeks)) (PP (IN of) (NP (NN therapy))) (, ,) (PP (IN in) (NP (NP (NNS patients)) (SBAR (WP$ whose) (S (NP (NN blood) (NN pressure)) (VP (VBD remained) (NP (JJ uncontrolled))))))))) (, ,) (NP (CD 5) (NN mg) (NNS Doc_8841157_590_600_Chemical)) (VP (VBD was) (VP (VBN added) (PP (TO to) (NP (DT the) (JJ initial) (NN therapy))))) (. .)))
8841157	4	(ROOT (S (NP (NNS Patients)) (VP (VBD were) (VP (VBN assessed) (PP (IN at) (NP (NP (CD 4)) (, ,) (NP (CD 8)) (, ,) (CC and) (NP (CD 12) (NNS weeks)))))) (. .)))
8841157	5	(ROOT (S (NP (DT The) (JJ primary) (NN efficacy) (NN variable)) (VP (VBD was) (NP (NN change)) (PP (IN from) (S (NP (NP (NN baseline)) (PP (IN in) (NP (NN mean)))) (VP (VBG sitting) (NP (JJ diastolic) (NN blood) (NN pressure)) (PP (IN at) (NP (CD 8) (NNS weeks))))))) (. .)))
8841157	6	(ROOT (S (NP (JJ Secondary) (NNS variables)) (VP (VBD included) (NP (NN change)) (PP (IN in) (S (VP (VBG sitting) (NP (JJ systolic) (NN blood) (NN pressure) (CC and) (NN responder) (NNS rates)))))) (. .)))
8841157	7	(ROOT (S (NP (DT Both) (NNS Doc_8841157_895_904_Chemical) (CC and) (NNS Doc_8841157_909_919_Chemical)) (VP (VBD were) (ADJP (JJ effective) (PP (IN at) (S (VP (VBG lowering) (NP (NN blood) (NN pressure)) (PP (IN at) (NP (NP (CD 4)) (, ,) (NP (CD 8)) (, ,) (CC and) (NP (CD 12) (NNS weeks))))))))) (. .)))
8841157	8	(ROOT (S (NP (JJ Similar) (NNS decreases)) (VP (VBD were) (VP (VBN observed) (PP (IN in) (NP (DT both) (NNS groups))) (, ,) (PP (IN with) (NP (NP (DT no) (ADJP (RB statistically) (JJ significant)) (NNS differences)) (PP (IN between) (NP (NP (DT the) (NNS groups)) (PP (IN for) (NP (NP (DT any) (NN variable)) (VP (VBN analyzed)))))))))) (. .)))
8841157	9	(ROOT (S (PP (IN For) (NP (DT the) (JJ primary) (NN variable))) (NP (DT the) (NN difference)) (VP (VBD was) (NP (NP (CD 0.5) (NN mm) (NNP Hg)) (PP (IN in) (NP (NP (NN favor)) (PP (IN of) (NP (NP (NNS Doc_8841157_1191_1200_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (NP (NP (NN p)) (SBAR (S (VP (SYM =) (NP (CD 0.68)))))) (: ;) (NP (NP (ADJP (CD 95) (NN %)) (NN confidence) (NN interval)) (, ,) (NP (CD -2.7)))) (PP (TO to) (NP (CD 1.7)))) (-RRB- -RRB-)))))))) (. .)))
8841157	10	(ROOT (S (NP (NP (JJ Responder) (NNS rates)) (PP (IN at) (NP (CD 8) (NNS weeks)))) (VP (VBD were) (NP (NP (CD 66.7) (NN %)) (PP (IN for) (NP (NP (QP (CD Doc_8841157_1293_1302_Chemical) (CC and) (CD 60.2)) (NN %)) (PP (IN for) (NP (NNS Doc_8841157_1317_1327_Chemical))) (PRN (-LRB- -LRB-) (VP (VBN p) (S (VP (SYM =) (NP (CD 0.39))))) (-RRB- -RRB-)))))) (. .)))
8841157	11	(ROOT (S (NP (DT Both) (NNS treatments)) (VP (VBD were) (ADJP (RB well) (JJ tolerated))) (. .)))
8841157	12	(ROOT (S (NP (NP (DT The) (NN incidence)) (PP (IN of) (NP (JJ drug-related) (JJ dependent) (NNS Doc_8841157_1417_1422_Disease)))) (VP (VBD was) (ADJP (RB somewhat) (JJR higher)) (PP (IN in) (NP (DT the) (JJ Doc_8841157_1450_1460_Chemical) (NN group))) (, ,) (ADVP (RB particularly)) (PP (IN at) (NP (NP (DT a) (NN dose)) (PP (IN of) (NP (NP (CD 10) (NN mg)) (PP (IN per) (NP (NP (NN day)) (PRN (-LRB- -LRB-) (NP (NP (NP (NP (CD 2.4) (NN %)) (PP (IN for) (NP (CD 80) (NN mg) (NNS Doc_8841157_1524_1533_Chemical)))) (: ;) (NP (NP (CD 3.6) (NN %)) (PP (IN for) (NP (CD 5) (NN mg) (NNS Doc_8841157_1549_1559_Chemical)))) (: ;) (NP (NP (CD 0) (NN %)) (PP (IN for) (NP (NP (NNS Doc_8841157_1568_1577_Chemical)) (PP (CC plus) (NP (CD 5) (NN mg) (NNS Doc_8841157_1588_1598_Chemical)))))) (: ;) (NP (NP (CD 14.3) (NN %)) (PP (IN for) (NP (CD 10))))) (NP (NN mg) (NNS Doc_8841157_1616_1626_Chemical))) (-RRB- -RRB-))))))))) (. .)))
8841157	13	(ROOT (S (NP (DT The) (NNS data)) (VP (VBP show) (SBAR (IN that) (S (NP (NNS Doc_8841157_1661_1670_Chemical)) (VP (VBZ is) (ADVP (IN at) (JJS least)) (ADJP (RB as) (JJ effective) (PP (IN as) (NP (NP (NNS Doc_8841157_1699_1709_Chemical)) (PP (IN in) (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (ADJP (JJ mild) (TO to) (JJ moderate)) (NNS Doc_8841157_1747_1759_Disease)))))))))))) (. .)))
8841157	14	(ROOT (S (NP (DT The) (NNS results)) (ADVP (RB also)) (VP (VBP show) (S (NP (NNS Doc_8841157_1783_1792_Chemical)) (VP (TO to) (VP (VP (VB be) (ADJP (RB well) (JJ tolerated))) (CC and) (VP (VB suggest) (SBAR (IN that) (S (NP (PRP it)) (VP (VBZ is) (RB not) (VP (VBN associated) (PP (IN with) (NP (NP (NN side) (NNS effects) (NN characteristic)) (PP (IN of) (NP (NP (DT this) (NN comparator) (NN class)) (, ,) (NP (JJ Doc_8841157_1911_1926_Chemical) (JJ Doc_8841157_1927_1934_Chemical) (NNS antagonists))))))))))))))) (. .)))
8854309	0	(ROOT (NP (NP (DT A) (NN measure)) (PP (IN of) (NP (NP (NNS Doc_8854309_13_34_Disease)) (PP (IN as) (NP (DT a) (NN marker))))) (PP (IN of) (NP (NN Doc_8854309_50_57_Chemical-induced) (NNS Doc_8854309_66_74_Disease))) (. .)))
8854309	1	(ROOT (S (NP (NP (JJ Doc_8854309_76_83_Chemical-induced) (NN paranoia)) (PRN (-LRB- -LRB-) (NP (NNP Doc_8854309_102_105_Disease)) (-RRB- -RRB-))) (VP (VBZ remains) (NP (NP (DT an) (JJ important) (JJ drug-induced) (NN model)) (PP (IN of) (NP (JJ idiopathic) (NNS Doc_8854309_161_169_Disease))) (SBAR (WHPP (IN for) (WHNP (WDT which))) (S (NP (DT no) (JJ psychophysiologic) (NN marker)) (VP (VBZ has) (ADVP (RB yet)) (VP (VBN emerged))))))) (. .)))
8854309	2	(ROOT (S (NP (NP (NNS Measures)) (PP (IN of) (NP (NNS Doc_8854309_237_258_Disease)))) (VP (VBD were) (ADJP (JJ able) (S (VP (TO to) (VP (ADVP (RB significantly)) (VB distinguish) (NP (NP (DT a) (NN group)) (PP (IN of) (NP (NP (JJ abstinent) (JJ Doc_8854309_319_332_Chemical) (NNS abusers)) (VP (VBG endorsing) (NP (NP (JJ past) (NNS Doc_8854309_356_359_Disease)) (PRN (-LRB- -LRB-) (VP (VBN n) (S (VP (SYM =) (NP (CD 32))))) (-RRB- -RRB-)) (PP (IN from) (NP (NP (DT another) (NN group)) (PP (IN of) (NP (NN crack) (NNS addicts))) (SBAR (WHNP (WP who)) (S (VP (VBD denied) (NP (JJ past) (NNS Doc_8854309_421_424_Disease))))))))) (PRN (-LRB- -LRB-) (VP (VBN n) (S (VP (SYM =) (NP (CD 29))))) (-RRB- -RRB-)))))))))) (. .)))
8888541	0	(ROOT (NP (NP (JJ Doc_8888541_0_9_Chemical) (NN syndrome)) (PP (IN from) (NP (NN Doc_8888541_24_35_Chemical-Doc_8888541_36_51_Chemical) (NN interaction))) (. .)))
8888541	1	(ROOT (S (NP (NP (JJ Excessive) (NN stimulation)) (PP (IN of) (NP (JJ Doc_8888541_90_99_Chemical) (CD 5HT1A) (NNS receptors)))) (VP (VBZ causes) (NP (NP (DT a) (NN syndrome)) (PP (IN of) (NP (JJ Doc_8888541_137_146_Chemical) (NN excess))) (SBAR (WHNP (WDT that)) (S (VP (VBZ consists) (PP (IN of) (NP (NNS shivering) (, ,) (NNS Doc_8888541_182_197_Disease) (, ,) (NNS salivation) (, ,) (NNS Doc_8888541_211_220_Disease) (, ,) (NNS Doc_8888541_222_231_Disease) (CC and) (NNS Doc_8888541_236_248_Disease)))))))) (. .)))
8888541	2	(ROOT (S (NP (NP (DT The) (ADJP (RBS most) (JJ common)) (NN cause)) (PP (IN of) (NP (DT this) (NN syndrome)))) (VP (VBZ is) (NP (NP (DT an) (NN interaction)) (PP (IN between) (NP (NP (NP (DT a) (JJ Doc_8888541_317_326_Chemical) (NN oxidase) (NN inhibitor)) (PRN (-LRB- -LRB-) (NP (NNP MAOI)) (-RRB- -RRB-))) (CC and) (NP (DT a) (JJ specific) (JJ Doc_8888541_367_376_Chemical) (NN reuptake) (NN inhibitor)))))) (. .)))
8888541	3	(ROOT (S (NP (NNP Doc_8888541_397_408_Chemical)) (VP (VBZ is) (NP (NP (DT a) (JJ new) (NN antidepressant) (NN agent)) (SBAR (WHNP (WDT that)) (S (VP (VBZ inhibits) (NP (NP (DT the) (NN reuptake)) (PP (IN of) (NP (NNS Doc_8888541_469_478_Chemical) (CC and) (NNS Doc_8888541_483_497_Chemical))))))))) (. .)))
8888541	4	(ROOT (S (NP (PRP We)) (VP (VBP report) (NP (NP (DT a) (NN Doc_8888541_511_522_Chemical-MAOI) (NN interaction)) (SBAR (WHNP (WDT that)) (S (VP (VBD resulted) (PP (IN in) (NP (DT the) (JJ Doc_8888541_561_570_Chemical) (NN syndrome))) (PP (IN in) (NP (NP (DT a) (JJ 23-y-old) (NN male)) (SBAR (WHNP (WP who)) (S (VP (VBD was) (VP (VBG taking) (NP (NP (NNS Doc_8888541_614_629_Chemical)) (PP (IN for) (NP (NNS Doc_8888541_634_644_Disease))))))))))))))) (. .)))
8888541	5	(ROOT (S (NP (PRP He)) (VP (VBD had) (VP (VBN been) (PP (RB well) (IN until) (NP (NP (DT the) (NN morning)) (PP (IN of) (NP (NN presentation))))) (SBAR (WHADVP (WRB when)) (S (NP (PRP he)) (VP (VBD took) (NP (NP (CD 1/2) (NN tab)) (PP (IN of) (NP (NNS Doc_8888541_721_732_Chemical))))))))) (. .)))
8888541	6	(ROOT (S (PP (IN Within) (NP (CD 2) (NN h))) (NP (PRP he)) (VP (VBD became) (ADJP (VBN confused) (PP (IN with) (S (VP (VBG jerking) (NP (NP (NNS movements)) (PP (IN of) (NP (PRP$ his) (NNS extremities) (, ,) (NNS Doc_8888541_807_814_Disease) (CC and) (NNS Doc_8888541_819_827_Disease))))))))) (. .)))
8888541	7	(ROOT (S (NP (PRP He)) (VP (VBD was) (VP (VBN brought) (ADVP (RB directly)) (PP (TO to) (NP (DT a) (NN hospital))) (SBAR (WHADVP (WRB where)) (S (NP (PRP he)) (VP (VBD was) (VP (VBN found) (S (VP (TO to) (VP (VB be) (VP (VBN agitated) (CC and) (VBN confused) (PP (IN with) (NP (NNS shivering) (, ,) (NNS Doc_8888541_930_945_Disease) (, ,) (NNS Doc_8888541_947_955_Disease) (, ,) (NNS salivation) (CC and) (NNS diaphoresis))))))))))))) (. .)))
8888541	8	(ROOT (S (NP (PRP$ His) (NNS pupils)) (VP (VBD were) (UCP (NP (CD 7) (NN mm)) (CC and) (ADJP (RB sluggishly) (JJ reactive) (PP (TO to) (NP (NN light)))))) (. .)))
8888541	9	(ROOT (NP (NP (NP (JJ Vital) (NNS signs)) (VP (VBD were))) (: :) (NP (NP (NN blood) (NN pressure) (NNP 120/67) (NNP mm) (NNP Hg)) (, ,) (NP (NN heart) (NN rate) (NNS 127/min)) (, ,) (NP (JJ respiratory) (NN rate) (NNS 28/min)) (, ,) (CC and) (NP (NN temperature) (CD 97) (NNP F.)))))
8888541	10	(ROOT (S (PP (IN After) (NP (NP (CD 180) (NN mg)) (PP (IN of) (NP (JJ Doc_8888541_1170_1178_Chemical) (NN i.v.))))) (NP (PRP he)) (VP (VBD remained) (NP (JJ tremulous)) (PP (IN with) (NP (JJ Doc_8888541_1211_1226_Disease) (CC and) (JJ clenched) (NNS jaws)))) (. .)))
8888541	11	(ROOT (S (NP (PRP He)) (VP (VP (VBD was) (VP (VBN intubated) (PP (PP (IN for) (NP (JJ airway) (NN protection))) (CC and) (RB because) (PP (IN of) (NP (NNS Doc_8888541_1300_1315_Disease)))))) (, ,) (CC and) (VP (VBD was) (VP (VBN paralyzed) (S (VP (TO to) (VP (VB control) (NP (NNS Doc_8888541_1346_1361_Disease)))))))) (. .)))
8888541	12	(ROOT (S (NP (PRP$ His) (JJ subsequent) (NN course)) (VP (VBD was) (ADJP (JJ remarkable) (PP (IN for) (NP (NP (JJ non-immune) (NNS Doc_8888541_1415_1431_Disease)) (SBAR (WHNP (WDT which)) (S (VP (VBN resolved)))))))) (. .)))
8888541	13	(ROOT (S (S (NP (NP (DT The) (NN patient) (POS 's)) (JJ maximal) (NN temperature)) (VP (VBD was) (NP (CD 101.2) (NN F)))) (CC and) (S (NP (PRP$ his) (NN CPK)) (VP (VBD remained) (NP (QP (CD <) (CD 500)) (NN units/L)) (PP (IN with) (NP (NP (DT no) (JJ other) (NN evidence)) (PP (IN of) (NP (NNS Doc_8888541_1555_1569_Disease))))))) (. .)))
8888541	14	(ROOT (S (S (NP (JJ Doc_8888541_1571_1574_Chemical) (JJ mental) (NN status)) (VP (VBD normalized))) (CC and) (S (NP (PRP he)) (VP (VBD was) (VP (VBN transferred) (PP (TO to) (NP (DT a) (NN psychiatry) (NN ward)))))) (. .)))
8888541	15	(ROOT (S (NP (DT This) (NN patient)) (VP (VBD survived) (PP (IN without) (NP (NN sequelae))) (PP (JJ due) (TO to) (NP (NP (DT the) (JJ aggressive) (NN sedation)) (CC and) (NP (NN neuromuscular) (NNS Doc_8888541_1733_1742_Disease))))) (. .)))
8911359	0	(ROOT (NP (NP (JJ Doc_8911359_0_16_Chemical) (JJ associated) (NNS Doc_8911359_28_42_Disease)) (: --) (NP (NP (DT a) (ADJP (RB highly) (JJ aggressive)) (NN disease)) (: :) (NP (NP (NN analysis)) (PP (IN of) (NP (CD 12) (NNS cases))))) (. .)))
8911359	1	(ROOT (S (NP (PRP We)) (VP (VBD gained) (NP (NP (NN knowledge)) (PP (IN of) (NP (NP (DT the) (NN etiology) (, ,) (NN treatment) (CC and) (NN prevention)) (PP (IN of) (NP (JJ Doc_8911359_169_185_Chemical) (VBN associated) (NNS Doc_8911359_197_214_Disease))))))) (. .)))
8911359	2	(ROOT (S (NP (NNP MATERIALS) (CC AND) (NNP METHODS)) (: :) (NP (NP (DT The) (JJ medical) (NNS records)) (PP (IN of) (NP (NP (CD 6) (NNS men)) (CC and) (NP (CD 6) (NNS women)))) (PRN (-LRB- -LRB-) (NP (NP (JJ mean) (NN age)) (NP (CD 55) (NNS years))) (-RRB- -RRB-)) (PP (IN with) (NP (JJ Doc_8911359_305_321_Chemical) (VBN associated) (NNS Doc_8911359_333_347_Disease)))) (VP (VBD were) (VP (VBN reviewed))) (. .)))
8911359	3	(ROOT (S (NP (DT All) (NNS Doc_8911359_376_382_Disease)) (VP (VBD were) (NP (NP (NN grade) (CD 3)) (CC or) (NP (CD 4) (JJ transitional) (NN cell) (NNS Doc_8911359_419_428_Disease)))) (. .)))
8911359	4	(ROOT (S (PP (IN Of) (NP (NP (DT the) (CD 5) (NNS patients)) (VP (ADVP (RB initially)) (VBN treated) (PP (IN with) (NP (NP (JJ endoscopic) (NN resection)) (ADVP (RB alone))))))) (NP (RB only) (CD 1)) (VP (VBZ is) (ADJP (JJ alive) (PP (IN without) (NP (NN disease))))) (. .)))
8911359	5	(ROOT (S (PP (IN Of) (NP (NP (DT the) (CD 6) (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBD underwent) (NP (JJ early) (NN cystectomy))))))) (NP (CD 4)) (VP (VBD were) (ADJP (JJ alive) (PP (IN at) (NP (QP (CD 24) (TO to) (CD 111)) (NNS months))))) (. .)))
8911359	6	(ROOT (S (NP (NP (DT The) (VBG remaining) (NN patient)) (PP (IN with) (NP (JJ extensive) (NNS Doc_8911359_651_657_Disease)))) (VP (VP (VBD underwent) (NP (JJ partial) (NN cystectomy)) (PP (IN for) (NP (NN palliation)))) (CC and) (VP (VBD died) (NP (CD 3) (NNS months) (RB later)))) (. .)))
8911359	7	(ROOT (S (NP (JJ Doc_8911359_740_756_Chemical) (VBN associated) (NNS Doc_8911359_768_781_Disease)) (VP (VBZ is) (NP (DT an) (JJ aggressive) (NN disease))) (. .)))
8911359	8	(ROOT (S (ADVP (RB However)) (, ,) (NP (JJ long-term) (NN survival)) (VP (VBZ is) (ADJP (JJ possible)) (SBAR (WHADVP (WRB when)) (S (NP (JJ radical) (NN cystectomy)) (VP (VBZ is) (VP (VBN performed) (PP (PP (IN for) (NP (NP (NNS Doc_8911359_889_903_Disease)) (PP (IN with) (NP (NP (DT any) (NN sign)) (PP (IN of) (NP (NN invasion))))))) (CC and) (PP (IN for) (NP (JJ recurrent) (JJ high) (NN grade) (NN disease)))) (, ,) (SBAR (RB even) (WHADVP (WRB when)) (S (VP (VBP noninvasive))))))))) (. .)))
8958188	0	(ROOT (S (NP (NP (NP (DT A) (NN phase) (NN I) (JJ clinical) (NN study)) (PP (IN of) (NP (DT the) (JJ Doc_8958188_32_42_Chemical) (JJ antifolate) (NNS Doc_8958188_54_64_Chemical)))) (PRN (-LRB- -LRB-) (NP (NNP Doc_8958188_66_72_Chemical)) (-RRB- -RRB-))) (VP (VBN given) (PP (IN with) (NP (JJ oral) (NNS Doc_8958188_90_100_Chemical)))) (. .)))
8958188	1	(ROOT (S (NP (NNP Doc_8958188_102_112_Chemical)) (VP (VBZ is) (NP (NP (DT an) (NN antifolate)) (SBAR (WHNP (WDT which)) (S (VP (VBZ inhibits) (NP (NP (NP (JJ Doc_8958188_145_171_Chemical) (NN formyltransferase)) (PRN (-LRB- -LRB-) (NP (NNP GARFT)) (-RRB- -RRB-))) (, ,) (NP (DT an) (JJ enzyme) (ADJP (JJ essential) (PP (IN for) (NP (NNP de) (NN novo) (NNS Doc_8958188_231_237_Chemical)))) (NN synthesis)))))))) (. .)))
8958188	2	(ROOT (S (ADVP (RB Extensive)) (NP (ADJP (JJ experimental) (CC and) (JJ limited)) (JJ clinical) (NNS data)) (VP (VBP have) (VP (VBN shown) (SBAR (IN that) (S (NP (NNS Doc_8958188_314_324_Chemical)) (VP (VBZ has) (NP (NP (NN activity)) (PP (IN against) (NP (NP (NNS Doc_8958188_346_353_Disease)) (SBAR (WHNP (WDT which)) (S (VP (VBP are) (ADJP (JJ refractory) (PP (TO to) (NP (NP (JJ other) (NNS drugs)) (, ,) (RB notably) (NP (NNS Doc_8958188_399_411_Chemical)))))))))))))))) (. .)))
8958188	3	(ROOT (S (ADVP (RB However)) (, ,) (NP (NP (DT the) (JJ initial) (JJ clinical) (NN development)) (PP (IN of) (NP (NNS Doc_8958188_458_468_Chemical)))) (VP (VBD was) (VP (VBN curtailed) (PP (RB because) (IN of) (NP (ADJP (JJ severe) (CC and) (JJ cumulative)) (NN antiproliferative) (NNS Doc_8958188_534_544_Disease))))) (. .)))
8958188	4	(ROOT (S (NP (JJ Preclinical) (NN murine) (NNS studies)) (VP (VBD demonstrated) (SBAR (IN that) (S (NP (NP (DT the) (NNS Doc_8958188_595_603_Disease)) (PP (IN of) (NP (NNS Doc_8958188_607_617_Chemical)))) (VP (MD can) (VP (VB be) (VP (VBN prevented) (PP (IN by) (NP (JJ low) (NN dose) (NNS Doc_8958188_647_657_Chemical) (NN administration))) (, ,) (ADVP (ADJP (JJ i.e.)) (PP (IN for) (ADVP (NP (CD 7) (NNS days)) (RB prior))) (PP (TO to) (NP (NP (QP (CC and) (CD 7)) (NNS days)) (PP (VBG following) (NP (DT a) (JJ single) (NNS bolus) (NN dose)))))))))))) (. .)))
8958188	5	(ROOT (S (NP (DT This) (NN observation)) (VP (VBD prompted) (NP (NP (DT a) (NN Phase) (NN I) (JJ clinical) (NN study)) (PP (IN of) (NP (NNS Doc_8958188_795_805_Chemical)))) (PP (VBN given) (PP (IN with) (NP (NP (JJ Doc_8958188_817_827_Chemical) (NN supplementation)) (SBAR (WHNP (WDT which)) (S (VP (VBZ has) (VP (VBN confirmed) (SBAR (IN that) (S (NP (NP (DT the) (NNS Doc_8958188_873_881_Disease)) (PP (IN of) (NP (NNS Doc_8958188_885_895_Chemical)))) (VP (MD can) (VP (VB be) (ADJP (RB markedly) (JJ reduced) (PP (IN by) (NP (JJ Doc_8958188_923_933_Chemical) (NN supplementation)))))))))))))))) (. .)))
8958188	6	(ROOT (S (NP (NNS Doc_8958188_951_967_Disease) (CC and) (NNS Doc_8958188_972_981_Disease)) (VP (VBD were) (NP (DT the) (JJ major) (NNS Doc_8958188_997_1007_Disease))) (. .)))
8958188	7	(ROOT (S (NP (EX There)) (VP (VBD was) (NP (NP (NP (DT no) (JJ clear) (NN relationship)) (PP (IN between) (NP (JJ clinical) (NNS Doc_8958188_1058_1066_Disease)))) (CC and) (NP (NP (DT the) (NN extent)) (PP (IN of) (NP (JJ plasma) (JJ Doc_8958188_1092_1098_Chemical) (NN elevation)))))) (. .)))
8958188	8	(ROOT (S (NP (NNP Associated) (NNS studies)) (VP (VBD demonstrated) (SBAR (IN that) (S (NP (JJ Doc_8958188_1147_1157_Chemical) (NN plasma) (NNS pharmacokinetics)) (VP (VBD were) (RB not) (VP (VBN altered) (PP (IN by) (NP (JJ Doc_8958188_1202_1212_Chemical) (NN administration))) (S (VP (VBG indicating) (SBAR (IN that) (S (NP (NN supplementation)) (VP (VBZ is) (ADJP (JJ unlikely) (S (VP (TO to) (VP (VB reduce) (NP (NNS Doc_8958188_1282_1290_Disease)) (PP (IN by) (S (VP (VBG enhancing) (NP (JJ Doc_8958188_1304_1314_Chemical) (NN plasma) (NN clearance))))))))))))))))))) (. .)))
8958188	9	(ROOT (S (NP (NP (DT The) (NN work)) (VP (VBN described) (PP (IN in) (NP (DT this) (NN report))))) (VP (VBZ has) (VP (VBN identified) (PP (IN for) (NP (DT the) (JJ first) (NN time))) (NP (NP (DT a) (ADJP (RB clinically) (JJ acceptable)) (NN schedule)) (PP (IN for) (NP (NP (DT the) (NN administration)) (PP (IN of) (NP (DT a) (JJ GARFT) (NN inhibitor)))))))) (. .)))
8958188	10	(ROOT (S (NP (DT This) (NN information)) (VP (MD will) (VP (VB facilitate) (NP (NP (DT the) (JJ future) (NN evaluation)) (PP (IN of) (NP (NP (DT this) (NN class)) (PP (IN of) (NP (NP (NNS compounds)) (PP (IN in) (NP (JJ Doc_8958188_1564_1570_Disease) (NN therapy)))))))))) (. .)))
8988571	0	(ROOT (NP (NP (JJ Fatal) (VBN excited) (JJ Doc_8988571_14_22_Disease) (VBG following) (JJ Doc_8988571_33_40_Chemical) (NN use)) (: :) (S (NP (JJ epidemiologic) (NNS findings)) (VP (VB provide) (NP (JJ new) (NN evidence)) (PP (IN for) (NP (NP (NNS mechanisms)) (PP (IN of) (NP (JJ Doc_8988571_108_115_Chemical) (NNS Doc_8988571_116_124_Disease))))))) (. .)))
8988571	1	(ROOT (S (NP (PRP We)) (VP (VBP describe) (NP (NP (DT an) (NN outbreak)) (PP (IN of) (NP (NP (NNS deaths)) (PP (IN from) (NP (NP (ADJP (JJ Doc_8988571_165_172_Chemical-induced) (JJ excited)) (NNS Doc_8988571_189_197_Disease)) (PRN (-LRB- -LRB-) (NP (NNP EDDs)) (-RRB- -RRB-))))))) (PP (IN in) (NP (NP (NNP Dade) (NNP County)) (, ,) (NP (NP (NNP Florida)) (PP (IN between) (NP (CD 1979) (CC and) (CD 1990))))))) (. .)))
8988571	2	(ROOT (S (PP (IN From) (NP (NP (DT a) (NN registry)) (PP (IN of) (NP (NP (DT all) (NN Doc_8988571_275_282_Chemical-related) (NNS deaths)) (PP (IN in) (NP (NP (NP (NNP Dade) (NNP County)) (, ,) (NP (NNP Florida)) (, ,)) (PP (IN from) (NP (CD 1969-1990))))))))) (, ,) (NP (CD 58) (NNS EDDs)) (VP (VBD were) (VP (VBN compared) (PP (IN with) (NP (NP (CD 125) (NNS victims)) (PP (IN of) (NP (JJ accidental) (JJ Doc_8988571_392_399_Chemical) (NNS Doc_8988571_400_408_Disease))))) (PP (IN without) (NP (VBN excited) (NNS Doc_8988571_425_433_Disease))))) (. .)))
8988571	3	(ROOT (S (PP (VBN Compared) (PP (IN with) (NP (NNS controls)))) (, ,) (NP (NNP EDDs)) (VP (VBD were) (ADJP (ADJP (ADVP (RBR more) (RB frequently)) (JJ black)) (, ,) (ADJP (JJ male)) (, ,) (CC and) (ADJP (JJ younger)))) (. .)))
8988571	4	(ROOT (S (NP (PRP They)) (VP (VBD were) (ADJP (ADJP (RBR less) (JJ likely) (S (VP (TO to) (VP (VB have) (NP (DT a) (JJ low) (NN body) (NN mass) (NN index)))))) (, ,) (CC and) (ADJP (RBR more) (JJ likely) (S (VP (TO to) (VP (VB have) (VP (VBN died) (PP (IN in) (NP (NN police) (NN custody))) (, ,) (S (VP (TO to) (VP (VB have) (VP (VBN received) (NP (JJ medical) (NN treatment)) (ADVP (RB immediately)) (PP (IN before) (NP (NN death))) (, ,) (S (VP (VP (TO to) (VP (VB have) (VP (VBN survived) (PP (IN for) (NP (DT a) (JJR longer) (NN period)))))) (, ,) (VP (TO to) (VP (VB have) (VP (VBN developed) (NP (NNS Doc_8988571_729_741_Disease))))) (, ,) (CC and) (VP (TO to) (VP (VB have) (VP (VBN died) (PP (IN in) (NP (NN summer) (NNS months))))))))))))))))))) (. .)))
8988571	5	(ROOT (S (NP (NNS EDDs)) (VP (VBD had) (NP (NP (NNS concentrations)) (PP (IN of) (NP (NNS Doc_8988571_805_812_Chemical) (CC and) (NNS Doc_8988571_817_832_Chemical)))) (PP (IN in) (NP (NP (JJ autopsy) (NN blood)) (SBAR (WHNP (WDT that)) (S (VP (VBD were) (ADJP (JJ similar) (PP (TO to) (NP (NP (DT those)) (PP (IN for) (NP (NNS controls)))))))))))) (. .)))
8988571	6	(ROOT (S (NP (DT The) (JJ epidemiologic) (NNS findings)) (VP (VBP are) (ADJP (ADJP (RBS most) (JJ consistent)) (PP (IN with) (NP (DT the) (NNS hypothesis)))) (SBAR (IN that) (S (NP (JJ chronic) (JJ Doc_8988571_971_978_Chemical) (NN use)) (VP (VP (VBZ disrupts) (NP (JJ dopaminergic) (NN function))) (CC and) (PRN (, ,) (SBAR (WHADVP (WRB when)) (S (VP (VBN coupled) (PP (IN with) (NP (JJ recent) (JJ Doc_8988571_1044_1051_Chemical) (NN use)))))) (, ,)) (VP (MD may) (VP (VB precipitate) (NP (NP (NNS Doc_8988571_1073_1082_Disease)) (, ,) (NP (NNS Doc_8988571_1084_1092_Disease)) (, ,) (NP (JJ aberrant) (NN thermoregulation)) (, ,) (NP (NNS Doc_8988571_1121_1135_Disease)) (, ,) (CC and) (NP (NNS Doc_8988571_1141_1153_Disease))))))))) (. .)))
9022662	0	(ROOT (NP (NP (JJ Doc_9022662_0_8_Chemical) (JJ induced) (JJ acute) (NNS Doc_9022662_23_38_Disease)) (: :) (NP (NP (NN case) (NN report) (CC and) (NN review)) (PP (IN of) (NP (DT the) (NN literature)))) (. .)))
9022662	1	(ROOT (S (NP (NNP Doc_9022662_94_102_Chemical)) (VP (VBZ is) (NP (NP (DT an) (JJ Doc_9022662_109_120_Chemical) (NN derivative)) (SBAR (WHNP (WDT that)) (S (VP (VBZ is) (UCP (ADJP (RB structurally) (JJ different) (PP (IN from) (NP (NNS Doc_9022662_168_180_Chemical)))) (CC and) (VP (VBN used) (PP (IN in) (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (NNS Doc_9022662_210_236_Disease)))))))))))) (. .)))
9022662	2	(ROOT (S (NP (NNP Doc_9022662_238_246_Chemical)) (VP (VBZ has) (RB not) (VP (VBN been) (VP (ADVP (RB commonly)) (VBN associated) (PP (IN in) (NP (NP (DT the) (NN literature)) (PP (IN as) (NP (NP (DT a) (NN cause)) (PP (IN of) (NP (JJ acute) (NNS Doc_9022662_318_336_Disease)))))))))) (. .)))
9022662	3	(ROOT (S (NP (DT The) (JJ following) (NN case)) (VP (VBZ describes) (NP (NP (CD two) (NNS children)) (ADJP (RB acutely) (JJ poisoned))) (PP (IN with) (NP (NP (NNS Doc_9022662_402_410_Chemical)) (SBAR (WHNP (WP who)) (S (VP (VBD experienced) (NP (JJ profound) (NNS Doc_9022662_436_451_Disease)))))))) (. .)))
9022662	4	(ROOT (NP (NP (NNP CASE) (NNP REPORT)) (: :) (NP (NP (CD Two)) (, ,) (NP (JJ 3-year-old) (NN male)) (, ,) (NP (NP (JJ identical) (JJ twin) (NNS siblings)) (VP (VBN presented) (PP (TO to) (NP (DT the) (NN emergency) (NN department))) (SBAR (IN after) (S (VP (VBD found) (S (VP (VBG playing) (PP (IN with) (S (NP (DT a) (NP (NP (DT an) (JJ empty) (NN bottle)) (PP (IN of) (NP (NNS Doc_9022662_596_604_Chemical))))) (ADVP (RB originally)) (VP (VBG containing) (NP (CD 59) (NNS tablets))))))))))))) (. .)))
9022662	5	(ROOT (S (NP (DT The) (NNS children)) (VP (VBD had) (NP (NP (DT a) (JJ medical) (NN history)) (ADJP (JJ significant) (PP (IN for) (NP (NP (NNS Doc_9022662_690_716_Disease)) (VP (ADVP (RB previously)) (VBN treated) (PP (IN with) (NP (NNS Doc_9022662_741_756_Chemical))) (PP (IN without) (NP (NN success))))))))) (. .)))
9022662	6	(ROOT (S (NP (DT This)) (VP (VBD was) (NP (NP (PRP$ their) (JJ first) (NN day)) (PP (IN of) (NP (JJ Doc_9022662_802_810_Chemical) (NN therapy))))) (. .)))
9022662	7	(ROOT (S (NP (DT The) (JJ choreoathetoid) (NNS movements)) (VP (VBD began) (NP (CD 45) (NN min)) (PP (TO to) (NP (QP (CD 1) (CD h)))) (PP (IN after) (NP (NN ingestion)))) (. .)))
9022662	8	(ROOT (S (S (NP (DT The) (NNS children)) (VP (VBD gave) (NP (NP (DT no) (NN history)) (PP (IN of) (NP (JJ prior) (NNS Doc_9022662_924_942_Disease)))))) (CC and) (S (NP (EX there)) (VP (VBD was) (NP (NP (DT no) (NN family) (NN history)) (PP (IN of) (NP (NNS Doc_9022662_978_996_Disease)))))) (. .)))
9022662	9	(ROOT (S (NP (DT The) (NNS children)) (VP (VBD received) (NP (NP (JJ gastrointestinal) (NN decontamination) (CC and) (JJ high) (NNS doses)) (PP (IN of) (NP (JJ intravenous) (NNS Doc_9022662_1083_1098_Chemical)))) (PP (IN in) (NP (DT an) (NN attempt) (S (VP (TO to) (VP (VB control) (NP (DT the) (JJ choreoathetoid) (NNS movements)))))))) (. .)))
9022662	10	(ROOT (S (PP (IN Despite) (NP (NN treatment))) (, ,) (NP (DT the) (NNS children)) (VP (VBD continued) (S (VP (TO to) (VP (VB have) (NP (NP (NNS Doc_9022662_1204_1219_Disease)) (PP (IN for) (NP (QP (RB approximately) (CD 24)) (NNS hours)))))))) (. .)))
9022662	11	(ROOT (S (PP (NP (JJ Forty-eight) (NNS hours)) (IN after) (NP (NN admission))) (, ,) (NP (DT the) (NNS children)) (VP (VP (VBD appeared) (S (VP (TO to) (VP (VB be) (PP (IN at) (NP (PRP$ their) (NN baseline))))))) (CC and) (VP (VBD were) (VP (VBN discharged) (ADVP (RB home))))) (. .)))
9022662	12	(ROOT (S (NP (JJ Doc_9022662_1367_1375_Chemical) (VBN associated) (NNS Doc_9022662_1387_1404_Disease)) (VP (VBZ has) (VP (VBN been) (VP (ADVP (RB rarely)) (VBN reported) (PP (IN in) (NP (DT the) (JJ acute) (NN toxicology) (NN literature)))))) (. .)))
9022662	13	(ROOT (S (NP (NP (DT The) (NN possibility)) (PP (IN of) (NP (JJ choreoathetoid) (NNS movements)))) (VP (MD should) (VP (VB be) (VP (VBN considered) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG presenting) (PP (IN after) (NP (JJ Doc_9022662_1560_1568_Chemical) (NNS Doc_9022662_1569_1577_Disease))))))))) (. .)))
9041081	0	(ROOT (S (NP (NP (NN Effect)) (PP (IN of) (NP (JJ myopic) (NN excimer) (NN laser)))) (VP (VBP photorefractive) (ADVP (RB keratectomy)) (PP (IN on) (NP (NP (DT the) (JJ electrophysiologic) (NN function)) (PP (IN of) (NP (DT the) (ADJP (JJ retina) (CC and) (JJ optic)) (NN nerve)))))) (. .)))
9041081	1	(ROOT (S (VP (TO To) (VP (VB assess) (PP (IN by) (NP (JJ electrophysiologic) (NN testing))) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (NP (NP (JJ photorefractive) (NN keratectomy)) (PRN (-LRB- -LRB-) (NP (NNP PRK)) (-RRB- -RRB-))) (PP (IN on) (NP (DT the) (ADJP (JJ retina) (CC and) (JJ optic)) (NN nerve)))))))) (. .)))
9041081	2	(ROOT (NP (NP (NNP Eye) (NNP Clinic)) (, ,) (NP (NNP S.) (NNP Salvatore) (NNP Hospital)) (, ,) (NP (NNP L'Aquila) (NNP University)) (, ,) (NP (NNP Italy)) (. .)))
9041081	3	(ROOT (S (NP (NP (NP (NNP Standard) (NN pattern) (NNS electroretinograms)) (PRN (-LRB- -LRB-) (NP (NNP P-ERGs)) (-RRB- -RRB-))) (CC and) (NP (NP (JJ standard) (NN pattern) (JJ visual) (JJ evoked) (NNS potentials)) (PRN (-LRB- -LRB-) (NP (NNP P-VEPs)) (-RRB- -RRB-)))) (VP (VBD were) (VP (VBN done) (PP (IN in) (NP (NP (CD 25) (NNS eyes)) (PP (IN of) (NP (NP (NP (CD 25) (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBD had) (NP (NP (JJ myopic) (NN PRK)) (PP (IN for) (NP (NP (DT an) (VBN attempted) (NN correction)) (PP (IN between) (NP (CD 5.00) (CC and) (CD 15.00) (NNS diopters))))))))) (PRN (-LRB- -LRB-) (NP (NNP D)) (-RRB- -RRB-))) (PRN (-LRB- -LRB-) (S (VP (VB mean) (NP (NNP 8.00) (NNP D)))) (-RRB- -RRB-)))))))) (. .)))
9041081	4	(ROOT (S (NP (NNP Testing)) (VP (VBD was) (VP (VBN done) (NP (NP (NN preoperatively)) (CC and) (NP (CD 3)) (, ,) (NP (CD 6)) (, ,) (NP (CD 12)) (, ,) (CC and) (NP (CD 18) (NNS months))) (ADVP (RB postoperatively)))) (. .)))
9041081	5	(ROOT (S (NP (DT The) (JJ contralateral) (NNS eyes)) (VP (VBD served) (PP (IN as) (NP (NNS controls)))) (. .)))
9041081	6	(ROOT (S (PP (IN During) (NP (DT the) (NN follow-up))) (, ,) (NP (NP (CD 3) (NNS patients)) (PRN (-LRB- -LRB-) (NP (CD 12) (NN %)) (-RRB- -RRB-))) (VP (VBD developed) (NP (NP (NN Doc_9041081_737_744_Chemical-induced) (NNS Doc_9041081_753_782_Disease)) (PRN (-LRB- -LRB-) (NP (NNP IOP)) (-RRB- -RRB-)) (SBAR (WHNP (WDT that)) (S (VP (VBN resolved) (SBAR (IN after) (S (NP (JJ Doc_9041081_809_823_Chemical) (NN therapy)) (VP (VBD was) (VP (VBN discontinued)))))))))) (. .)))
9041081	7	(ROOT (S (NP (DT No) (ADJP (RB statistically) (JJ significant)) (NNS differences)) (VP (VBD were) (UCP (VP (VBN seen) (PP (IN between) (NP (NN treated) (CC and) (NN control) (NNS eyes)))) (CC nor) (ADVP (IN between) (NP (CD treated) (NNS eyes))) (ADJP (JJ preoperatively) (CC and) (JJ postoperatively)))) (. .)))
9041081	8	(ROOT (S (NP (JJ Myopic) (NN excimer) (NN laser) (NNP PRK)) (VP (VBD did) (RB not) (VP (VB seem) (S (VP (TO to) (VP (VB affect) (NP (DT the) (NN posterior) (NN segment))))))) (. .)))
9041081	9	(ROOT (S (NP (DT The) (JJ transient) (NN Doc_9041081_1101_1108_Chemical-induced) (NNS Doc_9041081_1117_1125_Disease)) (VP (VBD did) (RB not) (VP (VB seem) (S (VP (TO to) (VP (VB cause) (NP (ADJP (JJ functional)) (NN impairment))))))) (. .)))
9061311	0	(ROOT (NP (NP (JJ Neutrophil) (NNS Doc_9061311_11_21_Chemical) (CC and) (NNS Doc_9061311_26_43_Chemical) (NN production)) (PP (IN in) (NP (NNS patients))) (PP (IN with) (NP (NNS Doc_9061311_72_91_Disease))) (. .)))
9061311	1	(ROOT (S (NP (NP (NNS Defects)) (PP (IN in) (NP (NNS Doc_9061311_104_114_Chemical) (CC and) (NNS Doc_9061311_119_136_Chemical) (NN production)))) (VP (MD may) (VP (VB be) (VP (VBN implicated) (PP (IN in) (NP (NP (DT the) (JJ high) (NN incidence)) (PP (IN of) (NP (NP (NNS Doc_9061311_191_211_Disease)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (NNS Doc_9061311_229_248_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_9061311_250_253_Disease)) (-RRB- -RRB-))))))))))))) (. .)))
9061311	2	(ROOT (S (PP (IN In) (NP (DT the) (JJ present) (NN study))) (, ,) (NP (NP (JJ Doc_9061311_278_284_Chemical) (JJ radical) (NN production)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ Doc_9061311_321_324_Disease) (ADJP (JJ due) (PP (TO to) (NP (NNS Doc_9061311_332_343_Chemical)))) (NNS Doc_9061311_344_352_Disease)))))) (VP (VBD was) (VP (VBN compared) (PP (IN with) (NP (NP (DT that)) (PP (IN of) (NP (JJ healthy) (NNS volunteers))))))) (. .)))
9061311	3	(ROOT (S (NP (NP (NNS Neutrophils)) (PP (IN from) (NP (CD 14) (JJ Doc_9061311_419_422_Disease) (NNS patients)))) (VP (VBD were) (VP (VBN stimulated) (PP (IN via) (NP (NP (DT the) (JJ complement) (NNS receptors)) (VP (VBG using) (NP (NP (NN zymosan)) (VP (VBN opsonized) (PP (IN with) (NP (NNS Doc_9061311_506_509_Disease) (CC or) (NN control) (NN serum)))))))))) (. .)))
9061311	4	(ROOT (S (NP (NP (NN Doc_9061311_528_538_Chemical) (CC and) (NNS Doc_9061311_543_560_Chemical) (NN production)) (PP (IN by) (NP (NP (JJ Doc_9061311_575_578_Disease) (NNS neutrophils)) (VP (VBN stimulated) (PP (IN with) (NP (NP (NN zymosan)) (VP (VBN opsonized) (PP (IN with) (NP (JJ Doc_9061311_630_633_Disease) (NN serum)))))))))) (VP (VBD was) (ADVP (RB significantly)) (VP (VBN reduced) (PP (VBN compared) (PP (IN with) (NP (NP (DT the) (NN control) (NNS subjects)) (PRN (-LRB- -LRB-) (NP (NNP P) (NNP <) (NNP 0.01)) (-RRB- -RRB-))))))) (. .)))
9061311	5	(ROOT (S (NP (DT This) (NN defect)) (VP (VBD persisted) (SBAR (WHADVP (WRB when)) (S (NP (NP (NN zymosan)) (VP (VBN opsonized) (PP (IN by) (NP (NN control) (NN serum))))) (VP (VBD was) (VP (VBN used) (PRN (-LRB- -LRB-) (ADVP (RB P)) (ADJP (JJ <) (NP (CD 0.05))) (-RRB- -RRB-))))))) (. .)))
9061311	6	(ROOT (S (NP (NP (NN Doc_9061311_796_806_Chemical) (CC and) (NNS Doc_9061311_811_828_Chemical) (NN production)) (PP (IN in) (NP (NP (NNS neutrophils)) (VP (VBN stimulated) (PP (IN with) (NP (NP (NNS Doc_9061311_871_908_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_9061311_910_914_Chemical)) (-RRB- -RRB-)))) (PP (IN from) (NP (DT a) (JJ further) (CD 18) (JJ Doc_9061311_934_937_Disease) (NNS patients))))))) (VP (VBD was) (ADJP (JJ unaffected)) (PP (VBN compared) (PP (IN with) (NP (NN control) (NNS neutrophils))))) (. .)))
9061311	7	(ROOT (S (NP (NNP Serum) (NNP C3) (NNP complement) (NNS levels)) (VP (VBD were) (ADVP (RB significantly)) (VP (VBN reduced) (PP (IN in) (NP (JJ Doc_9061311_1054_1057_Disease) (NNS patients))) (PP (VBN compared) (PP (IN with) (NP (NP (NN control) (NNS subjects)) (PRN (-LRB- -LRB-) (NP (NNP P) (QP (CD <) (CD 0.0005))) (-RRB- -RRB-))))))) (. .)))
9061311	8	(ROOT (S (NP (DT These) (NNS results)) (VP (VBP demonstrate) (S (NP (NP (DT a) (JJ neutrophil) (NN defect)) (PP (IN in) (NP (NNS Doc_9061311_1161_1164_Disease)))) (ADJP (JJ due) (PP (TO to) (NP (NP (JJ Doc_9061311_1172_1183_Chemical) (NNS Doc_9061311_1184_1192_Disease)) (, ,) (SBAR (WHNP (WDT that)) (S (VP (VBZ is) (ADJP (RB complement) (JJ dependent) (CC but) (JJ independent) (PP (IN of) (NP (NN serum) (NNS complement))))))))))) (, ,) (S (ADVP (RB possibly)) (VP (VBN connected) (PP (TO to) (NP (DT the) (JJ complement) (NN receptor)))))) (. .)))
9067481	0	(ROOT (S (NP (JJ Doc_9067481_0_25_Chemical) (NN treatment)) (VP (VBZ protects) (NP (NNS rodents)) (PP (IN from) (NP (NP (DT the) (JJ toxic) (NNS effects)) (PP (IN of) (NP (NNS Doc_9067481_79_92_Chemical) (, ,) (NNS Doc_9067481_94_104_Chemical) (, ,) (NNS Doc_9067481_106_126_Chemical) (, ,) (NNS Doc_9067481_128_138_Chemical) (CC and) (NNS Doc_9067481_143_156_Chemical)))))) (. .)))
9067481	1	(ROOT (S (PP (IN In) (NP (NP (NN addition)) (PP (TO to) (NP (NP (PRP$ its) (NN use)) (PP (IN as) (NP (NP (DT a) (NN stabilizer/rigidifier)) (PP (IN of) (NP (NNS membranes))))))))) (, ,) (NP (NP (NNS Doc_9067481_222_247_Chemical)) (, ,) (NP (JJ Doc_9067481_249_258_Chemical) (PRN (-LRB- -LRB-) (NP (NNP CS)) (-RRB- -RRB-)) (NN administration))) (VP (VBZ has) (ADVP (RB also)) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB protect) (NP (NNS rats)) (PP (IN from) (NP (NP (DT the) (JJ hepatotoxic) (NNS effects)) (PP (IN of) (NP (NP (NNS Doc_9067481_347_367_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_9067481_369_373_Chemical)) (-RRB- -RRB-)))))))))))) (. .)))
9067481	2	(ROOT (S (S (VP (TO To) (VP (VB further) (NP (NP (PRP$ our) (NN understanding)) (PP (IN of) (NP (NP (DT the) (NN mechanism)) (PP (IN of) (NP (NNP CS) (NN cytoprotection))))))))) (, ,) (NP (PRP we)) (VP (VBD examined) (PP (IN in) (NP (NNS rats) (CC and) (NNS mice))) (NP (NP (NP (DT the) (JJ protective) (NNS abilities)) (PP (IN of) (NP (NNP CS)))) (CC and) (NP (NP (DT the) (JJ non-hydrolyzable) (NN ether) (NN form)) (PP (IN of) (NP (NP (NP (NNP CS)) (, ,) (NP (NP (NNS Doc_9067481_547_579_Chemical)) (, ,) (NP (NP (NP (NNS Doc_9067481_581_590_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP CSE)) (-RRB- -RRB-))) (PP (IN against) (NP (NNS Doc_9067481_605_618_Chemical)) (: -)) (, ,) (NP (NNS Doc_9067481_621_631_Chemical)) (: -)) (, ,) (NP (NNS Doc_9067481_634_654_Chemical))) (: -)) (, ,) (NP (ADJP (JJ Doc_9067481_657_667_Chemical) (: -) (CC and) (JJ Doc_9067481_673_686_Chemical-induced)) (NNS Doc_9067481_695_703_Disease))))))) (. .)))
9067481	3	(ROOT (S (NP (NP (DT The) (NNS results)) (PP (IN of) (NP (DT these) (NNS studies)))) (VP (VBD demonstrated) (SBAR (IN that) (S (NP (JJ CS-mediated) (NN protection)) (VP (VBZ is) (RB not) (ADJP (JJ selective) (PP (IN for) (NP (NP (DT a) (JJ particular) (NN species)) (, ,) (NP (NN organ) (NN system)) (CC or) (NP (JJ toxic) (NN chemical))))))))) (. .)))
9067481	4	(ROOT (S (NP (NP (NP (DT A) (JJ 24-h) (NN pretreatment)) (PP (IN of) (NP (NP (DT both) (NNS rats) (CC and) (NNS mice)) (PP (IN with) (NP (NP (DT a) (JJ single) (NN dose)) (PP (IN of) (NP (NNP CS)))))))) (PRN (-LRB- -LRB-) (NP (NNP 100mg/kg)) (, ,) (NP (NNP i.p.)) (-RRB- -RRB-) (, ,))) (VP (VBD resulted) (PP (IN in) (NP (JJ significant) (NN protection))) (PP (PP (IN against) (NP (NP (DT the) (JJ hepatotoxic) (NNS effects)) (PP (IN of) (NP (NNS Doc_9067481_1005_1009_Chemical) (, ,) (NNS Doc_9067481_1011_1016_Chemical) (, ,) (NNS Doc_9067481_1018_1031_Chemical) (CC and) (NNS Doc_9067481_1036_1049_Chemical))))) (CC and) (PP (IN against) (NP (NP (DT the) (ADJP (ADJP (JJ lethal)) (PRN (-LRB- -LRB-) (CC and) (FRAG (ADVP (RB presumably)) (NP (NNS Doc_9067481_1089_1100_Disease))) (-RRB- -RRB-))) (NN effect)) (PP (IN of) (NP (JJ Doc_9067481_1112_1122_Chemical) (NN administration))))))) (. .)))
9067481	5	(ROOT (S (NP (JJ Maximal) (JJ CS-mediated) (NN protection)) (VP (VBD was) (VP (VBN observed) (PP (IN in) (NP (NP (JJ experimental) (NNS animals)) (VP (VBN pretreated) (ADVP (NP (CD 24) (NN h)) (RB prior)) (PP (TO to) (NP (DT the) (JJ toxic) (NN insult)))))))) (. .)))
9067481	6	(ROOT (S (NP (DT These) (NNS data)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NNS Doc_9067481_1274_1276_Chemical)) (VP (VBZ intervenes) (PP (IN in) (NP (NP (DT a) (JJ critical) (JJ cellular) (NN event)) (SBAR (WHNP (WDT that)) (S (VP (VBZ is) (NP (NP (DT an) (JJ important) (JJ common) (NN pathway)) (PP (TO to) (NP (JJ toxic) (NN cell) (NN death))))))))))))) (. .)))
9067481	7	(ROOT (S (NP (NP (DT The) (NN mechanism)) (PP (IN of) (NP (NNP CS) (NN protection)))) (VP (VBZ does) (RB not) (VP (VB appear) (S (VP (TO to) (VP (VB be) (ADJP (JJ dependent) (PP (IN on) (NP (NP (DT the) (NN inhibition)) (PP (IN of) (NP (NN chemical) (NN bioactivation)))))) (PP (TO to) (NP (NP (DT a) (JJ toxic) (NN reactive)) (ADJP (ADJP (JJ intermediate)) (PRN (-LRB- -LRB-) (PP (IN in) (NP (NP (NN light)) (PP (IN of) (NP (NP (DT the) (NN protection)) (VP (VBN observed) (PP (IN against) (NP (JJ Doc_9067481_1559_1572_Chemical) (NN hepatotoxicity)))))))) (-RRB- -RRB-)))))))))) (. .)))
9067481	8	(ROOT (S (ADVP (RB However)) (, ,) (PP (VBN based) (PP (IN on) (NP (NP (DT the) (NNS data)) (VP (VBN presented))))) (, ,) (NP (PRP we)) (VP (MD can) (RB not) (VP (VB exclude) (NP (DT the) (NN possibility)) (SBAR (IN that) (S (NP (NNP CS) (NN administration)) (VP (VBZ inhibits) (NP (NN chemical) (NN bioactivation))))))) (. .)))
9067481	9	(ROOT (S (NP (PRP$ Our) (NNS findings)) (VP (VBP do) (SBAR (S (VP (VBP suggest) (SBAR (IN that) (S (NP (JJ CS-mediated) (NN protection)) (VP (VBZ is) (ADJP (JJ dependent) (PP (IN on) (NP (NP (DT the) (NN action)) (PP (IN of) (NP (NP (NP (DT the) (ADJP (JJ intact) (JJ anionic)) (NNP CS) (NN molecule)) (PRN (-LRB- -LRB-) (S (NP (JJ non-hydrolyzable) (NNP CSE)) (VP (VBD was) (ADJP (RB as) (JJ protective)) (PP (IN as) (NP (NNP CS))))) (-RRB- -RRB-))) (, ,) (SBAR (WHNP (WP$ whose) (NNS mechanism)) (S (VP (VBZ has) (ADVP (RB yet)) (S (VP (TO to) (VP (VB be) (VP (VBN defined)))))))))))))))))))) (. .)))
9098464	0	(ROOT (NP (NP (NP (DT A) (JJ murine) (NN model)) (PP (IN of) (NP (NNS Doc_9098464_18_29_Disease)))) (: :) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NP (NNS Doc_9098464_46_64_Disease)) (VP (VBN induced) (PP (IN by) (NP (NP (NNS Doc_9098464_76_100_Chemical)) (, ,) (NP (DT a) (JJ selective) (JJ Doc_9098464_114_123_Chemical) (NN reuptake) (NN inhibitor)) (, ,))) (PP (IN on) (NP (NP (JJ Doc_9098464_147_158_Disease) (NN induction)) (PP (IN in) (NP (NNP Wistar) (NN albino) (NNS rats))))))))) (. .)))
9098464	1	(ROOT (S (NP (NP (DT The) (NN aim)) (PP (IN of) (NP (DT this) (NN study)))) (VP (VBD was) (S (VP (TO to) (VP (VB investigate) (SBAR (IN whether) (S (NP (NP (NNS Doc_9098464_252_262_Chemical)) (PP (VBN given) (PP (TO to) (NP (ADJP (JJ castrated) (CC and) (JJ noncastrated)) (NNS rats))))) (VP (VBD caused) (NP (NP (NNS Doc_9098464_311_329_Disease)) (CC and) (NP (PRP$ its) (NNS effects))) (PP (IN with) (NP (NN respect))) (PP (TO to) (NP (NNS Doc_9098464_362_373_Disease)))))))))) (. .)))
9098464	2	(ROOT (S (NP (NP (NNP Doc_9098464_383_393_Chemical)) (, ,) (NP (DT a) (JJ Doc_9098464_397_406_Chemical) (NN reuptake) (NN inhibitor)) (, ,)) (VP (VBD was) (VP (VBN given) (PP (TO to) (NP (NP (NNP Wistar) (NNP Albino) (NNS rats)) (PP (IN for) (NP (CD 98) (NNS days))))) (S (VP (TO to) (VP (VB produce) (NP (NNS Doc_9098464_482_500_Disease))))))) (. .)))
9098464	3	(ROOT (S (NP (DT The) (NN drug)) (VP (VBD was) (VP (VBN given) (PP (PP (TO to) (NP (NP (CD two) (NNS groups)) (VP (VBG consisting) (PP (IN of) (NP (ADJP (JJ castrated) (CC and) (JJ noncastrated)) (NNS rats)))))) (CC and) (PP (VBN compared) (PP (TO to) (NP (NP (CD two) (NNS groups)) (PP (IN of) (NP (ADJP (JJ castrated) (CC and) (JJ noncastrated)) (NNS controls))))))))) (. .)))
9098464	4	(ROOT (S (S (NP (NN Prolactin) (NNS levels)) (VP (VBD were) (VP (VBN measured)))) (CC and) (S (NP (NP (DT the) (NN uteri)) (PP (IN of) (NP (DT the) (NNS rats)))) (VP (VBD were) (VP (VBN removed) (PP (IN for) (NP (JJ histopathological) (NN analysis))) (PP (IN at) (NP (NP (DT the) (NN end)) (PP (IN of) (NP (CD 98) (NNS days)))))))) (. .)))
9098464	5	(ROOT (NP (NP (NNP Marmara) (NNP University) (NNP School)) (PP (IN of) (NP (NNP Medicine))) (, ,) (NP (NP (NNP Department)) (PP (IN of) (NP (NNP Histology) (CC and) (NNP Embryology)))) (, ,) (NP (NP (NNP Zeynep) (NNP Kamil) (NNP Women)) (CC and) (NP (NP (NNP Children) (POS 's)) (NN Hospital))) (. .)))
9098464	6	(ROOT (NP (NP (NNP MAIN) (NNP OUTCOME) (NNP MEASURES)) (: :) (NP (NP (NNP Serum) (NN prolactin) (NNS levels)) (, ,) (NP (JJ uterine) (NN histopathology))) (. .)))
9098464	7	(ROOT (S (NP (NP (DT The) (NN prolactin) (NNS levels)) (PP (IN of) (NP (NP (ADJP (JJ castrated) (CC and) (JJ noncastrated)) (NNS groups)) (VP (VBN treated) (PP (IN with) (NP (NNS Doc_9098464_1055_1065_Chemical))))))) (VP (VBD were) (ADJP (RB statistically) (RB significantly) (JJR higher)) (SBAR (WHADVP (WRB when)) (S (VP (VBN compared) (PP (TO to) (NP (PRP$ their) (JJ respective) (NN control) (NNS groups))))))) (. .)))
9098464	8	(ROOT (S (NP (JJ Histological) (NNS studies)) (VP (VBD revealed) (NP (NP (CD 11) (NNS cases)) (PP (IN of) (NP (NNS Doc_9098464_1198_1209_Disease)))) (, ,) (PP (DT all) (IN within) (NP (NP (DT the) (JJ noncastrated) (NN group)) (VP (VBG receiving) (NP (NNS Doc_9098464_1255_1265_Chemical)))))) (. .)))
9098464	9	(ROOT (S (NP (PRP It)) (VP (VBD was) (VP (VBN suggested) (SBAR (IN that) (S (NP (JJ high) (NN serum) (NN prolactin) (NNS levels)) (VP (VBP cause) (NP (NP (NN degeneration)) (PP (IN of) (NP (JJ myometrial) (NNS cells)))) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NN ovarian) (NNS Doc_9098464_1395_1403_Chemical))) (SBAR (WHNP (WDT that)) (S (VP (VBZ results) (PP (IN in) (NP (DT a) (JJ myometrial) (NN invasion))) (PP (IN by) (NP (JJ endometrial) (NN stroma))))))))))))) (. .)))
9098464	10	(ROOT (S (NP (DT This) (NN invasion)) (ADVP (RB eventually)) (VP (VBZ progresses) (PP (TO to) (NP (NNS Doc_9098464_1504_1515_Disease)))) (. .)))
9105126	0	(ROOT (S (NP (NNP Postinfarction) (NNP Doc_9105126_15_40_Disease)) (VP (VBN associated) (PP (IN with) (NP (JJ long-term) (JJ Doc_9105126_67_74_Chemical) (NN therapy)))) (. .)))
9105126	1	(ROOT (S (S (NP (NP (CD Two) (NNS cases)) (PP (IN of) (NP (NP (NN postinfarction) (NNS Doc_9105126_112_138_Disease)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN on) (NP (JJ long-term) (JJ Doc_9105126_164_171_Chemical) (NN therapy)))))))) (VP (VBP are) (VP (VBN presented)))) (CC and) (S (NP (NP (DT the) (JJ favourable) (NN outcome)) (PP (IN in) (NP (DT both) (NNS cases)))) (VP (VBD described))) (. .)))
9105126	2	(ROOT (S (NP (NP (DT A) (JJ possible) (NN association)) (PP (IN between) (NP (JJ Doc_9105126_277_284_Chemical) (NN therapy) (CC and) (JJ subsequent) (NN postinfarction) (NNS Doc_9105126_323_337_Disease)))) (VP (VBZ is) (VP (VBN discussed))) (. .)))
9121607	0	(ROOT (S (NP (JJ Neuroactive) (NNS Doc_9121607_12_20_Chemical)) (VP (VBP protect) (PP (IN against) (NP (NP (ADJP (JJ Doc_9121607_37_48_Chemical) (: -) (CC and) (JJ Doc_9121607_54_65_Chemical-induced)) (JJ limbic) (NNS Doc_9121607_81_89_Disease)) (CC and) (NP (NP (NNS Doc_9121607_94_112_Disease)) (PP (IN in) (NP (NNS mice))))))) (. .)))
9121607	1	(ROOT (NP (NP (NP (NP (NP (JJ Several) (JJ structurally) (VBN related) (NNS metabolites)) (PP (IN of) (NP (NP (NNS Doc_9121607_166_178_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_9121607_180_212_Chemical)) (-RRB- -RRB-)) (CC and) (NP (NNS Doc_9121607_218_237_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_9121607_239_279_Chemical)) (-RRB- -RRB-))))) (CC and) (NP (NP (NP (PRP$ their) (CD 3) (NNS beta-epimers)) (SBAR (S (VP (VBD were) (VP (VBN evaluated) (PP (IN for) (NP (NP (JJ protective) (NN activity)) (PP (IN against) (NP (NNS Doc_9121607_353_364_Chemical)) (: -))))))))) (, ,) (NP (NNS Doc_9121607_367_378_Chemical))) (: -) (CC and) (NP (NNS Doc_9121607_384_404_Chemical))) (PRN (-LRB- -LRB-) (NP (NNP Doc_9121607_406_410_Chemical)) (-RRB- -RRB-))) (: -) (NP (NP (JJ induced) (NNS Doc_9121607_420_428_Disease)) (PP (IN in) (NP (NNS mice)))) (. .)))
9121607	2	(ROOT (S (NP (NP (NNP Doc_9121607_438_446_Chemical)) (PP (IN with) (NP (NP (NP (DT the) (JJ Doc_9121607_456_465_Chemical) (NN group)) (PP (IN in) (NP (DT the) (NN alpha-position)))) (CC and) (NP (NP (NNS Doc_9121607_498_501_Chemical)) (PP (IN in) (NP (DT the) (ADJP (NN alpha) (: -) (CC or) (JJ beta-configurations)))))))) (VP (VBD were) (ADJP (RB highly) (JJ effective) (PP (IN in) (S (VP (VBG protecting) (PP (IN against) (NP (NP (NP (NNS Doc_9121607_583_594_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 416) (NN mg/kg)) (, ,) (NP (NNP s.c.)) (-RRB- -RRB-))) (: -) (NP (ADJP (RB induced) (JJ limbic)) (NN motor) (NNS Doc_9121607_634_642_Disease)) (CC and) (NP (NP (NNS Doc_9121607_647_665_Disease)) (PRN (-LRB- -LRB-) (NP (CD ED50) (NNS values)) (, ,) (NP (CD 7.0-18) (NN .7) (NN mg/kg)) (, ,) (NP (NNP i.p.)) (-RRB- -RRB-)))))))))) (. .)))
9121607	3	(ROOT (S (NP (NP (DT The) (JJ corresponding) (NNS epimers)) (PP (IN with) (NP (NP (DT the) (JJ Doc_9121607_738_747_Chemical) (NN group)) (PP (IN in) (NP (DT the) (NN beta-position)))))) (VP (VBD were) (ADVP (RB also)) (ADJP (ADJP (JJ effective)) (CC but) (ADJP (ADJP (RBR less) (JJ potent)) (PRN (-LRB- -LRB-) (NP (NP (CD ED50) (NNS values)) (, ,) (NP (CD 33.8-63) (CD .5)) (, ,) (NP (NN i.p.))) (-RRB- -RRB-))))) (. .)))
9121607	4	(ROOT (S (SBAR (IN Although) (S (NP (DT the) (JJ neuroactive) (NNS Doc_9121607_868_876_Chemical)) (VP (VBD were) (ADJP (ADJP (RB considerably) (RBR less) (JJ potent)) (PP (IN than) (NP (DT the) (JJ Doc_9121607_916_930_Chemical) (NNS Doc_9121607_931_941_Chemical)))) (PP (IN in) (S (VP (VBG protecting) (PP (IN against) (NP (JJ Doc_9121607_964_975_Chemical) (NNS Doc_9121607_976_984_Disease))))))))) (, ,) (NP (NP (NNS Doc_9121607_986_994_Chemical)) (PP (IN with) (NP (DT the) (ADJP (CD 5) (NN alpha)) (NN ,3) (NN alpha-configuration)))) (VP (VBD had) (NP (NP (NP (ADJP (JJ comparable) (CC or) (JJR higher)) (JJ protective) (NN index) (NNS values)) (PRN (-LRB- -LRB-) (NP (NP (NNP TD50)) (PP (IN for) (NP (NN motor) (NN impairment))) (VP (VBN divided) (PP (IN by) (NP (NP (NNP ED50)) (PP (IN for) (NP (JJ Doc_9121607_1130_1137_Disease) (NN protection))))))) (-RRB- -RRB-))) (PP (IN than) (NP (NNS Doc_9121607_1155_1165_Chemical))) (, ,) (VP (VBG indicating) (SBAR (IN that) (S (NP (DT some) (JJ neuroactive) (NNS Doc_9121607_1200_1208_Chemical)) (VP (MD may) (VP (VB have) (NP (JJR lower) (JJ relative) (NNS Doc_9121607_1233_1241_Disease))))))))) (. .)))
9121607	5	(ROOT (S (NP (NP (NNP Doc_9121607_1243_1251_Chemical)) (PP (IN with) (NP (NP (DT the) (ADJP (CD 5) (NN alpha)) (CD ,3)) (ADJP (ADJP (NN alpha)) (: -) (CC or) (ADJP (CD 5) (NN beta)) (NP (CD ,3) (NNS alpha-configurations)))))) (ADVP (RB also)) (VP (VP (VBD produced) (NP (DT a) (JJ dose-dependent) (NN delay)) (PP (IN in) (NP (NP (DT the) (NN onset)) (PP (IN of) (NP (NP (JJ limbic) (NNS Doc_9121607_1371_1379_Disease)) (VP (VBN induced) (PP (IN by) (NP (NP (NNS Doc_9121607_1391_1402_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 32) (NN mg/kg)) (, ,) (NP (NNP s.c.)) (-RRB- -RRB-)))))))))) (, ,) (CC but) (VP (VBD did) (RB not) (VP (ADVP (RB completely)) (VB protect) (PP (IN against) (NP (DT the) (NNS Doc_9121607_1464_1472_Disease)))))) (. .)))
9121607	6	(ROOT (S (ADVP (RB However)) (, ,) (SBAR (WHADVP (WRB when)) (S (NP (NP (DT a) (JJ second) (NN dose)) (PP (IN of) (NP (DT the) (NNS Doc_9121607_1509_1516_Chemical)))) (VP (VBD was) (VP (VBN administered) (NP (CD 1) (NN hr)) (PP (IN after) (NP (DT the) (JJ first) (NN dose))))))) (, ,) (NP (NP (JJ complete) (NN protection)) (PP (IN from) (NP (DT the) (JJ Doc_9121607_1590_1601_Chemical-induced) (JJ limbic) (NNS Doc_9121607_1617_1625_Disease) (CC and) (NNS Doc_9121607_1630_1648_Disease)))) (VP (VBD was) (VP (VBN obtained))) (. .)))
9121607	7	(ROOT (S (NP (DT The) (NNS Doc_9121607_1667_1675_Chemical)) (ADVP (RB also)) (VP (VBD caused) (NP (NP (NP (DT a) (JJ dose-dependent) (NN delay)) (PP (IN in) (NP (NP (NNS Doc_9121607_1714_1718_Chemical)) (PRN (-LRB- -LRB-) (NP (JJ 257) (NN mg/kg)) (, ,) (NP (NNP s.c.)) (-RRB- -RRB-))))) (: -) (UCP (VP (VP (VBN induced) (ADVP (RB lethality))) (, ,) (CC but) (VP (VBD did) (RB not) (VP (ADVP (RB completely)) (VB protect) (PP (IN against) (NP (JJ Doc_9121607_1795_1799_Chemical) (NNS Doc_9121607_1800_1808_Disease)))))) (CC or) (ADJP (JJ lethality))))) (. .)))
9121607	8	(ROOT (S (NP (PRP We)) (VP (VBP conclude) (SBAR (IN that) (S (NP (JJ neuroactive) (NNS Doc_9121607_1852_1860_Chemical)) (VP (VP (VBP are) (ADJP (RB highly) (JJ effective) (PP (IN in) (S (VP (VBG protecting) (PP (IN against) (NP (NP (ADJP (JJ Doc_9121607_1904_1915_Chemical) (: -) (CC and) (JJ Doc_9121607_1921_1932_Chemical-induced)) (NNS Doc_9121607_1941_1949_Disease) (CC and) (NNS Doc_9121607_1954_1972_Disease)) (PP (IN in) (NP (NNS mice)))))))))) (, ,) (CC and) (VP (MD may) (VP (VB be) (PP (IN of) (NP (NN utility))) (PP (IN in) (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (NP (DT some) (NNS forms)) (PP (IN of) (NP (NP (NNS Doc_9121607_2038_2056_Disease)) (PP (IN in) (NP (NNS humans))))))))))))))) (. .)))
9154656	0	(ROOT (S (NP (NP (NNP Hepatic)) (CC and) (NP (JJ extrahepatic) (NN angiotensinogen) (NN gene))) (VP (VBD expression) (PP (IN in) (NP (NNS rats))) (PP (IN with) (NP (JJ acute) (NNS Doc_9154656_76_94_Disease)))) (. .)))
9154656	1	(ROOT (S (NP (NP (NNP Plasma) (NN concentration) (CC and) (NN urine) (NN excretion)) (PP (IN of) (NP (DT the) (JJ renin-angiotensin) (NN system) (NNS proteins)))) (VP (VBP are) (VP (VBN altered) (PP (IN in) (NP (NP (NNS rats)) (PP (IN with) (NP (NP (NNS Doc_9154656_203_221_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_9154656_223_225_Disease)) (-RRB- -RRB-)))))))) (. .)))
9154656	2	(ROOT (S (PP (IN In) (NP (DT this) (NN work))) (NP (NP (NP (DT the) (NN messenger) (NN Doc_9154656_255_271_Chemical) (PRN (-LRB- -LRB-) (NP (NNP mRNA)) (-RRB- -RRB-)) (NNS levels)) (PP (IN of) (NP (NN angiotensinogen)))) (PRN (-LRB- -LRB-) (NP (NNP Ao)) (-RRB- -RRB-))) (VP (VBD were) (VP (VBN analyzed) (PP (IN with) (NP (NP (NP (NP (DT the) (JJ slot-blot) (NN hybridization) (NN technique)) (PP (IN in) (NP (NN liver) (CC and) (JJ other) (JJ extrahepatic) (NNS tissues)))) (: :) (NP (NP (NN kidney) (, ,) (NN heart) (, ,) (NN brain) (, ,) (CC and) (NN adrenal)) (VP (VBN gland) (PP (IN from) (NP (NN control)))))) (, ,) (NP (NNS Doc_9154656_462_471_Disease)) (, ,) (CC and) (NP (ADJP (ADJP (JJ pair-fed)) (PRN (-LRB- -LRB-) (NP (NNP PF)) (-RRB- -RRB-))) (NNS rats)))))) (. .)))
9154656	3	(ROOT (S (NP (NNP Doc_9154656_497_499_Disease)) (VP (VBD was) (VP (VBN induced) (PP (IN by) (NP (NP (DT a) (JJ single) (NN injection)) (PP (IN of) (NP (NP (NNS Doc_9154656_537_563_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_9154656_565_568_Chemical)) (-RRB- -RRB-)))))))) (. .)))
9154656	4	(ROOT (S (SBAR (IN Although) (S (NP (NP (DT a) (JJ great) (NN urinary) (NN excretion)) (CC and) (NP (NP (JJ half-normal) (NN plasma) (NNS levels)) (PP (IN of) (NP (NNP Ao))))) (VP (VBD were) (VP (VBN observed) (PP (IN on) (NP (NN day) (CD 6))) (PP (IN after) (NP (NP (JJ Doc_9154656_671_674_Chemical) (NN injection)) (, ,) (SBAR (WHADVP (WRB when)) (S (NP (NNS Doc_9154656_691_693_Disease)) (VP (VBD was) (VP (ADVP (RB clearly)) (VBN established))))))))))) (, ,) (NP (JJ hepatic) (NNP Ao) (NN mRNA) (NNS levels)) (VP (VBD did) (RB not) (VP (VB change))) (. .)))
9154656	5	(ROOT (S (ADVP (RB Furthermore)) (, ,) (NP (DT the) (NNP Ao) (NN mRNA) (NNS levels)) (VP (VP (VBD did) (RB not) (VP (VB change) (PP (IN in) (NP (NP (DT any)) (PP (IN of) (NP (NP (DT the) (JJ extrahepatic) (NNS tissues)) (VP (VBN studied) (PP (IN on) (NP (NN day) (CD 6)))))))))) (, ,) (CC nor) (VP (VBD did) (NP (PRP$ its) (JJ hepatic) (NNS levels)) (PP (IN at) (S (NP (NNS days) (CD 1) (, ,) (CD 3) (, ,) (CD 5) (, ,) (CC or) (CD 7)) (PP (IN after) (S (VP (VBG Doc_9154656_913_916_Chemical) (NP (NN injection))))))))) (. .)))
9154656	6	(ROOT (S (NP (DT These) (NNS data)) (VP (VBP suggest) (SBAR (IN that) (S (NP (DT the) (ADJP (JJ hepatic) (CC and) (JJ extrahepatic)) (NNP Ao) (NN mRNA) (NNS levels)) (VP (VBP are) (ADJP (JJ unaltered) (PP (IN during) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (NP (DT the) (JJ acute) (NNS Doc_9154656_1046_1048_Disease)) (VP (VBN induced) (PP (IN by) (NP (NNS Doc_9154656_1060_1063_Chemical))))))))))))) (. .)))
9165568	0	(ROOT (S (VP (VB Doc_9165568_0_30_Disease) (PP (IN with) (NP (NNS Doc_9165568_36_47_Chemical)))) (. .)))
9165568	1	(ROOT (S (NP (NNP Doc_9165568_49_79_Disease)) (VP (VBZ is) (VP (VBN thought) (S (VP (TO to) (VP (VB be) (NP (NP (DT a) (NN result)) (PP (IN of) (NP (NP (NNP Doc_9165568_109_117_Chemical) (NNP D2) (NN receptor) (NN blockade)) (PP (IN in) (NP (NP (DT the) (NN striatum)) (PP (IN of) (NP (DT the) (JJ basal) (NN ganglia))))))))))))) (. .)))
9165568	2	(ROOT (S (NP (NP (NNP Doc_9165568_177_188_Chemical)) (, ,) (NP (DT a) (JJ Doc_9165568_192_205_Chemical) (JJ derivative) (NN antipsychotic)) (, ,)) (VP (VBZ has) (NP (NP (JJ high) (JJ Doc_9165568_241_250_Chemical) (JJ 5-HT2) (NN receptor) (NN blockade)) (CC and) (NP (JJ dose-related) (NN D2) (NN receptor) (NN blockade)))) (. .)))
9165568	3	(ROOT (S (NP (DT The) (JJ high) (NN ratio)) (VP (VBZ is) (VP (VBN believed) (S (VP (TO to) (VP (VB impart) (NP (NP (DT the) (JJ low) (NN frequency)) (PP (IN of) (NP (NNS Doc_9165568_372_395_Disease)))) (PP (IN with) (NP (NP (NNS Doc_9165568_401_412_Chemical)) (PP (IN at) (NP (JJ low) (NNS dosages)))))))))) (. .)))
9165568	4	(ROOT (S (PP (IN With) (NP (NP (DT this) (JJ low) (NN frequency)) (PP (IN of) (NP (NNS Doc_9165568_456_479_Disease))))) (, ,) (NP (PRP it)) (VP (VBD was) (VP (VBN thought) (SBAR (S (NP (NP (DT the) (NN frequency)) (PP (IN of) (NP (NNS Doc_9165568_513_543_Disease)))) (VP (MD might) (ADVP (RB also)) (VP (VB be) (VP (VBN lowered)))))))) (. .)))
9165568	5	(ROOT (S (NP (DT A) (JJ 73-year-old) (NN woman)) (VP (VBD developed) (NP (NNS Doc_9165568_597_627_Disease)) (PP (IN after) (NP (NN monotherapy))) (PP (IN with) (NP (NNS Doc_9165568_651_662_Chemical)))) (. .)))
9165568	6	(ROOT (S (NP (DT The) (NN syndrome)) (VP (VBD reversed) (PP (IN after) (S (VP (VP (VBG discontinuing) (NP (NNS Doc_9165568_706_717_Chemical))) (CC and) (VP (VBG starting) (NP (NN treatment)) (PP (IN with) (NP (NNS Doc_9165568_746_756_Chemical) (CC and) (NNS Doc_9165568_761_774_Chemical)))))))) (. .)))
9165568	7	(ROOT (S (NP (PRP It)) (VP (VBZ appears) (SBAR (IN that) (S (NP (NP (DT the) (NN protection)) (PP (IN from) (NP (JJ extrapyramidal) (NN side) (NNS effects)))) (VP (VBD observed) (SBAR (IN with) (S (NP (NNS Doc_9165568_854_865_Chemical)) (VP (VBZ does) (RB not) (VP (VB ensure) (NP (NN protection)) (PP (IN from) (NP (NNS Doc_9165568_898_928_Disease))))))))))) (. .)))
9201797	0	(ROOT (NP (NP (DT The) (JJ attenuating) (NN effect)) (PP (IN of) (NP (NP (NNS Doc_9201797_26_49_Chemical)) (, ,) (NP (DT a) (JJ beta-adrenoceptor) (NN antagonist)) (, ,))) (PP (IN on) (NP (JJ neuroleptic-induced) (NNS Doc_9201797_106_115_Disease))) (PP (IN in) (NP (NNS rats))) (. .)))
9201797	1	(ROOT (S (NP (PRP It)) (VP (VBZ is) (VP (VBN known) (SBAR (IN that) (S (NP (JJ beta-adrenoceptor) (NNS antagonists)) (VP (VBP are) (ADJP (JJ effective) (PP (IN in) (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (NP (NNS Doc_9201797_206_215_Disease)) (, ,) (NP (NP (CD one)) (PP (IN of) (NP (DT the) (JJ extrapyramidal) (NN side) (NNS effects))) (SBAR (WHNP (WDT that)) (S (VP (VBP occur) (PP (IN during) (NP (JJ neuroleptic) (NN treatment))))))))))))))))) (. .)))
9201797	2	(ROOT (S (NP (NP (JJ Neuroleptic-induced) (NNS Doc_9201797_317_326_Disease)) (, ,) (NP (NP (DT a) (NN model)) (PP (IN of) (NP (JJ neuroleptic-induced) (JJ extrapyramidal) (NN side) (NNS effects)))) (, ,)) (VP (VBD was) (VP (VBN considered) (ADJP (JJ suitable) (PP (IN as) (NP (DT a) (NN model)))) (PP (IN for) (S (VP (VBG predicting) (NP (JJ neuroleptic-induced) (NNS Doc_9201797_458_467_Disease)) (PP (IN in) (NP (NP (NNS humans)) (, ,) (SBAR (IN although) (S (NP (JJ neuroleptic-induced) (NNS Doc_9201797_508_517_Disease)) (VP (VBD was) (RB not) (VP (VBN considered) (NP (NP (DT a) (JJ specific) (NN test)) (PP (IN for) (NP (JJ neuroleptic-induced) (NNS Doc_9201797_577_586_Disease))))))))))))))) (. .)))
9201797	3	(ROOT (S (ADVP (RB Therefore)) (, ,) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NP (NP (NNS Doc_9201797_614_623_Chemical)) (, ,) (NP (DT a) (JJ beta-adrenoceptor) (NN antagonist)) (, ,)) (PP (IN on) (NP (NP (NN Doc_9201797_660_671_Chemical-induced) (NNS Doc_9201797_680_689_Disease)) (PP (IN in) (NP (NNS rats)))))))) (VP (VBD were) (ADVP (RB behaviorally)) (VP (VBN studied) (CC and) (VBN compared) (PP (IN with) (NP (NP (DT those)) (PP (IN of) (NP (NP (NNS Doc_9201797_751_762_Chemical) (CC and) (NNS Doc_9201797_767_776_Chemical)) (, ,) (NP (DT a) (JJ muscarinic) (NN receptor) (NN antagonist)))))))) (. .)))
9201797	4	(ROOT (S (NP (NP (NNP Doc_9201797_812_821_Chemical)) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (NNS Doc_9201797_834_845_Chemical) (CC and) (NNS Doc_9201797_850_859_Chemical)) (, ,)) (VP (VBD inhibited) (NP (DT the) (NN Doc_9201797_875_886_Chemical-induced) (NNS Doc_9201797_895_904_Disease))) (. .)))
9201797	5	(ROOT (S (NP (NP (DT The) (JJ inhibitory) (NN effect)) (PP (IN of) (NP (NNS Doc_9201797_931_940_Chemical)))) (VP (VP (VBD was) (ADJP (RB almost) (JJ comparable)) (PP (TO to) (NP (NP (DT that)) (PP (IN of) (NP (NNS Doc_9201797_974_985_Chemical)))))) (, ,) (CC but) (VP (VBD was) (ADJP (JJR weaker)) (PP (IN than) (NP (NP (DT that)) (PP (IN of) (NP (NNS Doc_9201797_1015_1024_Chemical))))))) (. .)))
9201797	6	(ROOT (S (NP (NNP Doc_9201797_1026_1035_Chemical)) (VP (VBD did) (RB not) (VP (VB evoke) (NP (NP (JJ postsynaptic) (JJ Doc_9201797_1063_1071_Chemical) (JJ receptor-stimulating) (JJ behavioral) (NNS signs)) (PP (JJ such) (IN as) (NP (NP (NN stereotypy) (CC and) (NN hyperlocomotion)) (PP (IN in) (NP (NNS rats)))))))) (. .)))
9201797	7	(ROOT (S (NP (NNP Doc_9201797_1158_1167_Chemical)) (VP (VBD did) (RB not) (VP (VB antagonize) (NP (NP (DT the) (JJ inhibitory) (NNS effects)) (PP (IN of) (NP (NNS Doc_9201797_1213_1224_Chemical)))) (PP (IN on) (NP (NP (NN Doc_9201797_1228_1239_Chemical-induced) (NN stereotypy) (CC and) (NN locomotor) (NN activity)) (PP (IN in) (NP (NNS rats))))))) (. .)))
9201797	8	(ROOT (S (PP (IN In) (NP (NN addition))) (, ,) (NP (NNS Doc_9201797_1304_1313_Chemical)) (VP (VP (VBD did) (RB not) (VP (VB evoke) (NP (NP (CD 5-HT1A) (JJ receptor-stimulating) (JJ behavioral) (NNS signs)) (PP (JJ such) (IN as) (NP (JJ flat) (NN body) (NN posture) (CC and) (NN forepaw) (NN treading)))))) (CC and) (VP (VBD did) (RB not) (VP (VB inhibit) (S (NP (NN Doc_9201797_1440_1459_Chemical-induced) (NN head)) (VP (VB twitch) (PP (IN in) (NP (NNS rats)))))))) (. .)))
9201797	9	(ROOT (S (ADVP (RB Finally)) (, ,) (NP (NNS Doc_9201797_1498_1507_Chemical)) (VP (VBD did) (RB not) (VP (VB inhibit) (NP (NNS Doc_9201797_1524_1537_Chemical-induced)) (ADVP (RB lethality)) (PP (IN in) (NP (NNS rats))))) (. .)))
9201797	10	(ROOT (S (NP (DT These) (NNS results)) (ADVP (RB strongly)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NNS Doc_9201797_1601_1610_Chemical)) (VP (VP (VBZ improves) (NP (NP (NN Doc_9201797_1620_1631_Chemical-induced) (NNS Doc_9201797_1640_1649_Disease)) (PP (IN via) (NP (PRP$ its) (JJ beta-adrenoceptor) (JJ antagonistic) (NN activity))))) (CC and) (VP (VBZ is) (VP (VBN expected) (S (VP (TO to) (VP (VB be) (ADJP (JJ effective) (PP (IN in) (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (NNS Doc_9201797_1750_1759_Disease)))))) (PP (IN without) (S (VP (VBG attenuating) (S (NP (JJ neuroleptic-induced) (JJ antipsychotic) (NNS effects)) (ADJP (JJ due) (PP (TO to) (NP (PRP$ its) (JJ postsynaptic) (JJ Doc_9201797_1846_1854_Chemical) (NN receptor) (JJ antagonistic) (NN activity))))))))))))))))) (. .)))
9205462	0	(ROOT (S (NP (NNP Doc_9205462_0_33_Disease)) (VP (VBN associated) (PP (IN with) (NP (JJ antecedent) (JJ Doc_9205462_61_70_Chemical) (NN use)))) (. .)))
9205462	1	(ROOT (S (NP (VBN Increased) (NN attention)) (VP (VBZ has) (VP (VBN been) (VP (VBN focused) (ADVP (RB recently)) (PP (IN on) (NP (NP (DT the) (JJ estrogenic) (NNS effects)) (PP (IN of) (NP (NNS Doc_9205462_163_172_Chemical)))))))) (. .)))
9205462	2	(ROOT (S (NP (NP (NNP Review)) (PP (IN of) (NP (DT the) (NN literature)))) (VP (VBZ reveals) (NP (NP (DT an) (NN association)) (PP (IN between) (NP (JJ Doc_9205462_230_239_Chemical) (NN use) (CC and) (NN gynecologic) (NNS Doc_9205462_260_266_Disease))))) (. .)))
9205462	3	(ROOT (S (NP (DT A) (JJ 52-year-old) (JJ postmenopausal) (NN woman)) (VP (VBD was) (VP (VBN treated) (PP (IN with) (NP (NP (NNS Doc_9205462_326_335_Chemical)) (PP (IN for) (NP (NN stage) (ADJP (NNP II) (JJ Doc_9205462_349_357_Chemical)) (NN receptor-positive) (NNS Doc_9205462_376_392_Disease))))))) (. .)))
9205462	4	(ROOT (S (NP (NP (PRP$ Her) (JJ Doc_9205462_398_407_Chemical) (NN transaminase)) (CC and) (NP (JJ Doc_9205462_425_432_Chemical) (NN transaminase) (NNS levels))) (VP (VBP increase) (ADVP (RB markedly) (PP (IN after) (NP (NP (CD 6) (NNS months)) (PP (IN of) (NP (JJ Doc_9205462_489_498_Chemical) (NN use))))))) (. .)))
9205462	5	(ROOT (S (PP (IN After) (NP (NP (DT an) (JJ additional) (CD 17) (NNS months)) (PP (IN of) (NP (JJ elevated) (NN serum) (NNS transaminases))))) (, ,) (NP (DT the) (NN patient)) (VP (VBD was) (VP (VBN found) (S (VP (TO to) (VP (VB have) (NP (DT a) (NN stage) (NN Ic) (NN Doc_9205462_608_641_Disease))))))) (. .)))
9205462	6	(ROOT (S (NP (NP (NNS Patients)) (PP (IN with) (NP (NN Doc_9205462_669_678_Chemical-induced) (NNS Doc_9205462_687_704_Disease)))) (VP (MD may) (VP (VB be) (PP (IN at) (NP (NP (VBN increased) (NN risk)) (PP (IN for) (NP (NP (NNS Doc_9205462_734_755_Disease)) (PP (RB because) (IN of) (NP (NP (NNS alterations)) (PP (IN in) (NP (JJ Doc_9205462_782_791_Chemical) (NN metabolism))))))))))) (. .)))
9209318	0	(ROOT (S (NP (NP (JJ Lifetime) (NN treatment)) (PP (IN of) (NP (NP (NNS mice)) (PP (IN with) (NP (NP (NNS Doc_9209318_32_46_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_9209318_48_51_Chemical)) (-RRB- -RRB-))))))) (VP (VBZ produces) (NP (NNS Doc_9209318_62_76_Disease))) (. .)))
9209318	1	(ROOT (S (NP (NNP Doc_9209318_78_81_Chemical)) (VP (VBZ has) (VP (VBN induced) (NP (NP (DT a) (NNS Doc_9209318_96_113_Disease)) (PP (IN in) (NP (JJ Doc_9209318_117_121_Disease) (NNS patients)))) (PP (IN on) (NP (JJ long) (NN term) (NNS Doc_9209318_144_147_Chemical) (NN therapy))))) (. .)))
9209318	2	(ROOT (S (NP (PRP It)) (VP (VBZ is) (ADVP (RB generally)) (VP (VBN assumed) (SBAR (IN that) (S (NP (NNP DNA) (NNP elongation)) (VP (VP (VBZ is) (VP (VBN stopped) (PP (IN by) (NP (NP (DT the) (NN insertion)) (PP (IN of) (NP (NNS Doc_9209318_232_235_Chemical))))) (PP (IN into) (S (NP (NP (DT the) (NN chain)) (PP (IN in) (NP (NP (NN place)) (PP (IN of) (NP (NNS Doc_9209318_263_272_Chemical)))))) (ADVP (RB thus)) (VP (VBG preventing) (NP (DT the) (JJ Doc_9209318_293_302_Chemical) (JJ hydroxyl) (NNS linkages))))))) (CC and) (VP (ADVP (RB therefore)) (VBZ suppresses) (NP (NP (JJ hemopoietic) (NN progenitor) (NN cell) (NN proliferation)) (PP (IN in) (NP (NP (DT an) (JJ early) (NN stage)) (PP (IN of) (NP (NN differentiation)))))))))))) (. .)))
9209318	3	(ROOT (FRAG (NP (NNP Doc_9209318_426_429_Chemical)) (: /) (S (S (NP (ADJP (JJ Ca) (NN male)) (NNS mice)) (VP (VP (VBD started) (PP (IN on) (NP (NN Doc_9209318_454_457_Chemical) (CD 0.75) (NN mg/ml) (NN H2O))) (PP (IN at) (NP (NP (CD 84) (NNS days)) (PP (IN of) (NP (NN age)))))) (CC and) (VP (VBD kept) (PP (IN on) (NP (PRP it))) (PP (IN for) (NP (NP (CD 687) (NNS days)) (SBAR (WHADVP (WRB when)) (S (NP (NN dosage)) (VP (VBD reduced) (PP (TO to) (NP (CD 0.5) (JJ mg/ml) (NNS Doc_9209318_552_555_Chemical))) (PP (IN for) (NP (NP (DT a) (NN group)) (, ,) (NP (NP (DT another) (NN group)) (VP (VBN removed) (PP (IN from) (NP (NNS Doc_9209318_596_599_Chemical))) (S (VP (TO to) (VP (VB see) (NP (NN recovery))))))))))))))))) (, ,) (CC and) (S (NP (JJ third) (NN group)) (VP (VBD remained) (PP (IN on) (NP (CD 0.75) (NN mg)))))) (. .)))
9209318	4	(ROOT (S (PP (IN At) (NP (CD 687) (NNS days))) (NP (NP (NNS mice)) (SBAR (WHNP (WDT that)) (S (VP (VBD had) (VP (VBN been) (PP (IN on) (NP (CD 0.75) (NN mg)))))))) (VP (VBD had) (NP (NP (JJ average) (NN platelet) (NNS counts)) (PP (IN of) (NP (NP (QP (CD 2.5) (CD x)) (CD 10)) (PRN (-LRB- -LRB-) (NP (CD 6)) (-RRB- -RRB-)))))) (. .)))
9209318	5	(ROOT (S (NP (NP (JJ Histological) (NN examination)) (PP (IN on) (NP (NP (CD 9)) (PP (IN of) (NP (NP (CD 10) (NNS mice)) (PP (IN with) (NP (JJ such) (NNS Doc_9209318_791_807_Disease)))))))) (VP (VBD showed) (S (NP (NNS changes)) (ADJP (JJ compatible) (PP (IN with) (NP (NP (NNS Doc_9209318_839_863_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_9209318_865_868_Disease)) (-RRB- -RRB-))))))) (. .)))
9209318	6	(ROOT (S (NP (NP (DT A) (NN variety)) (PP (IN of) (NP (JJ histological) (NNS patterns)))) (VP (VBD was) (ADJP (JJ observed))) (. .)))
9209318	7	(ROOT (S (S (NP (EX There)) (VP (VBD were) (NP (NP (NP (CD two) (NNS cases)) (PP (IN of) (NP (NN hypocellular) (NNS Doc_9209318_957_971_Disease)))) (, ,) (NP (NP (CD two) (NNS cases)) (PP (IN of) (NP (JJ hypersegmented) (JJ Doc_9209318_1001_1016_Disease) (NNS granulocytosis)))) (, ,) (NP (NP (CD two) (NNS cases)) (PP (IN of) (NP (NN hypercellular) (NN marrow)))) (PP (IN with) (NP (NP (JJ abnormal) (NNS megakaryocytes)) (PP (IN with) (NP (JJ bizarre) (NNS nuclei)))))))) (, ,) (NP (NP (CD one) (NN case)) (PP (IN of) (NP (JJ megakaryocytic) (NNS myelosis)))) (VP (JJ associated) (PP (IN with) (NP (NP (NP (DT a) (NNS Doc_9209318_1171_1190_Disease)) (, ,) (NP (NNS dysmyelopoiesis)) (CC and) (NP (DT a) (NNS Doc_9209318_1214_1233_Disease))) (CC and) (NP (NP (CD two) (NNS cases)) (PP (IN of) (NP (NNS Doc_9209318_1251_1265_Disease)))))) (PP (IN with) (NP (NP (NNS Doc_9209318_1271_1288_Disease)) (, ,) (NP (NNS Doc_9209318_1290_1303_Disease)) (CC and) (NP (DT a) (NNS Doc_9209318_1310_1329_Disease))))) (. .)))
9209318	8	(ROOT (SINV (ADVP (IN Above)) (VP (VBN mentioned) (NP (JJ Doc_9209318_1347_1350_Chemical) (NN incorporation))) (VP (MD may) (VP (VB have) (VP (VBN induced) (NP (NP (DT an) (JJ ineffective) (NNS hemopoiesis)) (PP (IN in) (NP (DT the) (JJ primitive) (JJ hemopoietic) (NN progenitor))))))) (NP (NP (NNS cells)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (VP (VBN known) (S (VP (TO to) (VP (VB be) (VP (VBN seen) (ADVP (RB commonly)) (PP (IN in) (NP (DT the) (NNS Doc_9209318_1498_1522_Disease)))))))))))) (. .)))
921394	0	(ROOT (NP (NP (JJ Biphasic) (NN response)) (PP (IN of) (NP (DT the) (NNP SA) (NN node))) (PP (IN of) (NP (NP (DT the) (NN dog) (NN heart)) (PP (IN in) (NP (NP (NN vivo)) (PP (TO to) (NP (JJ selective) (NN administration))))))) (PP (IN of) (NP (NNS Doc_921394_89_97_Chemical))) (. .)))
921394	1	(ROOT (S (NP (NP (NN Effect)) (PP (IN of) (NP (NP (NNS Doc_921394_109_117_Chemical)) (PP (IN on) (NP (NP (DT the) (NNP SA) (NN node)) (PP (IN of) (NP (DT the) (NN dog) (NN heart)))))))) (VP (VBD was) (VP (VBN studied) (PP (IN in) (NP (NP (NN vivo)) (VP (VBG using) (NP (NP (DT a) (JJ selective) (NN perfusion) (NN technique)) (PP (IN of) (NP (DT the) (NNP SA) (NN node) (NN artery))))))))) (. .)))
921394	2	(ROOT (S (NP (NP (NNS Injections)) (PP (IN of) (NP (NP (NNS Doc_921394_245_253_Chemical)) (PP (IN in) (NP (NP (NNS doses)) (PP (IN from) (NP (NP (CD 100) (NN microgram)) (PP (TO to) (NP (NP (CD 3) (NN mg)) (PP (IN into) (NP (DT the) (NN artery)))))))))))) (VP (VBD produced) (NP (NP (DT a) (NNS Doc_921394_317_327_Disease)) (PP (IN of) (NP (DT the) (NNP SA) (NN nodal) (NN activity)))) (PP (IN by) (NP (DT a) (JJ direct) (NN action)))) (. .)))
921394	3	(ROOT (S (NP (DT This) (NNS Doc_921394_378_388_Disease)) (VP (VBD was) (VP (VBN followed) (PP (IN by) (NP (NP (DT the) (JJ sudden) (NN appearance)) (PP (IN of) (NP (DT a) (JJ stimulatory) (NN phase))))))) (. .)))
921394	4	(ROOT (S (NP (NP (JJ Bilateral) (NN vagotomy) (CC and) (NN sympathectomy)) (CC or) (NP (NP (JJ prior) (NN administration)) (PP (IN of) (NP (DT a) (NN ganglion) (NN blocker))))) (VP (VBD failed) (S (VP (TO to) (VP (VB inhibit) (NP (NP (DT the) (NN occurrence)) (PP (IN of) (NP (DT the) (NN Doc_921394_574_582_Chemical-induced) (NNS Doc_921394_591_602_Disease))))))) (, ,) (SBAR (IN while) (S (NP (PRP it)) (VP (VBD was) (ADVP (RB completely)) (VP (VBN abolished) (PP (PP (IN in) (NP (DT the) (JJ reserpinized) (NNS dogs))) (CC or) (PP (IN by) (NP (NP (DT a) (JJ prior) (NN injection)) (PP (IN of) (NP (DT a) (JJ beta-blocking) (NN agent)))))) (PP (IN into) (NP (DT the) (NNP SA) (NN node) (NN artery)))))))) (. .)))
921394	5	(ROOT (S (NP (DT This)) (VP (MD may) (VP (VB indicate) (SBAR (IN that) (S (NP (NP (DT an) (NN activation)) (PP (IN of) (NP (DT the) (JJ peripheral) (JJ adrenergic) (NN mechanism)))) (VP (VBZ plays) (NP (NP (DT an) (JJ important) (NN role)) (PP (IN in) (NP (NP (DT the) (NN induction)) (PP (IN of) (NP (NP (DT the) (JJ excitatory) (NN effect)) (PP (IN of) (NP (NP (NNS Doc_921394_882_890_Chemical)) (VP (VBN injected) (PP (IN in) (NP (DT the) (NNP SA) (NN node) (NN artery)))))))))))))))) (. .)))
9214597	0	(ROOT (S (PP (IN Over) (NP (NP (NN expression)) (PP (IN of) (NP (NN vascular))))) (NP (NP (JJ endothelial) (NN growth) (NN factor)) (CC and) (NP (NP (PRP$ its) (NN receptor)) (PP (IN during) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (NN Doc_9214597_97_105_Chemical-induced) (NN rat) (NNS Doc_9214597_118_134_Disease))))))) (VP (MD may) (VP (VB mediate) (NP (JJ Doc_9214597_147_155_Chemical-initiated) (JJ Doc_9214597_166_171_Disease) (NNS angiogenesis)))) (. .)))
9214597	1	(ROOT (S (NP (NP (NNP Doc_9214597_186_195_Chemical)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP have) (VP (VBN been) (VP (VBN associated) (PP (IN with) (NP (NP (JJ several) (NNS types)) (PP (IN of) (NP (UCP (NN human) (CC and) (NN animal)) (NNS Doc_9214597_263_270_Disease)))))))))) (, ,)) (VP (MD can) (VP (VB induce) (NP (JJ Doc_9214597_283_288_Disease) (NNS angiogenesis)) (PP (IN in) (NP (NP (DT the) (NN pituitary)) (PP (IN of) (NP (NNP Fischer) (CD 344) (NNS rats))))))) (. .)))
9214597	2	(ROOT (S (NP (NP (DT The) (JJ mechanistic) (NNS details)) (PP (IN of) (NP (JJ Doc_9214597_367_372_Disease) (NNS angiogenesis) (NN induction)))) (, ,) (PP (IN during) (NP (JJ Doc_9214597_404_412_Chemical) (NNS Doc_9214597_413_427_Disease))) (, ,) (VP (VBP are) (ADVP (RB still)) (ADJP (JJ unknown))) (. .)))
9214597	3	(ROOT (S (S (VP (TO To) (VP (VB elucidate) (NP (NP (DT the) (NN role)) (PP (IN of) (NP (NP (NNS Doc_9214597_473_481_Chemical)) (PP (IN in) (NP (NP (DT the) (NN regulation)) (PP (IN of) (NP (JJ Doc_9214597_503_508_Disease) (NNS angiogenesis)))))))) (PP (IN in) (NP (NP (DT the) (NN pituitary)) (PP (IN of) (NP (JJ female) (NNS rats)))))))) (, ,) (NP (NP (DT the) (NN density)) (PP (IN of) (NP (NN blood) (NNS vessels)))) (VP (VBD was) (VP (VBN analysed) (NP (NP (NP (NP (VBG using) (NN factor) (CD VIII) (VBN related) (NN antigen)) (PRN (-LRB- -LRB-) (NP (NNP FVIIIRAg)) (-RRB- -RRB-))) (ADVP (RB immunohistochemistry))) (CC and) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (NP (JJ vascular) (JJ endothelial) (NN growth) (NN factor/vascular)) (SBAR (S (NP (NP (JJ permeability) (NN factor)) (PRN (-LRB- -LRB-) (NP (NNP VEGF/VPF)) (-RRB- -RRB-))) (VP (VBD was) (VP (VBN examined) (PP (IN by) (NP (JJ Western) (NN blot) (CC and) (NN immunohistochemical) (NN analysis))))))))))))) (. .)))
9214597	4	(ROOT (S (NP (NP (NP (DT The) (NN expression)) (PP (IN of) (NP (NNP VEGF) (NN receptor)))) (PRN (-LRB- -LRB-) (NP (NNP VEGFR-2)) (: /) (NP (NP (NNS Flk-1)) (NP (NNP /) (NNP KDR))) (-RRB- -RRB-))) (VP (VBD was) (ADVP (RB also)) (VP (VBN examined) (PP (IN by) (NP (NN immunohistochemistry))))) (. .)))
9214597	5	(ROOT (S (NP (DT The) (NNS results)) (VP (VBD demonstrated) (SBAR (IN that) (S (NP (NP (NNS Doc_9214597_948_964_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP E2)) (-RRB- -RRB-))) (VP (VBZ induces) (NP (NP (NN neovascularization)) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (NP (DT the) (NN growth) (CC and) (NN enlargement)) (PP (IN of) (NP (NN blood) (NNS vessels))))) (PP (IN after) (NP (NP (CD 7) (NNS days)) (PP (IN of) (NP (NN exposure))))))))) (. .)))
9214597	6	(ROOT (S (NP (DT The) (JJ high) (JJ Doc_9214597_1088_1093_Disease) (JJ angiogenic) (NN potential)) (VP (VBD was) (VP (VBN associated) (PP (IN with) (NP (DT an) (JJ elevated) (NNP VEGF/VPF) (NN protein) (NN expression))) (PP (IN in) (NP (NP (DT the) (NN E2)) (VP (VBN exposed) (ADVP (RB pituitary)) (PP (IN of) (NP (JJ ovariectomized) (PRN (-LRB- -LRB-) (NP (NNP OVEX)) (-RRB- -RRB-)) (NNS rats)))))))) (. .)))
9214597	7	(ROOT (S (S (NP (NNP VEGF/VPF) (CC and) (NNP FVIIIRAg)) (VP (VBP immunohistochemistry))) (CC and) (S (NP (NP (JJ endothelial) (JJ specific) (NN lectin)) (PRN (-LRB- -LRB-) (NP (NNP UEA1)) (-RRB- -RRB-)) (NP (JJ binding) (NNS studies)) (, ,)) (VP (VBP indicate) (SBAR (IN that) (S (NP (NP (DT the) (NN elevation)) (PP (IN of) (NP (NNP VEGF) (NN protein) (NN expression)))) (ADVP (RB initially)) (VP (VBD occurred) (PP (IN in) (NP (NP (DT both) (NN blood) (NNS vessels)) (CC and) (NP (JJ non-endothelial) (NNS cells))))))))) (. .)))
9214597	8	(ROOT (S (PP (IN After) (NP (NP (CD 15) (NNS days)) (PP (IN of) (NP (NN E2) (NN exposure))))) (, ,) (NP (NP (JJ VEGF/VPF) (NN protein) (NN expression)) (, ,) (PP (IN in) (NP (DT the) (JJ non-endothelial) (NN cell) (NN population))) (, ,)) (ADVP (RB sharply)) (VP (VP (VBD declined)) (CC and) (VP (VBD was) (VP (VBN restricted) (PP (TO to) (NP (DT the) (NN blood) (NNS vessels)))))) (. .)))
9214597	9	(ROOT (S (NP (NP (DT The) (NN function)) (PP (IN of) (NP (JJ non-endothelial-derived) (NNP VEGF)))) (VP (VBZ is) (RB not) (ADJP (JJ clear))) (. .)))
9214597	10	(ROOT (S (ADVP (RB Furthermore)) (, ,) (NP (JJ immunohistochemical) (NNS studies)) (VP (VBD demonstrated) (SBAR (IN that) (S (NP (NP (NP (NN VEGFR-2)) (PRN (-LRB- -LRB-) (NP (JJ flk-1) (JJ /) (NN KDR)) (-RRB- -RRB-))) (, ,) (NP (NN expression))) (VP (VBD was) (VP (VBN elevated) (ADVP (RB significantly)) (PP (IN in) (NP (NP (DT the) (JJ endothelial) (NNS cells)) (PP (IN of) (NP (JJ microblood) (NNS vessels))))) (PP (IN after) (NP (NP (CD 7) (NNS days)) (PP (IN of) (NP (NN E2) (NN exposure)))))))))) (. .)))
9214597	11	(ROOT (S (S (NP (DT These) (NNS findings)) (VP (VBP suggest) (NP (NP (DT that)) (PP (IN over) (NP (NP (NN expression)) (PP (IN of) (NP (NNP VEGF)))))))) (CC and) (S (NP (NP (PRP$ its) (NN receptor)) (PRN (-LRB- -LRB-) (NP (NNP VEGFR-2)) (-RRB- -RRB-))) (VP (MD may) (VP (VB play) (NP (DT an) (JJ important) (NN role)) (PP (IN in) (NP (NP (DT the) (JJ initial) (NN step)) (PP (IN of) (NP (NP (DT the) (NN regulation)) (PP (IN of) (NP (NP (NNS Doc_9214597_2013_2021_Chemical)) (VP (VBN induced) (NP (JJ Doc_9214597_2030_2035_Disease) (NNS angiogenesis)) (PP (IN in) (NP (DT the) (NN rat) (NN pituitary))))))))))))) (. .)))
9226773	0	(ROOT (NP (NP (JJ Persistent) (NNS Doc_9226773_11_41_Disease)) (PP (VBG following) (NP (JJ Doc_9226773_52_59_Chemical) (NN therapy))) (. .)))
9226773	1	(ROOT (S (NP (PRP We)) (VP (VBP report) (NP (NP (DT the) (NN case)) (PP (IN of) (NP (NP (DT a) (NN patient)) (SBAR (WHNP (WP who)) (S (VP (VBD developed) (NP (NP (JJ severe) (JJ hypernatraemic) (NNS Doc_9226773_137_148_Disease)) (PP (VBG following) (NP (DT a) (NNS Doc_9226773_161_172_Disease))))))))))) (. .)))
9226773	2	(ROOT (S (S (NP (CD Ten) (NNS years) (RB previously)) (NP (PRP he)) (VP (VBD had) (VP (VBN been) (VP (VBN diagnosed) (S (VP (TO to) (VP (VB have) (NP (NN Doc_9226773_225_232_Chemical-induced) (NNS Doc_9226773_241_271_Disease))))))))) (, ,) (CC and) (S (NP (JJ Doc_9226773_277_284_Chemical) (NN therapy)) (VP (VBD had) (VP (VBN been) (VP (VBN discontinued))))) (. .)))
9226773	3	(ROOT (S (S (NP (PRP He)) (VP (VBD remained) (ADJP (JJ thirsty) (CC and) (JJ polyuric)) (PP (IN despite) (NP (NP (NN cessation)) (PP (IN of) (NP (NNS Doc_9226773_370_377_Chemical))))))) (CC and) (S (NP (NP (NNS investigations)) (PP (IN on) (NP (NN admission)))) (VP (VBD showed) (S (NP (PRP him)) (VP (TO to) (VP (VB have) (NP (NP (JJ normal) (JJ osmoregulated) (NN thirst)) (CC and) (NP (JJ Doc_9226773_461_472_Chemical) (NN secretion)))))) (, ,) (PP (IN with) (NP (NP (JJ clear) (NN evidence)) (PP (IN of) (NP (NNS Doc_9226773_507_537_Disease))))))) (. .)))
9226773	4	(ROOT (S (S (NP (NNP Doc_9226773_539_546_Chemical) (NNP induced) (NNS Doc_9226773_555_585_Disease)) (VP (VBZ is) (VP (VBN considered) (S (VP (TO to) (VP (VB be) (ADJP (JJ reversible) (PP (IN on) (NP (NP (NN cessation)) (PP (IN of) (NP (NN therapy)))))))))))) (CC but) (S (NP (NNS Doc_9226773_645_653_Disease)) (VP (VBD persisted) (PP (IN in) (NP (NP (DT this) (NN patient)) (PP (IN for) (NP (CD ten) (NNS years))))) (SBAR (IN after) (S (NP (NNS Doc_9226773_700_707_Chemical)) (VP (VBD was) (VP (VBN stopped))))))) (. .)))
9226773	5	(ROOT (S (NP (PRP We)) (VP (VB discuss) (NP (NP (DT the) (JJ possible) (JJ renal) (NNS mechanisms)) (CC and) (NP (NP (DT the) (NNS implications)) (PP (IN for) (NP (NP (NN management)) (PP (IN of) (NP (NP (NNS patients)) (PP (IN with) (NP (NN Doc_9226773_815_822_Chemical-induced) (NNS Doc_9226773_831_861_Disease)))))))))) (. .)))
9228650	0	(ROOT (NP (NP (NNPS Effects)) (PP (IN of) (NP (NNS Doc_9228650_11_18_Chemical))) (PP (IN on) (NP (ADJP (JJ cholinesterase) (CC and) (JJ Doc_9228650_41_52_Chemical-induced)) (NNS Doc_9228650_61_68_Disease))) (. .)))
9228650	1	(ROOT (S (NP (NP (DT The) (NNS effects)) (PP (IN of) (NP (NP (NNS Doc_9228650_85_92_Chemical)) (PP (IN on) (NP (NP (NN cholinesterase)) (, ,) (NP (NN Doc_9228650_112_123_Chemical-induced) (NNS Doc_9228650_132_139_Disease)) (CC and) (NP (JJ spontaneous) (NN movement))))))) (VP (VBD were) (VP (VBN examined) (CC and) (VBN compared) (PP (IN with) (NP (NP (DT those)) (PP (IN of) (NP (DT the) (JJ well-known) (JJ cholinesterase) (NN inhibitors) (NNS Doc_9228650_247_254_Chemical) (CC and) (NNS Doc_9228650_259_265_Chemical))))))) (. .)))
9228650	2	(ROOT (S (NP (JJ Doc_9228650_267_274_Chemical) (, ,) (NNS Doc_9228650_276_283_Chemical) (CC and) (NNS Doc_9228650_288_294_Chemical)) (ADVP (RB all) (RB strongly)) (VP (VBD inhibited) (NP (NP (NP (NN acetylcholinesterase)) (PRN (-LRB- -LRB-) (NP (NNP AChE)) (-RRB- -RRB-))) (PP (IN in) (NP (NP (JJ human) (JJ red) (NN blood) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NP (NP (NP (NP (NNS IC50s)) (SBAR (S (VP (SYM =) (NP (CD 1.0) (JJ x) (CD 10)))))) (PRN (-LRB- -LRB-) (NP (CD -6)) (-RRB- -RRB-))) (, ,) (NP (NP (CD 2.9) (NNP x) (CD 10)) (PRN (-LRB- -LRB-) (NP (CD -7)) (-RRB- -RRB-))) (CC and) (NP (CD 3.7) (NAC (NAC (NNP x) (CD 10)) (PRN (-LRB- -LRB-) (NP (CD -8)) (-RRB- -RRB-))) (NNS M))) (, ,) (ADVP (RB respectively))) (-RRB- -RRB-)))))) (. .)))
9228650	3	(ROOT (S (PP (IN In) (NP (NN addition))) (, ,) (NP (NP (NNS Doc_9228650_455_462_Chemical) (CC and) (NNS Doc_9228650_467_474_Chemical)) (, ,) (CONJP (CC but) (RB not)) (NP (NNS Doc_9228650_484_490_Chemical)) (, ,)) (ADVP (RB strongly)) (VP (VBD inhibited) (NP (NP (NN butyrylcholinestrase)) (PRN (-LRB- -LRB-) (NP (NNP BuChE)) (-RRB- -RRB-))) (PP (IN in) (NP (JJ human) (NN serum)))) (. .)))
9228650	4	(ROOT (S (NP (DT All) (CD three) (NNS drugs)) (VP (VBD produced) (NP (NP (VBN mixed) (NN inhibition)) (PP (IN of) (NP (NNP AChE) (NN activity))))) (. .)))
9228650	5	(ROOT (S (ADVP (RB Moreover)) (, ,) (NP (NP (DT the) (JJ inhibitory) (NN effect)) (PP (IN of) (NP (NP (NNS Doc_9228650_651_658_Chemical)) (PP (IN on) (NP (NNP AChE)))))) (VP (VBD was) (ADJP (JJ reversible))) (. .)))
9228650	6	(ROOT (S (NP (DT All) (ADJP (JJ compounds) (PP (IN at) (NP (CD 0.1-1)))) (VBG mg/kg) (NN p.o.)) (ADVP (RB significantly)) (VP (VBD improved) (NP (NP (DT the) (NNS Doc_9228650_744_751_Disease)) (VP (VBN induced) (PP (IN by) (NP (NP (NNS Doc_9228650_763_774_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 0.5) (NN mg/kg) (NN s.c.)) (-RRB- -RRB-)))) (PP (IN in) (NP (NP (NNS rats)) (VP (VBG performing) (NP (DT a) (JJ passive) (NN avoidance) (NN task)))))))) (. .)))
9228650	7	(ROOT (S (NP (NP (DT The) (CD three) (NNS compounds)) (PP (IN at) (NP (CD 1) (CC and) (CD 3))) (VP (VBG mg/kg) (NP (NN p.o.)))) (VP (VBD did) (RB not) (ADVP (RB significantly)) (VP (VB decrease) (NP (JJ spontaneous) (NN movement)) (PP (IN by) (NP (NNS rats))))) (. .)))
9228650	8	(ROOT (S (NP (DT These) (NNS findings)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NP (NNS Doc_9228650_968_975_Chemical)) (PP (IN at) (NP (NP (DT a) (JJ low) (NN dose)) (PRN (-LRB- -LRB-) (NP (CD 0.1-1) (NN mg/kg) (NN p.o.)) (-RRB- -RRB-))))) (VP (VP (VBZ improves) (NP (NN Doc_9228650_1018_1029_Chemical-induced) (NNS Doc_9228650_1038_1045_Disease))) (CC but) (VP (VBZ does) (RB not) (VP (VB affect) (NP (JJ spontaneous) (NN movement)))))))) (. .)))
9228650	9	(ROOT (S (NP (DT The) (NNS findings)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NNS Doc_9228650_1114_1121_Chemical)) (VP (MD may) (VP (VB be) (NP (NP (DT a) (JJ useful) (NN drug)) (PP (IN for) (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (NNS Doc_9228650_1164_1183_Disease))))))))))) (. .)))
9270571	0	(ROOT (NP (NP (NP (JJ Potential) (JJ therapeutic) (NN use)) (PP (IN of) (NP (NP (DT the) (JJ selective) (NNP Doc_9270571_43_51_Chemical) (NNP D1) (NN receptor) (NN agonist)) (, ,) (NP (NNS Doc_9270571_73_80_Chemical))))) (: :) (NP (NP (DT an) (JJ acute) (NN study)) (PP (IN in) (NP (JJ Doc_9270571_100_112_Disease) (NN Doc_9270571_113_121_Chemical-primed) (NNS monkeys)))) (. .)))
9270571	1	(ROOT (S (NP (NP (DT The) (JJ clinical) (NN utility)) (PP (IN of) (NP (NP (NNS Doc_9270571_162_170_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP DA)) (-RRB- -RRB-))))) (VP (VBD D1) (SBAR (S (NP (NP (NN receptor) (NNS agonists)) (PP (IN in) (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (NP (NNS Doc_9270571_217_236_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_9270571_238_240_Disease)) (-RRB- -RRB-))))))) (VP (VBZ is) (ADVP (RB still)) (ADJP (JJ unclear)))))) (. .)))
9270571	2	(ROOT (S (NP (NP (DT The) (JJ therapeutic) (NN use)) (PP (IN of) (NP (JJ selective) (NNP DA) (NNP D1) (NN receptor) (NNS agonists))) (PP (JJ such) (IN as) (NP (NP (NNS Doc_9270571_325_334_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_9270571_336_425_Chemical)) (-RRB- -RRB-)) (CC and) (NP (NNS Doc_9270571_431_438_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_9270571_440_535_Chemical)) (-RRB- -RRB-))))) (VP (VBZ seems) (ADJP (JJ limited)) (PP (RB because) (IN of) (NP (NP (PRP$ their) (NN duration)) (PP (IN of) (NP (NP (NN action)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (ADJP (ADJP (RB too) (JJ short) (PP (IN for) (NP (NNS Doc_9270571_611_620_Chemical)))) (PRN (-LRB- -LRB-) (S (VP (VBG <) (NP (CD 1) (NN hr)))) (-RRB- -RRB-)) (CC and) (ADJP (RB too) (JJ long) (PP (IN for) (NP (NNS Doc_9270571_647_654_Chemical)))) (PRN (-LRB- -LRB-) (S (VP (VP (VBG >) (NP (CD 20) (NN hr))) (, ,) (VP (VBG leading) (PP (TO to) (NP (JJ behavioral) (NN tolerance)))))) (-RRB- -RRB-))))))))))) (. .)))
9270571	3	(ROOT (S (NP (PRP We)) (ADVP (RB therefore)) (VP (VBD conducted) (NP (DT the) (ADJP (RB present) (JJ acute)) (JJ dose-response) (NN study)) (PP (IN in) (NP (NP (CD four) (NNS Doc_9270571_768_812_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_9270571_814_818_Chemical)) (-RRB- -RRB-)) (: -) (NP (NP (VBN exposed) (NN cynomolgus) (NNS monkeys)) (VP (VBN primed) (S (VP (TO to) (VP (VB exhibit) (NP (NN Doc_9270571_865_873_Chemical-induced) (NNS Doc_9270571_882_893_Disease)) (S (VP (TO to) (VP (VB evaluate) (NP (DT the) (NN locomotor)))))))))) (CC and) (NP (NP (JJ Doc_9270571_924_934_Disease) (NNS effects)) (PP (IN on) (NP (NP (NP (NN challenge)) (PP (IN with) (NP (CD four) (NNS doses)))) (PRN (-LRB- -LRB-) (PP (IN from) (NP (NP (CD 0.03) (TO to) (CD 1.0)) (VP (VBG mg/kg)))) (-RRB- -RRB-)) (PP (IN of) (NP (NP (NP (NNS Doc_9270571_1000_1007_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_9270571_1009_1114_Chemical)) (-RRB- -RRB-))) (, ,) (NP (NP (DT a) (ADJP (JJ selective) (CC and) (JJ full)) (NNP DA) (NN D1-like) (NN receptor)) (VP (VBN agonist) (PP (IN with) (NP (NP (DT an) (JJ intermediate) (NN duration)) (PP (IN of) (NP (NN action))))))))))))))) (. .)))
9270571	4	(ROOT (S (NP (NP (NNP Doc_9270571_1207_1215_Chemical)) (CC and) (NP (DT the) (NNP DA) (NN D2-like) (NN receptor) (NN agonist))) (, ,) (NP (NP (NNS Doc_9270571_1253_1262_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_9270571_1264_1354_Chemical)) (-RRB- -RRB-))) (VP (VBD were) (ADVP (RB also)) (VP (VBN used) (PP (IN for) (NP (NN comparison))))) (. .)))
9270571	5	(ROOT (S (NP (NP (JJ Acute) (NN administration)) (PP (IN of) (NP (NNS Doc_9270571_1411_1418_Chemical)))) (VP (VP (VBD was) (ADJP (RB as) (JJ efficacious) (PP (IN in) (S (VP (VBG alleviating) (NP (NN Doc_9270571_1453_1457_Chemical-induced) (NNS Doc_9270571_1466_1478_Disease)) (PP (IN as) (NP (NNS Doc_9270571_1482_1490_Chemical) (CC and) (NNS Doc_9270571_1495_1504_Chemical)))))))) (, ,) (CC but) (VP (VBD was) (ADJP (RBR less) (JJ likely) (S (VP (TO to) (VP (VB reproduce) (NP (DT the) (NN Doc_9270571_1543_1551_Chemical-induced) (NNS Doc_9270571_1560_1571_Disease)) (PP (IN in) (NP (DT these) (NNS animals))))))) (PP (IN than) (IN with) (NP (NP (DT either) (JJ Doc_9270571_1606_1615_Chemical) (CC or) (JJ subsequent) (NN challenge)) (PP (IN of) (NP (NNS Doc_9270571_1643_1651_Chemical))))))) (. .)))
9270571	6	(ROOT (S (NP (NP (JJ Selective) (NN stimulation)) (PP (IN of) (NP (DT the) (NNP DA) (NNP D1) (NN receptor)))) (VP (MD may) (VP (VB provide) (NP (NP (NP (JJR better) (NN integration)) (PP (IN of) (NP (JJ neural) (NNS inputs)))) (VP (VBN transmitted) (PP (TO to) (NP (NP (DT the) (JJ internal) (NN segment)) (PP (IN of) (NP (DT the) (JJ globus) (NNS pallidus)))))) (PRN (-LRB- -LRB-) (VP (VBN referred) (S (VP (TO to))) (PP (IN as) (NP (DT the) (JJ basal) (NN ganglia) (NN output)))) (-RRB- -RRB-))) (PP (VBN compared) (PP (IN with) (NP (NP (NNS Doc_9270571_1860_1868_Chemical)) (CC and) (NP (JJ selective) (NNP DA) (NNP D2) (NN receptor) (NN agonist))))))) (. .)))
9270571	7	(ROOT (S (NP (NP (NNP Potent) (NNP DA) (NNP D1)) (RRC (NP (NP (NN receptor) (NNS agents)) (PP (IN with) (NP (NP (DT an) (JJ intermediate) (NN duration)) (PP (IN of) (NP (NN efficacy)))))) (PP (JJ such) (IN as) (NP (NNS Doc_9270571_1986_1993_Chemical)))) (PRN (-LRB- -LRB-) (NP (NP (RB approximately) (CD 4) (NN hr)) (PP (IN at) (NP (JJR higher) (NNS doses))) (VP (VBN tested))) (-RRB- -RRB-))) (VP (VP (VBP are) (NP (NP (JJ potential) (JJ therapeutic) (NNS tools)) (PP (IN in) (NP (NNS Doc_9270571_2073_2075_Disease))))) (CC and) (VP (NN merit) (NP (JJ further) (NN attention)))) (. .)))
9305828	0	(ROOT (NP (NP (JJ Neuropeptide-Y) (NN immunoreactivity)) (PP (IN in) (NP (DT the) (JJ Doc_9305828_39_50_Chemical) (NN model))) (PP (IN of) (NP (NNS Doc_9305828_60_82_Disease))) (. .)))
9305828	1	(ROOT (S (NP (NP (NN Neuropeptide-Y)) (PRN (-LRB- -LRB-) (NP (NNP NPY)) (-RRB- -RRB-))) (VP (VBZ is) (VP (VBN expressed) (PP (IN by) (NP (NP (JJ granule) (NNS cells) (CC and) (NN mossy) (NNS fibres)) (PP (IN of) (NP (DT the) (JJ hippocampal) (JJ dentate) (NNS gyrus))))) (PP (IN during) (NP (NP (JJ experimental) (NNS Doc_9305828_205_227_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_9305828_229_232_Disease)) (-RRB- -RRB-)))))) (. .)))
9305828	2	(ROOT (S (NP (DT This) (NN expression)) (VP (MD may) (VP (VB represent) (NP (NP (DT an) (NNS endogenous)) (VP (VBG damping) (NP (NN mechanism)) (SBAR (IN since) (S (NP (NNP NPY)) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB block) (NP (NP (NN Doc_9305828_331_338_Disease-like) (NNS events)) (PP (VBG following) (NP (NP (JJ high-frequency) (NN stimulation)) (PP (IN in) (NP (JJ hippocampal) (NNS slices)))))))))))))))))) (. .)))
9305828	3	(ROOT (S (NP (NP (DT The) (NNP Doc_9305828_415_426_Chemical) (PRN (-LRB- -LRB-) (NP (NNP Doc_9305828_428_432_Chemical)) (-RRB- -RRB-)) (NN model)) (PP (IN of) (NP (NNS Doc_9305828_443_451_Disease)))) (VP (VBZ is) (VP (VBN characterized) (PP (IN by) (NP (NP (DT an) (JJ acute) (NN period)) (PP (IN of) (NP (NP (NNS Doc_9305828_491_509_Disease)) (VP (VBN followed) (PP (IN by) (NP (NP (JJ spontaneous) (NN recurrent) (NNS Doc_9305828_544_552_Disease)) (CC and) (NP (VBN related) (NNS Doc_9305828_565_577_Disease))))))))))) (. .)))
9305828	4	(ROOT (S (NP (PRP We)) (VP (VBP report) (NP (NP (JJ peroxidase-antiperoxidase) (NN immunostaining)) (PP (IN for) (NP (NNP NPY)))) (PP (IN in) (NP (NP (JJ several) (NN brain) (NNS regions)) (PP (IN in) (NP (DT this) (NN model)))))) (. .)))
9305828	5	(ROOT (S (NP (JJ Doc_9305828_678_682_Chemical-injected) (NNS animals)) (VP (VBD exhibited) (NP (NNP NPY) (NN immunoreactivity)) (PP (IN in) (NP (NP (DT the) (NN region)) (PP (IN of) (NP (DT the) (JJ mossy) (NN fibre) (NNS terminals))))) (, ,) (PP (PP (IN in) (NP (DT the) (ADJP (JJ dentate) (JJ gyrus)) (JJ inner) (JJ molecular) (NN layer))) (CC and) (PRN (, ,) (PP (IN in) (NP (DT a) (JJ few) (NNS cases))) (, ,)) (PP (IN within) (NP (JJ presumed) (NN granule) (NNS cells))))) (. .)))
9305828	6	(ROOT (S (NP (NNP NPY)) (ADVP (RB immunoreactivity)) (VP (VBD was) (ADVP (RB also)) (VP (ADVP (RB dramatically)) (VBN changed) (PP (IN in) (NP (DT the) (JJ entorhinal) (NN cortex) (, ,) (NN amygdala) (CC and) (NN sensorimotor) (NNS areas))))) (. .)))
9305828	7	(ROOT (S (PP (IN In) (NP (NN addition))) (, ,) (NP (NNS Doc_9305828_993_997_Chemical)) (VP (VBD injected) (SBAR (S (NP (NNS animals)) (VP (VBD exhibited) (NP (DT a) (NN reduction)) (PP (IN in) (NP (NP (DT the) (NN number)) (PP (IN of) (NP (JJ NPY-immunoreactive) (NNS interneurons))))) (PP (VBN compared) (PP (IN with) (NP (NNS controls)))))))) (. .)))
9305828	8	(ROOT (S (NP (DT The) (NNS results)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP (NP (NNS changes)) (PP (IN in) (NP (NNP NPY) (NN expression)))) (, ,) (PP (VBG including) (NP (NP (NP (NN expression)) (PP (IN in) (NP (DT the) (NN granule) (NNS cells) (CC and) (NN mossy) (NNS fibres)))) (CC and) (NP (NP (DT the) (NN loss)) (PP (IN of) (NP (JJ vulnerable) (NNP NPY) (NNS neurons)))))) (, ,) (VP (VBP are) (ADJP (JJ present) (PP (IN in) (NP (NP (DT the) (JJ Doc_9305828_1284_1288_Chemical) (NN model)) (PP (IN of) (NP (NNS Doc_9305828_1298_1301_Disease)))))))))) (. .)))
9305828	9	(ROOT (S (ADVP (RB However)) (, ,) (NP (NP (DT the) (NN significance)) (PP (IN of) (NP (NP (DT this) (VBN changed) (NN synthesis)) (PP (IN of) (NP (NNP NPY)))))) (VP (VBZ remains) (S (VP (TO to) (VP (VB be) (VP (VBN determined)))))) (. .)))
9321531	0	(ROOT (S (NP (NNP Posteroventral)) (VP (VBP medial) (ADVP (RB pallidotomy)) (PP (IN in) (NP (JJ advanced) (NNS Doc_9321531_46_65_Disease)))) (. .)))
9321531	1	(ROOT (S (S (NP (JJ Posteroventral) (JJ medial) (NN pallidotomy)) (ADVP (RB sometimes)) (VP (VBZ produces) (NP (JJ striking) (NN improvement)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ advanced) (NNS Doc_9321531_179_198_Disease))))))) (, ,) (CC but) (S (NP (NP (DT the) (NNS studies)) (PP (TO to) (NP (NN date)))) (VP (VBP have) (VP (VBN involved) (NP (NP (JJ small) (NNS numbers)) (PP (IN of) (NP (NP (NNS patients)) (CC and) (NP (JJ short-term) (NN follow-up)))))))) (. .)))
9321531	2	(ROOT (S (NP (NP (JJ Forty) (NNS patients)) (PP (IN with) (NP (NNS Doc_9321531_319_338_Disease)))) (VP (VBD underwent) (NP (JJ serial) (, ,) (JJ detailed) (NNS assessments)) (PP (DT both) (IN after) (NP (NP (NP (NN drug) (NN withdrawal)) (-LRB- -LRB-) (NP (`` ``) (JJ off) ('' '') (NN period)) (-RRB- -RRB-)) (CC and) (NP (NP (NP (NN while)) (VP (VBG taking) (NP (PRP$ their) (JJ optimal) (JJ medical) (NNS regimens)))) (-LRB- -LRB-) (NP (`` ``) (JJ on) ('' '') (NN period)) (-RRB- -RRB-))))) (. .)))
9321531	3	(ROOT (S (S (S (NP (DT All) (NNS patients)) (VP (VBD were) (VP (VBN examined) (ADVP (RB preoperatively))))) (CC and) (S (NP (CD 39)) (VP (VBD were) (VP (VBN examined) (PP (IN at) (NP (CD six) (NNS months))))))) (: ;) (S (NP (NP (CD 27)) (PP (IN of) (NP (DT the) (NNS patients)))) (VP (VBD were) (ADVP (RB also)) (VP (VBN examined) (PP (IN at) (NP (NP (CD one) (NN year)) (, ,) (CC and) (NP (NP (CD 11)) (PP (IN at) (NP (CD two) (NNS years))))))))) (. .)))
9321531	4	(ROOT (S (NP (NP (DT The) (NN percent) (NNS improvements)) (PP (IN at) (NP (CD six) (NNS months)))) (VP (VBD were) (SBAR (IN as) (S (VP (VBZ follows) (: :) (NP (NP (JJ off-period) (NN score)) (PP (IN for) (NP (NP (JJ overall) (NN motor) (NN function)) (, ,) (NP (NP (CD 28) (NN percent)) (PRN (-LRB- -LRB-) (NP (NP (CD 95) (NN percent) (NN confidence) (NN interval)) (, ,) (NP (NP (QP (CD 19) (TO to) (CD 38))) (NP (NN percent)))) (-RRB- -RRB-)) (, ,) (PP (IN with) (NP (NP (JJS most)) (PP (IN of) (NP (NP (NP (DT the) (NN improvement)) (PP (IN in) (NP (DT the) (JJ contralateral) (NNS limbs)))) (: ;) (NP (NP (JJ off-period) (NN score)) (PP (IN for) (NP (NP (NNS activities)) (PP (IN of) (NP (NP (JJ daily) (NN living)) (, ,) (NP (CD 29) (NN percent) (PRN (-LRB- -LRB-) (NP (NP (CD 95) (NN percent) (NN confidence) (NN interval)) (, ,) (NP (NP (QP (CD 19) (TO to) (CD 39))) (NP (NN percent)))) (-RRB- -RRB-)))))))) (: ;) (NP (NP (JJ on-period) (NN score)) (PP (IN for) (NP (NP (JJ contralateral) (NNS Doc_9321531_1009_1020_Disease)) (, ,) (NP (CD 82) (NN percent) (PRN (-LRB- -LRB-) (NP (NP (CD 95) (NN percent) (NN confidence) (NN interval)) (, ,) (NP (NP (CD 72)) (PP (TO to) (NP (CD 91) (NN percent))))) (-RRB- -RRB-)))))) (: ;) (CC and) (NP (NP (JJ on-period) (NN score)) (PP (IN for) (NP (NP (JJ ipsilateral) (NNS Doc_9321531_1121_1132_Disease)) (, ,) (NP (CD 44) (NN percent) (PRN (-LRB- -LRB-) (NP (NP (CD 95) (NN percent) (NN confidence) (NN interval)) (, ,) (NP (NP (QP (CD 29) (TO to) (CD 59))) (NP (NN percent)))) (-RRB- -RRB-)))))))))))))))))) (. .)))
9321531	5	(ROOT (S (NP (NP (DT The) (NNS improvements)) (PP (IN in) (NP (NP (NNS Doc_9321531_1217_1228_Disease)) (CC and) (NP (NP (DT the) (JJ total) (NNS scores)) (PP (IN for) (NP (NP (JJ off-period) (NNS Doc_9321531_1265_1277_Disease)) (, ,) (NP (JJ contralateral) (NNS Doc_9321531_1293_1305_Disease)) (, ,) (CC and) (NP (NNS Doc_9321531_1311_1319_Disease)))))))) (VP (VBD were) (VP (VBN sustained) (PP (IN in) (NP (NP (DT the) (CD 11) (NNS patients)) (VP (VBN examined) (PP (IN at) (NP (CD two) (NNS years)))))))) (. .)))
9321531	6	(ROOT (S (S (NP (NP (DT The) (NN improvement)) (PP (IN in) (NP (JJ ipsilateral) (NNS Doc_9321531_1408_1419_Disease)))) (VP (VBD was) (VP (VBN lost) (PP (IN after) (NP (CD one) (NN year)))))) (, ,) (CC and) (S (NP (NP (DT the) (NNS improvements)) (PP (IN in) (NP (JJ postural) (NN stability) (CC and) (NN gait)))) (VP (VBD lasted) (NP (QP (RB only) (CD three))) (PP (TO to) (NP (CD six) (NNS months))))) (. .)))
9321531	7	(ROOT (S (NP (QP (RB Approximately) (PDT half)) (NP (DT the) (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBD had) (VP (VBN been) (ADJP (JJ dependent) (PP (IN on) (NP (NN assistance)))) (PP (IN in) (NP (NP (NNS activities)) (PP (IN of) (NP (NP (JJ daily) (NN living)) (PP (IN in) (NP (DT the) (JJ off) (NN period))))))) (PP (IN before) (NP (NN surgery)))))))) (VP (VBD became) (ADJP (JJ independent)) (PP (IN after) (NP (NN surgery)))) (. .)))
9321531	8	(ROOT (S (S (NP (NP (DT The) (NNS complications)) (PP (IN of) (NP (NN surgery)))) (VP (VBD were) (ADVP (RB generally)) (ADJP (RB well) (JJ tolerated)))) (, ,) (CC and) (S (NP (EX there)) (VP (VBD were) (NP (NP (DT no) (JJ significant) (NNS changes)) (PP (IN in) (NP (NP (DT the) (NN use)) (PP (IN of) (NP (NN medication)))))))) (. .)))
9321531	9	(ROOT (S (PP (IN In) (NP (JJ late-stage) (NNS Doc_9321531_1847_1866_Disease))) (, ,) (NP (NN pallidotomy)) (ADVP (RB significantly)) (VP (VBZ reduces) (NP (NP (NN Doc_9321531_1902_1910_Chemical-induced) (NNS Doc_9321531_1919_1930_Disease)) (CC and) (NP (JJ off-period) (NN disability)))) (. .)))
9321531	10	(ROOT (S (NP (NP (RB Much)) (PP (IN of) (NP (DT the) (NN benefit)))) (VP (VBZ is) (VP (VBN sustained) (PP (IN at) (NP (CD two) (NNS years))) (, ,) (SBAR (IN although) (S (NP (NP (DT some) (NNS improvements)) (, ,) (PP (JJ such) (IN as) (NP (NP (DT those)) (PP (PP (IN on) (NP (DT the) (JJ ipsilateral) (NN side))) (CC and) (PP (IN in) (NP (JJ axial) (NNS symptoms)))))) (, ,)) (VP (VBP wane) (PP (IN within) (NP (DT the) (JJ first) (NN year)))))))) (. .)))
9321531	11	(ROOT (S (NP (NP (DT The) (JJ on-period) (NNS symptoms)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (ADJP (JJ resistant) (PP (TO to) (NP (JJ dopaminergic) (NN therapy)))))))) (VP (VBP do) (RB not) (VP (VB respond) (PP (TO to) (NP (NN pallidotomy))))) (. .)))
9326871	0	(ROOT (NP (CD Doc_9326871_0_14_Chemical-induced) (NNS Doc_9326871_23_46_Disease) (. .)))
9326871	1	(ROOT (S (NP (NNP Doc_9326871_48_62_Chemical)) (VP (VBZ is) (NP (NP (DT a) (ADJP (RB relatively) (JJ new)) (JJ Doc_9326871_83_92_Chemical) (NN antibiotic)) (SBAR (WHNP (WDT that)) (S (VP (VBZ offers) (NP (JJ twice-daily) (NN dosing))))))) (. .)))
9326871	2	(ROOT (S (NP (PRP It)) (VP (VBZ differs) (PP (IN from) (NP (NNS Doc_9326871_152_164_Chemical))) (PP (RB only) (IN in) (NP (NP (DT the) (NN methylation)) (PP (IN of) (NP (NP (DT the) (JJ Doc_9326871_196_204_Chemical) (NN group)) (PP (IN at) (NP (NN position) (CD 6)))))))) (. .)))
9326871	3	(ROOT (S (SBAR (IN Although) (S (NP (NP (DT the) (JJ side-effect) (NN profile)) (PP (IN of) (NP (NNS Doc_9326871_262_274_Chemical)))) (VP (VBZ is) (VP (VBN established) (, ,) (PP (VBG including) (NP (NP (NNS Doc_9326871_301_316_Disease) (CC and) (NNS interactions)) (PP (IN with) (NP (NP (JJ other) (NNS drugs)) (ADJP (JJ subject) (PP (TO to) (NP (JJ hepatic) (JJ mixed-function) (NN oxidase) (NN metabolism)))))))))))) (, ,) (NP (NP (NN experience)) (PP (IN with) (NP (DT the) (JJR newer) (NNS Doc_9326871_431_441_Chemical)))) (VP (VBZ is) (ADVP (RB still)) (VP (VBG being) (VP (VBN recorded)))) (. .)))
9326871	4	(ROOT (S (NP (NNP Doc_9326871_467_481_Disease)) (VP (VP (VBZ has) (VP (VBN been) (VP (VBN demonstrated) (PP (IN after) (NP (NP (DT both) (JJ intravenous) (CC and) (JJ oral) (NN administration)) (PP (IN of) (NP (NNS Doc_9326871_554_566_Chemical)))))))) (CC but) (VP (VBZ has) (ADVP (RB never)) (VP (VBN been) (VP (VBN reported) (PP (IN with) (NP (DT the) (JJR newer) (NNS Doc_9326871_610_620_Chemical))))))) (. .)))
9326871	5	(ROOT (S (NP (PRP We)) (VP (VBP report) (NP (NP (DT a) (NN case)) (PP (IN of) (NP (NP (NNS Doc_9326871_642_666_Disease)) (SBAR (WHNP (WDT that)) (S (VP (VBD occurred) (PP (IN after) (NP (NP (CD six) (JJ therapeutic) (NNS doses)) (PP (IN of) (NP (NNS Doc_9326871_712_726_Chemical)))))))))))) (. .)))
9326871	6	(ROOT (S (NP (DT The) (NNS Doc_9326871_732_744_Disease)) (VP (VBN resolved) (PP (IN after) (NP (NP (NN discontinuation)) (PP (IN of) (NP (DT the) (NN drug)))))) (. .)))
9431903	0	(ROOT (S (NP (NP (NN Effect)) (PP (IN of) (NP (NP (NNS Doc_9431903_10_29_Chemical)) (PP (IN on) (NP (DT the) (NNS Doc_9431903_37_60_Disease)))))) (VP (VBD evoked) (PP (IN by) (NP (NN Doc_9431903_71_82_Chemical-Doc_9431903_83_91_Chemical) (NN administration)))) (. .)))
9431903	1	(ROOT (S (PP (IN In) (NP (DT this) (NN study))) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (NP (NNS Doc_9431903_147_166_Chemical)) (PP (IN on) (NP (DT the) (NN Doc_9431903_174_185_Chemical-Doc_9431903_186_194_Chemical-induced) (NNS Doc_9431903_203_226_Disease)))))) (VP (VBD was) (VP (VBN evaluated) (PP (IN in) (NP (NP (CD nine) (JJ female) (NNS patients)) (PP (IN with) (NP (NNS Doc_9431903_270_298_Disease))))))) (. .)))
9431903	2	(ROOT (S (NP (NNP Doc_9431903_308_331_Disease)) (VP (VBD was) (VP (VP (VBN induced) (PP (IN by) (NP (NN Doc_9431903_347_358_Chemical-Doc_9431903_359_367_Chemical) (NN administration)))) (PRN (-LRB- -LRB-) (S (NP (CD 0.5)) (VP (VBP mg) (NP (JJ Doc_9431903_391_402_Chemical) (NN intramuscularly) (CC and) (CD 10) (NN mg) (NNS Doc_9431903_429_437_Chemical)) (ADVP (RB subcutaneously)))) (-RRB- -RRB-)) (CC and) (VP (VBN visualized) (PP (IN by) (NP (JJ quantitative) (JJ hepatobiliary) (NN scintigraphy)))))) (. .)))
9431903	3	(ROOT (S (NP (DT The) (JJ entire) (NN procedure)) (VP (VBD was) (VP (VBN repeated) (PP (IN during) (NP (NP (JJ Doc_9431903_554_573_Chemical) (NN infusion)) (PRN (-LRB- -LRB-) (NP (NP (NNP Nitrolingual) (CD 1) (NN microg/kg/min)) (PP (IN for) (NP (CD 120) (NN min)))) (-RRB- -RRB-)))))) (. .)))
9431903	4	(ROOT (S (NP (NNP Doc_9431903_636_647_Chemical-Doc_9431903_648_656_Chemical) (NNP provocation)) (VP (VBD caused) (NP (JJ significant) (NNS increases)) (PP (IN in) (NP (NP (DT the) (NN time)) (PP (PP (TO to) (NP (NP (NP (JJ peak) (NN activity)) (PRN (-LRB- -LRB-) (NP (NNP Tmax)) (-RRB- -RRB-))) (PP (IN over) (NP (NP (DT the) (JJ hepatic) (NN hilum)) (PRN (-LRB- -LRB-) (NP (NP (NNP HH)) (: :) (NP (NP (NP (QP (CD 34.33) (CD +)) (NNS /)) (PRN (: -) (NP (NP (CD 5.05)) (CC vs.) (NP (CD 22.77) (NNS +))) (: /))) (: -) (NP (CD 3.26)))) (-RRB- -RRB-)) (CC and) (NP (DT the) (JJ common) (NN bile) (NN duct)) (PRN (-LRB- -LRB-) (NP (NP (NNP CBD)) (: :) (NP (NP (NP (QP (CD 60.44) (CD +)) (NNS /)) (PRN (: -) (NP (NP (CD 5.99)) (CC vs.) (NP (CD 40.0) (NNS +))) (: /))) (: -) (NP (CD 2.88)))) (-RRB- -RRB-)))))) (CC and) (PP (IN in) (NP (NP (DT the) (NN half-time)) (PP (IN of) (NP (NP (NN excretion)) (PRN (-LRB- -LRB-) (NP (NNP T1/2)) (-RRB- -RRB-))))))))) (PP (IN over) (NP (NP (NP (DT the) (NN liver) (NN parenchyma)) (PRN (-LRB- -LRB-) (NP (NP (NN LP)) (: :) (NP (NP (NP (QP (CD 120.04) (CD +)) (NNS /)) (PRN (: -) (NP (NP (CD 16.01)) (CC vs.) (NP (CD 27.37) (NNS +))) (: /))) (: -) (NP (CD 2.19)))) (-RRB- -RRB-))) (, ,) (NP (NP (NNP HH)) (PRN (-LRB- -LRB-) (NP (CD 117.61) (NNS +)) (: /) (NP (NP (QP (CD -) (CD 14.71))) (PP (IN vs.) (NP (NP (QP (CD 31.85) (CD +)) (NNS /)) (: -) (NP (CD 3.99))))) (-RRB- -RRB-))) (CC and) (NP (NP (NNP CBD)) (PRN (-LRB- -LRB-) (FRAG (FRAG (NP (NP (CD 158.11)) (NP (NNP +) (NNP /))) (: -) (NP (NP (CD 9.18)) (PP (IN vs.) (NP (QP (CD 40.1) (CD +)) (NNS /))))) (: -) (FRAG (RB 6.24))) (-RRB- -RRB-))))) (, ,) (S (VP (VBG indicating) (NP (DT a) (JJ complete) (NNS Doc_9431903_1080_1085_Disease)) (PP (IN at) (NP (NP (DT the) (NN level)) (PP (IN of) (NP (NP (DT the) (NN sphincter)) (PP (IN of) (NP (NNP Oddi)))))))))) (. .)))
9431903	5	(ROOT (S (NP (JJ Doc_9431903_1125_1144_Chemical) (NN infusion)) (ADVP (RB completely)) (VP (VBD normalized) (NP (DT the) (NN Doc_9431903_1180_1191_Chemical-Doc_9431903_1192_1200_Chemical-induced) (NNS alterations)) (PP (IN in) (NP (NP (DT these) (JJ quantitative) (NNS parameters)) (PRN (-LRB- -LRB-) (NP (NP (NNP TmaX)) (PP (IN over) (NP (NP (DT the) (NN LP)) (: :) (NP (CD 11.33) (JJ +) (NNS /)) (: -) (NP (CD 1.13)) (: ;) (NP (IN over) (DT the) (NN HH)) (: :) (NP (CD 18.88) (JJ +) (NNS /)) (: -) (NP (CD 1.48)) (: ;) (NP (NP (QP (CC and) (IN over))) (NP (DT the) (NNP CBD))) (: :) (NP (CD 36.22) (JJ +) (NNS /)) (: -) (NP (CD 1.92)) (: ;) (NP (NP (QP (CC and) (CD T1/2))) (PP (IN over) (NP (DT the) (NN LP)))) (: :) (NP (CD 28.21) (JJ +) (NNS /)) (: -) (NP (CD 1.83)) (: ;) (NP (IN over) (DT the) (NN HH)) (: :) (NP (CD 33.42) (JJ +) (NNS /)) (: -) (NP (CD 3.10)) (: ;) (NP (NP (QP (CC and) (IN over))) (NP (DT the) (NNP CBD))) (: :) (NP (CD 41.66) (JJ +) (NNS /)) (: -) (NP (CD 6.33))))) (-RRB- -RRB-)))) (, ,) (S (VP (VBG suggesting) (NP (NP (DT an) (JJ effective) (JJ sphincter-relaxing) (NN effect)) (PP (IN of) (NP (NNS Doc_9431903_1507_1526_Chemical))))))) (. .)))
9431903	6	(ROOT (S (NP (DT These) (NNS results)) (VP (VBP provide) (NP (NP (DT the) (JJ first) (NN evidence)) (PP (IN of) (NP (NP (DT the) (NN effectiveness)) (PP (IN of) (NP (NP (NNS Doc_9431903_1605_1624_Chemical)) (PP (IN on) (NP (NP (DT the) (NN Doc_9431903_1632_1640_Chemical-induced) (NNS Doc_9431903_1649_1672_Disease)) (PP (IN in) (NP (NNS humans))))))))))) (. .)))
9431903	7	(ROOT (S (SBAR (IN Since) (S (NP (NNS Doc_9431903_1690_1709_Chemical)) (VP (VBZ is) (ADJP (JJ able) (S (VP (TO to) (VP (VB overcome) (NP (NP (RB even) (DT the) (JJ drastic) (NN effect)) (PP (IN of) (NP (NNS Doc_9431903_1757_1765_Chemical))))))))))) (, ,) (NP (PRP it)) (VP (MD might) (VP (VB be) (PP (IN of) (NP (NN relevance))) (PP (IN in) (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (NNS Doc_9431903_1812_1840_Disease))))))) (. .)))
950631	0	(ROOT (NP (NP (NNP Immunopathology)) (PP (IN of) (NP (NN Doc_950631_19_32_Chemical-induced) (NNS Doc_950631_41_59_Disease))) (. .)))
950631	1	(ROOT (S (NP (NP (CD Four) (NNS patients)) (PP (IN with) (NP (NNS Doc_950631_80_100_Disease)))) (VP (VBD developed) (NP (JJ heavy) (NNS Doc_950631_117_128_Disease)) (PP (IN after) (NP (NP (QP (CD five) (TO to) (CD 12)) (NNS months)) (PP (IN of) (NP (NN treatment))))) (PP (IN with) (NP (NNS Doc_950631_171_186_Chemical)))) (. .)))
950631	2	(ROOT (S (NP (NP (JJ Light) (NN microscopy)) (PP (IN of) (NP (JJ renal) (NN biopsy) (NNS samples)))) (VP (VBD showed) (NP (NP (JJ minimal) (ADJP (JJ glomerular) (JJ capillary)) (NN wall) (NN thickening) (CC and) (JJ mesangial) (NN matrix) (NN increase)) (, ,) (CC or) (NP (NP (DT no) (NN departure)) (PP (IN from) (NP (JJ normal)))))) (. .)))
950631	3	(ROOT (S (NP (NNP Electron) (NN microscopy)) (, ,) (ADVP (RB however)) (, ,) (VP (VBD revealed) (NP (NP (JJ subepithelial) (JJ electron-dense) (NNS deposits)) (, ,) (NP (NP (NN fusion)) (PP (IN of) (NP (JJ epithelial) (NN cell) (NN foot) (NNS processes)))) (, ,) (CC and) (NP (NP (NN evidence)) (PP (IN of) (NP (JJ mesangial) (NN cell) (NN hyperactivity)))))) (. .)))
950631	4	(ROOT (S (NP (NNP Immunofluorescence)) (ADVP (RB microscopy)) (VP (VBD demonstrated) (NP (NP (JJ granular) (JJ capillary) (NN wall) (NNS deposits)) (PP (IN of) (NP (NNP IgG) (CC and) (NNP C3))))) (. .)))
950631	5	(ROOT (S (NP (DT The) (NNS findings)) (VP (VBD were) (ADJP (JJ similar) (PP (TO to) (NP (NP (DT those)) (PP (IN in) (NP (NP (JJ early) (NNS Doc_950631_642_671_Disease)) (, ,) (NP (NP (NNS differences)) (VP (VBG being) (VP (VBN observed) (ADVP (RB however)) (PP (IN in) (NP (NP (DT the) (NNS results)) (PP (IN of) (NP (ADJP (JJ staining) (PP (IN for) (NP (DT the) (JJ early-acting) (CD complement) (NNS components)))) (NNS C1q) (CC and) (NN C4)))))))))))))) (. .)))
950631	6	(ROOT (S (NP (PRP It)) (VP (VBZ is) (ADVP (RB tentatively)) (VP (VBN concluded) (SBAR (IN that) (S (NP (NNP complement)) (VP (VBD was) (VP (VBN activated) (PP (IN by) (NP (DT the) (JJ classical) (NN pathway))))))))) (. .)))
9514561	0	(ROOT (S (NP (JJ Experimental) (JJ cranial) (NNS Doc_9514561_21_25_Disease)) (VP (VBD elicited) (PP (IN by) (NP (NP (NNS Doc_9514561_38_47_Chemical)) (: :) (NP (DT a) (NNP PET) (NN study))))) (. .)))
9514561	1	(ROOT (S (S (VP (VBG Using) (NP (DT a) (NN positron) (NN emission)) (ADVP (RB tomography)) (PRN (-LRB- -LRB-) (NP (NNP PET)) (-RRB- -RRB-)))) (VP (VBP study) (SBAR (S (NP (PRP it)) (VP (VBD was) (VP (VBN shown) (ADVP (RB recently)) (SBAR (IN that) (S (PP (IN in) (NP (NP (NNS Doc_9514561_141_149_Disease)) (PP (IN without) (NP (NN aura))))) (NP (NP (JJ certain) (NNS areas)) (PP (IN in) (NP (DT the) (NN brain) (NN stem)))) (VP (VBD were) (VP (VBN activated) (PP (PP (IN during) (NP (DT the) (JJ Doc_9514561_221_229_Disease) (NN state))) (, ,) (CC but) (RB not) (PP (IN in) (NP (DT the) (JJ Doc_9514561_252_260_Disease) (JJ free) (NN interval))))))))))))) (. .)))
9514561	2	(ROOT (S (NP (PRP It)) (VP (VBD was) (VP (VBN suggested) (SBAR (IN that) (S (NP (DT this) (NN brain)) (VP (VBP stem) (SBAR (S (NP (NN activation)) (VP (VP (VBZ is) (ADJP (JJ inherent) (PP (TO to) (NP (DT the) (JJ Doc_9514561_344_352_Disease) (NN attack) (PRP itself))))) (CC and) (VP (VBZ represents)) (ADVP (DT the) (RB so)) (VP (VBD called) (`` `) (NP (JJ Doc_9514561_397_405_Disease) (NN generator)) ('' ')))))))))) (. .)))
9514561	3	(ROOT (S (S (VP (TO To) (VP (VB test) (NP (DT this) (NNS hypothesis))))) (NP (PRP we)) (VP (VBD performed) (NP (DT an) (JJ experimental) (JJ Doc_9514561_471_475_Disease) (NN study)) (PP (IN in) (NP (CD seven) (JJ healthy) (NNS volunteers))) (, ,) (S (VP (VBG using) (NP (NP (DT the) (JJ same) (NN positioning)) (PP (IN in) (NP (DT the) (NNP PET) (NN scanner)))) (PP (IN as) (PP (IN in) (NP (DT the) (JJ Doc_9514561_567_575_Disease) (NNS patients))))))) (. .)))
9514561	4	(ROOT (S (NP (NP (DT A) (JJ small) (NN amount)) (PP (IN of) (NP (NNS Doc_9514561_604_613_Chemical)))) (VP (VBD was) (VP (VBN administered) (ADVP (RB subcutaneously)) (PP (IN in) (NP (DT the) (JJ right) (NN forehead))) (S (VP (TO to) (VP (VB evoke) (NP (NP (DT a) (VBG burning) (JJ Doc_9514561_687_694_Disease) (NN sensation)) (PP (IN in) (NP (NP (DT the) (JJ first) (NN division)) (PP (IN of) (NP (DT the) (JJ trigeminal) (NN nerve))))))))))) (. .)))
9514561	5	(ROOT (S (NP (NP (NNS Increases)) (PP (IN of) (NP (NP (JJ regional) (JJ cerebral) (NN blood) (NN flow)) (PRN (-LRB- -LRB-) (NP (NN rCBF)) (-RRB- -RRB-))))) (VP (VBD were) (VP (VBN found) (ADVP (RB bilaterally)) (PP (IN in) (NP (DT the) (NN insula))) (, ,) (PP (IN in) (NP (NP (DT the) (NN anterior) (NN cingulate) (NN cortex)) (, ,) (NP (DT the) (JJ cavernous) (NNS sinus)) (CC and) (NP (DT the) (NN cerebellum)))))) (. .)))
9514561	6	(ROOT (S (S (VP (VBG Using) (NP (DT the) (JJ same) (JJ stereotactic) (NN space)))) (VP (VBZ limits) (SBAR (IN as) (S (PP (IN in) (NP (DT the) (JJ above) (JJ mentioned) (NNS Doc_9514561_980_988_Disease) (NN study))) (NP (DT no) (NN brain)) (VP (VBP stem) (SBAR (S (NP (NN activation)) (VP (VBD was) (VP (VBN found) (PP (IN in) (NP (DT the) (JJ acute) (JJ Doc_9514561_1043_1047_Disease) (NN state))) (PP (VBN compared) (PP (TO to) (NP (DT the) (JJ Doc_9514561_1070_1074_Disease) (JJ free) (NN state)))))))))))) (. .)))
9514561	7	(ROOT (S (NP (NP (DT The) (NN increase)) (PP (IN of) (NP (NP (NN activation)) (PP (IN in) (NP (NP (DT the) (NN region)) (PP (IN of) (NP (DT the) (JJ cavernous) (NNS sinus)))))))) (ADVP (RB however)) (, ,) (VP (VBZ suggests) (SBAR (IN that) (S (NP (DT this) (NN structure)) (VP (VBZ is) (ADJP (ADJP (RBR more) (JJ likely) (S (VP (TO to) (VP (VB be) (VP (VBN involved) (PP (IN in) (NP (JJ trigeminal) (JJ transmitted) (NNS Doc_9514561_1245_1249_Disease)))))))) (PP (PP (IN as) (NP (JJ such))) (, ,) (CONJP (RB rather) (IN than)) (PP (IN in) (NP (NP (DT a) (JJ specific) (NN type)) (PP (IN of) (NP (NNS Doc_9514561_1293_1301_Disease)))))) (SBAR (IN as) (S (VP (VBD was) (VP (VBN suggested) (PP (IN for) (NP (NNS Doc_9514561_1323_1339_Disease)))))))))))) (. .)))
9523850	0	(ROOT (S (NP (NP (NNP Value)) (PP (IN of) (NP (NP (NNS Doc_9523850_9_27_Chemical)) (PP (IN in) (NP (NP (NN prevention)) (PP (IN of) (NP (DT the) (NN Doc_9523850_49_59_Disease-Doc_9523850_60_67_Disease) (NN syndrome)))))))) (VP (VBN associated) (PP (IN with) (NP (NP (DT the) (JJ total) (NN dose) (NN infusion)) (PP (IN of) (NP (NP (NNS Doc_9523850_120_132_Chemical)) (: :) (NP (DT a) (JJ double) (ADJP (JJ blind) (JJ randomized)) (NN trial))))))) (. .)))
9523850	1	(ROOT (S (NP (NP (DT The) (NN safety) (CC and) (NN efficacy)) (PP (IN of) (NP (NP (NP (JJ total) (NN dose) (NN infusion)) (PRN (-LRB- -LRB-) (NP (NNP TDI)) (-RRB- -RRB-))) (PP (IN of) (NP (NNS Doc_9523850_223_235_Chemical)))))) (VP (VBZ has) (VP (VBN been) (ADJP (RB well) (VBN documented)))) (. .)))
9523850	2	(ROOT (S (PP (IN In) (NP (NP (CD 40) (NN %)) (PP (IN of) (NP (JJ treated) (NNS patients))))) (, ,) (NP (DT an) (NN Doc_9523850_293_303_Disease-Doc_9523850_304_311_Disease) (NN syndrome)) (VP (VBZ develops)) (. .)))
9523850	3	(ROOT (S (NP (NP (DT The) (NN purpose)) (PP (IN of) (NP (DT this) (JJ randomized) (, ,) (JJ double-blind) (, ,) (JJ prospective) (NN study)))) (VP (VBD was) (S (VP (TO to) (VP (VB investigate) (SBAR (IN whether) (S (NP (NP (JJ intravenous) (PRN (-LRB- -LRB-) (NP (NNP i.v.)) (-RRB- -RRB-)) (NN administration)) (PP (IN of) (NP (NP (NNS Doc_9523850_459_477_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_9523850_479_481_Chemical)) (-RRB- -RRB-))))) (VP (VBZ prevents) (NP (DT this) (NN complication))))))))) (. .)))
9523850	4	(ROOT (S (NP (NP (NP (JJ Sixty-five) (NNS patients)) (, ,) (NP (CD 34) (NNS women)) (CC and) (NP (CD 31) (NNS men))) (, ,) (NP (NP (NNS ages)) (NP (QP (CD 36) (TO to) (CD 80)) (NNS years))) (, ,)) (VP (VP (VBD received) (NP (DT either) (JJ normal) (NN saline)) (PP (IN before) (CC and) (IN after) (NP (NP (NP (NNP TDI)) (PRN (-LRB- -LRB-) (NP (NN group) (CD 1)) (-RRB- -RRB-))) (, ,) (NP (QP (CD 125) (CD mg)) (NNP i.v.) (NNP MP)) (ADVP (IN before))))) (CC and) (VP (VBD saline) (PP (IN after) (NP (NP (NP (NNP TDI)) (PRN (-LRB- -LRB-) (NP (NN group) (CD 2)) (-RRB- -RRB-))) (, ,) (CC or) (NP (NP (CD 125) (NN mg)) (NP (NNP i.v.) (NNP MP))))) (PP (IN before) (CC and) (IN after) (NP (NNP TDI))) (PRN (-LRB- -LRB-) (NP (NN group) (CD 3)) (-RRB- -RRB-)))) (. .)))
9523850	5	(ROOT (S (S (NP (NNS Patients)) (VP (VBD were) (VP (VBN observed) (PP (IN for) (NP (CD 72) (NNS hours)))))) (CC and) (S (NP (NNS reactions)) (VP (VBD were) (VP (VBN recorded) (CC and) (VBN graded) (PP (VBG according) (PP (TO to) (NP (NN severity))))))) (. .)))
9523850	6	(ROOT (S (NP (NP (JJ Fifty-eight) (NN percent)) (PP (IN of) (NP (NP (NP (NN group)) (NP (CD 1) (NNS patients))) (, ,) (NP (NP (CD 33) (NN %)) (PP (IN of) (NP (NN group) (CD 2)))) (, ,) (CC and) (NP (NP (CD 26) (NN %)) (PP (IN of) (NP (NN group) (CD 3))))))) (VP (VBD had) (NP (NP (NNS reactions)) (PP (TO to) (NP (NNP TDI))))) (. .)))
9523850	7	(ROOT (S (NP (NP (DT The) (NN severity)) (PP (IN of) (NP (NP (NNS reactions)) (PRN (-LRB- -LRB-) (NP (NP (JJ minimal)) (, ,) (NP (JJ mild)) (, ,) (CC and) (NP (NP (JJ moderate)) (, ,) (ADVP (RB respectively)))) (-RRB- -RRB-))))) (VP (VBD was) (PP (IN as) (NP (NP (NNP follows)) (: :) (NP (NN group) (CD 1)) (: --) (NP (CD 6) (, ,) (CD 6) (, ,) (CC and) (CD 2)) (: ;) (NP (NN group) (CD 2)) (: --) (NP (CD 1) (, ,) (CD 5) (, ,) (CC and) (CD 0)) (: ;) (NP (NN group) (CD 3)) (: --) (NP (CD 5) (, ,) (CD 1) (, ,) (CC and) (CD 0))))) (. .)))
9523850	8	(ROOT (S (NP (NNP Data)) (VP (VBD were) (VP (VBN analyzed) (PP (IN by) (NP (NP (DT the) (JJ two-sided) (NNP Fisher) (POS 's)) (JJ exact) (NN test))) (S (VP (VBG using) (NP (ADJP (CD 95) (NN %)) (NN confidence) (NNS intervals)) (PP (IN with) (NP (NP (DT the) (NN approximation)) (PP (IN of) (NP (NNP Woolf))))))))) (. .)))
9523850	9	(ROOT (S (NP (DT These) (NNS data)) (VP (VBP demonstrate) (NP (NP (DT that) (NN administration)) (PP (IN of) (NP (NNP MP)))) (SBAR (IN before) (CC and) (RB after) (S (NP (NNP TDI)) (VP (VBZ reduces) (NP (NP (DT the) (NN frequency) (CC and) (NN severity)) (PP (IN of) (NP (DT the) (NN Doc_9523850_1320_1330_Disease-Doc_9523850_1331_1338_Disease) (NN syndrome)))))))) (. .)))
9523850	10	(ROOT (S (NP (PRP We)) (VP (VBP conclude) (SBAR (IN that) (S (NP (CD 125) (NN mg) (NN i.v.) (NNS MP)) (VP (MD should) (VP (VB be) (VP (VBN given) (ADVP (RB routinely)) (PP (IN before) (CC and) (IN after) (NP (NP (NNP TDI)) (PP (IN of) (NP (NNS Doc_9523850_1431_1443_Chemical))))))))))) (. .)))
9545159	0	(ROOT (S (NP (NNP Doc_9545159_0_31_Disease)) (VP (VBN related) (PP (TO to) (NP (NN Doc_9545159_43_52_Chemical-Doc_9545159_53_62_Chemical) (NN interaction)))) (. .)))
9545159	1	(ROOT (S (NP (NP (NNP Doc_9545159_76_85_Chemical)) (, ,) (NP (DT a) (JJ cytochrome) (ADJP (ADJP (QP (CD P450) (CD 3A4))) (PRN (-LRB- -LRB-) (NP (NNP CYP3A4)) (-RRB- -RRB-))) (NN substrate)) (, ,)) (VP (VBZ is) (ADVP (RB widely)) (VP (VBN prescribed) (PP (IN for) (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (NNS Doc_9545159_171_206_Disease))))))) (. .)))
9545159	2	(ROOT (S (NP (NNP Doc_9545159_208_235_Disease) (, ,) (NNP Doc_9545159_237_256_Disease) (, ,) (CC and) (NNP Doc_9545159_262_282_Disease)) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (PP (IN after) (NP (JJ concomitant) (NN administration))) (PP (PP (IN with) (NP (NP (NNS Doc_9545159_340_352_Chemical)) (CC or) (NP (JJ Doc_9545159_356_361_Chemical) (JJ antifungal) (NNS agents)))) (, ,) (CC but) (RB not) (PP (IN with) (NP (JJ other) (NN CYP3A4) (NNS inhibitors))))))) (. .)))
9545159	3	(ROOT (S (NP (DT A) (JJ possible) (NN drug) (NN interaction)) (VP (VBD occurred) (PP (IN in) (NP (NP (DT a) (JJ 45-year-old) (NN woman)) (SBAR (WHNP (WP who)) (S (VP (VBD was) (VP (VBG taking) (NP (NNS Doc_9545159_494_503_Chemical)) (PP (IN for) (NP (NP (NNS Doc_9545159_508_540_Disease) (CC and) (NNS Doc_9545159_545_554_Chemical)) (, ,) (NP (NP (DT an) (NN agent)) (SBAR (WHNP (WDT that)) (S (VP (VBZ has) (NP (NP (JJ inhibitory) (NN effect)) (PP (IN on) (NP (NNP CYP3A4)))))))))))))))) (, ,) (PP (IN for) (NP (NNS Doc_9545159_607_619_Disease)))) (. .)))
9545159	4	(ROOT (S (NP (DT The) (NN patient)) (VP (VP (VBD was) (PP (IN in) (NP (JJ near) (NNS Doc_9545159_645_652_Disease)))) (CC and) (VP (VBD had) (NP (NNS Doc_9545159_661_685_Disease)))) (. .)))
9545159	5	(ROOT (S (PP (IN After) (S (VP (VBG discontinuing) (NP (NNS Doc_9545159_707_716_Chemical))))) (, ,) (S (NP (DT the) (NNP QT) (NN interval)) (VP (VBD returned) (PP (TO to) (ADJP (JJ normal))))) (CC and) (S (NP (NNS symptoms)) (VP (VBD did) (RB not) (VP (VB recur)))) (. .)))
9545159	6	(ROOT (S (NP (PRP We)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NN caution)) (VP (VB be) (VP (VBN taken) (SBAR (WHADVP (WRB when)) (S (NP (NNS Doc_9545159_819_828_Chemical)) (VP (VBZ is) (VP (VBN prescribed) (PP (IN with) (NP (NP (DT any) (JJ potent) (NN inhibitor)) (PP (IN of) (NP (NNP CYP3A4))) (, ,) (PP (VBG including) (NP (NNS Doc_9545159_890_899_Chemical)))))))))))))) (. .)))
9549528	0	(ROOT (NP (NP (JJ Cortical) (NN motor) (NN overactivation)) (PP (IN in) (NP (JJ Doc_9549528_33_45_Disease) (NNS patients))) (PP (IN with) (NP (JJ Doc_9549528_60_66_Chemical-induced) (JJ peak-dose) (NNS Doc_9549528_85_95_Disease))) (. .)))
9549528	1	(ROOT (S (NP (PRP We)) (VP (VBP have) (VP (VBN studied) (NP (NP (DT the) (JJ regional) (JJ cerebral) (NN blood) (NN flow) (PRN (-LRB- -LRB-) (NP (NN rCBF)) (-RRB- -RRB-)) (NNS changes)) (VP (VBN induced) (PP (IN by) (NP (NP (DT the) (NN execution)) (PP (IN of) (NP (NP (DT a) (JJ finger-to-thumb) (NN opposition) (NN motor) (NN task)) (PP (IN in) (NP (NP (DT the) (NN supplementary) (CC and) (JJ primary) (NN motor) (NN cortex)) (PP (IN of) (NP (NP (CD two) (NNS groups)) (PP (IN of) (NP (JJ Doc_9549528_292_304_Disease) (NNS patients))))))))))) (PP (IN on) (NP (JJ Doc_9549528_317_323_Chemical) (NN medication)))) (, ,) (NP (NP (DT the) (JJ first) (NN one)) (PP (IN without) (NP (NP (JJ Doc_9549528_358_364_Chemical) (JJ induced) (NNS Doc_9549528_373_383_Disease)) (PRN (-LRB- -LRB-) (VP (VBN n) (S (VP (SYM =) (NP (CD 23))))) (-RRB- -RRB-))))) (CC and) (NP (DT the) (ADJP (JJ other) (PP (PP (IN with) (NP (NP (JJ moderate) (JJ peak-dose) (NNS Doc_9549528_431_441_Disease)) (PRN (-LRB- -LRB-) (VP (VBN n) (S (VP (SYM =) (NP (CD 15))))) (-RRB- -RRB-)))) (, ,) (CC and) (PP (IN of) (NP (NP (DT a) (NN group)) (PP (IN of) (NP (CD 14))))))) (JJ normal) (NNS subjects))))) (. .)))
9549528	2	(ROOT (S (NP (NP (JJ Single) (NN photon) (NN emission) (NN tomography)) (PP (IN with) (NP (NN i.v.) (NNS 133Xe)))) (VP (VBD was) (VP (VBN used) (S (VP (TO to) (VP (VB measure) (NP (DT the) (NN rCBF) (NNS changes))))))) (. .)))
9549528	3	(ROOT (S (NP (DT The) (JJ Doc_9549528_582_592_Disease) (JJ Doc_9549528_593_605_Disease) (NNS patients)) (VP (VBD exhibited) (NP (NP (DT a) (NN pattern)) (PP (IN of) (NP (NN response))) (SBAR (WHNP (WDT which)) (S (VP (VBD was) (ADJP (RB markedly) (JJ different) (PP (IN from) (NP (NP (DT those)) (PP (IN of) (NP (NP (DT the) (JJ normal) (NNS subjects)) (CC and) (NP (JJ non-Doc_9549528_718_728_Disease) (JJ Doc_9549528_729_741_Disease) (NNS patients))))))) (, ,) (PP (IN with) (NP (NP (NP (DT a) (JJ significant) (NN overactivation)) (PP (IN in) (NP (DT the) (JJ supplementary) (NN motor) (NN area)))) (CC and) (NP (DT the) (ADJP (JJ ipsi) (: -) (CC and) (JJ contralateral)) (JJ primary) (NN motor) (NNS areas))))))))) (. .)))
9549528	4	(ROOT (S (NP (DT These) (NNS results)) (VP (VBP are) (ADJP (JJ compatible) (PP (IN with) (NP (DT the) (NNS hypothesis)))) (SBAR (IN that) (S (NP (DT an) (JJ Doc_9549528_928_940_Disease) (NNS Doc_9549528_941_970_Disease)) (, ,) (PP (IN like) (NP (NN Doc_9549528_977_983_Chemical-induced) (NN peak) (NN dose) (NNS Doc_9549528_1002_1012_Disease))) (, ,) (VP (VBZ is) (ADJP (JJ due) (PP (TO to) (NP (NP (DT a) (NN disinhibition)) (PP (IN of) (NP (NP (DT the) (JJ primary) (CC and) (JJ associated) (NN motor) (NN cortex)) (ADJP (JJ secondary) (PP (TO to) (NP (NP (DT an) (JJ excessive) (NN outflow)) (PP (IN of) (NP (DT the) (JJ pallidothalamocortical) (NN motor) (NN loop))))))))))))))) (. .)))
9564988	0	(ROOT (NP (NP (JJ Open-label) (NN assessment)) (PP (IN of) (NP (NP (NNS Doc_9564988_25_37_Chemical)) (PP (IN for) (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (JJ acute) (JJ bacterial) (NNS Doc_9564988_75_84_Disease))))))) (PP (IN in) (NP (NNS adults))) (. .)))
9564988	1	(ROOT (S (VP (TO To) (VP (VB evaluate) (NP (NP (DT the) (NN efficacy) (CC and) (NN safety)) (PP (IN of) (NP (NP (NNS Doc_9564988_144_156_Chemical)) (PRN (-LRB- -LRB-) (NP (NP (NP (CD 500) (NN mg) (NN orally)) (ADVP (RB once) (JJ daily))) (PP (IN for) (NP (QP (CD 10) (TO to) (CD 14)) (NNS days)))) (-RRB- -RRB-))))) (PP (IN in) (S (VP (VBG treating) (NP (JJ adult) (NNS outpatients)) (PP (IN with) (NP (JJ acute) (JJ bacterial) (NNS Doc_9564988_253_262_Disease)))))))) (. .)))
9564988	2	(ROOT (FRAG (NP (NNS PATIENTS) (CC AND) (NNS METHODS)) (: :) (S (NP (NP (DT A) (NN total)) (PP (IN of) (NP (CD 329) (NNS patients)))) (VP (VBD enrolled) (PP (IN in) (NP (DT the) (NN study))) (PP (IN at) (NP (CD 24) (NNS centers))))) (. .)))
9564988	3	(ROOT (S (NP (DT All) (NNS patients)) (VP (VBD had) (NP (DT a) (JJ pre-therapy) (NP (NNP Gram) (POS 's)) (NN stain) (CC and) (NN culture)) (PP (IN of) (NP (NNS sinus))) (ADVP (RB exudate)) (VP (VBN obtained) (PP (IN by) (NP (JJ antral) (NN puncture) (CC or) (NN nasal) (NN endoscopy))))) (. .)))
9564988	4	(ROOT (S (NP (JJ Clinical) (NN response)) (VP (VP (VBD was) (VP (VBN assessed) (PP (IN on) (NP (NP (DT the) (NN basis)) (PP (IN of) (NP (NNS signs) (CC and) (NNS symptoms))))))) (CC and) (VP (VBZ sinus) (NP (ADJP (JJ radiograph) (CC or) (JJ computed)) (JJ tomography) (NNS results)))) (. .)))
9564988	5	(ROOT (S (NP (JJ Microbiologic) (NN cure) (NNS rates)) (VP (VBD were) (VP (VBN determined) (PP (IN on) (NP (NP (DT the) (NN basis)) (PP (IN of) (NP (NP (VBN presumed) (NN plus) (VBN documented) (NN eradication)) (PP (IN of) (NP (NP (DT the) (JJ pre-therapy) (NN pathogen)) (PRN (-LRB- -LRB-) (PRP s) (-RRB- -RRB-)))))))))) (. .)))
9564988	6	(ROOT (S (NP (DT The) (RBS most) (JJ common) (NNS pathogens)) (VP (VBD were) (NP (NP (NNP Haemophilus) (NNP influenzae)) (, ,) (NP (NNP Streptococcus) (NNP pneumoniae)) (, ,) (NP (NNP Staphylococcus) (NNP aureus)) (, ,) (CC and) (NP (NNP Moraxella) (NNS catarrhalis)))) (. .)))
9564988	7	(ROOT (S (PP (IN Of) (NP (CD 300) (ADJP (RB clinically) (JJ evaluable)) (NNS patients))) (, ,) (S (NP (NP (CD 175)) (PRN (-LRB- -LRB-) (NP (CD 58) (NN %)) (-RRB- -RRB-))) (VP (VBD were) (VP (VBN cured)))) (CC and) (S (NP (NP (CD 90)) (PRN (-LRB- -LRB-) (NP (CD 30) (NN %)) (-RRB- -RRB-))) (VP (VBD were) (VP (VBN improved) (PP (IN at) (NP (DT the) (JJ post-therapy) (NN evaluation))) (, ,) (S (VP (VBG resulting) (PP (IN in) (NP (NP (DT a) (JJ clinical) (NN success) (NN rate)) (PP (IN of) (NP (CD 88) (NN %)))))))))) (. .)))
9564988	8	(ROOT (S (NP (NP (JJ Thirty-five) (NNS patients)) (PRN (-LRB- -LRB-) (NP (CD 12) (NN %)) (-RRB- -RRB-))) (VP (VBZ clinically) (NP (VBN failed) (NN treatment))) (. .)))
9564988	9	(ROOT (S (NP (NP (NP (DT The) (JJ microbiologic) (NN eradication) (NN rate)) (PRN (-LRB- -LRB-) (NP (NNP presumed) (CC plus) (NNP documented)) (-RRB- -RRB-))) (PP (IN among) (NP (CD 138) (JJ microbiologically) (NN evaluable) (NNS patients)))) (VP (VBD was) (NP (CD 92) (NN %))) (. .)))
9564988	10	(ROOT (S (NP (NP (NP (JJ Microbiologic) (NN eradication) (NNS rates)) (PRN (-LRB- -LRB-) (NP (NNP presumed) (CC plus) (NNP documented)) (-RRB- -RRB-))) (PP (IN of) (NP (DT the) (JJS most) (JJ common) (NNS pathogens)))) (VP (VBD ranged) (PP (IN from) (NP (NP (CD 93) (NN %)) (PRN (-LRB- -LRB-) (NP (NNP M.) (NNS catarrhalis)) (-RRB- -RRB-)))) (PP (TO to) (NP (NP (CD 100) (NN %)) (PRN (-LRB- -LRB-) (NP (NNP S.) (NN pneumoniae)) (-RRB- -RRB-)))) (PP (IN at) (NP (DT the) (JJ post-therapy) (NN visit)))) (. .)))
9564988	11	(ROOT (S (S (NP (NP (QP (DT All) (CC but) (CD one))) (PP (IN of) (NP (NP (DT the) (CD 265) (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBD were) (VP (VBN cured) (CC or) (VBN improved) (PP (IN at) (NP (NN post-therapy)))))))))) (VP (VBD returned) (PP (IN for) (NP (DT a) (JJ long-term) (NN follow-up) (NN visit))))) (: ;) (S (NP (NP (NNP 243)) (PRN (-LRB- -LRB-) (NP (CD 92) (NN %)) (-RRB- -RRB-))) (VP (VBD remained) (ADVP (RB well) (NP (QP (CD 4) (TO to) (CD 6)) (NNS weeks))) (PP (IN after) (NP (NN therapy))))) (: ;) (CC and) (S (NP (NP (CD 21)) (PRN (-LRB- -LRB-) (NP (CD 8) (NN %)) (-RRB- -RRB-))) (VP (VBD had) (NP (NP (DT a) (NN relapse)) (PP (IN of) (NP (NNS symptoms)))))) (. .)))
9564988	12	(ROOT (S (NP (NP (JJ Adverse) (NNS events)) (VP (VBN considered) (S (VP (TO to) (VP (VB be) (VP (VBN related) (PP (TO to) (NP (JJ Doc_9564988_1613_1625_Chemical) (NN administration))))))))) (VP (VBD were) (VP (VBN reported) (PP (IN by) (NP (NP (CD 29) (NNS patients)) (PRN (-LRB- -LRB-) (NP (CD 9) (NN %)) (-RRB- -RRB-)))))) (. .)))
9564988	13	(ROOT (S (S (NP (DT The) (ADJP (RBS most) (JJ common) (JJ drug-related)) (JJ adverse) (NNS events)) (VP (VBD were) (NP (NP (NNS Doc_9564988_1725_1733_Disease)) (, ,) (NP (NNS Doc_9564988_1735_1745_Disease)) (, ,) (CC and) (NP (NNS Doc_9564988_1751_1757_Disease))))) (: ;) (S (NP (RBS most) (JJ adverse) (NNS events)) (VP (VBD were) (ADJP (JJ mild) (S (VP (TO to) (VP (VB moderate) (PP (IN in) (NP (NN severity))))))))) (. .)))
9564988	14	(ROOT (S (NP (NP (DT The) (NNS results)) (PP (IN of) (NP (DT this) (NN study)))) (VP (VBP indicate) (SBAR (IN that) (S (NP (JJ Doc_9564988_1866_1878_Chemical) (CD 500) (NN mg)) (ADVP (RB once) (RB daily)) (VP (VBZ is) (NP (NP (DT an) (ADJP (JJ effective) (CC and) (JJ safe)) (NN treatment)) (PP (IN for) (NP (JJ acute) (JJ bacterial) (NNS Doc_9564988_1952_1961_Disease)))))))) (. .)))
9579567	0	(ROOT (NP (NP (JJ Iatrogenic) (NNS risks)) (PP (IN of) (NP (NP (NNS Doc_9579567_20_41_Disease)) (PP (IN after) (NP (NN treatment))))) (PP (IN for) (NP (NP (NNS Doc_9579567_62_75_Disease)) (PP (IN in) (NP (DT a) (JJ large) (JJ French) (JJ case-control) (NN study))))) (. .)))
9579567	1	(ROOT (NP (NP (NNP F) (NNP d) (NN ration) (NNP Nationale) (FW des) (NNP Centres) (NNP de) (NNP Lutte) (NNP Contre) (FW le) (NNP Cancer)) (PRN (-LRB- -LRB-) (NP (NNP FNCLCC)) (-RRB- -RRB-)) (. .)))
9579567	2	(ROOT (S (SBAR (IN Since) (S (NP (NNS Doc_9579567_191_200_Chemical)) (VP (VP (VBZ is) (ADVP (RB widely)) (VP (VBN used) (PP (IN in) (NP (JJ Doc_9579567_219_232_Disease) (NN treatment))))) (CC and) (VP (VBZ has) (VP (VBN been) (VP (VBN proposed) (PP (IN for) (NP (NP (DT the) (NN prevention)) (PP (IN of) (NP (NNS Doc_9579567_287_300_Disease))))))))))) (, ,) (NP (PRP$ its) (JJ endometrial) (JJ iatrogenic) (NNS effects)) (VP (MD must) (VP (VB be) (VP (ADVP (RB carefully)) (VBN examined)))) (. .)))
9579567	3	(ROOT (S (NP (PRP We)) (VP (VBP have) (VP (VBN investigated) (NP (NP (NP (DT the) (NN association)) (PP (IN between) (NP (NNS Doc_9579567_410_428_Disease)))) (CC and) (NP (NNS Doc_9579567_433_442_Chemical)) (NX (NX (NN use)) (CC or) (NX (JJ other) (NNS treatments)))) (PP (IN in) (NP (NP (NNS women)) (VP (VBN treated) (PP (IN for) (NP (NP (NNS Doc_9579567_488_501_Disease)) (PP (IN in) (NP (DT a) (JJ case-control) (NN study)))))))))) (. .)))
9579567	4	(ROOT (S (NP (NP (NNS Cases)) (PP (IN of) (NP (NNS Doc_9579567_536_554_Disease)))) (VP (VBD diagnosed) (SBAR (IN after) (S (NP (NP (NP (NNS Doc_9579567_571_584_Disease)) (PRN (-LRB- -LRB-) (VP (VBN n) (S (VP (SYM =) (NP (CD 135))))) (-RRB- -RRB-))) (CC and) (NP (NP (JJ 467) (NNS controls)) (VP (VBN matched) (PP (IN for) (NP (NP (NN age)) (, ,) (NP (NP (NN year)) (PP (IN of) (NP (NP (NN diagnosis)) (PP (IN of) (NP (NNS Doc_9579567_650_663_Disease)))))) (CC and) (NP (NP (NN hospital) (CC and) (NN survival) (NN time)) (PP (IN with) (NP (DT an) (JJ intact) (NN uterus))))))))) (VP (VBD were) (VP (VBN included)))))) (. .)))
9579567	5	(ROOT (S (NP (NP (NNP Women)) (SBAR (WHNP (WP who)) (S (VP (VBD had) (VP (VBN received) (NP (NNS Doc_9579567_755_764_Chemical))))))) (VP (VBD were) (ADJP (RB significantly) (RBR more) (JJ likely) (S (VP (TO to) (VP (VB have) (NP (NP (NP (NNS Doc_9579567_804_822_Disease)) (VP (VBN diagnosed) (PP (IN than) (NP (NP (DT those)) (SBAR (WHNP (WP who)) (S (VP (VBD had) (RB not)))))))) (PRN (-LRB- -LRB-) (NP (NP (JJ crude) (JJ relative) (NN risk)) (SBAR (S (S (VP (SYM =) (NP (CD 4.9)))) (, ,) (VP (VBP p) (S (VP (SYM =) (NP (CD 0.0001)))))))) (-RRB- -RRB-)))))))) (. .)))
9579567	6	(ROOT (S (NP (ADJP (JJ Univariate) (CC and) (JJ adjusted)) (NNS analyses)) (VP (VBD showed) (SBAR (IN that) (S (NP (DT the) (NN risk)) (VP (VBD increased) (PP (IN with) (NP (NP (NP (DT the) (NN length)) (PP (IN of) (NP (NN treatment)))) (PRN (-LRB- -LRB-) (VP (VBN p) (S (VP (SYM =) (NP (CD 0.0001))))) (-RRB- -RRB-)) (CC or) (NP (NP (DT the) (JJ cumulative) (NN dose)) (PP (IN of) (NP (NP (NP (NP (NNS Doc_9579567_1029_1038_Chemical)) (VP (VBN received))) (PRN (-LRB- -LRB-) (VP (VBN p) (S (VP (SYM =) (NP (CD 0.0001))))) (-RRB- -RRB-))) (, ,) (ADVP (RB irrespective) (PP (IN of) (NP (DT the) (JJ daily) (NN dose))))))))))))) (. .)))
9579567	7	(ROOT (S (NP (NP (NNP Women)) (SBAR (WHNP (WP who)) (S (VP (VBD had) (VP (VBN undergone) (NP (JJ pelvic) (NN radiotherapy))))))) (ADVP (RB also)) (VP (VBD had) (NP (NP (DT a) (JJR higher) (NN risk)) (PRN (-LRB- -LRB-) (NP (NP (JJ crude) (JJ relative) (NN risk)) (SBAR (S (S (VP (SYM =) (NP (CD 7.8)))) (, ,) (VP (VBP p) (S (VP (SYM =) (NP (CD 0.0001)))))))) (-RRB- -RRB-)))) (. .)))
9579567	8	(ROOT (S (PP (IN After) (S (VP (VBG adjusting) (PP (IN for) (NP (VBG confounding) (NNS factors)))))) (, ,) (NP (DT the) (NN risk)) (VP (VBD was) (ADJP (JJR higher)) (PP (IN for) (NP (NP (NP (JJ Doc_9579567_1267_1276_Chemical) (NNS users)) (PRN (-LRB- -LRB-) (VP (VBN p) (S (VP (SYM =) (NP (CD 0.0012))))) (-RRB- -RRB-))) (, ,) (NP (NP (NP (NN treatment)) (PP (IN for) (NP (QP (JJR more) (IN than) (CD 3)) (NNS years)))) (PRN (-LRB- -LRB-) (S (NP (DT all) (NN p)) (VP (VBZ <) (NP (CD 0.03)))) (-RRB- -RRB-))) (CC and) (NP (NP (JJ pelvic) (NN radiotherapy)) (PRN (-LRB- -LRB-) (VP (VBN p) (S (VP (SYM =) (NP (CD 0.012))))) (-RRB- -RRB-)))))) (. .)))
9579567	9	(ROOT (S (NP (NP (NNP Women)) (SBAR (WHNP (WP who)) (S (VP (VP (VBD had) (NP (NNS Doc_9579567_1395_1413_Disease))) (CC and) (VP (VBD had) (VP (VBN received) (NP (NNS Doc_9579567_1431_1440_Chemical)))))))) (VP (VBD had) (NP (NP (JJR more) (NNS Doc_9579567_1450_1466_Disease)) (CC and) (NP (JJR poorer) (NN prognosis))) (PP (IN than) (NP (NP (DT those)) (PP (IN with) (NP (NP (NNS Doc_9579567_1504_1522_Disease)) (SBAR (WHNP (WP who)) (S (VP (VBD had) (RB not) (VP (VBN received) (NP (DT this) (NN treatment))))))))))) (. .)))
9579567	10	(ROOT (S (NP (PRP$ Our) (NNS results)) (VP (VBP suggest) (NP (NP (DT a) (JJ causal) (NN role)) (PP (IN of) (NP (NP (NNS Doc_9579567_1597_1606_Chemical)) (PP (IN in) (NP (NNS Doc_9579567_1610_1628_Disease)))))) (, ,) (SBAR (RB particularly) (WHADVP (WRB when)) (S (VP (VBD used) (SBAR (IN as) (S (ADVP (RB currently)) (VP (VBN proposed) (PP (IN for) (NP (JJ Doc_9579567_1679_1692_Disease) (NN prevention)))))))))) (. .)))
9579567	11	(ROOT (S (NP (NNP Pelvic)) (ADVP (RB radiotherapy)) (VP (MD may) (VP (VB be) (NP (NP (DT an) (JJ additional) (JJ iatrogenic) (NN factor)) (PP (IN for) (NP (NP (NNS women)) (PP (IN with) (NP (NNS Doc_9579567_1779_1792_Disease)))))))) (. .)))
9579567	12	(ROOT (S (NP (NP (NNP Doc_9579567_1794_1813_Disease)) (VP (VBN diagnosed) (PP (IN in) (NP (NP (NNS women)) (VP (VBN treated) (PP (IN with) (NP (NNS Doc_9579567_1846_1855_Chemical)))))))) (VP (VBP have) (NP (JJR poorer) (NN prognosis))) (. .)))
9579567	13	(ROOT (S (NP (NP (NNP Women)) (SBAR (WHNP (WP who)) (S (VP (VBP receive) (NP (NP (NNS Doc_9579567_1897_1906_Chemical)) (PP (IN for) (NP (NNS Doc_9579567_1911_1924_Disease)))))))) (VP (MD should) (VP (VB be) (VP (VBN offered) (NP (JJ gynaecological) (NN surveillance)) (PP (IN during) (CC and) (IN after) (NP (NN treatment)))))) (. .)))
9579567	14	(ROOT (S (NP (NP (DT A) (JJ long-term) (NN evaluation)) (PP (IN of) (NP (NP (DT the) (JJ risk-benefit) (NN ratio)) (PP (IN of) (NP (NP (NNS Doc_9579567_2051_2060_Chemical)) (PP (IN as) (NP (NP (DT a) (JJ preventive) (NN treatment)) (PP (IN for) (NP (NNS Doc_9579567_2091_2104_Disease)))))))))) (VP (VBZ is) (ADJP (RB clearly) (JJ warranted))) (. .)))
9630698	0	(ROOT (NP (NP (NNP Contribution)) (PP (IN of) (NP (NP (DT the) (JJ Doc_9630698_20_27_Chemical) (NN site)) (PP (IN of) (NP (NP (JJ Doc_9630698_36_40_Chemical) (NNS receptors)) (PP (IN in) (NP (JJ rostral) (CC and) (JJ intermediate-caudal) (NNS parts))))))) (PP (IN of) (NP (NP (DT the) (NN striatum)) (PP (TO to) (NP (NP (DT the) (NN regulation)) (PP (IN of) (NP (NN muscle) (NN tone))))))) (PP (IN in) (NP (NNS rats))) (. .)))
9630698	1	(ROOT (S (NP (NP (DT The) (NN aim)) (PP (IN of) (NP (DT the) (JJ present) (NN study)))) (VP (VBD was) (S (VP (TO to) (VP (VB assess) (NP (NP (DT the) (NN contribution)) (PP (IN of) (NP (NP (DT the) (JJ Doc_9630698_217_224_Chemical) (NN site)) (PP (IN of) (NP (JJ Doc_9630698_233_237_Chemical) (NNS receptors)))))) (PP (IN in) (NP (DT the) (NN striatum))) (PP (TO to) (NP (NP (DT the) (NN regulation)) (PP (IN of) (NP (NN muscle) (NN tone))))))))) (. .)))
9630698	2	(ROOT (S (S (NP (JJ Muscle) (NN tone)) (VP (VBD was) (VP (VBN examined) (S (VP (VBG using) (NP (NP (DT a) (VBN combined) (ADJP (JJ mechanoand) (JJ electromyographic)) (NN method)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VP (VBN measured) (ADVP (RB simultaneously)) (NP (NP (NP (DT the) (NN muscle) (NN resistance)) (PRN (-LRB- -LRB-) (NP (NNP MMG)) (-RRB- -RRB-))) (PP (IN of) (NP (NP (DT the) (NN rat) (POS 's)) (JJ hind) (NN foot)))) (PP (TO to) (NP (JJ passive) (NN extension)))) (CC and) (VP (VBN flexion) (PP (IN in) (NP (NP (DT the) (JJ ankle) (NN joint)) (CC and) (NP (NP (NP (DT the) (JJ electromyographic) (NN activity)) (PRN (-LRB- -LRB-) (NP (NNP EMG)) (-RRB- -RRB-))) (PP (IN of) (NP (NP (DT the) (JJ antagonistic) (NNS muscles)) (PP (IN of) (NP (DT that) (NN joint)))))))))))))))))) (: :) (S (NP (NNS gastrocnemius) (CC and) (NNS tibialis)) (VP (VBP anterior))) (. .)))
9630698	3	(ROOT (S (NP (NNP Doc_9630698_631_646_Disease)) (PRN (SINV (VP (VBD was) (VP (VBN induced) (PP (IN by) (NP (NP (NNS Doc_9630698_662_673_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 2.5) (NN mg/kg) (NN i.p.)) (-RRB- -RRB-)))) (. .))) (NP (NP (NNS Doc_9630698_692_718_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_9630698_720_728_Chemical)) (-RRB- -RRB-))) (, ,) (S (NP (NP (DT a) (JJ selective) (JJ Doc_9630698_743_750_Chemical) (NN site) (NN antagonist)) (, ,) (VP (VBN injected) (PP (IN in) (NP (NP (NNS doses)) (PP (IN of) (NP (QP (CD 2.5) (CC and) (CD 4.5)) (JJ microg/0) (CD .5) (JJ microl) (NNS bilaterally))))) (, ,) (PP (IN into) (NP (NP (DT the) (JJ rostral) (NN region)) (PP (IN of) (NP (DT the) (NN striatum)))))) (, ,)) (VP (VBD decreased) (NP (NP (NP (PDT both) (DT the) (NN Doc_9630698_892_903_Chemical-induced) (NNS Doc_9630698_912_927_Disease)) (PRN (-LRB- -LRB-) (NP (NNP MMG)) (-RRB- -RRB-))) (CC and) (NP (NP (DT the) (VBN enhanced) (JJ electromyographic) (NN activity)) (PRN (-LRB- -LRB-) (NP (NNP EMG)) (-RRB- -RRB-)))))) (. .))) (NP (NNS Doc_9630698_985_993_Chemical)) (VP (VBD injected) (ADVP (RB bilaterally)) (PP (IN in) (NP (NP (DT a) (NN dose)) (PP (IN of) (NP (NP (CD 4.5) (NNS microg/0)) (SBAR (S (NP (NP (CD .5) (NN microl)) (PP (IN into) (NP (NP (DT the) (JJ intermediate-caudal) (NN region)) (PP (IN of) (NP (NP (DT the) (NN striatum)) (PP (IN of) (NP (NP (NNS rats)) (VP (RB not) (VBN pretreated) (PP (IN with) (NP (NNS Doc_9630698_1130_1141_Chemical))))))))))) (VP (VBD had) (NP (NP (DT no) (NN effect)) (PP (IN on) (NP (DT the) (NN muscle) (NN tone)))))))))))) (. .)))
9630698	4	(ROOT (S (NP (DT The) (JJ present) (NNS results)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NP (NN blockade)) (PP (IN of) (NP (NP (DT the) (JJ Doc_9630698_1225_1232_Chemical) (NN site)) (PP (IN of) (NP (NP (JJ Doc_9630698_1241_1245_Chemical) (NNS receptors)) (PP (IN in) (NP (NP (DT the) (JJ rostral) (NN part)) (PP (IN of) (NP (DT the) (NN striatum)))))))))) (VP (MD may) (VP (VB be) (ADJP (RB mainly) (JJ responsible)) (PP (IN for) (NP (NP (DT the) (NN antiparkinsonian) (NN action)) (PP (IN of) (NP (DT this) (NN drug)))))))))) (. .)))
9636837	0	(ROOT (NP (NP (JJ Doc_9636837_0_11_Chemical) (JJ toxic) (NNS effects)) (PP (IN on) (NP (DT the) (JJ peripheral) (JJ nervous) (NN system))) (PP (IN of) (NP (DT the) (NN rat))) (. .)))
9636837	1	(ROOT (S (NP (NP (DT The) (ADJP (RBS most) (JJ striking))) (PP (IN of) (NP (NP (NP (NNP Doc_9636837_104_115_Chemical) (POS 's)) (NNS advantages)) (PRN (-LRB- -LRB-) (NP (NNP Doc_9636837_130_135_Chemical)) (-RRB- -RRB-)))) (PP (IN over) (NP (NP (NNS Doc_9636837_142_151_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_9636837_153_157_Chemical)) (-RRB- -RRB-))))) (VP (VBZ is) (NP (NP (PRP$ its) (ADJP (RB markedly) (JJ reduced)) (NN rate)) (PP (IN of) (NP (JJ Doc_9636837_191_201_Disease) (NNS effects))))) (. .)))
9636837	2	(ROOT (S (ADVP (RB However)) (, ,) (NP (NP (NP (DT the) (NN use)) (PP (IN of) (NP (JJ Doc_9636837_231_236_Chemical) (JJ higher-intensity) (NNS schedules)))) (CC and) (NP (NP (DT the) (NN association)) (PP (IN with) (NP (NP (JJ other) (JJ Doc_9636837_295_305_Disease) (NNS drugs)) (PP (IN in) (NP (NN polychemotherapy))))))) (VP (MD may) (VP (VB cause) (NP (NP (DT some) (NN concern)) (PP (IN about) (NP (PRP$ its) (NN safety)))) (PP (IN with) (NP (NN respect))) (PP (TO to) (NP (NNS Doc_9636837_388_420_Disease))))) (. .)))
9636837	3	(ROOT (S (NP (NP (NP (NNP MATERIALS) (CC AND) (NNP METHODS)) (: :) (NP (NP (CD Two) (JJ different) (NNS schedules)) (PP (IN of) (NP (JJ Doc_9636837_472_477_Chemical) (NN administration))))) (PRN (-LRB- -LRB-) (S (NP (NP (CD 10) (NN mg/kg)) (CC and) (NP (CD 15))) (VP (VBG mg/kg) (NP (NN i.p.)) (NP (RB twice) (DT a) (NN week)) (PP (IN for) (NP (CD nine) (NNS times))))) (-RRB- -RRB-))) (VP (VBD were) (VP (VBN evaluated) (PP (IN in) (NP (NNP Wistar) (NNS rats))))) (. .)))
9636837	4	(ROOT (S (NP (NNP Doc_9636837_581_594_Disease)) (VP (VBD was) (VP (VBN assessed) (PP (IN for) (NP (NP (NP (NP (JJ behavioral)) (PRN (-LRB- -LRB-) (NP (JJ tail-flick) (NN test)) (-RRB- -RRB-))) (, ,) (NP (NP (NN neurophysiological)) (PRN (-LRB- -LRB-) (NP (NP (NN nerve) (NN conduction) (NN velocity)) (PP (IN in) (NP (DT the) (JJ tail) (NN nerve)))) (-RRB- -RRB-))) (, ,) (ADJP (JJ morphological) (, ,) (JJ morphometrical))) (CC and) (NP (JJ analytical) (NNS effects)))))) (. .)))
9636837	5	(ROOT (S (NP (JJ Doc_9636837_771_776_Chemical) (NN administration)) (VP (VBN induced) (NP (JJ dose-dependent) (NNS Doc_9636837_815_839_Disease))) (. .)))
9636837	6	(ROOT (S (NP (NP (JJ Doc_9636837_841_845_Disease) (NN perception) (CC and) (NN nerve) (NN conduction) (NN velocity)) (PP (IN in) (NP (DT the) (NN tail)))) (VP (VBD were) (ADVP (RB significantly)) (ADJP (JJ impaired)) (, ,) (ADVP (RB particularly)) (PP (IN after) (NP (DT the) (JJ high-dose) (NN treatment)))) (. .)))
9636837	7	(ROOT (S (S (NP (DT The) (NN dorsal)) (VP (VBP root) (NP (JJ ganglia) (JJ sensory) (NNS neurons)))) (CC and) (, ,) (S (PP (TO to) (NP (DT a) (JJR lesser) (NN extent))) (, ,) (NP (NN satellite) (NNS cells)) (VP (VBD showed) (NP (DT the) (JJ same) (NNS changes)) (PP (IN as) (NP (NP (DT those)) (VP (VBN induced) (PP (IN by) (NP (NNS Doc_9636837_1097_1101_Chemical)))))) (, ,) (S (ADVP (RB mainly)) (VP (VBG affecting) (NP (NP (DT the) (NN nucleus) (CC and) (NNS nucleolus)) (PP (IN of) (NP (JJ ganglionic) (JJ sensory) (NNS neurons)))))))) (. .)))
9636837	8	(ROOT (S (ADVP (RB Moreover)) (, ,) (NP (NP (JJ significant) (NNS amounts)) (PP (IN of) (NP (NNS Doc_9636837_1210_1218_Chemical)))) (VP (VBD were) (VP (VBN detected) (PP (IN in) (NP (NP (DT the) (JJ dorsal) (NN root) (NN ganglia)) (CC and) (NP (NN kidney)))) (PP (IN after) (NP (JJ Doc_9636837_1277_1282_Chemical) (NN treatment))))) (. .)))
9636837	9	(ROOT (S (S (NP (NNP Doc_9636837_1307_1312_Chemical)) (VP (VBZ is) (NP (NP (NNS Doc_9636837_1316_1326_Disease)) (PP (IN in) (NP (PRP$ our) (NN model)))))) (, ,) (CC and) (S (NP (NP (DT the) (NN type)) (PP (IN of) (NP (NP (JJ pathological) (NNS changes)) (SBAR (S (NP (PRP it)) (VP (VBZ induces))))))) (VP (VBP are) (ADJP (ADJP (RB so) (RB closely) (JJ similar)) (PP (TO to) (NP (NP (DT those)) (VP (VBN caused) (PP (IN by) (NP (NNS Doc_9636837_1431_1435_Chemical))))))) (SBAR (IN that) (S (NP (PRP it)) (VP (VBZ is) (ADJP (JJ probable)) (SBAR (IN that) (S (NP (NNS Doc_9636837_1461_1474_Disease)) (VP (VBZ is) (VP (VBN induced) (PP (IN in) (NP (DT the) (CD two) (NNS drugs))) (PP (IN by) (NP (DT the) (JJ same) (NN mechanism)))))))))))) (. .)))
9636837	10	(ROOT (S (NP (DT This) (NN model)) (VP (MD can) (VP (VB be) (VP (VBN used) (ADVP (ADVP (RB alone)) (CC or) (PP (IN in) (NP (NN combination)))) (PP (IN with) (NP (JJ other) (NNS drugs))) (S (VP (TO to) (VP (VB explore) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (NP (NNS Doc_9636837_1615_1620_Chemical)) (PP (IN on) (NP (DT the) (JJ peripheral) (JJ nervous) (NN system)))))))))))) (. .)))
9669632	0	(ROOT (S (NP (NP (NNPS Effects)) (PP (IN of) (NP (NP (NNS Doc_9669632_11_20_Chemical)) (PP (IN on) (NP (NP (NNS symptoms)) (CC and) (NP (JJ postcibal) (JJ small-bowel) (NN motor))))))) (VP (VBP function) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NNS Doc_9669632_91_115_Disease)))))) (. .)))
9669632	1	(ROOT (S (NP (NNP Doc_9669632_129_153_Disease)) (VP (VP (VBZ is) (NP (NP (DT a) (JJ common) (NN cause)) (PP (IN of) (NP (NNS Doc_9669632_175_189_Disease) (CC and) (NN discomfort))))) (CC and) (VP (MD may) (VP (VB be) (VP (VBN related) (PP (TO to) (NP (NNS Doc_9669632_227_263_Disease))))))) (. .)))
9669632	2	(ROOT (S (NP (PRP$ Our) (NN aim)) (VP (VBD was) (S (VP (TO to) (VP (VB assess) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (JJ long-term) (NN treatment)))) (PP (IN with) (NP (NP (NP (NP (DT a) (JJ prokinetic) (NN agent)) (, ,) (NP (NNS Doc_9669632_347_356_Chemical)) (, ,)) (PP (IN on) (NP (JJ postprandial) (JJ jejunal) (NN motility)))) (CC and) (NP (NP (NNS symptoms)) (PP (IN in) (NP (NP (DT the) (NNS Doc_9669632_411_435_Disease)) (PRN (-LRB- -LRB-) (NP (NNP Doc_9669632_437_440_Disease)) (-RRB- -RRB-))))))))))) (. .)))
9669632	3	(ROOT (S (NP (NP (NP (JJ Thirty-eight) (NNS patients)) (PP (IN with) (NP (NNS Doc_9669632_479_482_Disease)))) (PRN (-LRB- -LRB-) (NP (NP (NNS Doc_9669632_484_496_Disease-predominant)) (, ,) (NP (NP (NP (NN n)) (SBAR (S (VP (SYM =) (NP (CD 17)))))) (: ;) (NP (NP (NNS Doc_9669632_518_527_Disease-predominant)) (, ,) (VP (VBN n) (S (VP (SYM =) (NP (CD 21)))))))) (-RRB- -RRB-))) (VP (VBD underwent) (NP (JJ 24-h) (JJ ambulatory) (JJ jejunal) (NN manometry)) (PP (IN before) (CC and) (IN after) (NP (NP (CD 12) (NN week) (POS 's)) (NN treatment) (NN -LSB-) (NNS Doc_9669632_631_640_Chemical))) (, ,) (S (NP (NP (NP (NP (CD 5)) (VP (VBN mg) (NP (CD three) (NNS times) (RB daily)))) (PRN (-LRB- -LRB-) (VP (VBN n) (S (VP (SYM =) (NP (CD 19))))) (-RRB- -RRB-))) (CC or) (NP (NP (NN placebo)) (PRN (-LRB- -LRB-) (VP (VBN n) (S (VP (SYM =) (NP (CD 19))))) (-RRB- -RRB-)))) (ADJP (JJ -RSB-)))) (. .)))
9669632	4	(ROOT (S (PP (IN In) (NP (NN Doc_9669632_708_717_Disease-predominant) (NNS patients))) (NP (NP (JJ significant) (NNS differences)) (PP (IN in) (NP (NN contraction) (NNS characteristics)))) (VP (VBD were) (VP (VBN observed) (PP (IN between) (NP (DT the) (NNS Doc_9669632_820_829_Chemical) (CC and) (NN placebo) (NNS groups))))) (. .)))
9669632	5	(ROOT (S (S (PP (IN In) (NP (NN Doc_9669632_853_862_Chemical-treated) (NN Doc_9669632_871_880_Disease-predominant) (NNS patients))) (NP (DT the) (JJ mean) (NN contraction) (NN amplitude)) (VP (VBD was) (ADJP (ADJP (JJR higher)) (PRN (-LRB- -LRB-) (NP (NP (CD 29.3) (JJ +) (NNS /)) (: -) (NP (NP (NP (CD 3.2)) (PP (IN versus) (NP (QP (CD 24.9) (CD +)) (NNS /)))) (: -) (NP (NP (CD 2.6) (NN mm)) (NP (NP (NNP Hg) (, ,) (NNP Doc_9669632_985_994_Chemical) (CC versus) (NNP placebo)) (PRN (-LRB- -LRB-) (NP (NNP P) (QP (CD <) (CD 0.001))) (-RRB- -RRB-)))) (: ;) (NP (NP (NN pretreatment)) (, ,) (NP (CD 25.7) (JJ +) (NNS /))) (: -) (NP (NP (NP (CD 6.0) (NNP mm) (NNP Hg) (-RRB- -RRB-)) (, ,) (ADVP (NP (DT the) (JJ mean) (NN contraction) (NN duration)) (RBR longer))) (PRN (-LRB- -LRB-) (ADVP (RB 3.4)) (NP (NNP +)) (: /))) (: -) (NP (NP (CD 0.2)) (PP (IN versus) (NP (CD 3.0) (JJ +) (NNS /)))) (: -) (NP (NP (CD 0.2) (NN sec)) (, ,) (NP (NP (NNS Doc_9669632_1132_1141_Chemical)) (PP (IN versus) (NP (NP (NP (NN placebo)) (PRN (-LRB- -LRB-) (NP (NNP P) (QP (CD <) (CD 0.001))) (-RRB- -RRB-))) (PRN (: ;) (NP (NP (NN pretreatment)) (, ,) (NP (CD 3.1) (NNS +))) (: /)))))) (: -) (NP (NP (CD 0.5)) (NP (NN sec))))) (-RRB- -RRB-))))) (, ,) (CC and) (S (NP (NP (DT the) (JJ mean) (NN contraction) (NN frequency)) (ADJP (ADJP (ADJP (JJR lower)) (PRN (-LRB- -LRB-) (NP (NP (QP (CD 2.0) (CD +)) (NNP /) (PRN (: -) (NP (NP (CD 0.2)) (PP (IN versus) (NP (CD 2.5) (NNS +)) (X (X (SYM /)) (: -) (NP (CD 0.4) (NN cont)) (. .)))) (: /)) (NN min)) (, ,) (NP (NNP Doc_9669632_1286_1295_Chemical) (CC versus) (NNP placebo) (-LRB- -LRB-) (NNP P) (NNP <) (CD 0.001))) (-RRB- -RRB-))) (PRN (: ;) (FRAG (FRAG (ADJP (JJ pretreatment)) (, ,) (NP (CD 2.5) (CD +)) (: /)) (: -) (FRAG (NP (CD 1.1) (NN cont)) (. .))) (: /)))) (VP (VBP min) (NP (NNS -RSB-)) (PP (IN than) (NP (NP (NNS patients)) (VP (VBN treated) (PP (IN with) (NP (NN placebo)))))))) (. .)))
9669632	6	(ROOT (S (NP (NP (DT No) (JJ significant) (NNS differences)) (PP (IN in) (NP (JJ jejunal) (NN motility)))) (VP (VBD were) (VP (VBN found) (PP (IN in) (NP (DT the) (NN Doc_9669632_1462_1474_Disease-predominant) (NNS Doc_9669632_1487_1490_Disease) (NN group))))) (. .)))
9669632	7	(ROOT (S (NP (NNS Symptoms)) (VP (VBD were) (VP (VBN assessed) (PP (IN by) (S (VP (VBG using) (NP (DT a) (JJ visual) (JJ analogue) (NN scale)) (PP (IN before) (CC and) (IN after) (NP (NN treatment)))))))) (. .)))
9669632	8	(ROOT (S (NP (NP (JJ Symptom) (NNS scores)) (VP (VBG relating) (PP (TO to) (NP (NP (DT the) (NN severity)) (PP (IN of) (NP (NNS Doc_9669632_1625_1637_Disease))))))) (VP (VBD were) (ADJP (ADJP (JJR lower) (PP (IN in) (NP (NP (NP (NP (ADJP (JJ Doc_9669632_1652_1661_Chemical-treated) (JJ Doc_9669632_1670_1682_Disease-predominant)) (JJ Doc_9669632_1695_1698_Disease) (NNS patients)) (NP (JJ -LSB-) (NN score))) (, ,) (NP (NP (QP (CD 54) (CD +)) (NNS /)) (PRN (: -) (NP (NP (CD 5)) (CC versus) (NP (CD 67) (NNS +))) (: /))) (: -) (NP (NP (CD 14) (NN mm)) (, ,) (NP (NNP Doc_9669632_1746_1755_Chemical) (CC versus) (NNP placebo) (-LRB- -LRB-) (NNP P) (NNP <) (CD 0.05))) (-RRB- -RRB-)) (PRN (: ;) (NP (NP (NN pretreatment)) (, ,) (NP (CD 62) (NNS +))) (: /))))) (: -) (ADJP (NP (CD 19) (NNS mm)) (JJ -RSB-)))) (. .)))
9669632	9	(ROOT (SINV (VP (VBG Doc_9669632_1812_1821_Disease-predominant) (NP (JJ Doc_9669632_1834_1837_Disease) (NNS patients))) (VP (VBD had) (NP (DT a) (JJR higher) (JJ Doc_9669632_1860_1864_Disease) (NN score)) (PP (IN after) (NP (JJ Doc_9669632_1877_1886_Chemical) (NN therapy)))) (NP (NP (JJ -LSB-) (NN score)) (, ,) (NP (NP (NP (QP (CD 55) (CD +)) (NNS /)) (PRN (: -) (NP (NP (CD 15)) (CC versus) (NP (CD 34) (NNS +))) (: /))) (: -) (NP (NP (CD 12) (NN mm)) (, ,) (NP (NP (NNS Doc_9669632_1934_1943_Chemical)) (PP (IN versus) (NP (NP (NP (NN placebo)) (PRN (-LRB- -LRB-) (NP (NNP P) (NNP <) (NNP 0.05)) (-RRB- -RRB-))) (PRN (: ;) (NP (NP (NN pretreatment)) (, ,) (NP (CD 67) (NNS +))) (: /)))))) (: -) (NP (NP (CD 19) (NN mm)) (NP (NNP -RSB-))))) (. .)))
9669632	10	(ROOT (S (NP (NNP Doc_9669632_2012_2021_Chemical)) (VP (VBZ affects) (NP (NP (JJ jejunal) (NN contraction) (NNS characteristics)) (CC and) (NP (NP (DT some) (NNS symptoms)) (PP (IN in) (NP (NNS Doc_9669632_2087_2090_Disease)))))) (. .)))
9672273	0	(ROOT (NP (NP (NP (NNP Prevention)) (PP (IN of) (NP (NP (NNS Doc_9672273_14_27_Disease)) (PP (IN with) (NP (NNS Doc_9672273_33_42_Chemical)))))) (: :) (NP (NP (JJ preliminary) (NNS findings)) (PP (IN from) (NP (NP (DT the) (JJ Italian) (JJ randomised) (NN trial)) (PP (IN among) (NP (JJ hysterectomised) (NNS women)))))) (. .)))
9672273	1	(ROOT (NP (NNP Italian) (NNP Doc_9672273_136_145_Chemical) (NNP Prevention) (NNP Study) (. .)))
9672273	2	(ROOT (S (NP (NNP Doc_9672273_176_185_Chemical)) (VP (VBZ is) (NP (NP (DT a) (NN candidate) (NN chemopreventive) (NN agent)) (PP (IN in) (NP (NNS Doc_9672273_226_239_Disease)))) (, ,) (SBAR (IN although) (S (NP (DT the) (NN drug)) (VP (MD may) (VP (VB be) (VP (VBN associated) (PP (IN with) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (NNS Doc_9672273_301_319_Disease))))))))))) (. .)))
9672273	3	(ROOT (S (ADVP (RB Therefore)) (NP (PRP we)) (VP (VBD did) (NP (DT a) (NN trial)) (PP (IN in) (NP (NP (JJ hysterectomised) (NNS women)) (PP (IN of) (NP (NNS Doc_9672273_374_383_Chemical))))) (PP (IN as) (NP (DT a) (NN chemopreventive)))) (. .)))
9672273	4	(ROOT (S (PP (IN In) (NP (NP (NNP October)) (, ,) (NP (CD 1992)))) (, ,) (NP (PRP we)) (VP (VBD started) (NP (NP (DT a) (JJ double-blind) (JJ placebo-controlled) (, ,) (JJ randomised) (NN trial)) (PP (IN of) (NP (NP (NNS Doc_9672273_499_508_Chemical)) (PP (IN in) (NP (NNS women)))))) (PRN (-LRB- -LRB-) (PP (ADVP (RB mainly)) (IN in) (NP (NNP Italy))) (-RRB- -RRB-)) (SBAR (SBAR (WHNP (WP who)) (S (VP (VBD did) (RB not) (VP (VB have) (NP (NNS Doc_9672273_553_566_Disease)))))) (CC and) (SBAR (WHNP (WP who)) (S (VP (VBD had) (VP (VBN had) (NP (DT a) (NN hysterectomy)))))))) (. .)))
9672273	5	(ROOT (S (NP (NNP Women)) (VP (VBD were) (VP (VBN randomised) (S (VP (TO to) (VP (VB receive) (NP (NP (QP (CD Doc_9672273_632_641_Chemical) (CD 20)) (NN mg)) (PP (IN per) (NP (NP (NN day) (CC or) (NN placebo)) (, ,) (NP (NP (DT both) (NN orally)) (PP (IN for) (NP (CD 5) (NNS years)))))))))))) (. .)))
9672273	6	(ROOT (S (NP (DT The) (JJ original) (NN plan)) (VP (VBD was) (S (VP (TO to) (VP (VB follow) (NP (DT the) (NN intervention) (NN phase)) (PP (IN by) (NP (NP (CD 5) (NNS years) (POS ')) (NN follow-up))))))) (. .)))
9672273	7	(ROOT (S (PP (IN In) (NP (NNP June))) (, ,) (NP (NP (CD 1997)) (, ,) (NP (DT the) (NNS trialists)) (CC and) (NP (DT the) (JJ data-monitoring) (NN committee))) (VP (VBD decided) (S (VP (TO to) (VP (VB end) (NP (NP (NN recruitment)) (PP (RB primarily) (RB because) (IN of) (NP (NP (DT the) (NN number)) (PP (IN of) (NP (NNS women)))))) (S (VP (VBG dropping) (PRT (RP out)) (PP (IN of) (NP (DT the) (NN study))))))))) (. .)))
9672273	8	(ROOT (S (S (NP (NNP Recruitment)) (VP (VBD ended) (PP (IN on) (NP (NNP July) (CD 11) (, ,) (CD 1997))))) (, ,) (CC and) (S (NP (DT the) (NN study)) (VP (MD will) (VP (VB continue) (ADJP (RB as) (VBN planned))))) (. .)))
9672273	9	(ROOT (S (NP (DT The) (JJ primary) (NNS endpoints)) (VP (VBP are) (NP (NP (NP (DT the) (NN occurrence)) (PP (IN of))) (CC and) (NP (NP (NNS deaths)) (PP (IN from) (NP (NNS Doc_9672273_1065_1078_Disease)))))) (. .)))
9672273	10	(ROOT (S (NP (DT This) (JJ preliminary) (JJ interim) (NN analysis)) (VP (VBZ is) (VP (VBN based) (PP (IN on) (NP (NN intention-to-treat))))) (. .)))
9672273	11	(ROOT (S (S (NP (CD 5408) (NNS women)) (VP (VBD were) (VP (VBN randomised)))) (: ;) (S (NP (VBG participating) (NNS women)) (VP (VBP have) (NP (NP (DT a) (JJ median) (NN follow-up)) (PP (IN of) (NP (NP (CD 46) (NNS months)) (RRC (PP (IN for) (NP (JJ major) (NNS endpoints)) (. .)) (NP (CD 41) (NNS cases))))) (PP (IN of) (NP (NP (NNS Doc_9672273_1274_1287_Disease)) (VP (VBN occurred) (ADVP (RB so) (RB far)))))))) (: ;) (S (NP (EX there)) (VP (VBP have) (VP (VBN been) (NP (NP (DT no) (NNS deaths)) (PP (IN from) (NP (NNS Doc_9672273_1336_1349_Disease))))))) (. .)))
9672273	12	(ROOT (S (NP (EX There)) (VP (VBZ is) (NP (NP (DT no) (NN difference)) (PP (IN in) (NP (NP (NP (JJ Doc_9672273_1377_1390_Disease) (NN frequency)) (PP (IN between) (NP (NP (DT the) (NN placebo)) (PRN (-LRB- -LRB-) (NP (CD 22) (NNS cases)) (-RRB- -RRB-))))) (CC and) (NP (NP (NNS Doc_9672273_1436_1445_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 19)) (-RRB- -RRB-)) (NP (NNS arms))))))) (. .)))
9672273	13	(ROOT (S (S (NP (EX There)) (VP (VBZ is) (NP (NP (DT a) (ADJP (RB statistically) (JJ significant)) (NN reduction)) (PP (IN of) (NP (NP (NNS Doc_9672273_1507_1520_Disease)) (PP (IN among) (NP (NP (NNS women)) (VP (VBG receiving) (NP (NP (NNS Doc_9672273_1543_1552_Chemical)) (SBAR (WHNP (WP who)) (S (ADVP (RB also)) (VP (VP (VBN used) (S (NP (NP (JJ hormone-replacement) (NN therapy)) (PP (IN during) (NP (DT the) (NN trial))))) (: :) (PP (IN among) (NP (NP (CD 390) (NNS women)) (PP (IN on) (NP (JJ such) (NN therapy)))))) (CC and) (VP (VBN allocated) (PP (TO to) (NP (NN placebo)))))))))))))))) (, ,) (NP (PRP we)) (VP (VBD found) (NP (NP (CD eight) (NNS cases)) (PP (IN of) (NP (NNS Doc_9672273_1695_1708_Disease)))) (PP (VBN compared) (PP (IN with) (NP (NP (CD one) (NN case)) (PP (IN among) (NP (NP (CD 362) (NNS women)) (VP (VBN allocated) (PP (TO to) (NP (NNS Doc_9672273_1761_1770_Chemical)))))))))) (. .)))
9672273	14	(ROOT (S (PP (VBN Compared) (PP (IN with) (NP (DT the) (NN placebo) (NN group)))) (, ,) (NP (EX there)) (VP (VBD was) (NP (NP (DT a) (RB significantly) (VBN increased) (NN risk)) (PP (IN of) (NP (NNS Doc_9672273_1849_1864_Disease) (CC and) (NN hypertriglyceridaemia))) (PP (IN among) (NP (NP (NNS women)) (PP (IN on) (NP (NNS Doc_9672273_1906_1915_Chemical))))))) (. .)))
9672273	15	(ROOT (S (SBAR (IN Although) (S (NP (DT this) (JJ preliminary) (NN analysis)) (VP (VBZ has) (NP (JJ low) (NN power)) (, ,) (PP (IN in) (NP (NP (DT this) (NN cohort)) (PP (IN of) (NP (NP (NNS women)) (PP (IN at) (NP (NP (JJ low-to-normal) (NN risk)) (PP (IN of) (NP (NNS Doc_9672273_2032_2045_Disease)))))))))))) (, ,) (NP (NP (DT the) (JJ postulated) (JJ protective) (NNS effects)) (PP (IN of) (NP (NNS Doc_9672273_2084_2093_Chemical)))) (VP (VBP are) (RB not) (ADVP (RB yet)) (ADJP (JJ apparent))) (. .)))
9672273	16	(ROOT (S (NP (NP (NNP Women)) (VP (VBG using) (NP (JJ hormone-replacement) (NN therapy)))) (VP (VBP appear) (S (VP (TO to) (VP (VB have) (VP (VBN benefited) (PP (IN from) (NP (NP (NN use)) (PP (IN of) (NP (NNS Doc_9672273_2193_2202_Chemical)))))))))) (. .)))
9672273	17	(ROOT (S (NP (EX There)) (VP (VBD were) (NP (NP (DT no) (NNS deaths)) (PP (IN from) (NP (NP (NNS Doc_9672273_2230_2243_Disease)) (VP (VBN recorded) (PP (IN in) (NP (NP (NNS women)) (PP (IN in) (NP (DT the) (NN study)))))))))) (. .)))
9672273	18	(ROOT (S (NP (PRP It)) (VP (VBZ is) (ADJP (JJ essential) (S (VP (TO to) (VP (VB continue) (NP (NN follow-up)) (S (VP (TO to) (VP (VB quantify) (NP (NP (DT the) (JJ long-term) (NNS risks) (CC and) (NNS benefits)) (PP (IN of) (NP (JJ Doc_9672273_2362_2371_Chemical) (NN therapy)))))))))))) (. .)))
9758264	0	(ROOT (S (NP (NP (JJ Epileptogenic) (NN activity)) (PP (IN of) (NP (NP (NNS Doc_9758264_26_36_Chemical)) (PP (IN after) (NP (NN drug)))))) (VP (VBZ induces) (NP (NP (NNS Doc_9758264_56_59_Disease)) (PRN (-LRB- -LRB-) (NP (JJ Doc_9758264_61_71_Chemical) (CC and) (JJ Doc_9758264_76_84_Disease)) (-RRB- -RRB-))))))
9758264	1	(ROOT (S (S (VP (TO To) (VP (VB study) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (NN Doc_9758264_120_130_Chemical-containing) (NN multivitamin))))))) (VP (VBN supplementation) (PP (IN in) (NP (JJ Doc_9758264_174_183_Disease) (NNS women))) (PP (IN before) (CC and) (IN during) (NP (NN pregnancy))) (SBAR (IN in) (NN order) (S (VP (TO to) (VP (VB determine) (NP (NP (DT the) (NN rate)) (PP (IN of) (NP (JJ structural) (NNS Doc_9758264_263_276_Disease) (CC and) (NN Doc_9758264_281_289_Disease-related) (NN side) (NNS effects))))))))) (. .)))
9758264	2	(ROOT (FRAG (NP (NNP STUDY) (NNP DESIGN)) (: :) (S (NP (RB First) (NP (DT a) (JJ randomised) (NN trial)) (, ,) (RB later) (NP (NN periconception))) (VP (VBP care) (PP (VBG including) (PP (IN in) (NP (JJ total) (CD 12225) (NNS females)))))) (. .)))
9758264	3	(ROOT (S (PP (IN Of) (NP (NP (CD 60) (JJ Doc_9758264_427_436_Disease) (NNS women)) (PP (IN with) (NP (NP (JJ periconceptional) (NNS Doc_9758264_465_475_Chemical)) (PRN (-LRB- -LRB-) (NP (QP (CD 0.8) (CD mg))) (-RRB- -RRB-)) (: -) (S (VP (VBG containing) (NP (NN multivitamin) (NN supplementation)))))))) (, ,) (NP (DT no) (NN one)) (VP (VBD developed) (NP (NN Doc_9758264_543_551_Disease-related) (NN side) (NNS effects)) (PP (IN during) (NP (DT the) (NN periconception) (NN period)))) (. .)))
9758264	4	(ROOT (S (NP (CD One) (JJ Doc_9758264_611_620_Disease) (NN woman)) (VP (VBD delivered) (NP (DT a) (JJ newborn)) (PP (IN with) (NP (NNS Doc_9758264_652_672_Disease)))) (. .)))
9758264	5	(ROOT (S (NP (DT Another) (NN patient)) (VP (VBD exhibited) (PP (IN with) (NP (NP (DT a) (NN cluster)) (PP (IN of) (NP (NNS Doc_9758264_718_726_Disease))))) (PP (IN after) (NP (DT the) (NN periconception) (NN period))) (S (VP (VBG using) (NP (DT another) (NN multivitamin))))) (. .)))
9758264	6	(ROOT (S (S (NP (DT This) (JJ 22-year-old) (JJ Doc_9758264_804_813_Disease) (NN woman)) (VP (VBD was) (VP (VBN treated) (ADVP (RB continuously)) (PP (IN by) (NP (NP (NNS Doc_9758264_848_861_Chemical)) (CC and) (NP (NP (DT a) (NNS Doc_9758264_868_878_Chemical)) (PRN (-LRB- -LRB-) (NP (QP (CD 1) (CD mg))) (-RRB- -RRB-)))))))) (: -) (S (VP (VBG containing) (NP (NN multivitamin)) (PP (IN from) (NP (NP (DT the) (JJ 20th) (NN week)) (PP (IN of) (NP (NN gestation))))))) (. .)))
9758264	7	(ROOT (S (NP (PRP She)) (VP (VBD developed) (NP (NP (NNS Doc_9758264_957_975_Disease)) (CC and) (RB later) (NP (NP (NNS symptoms)) (PP (IN of) (NP (NNS Doc_9758264_998_1026_Disease)))))) (. .)))
9758264	8	(ROOT (S (NP (PRP$ Her) (NN pregnancy)) (VP (VBD ended) (PP (IN with) (NP (NNS Doc_9758264_1053_1063_Disease)))) (. .)))
9758264	9	(ROOT (S (S (NP (NP (NP (DT The) (JJ Doc_9758264_1082_1091_Disease) (JJ pregnant) (NN patient) (POS 's)) (NNS Doc_9758264_1111_1129_Disease)) (PRN (-LRB- -LRB-) (NP (RB probably) (JJ drug-induced) (NN Doc_9758264_1153_1158_Disease)) (-RRB- -RRB-))) (VP (MD could) (VP (VB damage) (NP (DT the) (JJ blood-brain) (NN barrier))))) (, ,) (ADVP (RB therefore)) (S (NP (NP (NP (DT the) (JJ therapeutic) (NN dose)) (PRN (-LRB- -LRB-) (NP (QP (CD >) (CC or) (CD =) (CD 1) (CD mg))) (-RRB- -RRB-))) (PP (IN of) (NP (NNS Doc_9758264_1245_1255_Chemical)))) (VP (VBD triggered) (NP (NP (DT a) (NN cluster)) (PP (IN of) (NP (NNS Doc_9758264_1279_1287_Disease)))))) (. .)))
9758264	10	(ROOT (S (NP (NP (NP (NP (JJ Physiological) (NN dose)) (PRN (-LRB- -LRB-) (NP (QP (CD <) (CD 1)) (NNS mg)) (-RRB- -RRB-))) (PP (IN of) (NP (NP (NNS Doc_9758264_1319_1329_Chemical)) (PP (DT both) (IN in) (NP (NP (JJ healthy)) (CC and) (NP (CD 60) (JJ Doc_9758264_1353_1362_Disease) (NNS women))))))) (, ,) (NP (NP (DT all)) (PP (IN without) (NP (DT any) (NNS Doc_9758264_1386_1404_Disease)))) (, ,)) (VP (VBD did) (RB not) (VP (VB increase) (NP (NP (DT the) (NN risk)) (PP (IN for) (NP (NNS Doc_9758264_1436_1454_Disease)))))) (. .)))
9799166	0	(ROOT (S (NP (NP (NNP Doc_9799166_0_6_Disease)) (CC and) (NP (NNS Doc_9799166_11_18_Chemical) (CC or) (NNS Doc_9799166_22_33_Chemical))) (VP (VBP use)) (. .)))
9799166	1	(ROOT (S (NP (NP (DT The) (NN association)) (PP (IN of) (NP (NNS Doc_9799166_58_65_Chemical) (CC and) (NNS Doc_9799166_70_81_Chemical)))) (VP (VBP use) (SBAR (IN with) (S (NP (JJ hemorrhagic) (CC and) (JJ Doc_9799166_107_115_Disease) (NNS Doc_9799166_116_122_Disease)) (VP (VBZ is) (VP (VBN based) (ADVP (RB almost)) (PP (RB solely) (IN on) (NP (NP (NNS data)) (PP (IN from) (NP (NN case) (NN series)))))))))) (. .)))
9799166	2	(ROOT (S (NP (NP (DT The) (JJ limited) (NN number)) (PP (IN of) (NP (NP (JJ epidemiologic) (NNS studies)) (PP (IN of) (NP (NNS Doc_9799166_219_225_Disease) (CC and) (NN use))) (PP (IN of) (NP (JJ Doc_9799166_237_244_Chemical) (JJ and/or) (NNS Doc_9799166_252_263_Chemical)))))) (VP (VBP have) (VP (VBN been) (VP (VBN done) (PP (IN in) (NP (NP (NNS settings)) (SBAR (WHNP (WDT that)) (S (VP (VBP serve) (PP (RB mostly) (NP (DT the) (JJ poor) (CD and/or) (NNS minorities))))))))))) (. .)))
9799166	3	(ROOT (S (NP (DT This) (JJ case-control) (NN study)) (VP (VBD was) (VP (VBN conducted) (PP (IN in) (NP (NP (DT the) (JJ defined) (NN population)) (VP (VBG comprising) (NP (NP (NNS members)) (PP (IN of) (NP (NP (NNP Kaiser) (NNP Permanente)) (PP (IN of) (NP (NNP Northern) (CC and) (NNP Southern) (NNP California))))))))))) (. .)))
9799166	4	(ROOT (S (S (NP (PRP We)) (VP (VBD attempted) (S (VP (TO to) (VP (VB identify) (NP (DT all) (NN incident) (NNS Doc_9799166_516_523_Disease)) (PP (IN in) (NP (NNS women) (NNS ages)))))) (NP (CD 15-44) (NNS years)) (PP (IN during) (NP (NP (DT a) (JJ 3-year) (NN period)) (VP (VBG using) (NP (NN hospital) (NN admission) (CC and) (NN discharge) (NNS records))))))) (, ,) (NP (NN emergency) (NN department)) (VP (VP (VBZ logs)) (, ,) (CC and) (VP (NP (NN payment) (NNS requests)) (PP (IN for) (NP (JJ out-of-plan) (NNS hospitalizations))))) (. .)))
9799166	5	(ROOT (S (NP (PRP We)) (VP (VBD selected) (NP (NP (NNS controls)) (, ,) (VP (VBN matched) (PP (IN on) (NP (NP (NN age) (CC and) (NN facility)) (PP (IN of) (NP (JJ usual) (NN care)))))) (, ,) (PP (IN at) (NP (ADJP (JJ random) (PP (IN from) (NP (NP (JJ healthy) (NNS members)) (PP (IN of) (NP (DT the) (NN health)))))) (NN plan))))) (. .)))
9799166	6	(ROOT (S (NP (PRP We)) (VP (VBD obtained) (NP (NN information)) (PP (IN in) (NP (JJ face-to-face) (NNS interviews)))) (. .)))
9799166	7	(ROOT (S (NP (EX There)) (VP (VBD were) (NP (NP (CD 347)) (VP (VBN confirmed) (NP (NP (JJ Doc_9799166_896_902_Disease) (NNS cases)) (CC and) (NP (CD 1,021) (NNS controls)))))) (. .)))
9799166	8	(ROOT (S (NP (DT The) (NN univariate)) (VP (VBD matched) (SBAR (S (NP (NP (NNS odds) (NN ratio)) (PP (IN for) (NP (NP (NNS Doc_9799166_967_973_Disease)) (PP (IN in) (NP (NP (NNS women)) (SBAR (WHNP (WP who)) (S (VP (VP (VBN admitted) (PP (TO to) (S (VP (VBG using) (NP (NNS Doc_9799166_1005_1012_Chemical)))))) (CC and/or) (VP (VBZ Doc_9799166_1020_1031_Chemical)))))))))) (VP (VBD was) (NP (NP (CD 8.5)) (PRN (-LRB- -LRB-) (NP (NP (CD 95) (NN %)) (NP (NP (NN confidence) (NN interval)) (SBAR (S (VP (SYM =) (NP (CD 3.6-20) (CD .0))))))) (-RRB- -RRB-))))))) (. .)))
9799166	9	(ROOT (S (PP (IN After) (NP (NP (JJ further) (NN adjustment)) (PP (IN for) (NP (JJ potential) (NNS confounders))))) (, ,) (NP (NP (DT the) (NNS odds) (NN ratio)) (PP (IN in) (NP (NP (NNS women)) (SBAR (WHNP (WP who)) (S (VP (VP (VBD reported) (S (VP (VBG using) (NP (NNS Doc_9799166_1173_1180_Chemical))))) (CC and/or) (VP (VBZ Doc_9799166_1188_1199_Chemical)))))))) (VP (VBD was) (NP (NP (CD 7.0)) (PRN (-LRB- -LRB-) (NP (NP (CD 95) (NN %)) (NP (NP (NN confidence) (NN interval)) (SBAR (S (VP (SYM =) (NP (CD 2.8-17) (CD .9))))))) (-RRB- -RRB-)))) (. .)))
9799166	10	(ROOT (S (NP (NP (DT The) (NN use)) (PP (IN of) (NP (JJ Doc_9799166_1257_1264_Chemical) (JJ and/or) (NNS Doc_9799166_1272_1283_Chemical)))) (VP (VBZ is) (NP (NP (DT a) (JJ strong) (NN risk) (NN factor)) (PP (IN for) (NP (NP (NNS Doc_9799166_1312_1318_Disease)) (PP (IN in) (NP (NP (DT this) (RB socioeconomically) (JJ heterogeneous)) (, ,) (NP (VBN insured) (JJ urban) (NN population)))))))) (. .)))
982002	0	(ROOT (S (VP (VB Doc_982002_0_19_Disease) (ADJP (JJ subsequent) (PP (TO to) (NP (NP (DT the) (NN administration)) (PP (IN of) (NP (NNS Doc_982002_56_66_Chemical))))))) (. .)))
982002	1	(ROOT (S (NP (NP (DT A) (NN follow-up) (NN study)) (PP (IN of) (NP (NNS cases)))) (VP (VBD reported) (ADVP (RBR earlier))) (. .)))
982002	2	(ROOT (S (NP (DT A) (JJ clinical) (NN presentation)) (VP (VBZ is) (VP (VBN made) (PP (IN of) (NP (NP (DT a) (CD 2-3) (NN year) (NN follow-up)) (PP (IN of) (NP (NP (CD six) (NNS cases)) (PP (IN of) (NP (NP (NNS Doc_982002_185_204_Disease)) (SBAR (WHNP (WDT that)) (S (VP (VBP have) (VP (VBN been) (VP (VBN reported) (ADVP (RBR earlier))))))))))))))) (. .)))
982002	3	(ROOT (S (NP (DT The) (NNS patients)) (VP (VBD had) (VP (VBN developed) (NP (JJ transient) (NNS Doc_982002_275_288_Disease)) (PP (IN after) (NP (NP (DT the) (JJ intermittent) (NN administration)) (PP (IN of) (NP (NNS Doc_982002_330_340_Chemical))))))) (. .)))
982002	4	(ROOT (S (S (NP (NP (DT The) (NN stage)) (PP (IN of) (NP (CD olig-Doc_982002_360_366_Disease)))) (VP (VBD lasted) (PP (IN for) (NP (CD 1-3) (NNS weeks))))) (, ,) (CC and) (S (NP (NP (CD five)) (PP (IN of) (NP (DT the) (NNS patients)))) (VP (VBD were) (VP (VBN treated) (PP (IN by) (NP (NNS hemodialysis)))))) (. .)))
982002	5	(ROOT (S (NP (NP (CD Two)) (PP (IN of) (NP (DT the) (NNS patients)))) (VP (VBD died) (NP (ADJP (JJ due) (TO to) (JJ unrelated)) (NNS causes)) (PP (IN during) (NP (DT the) (NN follow-up) (NN period)))) (. .)))
982002	6	(ROOT (S (NP (DT The) (ADJP (NP (CD four) (NNS patients)) (JJ re-examined))) (VP (VBD were) (ADJP (RB clinically) (JJ cured))) (. .)))
982002	7	(ROOT (S (NP (NP (JJ Pathologic) (NNS findings)) (PP (IN by) (NP (NP (JJ light) (NN microscopy) (CC and) (NN immunofluorescence)) (PP (IN at) (NP (NN biopsy)))))) (VP (VBD were) (ADJP (JJ scarce))) (. .)))
982002	8	(ROOT (S (NP (NN Nothing) (NNS abnormal)) (VP (VBD was) (VP (VBN seen) (PP (IN by) (NP (NN electron) (NN microscopy))) (PP (IN in) (NP (NP (CD two)) (PP (IN of) (NP (NP (DT the) (NNS cases)) (VP (VBN studied)))))))) (. .)))
982002	9	(ROOT (S (NP (JJ Renal) (NN function)) (VP (VBD was) (ADJP (JJ normal))) (. .)))
982002	10	(ROOT (S (PP (IN In) (NP (CD three) (NNS cases))) (NP (NP (DT the) (NN excretion)) (PP (IN at) (NP (JJ 131I-hippuran) (NN renography)))) (VP (VBD was) (VP (ADVP (RB slightly)) (VBN slowed))) (. .)))
982002	11	(ROOT (S (SBAR (IN Although) (S (PP (IN in) (NP (DT the) (JJ acute) (NN stage))) (NP (DT the) (JJ Doc_982002_876_889_Disease) (NN histologically)) (VP (VBD appeared) (ADJP (JJ toxic))))) (, ,) (NP (NP (NN evidence) (NN suggestive)) (PP (IN of) (NP (DT an) (JJ immunological) (NN mechanism)))) (VP (MD can) (RB not) (VP (VB be) (VP (VBN excluded)))) (. .)))
9848575	0	(ROOT (NP (NP (JJ Chronic) (NNS effects)) (PP (IN of) (NP (DT a) (JJ novel) (JJ synthetic) (NNS Doc_9848575_37_50_Chemical) (NN derivative))) (PRN (-LRB- -LRB-) (NP (NNP Doc_9848575_63_70_Chemical)) (-RRB- -RRB-)) (PP (IN on) (NP (NP (JJ normal) (NN heart) (CC and) (NN Doc_9848575_92_103_Chemical-induced) (NNS Doc_9848575_112_126_Disease)) (PP (IN in) (NP (JJ beagle) (NNS dogs))))) (. .)))
9848575	1	(ROOT (S (NP (DT This) (NN study)) (VP (VBD was) (VP (VBN designed) (S (VP (TO to) (VP (VB investigate) (NP (NP (DT the) (JJ chronic) (JJ Doc_9848575_194_205_Disease) (NN potential)) (PP (IN of) (NP (NP (NNS Doc_9848575_219_226_Chemical)) (CC and) (NP (NP (DT a) (JJ possible) (VBG deteriorating) (NN effect)) (PP (IN of) (NP (NP (NNS Doc_9848575_266_273_Chemical)) (PP (IN on) (NP (JJ low-grade) (NNS Doc_9848575_287_301_Disease))))) (VP (VBN pre-induced) (PP (IN by) (NP (NP (NNS Doc_9848575_317_328_Chemical)) (PP (IN in) (NP (JJ beagle) (NNS dogs))))))))))))))) (. .)))
9848575	2	(ROOT (S (PP (IN In) (NP (DT the) (JJ chronic) (NN treatment))) (, ,) (NP (NP (JJ beagle) (NNS dogs)) (PP (IN of) (NP (DT each) (NN sex)))) (VP (VBD were) (VP (VBN given) (NP (NN intravenously)) (NP (ADVP (RB once)) (NP (DT every) (CD 3) (NNS weeks)) (, ,) (CC either) (NP (NP (DT a) (JJ sublethal) (NN dose)) (PP (IN of) (NP (NP (NNS Doc_9848575_467_478_Chemical)) (PRN (-LRB- -LRB-) (NP (QP (CD 1.5) (CD mg/kg))) (-RRB- -RRB-)) (CC or) (NP (NNS Doc_9848575_494_501_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 2.5) (NN mg/kg)) (-RRB- -RRB-)))))))) (. .)))
9848575	3	(ROOT (S (NP (DT The) (NN experiment)) (VP (VBD was) (VP (VBN terminated) (NP (CD 3) (NNS weeks)) (PP (IN after) (NP (DT the) (JJ ninth) (NN dosing))))) (. .)))
9848575	4	(ROOT (S (NP (NP (NNS Animals)) (SBAR (WHNP (WDT which)) (S (VP (VBD received) (PP (IN over) (NP (NP (CD six) (NNS courses)) (PP (IN of) (NP (NNS Doc_9848575_620_631_Chemical))))))))) (VP (VBD demonstrated) (SBAR (S (NP (NP (DT the) (NN electrocardiogram)) (PRN (-LRB- -LRB-) (NP (NNP ECG)) (-RRB- -RRB-))) (VP (VBZ changes) (, ,) (NP (NP (NN decrease)) (PP (IN of) (NP (NN blood) (NN pressure) (CC and) (JJ high-grade) (NN histopathological) (NNS Doc_9848575_742_756_Disease)))) (, ,) (SBAR (IN while) (S (NP (NP (NNS animals)) (SBAR (WHNP (WDT which)) (S (VP (VBD were) (ADVP (RB terminally)) (VP (VBN sacrificed) (PP (IN after) (NP (DT the) (JJ Doc_9848575_815_822_Chemical) (NN administration)))))))) (VP (VBD did) (RB not) (VP (VB show) (NP (DT any) (NNS changes)) (PP (IN in) (NP (NP (NNP ECG)) (, ,) (NP (NN blood) (NN pressure)) (CC and) (NP (JJ histopathological) (NNS examinations)))))))))))) (. .)))
9848575	5	(ROOT (S (S (VP (TO To) (VP (VB examine) (NP (NP (DT a) (ADJP (RB possibly) (VBG deteriorating)) (JJ Doc_9848575_958_969_Disease) (NN effect)) (PP (IN of) (NP (NNS Doc_9848575_980_987_Chemical))))))) (, ,) (NP (JJ low-grade) (NNS Doc_9848575_999_1013_Disease)) (VP (VBD was) (VP (VBN induced) (PP (IN in) (NP (NNS dogs))) (PP (IN by) (NP (NP (CD four) (NNS courses)) (PP (IN of) (NP (NP (NNS Doc_9848575_1053_1064_Chemical)) (PRN (-LRB- -LRB-) (NP (QP (CD 1.5) (CD mg/kg))) (-RRB- -RRB-)))))))) (. .)))
9848575	6	(ROOT (S (PP (NP (CD Nine) (NNS weeks)) (IN after) (NP (NN pre-treatment))) (, ,) (NP (NNS dogs)) (VP (VBD were) (VP (VBN given) (NP (NP (CD four) (NNS courses)) (PP (IN of) (NP (NP (DT either) (NNS Doc_9848575_1149_1160_Chemical)) (PRN (-LRB- -LRB-) (NP (QP (CD 1.5) (CD mg/kg))) (-RRB- -RRB-)) (CC or) (NP (NNS Doc_9848575_1176_1183_Chemical)) (PRN (-LRB- -LRB-) (NP (CD 2.5) (NN mg/kg)) (-RRB- -RRB-))))) (ADVP (RB once) (NP (QP (DT every) (CD 3)) (NNS weeks))))) (. .)))
9848575	7	(ROOT (S (NP (DT The) (JJ low-grade) (JJ Doc_9848575_1230_1241_Disease) (NNS changes)) (VP (VBD were) (VP (VBN enhanced) (PP (IN by) (NP (DT the) (JJ additional) (JJ Doc_9848575_1282_1293_Chemical) (NN treatment))))) (. .)))
9848575	8	(ROOT (S (PP (IN On) (NP (DT the) (NN contrary))) (, ,) (NP (DT the) (JJ Doc_9848575_1326_1333_Chemical) (NN treatment)) (VP (VBD did) (RB not) (VP (VB progress) (NP (NP (DT the) (NN grade)) (PP (IN of) (NP (NNS Doc_9848575_1374_1388_Disease)))))) (. .)))
9848575	9	(ROOT (S (PP (IN In) (NP (NN conclusion))) (, ,) (NP (NNS Doc_9848575_1405_1412_Chemical)) (VP (VBZ does) (RB not) (VP (VB have) (NP (NP (NP (DT any) (NN potential)) (PP (IN of) (NP (JJ chronic) (NNS Doc_9848575_1452_1466_Disease)))) (CC and) (NP (NP (VBG deteriorating) (NN effect)) (PP (IN on) (NP (NN Doc_9848575_1495_1506_Chemical-induced) (NNS Doc_9848575_1515_1529_Disease))) (PP (IN in) (NP (NNS dogs))))))) (. .)))
9867728	0	(ROOT (NP (NP (NN Risk)) (PP (IN for) (NP (NP (NNS Doc_9867728_9_31_Disease)) (PP (IN among) (NP (NP (NNS users)) (PP (IN of) (NP (NNS Doc_9867728_47_59_Chemical) (CC and) (NNS Doc_9867728_64_79_Chemical))))) (SBAR (WHNP (WP who)) (S (VP (VBD underwent) (ADVP (RB echocardiography)) (PP (IN before) (NP (NP (NN use)) (PP (IN of) (NP (NN medication)))))))))) (. .)))
9867728	1	(ROOT (S (SBAR (IN Because) (S (NP (JJ uncontrolled) (JJ echocardiographic) (NNS surveys)) (VP (VBD suggested) (SBAR (IN that) (S (NP (NP (QP (IN up) (TO to) (CD 30) (NN %) (TO to) (CD 38) (NN %))) (PP (IN of) (NP (NP (NNS users)) (PP (IN of) (NP (NNS Doc_9867728_240_252_Chemical) (CC and) (NNS Doc_9867728_257_272_Chemical)))))) (VP (VBD had) (NP (NNS Doc_9867728_277_293_Disease)))))))) (, ,) (NP (DT these) (NNS drugs)) (VP (VBD were) (VP (VBN withdrawn) (PP (IN from) (NP (DT the) (NN market))))) (. .)))
9867728	2	(ROOT (S (VP (TO To) (VP (VB determine) (NP (DT the) (NN risk)) (PP (IN for) (NP (NP (JJ new)) (CC or) (NP (NP (VBG worsening) (NNS Doc_9867728_393_415_Disease)) (PP (IN among) (NP (NP (NNS users)) (PP (IN of) (NP (NNS Doc_9867728_431_443_Chemical) (CC or) (NNS Doc_9867728_447_462_Chemical))))) (SBAR (WHNP (WP who)) (S (VP (VBD underwent) (ADVP (RB echocardiography)) (SBAR (IN before) (S (NP (PRP they)) (VP (VBD began) (S (VP (TO to) (VP (VB take) (NP (DT these) (NNS medications)))))))))))))))) (. .)))
9867728	3	(ROOT (S (NP (NNP Cohort)) (VP (VBP study)) (. .)))
9867728	4	(ROOT (S (VP (VB Academic) (NP (JJ primary) (NN care) (NNS practices))) (. .)))
9867728	5	(ROOT (S (NP (NP (CD 46) (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VP (VBD used) (NP (NNS Doc_9867728_634_646_Chemical) (CC or) (NNS Doc_9867728_650_665_Chemical)) (PP (IN for) (NP (CD 14) (NNS days) (QP (CC or) (JJR more))))) (CC and) (VP (VBD had) (NP (NNS echocardiograms))))))) (VP (VBD obtained) (PP (IN before) (NP (NN therapy)))) (. .)))
9867728	6	(ROOT (NP (JJ Follow-up) (NN echocardiography) (. .)))
9867728	7	(ROOT (S (NP (DT The) (JJ primary) (NN outcome)) (VP (VBD was) (NP (NP (NP (JJ new)) (CC or) (NP (VBG worsening) (NN valvulopathy))) (, ,) (VP (VBN defined) (PP (IN as) (NP (NP (NN progression)) (PP (IN of) (NP (DT either) (NNS Doc_9867728_865_895_Disease))))) (PP (IN by) (NP (NP (QP (IN at) (JJS least) (CD one)) (NN degree)) (PP (IN of) (NP (NP (NN severity) (CC and) (NN disease)) (SBAR (WHNP (WDT that)) (S (VP (VBD met) (NP (NNP U.S.) (NNP Food) (CC and) (NNP Drug) (NNP Administration) (NNS criteria))))))) (PRN (-LRB- -LRB-) (ADVP (IN at) (JJS least)) (NP (NP (JJ mild) (NNS Doc_9867728_1010_1030_Disease)) (CC or) (NP (JJ moderate) (NNS Doc_9867728_1043_1063_Disease))) (-RRB- -RRB-))))))) (. .)))
9867728	8	(ROOT (S (NP (NP (NP (CD Two) (NNS patients)) (PRN (-LRB- -LRB-) (NP (NP (CD 4.3) (NN %)) (VP (VBN -LSB-) (NP (NP (ADJP (CD 95) (NN %)) (NNP CI)) (, ,) (ADJP (NP (CD 0.6) (NN %) (TO to) (CD 14.8) (NN %)) (JJ -RSB-))))) (-RRB- -RRB-))) (VP (VBG receiving) (NP (NNS Doc_9867728_1129_1141_Chemical-Doc_9867728_1142_1153_Chemical)))) (VP (VBD developed) (NP (NNS Doc_9867728_1164_1186_Disease))) (. .)))
9867728	9	(ROOT (S (NP (PRP One)) (VP (VBD had) (NP (NP (NN baseline) (NNS Doc_9867728_1205_1226_Disease)) (CC and) (NP (NP (JJ mild) (NNS Doc_9867728_1236_1256_Disease)) (SBAR (WHNP (WDT that)) (S (VP (VBD progressed) (PP (TO to) (NP (JJ moderate) (NN regurgitation))))))))) (. .)))
9867728	10	(ROOT (S (NP (DT The) (JJ second) (NN patient)) (VP (VBD developed) (NP (JJ new) (JJ moderate) (NNS Doc_9867728_1342_1362_Disease))) (. .)))
9867728	11	(ROOT (S (NP (NP (NNS Users)) (PP (IN of) (NP (NN diet) (NNS medications)))) (VP (VBP are) (PP (IN at) (NP (NP (NN risk)) (PP (IN for) (NP (NNS Doc_9867728_1418_1440_Disease)))))) (. .)))
9867728	12	(ROOT (S (ADVP (RB However)) (, ,) (NP (DT the) (NN incidence)) (VP (MD may) (VP (VB be) (ADJP (ADJP (JJR lower)) (SBAR (IN than) (S (NP (DT that)) (VP (VBD reported) (ADVP (RB previously)))))))) (. .)))
9875685	0	(ROOT (NP (NP (NP (JJ Therapeutic) (NN drug) (NN monitoring)) (PP (IN of) (NP (NNS Doc_9875685_31_41_Chemical)))) (: :) (NP (NP (NN once-daily)) (PP (IN versus) (NP (JJ twice-daily) (NN dosage) (NNS schedules)))) (. .)))
9875685	1	(ROOT (S (VP (TO To) (VP (VB evaluate) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (NP (NP (NN dosage) (NN regimen)) (PRN (-LRB- -LRB-) (NP (NP (NN once-daily)) (CC vs.) (NP (JJ twice-daily))) (-RRB- -RRB-))) (PP (IN of) (NP (NP (NNS Doc_9875685_175_185_Chemical)) (PP (IN on) (NP (JJ steady-state) (NN serum) (NNS concentrations) (CC and) (NNS Doc_9875685_227_235_Disease)))))))))) (. .)))
9875685	2	(ROOT (S (NP (NP (NP (NNP MATERIALS) (CC AND) (NNP METHODS)) (: :) (NP (NP (NNS Patients)) (VP (VBG undergoing) (NP (NN treatment)) (PP (IN with) (NP (NN i.v.) (NNS Doc_9875685_300_310_Chemical)))))) (PRN (-LRB- -LRB-) (NP (CD 4) (NN mg/kg/day)) (-RRB- -RRB-))) (VP (VBD were) (VP (VBN randomised) (PP (TO to) (NP (CD two) (NNS groups))))) (. .)))
9875685	3	(ROOT (S (NP (NP (NNP Group) (NNP OD)) (PRN (-LRB- -LRB-) (VP (VBN n) (S (VP (SYM =) (NP (CD 22))))) (-RRB- -RRB-))) (VP (VBD received) (SBAR (S (NP (NP (NP (DT a) (JJ once-daily) (NN dose)) (PP (IN of) (NP (NNS Doc_9875685_404_414_Chemical) (CC and) (NN group) (NN TD)))) (PRN (-LRB- -LRB-) (VP (VBN n) (S (VP (SYM =) (NP (CD 21))))) (-RRB- -RRB-))) (VP (VBD received) (NP (NP (DT the) (JJ same) (NN dose)) (VP (VBN divided) (PP (IN into) (NP (CD two) (NNS doses))) (ADVP (RB daily)))))))) (. .)))
9875685	4	(ROOT (S (NP (NP (JJ Doc_9875685_490_500_Chemical) (NN serum) (NNS concentrations)) (PRN (-LRB- -LRB-) (NP (NP (NN peak)) (CC and) (NP (NN trough))) (-RRB- -RRB-))) (VP (VBD were) (VP (VBN measured) (PP (IN by) (NP (NP (NN enzyme)) (VP (VBN multiplied) (ADVP (RB immunoassay))))))) (. .)))
9875685	5	(ROOT (S (NP (NP (DT The) (JJ renal) (CC and) (JJ auditory) (NNS functions)) (PP (IN of) (NP (DT the) (NNS patients)))) (VP (VBD were) (ADJP (VBN monitored) (PP (PP (IN before)) (, ,) (PP (IN during)) (CC and) (ADVP (RB immediately)) (PP (IN after) (NP (NN treatment)))))) (. .)))
9875685	6	(ROOT (S (NP (DT The) (CD two) (NNS groups)) (VP (VBD were) (ADJP (JJ comparable) (PP (IN with) (NP (NN respect)))) (PP (TO to) (NP (NP (NN sex)) (, ,) (NP (NN age)) (, ,) (NP (NN body) (NN weight)) (CC and) (NP (JJ renal) (NN function))))) (. .)))
9875685	7	(ROOT (S (NP (DT No) (ADJP (RB statistically) (JJ significant)) (NNS differences)) (VP (VBD were) (VP (VBN found) (PP (IN in) (NP (NP (JJ mean) (JJ daily) (NN dose)) (, ,) (NP (NP (NN duration)) (PP (IN of) (NP (NN treatment)))) (, ,) (CC or) (NP (JJ cumulative) (NN dose)))))) (. .)))
9875685	8	(ROOT (S (NP (JJ Trough) (NNS concentrations)) (VP (VBD were) (VP (VBG <) (NP (NP (CD 2) (NN g/ml)) (PP (IN in) (NP (NP (DT the) (CD two) (NNS groups)) (PRN (-LRB- -LRB-) (NP (CD 100) (NN %)) (-RRB- -RRB-))))))) (. .)))
9875685	9	(ROOT (S (NP (NNP Peak) (NNS concentrations)) (VP (VBD were) (VP (VBN >) (S (ADJP (CD 6) (JJ microg/ml))) (PP (PP (IN in) (NP (NP (CD 100) (NN %)) (PP (IN of) (NP (DT the) (NNP OD) (NN group))))) (CC and) (PP (IN in) (NP (NP (CD 67) (NN %)) (PP (IN of) (NP (NP (DT the) (NNP TD) (NN group)) (PRN (-LRB- -LRB-) (NP (NNP P) (NNP <) (NNP 0.01)) (-RRB- -RRB-))))))))) (. .)))
9875685	10	(ROOT (FRAG (S (NP (NNP Mean) (NN peak) (NNS concentrations)) (VP (VBD were) (ADJP (RB markedly) (JJ different)))) (: :) (FRAG (NP (CD 11.00) (CD +)) (: /) (NP (NP (CD -2.89) (NN microg/ml)) (PP (IN in) (NP (NNP OD))) (PP (IN vs.) (NP (CD 6.53) (NNS +)))) (: /) (VP (VBN -1.45) (ADJP (JJ microg/ml)) (PP (IN in) (NP (NP (NNP TD)) (PRN (-LRB- -LRB-) (NP (NNP P) (NNP <) (NNP 0.01)) (-RRB- -RRB-)))))) (. .)))
9875685	11	(ROOT (S (NP (DT The) (JJ pharmacokinetics) (NNS parameters)) (VP (VP (VBD were)) (: :) (VP (VBD Ke) (NP (NP (PRN (, ,) (FRAG (-LRB- -LRB-) (NP (CD 0.15) (CD +)) (: /) (NP (NP (CD -0.03) (JJ /) (NN h)) (PP (IN in) (NP (NP (NNP OD) (CC vs.) (NNP 0.24) (NNP +) (PRN (: /) (NP (CD -0.06)) (: /)) (NN h)) (PP (IN in) (NP (NNP TD)))))) (-RRB- -RRB-)) (, ,)) (NNS t1/2)) (PRN (, ,) (FRAG (-LRB- -LRB-) (NP (CD 4.95) (CD +)) (: /) (NP (NP (CD -1.41) (NN h)) (PP (IN in) (NP (NNP OD))) (PP (IN vs.) (NP (NP (QP (CD 3.07) (CD +))) (PRN (: /) (NP (NP (CD -0.71) (NN h)) (PP (IN in) (NP (NNP TD)))))))) (-RRB- -RRB-)) (, ,)))) (ADJP (ADJP (JJ Vd)) (PRN (-LRB- -LRB-) (FRAG (NP (CD 0.35) (CD +)) (: /) (NP (NP (CD -0.11) (NN l/kg)) (PP (IN in) (NP (NNP OD))) (PP (IN vs.) (NP (CD 0.33) (NNS +)))) (: /) (VP (VBN -0.09) (S (VP (VBG l/kg) (PP (IN in) (NP (NNP TD))))))) (-RRB- -RRB-)) (, ,) (ADJP (JJ Doc_9875685_1396_1398_Chemical)) (PRN (-LRB- -LRB-) (FRAG (NP (CD 0.86) (CD +)) (: /) (NP (NP (CD -0.29) (NN ml/min/kg)) (PP (IN in) (NP (NNP OD))) (PP (IN vs.) (NP (CD 1.28) (NNS +)))) (: /) (VP (VBN -0.33) (S (VP (VBG ml/min/kg) (PP (IN in) (NP (NNP TD))))))) (-RRB- -RRB-)))) (. .)))
9875685	12	(ROOT (S (NP (VBN Increased) (NN serum) (NNS Doc_9875685_1478_1488_Chemical)) (VP (VBD was) (VP (VBN observed) (PP (IN in) (NP (NP (CD 73) (NN %)) (PP (IN of) (NP (NP (NNS patients)) (PP (IN in) (NP (NNP OD))))))) (PP (FW versus) (NP (NP (CD 57) (NN %)) (PP (IN of) (NP (NP (NNS patients)) (PP (IN in) (NP (NNP TD))))))) (, ,) (PP (IN without) (NP (NP (NN evidence)) (PP (IN of) (NP (NN nephrotoxicity))))))) (. .)))
9875685	13	(ROOT (S (PP (IN In) (NP (NNP TD) (NN group))) (, ,) (NP (CD three) (NNS patients)) (VP (VBD developed) (NP (NP (NNS Doc_9875685_1631_1658_Disease)) (, ,) (SBAR (WHPP (IN of) (WHNP (WDT which))) (S (NP (PRP one)) (VP (VBD presented) (PP (IN with) (NP (NP (DT an) (NNS Doc_9875685_1691_1704_Disease)) (PP (IN of) (NP (CD -30) (NN dB))))) (, ,) (SBAR (IN whereas) (S (PP (IN in) (NP (DT the) (NNP OD) (NN group))) (NP (RB only) (CD one) (NN patient)) (VP (VBD presented) (NP (NNS Doc_9875685_1767_1794_Disease)))))))))) (. .)))
9875685	14	(ROOT (S (NP (DT This) (JJ small) (NN study)) (VP (VBZ suggests) (SBAR (IN that) (S (NP (NP (DT a) (JJ once-daily) (NN dosing) (NN regimen)) (PP (IN of) (NP (NNS Doc_9875685_1870_1880_Chemical)))) (VP (VP (VBZ is) (ADVP (IN at) (JJS least)) (ADJP (RB as) (JJ effective) (RB as))) (CC and) (VP (VBZ is) (ADJP (ADJP (RB no) (JJR more)) (CC and) (ADJP (RB possibly) (RBR less) (JJ toxic))) (PP (IN than) (NP (DT the) (JJ twice-daily) (NN regimen)))))))) (. .)))
9875685	15	(ROOT (S (S (VP (VBG Using) (NP (DT a) (JJ single-dose) (NN therapy)))) (, ,) (NP (JJ peak) (NN concentration) (NN determination)) (VP (VBZ is) (RB not) (ADJP (JJ necessary)) (, ,) (SBAR (RB only) (S (NP (NN trough) (NNS samples)) (VP (MD should) (VP (VB be) (VP (VBN monitored) (S (VP (TO to) (VP (VB ensure) (NP (NNS levels)) (PP (IN below) (NP (CD 2) (NN microg/ml)))))))))))) (. .)))
9915601	0	(ROOT (S (NP (NP (JJ Enhanced) (NNS Doc_9915601_9_20_Disease)) (VP (VBN induced) (PP (IN by) (NP (NP (JJ beta-adrenoceptor) (NNS antagonists)) (PP (IN in) (NP (NNS rats))))))) (VP (VBD pretreated) (PP (IN with) (NP (NNS Doc_9915601_86_95_Chemical)))) (. .)))
9915601	1	(ROOT (S (S (NP (NP (JJ High) (NNS doses)) (PP (IN of) (NP (JJ Doc_9915601_111_120_Chemical) (NN increase) (NNS Doc_9915601_130_141_Disease)))) (VP (VBN induced) (PP (IN by) (NP (NNS vasodilators) (CC and) (NN change))) (NP (NP (DT the) (VBG accompanying) (JJ reflex) (NNS Doc_9915601_201_212_Disease)) (PP (TO to) (NP (NNS Doc_9915601_216_227_Disease)))))) (, ,) (NP (DT an) (NN interaction)) (VP (VBD attributed) (PP (TO to) (NP (NP (VBN decreased) (NN synthesis)) (PP (IN of) (NP (NP (NN brain) (NNS Doc_9915601_287_310_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_9915601_312_316_Chemical)) (-RRB- -RRB-))))))) (. .)))
9915601	2	(ROOT (S (PP (IN In) (NP (DT the) (JJ present) (NN study))) (, ,) (NP (NP (DT the) (JJ possible) (NN enhancement)) (PP (IN by) (NP (NP (NNS Doc_9915601_369_378_Chemical)) (PP (IN of) (NP (NP (NNS Doc_9915601_382_393_Disease)) (VP (VBN induced) (PP (IN by) (NP (JJ beta-adrenoceptor) (NNS antagonists))))))))) (VP (VBD was) (VP (VBN determined) (PP (IN in) (NP (NP (NNS rats)) (VP (VBN anaesthetised) (PP (IN with) (NP (NNS Doc_9915601_477_487_Chemical-Doc_9915601_488_496_Chemical)))))))) (. .)))
9915601	3	(ROOT (S (NP (NNP Doc_9915601_498_507_Chemical)) (ADVP (RB significantly)) (VP (VBD increased) (NP (NNS Doc_9915601_532_543_Disease)) (PP (IN after) (NP (NNS Doc_9915601_550_561_Chemical) (, ,) (NNS Doc_9915601_563_571_Chemical) (, ,) (NNS Doc_9915601_573_582_Chemical) (CC and) (NNS Doc_9915601_587_595_Chemical))) (, ,) (PP (CONJP (RB as) (RB well) (IN as)) (PP (IN after) (NP (NNS Doc_9915601_614_623_Chemical))) (, ,) (CONJP (CC but) (RB not)) (PP (IN after) (NP (NNS Doc_9915601_639_652_Chemical) (CC or) (NNS Doc_9915601_656_665_Chemical))))) (. .)))
9915601	4	(ROOT (S (NP (NNP Enhancement)) (VP (VBD was) (RB not) (ADJP (ADJP (JJ observed) (PP (IN in) (NP (NP (NNS rats)) (VP (VBN pretreated) (PP (IN with) (NP (NNS Doc_9915601_720_734_Chemical))))))) (CC or) (ADJP (RB previously) (JJ vagotomised)))) (. .)))
9915601	5	(ROOT (S (NP (DT These) (NNS results)) (VP (VBP are) (ADJP (JJ compatible) (PP (IN with) (NP (NN interference)))) (PP (IN by) (NP (NP (NNS Doc_9915601_812_821_Chemical)) (PP (IN with) (NP (NP (JJ GABAergic) (NN inhibition)) (PP (IN of) (NP (JJ cardiac) (JJ parasympathetic) (NN tone)))))))) (. .)))
9915601	6	(ROOT (S (NP (JJ Such) (NN interference)) (VP (MD could) (VP (VB be) (VP (VBN exerted) (ADVP (RB centrally)) (, ,) (ADVP (RB possibly)) (PP (PP (IN at) (NP (DT the) (NN nucleus) (NNS ambiguus))) (, ,) (CC or) (ADVP (RB peripherally)) (PP (IN at) (NP (DT the) (JJ sinus) (NN node))))))) (. .)))
9952311	0	(ROOT (NP (NP (NP (NNP Doc_9952311_0_52_Disease)) (PP (IN in) (NP (NP (NN Doc_9952311_56_66_Chemical-induced) (NNS Doc_9952311_75_89_Disease)) (PP (IN in) (NP (NNS mice)))))) (: :) (NP (NP (NN suppression)) (PP (IN of) (NP (NN cytochrome)) (X (X (SYM c)) (NP (NNP oxidase) (NNP II) (NN gene) (NN expression))))) (. .)))
9952311	1	(ROOT (S (NP (NP (DT The) (NN use)) (PP (IN of) (NP (NP (NP (NNS Doc_9952311_166_176_Chemical)) (PRN (-LRB- -LRB-) (NP (NNP Doc_9952311_178_181_Chemical)) (-RRB- -RRB-))) (PP (IN in) (NP (NNS Doc_9952311_186_192_Disease)))))) (ADVP (RB chemotherapy)) (VP (VBZ has) (VP (VBN been) (VP (VBN limited) (S (ADJP (JJ due) (PP (TO to) (NP (PRP$ its) (JJ cumulative) (NNS Doc_9952311_245_268_Disease)))))))) (. .)))
9952311	2	(ROOT (S (NP (NP (JJR Earlier) (NNS observations)) (SBAR (IN that) (S (NP (NNS Doc_9952311_296_299_Chemical)) (VP (VP (VBZ interacts) (PP (IN with) (NP (NP (JJ mitochondrial) (JJ cytochrome) (NN c) (NN oxidase)) (PRN (-LRB- -LRB-) (NP (NNP COX)) (-RRB- -RRB-))))) (CC and) (VP (VBZ suppresses) (NP (PRP$ its) (JJ enzyme) (NN activity))))))) (VP (VBD led) (S (NP (PRP us)) (VP (TO to) (VP (VB investigate) (NP (NP (NNP ADR) (POS 's)) (NN action)) (PP (IN on) (NP (NP (DT the) (JJ cardiovascular) (NNS functions) (CC and) (NN heart) (NN mitochondrial) (NN morphology)) (PP (IN in) (NP (NP (NNP Balb-c) (NNP mice) (NNP i.p.)) (VP (VBN treated) (PP (IN with) (NP (NP (NNS Doc_9952311_526_529_Chemical)) (PP (IN for) (NP (JJ several) (NNS weeks)))))))))))))) (. .)))
9952311	3	(ROOT (S (PP (IN At) (NP (NP (JJ various) (NNS times)) (PP (IN during) (NP (NN treatment))))) (, ,) (NP (DT the) (NNS animals)) (VP (VBD were) (VP (VBN assessed) (PP (IN for) (NP (JJ cardiovascular) (NNS functions))) (PP (IN by) (NP (UCP (ADVP (RB electrocardiography)) (CC and) (PP (IN for) (NP (NN heart)))) (NN tissue) (NN damage))) (PP (IN by) (NP (NN electron) (NN microscopy))))) (. .)))
9952311	4	(ROOT (S (PP (IN In) (NP (NN parallel))) (, ,) (NP (JJ total) (NNS RNA)) (VP (VBD was) (VP (VP (VBN extracted) (PP (IN from) (NP (NP (NNS samples)) (PP (IN of) (NP (JJ dissected) (NN heart)))))) (CC and) (VP (VBN analyzed) (PP (IN by) (NP (JJ Northern) (NN blot) (NN hybridization))) (S (VP (TO to) (VP (VB determine) (NP (NP (DT the) (JJ steady-state) (NN level)) (PP (IN of) (NP (NP (CD three) (NNP RNA) (NNS transcripts)) (VP (VBN encoded) (PP (IN by) (NP (DT the) (NNP COXII) (, ,) (NNP COXIII) (, ,) (CC and) (NNP COXIV) (NNS genes))))))))))))) (. .)))
9952311	5	(ROOT (S (ADVP (RB Similarly)) (, ,) (NP (NP (NNS samples)) (VP (VBN obtained) (PP (IN from) (NP (NP (DT the) (NN liver)) (PP (IN of) (NP (DT the) (JJ same) (NNS animals))))))) (VP (VBD were) (VP (VBN analyzed) (PP (IN for) (NP (JJ comparative) (NNS studies))))) (. .)))
9952311	6	(ROOT (S (S (NP (PRP$ Our) (NNS results)) (VP (VBD indicated) (SBAR (IN that) (S (NP (NP (LST (LS 1) (-RRB- -RRB-)) (NP (NN treatment)) (PP (IN of) (NP (NNS mice)))) (PP (IN with) (NP (NNS Doc_9952311_1090_1093_Chemical)))) (VP (VBD caused) (SBAR (S (NP (NNS Doc_9952311_1101_1127_Disease)) (VP (VBD characterized) (PP (IN by) (NP (NP (NNS Doc_9952311_1145_1156_Disease)) (, ,) (NP (NP (NN extension)) (PP (IN of) (NP (NP (NP (NN ventricular) (NN depolarization) (NN time)) (PRN (-LRB- -LRB-) (NP (NNS tQRS)) (-RRB- -RRB-))) (, ,) (CC and) (NP (NP (NN failure)) (PP (IN of) (NP (NNP QRS))))))))) (PP (IN at) (NP (JJ high) (NNS concentrations))) (PRN (-LRB- -LRB-) (NP (NP (CD 10-14) (JJ mg/kg) (NN body) (NN weight)) (NP (JJ cumulative) (NN dose))) (-RRB- -RRB-)))))))))) (: ;) (S (LST (LS 2) (-RRB- -RRB-)) (NP (DT the) (NN heart) (NN mitochondria)) (VP (VBD underwent) (NP (NP (JJ Doc_9952311_1332_1340_Disease) (, ,) (NN fusion) (, ,) (NN dissolution) (, ,) (JJ and/or) (NN disruption)) (PP (IN of) (NP (JJ mitochondrial) (NN cristae)))) (PP (IN after) (NP (NP (JJ several) (NNS weeks)) (PP (IN of) (NP (NN treatment))))))) (. .)))
9952311	7	(ROOT (S (S (NP (JJ Such) (NNS abnormalities)) (VP (VBD were) (RB not) (VP (VBN observed) (PP (IN in) (NP (NP (DT the) (NN mitochondria)) (PP (IN of) (NP (NN liver) (NN tissue)))))))) (: ;) (CC and) (S (LST (LS 3) (-RRB- -RRB-)) (SBAR (PP (IN among) (NP (NP (DT the) (CD three) (NNS genes)) (PP (IN of) (NP (NNP COX) (NN enzyme))))) (S (VP (VBD examined)))) (, ,) (NP (JJ only) (NN COXII) (NN gene) (NN expression)) (VP (VBD was) (VP (VBN suppressed) (PP (IN by) (NP (JJ Doc_9952311_1612_1615_Chemical) (NN treatment))) (, ,) (ADVP (RB mainly)) (PP (IN after) (NP (NP (CD 8) (NNS weeks)) (PP (IN in) (NP (DT both) (NN heart) (CC and) (NN liver)))))))) (. .)))
9952311	8	(ROOT (S (S (VP (VBG Knowing) (SBAR (IN that) (S (NP (NN heart) (NN mitochondria)) (VP (VBP represent) (NP (NP (QP (RB almost) (CD 40)) (NN %)) (PP (IN of) (NP (NN heart) (NN muscle)))) (PP (IN by) (NP (NN weight)))))))) (, ,) (NP (PRP we)) (VP (VBP conclude) (SBAR (IN that) (S (NP (NP (DT the) (VBG deteriorating) (NNS effects)) (PP (IN of) (NP (NP (NNS Doc_9952311_1799_1802_Chemical)) (PP (IN on) (NP (JJ cardiovascular) (NN function)))))) (VP (VBP involve) (NP (NNS Doc_9952311_1838_1888_Disease)))))) (. .)))
